New	O
complexities	O
in	O
helper	O
T	O
Cell	O
fate	O
determination	O
and	O
the	O
implications	O
for	O
autoimmune	O
diseases	O

Abstract	O

Recently	O
,	O
new	O
complexities	O
in	O
cell	O
fate	O
decision	O
for	O
helper	O
T	O
cells	O
have	O
emerged	O
.	O

One	O
new	O
lineage	O
,	O
which	O
has	O
come	O
to	O
be	O
called	O
Th17	O
cells	O
,	O
selectively	O
produces	O
proinflammatory	O
cytokines	O
including	O
interleukin-17	O
(	O
IL-17	O
,	O
A	O
and	O
F	O
)	O
,	O
IL-21	O
,	O
and	O
IL-22	O
.	O

In	O
conjunction	O
with	O
transforming	O
growth	O
factor	O
ß-1	O
(	O
TGFß-1	O
)	O
,	O
IL-6	O
,	O
IL-21	O
,	O
and	O
IL-23	O
,	O
which	O
activate	O
the	O
transcription	O
factor	O
,	O
signal	O
transducer	O
,	O
and	O
activator	O
of	O
transcription	O
3	O
(	O
Stat3	O
)	O
,	O
the	O
expression	O
of	O
another	O
transcription	O
factor	O
,	O
retinoic	O
acid-related	O
orphan	O
receptor-γt	O
(	O
RORγt	O
)	O
leads	O
to	O
the	O
differentiation	O
of	O
Th17	O
cells	O
in	O
mice	O
.	O

Other	O
cytokines	O
including	O
IL-2	O
,	O
IL-4	O
,	O
interferon-γ	O
(	O
IFN-γ	O
)	O
and	O
IL-27	O
inhibit	O
Th17	O
differentiation	O
.	O

However	O
,	O
IL-2	O
acting	O
with	O
TGFß-1	O
induces	O
differentiation	O
of	O
naive	O
CD4+	O
T	O
cells	O
to	O
become	O
regulatory	O
T	O
cells	O
(	O
Tregs	O
)	O
.	O

Th17	O
cells	O
are	O
now	O
known	O
to	O
play	O
an	O
important	O
role	O
not	O
only	O
in	O
the	O
pathogenesis	O
of	O
inflammation	O
and	O
autoimmune	O
diseases	O
,	O
but	O
also	O
host	O
defense	O
against	O
extracellular	O
bacteria	O
.	O

Conversely	O
,	O
extensive	O
data	O
substantiate	O
the	O
role	O
of	O
Tregs	O
as	O
essential	O
in	O
maintenance	O
of	O
peripheral	O
tolerance	O
.	O

Selectively	C
targeting	C
Tregs	C
and	C
Th17	C
cells	C
are	C
likely	C
to	C
be	C
important	C
strategies	C
in	C
the	C
treatment	C
of	C
inflammatory	C
and	C
autoimmune	C
diseases	C
in	C
humans	C
.	C

Keywords	O
:	O
Th17	O
cells	O
,	O
autoimmune	O
diseases	O
,	O
inflammation	O
,	O
IL-17	O
,	O
Rheumatoid	O
arthritis	O

Introduction	O

It	O
is	O
well-established	O
that	O
the	O
innate	O
immune	O
response	O
leads	O
to	O
activation	O
of	O
adaptive	O
immunity	O
,	O
shaping	O
the	O
proper	O
response	O
,	O
depending	O
upon	O
the	O
pathogen	O
eliciting	O
the	O
reaction	O
.	O

Conversely	O
,	O
though	O
,	O
it	O
is	O
also	O
clear	O
that	O
adaptive	O
immune	O
response	O
,	O
especially	O
,	O
CD4+	O
or	O
helper	O
T	O
cells	O
orchestrate	O
responses	O
to	O
effectively	O
eliminate	O
pathogens	O
.	O

Classically	O
,	O
helper	O
T	O
cells	O
were	O
considered	O
to	O
differentiate	O
into	O
two	O
lineages	O
,	O
T	O
helper	O
1	O
(	O
Th1	O
)	O
cells	O
or	O
Th2	O
cells	O
(	O
1	O
)	O
.	O

In	O
addition	O
to	O
ligation	O
of	O
the	O
T-cell	O
receptor	O
(	O
TCR	O
)	O
and	O
co-stimulatory	O
receptors	O
,	O
a	O
suitable	O
cytokine	O
milieu	O
is	O
required	O
for	O
fate	O
decision	O
of	O
helper	O
T	O
cells	O
(	O
1	O
)	O
.	O

In	O
particular	O
,	O
interleukin-12	O
(	O
IL-12	O
)	O
,	O
which	O
is	O
produced	O
by	O
activated	O
antigen-presenting	O
cells	O
(	O
APCs	O
)	O
,	O
promotes	O
Th1	O
differentiation	O
(	O
2	O
)	O
,	O
whereas	O
IL-4	O
,	O
produced	O
by	O
activated	O
T	O
cells	O
and	O
some	O
innate	O
immune	O
cells	O
,	O
drives	O
Th2	O
differentiation	O
(	O
1	O
)	O
.	O

While	O
the	O
Th1/Th2	O
paradigm	O
provided	O
invaluable	O
insights	O
for	O
immunologists	O
,	O
its	O
limitations	O
were	O
also	O
clear	O
.	O

What	O
was	O
the	O
most	O
obvious	O
was	O
the	O
inability	O
of	O
this	O
dichotomy	O
to	O
explain	O
autoimmune	O
diseases	O
.	O

More	O
recent	O
studies	O
have	O
shown	O
the	O
existence	O
of	O
the	O
additional	O
subpopulations	O
of	O
T	O
helper	O
cells	O
that	O
are	O
also	O
important	O
in	O
immunoregulation	O
and	O
host	O
defense	O
.	O

One	O
important	O
subset	O
is	O
CD4+CD25+	O
,	O
regulatory	O
T	O
cells	O
(	O
Tregs	O
)	O
(	O
3	O
,	O
4	O
)	O
.	O

Tregs	O
suppress	O
the	O
proliferation	O
and	O
function	O
of	O
effector	O
T	O
cells	O
,	O
and	O
attenuate	O
immune	O
responses	O
against	O
self	O
or	O
nonself-antigens	O
(	O
3	O
,	O
4	O
)	O
.	O

Another	O
recently	O
identified	O
new	O
fate	O
of	O
T	O
cells	O
is	O
Th17	O
cells	O
that	O
selectively	O
produce	O
IL-17	O
(	O
A	O
and	O
F	O
)	O
(	O
5	O
,	O
6	O
)	O
.	O

In	O
the	O
past	O
three	O
years	O
,	O
discoveries	O
pertaining	O
to	O
this	O
newly	O
identified	O
T	O
helper	O
subset	O
in	O
humans	O
and	O
mice	O
have	O
accumulated	O
with	O
tremendous	O
speed	O
(	O
7-10	O
)	O
.	O

It	C
is	C
also	C
clear	C
that	C
the	C
notion	C
of	C
a	C
single	C
type	C
of	C
Th17	C
cell	C
may	C
not	C
be	C
correct	C
,	C
as	C
there	C
seems	C
to	C
be	C
further	C
complexity	C
in	C
terms	C
of	C
the	C
cytokines	C
produced	C
by	C
these	C
cells	C
.	C

In	O
this	O
review	O
,	O
we	O
will	O
discuss	O
the	O
historical	O
developments	O
that	O
led	O
to	O
a	O
new	O
understanding	O
of	O
the	O
role	O
of	O
T	O
cells	O
in	O
autoimmune	O
diseases	O
and	O
recent	O
advances	O
that	O
have	O
led	O
to	O
even	O
newer	O
insights	O
into	O
T	O
cell	O
biology	O
.	O

Pathogenicity	O
of	O
IL-23	O
,	O
but	O
not	O
IL-12	O
in	O
autoimmune	O
diseases	O

Until	C
a	C
few	C
years	C
ago	C
we	C
thought	C
we	C
knew	C
which	C
subset	C
of	C
helper	C
T	C
cells	C
was	C
responsible	C
for	C
host	C
defense	C
or	C
exacerbation	C
of	C
autoimmune	C
diseases	C
and	C
we	C
thought	C
that	C
answer	C
fit	C
well	C
with	C
the	C
standard	C
Th1/Th2	C
cells	C
paradigm	C
(	C
11	C
)	C
.	C

Th1	O
cells	O
produce	O
interferon-γ	O
(	O
IFN-γ	O
)	O
and	O
lymphotoxin	O
,	O
and	O
are	O
responsible	O
for	O
protection	O
against	O
intracellular	O
pathogens	O
such	O
as	O
viruses	O
,	O
mycobacteria	O
,	O
and	O
protozoa	O
(	O
11	O
)	O
.	O

Produced	O
by	O
activated	O
APCs	O
,	O
IL-12	O
activates	O
the	O
transcription	O
factor	O
,	O
signal	O
transducer	O
,	O
and	O
activator	O
of	O
transcription	O
4	O
(	O
Stat4	O
)	O
(	O
2	O
)	O
.	O

Stat4-dependent	O
signaling	O
in	O
conjunction	O
with	O
TCR-dependent	O
signals	O
induces	O
the	O
expression	O
of	O
T-box-expressed-in-T-cells	O
(	O
T-bet	O
)	O
,	O
the	O
so-called	O
master	O
regulator	O
of	O
Th1	O
differentiation	O
(	O
2	O
)	O
.	O

Recently	O
,	O
in	O
humans	O
,	O
it	O
has	O
been	O
shown	O
that	O
STAT4	O
polymorphisms	O
are	O
associated	O
with	O
rheumatoid	O
arthritis	O
(	O
RA	O
)	O
and	O
systemic	O
lupus	O
erythematosus	O
(	O
SLE	O
)	O
(	O
12	O
)	O
.	O

IFN-γ	O
also	O
activates	O
Stat1	O
which	O
further	O
induces	O
T-bet	O
to	O
form	O
an	O
autocrine	O
feedback	O
loop	O
for	O
IFN-γ	O
production	O
(	O
2	O
)	O
.	O

T-bet	O
promotes	O
not	O
only	O
IFN-γ	O
production	O
but	O
also	O
suppression	O
of	O
Th2	O
cytokines	O
production	O
by	O
T	O
cells	O
(	O
2	O
)	O
.	O

On	O
the	O
other	O
hand	O
,	O
Th2	O
cells	O
produce	O
IL-4	O
,	O
IL-5	O
,	O
and	O
IL-13	O
(	O
1	O
)	O
.	O

IL-4	O
activates	O
Stat6	O
,	O
which	O
up-regulates	O
the	O
expression	O
of	O
GATA-binding	O
protein	O
3	O
(	O
GATA-3	O
)	O
(	O
1	O
)	O
.	O

Th2	O
cytokines	O
are	O
potent	O
activators	O
of	O
B-cell	O
Immunoglobulin	O
E	O
production	O
,	O
eosinophil	O
recruitment	O
,	O
and	O
mucosal	O
expulsion	O
mechanisms	O
,	O
and	O
are	O
essential	O
for	O
promoting	O
host	O
defense	O
against	O
helminths	O
and	O
other	O
parasites	O
(	O
1	O
)	O
.	O

In	O
addition	O
,	O
Th2	O
cells	O
have	O
been	O
shown	O
to	O
mediate	O
allergic	O
diseases	O
such	O
as	O
asthma	O
,	O
rhinitis	O
,	O
and	O
atopic	O
dermatitis	O
(	O
11	O
)	O
.	O

Traditionally	C
,	C
autoimmune	C
diseases	C
had	C
been	C
assumed	C
to	C
be	C
associated	C
with	C
dysregulated	C
Th1	C
responses	C
(	C
13	C
)	C
.	C

Because	C
the	C
treatment	C
with	C
anti-IL-12p40	C
antibody	C
was	C
effective	C
in	C
Crohn	C
's	C
disease	C
(	C
CD	C
)	C
and	C
psoriasis	C
(	C
14	C
,	C
15	C
)	C
,	C
it	C
was	C
further	C
assumed	C
that	C
IL-12-mediated	C
IFN-γ	C
production	C
and	C
Th1	C
response	C
were	C
involved	C
in	C
the	C
pathogenesis	C
of	C
autoimmunity	C
.	C

However	O
,	O
it	O
was	O
shown	O
that	O
IFN-γ	O
deficiency	O
exacerbated	O
rather	O
than	O
ameliorated	O
mouse	O
models	O
of	O
autoimmune	O
diseases	O
such	O
as	O
experimental	O
autoimmune	O
encephalomyelitis	O
(	O
EAE	O
)	O
(	O
16	O
)	O
.	O

Subsequently	O
,	O
a	O
new	O
cytokine	O
,	O
which	O
consists	O
of	O
IL-23p19	O
and	O
IL-12p40	O
,	O
was	O
identified	O
and	O
termed	O
IL-23	O
(	O
17	O
)	O
.	O

Interestingly	O
,	O
the	O
IL-23	O
receptor	O
(	O
IL-23R	O
)	O
forms	O
dimers	O
with	O
the	O
IL-12Rß1	O
chain	O
shared	O
by	O
IL-12	O
and	O
IL-23	O
(	O
18	O
)	O
.	O

IL-23R	O
is	O
predominantly	O
expressed	O
on	O
T	O
and	O
natural	O
killer	O
(	O
NK	O
)	O
cells	O
(	O
18	O
,	O
19	O
)	O
.	O

IL-23	O
activates	O
Janus	O
kinase	O
2	O
(	O
Jak2	O
)	O
and	O
tyrosine	O
kinase	O
2	O
(	O
Tyk2	O
)	O
,	O
which	O
in	O
turn	O
leads	O
to	O
activation	O
of	O
Stat1	O
,	O
Stat3	O
,	O
Stat4	O
,	O
and	O
Stat5	O
,	O
among	O
which	O
Stat3	O
is	O
the	O
predominant	O
factor	O
phosphorylated	O
by	O
this	O
cytokine	O
(	O
17	O
,	O
18	O
)	O
.	O

Of	O
note	O
,	O
IL-23p19-deficient	O
mice	O
or	O
IL-12p40-deficient	O
(	O
IL-12/IL-23-deficient	O
)	O
mice	O
were	O
resistant	O
to	O
collagen-induced	O
arthritis	O
(	O
CIA	O
)	O
and	O
EAE	O
(	O
20	O
,	O
21	O
)	O
.	O

However	O
,	O
IL-12p35-deficient	O
mice	O
had	O
increased	O
susceptibility	O
to	O
CIA	O
and	O
EAE	O
(	O
20	O
,	O
21	O
)	O
.	O

These	O
studies	O
directly	O
negated	O
the	O
pathogenic	O
role	O
of	O
the	O
IL-12/IFN-γ	O
axis	O
in	O
autoimmunity	O
.	O

This	O
was	O
an	O
important	O
piece	O
of	O
information	O
that	O
led	O
to	O
the	O
unraveling	O
of	O
the	O
Th1/Th2	O
paradigm	O
as	O
an	O
explanation	O
of	O
autoimmunity	O
.	O

Accordingly	O
,	O
additional	O
studies	O
on	O
IL-23p19-deficient	O
mice	O
and	O
the	O
anti-IL-23p19	O
antibody	O
revealed	O
that	O
IL-23	O
,	O
but	O
not	O
IL-12	O
,	O
was	O
the	O
culprit	O
in	O
autoimmunity	O
,	O
at	O
least	O
in	O
mouse	O
disease	O
models	O
(	O
21-23	O
)	O
.	O

The	O
pathogenic	O
role	O
of	O
IL-23	O
was	O
also	O
confirmed	O
by	O
the	O
phenotype	O
of	O
IL-23p19	O
transgenic	O
mice	O
,	O
in	O
which	O
premature	O
death	O
,	O
systemic	O
inflammation	O
,	O
anemia	O
,	O
and	O
elevated	O
serum	O
levels	O
of	O
inflammatory	O
cytokines	O
and	O
acute	O
phase	O
proteins	O
were	O
observed	O
(	O
22	O
)	O
.	O

In	C
human	C
disease	C
,	C
the	C
mRNA	C
levels	C
of	C
both	C
IL-23p19	C
and	C
IL-12p40	C
were	C
shown	C
to	C
be	C
increased	C
in	C
skin	C
lesions	C
of	C
psoriatic	C
patients	C
(	C
24	C
)	C
,	C
suggesting	C
that	C
elevated	C
IL-23	C
contributed	C
to	C
the	C
pathogenesis	C
of	C
psoriasis	C
.	C

Therefore	O
,	O
IL-23	O
began	O
to	O
attract	O
attention	O
as	O
a	O
factor	O
crucial	O
to	O
inflammation	O
and	O
autoimmune	O
diseases	O
.	O

The	O
IL-23/IL17	O
axis	O
in	O
inflammation	O

While	O
it	O
was	O
becoming	O
clear	O
that	O
IL-23	O
was	O
the	O
culprit	O
in	O
autoimmune	O
and	O
inflammatory	O
diseases	O
,	O
the	O
question	O
remained	O
,	O
how	O
was	O
it	O
acting	O
?	O

Another	O
inflammatory	O
cytokine	O
,	O
IL-17	O
,	O
was	O
noted	O
to	O
be	O
produced	O
by	O
activated	O
purified	O
T	O
cells	O
in	O
the	O
presence	O
of	O
LPS-stimulated	O
dendritic	O
cells	O
(	O
DCs	O
)	O
(	O
5	O
)	O
.	O

It	O
was	O
also	O
found	O
that	O
IL-23	O
promoted	O
IL-17	O
production	O
from	O
memory	O
T	O
cells	O
and	O
this	O
production	O
was	O
suppressed	O
by	O
treatment	O
with	O
anti-IL-12p40	O
antibody	O
(	O
5	O
)	O
.	O

Now	O
IL-17	O
is	O
recognized	O
as	O
the	O
founding	O
member	O
of	O
a	O
family	O
of	O
proinflammatory	O
cytokines	O
:	O
IL-17	O
(	O
IL-17A	O
)	O
,	O
IL-17B	O
,	O
IL-17C	O
,	O
IL-17D	O
,	O
IL-17E	O
(	O
known	O
as	O
IL-25	O
)	O
,	O
and	O
IL-17F	O
(	O
6	O
)	O
.	O

IL-17A	O
and	O
IL-17F	O
induce	O
the	O
production	O
of	O
various	O
proinflammatory	O
cytokines	O
such	O
as	O
tumor	O
necrosis	O
factor-α	O
(	O
TNF-	O
α	O
)	O
,	O
IL-1ß	O
,	O
and	O
IL-6	O
,	O
and	O
CXC	O
chemokines	O
from	O
monocytes	O
,	O
airway	O
epithelial	O
cells	O
,	O
vein	O
endothelial	O
cells	O
,	O
and	O
fibroblasts	O
to	O
mount	O
defense	O
against	O
extracellular	O
bacteria	O
such	O
as	O
Klebsiella	O
pneumonia	O
,	O
Bacteroides	O
fragilis	O
,	O
and	O
Mycobacterium	O
tuberculosis	O
(	O
6	O
,	O
25	O
,	O
26	O
)	O
.	O

These	O
responses	O
result	O
in	O
the	O
recruitment	O
,	O
activation	O
and	O
migration	O
of	O
neutrophils	O
to	O
the	O
sites	O
of	O
inflammation	O
and	O
infection	O
(	O
6	O
)	O
.	O

CD4+	O
T	O
cells	O
are	O
major	O
producers	O
of	O
IL-17	O
,	O
but	O
in	O
addition	O
CD8+	O
T	O
cells	O
,	O
neutrophils	O
,	O
γδ	O
T	O
cells	O
,	O
and	O
invariant	O
natural	O
killer	O
T	O
(	O
NKT	O
)	O
cells	O
also	O
produce	O
this	O
cytokine	O
(	O
26-28	O
)	O
.	O

Various	O
reports	O
associated	O
IL-23	O
with	O
IL-17	O
production	O
with	O
the	O
onset	O
or	O
exacerbation	O
of	O
inflammation	O
(	O
20-23	O
,	O
29	O
)	O
.	O

For	O
instance	O
,	O
IL-23p19-deficient	O
mice	O
showed	O
reduced	O
incidence	O
of	O
CIA	O
,	O
with	O
fewer	O
IL-17-producing	O
CD4+	O
T	O
cells	O
(	O
20	O
)	O
.	O

Consistent	O
with	O
this	O
report	O
,	O
treatment	O
with	O
anti-IL-23p19	O
antibody	O
reduced	O
serum	O
levels	O
of	O
IL-17	O
and	O
inhibited	O
development	O
of	O
EAE	O
(	O
29	O
)	O
.	O

Moreover	O
,	O
IL-23	O
was	O
found	O
to	O
be	O
essential	O
for	O
production	O
of	O
IL-17	O
and	O
IL-6	O
in	O
colitis	O
mouse	O
models	O
(	O
22	O
,	O
23	O
)	O
.	O

Regardless	O
of	O
exactly	O
how	O
IL-23	O
works	O
,	O
these	O
reports	O
supported	O
the	O
idea	O
that	O
an	O
IL-23/IL-17	O
axis	O
,	O
but	O
not	O
IL-12/IFN-γ	O
axis	O
,	O
was	O
a	O
crucial	O
pathway	O
in	O
the	O
pathogenesis	O
of	O
various	O
autoimmune	O
diseases	O
(	O
21	O
,	O
30	O
)	O
.	O

Regulation	O
of	O
Th17	O
differentiation	O

Although	O
many	O
results	O
linked	O
IL-23	O
with	O
IL-17	O
production	O
in	O
CD4+	O
T	O
cells	O
,	O
less	O
was	O
known	O
about	O
how	O
Th17	O
cells	O
arose	O
from	O
naive	O
CD4+	O
T	O
cells	O
.	O

It	C
was	C
very	C
clear	C
that	C
development	C
of	C
IL-17-producing	C
T	C
cells	C
was	C
not	C
dependent	C
on	C
the	C
cytokines	C
and	C
the	C
transcription	C
factors	C
required	C
for	C
Th1	C
or	C
Th2	C
differentiation	C
and	C
then	C
it	C
was	C
proposed	C
that	C
IL-17-producing	C
CD4+	C
T	C
cells	C
represented	C
a	C
new	C
subset	C
of	C
helper	C
T	C
cells	C
(	C
Th17	C
cells	C
)	C
,	C
which	C
were	C
crucial	C
in	C
mediating	C
inflammatory	C
responses	C
(	C
30-32	C
)	C
.	C

While	C
there	C
was	C
evidence	C
that	C
IL-23	C
stimulated	C
CD4+	C
T	C
cells	C
to	C
express	C
various	C
genes	C
,	C
including	C
IL-17	C
,	C
and	C
that	C
IL-23-stimulated	C
T	C
cells	C
were	C
important	C
in	C
the	C
pathogenesis	C
of	C
EAE	C
(	C
30	C
)	C
,	C
it	C
was	C
less	C
clear	C
whether	C
IL-23	C
was	C
the	C
factor	C
that	C
drove	C
naive	C
CD4+	C
T	C
cells	C
to	C
become	C
IL-17	C
producers	C
.	C

It	O
was	O
especially	O
puzzling	O
that	O
naive	O
CD4+	O
T	O
cells	O
did	O
not	O
express	O
IL-23R	O
(	O
18	O
)	O
.	O

In	O
a	O
search	O
for	O
optinum	O
culture	O
condition	O
for	O
Th17	O
differentiation	O
it	O
was	O
recognized	O
that	O
naive	O
CD4+	O
T	O
cells	O
cultured	O
with	O
activated	O
DCs	O
produced	O
IL-17	O
(	O
16	O
)	O
.	O

It	O
was	O
then	O
recognized	O
that	O
the	O
combination	O
of	O
IL-6	O
and	O
transforming	O
growth	O
factor	O
ß-1	O
(	O
TGFß-1	O
)	O
,	O
with	O
appropriate	O
stimulation	O
of	O
TCR	O
,	O
were	O
the	O
optinum	O
stimuli	O
inducing	O
Th17	O
differentiation	O
(	O
Fig	O
.	O
1a	O
)	O
(	O
16	O
)	O
.	O

Accordingly	O
,	O
TGFß-1-deficient	O
mice	O
showed	O
impaired	O
Th17	O
development	O
,	O
whereas	O
addition	O
of	O
TGFß-1	O
rescued	O
the	O
number	O
of	O
Th17	O
cells	O
(	O
7	O
,	O
33	O
)	O
.	O

Thus	O
it	O
became	O
clear	O
that	O
IL-23	O
was	O
not	O
the	O
direct	O
initiator	O
of	O
Th17	O
production	O
(	O
16	O
)	O
,	O
but	O
rather	O
was	O
an	O
important	O
factor	O
for	O
expanding	O
and	O
maintaining	O
Th17	O
cells	O
in	O
vivo	O
(	O
34	O
)	O
.	O

New	O
T	O
cell	O
lineages	O
in	O
mice	O
(	O
a	O
)	O
and	O
humans	O
(	O
c	O
)	O
.	O

When	O
stimulated	O
by	O
APCs	O
such	O
as	O
DCs	O
and	O
macrophages	O
,	O
and	O
cognate	O
peptide	O
,	O
naive	O
helper	O
T	O
cells	O
differentiate	O
into	O
lineages	O
determined	O
by	O
the	O
cytokine	O
milieu	O
.	O

TGFß-1	O
is	O
a	O
critical	O
factor	O
in	O
the	O
differentiation	O
of	O
new	O
two	O
lineages	O
in	O
mice	O
T	O
cells	O
.	O

In	O
conjunction	O
with	O
TCR	O
stimulation	O
,	O
the	O
combination	O
of	O
TGFß-1	O
and	O
IL-2	O
(	O
and	O
other	O
γc	O
cytokines	O
)	O
induces	O
the	O
expression	O
of	O
Foxp3	O
,	O
leading	O
to	O
the	O
differentiation	O
of	O
naive	O
CD4+	O
T	O
cells	O
into	O
anti-inflammatory	O
Tregs	O
(	O
a	O
)	O
.	O

However	O
,	O
in	O
the	O
presence	O
of	O
TGFß-1	O
with	O
IL-6	O
or	O
IL-21	O
,	O
which	O
activates	O
Stat3	O
and	O
up-regulates	O
RORγt	O
,	O
naive	O
CD4+	O
T	O
cells	O
develop	O
to	O
become	O
pro-inflammatory	O
Th17	O
cells	O
(	O
a	O
)	O
.	O

Th17	O
differentiation	O
is	O
suppressed	O
by	O
IFN-γ	O
,	O
IL-4	O
,	O
IL-2	O
,	O
IL-25	O
,	O
IL-27	O
,	O
and	O
retinoic	O
acid	O
in	O
mice	O
(	O
b	O
)	O
.	O

Both	O
Th17	O
cells	O
and	O
Tregs	O
are	O
also	O
present	O
in	O
humans	O
(	O
c	O
)	O
.	O

TGFß-1	O
,	O
IL-1ß	O
,	O
and	O
IL-2	O
in	O
combination	O
with	O
IL-6	O
,	O
IL-21	O
or	O
IL-23	O
are	O
necessary	O
for	O
human	O
Th17	O
differentiation	O
(	O
c	O
)	O
.	O

APCs	O
,	O
antigen-presenting	O
cells	O
;	O
iTregs	O
,	O
inducible	O
Tregs	O

Autocrine	O
regulation	O
of	O
Th17	O
differentiation	O
by	O
IL-21	O

In	O
the	O
classic	O
Th1/Th2	O
paradigm	O
,	O
T	O
cell	O
subsets	O
produce	O
factors	O
that	O
promote	O
their	O
differentiation	O
and	O
constrain	O
the	O
differentiation	O
of	O
the	O
opposing	O
lineage	O
.	O

It	O
was	O
of	O
interest	O
in	O
this	O
regard	O
that	O
the	O
Th17	O
cells	O
were	O
found	O
to	O
selectively	O
produce	O
IL-21	O
(	O
35-38	O
)	O
.	O

IL-21	O
has	O
structural	O
homology	O
with	O
IL-2	O
and	O
IL-15	O
,	O
and	O
the	O
initial	O
report	O
showed	O
the	O
effects	O
of	O
IL-21	O
produced	O
by	O
CD4+	O
T	O
cells	O
and	O
NKT	O
cells	O
on	O
the	O
proliferation	O
and	O
function	O
of	O
NK	O
cells	O
,	O
B	O
cells	O
,	O
and	O
T	O
cells	O
(	O
39	O
,	O
40	O
)	O
.	O

Recently	O
though	O
,	O
it	O
has	O
also	O
been	O
found	O
that	O
the	O
autocrine	O
production	O
of	O
IL-21	O
by	O
Th17	O
cells	O
promotes	O
Th17	O
differentiation	O
while	O
inhibiting	O
IFN-γ	O
production	O
(	O
35-38	O
)	O
.	O

Accordingly	O
,	O
the	O
deficiency	O
of	O
IL-21	O
(	O
or	O
its	O
receptor	O
)	O
,	O
or	O
blocking	O
of	O
IL-21	O
,	O
attenuates	O
the	O
generation	O
of	O
Th17	O
cells	O
(	O
35-37	O
)	O
.	O

Transcription	O
factors	O
for	O
Th17	O
differentiation	O

To	O
precisely	O
understand	O
the	O
molecular	O
mechanisms	O
of	O
Th17	O
differentiation	O
,	O
it	O
is	O
important	O
to	O
define	O
the	O
transcription	O
factors	O
that	O
directly	O
regulate	O
IL-17	O
production	O
.	O

All	O
of	O
IL-6	O
,	O
IL-21	O
,	O
and	O
IL-23	O
activate	O
the	O
transcription	O
factor	O
Stat3	O
in	O
T	O
cells	O
(	O
38	O
,	O
41	O
,	O
42	O
)	O
;	O
accordingly	O
,	O
Th17	O
differentiation	O
is	O
abrogated	O
in	O
Stat3-deficient	O
T	O
cells	O
(	O
38	O
,	O
42-45	O
)	O
.	O

Moreover	O
,	O
conditional	O
deletion	O
of	O
Stat3	O
in	O
T	O
cells	O
also	O
abrogates	O
the	O
development	O
of	O
autoimmune	O
diseases	O
such	O
as	O
EAE	O
and	O
autoimmune	O
pneumonitis	O
in	O
mice	O
(	O
43	O
)	O
.	O

The	C
role	C
of	C
Stat3	C
in	C
Th17	C
differentiation	C
seems	C
to	C
be	C
remarkably	C
direct	C
–	C
i.e	C
.	C
Stat3	C
binds	C
to	C
the	C
Il17	C
and	C
Il21	C
loci	C
,	C
as	C
detected	C
by	C
using	C
chromatin	C
immunoprecipitation	C
(	C
ChiP	C
)	C
assays	C
(	C
38	C
,	C
41	C
)	C
.	C

In	O
addition	O
,	O
IL-6	O
and	O
IL-23	O
promote	O
IL-23R	O
expression	O
and	O
this	O
also	O
is	O
Stat3-dependent	O
(	O
10	O
,	O
36	O
,	O
37	O
)	O
.	O

Recently	O
,	O
the	O
importance	O
of	O
Stat3	O
in	O
human	O
Th17	O
differentiation	O
has	O
been	O
documented	O
(	O
46	O
)	O
.	O

Like	O
other	O
T	O
cell	O
subsets	O
,	O
Th17	O
cells	O
also	O
have	O
a	O
lineage-specific	O
transcription	O
factor	O
,	O
namely	O
the	O
retinoic	O
acid-related	O
orphan	O
receptor-γt	O
(	O
RORγt	O
)	O
(	O
8	O
)	O
.	O

Interestingly	O
,	O
RORγt-deficient	O
T	O
cells	O
produce	O
fewer	O
Th17	O
cells	O
,	O
whereas	O
overexpression	O
of	O
RORγt	O
in	O
T	O
cells	O
promotes	O
IL-17	O
expression	O
(	O
8	O
)	O
.	O

Furthermore	C
,	C
RORγt-deficient	C
mice	C
are	C
less	C
susceptible	C
to	C
EAE	C
,	C
suggesting	C
that	C
RORγt	C
is	C
a	C
key	C
regulator	C
of	C
Th17	C
differentiation	C
(	C
8	C
)	C
.	C

Recent	O
studies	O
have	O
shown	O
that	O
RORγt	O
expression	O
is	O
significantly	O
reduced	O
in	O
Stat3-deficient	O
T	O
cells	O
(	O
43-45	O
)	O
.	O

However	C
,	C
the	C
precise	C
molecular	C
mechanisms	C
of	C
Stat3-mediated	C
expression	C
of	C
RORγt	C
are	C
still	C
unclear	C
.	C

Even	C
so	C
,	C
RORγt	C
could	C
be	C
a	C
good	C
candidate	C
to	C
target	C
in	C
treating	C
inflammatory	C
diseases	C
(	C
discussed	C
in	C
further	C
detail	C
below	C
)	C
.	C

Also	O
,	O
it	O
has	O
been	O
shown	O
that	O
expression	O
of	O
another	O
retinoic	O
acid	O
related	O
nuclear	O
receptor	O
,	O
RORα	O
also	O
induces	O
Th17	O
differentiation	O
(	O
47	O
)	O
.	O

RORα	C
seems	C
to	C
synergize	C
with	C
RORγt	C
to	C
promote	C
development	C
of	C
Th17	C
lineage	C
(	C
47	C
)	C
.	C

Counter-regulation	O
of	O
IL-17	O
and	O
the	O
Yin/Yang	O
of	O
Th17	O
cells	O
and	O
Tregs	O

Because	C
of	C
their	C
potential	C
for	C
inducing	C
immune-mediated	C
damage	C
to	C
the	C
host	C
,	C
it	C
is	C
perhaps	C
not	C
surprising	C
that	C
multiple	C
mechanisms	C
exist	C
to	C
inhibit	C
the	C
production	C
of	C
Th17	C
cells	C
(	C
Fig	C
.	C
1b	C
)	C
.	C

Indeed	O
,	O
it	O
has	O
been	O
recognized	O
that	O
the	O
Th1-related	O
cytokine	O
IFN-γ	O
inhibits	O
Th17	O
differentiation	O
(	O
31	O
,	O
32	O
)	O
.	O

Consistent	O
with	O
this	O
concept	O
,	O
T-bet-deficient	O
mice	O
show	O
enhanced	O
Th17	O
differentiation	O
(	O
48	O
)	O
.	O

Similarly	O
,	O
the	O
Th2-related	O
IL-4	O
is	O
also	O
shown	O
to	O
down-regulate	O
Th17	O
differentiation	O
(	O
49	O
)	O
.	O

However	C
,	C
how	C
IFN-γ	C
and	C
IL-4	C
inhibit	C
IL-17	C
production	C
is	C
not	C
yet	C
known	C
.	C

Interestingly	O
,	O
IL-27	O
,	O
an	O
IL-12-related	O
heterodimeric	O
cytokine	O
,	O
also	O
has	O
anti-inflammatory	O
effect	O
by	O
inhibiting	O
the	O
generation	O
of	O
Th17	O
lineage	O
and	O
leads	O
to	O
limitation	O
of	O
EAE	O
(	O
50	O
)	O
.	O

Like	O
IFN-γ	O
,	O
IL-27	O
suppresses	O
Th17	O
differentiation	O
through	O
a	O
STAT1-dependent	O
manner	O
(	O
51	O
,	O
52	O
)	O
.	O

IL-25	O
(	O
IL-17E	O
)	O
was	O
also	O
shown	O
to	O
inhibit	O
IL-17	O
production	O
by	O
promoting	O
Th2	O
differentiation	O
(	O
53	O
)	O
.	O

These	C
reports	C
suggest	C
a	C
cross-regulatory	C
relationship	C
among	C
Th1	C
,	C
Th2	C
,	C
and	C
Th17	C
differentiation	C
.	C

However	C
,	C
it	C
still	C
remains	C
to	C
be	C
determined	C
how	C
Th1-related	C
and	C
Th2-related	C
transcription	C
factors	C
negatively	C
regulate	C
IL-17	C
production	C
.	C

Another	O
new	O
subset	O
of	O
helper	O
T	O
cells	O
that	O
provides	O
considerable	O
insight	O
into	O
the	O
pathogenesis	O
of	O
autoimmunity	O
is	O
the	O
CD4+CD25+	O
regulatory	O
T	O
cells	O
(	O
Tregs	O
)	O
(	O
3	O
,	O
4	O
,	O
54	O
)	O
.	O

Tregs	O
suppress	O
proliferation	O
of	O
effector	O
T	O
cells	O
and	O
maintain	O
self	O
tolerance	O
by	O
down-regulating	O
immune	O
responses	O
against	O
self	O
or	O
nonself-antigens	O
(	O
3	O
,	O
4	O
,	O
54	O
)	O
.	O

The	C
mechanism	C
by	C
which	C
Tregs	C
preserve	C
peripheral	C
tolerance	C
is	C
still	C
not	C
entirely	C
clear	C
;	C
however	C
,	C
they	C
preferentially	C
express	C
cytotoxic	C
T-lymphocyte	C
antigen	C
4	C
(	C
CTLA-4	C
)	C
,	C
and	C
immunosuppressive	C
cytokines	C
including	C
TGFß-1	C
and	C
IL-10	C
(	C
55-57	C
)	C
.	C

Naturally	O
arising	O
Tregs	O
(	O
nTregs	O
)	O
are	O
generated	O
in	O
the	O
thymus	O
,	O
whereas	O
inducible	O
Tregs	O
(	O
iTregs	O
)	O
arise	O
from	O
naive	O
T	O
cells	O
after	O
antigen	O
exposure	O
and	O
cytokine	O
stimulation	O
in	O
the	O
periphery	O
,	O
especially	O
in	O
the	O
gut	O
(	O
58	O
)	O
.	O

Recently	O
,	O
it	O
has	O
been	O
shown	O
that	O
CD4+CD25+	O
T	O
cells	O
express	O
the	O
transcription	O
factor	O
,	O
forkhead	O
box	O
protein	O
3	O
(	O
Foxp3	O
)	O
,	O
which	O
is	O
necessary	O
and	O
sufficient	O
for	O
Tregs	O
to	O
develop	O
and	O
function	O
(	O
59	O
,	O
60	O
)	O
.	O

In	O
mice	O
,	O
IL-2	O
and	O
TGFß-1	O
were	O
able	O
to	O
differentiate	O
CD4+CD25-	O
naive	O
T	O
cells	O
into	O
CD4+	O
CD25+	O
Foxp3+	O
Tregs	O
(	O
61	O
,	O
62	O
)	O
.	O

Therefore	O
,	O
the	O
importance	O
of	O
TGFß-1	O
for	O
both	O
Tregs	O
and	O
Th17	O
lineage	O
led	O
to	O
the	O
speculation	O
that	O
these	O
lineages	O
were	O
related	O
.	O

This	C
putative	C
relationship	C
also	C
led	C
to	C
investigation	C
of	C
the	C
importance	C
of	C
IL-2	C
in	C
Th17	C
differentiation	C
(	C
44	C
)	C
.	C

In	O
fact	O
,	O
IL-2	O
was	O
found	O
to	O
inhibit	O
the	O
expression	O
of	O
RORγt	O
while	O
the	O
enhancing	O
expression	O
of	O
Foxp3	O
(	O
44	O
)	O
.	O

Furthermore	C
,	C
blockade	C
of	C
IL-2	C
or	C
deletion	C
of	C
Stat5	C
promoted	C
Th17	C
differentiation	C
,	C
suggesting	C
that	C
IL-2	C
inhibited	C
Th17	C
lineage	C
by	C
affecting	C
the	C
RORγt-Foxp3	C
balance	C
(	C
44	C
)	C
.	C

Therefore	C
,	C
helper	C
T	C
cells	C
seem	C
to	C
have	C
a	C
unique	C
way	C
of	C
achieving	C
a	C
balance	C
between	C
Tregs	C
and	C
Th17	C
cells	C
during	C
ongoing	C
immune	C
responses	C
.	C

Recently	O
,	O
it	O
has	O
been	O
reported	O
that	O
TGFß-1	O
can	O
promote	O
either	O
Th17	O
or	O
Tregs	O
lineage	O
differentiation	O
,	O
depending	O
on	O
its	O
local	O
concentration	O
(	O
63	O
)	O
.	O

Interestingly	C
,	C
Foxp3	C
may	C
inhibit	C
RORγt	C
activity	C
on	C
its	C
target	C
genes	C
,	C
at	C
least	C
in	C
par	C
,	C
t	C
through	C
direct	C
interaction	C
with	C
RORγt	C
(	C
63	C
)	C
.	C

Further	O
complexities	O
of	O
Th17	O
cells	O

The	O
roles	O
of	O
Th17	O
cells	O
are	O
complicated	O
by	O
the	O
fact	O
that	O
these	O
cells	O
also	O
have	O
the	O
ability	O
to	O
produce	O
anti-inflammatory	O
cytokines	O
such	O
as	O
IL-10	O
(	O
34	O
)	O
.	O

This	O
cytokine	O
has	O
anti-inflammatory	O
properties	O
that	O
suppress	O
functions	O
of	O
DCs	O
and	O
macrophages	O
(	O
64	O
)	O
.	O

IL-10	O
can	O
be	O
produced	O
by	O
many	O
cell	O
types	O
such	O
as	O
B	O
cells	O
,	O
macrophages	O
,	O
DCs	O
,	O
Th2	O
cells	O
,	O
and	O
distinct	O
populations	O
of	O
Tregs	O
(	O
64	O
)	O
.	O

Recently	O
,	O
it	O
has	O
been	O
reported	O
that	O
de-novo	O
generation	O
of	O
Th17	O
cells	O
in	O
the	O
presence	O
of	O
IL-6	O
and	O
TGFß-1	O
leads	O
to	O
the	O
production	O
of	O
IL-10	O
with	O
up-regulation	O
of	O
RORγt	O
and	O
IL-17	O
(	O
34	O
)	O
.	O

Furthermore	O
,	O
IL-1ß	O
,	O
but	O
not	O
IL-23	O
,	O
potentiates	O
IL-10	O
production	O
in	O
Th17	O
cells	O
along	O
with	O
IL-6	O
and	O
TGFß-1	O
(	O
34	O
)	O
.	O

Paradoxically	C
,	C
IL-6	C
and	C
TGFß-1	C
seem	C
to	C
drive	C
initial	C
Th17	C
lineage	C
commitment	C
but	C
also	C
restrain	C
the	C
pathogenic	C
potential	C
of	C
Th17	C
cells	C
by	C
producing	C
IL-10	C
also	C
(	C
34	C
)	C
.	C

Another	O
cytokine	O
produced	O
by	O
Th17	O
cells	O
is	O
IL-22	O
(	O
25	O
,	O
65	O
,	O
66	O
)	O
.	O

IL-22	O
belongs	O
to	O
the	O
IL-10	O
family	O
of	O
cytokines	O
which	O
include	O
IL-19	O
,	O
IL-20	O
,	O
IL-24	O
,	O
and	O
IL-26	O
.	O

Expressed	O
in	O
activated	O
T	O
cells	O
,	O
Th1	O
cells	O
and	O
NK	O
cells	O
(	O
67	O
)	O
,	O
IL-22	O
induces	O
expression	O
of	O
various	O
antimicrobial	O
peptides	O
such	O
as	O
ß-defensins	O
in	O
skin	O
,	O
respiratory	O
,	O
and	O
digestive	O
tissues	O
,	O
which	O
express	O
IL-22R	O
(	O
68	O
)	O
.	O

In	O
fact	O
,	O
expression	O
of	O
IL-22	O
and	O
ß-defensins	O
is	O
higher	O
in	O
skin	O
from	O
patients	O
with	O
psoriasis	O
and	O
atopic	O
dermatitis	O
than	O
in	O
that	O
from	O
healthy	O
individuals	O
(	O
69	O
)	O
.	O

While	O
it	O
is	O
clear	O
that	O
IL-22	O
and	O
IL-17	O
can	O
contribute	O
to	O
host	O
defense	O
and	O
to	O
pathogenesis	O
of	O
various	O
autoimmune	O
diseases	O
(	O
25	O
)	O
,	O
it	O
is	O
also	O
notable	O
that	O
IL-22	O
also	O
has	O
important	O
anti-inflammatory	O
effects	O
(	O
70	O
)	O
.	O

Specifically	O
,	O
IL-22-expressing	O
Th17	O
cells	O
provided	O
protection	O
in	O
models	O
of	O
hepatitis	O
(	O
70	O
)	O
.	O

Recently	O
,	O
IL-22	O
also	O
has	O
been	O
shown	O
not	O
to	O
be	O
required	O
for	O
the	O
development	O
of	O
EAE	O
in	O
mice	O
(	O
71	O
)	O
.	O

These	O
facts	O
indicate	O
the	O
complexity	O
of	O
Th17	O
cells	O
,	O
which	O
produce	O
multiple	O
cytokines	O
and	O
have	O
diverse	O
functions	O
during	O
inflammation	O
.	O

As	C
such	C
,	C
their	C
relevance	C
may	C
vary	C
among	C
different	C
autoimmune	C
diseases	C
.	C

Human	O
Th17	O
differentiation	O

While	O
a	O
large	O
body	O
of	O
evidence	O
has	O
documented	O
that	O
the	O
best	O
recipe	O
for	O
generating	O
Th17	O
cells	O
from	O
murine	O
naive	O
CD4+	O
T	O
cells	O
is	O
the	O
combination	O
of	O
TGFß-1	O
and	O
IL-6	O
or	O
IL-21	O
,	O
several	O
groups	O
initially	O
reported	O
that	O
the	O
regulation	O
of	O
human	O
Th17	O
differentiation	O
was	O
quite	O
distinct	O
(	O
Fig	O
.	O
1c	O
)	O
(	O
9	O
,	O
10	O
,	O
66	O
,	O
72-74	O
)	O
.	O

Specifically	O
,	O
TGFß-1	O
was	O
initially	O
considered	O
to	O
have	O
inhibitory	O
effect	O
on	O
human	O
IL-17	O
production	O
;	O
however	O
,	O
the	O
role	O
of	O
TGFß-1	O
in	O
human	O
Th17	O
differentiation	O
has	O
recently	O
become	O
clearer	O
.	O

While	O
TGFß-1	O
alone	O
had	O
an	O
inhibitory	O
effect	O
on	O
production	O
of	O
IL-17	O
by	O
T	O
cells	O
,	O
culturing	O
human	O
naive	O
CD4+	O
T	O
cells	O
from	O
cord	O
blood	O
in	O
serum-free	O
medium	O
revealed	O
a	O
requirement	O
of	O
TGFß-1	O
for	O
Th17	O
differentiation	O
(	O
72	O
)	O
.	O

TGFß-1	C
seems	C
to	C
have	C
dual	C
effects	C
on	C
human	C
Th17	C
differentiation	C
in	C
a	C
dose-dependent	C
manner	C
.	C

While	O
TGFß-1	O
is	O
required	O
for	O
the	O
expression	O
of	O
RORγt	O
in	O
human	O
naive	O
CD4+	O
T	O
cells	O
from	O
cord	O
blood	O
,	O
TGFß-1	O
can	O
inhibit	O
the	O
function	O
of	O
RORγt	O
at	O
high	O
doses	O
(	O
72	O
)	O
.	O

However	O
,	O
inflammatory	O
cytokines	O
(	O
IL-1ß	O
,	O
IL-6	O
,	O
and	O
IL-21	O
or	O
IL-23	O
)	O
relieve	O
the	O
latter	O
effect	O
of	O
TGFß-1	O
(	O
72	O
)	O
.	O

By	O
using	O
serum-free	O
medium	O
it	O
has	O
thus	O
been	O
clarified	O
that	O
the	O
optimum	O
conditions	O
for	O
human	O
Th17	O
differentiation	O
are	O
TGFß-1	O
,	O
IL-1ß	O
,	O
and	O
IL-2	O
in	O
combination	O
with	O
IL-6	O
,	O
IL-21	O
or	O
IL-23	O
(	O
72-74	O
)	O
.	O

Of	C
these	C
latter	C
cytokines	C
,	C
IL-23	C
seems	C
to	C
be	C
the	C
most	C
effective	C
(	C
10	C
,	C
66	C
,	C
72	C
,	C
73	C
)	C
.	C

A	O
key	O
aspect	O
of	O
Th17	O
regulation	O
is	O
the	O
regulation	O
of	O
IL-23R	O
(	O
10	O
)	O
.	O

Naive	O
CD4+	O
T	O
cells	O
express	O
low	O
levels	O
of	O
this	O
receptor	O
,	O
but	O
the	O
combination	O
of	O
TGFß-1	O
,	O
IL-1ß	O
,	O
and	O
IL-23	O
can	O
strongly	O
induce	O
this	O
receptor	O
(	O
10	O
,	O
72	O
)	O
.	O

Thus	O
,	O
IL-23	O
promotes	O
expression	O
of	O
its	O
own	O
receptor	O
,	O
allowing	O
it	O
to	O
be	O
an	O
effective	O
inducer	O
of	O
IL-17	O
.	O

It	O
is	O
of	O
note	O
is	O
that	O
CCR6+IL-23R+	O
human	O
memory	O
CD4+	O
T	O
cells	O
are	O
major	O
producers	O
of	O
IL-17	O
(	O
75	O
,	O
76	O
)	O
.	O

Because	C
CCR6+CD4+	C
T	C
cells	C
,	C
but	C
not	C
CCR6-CD4+	C
T	C
cells	C
,	C
secrete	C
IL-17	C
and	C
expression	C
of	C
IL-23R	C
,	C
CCR6	C
,	C
and	C
RORγt	C
is	C
up-regulated	C
during	C
Th17	C
differentiation	C
(	C
72	C
)	C
,	C
these	C
factors	C
seem	C
to	C
be	C
essential	C
for	C
development	C
of	C
human	C
Th17	C
lineage	C
.	C

Importantly	C
,	C
it	C
has	C
been	C
shown	C
that	C
mutations	C
presumed	C
to	C
underlie	C
hyper-IgE	C
syndrome	C
(	C
HIES	C
,	C
“Job	C
's	C
syndrome”	C
)	C
are	C
identified	C
in	C
the	C
STAT3	C
gene	C
(	C
46	C
)	C
.	C

Purified	C
naive	C
CD4+	C
T	C
cells	C
from	C
HIES	C
individuals	C
can	C
not	C
differentiate	C
into	C
Th17	C
cells	C
in	C
vitro	C
and	C
have	C
lower	C
expression	C
of	C
RORγt	C
(	C
46	C
)	C
,	C
suggesting	C
that	C
Stat3	C
signaling	C
is	C
also	C
a	C
crucial	C
factor	C
for	C
the	C
generation	C
of	C
human	C
Th17	C
cells	C
.	C

Th17	O
cells	O
in	O
autoimmune	O
diseases	O

Although	C
Th17	C
cells	C
are	C
important	C
and	C
essential	C
subsets	C
participating	C
in	C
host	C
defense	C
against	C
extracellular	C
antigens	C
,	C
evidence	C
implicating	C
Th17	C
cells	C
as	C
a	C
causal	C
factor	C
of	C
autoimmune	C
diseases	C
is	C
also	C
mounting	C
(	C
25	C
)	C
.	C

Following	O
extensive	O
analysis	O
of	O
mouse	O
disease	O
models	O
such	O
as	O
EAE	O
,	O
CIA	O
,	O
and	O
IBD	O
,	O
it	O
has	O
also	O
become	O
evident	O
that	O
IL-17	O
is	O
a	O
contributing	O
factor	O
in	O
human	O
autoimmune	O
diseases	O
.	O

For	O
instance	O
,	O
perivascular	O
IL-17-producing	O
T	O
cells	O
are	O
present	O
in	O
brain	O
lesions	O
of	O
active	O
MS	O
patients	O
and	O
these	O
cells	O
are	O
reduced	O
in	O
quiescent	O
MS	O
patients	O
(	O
77	O
)	O
.	O

Moreover	O
,	O
DCs	O
from	O
MS	O
patients	O
secrete	O
more	O
IL-23	O
than	O
healthy	O
controls	O
,	O
and	O
T	O
cells	O
from	O
MS	O
patients	O
secrete	O
more	O
IL-17	O
than	O
healthy	O
controls	O
(	O
78	O
)	O
.	O

Also	O
,	O
elevated	O
levels	O
of	O
IL-17	O
have	O
been	O
noted	O
in	O
the	O
sera	O
and	O
in	O
tissues	O
of	O
patients	O
with	O
RA	O
,	O
IBD	O
,	O
and	O
psoriasis	O
(	O
25	O
)	O
.	O

We	O
will	O
see	O
more	O
evidence	O
confirming	O
the	O
roles	O
of	O
IL-17	O
in	O
human	O
diseases	O
and	O
inflammation	O
in	O
the	O
future	O
.	O

Recent	O
genetic	O
data	O
has	O
linked	O
polymorphisms	O
of	O
the	O
Il23r	O
gene	O
to	O
various	O
human	O
diseases	O
such	O
as	O
ankylosing	O
spondylitis	O
,	O
CD	O
,	O
and	O
psoriasis	O
(	O
79-81	O
)	O
.	O

Accordingly	O
treating	O
CD	O
and	O
psoriasis	O
patients	O
with	O
anti-IL-12p40	O
antibody	O
has	O
resulted	O
in	O
some	O
success	O
(	O
14	O
,	O
15	O
)	O
.	O

These	C
results	C
argue	C
strongly	C
for	C
a	C
role	C
of	C
the	C
IL-23/IL-17	C
axis	C
in	C
human	C
autoimmune	C
diseases	C
.	C

Th17	O
cells	O
in	O
rheumatoid	O
arthritis	O

It	C
is	C
of	C
particular	C
interest	C
to	C
evaluate	C
the	C
contribution	C
of	C
Th17	C
cells	C
to	C
the	C
pathogenesis	C
of	C
RA	C
,	C
because	C
targeting	C
pathogenetic	C
Th17	C
might	C
be	C
a	C
reasonable	C
strategy	C
for	C
treating	C
RA	C
.	C

First	O
,	O
IL-17-deficient	O
mice	O
fail	O
to	O
develop	O
CIA	O
when	O
challenged	O
(	O
82	O
)	O
.	O

Consistent	O
with	O
this	O
,	O
treatment	O
with	O
neutralizing	O
IL-17	O
monoclonal	O
antibody	O
ameliorates	O
joint	O
inflammation	O
in	O
CIA	O
models	O
(	O
83	O
)	O
.	O

Furthermore	O
,	O
it	O
has	O
been	O
reported	O
that	O
active	O
immunization	O
using	O
virus-like	O
particles	O
conjugated	O
with	O
recombinant	O
IL-17	O
leads	O
to	O
high	O
levels	O
of	O
anti-IL-17	O
antibodies	O
in	O
mice	O
and	O
reduces	O
scores	O
of	O
disease	O
severity	O
in	O
CIA	O
(	O
84	O
)	O
.	O

These	O
results	O
highlight	O
the	O
role	O
of	O
IL-17	O
as	O
an	O
exacerbation	O
factor	O
in	O
rodent	O
arthritis	O
models	O
.	O

Because	C
the	C
expression	C
of	C
IL-17	C
and	C
IL-23p19	C
was	C
observed	C
in	C
the	C
synovial	C
fluid	C
and	C
serum	C
of	C
RA	C
patients	C
,	C
these	C
factors	C
were	C
presumed	C
to	C
be	C
pathogenic	C
(	C
85	C
)	C
.	C

In	O
particular	O
,	O
IL-17	O
up-regulates	O
the	O
production	O
of	O
IL-1ß	O
and	O
TNF-α	O
from	O
APCs	O
in	O
arthritic	O
joints	O
(	O
86	O
,	O
87	O
)	O
.	O

Moreover	O
,	O
IL-17	O
induces	O
IL-6	O
,	O
IL-8	O
,	O
and	O
IL-23	O
from	O
RA	O
synovial	O
fibroblasts	O
and	O
chemokines	O
such	O
as	O
CCL20/MIP3α	O
from	O
synoviocytes	O
to	O
induce	O
migration	O
of	O
T	O
cells	O
and	O
DCs	O
into	O
inflammatory	O
lesions	O
(	O
86	O
,	O
87	O
)	O
.	O

IL-17	O
also	O
promotes	O
cartilage	O
breakdown	O
by	O
inducing	O
matrix	O
metalloproteinases-1	O
(	O
MMP-1	O
)	O
from	O
RA	O
synovium	O
(	O
86	O
,	O
87	O
)	O
.	O

Additionally	O
,	O
IL-17	O
induces	O
cyclooxygenase-2	O
(	O
COX-2	O
)	O
-dependent	O
prostaglandin	O
E2	O
(	O
PGE2	O
)	O
synthesis	O
by	O
osteoblasts	O
and	O
it	O
then	O
induces	O
expression	O
of	O
receptor	O
activator	O
of	O
NF-κB	O
ligand	O
(	O
RANKL	O
)	O
to	O
differentiate	O
osteoclast	O
progenitors	O
into	O
mature	O
osteoclasts	O
(	O
86	O
,	O
87	O
)	O
.	O

Pro-oxidants	O
such	O
as	O
nitric	O
oxide	O
are	O
also	O
produced	O
by	O
chondrocytes	O
and	O
osteoblasts	O
in	O
response	O
to	O
IL-17	O
(	O
86	O
,	O
87	O
)	O
.	O

Taken	C
together	C
,	C
these	C
multiple	C
factors	C
induced	C
by	C
IL-17	C
seem	C
to	C
promote	C
bone	C
resorption	C
,	C
extracellular	C
matrix	C
degradation	C
,	C
synovium	C
proliferation	C
,	C
angiogenesis	C
,	C
and	C
recruitment	C
and	C
activation	C
of	C
immune	C
cells	C
for	C
bone	C
erosion	C
and	C
articular	C
destruction	C
in	C
RA	C
joints	C
.	C

This	C
being	C
said	C
,	C
there	C
is	C
little	C
evidence	C
of	C
T	C
cell	C
proliferation	C
in	C
RA	C
and	C
we	C
still	C
do	C
not	C
know	C
for	C
certain	C
the	C
cellular	C
source	C
of	C
IL-17	C
in	C
RA	C
synovium	C
(	C
88	C
)	C
.	C

For	C
these	C
reasons	C
,	C
IL-17	C
seems	C
to	C
be	C
a	C
rational	C
target	C
in	C
the	C
treatment	C
of	C
RA	C
,	C
and	C
Phase	C
I/II	C
clinical	C
trials	C
of	C
anti-IL-17	C
monoclonal	C
antibody	C
(	C
AIN457	C
)	C
have	C
commenced	C
(	C
http	C
:	C
//www.clinicaltrials.gov/	C
)	C
.	C

It	O
has	O
been	O
reported	O
that	O
combining	O
inhibitors	O
to	O
block	O
TNF-α	O
and	O
IL-17	O
has	O
the	O
synergistic	O
effect	O
of	O
suppressing	O
IL-6	O
production	O
and	O
collagen	O
degradation	O
in	O
the	O
synovium	O
and	O
bone	O
of	O
RA	O
patients	O
(	O
89	O
)	O
.	O

Therefore	C
,	C
anti-IL-17	C
therapy	C
may	C
become	C
an	C
alternative	C
for	C
treating	C
patients	C
unresponsive	C
to	C
conventional	C
anti-TNF	C
therapy	C
.	C

It	C
still	C
remains	C
to	C
be	C
seen	C
whether	C
blocking	C
IL-17	C
will	C
affect	C
other	C
proinflammatory	C
cytokines	C
for	C
example	C
IL-6	C
,	C
IL-1	C
,	C
and	C
IL-22	C
in	C
RA	C
patients	C
.	C

More	O
studies	O
will	O
shed	O
light	O
on	O
the	O
validity	O
of	O
anti-IL-17	O
therapy	O
.	O

While	O
the	O
role	O
of	O
IL-6	O
in	O
regulating	O
IL-17	O
production	O
has	O
only	O
recently	O
been	O
appreciated	O
,	O
the	O
role	O
of	O
IL-6	O
as	O
a	O
proinflammatory	O
cytokine	O
has	O
long	O
been	O
recognized	O
.	O

For	O
this	O
reason	O
,	O
targeting	O
IL-6	O
in	O
RA	O
has	O
been	O
considered	O
for	O
some	O
time	O
.	O

Indeed	O
the	O
efficacy	O
of	O
humanized	O
anti	O
IL-6R	O
monoclonal	O
antibodies	O
(	O
tocilizumab/atlizumab	O
)	O
in	O
the	O
treatment	O
of	O
adults	O
and	O
children	O
with	O
arthritis	O
has	O
recently	O
been	O
reported	O
(	O
90	O
)	O
.	O

Also	O
,	O
in	O
April	O
2008	O
tocilizumab	O
was	O
been	O
approved	O
in	O
Japan	O
for	O
treatment	O
of	O
RA	O
in	O
Japan	O
,	O
and	O
Phase	O
III	O
trials	O
have	O
been	O
completed	O
in	O
the	O
US	O
(	O
http	O
:	O
//www.clinicaltrials.gov/	O
)	O
.	O

To	C
what	C
extent	C
their	C
efficacy	C
relates	C
to	C
inhibition	C
of	C
IL-17	C
will	C
be	C
important	C
to	C
ascertain	C
.	C

Similarly	O
,	O
in	O
the	O
US	O
,	O
recombinant	O
human	O
anti-IL-1Rα	O
antagonist	O
(	O
anakinra	O
)	O
has	O
been	O
approved	O
for	O
use	O
in	O
the	O
treatment	O
of	O
RA	O
(	O
91	O
)	O
.	O

Recently	O
,	O
more	O
IL-1-targeting	O
therapies	O
for	O
RA	O
patients	O
are	O
in	O
Phase	O
II	O
studies	O
including	O
anti-IL-1ß	O
monoclonal	O
antibody	O
(	O
ACZ885	O
)	O
,	O
human	O
monoclonal	O
antibody	O
to	O
IL-1R	O
(	O
AMG108	O
)	O
,	O
and	O
IL-1	O
Trap/rilonacept	O
(	O
http	O
:	O
//www.clinicaltrials.gov/	O
)	O
.	O

Although	C
IL-1	C
has	C
been	C
reported	C
to	C
contribute	C
to	C
Th17	C
differentiation	C
in	C
mouse	C
and	C
man	C
,	C
it	C
remains	C
to	C
be	C
determined	C
whether	C
therapeutic	C
targeting	C
of	C
IL-1	C
will	C
substantially	C
affect	C
IL-17	C
in	C
RA	C
.	C

On	O
the	O
basis	O
of	O
the	O
efficacy	O
of	O
anti-IL-12p40	O
therapy	O
in	O
human	O
autoimmune	O
diseases	O
(	O
14	O
,	O
15	O
)	O
,	O
a	O
humanized	O
monoclonal	O
anti-IL-12p40	O
antibody	O
(	O
ABT-874	O
)	O
was	O
tested	O
in	O
RA	O
(	O
92	O
)	O
.	O

However	O
this	O
antibody	O
was	O
not	O
shown	O
to	O
be	O
effective	O
because	O
of	O
the	O
trial	O
design	O
(	O
92	O
)	O
.	O

Another	O
strategy	O
for	O
targeting	O
IL-12/IL-23	O
is	O
apilimod	O
mesylate	O
(	O
STA-5326	O
)	O
,	O
an	O
oral	O
inhibitor	O
of	O
IL-12p35/p40	O
,	O
which	O
has	O
been	O
tested	O
in	O
a	O
Phase	O
II	O
study	O
for	O
RA	O
(	O
http	O
:	O
//www.clinicaltrials.gov/	O
)	O
.	O

Whether	C
selectively	C
targeting	C
IL-23p19	C
will	C
be	C
more	C
efficacious	C
or	C
have	C
a	C
better	C
safety	C
profile	C
remains	C
to	C
be	C
determined	C
.	C

In	C
principle	C
,	C
targeting	C
IL-21	C
might	C
also	C
be	C
efficacious	C
in	C
treating	C
RA	C
in	C
which	C
IL-17	C
is	C
involved	C
in	C
immune-mediated	C
damage	C
.	C

Importantly	O
,	O
the	O
common	O
gamma	O
chain	O
and	O
JAK3	O
play	O
a	O
pivotal	O
role	O
in	O
the	O
signal	O
transduction	O
of	O
IL-21	O
(	O
25	O
)	O
.	O

In	O
fact	O
,	O
a	O
JAK3	O
inhibitor	O
(	O
CP-690550	O
)	O
is	O
about	O
to	O
be	O
tested	O
in	O
RA	O
(	O
Phase	O
II	O
trial	O
)	O
(	O
http	O
:	O
//www.clinicaltrials.gov/	O
)	O
.	O

It	C
will	C
be	C
important	C
to	C
know	C
whether	C
the	C
efficacy	C
of	C
this	C
drug	C
is	C
related	C
to	C
inhibition	C
of	C
IL-17	C
.	C

Concluding	O
remarks	O

The	O
past	O
four	O
years	O
have	O
witnessed	O
major	O
revisions	O
of	O
our	O
views	O
on	O
the	O
lineage	O
commitment	O
of	O
helper	O
T	O
cells	O
.	O

The	O
conventional	O
Th1/Th2	O
dichotomy	O
has	O
been	O
replaced	O
by	O
more	O
complex	O
multi-lineage	O
models	O
which	O
do	O
a	O
much	O
better	O
job	O
of	O
explaining	O
the	O
pathogenesis	O
of	O
autoimmunity	O
(	O
Fig	O
.	O
1	O
)	O
.	O

It	C
now	C
seems	C
that	C
Th17	C
cells	C
are	C
one	C
of	C
the	C
more	C
important	C
villains	C
in	C
the	C
pathogenesis	C
of	C
autoimmune	C
diseases	C
.	C

However	O
,	O
it	O
is	O
of	O
note	O
that	O
they	O
are	O
also	O
essential	O
for	O
host	O
defense	O
against	O
extracellular	O
bacteria	O
.	O

Therefore	O
,	O
the	O
challenge	O
will	O
be	O
to	O
keep	O
Th17	O
function	O
in	O
check	O
to	O
control	O
autoimmunity	O
,	O
while	O
maintaining	O
host	O
defense	O
at	O
the	O
same	O
time	O
.	O

In	O
this	O
regard	O
,	O
we	O
still	O
need	O
to	O
learn	O
what	O
are	O
the	O
most	O
critical	O
factors	O
for	O
Th17	O
differentiation	O
.	O

We	O
also	O
need	O
to	O
better	O
understand	O
which	O
human	O
autoimmune	O
diseases	O
are	O
truly	O
mediated	O
by	O
IL-17	O
and	O
,	O
by	O
extension	O
,	O
which	O
diseases	O
will	O
benefit	O
most	O
from	O
anti-IL-17	O
therapy	O
.	O

With	O
the	O
current	O
pace	O
of	O
investigations	O
on	O
Th17	O
,	O
this	O
field	O
has	O
a	O
great	O
potential	O
for	O
advances	O
.	O

There	C
is	C
no	C
doubt	C
that	C
IL-17	C
and	C
the	C
other	C
proinflammatory	C
cytokines	C
are	C
likely	C
to	C
be	C
relevant	C
therapeutic	C
targets	C
in	C
the	C
treatment	C
of	C
human	C
autoimmune	C
diseases	C
.	C

Estrogen	O
directly	O
activates	O
AID	O
transcription	O
and	O
function	O

Abstract	O

The	O
immunological	O
targets	O
of	O
estrogen	O
at	O
the	O
molecular	O
,	O
humoral	O
,	O
and	O
cellular	O
level	O
have	O
been	O
well	O
documented	O
,	O
as	O
has	O
estrogen	O
's	O
role	O
in	O
establishing	O
a	O
gender	O
bias	O
in	O
autoimmunity	O
and	O
cancer	O
.	O

During	O
a	O
healthy	O
immune	O
response	O
,	O
activation-induced	O
deaminase	O
(	O
AID	O
)	O
deaminates	O
cytosines	O
at	O
immunoglobulin	O
(	O
Ig	O
)	O
loci	O
,	O
initiating	O
somatic	O
hypermutation	O
(	O
SHM	O
)	O
and	O
class	O
switch	O
recombination	O
(	O
CSR	O
)	O
.	O

Protein	C
levels	C
of	C
nuclear	C
AID	C
are	C
tightly	C
controlled	C
,	C
as	C
unregulated	C
expression	C
can	C
lead	C
to	C
alterations	C
in	C
the	C
immune	C
response	C
.	C

Furthermore	O
,	O
hyperactivation	O
of	O
AID	O
outside	O
the	O
immune	O
system	O
leads	O
to	O
oncogenesis	O
.	O

Here	O
,	O
we	O
demonstrate	O
that	O
the	O
estrogen–estrogen	O
receptor	O
complex	O
binds	O
to	O
the	O
AID	O
promoter	O
,	O
enhancing	O
AID	O
messenger	O
RNA	O
expression	O
,	O
leading	O
to	O
a	O
direct	O
increase	O
in	O
AID	O
protein	O
production	O
and	O
alterations	O
in	O
SHM	O
and	O
CSR	O
at	O
the	O
Ig	O
locus	O
.	O

Enhanced	O
translocations	O
of	O
the	O
c-myc	O
oncogene	O
showed	O
that	O
the	O
genotoxicity	O
of	O
estrogen	O
via	O
AID	O
production	O
was	O
not	O
limited	O
to	O
the	O
Ig	O
locus	O
.	O

Outside	O
of	O
the	O
immune	O
system	O
(	O
e.g.	O
,	O
breast	O
and	O
ovaries	O
)	O
,	O
estrogen	O
induced	O
AID	O
expression	O
by	O
>	O
20-fold	O
.	O

The	O
estrogen	O
response	O
was	O
also	O
partially	O
conserved	O
within	O
the	O
DNA	O
deaminase	O
family	O
(	O
APOBEC3B	O
,	O
-3F	O
,	O
and	O
-3G	O
)	O
,	O
and	O
could	O
be	O
inhibited	O
by	O
tamoxifen	O
,	O
an	O
estrogen	O
antagonist	O
.	O

We	C
therefore	C
suggest	C
that	C
estrogen-induced	C
autoimmunity	C
and	C
oncogenesis	C
may	C
be	C
derived	C
through	C
AID-dependent	C
DNA	C
instability	C
.	C

Humoral	O
immune	O
responses	O
triggered	O
by	O
foreign	O
antigens	O
require	O
B	O
cell	O
activation	O
.	O

The	O
activated	O
B	O
cell	O
undergoes	O
antibody	O
affinity	O
maturation	O
,	O
which	O
in	O
higher	O
vertebrates	O
includes	O
somatic	O
hypermutation	O
(	O
SHM	O
)	O
,	O
gene	O
conversion	O
of	O
antigen-binding	O
V	O
regions	O
,	O
and	O
class	O
switching	O
(	O
1	O
)	O
;	O
all	O
of	O
these	O
processes	O
require	O
activation-induced	O
deaminase	O
(	O
AID	O
)	O
(	O
2–5	O
)	O
.	O

AID	O
initiates	O
these	O
events	O
by	O
deaminating	O
deoxycytosine	O
to	O
deoxyuracil	O
in	O
DNA	O
(	O
for	O
review	O
see	O
reference	O
[	O
6–8	O
]	O
)	O
.	O

The	O
resulting	O
dU	O
:	O
dG	O
lesion	O
can	O
be	O
recognized	O
by	O
several	O
different	O
DNA	O
repair	O
pathways	O
to	O
create	O
the	O
aforementioned	O
antibody	O
diversifications	O
.	O

This	O
necessity	O
for	O
immune	O
diversification	O
and	O
sufficiency	O
for	O
genome	O
instability	O
also	O
highlights	O
AID	O
as	O
an	O
important	O
pathogenic	O
regulator	O
.	O

In	O
the	O
immune	O
system	O
,	O
hyper-	O
or	O
hypoexpression	O
of	O
AID	O
can	O
alter	O
autoimmune	O
pathologies	O
(	O
9–11	O
)	O
.	O

Furthermore	C
,	C
SHM	C
,	C
by	C
way	C
of	C
AID	C
,	C
may	C
contribute	C
to	C
lymphomagenesis	C
by	C
mutating	C
(	C
proto-	C
)	C
oncogenes	C
and	C
tumor	C
suppressor	C
genes	C
,	C
or	C
by	C
promoting	C
chromosomal	C
translocations	C
(	C
12–14	C
)	C
.	C

There	O
is	O
strong	O
evidence	O
that	O
AID	O
is	O
required	O
for	O
c-myc	O
translocation	O
,	O
leading	O
to	O
tumorgenesis	O
in	O
a	O
murine	O
model	O
for	O
Burkitt	O
's	O
lymphoma	O
(	O
15	O
,	O
16	O
)	O
.	O

Other	O
nonphysiological	O
AID	O
targets	O
include	O
BCL6	O
,	O
CD95/Fas	O
,	O
RHO/TTF	O
,	O
PAX-5	O
,	O
and	O
PIM1	O
(	O
12	O
,	O
17–19	O
)	O
.	O

Outside	C
the	C
immune	C
system	C
,	C
there	C
are	C
indications	C
that	C
systemic	C
hyperexpression	C
of	C
AID	C
can	C
induce	C
non–B	C
cell	C
cancers	C
from	C
lung	C
(	C
20	C
)	C
,	C
lymphatic	C
(	C
20	C
)	C
,	C
and	C
liver	C
(	C
21	C
)	C
tissues	C
.	C

AID	C
has	C
also	C
been	C
implicated	C
as	C
a	C
developmental	C
epigenetic	C
reprogramming	C
factor	C
,	C
and	C
its	C
expression	C
levels	C
in	C
oocytes	C
is	C
almost	C
equivalent	C
to	C
that	C
in	C
lymph	C
nodes	C
(	C
22	C
)	C
,	C
suggesting	C
that	C
AID	C
could	C
be	C
regulated	C
by	C
pathways	C
other	C
than	C
B	C
cell	C
activation	C
pathways	C
(	C
e.g.	C
,	C
E-box	C
proteins	C
[	C
23	C
]	C
,	C
NF-κB	C
[	C
24	C
]	C
,	C
and	C
Pax5	C
[	C
25	C
]	C
)	C
,	C
with	C
hormones	C
being	C
plausible	C
candidates	C
.	C

Several	C
clinical	C
and	C
epidemiological	C
studies	C
have	C
indicated	C
that	C
females	C
can	C
have	C
stronger	C
and	C
more	C
rapid	C
immune	C
responses	C
upon	C
antigen	C
encounter	C
(	C
26	C
,	C
27	C
)	C
.	C

This	O
gender	O
bias	O
is	O
also	O
reflected	O
in	O
the	O
occurrence	O
of	O
pathogenic	O
immune	O
responses	O
,	O
as	O
found	O
in	O
asthma	O
and	O
other	O
autoimmune	O
diseases	O
(	O
28–31	O
)	O
.	O

Several	O
nonimmune	O
pathologies	O
are	O
also	O
strongly	O
influenced	O
by	O
the	O
activity	O
of	O
sex	O
hormones	O
,	O
most	O
notably	O
certain	O
types	O
of	O
cancer	O
.	O

Estrogen	C
and	C
its	C
biological	C
and	C
synthetic	C
derivatives	C
are	C
thought	C
to	C
be	C
oncogenic	C
for	C
breast	C
and	C
ovarian	C
tissue	C
(	C
32	C
,	C
33	C
)	C
,	C
most	C
often	C
being	C
associated	C
with	C
their	C
growth-promoting	C
and	C
differentiating	C
capacity	C
.	C

To	O
further	O
elucidate	O
how	O
AID	O
can	O
be	O
regulated	O
,	O
both	O
within	O
and	O
outside	O
the	O
immune	O
system	O
,	O
and	O
to	O
determine	O
which	O
signaling	O
pathways	O
could	O
use	O
DNA	O
deaminases	O
as	O
DNA	O
instability	O
factors	O
,	O
we	O
analyzed	O
the	O
effect	O
of	O
estrogen	O
on	O
AID	O
's	O
expression	O
and	O
on	O
downstream	O
pathways	O
such	O
as	O
SHM	O
and	O
class	O
switch	O
recombination	O
(	O
CSR	O
)	O
.	O

We	O
show	O
that	O
AID	O
can	O
be	O
up-regulated	O
by	O
estrogen	O
,	O
whereas	O
tamoxifen	O
(	O
Tam	O
)	O
can	O
inhibit	O
this	O
stimulation	O
.	O

This	O
effect	O
was	O
most	O
pronounced	O
,	O
but	O
not	O
limited	O
to	O
regulation	O
at	O
the	O
level	O
of	O
transcription	O
.	O

Treatment	O
with	O
estrogen	O
increased	O
AID	O
protein	O
expression	O
,	O
enhanced	O
CSR	O
,	O
augmented	O
mutation	O
frequency	O
in	O
Ig	O
and	O
non-Ig	O
genes	O
,	O
and	O
increased	O
the	O
translocation	O
frequency	O
of	O
c-myc	O
.	O

Estrogen-induced	O
AID	O
messenger	O
RNA	O
(	O
mRNA	O
)	O
production	O
was	O
independent	O
of	O
other	O
B	O
cell	O
stimulatory	O
pathways	O
and	O
could	O
be	O
observed	O
outside	O
immune	O
tissue	O
.	O

We	O
were	O
able	O
to	O
identify	O
two	O
potential	O
estrogen	O
response	O
elements	O
(	O
EREs	O
)	O
near	O
the	O
AID	O
promoter	O
,	O
and	O
determined	O
enhanced	O
ERα	O
binding	O
to	O
the	O
promoter	O
after	O
estrogen	O
treatment	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

APOBEC3	O
,	O
the	O
evolutionarily	O
related	O
DNA	O
deaminases	O
(	O
34	O
)	O
,	O
were	O
also	O
responsive	O
to	O
estrogen	O
treatment	O
in	O
different	O
tissues	O
and	O
cell	O
types	O
.	O

Our	C
data	C
indicate	C
that	C
the	C
mutagenic	C
DNA	C
deaminases	C
are	C
potentially	C
an	C
important	C
target	C
for	C
hormonal	C
regulation	C
.	C

RESULTS	O

Differential	O
effect	O
of	O
sex	O
hormones	O
on	O
AID	O
mRNA	O

Hormones	O
such	O
as	O
estrogen	O
and	O
progesterone	O
exert	O
their	O
biological	O
effects	O
through	O
binding	O
to	O
their	O
intracellular	O
receptors	O
and	O
,	O
upon	O
entering	O
the	O
nucleus	O
,	O
act	O
as	O
transcription	O
factors	O
(	O
35	O
)	O
.	O

To	O
determine	O
the	O
effects	O
of	O
hormones	O
on	O
AID	O
expression	O
,	O
we	O
stimulated	O
isolated	O
murine	O
splenic	O
B	O
cells	O
with	O
IL-4	O
and	O
LPS	O
,	O
which	O
are	O
known	O
to	O
induce	O
AID	O
(	O
24	O
)	O
,	O
while	O
adding	O
physiological	O
amounts	O
of	O
progesterone	O
and	O
estrogen	O
.	O

Progesterone	O
addition	O
reduced	O
AID	O
mRNA	O
levels	O
by	O
fivefold	O
,	O
as	O
revealed	O
by	O
quantitative	O
real-time	O
PCR	O
(	O
qRT-PCR	O
;	O
Fig	O
.	O
1	O
A	O
)	O
.	O

This	O
and	O
all	O
subsequent	O
qRT-PCR	O
analyses	O
were	O
normalized	O
to	O
GAPDH	O
expression	O
,	O
and	O
all	O
enhancements	O
or	O
repressions	O
were	O
analyzed	O
as	O
relative	O
changes	O
to	O
DMSO	O
.	O

To	O
observe	O
a	O
stimulatory	O
effect	O
of	O
estrogen	O
,	O
cells	O
were	O
only	O
treated	O
for	O
a	O
short	O
time	O
period	O
(	O
8	O
h	O
)	O
rather	O
than	O
the	O
usual	O
24–48	O
h	O
.	O

This	C
was	C
done	C
to	C
avoid	C
a	C
possible	C
maximal	C
induction	C
of	C
LPS/IL-4	C
caused	C
by	C
longer	C
treatment	C
.	C

In	O
contrast	O
to	O
progesterone	O
,	O
physiological	O
amounts	O
of	O
estrogen	O
were	O
able	O
to	O
enhance	O
AID	O
expression	O
threefold	O
in	O
these	O
cells	O
(	O
Fig	O
.	O
1	O
A	O
)	O
.	O

This	C
antithetical	C
effect	C
of	C
estrogen	C
and	C
progesterone	C
indicated	C
that	C
AID	C
gene	C
regulation	C
is	C
embedded	C
within	C
a	C
systemic	C
sex	C
hormone	C
pathway	C
.	C

The	O
effects	O
of	O
estrogen	O
and	O
progesterone	O
on	O
AID	O
mRNA	O
in	O
murine	O
splenic	O
B-cells	O
.	O

(	O
A	O
)	O
AID	O
mRNA	O
in	O
response	O
to	O
estrogen	O
and	O
progesterone	O
treatment	O
in	O
stimulated	O
B	O
cells	O
.	O

Isolated	O
mouse	O
spleen	O
B	O
cells	O
were	O
stimulated	O
with	O
LPS	O
and	O
IL-4	O
and	O
treated	O
with	O
different	O
physiological	O
concentrations	O
of	O
estrogen	O
for	O
8	O
h	O
or	O
progesterone	O
for	O
24	O
h	O
.	O

Unless	O
indicated	O
,	O
DMSO	O
is	O
set	O
to	O
1	O
,	O
and	O
treatments	O
are	O
represented	O
as	O
relative	O
change	O
to	O
DMSO	O
.	O

(	O
B	O
)	O
AID	O
mRNA	O
in	O
response	O
to	O
estrogen	O
treatment	O
in	O
unstimulated	O
B	O
cells	O
after	O
8	O
h	O
treatment	O
with	O
physiological	O
concentrations	O
of	O
estrogen	O
.	O

(	O
C	O
)	O
AID	O
mRNA	O
induction	O
upon	O
different	O
treatment	O
.	O

Cells	O
were	O
treated	O
with	O
1	O
nM	O
estrogen	O
and/or	O
50	O
nM	O
Tam	O
(	O
Tam	O
)	O
for	O
up	O
to	O
8	O
h	O
.	O

DMSO	O
at	O
0	O
h	O
is	O
set	O
to	O
1	O
.	O

All	O
qRT-PCR	O
data	O
are	O
representative	O
of	O
three	O
independent	O
experiments	O
,	O
and	O
error	O
bars	O
indicate	O
standard	O
deviations	O
from	O
the	O
mean	O
.	O

Timelines	O
of	O
cell	O
treatments	O
are	O
indicated	O
next	O
to	O
the	O
graphs	O
.	O

NT	O
,	O
not	O
treated	O
.	O

For	O
A	O
and	O
B	O
,	O
absolute	O
values	O
as	O
compared	O
with	O
GAPDH	O
mRNA	O
are	O
shown	O
in	O
Fig	O
.	O
S10	O
,	O
available	O
at	O
http	O
:	O
//www.jem.org/cgi/content/full/jem.20080521/DC1	O
.	O

We	O
focused	O
our	O
subsequent	O
experiments	O
on	O
the	O
verification	O
that	O
the	O
estrogen-induced	O
stimulation	O
on	O
AID	O
was	O
analogous	O
to	O
another	O
known	O
estrogen	O
response	O
gene	O
.	O

Because	C
we	C
could	C
determine	C
that	C
the	C
expression	C
of	C
gene	C
regulated	C
in	C
breast	C
cancer	C
1	C
(	C
a	C
known	C
estrogen	C
response	C
gene	C
)	C
(	C
36	C
)	C
had	C
a	C
similar	C
stimulation	C
profile	C
in	C
B	C
cells	C
(	C
unpublished	C
data	C
)	C
,	C
it	C
seemed	C
likely	C
that	C
the	C
AID	C
gene	C
could	C
also	C
be	C
activated	C
in	C
uninduced	C
B	C
cells	C
with	C
estrogen	C
.	C

Stimulation	O
of	O
isolated	O
splenic	O
B	O
cells	O
with	O
physiological	O
amounts	O
of	O
estrogen	O
produced	O
a	O
sevenfold	O
increase	O
in	O
AID	O
mRNA	O
(	O
Fig	O
.	O
1	O
B	O
)	O
.	O

This	O
induction	O
began	O
to	O
plateau	O
at	O
4	O
h	O
,	O
with	O
the	O
earliest	O
indication	O
of	O
an	O
increase	O
detectable	O
at	O
~2	O
h	O
(	O
Fig	O
.	O
1	O
C	O
)	O
.	O

In	C
most	C
systems	C
,	C
the	C
synthetic	C
hormone	C
Tam	C
acts	C
as	C
an	C
antagonist	C
to	C
estrogen	C
stimulation	C
,	C
presumably	C
by	C
binding	C
to	C
the	C
estrogen	C
receptor	C
(	C
ER	C
)	C
and	C
altering	C
its	C
DNA	C
binding	C
capacity	C
(	C
37	C
)	C
.	C

The	O
presence	O
of	O
Tam	O
during	O
the	O
estrogen	O
treatment	O
of	O
isolated	O
splenic	O
B	O
cells	O
inhibited	O
the	O
stimulatory	O
activity	O
,	O
whereas	O
Tam	O
on	O
its	O
own	O
had	O
only	O
a	O
limited	O
effect	O
on	O
AID	O
mRNA	O
expression	O
at	O
the	O
concentration	O
used	O
(	O
Fig	O
.	O
1	O
C	O
,	O
Estrogen	O
1	O
nM/Tam	O
and	O
Tam	O
,	O
respectively	O
)	O
.	O

Interestingly	C
,	C
at	C
very	C
low	C
concentrations	C
,	C
Tam	C
can	C
have	C
a	C
stimulatory	C
effect	C
on	C
AID	C
mRNA	C
(	C
Fig	C
.	C
S1	C
A	C
,	C
available	C
at	C
http	C
:	C
//www.jem.org/cgi/content/full/jem.20080521/DC1	C
)	C
,	C
which	C
may	C
reflect	C
Tam	C
's	C
agonistic	C
activity	C
(	C
see	C
Discussion	C
)	C
.	C

Hormonal	O
regulation	O
of	O
AID	O
mRNA	O
is	O
predominantly	O
via	O
transcription	O

Although	C
we	C
were	C
able	C
to	C
observe	C
an	C
increase	C
in	C
AID	C
mRNA	C
at	C
2	C
h	C
(	C
Fig	C
.	C
1	C
)	C
,	C
we	C
needed	C
to	C
determine	C
if	C
this	C
regulation	C
was	C
direct	C
or	C
indirect	C
.	C

We	O
pretreated	O
splenic	O
B	O
cells	O
with	O
the	O
translational	O
inhibitor	O
cycloheximide	O
(	O
CHX	O
)	O
,	O
followed	O
by	O
stimulation	O
with	O
estrogen	O
,	O
and	O
observed	O
an	O
increase	O
in	O
mRNA	O
production	O
equivalent	O
to	O
treatment	O
without	O
inhibitor	O
(	O
Fig	O
.	O
S1	O
B	O
)	O
.	O

This	C
suggested	C
that	C
the	C
effect	C
of	C
estrogen	C
was	C
directly	C
mediated	C
on	C
AID	C
's	C
mRNA	C
synthesis	C
.	C

Because	C
qRT-PCR	C
of	C
cDNA	C
is	C
a	C
readout	C
of	C
steady-state	C
mRNA	C
,	C
we	C
also	C
tested	C
if	C
the	C
increase	C
by	C
estrogen	C
was	C
caused	C
by	C
transcription	C
or	C
mRNA	C
metabolism	C
.	C

Treatment	C
of	C
cells	C
with	C
transcription	C
inhibitors	C
(	C
actinomycin	C
D	C
[	C
ACT	C
]	C
and	C
α-amanitin	C
[	C
AMA	C
]	C
)	C
abrogated	C
the	C
effect	C
of	C
estrogen	C
,	C
indicating	C
that	C
this	C
alteration	C
in	C
AID	C
's	C
mRNA	C
was	C
not	C
caused	C
by	C
message	C
stability	C
(	C
Fig	C
.	C
S1	C
B	C
)	C
.	C

As	O
estrogen	O
can	O
affect	O
pre-mRNA	O
to	O
mRNA	O
processing	O
(	O
38	O
)	O
,	O
we	O
designed	O
qRT-PCR	O
primers	O
to	O
span	O
the	O
complete	O
transcription	O
unit	O
of	O
AID	O
(	O
Fig	O
.	O
S2	O
A	O
,	O
available	O
at	O
http	O
:	O
//www.jem.org/cgi/content/full/jem.20080521/DC1	O
)	O
.	O

When	O
we	O
compared	O
the	O
relative	O
change	O
in	O
expression	O
of	O
the	O
various	O
pre-mRNA	O
's	O
exons	O
and	O
introns	O
to	O
that	O
of	O
the	O
mature	O
mRNA	O
,	O
we	O
found	O
only	O
a	O
minor	O
effect	O
caused	O
by	O
estrogen	O
treatment	O
(	O
the	O
5'-most	O
PCR	O
unit	O
,	O
<	O
100	O
bp	O
away	O
from	O
the	O
start	O
of	O
AID	O
gene	O
,	O
was	O
up-regulated	O
to	O
almost	O
the	O
same	O
extent	O
as	O
the	O
mature	O
mRNA	O
[	O
Fig	O
.	O
S2	O
B	O
]	O
)	O
.	O

The	C
intron	C
between	C
exon	C
3	C
and	C
4	C
(	C
7,538–7,689	C
bp	C
)	C
showed	C
a	C
marginal	C
increase	C
in	C
response	C
to	C
estrogen	C
over	C
that	C
of	C
the	C
mature	C
RNA	C
,	C
indicating	C
a	C
potential	C
region	C
for	C
estrogen-induced	C
splicing	C
of	C
AID	C
RNA	C
.	C

Because	C
the	C
relative	C
change	C
did	C
not	C
significantly	C
alter	C
the	C
overall	C
effect	C
,	C
we	C
did	C
not	C
pursue	C
this	C
analysis	C
further	C
,	C
although	C
recent	C
data	C
suggests	C
that	C
alternative	C
splicing	C
may	C
influence	C
AID	C
expression	C
(	C
39	C
)	C
.	C

The	O
experiments	O
substantiate	O
the	O
notion	O
that	O
estrogen	O
's	O
main	O
mode	O
of	O
action	O
on	O
AID	O
is	O
through	O
transcriptional	O
regulation	O
and	O
not	O
mRNA	O
metabolism	O
.	O

Identification	O
of	O
hormone	O
response	O
elements	O
in	O
the	O
AID	O
promoter	O
regions	O

The	C
rapid	C
effect	C
of	C
the	C
hormones	C
on	C
AID	C
message	C
via	C
transcription	C
suggested	C
that	C
the	C
AID	C
gene	C
is	C
a	C
direct	C
target	C
for	C
hormonal	C
regulation	C
.	C

Using	O
bioinformatic	O
analysis	O
(	O
Fig	O
.	O
2	O
A	O
)	O
,	O
we	O
were	O
able	O
to	O
identify	O
putative	O
EREs	O
in	O
the	O
context	O
of	O
other	O
response	O
elements	O
,	O
such	O
as	O
NF-κB	O
.	O

We	O
dissected	O
the	O
1.5	O
kb	O
upstream	O
and	O
the	O
2	O
kb	O
downstream	O
of	O
the	O
ATG	O
regions	O
for	O
hormone-responsive	O
elements	O
in	O
a	O
heterologous	O
transcription	O
assay	O
.	O

The	C
potential	C
response	C
regions	C
were	C
placed	C
into	C
a	C
luciferase	C
reporter	C
construct	C
and	C
transfected	C
into	C
human	C
SiHa	C
cells	C
,	C
followed	C
by	C
treatment	C
with	C
the	C
indicated	C
hormone	C
(	C
or	C
cotransfected	C
with	C
expression	C
plasmids	C
)	C
,	C
and	C
then	C
analyzed	C
for	C
luciferase	C
activity	C
.	C

As	C
we	C
were	C
primarily	C
interested	C
in	C
the	C
effect	C
of	C
hormones	C
on	C
expression	C
,	C
we	C
used	C
relative	C
change	C
as	C
a	C
readout	C
rather	C
than	C
absolute	C
values	C
,	C
which	C
provided	C
a	C
more	C
direct	C
evaluation	C
of	C
the	C
hormone	C
treatment	C
but	C
potentially	C
obscured	C
the	C
individual	C
effect	C
of	C
the	C
various	C
DNA	C
elements	C
.	C

When	C
compared	C
with	C
DMSO	C
treatment	C
,	C
estrogen	C
responsiveness	C
was	C
most	C
significant	C
with	C
Fragment	C
C	C
,	C
indicating	C
that	C
this	C
contained	C
the	C
predominant	C
estrogen-responsive	C
DNA	C
element	C
.	C

Comparable	O
to	O
the	O
mRNA	O
production	O
of	O
AID	O
in	O
B	O
cells	O
,	O
Fragment	O
C	O
also	O
responded	O
in	O
a	O
dose-dependent	O
manner	O
to	O
estrogen	O
(	O
Fig	O
.	O
2	O
C	O
)	O
.	O

Aside	O
from	O
the	O
putative	O
ERE	O
,	O
Fragment	O
C	O
also	O
harbored	O
the	O
two	O
published	O
NF-κB	O
binding	O
sites	O
(	O
24	O
)	O
.	O

As	C
indicated	C
by	C
the	C
qRT-PCR	C
analysis	C
in	C
Fig	C
.	C
1	C
A	C
,	C
estrogen	C
and	C
the	C
LPS/IL-4–induced	C
NF-κB	C
stress-response	C
pathway	C
could	C
act	C
synergistically	C
on	C
AID	C
mRNA	C
production	C
.	C

To	O
more	O
directly	O
stimulate	O
the	O
NF-κB	O
pathway	O
in	O
SiHa	O
cells	O
,	O
we	O
used	O
the	O
cell-autonomous	O
activator	O
TNF-α	O
(	O
Fig	O
.	O
2	O
C	O
)	O
.	O

Interestingly	O
,	O
aside	O
from	O
the	O
synergy	O
(	O
e.g.	O
,	O
10-9	O
M	O
)	O
,	O
the	O
two	O
maxima	O
of	O
the	O
dose	O
response	O
were	O
offset	O
(	O
TNF-γ	O
treated	O
,	O
10-9	O
M	O
;	O
untreated	O
,	O
10-7	O
M	O
)	O
,	O
indicating	O
a	O
higher	O
complexity	O
of	O
the	O
two	O
interacting	O
pathways	O
.	O

To	O
demonstrate	O
independence	O
of	O
the	O
two	O
pathways	O
,	O
we	O
analyzed	O
the	O
response	O
of	O
Fragment	O
C	O
to	O
treatment	O
with	O
TNF-α	O
and	O
estrogen	O
upon	O
cotransfection	O
of	O
the	O
dominant-negative	O
mutant	O
of	O
IκBα	O
(	O
IκBα	O
S32A/S36A	O
dominant	O
mutant	O
[	O
IκBα-mt	O
]	O
)	O
,	O
which	O
is	O
known	O
to	O
inhibit	O
the	O
release	O
of	O
NF-κB	O
from	O
the	O
cytoplasm	O
into	O
the	O
nucleus	O
after	O
stimulation	O
.	O

As	O
shown	O
in	O
Fig	O
.	O
2	O
D	O
,	O
the	O
TNF-α	O
activation	O
was	O
inhibited	O
in	O
the	O
presence	O
of	O
IκBα-mt	O
,	O
yet	O
estrogen	O
was	O
able	O
to	O
independently	O
activate	O
the	O
transcription	O
.	O

This	C
indicated	C
that	C
in	C
the	C
AID	C
promoter	C
,	C
the	C
NF-κB	C
site	C
and	C
its	C
proximal	C
ERE	C
could	C
act	C
independently	C
as	C
well	C
as	C
synergistically	C
.	C

Human	O
AID	O
promoter	O
analysis	O
for	O
hormone	O
response	O
elements	O
.	O

(	O
A	O
)	O
Schematic	O
representation	O
of	O
potential	O
EREs	O
(	O
square	O
)	O
and	O
NF-κB	O
sites	O
(	O
circle	O
)	O
and	O
their	O
respective	O
locations	O
in	O
the	O
human	O
promoter	O
.	O

The	O
indicated	O
promoter	O
regions	O
(	O
marked	O
A–E	O
)	O
were	O
inserted	O
into	O
a	O
luciferase	O
reporter	O
construct	O
with	O
a	O
minimal	O
promoter	O
.	O

The	O
vectors	O
were	O
transfected	O
into	O
SiHa	O
cells	O
,	O
incubated	O
for	O
24	O
h	O
,	O
treated	O
for	O
4	O
h	O
with	O
hormones	O
or	O
TNF-α	O
,	O
and	O
analyzed	O
for	O
luciferase	O
activity	O
.	O

(	O
B	O
)	O
Relative	O
luciferase	O
activity	O
after	O
estrogen	O
treatment	O
.	O

Cells	O
were	O
transfected	O
with	O
constructs	O
containing	O
AID	O
promoter	O
fragments	O
and	O
treated	O
with	O
estrogen	O
for	O
4	O
h	O
.	O

(	O
C	O
)	O
Effect	O
of	O
TNF-α	O
and	O
estrogen	O
on	O
the	O
human	O
AID	O
promoter	O
.	O

Expression	O
construct	O
with	O
an	O
AID	O
promoter	O
region	O
containing	O
NF-κB	O
sites	O
and	O
putative	O
ERE	O
(	O
Fragment	O
C	O
)	O
were	O
transfected	O
into	O
cells	O
,	O
followed	O
by	O
TNF-α	O
and/or	O
estrogen	O
treatment	O
for	O
4	O
h	O
.	O

(	O
D	O
)	O
Estrogen	O
can	O
act	O
independently	O
from	O
NF-κB	O
.	O

Cells	O
were	O
cotransfected	O
with	O
Fragment	O
C	O
and	O
an	O
IκBα-mt	O
expression	O
vector	O
.	O

After	O
24	O
h	O
,	O
cells	O
were	O
treated	O
with	O
TNF-α	O
and/or	O
100	O
nM	O
estrogen	O
for	O
4	O
h	O
.	O

Timelines	O
of	O
cell	O
treatments	O
are	O
indicated	O
below	O
the	O
graphs	O
.	O

NT	O
,	O
not	O
treated	O
.	O

ERE	O
binding	O
in	O
B	O
cell	O
extracts	O

The	C
transient	C
transfection	C
assay	C
indicated	C
that	C
a	C
predicted	C
ERE	C
was	C
subject	C
to	C
estrogen	C
regulation	C
.	C

Thus	O
,	O
we	O
analyzed	O
ER	O
binding	O
to	O
the	O
AID	O
promoter	O
and	O
focused	O
on	O
the	O
more	O
widely	O
expressed	O
receptor	O
subtype	O
ERα	O
.	O

To	O
analyze	O
the	O
binding	O
of	O
ER	O
to	O
parts	O
of	O
the	O
AID	O
promoter	O
in	O
vitro	O
,	O
we	O
prepared	O
nuclear	O
extracts	O
from	O
treated	O
and	O
untreated	O
cells	O
and	O
performed	O
electromobility	O
shift	O
assays	O
(	O
EMSA	O
)	O
.	O

For	O
the	O
biochemical	O
analysis	O
of	O
the	O
ER	O
binding	O
to	O
the	O
ERE	O
,	O
we	O
focused	O
on	O
NF-κB	O
proximal	O
ERE	O
of	O
Fragment	O
C	O
.	O

A	O
34-bp	O
fragment	O
containing	O
the	O
5'-most	O
proposed	O
ER	O
binding	O
site	O
was	O
incubated	O
with	O
untreated	O
and	O
treated	O
extract	O
(	O
Fig	O
.	O
3	O
B	O
,	O
lanes	O
2	O
and	O
3	O
)	O
.	O

The	O
estrogen	O
treatment	O
clearly	O
induced	O
a	O
protein	O
that	O
could	O
bind	O
the	O
fragment	O
(	O
arrow	O
)	O
,	O
which	O
was	O
not	O
induced	O
when	O
treating	O
the	O
B	O
cells	O
with	O
TNF-α	O
before	O
extract	O
preparation	O
(	O
lane	O
4	O
)	O
.	O

Cotreatment	C
with	C
estrogen	C
and	C
TNF-α	C
had	C
the	C
same	C
effect	C
as	C
estrogen	C
alone	C
(	C
Fig	C
.	C
3	C
B	C
,	C
lane	C
5	C
)	C
,	C
indicating	C
that	C
the	C
two	C
pathways	C
act	C
through	C
different	C
nuclear	C
proteins	C
.	C

Competition	O
experiments	O
with	O
the	O
ER	O
binding	O
site	O
(	O
Fig	O
.	O
3	O
B	O
,	O
lanes	O
6–8	O
)	O
or	O
a	O
mutation	O
of	O
the	O
proposed	O
ER	O
site	O
(	O
Fig	O
.	O
3	O
B	O
,	O
lanes	O
9–11	O
)	O
showed	O
a	O
specific	O
competition	O
,	O
indicating	O
ER-like	O
binding	O
kinetics	O
.	O

Using	O
antibodies	O
to	O
the	O
DNA-binding	O
domain	O
of	O
ERα	O
strongly	O
inhibited	O
the	O
formation	O
of	O
the	O
estrogen-induced	O
band	O
(	O
Fig	O
.	O
3	O
C	O
,	O
lanes	O
2	O
vs.	O
3–5	O
)	O
,	O
but	O
the	O
shift	O
was	O
unaffected	O
by	O
a	O
control	O
antibody	O
(	O
Fig	O
.	O
3	O
C	O
,	O
lanes	O
2	O
vs.	O
6–8	O
,	O
arrow	O
)	O
.	O

The	C
anti-ERα	C
antibody	C
did	C
induce	C
the	C
appearance	C
of	C
a	C
high	C
molecular	C
weight	C
complex	C
(	C
Fig	C
.	C
3	C
C	C
,	C
triangle	C
in	C
lanes	C
4	C
and	C
5	C
)	C
,	C
which	C
could	C
be	C
caused	C
by	C
either	C
the	C
supershift	C
of	C
a	C
dimerized	C
ERα	C
or	C
heterodimer	C
ERα/ERß	C
;	C
however	C
,	C
this	C
needs	C
to	C
be	C
analyzed	C
further	C
.	C

Identification	O
of	O
ER	O
binding	O
to	O
human	O
AID	O
promoter	O
by	O
EMSA	O
and	O
ChIP	O
.	O

(	O
A	O
)	O
Schematic	O
representation	O
of	O
human	O
AID	O
promoter	O
region	O
(	O
as	O
in	O
Fig	O
.	O
2	O
A	O
)	O
.	O

The	O
position	O
of	O
the	O
oligonucleotide	O
used	O
for	O
EMSA	O
and	O
the	O
region	O
amplified	O
by	O
qRT-PCR	O
for	O
ChIP	O
are	O
marked	O
as	O
a	O
black	O
line	O
and	O
a	O
dashed	O
line	O
,	O
respectively	O
.	O

(	O
B	O
)	O
Estrogen	O
(	O
denoted	O
as	O
E	O
)	O
-induced	O
oligonucleotide	O
shift	O
(	O
marked	O
with	O
an	O
arrow	O
)	O
in	O
Ramos	O
nuclear	O
extracts	O
.	O

Cells	O
were	O
treated	O
for	O
72	O
h	O
in	O
hormone-depleted	O
serum	O
,	O
followed	O
by	O
4-h	O
treatment	O
with	O
10	O
nM	O
estrogen	O
(	O
lanes	O
3	O
and	O
5–11	O
)	O
and/or	O
TNF-α	O
(	O
lanes	O
4	O
and	O
5	O
)	O
,	O
and	O
nuclear	O
extract	O
preparation	O
.	O

Different	O
concentrations	O
of	O
unlabeled	O
competitors	O
ER	O
(	O
lanes	O
6–8	O
)	O
and	O
mutated	O
ER	O
mut	O
(	O
lanes	O
9–11	O
)	O
were	O
added	O
to	O
the	O
binding	O
reaction	O
.	O

Open	O
triangle	O
,	O
nonspecific	O
DNA	O
binding	O
band	O
.	O

(	O
C	O
)	O
EMSA	O
with	O
anti-ERα	O
antibodies	O
.	O

Increasing	O
concentrations	O
of	O
anti-ERα	O
antibody	O
and	O
a	O
nonspecific	O
antibody	O
were	O
added	O
to	O
the	O
binding	O
reaction	O
(	O
see	O
Materials	O
and	O
methods	O
)	O
.	O

The	O
estrogen-induced	O
band	O
is	O
marked	O
with	O
an	O
arrow	O
,	O
and	O
a	O
super-shifted	O
band	O
appearing	O
upon	O
anti-ERα	O
antibody	O
addition	O
is	O
marked	O
with	O
a	O
closed	O
triangle	O
.	O

Open	O
triangle	O
,	O
nonspecific	O
DNA-binding	O
band	O
.	O

(	O
D	O
)	O
ERα	O
binds	O
to	O
upstream	O
region	O
of	O
human	O
AID	O
promoter	O
.	O

Cells	O
were	O
treated	O
as	O
in	O
B	O
.	O

Data	O
are	O
representative	O
of	O
three	O
independent	O
experiments	O
and	O
error	O
bars	O
indicate	O
standard	O
deviations	O
from	O
the	O
mean	O
.	O

ChIP	O
was	O
performed	O
using	O
anti-ERα	O
or	O
control	O
antibodies	O
,	O
and	O
the	O
bound	O
DNA	O
was	O
subjected	O
to	O
qRT-PCR	O
.	O

Estrogen	O
and	O
Tam	O
treatments	O
are	O
marked	O
with	O
E1	O
(	O
estrogen	O
1	O
nM	O
)	O
,	O
E10	O
(	O
estrogen	O
10	O
nM	O
)	O
,	O
and	O
Tam	O
,	O
respectively	O
.	O

(	O
E	O
)	O
Estrogen	O
can	O
cooperate	O
with	O
TNF-α	O
in	O
recruiting	O
NF-κB	O
to	O
AID	O
promoter	O
.	O

ChIP	O
is	O
as	O
in	O
D	O
,	O
using	O
anti–NF-κB	O
or	O
control	O
antibodies	O
.	O

NT	O
,	O
not	O
treated	O
.	O

Because	C
estrogen	C
and	C
TNF-α	C
co-stimulation	C
did	C
not	C
alter	C
ER	C
binding	C
to	C
the	C
ERE	C
,	C
we	C
wanted	C
to	C
determine	C
if	C
the	C
reciprocal	C
of	C
NF-κB	C
binding	C
to	C
the	C
NF-κB	C
site	C
,	C
after	C
the	C
combined	C
treatment	C
,	C
was	C
also	C
unaffected	C
.	C

To	O
that	O
end	O
,	O
we	O
probed	O
the	O
published	O
NF-κB	O
site	O
(	O
24	O
)	O
with	O
our	O
extracts	O
.	O

Using	O
cold	O
competitors	O
(	O
Fig	O
.	O
S3	O
B	O
,	O
lane	O
4	O
vs.	O
6–11	O
,	O
available	O
at	O
http	O
:	O
//www.jem.org/cgi/content/full/jem.20080521/DC1	O
)	O
,	O
as	O
well	O
as	O
anti–NF-κB	O
antibodies	O
(	O
Fig	O
.	O
S3	O
C	O
)	O
,	O
we	O
could	O
demonstrate	O
the	O
specificity	O
of	O
the	O
NF-κB	O
binding	O
site	O
.	O

As	O
with	O
the	O
ER	O
binding	O
site	O
,	O
NF-κB	O
binding	O
was	O
not	O
altered	O
by	O
cotreatment	O
with	O
estrogen	O
and	O
TNF-α	O
(	O
Fig	O
.	O
S3	O
B	O
,	O
lanes	O
4	O
vs.	O
5	O
)	O
.	O

This	C
indicated	C
that	C
the	C
respective	C
treatments	C
did	C
not	C
alter	C
the	C
general	C
DNA-binding	C
properties	C
of	C
ER	C
or	C
NF-κB	C
proteins	C
.	C

Because	O
the	O
distance	O
,	O
on	O
the	O
AID	O
promoter	O
,	O
between	O
the	O
ER	O
and	O
NF-κB	O
sites	O
was	O
larger	O
than	O
our	O
EMSA	O
probes	O
(	O
i.e.	O
,	O
neither	O
probe	O
contained	O
both	O
binding	O
sites	O
)	O
,	O
we	O
could	O
not	O
study	O
the	O
effect	O
of	O
cooperative	O
binding	O
.	O

ER	O
binding	O
to	O
AID	O
promoter	O
in	O
vivo	O

Although	C
the	C
in	C
vitro	C
binding	C
of	C
the	C
ER	C
to	C
the	C
AID	C
promoter	C
indicated	C
a	C
direct	C
binding	C
,	C
we	C
also	C
wanted	C
to	C
probe	C
this	C
interaction	C
in	C
vivo	C
.	C

To	O
this	O
end	O
,	O
we	O
used	O
the	O
constitutive	O
AID-expressing	O
and	O
mutating	O
Burkitt	O
lymphoma	O
Ramos	O
cells	O
and	O
performed	O
chromatin	O
immunoprecipitation	O
(	O
ChIP	O
)	O
assay	O
,	O
followed	O
by	O
qRT-PCR	O
.	O

Treated	O
cells	O
were	O
fixed	O
,	O
lysed	O
,	O
DNA	O
sheared	O
,	O
and	O
ERα	O
or	O
NF-κB	O
immunoprecipitated	O
,	O
and	O
the	O
DNA	O
was	O
released	O
for	O
PCR	O
.	O

As	O
shown	O
in	O
Fig	O
.	O
3	O
D	O
,	O
the	O
anti-ER	O
antibody	O
specifically	O
immunoprecipitated	O
the	O
AID	O
promoter	O
upon	O
estrogen	O
stimulation	O
in	O
a	O
dose-dependent	O
manner	O
.	O

A	O
control	O
antibody	O
was	O
unable	O
to	O
precipitate	O
this	O
region	O
.	O

Analogous	O
to	O
the	O
EMSA	O
assay	O
,	O
we	O
did	O
not	O
detect	O
a	O
significant	O
increase	O
in	O
ER	O
binding	O
to	O
AID	O
promoter	O
when	O
we	O
co-stimulated	O
with	O
TNF-α	O
,	O
just	O
as	O
TNF-α	O
treatment	O
alone	O
did	O
not	O
enhance	O
ER	O
binding	O
.	O

Again	O
,	O
cotreatment	O
of	O
cells	O
with	O
Tam	O
and	O
estrogen	O
before	O
ChIP	O
did	O
reduce	O
the	O
binding	O
of	O
ERα	O
to	O
the	O
AID	O
promoter	O
,	O
whereas	O
Tam	O
on	O
its	O
own	O
did	O
not	O
significantly	O
alter	O
ERα	O
binding	O
(	O
Fig	O
.	O
3	O
D	O
,	O
E	O
10/Tam	O
and	O
Tam	O
,	O
respectively	O
)	O
,	O
providing	O
further	O
evidence	O
for	O
a	O
direct	O
binding	O
of	O
ERα	O
to	O
the	O
AID	O
promoter	O
.	O

Treatment	O
of	O
the	O
cells	O
with	O
TNF-α	O
increased	O
the	O
binding	O
of	O
NF-κB	O
to	O
the	O
AID	O
promoter	O
by	O
more	O
than	O
sevenfold	O
(	O
Fig	O
.	O
3	O
E	O
)	O
.	O

Interestingly	O
,	O
co-stimulation	O
of	O
the	O
cells	O
with	O
TNF-α	O
and	O
estrogen	O
had	O
a	O
synergistic	O
effect	O
on	O
the	O
NF-κB	O
binding	O
;	O
the	O
binding	O
increased	O
to	O
>	O
30-fold	O
above	O
unstimulated	O
treatment	O
(	O
4.5-fold	O
above	O
TNF-α	O
alone	O
)	O
.	O

Estrogen	O
up-regulates	O
AID	O
protein	O
production	O

For	C
us	C
to	C
determine	C
if	C
the	C
effect	C
of	C
estrogen	C
on	C
AID	C
would	C
also	C
extend	C
to	C
the	C
protein	C
level	C
,	C
we	C
developed	C
a	C
quantitative	C
approach	C
for	C
measuring	C
AID	C
protein	C
.	C

We	O
generated	O
a	O
DT40	O
cell	O
line	O
(	O
a	O
cell	O
line	O
derived	O
from	O
a	O
chicken	O
B	O
cell	O
lymphoma	O
that	O
constitutively	O
expresses	O
AID	O
and	O
undergoes	O
Ig	O
diversification	O
)	O
to	O
express	O
a	O
double	O
tag	O
(	O
3xFLAG-2xTEV-3xc-Myc	O
)	O
fused	O
to	O
the	O
C	O
terminal	O
exon	O
of	O
endogenous	O
AID	O
(	O
AID	O
FLAG-Myc–tagged	O
AID	O
protein	O
[	O
AID-FM	O
]	O
;	O
Fig	O
.	O
S4	O
,	O
available	O
at	O
http	O
:	O
//www.jem.org/cgi/content/full/jem.20080521/DC1	O
)	O
.	O

The	O
modified	O
DT40	O
express	O
a	O
WT	O
AID	O
protein	O
and	O
an	O
AID-FM	O
fusion	O
protein	O
,	O
both	O
transcribed	O
from	O
the	O
endogenous	O
AID	O
locus	O
.	O

Comparing	O
the	O
qRT-PCR	O
induction	O
kinetics	O
with	O
that	O
of	O
the	O
AID-FM	O
expression	O
,	O
we	O
determined	O
that	O
the	O
steady-state	O
levels	O
of	O
AID	O
protein	O
correlated	O
to	O
those	O
of	O
the	O
mRNA	O
(	O
Fig	O
.	O
4	O
,	O
A	O
and	O
B	O
)	O
.	O

Using	O
the	O
translation	O
inhibitor	O
CHX	O
(	O
Fig	O
.	O
4	O
C	O
)	O
,	O
we	O
showed	O
that	O
estrogen	O
was	O
not	O
able	O
to	O
increase	O
AID-FM	O
expression	O
in	O
the	O
absence	O
of	O
translation	O
.	O

In	C
the	C
presence	C
of	C
the	C
proteasome	C
inhibitor	C
MG-132	C
(	C
Fig	C
.	C
4	C
C	C
)	C
,	C
estrogen	C
increased	C
AID-FM	C
production	C
above	C
that	C
of	C
the	C
MG-132	C
alone	C
,	C
indicating	C
that	C
estrogen	C
was	C
not	C
acting	C
on	C
the	C
proteasome	C
to	C
increase	C
AID-FM	C
activity	C
.	C

The	O
aforementioned	O
co-stimulatory	O
effects	O
of	O
TNF-α	O
were	O
also	O
observed	O
at	O
the	O
level	O
of	O
protein	O
production	O
(	O
Fig	O
.	O
4	O
,	O
E	O
10/TNF-α	O
)	O
.	O

The	O
effects	O
of	O
estrogen	O
on	O
AID	O
protein	O
in	O
DT40	O
.	O

(	O
A	O
)	O
Estrogen	O
induces	O
AID	O
mRNA	O
expression	O
.	O

AID-FM–tagged	O
DT40	O
cells	O
were	O
treated	O
with	O
DMSO	O
,	O
100	O
nM	O
estrogen	O
,	O
and	O
10	O
nM	O
estrogen	O
with	O
TNF-α	O
,	O
lysed	O
,	O
and	O
analyzed	O
for	O
AID	O
mRNA	O
expression	O
with	O
pRT-PCR	O
at	O
various	O
time-points	O
.	O

(	O
B	O
)	O
Estrogen	O
induces	O
AID-FM	O
fusion	O
protein	O
expression	O
.	O

Treatment	O
as	O
in	O
A	O
,	O
but	O
lysates	O
were	O
analyzed	O
by	O
quantitative	O
Western	O
blot	O
.	O

For	O
each	O
sample	O
,	O
FLAG	O
and	O
Tubulin	O
expression	O
was	O
quantitated	O
.	O

The	O
graph	O
is	O
derived	O
from	O
correlating	O
the	O
FLAG	O
expression	O
to	O
Tubulin	O
expression	O
,	O
and	O
then	O
determining	O
the	O
ratio	O
of	O
estrogen-induced	O
FLAG	O
expression	O
to	O
untreated	O
DMSO	O
samples	O
.	O

(	O
C	O
)	O
Estrogen	O
does	O
not	O
affect	O
AID-FM	O
fusion	O
protein	O
stability	O
.	O

Cells	O
were	O
incubated	O
with	O
CHX	O
or	O
MG-132	O
for	O
2	O
h	O
,	O
followed	O
by	O
estrogen	O
treatment	O
for	O
4	O
h	O
.	O

Protein	O
levels	O
were	O
determined	O
by	O
quantitative	O
Western	O
blot	O
.	O

For	O
all	O
experiments	O
,	O
cells	O
were	O
grown	O
in	O
hormone	O
depleted	O
media	O
for	O
48	O
h	O
.	O

Results	O
are	O
normalized	O
to	O
control	O
treatments	O
as	O
indicated	O
on	O
each	O
graph	O
.	O

Timelines	O
of	O
cell	O
treatments	O
are	O
indicated	O
below	O
the	O
graphs	O
.	O

Hormonal	O
regulation	O
of	O
CSR	O
and	O
SHM	O

On	C
the	C
molecular	C
level	C
,	C
CSR	C
requires	C
AID	C
,	C
yet	C
regulation	C
can	C
be	C
achieved	C
on	C
multiple	C
levels	C
,	C
some	C
of	C
which	C
may	C
be	C
hormonally	C
influenced	C
.	C

To	O
analyze	O
CSR	O
,	O
isolated	O
mouse	O
splenic	O
B	O
cells	O
were	O
treated	O
with	O
different	O
combinations	O
of	O
cytokines	O
and	O
hormones	O
.	O

B	O
cell	O
stimulation	O
with	O
LPS	O
,	O
LPS	O
and	O
IL-4	O
,	O
LPS	O
and	O
IFN-γ	O
,	O
or	O
LPS	O
and	O
TGF-ß	O
results	O
in	O
switching	O
to	O
IgG3	O
,	O
IgG1	O
,	O
IgG2a	O
,	O
or	O
IgG2b/IgA	O
,	O
respectively	O
.	O

To	C
ensure	C
we	C
could	C
correlate	C
AID	C
activity	C
precisely	C
,	C
and	C
to	C
avoid	C
possible	C
proliferative	C
and	C
antiapoptotic	C
effects	C
of	C
estrogen	C
on	C
stimulated	C
B	C
cells	C
,	C
we	C
monitored	C
the	C
early	C
molecular	C
events	C
of	C
class	C
switching	C
.	C

One	O
of	O
the	O
molecular	O
intermediates	O
during	O
class	O
switching	O
is	O
the	O
generation	O
of	O
a	O
looped-out	O
circular	O
DNA	O
called	O
a	O
switch	O
circle	O
(	O
Fig	O
.	O
S5	O
,	O
available	O
at	O
http	O
:	O
//www.jem.org/cgi/content/full/jem.20080521/DC1	O
)	O
.	O

The	O
circular	O
DNA	O
contains	O
a	O
recombined	O
transcription	O
unit	O
that	O
produces	O
switch	O
circle	O
transcripts	O
;	O
it	O
is	O
generated	O
from	O
the	O
promoter	O
of	O
the	O
downstream	O
switch	O
region	O
and	O
the	O
Igµ	O
switch	O
region	O
.	O

Using	O
a	O
previously	O
described	O
qRT-PCR	O
approach	O
(	O
40	O
)	O
,	O
we	O
were	O
able	O
to	O
show	O
enhanced	O
switching	O
to	O
IgG1	O
,	O
IgG3	O
,	O
IgA	O
,	O
or	O
IgE	O
after	O
hormone	O
treatment	O
of	O
splenic	O
B	O
cells	O
(	O
Fig	O
.	O
5	O
A	O
)	O
.	O

Presumably	C
through	C
the	C
increased	C
production	C
of	C
AID	C
,	C
estrogen	C
was	C
able	C
to	C
enhance	C
switch	C
circle	C
formation	C
for	C
all	C
subclasses	C
tested	C
.	C

As	O
with	O
the	O
AID	O
production	O
,	O
this	O
link	O
was	O
perturbed	O
with	O
the	O
addition	O
of	O
Tam	O
during	O
estrogen	O
treatment	O
(	O
Fig	O
.	O
5	O
A	O
,	O
Estrogen	O
10	O
nM/Tam	O
and	O
Tam	O
)	O
.	O

Hormonal	O
effects	O
on	O
Ig	O
class	O
switching	O
,	O
hypermutation	O
,	O
and	O
translocation	O
.	O

(	O
A	O
)	O
Estrogen	O
induces	O
isotype	O
switching	O
.	O

Isolated	O
mouse	O
splenic	O
B	O
cells	O
were	O
stimulated	O
for	O
48	O
h	O
with	O
LPS	O
+	O
IL-4	O
for	O
switching	O
to	O
IgG1	O
and	O
IgE	O
,	O
LPS	O
+	O
TGF-ß	O
for	O
switching	O
to	O
IgA	O
,	O
and	O
LPS	O
for	O
switching	O
to	O
IgG3	O
.	O

Indicated	O
amounts	O
of	O
estrogen	O
and/or	O
Tam	O
were	O
added	O
to	O
the	O
cells	O
together	O
with	O
cytokines	O
.	O

Relative	O
efficiency	O
of	O
class	O
switching	O
was	O
determined	O
by	O
detecting	O
circle	O
transcripts	O
with	O
qRT-PCR	O
,	O
and	O
data	O
are	O
normalized	O
to	O
the	O
control	O
treatment	O
with	O
DMSO	O
from	O
three	O
independent	O
experiments	O
(	O
error	O
bars	O
indicate	O
standard	O
deviations	O
)	O
.	O

(	O
B	O
)	O
Estrogen	O
increases	O
the	O
mutation	O
frequency	O
in	O
VH	O
and	O
CD95/Fas	O
loci	O
of	O
Ramos	O
,	O
and	O
in	O
Sγ3	O
of	O
splenic	O
mouse	O
cells	O
.	O

Ramos	O
cells	O
were	O
grown	O
in	O
the	O
presence	O
of	O
100	O
nM	O
estrogen	O
for	O
~20	O
doublings	O
,	O
followed	O
by	O
sequencing	O
of	O
341	O
bp	O
from	O
human	O
VH	O
or	O
750	O
bp	O
from	O
human	O
CD95/Fas	O
locus	O
.	O

Splenic	O
mouse	O
cells	O
were	O
treated	O
for	O
6	O
d	O
with	O
LPS	O
and	O
10	O
nM	O
estrogen	O
,	O
and	O
switch	O
gamma3	O
loci	O
amplified	O
and	O
sequenced	O
(	O
Fig	O
.	O
S7	O
)	O
.	O

Mutation	O
frequencies	O
are	O
normalized	O
to	O
the	O
control	O
treatments	O
with	O
DMSO	O
.	O

A	O
standard	O
unpaired	O
two-tailed	O
Student	O
's	O
t	O
test	O
showed	O
a	O
significant	O
difference	O
in	O
mutation	O
frequency	O
in	O
the	O
Sγ3	O
loci	O
of	O
DMSO-	O
and	O
estrogen-treated	O
spleen	O
cells	O
.	O

(	O
C	O
)	O
Estrogen	O
enhances	O
the	O
c-myc/IgH	O
translocations	O
in	O
splenic	O
B	O
cells	O
from	O
p53+/-	O
mice	O
.	O

In	C
each	C
experiment	C
,	C
2	C
spleens	C
per	C
sample	C
were	C
treated	C
with	C
or	C
without	C
50	C
nM	C
estrogen	C
in	C
the	C
presence	C
of	C
LPS	C
for	C
72	C
h	C
.	C

More	O
than	O
7	O
×	O
107	O
cells	O
were	O
analyzed	O
by	O
long-range	O
PCR	O
(	O
5	O
×	O
104	O
cells/PCR	O
;	O
Fig	O
.	O
S8	O
and	O
Supplemental	O
materials	O
and	O
methods	O
)	O
.	O

Frequency	O
was	O
determined	O
as	O
c-myc/IgH	O
translocation	O
events	O
per	O
cell	O
number	O
analyzed	O
.	O

Statistics	O
was	O
performed	O
on	O
the	O
results	O
of	O
the	O
pooled	O
experiments	O
(	O
two-tailed	O
,	O
unpaired	O
Student	O
's	O
t	O
test	O
:	O
P	O
=	O
0.026	O
)	O
.	O

Fig	O
.	O
S7	O
,	O
Fig	O
.	O
S8	O
,	O
and	O
Supplemental	O
materials	O
and	O
methods	O
are	O
available	O
at	O
http	O
:	O
//www.jem.org/cgi/content/full/jem.20080521/DC1	O
.	O

To	O
determine	O
the	O
effect	O
of	O
estrogen-induced	O
AID	O
on	O
SHM	O
,	O
we	O
sequenced	O
the	O
VH	O
region	O
of	O
in	O
vitro–cultured	O
Ramos	O
cells	O
,	O
as	O
well	O
as	O
the	O
switch	O
region	O
of	O
γ3	O
from	O
ex	O
vivo–stimulated	O
splenic	O
B	O
cells	O
.	O

A	O
3-wk	O
estrogen	O
treatment	O
of	O
Ramos	O
HS13	O
(	O
41	O
)	O
,	O
which	O
possesses	O
a	O
premature	O
stop	O
codon	O
embedded	O
within	O
the	O
AID	O
target	O
motif	O
WRC	O
,	O
showed	O
enhanced	O
surface	O
Ig	O
expression	O
and	O
VH	O
SHM	O
(	O
Fig	O
.	O
5	O
B	O
and	O
Fig	O
.	O
S6	O
,	O
available	O
at	O
http	O
:	O
//www.jem.org/cgi/content/full/jem.20080521/DC1	O
)	O
.	O

Because	O
Ramos	O
expresses	O
constitutive	O
amounts	O
of	O
AID	O
,	O
estrogen	O
treatment	O
did	O
not	O
enhance	O
AID	O
production	O
substantially	O
;	O
thus	O
,	O
we	O
used	O
the	O
ex	O
vivo	O
treatment	O
of	O
spleens	O
as	O
a	O
means	O
to	O
detect	O
mutations	O
in	O
the	O
switch	O
region	O
(	O
42	O
)	O
.	O

To	O
this	O
end	O
,	O
we	O
treated	O
LPS-activated	O
splenic	O
B	O
cells	O
with	O
10	O
nM	O
estrogen	O
for	O
6	O
d	O
and	O
sequenced	O
the	O
Sγ3	O
region	O
.	O

Because	C
AID+/-	C
mice	C
show	C
a	C
haploinsufficiency	C
effect	C
(	C
43	C
,	C
44	C
)	C
,	C
we	C
used	C
F1	C
spleens	C
from	C
an	C
AID-/-	C
and	C
BALB/c	C
cross	C
for	C
analysis	C
,	C
hypothesizing	C
that	C
the	C
estrogen	C
effect	C
would	C
be	C
more	C
pronounced	C
.	C

As	O
can	O
be	O
seen	O
in	O
Fig	O
.	O
5	O
B	O
and	O
Fig	O
.	O
S7	O
,	O
there	O
was	O
a	O
significant	O
(	O
P	O
<	O
0.02	O
)	O
enhancement	O
of	O
mutation	O
frequency	O
in	O
the	O
switch	O
region	O
after	O
estrogen	O
treatment	O
.	O

Enhanced	O
non-Ig	O
loci	O
targeting	O
of	O
AID	O

It	O
is	O
known	O
that	O
AID	O
can	O
be	O
mistargeted	O
to	O
non-Ig	O
genes	O
(	O
12	O
,	O
17–19	O
)	O
.	O

The	C
effect	C
of	C
aberrant	C
AID	C
targeting	C
can	C
lead	C
to	C
somatic	C
mutations	C
or	C
even	C
translocations	C
of	C
protooncogenes	C
or	C
tumor	C
suppressors	C
,	C
and	C
subsequently	C
to	C
oncogenesis	C
(	C
16	C
)	C
.	C

To	C
determine	C
if	C
the	C
activity	C
of	C
hormones	C
via	C
AID	C
can	C
also	C
lead	C
to	C
an	C
alteration	C
in	C
non-Ig	C
loci	C
,	C
we	C
chose	C
to	C
look	C
at	C
the	C
proapoptotic	C
tumor	C
suppressor	C
CD95/Fas	C
.	C

CD95/Fas	O
has	O
been	O
shown	O
to	O
be	O
somatically	O
hypermutated	O
in	O
human	O
B	O
cells	O
,	O
albeit	O
100–1,000-fold	O
less	O
frequently	O
than	O
the	O
Ig	O
genes	O
(	O
18	O
)	O
.	O

We	O
analyzed	O
the	O
effects	O
of	O
estrogen	O
on	O
CD95/Fas	O
mutations	O
in	O
Ramos	O
HS13	O
.	O

As	C
with	C
the	C
physiological	C
B	C
cell	C
maturation	C
events	C
of	C
SHM	C
and	C
CSR	C
,	C
estrogen	C
was	C
able	C
to	C
increase	C
the	C
potentially	C
pathogenic	C
mutation	C
frequency	C
in	C
CD95/Fas	C
(	C
Fig	C
.	C
5	C
C	C
and	C
Fig	C
.	C
S7	C
B	C
)	C
.	C

Because	O
of	O
the	O
direct	O
effect	O
on	O
AID	O
function	O
(	O
mutation	O
)	O
,	O
this	O
data	O
provides	O
evidence	O
for	O
a	O
novel	O
way	O
in	O
which	O
estrogen	O
can	O
exert	O
a	O
direct	O
genotoxic	O
effect	O
on	O
oncogenes	O
or	O
tumor	O
suppressors	O
.	O

Estrogen	O
enhances	O
c-myc	O
IgH	O
translocations	O

The	O
off-target	O
effect	O
of	O
AID	O
was	O
also	O
detected	O
in	O
recent	O
work	O
on	O
chromosome	O
translocations	O
of	O
the	O
c-myc	O
oncogene	O
into	O
the	O
IgH	O
locus	O
.	O

More	O
importantly	O
,	O
the	O
levels	O
of	O
AID	O
protein	O
directly	O
influenced	O
chromosome	O
translocation	O
frequency	O
.	O

This	O
was	O
determined	O
from	O
both	O
the	O
analysis	O
of	O
AID	O
haploinsufficiency	O
(	O
44	O
)	O
and	O
microRNA	O
regulation	O
of	O
AID	O
protein	O
expression	O
(	O
45	O
,	O
46	O
)	O
.	O

In	O
both	O
cases	O
,	O
reduced	O
levels	O
of	O
AID	O
had	O
a	O
direct	O
bearing	O
on	O
the	O
number	O
of	O
observed	O
c-myc/IgH	O
translocations	O
.	O

Using	O
a	O
previously	O
described	O
assay	O
(	O
16	O
,	O
47	O
)	O
,	O
we	O
were	O
able	O
to	O
determine	O
that	O
estrogen	O
treatment	O
of	O
isolated	O
splenic	O
B	O
cells	O
enhances	O
c-myc/IgH	O
translocations	O
in	O
p53+/-	O
animals	O
(	O
Fig	O
.	O
5	O
C	O
and	O
Fig	O
.	O
S8	O
,	O
available	O
at	O
http	O
:	O
//www.jem.org/cgi/content/full/jem.20080521/DC1	O
)	O
.	O

Although	O
,	O
the	O
overall	O
frequency	O
of	O
translocations	O
was	O
low	O
,	O
we	O
have	O
not	O
been	O
able	O
to	O
observe	O
any	O
translocations	O
in	O
LPS/DMSO-treated	O
spleen	O
cells	O
,	O
yet	O
we	O
observed	O
five	O
(	O
two	O
in	O
one	O
experiment	O
and	O
three	O
in	O
another	O
)	O
translocations	O
in	O
the	O
LPS/estrogen	O
treatment	O
.	O

This	C
highlights	C
the	C
importance	C
of	C
regulating	C
AID	C
protein	C
amounts	C
within	C
a	C
cell	C
,	C
and	C
the	C
potential	C
pathogenic	C
consequences	C
of	C
unregulated	C
AID	C
expression	C
.	C

AID	O
induction	O
is	O
not	O
limited	O
to	O
B	O
cells	O

In	C
the	C
past	C
,	C
we	C
demonstrated	C
that	C
AID	C
mRNA	C
expression	C
is	C
not	C
limited	C
to	C
activated	C
B	C
cells	C
,	C
but	C
can	C
also	C
be	C
detected	C
in	C
oocytes	C
(	C
22	C
)	C
.	C

We	C
therefore	C
set	C
out	C
to	C
determine	C
if	C
the	C
increase	C
in	C
AID	C
mRNA	C
production	C
by	C
estrogen	C
was	C
also	C
detectable	C
in	C
dissected	C
tissues	C
and	C
various	C
tumor	C
cell	C
lines	C
.	C

Analysis	O
of	O
dissected	O
organs	O
and	O
tissue	O
from	O
mice	O
showed	O
AID	O
responsiveness	O
to	O
hormones	O
outside	O
the	O
immune	O
system	O
in	O
breast	O
and	O
ovarian	O
tissue	O
(	O
Fig	O
.	O
6	O
)	O
.	O

As	O
we	O
were	O
primarily	O
interested	O
in	O
the	O
hormone	O
sensitivity	O
of	O
the	O
transcripts	O
,	O
we	O
determined	O
the	O
relative	O
fold	O
stimulation	O
compared	O
with	O
DMSO	O
,	O
which	O
did	O
not	O
reflect	O
the	O
absolute	O
AID	O
mRNA	O
in	O
each	O
tissue	O
.	O

Interestingly	O
,	O
in	O
ovaries	O
,	O
AID	O
mRNA	O
was	O
induced	O
almost	O
25-fold	O
,	O
which	O
is	O
higher	O
than	O
in	O
any	O
other	O
organ	O
or	O
tissue	O
.	O

Because	C
isolated	C
oocytes	C
produce	C
AID	C
mRNA	C
(	C
22	C
)	C
,	C
we	C
suggest	C
that	C
the	C
increase	C
was	C
predominantly	C
caused	C
by	C
oocytes	C
or	C
other	C
ovarian-derived	C
tissue	C
,	C
rather	C
than	C
infiltrating	C
lymphocytes	C
.	C

Estrogen	O
induces	O
AID	O
and	O
Apobec3	O
transcription	O
in	O
mouse	O
tissue	O
.	O

The	O
red	O
and	O
blue	O
colors	O
indicate	O
the	O
results	O
for	O
mApobec3	O
and	O
mAID	O
,	O
respectively	O
.	O

Tissues	O
were	O
treated	O
with	O
DMSO	O
,	O
1	O
nM	O
estrogen	O
(	O
E1	O
)	O
,	O
or	O
10	O
nM	O
estrogen	O
(	O
E10	O
)	O
.	O

Gene	O
expression	O
is	O
normalized	O
to	O
the	O
control	O
treatments	O
with	O
DMSO	O
.	O

The	O
tissue	O
expression	O
profiles	O
represent	O
pooled	O
data	O
for	O
the	O
respective	O
tissues	O
from	O
two	O
experiments	O
.	O

Timelines	O
of	O
cell	O
treatments	O
are	O
indicated	O
below	O
the	O
graphs	O
.	O

Absolute	O
values	O
as	O
compared	O
with	O
GAPDH	O
mRNA	O
are	O
shown	O
in	O
Fig	O
.	O
S10	O
,	O
available	O
at	O
http	O
:	O
//www.jem.org/cgi/content/full/jem.20080521/DC1	O
.	O

Gross	C
tissue	C
dissection	C
can	C
provide	C
a	C
good	C
indication	C
of	C
possible	C
cell	C
types	C
that	C
can	C
induce	C
AID	C
mRNA	C
upon	C
estrogen	C
treatment	C
,	C
but	C
tissue	C
complexity	C
could	C
also	C
obscure	C
potential	C
targets	C
.	C

Although	O
we	O
did	O
not	O
detect	O
a	O
substantial	O
mRNA	O
increase	O
in	O
hepatocyte	O
or	O
cervix	O
cell	O
lines	O
(	O
Fig	O
.	O
S9	O
,	O
available	O
at	O
http	O
:	O
//www.jem.org/cgi/content/full/jem.20080521/DC1	O
)	O
,	O
we	O
were	O
able	O
to	O
show	O
a	O
significant	O
increase	O
(	O
ranging	O
from	O
2.5-	O
to	O
22-fold	O
)	O
of	O
AID	O
in	O
cell	O
lines	O
,	O
including	O
T	O
cells	O
,	O
placenta	O
,	O
ovary	O
,	O
breast	O
,	O
and	O
prostate	O
.	O

The	O
induction	O
observed	O
in	O
breast	O
cells	O
mimics	O
that	O
of	O
the	O
tissues	O
isolated	O
in	O
Fig	O
.	O
6	O
A	O
,	O
and	O
confirms	O
a	O
previous	O
report	O
that	O
AID	O
has	O
been	O
detected	O
in	O
the	O
breast	O
cell	O
line	O
MCF-7	O
(	O
48	O
)	O
.	O

Importantly	O
,	O
AID	O
mRNA	O
was	O
not	O
only	O
present	O
at	O
basal	O
levels	O
but	O
was	O
also	O
significantly	O
up-regulated	O
.	O

Estrogen	O
activates	O
APOBEC3B	O
,	O
3F	O
,	O
and	O
3G	O
mRNA	O
transcription	O

AID	O
is	O
the	O
ancestral	O
member	O
of	O
the	O
DNA	O
deaminase	O
family	O
,	O
and	O
the	O
APOBEC3	O
members	O
are	O
considered	O
to	O
have	O
arisen	O
from	O
AID	O
by	O
gene	O
duplication	O
events	O
(	O
34	O
)	O
.	O

Within	O
the	O
DNA	O
deaminase	O
family	O
,	O
APOBEC3	O
members	O
function	O
predominantly	O
in	O
the	O
cytoplasm	O
and	O
inactivate	O
foreign	O
DNA	O
such	O
as	O
retroviruses	O
and	O
retrotransposable	O
elements	O
(	O
49	O
)	O
.	O

We	C
hypothesized	C
that	C
hormonal	C
responsiveness	C
may	C
have	C
been	C
conserved	C
among	C
members	C
of	C
the	C
APOBEC3	C
family	C
.	C

To	O
this	O
end	O
,	O
we	O
designed	O
qRT-PCR	O
primers	O
to	O
detect	O
APOBEC	O
family	O
member	O
mRNAs	O
in	O
mouse	O
and	O
human	O
cells	O
.	O

APOBEC2	O
,	O
a	O
related	O
member	O
of	O
the	O
DNA	O
deaminases	O
without	O
any	O
apparent	O
catalytic	O
activity	O
(	O
34	O
)	O
,	O
was	O
not	O
affected	O
by	O
estrogen	O
treatment	O
;	O
however	O
,	O
we	O
were	O
able	O
to	O
show	O
that	O
estrogen	O
enhanced	O
transcription	O
of	O
mouse	O
Apobec3	O
from	O
ovaries	O
,	O
spleen	O
,	O
and	O
splenic	O
B	O
cells	O
(	O
Fig	O
.	O
6	O
)	O
.	O

Expression	O
of	O
human	O
APOBEC3B	O
,	O
3F	O
,	O
and	O
3G	O
family	O
members	O
was	O
also	O
enhanced	O
upon	O
estrogen	O
treatment	O
from	O
several	O
different	O
cell	O
lines	O
(	O
including	O
those	O
of	O
T	O
cell	O
,	O
ovarian	O
,	O
placental	O
,	O
and	O
cervical	O
origin	O
;	O
Fig	O
.	O
S9	O
)	O
.	O

DISCUSSION	O

The	O
physiological	O
panpleiotropic	O
effects	O
of	O
hormones	O
are	O
well	O
documented	O
in	O
many	O
aspects	O
of	O
development	O
,	O
although	O
their	O
effector	O
mechanisms	O
at	O
the	O
molecular	O
level	O
,	O
as	O
well	O
as	O
their	O
pathogenic	O
effects	O
upon	O
cancer	O
and	O
immunity	O
are	O
not	O
well	O
understood	O
(	O
i.e.	O
,	O
the	O
gender	O
bias	O
for	O
autoimmunity	O
[	O
29	O
,	O
31	O
,	O
50	O
]	O
is	O
as	O
striking	O
as	O
the	O
gender	O
bias	O
for	O
some	O
cancers	O
[	O
51	O
,	O
52	O
]	O
)	O
.	O

The	O
correlation	O
between	O
the	O
expression	O
of	O
hormones	O
or	O
their	O
cognitive	O
receptors	O
and	O
development	O
of	O
pathologies	O
,	O
has	O
led	O
to	O
several	O
different	O
hypotheses	O
;	O
most	O
of	O
which	O
involve	O
hyperactivation	O
of	O
cell	O
proliferation	O
,	O
unregulated	O
differentiation	O
,	O
alteration	O
in	O
DNA	O
repair	O
,	O
or	O
repression	O
of	O
apoptosis	O
(	O
51	O
)	O
.	O

Here	C
,	C
we	C
propose	C
another	C
means	C
by	C
which	C
estrogen	C
can	C
be	C
a	C
genotoxin	C
,	C
by	C
directly	C
inducing	C
DNA	C
deaminases	C
such	C
as	C
AID	C
.	C

Our	O
initial	O
experiment	O
using	O
progesterone	O
and	O
estrogen	O
identified	O
AID	O
as	O
being	O
part	O
of	O
a	O
hormonally	O
regulated	O
system	O
.	O

Estrogen	C
exerted	C
its	C
activity	C
through	C
the	C
estrogen–ER	C
complex	C
,	C
directly	C
binding	C
to	C
the	C
AID	C
promoter	C
,	C
whereas	C
our	C
preliminary	C
data	C
suggests	C
that	C
progesterone	C
acts	C
through	C
an	C
estrogen-independent	C
pathway	C
(	C
unpublished	C
data	C
)	C
.	C

The	C
consequences	C
of	C
estrogen	C
activation	C
on	C
AID	C
mRNA	C
could	C
also	C
be	C
detected	C
as	C
an	C
increase	C
in	C
AID	C
protein	C
and	C
enhanced	C
downstream	C
physiological	C
effects	C
,	C
such	C
as	C
SHM	C
and	C
CSR	C
.	C

Interestingly	O
,	O
AID	O
activation	O
(	O
mRNA	O
)	O
by	O
estrogen	O
was	O
more	O
pronounced	O
than	O
the	O
effect	O
on	O
SHM	O
.	O

This	C
could	C
indicate	C
that	C
although	C
AID	C
production	C
is	C
necessary	C
for	C
SHM	C
,	C
other	C
factors	C
(	C
e.g.	C
,	C
lesion	C
processing	C
,	C
AID	C
targeting	C
,	C
etc	C
)	C
can	C
play	C
a	C
significant	C
role	C
in	C
overall	C
SHM	C
efficiency	C
(	C
53	C
)	C
.	C

Similar	O
to	O
SHM	O
,	O
CSR	O
was	O
enhanced	O
upon	O
estrogen	O
treatment	O
,	O
but	O
was	O
lagging	O
behind	O
AID	O
mRNA	O
production	O
.	O

The	O
most	O
dramatic	O
effect	O
from	O
estrogen-induced	O
overexpression	O
of	O
AID	O
was	O
seen	O
at	O
the	O
level	O
of	O
c-myc/IgH	O
translocations	O
.	O

This	O
is	O
analogous	O
to	O
the	O
recent	O
observations	O
that	O
the	O
effect	O
of	O
AID	O
mRNA	O
down-regulation	O
(	O
either	O
by	O
microRNA	O
targeting	O
or	O
haploinsufficiency	O
)	O
was	O
most	O
pronounced	O
at	O
the	O
level	O
of	O
translocations	O
(	O
44–46	O
)	O
.	O

Autoimmunity	O
encompasses	O
a	O
broadly	O
defined	O
area	O
of	O
clinical	O
pathologies	O
that	O
stem	O
from	O
abnormalities	O
in	O
numerous	O
systemic	O
,	O
cellular	O
,	O
and	O
molecular	O
mechanisms	O
,	O
a	O
subset	O
of	O
which	O
are	O
B	O
cell–related	O
pathologies	O
(	O
50	O
)	O
.	O

In	O
systemic	O
lupus	O
erythematosus	O
,	O
abnormalities	O
in	O
B	O
cell	O
development	O
and	O
the	O
production	O
of	O
autoreactive	O
antibodies	O
play	O
an	O
important	O
pathological	O
role	O
.	O

Overexpression	C
of	C
AID	C
in	C
autoimmune-prone	C
mice	C
induced	C
a	C
more	C
severe	C
systemic	C
lupus	C
erythematosus–like	C
phenotype	C
(	C
10	C
)	C
,	C
whereas	C
breeding	C
AID-deficient	C
mice	C
with	C
autoimmune-prone	C
MRL/lpr	C
mice	C
significantly	C
reduced	C
the	C
onset	C
and	C
extent	C
of	C
disease	C
(	C
11	C
)	C
,	C
indicating	C
that	C
alterations	C
in	C
AID	C
can	C
change	C
the	C
severity	C
of	C
B	C
cell	C
autoimmunity	C
.	C

Correlating	C
our	C
data	C
with	C
the	C
known	C
effects	C
of	C
estrogen	C
on	C
autoimmunity	C
(	C
28	C
,	C
30	C
,	C
50	C
,	C
54	C
)	C
,	C
we	C
propose	C
that	C
the	C
effect	C
of	C
sex-hormones	C
on	C
autoimmunity	C
could	C
partially	C
be	C
through	C
AID	C
transcription	C
and	C
subsequent	C
increase	C
in	C
genome	C
instability	C
.	C

In	C
addition	C
to	C
the	C
direct	C
binding	C
of	C
the	C
estrogen–ER	C
complex	C
to	C
the	C
AID	C
promoter	C
,	C
estrogen	C
may	C
also	C
hyperstimulate	C
AID	C
production	C
through	C
the	C
NF-κB	C
pathway	C
,	C
as	C
we	C
were	C
able	C
to	C
demonstrate	C
that	C
cotreatment	C
of	C
TNF-α	C
and	C
estrogen	C
enhanced	C
NF-κB	C
binding	C
to	C
the	C
AID	C
promoter	C
(	C
Fig	C
.	C
3	C
D	C
)	C
.	C

Whether	C
this	C
effect	C
is	C
caused	C
by	C
protein–protein	C
interaction	C
or	C
estrogen-induced	C
chromatin	C
modification	C
has	C
yet	C
to	C
be	C
determined	C
,	C
but	C
the	C
synergistic	C
or	C
even	C
cooperative	C
interaction	C
of	C
two	C
important	C
autoimmune	C
modulator	C
pathways	C
on	C
AID	C
expression	C
may	C
have	C
substantially	C
pathogenic	C
effects	C
.	C

There	C
are	C
several	C
hypotheses	C
on	C
how	C
unregulated	C
AID	C
can	C
affect	C
autoimmunity	C
in	C
addition	C
to	C
overstimulation	C
of	C
SHM	C
and	C
CSR	C
,	C
e.g.	C
,	C
debilitating	C
mutations	C
in	C
the	C
signaling	C
pathways	C
,	C
of	C
tumor	C
suppressors	C
,	C
or	C
of	C
proapoptotic	C
genes	C
,	C
or	C
alterations	C
that	C
activate	C
oncogenes	C
or	C
antiapoptotic	C
genes	C
(	C
for	C
review	C
see	C
reference	C
[	C
55	C
]	C
)	C
.	C

Mutation	O
and	O
subsequent	O
loss	O
of	O
growth	O
control	O
is	O
usually	O
associated	O
with	O
oncogenesis	O
,	O
and	O
this	O
similarity	O
with	O
autoimmunity	O
has	O
previously	O
been	O
noted	O
(	O
55	O
)	O
(	O
e.g.	O
,	O
mutations	O
in	O
CD95/Fas	O
have	O
been	O
associated	O
with	O
autoimmunity	O
,	O
as	O
well	O
as	O
B	O
cell	O
lymphomas	O
)	O
.	O

Therefore	C
,	C
our	C
data	C
on	C
estrogen-induced	C
mutations	C
in	C
CD95/Fas	C
(	C
Fig	C
.	C
5	C
and	C
Fig	C
.	C
S7	C
)	C
,	C
derived	C
from	C
increased	C
AID	C
production	C
,	C
may	C
provide	C
a	C
novel	C
molecular	C
mechanism	C
that	C
is	C
important	C
for	C
both	C
pathologies	C
.	C

AID	O
's	O
targeting	O
outside	O
the	O
Ig	O
locus	O
,	O
its	O
apparently	O
crucial	O
involvement	O
with	O
germinal	O
center–derived	O
B	O
cell	O
malignancies	O
(	O
43	O
,	O
56	O
)	O
,	O
and	O
its	O
ability	O
to	O
cause	O
various	O
malignancies	O
when	O
overexpressed	O
in	O
transgenic	O
mice	O
(	O
20	O
,	O
21	O
,	O
57	O
)	O
are	O
strong	O
indicators	O
for	O
AID	O
's	O
oncogenic	O
potential	O
.	O

Estrogen	O
is	O
one	O
of	O
the	O
most	O
important	O
and	O
thoroughly	O
studied	O
mitogenic	O
agents	O
in	O
cancer	O
,	O
but	O
it	O
does	O
not	O
possess	O
any	O
direct	O
DNA	O
mutability	O
,	O
and	O
induces	O
transformation	O
by	O
proliferation	O
.	O

In	O
vitro	O
,	O
high	O
concentrations	O
of	O
estrogen	O
derivatives	O
(	O
usually	O
metabolites	O
)	O
can	O
form	O
DNA	O
adducts	O
or	O
produce	O
reactive	O
oxygen-damaging	O
DNA	O
(	O
for	O
review	O
see	O
reference	O
[	O
58–60	O
]	O
)	O
,	O
but	O
their	O
role	O
as	O
physiological	O
genotoxins	O
is	O
limited	O
.	O

Furthermore	C
,	C
because	C
the	C
estrogen	C
derivative	C
Tam	C
(	C
61	C
)	C
can	C
inhibit	C
estrogen	C
's	C
oncogenesis	C
in	C
breast	C
cancer	C
,	C
it	C
is	C
unlikely	C
that	C
estrogen	C
(	C
or	C
its	C
derivatives	C
)	C
form	C
DNA	C
adducts	C
under	C
those	C
conditions	C
.	C

It	O
is	O
interesting	O
to	O
note	O
that	O
the	O
antagonistic	O
activity	O
of	O
Tam	O
has	O
recently	O
been	O
used	O
to	O
inhibit	O
some	O
of	O
the	O
pathologies	O
of	O
estrogen-induced	O
autoimmunity	O
(	O
54	O
)	O
.	O

On	O
the	O
other	O
hand	O
,	O
because	O
of	O
the	O
pharmacological	O
action	O
of	O
Tam	O
(	O
binding	O
and	O
altering	O
the	O
ER	O
DNA	O
binding	O
capacity	O
)	O
,	O
under	O
certain	O
circumstances	O
Tam	O
acts	O
as	O
an	O
estrogen	O
agonist	O
(	O
62	O
)	O
.	O

This	O
activity	O
leads	O
to	O
an	O
increased	O
risk	O
in	O
secondary	O
(	O
e.g.	O
,	O
ovarian	O
)	O
cancer	O
after	O
Tam	O
treatment	O
for	O
breast	O
cancer	O
(	O
63	O
)	O
.	O

Thus	C
,	C
our	C
findings	C
that	C
low	C
concentrations	C
of	C
Tam	C
induced	C
AID	C
mRNA	C
(	C
Fig	C
.	C
S1	C
)	C
also	C
suggest	C
that	C
Tam	C
acts	C
as	C
an	C
agonist	C
and	C
indicates	C
that	C
the	C
proposed	C
usage	C
of	C
synthetic	C
estrogen	C
derivatives	C
as	C
a	C
means	C
to	C
inhibit	C
AID	C
has	C
to	C
be	C
carefully	C
evaluated	C
.	C

Future	C
work	C
on	C
identifying	C
a	C
potential	C
role	C
of	C
AID	C
in	C
mouse	C
models	C
of	C
hormonally	C
induced	C
cancers	C
may	C
provide	C
further	C
evidence	C
on	C
how	C
AID	C
can	C
act	C
as	C
an	C
environmentally	C
stimulated	C
oncogene	C
.	C

As	C
our	C
data	C
indicate	C
,	C
AID	C
's	C
response	C
to	C
estrogen	C
seems	C
to	C
have	C
been	C
evolutionarily	C
conserved	C
among	C
the	C
APOBEC3	C
family	C
members	C
,	C
different	C
tissues	C
,	C
and	C
cell	C
lines	C
(	C
Fig	C
.	C
6	C
and	C
Fig	C
.	C
S8	C
)	C
;	C
mouse	C
Apobec3	C
and	C
human	C
APOBEC3B	C
,	C
-3F	C
,	C
and	C
-3G	C
(	C
and	C
-H	C
to	C
a	C
lesser	C
extent	C
)	C
mRNA	C
were	C
induced	C
by	C
estrogen	C
treatment	C
.	C

In	C
the	C
past	C
,	C
we	C
have	C
hypothesized	C
that	C
the	C
predominant	C
function	C
of	C
AID	C
and	C
its	C
evolved	C
DNA	C
deaminase	C
family	C
members	C
was	C
to	C
inactivate	C
foreign	C
DNA	C
in	C
the	C
cell	C
(	C
8	C
,	C
34	C
,	C
64	C
,	C
65	C
)	C
.	C

It	O
is	O
therefore	O
plausible	O
that	O
the	O
observed	O
estrogen	O
response	O
of	O
AID	O
,	O
as	O
well	O
as	O
its	O
expression	O
in	O
oocytes	O
(	O
22	O
)	O
,	O
had	O
served	O
a	O
purpose	O
other	O
than	O
targeting	O
AID	O
to	O
Ig	O
genes	O
in	O
B	O
cells	O
.	O

Data	C
indicating	C
that	C
AID	C
has	C
retained	C
some	C
ability	C
to	C
inhibit	C
retroviral	C
elements	C
have	C
substantiated	C
this	C
hypothesis	C
(	C
66	C
)	C
.	C

Our	C
work	C
has	C
highlighted	C
that	C
there	C
is	C
a	C
novel	C
pathway	C
by	C
which	C
the	C
nonmutagenic	C
hormone	C
estrogen	C
can	C
mediate	C
genome	C
instability	C
via	C
the	C
activation	C
of	C
AID	C
and	C
other	C
DNA	C
deaminases	C
,	C
in	C
turn	C
possibly	C
altering	C
the	C
predispositions	C
,	C
induction	C
,	C
or	C
severity	C
for	C
cancer	C
,	C
autoimmunity	C
,	C
and	C
viral	C
infectivity	C
.	C

MATERIALS	O
AND	O
METHODS	O

Unless	O
indicated	O
,	O
mouse	O
tissue	O
samples	O
and	O
splenic	O
B	O
cells	O
were	O
derived	O
from	O
8–12-wk-old	O
female	O
unplugged	O
BALB/c	O
mice	O
,	O
and	O
prepared	O
by	O
standard	O
protocol	O
(	O
see	O
Supplemental	O
materials	O
and	O
methods	O
,	O
available	O
at	O
available	O
at	O
http	O
:	O
//www.jem.org/cgi/content/full/jem.20080521/DC1	O
)	O
.	O

Human	O
cell	O
lines	O
Jurkat	O
,	O
T47D	O
,	O
Ramos	O
HS13	O
(	O
Ramos	O
)	O
,	O
JAR	O
,	O
and	O
mouse	O
B	O
cells	O
were	O
cultivated	O
in	O
RPMI-1640+GlutaMax	O
medium	O
(	O
Invitrogen	O
)	O
;	O
the	O
cell	O
lines	O
MCF7	O
,	O
JAMA2	O
,	O
HeLa	O
,	O
and	O
HepG2	O
were	O
cultivated	O
in	O
E4	O
medium	O
;	O
and	O
PC3	O
was	O
cultivated	O
in	O
HAMS	O
F12	O
medium	O
.	O

Chicken	O
DT40	O
cells	O
were	O
maintained	O
in	O
RPMI-1640+GlutaMax	O
with	O
10	O
%	O
FCS	O
,	O
1	O
%	O
chicken	O
serum	O
,	O
50	O
µM	O
ß-mercaptoethanol	O
,	O
100	O
U/ml	O
penicillin	O
,	O
and	O
100	O
µg/ml	O
streptomycin	O
at	O
39°C	O
with	O
10	O
%	O
CO2	O
.	O

For	O
indicated	O
experiments	O
,	O
cells	O
were	O
treated	O
for	O
72	O
h	O
in	O
hormone-depleted	O
serum	O
(	O
Opti-MeM	O
Reduced	O
Serum	O
Medium	O
;	O
Invitrogen	O
)	O
supplemented	O
with	O
Charcoal	O
Stripped	O
Fetal	O
Bovine	O
Serum	O
(	O
Invitrogen	O
)	O
;	O
and	O
nonessential	O
amino	O
acids	O
(	O
final	O
concentration	O
;	O
Sigma-Aldrich	O
)	O
,	O
as	O
follows	O
:	O
l-Alanine	O
(	O
8.9	O
µg/ml	O
)	O
,	O
l-Asparagine	O
(	O
15.0	O
µg/ml	O
)	O
,	O
l-Aspartic	O
acid	O
(	O
13.3	O
µg/ml	O
)	O
,	O
l-Glutamic	O
acid	O
(	O
14.7	O
µg/ml	O
)	O
,	O
Glycine	O
(	O
7.5	O
µg/ml	O
)	O
,	O
Proline	O
(	O
11.5	O
µg/ml	O
)	O
,	O
and	O
l-Serine	O
(	O
10.5	O
µg/ml	O
)	O
.	O

B	O
cell	O
stimulation	O
was	O
performed	O
using	O
25	O
µg/ml	O
LPS	O
(	O
Sigma-Aldrich	O
)	O
,	O
50	O
ng/ml	O
mouse	O
IL-4	O
(	O
R	O
&	O
D	O
Systems	O
)	O
,	O
20	O
ng/ml	O
human	O
TNF-α	O
(	O
R	O
&	O
D	O
Systems	O
)	O
,	O
and	O
2	O
ng/ml	O
human	O
TGF-ß1	O
(	O
R	O
&	O
D	O
Systems	O
)	O
.	O

Estrogen	O
(	O
17-ß-estradiol	O
;	O
Sigma-Aldrich	O
)	O
and	O
progesterone	O
(	O
Sigma-Aldrich	O
)	O
were	O
dissolved	O
in	O
DMSO	O
at	O
a	O
concentration	O
of	O
100	O
mM	O
;	O
this	O
solution	O
was	O
then	O
diluted	O
in	O
DMSO	O
to	O
give	O
1,000×	O
stock	O
solutions	O
,	O
and	O
final	O
dilutions	O
were	O
made	O
in	O
media	O
(	O
final	O
DMSO	O
concentration	O
was	O
never	O
>	O
0.1	O
%	O
)	O
.	O

The	O
final	O
concentrations	O
of	O
estrogen	O
are	O
indicated	O
in	O
the	O
text	O
and	O
figure	O
legends	O
.	O

The	O
concentration	O
of	O
Tam	O
(	O
Sigma-Aldrich	O
)	O
was	O
50	O
nM	O
unless	O
otherwise	O
stated	O
.	O

The	O
final	O
concentration	O
for	O
CHX	O
(	O
Sigma-Aldrich	O
)	O
was	O
10	O
µg/ml	O
,	O
20	O
nM	O
for	O
ACT	O
(	O
Calbiochem	O
)	O
,	O
4	O
µg/ml	O
for	O
AMA	O
(	O
Calbiochem	O
)	O
,	O
and	O
10	O
µM	O
for	O
MG-132	O
(	O
Sigma-Aldrich	O
)	O
.	O

qRT-PCR	O
of	O
mRNAs	O
was	O
based	O
on	O
a	O
previous	O
study	O
(	O
67	O
)	O
,	O
with	O
modifications	O
(	O
see	O
Supplemental	O
materials	O
and	O
methods	O
)	O
.	O

The	O
primers	O
for	O
qRT-PCR	O
(	O
Table	O
S1	O
,	O
available	O
at	O
http	O
:	O
//www.jem.org/cgi/content/full/jem.20080521/DC1	O
)	O
were	O
designed	O
using	O
PrimerExpress	O
software	O
.	O

qRT-PCR	O
analysis	O
was	O
performed	O
using	O
the	O
QuantiTect	O
SYBR	O
Green	O
PCR	O
kit	O
(	O
QIAGEN	O
)	O
according	O
to	O
the	O
manufacturer	O
's	O
instructions	O
,	O
Abi	O
7000	O
Sequence	O
Detection	O
System	O
(	O
Applied	O
Biosystems	O
)	O
,	O
and	O
Abi	O
software	O
.	O

Tissue	O
or	O
cell	O
line	O
hormone	O
responsiveness	O
was	O
determined	O
by	O
qRT-PCR	O
of	O
gene	O
regulated	O
by	O
breast	O
cancer	O
1	O
,	O
a	O
known	O
estrogen-responsive	O
gene	O
(	O
36	O
)	O
.	O

Human	O
AID	O
promoter	O
fragments	O
were	O
analyzed	O
using	O
pE1BLuc	O
plasmid	O
backbone	O
(	O
provided	O
by	O
G.	O
Akusjärvi	O
,	O
Uppsala	O
University	O
,	O
Uppsala	O
,	O
Sweden	O
)	O
containing	O
a	O
luciferase	O
ORF	O
and	O
a	O
minimal	O
promoter	O
region	O
.	O

Primers	O
(	O
Tables	O
S2	O
and	O
S3	O
,	O
available	O
at	O
http	O
:	O
//www.jem.org/cgi/content/full/jem.20080521/DC1	O
)	O
approximately	O
every	O
500	O
bp	O
from	O
the	O
human	O
AID	O
transcription	O
start	O
site	O
were	O
used	O
for	O
amplifying	O
AID	O
promoter	O
regions	O
.	O

The	O
obtained	O
PCR	O
products	O
were	O
cloned	O
into	O
pE1BLuc	O
vector	O
,	O
and	O
3	O
µg	O
DNA	O
were	O
transfected	O
into	O
SiHa	O
cells	O
using	O
Lipofectamine	O
2000	O
(	O
Invitrogen	O
)	O
according	O
to	O
the	O
manufacturer	O
's	O
protocols	O
.	O

24	O
h	O
after	O
transfection	O
,	O
cells	O
were	O
treated	O
with	O
the	O
indicated	O
concentrations	O
of	O
hormones	O
or	O
TNF-α	O
for	O
4	O
h	O
and	O
analyzed	O
thereafter	O
for	O
luciferase	O
signal	O
using	O
Dual	O
Luciferase	O
Reporter	O
Assay	O
System	O
(	O
Promega	O
)	O
and	O
Glomax	O
luminometer	O
(	O
Promega	O
)	O
.	O

The	O
expression	O
vector	O
containing	O
a	O
dominant-negative	O
mutant	O
for	O
IκBα	O
(	O
S32A	O
S36A	O
;	O
a	O
gift	O
from	O
Felix	O
Randow	O
,	O
Medical	O
Research	O
Council-Laboratory	O
of	O
Molecular	O
Biology	O
,	O
Cambridge	O
,	O
England	O
,	O
UK	O
)	O
was	O
cotransfected	O
with	O
pE1BLuc	O
constructs	O
where	O
indicated	O
.	O

1	O
µg	O
CMV	O
promoter-driven	O
Renilla	O
luciferase	O
expression	O
vector	O
(	O
Promega	O
)	O
was	O
included	O
in	O
all	O
transfections	O
and	O
used	O
as	O
an	O
internal	O
control	O
for	O
transfection	O
efficiency	O
.	O

Ramos	O
cells	O
were	O
treated	O
for	O
72	O
h	O
in	O
hormone-depleted	O
serum	O
before	O
the	O
4-h	O
hormone	O
treatment	O
.	O

EMSA	O
was	O
performed	O
by	O
standard	O
protocol	O
(	O
68	O
)	O
with	O
minor	O
modifications	O
(	O
for	O
more	O
detail	O
see	O
Supplemental	O
materials	O
and	O
methods	O
)	O
.	O

0.25	C
pmol	C
of	C
complementary	C
oligonucleotides	C
containing	C
either	C
NF-κB	C
or	C
putative	C
ER	C
binding	C
elements	C
were	C
annealed	C
,	C
labeled	C
,	C
and	C
added	C
to	C
7	C
µg	C
of	C
Ramos	C
(	C
treated	C
or	C
untreated	C
)	C
nuclear	C
extract	C
.	C

Reactions	O
were	O
incubated	O
for	O
20	O
min	O
at	O
room	O
temperature	O
in	O
the	O
absence	O
or	O
presence	O
of	O
1-	O
,	O
3-	O
,	O
and	O
10-fold	O
mass	O
excess	O
of	O
unlabeled	O
oligonucleotides	O
or	O
antibodies	O
.	O

Samples	O
were	O
electrophoresed	O
at	O
4°C	O
on	O
4.5	O
%	O
polyacrylamide	O
gels	O
for	O
120	O
min	O
,	O
followed	O
by	O
autoradiography	O
on	O
imaging	O
plates	O
(	O
FujiFilm	O
)	O
and	O
analysis	O
with	O
a	O
FLA-5000	O
Scanner	O
(	O
FujiFilm	O
)	O
.	O

Ramos	O
cells	O
were	O
treated	O
for	O
72	O
h	O
in	O
hormone-depleted	O
serum	O
before	O
the	O
4-h	O
hormone	O
treatment	O
.	O

ChIP	O
procedure	O
was	O
done	O
as	O
previously	O
published	O
,	O
with	O
minor	O
modifications	O
(	O
69	O
)	O
(	O
for	O
further	O
details	O
see	O
Supplemental	O
materials	O
and	O
methods	O
)	O
.	O

Approximately	O
107	O
cells	O
were	O
fixed	O
with	O
1	O
%	O
formaldehyde	O
in	O
the	O
culture	O
media	O
for	O
10	O
min	O
at	O
37°C	O
,	O
and	O
then	O
quenched	O
with	O
0.125	O
M	O
glycine	O
for	O
5	O
min	O
at	O
RT	O
.	O

Cells	O
were	O
pelleted	O
and	O
washed	O
twice	O
with	O
cold	O
PBS	O
.	O

The	O
cell	O
pellet	O
was	O
resuspended	O
in	O
300	O
µl	O
SDS	O
lysis	O
buffer	O
and	O
incubated	O
on	O
ice	O
for	O
10	O
min	O
.	O

Cell	O
lysates	O
were	O
sonicated	O
for	O
6	O
min	O
with	O
a	O
30-s	O
on/off	O
sonication	O
cycle	O
in	O
1.5	O
ml	O
eppendorf	O
tubes	O
.	O

Samples	O
were	O
centrifuged	O
for	O
5	O
min	O
at	O
13,000	O
rpm	O
at	O
4°C	O
,	O
and	O
supernatants	O
were	O
diluted	O
to	O
1.5	O
ml	O
with	O
ChIP	O
buffer	O
.	O

An	O
aliquot	O
was	O
kept	O
as	O
input	O
measurement	O
.	O

Samples	O
were	O
precleared	O
with	O
60	O
µl	O
Protein	O
G	O
beads	O
(	O
ProtG	O
;	O
Roche	O
)	O
and	O
1	O
µg	O
salmon	O
sperm	O
DNA	O
(	O
Invitrogen	O
)	O
for	O
45	O
min	O
at	O
4°C	O
.	O

Anti–NF-κB	O
p65	O
antibody	O
,	O
rabbit	O
anti-ERα	O
HC-20	O
antibody	O
(	O
Santa	O
Cruz	O
Biotechnology	O
,	O
Inc.	O
)	O
,	O
or	O
goat	O
anti–mouse	O
λ	O
control	O
antibody	O
(	O
see	O
Supplemental	O
materials	O
and	O
methods	O
)	O
was	O
added	O
to	O
the	O
supernatant	O
at	O
a	O
concentration	O
of	O
2	O
µg/assay	O
and	O
incubated	O
for	O
12	O
h	O
at	O
4°C	O
.	O

60	O
µl	O
of	O
salmon	O
sperm	O
DNA	O
(	O
1	O
µg	O
DNA/20	O
µl	O
ProtG	O
)	O
was	O
added	O
to	O
the	O
samples	O
and	O
incubated	O
for	O
1	O
h	O
while	O
rotating	O
.	O

The	O
ProtG–antibody–protein	O
complex	O
was	O
pelleted	O
and	O
washed	O
with	O
the	O
following	O
buffers	O
:	O
low-salt	O
wash	O
buffer	O
,	O
high-salt	O
wash	O
buffer	O
,	O
LiCl	O
wash	O
buffer	O
,	O
and	O
standard	O
TE	O
buffer	O
(	O
twice	O
)	O
.	O

The	O
sample	O
was	O
eluted	O
with	O
250	O
µl	O
of	O
elution	O
buffer	O
and	O
incubated	O
for	O
15	O
min	O
at	O
room	O
temperature	O
with	O
agitation	O
.	O

The	O
beads	O
were	O
centrifuged	O
and	O
the	O
elution	O
was	O
repeated	O
once	O
.	O

Bound	O
immunocomplexes	O
were	O
then	O
reverse	O
cross-linked	O
with	O
200	O
mM	O
NaCl	O
by	O
incubating	O
it	O
at	O
65°C	O
for	O
12	O
h	O
.	O

Proteinase	O
K	O
was	O
added	O
to	O
the	O
sample	O
and	O
incubated	O
for	O
1	O
h	O
at	O
45°C	O
.	O

DNA	O
was	O
then	O
extracted	O
with	O
phenol/chloroform	O
and	O
precipitated	O
,	O
resuspended	O
in	O
50	O
µl	O
of	O
water	O
and	O
subjected	O
to	O
qRT-PCR	O
,	O
using	O
CHIP1	O
and	O
CHIP2	O
primers	O
for	O
amplifying	O
the	O
-1,189	O
to	O
-1,039	O
region	O
of	O
the	O
AID	O
promoter	O
.	O

The	O
surface	O
IgM	O
(	O
sIgM	O
)	O
expression	O
was	O
investigated	O
in	O
Ramos	O
HS13	O
cells	O
(	O
41	O
)	O
,	O
which	O
contain	O
a	O
stop	O
codon	O
in	O
the	O
λ	O
locus	O
,	O
with	O
reversion	O
mutations	O
resulting	O
in	O
sIgM	O
production	O
.	O

IgM	O
stained	O
(	O
anti–human	O
IgM-FITC	O
[	O
Sigma	O
,	O
UK	O
]	O
)	O
and	O
sorted	O
single	O
sIgM-negative	O
cells	O
were	O
grown	O
for	O
~20	O
doublings	O
,	O
with	O
fresh	O
hormone	O
containing	O
media	O
added	O
every	O
48	O
h	O
.	O

The	O
cells	O
were	O
then	O
stained	O
(	O
anti–human	O
IgM-FITC	O
)	O
for	O
surface	O
expression	O
of	O
IgM	O
and	O
analyzed	O
by	O
flow	O
cytometry	O
.	O

VH	O
and	O
C	O
regions	O
were	O
cloned	O
and	O
sequenced	O
from	O
hormonally	O
treated	O
(	O
20	O
doublings	O
)	O
Ramos	O
HS13	O
cells	O
,	O
as	O
previously	O
described	O
(	O
41	O
)	O
.	O

The	O
human	O
CD95/Fas	O
locus	O
was	O
PCR	O
amplified	O
and	O
sequenced	O
from	O
isolated	O
genomic	O
DNA	O
,	O
as	O
previously	O
described	O
(	O
18	O
)	O
.	O

Mouse	O
Sγ3	O
switch	O
regions	O
were	O
analyzed	O
from	O
2	O
AID+/-	O
spleens	O
and	O
treated	O
with	O
either	O
DMSO	O
alone	O
or	O
10	O
nM	O
estrogen	O
for	O
6	O
d	O
.	O

AID+/-	O
were	O
derived	O
from	O
breeding	O
AID-/-	O
(	O
gift	O
from	O
T.	O
Honjo	O
,	O
Kyoto	O
University	O
,	O
Kyoto	O
,	O
Japan	O
)	O
with	O
BALB/c	O
mice	O
.	O

Cloning	O
and	O
sequencing	O
were	O
as	O
previously	O
described	O
(	O
42	O
)	O
.	O

Sequencing	O
was	O
performed	O
at	O
the	O
LRI	O
sequencing	O
facility	O
.	O

Further	O
details	O
are	O
described	O
in	O
the	O
Supplemental	O
materials	O
and	O
methods	O
.	O

c-myc/IgH	O
translocations	O
were	O
detected	O
by	O
PCR	O
as	O
previously	O
described	O
(	O
47	O
,	O
70	O
)	O
.	O

In	O
brief	O
,	O
DNA	O
was	O
isolated	O
from	O
p53+/-	O
B	O
cells	O
after	O
72	O
h	O
of	O
LPS	O
stimulation	O
in	O
the	O
presence	O
or	O
absence	O
of	O
50	O
nM	O
estrogen	O
.	O

Two	O
rounds	O
of	O
PCR	O
(	O
for	O
primers	O
see	O
Supplemental	O
materials	O
and	O
methods	O
)	O
were	O
performed	O
using	O
Expand	O
Long	O
Template	O
PCR	O
system	O
(	O
Roche	O
)	O
with	O
primers	O
MycIg1A	O
and	O
primers	O
MycIg1B	O
in	O
the	O
first	O
round	O
,	O
and	O
MycIg2A	O
and	O
MycIg2B	O
in	O
the	O
second	O
round	O
.	O

PCR	O
products	O
were	O
separated	O
on	O
agarose	O
gels	O
,	O
transferred	O
to	O
nylon	O
membranes	O
,	O
and	O
probed	O
with	O
γ-	O
[	O
P32	O
]	O
-ATP–labeled	O
oligonucleotides	O
IgH	O
probe	O
and	O
c-myc	O
probe	O
.	O

P	O
values	O
were	O
calculated	O
using	O
two-tailed	O
unpaired	O
Student	O
's	O
t	O
test	O
.	O

Ig	O
class	O
switching	O
was	O
investigated	O
by	O
detecting	O
switch-circle	O
transcripts	O
in	O
stimulated	O
mouse	O
spleen	O
B	O
cells	O
(	O
40	O
)	O
by	O
qRT-PCR	O
(	O
71	O
)	O
.	O

Isolated	O
splenic	O
B-cells	O
were	O
stimulated	O
for	O
up	O
to	O
72	O
h	O
with	O
LPS	O
+	O
IL-4	O
for	O
inducing	O
switching	O
to	O
IgG1	O
and	O
IgE	O
,	O
LPS	O
+	O
TGF-ß	O
for	O
switching	O
to	O
IgA	O
,	O
and	O
LPS	O
+	O
IFN-γ	O
for	O
switching	O
to	O
IgG3	O
.	O

Hormones	O
were	O
added	O
to	O
the	O
cells	O
together	O
with	O
LPS	O
and	O
cytokines	O
in	O
fresh	O
media	O
.	O

Primers	O
(	O
Tables	O
S4	O
and	O
S5	O
,	O
available	O
at	O
http	O
:	O
//www.jem.org/cgi/content/full/jem.20080521/DC1	O
)	O
that	O
were	O
used	O
for	O
detecting	O
IgG1	O
(	O
71	O
)	O
,	O
IgG3	O
,	O
IgA	O
(	O
40	O
)	O
,	O
and	O
IgE	O
(	O
72	O
)	O
,	O
have	O
been	O
previously	O
described	O
.	O

Mouse	O
tissue	O
was	O
dissected	O
(	O
from	O
two	O
animals	O
)	O
and	O
passed	O
through	O
cell	O
strainers	O
.	O

Cells	O
were	O
incubated	O
for	O
6	O
h	O
in	O
hormone-depleted	O
media	O
before	O
estrogen	O
treatment	O
for	O
4	O
h	O
.	O

Total	O
RNA	O
was	O
extracted	O
,	O
cDNA	O
was	O
synthesized	O
,	O
and	O
gene	O
expression	O
was	O
analyzed	O
by	O
qRT-PCR	O
.	O

All	O
experiments	O
were	O
approved	O
by	O
the	O
Cancer	O
Research	O
UK	O
Animal	O
Ethics	O
Committee	O
and	O
the	O
UK	O
Home	O
Office	O
.	O

The	O
Supplemental	O
materials	O
and	O
methods	O
includes	O
details	O
for	O
cells	O
and	O
reagents	O
,	O
qRT-PCR	O
,	O
promoter	O
analysis	O
,	O
EMSA	O
,	O
ChIP	O
,	O
mutation	O
analysis	O
,	O
and	O
c-myc/IgH	O
translocations	O
.	O

It	O
also	O
describes	O
in	O
detail	O
the	O
generation	O
of	O
endogenously	O
tagged	O
AID	O
.	O

Fig	O
.	O
S1	O
describes	O
the	O
effect	O
of	O
Tam	O
treatment	O
and	O
translation	O
inhibitors	O
on	O
AID	O
expression	O
.	O

Fig	O
.	O
S2	O
shows	O
the	O
effect	O
of	O
estrogen	O
on	O
AID	O
splicing	O
.	O

Fig	O
.	O
S3	O
demonstrates	O
the	O
effect	O
of	O
estrogen	O
on	O
NF-kB	O
promoter	O
binding	O
.	O

Fig	O
.	O
S4	O
provides	O
details	O
on	O
how	O
we	O
generated	O
the	O
DT40	O
AID	O
knockin	O
allele	O
.	O

Fig	O
.	O
S5	O
is	O
a	O
schematic	O
of	O
class	O
switching	O
and	O
switch	O
circle	O
formation	O
.	O

Fig	O
.	O
S6	O
shows	O
the	O
effect	O
of	O
estrogen	O
on	O
Ramos	O
Ig	O
diversification	O
.	O

Fig	O
.	O
S7	O
provides	O
details	O
on	O
the	O
mutation	O
analysis	O
of	O
IgH	O
and	O
CD95/Fas	O
after	O
estrogen	O
treatment	O
.	O

Fig	O
.	O
S8	O
provides	O
details	O
on	O
the	O
c-myc/IgH	O
translocation	O
analysis	O
.	O

Fig	O
.	O
S9	O
shows	O
the	O
effect	O
of	O
estrogen	O
on	O
the	O
expression	O
of	O
DNA	O
deaminase	O
family	O
members	O
in	O
various	O
cell	O
lines	O
.	O

Fig	O
.	O
S10	O
provides	O
absolute	O
values	O
of	O
qRT-PCR	O
analysis	O
from	O
selected	O
experiments	O
.	O

We	O
also	O
included	O
primer	O
sequences	O
used	O
in	O
this	O
study	O
in	O
five	O
tables	O
(	O
Tables	O
S1-S5	O
)	O
.	O

Online	O
supplemental	O
material	O
is	O
available	O
at	O
http	O
:	O
//www.jem.org/cgi/content/full/jem.20080521/DC1	O
.	O

A	O
Drosophila	O
Model	O
for	O
EGFR-Ras	O
and	O
PI3K-Dependent	O
Human	O
Glioma	O

Abstract	O

Gliomas	O
,	O
the	O
most	O
common	O
malignant	O
tumors	O
of	O
the	O
nervous	O
system	O
,	O
frequently	O
harbor	O
mutations	O
that	O
activate	O
the	O
epidermal	O
growth	O
factor	O
receptor	O
(	O
EGFR	O
)	O
and	O
phosphatidylinositol-3	O
kinase	O
(	O
PI3K	O
)	O
signaling	O
pathways	O
.	O

To	O
investigate	O
the	O
genetic	O
basis	O
of	O
this	O
disease	O
,	O
we	O
developed	O
a	O
glioma	O
model	O
in	O
Drosophila	O
.	O

We	O
found	O
that	O
constitutive	O
coactivation	O
of	O
EGFR-Ras	O
and	O
PI3K	O
pathways	O
in	O
Drosophila	O
glia	O
and	O
glial	O
precursors	O
gives	O
rise	O
to	O
neoplastic	O
,	O
invasive	O
glial	O
cells	O
that	O
create	O
transplantable	O
tumor-like	O
growths	O
,	O
mimicking	O
human	O
glioma	O
.	O

Our	C
model	C
represents	C
a	C
robust	C
organotypic	C
and	C
cell-type-specific	C
Drosophila	C
cancer	C
model	C
in	C
which	C
malignant	C
cells	C
are	C
created	C
by	C
mutations	C
in	C
signature	C
genes	C
and	C
pathways	C
thought	C
to	C
be	C
driving	C
forces	C
in	C
a	C
homologous	C
human	C
cancer	C
.	C

Genetic	O
analyses	O
demonstrated	O
that	O
EGFR	O
and	O
PI3K	O
initiate	O
malignant	O
neoplastic	O
transformation	O
via	O
a	O
combinatorial	O
genetic	O
network	O
composed	O
primarily	O
of	O
other	O
pathways	O
commonly	O
mutated	O
or	O
activated	O
in	O
human	O
glioma	O
,	O
including	O
the	O
Tor	O
,	O
Myc	O
,	O
G1	O
Cyclins-Cdks	O
,	O
and	O
Rb-E2F	O
pathways	O
.	O

This	O
network	O
acts	O
synergistically	O
to	O
coordinately	O
stimulate	O
cell	O
cycle	O
entry	O
and	O
progression	O
,	O
protein	O
translation	O
,	O
and	O
inappropriate	O
cellular	O
growth	O
and	O
migration	O
.	O

In	O
particular	O
,	O
we	O
found	O
that	O
the	O
fly	O
orthologs	O
of	O
CyclinE	O
,	O
Cdc25	O
,	O
and	O
Myc	O
are	O
key	O
rate-limiting	O
genes	O
required	O
for	O
glial	O
neoplasia	O
.	O

Moreover	O
,	O
orthologs	O
of	O
Sin1	O
,	O
Rictor	O
,	O
and	O
Cdk4	O
are	O
genes	O
required	O
only	O
for	O
abnormal	O
neoplastic	O
glial	O
proliferation	O
but	O
not	O
for	O
glial	O
development	O
.	O

These	C
and	C
other	C
genes	C
within	C
this	C
network	C
may	C
represent	C
important	C
therapeutic	C
targets	C
in	C
human	C
glioma	C
.	C

Author	O
Summary	O

Malignant	O
gliomas	O
,	O
tumors	O
composed	O
of	O
glial	O
cells	O
and	O
their	O
precursors	O
,	O
are	O
the	O
most	O
common	O
and	O
deadly	O
human	O
brain	O
tumors	O
.	O

These	O
tumors	O
infiltrate	O
the	O
brain	O
and	O
proliferate	O
rapidly	O
,	O
properties	O
that	O
render	O
them	O
largely	O
incurable	O
even	O
with	O
current	O
therapies	O
.	O

Mutations	C
in	C
genes	C
within	C
the	C
EGFR-Ras	C
and	C
PI3K	C
signaling	C
pathways	C
are	C
common	C
in	C
malignant	C
gliomas	C
,	C
although	C
how	C
these	C
genes	C
specifically	C
control	C
glial	C
pathogenesis	C
is	C
unclear	C
.	C

To	O
investigate	O
the	O
genetic	O
basis	O
of	O
this	O
disease	O
,	O
we	O
developed	O
a	O
glioma	O
model	O
in	O
the	O
fruit	O
fly	O
,	O
Drosophila	O
melanogaster	O
.	O

We	O
found	O
that	O
constitutive	O
coactivation	O
of	O
the	O
EGFR-Ras	O
and	O
PI3K	O
pathways	O
in	O
Drosophila	O
glia	O
gives	O
rise	O
to	O
highly	O
proliferative	O
and	O
invasive	O
neoplastic	O
cells	O
that	O
create	O
transplantable	O
tumor-like	O
growths	O
,	O
mimicking	O
human	O
glioma	O
.	O

This	C
represents	C
a	C
robust	C
cell-type-specific	C
Drosophila	C
cancer	C
model	C
in	C
which	C
malignant	C
cells	C
are	C
created	C
by	C
mutations	C
in	C
genetic	C
pathways	C
thought	C
to	C
be	C
driving	C
forces	C
in	C
a	C
homologous	C
human	C
cancer	C
.	C

Genetic	O
analyses	O
demonstrated	O
that	O
EGFR-Ras	O
and	O
PI3K	O
induce	O
fly	O
glial	O
neoplasia	O
through	O
activation	O
of	O
a	O
combinatorial	O
genetic	O
network	O
composed	O
,	O
in	O
part	O
,	O
of	O
other	O
genetic	O
pathways	O
also	O
commonly	O
mutated	O
in	O
human	O
glioma	O
.	O

This	O
network	O
acts	O
synergistically	O
to	O
coordinately	O
stimulate	O
cellular	O
proliferation	O
,	O
protein	O
translation	O
,	O
and	O
inappropriate	O
migration	O
.	O

Rate-limiting	C
genes	C
within	C
this	C
network	C
may	C
represent	C
important	C
therapeutic	C
targets	C
in	C
human	C
glioma	C
.	C

Introduction	O

Malignant	O
gliomas	O
,	O
neoplasms	O
of	O
glial	O
cells	O
and	O
their	O
precursors	O
,	O
are	O
the	O
most	O
common	O
tumors	O
of	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
.	O

These	O
tumors	O
typically	O
proliferate	O
rapidly	O
,	O
diffusely	O
infiltrate	O
the	O
brain	O
,	O
and	O
resist	O
standard	O
chemotherapies	O
,	O
properties	O
that	O
render	O
them	O
largely	O
incurable	O
.	O

One	O
key	O
to	O
developing	O
more	O
effective	O
therapies	O
against	O
these	O
tumors	O
is	O
to	O
understand	O
the	O
genetic	O
and	O
molecular	O
logic	O
underlying	O
gliomagenesis	O
.	O

The	O
most	O
frequent	O
genetic	O
lesions	O
in	O
gliomas	O
include	O
mutation	O
or	O
amplification	O
of	O
the	O
Epidermal	O
Growth	O
Factor	O
Receptor	O
(	O
EGFR	O
)	O
tyrosine	O
kinase	O
.	O

Glioma-associated	O
EGFR	O
mutant	O
forms	O
show	O
constitutive	O
kinase	O
activity	O
that	O
chronically	O
stimulates	O
Ras	O
signaling	O
to	O
drive	O
cellular	O
proliferation	O
and	O
migration	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
.	O

Other	O
common	O
genetic	O
lesions	O
include	O
loss	O
of	O
the	O
lipid	O
phosphatase	O
PTEN	O
,	O
which	O
antagonizes	O
the	O
phosphatidylinositol-3	O
kinase	O
(	O
PI3K	O
)	O
signaling	O
pathway	O
,	O
and	O
activating	O
mutations	O
in	O
PIK3CA	O
,	O
which	O
encodes	O
the	O
p110α	O
catalytic	O
subunit	O
of	O
PI3K	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
.	O

Gliomas	O
often	O
show	O
constitutively	O
active	O
Akt	O
,	O
a	O
major	O
PI3K	O
effector	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
.	O

However	O
,	O
EGFR-Ras	O
or	O
PI3K	O
mutations	O
alone	O
are	O
not	O
sufficient	O
to	O
transform	O
glial	O
cells	O
,	O
rather	O
multiple	O
mutations	O
that	O
coactivate	O
EGFR-Ras	O
and	O
PI3K-Akt	O
pathways	O
are	O
sufficient	O
to	O
induce	O
glioma	O
[	O
2	O
]	O
–	O
[	O
4	O
]	O
.	O

Understanding	C
the	C
interplay	C
of	C
these	C
mutations	C
and	C
the	C
neurodevelopmental	C
origins	C
of	C
these	C
tumors	C
could	C
lead	C
to	C
new	C
insights	C
into	C
the	C
mechanisms	C
of	C
gliomagenesis	C
.	C

The	O
mammalian	O
brain	O
contains	O
multiple	O
glial	O
cell	O
types	O
that	O
maintain	O
proliferative	O
capacities	O
,	O
including	O
differentiated	O
astrocytes	O
,	O
glial	O
progenitors	O
,	O
and	O
multipotent	O
neural	O
stem	O
cells	O
.	O

EGFR-Ras	O
and	O
PTEN-PI3K	O
signaling	O
regulates	O
many	O
developmental	O
processes	O
in	O
these	O
cell	O
types	O
,	O
particularly	O
proliferation	O
and	O
self-renewal	O
,	O
which	O
are	O
also	O
properties	O
of	O
glioma	O
cells	O
[	O
1	O
]	O
.	O

Although	O
recent	O
hypotheses	O
favor	O
that	O
gliomas	O
arise	O
from	O
multipotent	O
stem	O
cells	O
,	O
data	O
from	O
mouse	O
models	O
demonstrate	O
that	O
differentiated	O
glia	O
,	O
glial	O
progenitors	O
,	O
and	O
stem	O
cells	O
can	O
all	O
produce	O
gliomas	O
in	O
response	O
to	O
genetic	O
lesions	O
found	O
in	O
human	O
gliomas	O
[	O
5	O
]	O
,	O
[	O
6	O
]	O
.	O

Thus	C
,	C
misregulation	C
of	C
these	C
genetic	C
pathways	C
may	C
confer	C
unrestricted	C
proliferative	C
capacities	C
to	C
a	C
range	C
of	C
glial	C
cell	C
types	C
,	C
but	C
how	C
this	C
occurs	C
remains	C
unclear	C
.	C

While	C
many	C
of	C
the	C
same	C
effectors	C
are	C
utilized	C
by	C
EGFR-Ras	C
and	C
PI3K	C
in	C
both	C
glial	C
development	C
and	C
cancer	C
,	C
constitutive	C
activation	C
of	C
these	C
pathways	C
may	C
deploy	C
distinct	C
outputs	C
,	C
not	C
utilized	C
in	C
development	C
,	C
that	C
allow	C
particular	C
cells	C
to	C
escape	C
normal	C
physiological	C
cues	C
that	C
restrain	C
proliferation	C
and	C
self-renewal	C
.	C

The	C
identity	C
of	C
such	C
outputs	C
remains	C
unclear	C
.	C

With	O
these	O
issues	O
in	O
mind	O
,	O
we	O
developed	O
a	O
Drosophila	O
glioma	O
model	O
to	O
facilitate	O
genetic	O
analysis	O
of	O
glial	O
pathogenesis	O
.	O

Drosophila	O
offers	O
many	O
tools	O
for	O
precise	O
manipulation	O
of	O
cell-type-specific	O
gene	O
expression	O
and	O
dissection	O
of	O
multigene	O
interactions	O
.	O

Most	O
human	O
genes	O
,	O
including	O
70	O
%	O
of	O
known	O
disease	O
genes	O
,	O
have	O
functional	O
Drosophila	O
orthologs	O
[	O
7	O
]	O
.	O

Among	O
the	O
most	O
conserved	O
genes	O
are	O
components	O
of	O
major	O
signal	O
transduction	O
pathways	O
,	O
including	O
many	O
gliomagenic	O
genes	O
.	O

Recently	O
,	O
Drosophila	O
has	O
emerged	O
as	O
a	O
model	O
system	O
for	O
human	O
neurological	O
diseases	O
because	O
the	O
CNS	O
shows	O
remarkable	O
evolutionary	O
conservation	O
in	O
cellular	O
composition	O
and	O
neurodevelopmental	O
mechanisms	O
[	O
8	O
]	O
.	O

Similarly	O
,	O
Drosophila	O
have	O
multiple	O
glial	O
cell	O
types	O
that	O
require	O
the	O
EGFR	O
pathway	O
for	O
their	O
normal	O
development	O
,	O
and	O
these	O
cells	O
appear	O
homologous	O
to	O
mammalian	O
glia	O
in	O
terms	O
of	O
function	O
,	O
development	O
,	O
and	O
gene	O
expression	O
[	O
9	O
]	O
.	O

These	O
similarities	O
between	O
flies	O
and	O
humans	O
make	O
Drosophila	O
an	O
attractive	O
system	O
for	O
modeling	O
gliomas	O
.	O

Results	O

Coactivation	O
of	O
EGFR-Ras	O
and	O
PI3K	O
in	O
Drosophila	O
Glia	O
Causes	O
Neoplasia	O

Since	O
concurrent	O
activation	O
of	O
EGFR-Ras	O
and	O
PI3K	O
signaling	O
in	O
glial	O
precursors	O
induces	O
glioma	O
in	O
the	O
mouse	O
[	O
4	O
]	O
,	O
we	O
sought	O
to	O
create	O
mutant	O
phenotypes	O
by	O
hyperactivation	O
of	O
these	O
pathways	O
in	O
fly	O
glia	O
and	O
glial	O
precursors	O
.	O

Drosophila	O
has	O
a	O
single	O
functional	O
ortholog	O
each	O
for	O
EGFR	O
(	O
dEGFR	O
)	O
,	O
Raf	O
(	O
dRaf	O
)	O
,	O
PIK3CA	O
(	O
dp110	O
)	O
,	O
PTEN	O
(	O
dPTEN	O
)	O
,	O
and	O
Akt	O
(	O
dAkt	O
)	O
,	O
and	O
two	O
functional	O
orthologs	O
for	O
Ras	O
(	O
dRas85D	O
,	O
dRas64B	O
)	O
(	O
www.flybase.org	O
)	O
.	O

A	O
diagram	O
of	O
the	O
specific	O
mutant	O
forms	O
of	O
dEGFR	O
used	O
in	O
our	O
assays	O
can	O
be	O
found	O
in	O
Figure	O
S1	O
.	O

We	O
performed	O
glial	O
overexpression	O
assays	O
with	O
the	O
Gal4-UAS	O
system	O
[	O
10	O
]	O
,	O
using	O
the	O
repo-Gal4	O
driver	O
,	O
which	O
gives	O
sustained	O
UAS-transgene	O
expression	O
in	O
almost	O
all	O
glia	O
,	O
from	O
embryogenesis	O
through	O
adulthood	O
.	O

For	O
glial-specific	O
RNAi	O
,	O
we	O
employed	O
UAS-dsRNA	O
constructs	O
[	O
11	O
]	O
,	O
which	O
we	O
verified	O
with	O
phenotypic	O
tests	O
and/or	O
antibody	O
staining	O
(	O
see	O
Materials	O
and	O
Methods	O
)	O
.	O

Glial	O
morphology	O
was	O
visualized	O
with	O
membrane-localized	O
GFP	O
(	O
CD8GFP	O
)	O
[	O
12	O
]	O
.	O

Cell	O
number	O
was	O
determined	O
with	O
staining	O
for	O
Repo	O
,	O
a	O
homeobox	O
transcription	O
factor	O
expressed	O
by	O
repo-Gal4	O
positive	O
glia	O
[	O
13	O
]	O
.	O

Glial-specific	O
coactivation	O
of	O
EGFR-Ras	O
and	O
PI3K	O
stimulated	O
glial	O
neoplasia	O
,	O
giving	O
rise	O
to	O
CNS	O
enlargement	O
and	O
malformation	O
,	O
neurologic	O
defects	O
,	O
and	O
late	O
larval	O
lethality	O
.	O

repo-Gal4-driven	O
co-overexpression	O
of	O
activated	O
dEGFR	O
(	O
dEGFRλ	O
)	O
and	O
dp110	O
(	O
dp110CAAX	O
)	O
induced	O
progressive	O
accumulation	O
of	O
~50-fold	O
excess	O
glia	O
(	O
Figure	O
1A	O
and	O
1B	O
)	O
[	O
14	O
]	O
,	O
[	O
15	O
]	O
.	O

dEGFR	O
(	O
dEGFRλ	O
)	O
and	O
dp110	O
(	O
dp110CAAX	O
)	O
induced	O
progressive	O
accumulation	O
of	O
~50-fold	O
excess	O
glia	O
(	O
Figure	O
1A	O
and	O
1B	O
)	O
[	O
14	O
]	O
,	O
[	O
15	O
]	O
.	O
dEGFRλ	O
is	O
a	O
constitutively	O
active	O
dEGFR	O
variant	O
in	O
which	O
a	O
lambda	O
dimerization	O
domain	O
replaces	O
the	O
extracellular	O
domain	O
[	O
14	O
]	O
(	O
Figure	O
S1	O
)	O
.	O

Co-overexpression	O
of	O
combinations	O
of	O
dEGFRλ	O
and	O
core	O
components	O
of	O
the	O
PI3K	O
pathway	O
,	O
such	O
as	O
dAkt	O
,	O
induced	O
phenotypes	O
similar	O
to	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
,	O
although	O
phenotypes	O
varied	O
somewhat	O
depending	O
on	O
strength	O
of	O
pathway	O
activation	O
and	O
transgene	O
expression	O
(	O
Figure	O
S2	O
and	O
Table	O
S1	O
)	O
.	O

Dramatic	O
glial	O
overgrowth	O
also	O
occurred	O
upon	O
co-overexpression	O
of	O
constitutively	O
active	O
dRas	O
(	O
dRas85DV12	O
)	O
or	O
its	O
effector	O
dRaf	O
(	O
dRafgof	O
)	O
with	O
dp110CAAX	O
,	O
dAkt	O
,	O
or	O
a	O
dPTENdsRNA	O
,	O
which	O
partially	O
knocked-down	O
dPTEN	O
(	O
Figure	O
S2	O
and	O
Table	O
S1	O
)	O
.	O

Finally	C
,	C
glial	C
overgrowth	C
in	C
repo	C
>	C
dEGFRλ	C
;	C
dp110CAAX	C
larvae	C
was	C
strongly	C
suppressed	C
by	C
co-overexpression	C
of	C
dPTEN	C
or	C
more	C
moderately	C
by	C
dominant	C
negative	C
dRas85D	C
(	C
dRas85DN17	C
)	C
(	C
Figure	C
1D	C
and	C
1E	C
)	C
,	C
indicating	C
that	C
Ras	C
activity	C
and	C
excess	C
phospho-inositols	C
are	C
essential	C
for	C
neoplasia	C
.	C

Coactivation	O
of	O
EGFR-Ras	O
and	O
PI3K	O
in	O
Drosophila	O
glia	O
causes	O
neoplasia	O
.	O

In	O
contrast	O
,	O
glial-specific	O
activation	O
of	O
the	O
EGFR-Ras	O
pathway	O
alone	O
,	O
through	O
overexpression	O
of	O
dEGFRλ	O
or	O
Rafgof	O
,	O
induced	O
5–10	O
fold	O
excess	O
glia	O
in	O
the	O
larval	O
brain	O
and	O
later	O
pupal	O
lethality	O
(	O
Figure	O
1F	O
and	O
Table	O
S1	O
)	O
.	O

dRas85DV12	O
overexpression	O
induced	O
approximately	O
5–10-fold	O
excess	O
glia	O
,	O
and	O
these	O
glia	O
were	O
smaller	O
than	O
wild-type	O
or	O
dEGFRλ	O
;	O
dp110CAAX	O
glia	O
.	O

(	O
Figure	O
1G	O
)	O
.	O

dRas85DV12	C
may	C
be	C
more	C
potent	C
than	C
dEGFRλ	C
because	C
dRas85DV12	C
can	C
activate	C
endogenous	C
PI3K	C
signaling	C
[	C
16	C
]	C
.	C

Overexpression	O
of	O
dEGFRElp	O
,	O
a	O
classical	O
hypermorphic	O
mutant	O
form	O
of	O
dEGFR	O
[	O
17	O
]	O
,	O
induced	O
excess	O
glial	O
proliferation	O
and	O
neural	O
morphogenesis	O
defects	O
(	O
Figure	O
S2	O
)	O
,	O
but	O
also	O
caused	O
early	O
lethality	O
which	O
precluded	O
examination	O
of	O
dEGFRElp-dp110	O
interactions	O
.	O

As	O
in	O
mouse	O
models	O
,	O
overexpression	O
of	O
wild-type	O
dEGFR	O
failed	O
to	O
induce	O
excess	O
glia	O
[	O
6	O
]	O
,	O
[	O
17	O
]	O
,	O
and	O
instead	O
retarded	O
CNS	O
growth	O
(	O
Figure	O
S2	O
)	O
.	O

Unlike	C
dEGFRλ	C
,	C
dEGFRWT	C
and	C
dEGFRElp	C
have	C
functional	C
ligand-binding	C
domains	C
(	C
Figure	C
S1	C
)	C
,	C
and	C
may	C
cause	C
additional	C
defects	C
by	C
sequestering	C
ligand	C
otherwise	C
required	C
for	C
normal	C
development	C
[	C
17	C
]	C
.	C

Glial-specific	O
activation	O
of	O
the	O
PI3K	O
pathway	O
alone	O
,	O
either	O
by	O
overexpression	O
of	O
dp110CAAX	O
,	O
dp110wild-type	O
,	O
dAkt	O
,	O
or	O
dPTENdsRNA	O
gave	O
viable	O
animals	O
with	O
relatively	O
normal	O
brains	O
(	O
Figure	O
1H	O
,	O
Figure	O
S2	O
,	O
and	O
Table	O
S1	O
)	O
.	O

Therefore	O
,	O
coactivation	O
of	O
the	O
EGFR	O
and	O
PI3K	O
pathways	O
synergize	O
to	O
produce	O
much	O
more	O
severe	O
phenotypes	O
than	O
would	O
be	O
expected	O
if	O
the	O
effects	O
of	O
these	O
pathways	O
were	O
additive	O
.	O

In	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
,	O
excess	O
glia	O
emerged	O
in	O
early	O
larval	O
stages	O
and	O
accumulated	O
over	O
5–7	O
days	O
.	O
dEGFRλ	O
;	O
dp110CAAX	O
glia	O
severely	O
disrupt	O
the	O
normal	O
cellular	O
architecture	O
of	O
the	O
larval	O
brain	O
(	O
Figure	O
1A	O
and	O
1B	O
and	O
Figure	O
2A–C	O
)	O
,	O
lose	O
normal	O
stellate	O
glial	O
morphologies	O
(	O
Figure	O
2A–C	O
)	O
,	O
and	O
generate	O
multilayered	O
aggregations	O
of	O
abnormal	O
glia	O
throughout	O
the	O
brain	O
(	O
Figure	O
2A–C	O
)	O
;	O
in	O
these	O
ways	O
dEGFRλ	O
;	O
dp110CAAX	O
glia	O
are	O
neoplastic	O
[	O
18	O
]	O
.	O

Like	C
neoplastic	C
epithelial	C
cells	C
,	C
dEGFRλ	C
;	C
dp110CAAX	C
glia	C
ectopically	C
expressed	C
an	C
active	C
form	C
of	C
the	C
matrix	C
metalloprotease	C
dMMP1	C
(	C
Figure	C
S3	C
)	C
,	C
which	C
can	C
confer	C
an	C
invasive	C
potential	C
[	C
19	C
]	C
,	C
[	C
20	C
]	C
,	C
implying	C
that	C
abnormal	C
dEGFRλ	C
;	C
dp110CAAX	C
glia	C
may	C
be	C
invasive	C
within	C
the	C
brain	C
.	C

Unlike	O
neoplastic	O
epithelia	O
,	O
neoplastic	O
neural	O
cells	O
,	O
such	O
as	O
dEGFRλ	O
;	O
dp110CAAX	O
glia	O
,	O
typically	O
retain	O
expression	O
of	O
genes	O
that	O
regulate	O
neural	O
cell	O
fate	O
,	O
such	O
as	O
Repo	O
[	O
21	O
]	O
,	O
[	O
22	O
]	O
.	O

Coactivation	O
of	O
EGFR	O
and	O
PI3K	O
cell-autonomously	O
promotes	O
cell	O
cycle	O
entry	O
.	O

Relative	C
to	C
controls	C
,	C
many	C
dEGFRλ	C
;	C
dp110CAAX	C
glia	C
showed	C
BrdU	C
incorporation	C
,	C
which	C
marks	C
S-phase	C
cells	C
(	C
Figure	C
2D	C
and	C
2E	C
)	C
,	C
indicating	C
that	C
neoplastic	C
glia	C
arise	C
from	C
overproliferation	C
.	C

repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
animals	O
also	O
showed	O
reduced	O
BrdU	O
in	O
neuronal	O
precursors	O
(	O
Figure	O
2E	O
,	O
data	O
not	O
shown	O
)	O
,	O
demonstrating	O
that	O
neoplastic	O
glia	O
disrupt	O
neuronal	O
development	O
.	O

The	O
cell	O
cycle	O
is	O
governed	O
by	O
CyclinD-Cdk4	O
and	O
CyclinE-Cdk2	O
complexes	O
,	O
which	O
phosphorylate	O
and	O
inactivate	O
Rb	O
proteins	O
,	O
to	O
release	O
E2F	O
activators	O
to	O
stimulate	O
G1-S-phase	O
entry	O
[	O
23	O
]	O
.	O

Kip-type	O
(	O
p21/p27/p57	O
)	O
and	O
Ink-type	O
cyclin-dependent	O
kinase	O
inhibitors	O
antagonize	O
proliferation	O
by	O
inhibiting	O
CyclinE-Cdk2	O
and	O
CyclinD-Cdk4	O
,	O
respectively	O
.	O

Cdc25	O
phosphatases	O
and	O
mitotic	O
cyclins	O
,	O
including	O
CyclinB	O
,	O
promote	O
G2-M	O
progression	O
.	O

Flies	O
have	O
single	O
orthologs	O
each	O
for	O
CyclinE	O
,	O
Cdk2	O
,	O
CyclinD	O
,	O
Cdk4	O
,	O
CyclinB	O
,	O
and	O
p21/p27/p57	O
(	O
Dap	O
)	O
,	O
E2F	O
activators	O
(	O
E2F1	O
)	O
and	O
two	O
orthologs	O
for	O
Rb	O
(	O
Rbf1	O
and	O
Rbf2	O
)	O
and	O
Cdc25	O
(	O
Stg	O
and	O
Twe	O
)	O
but	O
no	O
Ink	O
ortholog	O
[	O
23	O
]	O
.	O

dEGFRλ	O
;	O
dp110CAAX	O
glia	O
showed	O
ectopic	O
expression	O
of	O
dCyclinE	O
and	O
dCyclinB	O
(	O
Figure	O
2F–I	O
)	O
,	O
demonstrating	O
that	O
EGFR	O
and	O
PI3K	O
activity	O
upregulated	O
proteins	O
that	O
promote	O
cell	O
cycle	O
entry	O
and	O
progression	O
.	O

High-grade	O
human	O
gliomas	O
contain	O
highly	O
proliferative	O
anaplastic	O
glia	O
and	O
enlarged	O
pleiomorphic	O
polyploid	O
glia	O
[	O
24	O
]	O
.	O

Similarly	O
,	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
larvae	O
showed	O
accumulation	O
of	O
small	O
,	O
highly	O
proliferative	O
glia	O
that	O
strongly	O
expressed	O
cyclins	O
and	O
labeled	O
with	O
BrdU	O
.	O

repo	C
>	C
dEGFRλ	C
;	C
dp110CAAX	C
larvae	C
showed	C
accumulation	C
of	C
small	C
,	C
highly	C
proliferative	C
glia	C
that	C
strongly	C
expressed	C
cyclins	C
and	C
labeled	C
with	C
BrdU	C
.	C
repo	C
>	C
dEGFRλ	C
;	C
dp110CAAX	C
larval	C
brains	C
also	C
displayed	C
abnormal	C
pol	C
yploid	C
glia	C
,	C
as	C
assessed	C
by	C
DAPI	C
staining	C
(	C
data	C
not	C
show	C
n	C
)	C
,	C
and	C
these	C
cells	C
typically	C
expressed	C
only	C
dCyclinE	C
but	C
not	C
dCyclinB	C
,	C
and	C
thereby	C
likely	C
underwent	C
ectopic	C
DNA	C
replication	C
without	C
mitosis	C
(	C
Figure	C
2G	C
and	C
2I	C
,	C
data	C
not	C
shown	C
)	C
.	C

However	O
,	O
overexpression	O
of	O
dCyclinE-dCdk2	O
,	O
dCyclinD-dCdk4	O
,	O
or	O
dE2F1-dDp	O
complexes	O
and/or	O
Rbf1	O
knock-down	O
did	O
not	O
cause	O
neoplasia	O
,	O
and	O
instead	O
either	O
doubled	O
glial	O
cell	O
numbers	O
or	O
resulted	O
in	O
embryonic	O
lethality	O
(	O
Figure	O
S4	O
,	O
data	O
not	O
shown	O
)	O
.	O

We	O
next	O
examined	O
negative	O
regulators	O
of	O
the	O
cell	O
cycle	O
.	O

dEGFRλ	O
;	O
dp110CAAX	O
glia	O
expressed	O
Rbf1	O
,	O
but	O
showed	O
little	O
Dap	O
,	O
a	O
result	O
we	O
also	O
observed	O
in	O
wild-type	O
glia	O
(	O
Figure	O
S5	O
)	O
.	O

Dap	O
inhibits	O
dCyclinE-cdk2	O
complexes	O
[	O
25	O
]	O
,	O
and	O
is	O
transiently	O
expressed	O
in	O
neural	O
progenitors	O
to	O
promote	O
cell	O
cycle	O
exit	O
as	O
they	O
begin	O
differentiation	O
[	O
26	O
]	O
.	O

Dap	O
overexpression	O
completely	O
suppressed	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
glial	O
overgrowth	O
(	O
Figure	O
2L	O
)	O
,	O
demonstrating	O
that	O
glial	O
neoplasia	O
is	O
cell-autonomous	O
and	O
requires	O
dCyclinE-dCdk2	O
.	O

Similarly	O
,	O
overexpressed	O
Rbf1	O
and	O
dCyclinE	O
mutations	O
also	O
reduced	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
glial	O
overproliferation	O
(	O
Figure	O
2M	O
,	O
data	O
not	O
shown	O
)	O
.	O

The	C
gross	C
neural	C
morphogenesis	C
defects	C
observed	C
in	C
repo	C
>	C
dEGFRλ	C
;	C
dp110CAAX	C
brains	C
may	C
be	C
secondary	C
to	C
glial	C
overproliferation	C
since	C
these	C
defects	C
were	C
largely	C
prevented	C
by	C
Dap	C
or	C
Rbf1	C
co-overexpression	C
(	C
Figure	C
2J–M	C
)	C
.	C

In	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
animals	O
,	O
other	O
mutant	O
glia	O
outside	O
of	O
the	O
brain	O
,	O
such	O
as	O
peripheral	O
glia	O
,	O
also	O
became	O
highly	O
proliferative	O
and	O
invasive	O
,	O
and	O
these	O
defects	O
,	O
too	O
,	O
were	O
corrected	O
by	O
Rbf1	O
or	O
Dap	O
overexpression	O
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
controls	O
,	O
Rbf1	O
or	O
Dap	O
overexpression	O
in	O
wild-type	O
glia	O
inhibited	O
proliferation	O
(	O
Figure	O
S4	O
)	O
,	O
reducing	O
numbers	O
of	O
glia	O
by	O
approximately	O
half	O
.	O

Together	C
,	C
these	C
results	C
suggest	C
that	C
repo-Gal4	C
glia	C
undergo	C
at	C
least	C
one	C
round	C
of	C
cell	C
division	C
,	C
consistent	C
with	C
published	C
studies	C
[	C
27	C
]	C
,	C
[	C
28	C
]	C
,	C
and	C
this	C
proliferation	C
becomes	C
prolonged	C
by	C
constitutive	C
coactivation	C
of	C
EGFR	C
and	C
PI3K	C
signaling	C
.	C

Coactivation	O
of	O
EGFR	O
and	O
PI3K	O
Does	O
Not	O
Elicit	O
Neoplasia	O
in	O
All	O
Neural	O
Cell	O
Types	O

The	O
phenotype	O
triggered	O
by	O
coactivation	O
of	O
EGFR	O
and	O
PI3K	O
in	O
glia	O
is	O
distinct	O
from	O
other	O
Drosophila	O
brain-overgrowth	O
mutant	O
phenotypes	O
,	O
which	O
involve	O
accretion	O
of	O
excess	O
neurons	O
or	O
neuroblasts	O
[	O
21	O
]	O
,	O
[	O
29	O
]	O
.	O

repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
cells	O
were	O
not	O
transformed	O
into	O
neurons	O
or	O
neuroblasts	O
as	O
they	O
lacked	O
expression	O
of	O
the	O
Elav	O
and	O
Miranda	O
markers	O
(	O
Figure	O
S6	O
)	O
.	O

Lineage-tracing	O
with	O
a	O
Su	O
(	O
H	O
)	O
-lacZ	O
neuroblast	O
reporter	O
showed	O
that	O
excess	O
dEGFRλ	O
;	O
dp110CAAX	O
glia	O
did	O
not	O
express	O
LacZ	O
,	O
and	O
thus	O
are	O
not	O
directly	O
derived	O
from	O
larval	O
neuroblasts	O
(	O
data	O
not	O
shown	O
)	O
.	O

Moreover	O
,	O
constitutive	O
EGFR-Ras	O
and	O
PI3K	O
signaling	O
does	O
not	O
elicit	O
overgrowth	O
in	O
all	O
neural	O
cell	O
types	O
,	O
as	O
assessed	O
with	O
defined	O
cell-type	O
specific	O
Gal4-drivers	O
(	O
Table	O
S2	O
)	O
.	O

For	O
example	O
,	O
dRas85DV12	O
overexpression	O
in	O
fly	O
neurons	O
causes	O
defects	O
in	O
fate	O
specification	O
,	O
patterning	O
,	O
and	O
apoptosis	O
[	O
30	O
]	O
,	O
[	O
31	O
]	O
.	O

Co-overexpression	O
of	O
dEGFRλ	O
or	O
dRas85DV12	O
with	O
dp110CAAX	O
in	O
neurons	O
(	O
elav-Gal4	O
,	O
scratch-Gal4	O
,	O
OK107-Gal4	O
,	O
and	O
Appl-Gal4	O
)	O
and	O
neuroblasts/neuronal	O
precursors	O
(	O
pros-Gal4	O
,	O
wor-Gal4	O
,	O
and	O
1407-Gal4	O
)	O
did	O
not	O
induce	O
overgrowth	O
(	O
Figure	O
S7	O
,	O
data	O
not	O
shown	O
)	O
,	O
even	O
with	O
increased	O
transgene	O
expression	O
from	O
Gal4	O
amplification	O
[	O
32	O
]	O
.	O

In	C
fact	C
,	C
broad	C
co-overexpression	C
of	C
dEGFRλ	C
and	C
dp110CAAX	C
in	C
neuroblasts	C
and	C
neuronal	C
precursors	C
(	C
pros-Gal4	C
)	C
reduced	C
brain	C
size	C
,	C
perhaps	C
because	C
signaling	C
through	C
these	C
pathways	C
stimulates	C
precocious	C
cell	C
cycle	C
exit	C
of	C
neuronal	C
precursors	C
,	C
as	C
in	C
the	C
developing	C
eye	C
[	C
33	C
]	C
.	C

Furthermore	O
,	O
transient	O
expression	O
of	O
dRas85DV12	O
or	O
dEGFRλ	O
and	O
dp110CAAX	O
in	O
embryonic	O
glia	O
(	O
gcm-Gal4	O
)	O
also	O
failed	O
to	O
promote	O
glial	O
overgrowth	O
(	O
Figure	O
S7	O
)	O
[	O
27	O
]	O
,	O
demonstrating	O
that	O
sustained	O
activation	O
of	O
these	O
pathways	O
is	O
required	O
for	O
glial	O
overproliferation	O
.	O

Certain	O
glial	O
subtypes	O
,	O
such	O
as	O
oligodendrocyte-like	O
neuropil	O
glia	O
(	O
Eaat1-Gal4	O
)	O
,	O
some	O
astrocyte-like	O
cortex	O
glia	O
(	O
Nrv2-Gal4	O
)	O
,	O
and	O
peripheral	O
perineurial	O
glia	O
(	O
gli-Gal4	O
)	O
also	O
failed	O
to	O
become	O
neoplastic	O
in	O
response	O
to	O
EGFR-Ras	O
and	O
PI3K	O
(	O
Figure	O
S7	O
,	O
data	O
not	O
shown	O
)	O
[	O
34	O
]	O
–	O
[	O
36	O
]	O
.	O

Therefore	O
,	O
neoplastic	O
proliferation	O
is	O
not	O
a	O
uniform	O
cellular	O
response	O
to	O
EGFR	O
and	O
PI3K	O
.	O

Coactivation	O
of	O
EGFR	O
and	O
PI3K	O
Inhibits	O
Cell	O
Cycle	O
Exit	O
in	O
Glia	O

Since	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
animals	O
die	O
in	O
5–7	O
days	O
,	O
we	O
assessed	O
the	O
proliferative	O
potential	O
of	O
mutant	O
glia	O
using	O
an	O
abdominal	O
transplant	O
assay	O
,	O
a	O
classic	O
test	O
of	O
tumorigencity	O
in	O
flies	O
[	O
37	O
]	O
.	O

Brain	O
fragments	O
from	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
and	O
wild-type	O
larvae	O
were	O
transplanted	O
into	O
young	O
adults	O
.	O

Wild-type	O
transplants	O
grew	O
and	O
survived	O
over	O
1–6	O
weeks	O
,	O
but	O
produced	O
few	O
glia	O
(	O
Figure	O
3A	O
and	O
3C	O
)	O
.	O

dEGFRλ	O
;	O
dp110CAAX	O
mutant	O
glia	O
survived	O
and	O
proliferated	O
into	O
massive	O
tumors	O
that	O
filled	O
the	O
hosts	O
'	O
abdomens	O
,	O
often	O
causing	O
premature	O
death	O
(	O
Figure	O
3B	O
)	O
.	O

Tumors	O
were	O
composed	O
of	O
small	O
glial	O
cells	O
with	O
little	O
cytoplasm	O
(	O
Figure	O
3D–F	O
)	O
.	O

Tumors	C
also	C
contained	C
trachea	C
embedded	C
throughout	C
their	C
mass	C
(	C
Figure	C
3D	C
and	C
3E	C
and	C
Video	C
S1	C
)	C
,	C
suggesting	C
that	C
tumors	C
stimulated	C
growth	C
of	C
new	C
trachea	C
or	C
enveloped	C
existing	C
trachea	C
,	C
perhaps	C
in	C
a	C
process	C
akin	C
to	C
tumor	C
angiogenesis	C
.	C

The	O
leading	O
edges	O
of	O
the	O
tumors	O
harbored	O
individual	O
cells	O
invading	O
nearby	O
tissues	O
,	O
such	O
as	O
the	O
ovary	O
(	O
Figure	O
3F	O
and	O
Video	O
S2	O
)	O
,	O
which	O
is	O
consistent	O
with	O
the	O
ectopic	O
expression	O
of	O
active	O
dMMP1	O
observed	O
in	O
dEGFRλ	O
;	O
dp110CAAX	O
glia	O
in	O
the	O
larval	O
brain	O
(	O
Figure	O
S3	O
)	O
.	O

However	O
,	O
some	O
tissues	O
,	O
such	O
as	O
the	O
gut	O
,	O
did	O
not	O
contain	O
metastases	O
,	O
implying	O
some	O
degree	O
of	O
selective	O
invasion	O
.	O

Thus	O
,	O
once	O
unconstrained	O
by	O
the	O
larval	O
life	O
cycle	O
,	O
dEGFRλ	O
;	O
dp110CAAX	O
glia	O
fail	O
to	O
exit	O
the	O
cell	O
cycle	O
,	O
continue	O
to	O
proliferate	O
,	O
and	O
form	O
highly	O
invasive	O
tumors	O
,	O
all	O
properties	O
of	O
human	O
cancer	O
cells	O
.	O

Coactivation	O
of	O
EGFR	O
and	O
PI3K	O
inhibits	O
cell	O
cycle	O
exit	O
in	O
glia	O
.	O

Coactivation	O
of	O
EGFR-Ras	O
and	O
PI3K	O
Creates	O
Invasive	O
Neoplastic	O
Glia	O

To	O
explore	O
the	O
invasive	O
potential	O
of	O
mutant	O
glia	O
,	O
we	O
used	O
FLP-FRT	O
clonal	O
analysis	O
,	O
a	O
technique	O
in	O
which	O
discrete	O
clones	O
of	O
mutant	O
cells	O
are	O
induced	O
in	O
otherwise	O
normal	O
tissues	O
,	O
a	O
situation	O
analogous	O
to	O
somatic	O
tumorigenesis	O
.	O

We	O
used	O
a	O
heat-shock-driven	O
FLP-recombinase	O
to	O
catalyze	O
mitotic	O
recombination	O
between	O
FRT-bearing	O
chromosomes	O
such	O
that	O
a	O
daughter	O
cell	O
(	O
and	O
all	O
of	O
its	O
clonal	O
progeny	O
)	O
initiated	O
expression	O
of	O
GFP	O
and	O
UAS-containing	O
transgenes	O
only	O
in	O
repo-Gal4-expressing	O
cells	O
[	O
12	O
]	O
.	O

Clones	O
were	O
induced	O
late	O
in	O
development	O
,	O
from	O
mitotic	O
founder	O
cells	O
,	O
and	O
were	O
examined	O
in	O
adults	O
.	O

We	C
could	C
not	C
definitively	C
determine	C
if	C
clones	C
were	C
derived	C
from	C
single	C
cell	C
events	C
since	C
our	C
study	C
of	C
these	C
clones	C
was	C
retrospective	C
,	C
but	C
given	C
the	C
frequency	C
of	C
control	C
clone	C
induction	C
,	C
many	C
mutant	C
clones	C
likely	C
originated	C
from	C
single	C
cells	C
.	C

In	O
wild-type	O
controls	O
,	O
we	O
observed	O
clones	O
in	O
68	O
%	O
of	O
brains	O
examined	O
(	O
N=149	O
)	O
.	O

Of	O
the	O
brains	O
with	O
clones	O
,	O
75	O
%	O
had	O
1–3	O
clones	O
,	O
and	O
83	O
%	O
of	O
these	O
clones	O
consisted	O
of	O
1–3	O
cells	O
of	O
the	O
same	O
glial	O
subtype	O
(	O
Figure	O
4A	O
and	O
4B	O
)	O
.	O

Glial	O
clones	O
overexpressing	O
dRas85DV12	O
,	O
dEGFRλ	O
,	O
or	O
dEGFRElp	O
alone	O
typically	O
contained	O
2-fold	O
more	O
cells	O
than	O
wild-type	O
(	O
dRas85DV12	O
shown	O
in	O
Figure	O
4C	O
)	O
.	O

To	O
examine	O
PI3K	O
signaling	O
,	O
we	O
used	O
a	O
dPTEN	O
null	O
allele	O
,	O
which	O
became	O
homozygous	O
in	O
FLP-FRT	O
clones	O
.	O

dPTEN-/-	C
glia	C
did	C
not	C
overgrow	C
,	C
but	C
did	C
show	C
aberrant	C
cytoplasmic	C
projections	C
(	C
Figure	C
4D	C
)	C
,	C
perhaps	C
reflecting	C
dPTEN	C
function	C
in	C
the	C
cytoskeleton	C
[	C
38	C
]	C
.	C

Coactivation	O
of	O
EGFR-Ras	O
and	O
PI3K	O
creates	O
invasive	O
neoplastic	O
glia	O
.	O

To	O
coactivate	O
EGFR-Ras	O
and	O
PI3K	O
in	O
glial	O
clones	O
,	O
dRas85DV12	O
,	O
dEGFRElp	O
,	O
or	O
dEGFRλ	O
was	O
overexpressed	O
within	O
dPTEN-/-	O
glia	O
,	O
using	O
repo-Gal4	O
.	O

We	O
observed	O
overgrown	O
and	O
invasive	O
dRas85DV12	O
;	O
dPTEN-/-	O
and	O
dEGFRElp	O
;	O
dPTEN-/-	O
clones	O
(	O
Figure	O
4E–G	O
)	O
.	O
dEGFR	O
;	O
dPTEN-/-	O
clones	O
were	O
less	O
affected	O
(	O
Figure	O
4F	O
and	O
4G	O
)	O
,	O
consistent	O
with	O
the	O
larval	O
overexpression	O
of	O
dRas85DV12	O
giving	O
more	O
severe	O
growth	O
phenotypes	O
.	O

Tumor-like	O
overgrowth	O
was	O
only	O
observed	O
in	O
dEGFR-dRas85D	O
;	O
dPTEN-/-	O
cells	O
,	O
illustrating	O
that	O
chronic	O
EGFR-Ras	O
activation	O
and	O
PTEN	O
loss	O
can	O
cause	O
cell-autonomous	O
over-proliferation	O
.	O

Cells	C
from	C
these	C
double	C
mutant	C
clones	C
appeared	C
to	C
invade	C
the	C
brain	C
,	C
typically	C
following	C
fiber	C
tracts	C
,	C
and	C
sometimes	C
induced	C
the	C
formation	C
of	C
trachea	C
(	C
Figure	C
4E	C
)	C
.	C

Tumor-like	O
growths	O
of	O
dEGFR-dRas85D	O
;	O
dPTEN-/-	O
cells	O
often	O
penetrated	O
deep	O
into	O
the	O
brain	O
,	O
as	O
exemplified	O
by	O
Videos	O
S3	O
and	O
S4	O
which	O
show	O
an	O
animated	O
88	O
µm	O
thick	O
confocal	O
z-stack	O
of	O
the	O
dRas85DV12	O
;	O
dPTEN-/-	O
clone	O
in	O
Figure	O
4E	O
compared	O
to	O
a	O
16	O
µm	O
thick	O
z-stack	O
of	O
a	O
wild-type	O
control	O
clone	O
in	O
Figure	O
4A	O
.	O

These	O
phenotypes	O
were	O
reminiscent	O
of	O
invasion	O
and	O
angiogenesis	O
in	O
human	O
gliomas	O
[	O
24	O
]	O
.	O

We	C
more	C
commonly	C
observed	C
smaller	C
dEGFR-dRas85D	C
;	C
dPTEN-/-	C
clones	C
composed	C
of	C
relatively	C
differentiated	C
,	C
enlarged	C
glia	C
with	C
diffusely	C
invasive	C
projections	C
(	C
Figure	C
4G	C
)	C
;	C
these	C
clones	C
likely	C
derive	C
from	C
glia	C
that	C
differentiated	C
prior	C
to	C
achieving	C
sufficient	C
EGFR-Ras	C
transgene	C
expression	C
,	C
and	C
are	C
consistent	C
with	C
findings	C
that	C
not	C
all	C
glial	C
subtypes	C
become	C
neoplastic	C
.	C

Since	C
neoplastic	C
larval	C
glia	C
were	C
concentrated	C
in	C
the	C
outer	C
anterior	C
central	C
brain	C
and	C
developing	C
optic	C
lobe	C
,	C
they	C
may	C
be	C
derived	C
from	C
glial	C
progenitor	C
cells	C
present	C
in	C
these	C
regions	C
[	C
27	C
]	C
,	C
[	C
28	C
]	C
,	C
[	C
39	C
]	C
.	C

To	O
create	O
clones	O
from	O
a	O
discrete	O
subpopulation	O
of	O
glial	O
progenitors	O
,	O
we	O
used	O
an	O
eyeless	O
(	O
ey	O
)	O
-promoter	O
driven	O
FLP-recombinase	O
(	O
ey-FLP	O
)	O
,	O
which	O
is	O
active	O
in	O
ey-expressing	O
glial	O
progenitors	O
in	O
the	O
optic	O
lobe	O
[	O
27	O
]	O
.	O

Single	O
mutant	O
ey-FLP	O
clones	O
of	O
dPTEN-/-	O
,	O
dRas85DV12	O
,	O
or	O
dEGFRElp	O
cells	O
contained	O
a	O
modest	O
number	O
of	O
excess	O
and	O
abnormal	O
glia	O
relative	O
to	O
wild-type	O
controls	O
(	O
Figure	O
4H–J	O
and	O
Figure	O
S8	O
)	O
.	O

In	O
contrast	O
,	O
the	O
double	O
mutant	O
dRas85DV12	O
;	O
dPTEN-/-	O
,	O
dEGFRElp	O
;	O
dPTEN-/-	O
,	O
or	O
dEGFRλ	O
;	O
dPTEN-/-	O
ey-FLP	O
clones	O
,	O
which	O
emerge	O
as	O
approximately	O
tens	O
of	O
cells	O
in	O
3rd	O
instar	O
larval	O
brains	O
(	O
Figure	O
4K	O
)	O
,	O
became	O
large	O
invasive	O
tumors	O
composed	O
of	O
hundreds	O
to	O
thousands	O
of	O
cells	O
in	O
adults	O
(	O
Figure	O
4L	O
and	O
Figure	O
S8	O
)	O
.	O

EGFR	O
;	O
PI3K	O
Induces	O
Glial	O
Neoplasia	O
via	O
Pnt	O
and	O
Stg	O
Expression	O

To	O
address	O
the	O
function	O
of	O
EGFR-Ras	O
and	O
PI3K	O
in	O
glioma	O
,	O
we	O
analyzed	O
the	O
genetic	O
basis	O
of	O
glial	O
pathogenesis	O
in	O
our	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
model	O
,	O
as	O
this	O
model	O
shows	O
robust	O
neoplasia	O
,	O
similarity	O
to	O
human	O
tumor	O
genotypes	O
,	O
and	O
sensitivity	O
to	O
dEGFR	O
and	O
dPTEN	O
gene	O
dosage	O
(	O
data	O
not	O
shown	O
)	O
.	O

EGFR-Ras	C
signaling	C
can	C
promote	C
proliferation	C
through	C
Erk	C
kinase-mediated	C
induction	C
of	C
nuclear	C
targets	C
.	C

In	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
,	O
mutant	O
glia	O
showed	O
high	O
levels	O
of	O
nuclear	O
,	O
activated	O
di-phospho-Erk	O
relative	O
to	O
wild-type	O
glia	O
in	O
control	O
brains	O
(	O
Figure	O
5A	O
and	O
5B	O
)	O
.	O

In	O
flies	O
,	O
Erk	O
activity	O
can	O
induce	O
expression	O
of	O
PntP1	O
,	O
an	O
ETS-family	O
transcription	O
factor	O
encoded	O
by	O
the	O
pointed	O
(	O
pnt	O
)	O
locus	O
[	O
40	O
]	O
,	O
[	O
41	O
]	O
.	O

PntP1	O
,	O
which	O
is	O
expressed	O
in	O
embryonic	O
glia	O
and	O
is	O
required	O
for	O
their	O
normal	O
development	O
[	O
40	O
]	O
,	O
was	O
upregulated	O
in	O
dEGFRλ	O
;	O
dp110CAAX	O
glia	O
(	O
Figure	O
5C	O
and	O
5D	O
)	O
.	O

High	C
levels	C
of	C
PntP1	C
can	C
be	C
detected	C
normally	C
in	C
neuronal	C
progenitors	C
(	C
data	C
not	C
shown	C
)	C
,	C
suggesting	C
that	C
it	C
promotes	C
a	C
proliferative	C
progenitor	C
state	C
.	C

In	O
developing	O
eye	O
tissue	O
,	O
EGFR-Ras-Erk	O
signaling	O
induces	O
Pnt	O
proteins	O
to	O
stimulate	O
G2-M	O
cell	O
cycle	O
progression	O
through	O
direct	O
upregulation	O
of	O
Stg	O
(	O
Cdc25	O
ortholog	O
)	O
expression	O
[	O
41	O
]	O
.	O

Glial-specific	O
RNAi	O
knock	O
down	O
of	O
pnt	O
reduced	O
Stg	O
expression	O
and	O
completely	O
suppressed	O
dEGFRλ	O
;	O
dp110CAAX	O
neoplasia	O
(	O
Figure	O
5E–H	O
)	O
,	O
demonstrating	O
that	O
Pnt	O
proteins	O
are	O
required	O
for	O
both	O
Stg	O
expression	O
and	O
neoplastic	O
overproliferation	O
in	O
dEGFRλ	O
;	O
dp110CAAX	O
glia	O
.	O

Notably	O
,	O
in	O
repo	O
>	O
pntdsRNA	O
;	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
,	O
glia	O
maintained	O
their	O
fate	O
,	O
as	O
evidenced	O
by	O
repo-Gal4	O
and	O
Repo	O
expression	O
.	O

EGFR	O
;	O
PI3K	O
induces	O
glial	O
neoplasia	O
via	O
Pnt	O
and	O
Stg	O
expression	O
.	O

Stg	O
itself	O
was	O
rate	O
limiting	O
for	O
glial	O
neoplasia	O
.	O

Reduction	O
of	O
stg	O
with	O
a	O
mutation	O
or	O
a	O
stgdsRNA	O
partially	O
suppressed	O
the	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
phenotype	O
,	O
whereas	O
overexpressed	O
Stg	O
synergistically	O
enhanced	O
neoplasia	O
(	O
Figure	O
5E	O
and	O
Figure	O
S9	O
,	O
data	O
not	O
shown	O
)	O
.	O

In	O
contrast	O
,	O
Stg	O
overexpression	O
alone	O
increased	O
glial	O
cell	O
numbers	O
approximately	O
2-fold	O
,	O
and	O
could	O
not	O
induce	O
neoplasia	O
when	O
combined	O
with	O
PI3K	O
effectors	O
(	O
data	O
not	O
shown	O
)	O
.	O

Thus	O
,	O
dEGFRλ	O
;	O
dp110CAAX	O
induces	O
neoplasia	O
via	O
coordinated	O
stimulation	O
of	O
G1-S	O
entry	O
through	O
dCyclinE	O
,	O
and	O
G2-M	O
progression	O
through	O
Stg	O
,	O
both	O
of	O
which	O
are	O
EGFR-Ras	O
dependent	O
outputs	O
[	O
41	O
]	O
,	O
[	O
42	O
]	O
.	O

EGFR	O
;	O
PI3K	O
Glial	O
Neoplasia	O
Requires	O
Akt	O
and	O
Tor	O
Activation	O
and	O
FoxO	O
Inactivation	O

We	O
sought	O
to	O
determine	O
which	O
PI3K	O
effectors	O
contribute	O
to	O
the	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
phenotype	O
.	O

Genetic	O
reduction	O
of	O
dAkt	O
,	O
a	O
major	O
target	O
of	O
PI3K	O
signaling	O
,	O
with	O
a	O
dAktdsRNA	O
or	O
a	O
mutant	O
allele	O
strongly	O
suppressed	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
glial	O
neoplasia	O
(	O
Figure	O
6A–C	O
,	O
data	O
not	O
shown	O
)	O
.	O

Therefore	O
,	O
Akt	O
is	O
necessary	O
for	O
the	O
outcome	O
of	O
EGFR-PI3K	O
coactivation	O
.	O

Many	O
Akt	O
effectors	O
are	O
implicated	O
in	O
glioma	O
,	O
and	O
we	O
tested	O
orthologs	O
of	O
these	O
loci	O
in	O
our	O
model	O
(	O
Table	O
S3	O
)	O
.	O

EGFR	O
;	O
PI3K	O
glial	O
neoplasia	O
requires	O
Akt	O
and	O
Tor	O
activation	O
and	O
FoxO	O
inactivation	O
.	O

Tor	O
,	O
a	O
kinase	O
that	O
promotes	O
cell	O
growth	O
and	O
proliferation	O
,	O
is	O
a	O
key	O
Akt	O
target	O
.	O

In	O
glioma	O
models	O
,	O
coactivation	O
of	O
EGFR-Ras	O
and	O
PI3K	O
stimulates	O
Tor	O
,	O
and	O
in	O
humans	O
,	O
Tor	O
activity	O
is	O
correlated	O
with	O
poor	O
patient	O
prognosis	O
[	O
43	O
]	O
,	O
[	O
44	O
]	O
.	O

We	O
tested	O
the	O
single	O
Drosophila	O
Tor	O
ortholog	O
,	O
dTor	O
,	O
by	O
genetically	O
reducing	O
dTor	O
activity	O
in	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
larvae	O
with	O
a	O
viable	O
combination	O
of	O
hypomorphic	O
dTor	O
alleles	O
or	O
by	O
co-overexpression	O
of	O
dominant	O
negative	O
dTor	O
45,46	O
.	O

Both	O
of	O
these	O
manipulations	O
reduced	O
glial	O
overgrowth	O
(	O
Figure	O
6D	O
,	O
data	O
not	O
shown	O
)	O
.	O

In	O
flies	O
and	O
mammals	O
,	O
Tor	O
exists	O
in	O
two	O
different	O
signaling	O
complexes	O
,	O
TORC1	O
and	O
TORC2	O
.	O

TORC2	O
,	O
a	O
complex	O
including	O
Tor	O
and	O
the	O
Sin1	O
and	O
Rictor	O
regulatory	O
proteins	O
,	O
directly	O
phosphorylates	O
Akt	O
,	O
creating	O
a	O
positive	O
feedback	O
loop	O
that	O
fully	O
activates	O
Akt	O
[	O
47	O
]	O
.	O

In	O
mouse	O
,	O
Sin1	O
and	O
Rictor	O
mutants	O
die	O
early	O
due	O
to	O
extraembryonic	O
defects	O
,	O
but	O
dSin1	O
and	O
dRictor	O
mutant	O
flies	O
are	O
viable	O
as	O
homozygous	O
nulls	O
,	O
allowing	O
us	O
to	O
remove	O
TORC2	O
function	O
genetically	O
[	O
47	O
]	O
,	O
[	O
48	O
]	O
.	O

dSin1-/-	O
;	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
larval	O
brains	O
showed	O
a	O
near-wild	O
type	O
phenotype	O
(	O
Figure	O
6E	O
)	O
.	O

Results	O
were	O
similar	O
with	O
a	O
dRictor	O
null	O
allele	O
and	O
a	O
dSin1dsRNA	O
(	O
data	O
not	O
shown	O
)	O
.	O

dSin1-/-	O
and	O
dRictor-/-	O
mutants	O
display	O
reduced	O
Akt-dependent	O
phosphorylation	O
and	O
inactivation	O
of	O
dFoxO	O
[	O
49	O
]	O
,	O
the	O
single	O
Drosophila	O
ortholog	O
of	O
FoxO	O
transcription	O
factors	O
.	O

This	C
suggests	C
that	C
TORC2	C
loss	C
might	C
antagonize	C
glial	C
neoplasia	C
through	C
dFoxO	C
upregulation	C
.	C

However	O
,	O
excess	O
dFoxOSA	O
,	O
which	O
is	O
resistant	O
to	O
dAkt	O
phosphorylation	O
[	O
45	O
]	O
,	O
only	O
partially	O
suppressed	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
glial	O
overproliferation	O
(	O
Figure	O
6F	O
)	O
,	O
arguing	O
that	O
TORC2	O
has	O
additional	O
roles	O
.	O

Notably	O
,	O
on	O
their	O
own	O
,	O
dSin1-/-	O
and	O
dRictor-/-	O
mutant	O
flies	O
did	O
not	O
show	O
any	O
detectable	O
glial	O
defects	O
(	O
Figure	O
6G	O
,	O
data	O
not	O
shown	O
)	O
.	O

Thus	O
,	O
TORC2	O
is	O
dispensible	O
for	O
normal	O
glial	O
development	O
,	O
but	O
is	O
necessary	O
for	O
dEGFRλ	O
;	O
dp110CAAX	O
glial	O
neoplasia	O
.	O

TORC1	O
,	O
a	O
complex	O
including	O
Tor	O
and	O
the	O
Raptor	O
regulatory	O
protein	O
,	O
drives	O
cellular	O
growth	O
by	O
stimulating	O
protein	O
synthesis	O
through	O
its	O
effectors	O
S6	O
kinase	O
and	O
the	O
eIF-4E	O
translation	O
initiation	O
factor	O
[	O
47	O
]	O
.	O

Akt	O
and	O
Erk	O
stimulate	O
TORC1	O
through	O
phosphorylation	O
and	O
inactivation	O
of	O
the	O
TSC1-TSC2	O
protein	O
complex	O
,	O
which	O
activates	O
Rheb	O
,	O
and	O
stimulates	O
TORC1	O
kinase	O
activity	O
.	O

We	O
tested	O
TORC1	O
function	O
by	O
glial-specific	O
overexpression	O
of	O
dsRNAs	O
for	O
the	O
single	O
Drosophila	O
orthologs	O
of	O
Raptor	O
(	O
dRaptor	O
)	O
,	O
S6-kinase	O
(	O
dS6K	O
)	O
,	O
and	O
eIF4E	O
(	O
deIF4E	O
)	O
;	O
these	O
all	O
significantly	O
reduced	O
accumulation	O
of	O
dEGFRλ	O
;	O
dp110CAAX	O
mutant	O
glial	O
cells	O
,	O
but	O
only	O
caused	O
mild	O
glial	O
hypoplasia	O
in	O
controls	O
(	O
Figure	O
6I–K	O
and	O
Figure	O
S10	O
)	O
.	O

Co-overexpression	O
of	O
d4EBP	O
,	O
a	O
deIF4E	O
antagonist	O
and	O
dFoxO	O
target	O
gene	O
,	O
also	O
blocked	O
glial	O
neoplasia	O
(	O
Figure	O
6L	O
)	O
.	O

Glial-specific	O
RNAi	O
of	O
dTSC1	O
enhanced	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
glial	O
overgrowth	O
(	O
Figure	O
6H	O
)	O
.	O

However	O
,	O
overexpression	O
of	O
dTSC1dsRNA	O
,	O
dRheb	O
,	O
activated	O
dS6K	O
(	O
dS6Kact	O
)	O
,	O
or	O
deIF4E	O
alone	O
did	O
not	O
produce	O
glial	O
overproliferation	O
,	O
even	O
though	O
these	O
constructs	O
can	O
mimic	O
TORC1	O
activation	O
(	O
Figure	O
S10	O
,	O
data	O
not	O
shown	O
)	O
[	O
47	O
]	O
,	O
[	O
49	O
]	O
.	O

Thus	O
,	O
TORC1	O
activity	O
is	O
necessary	O
for	O
EGFR-PI3K-driven	O
glial	O
neoplasia	O
,	O
but	O
is	O
not	O
sufficient	O
.	O

Moreover	O
,	O
neither	O
deIF4E	O
nor	O
dS6Kact	O
produced	O
glial	O
neoplasia	O
when	O
co-overexpressed	O
with	O
dEGFRλ	O
(	O
data	O
not	O
shown	O
)	O
,	O
illustrating	O
that	O
additional	O
dTor-dependent	O
outputs	O
synergize	O
with	O
dEGFR	O
signaling	O
to	O
drive	O
neoplasia	O
.	O

Myc	O
and	O
Max	O
Drive	O
EGFR	O
;	O
PI3K	O
Glial	O
Neoplasia	O
via	O
CyclinD-Cdk4	O

dTor	O
coordinates	O
increased	O
translation	O
,	O
mediated	O
by	O
dS6K	O
and	O
deIF4E	O
,	O
with	O
expression	O
of	O
cell	O
cycle	O
regulators	O
and	O
ribosomal	O
components	O
,	O
through	O
dMyc	O
,	O
the	O
single	O
Drosophila	O
ortholog	O
of	O
the	O
Myc	O
bHLH	O
transcription	O
factors	O
[	O
49	O
]	O
.	O

Within	O
developing	O
epithelial	O
tissues	O
,	O
dMyc	O
is	O
required	O
for	O
TORC1-dependent	O
growth	O
and	O
can	O
substitute	O
for	O
dTor	O
activity	O
[	O
49	O
]	O
,	O
[	O
50	O
]	O
.	O

Myc	C
protein	C
levels	C
can	C
also	C
be	C
posttranslationally	C
upregulated	C
by	C
EGFR-Ras-Raf	C
signaling	C
[	C
16	C
]	C
,	C
[	C
51	C
]	C
.	C

Thus	C
,	C
we	C
suspected	C
that	C
dMyc	C
might	C
mediate	C
signal	C
integration	C
between	C
EGFR-Ras	C
and	C
PI3K	C
.	C

dEGFRλ	O
;	O
dp110CAAX	O
glia	O
showed	O
high	O
levels	O
of	O
nuclear	O
dMyc	O
compared	O
to	O
wild-type	O
glia	O
(	O
Figure	O
7A	O
and	O
7B	O
)	O
.	O

dMyc	C
was	C
also	C
highly	C
expressed	C
in	C
wild-type	C
neuroblasts	C
(	C
Figure	C
7A	C
)	C
,	C
suggesting	C
that	C
dMyc	C
promotes	C
a	C
proliferative	C
progenitor	C
state	C
[	C
21	C
]	C
.	C

Genetic	O
reduction	O
of	O
dMyc	O
with	O
a	O
dsRNA	O
or	O
a	O
single	O
loss-of-function	O
allele	O
strongly	O
suppressed	O
dEGFRλ	O
;	O
dp110CAAX	O
glial	O
neoplasia	O
(	O
Figure	O
7D	O
,	O
data	O
not	O
shown	O
)	O
.	O

In	C
fact	C
,	C
some	C
dMyc+/-	C
;	C
repo	C
>	C
dEGFRλ	C
;	C
dp110CAAX	C
animals	C
were	C
rescued	C
to	C
viability	C
,	C
indicating	C
that	C
dMyc	C
is	C
an	C
essential	C
rate-limiting	C
output	C
of	C
EGFR-PI3K	C
coactivation	C
.	C

Myc	O
and	O
Max	O
are	O
required	O
to	O
drive	O
EGFR	O
;	O
PI3K	O
glial	O
neoplasia	O
via	O
CyclinD-Cdk4	O
.	O

Myc	O
proteins	O
activate	O
transcription	O
through	O
heterodimerization	O
with	O
the	O
bHLH	O
Max	O
.	O

Max	O
activity	O
was	O
also	O
required	O
for	O
glial	O
neoplasia	O
;	O
a	O
dsRNA	O
for	O
dMax	O
,	O
the	O
single	O
Drosophila	O
Max	O
ortholog	O
,	O
strongly	O
suppressed	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
overgrowth	O
(	O
Figure	O
7E	O
)	O
.	O

dMyc-dMax	O
heterodimers	O
promote	O
proliferation	O
by	O
activating	O
expression	O
of	O
multiple	O
cell	O
cycle	O
genes	O
,	O
including	O
dCyclinD	O
and	O
dCdk4	O
[	O
52	O
]	O
.	O

dCyclinD	C
expression	C
,	C
which	C
is	C
high	C
in	C
repo	C
>	C
dEGFRλ	C
;	C
dp110CAAX	C
glia	C
,	C
was	C
inhibited	C
by	C
a	C
dMycdsRNA	C
(	C
Figure	C
7F–H	C
)	C
,	C
suggesting	C
that	C
dMyc	C
reduction	C
suppresses	C
glial	C
neoplasia	C
through	C
reduced	C
dCyclinD-dCdk4	C
activity	C
.	C

To	O
test	O
this	O
we	O
used	O
loss-of-function	O
mutations	O
in	O
dCdk4	O
,	O
which	O
are	O
viable	O
[	O
23	O
]	O
.	O

dCdk4-/-	O
;	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
larvae	O
showed	O
near	O
complete	O
absence	O
of	O
excess	O
glia	O
and	O
rescue	O
of	O
glial	O
morphogenesis	O
defects	O
(	O
Figure	O
7I	O
)	O
.	O

Moreover	O
,	O
a	O
dCdk4dsRNA	O
and	O
dCyclinDdsRNA	O
suppressed	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
(	O
data	O
not	O
shown	O
)	O
.	O

Thus	O
,	O
dCyclinD-dCdk4	O
is	O
essential	O
for	O
EGFR-PI3K	O
glial	O
neoplasia	O
,	O
although	O
dCdk4	O
is	O
not	O
required	O
for	O
development	O
(	O
Figure	O
7J	O
)	O
.	O

Myc	O
Overexpression	O
or	O
Rb	O
Loss	O
Synergizes	O
with	O
EGFR	O

dMyc	O
is	O
necessary	O
for	O
glial	O
neoplasia	O
,	O
but	O
is	O
not	O
sufficient	O
when	O
overexpressed	O
alone	O
(	O
Figure	O
8C	O
)	O
.	O

dMyc-overexpressing	C
glia	C
showed	C
polyploidy	C
(	C
Figure	C
8C	C
,	C
data	C
not	C
shown	C
)	C
,	C
indicating	C
that	C
these	C
cells	C
undergo	C
DNA	C
replication	C
without	C
mitosis	C
,	C
but	C
require	C
additional	C
signals	C
for	C
cell	C
cycle	C
progression	C
.	C

In	C
contrast	C
,	C
co-overexpression	C
of	C
dMyc	C
with	C
dEGFRλ	C
produced	C
a	C
phenotype	C
on	C
par	C
with	C
that	C
of	C
repo	C
>	C
dEGFRλ	C
;	C
dp110CAAX	C
(	C
Figure	C
8D	C
)	C
,	C
indicating	C
that	C
dMyc	C
overexpression	C
can	C
substitute	C
for	C
PI3K	C
activation	C
and	C
promote	C
neoplasia	C
when	C
combined	C
with	C
EGFR	C
signaling	C
.	C

Myc	O
overexpression	O
or	O
Rb	O
loss	O
synergizes	O
with	O
EGFR	O
.	O

Given	C
that	C
the	C
dMyc	C
targets	C
dCyclinD-dCdk4	C
are	C
required	C
for	C
dEGFRλ	C
;	C
dp110CAAX	C
neoplasia	C
,	C
we	C
tested	C
whether	C
dCyclinD-dCdk4	C
overexpression	C
could	C
cooperate	C
with	C
dEGFRλ	C
.	C

Additionally	O
,	O
we	O
tested	O
loss	O
of	O
Rbf1	O
,	O
the	O
only	O
known	O
dCdk4	O
substrate	O
that	O
controls	O
proliferation	O
[	O
23	O
]	O
.	O

repo	O
>	O
dCyclinD	O
;	O
dCdk4	O
;	O
dEGFRλ	O
and	O
repo	O
>	O
Rbf1dsRNA	O
;	O
dEGFRλ	O
animals	O
showed	O
glial	O
overgrowth	O
,	O
but	O
did	O
not	O
accumulate	O
as	O
many	O
cells	O
as	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
animals	O
(	O
Figure	O
8E	O
and	O
8F	O
)	O
.	O

Thus	C
,	C
glia	C
likely	C
require	C
additional	C
dp110	C
or	C
dMyc	C
effectors	C
to	C
undergo	C
full	C
neoplastic	C
proliferation	C
.	C

Other	O
known	O
PI3K	O
and	O
dMyc-dMax	O
target	O
genes	O
that	O
promote	O
proliferation	O
include	O
ribosomal	O
proteins	O
and	O
translation	O
regulators	O
[	O
49	O
]	O
,	O
[	O
52	O
]	O
,	O
such	O
as	O
eIF4E	O
,	O
which	O
is	O
highly	O
expressed	O
in	O
dEGFRλ	O
;	O
dp110CAAX	O
glia	O
and	O
required	O
for	O
neoplasia	O
(	O
Figure	O
6	O
and	O
Figure	O
S11	O
)	O
.	O

Our	C
data	C
imply	C
that	C
PI3K	C
,	C
dMyc	C
,	C
and	C
dCyclinD-dCdk4	C
exist	C
in	C
a	C
linear	C
system	C
,	C
in	C
which	C
Rbf1	C
inactivation	C
by	C
dCyclinD-dCdk4	C
is	C
one	C
direct	C
output	C
of	C
dp110CAAX	C
or	C
dMyc	C
.	C

However	C
,	C
in	C
high-grade	C
glioma	C
,	C
Rb	C
loss	C
co-occurs	C
with	C
EGFR	C
and	C
PTEN	C
mutations	C
[	C
2	C
]	C
,	C
implying	C
that	C
these	C
mutations	C
cooperate	C
to	C
promote	C
gliomagenesis	C
.	C

To	O
explore	O
interactions	O
between	O
Rb	O
and	O
EGFR-PI3K	O
,	O
we	O
created	O
the	O
triple	O
mutant	O
repo	O
>	O
Rbf1dsRNA	O
;	O
dEGFRλ	O
;	O
dp110CAAX	O
.	O

These	O
animals	O
displayed	O
exacerbated	O
glial	O
neoplasia	O
,	O
with	O
a	O
substantial	O
increase	O
in	O
small	O
anaplastic-like	O
glia	O
throughout	O
the	O
CNS	O
(	O
Figure	O
8G	O
)	O
.	O

This	C
synergistic	C
interaction	C
likely	C
derives	C
from	C
derepression	C
of	C
dE2F1	C
upon	C
Rbf1	C
loss	C
,	C
and	C
concomitant	C
increased	C
expression	C
of	C
dE2F1	C
target	C
genes	C
,	C
including	C
Stg	C
and	C
dCyclinE	C
[	C
53	C
]	C
.	C

Increased	C
dCyclinE	C
and	C
Stg	C
expression	C
may	C
accelerate	C
cell	C
cycle	C
progression	C
,	C
perhaps	C
through	C
increased	C
dCdk2	C
and	C
dCdk1	C
activity	C
and/or	C
truncated	C
G1	C
and	C
G2	C
gap	C
phases	C
caused	C
by	C
constant	C
dCyclinE	C
and	C
Stg	C
protein	C
levels	C
[	C
23	C
]	C
.	C

Consistent	O
with	O
this	O
,	O
we	O
observed	O
increased	O
dCyclinE	O
expression	O
in	O
Rbf1dsRNA	O
;	O
dEGFRλ	O
;	O
dp110CAAX	O
glia	O
relative	O
to	O
dEGFRλ	O
;	O
dp110CAAX	O
glia	O
(	O
Figure	O
8H	O
and	O
8I	O
)	O
,	O
and	O
co-overexpression	O
of	O
Stg	O
or	O
dCyclinE-dCdk2	O
with	O
dEGFRλ	O
;	O
dp110CAAX	O
synergistically	O
exacerbated	O
glial	O
neoplasia	O
,	O
yielding	O
phenotypes	O
similar	O
to	O
repo	O
>	O
RbfdsRNA	O
;	O
dEGFRλ	O
;	O
dp110CAAX	O
(	O
Figure	O
5E	O
and	O
Figure	O
S9	O
,	O
data	O
not	O
shown	O
)	O
.	O

To	O
assess	O
dCdk2	O
activity	O
in	O
repo	O
>	O
Rbf1dsRNA	O
;	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
compared	O
to	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
,	O
we	O
stained	O
for	O
phospho-MPM2	O
(	O
Figure	O
S12	O
)	O
,	O
which	O
detects	O
nuclear	O
foci	O
in	O
cells	O
with	O
active	O
dCyclinE-dCdk2	O
complexes	O
[	O
54	O
]	O
.	O

Phospho-MPM2	C
foci	C
were	C
present	C
in	C
glia	C
of	C
both	C
genotypes	C
,	C
although	C
repo	C
>	C
Rbf1dsRNA	C
;	C
dEGFRλ	C
;	C
dp110CAAX	C
brains	C
appeared	C
to	C
have	C
a	C
higher	C
density	C
of	C
glia	C
with	C
phospho-MPM2	C
foci	C
(	C
Figure	C
S12	C
)	C
,	C
suggesting	C
that	C
expanded	C
expression	C
of	C
dCyclinE	C
results	C
in	C
broader	C
activation	C
of	C
dCdk2	C
.	C

Thus	O
,	O
while	O
PI3K	O
and	O
Rbf1	O
act	O
in	O
a	O
common	O
genetic	O
pathway	O
linked	O
by	O
dCyclinD-dCdk4	O
,	O
Rbf1	O
loss	O
nevertheless	O
synergizes	O
with	O
mitogenic	O
stimulation	O
from	O
combined	O
EGFR	O
and	O
PI3K	O
signaling	O
,	O
and	O
this	O
synergy	O
emerges	O
from	O
increased	O
expression	O
of	O
dCyclinE	O
and	O
Stg	O
,	O
rate-limiting	O
regulators	O
of	O
the	O
cell	O
cycle	O
.	O

Discussion	O

We	O
show	O
that	O
constitutive	O
coactivation	O
of	O
EGFR-Ras	O
and	O
PI3K	O
signaling	O
in	O
Drosophila	O
glia	O
and	O
glial	O
precursors	O
gives	O
rise	O
to	O
neoplastic	O
,	O
invasive	O
cells	O
that	O
create	O
transplantable	O
tumor-like	O
growths	O
,	O
mimicking	O
human	O
glioma	O
,	O
and	O
mirroring	O
mouse	O
glioma	O
models	O
.	O

This	C
represents	C
a	C
robust	C
organotypic	C
and	C
cell-type	C
specific	C
Drosophila	C
cancer	C
model	C
in	C
which	C
malignant	C
cells	C
are	C
created	C
by	C
mutations	C
in	C
the	C
signature	C
genes	C
and	C
pathways	C
thought	C
to	C
be	C
driving	C
forces	C
in	C
a	C
homologous	C
human	C
cancer	C
.	C

This	O
was	O
not	O
necessarily	O
an	O
expected	O
result	O
since	O
fly	O
and	O
human	O
glia	O
show	O
many	O
biological	O
differences	O
despite	O
displaying	O
important	O
similarities	O
[	O
9	O
]	O
,	O
[	O
55	O
]	O
,	O
[	O
56	O
]	O
.	O

Through	O
genetic	O
analysis	O
of	O
our	O
model	O
,	O
we	O
identified	O
crucial	O
downstream	O
effectors	O
of	O
EGFR	O
and	O
PI3K	O
signaling	O
,	O
many	O
of	O
which	O
are	O
mutated	O
and/or	O
activated	O
in	O
human	O
glioma	O
.	O

These	O
effectors	O
act	O
in	O
a	O
combinatorial	O
network	O
to	O
coordinately	O
stimulate	O
cell	O
cycle	O
entry	O
and	O
progression	O
,	O
block	O
cell	O
cycle	O
exit	O
,	O
and	O
promote	O
inappropriate	O
cellular	O
growth	O
and	O
migration	O
(	O
Figure	O
8J	O
)	O
.	O

Pathways	O
within	O
this	O
network	O
,	O
while	O
interdependent	O
,	O
act	O
synergistically	O
,	O
rather	O
than	O
additively	O
.	O

Thus	O
,	O
Drosophila	O
shows	O
evolutionary	O
conservation	O
of	O
oncogene	O
cooperation	O
.	O

At	O
least	O
four	O
pathway	O
circuits	O
are	O
necessary	O
for	O
glial	O
neoplasia	O
initiated	O
by	O
EGFR	O
and	O
PI3K	O
signaling	O
,	O
including	O
dRas	O
and	O
dMyc	O
circuits	O
,	O
which	O
induce	O
dCyclinE	O
and	O
dCyclinD	O
to	O
drive	O
cell	O
cycle	O
entry	O
,	O
a	O
Pnt	O
circuit	O
,	O
which	O
induces	O
Stg	O
to	O
promote	O
cell	O
cycle	O
progression	O
,	O
and	O
a	O
Tor-eIF4E-S6K	O
pathway	O
,	O
which	O
provides	O
protein	O
translation	O
necessary	O
for	O
proliferation	O
and	O
growth	O
(	O
Figure	O
8J	O
)	O
.	O

When	C
activated	C
individually	C
,	C
these	C
pathways	C
fail	C
to	C
elicit	C
glial	C
neoplasia	C
,	C
implying	C
a	C
requirement	C
for	C
coordinated	C
stimulation	C
of	C
multiple	C
effectors	C
and	C
inactivation	C
of	C
negative	C
regulators	C
.	C

Orthologs	C
for	C
many	C
of	C
the	C
genes	C
within	C
these	C
pathways	C
,	C
such	C
as	C
dRictor	C
,	C
are	C
implicated	C
in	C
human	C
glioma	C
,	C
although	C
specific	C
roles	C
for	C
some	C
,	C
such	C
as	C
ETS	C
transcription	C
factors	C
,	C
have	C
not	C
been	C
defined	C
despite	C
their	C
expression	C
in	C
glioma	C
[	C
2	C
]	C
,	C
[	C
57	C
]	C
,	C
[	C
58	C
]	C
.	C

While	O
many	O
of	O
these	O
genes	O
are	O
known	O
EGFR	O
and	O
PI3K	O
pathway	O
components	O
,	O
we	O
did	O
not	O
necessarily	O
expect	O
them	O
to	O
be	O
required	O
for	O
EGFR	O
and	O
PI3K	O
dependent	O
glial	O
neoplasia	O
.	O

Indeed	O
,	O
we	O
have	O
tested	O
many	O
other	O
pathway	O
components	O
and	O
outputs	O
,	O
such	O
as	O
Jun	O
kinase	O
,	O
that	O
did	O
not	O
significantly	O
suppress	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
phenotypes	O
upon	O
reduced	O
function	O
(	O
unpublished	O
data	O
)	O
.	O

Coactivation	O
of	O
EGFR	O
and	O
PI3K	O
signaling	O
upregulates	O
dMyc	O
,	O
which	O
is	O
necessary	O
for	O
glial	O
neoplasia	O
.	O

This	O
is	O
consistent	O
with	O
findings	O
that	O
,	O
in	O
flies	O
and	O
mammals	O
,	O
EGFR-Ras	O
,	O
PI3K	O
,	O
and	O
Tor	O
signaling	O
upregulate	O
Myc	O
protein	O
levels	O
[	O
16	O
]	O
,	O
[	O
49	O
]	O
,	O
[	O
51	O
]	O
,	O
[	O
59	O
]	O
,	O
[	O
60	O
]	O
.	O

Myc	O
oncogenes	O
are	O
well-known	O
to	O
cooperate	O
with	O
RTK-Ras	O
signaling	O
to	O
drive	O
neoplastic	O
transformation	O
[	O
51	O
]	O
,	O
and	O
we	O
demonstrate	O
that	O
this	O
property	O
of	O
Myc	O
is	O
conserved	O
in	O
flies	O
.	O

We	O
also	O
observed	O
sensitivity	O
to	O
reduced	O
Myc	O
gene	O
dosage	O
in	O
our	O
glioma	O
model	O
,	O
which	O
has	O
also	O
been	O
recently	O
documented	O
in	O
a	O
mouse	O
model	O
of	O
PTEN-dependent	O
glioma	O
[	O
61	O
]	O
.	O

c-myc	C
is	C
commonly	C
amplified	C
in	C
gliomas	C
[	C
62	C
]	C
,	C
implying	C
that	C
Myc	C
is	C
rate	C
limiting	C
,	C
and	C
c-myc	C
amplification	C
may	C
be	C
selected	C
for	C
this	C
reason	C
.	C

D-cyclins	O
,	O
established	O
Myc	O
target	O
genes	O
,	O
and	O
Cdk4	O
are	O
also	O
commonly	O
amplified	O
and/or	O
overexpressed	O
in	O
gliomas	O
[	O
1	O
]	O
,	O
[	O
51	O
]	O
.	O

We	O
observed	O
dMyc-dependent	O
dCyclinD	O
overexpression	O
,	O
and	O
a	O
requirement	O
for	O
dCyclinD-dCdk4	O
in	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
neoplasia	O
,	O
although	O
dCdk4	O
itself	O
is	O
not	O
required	O
for	O
normal	O
glial	O
proliferation	O
.	O

Together	O
with	O
our	O
analysis	O
of	O
TORC2	O
,	O
this	O
illustrates	O
that	O
oncogenic	O
EGFR-PI3K	O
co-opts	O
effectors	O
that	O
do	O
not	O
control	O
normal	O
glial	O
development	O
.	O

Similarly	O
,	O
cdk4-/-	O
mutant	O
mice	O
show	O
normal	O
proliferation	O
in	O
many	O
tissues	O
,	O
but	O
are	O
resistant	O
to	O
ErbB-2-driven	O
breast	O
cancers	O
[	O
63	O
]	O
,	O
[	O
64	O
]	O
.	O

Our	C
data	C
argue	C
that	C
Cdk4	C
activity	C
is	C
a	C
key	C
tumor-specific	C
rate-limiting	C
output	C
of	C
EGFR	C
and	C
PI3K	C
signaling	C
in	C
glioma	C
as	C
well	C
.	C

In	O
contrast	O
to	O
glia	O
,	O
coactivation	O
of	O
EGFR-Ras	O
and	O
PI3K	O
in	O
neuroblasts	O
,	O
which	O
are	O
fly	O
neural	O
stem	O
cells	O
,	O
does	O
not	O
promote	O
unchecked	O
proliferation	O
,	O
despite	O
the	O
fact	O
that	O
neuroblasts	O
express	O
dMyc	O
and	O
are	O
capable	O
of	O
undergoing	O
neoplastic	O
transformation	O
in	O
response	O
to	O
other	O
genetic	O
mutations	O
[	O
21	O
]	O
.	O

Thus	O
,	O
in	O
Drosophila	O
,	O
neither	O
a	O
neural	O
stem	O
cell	O
fate	O
nor	O
Myc	O
activity	O
confer	O
competence	O
to	O
undergo	O
EGFR-PI3K	O
neoplastic	O
transformation	O
.	O

Rather	C
,	C
our	C
results	C
suggest	C
that	C
neoplastic	C
cells	C
arise	C
from	C
committed	C
glial	C
progenitors	C
:	C
dEGFR-dRas85D	C
;	C
dPTEN-/-	C
clones	C
derived	C
from	C
progenitor	C
cells	C
produce	C
large	C
tumors	C
,	C
and	C
anaplastic	C
cells	C
in	C
repo	C
>	C
dEGFRλ	C
;	C
dp110CAAX	C
brains	C
are	C
concentrated	C
in	C
regions	C
enriched	C
for	C
glial	C
progenitors	C
.	C

Notably	O
,	O
regulated	O
developmental	O
signaling	O
through	O
the	O
EGFR	O
pathway	O
promotes	O
proliferation	O
of	O
normal	O
Repo-expressing	O
glial	O
progenitors	O
[	O
27	O
]	O
,	O
and	O
our	O
results	O
show	O
that	O
constitutive	O
EGFR	O
and	O
PI3K	O
signaling	O
prolongs	O
this	O
proliferative	O
progenitor	O
state	O
.	O

Further	C
studies	C
of	C
Drosophila	C
glial	C
progenitors	C
and	C
glioma-like	C
cells	C
may	C
illuminate	C
the	C
cellular	C
origins	C
of	C
human	C
gliomas	C
,	C
which	C
are	C
thought	C
to	C
arise	C
from	C
progenitor-like	C
glial	C
cells	C
.	C

Moreover	C
,	C
our	C
results	C
argue	C
that	C
cell-type	C
specific	C
factors	C
govern	C
glial	C
neoplasia	C
.	C

One	C
such	C
factor	C
may	C
be	C
Dap	C
,	C
the	C
single	C
p21/p27	C
ortholog	C
,	C
which	C
is	C
normally	C
expressed	C
in	C
only	C
5	C
%	C
of	C
all	C
glia	C
(	C
Figure	C
S4	C
)	C
.	C

Perhaps	C
glial	C
progenitors	C
do	C
not	C
express	C
Dap	C
,	C
whereas	C
neuronal	C
progenitors	C
do	C
[	C
26	C
]	C
,	C
and	C
this	C
underlies	C
susceptibility	C
to	C
transformation	C
by	C
EGFR-Ras	C
and	C
PI3K	C
.	C

Dap	C
is	C
highly	C
regulated	C
in	C
a	C
cell-type	C
specific	C
manner	C
[	C
26	C
]	C
,	C
and	C
studies	C
of	C
Dap	C
regulation	C
in	C
glia	C
may	C
further	C
illuminate	C
the	C
genetic	C
origins	C
of	C
glioma	C
,	C
especially	C
given	C
that	C
lack	C
of	C
p21	C
expression	C
may	C
underlie	C
the	C
tumorigenic	C
response	C
of	C
mammalian	C
glial	C
progenitors	C
to	C
constitutively	C
active	C
EGFR	C
[	C
65	C
]	C
.	C

While	O
EGFR-Ras	O
and	O
PI3K	O
are	O
commonly	O
upregulated	O
in	O
gliomas	O
and	O
experimental	O
models	O
demonstrate	O
that	O
these	O
pathways	O
are	O
required	O
for	O
tumorigenesis	O
,	O
therapies	O
that	O
target	O
EGFR	O
and	O
PI3K	O
signaling	O
have	O
proven	O
disappointing	O
.	O

This	O
discrepancy	O
between	O
clinical	O
and	O
experimental	O
data	O
has	O
many	O
possible	O
explanations	O
.	O

For	O
example	O
,	O
recent	O
studies	O
have	O
demonstrated	O
that	O
EGFR	O
inhibitors	O
are	O
attenuated	O
by	O
particular	O
mutations	O
found	O
in	O
glioma	O
cells	O
,	O
such	O
as	O
PTEN	O
loss	O
or	O
RTK	O
co-amplification	O
[	O
2	O
]	O
.	O

Addressing	O
these	O
and	O
other	O
possibilities	O
remains	O
a	O
challenge	O
that	O
dictates	O
a	O
need	O
for	O
new	O
experimental	O
models	O
.	O

The	O
results	O
presented	O
here	O
establish	O
Drosophila	O
as	O
a	O
viable	O
model	O
system	O
for	O
the	O
study	O
of	O
glioma	O
,	O
offering	O
a	O
complex	O
organismal	O
system	O
for	O
rapidly	O
identifying	O
and	O
evaluating	O
therapeutic	O
targets	O
using	O
genetic	O
approaches	O
.	O

Such	C
a	C
system	C
may	C
be	C
especially	C
useful	C
for	C
distinguishing	C
those	C
genetic	C
mutations	C
and	C
pathways	C
that	C
drive	C
tumorigenesis	C
from	C
the	C
large	C
number	C
of	C
genes	C
that	C
show	C
mutations	C
and	C
altered	C
expression	C
in	C
glioblastomas	C
uncovered	C
by	C
recent	C
genomic	C
analyses	C
of	C
patient	C
samples	C
[	C
66	C
]	C
,	C
[	C
67	C
]	C
.	C

Our	C
studies	C
have	C
already	C
identified	C
key	C
rate-limiting	C
genes	C
,	C
such	C
as	C
dCyclinE	C
,	C
Stg	C
,	C
and	C
dMyc	C
,	C
and	C
genes	C
only	C
required	C
for	C
abnormal	C
neoplastic	C
glial	C
proliferation	C
,	C
such	C
as	C
dSin1	C
,	C
dRictor	C
,	C
and	C
dCdk4	C
,	C
which	C
may	C
represent	C
important	C
therapeutic	C
targets	C
in	C
human	C
gliomas	C
.	C

Materials	O
and	O
Methods	O

Fly	O
Stocks	O
,	O
Genetics	O
,	O
and	O
Culture	O
Conditions	O

Flies	O
were	O
cultured	O
at	O
25°C	O
.	O

All	O
genotypes	O
were	O
established	O
by	O
standard	O
genetics	O
.	O

To	O
assess	O
larval	O
brain	O
overgrowth	O
phenotypes	O
,	O
embryos	O
were	O
collected	O
for	O
6–24	O
hrs	O
,	O
grown	O
for	O
120–140	O
hrs	O
,	O
and	O
wandering	O
3rd	O
instar	O
larvae	O
were	O
selected	O
for	O
dissection	O
.	O

Stocks	O
were	O
obtained	O
from	O
the	O
Bloomington	O
Stock	O
Center	O
unless	O
otherwise	O
noted	O
.	O

Other	O
than	O
UAS-PTENdsRNA	O
lines	O
from	O
Bloomington	O
,	O
all	O
UAS-dsRNA	O
lines	O
were	O
obtained	O
from	O
the	O
VDRC	O
stock	O
center	O
[	O
11	O
]	O
.	O

The	O
following	O
stocks	O
were	O
obtained	O
from	O
other	O
investigators	O
:	O
UAS-dEGFRλ	O
(	O
T.	O
Schubach	O
)	O
,	O
UAS-dEGFRElp	O
,	O
UAS-dEGFRwild-type	O
(	O
N.	O
Baker	O
)	O
,	O
UAS-dPTEN	O
,	O
FRT40A	O
dPTEN2L117	O
,	O
UAS-dFoxOSA	O
(	O
S.	O
Oldham	O
)	O
,	O
UAS-dap	O
(	O
I.	O
Hariharan	O
)	O
,	O
UAS-dp110wild-type	O
,	O
UAS-dCycD	O
,	O
UAS-dCdk4	O
,	O
UAS-dMyc	O
,	O
dMyc4	O
(	O
B.	O
Edgar	O
)	O
,	O
UAS-Rbf1	O
(	O
N.	O
Dyson	O
)	O
,	O
appl-Gal4	O
(	O
K.	O
Finley	O
)	O
,	O
pros-Gal4	O
(	O
B.	O
Ohlstein	O
)	O
,	O
wor-Gal4	O
(	O
C.	O
Doe	O
)	O
,	O
gcm-Gal4	O
(	O
V.	O
Hartenstein	O
)	O
,	O
dTor2L7	O
,	O
dTorl	O
(	O
2	O
)	O
k17004	O
(	O
R.	O
Bodmer	O
)	O
,	O
dRictorΔ2	O
(	O
S.	O
Cohen	O
)	O
,	O
and	O
stgCB03726	O
(	O
A.	O
Spradling	O
)	O

UAS-dsRNA	O
Validation	O

UAS-dMycdsRNA	O
,	O
UAS-TSC1dsRNA	O
lines	O
were	O
validated	O
in	O
prior	O
publications	O
[	O
48	O
]	O
.	O

UAS-dsRNA	O
lines	O
were	O
crossed	O
to	O
actin-Gal4	O
,	O
ey-Gal4	O
,	O
and	O
GMR-Gal4	O
to	O
assess	O
phenotypes	O
.	O

Lines	O
that	O
showed	O
phenotypes	O
inconsistent	O
with	O
known	O
phenotypes	O
for	O
their	O
target	O
genes	O
were	O
excluded	O
from	O
analysis	O
.	O

Gene	O
knock-down	O
in	O
repo-Gal4	O
glia	O
was	O
verified	O
with	O
immunohistochemical	O
stains	O
for	O
the	O
following	O
constructs	O
:	O
UAS-dMycdsRNA	O
,	O
UAS-dAktdsRNA	O
,	O
UAS-dS6KdsRNA	O
,	O
UAS-eIF4EdsRNA	O
,	O
UAS-Rbf1dsRNA	O
,	O
and	O
UAS-pntdsRNA	O
(	O
Figure	O
S11	O
)	O
.	O

Abdominal	O
Transplants	O

Larval	O
brains	O
were	O
dissected	O
into	O
sterile	O
PBS	O
,	O
washed	O
,	O
and	O
cut	O
into	O
fragments	O
.	O

Abdominal	O
incisions	O
were	O
made	O
in	O
virgin	O
female	O
hosts	O
and	O
single	O
brain	O
fragments	O
were	O
inserted	O
.	O

Hosts	O
were	O
cultured	O
for	O
1–6	O
weeks	O
,	O
dissected	O
and	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
,	O
incubated	O
in	O
10	O
%	O
sucrose	O
and	O
embedded	O
in	O
O.C.T	O
.	O
Thick	O
50	O
µm	O
sections	O
were	O
stained	O
as	O
described	O
below	O
.	O

Clonal	O
Analysis	O

For	O
hs-FLP	O
clones	O
,	O
genotypes	O
are	O
indicated	O
in	O
figure	O
legends	O
.	O

Flies	O
were	O
initially	O
grown	O
at	O
18°C	O
or	O
20°C	O
to	O
minimize	O
spontaneous	O
clones	O
,	O
which	O
occurred	O
at	O
a	O
low	O
frequency	O
during	O
late	O
larval-pupal	O
stages	O
.	O

3rd	O
instar	O
larvae	O
,	O
0–48	O
hr	O
pupae	O
,	O
or	O
0–2	O
day	O
old	O
young	O
adults	O
were	O
treated	O
with	O
heat	O
shock	O
to	O
induce	O
clones	O
and	O
subsequently	O
cultured	O
at	O
25°C	O
for	O
1–4	O
weeks	O
.	O

For	O
ey-FLP	O
clones	O
,	O
flies	O
were	O
cultured	O
at	O
25°C	O
continuously	O
.	O

Immunohistochemistry	O
and	O
Imaging	O

Larval	O
tissue	O
was	O
fixed	O
for	O
30–50	O
minutes	O
in	O
1×PBS	O
4	O
%	O
paraformaldehyde	O
.	O

Adult	O
brains	O
were	O
fixed	O
for	O
1–2	O
hr	O
in	O
1×PBS	O
4	O
%	O
paraformaldehyde	O
or	O
in	O
PLP	O
with	O
2	O
%	O
paraformaldehyde	O
.	O

For	O
BrdU	O
labeling	O
,	O
larvae	O
were	O
cultured	O
in	O
food	O
with	O
1	O
mg/ml	O
BrdU	O
for	O
4–6	O
hrs	O
,	O
and	O
fixed	O
larval	O
brains	O
were	O
treated	O
with	O
2	O
N	O
HCl	O
for	O
30	O
minutes	O
followed	O
by	O
DNase	O
for	O
1	O
hr	O
.	O

Stains	O
were	O
performed	O
in	O
1×PBS	O
10	O
%	O
BSA	O
with	O
0.3	O
%	O
Triton-X100	O
for	O
larval	O
brains	O
and	O
0.5	O
%	O
Triton-X100	O
for	O
adult	O
samples	O
.	O

The	O
following	O
antibodies	O
were	O
obtained	O
from	O
the	O
Developmental	O
Studies	O
Hybridoma	O
Bank	O
and	O
diluted	O
15–110	O
:	O
8D12	O
anti-Repo	O
,	O
anti-dMMP1	O
,	O
anti-dCyclinB	O
,	O
anti-Elav	O
,	O
and	O
40-1a	O
anti-lacZ	O
.	O

Larval	O
and/or	O
adult	O
brains	O
were	O
also	O
stained	O
with	O
rabbit	O
anti-Repo	O
(	O
G.	O
Technau	O
,	O
1500	O
)	O
,	O
rat	O
anti-dCyclinE	O
(	O
H.	O
Richardson	O
,	O
1100	O
)	O
,	O
anti-BrdU	O
(	O
BD	O
,	O
1100	O
)	O
,	O
rat	O
anti-Miranda	O
(	O
C.	O
Doe	O
,	O
1100	O
)	O
,	O
mouse	O
anti-diphospho-Erk	O
(	O
Sigma	O
,	O
1200	O
)	O
,	O
mouse	O
anti-Rbf1	O
(	O
N.	O
Dyson	O
,	O
15	O
)	O
,	O
mouse	O
anti-Dap	O
(	O
I.	O
Hariharan	O
,	O
110	O
)	O
,	O
rabbit	O
anti-PntP1	O
(	O
J.	O
Skeath	O
,	O
1500	O
)	O
,	O
rabbit	O
anti-eIF4E	O
(	O
P.	O
Lasko	O
,	O
1100	O
)	O
,	O
rabbit	O
anti-dMyc	O
(	O
D.	O
Stein	O
,	O
11000	O
)	O
,	O
and	O
anti-phospho-MPM2	O
(	O
Upstate	O
Biotechnology	O
,	O
1200	O
)	O
.	O

Anti-HRP-Cy5	O
and	O
anti-HRP-Cy3	O
(	O
Jackson	O
Labs	O
)	O
were	O
used	O
at	O
1250–1500	O
.	O

Secondary	O
antibodies	O
were	O
conjugated	O
to	O
Cy3	O
(	O
Jackson	O
Labs	O
)	O
or	O
Alexa-488	O
or	O
Alexa-647	O
(	O
Molecular	O
Probes	O
)	O
.	O

Actin	O
was	O
visualized	O
with	O
Rhodamine-labeled	O
phalloidin	O
(	O
Invitrogen	O
)	O
.	O

Brains	O
were	O
imaged	O
as	O
whole	O
mounts	O
on	O
a	O
Zeiss	O
LSM	O
510	O
confocal	O
system	O
.	O

Images	O
were	O
analyzed	O
in	O
Zeiss	O
LSM	O
Image	O
Browser	O
and	O
processed	O
in	O
Photoshop	O
CS3	O
.	O

For	O
experiments	O
in	O
which	O
protein	O
levels	O
were	O
compared	O
between	O
genotypes	O
,	O
all	O
sample	O
preparation	O
,	O
histochemistry	O
,	O
imaging	O
,	O
and	O
image	O
processing	O
was	O
performed	O
in	O
parallel	O
in	O
the	O
same	O
manner	O
.	O

Supporting	O
Information	O

Figure	O
S1	O
Diagram	O
of	O
Drosophila	O
EGFR	O
mutant	O
forms	O
.	O

Proteins	O
are	O
shown	O
as	O
horizontal	O
bars	O
along	O
which	O
functional	O
domains	O
are	O
indicated	O
,	O
and	O
the	O
locations	O
of	O
alterations	O
in	O
mutant	O
forms	O
are	O
noted	O
.	O

Wild-type	O
human	O
EGFR	O
and	O
Drosophila	O
EGFR	O
(	O
dEGFR	O
)	O
show	O
extensive	O
conservation	O
,	O
with	O
55	O
%	O
homology	O
in	O
the	O
kinase	O
domain	O
and	O
41	O
%	O
homology	O
in	O
the	O
ligand-binding	O
portion	O
of	O
the	O
extracellular	O
domain	O
,	O
which	O
includes	O
extensive	O
cysteine	O
repeats	O
.	O

The	O
signal	O
peptide	O
is	O
labeled	O
in	O
yellow	O
.	O

Following	O
the	O
signal	O
peptide	O
,	O
the	O
entire	O
cytoplasmic	O
domain	O
is	O
replaced	O
with	O
the	O
lambda	O
dimerization	O
domain	O
in	O
dEGFRλ	O
,	O
which	O
causes	O
constitutive	O
activation	O
.	O

Both	O
human	O
EGFR	O
and	O
dEGFR	O
show	O
extensive	O
cysteine	O
repeats	O
in	O
the	O
extracellular	O
domain	O
,	O
indicated	O
in	O
blue	O
.	O

The	O
tyrosine	O
kinase	O
domain	O
is	O
labeled	O
in	O
magenta	O
.	O

The	O
Elp	O
mutant	O
form	O
of	O
dEGFR	O
contains	O
an	O
A887T	O
substitution	O
in	O
the	O
N-lobe	O
of	O
the	O
kinase	O
domain	O
,	O
which	O
causes	O
constitutive	O
activation	O
.	O
(	O
0.23	O
MB	O
TIF	O
)	O

Figure	O
S2	O
Coactivation	O
of	O
Ras-Raf	O
and	O
PI3K	O
in	O
Drosophila	O
glia	O
causes	O
neoplasia	O
.	O

2	O
µm	O
optical	O
sections	O
of	O
representative	O
larval	O
brain	O
hemispheres	O
from	O
wandering	O
3rd	O
instar	O
larvae	O
(	O
A–H	O
)	O
and	O
an	O
early	O
2nd	O
instar	O
larval	O
brain	O
(	O
I	O
)	O
,	O
all	O
displayed	O
at	O
the	O
same	O
scale	O
.	O

20	O
µm	O
scale	O
bars	O
.	O

Frontal	O
sections	O
;	O
midway	O
through	O
brains	O
.	O

Anterior	O
up	O
;	O
midline	O
to	O
left	O
.	O

Glial	O
cell	O
nuclei	O
are	O
labeled	O
with	O
Repo	O
(	O
red	O
)	O
.	O

CD8GFP	O
(	O
green	O
)	O
,	O
driven	O
by	O
the	O
repo-Gal4	O
driver	O
,	O
labels	O
glial	O
cell	O
bodies	O
and	O
membranes	O
.	O

An	O
anti-HRP	O
counterstain	O
(	O
blue	O
)	O
reveals	O
neuropil	O
(	O
neuronal	O
fiber	O
tracts	O
)	O
at	O
high	O
intensity	O
and	O
some	O
cell	O
bodies	O
of	O
neurons	O
and	O
neuronal	O
precursors	O
at	O
low	O
intensity	O
,	O
and	O
this	O
varies	O
slightly	O
according	O
to	O
exact	O
plane	O
of	O
section	O
and	O
mutant	O
phenotype	O
.	O

repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
(	O
A	O
)	O
,	O
repo	O
>	O
dRas85DV12	O
;	O
dPTENdsRNA	O
(	O
B	O
)	O
,	O
and	O
repo	O
>	O
dRafgof	O
;	O
dp110CAAX	O
(	O
C	O
)	O
brains	O
show	O
increased	O
numbers	O
of	O
glia	O
relative	O
to	O
wild-type	O
(	O
D	O
)	O
,	O
repo	O
>	O
dRas85DV12	O
alone	O
(	O
E	O
)	O
,	O
or	O
repo	O
>	O
dPTENdsRNA	O
alone	O
(	O
F	O
)	O
.	O

Compared	O
to	O
wild-type	O
(	O
D	O
)	O
,	O
repo	O
>	O
dEGFRwild-type	O
(	O
H	O
)	O
brains	O
show	O
reduced	O
neurons	O
(	O
HRP	O
,	O
low	O
intensity	O
blue	O
)	O
,	O
which	O
renders	O
glia	O
more	O
densely	O
packed	O
and	O
the	O
entire	O
brain	O
smaller	O
than	O
normal	O
.	O

However	O
,	O
repo	O
>	O
dEGFRwild-type	O
brains	O
(	O
H	O
)	O
do	O
not	O
show	O
a	O
substantial	O
increase	O
the	O
number	O
of	O
glia	O
compared	O
to	O
wild-type	O
(	O
D	O
)	O
.	O

Brains	O
of	O
repo	O
>	O
dEGFRElp	O
2nd	O
instar	O
larvae	O
(	O
I	O
)	O
show	O
substantial	O
neuron	O
loss	O
,	O
brain	O
malformation	O
,	O
and	O
excess	O
glia	O
for	O
that	O
stage	O
of	O
development	O
.	O

Genotypes	O
:	O
(	O
A	O
)	O
UAS-dEGFRλ	O
UAS-dp110CAAX/+	O
;	O
repo-Gal4	O
UAS-CD8GFP/+	O
(	O
B	O
)	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/UAS-dRas85DV12	O
UAS-dPTENdsRNA	O
(	O
C	O
)	O
UAS-dp110CAAX	O
;	O
repo-Gal4	O
UAS-CD8GFP/UAS-dRafgof	O
(	O
D	O
)	O
repo-Gal4	O
UAS-CD8GFP/+	O
(	O
E	O
)	O
repo-Gal4	O
UAS-CD8GFP/UAS-dRas85DV12	O
(	O
F	O
)	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/UAS-dPTENdsRNA	O
(	O
G	O
)	O
UAS-dEGFRλ/+	O
;	O
repo-Gal4	O
UAS-CD8GFP/+	O
(	O
H	O
)	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/UAS-dEGFRwild-type	O
(	O
I	O
)	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/UAS-dEGFRElp	O
.	O
(	O
10.31	O
MB	O
TIF	O
)	O

Figure	O
S3	O
dMMP1	O
expression	O
in	O
wild-type	O
and	O
dEGFRλ	O
;	O
dp110CAAX	O
glia	O
.	O

(	O
A	O
,	O
B	O
)	O
3rd	O
instar	O
larval	O
brains	O
.	O

Frontal	O
sections	O
,	O
showing	O
medial	O
regions	O
enriched	O
for	O
proliferating	O
glia	O
.	O

Anterior	O
up	O
;	O
midline	O
to	O
left	O
.	O

4.5	O
µm	O
optical	O
projections	O
,	O
matched	O
in	O
scale	O
.	O

20	O
µm	O
scale	O
bars	O
.	O

Expression	O
of	O
the	O
active	O
form	O
of	O
dMMP1	O
(	O
red	O
)	O
in	O
wild-type	O
(	O
A	O
)	O
and	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
(	O
B	O
)	O
,	O
shown	O
alone	O
(	O
left	O
panels	O
)	O
and	O
overlaid	O
with	O
an	O
HRP	O
(	O
blue	O
)	O
neuronal	O
label	O
and	O
a	O
CD8GFP	O
(	O
green	O
)	O
glial	O
label	O
(	O
right	O
panels	O
)	O
.	O

In	O
wild-type	O
brains	O
,	O
glia	O
(	O
‘G’	O
)	O
rarely	O
express	O
active	O
dMMP1	O
,	O
although	O
some	O
glia	O
on	O
the	O
surface	O
of	O
the	O
brain	O
show	O
low	O
levels	O
of	O
dMMP1	O
staining	O
(	O
arrow	O
)	O
.	O

In	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
(	O
B	O
)	O
,	O
some	O
neoplastic	O
glia	O
(	O
‘G’	O
)	O
express	O
active	O
dMMP1	O
(	O
red	O
in	O
right	O
panel	O
,	O
yellow	O
in	O
overlay	O
)	O
,	O
which	O
is	O
largely	O
membrane-localized	O
in	O
individual	O
cells	O
(	O
arrow	O
)	O
.	O

Genotypes	O
:	O
(	O
A	O
)	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/+	O
(	O
B	O
)	O
UAS-dEGFRλ	O
UAS-dp110CAAX/+	O
;	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/+	O
.	O
(	O
3.93	O
MB	O
TIF	O
)	O

Figure	O
S4	O
Glial-specific	O
Rbf1	O
knock-down	O
or	O
overexpression	O
of	O
G1	O
Cyclin-Cdks	O
,	O
Dap	O
,	O
and	O
Rbf1	O
affects	O
glial	O
proliferation	O
.	O

(	O
A–F	O
)	O
2	O
µm	O
optical	O
sections	O
of	O
larval	O
brain	O
hemispheres	O
from	O
wandering	O
3rd	O
instar	O
larvae	O
displayed	O
at	O
the	O
same	O
scale	O
.	O

20	O
µm	O
scale	O
bars	O
.	O

Frontal	O
sections	O
;	O
midway	O
through	O
brains	O
.	O

Anterior	O
up	O
;	O
midline	O
to	O
left	O
.	O

Glial	O
cell	O
nuclei	O
are	O
labeled	O
with	O
Repo	O
(	O
red	O
)	O
.	O

Glial	O
cell	O
bodies	O
and	O
membranes	O
are	O
labeled	O
with	O
CD8GFP	O
(	O
green	O
)	O
driven	O
by	O
repo-Gal4	O
.	O

HRP	O
counter-staining	O
(	O
blue	O
)	O
reveals	O
neuropil	O
at	O
high	O
intensity	O
and	O
some	O
cell	O
bodies	O
of	O
neurons	O
and	O
neuronal	O
precursors	O
at	O
low	O
intensity	O
.	O

Rbf1	O
knock-down	O
in	O
repo	O
>	O
Rbf1dsRNA	O
(	O
B	O
)	O
does	O
not	O
significantly	O
alter	O
glial	O
cell	O
numbers	O
(	O
red	O
nuclei	O
)	O
compared	O
to	O
wild-type	O
(	O
A	O
)	O
.	O

Ectopic	O
expression	O
of	O
dCyclinE-dCdk2	O
(	O
C	O
)	O
or	O
dCyclinD-dCdk4	O
in	O
repo-Gal4-glia	O
promotes	O
an	O
approximate	O
doubling	O
of	O
glial	O
cells	O
numbers	O
(	O
red	O
nuclei	O
)	O
,	O
even	O
when	O
combined	O
with	O
Rbf1dsRNA	O
(	O
D	O
)	O
.	O

Continuous	O
expression	O
of	O
Dap	O
(	O
E	O
)	O
or	O
Rbf1	O
(	O
F	O
)	O
in	O
otherwise	O
wild-type	O
repo-Gal4-glia	O
substantially	O
reduces	O
glial	O
cell	O
numbers	O
,	O
showing	O
that	O
repo-Gal4	O
glia	O
normally	O
undergo	O
proliferation	O
controlled	O
by	O
dCyclinE-dCdk2	O
and	O
Rbf1-E2F1	O
.	O

Genotypes	O
:	O
(	O
A	O
)	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/+	O
(	O
B	O
)	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/UAS-Rbf1dsRNA	O
(	O
C	O
)	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/UAS-dCyclinE	O
UAS-dCdk2	O
(	O
D	O
)	O
UAS-CD8GFP/UAS-dCyclinD	O
UAS-dCdk4	O
;	O
repo-Gal4/UAS-Rbf1dsRNA	O
(	O
E	O
)	O
UAS-dap/+	O
;	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/+	O
(	O
F	O
)	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/UAS-Rbf1	O
.	O
(	O
8.27	O
MB	O
TIF	O
)	O

Figure	O
S5	O
Dap	O
and	O
Rbf1	O
expression	O
in	O
wild-type	O
and	O
dEGFRλ	O
;	O
dp110CAAX	O
glia	O
.	O

3rd	O
instar	O
larval	O
brains	O
.	O

Frontal	O
sections	O
,	O
showing	O
superficial	O
dorsal	O
regions	O
enriched	O
for	O
Dap-	O
and	O
Rbf1-expressing	O
cells	O
.	O

Anterior	O
up	O
;	O
midline	O
to	O
left	O
.	O

7	O
µm	O
optical	O
projections	O
,	O
all	O
matched	O
in	O
scale	O
.	O

20	O
µm	O
scale	O
bars	O
.	O

(	O
A	O
,	O
B	O
)	O
Dap	O
expression	O
(	O
red	O
)	O
in	O
wild-type	O
(	O
A	O
)	O
and	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
(	O
B	O
)	O
,	O
shown	O
alone	O
(	O
left	O
panels	O
)	O
and	O
overlaid	O
with	O
Repo	O
(	O
blue	O
)	O
and	O
repo	O
>	O
CD8GFP	O
(	O
green	O
)	O
glial	O
markers	O
(	O
right	O
panels	O
)	O
.	O

In	O
both	O
genotypes	O
,	O
Dap	O
is	O
primarily	O
expressed	O
in	O
neuroblasts	O
(	O
‘NB’	O
)	O
and	O
ganglion	O
mother	O
cell	O
neuronal	O
precursors	O
(	O
‘NP’	O
)	O
,	O
rarely	O
in	O
glia	O
(	O
‘G’	O
)	O
,	O
and	O
almost	O
never	O
in	O
neurons	O
(	O
‘N’	O
)	O
.	O

In	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
,	O
Dap	O
is	O
rarely	O
expressed	O
in	O
glia	O
as	O
seen	O
by	O
the	O
lack	O
of	O
substantial	O
overlap	O
between	O
Dap	O
expression	O
and	O
glial	O
markers	O
(	O
B	O
,	O
right	O
panel	O
)	O
.	O

White	O
arrows	O
denote	O
rare	O
Dap-positive	O
glia	O
in	O
both	O
wild-type	O
and	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
;	O
these	O
glia	O
show	O
lower	O
levels	O
of	O
Dap	O
protein	O
than	O
neighboring	O
neuroblasts	O
and	O
neuronal	O
precursors	O
.	O

Dap-positive	O
glia	O
were	O
counted	O
in	O
3	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
and	O
an	O
average	O
of	O
5	O
%	O
of	O
all	O
glia	O
expressed	O
Dap	O
(	O
87	O
glia	O
expressed	O
Dap	O
out	O
of	O
1738	O
total	O
glia	O
counted	O
)	O
.	O

(	O
C–D	O
)	O
Rbf1	O
expression	O
(	O
red	O
)	O
in	O
wild-type	O
(	O
E	O
)	O
and	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
(	O
F	O
)	O
,	O
shown	O
alone	O
(	O
left	O
)	O
and	O
overlaid	O
(	O
right	O
)	O
with	O
the	O
CD8GFP	O
(	O
green	O
)	O
glial	O
marker	O
and	O
HRP	O
(	O
blue	O
)	O
neuronal	O
marker	O
.	O

In	O
both	O
genotypes	O
,	O
Rbf1	O
is	O
highly	O
expressed	O
in	O
glia	O
(	O
‘G’	O
)	O
and	O
neuroblast	O
s	O
(	O
‘NB’	O
)	O
,	O
which	O
were	O
identified	O
by	O
their	O
characteristic	O
positions	O
and	O
large	O
cell	O
bodies	O
.	O

Neurons	O
(	O
‘N’	O
)	O
show	O
lower	O
expression	O
.	O

Genotypes	O
:	O
(	O
A	O
,	O
C	O
)	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/+	O
(	O
B	O
,	O
D	O
)	O
UAS-dEGFRλ	O
UAS-dp110CAAX/+	O
;	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/+	O
.	O
(	O
7.96	O
MB	O
TIF	O
)	O

Figure	O
S6	O
dEGFRλ	O
;	O
dp110CAAX	O
glia	O
do	O
not	O
express	O
neuronal	O
and	O
neuroblast	O
markers	O
.	O

Late	O
3rd	O
instar	O
larval	O
brains	O
.	O

Medial	O
anterior	O
regions	O
shown	O
.	O

Anterior	O
up	O
;	O
midline	O
to	O
left	O
.	O

2	O
µm	O
optical	O
sections	O
.	O

CD8GFP	O
(	O
green	O
)	O
,	O
driven	O
by	O
the	O
repo-Gal4	O
driver	O
,	O
labels	O
glial	O
cell	O
bodies	O
and	O
membranes	O
.	O

An	O
HRP	O
counter-stain	O
(	O
blue	O
)	O
reveals	O
neuropil	O
at	O
high	O
intensity	O
and	O
cell	O
bodies	O
of	O
neurons	O
and	O
some	O
neuronal	O
precursors	O
at	O
low	O
intensity	O
.	O

(	O
A	O
,	O
B	O
)	O
Repo	O
expression	O
(	O
red	O
)	O
in	O
glial	O
cell	O
nuclei	O
in	O
wild-type	O
(	O
A	O
)	O
and	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
(	O
B	O
)	O
.	O

In	O
wild-type	O
brains	O
,	O
neuronal	O
fibers	O
and	O
neurons	O
(	O
blue	O
)	O
are	O
enveloped	O
by	O
glial	O
processes	O
(	O
green	O
)	O
to	O
give	O
the	O
brain	O
a	O
honeycombed	O
appearance	O
.	O

In	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
,	O
neurons	O
(	O
‘N’	O
)	O
lack	O
GFP	O
or	O
Repo	O
expression	O
,	O
in	O
contrast	O
to	O
glia	O
(	O
‘G’	O
)	O
.	O

(	O
C–D	O
)	O
Elav	O
expression	O
(	O
red	O
)	O
in	O
wild-type	O
(	O
C	O
)	O
and	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
(	O
D	O
)	O
,	O
shown	O
alone	O
(	O
left	O
panels	O
)	O
and	O
overlaid	O
(	O
right	O
panels	O
)	O
with	O
the	O
CD8GFP	O
(	O
green	O
)	O
glial	O
marker	O
and	O
HRP	O
(	O
blue	O
)	O
neuronal	O
marker	O
.	O

In	O
both	O
genotypes	O
,	O
Elav	O
is	O
highly	O
expressed	O
in	O
neurons	O
(	O
‘N’	O
)	O
but	O
absent	O
from	O
glia	O
(	O
green	O
cell	O
bodies	O
indicated	O
by	O
white	O
arrows	O
)	O
.	O

(	O
E–F	O
)	O
Miranda	O
expression	O
(	O
red	O
)	O
in	O
wild-type	O
(	O
E	O
)	O
and	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
(	O
F	O
)	O
brains	O
,	O
shown	O
alone	O
(	O
left	O
panels	O
)	O
and	O
overlaid	O
(	O
right	O
panels	O
)	O
with	O
CD8GFP	O
(	O
green	O
)	O
glial	O
marker	O
and	O
HRP	O
(	O
blue	O
)	O
neuronal	O
marker	O
.	O

In	O
both	O
genotypes	O
,	O
Miranda	O
is	O
highly	O
expressed	O
in	O
neuroblasts	O
(	O
‘NB’	O
)	O
,	O
which	O
are	O
identified	O
by	O
their	O
characteristic	O
positions	O
and	O
large	O
cell	O
bodies	O
,	O
but	O
is	O
absent	O
from	O
glia	O
(	O
green	O
cell	O
bodies	O
,	O
indicated	O
by	O
white	O
arrows	O
)	O
.	O

Genotypes	O
:	O
(	O
A	O
,	O
C	O
,	O
E	O
)	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/+	O
(	O
B	O
,	O
D	O
,	O
F	O
)	O
UAS-dEGFRλ	O
UAS-dp110CAAX/+	O
;	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/+	O
.	O
(	O
9.24	O
MB	O
TIF	O
)	O

Figure	C
S7	C
dEGFRλ	C
and	C
dp110CAAX	C
do	C
not	C
induce	C
neoplasia	C
from	C
neurons	C
,	C
neuroblasts	C
,	C
or	C
certain	C
glia	C
.	C

Late	O
3rd	O
instar	O
larval	O
brain	O
hemispheres	O
.	O

Medial	O
anterior	O
regions	O
shown	O
.	O

Anterior	O
up	O
;	O
midline	O
to	O
left	O
.	O

3.5	O
µm	O
optical	O
projections	O
.	O

Repo	O
expression	O
(	O
red	O
)	O
in	O
glial	O
cell	O
nuclei	O
in	O
all	O
genotypes	O
.	O

An	O
HRP	O
counter-stain	O
(	O
blue	O
)	O
reveals	O
neuropil	O
at	O
high	O
intensity	O
and	O
cell	O
bodies	O
of	O
neurons	O
and	O
some	O
neuronal	O
precursors	O
at	O
low	O
intensity	O
,	O
and	O
this	O
varies	O
slightly	O
according	O
to	O
variance	O
in	O
exact	O
section	O
plane	O
.	O

(	O
A–D	O
)	O
Wild-type	O
(	O
A	O
)	O
,	O
dEGFRλ	O
;	O
dp110CAAX	O
overexpressed	O
using	O
the	O
1407-Gal4	O
neuroblast	O
driver	O
(	O
B	O
)	O
,	O
dEGFRλ	O
;	O
dp110CAAX	O
overexpressed	O
using	O
the	O
pros-Gal4	O
neural	O
driver	O
(	O
C	O
)	O
,	O
and	O
dEGFRλ	O
;	O
dp110CAAX	O
overexpressed	O
using	O
the	O
gcm-Gal4	O
embryonic	O
glial	O
driver	O
(	O
D	O
)	O
.	O

In	O
all	O
cases	O
,	O
dEGFRλ	O
;	O
dp110CAAX	O
overexpression	O
did	O
not	O
induce	O
neoplastic	O
overgrowth	O
of	O
glial	O
or	O
neuronal	O
cell	O
types	O
,	O
as	O
determined	O
by	O
brain	O
size	O
and	O
cell-type	O
specific	O
stains	O
.	O

(	O
E	O
,	O
F	O
)	O
Cytoplasmic	O
GFP	O
(	O
green	O
)	O
,	O
driven	O
by	O
the	O
Nrv2-Gal4	O
driver	O
,	O
labels	O
cell	O
bodies	O
and	O
cytoplasmic	O
processes	O
,	O
as	O
seen	O
in	O
wild-type	O
(	O
E	O
)	O
.	O

dEGFRλ	O
;	O
dp110CAAX	O
overexpressed	O
using	O
the	O
Nrv2-Gal4	O
glial	O
driver	O
(	O
B	O
)	O
.	O

Nrv2-Gal4	O
is	O
expressed	O
by	O
post-mitotic	O
cortex	O
glia	O
,	O
which	O
proliferate	O
somewhat	O
in	O
response	O
to	O
dEGFRλ	O
;	O
dp110CAAX	O
to	O
cause	O
slight	O
brain	O
enlargement	O
,	O
but	O
do	O
not	O
become	O
neoplastic	O
like	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
glia	O
.	O

Genotypes	O
:	O
(	O
A	O
)	O
+/CyO	O
(	O
B	O
)	O
UAS-dEGFRλ	O
UAS-dp110CAAX/+	O
;	O
1407-Gal4/UAS-Gal4	O
(	O
C	O
)	O
UAS-dEGFRλ	O
UAS-dp110CAAX/+	O
;	O
UAS-Gal4/+	O
;	O
pros-Gal4/+	O
(	O
D	O
)	O
UAS-dEGFRλ	O
UAS-dp110CAAX/+	O
;	O
gcm-Gal4/+	O
(	O
E	O
)	O
Nrv2-Gal4	O
UAS-GFP/+	O
;	O
Nrv2-Gal4	O
UAS-GFP/+	O
(	O
F	O
)	O
UAS-dEGFRλ	O
UAS-dp110CAAX/+	O
;	O
Nrv2-Gal4	O
UAS-GFP/UAS-Gal4	O
;	O
Nrv2-Gal4	O
UAS-GFP/+	O
.	O
(	O
7.96	O
MB	O
TIF	O
)	O

Figure	O
S8	O
Coactivation	O
of	O
EGFR	O
and	O
PI3K	O
in	O
glial	O
progenitors	O
creates	O
invasive	O
neoplastic	O
glia	O
.	O

(	O
A–E	O
)	O
FLP/FRT	O
clones	O
in	O
adult	O
brains	O
derived	O
from	O
a	O
population	O
of	O
ey-FLP	O
and	O
repo-Gal4-expressing	O
cells	O
.	O

CD8GFP	O
(	O
green	O
)	O
marks	O
cell	O
bodies	O
and	O
membranes	O
of	O
glial	O
clones	O
derived	O
by	O
FLP/FRT	O
mitotic	O
recombination	O
(	O
see	O
text	O
)	O
.	O

Repo	O
(	O
red	O
)	O
marks	O
all	O
glial	O
cell	O
nuclei	O
,	O
in	O
both	O
clones	O
and	O
surrounding	O
normal	O
tissue	O
.	O

8.5	O
µm	O
confocal	O
optical	O
sections	O
through	O
brains	O
of	O
similarly	O
aged	O
adults	O
,	O
all	O
matched	O
to	O
scale	O
.	O

20	O
µm	O
scale	O
bars	O
.	O

Each	O
panel	O
shows	O
half	O
brains	O
,	O
including	O
a	O
whole	O
optic	O
lobe	O
and	O
adjacent	O
central	O
brain	O
.	O

dEGFRElp	O
(	O
C	O
)	O
and	O
dPTEN-/-	O
(	O
J	O
)	O
clones	O
are	O
composed	O
of	O
2–5-fold	O
more	O
cells	O
than	O
wild-type	O
controls	O
(	O
H	O
)	O
.	O

In	O
contrast	O
,	O
dEGFRλ	O
;	O
dPTEN-/-	O
(	O
D	O
)	O
and	O
dEGFRElp	O
;	O
PTEN-/-	O
double	O
mutant	O
clones	O
form	O
large	O
tumors	O
visible	O
in	O
adult	O
brains	O
.	O

As	O
with	O
hs-FLP	O
clones	O
,	O
dEGFRλ	O
;	O
dPTEN-/-	O
and	O
dEGFRElp	O
;	O
dPTEN-/-	O
clones	O
are	O
less	O
cellular	O
and	O
more	O
invasive	O
than	O
dRas85DV12	O
;	O
PTEN-/-	O
clones	O
(	O
see	O
Figure	O
4	O
)	O
.	O

Genotypes	O
:	O
(	O
A	O
)	O
ey-flp/+	O
;	O
FRT40A	O
tubGal80/FRT,40A	O
;	O
repo-Gal4	O
UAS-CD8GFP/+	O
(	O
B	O
)	O
ey-flp/+	O
;	O
FRT40A	O
tubGal80/FRT40A	O
PTEN2L117	O
;	O
repo-Gal4	O
UAS-CD8GFP/+	O
(	O
C	O
)	O
ey-flp/+	O
;	O
FRTG13	O
tubGal80/FRTG13	O
UAS-CD8GFP	O
;	O
repo-Gal4/UAS-dEGFRElp	O
(	O
D	O
)	O
ey-flp/UAS-	O
dEGFRλ	O
;	O
FRT40A	O
tubGal80/FRT40A	O
PTEN2L117	O
;	O
repo-Gal4	O
UAS-CD8GFP/UAS-	O
dEGFRλ	O
(	O
E	O
)	O
ey-flp/+	O
;	O
FRT40A	O
tubGal80/FRT40A	O
PTEN2L117	O
;	O
repo-Gal4	O
UAS-CD8GFP/UAS-dEGFRElp	O
.	O
(	O
7.84	O
MB	O
TIF	O
)	O

Figure	O
S9	O
Stg	O
overexpression	O
exacerbates	O
EGFR-PI3K	O
glial	O
neoplasia	O
.	O

2	O
µm	O
optical	O
sections	O
of	O
larval	O
brain	O
hemispheres	O
from	O
late	O
3rd	O
instar	O
larvae	O
,	O
displayed	O
at	O
the	O
same	O
scale	O
.	O

20	O
µm	O
scale	O
bars	O
.	O

Frontal	O
sections	O
,	O
midway	O
through	O
brains	O
.	O

Anterior	O
up	O
;	O
midline	O
to	O
left	O
.	O

Glial	O
cell	O
nuclei	O
are	O
labeled	O
with	O
Repo	O
(	O
red	O
)	O
;	O
glial	O
cell	O
bodies	O
and	O
membranes	O
are	O
labeled	O
with	O
CD8GFP	O
(	O
green	O
)	O
driven	O
by	O
repo-Gal4	O
.	O

An	O
HRP	O
counter-stain	O
(	O
blue	O
)	O
reveals	O
neuropil	O
at	O
high	O
intensity	O
and	O
neuronal	O
cell	O
bodies	O
at	O
low	O
intensity	O
.	O

HRP	O
stains	O
varied	O
between	O
the	O
two	O
samples	O
according	O
to	O
effects	O
of	O
mutant	O
glia	O
and	O
slight	O
variance	O
in	O
section	O
plane	O
.	O

Stg	O
co-overexpression	O
with	O
dEGFRλ	O
;	O
dp110CAAX	O
(	O
B	O
)	O
enhances	O
neoplasia	O
compared	O
to	O
dEGFRλ	O
;	O
dp110CAAX	O
(	O
A	O
)	O
,	O
leading	O
to	O
a	O
dramatic	O
increase	O
in	O
aberrant	O
glia	O
and	O
yielding	O
a	O
phenotype	O
similar	O
to	O
that	O
of	O
repo	O
>	O
Rbf1dsRNA	O
;	O
dEGFRλ	O
;	O
dp110CAAX	O
(	O
see	O
Figure	O
8G	O
)	O
.	O

Genotypes	O
:	O
(	O
A	O
)	O
UAS-dEGFRλ	O
UAS-dp110CAAX/+	O
;	O
repo-Gal4	O
UAS-CD8GFP/+	O
(	O
B	O
)	O
UAS-dEGFRλ	O
UAS-dp110CAAX/+	O
;	O
UAS-stg/+	O
;	O
repo-Gal4	O
UAS-CD8GFP/+	O
.	O
(	O
6.27	O
MB	O
TIF	O
)	O

Figure	O
S10	O
Knock-down	O
and/or	O
overexpression	O
of	O
dTor	O
and	O
dTor	O
effectors	O
.	O

2	O
µm	O
optical	O
sections	O
of	O
larval	O
brain	O
hemispheres	O
from	O
wandering	O
3rd	O
instar	O
larvae	O
,	O
approximately	O
130hr	O
AED	O
,	O
all	O
displayed	O
at	O
the	O
same	O
scale	O
.	O

20	O
µm	O
scale	O
bars	O
.	O

Anterior	O
up	O
;	O
midline	O
to	O
the	O
left	O
.	O

Frontal	O
sections	O
;	O
midway	O
through	O
brains	O
.	O

Repo	O
(	O
red	O
)	O
marks	O
glial	O
cell	O
nuclei	O
;	O
CD8GFP	O
(	O
green	O
)	O
,	O
driven	O
by	O
repo-Gal4	O
,	O
labels	O
glial	O
cell	O
bodies	O
and	O
membranes	O
.	O

An	O
HRP-counter	O
stain	O
(	O
blue	O
)	O
reveals	O
neuropil	O
(	O
neuronal	O
fiber	O
tracts	O
)	O
at	O
high	O
intensity	O
and	O
some	O
cell	O
bodies	O
of	O
neurons	O
and	O
neuronal	O
precursors	O
at	O
low	O
intensity	O
,	O
and	O
this	O
varies	O
slightly	O
according	O
to	O
exact	O
plane	O
of	O
section	O
,	O
brain	O
orientation	O
,	O
and	O
mutant	O
phenotype	O
.	O

repo	O
>	O
dAktdsRNA	O
brains	O
(	O
B	O
)	O
are	O
smaller	O
and	O
have	O
fewer	O
glia	O
than	O
wild-type	O
controls	O
(	O
A	O
)	O
.	O

All	O
other	O
genotypes	O
have	O
relatively	O
normal	O
sized	O
brains	O
.	O

By	O
gross	O
examination	O
,	O
repo	O
>	O
TorTED	O
(	O
C	O
)	O
,	O
repo	O
>	O
dRaptordsRNA	O
(	O
E	O
)	O
,	O
repo	O
>	O
deIF4EdsRNA	O
(	O
F	O
)	O
and	O
repo	O
>	O
dS6KdsRNA	O
(	O
G	O
)	O
display	O
an	O
estimated	O
10–20	O
%	O
reduction	O
in	O
glial	O
cell	O
numbers	O
.	O

repo	O
>	O
dTSC1dsRNA	O
(	O
D	O
)	O
,	O
repo	O
>	O
Rheb	O
(	O
H	O
)	O
and	O
repo	O
>	O
deIF4E	O
(	O
I	O
)	O
brains	O
contain	O
normal	O
numbers	O
of	O
glia	O
.	O

Genotypes	O
:	O
(	O
A	O
)	O
repo-Gal4	O
UAS-CD8GFP/+	O
(	O
B	O
)	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/UAS-dAktdsRNA	O
(	O
C	O
)	O
UAS-TorTED/UAS-CD8GFP	O
;	O
repo-Gal4/+	O
(	O
D	O
)	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/UAS-dTSC1dsRNA	O
(	O
E	O
)	O
UAS-dRaptordsRNA/UAS-CD8GFP	O
;	O
repo-Gal4/+	O
(	O
F	O
)	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/UAS-deIF4EdsRNA	O
(	O
G	O
)	O
UAS-dS6KdsRNA	O
;	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/+	O
(	O
H	O
)	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/UAS-Rheb	O
(	O
I	O
)	O
UAS-CD8GFP//UAS-deIF4E	O
;	O
repo-Gal4/+	O
.	O
(	O
8.83	O
MB	O
TIF	O
)	O

Figure	O
S11	O
Validation	O
of	O
dsRNA	O
constructs	O
.	O

2	O
µm	O
optical	O
sections	O
of	O
larval	O
brain	O
hemispheres	O
from	O
wandering	O
3rd	O
instar	O
larvae	O
.	O

Frontal	O
sections	O
.	O

Anterior	O
up	O
,	O
midline	O
to	O
the	O
left	O
.	O

Each	O
individual	O
staining	O
pattern	O
is	O
shown	O
alone	O
(	O
left	O
panels	O
)	O
and	O
with	O
overlaid	O
glial	O
or	O
neuronal	O
markers	O
(	O
right	O
panels	O
)	O
.	O

Repo	O
(	O
blue	O
)	O
in	O
(	O
A–J	O
)	O
marks	O
glial	O
cell	O
nuclei	O
.	O

Glial	O
cell	O
bodies	O
and	O
membranes	O
are	O
labeled	O
with	O
CD8GFP	O
(	O
green	O
)	O
driven	O
by	O
repo-Gal4	O
.	O

In	O
(	O
K	O
,	O
L	O
)	O
an	O
HRP	O
counter-stain	O
(	O
blue	O
)	O
reveals	O
neurons	O
.	O

Red	O
marks	O
histochemical	O
stains	O
for	O
each	O
indicated	O
protein	O
in	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
(	O
A	O
,	O
C	O
,	O
E	O
,	O
G	O
,	O
I	O
,	O
K	O
)	O
and	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
with	O
each	O
indicated	O
dsRNA	O
construct	O
(	O
B	O
,	O
D	O
,	O
F	O
,	O
H	O
,	O
J	O
,	O
L	O
)	O
.	O

Each	O
dsRNA	O
construct	O
was	O
expressed	O
with	O
repo-Gal4	O
to	O
yield	O
glial-specific	O
knock-down	O
,	O
which	O
left	O
protein	O
expression	O
in	O
surrounding	O
neuronal	O
tissue	O
intact	O
.	O

For	O
the	O
nuclear	O
protein	O
PntP1	O
,	O
knock-down	O
was	O
verified	O
by	O
the	O
lack	O
of	O
glial-specific	O
staining	O
in	O
the	O
presence	O
of	O
the	O
pntdsRNA	O
(	O
B	O
)	O
,	O
although	O
PntP1	O
is	O
present	O
within	O
neighboring	O
neurons	O
(	O
‘N’	O
)	O
.	O

For	O
dAkt	O
,	O
deIF4E	O
,	O
and	O
dS6K	O
,	O
gene	O
knock-down	O
was	O
confirmed	O
using	O
antibodies	O
for	O
total	O
protein	O
.	O

Glial-specific	O
reduction	O
in	O
gene	O
expression	O
by	O
dAktdsRNA	O
and	O
deIF4EdsRNA	O
is	O
highlighted	O
by	O
white	O
outlines	O
in	O
(	O
D	O
)	O
and	O
(	O
F	O
)	O
.	O

dAkt	O
protein	O
is	O
higher	O
in	O
neuronal	O
tissue	O
(	O
‘N’	O
)	O
in	O
both	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
(	O
C	O
)	O
and	O
repo	O
>	O
dAktdsRNA	O
;	O
dEGFRλ	O
;	O
dp110CAAX	O
(	O
D	O
)	O
.	O

deIF4E	O
is	O
high	O
in	O
dEGFRλ	O
;	O
dp110CAAX	O
glia	O
(	O
E	O
)	O
and	O
low	O
in	O
neurons	O
(	O
E	O
,	O
F	O
)	O
.	O

repo	O
>	O
deIF4EdsRNA	O
;	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
(	O
F	O
)	O
have	O
reduced	O
glial	O
eIF4E	O
.	O

Reduced	O
glial	O
dS6K	O
protein	O
,	O
which	O
is	O
diffusely	O
cytoplasmic	O
,	O
is	O
observed	O
in	O
repo	O
>	O
dS6KdsRNA	O
;	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
(	O
H	O
)	O
compared	O
to	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
(	O
G	O
)	O
.	O

Reduced	O
glial	O
dMyc	O
expression	O
in	O
repo	O
>	O
dMycdsRNA	O
;	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
(	O
J	O
)	O
is	O
noted	O
by	O
white	O
outlines	O
,	O
and	O
the	O
absence	O
of	O
purple	O
nuclei	O
in	O
overlay	O
(	O
J	O
,	O
right	O
panel	O
)	O
,	O
relative	O
to	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
(	O
I	O
,	O
right	O
panel	O
)	O
.	O

dMyc	O
is	O
highly	O
expressed	O
in	O
neuroblasts	O
(	O
‘NB’	O
)	O
in	O
both	O
samples	O
(	O
I	O
,	O
J	O
)	O
,	O
which	O
do	O
not	O
express	O
the	O
dMycdsRNA	O
.	O

Glial	O
Rbf1	O
protein	O
is	O
absent	O
in	O
repo	O
>	O
dRbf1dsRNA	O
;	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
(	O
L	O
)	O
in	O
contrast	O
to	O
neighboring	O
neurons	O
(	O
‘N’	O
)	O
in	O
,	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
(	O
K	O
)	O
.	O

Genotypes	O
:	O
(	O
A	O
,	O
C	O
,	O
E	O
,	O
G	O
,	O
I	O
,	O
K	O
)	O
UAS-dEGFR	O
,	O
λ	O
UAS-dp110	O
,	O
CAAX/+	O
;	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/+	O
(	O
B	O
)	O
UAS-dEGFRλ	O
UAS-dp110CAAX/+	O
;	O
repo-Gal4	O
UAS-CD8GFP/UAS-pntdsRNA	O
(	O
D	O
)	O
UAS-dEGFRλ	O
UAS-dp110CAAX/+	O
;	O
repo-Gal4	O
UAS-CD8GFP/UAS-dAktdsRNA	O
(	O
F	O
)	O
UAS-dEGFRλ	O
UAS-dp110CAAX/+	O
;	O
repo-Gal4	O
UAS-CD8GFP/UAS-deIF4EdsRNA	O
(	O
H	O
)	O
UAS-dEGFRλ	O
UAS-dp110CAAX/UAS-dS6KdsRNA	O
;	O
repo-Gal4	O
UAS-CD8GFP/+	O
(	O
J	O
)	O
UAS-dEGFRλ	O
UAS-dp110CAAX/+	O
;	O
UAS-dMycdsRNA/+	O
;	O
repo-Gal4	O
UAS-CD8GFP/+	O
(	O
L	O
)	O
UAS-dEGFRλ	O
UAS-dp110CAAX/+	O
;	O
repo-Gal4	O
UAS-CD8GFP/UAS-Rbf1dsRNA	O
.	O
(	O
9.04	O
MB	O
TIF	O
)	O

Figure	O
S12	O
Phospho-MPM2	O
reveals	O
increased	O
S-phase	O
and	O
M-phase	O
glia	O
in	O
repo	O
>	O
dRbf1dsRNA	O
;	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
.	O

(	O
A–C	O
)	O
phospho-MPM2	O
expression	O
(	O
red	O
)	O
in	O
wild-type	O
brains	O
(	O
A	O
)	O
,	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
(	O
B	O
)	O
,	O
and	O
repo	O
>	O
dRbf1dsRNA	O
;	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
(	O
C	O
)	O
.	O

20	O
µm	O
scale	O
bars	O
.	O

Anterior	O
up	O
,	O
midline	O
to	O
the	O
left	O
.	O

6	O
µm	O
optical	O
projections	O
showing	O
representative	O
superficial	O
dorsal	O
regions	O
enriched	O
for	O
mitotic	O
glia	O
.	O

Phospho-MPM2	O
shown	O
alone	O
(	O
left	O
panels	O
)	O
,	O
overlaid	O
with	O
the	O
Repo	O
(	O
blue	O
,	O
middle	O
panels	O
)	O
,	O
and	O
CD8GFP	O
(	O
green	O
,	O
right	O
panels	O
)	O
glial	O
markers	O
.	O

Phospho-MPM2	O
nuclear	O
foci	O
are	O
present	O
in	O
S-phase	O
cells	O
(	O
arrows	O
note	O
examples	O
)	O
.	O

S-phase	O
glia	O
are	O
clearly	O
visible	O
in	O
the	O
middle	O
panel	O
as	O
purple	O
cells	O
with	O
MPM2	O
foci	O
,	O
which	O
appear	O
enriched	O
in	O
repo	O
>	O
dRbf1dsRNA	O
;	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
(	O
C	O
)	O
relative	O
to	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
(	O
B	O
)	O
.	O

In	O
all	O
genotypes	O
,	O
high	O
levels	O
of	O
phospho-MPM2	O
is	O
also	O
expressed	O
in	O
mitotic	O
cells	O
(	O
asterisks	O
note	O
examples	O
)	O
.	O

Mitotic	C
glia	C
showed	C
low	C
levels	C
of	C
Repo	C
(	C
middle	C
panels	C
)	C
,	C
but	C
are	C
clearly	C
GFP-positive	C
(	C
right	C
panels	C
)	C
,	C
suggesting	C
that	C
Repo	C
protein	C
expression	C
is	C
reduced	C
upon	C
mitosis	C
in	C
glia	C
.	C

repo	O
>	O
dRbf1dsRNA	O
;	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
(	O
C	O
)	O
also	O
show	O
increased	O
density	O
of	O
phospho-MPM2-positive	O
mitotic	O
glia	O
compared	O
to	O
repo	O
>	O
dEGFRλ	O
;	O
dp110CAAX	O
brains	O
(	O
B	O
)	O
.	O

In	O
wild-type	O
(	O
A	O
)	O
,	O
the	O
majority	O
of	O
phospho-MPM2-postive	O
cells	O
are	O
not	O
glial	O
and	O
are	O
neuroblasts	O
or	O
neuronal	O
precursors	O
,	O
as	O
revealed	O
by	O
the	O
lack	O
of	O
overlap	O
between	O
phospho-MPM2	O
staining	O
(	O
middle	O
panel	O
)	O
and	O
the	O
Repo	O
and	O
CD8GFP	O
markers	O
.	O

Genotypes	O
:	O
(	O
A	O
)	O
repo-Gal4	O
UAS-CD8GFP/+	O
(	O
B	O
)	O
UAS-dEGFRλ	O
UAS-dp110CAAX/+	O
;	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/+	O
(	O
C	O
)	O
UAS-dEGFRλ	O
UAS-dp110CAAX/+	O
;	O
repo-Gal4	O
UAS-CD8GFP/UAS-Rbf1dsRNA	O
.	O
(	O
8.99	O
MB	O
TIF	O
)	O

Table	O
S1	O
Overexpression	O
of	O
EGFR-Ras	O
and	O
PI3K-Akt	O
pathways	O
in	O
Drosophila	O
glia	O
.	O
(	O
0.08	O
MB	O
PDF	O
)	O

Table	O
S2	O
Coactivation	O
of	O
EGFR	O
and	O
PI3K	O
does	O
not	O
elicit	O
neoplasia	O
in	O
all	O
neural	O
cell	O
types	O
.	O
(	O
0.08	O
MB	O
PDF	O
)	O

Table	O
S3	O
Genetic	O
analysis	O
of	O
Akt	O
,	O
Tor	O
,	O
Myc	O
,	O
and	O
CyclinD-Cdk4	O
pathways	O
in	O
neoplastic	O
and	O
normal	O
glia	O
.	O
(	O
0.10	O
MB	O
PDF	O
)	O

Video	O
S1	O
An	O
animated	O
7.5	O
µm	O
thick	O
confocal	O
z-stack	O
of	O
dEGFRλ	O
;	O
dp110CAAX	O
tumor	O
cells	O
derived	O
from	O
transplanted	O
larval	O
glia	O
,	O
pictured	O
in	O
Figure	O
3D	O
.	O

The	O
depth	O
of	O
each	O
frame	O
is	O
noted	O
in	O
the	O
upper	O
left-hand	O
corner	O
.	O

20	O
µm	O
scale	O
bar	O
for	O
x/y-axis	O
.	O

Transplanted	O
mutant	O
glia	O
are	O
labeled	O
with	O
membrane	O
bound	O
CD8GFP	O
(	O
green	O
)	O
and	O
the	O
Repo	O
nuclear	O
protein	O
(	O
blue	O
)	O
.	O

Actin	O
staining	O
(	O
red	O
,	O
phalloidin	O
)	O
reveals	O
abdominal	O
anatomy	O
of	O
the	O
host	O
.	O

Asterisks	O
indicate	O
trachea	O
embedded	O
in	O
the	O
pictured	O
dEGFRλ	O
;	O
dp110CAAX	O
tumor	O
,	O
visible	O
as	O
hollow	O
actin-positive	O
(	O
red	O
)	O
tubules	O
running	O
through	O
tissues	O
.	O

Genotypes	O
:	O
Hosts	O
were	O
w1118	O
virgin	O
females	O
.	O

Transplanted	O
glia	O
were	O
UAS-dEGFRλ	O
UAS-dp110CAAX/+	O
;	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/+	O
.	O
(	O
1.54	O
MB	O
MOV	O
)	O

Video	O
S2	O
An	O
animated	O
27	O
µm	O
thick	O
confocal	O
z-stack	O
of	O
dEGFRλ	O
;	O
dp110CAAX	O
tumor	O
cells	O
derived	O
from	O
transplanted	O
larval	O
glia	O
,	O
pictured	O
in	O
Figure	O
3F	O
.	O

The	O
depth	O
of	O
each	O
frame	O
is	O
noted	O
in	O
the	O
upper	O
left-hand	O
corner	O
.	O

20	O
µm	O
scale	O
bar	O
for	O
x/y-axis	O
.	O

Transplanted	O
mutant	O
glia	O
are	O
labeled	O
with	O
membrane	O
bound	O
CD8GFP	O
(	O
green	O
)	O
and	O
the	O
Repo	O
nuclear	O
protein	O
(	O
blue	O
)	O
.	O

Actin	O
staining	O
(	O
red	O
,	O
phalloidin	O
)	O
reveals	O
abdominal	O
anatomy	O
of	O
the	O
host	O
.	O

Arrowheads	O
in	O
indicate	O
dEGFRλ	O
;	O
dp110CAAX	O
glial	O
cells	O
invading	O
an	O
ovary	O
,	O
distinguished	O
by	O
its	O
characteristic	O
actin	O
staining	O
(	O
bright	O
red	O
)	O
.	O

An	O
asterisk	O
indicates	O
trachea	O
embedded	O
in	O
this	O
dEGFRλ	O
;	O
dp110CAAX	O
tumor	O
,	O
visible	O
as	O
a	O
hollow	O
actin-positive	O
(	O
red	O
)	O
tubule	O
running	O
through	O
the	O
tissue	O
.	O

Genotypes	O
:	O
Hosts	O
were	O
w1118	O
virgin	O
females	O
.	O

Transplanted	O
glia	O
were	O
UAS-dEGFRλ	O
UAS-dp110CAAX/+	O
;	O
UAS-CD8GFP/+	O
;	O
repo-Gal4/+	O
.	O
(	O
1.16	O
MB	O
MOV	O
)	O

Video	O
S3	O
An	O
animated	O
88	O
µm	O
thick	O
confocal	O
z-stack	O
of	O
a	O
hs-FLP/FRT	O
clone	O
of	O
dPTEN-/-	O
;	O
dRas85DV12	O
cells	O
pictured	O
in	O
Figure	O
4E	O
.	O

The	O
depth	O
of	O
each	O
frame	O
is	O
noted	O
in	O
the	O
upper	O
left-hand	O
corner	O
.	O

20	O
µm	O
scale	O
bar	O
for	O
x/y-axis	O
.	O

Approximately	O
half	O
of	O
the	O
affected	O
brain	O
is	O
displayed	O
,	O
with	O
the	O
midline	O
to	O
the	O
left	O
.	O

The	O
dPTEN-/-	O
;	O
dRas85DV12	O
mutant	O
cells	O
are	O
labeled	O
with	O
membrane-bound	O
CD8GFP	O
(	O
green	O
)	O
and	O
penetrate	O
through	O
the	O
entire	O
depth	O
of	O
the	O
brain	O
,	O
some	O
of	O
which	O
is	O
visible	O
as	O
red	O
background	O
.	O

These	C
dPTEN-/-	C
;	C
dRas85DV12	C
cells	C
appear	C
to	C
originate	C
in	C
the	C
optic	C
lobe	C
(	C
right	C
)	C
and	C
extend	C
variable	C
tendrils	C
into	C
the	C
central	C
brain	C
(	C
middle	C
,	C
left	C
)	C
.	C

Genotype	O
:	O
hs-flp1/+	O
;	O
FRT40A	O
tubGal80/FRT40A	O
PTEN2L117	O
;	O
repo-Gal4	O
UAS-CD8GFP/UAS-dRas85DV12	O
.	O
(	O
1.06	O
MB	O
MOV	O
)	O

Video	O
S4	O
An	O
animated	O
16	O
µm	O
thick	O
confocal	O
z-stack	O
of	O
a	O
hs-FLP/FRT	O
clone	O
of	O
wild-type	O
cells	O
pictured	O
in	O
Figure	O
4A	O
.	O

The	O
depth	O
of	O
each	O
frame	O
is	O
noted	O
in	O
the	O
upper	O
left-hand	O
corner	O
.	O

20	O
µm	O
scale	O
bar	O
for	O
x/y-axis	O
.	O

Midline	O
to	O
the	O
left	O
.	O

This	O
clone	O
of	O
normal	O
glia	O
is	O
labeled	O
with	O
membrane-bound	O
CD8GFP	O
(	O
green	O
)	O
and	O
shows	O
cells	O
in	O
a	O
cell-body	O
rich	O
region	O
of	O
the	O
central	O
brain	O
adjacent	O
to	O
the	O
optic	O
lobe	O
.	O

The	O
clone	O
is	O
composed	O
of	O
2	O
cells	O
with	O
extensive	O
cytoplasmic	O
projections	O
.	O

Genotype	O
:	O
hs-flp1/+	O
;	O
FRTG13	O
tubGal80/FRTG13	O
UAS-CD8GFP	O
;	O
repo-Gal4/+	O
.	O
(	O
0.24	O
MB	O
MOV	O
)	O

Kinesin-5–dependent	O
Poleward	O
Flux	O
and	O
Spindle	O
Length	O
Control	O
in	O
Drosophila	O
Embryo	O
Mitosis	O

Abstract	O

We	C
used	C
antibody	C
microinjection	C
and	C
genetic	C
manipulations	C
to	C
dissect	C
the	C
various	C
roles	C
of	C
the	C
homotetrameric	C
kinesin-5	C
,	C
KLP61F	C
,	C
in	C
astral	C
,	C
centrosome-controlled	C
Drosophila	C
embryo	C
spindles	C
and	C
to	C
test	C
the	C
hypothesis	C
that	C
it	C
slides	C
apart	C
interpolar	C
(	C
ip	C
)	C
microtubules	C
(	C
MT	C
)	C
,	C
thereby	C
controlling	C
poleward	C
flux	C
and	C
spindle	C
length	C
.	C

In	O
wild-type	O
and	O
Ncd	O
null	O
mutant	O
embryos	O
,	O
anti-KLP61F	O
dissociated	O
the	O
motor	O
from	O
spindles	O
,	O
producing	O
a	O
spatial	O
gradient	O
in	O
the	O
KLP61F	O
content	O
of	O
different	O
spindles	O
,	O
which	O
was	O
visible	O
in	O
KLP61F-GFP	O
transgenic	O
embryos	O
.	O

The	C
resulting	C
mitotic	C
defects	C
,	C
supported	C
by	C
gene	C
dosage	C
experiments	C
and	C
time-lapse	C
microscopy	C
of	C
living	C
klp61f	C
mutants	C
,	C
reveal	C
that	C
,	C
after	C
NEB	C
,	C
KLP61F	C
drives	C
persistent	C
MT	C
bundling	C
and	C
the	C
outward	C
sliding	C
of	C
antiparallel	C
MTs	C
,	C
thereby	C
contributing	C
to	C
several	C
processes	C
that	C
all	C
appear	C
insensitive	C
to	C
cortical	C
disruption	C
.	C

KLP61F	O
activity	O
contributes	O
to	O
the	O
poleward	O
flux	O
of	O
both	O
ipMTs	O
and	O
kinetochore	O
MTs	O
and	O
to	O
the	O
length	O
of	O
the	O
metaphase	O
spindle	O
.	O

KLP61F	O
activity	O
maintains	O
the	O
prometaphase	O
spindle	O
by	O
antagonizing	O
Ncd	O
and	O
another	O
unknown	O
force-generator	O
and	O
drives	O
anaphase	O
B	O
,	O
although	O
the	O
rate	O
of	O
spindle	O
elongation	O
is	O
relatively	O
insensitive	O
to	O
the	O
motor	O
's	O
concentration	O
.	O

Finally	O
,	O
KLP61F	O
activity	O
contributes	O
to	O
normal	O
chromosome	O
congression	O
,	O
kinetochore	O
spacing	O
,	O
and	O
anaphase	O
A	O
rates	O
.	O

Thus	O
,	O
a	O
KLP61F-driven	O
sliding	O
filament	O
mechanism	O
contributes	O
to	O
multiple	O
aspects	O
of	O
mitosis	O
in	O
this	O
system	O
.	O

INTRODUCTION	O

Mitosis	O
,	O
the	O
process	O
by	O
which	O
identical	O
copies	O
of	O
the	O
replicated	O
genome	O
are	O
distributed	O
to	O
the	O
products	O
of	O
each	O
cell	O
division	O
,	O
involves	O
a	O
highly	O
dynamic	O
sequence	O
of	O
coordinated	O
motility	O
events	O
,	O
mediated	O
by	O
a	O
bipolar	O
protein	O
machine	O
,	O
the	O
mitotic	O
spindle	O
(	O
Karsenti	O
and	O
Vernos	O
,	O
2001	O
;	O
Mitchison	O
and	O
Salmon	O
,	O
2001	O
;	O
Gadde	O
and	O
Heald	O
,	O
2004	O
;	O
Wadsworth	O
and	O
Khodjakov	O
,	O
2004	O
;	O
Mogilner	O
et	O
al.	O
,	O
2006	O
;	O
Brust-Mascher	O
and	O
Scholey	O
,	O
2007	O
;	O
Walczak	O
and	O
Heald	O
,	O
2008	O
)	O
.	O

These	O
motility	O
events	O
are	O
driven	O
by	O
molecular-scale	O
forces	O
generated	O
by	O
mitotic	O
kinesins	O
and	O
dyneins	O
,	O
together	O
with	O
dynamic	O
microtubules	O
(	O
MTs	O
)	O
,	O
whose	O
activities	O
are	O
controlled	O
by	O
a	O
network	O
of	O
regulatory	O
proteins	O
,	O
e.g.	O
,	O
mitotic	O
kinases	O
,	O
phosphatases	O
,	O
and	O
proteolytic	O
enzymes	O
(	O
Sharp	O
et	O
al.	O
,	O
2000c	O
;	O
Bettencourt-Dias	O
et	O
al.	O
,	O
2004	O
;	O
Maiato	O
and	O
Sunkel	O
,	O
2004	O
;	O
Rogers	O
et	O
al.	O
,	O
2005	O
;	O
Goshima	O
et	O
al.	O
,	O
2007	O
)	O
.	O

Among	C
these	C
mitotic	C
proteins	C
,	C
the	C
kinesin-5	C
motor	C
is	C
thought	C
to	C
play	C
a	C
key	C
role	C
(	C
Cottingham	C
et	C
al.	C
,	C
1999	C
;	C
Valentine	C
et	C
al.	C
,	C
2006a	C
;	C
Civelekoglu-Scholey	C
and	C
Scholey	C
,	C
2007	C
)	C
.	C

Purified	O
kinesin-5	O
is	O
a	O
slow	O
,	O
modestly	O
processive	O
,	O
plus-end–directed	O
bipolar	O
homotetramer	O
capable	O
of	O
cross-linking	O
adjacent	O
MTs	O
and	O
sliding	O
apart	O
antiparallel	O
MTs	O
in	O
motility	O
assays	O
(	O
Sawin	O
et	O
al.	O
,	O
1992	O
;	O
Cole	O
et	O
al.	O
,	O
1994	O
;	O
Kashina	O
et	O
al.	O
,	O
1996a	O
;	O
Kapitein	O
et	O
al.	O
,	O
2005	O
;	O
Tao	O
et	O
al.	O
,	O
2006	O
;	O
Valentine	O
et	O
al.	O
,	O
2006b	O
;	O
Krzysiak	O
et	O
al.	O
,	O
2008	O
;	O
Van	O
den	O
Wildenberg	O
et	O
al.	O
,	O
2008	O
)	O
.	O

In	C
yeast	C
cells	C
the	C
homotetrameric	C
structure	C
of	C
kinesin-5	C
appears	C
to	C
be	C
essential	C
for	C
mitosis	C
(	C
Hildebrandt	C
et	C
al.	C
,	C
2006	C
)	C
,	C
and	C
in	C
Drosophila	C
embryos	C
KLP61F	C
displays	C
dynamic	C
properties	C
consistent	C
with	C
an	C
association	C
with	C
spindle	C
MTs	C
(	C
Cheerambathur	C
et	C
al.	C
,	C
2008	C
)	C
and	C
forms	C
presumptive	C
MT–MT	C
cross-bridges	C
(	C
Sharp	C
et	C
al.	C
,	C
1999a	C
)	C
.	C

These	C
results	C
suggest	C
that	C
ensembles	C
of	C
multiple	C
kinesin-5	C
motors	C
could	C
serve	C
as	C
dynamic	C
cross-links	C
that	C
organize	C
spindle	C
MTs	C
into	C
bundles	C
and	C
drive	C
a	C
sliding	C
filament	C
mechanism	C
that	C
pushes	C
apart	C
antiparallel	C
spindle	C
MTs	C
(	C
Sharp	C
et	C
al.	C
,	C
1999a	C
;	C
Brust-Mascher	C
et	C
al.	C
,	C
2004	C
)	C
,	C
although	C
alternative	C
mechanisms	C
of	C
action	C
for	C
kinesin-5	C
motors	C
have	C
also	C
been	C
proposed	C
(	C
Kapoor	C
and	C
Mitchison	C
,	C
2001	C
;	C
Tsai	C
et	C
al.	C
,	C
2006	C
;	C
Johansen	C
and	C
Johansen	C
,	C
2007	C
;	C
Gardner	C
et	C
al.	C
,	C
2008	C
)	C
.	C

The	O
most	O
obvious	O
and	O
frequently	O
observed	O
consequence	O
of	O
loss	O
of	O
activity	O
of	O
kinesin-5	O
motors	O
,	O
induced	O
by	O
loss-of-function	O
mutation	O
,	O
antibody	O
inhibition	O
,	O
small	O
molecule	O
inhibition	O
,	O
or	O
RNA	O
interference	O
,	O
is	O
the	O
formation	O
of	O
abnormal	O
monoastral	O
spindles	O
(	O
Enos	O
and	O
Morris	O
,	O
1990	O
;	O
Saunders	O
and	O
Hoyt	O
,	O
1992	O
;	O
Sawin	O
et	O
al.	O
,	O
1992	O
;	O
Heck	O
et	O
al.	O
,	O
1993	O
;	O
Saunders	O
et	O
al.	O
,	O
1997	O
;	O
Cottingham	O
et	O
al.	O
,	O
1999	O
;	O
Mayer	O
et	O
al.	O
,	O
1999	O
;	O
Sharp	O
et	O
al.	O
,	O
1999b	O
;	O
Sharp	O
et	O
al.	O
,	O
2000a	O
;	O
Goshima	O
and	O
Vale	O
,	O
2003	O
)	O
.	O

This	C
suggests	C
that	C
kinesin-5	C
may	C
normally	C
contribute	C
to	C
spindle	C
bipolarity	C
by	C
sliding	C
apart	C
interpolar	C
(	C
ip	C
)	C
MTs	C
to	C
drive	C
spindle	C
pole	C
separation	C
during	C
mitotic	C
spindle	C
assembly	C
,	C
elongation	C
and	C
function	C
.	C

(	O
Saunders	O
and	O
Hoyt	O
,	O
1992	O
;	O
Sawin	O
et	O
al.	O
,	O
1992	O
;	O
Heck	O
et	O
al.	O
,	O
1993	O
;	O
Saunders	O
et	O
al.	O
,	O
1997	O
;	O
Straight	O
et	O
al.	O
,	O
1998	O
;	O
Walczak	O
et	O
al.	O
,	O
1998	O
;	O
Sharp	O
et	O
al.	O
,	O
2000a	O
;	O
Brust-Mascher	O
and	O
Scholey	O
,	O
2002	O
;	O
Brust-Mascher	O
et	O
al.	O
,	O
2004	O
;	O
Cheerambathur	O
et	O
al.	O
,	O
2007	O
)	O
.	O

It	O
is	O
clear	O
that	O
this	O
activity	O
is	O
deployed	O
differently	O
in	O
different	O
systems	O
,	O
however	O
.	O

For	O
example	O
,	O
kinesin-5	O
activity	O
is	O
required	O
for	O
initial	O
spindle	O
assembly	O
in	O
yeast	O
but	O
not	O
in	O
Drosophila	O
embryos	O
,	O
whereas	O
it	O
is	O
required	O
for	O
spindle	O
maintenance	O
in	O
both	O
systems	O
(	O
Saunders	O
and	O
Hoyt	O
,	O
1992	O
;	O
Sharp	O
et	O
al.	O
,	O
1999b	O
)	O
.	O

Inhibition	O
of	O
kinesin-5	O
in	O
different	O
systems	O
has	O
also	O
resulted	O
in	O
defects	O
in	O
poleward	O
flux	O
(	O
Miyamoto	O
et	O
al.	O
,	O
2004	O
;	O
Cameron	O
et	O
al.	O
,	O
2006	O
)	O
and	O
spindle	O
pole	O
organization	O
(	O
Gaglio	O
et	O
al.	O
,	O
1996	O
)	O
.	O

However	O
,	O
in	O
Drosophila	O
S2	O
cells	O
,	O
perturbation	O
of	O
kinesin-5	O
levels	O
did	O
not	O
interfere	O
with	O
metaphase	O
spindle	O
length	O
(	O
Goshima	O
et	O
al.	O
,	O
2005b	O
)	O
.	O

In	O
Caenorhabditis	O
elegans	O
,	O
kinesin-5	O
was	O
also	O
found	O
to	O
exert	O
a	O
braking	O
effect	O
on	O
the	O
spindle	O
midzone	O
that	O
governs	O
the	O
rate	O
of	O
spindle	O
elongation	O
mediated	O
by	O
cortical	O
motors	O
(	O
Saunders	O
et	O
al.	O
,	O
2007	O
)	O
.	O

It	C
is	C
unclear	C
if	C
these	C
findings	C
are	C
relevant	C
to	C
all	C
spindles	C
and	C
if	C
they	C
all	C
reflect	C
the	C
antiparallel	C
MT	C
sliding	C
activity	C
of	C
kinesin-5	C
,	C
or	C
if	C
kinesin-5	C
functions	C
differently	C
in	C
different	C
systems	C
as	C
implied	C
by	C
the	C
proposal	C
that	C
kinesin-5	C
functions	C
as	C
a	C
MT	C
depolymerase	C
rather	C
than	C
a	C
sliding	C
motor	C
to	C
control	C
chromosome	C
congression	C
in	C
Saccharomyces	C
cerevisiae	C
(	C
Gardner	C
et	C
al.	C
,	C
2008	C
)	C
.	C

To	O
distinguish	O
these	O
possibilities	O
,	O
therefore	O
,	O
systematic	O
studies	O
of	O
kinesin-5	O
function	O
throughout	O
mitosis	O
are	O
needed	O
,	O
but	O
this	O
is	O
difficult	O
because	O
the	O
most	O
frequently	O
observed	O
effect	O
of	O
perturbing	O
kinesin-5	O
function	O
,	O
spindle	O
collapse	O
,	O
obscures	O
later	O
effects	O
in	O
mitosis	O
.	O

In	O
Drosophila	O
embryos	O
,	O
where	O
the	O
centrosomes	O
dictate	O
the	O
assembly	O
of	O
remarkably	O
dynamic	O
,	O
fast-acting	O
spindles	O
(	O
Megraw	O
et	O
al.	O
,	O
2001	O
;	O
Cheerambathur	O
et	O
al.	O
,	O
2007	O
)	O
,	O
inhibiting	O
the	O
function	O
of	O
the	O
kinesin-5	O
,	O
KLP61F	O
produced	O
collapsed	O
monoastral	O
spindles	O
at	O
a	O
specific	O
stage	O
during	O
prometaphase	O
,	O
and	O
this	O
was	O
rescued	O
by	O
loss	O
of	O
function	O
of	O
the	O
kinesin-14	O
,	O
Ncd	O
(	O
Sharp	O
et	O
al.	O
,	O
1999b	O
,	O
2000a	O
)	O
.	O

Biochemical	C
evidence	C
supports	C
the	C
idea	C
that	C
the	C
prometaphase	C
spindle	C
is	C
maintained	C
by	C
a	C
KLP61F-Ncd	C
force	C
balance	C
(	C
Tao	C
et	C
al.	C
,	C
2006	C
)	C
,	C
but	C
it	C
is	C
unclear	C
if	C
the	C
monoastral	C
spindles	C
form	C
by	C
the	C
drawing	C
together	C
of	C
focused	C
poles	C
due	C
to	C
Ncd-induced	C
inward	C
MT	C
sliding	C
or	C
by	C
the	C
disorganization	C
of	C
spindle	C
MTs	C
combined	C
with	C
the	C
fusion	C
of	C
microtubule	C
organizing	C
centers	C
(	C
Goshima	C
and	C
Vale	C
,	C
2003	C
)	C
.	C

We	C
previously	C
proposed	C
that	C
the	C
KLP61F-driven	C
outward	C
sliding	C
of	C
ipMTs	C
drives	C
pre-anaphase	C
B	C
poleward	C
flux	C
and	C
anaphase	C
B	C
spindle	C
elongation	C
(	C
Brust-Mascher	C
and	C
Scholey	C
,	C
2002	C
;	C
Brust-Mascher	C
et	C
al.	C
,	C
2004	C
)	C
.	C

However	C
,	C
reductionist	C
modeling	C
(	C
Brust-Mascher	C
et	C
al.	C
,	C
2004	C
)	C
and	C
system	C
level	C
modeling	C
(	C
Wollman	C
et	C
al.	C
,	C
2008	C
)	C
surprisingly	C
predicted	C
that	C
the	C
rate	C
of	C
anaphase	C
B	C
pole–pole	C
separation	C
is	C
insensitive	C
to	C
the	C
KLP61F	C
concentration	C
and	C
is	C
controlled	C
instead	C
by	C
the	C
unloaded	C
KLP61F	C
MT	C
sliding	C
velocity	C
together	C
with	C
a	C
pole-associated	C
MT	C
depolymerase	C
.	C

Although	O
experimental	O
evidence	O
supports	O
a	O
requirement	O
for	O
KLP61F	O
activity	O
in	O
anaphase	O
B	O
(	O
Sharp	O
et	O
al.	O
,	O
2000a	O
)	O
,	O
we	O
had	O
not	O
tested	O
the	O
effect	O
of	O
changing	O
its	O
concentration	O
on	O
the	O
rate	O
of	O
anaphase	O
B	O
or	O
its	O
contribution	O
to	O
poleward	O
flux	O
and	O
metaphase	O
spindle	O
length	O
.	O

Furthermore	C
,	C
it	C
is	C
unclear	C
if	C
some	C
of	C
these	C
activities	C
also	C
require	C
the	C
activity	C
of	C
the	C
overlying	C
cortex	C
,	C
e.g.	C
,	C
via	C
cortical	C
motors	C
pulling	C
astral	C
MTs	C
outward	C
.	C

In	O
the	O
current	O
study	O
we	O
addressed	O
some	O
of	O
these	O
uncertainties	O
by	O
undertaking	O
a	O
systematic	O
investigation	O
of	O
the	O
spectrum	O
of	O
mitotic	O
functions	O
of	O
kinesin-5	O
,	O
through	O
antibody-induced	O
dissociation	O
of	O
KLP61F	O
from	O
Drosophila	O
syncytial	O
blastoderm-stage	O
embryo	O
spindles	O
,	O
using	O
an	O
experimental	O
system	O
where	O
the	O
extent	O
of	O
dissociation	O
can	O
be	O
directly	O
observed	O
.	O

This	O
was	O
complemented	O
by	O
studies	O
of	O
the	O
effects	O
of	O
varying	O
the	O
KLP61F	O
gene	O
dosage	O
in	O
embryos	O
and	O
by	O
the	O
investigation	O
of	O
mutant	O
spindles	O
after	O
depletion	O
of	O
the	O
maternal	O
load	O
of	O
KLP61F	O
.	O

We	C
find	C
that	C
kinesin-5	C
contributes	C
to	C
various	C
aspects	C
of	C
mitosis	C
in	C
this	C
system	C
,	C
some	C
of	C
which	C
are	C
novel	C
and	C
perhaps	C
unexpected	C
.	C

MATERIALS	O
AND	O
METHODS	O

Drosophila	O
Stocks	O

Flies	O
were	O
maintained	O
and	O
embryos	O
were	O
collected	O
as	O
described	O
(	O
Sharp	O
et	O
al.	O
,	O
1999	O
)	O
.	O

Experiments	O
were	O
performed	O
on	O
embryos	O
expressing	O
green	O
fluorescent	O
protein	O
(	O
GFP	O
)	O
:	O
:tubulin	O
or	O
GFP	O
:	O
:CNN	O
(	O
provided	O
by	O
Dr.	O
Thomas	O
Kaufman	O
,	O
Indiana	O
University	O
Bloomington	O
)	O
or	O
GFP	O
:	O
:CID	O
,	O
the	O
Drosophila	O
CENPA	O
homolog	O
(	O
Henikoff	O
et	O
al.	O
,	O
2000	O
)	O
,	O
which	O
is	O
a	O
stable	O
and	O
specific	O
kinetochore	O
marker	O
(	O
provided	O
by	O
Dr.	O
Steven	O
Henikoff	O
,	O
Fred	O
Hutchinson	O
Cancer	O
Research	O
)	O
,	O
or	O
KLP61F	O
:	O
:GFP	O
(	O
Cheerambathur	O
et	O
al.	O
,	O
2008	O
)	O
,	O
as	O
well	O
as	O
on	O
Claret	O
nondisjunctional	O
(	O
cand	O
)	O
and	O
klp61f	O
mutant	O
embryos	O
.	O

Generation	O
of	O
klp61f	O
Mutant	O
Fly	O
Lines	O
Expressing	O
GFP-Tubulin	O

Standard	O
genetic	O
techniques	O
were	O
used	O
to	O
generate	O
flies	O
with	O
GFP	O
:	O
:tubulin	O
on	O
the	O
second	O
chromosome	O
and	O
these	O
were	O
then	O
crossed	O
into	O
different	O
alleles	O
of	O
klp61f	O
mutants	O
for	O
genetic	O
analyses	O
.	O

Briefly	C
,	C
we	C
first	C
crossed	C
y	C
[	C
1	C
]	C
w	C
[	C
*	C
]	C
;	C
P	C
{	C
w	C
[	C
+mC	C
]	C
=	C
UASp-GFPS65C-alphaTub84B	C
{	C
14-6-II/P	C
{	C
w	C
[	C
+mC	C
]	C
=	C
UASp-GFPS65C-alphaTub84B	C
{	C
14-6-II	C
with	C
yw	C
;	C
P	C
{	C
Act5C-Gal4	C
{	C
/CyO	C
,	C
y+	C
or	C
w*	C
;	C
P	C
{	C
w	C
[	C
+mC	C
]	C
=	C
matalpha4-GAL-VP16	C
{	C
V2H	C
.	C

We	C
selected	C
P	C
{	C
w	C
[	C
+mC	C
]	C
=	C
UASp-GFPS65C-alphaTub84B	C
{	C
14-6-II/P	C
{	C
Act5C-Gal4	C
{	C
or	C
P	C
{	C
w	C
[	C
+mC	C
]	C
=	C
UASp-GFPS65C-alphaTub84B	C
{	C
14-6-II/P	C
{	C
w	C
[	C
+mC	C
]	C
=	C
matalpha4-GAL-VP16	C
{	C
V2H	C
females	C
and	C
crossed	C
them	C
with	C
w	C
;	C
ln	C
(	C
2LR	C
)	C
Gla	C
,	C
wgGla-1Bc1/CyO	C
males	C
.	C

We	O
selected	O
progeny	O
in	O
which	O
recombination	O
between	O
the	O
UAS-GFP-tubulin	O
and	O
the	O
Gal4	O
driver	O
had	O
occurred	O
by	O
picking	O
fluorescent	O
larvae	O
and	O
used	O
individual	O
flies	O
to	O
make	O
balanced	O
stocks	O
.	O

All	O
stocks	O
were	O
from	O
the	O
Bloomington	O
Stock	O
Center	O
.	O

To	O
cross	O
these	O
balanced	O
lines	O
expressing	O
GFP-tubulin	O
under	O
the	O
Gal	O
4	O
driver	O
with	O
klp61f	O
mutants	O
(	O
provided	O
by	O
Margarete	O
Heck	O
,	O
University	O
of	O
Edinburgh	O
;	O
Andrea	O
Pereira	O
,	O
University	O
of	O
Massachusetts	O
;	O
and	O
Patricia	O
Wilson	O
,	O
Georgia	O
State	O
University	O
)	O
,	O
we	O
first	O
crossed	O
both	O
lines	O
with	O
w	O
;	O
Sp/CyORoi	O
;	O
Ly/TM3Sbe	O
flies	O
(	O
provided	O
by	O
Dr	O
Jeanette	O
Naetzle	O
,	O
University	O
of	O
California	O
Davis	O
)	O
,	O
in	O
which	O
we	O
had	O
replaced	O
the	O
TM3	O
balancer	O
with	O
KrGFPTM3	O
or	O
TM6	O
to	O
distinguish	O
homozygous	O
from	O
heterozygous	O
embryos	O
or	O
larvae	O
,	O
respectively	O
.	O

The	O
klp61f	O
alleles	O
used	O
(	O
7012	O
and	O
7415	O
)	O
are	O
null	O
or	O
severe	O
hypomorphic	O
,	O
late	O
larval	O
lethals	O
,	O
obtained	O
by	O
P-element	O
insertion	O
in	O
the	O
untranslated	O
region	O
of	O
KLP61F	O
(	O
Heck	O
et	O
al.	O
,	O
1993	O
)	O
.	O

Antibody	O
Generation	O

KLP61F	C
antibody	C
was	C
generated	C
against	C
amino	C
acids	C
900-1066	C
,	C
which	C
includes	C
the	C
BimC	C
box	C
containing	C
a	C
mutation	C
in	C
which	C
the	C
putative	C
phosphorylation	C
site	C
,	C
Threonine	C
933	C
,	C
was	C
mutated	C
to	C
aspartic	C
acid	C
.	C

To	O
generate	O
this	O
mutant	O
,	O
two	O
sets	O
of	O
primers	O
were	O
used	O
in	O
three	O
sequential	O
PCR	O
steps	O
:	O
two	O
anchor	O
primers	O
,	O
flanking	O
the	O
region	O
of	O
interest	O
and	O
containing	O
BamHI	O
and	O
EcoRI	O
restriction	O
sites	O
,	O
and	O
two	O
mutagenic	O
primers	O
containing	O
the	O
T933D	O
mutation	O
.	O

To	O
produce	O
KLP61F	O
antibody	O
,	O
PCR-amplified	O
KLP61F	O
(	O
nt	O
2698-3201	O
)	O
containing	O
the	O
T933D	O
mutation	O
was	O
subcloned	O
into	O
pGEX-JDK	O
and	O
the	O
expressed	O
protein	O
was	O
purified	O
using	O
glutathione-agarose	O
affinity	O
chromatography	O
.	O

Two	O
rabbit	O
polyclonal	O
antibodies	O
were	O
generated	O
using	O
standard	O
procedures	O
and	O
affinity-purified	O
on	O
GST-KLP61F	O
columns	O
.	O

The	O
antibody	O
was	O
acid	O
eluted	O
,	O
neutralized	O
in	O
Tris	O
buffer	O
,	O
dialyzed	O
into	O
PBS	O
buffer	O
,	O
and	O
concentrated	O
.	O

For	O
embryo	O
injection	O
,	O
the	O
concentration	O
in	O
the	O
needle	O
was	O
7–15	O
mg/ml	O
.	O

Time-Lapse	O
and	O
Fluorescent	O
Speckle	O
Microscopy	O
of	O
Embryos	O

Embryos	O
were	O
injected	O
with	O
rhodamine	O
labeled	O
tubulin	O
(	O
Cytoskeleton	O
,	O
Denver	O
,	O
CO	O
)	O
.	O

Time-lapse	O
images	O
were	O
acquired	O
with	O
an	O
Olympus	O
(	O
Melville	O
,	O
NY	O
)	O
microscope	O
equipped	O
with	O
an	O
Ultra-View	O
spinning	O
disk	O
confocal	O
head	O
(	O
Perkin	O
Elmer-Cetus	O
,	O
Boston	O
,	O
MA	O
)	O
and	O
a	O
100×	O
1.35	O
NA	O
objective	O
at	O
time	O
intervals	O
of	O
1–3	O
s	O
.	O

Images	O
were	O
analyzed	O
with	O
Metamorph	O
Imaging	O
software	O
(	O
Universal	O
Imaging	O
,	O
West	O
Chester	O
,	O
PA	O
)	O
.	O

No	O
neighbors	O
deconvolution	O
or	O
sharpen	O
high	O
filters	O
followed	O
by	O
a	O
low-pass	O
filter	O
were	O
applied	O
to	O
all	O
images	O
.	O

Pole-to-pole	O
distance	O
as	O
a	O
function	O
of	O
time	O
was	O
measured	O
from	O
the	O
position	O
of	O
the	O
poles	O
in	O
each	O
image	O
.	O

Kymography	O
was	O
used	O
to	O
quantify	O
speckle	O
movement	O
.	O

Calculations	O
and	O
statistical	O
analyses	O
were	O
done	O
on	O
Microsoft	O
Excel	O
(	O
Redmond	O
,	O
WA	O
)	O
.	O

To	O
quantify	O
the	O
amount	O
of	O
motor	O
on	O
the	O
spindle	O
we	O
measured	O
the	O
intensity	O
of	O
GFP	O
and	O
that	O
of	O
rhodamine	O
on	O
the	O
spindle	O
and	O
subtracted	O
background	O
intensity	O
and	O
ratioed	O
these	O
two	O
values	O
.	O

This	O
allowed	O
us	O
to	O
compare	O
the	O
amount	O
of	O
motor	O
remaining	O
on	O
spindles	O
within	O
single	O
embryos	O
,	O
but	O
we	O
can	O
not	O
control	O
the	O
amount	O
of	O
injected	O
rhodamine	O
tubulin	O
precisely	O
enough	O
to	O
permit	O
quantitative	O
comparisons	O
between	O
different	O
embryos	O
.	O

Time-Lapse	O
Analysis	O
of	O
Mitosis	O
in	O
Late	O
Embryos	O
and	O
Larval	O
Brains	O

Embryos	O
were	O
collected	O
for	O
1	O
h	O
and	O
imaged	O
after	O
at	O
least	O
7	O
h	O
.	O

Brains	O
were	O
dissected	O
from	O
wild-type	O
larvae	O
expressing	O
G147-GFP	O
(	O
Bloomington	O
Stock	O
Center	O
)	O
or	O
GFP-tubulin	O
and	O
from	O
klp61f	O
mutant	O
second	O
and	O
third	O
instar	O
larvae	O
expressing	O
GFP-tubulin	O
in	O
D-22	O
(	O
pH	O
6.7	O
)	O
insect	O
medium	O
(	O
U.S	O
.	O
Biological	O
,	O
Swampscott	O
,	O
MA	O
)	O
supplemented	O
with	O
7.5	O
%	O
fetal	O
bovine	O
serum	O
and	O
0.5	O
mM	O
ascorbic	O
acid	O
(	O
Sigma	O
,	O
St.	O
Louis	O
,	O
MO	O
)	O
.	O

The	O
explanted	O
brain	O
was	O
then	O
moved	O
carefully	O
in	O
a	O
drop	O
of	O
medium	O
onto	O
a	O
No	O
.	O
1	O
coverslip	O
placed	O
on	O
a	O
special	O
stainless	O
steel	O
slide	O
with	O
an	O
indentation	O
to	O
allow	O
observation	O
of	O
the	O
sample	O
.	O

The	O
brain	O
was	O
pushed	O
carefully	O
into	O
direct	O
contact	O
with	O
the	O
coverslip	O
,	O
and	O
an	O
additional	O
coverslip	O
was	O
placed	O
on	O
top	O
of	O
the	O
stainless	O
steel	O
slide	O
to	O
keep	O
the	O
medium	O
in	O
place	O
and	O
prevent	O
dehydration	O
of	O
the	O
sample	O
.	O

Late	O
embryos	O
and	O
brains	O
were	O
imaged	O
as	O
above	O
except	O
that	O
stacks	O
of	O
14–18	O
confocal	O
planes	O
spaced	O
0.5	O
µm	O
apart	O
were	O
taken	O
at	O
time	O
intervals	O
of	O
30	O
s	O
.	O

Images	O
were	O
analyzed	O
as	O
above	O
.	O

Online	O
Supplemental	O
Material	O

Supplemental	O
Video	O
1	O
shows	O
a	O
time-lapse	O
movie	O
of	O
an	O
embryo	O
expressing	O
KLP61F-GFP	O
and	O
injected	O
with	O
rhodamine	O
tubulin	O
and	O
anti-KLP61F	O
(	O
see	O
Figure	O
1	O
)	O
.	O

Supplemental	O
Video	O
2	O
shows	O
a	O
time-lapse	O
movie	O
of	O
an	O
embryo	O
injected	O
with	O
rhodamine	O
tubulin	O
and	O
anti-KLP61F	O
(	O
see	O
Figure	O
2	O
,	O
A	O
and	O
C	O
)	O
.	O

Supplemental	O
Video	O
3	O
shows	O
a	O
time-lapse	O
movie	O
of	O
an	O
embryo	O
expressing	O
GFP-CNN	O
and	O
injected	O
with	O
rhodamine	O
tubulin	O
and	O
anti-KLP61F	O
(	O
see	O
Figure	O
2	O
,	O
E–G	O
)	O
.	O

(	O
A	O
)	O
Microinjection	O
of	O
an	O
anti-KLP61F	O
antibody	O
(	O
designed	O
to	O
dissociate	O
KLP61F	O
from	O
spindles	O
)	O
results	O
in	O
a	O
gradient	O
of	O
antibody	O
concentration	O
and	O
produces	O
a	O
gradient	O
in	O
the	O
KLP61F	O
content	O
of	O
different	O
spindles	O
.	O

Images	O
from	O
time-lapse	O
movie	O
of	O
an	O
embryo	O
expressing	O
KLP61F-GFP	O
and	O
injected	O
with	O
rhodamine	O
tubulin	O
and	O
anti-KLP61F	O
(	O
see	O
Supplemental	O
Video	O
1	O
)	O
.	O

Time	O
in	O
each	O
frame	O
is	O
given	O
in	O
seconds	O
from	O
NEB	O
.	O

Bar	O
,	O
10	O
µm	O
.	O

The	O
injection	O
site	O
was	O
close	O
to	O
the	O
top	O
of	O
the	O
embryo	O
(	O
arrow	O
)	O
,	O
KLP61F-GFP	O
forms	O
immunoprecipitates	O
,	O
and	O
most	O
KLP61F-GFP	O
is	O
depleted	O
from	O
the	O
spindles	O
.	O

These	O
spindles	O
collapse	O
,	O
as	O
seen	O
at	O
247	O
s	O
.	O

Toward	C
the	C
bottom	C
of	C
the	C
embryo	C
,	C
KLP61F-GFP	C
is	C
still	C
present	C
on	C
the	C
spindles	C
and	C
consequently	C
these	C
spindles	C
assemble	C
,	C
though	C
they	C
may	C
exhibit	C
defects	C
.	C

(	O
B	O
)	O
Graph	O
of	O
pole–pole	O
distance	O
as	O
a	O
function	O
of	O
time	O
(	O
left	O
)	O
and	O
quantification	O
of	O
KLP61F	O
remaining	O
on	O
these	O
spindles	O
(	O
right	O
)	O
.	O

The	O
normalized	O
ratio	O
of	O
KLP61F-GFP	O
to	O
rhodamine	O
tubulin	O
is	O
used	O
to	O
compare	O
the	O
amount	O
of	O
motor	O
remaining	O
on	O
each	O
spindle	O
at	O
different	O
time	O
points	O
.	O

Spindles	O
that	O
collapse	O
have	O
practically	O
no	O
motor	O
on	O
them	O
,	O
whereas	O
spindles	O
that	O
do	O
not	O
collapse	O
or	O
recover	O
from	O
partial	O
collapse	O
have	O
at	O
least	O
40	O
%	O
remaining	O
.	O

(	O
A	O
)	O
Two	O
time	O
points	O
from	O
a	O
wild-type	O
embryo	O
injected	O
with	O
anti-KLP61F	O
antibody	O
showing	O
a	O
gradient	O
of	O
defects	O
(	O
see	O
Supplemental	O
Video	O
2	O
)	O
.	O

Bar	O
,	O
10	O
µm	O
.	O

(	O
B	O
)	O
Two	O
time	O
points	O
from	O
an	O
Ncd	O
null	O
embryo	O
injected	O
with	O
anti-KLP61F	O
antibody	O
showing	O
more	O
disorganized	O
spindles	O
due	O
to	O
the	O
loss	O
of	O
two	O
motors	O
.	O

Bar	O
,	O
10	O
µm	O
.	O

(	O
C	O
)	O
Graph	O
of	O
pole–pole	O
distance	O
as	O
a	O
function	O
of	O
time	O
for	O
the	O
embryo	O
shown	O
in	O
A	O
.	O

Close	O
to	O
the	O
injection	O
site	O
spindles	O
collapse	O
(	O
see	O
s1	O
and	O
s3	O
)	O
,	O
and	O
other	O
spindles	O
shorten	O
but	O
remain	O
small	O
(	O
see	O
s2	O
)	O
.	O

Further	O
away	O
from	O
the	O
injection	O
site	O
,	O
spindles	O
do	O
not	O
elongate	O
during	O
prometaphase	O
(	O
s5	O
,	O
and	O
the	O
most	O
distal	O
spindles	O
exhibit	O
anaphase	O
elongation	O
(	O
s6	O
,	O
s7	O
,	O
and	O
s8	O
)	O
.	O

For	O
comparison	O
,	O
we	O
show	O
graphs	O
from	O
a	O
wild-type	O
embryo	O
(	O
purple	O
)	O
and	O
most	O
severe	O
effect	O
(	O
an	O
embryo	O
injected	O
with	O
enough	O
antibody	O
to	O
collapse	O
all	O
spindles	O
within	O
the	O
field	O
of	O
view	O
;	O
red	O
)	O
.	O

(	O
D	O
)	O
Spindle	O
length	O
as	O
a	O
function	O
of	O
time	O
for	O
the	O
Ncd	O
null	O
embryo	O
shown	O
in	O
B	O
.	O

For	O
comparison	O
graphs	O
of	O
wild-type	O
embryos	O
(	O
purple	O
)	O
,	O
Ncd	O
null	O
embryos	O
(	O
dark	O
blue	O
)	O
,	O
and	O
Ncd	O
null	O
embryos	O
injected	O
with	O
a	O
high	O
concentration	O
of	O
anti-KLP61F	O
(	O
red	O
)	O
are	O
shown	O
.	O

The	O
gradient	O
of	O
concentration	O
of	O
antibody	O
leads	O
to	O
a	O
gradient	O
of	O
spindle	O
pole	O
lengths	O
.	O

A	O
high	O
inhibition	O
of	O
KLP61F	O
leads	O
to	O
spindle	O
collapse	O
;	O
lower	O
concentrations	O
lead	O
to	O
less	O
severe	O
defects	O
.	O

At	O
a	O
certain	O
concentration	O
the	O
spindle	O
maintains	O
a	O
steady	O
length	O
(	O
light	O
purple	O
)	O
.	O

(	O
E	O
)	O
Anti-KLP61F	O
antibody	O
causes	O
spindle	O
collapse	O
at	O
prometaphase	O
without	O
apparent	O
disruption	O
of	O
centrosomes	O
or	O
spindle	O
poles	O
.	O

Images	O
from	O
time-lapse	O
movie	O
of	O
an	O
embryo	O
expressing	O
GFP-CNN	O
(	O
green	O
)	O
and	O
injected	O
with	O
rhodamine	O
tubulin	O
(	O
red	O
)	O
and	O
anti-KLP61F	O
(	O
see	O
Supplemental	O
Video	O
3	O
)	O
.	O

Time	O
in	O
each	O
frame	O
is	O
given	O
in	O
seconds	O
.	O

Bar	O
,	O
10	O
µm	O
.	O

Note	O
how	O
the	O
centrosomes	O
move	O
toward	O
each	O
other	O
,	O
but	O
do	O
not	O
appear	O
disorganized	O
.	O

(	O
F	O
)	O
Tubulin	O
fluorescence	O
in	O
the	O
central	O
spindle	O
increases	O
as	O
the	O
spindle	O
collapses	O
.	O

Normalized	O
spindle	O
length	O
(	O
filled	O
symbols	O
)	O
and	O
fluorescent	O
tubulin	O
intensity	O
at	O
the	O
equator	O
(	O
empty	O
symbols	O
)	O
as	O
a	O
function	O
of	O
time	O
for	O
wild-type	O
(	O
black	O
)	O
and	O
KLP61F	O
inhibited	O
spindles	O
(	O
red	O
)	O
.	O

After	C
KLP61F	C
inhibition	C
spindles	C
collapse	C
with	C
a	C
correlated	C
increase	C
in	C
tubulin	C
intensity	C
,	C
suggesting	C
that	C
MTs	C
are	C
sliding	C
inward	C
and	C
not	C
depolymerizing	C
.	C

The	C
increase	C
is	C
much	C
higher	C
than	C
that	C
observed	C
in	C
wild-type	C
spindles	C
,	C
indicating	C
that	C
it	C
is	C
not	C
due	C
to	C
a	C
normal	C
increase	C
in	C
tubulin	C
.	C

(	O
G	O
)	O
Linescans	O
of	O
fluorescent	O
tubulin	O
intensity	O
along	O
a	O
single	O
ipMT	O
bundle	O
at	O
different	O
time	O
points	O
during	O
the	O
collapse	O
.	O

The	O
intensity	O
increases	O
as	O
the	O
spindle	O
collapses	O
.	O

RESULTS	O

Injection	O
of	O
Anti-KLP61F	O
Antibody	O
into	O
the	O
Drosophila	O
Syncytial	O
Embryo	O
Causes	O
a	O
Gradient	O
of	O
Mitotic	O
Defects	O

We	O
raised	O
new	O
rabbit	O
affinity-purified	O
polyclonal	O
antibodies	O
to	O
the	O
C-terminal	O
tail	O
domain	O
of	O
KLP61F	O
.	O

Studies	C
using	C
transient	C
transfection	C
with	C
Eg5	C
mutants	C
in	C
cultured	C
Xenopus	C
cells	C
(	C
Sawin	C
and	C
Mitchison	C
,	C
1995	C
)	C
,	C
with	C
KLP61F	C
mutants	C
in	C
live	C
Drosophila	C
embryos	C
(	C
Cheerambathur	C
et	C
al.	C
,	C
2008	C
)	C
and	C
using	C
antibodies	C
raised	C
against	C
phospho-	C
and	C
unphospho-epitopes	C
in	C
Drosophila	C
embryos	C
(	C
Sharp	C
et	C
al.	C
,	C
1999a	C
)	C
suggest	C
that	C
the	C
cyclin-dependent	C
kinase-mediated	C
phosphorylation	C
of	C
a	C
conserved	C
Thr-933	C
residue	C
in	C
the	C
bimC	C
box	C
of	C
kinesin-5	C
is	C
critical	C
for	C
its	C
localization	C
to	C
the	C
spindle	C
.	C

We	O
reasoned	O
that	O
antibodies	O
to	O
the	O
phosphorylated	O
form	O
of	O
this	O
domain	O
would	O
competitively	O
inhibit	O
the	O
binding	O
of	O
native	O
phosphorylated	O
KLP61F	O
to	O
the	O
spindle	O
and	O
,	O
by	O
displacing	O
the	O
motor	O
from	O
its	O
site	O
of	O
action	O
,	O
would	O
inhibit	O
its	O
function	O
.	O

Accordingly	O
antibodies	O
were	O
raised	O
against	O
a	O
tail	O
domain	O
fragment	O
in	O
which	O
the	O
Thr-933	O
residue	O
was	O
changed	O
to	O
an	O
aspartate	O
phospho-mimic	O
by	O
site-directed	O
mutagenesis	O
(	O
Materials	O
and	O
Methods	O
)	O
.	O

These	O
antibodies	O
react	O
with	O
a	O
single	O
polypeptide	O
of	O
appropriate	O
molecular	O
weight	O
on	O
immunoblots	O
of	O
embryonic	O
extracts	O
and	O
have	O
been	O
shown	O
to	O
stain	O
mitotic	O
spindles	O
by	O
immunofluorescence	O
(	O
our	O
unpublished	O
results	O
and	O
Silverman-Gavrila	O
and	O
Wilde	O
,	O
2006	O
)	O
,	O
consistent	O
with	O
our	O
previous	O
results	O
(	O
Sharp	O
et	O
al.	O
,	O
1999a	O
;	O
Cheerambathur	O
et	O
al.	O
,	O
2008	O
)	O
.	O

As	O
reported	O
previously	O
,	O
the	O
microinjection	O
of	O
affinity-purified	O
antibody	O
into	O
the	O
syncytial	O
blastoderm	O
embryo	O
blocked	O
mitosis	O
and	O
produced	O
monoastral	O
arrays	O
of	O
microtubules	O
(	O
Sharp	O
et	O
al.	O
,	O
1999b	O
,	O
2000a	O
)	O
similar	O
to	O
those	O
seen	O
in	O
fixed	O
loss-of-function	O
klp61f	O
mutants	O
after	O
depletion	O
of	O
the	O
maternal	O
load	O
in	O
larvae	O
(	O
Heck	O
et	O
al.	O
,	O
1993	O
;	O
see	O
below	O
)	O
.	O

To	O
directly	O
visualize	O
the	O
extent	O
of	O
the	O
anti-KLP61F	O
induced	O
dissociation	O
of	O
KLP61F	O
from	O
mitotic	O
spindles	O
in	O
the	O
injected	O
embryos	O
,	O
we	O
coinjected	O
fluorescent	O
tubulin	O
and	O
anti-KLP61F	O
into	O
stable	O
transgenic	O
strains	O
of	O
Drosophila	O
that	O
express	O
functional	O
KLP61F-GFP	O
(	O
Cheerambathur	O
et	O
al.	O
,	O
2008	O
;	O
Figure	O
1	O
;	O
Supplemental	O
Video	O
1	O
)	O
.	O

The	O
antibody	O
rapidly	O
displaced	O
KLP61F	O
from	O
spindles	O
and	O
formed	O
visible	O
,	O
fluorescent	O
immunoprecipitates	O
in	O
the	O
adjacent	O
cytoplasm	O
(	O
Figure	O
1	O
,	O
arrow	O
)	O
.	O

Moreover	O
this	O
experiment	O
provided	O
clear	O
visual	O
evidence	O
of	O
the	O
formation	O
of	O
a	O
spatial	O
gradient	O
of	O
inhibition	O
of	O
the	O
target	O
antigen	O
throughout	O
the	O
syncytial	O
blastoderm	O
,	O
as	O
had	O
been	O
inferred	O
indirectly	O
from	O
the	O
effects	O
of	O
inhibitory	O
antibody	O
microinjection	O
in	O
previous	O
studies	O
(	O
Sharp	O
et	O
al.	O
,	O
2000b	O
;	O
Blower	O
and	O
Karpen	O
,	O
2001	O
;	O
Kwon	O
et	O
al.	O
,	O
2004	O
)	O
.	O

Proximal	O
to	O
the	O
antibody	O
microinjection	O
site	O
,	O
where	O
the	O
anti-KLP61F	O
concentration	O
is	O
highest	O
,	O
KLP61F	O
is	O
completely	O
dissociated	O
from	O
spindles	O
and	O
consequently	O
spindles	O
form	O
monoasters	O
.	O

The	O
injected	O
antibody	O
diffuses	O
through	O
the	O
cytoplasm	O
,	O
setting	O
up	O
a	O
concentration	O
gradient	O
,	O
highest	O
at	O
the	O
injection	O
site	O
and	O
decreasing	O
at	O
increasingly	O
distal	O
sites	O
.	O

Accordingly	O
,	O
moving	O
away	O
from	O
the	O
injection	O
site	O
,	O
the	O
extent	O
of	O
depletion	O
of	O
KLP61F	O
from	O
spindles	O
decreases	O
,	O
and	O
increasingly	O
higher	O
concentrations	O
of	O
fluorescent	O
motor	O
are	O
retained	O
on	O
spindles	O
(	O
Figure	O
1	O
)	O
.	O

Thus	O
at	O
distal	O
sites	O
,	O
spindles	O
do	O
not	O
form	O
monoasters	O
but	O
display	O
less	O
severe	O
defects	O
,	O
producing	O
a	O
range	O
of	O
“phenotypes”	O
analogous	O
to	O
an	O
allelic	O
series	O
of	O
genetic	O
mutants	O
(	O
Figure	O
1	O
)	O
.	O

We	O
quantified	O
the	O
amount	O
of	O
KLP61F	O
present	O
on	O
spindles	O
at	O
different	O
sites	O
within	O
this	O
gradient	O
by	O
measuring	O
the	O
fluorescence	O
intensity	O
ratio	O
of	O
KLP61F-GFP	O
to	O
injected	O
rhodamine	O
tubulin	O
,	O
which	O
allows	O
us	O
to	O
compare	O
spindles	O
within	O
a	O
single	O
embryo	O
,	O
but	O
not	O
between	O
multiple	O
embryos	O
,	O
due	O
to	O
small	O
variations	O
in	O
the	O
amount	O
of	O
injected	O
tubulin	O
.	O

As	O
shown	O
in	O
Figure	O
1B	O
,	O
the	O
severity	O
of	O
spindle	O
pole	O
separation	O
defects	O
correlates	O
reasonably	O
well	O
with	O
the	O
extent	O
of	O
depletion	O
of	O
KLP61F	O
from	O
the	O
spindle	O
,	O
so	O
that	O
spindles	O
containing	O
maximal	O
levels	O
of	O
KLP61F-GFP	O
(	O
arbitrarily	O
assigned	O
a	O
value	O
1.0	O
)	O
displayed	O
spindle	O
pole	O
separation	O
profiles	O
similar	O
to	O
uninjected	O
controls	O
,	O
spindles	O
containing	O
only	O
0–10	O
%	O
residual	O
KLP61F-GFP	O
collapsed	O
into	O
monoasters	O
,	O
and	O
those	O
containing	O
intermediate	O
levels	O
of	O
the	O
motor	O
(	O
50–70	O
%	O
)	O
displayed	O
spindle	O
length	O
defects	O
but	O
completed	O
mitosis	O
nonetheless	O
.	O

Spindle	O
Pole	O
Separation	O
Defects	O
Produced	O
by	O
Varying	O
Levels	O
of	O
KLP61F	O
Depletion	O
in	O
Wild-Type	O
Versus	O
Ncd	O
Null	O
Mutant	O
Embryos	O

In	O
previous	O
studies	O
,	O
we	O
reported	O
that	O
prometaphase	O
spindles	O
collapse	O
into	O
monoasters	O
after	O
KLP61F	O
inhibition	O
and	O
are	O
“rescued”	O
in	O
Ncd	O
null	O
mutants	O
,	O
but	O
the	O
behavior	O
of	O
spindles	O
containing	O
intermediate	O
levels	O
of	O
KLP61F	O
was	O
not	O
systematically	O
examined	O
.	O

Results	O
presented	O
in	O
the	O
previous	O
section	O
now	O
permit	O
us	O
to	O
do	O
so	O
.	O

In	O
wild-type	O
embryos	O
,	O
we	O
observed	O
that	O
,	O
at	O
increasing	O
distances	O
from	O
the	O
injection	O
site	O
,	O
the	O
extent	O
of	O
perturbation	O
of	O
spindle	O
length	O
,	O
as	O
characterized	O
by	O
changes	O
in	O
pole–pole	O
spacing	O
versus	O
time	O
,	O
decreases	O
in	O
parallel	O
with	O
the	O
decrease	O
in	O
extent	O
of	O
depletion	O
of	O
KLP61F	O
from	O
spindles	O
(	O
Figures	O
1B	O
and	O
2C	O
)	O
.	O

The	O
most	O
severe	O
effect	O
,	O
prometaphase	O
spindle	O
collapse	O
,	O
occurred	O
at	O
a	O
rate	O
of	O
0.06	O
µm/s	O
(	O
Figure	O
1B	O
,	O
spindles	O
s5	O
and	O
s6	O
)	O
,	O
although	O
some	O
spindles	O
close	O
by	O
retained	O
sufficient	O
levels	O
of	O
KLP61F	O
to	O
slow	O
down	O
the	O
rate	O
of	O
collapse	O
(	O
Figure	O
2C	O
,	O
spindles	O
s1–s4	O
)	O
.	O

Further	O
away	O
,	O
spindles	O
were	O
observed	O
to	O
shorten	O
somewhat	O
,	O
but	O
did	O
not	O
collapse	O
and	O
instead	O
maintained	O
a	O
short	O
prometaphase	O
length	O
,	O
and	O
then	O
elongated	O
at	O
anaphase	O
B	O
(	O
Figures	O
1B	O
,	O
s3	O
and	O
s4	O
,	O
and	O
2C	O
,	O
s5	O
)	O
.	O

Even	O
further	O
away	O
,	O
spindles	O
did	O
not	O
elongate	O
during	O
prometaphase	O
,	O
or	O
did	O
so	O
only	O
slightly	O
,	O
but	O
then	O
elongated	O
at	O
approximately	O
wild-type	O
rates	O
during	O
anaphase	O
B	O
sometimes	O
after	O
a	O
slight	O
delay	O
(	O
Figures	O
1B	O
,	O
s1	O
and	O
s2	O
,	O
and	O
2C	O
,	O
s6–s8	O
)	O
.	O

Thus	O
,	O
particularly	O
noteworthy	O
features	O
of	O
the	O
spindles	O
that	O
do	O
not	O
collapse	O
after	O
partial	O
loss	O
of	O
KLP61F	O
are	O
their	O
short	O
lengths	O
during	O
metaphase	O
and	O
anaphase	O
A	O
and	O
their	O
relatively	O
normal	O
rates	O
of	O
anaphase	O
B	O
spindle	O
elongation	O
.	O

The	C
latter	C
result	C
was	C
intriguing	C
because	C
we	C
had	C
previously	C
proposed	C
that	C
KLP61F-driven	C
ipMT	C
sliding	C
drives	C
anaphase	C
B	C
,	C
yet	C
in	C
studying	C
the	C
gradient	C
of	C
intermediate	C
phenotypes	C
(	C
Figures	C
1B	C
and	C
2C	C
)	C
,	C
we	C
did	C
not	C
observe	C
spindles	C
that	C
circumvented	C
the	C
prometaphase	C
collapse	C
but	C
then	C
failed	C
to	C
elongate	C
normally	C
during	C
subsequent	C
anaphase	C
B	C
.	C

This	C
is	C
,	C
in	C
fact	C
,	C
consistent	C
with	C
mathematical	C
modeling	C
predicting	C
that	C
the	C
rate	C
of	C
anaphase	C
spindle	C
elongation	C
is	C
independent	C
of	C
the	C
number	C
of	C
motors	C
,	C
at	C
least	C
above	C
a	C
low	C
threshold	C
number	C
(	C
Brust-Mascher	C
et	C
al.	C
,	C
2004	C
;	C
Wollman	C
et	C
al.	C
,	C
2008	C
)	C
.	C

We	C
hypothesized	C
that	C
spindles	C
containing	C
sufficient	C
KLP61F	C
motor	C
to	C
circumvent	C
collapse	C
and	C
progress	C
through	C
prometaphase	C
might	C
also	C
contain	C
enough	C
motor	C
to	C
elongate	C
the	C
spindle	C
at	C
normal	C
rates	C
during	C
anaphase	C
B	C
.	C

We	C
further	C
reasoned	C
that	C
,	C
because	C
Ncd	C
generates	C
an	C
inward	C
force	C
capable	C
of	C
antagonizing	C
KLP61F	C
(	C
Sharp	C
et	C
al.	C
,	C
2000a	C
;	C
Tao	C
et	C
al.	C
,	C
2006	C
)	C
,	C
in	C
the	C
absence	C
of	C
Ncd	C
function	C
,	C
we	C
might	C
improve	C
our	C
chances	C
of	C
encountering	C
spindles	C
with	C
sufficient	C
KLP61F	C
to	C
proceed	C
through	C
prometaphase	C
but	C
below	C
the	C
threshold	C
level	C
of	C
KLP61F	C
needed	C
to	C
drive	C
normal	C
rates	C
of	C
anaphase	C
B	C
.	C

In	C
such	C
spindles	C
,	C
a	C
decreased	C
rate	C
of	C
anaphase	C
B	C
spindle	C
elongation	C
should	C
be	C
observed	C
.	C

Accordingly	O
,	O
we	O
inhibited	O
KLP61F	O
in	O
Ncd	O
null	O
mutant	O
embryos	O
,	O
which	O
totally	O
lack	O
kinesin-14	O
function	O
,	O
in	O
order	O
to	O
circumvent	O
prometaphase	O
spindle	O
collapse	O
and	O
to	O
study	O
the	O
role	O
of	O
KLP61F	O
during	O
spindle	O
elongation	O
.	O

In	C
uninjected	C
mutants	C
,	C
pole–pole	C
separation	C
occurred	C
prematurely	C
from	C
prometaphase	C
onward	C
,	C
supporting	C
our	C
hypothesis	C
that	C
Ncd	C
serves	C
as	C
a	C
“brake”	C
that	C
exerts	C
an	C
inward	C
force	C
on	C
spindle	C
poles	C
,	C
antagonistic	C
to	C
KLP61F	C
(	C
Figure	C
2D	C
,	C
dark	C
blue	C
)	C
.	C

Pole–pole	C
separation	C
in	C
Ncd	C
null	C
embryos	C
occurs	C
shortly	C
after	C
nuclear	C
envelope	C
breakdown	C
(	C
NEB	C
)	C
,	C
earlier	C
than	C
in	C
wild-type	C
embryos	C
,	C
suggesting	C
that	C
normally	C
Ncd	C
's	C
braking	C
activity	C
is	C
turned	C
on	C
throughout	C
prometaphase	C
.	C

Anti-KLP61F	O
injection	O
into	O
Ncd	O
null	O
mutant	O
embryos	O
produced	O
a	O
gradient	O
of	O
defects	O
(	O
Figure	O
2D	O
)	O
,	O
where	O
the	O
most	O
severe	O
effect	O
was	O
spindle	O
collapse	O
.	O

This	O
was	O
not	O
observed	O
in	O
our	O
previous	O
studies	O
(	O
Sharp	O
et	O
al.	O
,	O
1999b	O
,	O
2000a	O
)	O
because	O
more	O
antibody	O
is	O
needed	O
to	O
collapse	O
the	O
spindle	O
in	O
an	O
Ncd	O
null	O
background	O
than	O
in	O
a	O
wild-type	O
background	O
.	O

This	C
result	C
suggests	C
that	C
,	C
when	C
KLP61F	C
and	C
Ncd	C
function	C
are	C
both	C
missing	C
,	C
another	C
inward	C
force-generator	C
must	C
drive	C
pole–pole	C
collapse	C
.	C

In	C
addition	C
,	C
spindles	C
lacking	C
the	C
function	C
of	C
both	C
motors	C
are	C
disorganized	C
(	C
Figure	C
2B	C
)	C
,	C
suggesting	C
that	C
these	C
motors	C
contribute	C
to	C
spindle	C
organization	C
by	C
cross-linking	C
MTs	C
throughout	C
the	C
spindle	C
,	C
in	C
agreement	C
with	C
their	C
localization	C
in	C
these	C
cells	C
.	C

Significantly	O
,	O
at	O
more	O
distal	O
sites	O
where	O
spindles	O
retain	O
partial	O
KLP61F	O
function	O
but	O
Ncd	O
function	O
is	O
missing	O
,	O
the	O
spindles	O
do	O
not	O
collapse	O
and	O
either	O
do	O
not	O
elongate	O
at	O
all	O
(	O
Figure	O
2D	O
,	O
s1	O
)	O
or	O
elongate	O
after	O
a	O
significant	O
delay	O
(	O
Figure	O
2D	O
,	O
s2–s6	O
)	O
.	O

This	C
failure	C
to	C
elongate	C
was	C
not	C
observed	C
in	C
anti-KLP61F–injected	C
wild-type	C
embryos	C
,	C
and	C
it	C
supports	C
the	C
hypothesis	C
that	C
KLP61F	C
is	C
necessary	C
for	C
anaphase	C
B	C
.	C

The	O
Collapse	O
Observed	O
after	O
Strong	O
Inhibition	O
of	O
KLP61F	O
Is	O
Due	O
to	O
the	O
Drawing	O
Together	O
of	O
Intact	O
,	O
Organized	O
Spindle	O
Poles	O
by	O
Inward	O
MT	O
Sliding	O

We	C
wanted	C
to	C
better	C
understand	C
if	C
the	C
spindle	C
length	C
defects	C
we	C
observe	C
after	C
loss	C
of	C
kinesin-5	C
function	C
reflect	C
defects	C
in	C
spindle	C
pole	C
separation	C
(	C
Saunders	C
et	C
al.	C
,	C
1997	C
;	C
Sharp	C
et	C
al.	C
,	C
2000a	C
)	C
or	C
in	C
spindle	C
pole	C
focusing	C
(	C
Gaglio	C
et	C
al.	C
,	C
1996	C
;	C
Goshima	C
and	C
Vale	C
,	C
2003	C
)	C
.	C

To	O
simultaneously	O
observe	O
the	O
behavior	O
of	O
MTs	O
and	O
spindle	O
poles	O
and	O
see	O
if	O
anti-KLP61F	O
has	O
any	O
detectable	O
effect	O
on	O
pole	O
organization	O
,	O
we	O
microinjected	O
anti-KLP61F	O
with	O
rhodamine-labeled	O
tubulin	O
into	O
embryos	O
expressing	O
GFP-centrosomin	O
(	O
CNN	O
)	O
,	O
an	O
integral	O
component	O
of	O
the	O
mitotic	O
centrosome	O
(	O
Megraw	O
et	O
al.	O
,	O
2002	O
;	O
Figure	O
2E	O
;	O
Supplemental	O
Video	O
3	O
)	O
.	O

During	O
collapse	O
,	O
intact	O
spindle	O
poles	O
steadily	O
moved	O
toward	O
one	O
another	O
at	O
a	O
rate	O
of	O
~0.06	O
µm/s	O
,	O
and	O
the	O
appearance	O
of	O
focused	O
,	O
radial	O
sets	O
of	O
fluorescent	O
MTs	O
projecting	O
from	O
discrete	O
centrosomes	O
persisted	O
throughout	O
the	O
collapse	O
(	O
Figure	O
2E	O
)	O
.	O

There	C
was	C
no	C
obvious	C
disorganization	C
of	C
the	C
spindle	C
poles	C
,	C
although	C
some	C
MT	C
bundles	C
appeared	C
to	C
“splay”	C
laterally	C
,	C
projecting	C
from	C
the	C
pole	C
into	C
the	C
adjacent	C
cytoplasm	C
.	C

Injection	O
of	O
a	O
high	O
concentration	O
of	O
antibody	O
caused	O
all	O
observed	O
spindles	O
to	O
collapse	O
,	O
and	O
this	O
was	O
accompanied	O
by	O
a	O
concomitant	O
increase	O
in	O
the	O
fluorescent	O
intensity	O
of	O
tubulin	O
in	O
the	O
central	O
spindle	O
(	O
Figure	O
2F	O
)	O
as	O
seen	O
in	O
linescans	O
along	O
the	O
pole–pole	O
axis	O
of	O
the	O
collapsing	O
spindles	O
(	O
Figure	O
2G	O
)	O
.	O

This	C
indicates	C
that	C
ipMT	C
bundles	C
become	C
thicker	C
during	C
the	C
collapse	C
,	C
consistent	C
with	C
spindle	C
shortening	C
being	C
due	C
to	C
an	C
inward	C
sliding	C
of	C
adjacent	C
,	C
antiparallel	C
ipMTs	C
,	C
although	C
serial	C
section	C
electron	C
microscopy	C
(	C
EM	C
)	C
done	C
at	C
time	C
intervals	C
during	C
the	C
collapse	C
,	C
which	C
is	C
probably	C
not	C
feasible	C
,	C
would	C
be	C
required	C
to	C
establish	C
this	C
.	C

Genetic	O
Evidence	O
for	O
a	O
Role	O
of	O
KLP61F	O
in	O
Driving	O
Spindle	O
Pole	O
Separation	O

Loss-of-function	O
mutants	O
provide	O
a	O
complementary	O
method	O
to	O
antibody	O
inhibition	O
for	O
probing	O
motor	O
protein	O
function	O
(	O
Scholey	O
,	O
1998	O
;	O
Figure	O
3	O
)	O
.	O

Homozygous	O
klp61f	O
mutants	O
undergo	O
mitosis	O
in	O
embryos	O
due	O
to	O
the	O
maternal	O
load	O
of	O
KLP61F	O
but	O
display	O
late	O
larval	O
lethality	O
due	O
to	O
mitotic	O
defects	O
that	O
arise	O
when	O
the	O
maternal	O
load	O
of	O
KLP61F	O
is	O
depleted	O
(	O
Heck	O
et	O
al.	O
,	O
1993	O
)	O
.	O

Fixed	O
larval	O
neuroblasts	O
were	O
previously	O
found	O
to	O
contain	O
abnormal	O
monoastral	O
spindles	O
,	O
consistent	O
with	O
our	O
antibody	O
inhibition	O
results	O
(	O
Heck	O
et	O
al.	O
,	O
1993	O
)	O
.	O

However	C
,	C
in	C
the	C
absence	C
of	C
real-time	C
studies	C
,	C
it	C
is	C
unclear	C
if	C
these	C
monoasters	C
arise	C
from	C
an	C
initial	C
failure	C
in	C
spindle	C
pole	C
separation	C
,	C
from	C
a	C
collapse	C
of	C
assembled	C
bipolar	C
spindles	C
,	C
or	C
from	C
the	C
fixation	C
of	C
transiently	C
collapsing	C
structures	C
.	C

To	O
study	O
this	O
problem	O
,	O
we	O
created	O
klp61f	O
mutant	O
flies	O
(	O
Heck	O
et	O
al.	O
,	O
1993	O
)	O
expressing	O
GFP-tubulin	O
using	O
laborious	O
genetic	O
crosses	O
(	O
Materials	O
and	O
Methods	O
)	O
.	O

(	O
A	O
)	O
Still	O
images	O
from	O
real-time	O
recordings	O
of	O
spindle	O
pole	O
separation	O
dynamics	O
in	O
klp61f7012	O
mutant	O
embryos	O
expressing	O
GFP-tubulin	O
.	O

Top	O
row	O
,	O
spindle	O
in	O
wild-type	O
embryo	O
.	O

Second	O
row	O
,	O
a	O
monoastral	O
spindle	O
that	O
becomes	O
bipolar	O
.	O

Third	O
row	O
,	O
a	O
spindle	O
that	O
collapses	O
to	O
form	O
a	O
permanent	O
monoaster	O
.	O

Arrows	O
mark	O
the	O
poles	O
.	O

Fourth	O
row	O
,	O
monoaster	O
that	O
does	O
not	O
change	O
during	O
observation	O
time	O
.	O

Bar	O
,	O
5	O
µm	O
.	O

(	O
B	O
)	O
Still	O
images	O
from	O
real-time	O
recordings	O
of	O
spindle	O
pole	O
separation	O
dynamics	O
in	O
wild-type	O
and	O
klp61f7415	O
mutants	O
expressing	O
GFP-tubulin	O
.	O

Top	O
row	O
,	O
a	O
wild-type	O
neuroblast	O
.	O

Second	O
row	O
,	O
a	O
mutant	O
neuroblast	O
with	O
separated	O
spindle	O
poles	O
that	O
transiently	O
collapse	O
,	O
then	O
recover	O
and	O
separate	O
fully	O
.	O

Third	O
row	O
,	O
a	O
mutant	O
larval	O
spindle	O
that	O
collapses	O
to	O
form	O
a	O
permanent	O
monoaster	O
.	O

Bar	O
,	O
5	O
µm	O
.	O

(	O
C	O
)	O
Differences	O
in	O
spindle	O
pole	O
separation	O
due	O
to	O
varying	O
KLP61F	O
gene	O
dosage	O
.	O

Left	O
,	O
embryos	O
from	O
heterozygous	O
mothers	O
have	O
a	O
shorter	O
metaphase	O
length	O
than	O
wild-type	O
embryos	O
.	O

Right	O
,	O
klp61f	O
mutant	O
embryos	O
rescued	O
with	O
two	O
copies	O
of	O
a	O
KLP61F-GFP	O
transgene	O
have	O
a	O
longer	O
metaphase	O
spindle	O
length	O
than	O
those	O
rescued	O
with	O
one	O
copy	O
.	O

In	O
one	O
allele	O
(	O
klp61f7012	O
)	O
,	O
larvae	O
have	O
smaller	O
brains	O
than	O
wild	O
types	O
and	O
spindles	O
are	O
rare	O
.	O

In	O
these	O
mutants	O
,	O
spindles	O
start	O
collapsing	O
in	O
mitotic	O
domains	O
of	O
the	O
late	O
embryo	O
(	O
Figure	O
3A	O
)	O
,	O
where	O
we	O
observed	O
that	O
some	O
spindles	O
collapse	O
into	O
stable	O
monoasters	O
that	O
fail	O
to	O
complete	O
mitosis	O
.	O

Other	C
monoasters	C
seem	C
to	C
form	C
monoastral	C
bipolar	C
spindles	C
,	C
which	C
may	C
assemble	C
via	C
a	C
chromosome-directed	C
pathway	C
in	C
which	C
KLP61F	C
activity	C
is	C
required	C
to	C
focus	C
the	C
anastral	C
spindle	C
pole	C
as	C
proposed	C
for	C
S2	C
cells	C
(	C
Goshima	C
and	C
Vale	C
,	C
2003	C
)	C
.	C

Such	O
monoastral	O
bipolar	O
spindles	O
were	O
not	O
observed	O
in	O
our	O
antibody	O
inhibition	O
experiments	O
in	O
syncytial	O
embryos	O
,	O
but	O
they	O
have	O
previously	O
been	O
observed	O
in	O
fixed	O
larval	O
brains	O
and	O
gonial	O
cells	O
of	O
klp61f	O
mutants	O
(	O
Wilson	O
et	O
al.	O
,	O
1997	O
)	O
.	O

These	C
observations	C
are	C
consistent	C
with	C
the	C
idea	C
that	C
KLP61F	C
is	C
required	C
for	C
the	C
separation	C
of	C
spindle	C
poles	C
in	C
the	C
rapid	C
,	C
centrosome-dominant	C
mitoses	C
of	C
the	C
syncytial	C
embryo	C
,	C
but	C
as	C
development	C
proceeds	C
,	C
mitosis	C
slows	C
down	C
(	C
see	C
below	C
)	C
and	C
centrosomes	C
become	C
less	C
dominant	C
,	C
so	C
that	C
KLP61F	C
plays	C
increasingly	C
important	C
roles	C
in	C
anastral	C
spindle	C
pole	C
focusing	C
.	C

In	O
a	O
different	O
allele	O
(	O
klp61f7415	O
)	O
,	O
homozygous	O
larvae	O
had	O
brains	O
of	O
normal	O
size	O
,	O
and	O
we	O
could	O
follow	O
the	O
progression	O
of	O
living	O
mutant	O
cells	O
through	O
mitosis	O
(	O
Figure	O
3B	O
)	O
.	O

We	O
observed	O
collapsing	O
spindles	O
with	O
similar	O
pole–pole	O
separation	O
defects	O
to	O
those	O
seen	O
in	O
anti-KLP61F–injected	O
embryos	O
.	O

In	O
wild-type	O
brains	O
we	O
never	O
observed	O
such	O
collapsing	O
or	O
shortening	O
spindles	O
.	O

Figure	O
3B	O
shows	O
the	O
dynamics	O
of	O
spindle	O
pole	O
separation	O
in	O
a	O
wild-type	O
neuroblast	O
spindle	O
(	O
Figure	O
3B	O
,	O
top	O
row	O
)	O
,	O
a	O
mutant	O
spindle	O
that	O
initially	O
separates	O
its	O
poles	O
then	O
collapses	O
into	O
a	O
stable	O
monoaster	O
(	O
Figure	O
3B	O
,	O
bottom	O
)	O
,	O
and	O
a	O
mutant	O
spindle	O
that	O
transiently	O
collapses	O
and	O
then	O
recovers	O
(	O
Figure	O
3B	O
,	O
center	O
)	O
.	O

Careful	O
3D	O
observations	O
and	O
measurements	O
confirm	O
that	O
we	O
were	O
indeed	O
visualizing	O
spindle	O
pole	O
separation	O
dynamics	O
and	O
not	O
simply	O
changes	O
in	O
the	O
orientation	O
of	O
the	O
spindle	O
.	O

The	O
results	O
are	O
consistent	O
with	O
a	O
complete	O
and	O
partial	O
depletion	O
of	O
the	O
maternal	O
load	O
of	O
KLP61F	O
giving	O
rise	O
to	O
permanent	O
and	O
transient	O
spindle	O
collapse	O
,	O
respectively	O
.	O

Because	C
the	C
mutants	C
examined	C
are	C
recessive	C
lethal	C
(	C
Heck	C
et	C
al.	C
,	C
1993	C
)	C
,	C
this	C
result	C
makes	C
it	C
extremely	C
unlikely	C
that	C
the	C
collapse	C
of	C
prometaphase	C
spindles	C
seen	C
after	C
severe	C
antibody	C
inhibition	C
is	C
due	C
to	C
dominant	C
effects	C
of	C
the	C
antibody	C
.	C

Interestingly	O
,	O
the	O
rate	O
of	O
spindle	O
pole	O
separation	O
in	O
late	O
embryos	O
and	O
neuroblasts	O
is	O
slower	O
than	O
in	O
syncytial	O
embryos	O
;	O
the	O
time	O
from	O
NEB	O
to	O
telophase	O
takes	O
10–15	O
min	O
in	O
late	O
embryos	O
and	O
~20	O
min	O
in	O
neuroblasts	O
compared	O
with	O
4–6	O
min	O
in	O
the	O
syncytial	O
embryo	O
.	O

However	C
,	C
whether	C
this	C
difference	C
in	C
time	C
reflects	C
differences	C
in	C
the	C
balance	C
of	C
forces	C
operating	C
in	C
the	C
spindles	C
of	C
different	C
cell	C
types	C
or	C
some	C
other	C
unknown	C
factors	C
is	C
unclear	C
.	C

Further	C
evidence	C
in	C
support	C
of	C
the	C
idea	C
that	C
KLP61F	C
exerts	C
outward	C
forces	C
on	C
spindle	C
poles	C
was	C
obtained	C
by	C
examining	C
embryos	C
carrying	C
varying	C
“doses”	C
of	C
the	C
KLP61F	C
gene	C
(	C
Figure	C
3C	C
)	C
.	C

For	C
example	C
,	C
during	C
prometaphase	C
wild	C
types	C
harboring	C
two	C
copies	C
of	C
the	C
KLP61F	C
gene	C
separated	C
their	C
spindle	C
poles	C
further	C
than	C
klp61f	C
mutant	C
heterozygotes	C
containing	C
a	C
single	C
copy	C
,	C
suggesting	C
that	C
the	C
predicted	C
increase	C
in	C
the	C
concentration	C
of	C
the	C
motor	C
increases	C
the	C
outward	C
force	C
that	C
pushes	C
apart	C
the	C
poles	C
(	C
Figure	C
3C	C
,	C
left	C
)	C
.	C

In	C
addition	C
,	C
the	C
viability	C
of	C
klp61f	C
mutants	C
could	C
be	C
rescued	C
with	C
one	C
or	C
two	C
copies	C
of	C
a	C
KLP61F-GFP	C
transgene	C
that	C
express	C
the	C
expected	C
amount	C
of	C
protein	C
based	C
on	C
immunoblotting	C
(	C
Cheerambathur	C
et	C
al.	C
,	C
2008	C
)	C
.	C

Measurement	O
of	O
pole–pole	O
distances	O
in	O
these	O
embryos	O
also	O
showed	O
that	O
two	O
copies	O
of	O
the	O
GFP	O
transgene	O
supported	O
faster	O
prometaphase	O
spindle	O
elongation	O
and	O
the	O
formation	O
of	O
longer	O
metaphase	O
spindles	O
than	O
did	O
a	O
single	O
copy	O
of	O
the	O
transgene	O
(	O
Figure	O
3C	O
,	O
right	O
)	O
,	O
again	O
consistent	O
with	O
the	O
gradient	O
observed	O
after	O
antibody	O
inhibition	O
.	O

KLP61F	O
Is	O
Required	O
for	O
Poleward	O
Flux	O
and	O
Normal	O
Metaphase	O
Spindle	O
Length	O

The	O
gradient	O
of	O
defects	O
elicited	O
by	O
antibody	O
inhibition	O
experiments	O
revealed	O
additional	O
roles	O
for	O
KLP61F	O
in	O
embryos	O
.	O

On	C
the	C
basis	C
of	C
comparisons	C
of	C
the	C
rates	C
of	C
poleward	C
flux	C
within	C
ipMT	C
bundles	C
and	C
the	C
rates	C
of	C
MT	C
sliding	C
induced	C
by	C
purified	C
KLP61F	C
,	C
as	C
well	C
as	C
the	C
observation	C
that	C
poleward	C
flux	C
stops	C
at	C
the	C
onset	C
of	C
anaphase	C
B	C
,	C
we	C
previously	C
proposed	C
that	C
KLP61F	C
drives	C
poleward	C
flux	C
in	C
Drosophila	C
embryos	C
,	C
but	C
this	C
had	C
not	C
been	C
tested	C
in	C
vivo	C
(	C
Cole	C
et	C
al.	C
,	C
1994	C
;	C
Brust-Mascher	C
and	C
Scholey	C
,	C
2002	C
;	C
Brust-Mascher	C
et	C
al.	C
,	C
2004	C
;	C
Tao	C
et	C
al.	C
,	C
2006	C
)	C
.	C

If	O
we	O
classify	O
the	O
gradient	O
induced	O
by	O
KLP61F	O
antibody	O
injection	O
by	O
analyzing	O
spindle	O
pole	O
length	O
,	O
we	O
find	O
as	O
stated	O
above	O
that	O
the	O
most	O
severe	O
effect	O
is	O
spindle	O
collapse	O
.	O

The	O
next	O
most	O
severe	O
effect	O
is	O
partial	O
spindle	O
shortening	O
followed	O
by	O
a	O
steady-state	O
length	O
that	O
is	O
smaller	O
than	O
the	O
pole	O
spacing	O
at	O
NEB	O
.	O

Other	O
spindles	O
maintained	O
the	O
characteristic	O
NEB	O
pole	O
spacing	O
until	O
anaphase	O
B	O
or	O
displayed	O
only	O
a	O
small	O
prometaphase	O
elongation	O
.	O

In	O
these	O
spindles	O
we	O
measured	O
the	O
steady-state	O
length	O
and	O
the	O
rate	O
of	O
poleward	O
flux	O
during	O
these	O
periods	O
of	O
steady	O
spindle	O
length	O
maintenance	O
(	O
i.e.	O
,	O
metaphase	O
and	O
anaphase	O
A	O
)	O
.	O

The	O
average	O
metaphase	O
length	O
decreased	O
from	O
11.8	O
±	O
0.08	O
to	O
8.8	O
±	O
1.4	O
µm	O
(	O
Table	O
1	O
)	O
,	O
and	O
poleward	O
flux	O
was	O
significantly	O
inhibited	O
both	O
within	O
ipMTs	O
and	O
kinetochore	O
(	O
k	O
)	O
MTs	O
(	O
Figure	O
4	O
)	O
.	O

The	O
average	O
rate	O
of	O
flux	O
was	O
0.01	O
±	O
0.02	O
µm/s	O
in	O
KLP61F	O
inhibited	O
embryos	O
compared	O
with	O
0.05	O
±	O
0.02	O
µm/s	O
in	O
control	O
embryos	O
(	O
Figure	O
4	O
;	O
Table	O
1	O
)	O
.	O

This	C
indicates	C
that	C
KLP61F-driven	C
MT	C
sliding	C
is	C
necessary	C
to	C
achieve	C
the	C
wild-type	C
metaphase	C
spindle	C
length	C
and	C
that	C
it	C
also	C
contributes	C
to	C
poleward	C
flux	C
in	C
both	C
ipMTs	C
and	C
kMTs	C
.	C

Interestingly	O
,	O
17	O
%	O
of	O
our	O
flux	O
measurements	O
were	O
negative	O
(	O
Figure	O
4C	O
)	O
.	O

A	C
possible	C
source	C
of	C
negative	C
flux	C
numbers	C
,	C
especially	C
close	C
to	C
zero	C
,	C
is	C
noise	C
in	C
the	C
measurements	C
.	C

A	C
more	C
interesting	C
possibility	C
is	C
that	C
they	C
represent	C
speckles	C
on	C
ipMTs	C
associated	C
with	C
one	C
pole	C
that	C
slide	C
inward	C
as	C
the	C
spindle	C
transiently	C
shortens	C
,	C
bringing	C
them	C
closer	C
to	C
the	C
pole	C
in	C
the	C
opposite	C
half	C
spindle	C
.	C

Such	C
a	C
speckle	C
would	C
flux	C
toward	C
the	C
first	C
pole	C
but	C
away	C
from	C
the	C
second	C
,	C
now	C
closer	C
,	C
pole	C
,	C
and	C
this	C
would	C
be	C
measured	C
as	C
negative	C
flux	C
.	C

Partial	O
inhibition	O
of	O
KLP61F	O
decreases	O
the	O
rates	O
of	O
flux	O
and	O
anaphase	O
A	O
chromosome	O
to	O
pole	O
movement	O
as	O
well	O
as	O
the	O
metaphase	O
spindle	O
length	O
and	O
kinetochore-kinetochore	O
distance	O

Poleward	O
flux	O
requires	O
the	O
function	O
of	O
KLP61F	O
.	O

(	O
A	O
)	O
In	O
wild-type	O
embryos	O
kymographs	O
show	O
that	O
tubulin	O
speckles	O
flux	O
toward	O
the	O
poles	O
during	O
the	O
metaphase–anaphase	O
A	O
steady	O
state	O
,	O
but	O
move	O
at	O
the	O
same	O
rate	O
as	O
the	O
poles	O
during	O
anaphase	O
B	O
.	O
(	O
Brust-Mascher	O
and	O
Scholey	O
,	O
2002	O
)	O
.	O

(	C
B	C
)	C
In	C
embryos	C
injected	C
with	C
anti-KLP61F	C
antibody	C
,	C
kymographs	C
obtained	C
from	C
spindles	C
that	C
did	C
not	C
collapse	C
but	C
maintained	C
a	C
steady	C
length	C
show	C
that	C
tubulin	C
speckles	C
do	C
not	C
flux	C
toward	C
the	C
pole	C
,	C
indicating	C
that	C
the	C
function	C
of	C
KLP61F	C
is	C
required	C
for	C
this	C
movement	C
(	C
see	C
Supplemental	C
Video	C
2	C
for	C
speckled	C
movie	C
)	C
.	C

(	O
C	O
)	O
Histogram	O
of	O
all	O
the	O
flux	O
data	O
obtained	O
on	O
spindles	O
that	O
did	O
not	O
collapse	O
after	O
KLP61F	O
inhibition	O
.	O

Congression	O
Is	O
Defective	O
,	O
Kinetochore	O
Spacing	O
and	O
the	O
Rate	O
of	O
Anaphase	O
A	O
Are	O
Reduced	O
,	O
and	O
the	O
Relative	O
Timing	O
of	O
Anaphase	O
A	O
and	O
B	O
Is	O
Perturbed	O
in	O
Spindles	O
Partially	O
Depleted	O
of	O
KLP61F	O

In	O
those	O
spindles	O
that	O
retain	O
sufficient	O
KLP61F	O
to	O
maintain	O
pole–pole	O
spacing	O
and	O
resist	O
prometaphase	O
spindle	O
collapse	O
,	O
we	O
were	O
also	O
able	O
to	O
study	O
congression	O
and	O
measure	O
the	O
subsequent	O
rate	O
of	O
anaphase	O
A	O
in	O
transgenic	O
embryos	O
expressing	O
GFP-CID	O
that	O
were	O
injected	O
with	O
rhodamine	O
tubulin	O
and	O
anti-KLP61F	O
(	O
Figure	O
5	O
)	O
.	O

In	O
spindles	O
that	O
shorten	O
or	O
do	O
not	O
undergo	O
prometaphase-to-metaphase	O
elongation	O
,	O
but	O
then	O
proceed	O
through	O
anaphase	O
,	O
we	O
find	O
that	O
congression	O
is	O
defective	O
.	O

Kinetochores	O
occupy	O
a	O
larger	O
area	O
around	O
the	O
equator	O
compared	O
with	O
wild-type	O
spindles	O
,	O
revealing	O
subtle	O
defects	O
in	O
chromosome	O
positioning	O
on	O
the	O
metaphase	O
plate	O
(	O
Figure	O
5B	O
)	O
.	O

Interestingly	O
,	O
kinetochore–kinetochore	O
distance	O
is	O
reduced	O
from	O
1.31	O
±	O
0.22	O
µm	O
in	O
wild	O
type	O
to	O
0.77	O
±	O
0.20	O
µm	O
in	O
KLP61F-inhibited	O
spindles	O
(	O
Table	O
1	O
)	O
,	O
indicating	O
a	O
reduction	O
in	O
the	O
magnitude	O
of	O
poleward	O
forces	O
acting	O
on	O
the	O
kinetochores	O
.	O

Subsequently	O
,	O
the	O
average	O
rate	O
of	O
kinetochore-to-pole	O
movement	O
is	O
0.06	O
±	O
0.02	O
µm/s	O
(	O
144	O
kinetochores	O
in	O
37	O
spindles	O
)	O
compared	O
with	O
0.11	O
±	O
0.02	O
µm/s	O
for	O
wild-type	O
anaphase	O
A	O
movement	O
(	O
Figure	O
5	O
;	O
Table	O
1	O
)	O
.	O

Some	O
spindles	O
that	O
maintained	O
a	O
reduced	O
but	O
steady	O
pole–pole	O
spacing	O
displayed	O
no	O
kinetochore-to-pole	O
movement	O
and	O
a	O
single	O
nucleus	O
reformed	O
around	O
the	O
unsegregated	O
parental	O
chromosomes	O
.	O

Such	O
spindles	O
were	O
excluded	O
from	O
our	O
calculations	O
of	O
the	O
average	O
rate	O
.	O

Chromosome	O
congression	O
and	O
anaphase	O
A	O
are	O
perturbed	O
by	O
partial	O
KLP61F	O
inhibition	O
.	O

(	O
A	O
)	O
Time-lapse	O
images	O
of	O
one	O
spindle	O
in	O
an	O
embryo	O
expressing	O
GFP-CID	O
injected	O
with	O
rhodamine	O
tubulin	O
and	O
anti-KLP61F	O
antibody	O
.	O

The	O
spindle	O
shortens	O
slightly	O
(	O
compare	O
215	O
with	O
126	O
)	O
but	O
does	O
not	O
collapse	O
after	O
KLP61F	O
inhibition	O
.	O

Kinetochores	O
move	O
to	O
the	O
poles	O
albeit	O
slower	O
than	O
in	O
control	O
spindles	O
.	O

Time	O
in	O
each	O
frame	O
is	O
given	O
in	O
seconds	O
from	O
NEB	O
.	O

Bar	O
,	O
5	O
µm	O
.	O

(	O
B	O
)	O
Positions	O
of	O
the	O
center	O
of	O
kinetochore	O
pairs	O
in	O
wild-type	O
(	O
black	O
)	O
and	O
KLP61F-inhibited	O
(	O
red	O
)	O
spindles	O
.	O

In	O
anti-KLP61F–inhibited	O
spindles	O
,	O
kinetochores	O
do	O
not	O
congress	O
as	O
tightly	O
as	O
in	O
controls	O
,	O
and	O
they	O
exhibit	O
a	O
larger	O
displacement	O
around	O
the	O
equator	O
.	O

Triangles	O
mark	O
the	O
average	O
positions	O
of	O
the	O
poles	O
.	O

(	O
C	O
)	O
Pole–pole	O
distance	O
and	O
kinetochore-to-pole	O
distances	O
for	O
the	O
spindle	O
shown	O
in	O
A	O
(	O
averages	O
in	O
Table	O
1	O
)	O
.	O

Significantly	C
,	C
the	C
lower	C
rate	C
of	C
0.06	C
µm/s	C
parallels	C
the	C
observed	C
lack	C
of	C
poleward	C
flux	C
(	C
previous	C
section	C
)	C
and	C
supports	C
the	C
idea	C
that	C
anaphase	C
A	C
is	C
driven	C
by	C
a	C
combined	C
“flux-pacman”	C
mechanism	C
in	C
Drosophila	C
embryos	C
(	C
Brust-Mascher	C
and	C
Scholey	C
,	C
2002	C
;	C
Maddox	C
et	C
al.	C
,	C
2002	C
;	C
Rogers	C
et	C
al.	C
,	C
2004	C
)	C
.	C

Interestingly	O
,	O
we	O
noticed	O
that	O
in	O
many	O
of	O
these	O
spindles	O
,	O
kinetochore-to-pole	O
movement	O
occurs	O
at	O
the	O
same	O
time	O
as	O
pole–pole	O
separation	O
,	O
whereas	O
in	O
wild-type	O
spindles	O
,	O
anaphase	O
A	O
always	O
precedes	O
anaphase	O
B	O
.	O

How	C
loss	C
of	C
kinesin-5	C
function	C
could	C
lead	C
to	C
changes	C
in	C
the	C
temporal	C
relationship	C
between	C
chromosome-to-pole	C
motility	C
and	C
spindle	C
elongation	C
during	C
anaphase	C
is	C
unclear	C
.	C

As	O
predicted	O
(	O
Sharp	O
et	O
al.	O
,	O
2000a	O
;	O
Brust-Mascher	O
et	O
al.	O
,	O
2004	O
)	O
the	O
rate	O
of	O
anaphase	O
B	O
is	O
relatively	O
insensitive	O
to	O
KLP61F	O
concentration	O
to	O
a	O
certain	O
point	O
:	O
spindles	O
that	O
exhibited	O
a	O
partial	O
collapse	O
and	O
had	O
a	O
metaphase	O
length	O
of	O
<	O
7	O
µm	O
elongated	O
at	O
a	O
slower	O
rate	O
,	O
but	O
spindles	O
that	O
maintained	O
at	O
least	O
the	O
NEB	O
length	O
elongated	O
at	O
approximately	O
wild-type	O
rates	O
.	O

Influence	O
of	O
Cortical	O
Organization	O
on	O
KLP61F-dependent	O
Mitotic	O
Events	O

Cortical	C
pulling	C
forces	C
could	C
complement	C
the	C
outward	C
sliding	C
of	C
ipMTs	C
to	C
control	C
pole–pole	C
spacing	C
.	C

To	O
examine	O
this	O
,	O
we	O
measured	O
spindle	O
pole	O
dynamics	O
and	O
MT	O
speckle	O
movements	O
in	O
two	O
mutants	O
that	O
have	O
severely	O
disrupted	O
actin	O
cortices	O
surrounding	O
the	O
nucleus	O
.	O

In	O
the	O
Drosophila	O
syncytial	O
embryo	O
,	O
actin	O
caps	O
are	O
normally	O
formed	O
over	O
each	O
nucleus	O
and	O
a	O
furrow	O
is	O
formed	O
around	O
the	O
spindle	O
during	O
metaphase	O
(	O
Cytrynbaum	O
et	O
al.	O
,	O
2005	O
)	O
.	O

The	O
cortex-defective	O
Scrambled	O
(	O
sced	O
;	O
Stevenson	O
et	O
al.	O
,	O
2001	O
)	O
and	O
Sponge	O
(	O
spg	O
;	O
Postner	O
et	O
al.	O
,	O
1992	O
)	O
mutants	O
have	O
highly	O
reduced	O
actin	O
caps	O
and	O
no	O
metaphase	O
furrows	O
(	O
Supplemental	O
Figure	O
S1	O
)	O
.	O

If	C
cortical	C
dynein	C
or	C
cortical	C
MT	C
depolymerases	C
play	C
a	C
significant	C
role	C
in	C
pulling	C
spindle	C
poles	C
apart	C
by	C
sliding	C
astral	C
MTs	C
outward	C
relative	C
to	C
the	C
actin	C
cortex	C
,	C
this	C
activity	C
should	C
be	C
reduced	C
or	C
eliminated	C
due	C
to	C
the	C
depletion	C
of	C
actin	C
caps	C
and	C
furrows	C
in	C
these	C
mutants	C
.	C

Plots	O
of	O
pole–pole	O
separation	O
dynamics	O
(	O
Supplemental	O
Figure	O
S1	O
)	O
show	O
that	O
the	O
rate	O
of	O
separation	O
during	O
prometaphase	O
is	O
slower	O
in	O
these	O
mutants	O
,	O
but	O
during	O
anaphase	O
B	O
there	O
is	O
no	O
significant	O
difference	O
.	O

Using	O
fluorescence	O
speckle	O
microscopy	O
,	O
we	O
examined	O
the	O
rate	O
of	O
movement	O
of	O
tubulin	O
speckles	O
away	O
from	O
the	O
equator	O
during	O
metaphase	O
and	O
anaphase	O
.	O

This	C
could	C
reflect	C
the	C
sliding	C
apart	C
of	C
MTs	C
either	C
by	C
outward	C
ipMT	C
sliding	C
by	C
KLP61F	C
or	C
,	C
during	C
anaphase	C
B	C
,	C
by	C
outward	C
pulling	C
by	C
cortical	C
forces	C
.	C

In	C
wild-type	C
spindles	C
,	C
speckles	C
move	C
at	C
a	C
rate	C
of	C
0.05	C
±	C
0.02	C
µm/s	C
,	C
in	C
spg	C
mutants	C
they	C
move	C
at	C
0.05	C
±	C
0.02	C
µm/s	C
,	C
and	C
in	C
sced	C
mutants	C
at	C
0.06	C
±	C
0.02	C
µm/s	C
(	C
Supplemental	C
Figure	C
S1	C
)	C
,	C
indicating	C
that	C
outward	C
pulling	C
by	C
cortical	C
forces	C
is	C
not	C
significant	C
throughout	C
metaphase	C
and	C
anaphase	C
.	C

Together	O
these	O
results	O
are	O
consistent	O
with	O
the	O
hypothesis	O
that	O
cortical	O
forces	O
augment	O
ipMT	O
sliding	O
to	O
contribute	O
to	O
spindle	O
elongation	O
during	O
the	O
prometaphase-to-metaphase	O
transition	O
,	O
for	O
example	O
,	O
via	O
cortical	O
dynein	O
activity	O
(	O
Sharp	O
et	O
al.	O
,	O
2000a	O
)	O
.	O

However	C
,	C
cortical	C
pulling	C
forces	C
apparently	C
do	C
not	C
play	C
a	C
significant	C
role	C
after	C
metaphase	C
onset	C
,	C
whereupon	C
KLP61F	C
becomes	C
the	C
major	C
force	C
generator	C
for	C
the	C
outward	C
sliding	C
of	C
ipMTs	C
that	C
underlies	C
poleward	C
flux	C
and	C
anaphase	C
spindle	C
elongation	C
.	C

DISCUSSION	O

This	O
study	O
exploits	O
our	O
ability	O
to	O
create	O
and	O
directly	O
visualize	O
the	O
KLP61F	O
concentration	O
gradient	O
produced	O
by	O
the	O
microinjection	O
of	O
an	O
antibody	O
to	O
the	O
motor	O
's	O
spindle	O
targeting	O
domain	O
in	O
wild-type	O
and	O
Ncd	O
null	O
mutant	O
Drosophila	O
syncytial	O
blastoderm	O
embryos	O
in	O
order	O
to	O
examine	O
the	O
spectrum	O
of	O
functions	O
of	O
kinesin-5	O
.	O

The	C
work	C
suggests	C
that	C
MT–MT	C
crosslinking	C
and	C
sliding	C
by	C
KLP61F	C
contributes	C
to	C
1	C
)	C
the	C
maintenance	C
of	C
prometaphase	C
spindles	C
as	C
chromosomes	C
are	C
captured	C
;	C
2	C
)	C
poleward	C
flux	C
in	C
ipMTs	C
and	C
kMTs	C
;	C
3	C
)	C
the	C
bundling	C
and	C
organization	C
of	C
MTs	C
throughout	C
the	C
spindle	C
;	C
4	C
)	C
the	C
control	C
of	C
pre-anaphase	C
B	C
spindle	C
length	C
;	C
5	C
)	C
tight	C
congression	C
,	C
kinetochore–kinetochore	C
spacing	C
and	C
the	C
rate	C
of	C
anaphase	C
A	C
chromatid-to-pole	C
motility	C
;	C
and	C
6	C
)	C
the	C
elongation	C
of	C
the	C
anaphase	C
B	C
spindle	C
in	C
a	C
manner	C
that	C
is	C
relatively	C
insensitive	C
to	C
the	C
KLP61F	C
concentration	C
(	C
Figure	C
6	C
)	C
.	C

The	C
hypothesis	C
that	C
KLP61F	C
drives	C
MT	C
sliding	C
from	C
NEB	C
through	C
anaphase	C
B	C
to	C
push	C
apart	C
spindle	C
poles	C
was	C
also	C
supported	C
by	C
gene	C
dosage	C
experiments	C
in	C
embryos	C
and	C
real-time	C
fluorescence	C
microscopy	C
of	C
transgenic	C
late	C
embryonic/larval	C
klp61f	C
mutants	C
expressing	C
GFP-tubulin	C
.	C

The	C
latter	C
studies	C
also	C
revealed	C
monoastral	C
bipolar	C
spindles	C
that	C
were	C
never	C
seen	C
in	C
syncytial	C
embryos	C
,	C
suggesting	C
that	C
chromosome-directed	C
spindle	C
assembly	C
becomes	C
more	C
evident	C
as	C
embryonic	C
and	C
larval	C
development	C
proceeds	C
and	C
mitosis	C
slows	C
down	C
.	C

Model	O
for	O
the	O
multiple	O
roles	O
of	O
KLP61F	O
in	O
Drosophila	O
syncytial	O
embryo	O
mitosis	O
.	O

We	C
propose	C
that	C
kinesin-5	C
motors	C
function	C
as	C
ensembles	C
of	C
dynamic	C
,	C
transient	C
,	C
MT	C
crosslinkers	C
throughout	C
the	C
spindle	C
(	C
Sharp	C
et	C
al.	C
,	C
1999a	C
;	C
Cheerambathur	C
et	C
al.	C
,	C
2008	C
)	C
,	C
organizing	C
parallel	C
MTs	C
into	C
bundles	C
(	C
inset	C
i	C
)	C
and	C
sliding	C
apart	C
antiparallel	C
MTs	C
(	C
inset	C
ii	C
)	C
,	C
in	C
accordance	C
with	C
the	C
biochemical	C
properties	C
of	C
KLP61F	C
(	C
e.g.	C
,	C
Cole	C
et	C
al.	C
,	C
1994	C
;	C
Kashina	C
et	C
al.	C
,	C
1996a	C
;	C
Tao	C
et	C
al.	C
,	C
2006	C
;	C
Van	C
den	C
Wildenberg	C
et	C
al.	C
,	C
2008	C
)	C
.	C

The	C
results	C
suggest	C
that	C
KLP61F-driven	C
MT-MT	C
sliding	C
is	C
required	C
to	C
oppose	C
an	C
inward	C
force	C
(	C
ii	C
,	C
brown	C
arrows	C
)	C
and	C
maintain	C
the	C
spindle	C
during	C
early	C
prometaphase	C
,	C
as	C
well	C
as	C
to	C
elongate	C
it	C
to	C
the	C
metaphase	C
steady	C
state	C
length	C
.	C

In	O
preanaphase	O
B	O
(	O
i.e	O
.	O
metaphase	O
and	O
anaphase	O
A	O
)	O
spindles	O
,	O
KLP61F	O
driven	O
ipMT	O
outward	O
sliding	O
(	O
blue	O
solid	O
arrows	O
)	O
is	O
required	O
for	O
poleward	O
flux	O
in	O
both	O
kMT	O
and	O
ipMT	O
bundles	O
and	O
for	O
anaphase	O
A	O
chromosome	O
movement	O
.	O

The	C
kMTs	C
may	C
be	C
slid	C
poleward	C
(	C
dashed	C
blue	C
arrows	C
)	C
via	C
crosslinks	C
to	C
the	C
actively	C
sliding	C
antiparallel	C
ipMTs	C
.	C

Finally	O
,	O
KLP61F	O
drives	O
spindle	O
elongation	O
during	O
anaphase	O
B	O
.	O

This	O
model	O
is	O
proposed	O
only	O
for	O
Drosophila	O
embryos	O
(	O
see	O
Discussion	O
)	O
.	O

Experimental	O
Strategy	O

Several	O
methods	O
are	O
currently	O
available	O
for	O
inhibiting	O
target	O
proteins	O
in	O
cells	O
,	O
including	O
mutants	O
,	O
injection	O
of	O
dominant	O
negative	O
protein	O
fragments	O
,	O
chemical	O
inhibitors	O
,	O
RNA	O
interference	O
,	O
and	O
inhibitory	O
antibody	O
microinjection	O
.	O

In	O
the	O
current	O
study	O
,	O
microinjected	O
antibody	O
to	O
the	O
spindle-targeting	O
phospho-tail	O
domain	O
on	O
kinesin-5	O
(	O
Sawin	O
and	O
Mitchison	O
,	O
1995	O
;	O
Sharp	O
et	O
al.	O
,	O
1999a	O
;	O
Cheerambathur	O
et	O
al.	O
,	O
2008	O
)	O
rapidly	O
dissociated	O
KP61F	O
from	O
mitotic	O
spindles	O
.	O

By	O
utilizing	O
stable	O
transgenic	O
embryos	O
that	O
express	O
GFP-tagged	O
KLP61F	O
,	O
we	O
were	O
able	O
to	O
directly	O
visualize	O
the	O
extent	O
of	O
dissociation	O
of	O
the	O
target	O
antigen	O
from	O
spindles	O
in	O
different	O
regions	O
of	O
the	O
syncytium	O
relative	O
to	O
the	O
injection	O
site	O
.	O

This	O
in	O
turn	O
allowed	O
us	O
to	O
correlate	O
the	O
extent	O
of	O
KLP61F	O
depletion	O
with	O
the	O
mitotic	O
perturbation	O
observed	O
,	O
which	O
permitted	O
an	O
exploration	O
of	O
the	O
range	O
of	O
mitotic	O
functions	O
of	O
KLP61F	O
,	O
in	O
addition	O
to	O
the	O
unseparated/collapsed	O
spindle	O
pole	O
phenotype	O
seen	O
after	O
severe	O
inhibition	O
or	O
loss	O
of	O
function	O
(	O
Heck	O
et	O
al.	O
,	O
1993	O
;	O
Sharp	O
et	O
al.	O
,	O
1999b	O
)	O
.	O

Our	O
results	O
with	O
respect	O
to	O
spindle	O
pole	O
spacing	O
were	O
confirmed	O
by	O
the	O
observation	O
of	O
similar	O
defects	O
in	O
klp61f	O
mutants	O
,	O
including	O
spindle	O
collapse	O
into	O
monoasters	O
after	O
severe	O
loss	O
of	O
KLP61F	O
function	O
and	O
the	O
observation	O
that	O
spindles	O
depleted	O
of	O
~30–50	O
%	O
of	O
KLP61F	O
by	O
antibody	O
injection	O
,	O
like	O
those	O
in	O
embryos	O
carrying	O
half	O
the	O
normal	O
dose	O
of	O
the	O
corresponding	O
gene	O
,	O
are	O
shorter	O
than	O
normal	O
at	O
metaphase	O
,	O
but	O
complete	O
anaphase	O
successfully	O
(	O
Figures	O
1	O
and	O
3	O
)	O
.	O

Relation	O
to	O
Previous	O
Experimental	O
Studies	O
of	O
Kinesin-5	O
in	O
Drosophila	O
Syncytial	O
Embryos	O

The	C
results	C
support	C
previous	C
studies	C
suggesting	C
that	C
KLP61F	C
is	C
dispensable	C
for	C
the	C
assembly	C
of	C
astral	C
syncytial	C
embryo	C
spindles	C
but	C
is	C
essential	C
for	C
prometaphase	C
spindle	C
maintenance	C
where	C
it	C
is	C
antagonized	C
by	C
Ncd	C
(	C
Sharp	C
et	C
al.	C
,	C
1999b	C
;	C
Sharp	C
et	C
al.	C
,	C
2000a	C
;	C
Tao	C
et	C
al.	C
,	C
2006	C
)	C
,	C
and	C
it	C
further	C
implicates	C
the	C
action	C
of	C
an	C
additional	C
,	C
unknown	C
,	C
inward	C
motor	C
,	C
possibly	C
the	C
MT	C
depolymerase	C
,	C
KLP10A	C
.	C

Previously	O
,	O
we	O
had	O
predicted	O
that	O
KLP61F	O
has	O
a	O
role	O
in	O
driving	O
poleward	O
flux	O
and	O
that	O
the	O
rate	O
of	O
anaphase	O
B	O
is	O
insensitive	O
to	O
changes	O
in	O
the	O
concentration	O
of	O
KLP61F	O
(	O
Brust-Mascher	O
et	O
al.	O
,	O
2004	O
;	O
Wollman	O
et	O
al.	O
,	O
2008	O
)	O
.	O

Here	O
,	O
we	O
confirmed	O
these	O
predictions	O
experimentally	O
and	O
also	O
obtained	O
evidence	O
for	O
new	O
roles	O
in	O
controlling	O
the	O
length	O
of	O
the	O
metaphase	O
spindle	O
,	O
the	O
tightness	O
of	O
chromosome	O
congression	O
,	O
the	O
distance	O
between	O
sister	O
kinetochores	O
,	O
the	O
rate	O
of	O
anaphase	O
A	O
chromatid-to-pole	O
motility	O
,	O
and	O
the	O
relative	O
timing	O
of	O
anaphase	O
A	O
and	O
B	O
,	O
none	O
of	O
which	O
have	O
been	O
reported	O
previously	O
.	O

For	C
example	C
,	C
in	C
spindles	C
lacking	C
Ncd	C
function	C
,	C
spindle	C
collapse	C
driven	C
by	C
the	C
inward	C
force-generators	C
can	C
be	C
circumvented	C
and	C
the	C
results	C
,	C
specifically	C
the	C
failure	C
or	C
delay	C
of	C
spindle	C
elongation	C
,	C
then	C
reveal	C
a	C
role	C
for	C
KLP61F-driven	C
sliding	C
in	C
anaphase	C
B	C
.	C

In	C
the	C
spindles	C
that	C
fail	C
to	C
elongate	C
,	C
we	C
propose	C
that	C
there	C
is	C
enough	C
KLP61F	C
to	C
prevent	C
spindle	C
collapse	C
but	C
not	C
enough	C
to	C
drive	C
anaphase	C
B	C
(	C
Figure	C
2	C
)	C
.	C

An	C
outward	C
,	C
KLP61F-driven	C
ipMT	C
sliding	C
,	C
coupled	C
to	C
MT	C
depolymerization	C
at	C
the	C
poles	C
,	C
could	C
also	C
underlie	C
KLP61F	C
's	C
contribution	C
to	C
poleward	C
flux	C
as	C
predicted	C
,	C
but	C
not	C
previously	C
tested	C
(	C
Brust-Mascher	C
and	C
Scholey	C
,	C
2002	C
)	C
.	C

Perhaps	C
surprisingly	C
,	C
after	C
partial	C
KLP61F	C
inhibition	C
,	C
flux	C
is	C
slowed	C
down	C
in	C
all	C
MT	C
bundles	C
,	C
suggesting	C
that	C
all	C
bundles	C
are	C
interconnected	C
.	C

We	C
propose	C
that	C
the	C
sliding	C
apart	C
of	C
ipMTs	C
by	C
KLP61F	C
would	C
also	C
push	C
kMTs	C
poleward	C
,	C
if	C
the	C
kMTs	C
are	C
mechanically	C
coupled	C
to	C
the	C
sliding	C
ipMTs	C
by	C
KLP61F	C
(	C
or	C
other	C
)	C
MT–MT	C
cross-linkers	C
(	C
Figure	C
6	C
;	C
Sharp	C
et	C
al.	C
,	C
1999a	C
;	C
Cheerambathur	C
et	C
al.	C
,	C
2008	C
)	C
.	C

Depolymerization	C
of	C
ipMTs	C
and	C
kMTs	C
at	C
the	C
poles	C
would	C
then	C
create	C
KLP61F-dependent	C
poleward	C
flux	C
.	C

The	C
slowing	C
down	C
of	C
anaphase	C
A	C
chromatid-to-pole	C
motility	C
resulting	C
from	C
KLP61F	C
inhibition	C
could	C
be	C
explained	C
by	C
the	C
loss	C
of	C
flux	C
because	C
it	C
has	C
been	C
shown	C
that	C
in	C
Drosophila	C
embryos	C
,	C
anaphase	C
A	C
is	C
driven	C
by	C
a	C
combined	C
flux-pacman	C
mechanism	C
(	C
Rogers	C
et	C
al.	C
,	C
2004	C
)	C
.	C

Surprisingly	O
,	O
we	O
also	O
observed	O
a	O
loss	O
of	O
tension	O
between	O
sister	O
kinetochores	O
and	O
a	O
loss	O
of	O
congression	O
.	O

This	C
may	C
also	C
be	C
due	C
to	C
the	C
loss	C
of	C
flux	C
;	C
i.e.	C
,	C
normally	C
as	C
MTs	C
slide	C
outward	C
,	C
they	C
generate	C
a	C
pulling	C
force	C
on	C
the	C
kinetochores	C
.	C

This	O
force	O
maintains	O
the	O
tension	O
between	O
sister	O
kinetochores	O
so	O
that	O
the	O
loss	O
of	O
this	O
outward	O
sliding	O
leads	O
to	O
a	O
decrease	O
in	O
the	O
distance	O
between	O
sisters	O
.	O

Relation	O
to	O
Experimental	O
Studies	O
of	O
Kinesin-5	O
Function	O
in	O
Other	O
Systems	O

A	O
comprehensive	O
review	O
of	O
the	O
diverse	O
roles	O
of	O
kinesin-5	O
in	O
different	O
systems	O
is	O
beyond	O
the	O
scope	O
of	O
this	O
article	O
(	O
see	O
Valentine	O
et	O
al.	O
,	O
2006a	O
;	O
Civelekoglu-Scholey	O
and	O
Scholey	O
,	O
2007	O
)	O
,	O
but	O
a	O
brief	O
comparison	O
between	O
Drosophila	O
syncytial	O
embryos	O
and	O
other	O
systems	O
is	O
appropriate	O
.	O

Live	O
imaging	O
of	O
klp61f	O
mutant	O
late	O
embryos	O
and	O
larvae	O
(	O
Figure	O
3	O
)	O
revealed	O
that	O
bipolar	O
spindles	O
collapse	O
into	O
monoasters	O
,	O
as	O
observed	O
in	O
syncytial	O
embryos	O
,	O
and	O
also	O
revealed	O
the	O
formation	O
of	O
functional	O
bipolar	O
,	O
monoastral	O
spindles	O
,	O
as	O
observed	O
previously	O
in	O
studies	O
of	O
fixed	O
larval	O
brains	O
and	O
testis	O
(	O
Wilson	O
et	O
al.	O
,	O
1997	O
)	O
but	O
not	O
in	O
anti-KLP61F–injected	O
embryos	O
.	O

It	O
is	O
plausible	O
that	O
this	O
reflects	O
the	O
formation	O
of	O
bipolar	O
monoastral	O
spindles	O
by	O
chromosome-directed	O
,	O
KLP61F-mediated	O
acentrosomal	O
pole	O
focusing	O
as	O
proposed	O
for	O
Drosophila	O
S2	O
cells	O
,	O
based	O
on	O
RNA	O
interference	O
(	O
RNAi	O
)	O
experiments	O
(	O
Goshima	O
and	O
Vale	O
,	O
2003	O
)	O
.	O

We	C
hypothesize	C
that	C
the	C
syncytial	C
embryo	C
spindles	C
that	C
we	C
study	C
are	C
adapted	C
for	C
rapid	C
mitoses	C
(	C
Civelekoglu-Scholey	C
et	C
al.	C
,	C
2006	C
)	C
and	C
consequently	C
their	C
assembly	C
and	C
function	C
is	C
dominated	C
by	C
the	C
centrosome-directed	C
pathway	C
so	C
that	C
,	C
unlike	C
in	C
larvae	C
,	C
S2	C
cells	C
and	C
many	C
other	C
cells	C
,	C
the	C
chromosome-directed	C
spindle	C
assembly	C
pathway	C
plays	C
a	C
lesser	C
role	C
(	C
Heald	C
et	C
al.	C
,	C
1997	C
;	C
Megraw	C
et	C
al.	C
,	C
2001	C
)	C
.	C

The	C
relative	C
importance	C
of	C
centrosome-	C
versus	C
chromosome-directed	C
spindle	C
organization	C
may	C
be	C
a	C
key	C
factor	C
influencing	C
how	C
kinesin-5	C
is	C
deployed	C
in	C
different	C
spindles	C
,	C
e.g.	C
,	C
in	C
spindle	C
pole	C
focusing	C
versus	C
spindle	C
pole	C
separation	C
,	C
though	C
it	C
is	C
obviously	C
not	C
the	C
only	C
factor	C
.	C

Our	C
results	C
showing	C
that	C
KLP61F	C
appears	C
to	C
contribute	C
to	C
the	C
length	C
of	C
pre-anaphase	C
B	C
spindles	C
in	C
living	C
embryos	C
differ	C
from	C
the	C
results	C
obtained	C
in	C
fixed	C
S2	C
cells	C
where	C
,	C
above	C
the	C
critical	C
concentration	C
required	C
for	C
bipolar	C
spindle	C
assembly	C
,	C
increasing	C
concentrations	C
of	C
KLP61F	C
did	C
not	C
influence	C
metaphase	C
spindle	C
length	C
(	C
Goshima	C
et	C
al.	C
,	C
2005b	C
)	C
.	C

Although	C
we	C
can	C
not	C
rule	C
out	C
an	C
influence	C
of	C
technical	C
differences	C
between	C
the	C
two	C
studies	C
,	C
we	C
suspect	C
that	C
they	C
reflect	C
genuine	C
system-specific	C
differences	C
,	C
akin	C
to	C
the	C
different	C
consequences	C
of	C
loss	C
of	C
Ncd	C
function	C
in	C
embryos	C
versus	C
cultured	C
cells	C
of	C
Drosophila	C
(	C
Sharp	C
et	C
al.	C
,	C
2000a	C
;	C
Goshima	C
et	C
al.	C
,	C
2005a	C
;	C
Morales-Mulia	C
and	C
Scholey	C
,	C
2005	C
)	C
.	C

The	O
Drosophila	O
embryo	O
spindle	O
differs	O
from	O
that	O
of	O
S.	O
cerevisiae	O
in	O
using	O
only	O
one	O
,	O
rather	O
than	O
two	O
kinesin-5	O
motors	O
.	O

In	O
both	O
these	O
systems	O
,	O
kinesin-5	O
function	O
is	O
required	O
to	O
prevent	O
kinesin-14–induced	O
prometaphase	O
spindle	O
collapse	O
,	O
but	O
only	O
in	O
yeast	O
is	O
it	O
essential	O
for	O
de	O
novo	O
spindle	O
assembly	O
(	O
Saunders	O
and	O
Hoyt	O
,	O
1992	O
)	O
.	O

As	C
in	C
Drosophila	C
embryos	C
,	C
the	C
kinesin-5	C
motors	C
appear	C
to	C
contribute	C
to	C
metaphase	C
spindle	C
length	C
(	C
Saunders	C
et	C
al.	C
,	C
1997	C
)	C
and	C
to	C
anaphase	C
spindle	C
elongation	C
(	C
Saunders	C
et	C
al.	C
,	C
1995	C
;	C
Straight	C
et	C
al.	C
,	C
1998	C
)	C
.	C

In	C
some	C
respects	C
,	C
therefore	C
,	C
the	C
manner	C
in	C
which	C
kinesin-5	C
is	C
deployed	C
in	C
Drosophila	C
embryos	C
resembles	C
yeast	C
more	C
closely	C
than	C
S2	C
cells	C
,	C
again	C
possibly	C
reflecting	C
the	C
relative	C
dominance	C
of	C
centrosomes	C
and	C
spindle	C
pole	C
bodies	C
.	C

In	C
other	C
respects	C
the	C
two	C
systems	C
may	C
differ	C
significantly	C
;	C
for	C
instance	C
,	C
although	C
kinesin-5	C
contributes	C
to	C
congression	C
in	C
Drosophila	C
embryos	C
and	C
yeast	C
,	C
the	C
proposed	C
underlying	C
mechanisms	C
are	C
very	C
different	C
(	C
Figure	C
6	C
and	C
Gardner	C
et	C
al.	C
,	C
2008	C
)	C
.	C

The	O
kinesin-5	O
inhibitor	O
,	O
monastrol	O
,	O
unfortunately	O
does	O
not	O
interfere	O
with	O
purified	O
kinesin-5	O
motility	O
or	O
mitosis	O
in	O
Drosophila	O
(	O
our	O
unpublished	O
observations	O
)	O
,	O
but	O
it	O
has	O
been	O
used	O
extensively	O
to	O
probe	O
the	O
diverse	O
functions	O
of	O
vertebrate	O
kinesin-5	O
.	O

This	O
work	O
,	O
together	O
with	O
complementary	O
approaches	O
,	O
has	O
revealed	O
multiple	O
roles	O
for	O
kinesin-5	O
in	O
early	O
spindle	O
assembly	O
,	O
in	O
spindle	O
maintenance	O
(	O
in	O
Xenopus	O
but	O
not	O
cultured	O
cells	O
)	O
,	O
in	O
the	O
sorting	O
out	O
of	O
antiparallel	O
chromosome	O
nucleated	O
MTs	O
,	O
and	O
in	O
the	O
proper	O
biorientation	O
of	O
chromosomes	O
(	O
Gaglio	O
et	O
al.	O
,	O
1996	O
;	O
Walczak	O
et	O
al.	O
,	O
1998	O
;	O
Kapoor	O
et	O
al.	O
,	O
2000	O
;	O
Uteng	O
et	O
al.	O
,	O
2008	O
)	O
.	O

Roles	O
for	O
kinesin-5	O
in	O
driving	O
poleward	O
flux	O
and	O
controlling	O
metaphase	O
spindle	O
length	O
were	O
proposed	O
previously	O
for	O
Xenopus	O
extract	O
spindles	O
(	O
Miyamoto	O
et	O
al.	O
,	O
2004	O
;	O
Shirasu-Hiza	O
et	O
al.	O
,	O
2004	O
)	O
as	O
we	O
report	O
here	O
for	O
Drosophila	O
embryo	O
spindles	O
.	O

In	C
vertebrate	C
cultured	C
cells	C
,	C
in	C
contrast	C
,	C
the	C
inhibition	C
of	C
Eg5	C
function	C
led	C
to	C
only	C
a	C
25	C
%	C
decrease	C
in	C
the	C
rate	C
of	C
poleward	C
flux	C
while	C
spindle	C
length	C
remained	C
normal	C
,	C
suggesting	C
only	C
minor	C
contributions	C
from	C
kinesin-5	C
(	C
Cameron	C
et	C
al.	C
,	C
2006	C
)	C
.	C

The	C
latter	C
authors	C
also	C
reported	C
a	C
small	C
decrease	C
in	C
kinetochore–kinetochore	C
spacing	C
after	C
Eg5	C
inhibition	C
,	C
supporting	C
the	C
notion	C
that	C
kinesin-5	C
may	C
contribute	C
to	C
the	C
exertion	C
of	C
poleward	C
tension	C
on	C
kinetochores	C
in	C
some	C
systems	C
,	C
including	C
the	C
Drosophila	C
embryo	C
(	C
Figure	C
5	C
)	C
.	C

Thus	O
kinesin-5	O
motors	O
have	O
diverse	O
,	O
often	O
essential	O
mitotic	O
functions	O
in	O
many	O
systems	O
including	O
the	O
Drosophila	O
embryo	O
.	O

However	C
,	C
in	C
Dictyostelium	C
amoebae	C
and	C
C.	C
elegans	C
embryos	C
,	C
kinesin-5	C
motors	C
play	C
relatively	C
minor	C
mitotic	C
roles	C
,	C
and	C
they	C
appear	C
to	C
be	C
dispensable	C
for	C
mitosis	C
(	C
Saunders	C
et	C
al.	C
,	C
2007	C
;	C
Tikhonenko	C
et	C
al.	C
,	C
2008	C
)	C
.	C

Thus	C
,	C
mitotic	C
motors	C
can	C
be	C
deployed	C
to	C
carry	C
out	C
very	C
different	C
functions	C
in	C
different	C
types	C
of	C
spindles	C
,	C
presenting	C
a	C
challenge	C
for	C
the	C
formulation	C
of	C
general	C
,	C
integrated	C
models	C
of	C
kinesin-5	C
function	C
.	C

Relation	O
to	O
Studies	O
of	O
the	O
Mechanism	O
of	O
Kinesin-5	O
Action	O

The	O
multiple	O
mitotic	O
functions	O
of	O
KLP61F	O
in	O
Drosophila	O
syncytial	O
embryos	O
can	O
be	O
explained	O
by	O
a	O
model	O
in	O
which	O
KLP61F	O
cross-links	O
adjacent	O
MTs	O
throughout	O
the	O
spindle	O
(	O
Figure	O
6	O
)	O
,	O
in	O
accordance	O
with	O
the	O
biochemical	O
properties	O
of	O
the	O
purified	O
native	O
embryonic	O
or	O
recombinant	O
baculovirus-expressed	O
motor	O
(	O
Cole	O
et	O
al.	O
,	O
1994	O
;	O
Kashina	O
et	O
al.	O
,	O
1996a	O
;	O
Kashina	O
et	O
al.	O
,	O
1996b	O
;	O
Tao	O
et	O
al.	O
,	O
2006	O
;	O
Van	O
den	O
Wildenberg	O
et	O
al.	O
,	O
2008	O
)	O
,	O
its	O
immunolocalization	O
(	O
Sharp	O
et	O
al.	O
,	O
1999a	O
)	O
,	O
and	O
its	O
localization	O
and	O
dynamics	O
in	O
living	O
cells	O
(	O
Cheerambathur	O
et	O
al.	O
,	O
2008	O
)	O
.	O

By	C
cross-linking	C
parallel	C
MTs	C
,	C
KLP61F	C
would	C
“zip”	C
together	C
adjacent	C
MTs	C
to	C
bundle	C
and	C
organize	C
spindle	C
MTs	C
but	C
would	C
generate	C
no	C
force	C
on	C
them	C
.	C

By	C
cross-linking	C
and	C
moving	C
toward	C
the	C
plus	C
ends	C
of	C
antiparallel	C
ipMTs	C
,	C
however	C
,	C
it	C
would	C
persistently	C
slide	C
them	C
apart	C
to	C
drive	C
poleward	C
flux	C
when	C
ipMT	C
sliding	C
is	C
balanced	C
by	C
ipMT	C
depolymerization	C
at	C
spindle	C
poles	C
,	C
or	C
to	C
exert	C
outward	C
forces	C
on	C
spindles	C
poles	C
when	C
ipMT	C
depolymerization	C
is	C
turned	C
off	C
(	C
McIntosh	C
et	C
al.	C
,	C
1969	C
;	C
Sharp	C
et	C
al.	C
,	C
1999a	C
;	C
Van	C
den	C
Wildenberg	C
et	C
al.	C
,	C
2008	C
)	C
.	C

In	C
the	C
current	C
study	C
,	C
this	C
KLP61F-driven	C
,	C
outward	C
ipMT	C
sliding	C
was	C
directly	C
visualized	C
by	C
monitoring	C
fluorescent	C
tubulin	C
speckle	C
behavior	C
(	C
Brust-Mascher	C
and	C
Scholey	C
,	C
2002	C
;	C
Brust-Mascher	C
et	C
al.	C
,	C
2004	C
)	C
,	C
and	C
it	C
appeared	C
to	C
be	C
antagonized	C
by	C
the	C
inward	C
sliding	C
of	C
ipMTs	C
during	C
prometaphase	C
.	C

In	O
support	O
of	O
this	O
,	O
the	O
decrease	O
in	O
pole–pole	O
separation	O
after	O
KLP61F	O
inhibition	O
occurs	O
without	O
spindle	O
pole	O
disorganization	O
,	O
as	O
documented	O
in	O
embryos	O
expressing	O
GFP-CNN	O
,	O
and	O
is	O
accompanied	O
by	O
an	O
increase	O
in	O
microtubule	O
density	O
,	O
as	O
revealed	O
by	O
an	O
increase	O
in	O
fluorescent	O
tubulin	O
intensity	O
at	O
the	O
central	O
spindle	O
,	O
consistent	O
with	O
the	O
proposed	O
sliding	O
filament	O
mechanism	O
(	O
Figure	O
2	O
)	O
.	O

The	C
results	C
obtained	C
with	C
sponge	C
and	C
scrambled	C
mutants	C
,	C
which	C
have	C
severely	C
disrupted	C
cortices	C
,	C
suggest	C
that	C
cortical	C
organization	C
,	C
and	C
by	C
inference	C
,	C
the	C
pulling	C
activity	C
of	C
cortical	C
force	C
generators	C
,	C
do	C
not	C
play	C
a	C
significant	C
role	C
in	C
spindle	C
pole	C
separation	C
after	C
NEB	C
.	C

This	C
is	C
consistent	C
with	C
the	C
hypothesis	C
that	C
KLP61F-driven	C
outward	C
sliding	C
of	C
ipMTs	C
,	C
augmented	C
at	C
specific	C
stages	C
by	C
other	C
ipMT-bound	C
proteins	C
such	C
as	C
KLP3A	C
(	C
Kwon	C
et	C
al.	C
,	C
2004	C
)	C
,	C
plays	C
a	C
central	C
role	C
.	C

We	C
do	C
not	C
want	C
to	C
extrapolate	C
our	C
sliding	C
filament	C
model	C
for	C
kinesin-5	C
function	C
in	C
Drosophila	C
syncytial	C
embryos	C
(	C
Figure	C
6	C
)	C
to	C
other	C
systems	C
where	C
the	C
molecular	C
mechanism	C
of	C
action	C
of	C
kinesin-5	C
may	C
be	C
different	C
(	C
e.g.	C
,	C
Kapoor	C
and	C
Mitchison	C
,	C
2001	C
;	C
Gardner	C
et	C
al.	C
,	C
2008	C
)	C
.	C

The	O
slow	O
,	O
plus-end–directed	O
motility	O
of	O
kinesin-5	O
was	O
first	O
observed	O
using	O
recombinant	O
motor	O
domain	O
subfragments	O
of	O
Eg5	O
(	O
Sawin	O
et	O
al.	O
,	O
1992	O
)	O
,	O
and	O
subsequently	O
,	O
in	O
elegant	O
,	O
pioneering	O
work	O
,	O
full-length	O
recombinant	O
Eg5	O
was	O
shown	O
to	O
cross-link	O
and	O
slide	O
adjacent	O
MTs	O
(	O
Kapitein	O
et	O
al.	O
,	O
2005	O
)	O
.	O

The	O
dynamic	O
behavior	O
of	O
Eg5	O
in	O
spindles	O
is	O
also	O
consistent	O
with	O
it	O
driving	O
MT–MT	O
sliding	O
(	O
Uteng	O
et	O
al.	O
,	O
2008	O
)	O
,	O
but	O
to	O
our	O
knowledge	O
,	O
the	O
ultrastructure	O
of	O
Eg5	O
and	O
the	O
properties	O
of	O
the	O
purified	O
native	O
protein	O
have	O
not	O
been	O
studied	O
.	O

The	O
yeast	O
kinesin-5	O
,	O
Kip1	O
,	O
has	O
a	O
bipolar	O
ultrastructure	O
,	O
like	O
the	O
Drosophila	O
embryo	O
protein	O
,	O
but	O
its	O
motility	O
properties	O
have	O
not	O
been	O
described	O
(	O
Gordon	O
and	O
Roof	O
,	O
1999	O
)	O
.	O

Elsewhere	C
,	C
many	C
kinesin-5	C
motors	C
have	C
not	C
been	C
purified	C
and	C
studied	C
biochemically	C
,	C
so	C
it	C
is	C
possible	C
that	C
some	C
kinesin-5	C
motors	C
may	C
act	C
differently	C
,	C
e.g.	C
,	C
serving	C
as	C
MT	C
depolymerases	C
(	C
Gardner	C
et	C
al.	C
,	C
2008	C
)	C
or	C
sliding	C
MTs	C
relative	C
to	C
a	C
spindle	C
matrix	C
(	C
Kapoor	C
and	C
Mitchison	C
,	C
2001	C
)	C
.	C

Purified	O
kinesin-5	O
motors	O
have	O
been	O
shown	O
to	O
slide	O
MTs	O
over	O
inert	O
surfaces	O
but	O
not	O
to	O
depolymerize	O
MTs	O
(	O
Sawin	O
et	O
al.	O
,	O
1992	O
;	O
Tao	O
et	O
al.	O
,	O
2006	O
)	O
.	O

Further	C
biochemical	C
studies	C
on	C
the	C
mechanism	C
of	C
action	C
of	C
purified	C
kinesin-5	C
from	C
multiple	C
systems	C
would	C
obviously	C
be	C
fruitful	C
.	C

Relation	O
to	O
Quantitative	O
Force-Balance	O
Models	O
for	O
Mitosis	O

System	O
level	O
and	O
reductionist	O
models	O
have	O
been	O
used	O
to	O
describe	O
spindle	O
pole	O
separation	O
after	O
NEB	O
in	O
Drosophila	O
(	O
Brust-Mascher	O
et	O
al.	O
,	O
2004	O
;	O
Goshima	O
et	O
al.	O
,	O
2005b	O
;	O
Wollman	O
et	O
al.	O
,	O
2008	O
;	O
Civelekoglu-Scholey	O
,	O
Tao	O
,	O
Wollman	O
,	O
Brust-Mascher	O
,	O
and	O
Scholey	O
,	O
unpublished	O
data	O
)	O
.	O

In	O
Wollman	O
et	O
al	O
.	O
(	O
2008	O
)	O
a	O
system	O
level	O
search	O
was	O
undertaken	O
to	O
find	O
the	O
integration	O
of	O
force	O
generator	O
activity	O
that	O
best	O
explains	O
spindle	O
pole	O
separation	O
versus	O
time	O
in	O
embryos	O
,	O
using	O
experimental	O
data	O
to	O
constrain	O
the	O
number	O
of	O
plausible	O
models	O
.	O

Although	O
~1000	O
models	O
emerged	O
from	O
the	O
search	O
,	O
these	O
models	O
fall	O
into	O
only	O
six	O
groups	O
,	O
which	O
fit	O
the	O
experimental	O
data	O
,	O
including	O
most	O
of	O
the	O
data	O
on	O
spindle	O
pole	O
separation	O
presented	O
here	O
,	O
remarkably	O
well	O
.	O

Some	C
discrepancies	C
remain	C
,	C
e.g.	C
,	C
the	C
timing	C
of	C
activation	C
of	C
Ncd	C
,	C
but	C
this	C
is	C
perhaps	C
not	C
surprising	C
,	C
given	C
the	C
inherent	C
assumptions	C
in	C
such	C
a	C
broad	C
theoretical	C
approach	C
.	C

Reductionist	O
models	O
were	O
developed	O
for	O
Drosophila	O
S2	O
cells	O
(	O
Goshima	O
et	O
al.	O
,	O
2005b	O
)	O
and	O
for	O
embryos	O
(	O
Brust-Mascher	O
et	O
al.	O
,	O
2004	O
;	O
Civelekoglu-Scholey	O
,	O
G.	O
,	O
Tao	O
,	O
L.	O
,	O
Wollman	O
,	O
R.	O
,	O
Brust-Mascher	O
,	O
I.	O
,	O
and	O
Scholey	O
,	O
J.M.	O
,	O
unpublished	O
data	O
)	O
.	O

In	O
the	O
former	O
model	O
,	O
which	O
complemented	O
novel	O
high	O
throughput	O
microscopy	O
and	O
RNAi	O
experiments	O
,	O
coupling	O
of	O
outward	O
ipMT	O
sliding	O
to	O
MT	O
depolymerization	O
at	O
the	O
poles	O
was	O
introduced	O
to	O
account	O
for	O
the	O
lack	O
of	O
effect	O
of	O
KLP61F	O
concentration	O
on	O
spindle	O
length	O
.	O

We	C
now	C
understand	C
that	C
this	C
model	C
contains	C
a	C
physically	C
unrealistic	C
assumption	C
in	C
which	C
an	C
inward	C
motion	C
of	C
the	C
poles	C
through	C
increased	C
depolymerization	C
,	C
coupled	C
to	C
decreased	C
sliding	C
,	C
occurs	C
in	C
the	C
absence	C
of	C
an	C
associated	C
force	C
to	C
drive	C
this	C
movement	C
.	C

Of	C
course	C
,	C
this	C
imperfection	C
would	C
remain	C
undetected	C
if	C
the	C
same	C
mechanism	C
had	C
been	C
described	C
only	C
qualitatively	C
,	C
but	C
it	C
shows	C
that	C
this	C
model	C
requires	C
further	C
refinement	C
to	C
explain	C
the	C
KLP61F	C
concentration	C
versus	C
spindle	C
length	C
data	C
.	C

The	O
latter	O
models	O
were	O
based	O
closely	O
on	O
experimental	O
data	O
,	O
including	O
the	O
dynamics	O
,	O
physical	O
properties	O
,	O
and	O
geometry	O
of	O
embryo	O
spindles	O
as	O
well	O
as	O
the	O
biochemical	O
properties	O
of	O
MTs	O
and	O
mitotic	O
motors	O
.	O

The	O
Anaphase	O
B	O
(	O
Brust-Mascher	O
et	O
al.	O
,	O
2004	O
)	O
model	O
made	O
several	O
useful	O
predictions	O
,	O
for	O
example	O
,	O
that	O
although	O
KLP61F	O
acts	O
on	O
dynamically	O
unstable	O
ipMTs	O
to	O
drive	O
steady	O
spindle	O
elongation	O
,	O
the	O
actual	O
rate	O
of	O
anaphase	O
B	O
is	O
insensitive	O
to	O
KLP61F	O
concentration	O
,	O
in	O
agreement	O
with	O
the	O
experimental	O
data	O
presented	O
here	O
.	O

It	O
also	O
predicts	O
a	O
spatial	O
gradient	O
of	O
MT	O
catastrophe	O
events	O
at	O
anaphase	O
B	O
onset	O
,	O
which	O
would	O
be	O
difficult	O
to	O
formulate	O
using	O
purely	O
qualitative	O
arguments	O
and	O
which	O
is	O
now	O
being	O
tested	O
(	O
Cheerambathur	O
et	O
al.	O
,	O
2007	O
)	O
.	O

In	O
the	O
prometaphase	O
model	O
,	O
the	O
proposed	O
KLP61F	O
and	O
Ncd	O
force	O
balance	O
was	O
subjected	O
to	O
a	O
focused	O
reductionist	O
analysis	O
of	O
individual	O
spindles	O
and	O
purified	O
proteins	O
(	O
Civelekoglu-Scholey	O
,	O
Tao	O
,	O
Brust-Mascher	O
,	O
Wollman	O
,	O
and	O
Scholey	O
,	O
unpublished	O
data	O
)	O
.	O

This	C
work	C
supports	C
the	C
idea	C
that	C
the	C
KLP61F/Ncd	C
force	C
balance	C
engages	C
immediately	C
after	C
NEB	C
as	C
dynamic	C
ipMT	C
bundles	C
start	C
to	C
form	C
,	C
whereas	C
the	C
subsequent	C
elongation	C
phase	C
requires	C
additional	C
outward	C
acting	C
force-generators	C
,	C
for	C
example	C
,	C
KLP3A	C
on	C
chromosome	C
arms	C
and	C
cortical	C
dynein	C
(	C
Sharp	C
et	C
al.	C
,	C
2000a	C
;	C
Kwon	C
et	C
al.	C
,	C
2004	C
)	C
.	C

Although	O
all	O
modeling	O
approaches	O
are	O
useful	O
and	O
merit	O
further	O
refinement	O
and	O
exploration	O
,	O
reductionist	O
models	O
that	O
pay	O
close	O
attention	O
to	O
both	O
experimental	O
evidence	O
and	O
physical	O
chemical	O
principles	O
provide	O
the	O
most	O
useful	O
and	O
realistic	O
descriptions	O
of	O
mitosis	O
.	O

Our	C
own	C
force-balance	C
models	C
for	C
spindle	C
assembly	C
and	C
function	C
are	C
based	C
on	C
the	C
premise	C
that	C
antagonistic	C
motors	C
mediate	C
the	C
relative	C
sliding	C
(	C
e.g.	C
,	C
kinesin-5	C
and	C
-14	C
)	C
or	C
depolymerization	C
(	C
e.g.	C
,	C
kinesin-13	C
)	C
of	C
ipMTs	C
,	C
but	C
other	C
scenarios	C
are	C
also	C
possible	C
.	C

For	C
example	C
,	C
a	C
new	C
“slide-and-cluster”	C
model	C
for	C
anastral	C
spindle	C
assembly	C
proposes	C
that	C
kinesin-5	C
transports	C
MTs	C
that	C
assemble	C
around	C
chromosomes	C
to	C
the	C
spindle	C
poles	C
where	C
they	C
are	C
focused	C
by	C
minus-end–directed	C
motors	C
(	C
Burbank	C
et	C
al.	C
,	C
2007	C
)	C
.	C

This	C
model	C
apparently	C
generates	C
a	C
force-balance	C
capable	C
of	C
maintaining	C
a	C
robust	C
steady-state	C
spindle	C
length	C
,	C
and	C
it	C
provides	C
a	C
plausible	C
description	C
of	C
chromosome-directed	C
,	C
anastral	C
spindle	C
assembly	C
in	C
Xenopus	C
extracts	C
and	C
elsewhere	C
,	C
possibly	C
including	C
Drosophila	C
late	C
embryos/larvae	C
and	C
S2	C
cells	C
.	C

However	C
,	C
in	C
Drosophila	C
syncytial	C
embryo	C
spindles	C
,	C
where	C
MT	C
assembly	C
is	C
nucleated	C
predominantly	C
at	C
centrosomes	C
,	C
MTs	C
turn	C
over	C
very	C
quickly	C
(	C
half-time	C
,	C
5	C
s	C
)	C
,	C
and	C
it	C
seems	C
unlikely	C
that	C
kinesin-5	C
would	C
have	C
sufficient	C
time	C
to	C
transport	C
MTs	C
to	C
the	C
spindle	C
poles	C
for	C
focusing	C
there	C
(	C
Cheerambathur	C
et	C
al.	C
,	C
2007	C
)	C
.	C

This	C
suggestion	C
again	C
implies	C
that	C
kinesin-5	C
is	C
deployed	C
in	C
different	C
ways	C
in	C
different	C
systems	C
.	C

Summary	O

This	O
comprehensive	O
study	O
has	O
revealed	O
the	O
spectrum	O
of	O
mitotic	O
functions	O
of	O
the	O
kinesin-5	O
motor	O
,	O
KLP61F	O
,	O
in	O
a	O
single	O
system	O
,	O
the	O
Drosophila	O
embryo	O
.	O

We	O
conclude	O
that	O
KLP61F	O
has	O
multiple	O
mitotic	O
functions	O
,	O
all	O
of	O
which	O
are	O
consistent	O
with	O
its	O
MT–MT	O
cross-linking	O
and	O
antiparallel	O
MT	O
sliding	O
activity	O
.	O

Distinct	O
Roles	O
for	O
FOXP3+	O
and	O
FOXP3-	O
CD4+	O
T	O
Cells	O
in	O
Regulating	O
Cellular	O
Immunity	O
to	O
Uncomplicated	O
and	O
Severe	O
Plasmodium	O
falciparum	O
Malaria	O

Abstract	O

Failure	C
to	C
establish	C
an	C
appropriate	C
balance	C
between	C
pro-	C
and	C
anti-inflammatory	C
immune	C
responses	C
is	C
believed	C
to	C
contribute	C
to	C
pathogenesis	C
of	C
severe	C
malaria	C
.	C

To	C
determine	C
whether	C
this	C
balance	C
is	C
maintained	C
by	C
classical	C
regulatory	C
T	C
cells	C
(	C
CD4+	C
FOXP3+	C
CD127-/low	C
;	C
Tregs	C
)	C
we	C
compared	C
cellular	C
responses	C
between	C
Gambian	C
children	C
(	C
n=124	C
)	C
with	C
severe	C
Plasmodium	C
falciparum	C
malaria	C
or	C
uncomplicated	C
malaria	C
infections	C
.	C

Although	O
no	O
significant	O
differences	O
in	O
Treg	O
numbers	O
or	O
function	O
were	O
observed	O
between	O
the	O
groups	O
,	O
Treg	O
activity	O
during	O
acute	O
disease	O
was	O
inversely	O
correlated	O
with	O
malaria-specific	O
memory	O
responses	O
detectable	O
28	O
days	O
later	O
.	O

Thus	C
,	C
while	C
Tregs	C
may	C
not	C
regulate	C
acute	C
malarial	C
inflammation	C
,	C
they	C
may	C
limit	C
memory	C
responses	C
to	C
levels	C
that	C
subsequently	C
facilitate	C
parasite	C
clearance	C
without	C
causing	C
immunopathology	C
.	C

Importantly	O
,	O
we	O
identified	O
a	O
population	O
of	O
FOXP3-	O
,	O
CD45RO+	O
CD4+	O
T	O
cells	O
which	O
coproduce	O
IL-10	O
and	O
IFN-γ	O
.	O

These	C
cells	C
are	C
more	C
prevalent	C
in	C
children	C
with	C
uncomplicated	C
malaria	C
than	C
in	C
those	C
with	C
severe	C
disease	C
,	C
suggesting	C
that	C
they	C
may	C
be	C
the	C
regulators	C
of	C
acute	C
malarial	C
inflammation	C
.	C

Author	O
Summary	O

While	C
Tregs	C
have	C
been	C
implicated	C
in	C
regulation	C
of	C
the	C
immune	C
response	C
to	C
chronic	C
infections	C
,	C
their	C
potential	C
in	C
determining	C
disease	C
outcome	C
in	C
acute	C
infections	C
is	C
unclear	C
.	C

In	C
this	C
study	C
we	C
have	C
found	C
that	C
Tregs	C
are	C
unable	C
to	C
control	C
the	C
florid	C
inflammation	C
during	C
acute	C
,	C
severe	C
P.	C
falciparum	C
malaria	C
infections	C
,	C
suggesting	C
that	C
this	C
component	C
of	C
the	C
immunoregulatory	C
arsenal	C
may	C
be	C
rapidly	C
overwhelmed	C
by	C
virulent	C
infections	C
.	C

Further	C
,	C
we	C
identified	C
,	C
for	C
the	C
first	C
time	C
in	C
an	C
acute	C
human	C
infection	C
,	C
a	C
population	C
of	C
IL-10-producing	C
Th-1	C
effector	C
cells	C
and	C
found	C
that	C
IL-10-producing	C
Th-1	C
cells	C
were	C
associated	C
with	C
development	C
of	C
uncomplicated	C
as	C
opposed	C
to	C
severe	C
malaria	C
,	C
leading	C
us	C
to	C
suggest	C
that	C
such	C
“self-regulating”	C
Th-1	C
cells	C
may	C
contribute	C
to	C
clearing	C
malaria	C
infections	C
without	C
inducing	C
immune-mediated	C
pathology	C
.	C

In	C
addition	C
,	C
we	C
found	C
evidence	C
that	C
malaria-induced	C
Tregs	C
may	C
limit	C
the	C
magnitude	C
of	C
malaria-specific	C
memory	C
responses	C
detectable	C
28	C
days	C
later	C
,	C
which	C
may	C
reduce	C
the	C
risk	C
of	C
immune-mediated	C
pathology	C
upon	C
reinfection	C
and	C
may	C
explain	C
how	C
immunity	C
to	C
severe	C
disease	C
can	C
be	C
gained	C
after	C
as	C
little	C
as	C
one	C
or	C
two	C
infections	C
.	C

We	O
conclude	O
that	O
vaccines	O
designed	O
to	O
induce	O
cell-mediated	O
responses	O
should	O
be	O
assessed	O
for	O
their	O
ability	O
to	O
induce	O
IL-10	O
producing	O
Th-1	O
cells	O
and	O
Tregs	O
.	O

Introduction	O

The	C
clinical	C
spectrum	C
of	C
P.	C
falciparum	C
infection	C
ranges	C
from	C
asymptomatic	C
parasite	C
carriage	C
to	C
a	C
febrile	C
disease	C
that	C
may	C
develop	C
into	C
a	C
severe	C
,	C
life-threatening	C
illness	C
.	C

The	C
factors	C
that	C
determine	C
disease	C
severity	C
are	C
not	C
completely	C
understood	C
but	C
are	C
likely	C
to	C
include	C
both	C
parasite	C
and	C
host	C
components	C
[	C
1	C
]	C
–	C
[	C
3	C
]	C
.	C

Ultimately	C
,	C
the	C
interplay	C
between	C
the	C
parasite	C
and	C
the	C
immune	C
response	C
likely	C
determines	C
the	C
outcome	C
of	C
the	C
infection	C
[	C
4	C
]	C
.	C

Although	C
sterile	C
immunity	C
-	C
completely	C
preventing	C
re-infection	C
-	C
is	C
hardly	C
ever	C
seen	C
and	C
protection	C
against	C
clinical	C
symptoms	C
of	C
uncomplicated	C
disease	C
is	C
only	C
acquired	C
after	C
repeated	C
infections	C
[	C
5	C
]	C
,	C
immunity	C
to	C
severe	C
disease	C
and	C
death	C
may	C
be	C
acquired	C
after	C
as	C
few	C
as	C
one	C
or	C
two	C
infections	C
[	C
6	C
]	C
suggesting	C
that	C
different	C
immune	C
mechanisms	C
underlie	C
these	C
different	C
levels	C
of	C
immunity	C
.	C

While	C
there	C
is	C
a	C
growing	C
consensus	C
that	C
killing	C
of	C
malaria	C
parasites	C
or	C
malaria-infected	C
red	C
blood	C
cells	C
requires	C
the	C
synergistic	C
action	C
of	C
antibodies	C
and	C
cell-mediated	C
immune	C
responses	C
[	C
5	C
]	C
,	C
[	C
7	C
]	C
,	C
the	C
mechanisms	C
conferring	C
protection	C
against	C
severe	C
disease	C
are	C
less	C
clear	C
.	C

Given	C
that	C
pathology	C
of	C
severe	C
disease	C
has	C
repeatedly	C
been	C
linked	C
to	C
sustained	C
and/or	C
excessive	C
inflammatory	C
responses	C
[	C
4	C
]	C
,	C
acquiring	C
the	C
ability	C
to	C
regulate	C
these	C
responses	C
adequately	C
may	C
be	C
a	C
key	C
determinant	C
of	C
immunity	C
that	C
protects	C
against	C
severe	C
disease	C
[	C
8	C
]	C
.	C

Thus	O
,	O
while	O
an	O
early	O
inflammatory	O
response	O
is	O
needed	O
to	O
control	O
parasite	O
replication	O
in	O
human	O
P.	O
falciparum	O
malaria	O
[	O
9	O
]	O
–	O
[	O
11	O
]	O
,	O
excessive	O
levels	O
of	O
pro-inflammatory	O
cytokines	O
such	O
as	O
TNF-α	O
[	O
12	O
]	O
–	O
[	O
15	O
]	O
,	O
IFN-γ	O
,	O
[	O
16	O
]	O
,	O
[	O
17	O
]	O
,	O
IL-1ß	O
and	O
IL-6	O
[	O
14	O
]	O
,	O
[	O
18	O
]	O
,	O
[	O
19	O
]	O
are	O
associated	O
with	O
severe	O
pathology	O
.	O

Conversely	O
,	O
low	O
levels	O
of	O
regulatory	O
cytokines	O
such	O
as	O
TGF-ß	O
have	O
been	O
associated	O
with	O
acute	O
[	O
20	O
]	O
and	O
severe	O
malaria	O
[	O
21	O
]	O
,	O
[	O
22	O
]	O
,	O
a	O
relative	O
deficiency	O
in	O
IL-10	O
was	O
seen	O
in	O
those	O
who	O
succumbed	O
to	O
severe	O
malaria	O
[	O
23	O
]	O
,	O
significantly	O
lower	O
ratios	O
of	O
IL-10	O
to	O
TNF-α	O
were	O
found	O
in	O
patients	O
with	O
severe	O
malarial	O
anaemia	O
[	O
24	O
]	O
,	O
[	O
25	O
]	O
,	O
and	O
high	O
ratios	O
of	O
IFN-γ	O
,	O
TNF-α	O
and	O
IL-12	O
to	O
TGF-ß	O
or	O
IL-10	O
were	O
associated	O
with	O
decreased	O
risk	O
of	O
malaria	O
but	O
increased	O
risk	O
of	O
clinical	O
disease	O
in	O
those	O
who	O
became	O
infected	O
[	O
26	O
]	O
.	O

In	C
summary	C
,	C
therefore	C
,	C
immunity	C
against	C
severe	C
malaria	C
may	C
depend	C
upon	C
the	C
host	C
's	C
ability	C
to	C
regulate	C
the	C
magnitude	C
and	C
timing	C
of	C
the	C
cellular	C
immune	C
response	C
,	C
allowing	C
the	C
sequential	C
induction	C
of	C
appropriate	C
levels	C
of	C
inflammatory-	C
and	C
anti-inflammatory	C
cytokines	C
at	C
key	C
stages	C
of	C
the	C
infection	C
.	C

Given	O
these	O
associations	O
between	O
severe	O
disease	O
and	O
exacerbated	O
immune	O
pathology	O
,	O
a	O
number	O
of	O
studies	O
have	O
explored	O
the	O
role	O
of	O
CD4+CD25hiFOXP3+CD127-/lo	O
regulatory	O
T	O
cells	O
(	O
Tregs	O
)	O
in	O
determining	O
the	O
outcome	O
of	O
malaria	O
infection	O
.	O

Induced	C
and/or	C
activated	C
in	C
response	C
to	C
malaria	C
infection	C
[	C
27	C
]	C
,	C
Tregs	C
may	C
be	C
beneficial	C
to	C
the	C
host	C
in	C
the	C
later	C
part	C
of	C
the	C
infection	C
-	C
when	C
parasitaemia	C
is	C
being	C
cleared	C
-	C
by	C
down-regulating	C
the	C
inflammatory	C
response	C
and	C
thereby	C
preventing	C
immune-mediated	C
pathology	C
.	C

On	C
the	C
other	C
hand	C
,	C
if	C
Tregs	C
mediate	C
their	C
suppressive	C
effects	C
too	C
early	C
,	C
this	C
could	C
hamper	C
the	C
responses	C
required	C
for	C
initial	C
control	C
of	C
parasitaemia	C
,	C
permitting	C
unbridled	C
parasite	C
growth	C
which	C
may	C
also	C
lead	C
to	C
severe	C
disease	C
.	C

Malaria-specific	C
induction	C
of	C
Tregs	C
has	C
been	C
observed	C
in	C
a	C
variety	C
of	C
experimental	C
malaria	C
infections	C
in	C
mice	C
[	C
28	C
]	C
–	C
[	C
31	C
]	C
,	C
but	C
their	C
role	C
in	C
preventing	C
severe	C
malarial	C
pathology	C
is	C
unclear	C
.	C

Thus	O
,	O
in	O
BALB/c	O
mice	O
infected	O
with	O
a	O
lethal	O
strain	O
of	O
P.	O
yoelii	O
,	O
ablation	O
of	O
Treg	O
activity	O
by	O
depletion	O
of	O
CD25+	O
cells	O
either	O
allowed	O
mice	O
to	O
control	O
parasitaemia	O
and	O
survive	O
[	O
32	O
]	O
or	O
had	O
no	O
impact	O
on	O
the	O
course	O
of	O
disease	O
[	O
33	O
]	O
.	O

Depleting	C
CD25+	C
cells	C
of	C
BALB/c	C
mice	C
infected	C
with	C
either	C
P.	C
berghei	C
NK65	C
[	C
34	C
]	C
or	C
P	C
berghei	C
ANKA	C
[	C
35	C
]	C
reduced	C
neither	C
parasitaemia	C
nor	C
mortality	C
,	C
but	C
increased	C
the	C
severity	C
of	C
symptoms	C
in	C
the	C
diseased	C
mice	C
,	C
suggesting	C
at	C
least	C
some	C
benefit	C
from	C
Tregs	C
in	C
this	C
model	C
.	C

Rather	O
oddly	O
,	O
infection	O
of	O
CD25+	O
T	O
cell-depleted	O
BALB/c	O
mice	O
with	O
P.	O
chabaudi	O
adami	O
DS	O
led	O
to	O
increased	O
parasitaemia	O
and	O
more	O
severe	O
anaemia	O
[	O
30	O
]	O
.	O

Finally	O
,	O
CD25+	O
T	O
cell	O
depletion	O
around	O
the	O
time	O
of	O
parasite	O
inoculation	O
reduced	O
the	O
incidence	O
of	O
experimental	O
cerebral	O
malaria	O
in	O
C57BL/6	O
mice	O
infected	O
with	O
P.	O
berghei	O
ANKA	O
in	O
two	O
independent	O
studies	O
[	O
29	O
]	O
,	O
[	O
31	O
]	O
,	O
but	O
not	O
when	O
CD25+	O
T	O
cells	O
were	O
depleted	O
30	O
days	O
prior	O
to	O
infection	O
[	O
31	O
]	O
.	O

Whilst	O
various	O
explanations	O
have	O
been	O
offered	O
for	O
these	O
discrepant	O
results	O
,	O
including	O
differences	O
in	O
the	O
various	O
strains	O
of	O
mice	O
and	O
parasites	O
employed	O
,	O
the	O
microbial	O
microenvironment	O
in	O
which	O
the	O
mice	O
are	O
kept	O
,	O
and	O
the	O
precise	O
CD25	O
depletion	O
protocols	O
employed	O
,	O
these	O
studies	O
are	O
currently	O
not	O
very	O
helpful	O
when	O
trying	O
to	O
understand	O
the	O
role	O
of	O
Tregs	O
in	O
human	O
malaria	O
infections	O
.	O

Malaria	C
naive	C
individuals	C
undergoing	C
experimental	C
P.	C
falciparum	C
sporozoite	C
infection	C
showed	C
an	C
increase	C
in	C
FOXP3	C
mRNA	C
expression	C
and	C
expansion	C
of	C
Tregs	C
10	C
days	C
after	C
infection	C
;	C
Treg	C
induction	C
correlated	C
with	C
high	C
circulating	C
levels	C
of	C
TGF-ß	C
,	C
low	C
levels	C
of	C
pro-inflammatory	C
cytokines	C
and	C
rapid	C
parasite	C
growth	C
[	C
27	C
]	C
suggesting	C
-	C
but	C
not	C
proving	C
-	C
that	C
Treg	C
activation	C
early	C
in	C
infection	C
may	C
inhibit	C
the	C
development	C
of	C
effective	C
cellular	C
immunity	C
.	C

More	C
recently	C
,	C
we	C
have	C
observed	C
that	C
Treg	C
populations	C
appear	C
to	C
be	C
transiently	C
expanded	C
and	C
activated	C
during	C
the	C
malaria	C
transmission	C
season	C
in	C
individuals	C
from	C
a	C
malaria	C
endemic	C
community	C
[	C
36	C
]	C
,	C
again	C
suggesting	C
that	C
naturally	C
acquired	C
malaria	C
infection	C
can	C
drive	C
the	C
expansion	C
and	C
activation	C
of	C
Tregs	C
.	C

However	C
,	C
although	C
Tregs	C
have	C
been	C
implicated	C
in	C
IL-10-mediated	C
down-regulation	C
of	C
Th1-like	C
responses	C
in	C
the	C
placenta	C
of	C
malaria-infected	C
women	C
[	C
37	C
]	C
and	C
reduced	C
Treg	C
frequencies	C
and	C
function	C
have	C
been	C
linked	C
to	C
enhanced	C
anti-parasite	C
immunity	C
in	C
certain	C
ethnic	C
groups	C
in	C
West	C
Africa	C
[	C
38	C
]	C
the	C
potential	C
for	C
Tregs	C
to	C
influence	C
the	C
clinical	C
outcome	C
of	C
malaria	C
infections	C
is	C
still	C
unclear	C
.	C

To	O
investigate	O
the	O
role	O
of	O
Tregs	O
during	O
clinical	O
malaria	O
infection	O
,	O
we	O
have	O
compared	O
cellular	O
immune	O
responses	O
of	O
children	O
with	O
either	O
severe	O
or	O
uncomplicated	O
malaria	O
.	O

Interestingly	C
,	C
although	C
we	C
did	C
not	C
observe	C
any	C
significant	C
differences	C
in	C
Treg	C
numbers	C
or	C
function	C
between	C
severe	C
and	C
uncomplicated	C
malaria	C
cases	C
,	C
our	C
data	C
do	C
indicate	C
that	C
malaria-induced	C
Tregs	C
may	C
limit	C
the	C
magnitude	C
of	C
malaria-specific	C
Th1	C
memory	C
responses	C
and	C
thus	C
moderate	C
pro-inflammatory	C
responses	C
to	C
subsequent	C
infections	C
,	C
providing	C
a	C
possible	C
explanation	C
for	C
the	C
very	C
rapid	C
acquisition	C
of	C
immunity	C
to	C
severe	C
malaria	C
.	C

Moreover	O
,	O
we	O
have	O
identified	O
a	O
population	O
of	O
FOXP3-	O
,	O
CD45RO+	O
,	O
CD4+	O
T	O
cells	O
which	O
co-produce	O
IL-10	O
and	O
IFN-γ	O
and	O
which	O
are	O
more	O
prevalent	O
in	O
children	O
with	O
uncomplicated	O
malaria	O
than	O
in	O
those	O
with	O
severe	O
disease	O
.	O

We	C
suggest	C
that	C
these	C
IL-10	C
producing	C
effector	C
T	C
cells	C
may	C
contribute	C
to	C
clearing	C
malaria	C
infection	C
without-inducing	C
immune-mediated	C
pathology	C
.	C

Results	O

Immune	O
responses	O
of	O
59	O
Gambian	O
children	O
with	O
severe	O
P.	O
falciparum	O
malaria	O
were	O
compared	O
with	O
those	O
of	O
65	O
children	O
with	O
uncomplicated	O
clinical	O
malaria	O
and	O
with	O
20	O
healthy	O
(	O
control	O
)	O
children	O
of	O
similar	O
age	O
and	O
recruited	O
from	O
the	O
same	O
study	O
area	O
at	O
the	O
same	O
time	O
(	O
Table	O
1	O
)	O
.	O

On	C
admission	C
,	C
only	C
12	C
(	C
9.4	C
%	C
)	C
patients	C
had	C
a	C
white	C
blood	C
cell	C
count	C
(	C
WBC	C
)	C
above	C
the	C
age-specific	C
norm	C
and	C
there	C
was	C
no	C
significant	C
difference	C
in	C
median	C
WBC	C
count	C
between	C
uncomplicated	C
and	C
severe	C
cases	C
,	C
suggesting	C
that	C
few	C
if	C
any	C
children	C
had	C
a	C
concomitant	C
systemic	C
bacterial	C
infection	C
.	C

No	O
difference	O
was	O
observed	O
in	O
the	O
differential	O
WBC	O
between	O
the	O
two	O
groups	O
.	O

As	O
expected	O
,	O
[	O
39	O
]	O
–	O
[	O
41	O
]	O
numbers	O
of	O
lymphocytes	O
,	O
CD3+	O
and	O
CD4+	O
T	O
cells	O
were	O
significantly	O
lower	O
during	O
the	O
acute	O
disease	O
than	O
during	O
convalescence	O
in	O
both	O
the	O
severe	O
and	O
the	O
uncomplicated	O
groups	O
(	O
Table	O
1A	O
)	O
.	O

Parasite	O
density	O
on	O
admission	O
was	O
two-fold	O
higher	O
in	O
patients	O
with	O
severe	O
malaria	O
than	O
in	O
those	O
with	O
uncomplicated	O
malaria	O
;	O
severely	O
ill	O
children	O
also	O
had	O
significantly	O
lower	O
hemoglobin	O
levels	O
and	O
were	O
on	O
average	O
2.4	O
years	O
younger	O
than	O
children	O
with	O
uncomplicated	O
disease	O
.	O

The	O
number	O
of	O
P.	O
falciparum	O
clones	O
per	O
clinical	O
isolate	O
ranged	O
from	O
1	O
to	O
4	O
(	O
with	O
an	O
overall	O
mean	O
of	O
2	O
(	O
CI95	O
%	O
:	O
1.8–2.1	O
)	O
)	O
,	O
and	O
–	O
as	O
has	O
been	O
observed	O
previously	O
[	O
42	O
]	O
-	O
did	O
not	O
differ	O
significantly	O
between	O
the	O
three	O
groups	O
(	O
p=0.3	O
,	O
Table	O
1B	O
)	O
.	O

Other	C
factors	C
potentially	C
confounding	C
immune	C
responses	C
,	C
such	C
as	C
the	C
degree	C
of	C
malnutrition	C
or	C
intestinal	C
helminth	C
infections	C
were	C
of	C
similarly	C
low	C
prevalence	C
in	C
both	C
severe	C
and	C
uncomplicated	C
malaria	C
cases	C
and	C
were	C
not	C
associated	C
with	C
severity	C
of	C
disease	C
(	C
Table	C
1B	C
)	C
.	C

Characteristics	O
of	O
study	O
participants	O
(	O
A	O
)	O
and	O
distribution	O
of	O
potential	O
confounding	O
factors	O
(	O
B	O
)	O
.	O

For	O
statistical	O
analysis	O
,	O
patients	O
were	O
classified	O
as	O
uncomplicated	O
or	O
severe	O
cases	O
,	O
with	O
the	O
latter	O
being	O
further	O
subdivided	O
into	O
those	O
patients	O
suffering	O
from	O
cerebral	O
malaria	O
(	O
CM	O
)	O
,	O
severe	O
anaemia	O
(	O
SA	O
)	O
or	O
severe	O
respiratory	O
distress	O
(	O
SRD	O
)	O
(	O
grouped	O
together	O
as	O
SA	O
)	O
and	O
those	O
suffering	O
only	O
from	O
severe	O
pr	O
ostration	O
(	O
grouped	O
as	O
SB	O
)	O
.	O

Data	O
were	O
analysed	O
using	O
linear	O
regression	O
,	O
with	O
a	O
random	O
effect	O
to	O
allow	O
for	O
the	O
within	O
subject	O
measurements	O
over	O
time	O
,	O
adjusting	O
for	O
age	O
,	O
sex	O
,	O
duration	O
of	O
prior	O
symptoms	O
and	O
numbers	O
of	O
clones	O
causing	O
the	O
infection	O
.	O

Due	O
to	O
the	O
multiplicity	O
of	O
comparisons	O
that	O
were	O
made	O
within	O
the	O
model	O
,	O
resulting	O
from	O
multiple	O
responses	O
and	O
multiple	O
comparisons	O
within	O
response	O
,	O
hypotheses	O
rejected	O
with	O
a	O
probability	O
of	O
less	O
than	O
0.012	O
have	O
a	O
false	O
discovery	O
rate	O
of	O
5	O
%	O
[	O
43	O
]	O
.	O

Similar	O
numbers	O
and	O
proportions	O
of	O
Tregs	O
among	O
uncomplicated	O
and	O
severe	O
malaria	O
cases	O
,	O
increasing	O
during	O
convalescence	O

We	C
hypothesized	C
that	C
children	C
with	C
severe	C
malaria	C
would	C
have	C
fewer	C
circulating	C
Tregs	C
than	C
children	C
with	C
uncomplicated	C
malaria	C
,	C
or	C
that	C
Tregs	C
of	C
severely	C
ill	C
children	C
would	C
be	C
less	C
active	C
than	C
those	C
of	C
children	C
with	C
uncomplicated	C
disease	C
.	C

However	O
,	O
the	O
proportion	O
of	O
cells	O
expressing	O
a	O
Treg	O
phenotype	O
(	O
defined	O
by	O
flow	O
cytometry	O
as	O
CD3+CD4+	O
lymphocytes	O
being	O
FOXP3+and	O
CD127-/low	O
;	O
Figure	O
1A	O
,	O
1B	O
,	O
and	O
1C	O
)	O
was	O
similar	O
in	O
the	O
acute	O
(	O
D0	O
)	O
and	O
the	O
convalescent	O
phase	O
(	O
D28	O
)	O
for	O
both	O
uncomplicated	O
and	O
severe	O
cases	O
(	O
SA+SB	O
)	O
and	O
in	O
healthy	O
control	O
children	O
;	O
on	O
average	O
,	O
2–3	O
%	O
of	O
CD4+	O
T	O
cells	O
expressed	O
the	O
regulatory	O
phenotype	O
(	O
Figure	O
1D	O
)	O
.	O

However	O
,	O
when	O
the	O
number	O
of	O
cells	O
expressing	O
a	O
Treg	O
phenotype	O
was	O
calculated	O
using	O
lymphocyte	O
and	O
monocyte	O
counts	O
from	O
the	O
differential	O
WBC	O
,	O
we	O
found	O
that	O
the	O
absolute	O
numbers	O
of	O
Tregs	O
(	O
per	O
litre	O
of	O
blood	O
)	O
were	O
significantly	O
and	O
similarly	O
elevated	O
in	O
both	O
severe	O
and	O
uncomplicated	O
malaria	O
cases	O
during	O
convalescence	O
when	O
compared	O
to	O
the	O
acute	O
phase	O
(	O
p	O
<	O
0.001	O
)	O
or	O
when	O
compared	O
to	O
the	O
control	O
group	O
of	O
healthy	O
children	O
(	O
p=0.037	O
)	O
(	O
Figure	O
1E	O
)	O
.	O

A	O
similar	O
kinetic	O
was	O
observed	O
for	O
FOXP3	O
mRNA	O
levels	O
(	O
Figure	O
1F	O
)	O
.	O

Similar	O
number	O
and	O
proportion	O
of	O
Tregs	O
in	O
uncomplicated	O
and	O
severe	O
disease	O
,	O
increasing	O
during	O
convalescence	O
.	O

Although	O
not	O
supportive	O
of	O
our	O
original	O
hypothesis	O
,	O
these	O
observations	O
are	O
consistent	O
with	O
the	O
notion	O
that	O
acute	O
malaria	O
infection	O
drives	O
expansion	O
of	O
Treg	O
populations	O
which	O
then	O
persist	O
for	O
some	O
weeks	O
to	O
maintain	O
immune	O
homeostasis	O
during	O
the	O
contraction	O
phase	O
of	O
the	O
effector	O
response	O
[	O
36	O
]	O
.	O

In	O
accordance	O
with	O
this	O
notion	O
,	O
and	O
in	O
agreement	O
with	O
our	O
previous	O
observation	O
that	O
increased	O
levels	O
of	O
Tregs	O
were	O
associated	O
with	O
faster	O
parasite	O
growth	O
during	O
the	O
early	O
stages	O
of	O
blood	O
stage	O
infection	O
[	O
27	O
]	O
,	O
we	O
observe	O
here	O
in	O
-	O
children	O
with	O
either	O
severe	O
or	O
uncomplicated	O
malaria	O
infections	O
-	O
a	O
significant	O
positive	O
correlation	O
between	O
parasite	O
density	O
and	O
the	O
frequency	O
of	O
Tregs	O
within	O
the	O
CD4+	O
T	O
cell	O
population	O
(	O
p=0.002	O
,	O
Figure	O
2	O
)	O
.	O

Proportion	O
of	O
T	O
cells	O
expressing	O
a	O
Treg	O
phenotype	O
correlates	O
with	O
parasitaemia	O
.	O

Tregs	O
display	O
an	O
activated	O
memory	O
phenotype	O
during	O
acute	O
disease	O

Since	O
fully	O
differentiated	O
Tregs	O
predominantly	O
express	O
an	O
activated/memory	O
phenotype	O
[	O
44	O
]	O
T	O
cells	O
from	O
children	O
with	O
severe	O
and	O
uncomplicated	O
malaria	O
were	O
analysed	O
for	O
expression	O
of	O
CD45RO	O
(	O
Figure	O
3A	O
and	O
3B	O
)	O
.	O

In	O
both	O
uncomplicated	O
and	O
severe	O
cases	O
,	O
the	O
proportion	O
of	O
all	O
T	O
cells	O
expressing	O
CD45RO	O
was	O
significantly	O
higher	O
(	O
p	O
<	O
0.001	O
)	O
during	O
acute	O
infection	O
than	O
during	O
convalescence	O
(	O
data	O
not	O
shown	O
)	O
.	O

Irrespective	O
of	O
disease	O
severity	O
,	O
more	O
than	O
90	O
%	O
of	O
Tregs	O
expressed	O
CD45RO	O
during	O
the	O
acute	O
phase	O
of	O
infection	O
but	O
expression	O
of	O
this	O
marker	O
decreased	O
significantly	O
(	O
to	O
approx	O
70	O
%	O
)	O
during	O
convalescence	O
(	O
Figure	O
3C	O
)	O
.	O

Likewise	O
,	O
the	O
median	O
fluorescence	O
intensity	O
(	O
MFI	O
)	O
of	O
CD45RO	O
staining	O
was	O
1.5	O
fold	O
higher	O
(	O
p=0.0025	O
)	O
during	O
acute	O
disease	O
than	O
during	O
convalescence	O
(	O
Figure	O
3D	O
)	O
.	O

Taken	C
together	C
,	C
these	C
data	C
indicate	C
that	C
in	C
both	C
uncomplicated	C
and	C
severe	C
cases	C
of	C
malaria	C
Tregs	C
are	C
predominantly	C
of	C
a	C
memory	C
phenotype	C
and	C
are	C
activated	C
during	C
acute	C
malaria	C
infection	C
.	C

Tregs	O
display	O
an	O
activated	O
memory	O
phenotype	O
during	O
acute	O
disease	O
.	O

Similar	O
Treg	O
function	O
in	O
uncomplicated	O
and	O
severe	O
malaria	O
patients	O

Three	O
different	O
indicators	O
were	O
used	O
to	O
assess	O
the	O
regulatory	O
potential	O
of	O
Tregs	O
during	O
acute	O
malaria	O
infection	O
.	O

Firstly	O
,	O
using	O
a	O
classical	O
anti-CD25	O
depletion	O
assay	O
,	O
we	O
assessed	O
the	O
ability	O
of	O
Tregs	O
to	O
suppress	O
P.	O
falciparum	O
shizont	O
extract	O
(	O
PfSE	O
)	O
-driven	O
lymphocyte	O
proliferation	O
.	O

Anti	O
CD25	O
treatment	O
removed	O
approximately	O
half	O
(	O
geometric	O
mean	O
48.8	O
%	O
;	O
CI95	O
%	O
:	O
41–58	O
%	O
)	O
of	O
the	O
CD4+	O
T	O
cells	O
that	O
were	O
FOXP3+CD127-/low	O
and	O
this	O
was	O
associated	O
with	O
a	O
1.76	O
fold	O
and	O
1.57-fold	O
(	O
geometric	O
means	O
)	O
increase	O
in	O
PfSE-induced	O
lymphoproliferation	O
in	O
severe	O
and	O
uncomplicated	O
cases	O
,	O
respectively	O
,	O
with	O
no	O
significant	O
difference	O
between	O
the	O
groups	O
(	O
p=0.343	O
,	O
Figure	O
4A	O
)	O
.	O

Tregs	O
from	O
severe	O
and	O
uncomplicated	O
cases	O
have	O
similar	O
functional	O
capacity	O
.	O

Next	O
,	O
since	O
reduced	O
expression	O
of	O
SOCS-2	O
,	O
a	O
member	O
of	O
the	O
suppressors	O
of	O
cytokine	O
signaling	O
family	O
confined	O
to	O
Tregs	O
[	O
45	O
]	O
,	O
has	O
been	O
linked	O
to	O
impaired	O
Treg	O
function	O
in	O
Africans	O
[	O
38	O
]	O
we	O
compared	O
SOCS-2	O
mRNA	O
levels	O
among	O
severe	O
and	O
uncomplicated	O
cases	O
.	O

While	O
SOCS-2	O
levels	O
were	O
found	O
to	O
be	O
significantly	O
reduced	O
during	O
acute	O
disease	O
compared	O
to	O
convalescence	O
(	O
p=0.0076	O
)	O
,	O
no	O
difference	O
was	O
observed	O
between	O
those	O
with	O
severe	O
and	O
those	O
with	O
uncomplicated	O
malaria	O
(	O
data	O
not	O
shown	O
)	O
.	O

Finally	C
,	C
since	C
high	C
concentrations	C
of	C
TNF-α	C
have	C
been	C
reported	C
to	C
impair	C
Treg	C
activity	C
(	C
by	C
upregulating	C
and	C
then	C
signaling	C
via	C
TNFR2	C
,	C
leading	C
to	C
decreased	C
FOXP3	C
mRNA	C
and	C
protein	C
expression	C
[	C
46	C
]	C
)	C
,	C
and	C
the	C
functional	C
impairment	C
of	C
Tregs	C
observed	C
in	C
rheumatoid	C
arthritis	C
patients	C
can	C
be	C
reversed	C
by	C
anti-TNF-α	C
antibodies	C
[	C
47	C
]	C
,	C
we	C
considered	C
the	C
hypothesis	C
that	C
the	C
high	C
levels	C
of	C
TNF-α	C
seen	C
in	C
severe	C
malaria	C
patients	C
[	C
13	C
]	C
,	C
[	C
15	C
]	C
,	C
might	C
upregulate	C
TNFR2	C
and	C
impair	C
Treg	C
function	C
.	C

TNFR2	O
expression	O
on	O
Tregs	O
was	O
assessed	O
by	O
flow	O
cytometry	O
(	O
Figure	O
4B	O
and	O
4C	O
)	O
.	O

However	O
,	O
although	O
a	O
significantly	O
higher	O
proportion	O
of	O
Tregs	O
expressed	O
TNFR2	O
(	O
Figure	O
4D	O
)	O
-	O
with	O
higher	O
MFI	O
(	O
data	O
not	O
shown	O
,	O
p=0.028	O
)	O
-	O
during	O
acute	O
disease	O
compared	O
to	O
convalescence	O
,	O
no	O
difference	O
was	O
seen	O
in	O
TNFR2	O
expression	O
on	O
Tregs	O
between	O
severe	O
and	O
uncomplicated	O
cases	O
(	O
Figure	O
4D	O
)	O
.	O

Moreover	O
,	O
there	O
was	O
no	O
correlation	O
between	O
plasma	O
levels	O
of	O
TNF-α	O
and	O
TNFR2	O
expression	O
on	O
Tregs	O
,	O
neither	O
among	O
severe	O
or	O
uncomplicated	O
cases	O
nor	O
among	O
all	O
cases	O
combined	O
;	O
neither	O
did	O
we	O
observe	O
any	O
inverse	O
correlation	O
between	O
TNF-α	O
concentration	O
and	O
FOXP3	O
expression	O
.	O

Rather	O
,	O
the	O
MFI	O
of	O
TNFR2	O
on	O
Tregs	O
was	O
positively	O
correlated	O
with	O
the	O
MFI	O
of	O
FOXP3	O
in	O
Tregs	O
(	O
r	O
:	O
0.476	O
;	O
p	O
<	O
0.0001	O
)	O
.	O

Thus	C
,	C
our	C
data	C
seem	C
to	C
be	C
more	C
in	C
line	C
with	C
data	C
from	C
mice	C
suggesting	C
that	C
the	C
interaction	C
of	C
TNF-α	C
with	C
TNFR2	C
on	C
Tregs	C
promotes	C
their	C
expansion	C
and	C
upregulation	C
of	C
FOXP3	C
[	C
48	C
]	C
than	C
with	C
the	C
data	C
from	C
studies	C
of	C
human	C
rheumatoid	C
arthritis	C
.	C

Stronger	O
Th-1	O
responses	O
observed	O
in	O
severe	O
compared	O
to	O
uncomplicated	O
cases	O
are	O
balanced	O
by	O
IL-10	O

Since	C
the	C
balance	C
of	C
T-effector	C
to	C
Treg	C
responses	C
is	C
likely	C
to	C
be	C
as	C
important	C
,	C
or	C
more	C
important	C
,	C
than	C
the	C
absolute	C
levels	C
of	C
either	C
[	C
26	C
]	C
,	C
we	C
compared	C
the	C
ratio	C
of	C
the	C
levels	C
of	C
mRNA	C
for	C
the	C
Th1	C
transcription	C
factor	C
T-BET	C
with	C
those	C
for	C
FOXP3	C
,	C
currently	C
considered	C
the	C
best	C
marker	C
for	C
Tregs	C
,	C
and	C
the	C
ratio	C
of	C
T-effector	C
cells	C
(	C
defined	C
as	C
CD3+CD4+CD25+FOXP3-	C
,	C
T-effector	C
)	C
over	C
Tregs	C
among	C
the	C
various	C
groups	C
.	C

As	O
shown	O
in	O
Figure	O
5A	O
,	O
in	O
all	O
groups	O
the	O
T-BET/FOXP3	O
ratio	O
was	O
significantly	O
higher	O
during	O
acute	O
disease	O
than	O
during	O
convalescence	O
and	O
a	O
similar	O
,	O
albeit	O
not	O
significant	O
,	O
trend	O
was	O
observed	O
for	O
the	O
ratio	O
of	O
T-effector/Tregs	O
(	O
data	O
not	O
shown	O
)	O
.	O

Moreover	O
,	O
since	O
the	O
absolute	O
number	O
of	O
circulating	O
T-effector	O
cells	O
was	O
significantly	O
higher	O
in	O
severe	O
cases	O
than	O
in	O
uncomplicated	O
cases	O
(	O
p=0.01	O
,	O
data	O
not	O
shown	O
)	O
,	O
the	O
T-effector/Treg	O
ratio	O
tended	O
to	O
be	O
higher	O
among	O
severe	O
cases	O
than	O
uncomplicated	O
cases	O
on	O
day	O
0	O
(	O
p=0.039	O
)	O
and	O
a	O
similar	O
trend	O
was	O
seen	O
for	O
the	O
T-BET/FOXP3	O
ratio	O
(	O
p=0.058	O
)	O
.	O

The	C
ratio	C
of	C
FOXP3	C
to	C
GATA-3	C
(	C
Th2	C
lineage	C
factor	C
)	C
mRNA	C
was	C
similar	C
for	C
both	C
time	C
points	C
in	C
all	C
groups	C
(	C
data	C
not	C
shown	C
)	C
but	C
the	C
Th1/Th2	C
ratio	C
(	C
T-BET/GATA-3	C
mRNA	C
)	C
was	C
significantly	C
higher	C
during	C
acute	C
disease	C
in	C
children	C
with	C
CM	C
,	C
SA	C
or	C
SRD	C
compared	C
to	C
those	C
suffering	C
from	C
severe	C
prostration	C
(	C
p=0.0075	C
)	C
,	C
indicating	C
that	C
the	C
expansion	C
of	C
the	C
T-effector	C
population	C
is	C
biased	C
towards	C
Th1	C
responses	C
.	C

Ratios	O
of	O
Th1	O
over	O
Treg	O
cells	O
and	O
pro-inflammatory	O
over	O
regulatory	O
cytokines	O
.	O

These	C
data	C
confirm	C
previous	C
studies	C
indicating	C
a	C
shift	C
towards	C
a	C
more	C
inflammatory	C
response	C
during	C
acute	C
and	C
severe	C
malaria	C
but	C
,	C
significantly	C
,	C
our	C
data	C
extend	C
the	C
previous	C
observations	C
by	C
revealing	C
that	C
this	C
inflammation	C
is	C
not	C
balanced	C
by	C
a	C
commensurate	C
increase	C
in	C
Treg	C
function	C
.	C

Indeed	C
,	C
our	C
data	C
strongly	C
suggest	C
that	C
the	C
potent	C
inflammation	C
induced	C
during	C
an	C
acute	C
malaria	C
infection	C
overwhelms	C
the	C
normal	C
homeostatic	C
capacity	C
of	C
the	C
immune	C
system	C
and	C
,	C
in	C
particular	C
,	C
that	C
the	C
Treg	C
response	C
in	C
children	C
with	C
severe	C
malaria	C
is	C
insufficient	C
to	C
balance	C
a	C
much	C
stronger	C
Th1	C
effector	C
response	C
.	C

To	O
investigate	O
further	O
the	O
dynamics	O
of	O
pro-inflammatory/regulatory	O
responses	O
during	O
clinical	O
malaria	O
,	O
plasma	O
concentrations	O
and	O
mRNA	O
transcripts	O
of	O
inflammatory	O
(	O
IFN-γ	O
,	O
TNF-α	O
)	O
and	O
regulatory	O
cytokines	O
(	O
IL-10	O
)	O
were	O
assayed	O
.	O

In	O
accordance	O
with	O
previous	O
observations	O
,	O
plasma	O
concentrations	O
of	O
IFN-γ	O
,	O
TNF-α	O
and	O
IL-10	O
were	O
all	O
significantly	O
higher	O
during	O
acute	O
disease	O
than	O
during	O
convalescence	O
,	O
with	O
significantly	O
higher	O
levels	O
in	O
severely	O
ill	O
children	O
compared	O
to	O
uncomplicated	O
cases	O
(	O
Figure	O
5B	O
,	O
5C	O
,	O
and	O
5D	O
)	O
.	O

Levels	O
of	O
mRNA	O
transcripts	O
for	O
IL-10	O
and	O
IFN-γ	O
were	O
also	O
significantly	O
elevated	O
in	O
all	O
groups	O
during	O
acute	O
disease	O
,	O
but	O
there	O
was	O
no	O
significant	O
difference	O
between	O
severity	O
groups	O
(	O
Figure	O
S1A	O
and	O
S1B	O
)	O
.	O

For	C
both	C
severe	C
and	C
uncomplicated	C
cases	C
,	C
levels	C
of	C
IFN-γ	C
mRNA	C
were	C
highly	C
correlated	C
with	C
levels	C
of	C
IL-10	C
mRNA	C
during	C
the	C
acute	C
phase	C
(	C
severe	C
:	C
r=0.833	C
p	C
<	C
0.001	C
,	C
uncomplicated	C
:	C
r=0.693	C
p	C
<	C
0.001	C
)	C
,	C
suggesting	C
that	C
IFN-γ	C
production	C
is	C
being	C
balanced	C
by	C
IL-10	C
production	C
.	C

Interestingly	C
,	C
IFN-γ	C
mRNA	C
levels	C
on	C
day	C
0	C
correlated	C
with	C
FOXP3	C
mRNA	C
on	C
day	C
0	C
for	C
both	C
severe	C
(	C
r	C
:	C
0.39	C
p=0.003	C
)	C
and	C
uncomplicated	C
cases	C
(	C
r	C
:	C
0.44	C
p=0.0001	C
)	C
,	C
suggesting	C
that	C
IFN-γ	C
may	C
also	C
be	C
driving	C
FOXP3	C
expression	C
.	C

The	O
balance	O
of	O
pro-and	O
anti	O
inflammatory	O
cytokine	O
responses	O
clearly	O
changed	O
with	O
time	O
,	O
but	O
somewhat	O
surprisingly	O
,	O
there	O
were	O
no	O
marked	O
differences	O
in	O
cytokines	O
ratios	O
between	O
children	O
with	O
differing	O
levels	O
of	O
disease	O
severity	O
.	O

Thus	O
,	O
the	O
ratios	O
of	O
TNF-α	O
or	O
IFN-γ	O
to	O
IL-10	O
on	O
day	O
0	O
were	O
similar	O
in	O
all	O
disease	O
severity	O
groups	O
(	O
Figure	O
5E	O
and	O
5F	O
)	O
and	O
ratios	O
of	O
IFN-γ	O
to	O
IL-10	O
mRNA	O
were	O
similar	O
in	O
all	O
disease	O
severity	O
groups	O
both	O
on	O
day	O
0	O
and	O
day	O
28	O
(	O
Figure	O
S1F	O
)	O
.	O

However	O
,	O
IFN-γ	O
mRNA	O
levels	O
were	O
on	O
average	O
only	O
3.2-fold	O
higher	O
on	O
day	O
0	O
than	O
day	O
28	O
but	O
IL-10	O
mRNA	O
levels	O
were	O
29-fold	O
higher	O
on	O
day	O
0	O
,	O
resulting	O
in	O
a	O
significantly	O
lower	O
IFN-γ/IL-10	O
mRNA	O
ratio	O
on	O
day	O
0	O
than	O
day	O
28	O
(	O
Figure	O
S1F	O
)	O
.	O

CD25-FOXP3-	O
CD45RO+	O
T	O
cells	O
but	O
not	O
Tregs	O
are	O
the	O
major	O
source	O
of	O
IL-10	O
during	O
acute	O
malaria	O

IL-10	C
is	C
a	C
crucial	C
immunoregulatory	C
cytokine	C
in	C
both	C
human	C
[	C
23	C
]	C
and	C
murine	C
[	C
33	C
]	C
,	C
[	C
49	C
]	C
malaria	C
;	C
we	C
have	C
recently	C
identified	C
CD4+	C
T	C
effector	C
cells	C
as	C
a	C
major	C
source	C
of	C
IL-10	C
[	C
33	C
]	C
,	C
but	C
the	C
source	C
of	C
IL-10	C
in	C
human	C
malaria	C
infection	C
is	C
unknown	C
.	C

In	O
other	O
protozoal	O
infections	O
of	O
mice	O
CD4+	O
effector	O
T	O
cells	O
that	O
co-produce	O
IFN-γ	O
and	O
IL-10	O
have	O
been	O
identified	O
[	O
50	O
]	O
–	O
[	O
52	O
]	O
.	O

We	C
therefore	C
cultured	C
freshly	C
isolated	C
PBMCs	C
from	C
30	C
children	C
with	C
acute	C
malaria	C
(	C
17	C
severe	C
,	C
13	C
uncomplicated	C
)	C
and	C
20	C
healthy	C
control	C
children	C
,	C
with	C
or	C
without	C
PMA	C
and	C
Ionomycin	C
(	C
PI	C
)	C
,	C
for	C
5	C
hours	C
and	C
analyzed	C
them	C
for	C
the	C
presence	C
of	C
intracellular	C
IL-10	C
and	C
IFN-γ	C
by	C
flow	C
cytometry	C
(	C
Figure	C
6A	C
)	C
.	C

No	C
cytokine	C
production	C
was	C
observed	C
in	C
unstimulated	C
cells	C
(	C
data	C
not	C
shown	C
)	C
,	C
and	C
PBMC	C
from	C
healthy	C
children	C
failed	C
to	C
produce	C
any	C
IL-10	C
in	C
response	C
to	C
PI	C
(	C
data	C
not	C
shown	C
)	C
,	C
indicating	C
that	C
stimulation	C
with	C
PI	C
predominantly	C
induces	C
cytokine	C
production	C
from	C
recently	C
activated	C
cells	C
.	C

Phenotypic	O
characterization	O
of	O
cytokine-producing	O
cells	O
.	O

By	O
contrast	O
,	O
distinct	O
populations	O
of	O
IL-10+	O
and	O
IFN-γ+	O
cells	O
were	O
seen	O
among	O
the	O
PI-stimulated	O
cells	O
from	O
children	O
with	O
acute	O
severe	O
or	O
uncomplicated	O
malaria	O
,	O
with	O
a	O
small	O
but	O
easily	O
distinguishable	O
population	O
of	O
cells	O
(	O
approx	O
1	O
%	O
of	O
all	O
PBMC	O
)	O
producing	O
both	O
cytokines	O
simultaneously	O
(	O
Figure	O
6A	O
,	O
right	O
plot	O
)	O
.	O

In	O
both	O
severe	O
and	O
uncomplicated	O
cases	O
,	O
IL-10	O
producing	O
cells	O
were	O
predominantly	O
CD45RO+	O
CD4+	O
T	O
cells	O
(	O
Figure	O
6B	O
and	O
6C	O
)	O
and	O
were	O
almost	O
exclusively	O
FOXP3-	O
and	O
CD25-	O
(	O
Figure	O
6D	O
)	O
.	O

Moreover	O
,	O
although	O
a	O
transient	O
increase	O
of	O
FOXP3	O
in	O
activated	O
human	O
T-effector	O
cells	O
has	O
been	O
reported	O
[	O
53	O
]	O
,	O
in	O
our	O
hands	O
less	O
than	O
1	O
%	O
(	O
median	O
0.97	O
%	O
,	O
CI95	O
%	O
:	O
0.67–1.27	O
%	O
)	O
of	O
IFN-γ	O
producing	O
cells	O
were	O
FOXP3+	O
(	O
Figure	O
6E	O
)	O
.	O

Overall	O
,	O
among	O
children	O
with	O
acute	O
malaria	O
,	O
approx	O
4	O
%	O
of	O
PI-stimulated	O
CD4+	O
T	O
cells	O
produced	O
IL-10	O
and	O
approx	O
8	O
%	O
produced	O
IFN-γ	O
and	O
neither	O
the	O
proportions	O
of	O
cells	O
producing	O
one	O
or	O
the	O
other	O
cytokine	O
(	O
Figure	O
6F	O
)	O
nor	O
the	O
ratio	O
of	O
IFN-γ/IL-10	O
producing	O
cells	O
(	O
data	O
not	O
shown	O
)	O
differed	O
significantly	O
between	O
severe	O
and	O
uncomplicated	O
cases	O
.	O

However	O
,	O
intriguingly	O
,	O
the	O
proportion	O
of	O
CD4+	O
T	O
cells	O
simultaneously	O
producing	O
IL-10	O
and	O
IFN-γ	O
was	O
three	O
fold	O
higher	O
in	O
uncomplicated	O
cases	O
than	O
severe	O
cases	O
(	O
geometric	O
mean	O
5.2	O
%	O
vs	O
1.6	O
%	O
,	O
p=0.041	O
,	O
Figure	O
6F	O
)	O
.	O

Moreover	O
,	O
the	O
proportion	O
of	O
IFN-γ+	O
CD4+	O
T	O
cells	O
that	O
also	O
produce	O
IL-10	O
was	O
almost	O
twice	O
as	O
high	O
among	O
uncomplicated	O
cases	O
as	O
among	O
severe	O
cases	O
(	O
p=0.045	O
,	O
Figure	O
6G	O
)	O
.	O

Taken	C
together	C
,	C
these	C
data	C
indicate	C
that	C
during	C
acute	C
,	C
uncomplicated	C
or	C
severe	C
,	C
malaria	C
infections	C
IL-10	C
producing	C
cells	C
are	C
overwhelmingly	C
T	C
effector	C
cells	C
and	C
that	C
Th1	C
effector	C
cells	C
that	C
also	C
produce	C
IL-10	C
are	C
more	C
prevalent	C
in	C
children	C
with	C
uncomplicated	C
malaria	C
than	C
in	C
children	C
with	C
severe	C
malaria	C
.	C

The	O
frequency	O
of	O
Tregs	O
during	O
acute	O
disease	O
is	O
negatively	O
associated	O
with	O
the	O
magnitude	O
of	O
subsequent	O
malaria-specific	O
IFN-γ	O
memory	O
responses	O

It	C
has	C
been	C
reported	C
that	C
Tregs	C
present	C
at	C
the	C
time	C
of	C
infection	C
[	C
54	C
]	C
or	C
vaccination	C
[	C
55	C
]	C
may	C
restrict	C
the	C
development	C
of	C
subsequent	C
Th1	C
memory	C
responses	C
.	C

To	C
determine	C
whether	C
Tregs	C
present	C
during	C
acute	C
malaria	C
infection	C
might	C
similarly	C
affect	C
the	C
induction	C
of	C
immunological	C
memory	C
,	C
we	C
compared	C
FOXP3	C
mRNA	C
levels	C
on	C
day	C
0	C
with	C
malaria	C
specific	C
IFN-γ	C
memory	C
responses	C
(	C
as	C
assessed	C
by	C
PfSE-specific	C
cultured	C
ELISPOT	C
)	C
among	C
PBMC	C
collected	C
from	C
34	C
of	C
our	C
convalescent	C
malaria	C
patients	C
(	C
19	C
severe	C
and	C
15	C
uncomplicated	C
)	C
on	C
Day	C
28	C
.	C

As	O
shown	O
in	O
Figure	O
7A	O
,	O
cells	O
from	O
uncomplicated	O
and	O
severe	O
cases	O
mounted	O
similarly	O
strong	O
IFN-γ	O
memory	O
responses	O
following	O
culture	O
with	O
PfSE	O
.	O

When	C
plotted	C
against	C
FOXP3	C
mRNA	C
levels	C
measured	C
on	C
day	C
0	C
,	C
a	C
linear	C
by	C
linear	C
hyperbolic	C
fit	C
revealed	C
that	C
higher	C
levels	C
of	C
FOXP3	C
mRNA	C
on	C
day	C
0	C
were	C
highly	C
significantly	C
(	C
p=0.009	C
)	C
associated	C
with	C
lower	C
malaria-specific	C
IFN-γ	C
memory	C
responses	C
on	C
Day	C
28	C
,	C
suggesting	C
that	C
Tregs	C
induced	C
during	C
the	C
acute	C
infection	C
may	C
limit	C
the	C
magnitude	C
of	C
subsequent	C
Th1	C
responses	C
(	C
Figure	C
7B	C
)	C
.	C

For	O
neither	O
group	O
could	O
a	O
significant	O
effect	O
of	O
parasitaemia	O
on	O
the	O
memory	O
response	O
be	O
observed	O
(	O
r=-0.12	O
p=0.962	O
for	O
severe	O
and	O
r=0.015	O
,	O
p=0.957	O
for	O
uncomplicated	O
cases	O
)	O
.	O

Tregs	O
induced	O
during	O
the	O
clinical	O
episode	O
under	O
study	O
limit	O
the	O
magnitude	O
of	O
subsequent	O
malaria-specific	O
IFN-γ	O
memory	O
responses	O
.	O

Discussion	O

We	C
hypothesized	C
that	C
the	C
balance	C
of	C
inflammatory	C
to	C
regulatory	C
immune	C
responses	C
would	C
be	C
biased	C
towards	C
a	C
more	C
inflammatory	C
response	C
in	C
children	C
with	C
severe	C
malaria	C
than	C
in	C
children	C
with	C
uncomplicated	C
malaria	C
,	C
that	C
this	C
balance	C
would	C
be	C
restored	C
during	C
convalescence	C
and	C
–	C
crucially	C
–	C
that	C
this	C
would	C
be	C
associated	C
with	C
differences	C
in	C
the	C
proportion	C
,	C
absolute	C
number	C
or	C
function	C
of	C
circulating	C
classical	C
(	C
CD4+	C
CD127-/lo	C
FOXP3+	C
)	C
regulatory	C
T	C
cells	C
.	C

In	O
partial	O
support	O
of	O
these	O
hypotheses	O
,	O
the	O
number	O
of	O
cells	O
expressing	O
a	O
Treg	O
phenotype	O
and	O
FOXP3-mRNA	O
levels	O
were	O
both	O
significantly	O
higher	O
during	O
convalescence	O
than	O
during	O
the	O
acute	O
clinical	O
episode	O
and	O
the	O
ratio	O
of	O
the	O
Th1	O
transcription	O
factor	O
T-BET	O
to	O
the	O
Treg	O
transcription	O
factor	O
FOXP3	O
was	O
significantly	O
higher	O
during	O
acute	O
disease	O
than	O
during	O
convalescence	O
in	O
both	O
severe	O
and	O
uncomplicated	O
cases	O
,	O
compatible	O
with	O
the	O
notion	O
that	O
Tregs	O
fail	O
to	O
sufficiently	O
regulate	O
pro-inflammatory	O
responses	O
which	O
might	O
contribute	O
to	O
the	O
onset	O
of	O
symptomatic	O
malaria	O
infection	O
.	O

Given	C
our	C
previous	C
observation	C
of	C
Treg	C
expansion	C
during	C
the	C
pre-patent	C
phase	C
of	C
malaria	C
infection	C
[	C
27	C
]	C
,	C
we	C
suggest	C
that	C
Tregs	C
are	C
induced/activated	C
shortly	C
after	C
parasite	C
emergence	C
from	C
the	C
liver	C
,	C
that	C
their	C
numbers	C
in	C
peripheral	C
blood	C
then	C
decline	C
as	C
a	C
result	C
of	C
sequestration	C
of	C
CD4+	C
T	C
cells	C
during	C
acute	C
disease	C
[	C
40	C
]	C
,	C
[	C
41	C
]	C
,	C
[	C
56	C
]	C
and	C
then	C
,	C
as	C
has	C
been	C
described	C
for	C
other	C
T	C
cell	C
subsets	C
[	C
39	C
]	C
,	C
[	C
57	C
]	C
,	C
Tregs	C
regain	C
access	C
to	C
the	C
circulation	C
after	C
malaria	C
is	C
cured	C
.	C

The	O
significant	O
positive	O
correlation	O
of	O
Treg	O
numbers	O
with	O
parasitaemia	O
,	O
as	O
well	O
as	O
the	O
correlation	O
between	O
FOXP3	O
mRNA	O
and	O
IFN-γ	O
mRNA	O
levels	O
in	O
acute	O
samples	O
,	O
further	O
supports	O
the	O
notion	O
that	O
the	O
initial	O
infection	O
induces	O
a	O
proportional	O
increase	O
in	O
Tregs	O
,	O
attempting	O
to	O
balance	O
the	O
effector	O
T	O
cell	O
response	O
,	O
and	O
is	O
in	O
line	O
with	O
the	O
recently	O
proposed	O
concept	O
that	O
antigenic	O
challenge	O
will	O
give	O
rise	O
to	O
an	O
antigen	O
specific	O
Treg	O
response	O
,	O
proportional	O
in	O
size	O
to	O
the	O
inflammatory	O
response	O
[	O
58	O
]	O
.	O

Moreover	C
,	C
the	C
Tregs	C
circulating	C
during	C
acute	C
malaria	C
infections	C
almost	C
exclusively	C
expressed	C
an	C
activated	C
memory	C
phenotype	C
suggesting	C
that	C
they	C
have	C
expanded	C
from	C
a	C
pre-existing	C
pool	C
of	C
memory	C
T-cells	C
.	C

This	C
interpretation	C
would	C
be	C
in	C
line	C
with	C
recent	C
elegant	C
work	C
in	C
humans	C
demonstrating	C
that	C
Tregs	C
are	C
derived	C
by	C
rapid	C
turnover	C
of	C
memory	C
populations	C
in	C
vivo	C
[	C
59	C
]	C
,	C
and	C
with	C
data	C
from	C
murine	C
studies	C
where	C
,	C
after	C
CD25-depletion	C
,	C
malaria	C
infection	C
very	C
rapidly	C
drives	C
differentiation	C
of	C
Tregs	C
from	C
circulating	C
mature	C
CD4+	C
T	C
cells	C
[	C
60	C
]	C
.	C

Obviously	C
,	C
it	C
would	C
be	C
of	C
interest	C
to	C
study	C
the	C
relationship	C
between	C
Tregs	C
and	C
effector	C
T	C
cell	C
kinetics	C
and	C
parasite	C
biomass	C
,	C
which	C
is	C
not	C
readily	C
measurable	C
.	C

Future	C
studies	C
may	C
explore	C
the	C
usefulness	C
of	C
P.	C
falciparum	C
Histidine	C
Rich	C
Protein	C
2	C
in	C
this	C
context	C
,	C
which	C
has	C
recently	C
been	C
suggested	C
as	C
a	C
surrogate	C
marker	C
for	C
parasite	C
biomass	C
[	C
61	C
]	C
.	C

However	O
,	O
despite	O
clear	O
evidence	O
of	O
Treg	O
induction	O
and	O
reallocation	O
during	O
acute	O
malaria	O
infection	O
,	O
we	O
could	O
not	O
find	O
any	O
robust	O
differences	O
in	O
Treg	O
parameters	O
between	O
children	O
with	O
severe	O
and	O
uncomplicated	O
disease	O
.	O

Thus	O
,	O
neither	O
Treg	O
numbers	O
nor	O
FOXP3	O
mRNA	O
levels	O
differed	O
significantly	O
between	O
children	O
with	O
uncomplicated	O
malaria	O
and	O
those	O
with	O
severe	O
malaria	O
,	O
and	O
three	O
different	O
indicators	O
of	O
Treg	O
function	O
-	O
their	O
capacity	O
to	O
suppress	O
lymphoproliferation	O
,	O
their	O
expression	O
of	O
SOCS-2	O
[	O
45	O
]	O
and	O
TNFR2	O
[	O
46	O
]	O
,	O
[	O
48	O
]	O
were	O
all	O
similar	O
in	O
severely	O
ill	O
children	O
and	O
children	O
with	O
uncomplicated	O
disease	O
.	O

Furthermore	C
,	C
the	C
similar	C
distortion	C
in	C
the	C
T-BET/FOXP3	C
mRNA	C
ratio	C
during	C
acute	C
disease	C
and	C
the	C
lack	C
of	C
any	C
marked	C
differences	C
between	C
the	C
two	C
groups	C
in	C
ratios	C
of	C
inflammatory	C
to	C
anti-inflammatory	C
cytokines	C
,	C
as	C
well	C
as	C
the	C
close	C
correlation	C
between	C
IFN-γ	C
and	C
IL-10	C
in	C
both	C
groups	C
which	C
is	C
in	C
line	C
with	C
previous	C
observations	C
in	C
experimental	C
human	C
malaria	C
infections	C
[	C
62	C
]	C
,	C
suggests	C
that	C
the	C
systemic	C
shift	C
towards	C
a	C
pro-inflammatory	C
immune	C
response	C
is	C
similar	C
in	C
children	C
with	C
either	C
severe	C
or	C
uncomplicated	C
disease	C
.	C

At	C
first	C
glance	C
,	C
these	C
data	C
do	C
not	C
appear	C
to	C
support	C
the	C
hypothesis	C
that	C
deficiencies	C
in	C
Treg	C
function	C
underlie	C
the	C
tendency	C
of	C
some	C
children	C
to	C
develop	C
severe	C
,	C
life	C
threatening	C
malaria	C
.	C

However	C
,	C
we	C
did	C
observe	C
significantly	C
higher	C
Th1	C
effector	C
responses	C
(	C
more	C
T-effector	C
cells	C
,	C
higher	C
concentrations	C
of	C
IFN-γ	C
and	C
TNF-α	C
)	C
in	C
severely	C
ill	C
children	C
than	C
in	C
children	C
with	C
uncomplicated	C
disease	C
,	C
suggesting	C
that	C
the	C
classical	C
FOXP3+	C
Treg	C
response	C
that	C
develops	C
during	C
acute	C
malaria	C
infection	C
may	C
be	C
insufficient	C
to	C
balance	C
the	C
florid	C
effector	C
T	C
cell	C
response	C
that	C
develops	C
particularly	C
in	C
children	C
with	C
severe	C
disease	C
.	C

This	C
would	C
be	C
in	C
line	C
with	C
evidence	C
showing	C
that	C
as	C
the	C
strength	C
of	C
the	C
inflammatory	C
stimulus	C
increases	C
,	C
the	C
suppressive	C
capacity	C
of	C
human	C
Tregs	C
declines	C
and	C
the	C
resistance	C
of	C
T-effector	C
cells	C
to	C
regulation	C
increases	C
[	C
63	C
]	C
.	C

The	O
situation	O
observed	O
during	O
an	O
acute	O
,	O
clinical	O
malaria	O
infection	O
is	O
thus	O
in	O
clear	O
contrast	O
to	O
the	O
situation	O
in	O
healthy	O
,	O
malaria-exposed	O
individuals	O
where	O
Treg	O
numbers	O
closely	O
track	O
numbers	O
of	O
T-effectors	O
,	O
precisely	O
maintaining	O
an	O
apparently	O
optimal	O
T-effectorTreg	O
ratio	O
[	O
36	O
]	O
.	O

IL-10	O
is	O
well-established	O
as	O
a	O
vital	O
homeostatic	O
regulator	O
of	O
malaria-induced	O
inflammation	O
that	O
prevents	O
immune-pathology	O
in	O
mice	O
[	O
49	O
]	O
,	O
[	O
64	O
]	O
,	O
promotes	O
the	O
necessary	O
switch	O
from	O
early	O
Th1	O
to	O
subsequent	O
Th2	O
responses	O
[	O
65	O
]	O
,	O
[	O
66	O
]	O
,	O
and	O
has	O
been	O
linked	O
to	O
protection	O
from	O
severe	O
malaria	O
anaemia	O
[	O
24	O
]	O
,	O
[	O
25	O
]	O
,	O
and	O
death	O
[	O
23	O
]	O
in	O
humans	O
.	O

However	O
,	O
the	O
cellular	O
source	O
of	O
IL-10	O
in	O
human	O
malaria	O
cases	O
was	O
,	O
until	O
now	O
,	O
ill	O
defined	O
.	O

Contrary	O
to	O
our	O
expectations	O
,	O
but	O
in	O
striking	O
agreement	O
with	O
observations	O
in	O
P.	O
yoelii-infected	O
mice	O
[	O
33	O
]	O
,	O
CD45RO+	O
CD4+	O
T	O
cells	O
(	O
that	O
are	O
CD25-	O
and	O
FOXP3-	O
)	O
and	O
not	O
classical	O
Tregs	O
are	O
the	O
only	O
substantial	O
source	O
of	O
IL-10	O
during	O
acute	O
malaria	O
infection	O
.	O

This	O
observation	O
is	O
reminiscent	O
of	O
that	O
made	O
by	O
Nylen	O
[	O
67	O
]	O
in	O
patients	O
with	O
acute	O
visceral	O
leishmaniasis	O
.	O

Moreover	O
,	O
in	O
our	O
patients	O
,	O
a	O
significant	O
proportion	O
of	O
IL-10	O
producing	O
CD4+	O
T	O
cells	O
were	O
simultaneously	O
producing	O
IFN-γ	O
,	O
identifying	O
them	O
as	O
Th1	O
cells	O
.	O

Although	O
IL-10	O
secreting	O
Th1	O
cells	O
have	O
been	O
described	O
recently	O
in	O
two	O
murine	O
models	O
of	O
toxoplasmosis	O
[	O
50	O
]	O
,	O
and	O
cutaneous	O
leishmaniasis	O
[	O
51	O
]	O
,	O
as	O
far	O
as	O
we	O
are	O
aware	O
,	O
this	O
is	O
the	O
first	O
demonstration	O
of	O
IL-10	O
producing	O
Th1	O
cells	O
during	O
human	O
infections	O
.	O

Intriguingly	C
,	C
the	C
proportion	C
of	C
these	C
cells	C
within	C
the	C
total	C
CD4+	C
T	C
cell	C
population	C
was	C
significantly	C
higher	C
in	C
children	C
with	C
uncomplicated	C
malaria	C
than	C
in	C
children	C
with	C
severe	C
malaria	C
suggesting	C
that	C
in	C
human	C
P.	C
falciparum	C
infection	C
,	C
as	C
in	C
murine	C
T.gondii	C
infections	C
[	C
50	C
]	C
,	C
IL-10	C
producing	C
Th1	C
cells	C
,	C
activated	C
by	C
a	C
strong	C
inflammatory	C
stimulus	C
,	C
may	C
act	C
as	C
anti-parasitic	C
effector	C
cells	C
with	C
a	C
“built	C
in”	C
control	C
mechanism	C
to	C
prevent	C
the	C
onset	C
of	C
immune	C
pathology	C
.	C

If	C
so	C
,	C
then	C
the	C
ability	C
of	C
these	C
self-regulating	C
effector	C
cells	C
to	C
localize	C
to	C
sites	C
of	C
parasite	C
sequestration	C
in	C
tissues	C
,	C
where	C
they	C
mediate	C
parasite	C
killing	C
whilst	C
simultaneously	C
blocking	C
tissue	C
damage	C
,	C
may	C
be	C
key	C
to	C
clinical	C
immunity	C
to	C
malaria	C
.	C

Thus	C
,	C
our	C
data	C
strongly	C
suggest	C
that	C
the	C
percentage	C
of	C
IL-10-producing	C
Th1	C
effector	C
cells	C
,	C
rather	C
than	C
the	C
cocktail	C
of	C
circulating	C
cytokines	C
,	C
may	C
be	C
the	C
most	C
relevant	C
biomarker	C
of	C
effective	C
immunity	C
to	C
severe	C
malaria	C
.	C

Although	C
(	C
Tregs	C
may	C
not	C
seem	C
to	C
determine	C
the	C
outcome	C
of	C
current	C
P.	C
falciparum	C
infections	C
)	C
we	C
did	C
find	C
evidence	C
that	C
they	C
affect	C
the	C
magnitude	C
of	C
the	C
malaria	C
specific	C
memory	C
response	C
induced	C
by	C
the	C
current	C
infection	C
.	C

A	O
similar	O
observation	O
has	O
been	O
made	O
in	O
P.	O
berghei	O
ANKA-infected	O
mice	O
;	O
animals	O
that	O
were	O
depleted	O
of	O
CD25+	O
cells	O
prior	O
to	O
infection	O
and	O
drug-cured	O
on	O
day	O
5	O
developed	O
significantly	O
stronger	O
IFN-γ	O
memory	O
responses	O
on	O
day	O
14	O
than	O
did	O
intact	O
infected/cured	O
mice	O
,	O
and	O
these	O
mice	O
also	O
developed	O
much	O
more	O
severe	O
,	O
and	O
frequently	O
fatal	O
,	O
clinical	O
symptoms	O
upon	O
reinfection	O
,	O
despite	O
more	O
efficient	O
parasite	O
clearance	O
[	O
35	O
]	O
.	O

Thus	C
,	C
malaria	C
specific	C
Tregs	C
acquired	C
during	C
a	C
primary	C
infection	C
may	C
limit	C
the	C
magnitude	C
of	C
Th1	C
effector	C
responses	C
to	C
subsequent	C
infections	C
to	C
a	C
level	C
that	C
allows	C
parasite	C
clearance	C
without	C
causing	C
immunopathology	C
.	C

Future	C
studies	C
should	C
be	C
designed	C
to	C
test	C
the	C
hypothesis	C
that	C
Tregs	C
may	C
contribute	C
to	C
the	C
very	C
rapid	C
development	C
of	C
resistance	C
to	C
severe	C
malaria	C
.	C

In	C
summary	C
,	C
our	C
data	C
indicate	C
that	C
classical	C
FOXP3+	C
Tregs	C
are	C
unable	C
to	C
control	C
the	C
florid	C
inflammation	C
that	C
accompanies	C
acute	C
malaria	C
infections	C
and	C
this	C
component	C
of	C
the	C
immunoregulatory	C
arsenal	C
is	C
rapidly	C
overwhelmed	C
in	C
children	C
with	C
either	C
mild	C
or	C
severe	C
malaria	C
.	C

Importantly	C
however	C
we	C
have	C
identified	C
,	C
for	C
the	C
first	C
time	C
in	C
an	C
acute	C
human	C
infection	C
,	C
a	C
population	C
of	C
IL-10	C
producing	C
Th1	C
effector	C
cells	C
which	C
appear	C
to	C
be	C
a	C
major	C
source	C
of	C
this	C
key	C
anti-inflammatory	C
cytokine	C
during	C
acute	C
malaria	C
infection	C
,	C
and	C
which	C
are	C
associated	C
with	C
development	C
of	C
uncomplicated	C
as	C
opposed	C
to	C
severe	C
malaria	C
.	C

We	C
propose	C
that	C
IL-10-producing	C
Th1	C
cells	C
may	C
be	C
the	C
essential	C
regulators	C
of	C
acute	C
infection-induced	C
inflammation	C
and	C
that	C
such	C
“self-regulating”	C
Th1	C
cells	C
may	C
be	C
essential	C
for	C
the	C
infection	C
to	C
be	C
cleared	C
without	C
inducing	C
immune-mediated	C
pathology	C
.	C

Moreover	C
,	C
we	C
have	C
found	C
evidence	C
in	C
support	C
of	C
the	C
hypothesis	C
that	C
Tregs	C
limit	C
the	C
magnitude	C
of	C
the	C
Th1	C
memory	C
response	C
raising	C
the	C
intriguing	C
possibility	C
that	C
they	C
may	C
play	C
an	C
important	C
role	C
in	C
the	C
rapid	C
evolution	C
of	C
clinical	C
immunity	C
to	C
severe	C
malaria	C
.	C

Materials	O
and	O
Methods	O

Subject	O
recruitment	O
,	O
study	O
design	O
,	O
and	O
study	O
procedures	O

A	O
case-control	O
study	O
was	O
conducted	O
in	O
Gambian	O
children	O
with	O
severe	O
or	O
uncomplicated	O
malaria	O
,	O
resident	O
in	O
a	O
peri-urban	O
area	O
within	O
a	O
40	O
km	O
radius	O
south	O
of	O
the	O
capital	O
,	O
Banjul	O
,	O
with	O
low	O
levels	O
of	O
malaria	O
transmission	O
[	O
68	O
]	O
,	O
[	O
69	O
]	O
.	O

Patients	O
were	O
enrolled	O
at	O
Brikama	O
Health	O
Centre	O
,	O
the	O
MRC	O
Fajara	O
Gate	O
Clinic	O
or	O
the	O
Jammeh	O
Foundation	O
for	O
Peace	O
Hospital	O
in	O
Serekunda	O
between	O
September	O
2007	O
and	O
January	O
2008	O
,	O
after	O
written	O
informed	O
consent	O
was	O
obtained	O
from	O
the	O
parents	O
or	O
guardians	O
.	O

Uncomplicated	O
disease	O
was	O
defined	O
as	O
an	O
episode	O
of	O
fever	O
(	O
temperature	O
>	O
37.5°C	O
)	O
within	O
the	O
last	O
48	O
hours	O
with	O
more	O
than	O
5000	O
parasites/µl	O
detected	O
by	O
slide	O
microscopy	O
.	O

Severe	O
disease	O
was	O
defined	O
using	O
modified	O
WHO	O
criteria	O
[	O
70	O
]	O
:	O
SA	O
,	O
defined	O
as	O
Hb	O
<	O
6	O
g/dl	O
;	O
SRD	O
defined	O
as	O
serum	O
lactate	O
>	O
7	O
mmol/L	O
;	O
CM	O
defined	O
as	O
a	O
Blantyre	O
coma	O
score	O
≤2	O
in	O
the	O
absence	O
of	O
hypoglycaemia	O
,	O
with	O
the	O
coma	O
lasting	O
at	O
least	O
for	O
2	O
hours	O
.	O

To	O
avoid	O
the	O
confounding	O
effects	O
of	O
other	O
pathogens	O
in	O
children	O
with	O
concomitant	O
systemic	O
bacterial	O
infections	O
[	O
71	O
]	O
,	O
children	O
with	O
clinical	O
and/or	O
laboratory	O
evidence	O
of	O
infections	O
other	O
than	O
malaria	O
were	O
not	O
enrolled	O
into	O
the	O
study	O
.	O

For	O
some	O
experiments	O
,	O
healthy	O
children	O
of	O
the	O
same	O
age	O
and	O
recruited	O
from	O
the	O
same	O
area	O
at	O
the	O
same	O
time	O
of	O
the	O
year	O
were	O
enrolled	O
as	O
controls	O
.	O

In	O
total	O
,	O
59	O
severe	O
,	O
65	O
uncomplicated	O
and	O
20	O
control	O
cases	O
were	O
enrolled	O
.	O

On	O
admission	O
(	O
D0	O
)	O
and	O
after	O
4	O
weeks	O
(	O
D28±3	O
days	O
)	O
one	O
ml	O
of	O
blood	O
was	O
collected	O
in	O
RNA	O
stabilizing	O
agent	O
(	O
PAXgene™	O
Blood	O
RNA	O
system	O
,	O
Pre-AnalytiX	O
)	O
and	O
a	O
maximum	O
of	O
4	O
mls	O
of	O
blood	O
(	O
mean	O
:	O
3.2	O
mls	O
CI	O
95	O
%	O
:	O
3.1–3.3	O
mls	O
)	O
were	O
collected	O
into	O
heparinized	O
vacutainers®	O
(	O
BD	O
)	O
.	O

All	O
patients	O
received	O
standard	O
care	O
according	O
to	O
the	O
Gambian	O
Government	O
Treatment	O
Guidelines	O
,	O
provided	O
by	O
the	O
health	O
centre	O
staff	O
.	O

The	O
children	O
's	O
health	O
was	O
reviewed	O
7	O
days	O
after	O
admission	O
.	O

The	O
study	O
was	O
reviewed	O
and	O
approved	O
by	O
the	O
Joint	O
Gambian	O
Government/MRC	O
Ethics	O
Committee	O
and	O
the	O
Ethics	O
Committee	O
of	O
the	O
London	O
School	O
of	O
Hygiene	O
&	O
Tropical	O
Medicine	O
(	O
London	O
,	O
UK	O
)	O
.	O

P.	O
falciparum	O
parasites	O
were	O
identified	O
by	O
slide	O
microscopy	O
of	O
50	O
high	O
power	O
fields	O
of	O
a	O
thick	O
film	O
.	O

Full	O
differential	O
blood	O
counts	O
were	O
obtained	O
on	O
days	O
0	O
and	O
28	O
using	O
a	O
Medonic™	O
instrument	O
(	O
Clinical	O
Diagnostics	O
Solutions	O
,	O
Inc	O
)	O
;	O
the	O
presence	O
of	O
intestinal	O
helminths	O
was	O
assessed	O
by	O
microscopy	O
from	O
stool	O
samples	O
collected	O
into	O
BioSepar	O
ParasiTrap®	O
diagnosis	O
system	O
,	O
following	O
the	O
manufacturers	O
'	O
instructions	O
.	O

Sickle	O
cell	O
status	O
was	O
determined	O
by	O
metabisulfite	O
test	O
and	O
confirmed	O
on	O
cellulose	O
acetate	O
electrophoresis	O
[	O
72	O
]	O
.	O

Cell	O
preparation	O

Blood	O
samples	O
were	O
processed	O
within	O
2	O
hours	O
of	O
collection	O
.	O

Plasma	O
was	O
removed	O
,	O
stored	O
at	O
-80°C	O
and	O
replaced	O
by	O
an	O
equal	O
volume	O
of	O
RPMI	O
1640	O
(	O
Sigma-Aldrich	O
)	O
.	O

PBMC	O
were	O
isolated	O
after	O
density	O
centrifugation	O
over	O
a	O
1.077	O
Nycoprep	O
(	O
Nycomed	O
,	O
Sweden	O
)	O
gradient	O
(	O
800	O
g	O
,	O
30	O
min	O
)	O
and	O
washed	O
twice	O
in	O
RPM	O
1640	O
.	O

Cells	O
were	O
either	O
stained	O
for	O
flow	O
cytometry	O
directly	O
ex-vivo	O
,	O
or	O
cultured	O
in	O
RPMI	O
1640	O
containing	O
10	O
%	O
human	O
AB+	O
serum	O
,	O
100	O
µg/ml	O
streptomycin	O
,	O
100	O
U/ml	O
penicillin	O
(	O
all	O
Sigma-Aldrich	O
)	O
,	O
and	O
2	O
mM	O
L-glutamine	O
(	O
Invitrogen	O
Life	O
Technologies	O
)	O
,	O
referred	O
to	O
as	O
complete	O
growth	O
medium	O
(	O
GM	O
)	O
.	O

Flow	O
cytometry	O

Fresh	O
PBMC	O
were	O
stained	O
using	O
the	O
following	O
fluorochrome	O
labeled	O
mouse	O
or	O
rat	O
anti-human	O
antibodies	O
:	O
FITC	O
anti-TNF-receptor	O
II	O
(	O
R	O
&	O
D	O
)	O
,	O
PE	O
anti-FOXP3	O
(	O
clone	O
PCH101	O
)	O
,	O
Pacific	O
Blue	O
anti	O
CD3	O
,	O
APC-Alexa	O
Fluor	O
750	O
anti-CD127	O
(	O
all	O
Ebioscience	O
)	O
,	O
APC	O
anti-CD25	O
,	O
PerCP	O
anti	O
CD4	O
(	O
BD	O
systems	O
)	O
,	O
ECD	O
anti-CD45R0	O
(	O
Beckman-Coulter	O
)	O
,	O
and	O
appropriate	O
isotype	O
controls	O
.	O

IL-10	O
and	O
IFN-γ	O
production	O
by	O
PBMC	O
from	O
30	O
children	O
with	O
acute	O
P.	O
falciparum	O
(	O
D0	O
)	O
was	O
assessed	O
after	O
5	O
hours	O
stimulation	O
in	O
GM	O
containing	O
PMA	O
(	O
50	O
ng/ml	O
)	O
and	O
Ionomycin	O
(	O
1000	O
ng/ml	O
)	O
or	O
GM	O
alone	O
.	O

Cells	O
were	O
stained	O
with	O
FITC	O
anti-IFN-γ	O
,	O
PE	O
anti-FOXP3	O
,	O
PE-Cy7	O
anti-CD25	O
,	O
APC-AF750	O
anti-CD8	O
,	O
Pacific	O
Blue	O
anti-CD3	O
(	O
all	O
Ebioscience	O
)	O
,	O
PerCP	O
anti-CD4	O
,	O
APC	O
anti-IL-10	O
(	O
both	O
BD	O
)	O
,	O
and	O
ECD	O
anti-CD45R0	O
(	O
Beckman-Coulter	O
)	O
.	O

To	O
ascertain	O
specificity	O
of	O
the	O
intracellular	O
cytokine	O
staining	O
,	O
aliquots	O
of	O
some	O
samples	O
were	O
incubated	O
with	O
saturating	O
amounts	O
of	O
purified	O
non-labelled	O
antibody	O
of	O
the	O
same	O
clone	O
prior	O
to	O
staining	O
with	O
the	O
fluorochrome	O
labeled	O
ICS	O
antibody	O
.	O

The	O
FOXP3	O
staining	O
buffer	O
set	O
(	O
Ebioscience	O
)	O
was	O
used	O
following	O
the	O
manufacturer	O
's	O
protocol	O
.	O

Samples	O
were	O
acquired	O
on	O
a	O
3	O
laser/9	O
channel	O
CyAn™	O
ADP	O
flowcytometer	O
using	O
Summit	O
4.3	O
software	O
(	O
Dako	O
)	O
.	O

Analysis	O
was	O
performed	O
using	O
FlowJo	O
(	O
Tree	O
Star	O
Inc.	O
)	O
.	O

All	O
flowcytometric	O
analysis	O
was	O
performed	O
at	O
the	O
MRC	O
laboratories	O
,	O
The	O
Gambia	O
on	O
freshly	O
isolated	O
cells	O
.	O

Multiplex	O
analysis	O
of	O
plasma	O
cytokine	O
concentration	O

Plasma	O
concentrations	O
of	O
IFN-γ	O
,	O
TNF-α	O
and	O
IL-10	O
were	O
determined	O
for	O
each	O
subject	O
and	O
time	O
point	O
on	O
the	O
Bio-Plex®	O
200	O
system	O
,	O
using	O
X-Plex™	O
assays	O
(	O
both	O
Bio-Rad	O
Laboratories	O
)	O
,	O
according	O
to	O
the	O
manufacturer	O
's	O
instructions	O
.	O

Data	O
were	O
analysed	O
using	O
the	O
Bio-Plex®	O
Manager	O
software	O
.	O

The	O
detection	O
limit	O
was	O
defined	O
as	O
the	O
concentration	O
corresponding	O
to	O
a	O
fluorescence	O
value	O
above	O
the	O
mean	O
background	O
fluorescence	O
in	O
control	O
wells	O
plus	O
3	O
SD	O
,	O
being	O
8.76	O
pg/ml	O
for	O
IFN-γ	O
,	O
5	O
pg/ml	O
for	O
TNF-α	O
and	O
0.57	O
pg/ml	O
for	O
IL-10	O
.	O

Values	O
below	O
this	O
threshold	O
were	O
set	O
to	O
these	O
levels	O
.	O

Plasmodium	O
falciparum	O
culture	O
and	O
schizont	O
antigens	O

P.	O
falciparum	O
parasites	O
(	O
3D7	O
strain	O
)	O
were	O
cultured	O
in	O
vitro	O
as	O
described	O
[	O
73	O
]	O
and	O
were	O
routinely	O
shown	O
to	O
be	O
mycoplasma	O
free	O
by	O
PCR	O
(	O
Bio	O
Whittaker	O
)	O
.	O

Schizont-infected	O
erythrocytes	O
were	O
harvested	O
from	O
synchronized	O
cultures	O
by	O
centrifugation	O
through	O
a	O
Percoll	O
gradient	O
(	O
Sigma-Aldrich	O
)	O
.	O

PfSE	O
was	O
prepared	O
by	O
two	O
rapid	O
freeze-thaw	O
cycles	O
in	O
liquid	O
nitrogen	O
and	O
a	O
37°C	O
water	O
bath	O
.	O

Extracts	O
of	O
uninfected	O
erythrocytes	O
(	O
uRBC	O
)	O
were	O
prepared	O
in	O
the	O
same	O
way	O
.	O

Proliferation	O
assay	O

PBMC	O
from	O
10	O
severe	O
and	O
10	O
uncomplicated	O
malaria	O
cases	O
collected	O
on	O
day	O
0	O
were	O
depleted	O
of	O
CD25hi	O
cells	O
or	O
mock	O
depleted	O
using	O
magnetic	O
beads	O
(	O
Dynal	O
Biotech	O
,	O
UK	O
)	O
,	O
at	O
a	O
bead	O
to	O
PBMC	O
ratio	O
of	O
71	O
,	O
and	O
cell	O
proliferation	O
was	O
determined	O
by	O
[	O
3H	O
]	O
-thymidine	O
(	O
Amersham	O
,	O
UK	O
)	O
incorporation	O
after	O
6	O
days	O
in	O
culture	O
with	O
PfSE	O
,	O
uRBC	O
(	O
RBCPBMC	O
ratio	O
equivalent	O
to	O
21	O
)	O
,	O
GM	O
,	O
or	O
2	O
days	O
culture	O
with	O
PMA	O
(	O
10	O
ng/ml	O
)	O
+	O
Ionomycin	O
(	O
100	O
ng/ml	O
)	O
,	O
as	O
described	O
[	O
27	O
]	O
.	O

Cultured	O
ELISpot	O

Cultured	O
ELISPOTs	O
were	O
performed	O
to	O
assess	O
malaria	O
specific	O
IFN-γ	O
memory	O
responses	O
,	O
adapting	O
an	O
established	O
method	O
[	O
74	O
]	O
.	O

Up	O
to	O
1	O
million	O
PBMCs	O
collected	O
on	O
day	O
28	O
were	O
cultured	O
in	O
24	O
well	O
plates	O
for	O
6	O
days	O
in	O
1	O
ml	O
GM	O
and	O
stimulated	O
with	O
either	O
PfSE	O
,	O
uRBC	O
(	O
RBCPBMC	O
ratio	O
equivalent	O
to	O
21	O
)	O
,	O
or	O
GM	O
respectively	O
.	O

At	O
day	O
3	O
,	O
half	O
the	O
medium	O
was	O
exchanged	O
and	O
rIL-2	O
(	O
final	O
concentration	O
20	O
IU/well	O
)	O
was	O
added	O
.	O

On	O
day	O
6	O
cells	O
were	O
harvested	O
,	O
washed	O
three	O
times	O
,	O
and	O
1.5×105	O
cells	O
seeded	O
into	O
duplicate	O
wells	O
onto	O
Millipore	O
MAIP	O
S45	O
plates	O
and	O
restimulated	O
overnight	O
with	O
PfSE	O
,	O
uRBC	O
(	O
concentrations	O
as	O
above	O
)	O
,	O
GM	O
or	O
PHA-L	O
(	O
5	O
µg/ml	O
)	O
.	O

IFN-γ	O
ELISpot	O
was	O
performed	O
using	O
MabTech	O
antibodies	O
according	O
to	O
the	O
manufacturer	O
's	O
instructions	O
.	O

Spot	O
forming	O
cell	O
numbers	O
were	O
counted	O
using	O
an	O
ELISPOT	O
plate	O
reader	O
(	O
AutoImmuneDiagnostica	O
,	O
Vers	O
.	O
3.2	O
)	O
.	O

Results	O
are	O
expressed	O
as	O
spot	O
forming	O
units	O
(	O
SFU	O
)	O
per	O
million	O
PBMC	O
after	O
subtraction	O
of	O
individual	O
background	O
values	O
(	O
GM	O
for	O
PHA-L	O
,	O
uRBC	O
for	O
PfSE	O
)	O
being	O
deducted	O
.	O

Assays	O
were	O
discounted	O
if	O
the	O
positive	O
control	O
(	O
PHA-L	O
)	O
was	O
<	O
50	O
SFU	O
,	O
or	O
the	O
negative	O
control	O
was	O
>	O
30	O
SFU	O
.	O

RT-PCR	O

For	O
quantitative	O
reverse	O
transcription-polymerase	O
chain	O
reaction	O
(	O
RT-PCR	O
)	O
,	O
total	O
RNA	O
was	O
extracted	O
from	O
PAX	O
tubes	O
following	O
the	O
manufacturer	O
's	O
instructions	O
and	O
reverse	O
transcribed	O
into	O
cDNA	O
using	O
TaqMan®	O
reagents	O
for	O
reverse	O
transcription	O
(	O
Applied	O
Biosystems	O
)	O
,	O
following	O
the	O
manufacturer	O
's	O
protocol	O
.	O

Gene	O
expression	O
profiles	O
for	O
FOXP3	O
,	O
IL-10	O
,	O
SOCS-2	O
and	O
IFN-γ	O
were	O
measured	O
by	O
RT-PCR	O
on	O
a	O
DNA	O
Engine	O
Opticon®	O
(	O
MJ	O
Research	O
)	O
with	O
QuantiTect	O
SYBR	O
Green	O
PCR	O
kits	O
(	O
Qiagen	O
Ltd	O
)	O
using	O
primers	O
(	O
all	O
Sigma	O
Genosys	O
)	O
previously	O
described	O
:	O
IFN-γ	O
,	O
IL-10	O
;	O
FOXP3	O
designed	O
by	O
[	O
75	O
]	O
,	O
and	O
SOCS-2	O
designed	O
by	O
[	O
76	O
]	O
.	O

T-BET	O
and	O
GATA-3	O
gene	O
expression	O
was	O
determined	O
using	O
the	O
TaqMan®	O
Probe	O
kit	O
using	O
the	O
primers	O
(	O
all	O
Metabion	O
)	O
designed	O
by	O
[	O
77	O
]	O
.	O
18S	O
rRNA	O
,	O
amplified	O
using	O
a	O
commercially	O
available	O
kit	O
(	O
rRNA	O
primers	O
and	O
VIC	O
labeled	O
probe	O
,	O
Applied	O
Biosystems	O
)	O
,	O
was	O
used	O
as	O
an	O
internal	O
control	O
.	O

Data	O
were	O
analysed	O
using	O
Opticon	O
Monitor	O
3™	O
analysis	O
software	O
(	O
BioRad	O
)	O
and	O
are	O
expressed	O
as	O
the	O
ratio	O
of	O
the	O
transcript	O
number	O
of	O
the	O
gene	O
of	O
interest	O
over	O
the	O
endogenous	O
control	O
,	O
18S	O
rRNA	O
.	O

Parasite	O
genotyping	O

Genomic	O
DNA	O
from	O
each	O
parasite	O
isolate	O
was	O
genotyped	O
by	O
sequencing	O
the	O
highly	O
polymorphic	O
block	O
2	O
region	O
of	O
the	O
msp1	O
gene	O
to	O
assess	O
the	O
number	O
of	O
clones	O
infecting	O
each	O
patient	O
[	O
78	O
]	O
.	O

Statistical	O
analysis	O

Analysis	O
was	O
performed	O
using	O
linear	O
regression	O
,	O
with	O
a	O
random	O
effect	O
to	O
allow	O
for	O
the	O
within	O
subject	O
measurements	O
over	O
time	O
,	O
where	O
the	O
response	O
variables	O
were	O
log	O
transformed	O
to	O
improve	O
the	O
normality	O
and	O
constant	O
variance	O
assumptions	O
.	O

Significance	C
(	C
measured	C
at	C
the	C
5	C
%	C
level	C
)	C
tests	C
for	C
the	C
effects	C
of	C
malaria	C
group	C
(	C
uncomplicated	C
,	C
SA	C
or	C
SB	C
)	C
,	C
time	C
(	C
day	C
0	C
and	C
day	C
28	C
)	C
and	C
their	C
interaction	C
were	C
adjusted	C
for	C
the	C
possible	C
confounding	C
effects	C
of	C
age	C
,	C
sex	C
,	C
duration	C
of	C
prior	C
symptoms	C
and	C
numbers	C
of	C
clones	C
causing	C
the	C
infection	C
.	C

Where	O
there	O
was	O
no	O
significant	O
malaria	O
group	O
and	O
time	O
interaction	O
,	O
p-values	O
for	O
the	O
overall	O
comparison	O
of	O
day	O
0	O
vs.	O
day	O
28	O
are	O
given	O
.	O

Within	O
day	O
0	O
,	O
comparisons	O
of	O
severe	O
vs.	O
uncomplicated	O
and	O
the	O
two	O
groups	O
of	O
severely	O
ill	O
patients	O
(	O
SA	O
vs	O
SB	O
)	O
were	O
adjusted	O
for	O
any	O
malaria	O
group	O
and	O
time	O
interactions	O
.	O

To	O
allow	O
for	O
the	O
multiplicity	O
of	O
tests	O
resulting	O
from	O
multiple	O
responses	O
and	O
multiple	O
comparisons	O
within	O
a	O
response	O
performed	O
in	O
the	O
model	O
,	O
a	O
false	O
discovery	O
rate	O
(	O
FDR	O
)	O
of	O
5	O
%	O
was	O
assumed	O
.	O

Using	O
the	O
Benjamini	O
and	O
Hochberg	O
approach	O
[	O
43	O
]	O
only	O
tests	O
with	O
a	O
p-value	O
below	O
0.012	O
have	O
an	O
FDR	O
of	O
≤5	O
%	O
.	O

Due	O
to	O
the	O
large	O
number	O
of	O
tests	O
family-wise	O
error	O
rate	O
correction	O
methods	O
were	O
too	O
conservative	O
.	O

Analyses	O
were	O
performed	O
using	O
Stata	O
version	O
9	O
and	O
Matlab	O
version	O
R2008a	O
.	O

Supporting	O
Information	O

Figure	O
S1	O
mRNA	O
levels	O
for	O
IFN-γ	O
,	O
IL-10	O
and	O
Th-1	O
as	O
well	O
as	O
Th-2	O
lineage	O
transcription	O
factors	O
in	O
severe	O
and	O
mild	O
disease	O
.	O
(	O
1.99	O
MB	O
TIF	O
)	O

Myeloid	O
Neoplasia	O
:	O
CBFß	O
is	O
critical	O
for	O
AML1-ETO	O
and	O
TEL-AML1	O
activity	O

Abstract	O

AML1-ETO	O
and	O
TEL-AML1	O
are	O
chimeric	O
proteins	O
resulting	O
from	O
the	O
t	O
(	O
8	O
;	O
21	O
)	O
(	O
q22	O
;	O
q22	O
)	O
in	O
acute	O
myeloid	O
leukemia	O
,	O
and	O
the	O
t	O
(	O
12	O
;	O
21	O
)	O
(	O
p13	O
;	O
q22	O
)	O
in	O
pre-B-cell	O
leukemia	O
,	O
respectively	O
.	O

The	O
Runt	O
domain	O
of	O
AML1	O
in	O
both	O
proteins	O
mediates	O
DNA	O
binding	O
and	O
heterodimerization	O
with	O
the	O
core	O
binding	O
factor	O
ß	O
(	O
CBFß	O
)	O
subunit	O
.	O

To	C
determine	C
whether	C
CBFß	C
is	C
required	C
for	C
AML1-ETO	C
and	C
TEL-AML1	C
activity	C
,	C
we	C
introduced	C
amino	C
acid	C
substitutions	C
into	C
the	C
Runt	C
domain	C
that	C
disrupt	C
heterodimerization	C
with	C
CBFß	C
but	C
not	C
DNA	C
binding	C
.	C

We	O
show	O
that	O
CBFß	O
contributes	O
to	O
AML1-ETO	O
's	O
inhibition	O
of	O
granulocyte	O
differentiation	O
,	O
is	O
essential	O
for	O
its	O
ability	O
to	O
enhance	O
the	O
clonogenic	O
potential	O
of	O
primary	O
mouse	O
bone	O
marrow	O
cells	O
,	O
and	O
is	O
indispensable	O
for	O
its	O
cooperativity	O
with	O
the	O
activated	O
receptor	O
tyrosine	O
kinase	O
TEL-PDGFßR	O
in	O
generating	O
acute	O
myeloid	O
leukemia	O
in	O
mice	O
.	O

Similarly	O
,	O
CBFß	O
is	O
essential	O
for	O
TEL-AML1	O
's	O
ability	O
to	O
promote	O
self-renewal	O
of	O
B	O
cell	O
precursors	O
in	O
vitro	O
.	O

These	O
studies	O
validate	O
the	O
Runt	O
domain/CBFß	O
interaction	O
as	O
a	O
therapeutic	O
target	O
in	O
core	O
binding	O
factor	O
leukemias	O
.	O

Introduction	O

RUNX1	O
and	O
CBFB	O
are	O
very	O
frequent	O
targets	O
of	O
mutations	O
and	O
gene	O
rearrangements	O
in	O
leukemia.1,2	O

Among	O
the	O
most	O
commonly	O
identified	O
rearrangements	O
are	O
the	O
t	O
(	O
8	O
;	O
21	O
)	O
(	O
q22	O
;	O
q22	O
)	O
in	O
12	O
%	O
of	O
adult	O
acute	O
myeloid	O
leukemia	O
(	O
AML	O
)	O
and	O
the	O
t	O
(	O
12	O
;	O
21	O
)	O
(	O
p13	O
;	O
q22	O
)	O
in	O
25	O
%	O
of	O
pediatric	O
acute	O
lymphocytic	O
leukemia	O
(	O
ALL	O
)	O
,	O
both	O
of	O
which	O
involve	O
the	O
RUNX1	O
gene.3	O

The	O
molecular	O
consequence	O
of	O
these	O
translocations	O
is	O
the	O
generation	O
of	O
fusion	O
proteins	O
,	O
AML1-ETO	O
and	O
TEL-AML1	O
,	O
respectively.4–7	O

AML1-ETO	O
contains	O
the	O
N-terminal	O
177	O
amino	O
acids	O
of	O
the	O
Runx1	O
DNA-binding	O
subunit	O
fused	O
in	O
frame	O
with	O
nearly	O
all	O
of	O
ETO	O
(	O
821	O
;	O
encoded	O
by	O
RUNX1T1	O
)	O
.4,5	O

Runx1	O
is	O
required	O
for	O
normal	O
hematopoiesis.8	O

The	O
function	O
of	O
ETO	O
itself	O
is	O
not	O
particularly	O
well	O
understood	O
.	O

Its	O
Drosophila	O
homolog	O
,	O
Nervy	O
,	O
interacts	O
directly	O
with	O
the	O
transcription	O
factor	O
daughterless	O
,	O
and	O
represses	O
the	O
activity	O
of	O
enhancers	O
normally	O
activated	O
by	O
the	O
achaete-scute	O
complex	O
in	O
the	O
sensory	O
organ	O
precursor	O
cell.9	O

Homozygous	O
disruption	O
of	O
Runx1t1	O
in	O
mice	O
resulted	O
in	O
gastrointestinal	O
defects	O
,	O
but	O
no	O
hematopoietic	O
deficiencies.10	O

AML1-ETO	O
has	O
5	O
conserved	O
domains	O
,	O
one	O
from	O
Runx1	O
(	O
the	O
Runt	O
domain	O
)	O
and	O
4	O
from	O
ETO.11,12	O

The	O
eTAFH	O
(	O
or	O
NHR1	O
)	O
domain	O
interacts	O
with	O
the	O
nuclear	O
hormone	O
receptor	O
corepressor	O
(	O
N-CoR	O
)	O
,13	O
and	O
also	O
with	O
the	O
activation	O
domain	O
of	O
E	O
proteins	O
(	O
E2A	O
and	O
HEB	O
)	O
.14	O

The	O
HHR	O
(	O
NHR2	O
)	O
domain	O
forms	O
an	O
α-helical	O
tetramer	O
that	O
mediates	O
oligomerization	O
of	O
AML1-ETO	O
with	O
itself	O
and	O
other	O
ETO	O
proteins	O
and	O
interacts	O
with	O
the	O
corepressor	O
Sin3	O
,	O
Gfi1	O
,	O
and	O
histone	O
deacetylases	O
1	O
and	O
3.12,15–20	O

Nervy	O
(	O
NHR3	O
)	O
is	O
an	O
α-helical	O
domain	O
that	O
interacts	O
with	O
the	O
regulatory	O
subunit	O
of	O
type	O
II	O
cyclic	O
AMP-dependent	O
protein	O
kinase	O
.	O
21,22	O

Myeloid-Nervy-DEAF-1	O
(	O
MYND	O
or	O
NHR4	O
)	O
is	O
a	O
zinc-chelating	O
domain	O
structurally	O
homologous	O
to	O
the	O
PHD	O
and	O
RING	O
finger	O
domains	O
and	O
mediates	O
interactions	O
with	O
N-CoR	O
,	O
the	O
silencing	O
mediator	O
of	O
retinoid	O
and	O
thyroid	O
hormone	O
receptor	O
(	O
SMRT	O
)	O
,	O
and	O
the	O
DNA	O
binding	O
protein	O
SON	O
.	O
16,23–26	O

A	O
foreshortened	O
splice	O
variant	O
of	O
AML1-ETO	O
lacking	O
both	O
the	O
Nervy	O
and	O
MYND	O
domains	O
(	O
AML1-ETO9a	O
)	O
,	O
or	O
full-length	O
AML1-ETO	O
with	O
a	O
mutation	O
predicted	O
to	O
disrupt	O
the	O
structure	O
of	O
the	O
MYND	O
domain	O
and	O
shown	O
to	O
impair	O
SON	O
binding	O
had	O
increased	O
leukemogenic	O
potential.23,27,28	O

The	O
Runt	O
domain	O
from	O
Runx1	O
mediates	O
both	O
DNA	O
binding	O
and	O
heterodimerization	O
with	O
CBFß.29	O

Both	O
of	O
these	O
properties	O
are	O
essential	O
for	O
normal	O
Runx1	O
function	O
in	O
vivo.30	O

CBFß	C
enhances	C
the	C
affinity	C
of	C
the	C
Runt	C
domain	C
for	C
DNA	C
by	C
7-	C
to	C
10-fold	C
through	C
quenching	C
conformational	C
exchange	C
in	C
several	C
dynamic	C
regions	C
31–36	C
and	C
may	C
additionally	C
inhibit	C
Runx1	C
degradation	C
mediated	C
by	C
the	C
ubiquitin	C
proteasome	C
pathway	C
.37	C

An	O
R174Q	O
mutation	O
in	O
Runx1	O
found	O
in	O
AML	O
of	O
the	O
M0	O
subtype	O
and	O
in	O
familial	O
platelet	O
disorder	O
with	O
predisposition	O
for	O
AML	O
(	O
FPD/AML	O
)	O
that	O
disrupts	O
only	O
DNA	O
but	O
not	O
CBFß	O
binding	O
generated	O
a	O
weakly	O
dominant	O
negative	O
Runx1	O
allele.30,38–40	O

Single	O
amino	O
acid	O
substitutions	O
in	O
Runx1	O
that	O
impaired	O
CBFß	O
but	O
not	O
DNA	O
binding	O
resulted	O
in	O
hypomorphic	O
alleles	O
that	O
diminished	O
but	O
did	O
not	O
eliminate	O
Runx1	O
's	O
in	O
vivo	O
activity.30	O

The	O
most	O
commonly	O
accepted	O
models	O
of	O
AML1-ETO–mediated	O
leukemogenesis	O
posit	O
that	O
it	O
functions	O
either	O
as	O
a	O
dominant	O
inhibitor	O
of	O
CBF	O
function41–43	O
or	O
as	O
a	O
constitutive	O
repressor	O
of	O
CBF	O
target	O
gene	O
expression.44	O

Inhibition	C
or	C
repression	C
is	C
presumably	C
mediated	C
by	C
the	C
recruitment	C
of	C
corepressor	C
complexes	C
interacting	C
with	C
ETO	C
domains	C
to	C
genomic	C
targets	C
recognized	C
by	C
the	C
Runt	C
domain	C
.11,12	C

However	C
,	C
increasing	C
evidence	C
in	C
cell	C
line	C
models	C
suggests	C
that	C
the	C
real	C
situation	C
may	C
be	C
substantially	C
more	C
complex	C
.14,45–48	C

For	C
example	C
,	C
it	C
was	C
proposed	C
that	C
AML1-ETO	C
may	C
function	C
by	C
sequestering	C
transcription	C
factors	C
(	C
such	C
as	C
E-box	C
proteins	C
)	C
,	C
SON	C
,	C
or	C
other	C
regulatory	C
proteins	C
into	C
subnuclear	C
compartments	C
13,23	C
and	C
that	C
its	C
DNA	C
binding	C
function	C
may	C
not	C
be	C
necessary	C
.13	C

It	C
has	C
also	C
been	C
proposed	C
that	C
AML1-ETO	C
functions	C
by	C
dysregulating	C
the	C
expression	C
of	C
E-box	C
protein	C
targets	C
.14	C

The	O
essential	O
contribution	O
of	O
DNA	O
binding	O
by	O
the	O
Runt	O
domain	O
to	O
overt	O
leukemia	O
was	O
,	O
however	O
,	O
recently	O
and	O
unequivocally	O
established	O
by	O
demonstrating	O
that	O
an	O
R174Q	O
mutation	O
that	O
disrupts	O
DNA	O
but	O
not	O
CBFß	O
binding	O
abolished	O
AML1-ETO	O
's	O
activity.30,49	O

On	O
the	O
other	O
hand	O
,	O
the	O
role	O
of	O
CBFß	O
binding	O
for	O
AML1-ETO	O
's	O
leukemogenic	O
activity	O
has	O
not	O
been	O
accessed	O
.	O

TEL-AML1	O
contains	O
the	O
N-terminal	O
,	O
non-DNA	O
binding	O
region	O
of	O
TEL	O
(	O
translocation-ETS-leukemia	O
;	O
encoded	O
by	O
ETV6	O
)	O
fused	O
to	O
nearly	O
all	O
of	O
Runx1.7,50	O

The	O
components	O
of	O
TEL	O
retained	O
in	O
the	O
fusion	O
protein	O
include	O
the	O
Pointed	O
domain	O
,	O
which	O
forms	O
a	O
head-to-tail	O
polymeric	O
structure	O
,	O
as	O
well	O
as	O
a	O
corepressor	O
binding	O
domain	O
,	O
which	O
together	O
mediate	O
interaction	O
with	O
N-CoR	O
,	O
SMRT	O
,	O
and	O
mSin3a.6,51–55	O

The	O
predominant	O
model	O
of	O
TEL-AML1	O
function	O
posits	O
that	O
it	O
recruits	O
corepressor	O
complexes	O
to	O
CBF	O
target	O
genes	O
in	O
a	O
Runt	O
domain-dependent	O
manner	O
,	O
resulting	O
in	O
inappropriate	O
gene	O
regulation.52,56,57	O

Mechanisms	C
invoking	C
off-DNA	C
activities	C
including	C
sequestration	C
of	C
transcriptional	C
complexes	C
and	C
disruption	C
of	C
wild-type	C
TEL	C
function	C
have	C
also	C
been	C
proposed	C
.58–60	C

However	O
,	O
recent	O
work	O
using	O
the	O
equivalent	O
of	O
an	O
AML1-ETO	O
R174Q	O
substitution	O
in	O
the	O
Runt	O
domain	O
that	O
specifically	O
disrupted	O
DNA	O
binding	O
resulted	O
in	O
a	O
loss	O
of	O
TEL-AML1	O
activity	O
in	O
B-cell	O
precursors	O
,	O
demonstrating	O
the	O
centrality	O
of	O
this	O
function.61	O

These	O
mechanistic	O
uncertainties	O
underscore	O
the	O
importance	O
of	O
characterizing	O
the	O
specific	O
contributions	O
of	O
each	O
domain	O
in	O
AML1-ETO	O
and	O
TEL-AML1	O
to	O
their	O
in	O
vivo	O
activities	O
.	O

Herein	O
we	O
analyzed	O
the	O
importance	O
of	O
CBFß	O
binding	O
by	O
the	O
Runt	O
domain	O
for	O
both	O
AML1-ETO	O
and	O
TEL-AML1	O
function	O
.	O

The	O
residues	O
involved	O
in	O
DNA	O
binding	O
and	O
heterodimerization	O
are	O
on	O
distinct	O
surfaces	O
of	O
the	O
Runt	O
domain	O
,	O
and	O
extensive	O
mutational	O
analysis	O
has	O
been	O
performed	O
on	O
both	O
interfaces.30,34,36,62–65	O

Importantly	O
,	O
the	O
majority	O
of	O
mutations	O
in	O
the	O
Runt	O
domain	O
destabilize	O
its	O
structure	O
,	O
and	O
negatively	O
impact	O
both	O
DNA	O
and	O
CBFß	O
binding.30,63,65	O

We	O
used	O
the	O
available	O
biophysical	O
information	O
to	O
introduce	O
and	O
carefully	O
characterize	O
amino	O
acid	O
substitutions	O
that	O
selectively	O
target	O
CBFß	O
binding	O
.	O

We	O
incorporated	O
these	O
mutations	O
into	O
AML1-ETO	O
and	O
TEL-AML1	O
and	O
obtained	O
evidence	O
that	O
CBFß	O
binding	O
is	O
critical	O
for	O
their	O
respective	O
activities	O
.	O

Methods	O

Cloning	O
,	O
expression	O
,	O
and	O
protein	O
purification	O

A	O
retroviral	O
vector	O
expressing	O
TEL-PDGFßR	O
plus	O
human	O
CD4	O
(	O
hCD4	O
)	O
was	O
made	O
by	O
cloning	O
a	O
blunted	O
EcoRI	O
fragment	O
from	O
the	O
TEL-PDGFßR	O
cDNA	O
into	O
the	O
HpaI	O
site	O
of	O
the	O
MSV2.2-IRES-hCD4	O
vector	O
.	O

The	O
MigR1-AML1-ETO-IRES-EGFP	O
,	O
pMSCV-IRES-EGFP	O
(	O
MSCV-EGFP	O
)	O
,	O
and	O
pMSCV-TEL-AML1-IRES-EGFP	O
(	O
MSCV-T/A	O
)	O
vectors	O
were	O
described	O
previously.15,66	O

CBFß	O
(	O
amino	O
acids	O
1-141	O
)	O
and	O
the	O
wild-type	O
Runt	O
domain	O
(	O
residues	O
41-190	O
)	O
were	O
cloned	O
between	O
the	O
BamHI	O
and	O
EcoRI	O
sites	O
and	O
the	O
NcoI	O
and	O
XhoI	O
sites	O
of	O
the	O
pHis	O
parallel	O
vector,67	O
respectively	O
.	O

The	O
proteins	O
were	O
expressed	O
in	O
Rosetta	O
(	O
DE3	O
)	O
cells	O
(	O
Novagen	O
,	O
San	O
Diego	O
,	O
CA	O
)	O
by	O
inducing	O
with	O
0.8	O
mM	O
isopropyl-ß-D-thiogalactopyranoside	O
(	O
IPTG	O
)	O
at	O
25°C	O
(	O
for	O
CBFß	O
)	O
or	O
20°C	O
(	O
for	O
Runt	O
domain	O
)	O
when	O
optical	O
density	O
(	O
OD	O
)	O
600	O
nm	O
reached	O
0.5	O
to	O
approximately	O
0.7	O
,	O
and	O
purified	O
on	O
a	O
Ni-NTA	O
column	O
(	O
QIAGEN	O
,	O
Valencia	O
CA	O
)	O
.	O

The	O
6	O
×	O
His	O
tag	O
was	O
cleaved	O
by	O
AcTEV	O
(	O
Invitrogen	O
,	O
Carlsbad	O
,	O
CA	O
)	O
,	O
and	O
proteins	O
were	O
further	O
purified	O
on	O
an	O
S-100	O
column	O
(	O
CBFß	O
)	O
or	O
SP-Sepharose	O
column	O
(	O
Runt	O
domain	O
;	O
GE	O
Healthcare	O
,	O
Piscataway	O
,	O
NJ	O
)	O
.	O

All	O
mutations	O
were	O
generated	O
using	O
the	O
QuikChange	O
XLII	O
Site-Directed	O
Mutagenesis	O
kit	O
(	O
Stratagene	O
,	O
La	O
Jolla	O
,	O
CA	O
)	O
.	O

Urea	O
denaturation	O
,	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
and	O
isothermal	O
titration	O
calorimetry	O
measurements	O

All	O
assays	O
were	O
performed	O
as	O
previously	O
described.65,68	O

Retroviral	O
transduction	O

Bone	O
marrow	O
(	O
BM	O
)	O
harvested	O
from	O
C57BL/6J	O
mice	O
treated	O
7	O
days	O
previously	O
with	O
150	O
mg/kg	O
5-fluorouracil	O
(	O
5-FU	O
;	O
Sigma-Aldrich	O
,	O
St	O
Louis	O
,	O
MO	O
)	O
was	O
suspended	O
in	O
1	O
mL	O
transplant	O
media	O
per	O
mouse	O
hind-leg	O
[	O
RPMI	O
,	O
20	O
%	O
fetal	O
calf	O
serum	O
(	O
FCS	O
)	O
,	O
100	O
IU/mL	O
penicillin	O
,	O
100	O
µg/mL	O
streptomycin	O
(	O
Mediatech	O
,	O
Herndon	O
,	O
VA	O
)	O
,	O
10	O
ng/mL	O
interleukin-3	O
(	O
IL-3	O
)	O
,	O
20	O
ng/mL	O
IL-6	O
,	O
20	O
ng/mL	O
stem	O
cell	O
factor	O
(	O
SCF	O
;	O
R	O
&	O
D	O
Systems	O
,	O
Minneapolis	O
,	O
MN	O
)	O
]	O
and	O
incubated	O
overnight	O
at	O
37°C	O
in	O
ultra-low	O
attachment	O
plates	O
(	O
Costar	O
,	O
Corning	O
,	O
NY	O
)	O
.	O

One	O
milliliter	O
of	O
each	O
virus	O
(	O
MigR1-EGFP	O
,	O
AML1-ETO	O
,	O
and	O
mutants	O
thereof	O
,	O
TEL-PDGFßR	O
,	O
or	O
MSCV-hCD4	O
)	O
was	O
spun	O
(	O
1000g	O
for	O
90	O
minutes	O
at	O
31°C	O
)	O
onto	O
an	O
ultra-low	O
attachment	O
6-well	O
plate	O
well	O
,	O
previously	O
precoated	O
with	O
Retronectin	O
(	O
100	O
µg/well	O
;	O
Takara	O
,	O
Madison	O
,	O
WI	O
)	O
,	O
and	O
the	O
viral	O
supernatant	O
was	O
subsequently	O
removed	O
.	O

Cells	O
were	O
then	O
resuspended	O
in	O
fresh	O
transplant	O
media	O
with	O
cytokines	O
at	O
6	O
×	O
106	O
cells/3	O
mL	O
and	O
centrifuged	O
(	O
1000g	O
for	O
90	O
minutes	O
)	O
onto	O
the	O
virally	O
preloaded	O
plates	O
with	O
an	O
additional	O
0.5	O
mL	O
each	O
virus	O
.	O

A	O
second	O
spinfection	O
(	O
150g	O
for	O
10	O
minutes	O
)	O
was	O
performed	O
12	O
hours	O
later	O
onto	O
new	O
virally	O
precoated	O
plates	O
,	O
and	O
cells	O
were	O
incubated	O
at	O
37°C	O
for	O
3.5	O
hours	O
.	O

Hematopoietic	O
assays	O
and	O
flow	O
cytometry	O

Granulocyte	O
differentiation	O
,	O
BrDU	O
staining	O
,	O
serial	O
replating	O
,	O
and	O
c-Kit+	O
B-cell	O
progenitor	O
colony	O
forming	O
assays	O
were	O
performed	O
as	O
described	O
previously.15,25,61,66	O

Antibodies	O
used	O
were	O
:	O
allophycocyanin	O
(	O
APC	O
)	O
,	O
phycoerythrin	O
(	O
PE	O
)	O
,	O
or	O
PerCPcy5.5	O
conjugated	O
anti–Mac-1	O
(	O
clone	O
M1/70	O
)	O
,	O
APC	O
or	O
PerCP-Cy5.5	O
conjugated	O
anti–Gr-1	O
(	O
clone	O
RB6-8C5	O
)	O
,	O
APC-conjugated	O
anti-Sca1	O
(	O
clone	O
D7	O
)	O
,	O
PE-Cy5.5	O
conjugated	O
anti-CD117	O
(	O
clone	O
2B8	O
)	O
,	O
and	O
PE-conjugated	O
anti–human	O
CD4	O
(	O
clone	O
L3T4	O
;	O
eBioscience	O
,	O
San	O
Diego	O
,	O
CA	O
)	O
.	O

Transplantation	O
assays	O

Retrovirally	O
transduced	O
cells	O
were	O
washed	O
and	O
resuspended	O
in	O
phosphate-buffered	O
saline	O
(	O
PBS	O
)	O
.	O

C57BL/6J	O
males	O
(	O
5	O
to	O
6	O
weeks	O
old	O
)	O
were	O
lethally	O
irradiated	O
with	O
a	O
split	O
dose	O
of	O
5.5	O
Gy	O
3	O
to	O
4	O
hours	O
apart	O
and	O
injected	O
intravenously	O
with	O
106	O
infected	O
BM	O
cells	O
and	O
2	O
×	O
105	O
splenocytes	O
from	O
a	O
C57BL6/J	O
donor	O
.	O

Mice	O
were	O
monitored	O
for	O
development	O
of	O
leukemia	O
through	O
peripheral	O
blood	O
analysis	O
for	O
infected	O
cells	O
by	O
fluorescence-activated	O
cell	O
sorting	O
(	O
FACS	O
)	O
and	O
by	O
observation	O
of	O
physical	O
symptoms	O
characterized	O
by	O
lethargy	O
,	O
anemia	O
,	O
and	O
splenomegaly	O
.	O

Sick	O
mice	O
were	O
euthanized	O
,	O
and	O
all	O
remaining	O
mice	O
were	O
killed	O
at	O
63	O
days	O
.	O

All	O
animal	O
procedures	O
were	O
approved	O
by	O
the	O
Institutional	O
Animal	O
Care	O
and	O
Use	O
Committee	O
at	O
Dartmouth	O
College	O
.	O

Western	O
blot	O
analysis	O

AML1-ETO	O
and	O
TEL-AML1	O
proteins	O
were	O
detected	O
in	O
retrovirally	O
transduced	O
NIH3T3	O
cells	O
as	O
described	O
previously.15,25,61,66	O

Splenocyte	O
extracts	O
were	O
prepared	O
by	O
lysing	O
approximately	O
5	O
×	O
105	O
cells	O
in	O
3×	O
sodium	O
dodecyl	O
sulfate	O
(	O
SDS	O
)	O
sample	O
buffer	O
(	O
New	O
England	O
Biolabs	O
,	O
Ipswich	O
,	O
MA	O
)	O
with	O
0.1	O
M	O
dithiothreitol	O
for	O
10	O
minutes	O
on	O
ice	O
,	O
boiling	O
5	O
minutes	O
at	O
95°C	O
,	O
and	O
the	O
proteins	O
were	O
resolved	O
through	O
NuPAGE	O
Novex	O
4	O
%	O
-12	O
%	O
Bis-Tris	O
mini	O
gels	O
(	O
Invitrogen	O
)	O
and	O
transferred	O
onto	O
a	O
polyvinylidene	O
fluoride	O
,	O
(	O
PVDF	O
)	O
membrane	O
.	O

Blots	O
were	O
probed	O
with	O
primary	O
anti-ETO	O
Ab-1	O
(	O
2.5µg/mL	O
,	O
2	O
hours	O
;	O
Calbiochem	O
,	O
San	O
Diego	O
,	O
CA	O
)	O
and	O
anti-actin	O
(	O
1:1000	O
,	O
1	O
hour	O
;	O
Sigma-Aldrich	O
)	O
antibodies	O
,	O
and	O
secondary	O
goat	O
anti–rabbit	O
IgG	O
(	O
H	O
+	O
L	O
;	O
1:100000	O
,	O
45	O
minutes	O
;	O
Caltag	O
Laboratories	O
,	O
Carlsbad	O
,	O
CA	O
)	O
horseradish	O
peroxidase-conjugated	O
antibody	O
in	O
PBS/0.2	O
%	O
Tween/5	O
%	O
nonfat	O
milk	O
.	O

Band	O
intensities	O
were	O
determined	O
using	O
ImageQuant	O
5.0	O
software	O
.	O

Results	O

Generating	O
Runt	O
domain	O
mutations	O
that	O
independently	O
disrupt	O
DNA	O
and	O
CBFß	O
binding	O

We	O
compared	O
the	O
contribution	O
of	O
DNA	O
versus	O
CBFß	O
binding	O
to	O
AML1-ETO–mediated	O
leukemogenesis	O
by	O
introducing	O
amino	O
acid	O
substitutions	O
at	O
both	O
interfaces	O
.	O

An	O
R174Q	O
substitution	O
caused	O
a	O
greater	O
than	O
40000-fold	O
reduction	O
in	O
DNA	O
binding	O
by	O
the	O
isolated	O
Runt	O
domain	O
without	O
perturbing	O
heterodimerization	O
with	O
CBFß	O
,	O
its	O
structure	O
,	O
or	O
its	O
thermodynamic	O
stability.30	O

A	O
T161A	O
mutation	O
,	O
on	O
the	O
other	O
hand	O
,	O
caused	O
a	O
40-fold	O
reduction	O
in	O
CBFß	O
binding	O
while	O
having	O
no	O
effect	O
on	O
DNA	O
binding.65	O

The	O
T161A	O
mutation	O
did	O
not	O
perturb	O
the	O
Runt	O
domain	O
's	O
structure	O
as	O
assessed	O
in	O
15N-1H	O
HSQC	O
spectra,65	O
although	O
it	O
did	O
moderately	O
decrease	O
its	O
thermodynamic	O
stability.30	O

Since	O
the	O
T161A	O
mutation	O
,	O
when	O
introduced	O
into	O
the	O
Runx1	O
locus	O
in	O
mice	O
,	O
did	O
not	O
completely	O
eliminate	O
Runx1	O
's	O
in	O
vivo	O
function,30	O
we	O
sought	O
to	O
disrupt	O
CBFß	O
binding	O
further	O
by	O
combining	O
it	O
with	O
a	O
second	O
mutation	O
.	O

The	O
majority	O
(	O
approximately	O
two-thirds	O
)	O
of	O
alanine	O
substitutions	O
in	O
the	O
Runt	O
domain	O
perturb	O
its	O
fold	O
,	O
particularly	O
those	O
within	O
the	O
ß-barrel	O
,	O
one	O
surface	O
of	O
which	O
comprises	O
the	O
CBFß	O
interface.30,63,65	O

A	O
Y113A	O
mutation	O
was	O
one	O
of	O
only	O
a	O
few	O
that	O
decreased	O
the	O
affinity	O
for	O
CBFß	O
(	O
by	O
approximately	O
5-fold	O
)	O
,	O
while	O
causing	O
only	O
minimal	O
,	O
local	O
effects	O
on	O
the	O
Runt	O
domain	O
fold	O
as	O
assessed	O
in	O
15N-1H	O
HSQC	O
spectra.65	O

We	O
showed	O
that	O
the	O
Y113A/T161A	O
dual	O
mutations	O
did	O
not	O
further	O
decrease	O
the	O
Runt	O
domain	O
's	O
thermodynamic	O
stability	O
compared	O
with	O
the	O
T161A	O
mutation	O
alone	O
(	O
Figure	O
1B	O
)	O
.	O

The	O
dissociation	O
constant	O
(	O
K2	O
;	O
Figure	O
1C	O
)	O
of	O
the	O
Y113A/T161A	O
mutant	O
Runt	O
domain	O
for	O
DNA	O
was	O
unaltered	O
(	O
Figure	O
1D	O
)	O
.	O

Since	O
DNA	O
binding	O
is	O
highly	O
sensitive	O
to	O
mutations	O
in	O
the	O
Runt	O
domain	O
that	O
perturb	O
its	O
structure,30,63	O
we	O
reasoned	O
that	O
the	O
Y113A/T161A	O
mutant	O
Runt	O
domain	O
's	O
fold	O
is	O
intact	O
despite	O
its	O
modestly	O
decreased	O
thermodynamic	O
stability	O
.	O

Amino	O
acid	O
substitutions	O
in	O
the	O
Runx1	O
Runt	O
domain	O
that	O
specifically	O
disrupt	O
DNA	O
and	O
CBFß	O
binding	O
.	O

(	O
A	O
)	O
Structures	O
of	O
the	O
Runt	O
domain	O
and	O
CBFß	O
are	O
shown	O
in	O
gray	O
and	O
blue	O
,	O
respectively	O
,	O
and	O
the	O
DNA	O
is	O
purple.36	O

The	O
R174	O
side	O
chain	O
in	O
the	O
Runt	O
domain	O
is	O
green	O
,	O
and	O
the	O
T161	O
and	O
Y113	O
side	O
chains	O
are	O
orange	O
.	O

(	O
B	O
)	O
Urea	O
denaturation	O
monitored	O
by	O
tryptophan	O
fluorescence	O
for	O
the	O
wild-type	O
Runt	O
domain	O
and	O
point	O
mutants	O
thereof	O
.	O

Plotted	O
is	O
the	O
fraction	O
of	O
unfolded	O
Runt	O
domain	O
in	O
the	O
presence	O
of	O
increasing	O
concentrations	O
of	O
urea	O
.	O

Data	O
from	O
the	O
wild-type	O
Runt	O
domain	O
,	O
R174Q	O
,	O
and	O
T161A	O
are	O
from	O
Matheny	O
et	O
al.30	O

(	C
C	C
)	C
Diagram	C
of	C
the	C
potential	C
interactions	C
between	C
the	C
Runt	C
Domain	C
,	C
CBFß	C
,	C
and	C
DNA	C
.	C

(	O
D	O
)	O
EMSA	O
measuring	O
the	O
affinity	O
of	O
the	O
Y113A/T161A	O
Runt	O
domain	O
for	O
DNA	O
(	O
K2	O
)	O
.	O

Shown	O
is	O
a	O
representative	O
example	O
of	O
3	O
experiments	O
.	O

Triangles	O
indicate	O
decreasing	O
concentrations	O
of	O
the	O
Runt	O
domain	O
(	O
2	O
×	O
10-6	O
to	O
4	O
×	O
10-15	O
M	O
)	O
.	O

Arrow	O
indicates	O
the	O
lane	O
in	O
which	O
the	O
Runt	O
domain	O
concentration	O
approximates	O
K2	O
.	O

(	O
E	O
)	O
Isothermal	O
titration	O
calorimetric	O
measurements	O
of	O
CBFß	O
binding	O
to	O
the	O
wild-type	O
,	O
T161A	O
,	O
and	O
Y113A/T161A	O
mutant	O
Runt	O
domains	O
.	O

Wild-type	C
Runt	C
domain	C
(	C
45	C
µM	C
)	C
was	C
titrated	C
with	C
440	C
µM	C
CBFß	C
at	C
26°C	C
,	C
and	C
42	C
µM	C
T161A	C
or	C
38	C
µM	C
Y113A/T161A	C
were	C
titrated	C
with	C
396	C
µM	C
CBFß	C
at	C
22°C	C
.	C

In	O
each	O
panel	O
,	O
the	O
top	O
portion	O
is	O
the	O
raw	O
data	O
,	O
and	O
the	O
bottom	O
panel	O
is	O
a	O
plot	O
of	O
the	O
binding	O
corrected	O
for	O
dilution	O
enthalpy	O
.	O

Experimental	O
data	O
(	O
squares	O
)	O
are	O
fit	O
to	O
a	O
one-site	O
binding	O
model	O
(	O
line	O
)	O
.	O

The	O
equilibrium	O
dissociation	O
constants	O
(	O
K1	O
)	O
are	O
indicated	O
in	O
the	O
plots	O
.	O

The	O
average	O
values	O
from	O
2	O
independent	O
measurements	O
(	O
±	O
standard	O
deviation	O
[	O
SD	O
]	O
)	O
are	O
given	O
.	O

We	O
measured	O
the	O
affinity	O
of	O
the	O
T161A	O
and	O
Y113A/T161A	O
mutant	O
Runt	O
domains	O
for	O
CBFß	O
by	O
isothermal	O
titration	O
calorimetry	O
(	O
Figure	O
1E	O
)	O
.	O

The	O
dissociation	O
constant	O
(	O
K1	O
in	O
Figure	O
1C	O
)	O
for	O
the	O
T161A	O
mutant	O
Runt	O
domain	O
was	O
increased	O
by	O
63-fold	O
,	O
and	O
for	O
the	O
Y113A/T161A	O
mutant	O
by	O
430-fold	O
(	O
Figure	O
1E	O
)	O
.	O

Whereas	O
binding	O
of	O
the	O
wild-type	O
Runt	O
domain	O
to	O
CBFß	O
is	O
exothermic	O
(	O
release	O
of	O
heat	O
upon	O
binding	O
)	O
,	O
that	O
of	O
the	O
mutant	O
Runt	O
domains	O
is	O
endothermic	O
(	O
absorption	O
of	O
heat	O
upon	O
binding	O
)	O
.	O

For	O
this	O
reason	O
,	O
the	O
raw	O
heat	O
data	O
in	O
Figure	O
1E	O
switches	O
from	O
being	O
negative	O
for	O
the	O
wild-type	O
to	O
positive	O
for	O
the	O
T161A	O
and	O
Y113A/T161A	O
mutant	O
Runt	O
domains	O
.	O

Apparently	O
,	O
the	O
interactions	O
mediated	O
by	O
T161	O
contribute	O
strongly	O
to	O
the	O
enthalpy	O
of	O
binding	O
,	O
and	O
loss	O
of	O
these	O
interactions	O
results	O
in	O
a	O
binding	O
process	O
that	O
is	O
no	O
longer	O
enthalpically	O
favorable	O
but	O
remains	O
entropically	O
favorable	O
,	O
albeit	O
of	O
weaker	O
affinity	O
.	O

Disruption	O
of	O
DNA	O
or	O
CBFß	O
binding	O
impairs	O
AML1-ETO	O
's	O
ability	O
to	O
repress	O
granulocyte	O
differentiation	O
.	O

We	O
introduced	O
the	O
R174Q	O
,	O
T161A	O
,	O
and	O
Y113A/T161A	O
mutations	O
into	O
AML1-ETO	O
(	O
Figure	O
2A	O
)	O
and	O
expressed	O
AML1-ETO	O
and	O
its	O
mutated	O
derivates	O
in	O
lineage	O
negative	O
(	O
CD5-	O
,	O
B220-	O
,	O
Mac-1-	O
,	O
Gr-1-	O
,	O
Ter119-	O
)	O
mouse	O
BM	O
cells	O
(	O
Lin-	O
BM	O
)	O
.	O

The	O
retroviruses	O
also	O
expressed	O
the	O
enhanced	O
green	O
fluorescent	O
protein	O
(	O
EGFP	O
)	O
from	O
an	O
internal	O
ribosomal	O
entry	O
site	O
.	O

We	O
cultured	O
cells	O
following	O
transduction	O
in	O
the	O
presence	O
of	O
IL-3	O
,	O
IL-6	O
,	O
and	O
SCF	O
for	O
2	O
days	O
,	O
in	O
the	O
same	O
cytokines	O
plus	O
granulocyte	O
colony-stimulating	O
factor	O
(	O
G-CSF	O
)	O
for	O
an	O
additional	O
7	O
days	O
to	O
induce	O
granulocyte	O
differentiation	O
,	O
and	O
then	O
analyzed	O
EGFP+	O
cells	O
for	O
Mac-1	O
and	O
Gr-1	O
expression	O
(	O
Figure	O
2B	O
,	O
C	O
)	O
.	O

Approximately	O
32	O
%	O
of	O
cells	O
expressing	O
EGFP	O
alone	O
were	O
Mac-1+Gr-1+	O
(	O
Figure	O
2C	O
)	O
versus	O
10	O
%	O
of	O
those	O
expressing	O
AML1-ETO	O
.	O

Disruption	O
of	O
DNA	O
binding	O
(	O
R174Q	O
)	O
or	O
impairment	O
of	O
CBFß	O
heterodimerization	O
(	O
Y113A/T161A	O
)	O
increased	O
the	O
percentage	O
of	O
Mac-1+Gr-1+	O
cells	O
.	O

A	C
triple	C
Y113A/T161A/R174Q	C
mutation	C
in	C
AML1-ETO	C
did	C
not	C
further	C
increase	C
the	C
percentage	C
of	C
Mac-1+Gr-1+cells	C
compared	C
with	C
the	C
individually	C
mutated	C
AML1-ETO	C
proteins	C
,	C
indicating	C
that	C
the	C
residual	C
inhibitory	C
effect	C
of	C
AML1-ETO	C
resides	C
in	C
more	C
C-terminal	C
ETO	C
sequences	C
,	C
and	C
is	C
not	C
mediated	C
through	C
CBF	C
binding	C
sites	C
.	C

The	O
mutated	O
AML1-ETO	O
proteins	O
accumulated	O
to	O
similar	O
steady	O
state	O
levels	O
in	O
transduced	O
NIH3T3	O
cells	O
(	O
Figure	O
2E	O
)	O
.	O

AML1-ETO	O
function	O
is	O
impaired	O
by	O
mutations	O
that	O
disrupt	O
DNA	O
or	O
CBFß	O
binding	O
.	O

(	O
A	O
)	O
Diagram	O
of	O
AML1-ETO	O
and	O
location	O
of	O
the	O
mutations	O
affecting	O
DNA	O
(	O
R174Q	O
)	O
and	O
CBFß	O
binding	O
(	O
T161A	O
and	O
Y113A/T161A	O
)	O
.	O

(	O
B	O
)	O
Lin-	O
BM	O
cells	O
infected	O
with	O
MigR1	O
retroviruses	O
expressing	O
AML1-ETO	O
and	O
mutated	O
derivatives	O
after	O
7	O
days	O
of	O
culture	O
in	O
the	O
presence	O
of	O
IL-3	O
,	O
IL-6	O
,	O
SCF	O
,	O
and	O
G-CSF	O
.	O

EGFP+	O
gated	O
cells	O
(	O
not	O
shown	O
)	O
were	O
analyzed	O
for	O
Gr-1	O
and	O
Mac-1	O
expression	O
.	O

(	O
C	O
)	O
Summary	O
of	O
data	O
illustrated	O
in	O
panel	O
B	O
compiled	O
from	O
2	O
experiments	O
,	O
each	O
with	O
triplicate	O
samples	O
.	O

**P	O
≤	O
.01	O
compared	O
with	O
AML1-ETO	O
(	O
#	O
)	O
;	O
***P	O
≤	O
.001	O
(	O
Dunnett	O
test	O
and	O
analysis	O
of	O
variance	O
[	O
ANOVA	O
]	O
)	O
.	O

(	O
D	O
)	O
Serial	O
replating	O
analysis	O
.	O

Graphs	O
represent	O
the	O
average	O
number	O
of	O
colonies	O
from	O
each	O
round	O
of	O
replating	O
in	O
the	O
presence	O
of	O
IL-3	O
,	O
IL-6	O
,	O
and	O
SCF	O
.	O

Week	O
1	O
represents	O
colony	O
numbers	O
per	O
103	O
cells	O
plated	O
,	O
weeks	O
2	O
and	O
3	O
are	O
from	O
104	O
plated	O
cells	O
.	O

Numbers	O
are	O
averaged	O
from	O
2	O
experiments	O
,	O
each	O
containing	O
triplicate	O
samples	O
.	O

(	O
E	O
)	O
Western	O
blot	O
analysis	O
probed	O
with	O
an	O
antibody	O
to	O
the	O
Runt	O
domain	O
,	O
demonstrating	O
expression	O
of	O
AML1-ETO	O
and	O
its	O
mutated	O
derivatives	O
in	O
MigR1-transduced	O
NIH3T3	O
cells	O
.	O

(	O
F	O
)	O
BrdU	O
incorporation	O
48	O
hours	O
after	O
transduction	O
of	O
Lin-	O
BM	O
cells	O
with	O
AML1-ETO	O
and	O
its	O
mutants	O
.	O

EGFP+	O
cells	O
were	O
analyzed	O
after	O
a	O
1	O
hour	O
BrdU	O
pulse	O
for	O
BrdU	O
and	O
7-AAD	O
incorporation	O
.	O

Shown	O
is	O
a	O
representative	O
of	O
3	O
experiments	O
.	O

(	O
G	O
)	O
Average	O
percentages	O
of	O
gated	O
BrdU+	O
(	O
S	O
phase	O
)	O
cells	O
from	O
scatter	O
plots	O
in	O
panel	O
F	O
(	O
n	O
=	O
3	O
)	O
.	O

Error	O
bars	O
indicate	O
95	O
%	O
confidence	O
intervals	O
.	O

**P	O
≤	O
.01	O
compared	O
with	O
AML1-ETO	O
(	O
Dunnett	O
test	O
and	O
ANOVA	O
)	O
.	O

Disruption	O
of	O
DNA	O
binding	O
or	O
CBFß	O
binding	O
abrogates	O
AML1-ETO	O
's	O
ability	O
to	O
promote	O
self-renewal	O
and	O
inhibit	O
proliferation	O
.	O

We	O
assessed	O
the	O
importance	O
of	O
DNA	O
binding	O
and	O
heterodimerization	O
with	O
CBFß	O
for	O
AML1-ETO	O
's	O
ability	O
to	O
confer	O
increased	O
self-renewal	O
capacity	O
to	O
hematopoietic	O
progenitors	O
in	O
vitro.69–71	O

Cells	O
expressing	O
AML1-ETO	O
could	O
be	O
propagated	O
for	O
at	O
least	O
3	O
weeks	O
in	O
methylcellulose	O
cultures	O
(	O
Figure	O
2D	O
)	O
and	O
yielded	O
primarily	O
immature	O
myeloid	O
lineage	O
cells	O
and	O
a	O
smaller	O
percentage	O
of	O
differentiated	O
macrophages15,70	O
(	O
not	O
shown	O
)	O
.	O

Impaired	O
DNA	O
or	O
CBFß	O
binding	O
caused	O
by	O
the	O
R174Q	O
or	O
Y113A/T161A	O
mutations	O
,	O
respectively	O
,	O
completely	O
abolished	O
AML1-ETO	O
's	O
ability	O
to	O
sustain	O
this	O
clonogenic	O
activity	O
(	O
Figure	O
2D	O
)	O
.	O

Interestingly	C
,	C
it	C
appears	C
that	C
the	C
threshold	C
level	C
above	C
which	C
AML1-ETO	C
can	C
not	C
tolerate	C
disruption	C
of	C
CBFß	C
binding	C
and	C
maintain	C
clonogenicity	C
lies	C
above	C
60-fold	C
,	C
as	C
the	C
T161A	C
mutant	C
retains	C
activity	C
for	C
at	C
least	C
3	C
weeks	C
in	C
this	C
assay	C
(	C
Figure	C
2D	C
)	C
.	C

AML1-ETO	O
inhibits	O
the	O
short-term	O
proliferation	O
of	O
human	O
and	O
mouse	O
primary	O
BM	O
cells.70,71	O

The	O
R174Q	O
,	O
T161A	O
,	O
and	O
Y113A/T161A	O
mutations	O
alleviated	O
this	O
repressive	O
effect	O
,	O
although	O
the	O
percentage	O
of	O
cells	O
in	O
S	O
phase	O
was	O
still	O
significantly	O
lower	O
than	O
in	O
MigR1	O
transduced	O
cells	O
(	O
Figure	O
2F	O
,	O
G	O
)	O
.	O

CBFß	O
binding	O
is	O
required	O
for	O
AML1-ETO	O
's	O
leukemogenic	O
activity	O
.	O

Numerous	O
murine	O
models	O
have	O
demonstrated	O
that	O
full-length	O
AML1-ETO	O
alone	O
is	O
not	O
capable	O
of	O
causing	O
AML.69,72–76	O

Activating	O
mutations	O
in	O
the	O
platelet-derived	O
growth	O
factor	O
family	O
of	O
receptor	O
tyrosine	O
kinases	O
,	O
including	O
FLT3	O
and	O
KIT	O
,	O
and	O
in	O
RAS	O
are	O
common	O
in	O
core	O
binding	O
factor	O
leukemias,77–81	O
and	O
correspondingly	O
,	O
AML1-ETO	O
was	O
shown	O
to	O
be	O
capable	O
of	O
cooperating	O
with	O
activated	O
forms	O
of	O
both	O
platelet-derived	O
growth	O
factor	O
receptor-b	O
(	O
TEL-PDGFßR	O
)	O
and	O
FLT3	O
to	O
generate	O
AML	O
in	O
mice.82,83	O

Both	C
aforementioned	C
mouse	C
studies	C
reported	C
that	C
mutation	C
of	C
leucine	C
148	C
to	C
aspartic	C
acid	C
(	C
L148D	C
)	C
within	C
the	C
Runt	C
domain	C
of	C
AML1-ETO	C
,	C
which	C
disrupts	C
DNA	C
binding16	C
and	C
presumably	C
causes	C
a	C
severe	C
disruption	C
of	C
domain	C
stability,30,65	C
resulted	C
in	C
a	C
loss	C
of	C
cooperation	C
with	C
either	C
oncogene	C
.82,83	C

These	C
studies	C
underscored	C
the	C
importance	C
of	C
the	C
Runt	C
domain	C
for	C
AML1-ETO	C
's	C
cooperative	C
activity	C
,	C
but	C
did	C
not	C
address	C
whether	C
disruption	C
of	C
DNA	C
binding	C
,	C
CBFß	C
heterodimerization	C
,	C
or	C
both	C
were	C
responsible	C
for	C
the	C
observed	C
effect	C
.	C

We	O
retrovirally	O
transduced	O
AML1-ETO	O
(	O
and	O
derivative	O
mutants	O
)	O
and	O
TEL-PDGFßR	O
into	O
BM	O
cells	O
from	O
5-FU–treated	O
mice	O
(	O
Figure	O
3A	O
)	O
.	O

The	O
retrovirus	O
expressing	O
AML1-ETO	O
produced	O
EGFP	O
from	O
an	O
internal	O
ribosome	O
entry	O
site	O
,	O
and	O
the	O
TEL-PDGFßR	O
virus	O
produced	O
hCD4	O
.	O

The	O
percentages	O
of	O
doubly	O
transduced	O
cells	O
(	O
EGFP+hCD4+	O
)	O
were	O
similar	O
for	O
AML1-ETO	O
and	O
various	O
mutants	O
thereof	O
at	O
2	O
days	O
after	O
spinfection	O
(	O
Figure	O
3B	O
)	O
.	O

We	O
transplanted	O
lethally	O
irradiated	O
primary	O
recipient	O
animals	O
with	O
106	O
retrovirally	O
transduced	O
,	O
unsorted	O
cells	O
and	O
monitored	O
the	O
animals	O
for	O
disease	O
.	O

The	O
AML	O
that	O
develops	O
in	O
mice	O
transplanted	O
with	O
BM	O
cells	O
expressing	O
both	O
AML1-ETO	O
and	O
TEL-PDGFßR	O
is	O
marked	O
clinically	O
by	O
splenomegaly	O
,	O
hepatomegaly	O
,	O
thrombocytopenia	O
,	O
and	O
anemia	O
with	O
an	O
accumulation	O
of	O
myeloid	O
blasts	O
in	O
the	O
BM	O
and	O
an	O
infiltration	O
thereof	O
in	O
the	O
spleen	O
and	O
liver.82	O

TEL-PDGFßR	O
will	O
independently	O
generate	O
a	O
chronic	O
myeloproliferative	O
disorder	O
(	O
CMPD	O
)	O
marked	O
by	O
splenomegaly	O
,	O
hepatomegaly	O
,	O
and	O
neutrophilic	O
leukocytosis.84	O

We	C
predicted	C
that	C
if	C
mutations	C
in	C
AML1-ETO	C
impaired	C
its	C
leukemogenic	C
activity	C
,	C
the	C
disease	C
would	C
more	C
closely	C
resemble	C
the	C
CMPD	C
caused	C
by	C
TEL-PDGFßR	C
alone	C
.	C

Mutations	O
that	O
disrupt	O
DNA	O
or	O
CBFß	O
binding	O
impair	O
AML1-ETO	O
's	O
leukemogenic	O
activity	O
.	O

(	O
A	O
)	O
Schematic	O
of	O
transplantation	O
scheme	O
.	O

BM	O
mononuclear	O
cells	O
harvested	O
from	O
5-FU–treated	O
C57BL/6	O
mice	O
were	O
co-infected	O
with	O
MigR1	O
expressing	O
AML1-ETO	O
(	O
and	O
its	O
mutated	O
derivatives	O
)	O
and	O
TEL-PDGFßR	O
.	O

Internal	O
ribosome	O
entry	O
site	O
(	O
IRES	O
)	O
–mediated	O
expression	O
of	O
EGFP	O
marks	O
AML1-ETO	O
expressing	O
cells	O
,	O
while	O
hCD4	O
marks	O
TEL-PDGFßR	O
expressing	O
cells	O
.	O

Retrovirally	O
transduced	O
cells	O
(	O
106	O
)	O
were	O
transplanted	O
along	O
with	O
2	O
×	O
105	O
normal	O
BM	O
cells	O
into	O
lethally	O
irradiated	O
mice	O
.	O

(	O
B	O
)	O
FACS	O
plots	O
of	O
BM	O
cells	O
2	O
days	O
after	O
transduction	O
to	O
show	O
that	O
all	O
were	O
equivalently	O
infected	O
.	O

(	O
C	O
)	O
Kaplan-Meier	O
survival	O
curve	O
of	O
mice	O
after	O
transplantation	O
with	O
retroviruses	O
expressing	O
AML1-ETO	O
(	O
AE	O
)	O
or	O
its	O
mutated	O
derivatives	O
and	O
TEL-PDGFßR	O
(	O
TP	O
)	O
.	O

The	O
study	O
end	O
point	O
was	O
63	O
days	O
.	O

The	O
number	O
of	O
mice	O
in	O
each	O
group	O
is	O
indicated	O
.	O

(	O
D	O
)	O
Spleen	O
weights	O
of	O
mice	O
upon	O
sacrifice	O
.	O

Significant	O
differences	O
from	O
AML1-ETO	O
plus	O
TEL-PDGFßR	O
recipients	O
(	O
#	O
)	O
are	O
indicated	O
with	O
*	O
(	O
Dunnett	O
test	O
and	O
ANOVA	O
)	O
.	O

(	O
E	O
)	O
Representative	O
plots	O
of	O
BM	O
cells	O
in	O
transplant	O
recipients	O
upon	O
sacrifice	O
demonstrating	O
the	O
presence	O
of	O
EGFP+	O
and	O
hCD4+	O
cells	O
.	O

The	O
relatively	O
high	O
EGFP	O
fluorescence	O
in	O
the	O
AML1-ETO	O
(	O
Y113A/T161A	O
)	O
plus	O
TEL-PDGFßR	O
BM	O
cells	O
was	O
observed	O
in	O
19	O
of	O
24	O
mice	O
.	O

(	O
F	O
)	O
Average	O
percentage	O
of	O
EGFP-	O
hCD4+	O
and	O
EGFP+	O
hCD4+	O
BM	O
cells	O
in	O
transplant	O
recipients	O
upon	O
sacrifice	O
.	O

Error	O
bars	O
indicate	O
95	O
%	O
confidence	O
intervals	O
.	O

Differences	O
relative	O
to	O
AML1-ETO	O
plus	O
TEL-PDGFßR	O
(	O
#	O
)	O
for	O
each	O
group	O
were	O
determined	O
using	O
Dunnett	O
test	O
and	O
ANOVA	O
.	O

(	O
G	O
)	O
Cytospin	O
preparations	O
of	O
BM	O
cells	O
from	O
an	O
AML1-ETO	O
plus	O
TEL-PDGFßR	O
leukemic	O
mouse	O
purified	O
based	O
on	O
hCD4	O
and	O
EGFP	O
expression	O
.	O

Mice	O
transplanted	O
with	O
BM	O
cells	O
expressing	O
both	O
AML1-ETO	O
and	O
TEL-PDGFßR	O
developed	O
a	O
completely	O
penetrant	O
lethal	O
leukemia	O
,	O
as	O
reported	O
previously,82	O
and	O
succumbed	O
to	O
their	O
disease	O
within	O
4	O
weeks	O
(	O
Figure	O
3C	O
)	O
.	O

In	O
contrast	O
,	O
most	O
control	O
mice	O
transplanted	O
with	O
cells	O
expressing	O
AML1-ETO	O
alone	O
(	O
8/8	O
)	O
,	O
or	O
TEL-PDGFßR	O
alone	O
(	O
7/8	O
)	O
survived	O
for	O
63	O
days	O
,	O
at	O
which	O
point	O
they	O
were	O
killed	O
for	O
analysis	O
.	O

Diseased	O
AML1-ETO	O
plus	O
TEL-PDGFßR	O
transplanted	O
mice	O
presented	O
with	O
anemia	O
,	O
splenomegaly	O
,	O
and	O
pale	O
livers	O
(	O
not	O
shown	O
)	O
.	O

Their	O
BM	O
contained	O
blast	O
cells	O
characterized	O
by	O
a	O
high	O
nucleocytoplasmic	O
ratio	O
,	O
heterochromatic	O
nuclei	O
,	O
occasional	O
cytoplasmic	O
vacuoles	O
,	O
irregular	O
nuclear	O
contours	O
,	O
and	O
prominent	O
nucleoli	O
(	O
not	O
shown	O
)	O
.	O

Blast	O
cells	O
were	O
also	O
present	O
in	O
peripheral	O
blood	O
(	O
not	O
shown	O
)	O
.	O

However	C
the	C
BM	C
contained	C
many	C
more	C
differentiated	C
myeloid	C
cells	C
such	C
as	C
neutrophils	C
with	C
ring-shaped	C
nuclei	C
(	C
characteristic	C
of	C
CMPD	C
)	C
,	C
presumably	C
arising	C
from	C
the	C
large	C
population	C
of	C
EGFP-hCD4+	C
cells	C
expressing	C
TEL-PDGFßR	C
alone	C
(	C
Figure	C
3E	C
,	C
F	C
)	C
.	C

As	O
a	O
result	O
of	O
the	O
mixed	O
diseases	O
in	O
these	O
mice	O
,	O
BM	O
differentials	O
and	O
histology	O
were	O
not	O
useful	O
diagnostic	O
aids	O
.	O

We	O
therefore	O
isolated	O
EGFP-hCD4+	O
and	O
EGFP+hCD4+	O
cells	O
from	O
the	O
BM	O
of	O
leukemic	O
AML1-ETO	O
plus	O
TEL-PDGFßR	O
mice	O
and	O
analyzed	O
their	O
morphology	O
.	O

The	O
EGFP+hCD4+	O
population	O
(	O
expressing	O
AML1-ETO	O
plus	O
TEL-PDGFßR	O
)	O
contained	O
a	O
markedly	O
greater	O
percentage	O
of	O
blast	O
cells	O
,	O
consistent	O
with	O
AML	O
,	O
in	O
comparison	O
to	O
the	O
EGFP-hCD4+	O
population	O
(	O
Figure	O
3G	O
)	O
.	O

We	C
were	C
able	C
to	C
transplant	C
AML1-ETO	C
plus	C
TEL-PDGFßR	C
expressing	C
cells	C
into	C
secondary	C
recipients	C
and	C
reconstitute	C
the	C
disease	C
,	C
but	C
only	C
using	C
large	C
numbers	C
(	C
>	C
2	C
×	C
106	C
)	C
of	C
freshly	C
isolated	C
splenocytes	C
,	C
and	C
not	C
with	C
frozen	C
cells	C
(	C
not	C
shown	C
)	C
,	C
indicating	C
that	C
the	C
percentage	C
of	C
leukemia	C
initiating	C
cells	C
was	C
low	C
.	C

Most	O
mice	O
transplanted	O
with	O
BM	O
expressing	O
TEL-PDGFßR	O
plus	O
either	O
the	O
non-DNA	O
binding	O
or	O
non-CBFß	O
binding	O
AML1-ETO	O
mutants	O
(	O
R174Q	O
and	O
Y113A/T161A	O
,	O
respectively	O
)	O
survived	O
until	O
the	O
study	O
end	O
point	O
of	O
63	O
days	O
(	O
Figure	O
3C	O
)	O
.	O

The	O
majority	O
of	O
these	O
mice	O
had	O
evidence	O
of	O
disease	O
as	O
manifested	O
by	O
enlarged	O
spleens	O
[	O
15/22	O
for	O
AML1-ETO	O
(	O
R174Q	O
)	O
and	O
22/24	O
for	O
AML1-ETO	O
(	O
Y113A/T161A	O
)	O
]	O
.	O

Their	C
average	C
spleen	C
sizes	C
were	C
similar	C
to	C
those	C
of	C
mice	C
transplanted	C
with	C
BM	C
expressing	C
AML1-ETO	C
plus	C
TEL-PDGFßR	C
or	C
TEL-PDGFßR	C
alone	C
,	C
and	C
were	C
significantly	C
greater	C
than	C
those	C
of	C
mice	C
transplanted	C
with	C
BM	C
expressing	C
AML1-ETO	C
alone	C
(	C
Figure	C
3D	C
)	C
,	C
indicating	C
that	C
TEL-PDGFßR	C
contributed	C
significantly	C
to	C
the	C
splenomegaly	C
.	C

A	O
minority	O
of	O
the	O
mice	O
were	O
anemic	O
as	O
evidenced	O
by	O
pale	O
livers	O
[	O
2/22	O
for	O
AML1-ETO	O
(	O
R174Q	O
)	O
and	O
6/24	O
for	O
AML1-ETO	O
(	O
Y113A/T161A	O
)	O
]	O
,	O
whereas	O
anemia	O
was	O
more	O
prevalent	O
in	O
the	O
AML1-ETO	O
plus	O
TEL-PDGFßR	O
mice	O
(	O
16/22	O
)	O
.	O

The	C
BM	C
of	C
all	C
groups	C
contained	C
EGFP-hCD4+	C
and	C
EGFP+hCD4+	C
cells	C
,	C
but	C
relatively	C
few	C
cells	C
expressing	C
EGFP	C
(	C
AML1-ETO	C
)	C
alone	C
,	C
suggesting	C
a	C
competitive	C
advantage	C
for	C
cells	C
that	C
expressed	C
TEL-PDGFßR	C
(	C
Figure	C
3E	C
)	C
.	C

Interestingly	C
,	C
most	C
mice	C
(	C
19/24	C
)	C
transplanted	C
with	C
cells	C
expressing	C
the	C
AML1-ETO	C
(	C
Y113A/T161A	C
)	C
mutant	C
contained	C
an	C
EGFPhihCD4+	C
BM	C
population	C
,	C
presumably	C
resulting	C
from	C
a	C
selection	C
for	C
cells	C
expressing	C
high	C
AML1-ETO	C
(	C
Y113A/T161A	C
)	C
levels	C
(	C
Figure	C
3E	C
)	C
.	C

We	C
speculate	C
that	C
the	C
Y113A/T161A	C
mutant	C
has	C
residual	C
activity	C
and	C
that	C
more	C
highly	C
expressing	C
cells	C
partially	C
overcome	C
the	C
effects	C
of	C
the	C
mutations	C
and	C
thus	C
are	C
positively	C
selected	C
.	C

Despite	O
having	O
more	O
EGFP+hCD4+	O
cells	O
and	O
higher	O
AML1-ETO	O
levels	O
,	O
the	O
AML1-ETO	O
(	O
Y113A/T161A	O
)	O
plus	O
TEL-PDGFßR	O
group	O
survived	O
longer	O
than	O
the	O
AML1-ETO	O
plus	O
TEL-PDGFßR	O
group	O
,	O
thus	O
AML1-ETO	O
deficient	O
for	O
CBFß	O
binding	O
has	O
greatly	O
attenuated	O
activity	O
.	O

We	O
were	O
unable	O
to	O
detect	O
AML1-ETO	O
protein	O
in	O
spleen	O
samples	O
from	O
any	O
of	O
the	O
transplanted	O
mice	O
using	O
antibodies	O
that	O
recognize	O
either	O
ETO	O
or	O
the	O
Runt	O
domain	O
from	O
Runx1	O
,	O
although	O
we	O
could	O
detect	O
the	O
protein	O
in	O
Kasumi-1	O
cells	O
which	O
contain	O
the	O
t	O
(	O
8	O
;	O
21	O
)	O
,	O
and	O
actin	O
was	O
clearly	O
visible	O
in	O
all	O
of	O
the	O
samples	O
(	O
not	O
shown	O
)	O
.	O

We	C
suspect	C
our	C
inability	C
to	C
detect	C
AML1-ETO	C
was	C
due	C
to	C
the	C
relatively	C
low	C
percentage	C
of	C
AML1-ETO	C
expressing	C
spleen	C
cells	C
(	C
Figure	C
3F	C
)	C
.	C

EGFP+hCD4+	O
BM	O
cells	O
(	O
expressing	O
AML1-ETO	O
plus	O
TEL-PDGFßR	O
)	O
from	O
the	O
AML1-ETO	O
plus	O
TEL-PDGFßR	O
recipients	O
contained	O
significantly	O
higher	O
percentages	O
of	O
c-kit+	O
Sca-1+	O
cells	O
than	O
those	O
expressing	O
either	O
of	O
the	O
mutated	O
AML1-ETO	O
proteins	O
or	O
TEL-PDGFßR	O
alone	O
(	O
Figure	O
4A	O
,	O
B	O
)	O
.	O

The	O
percentage	O
of	O
Gr1+Mac1+	O
cells	O
in	O
the	O
EGFP+hCD4+	O
BM	O
population	O
was	O
correspondingly	O
lower	O
in	O
the	O
AML1-ETO	O
plus	O
TEL-PDGFßR	O
group	O
than	O
in	O
any	O
other	O
,	O
reflective	O
of	O
impaired	O
granulocyte	O
differentiation	O
(	O
Figure	O
4A	O
,	O
C	O
)	O
.	O

Interestingly	C
,	C
the	C
FACS	C
profiles	C
of	C
EGFP+hCD4+	C
BM	C
cells	C
from	C
the	C
AML1-ETO	C
(	C
Y113A/T161A	C
)	C
plus	C
TEL-PDGFßR	C
group	C
were	C
not	C
identical	C
to	C
those	C
of	C
the	C
AML1-ETO	C
(	C
R174Q	C
)	C
plus	C
TEL-PDGFßR	C
group	C
and	C
appeared	C
to	C
be	C
intermediate	C
between	C
CMPD	C
and	C
AML	C
.	C

For	C
instance	C
,	C
there	C
were	C
fewer	C
Gr1hiMac1hi	C
cells	C
in	C
the	C
AML1-ETO	C
(	C
Y113A/T161A	C
)	C
plus	C
TEL-PDGFßR	C
group	C
,	C
suggesting	C
that	C
granulocyte	C
differentiation	C
was	C
somewhat	C
more	C
impaired	C
(	C
Figure	C
4A	C
)	C
.	C

Flow	O
cytometric	O
analysis	O
of	O
BM	O
from	O
primary	O
transplant	O
recipients	O
.	O

(	O
A	O
)	O
Whole	O
BM	O
of	O
diseased	O
mice	O
was	O
gated	O
based	O
on	O
forward	O
and	O
side	O
scatter	O
characteristics	O
and	O
subsequently	O
analyzed	O
for	O
expression	O
of	O
hCD4	O
(	O
TEL-PDGFßR	O
)	O
and	O
EGFP	O
(	O
AML1-ETO	O
)	O
.	O

EGFP+hCD4+	O
cells	O
were	O
then	O
analyzed	O
for	O
the	O
expression	O
of	O
myeloid	O
and	O
progenitor	O
markers	O
.	O

Plots	O
are	O
from	O
a	O
single	O
animal	O
that	O
is	O
representative	O
of	O
the	O
experimental	O
group	O
.	O

(	O
B	O
)	O
Differences	O
in	O
the	O
percentage	O
of	O
EGFP+hCD4+	O
BM	O
cells	O
that	O
were	O
positive	O
for	O
both	O
c-kit	O
and	O
Sca-1	O
.	O

Error	O
bars	O
indicate	O
95	O
%	O
confidence	O
intervals	O
.	O

AE	O
+	O
TP	O
,	O
n	O
=	O
21	O
mice	O
;	O
R174Q	O
+	O
TP	O
,	O
n	O
=	O
22	O
;	O
Y113A/T161A	O
,	O
n	O
=	O
24	O
;	O
TP	O
,	O
n	O
=	O
8	O
;	O
AE	O
,	O
n	O
=	O
8	O
.	O

Differences	O
relative	O
to	O
AML1-ETO	O
plus	O
TEL-PDGFßR	O
(	O
#	O
)	O
for	O
each	O
group	O
were	O
determined	O
using	O
Dunnett	O
test	O
and	O
ANOVA	O
.	O

(	O
C	O
)	O
Differences	O
in	O
the	O
percentage	O
of	O
EGFP+hCD4+	O
BM	O
cells	O
that	O
were	O
positive	O
for	O
both	O
Gr-1	O
and	O
Mac-1	O
.	O

Error	O
bars	O
indicate	O
95	O
%	O
confidence	O
intervals	O
.	O

Differences	O
relative	O
to	O
AML1-ETO	O
plus	O
TEL-PDGFßR	O
(	O
#	O
)	O
for	O
each	O
group	O
were	O
determined	O
using	O
Dunnett	O
test	O
and	O
ANOVA	O
.	O

The	O
percentage	O
of	O
Gr-1+Mac-1+	O
cells	O
in	O
mice	O
transplanted	O
with	O
AML1-ETO	O
(	O
Y113A/T161A	O
)	O
plus	O
TEL-PDGFßR	O
transduced	O
cells	O
was	O
significantly	O
lower	O
(	O
P	O
<	O
.001	O
)	O
than	O
in	O
mice	O
transplanted	O
with	O
BM	O
expressing	O
AML1-ETO	O
(	O
R174Q	O
)	O
plus	O
TEL-PDGFßR	O
or	O
TEL-PDGFßR	O
alone	O
.	O

In	O
summary	O
,	O
cells	O
expressing	O
AML1-ETO	O
plus	O
TEL-PDGFßR	O
gave	O
rise	O
to	O
a	O
rapid	O
AML	O
as	O
reported	O
previously.82	O

Mutations	O
in	O
AML1-ETO	O
that	O
impaired	O
DNA	O
binding	O
significantly	O
weakened	O
its	O
activity	O
,	O
resulting	O
in	O
an	O
extended	O
latency	O
and	O
disease	O
specificity	O
more	O
closely	O
resembling	O
that	O
caused	O
by	O
TEL-PDGFßR	O
alone	O
.	O

Loss	O
of	O
CBFß	O
binding	O
also	O
weakened	O
AML1-ETO	O
's	O
activity	O
,	O
resulting	O
in	O
an	O
extended	O
disease	O
latency	O
,	O
selection	O
of	O
higher	O
AML1-ETO	O
expressing	O
cells	O
,	O
and	O
a	O
cell	O
surface	O
phenotype	O
intermediate	O
between	O
AML	O
and	O
CMPD	O
.	O

These	C
results	C
indicate	C
that	C
the	C
mutated	C
AML1-ETO	C
proteins	C
were	C
unable	C
to	C
appropriately	C
regulate	C
a	C
subset	C
of	C
genes	C
required	C
for	C
the	C
development	C
of	C
AML	C
.	C

Disruption	O
of	O
CBFß	O
binding	O
by	O
the	O
Runt	O
domain	O
of	O
TEL-AML1	O
abrogates	O
its	O
ability	O
to	O
enhance	O
self-renewal	O
of	O
B-cell	O
progenitors	O
.	O

TEL-AML1	O
is	O
critically	O
dependent	O
upon	O
DNA	O
binding	O
to	O
enhance	O
the	O
self-renewal	O
of	O
B-cell	O
progenitors	O
in	O
culture.61	O

To	C
determine	C
whether	C
disrupting	C
CBFß	C
binding	C
above	C
a	C
specific	C
threshold	C
results	C
in	C
functional	C
impairment	C
,	C
we	C
introduced	C
mutations	C
analogous	C
to	C
T161A	C
and	C
Y113A/T161A	C
(	C
T188A	C
and	C
Y140A/T188A	C
)	C
into	C
TEL-AML1	C
.	C

As	C
the	C
Runt	C
domains	C
of	C
AML1-ETO	C
and	C
TEL-AML1	C
are	C
identical	C
,	C
we	C
would	C
expect	C
the	C
biophysical	C
characteristics	C
of	C
the	C
mutated	C
proteins	C
to	C
be	C
comparable	C
.	C

We	O
transduced	O
c-Kit+	O
fetal	O
liver	O
cells	O
from	O
embryonic	O
day	O
12	O
C57BL/6	O
mice	O
with	O
retroviruses	O
expressing	O
TEL-AML1	O
or	O
its	O
mutated	O
derivatives	O
and	O
EGFP,61,66	O
and	O
serially	O
replated	O
them	O
in	O
methylcellulose	O
under	O
conditions	O
that	O
promote	O
B-cell	O
differentiation	O
.	O

Expression	O
of	O
similar	O
steady-state	O
levels	O
of	O
the	O
TEL-AML1	O
mutant	O
proteins	O
in	O
transduced	O
NIH3T3	O
cells	O
was	O
confirmed	O
by	O
Western	O
blot	O
analysis	O
,	O
and	O
retroviral	O
transduction	O
of	O
c-kit+	O
cells	O
was	O
measured	O
by	O
EGFP	O
fluorescence	O
(	O
Figure	O
5A	O
,	O
B	O
)	O
.	O

Cells	O
expressing	O
TEL-AML1	O
generated	O
increased	O
numbers	O
of	O
colonies	O
and	O
cells	O
,	O
which	O
are	O
B220	O
enriched	O
,	O
more	O
than	O
multiple	O
rounds	O
of	O
replating	O
relative	O
to	O
cells	O
expressing	O
EGFP	O
alone	O
(	O
Figure	O
5C-E	O
)	O
.	O

A	O
reduction	O
in	O
CBFß	O
heterodimerization	O
by	O
greater	O
than	O
400-fold	O
through	O
introduction	O
of	O
the	O
Y140A/T188A	O
mutations	O
severely	O
impaired	O
TEL-AML1	O
's	O
ability	O
to	O
enhance	O
the	O
clonogenic	O
potential	O
of	O
these	O
B-cell	O
precursors	O
,	O
as	O
the	O
numbers	O
of	O
cells	O
and	O
colonies	O
were	O
very	O
similar	O
to	O
those	O
of	O
EGFP-transduced	O
cells	O
.	O

Cells	O
expressing	O
the	O
T188A	O
TEL-AML1	O
mutant	O
,	O
which	O
is	O
expected	O
to	O
have	O
an	O
approximately	O
60-fold	O
reduction	O
in	O
CBFß	O
binding	O
,	O
produced	O
numbers	O
of	O
colonies	O
and	O
cells	O
similar	O
to	O
those	O
of	O
TEL-AML1–expressing	O
cells	O
during	O
secondary	O
replating	O
,	O
however	O
,	O
the	O
numbers	O
from	O
the	O
third	O
round	O
of	O
replating	O
were	O
very	O
significantly	O
decreased	O
and	O
therefore	O
somewhat	O
intermediate	O
between	O
the	O
TEL-AML1	O
and	O
TEL-AML1	O
(	O
Y140A/T188A	O
)	O
expressing	O
cells	O
.	O

It	C
appears	C
that	C
,	C
as	C
was	C
the	C
case	C
for	C
AML1-ETO	C
,	C
a	C
decrease	C
in	C
CBFß	C
binding	C
from	C
60-	C
to	C
400-fold	C
is	C
accompanied	C
by	C
a	C
progressive	C
impairment	C
in	C
TEL-AML1	C
's	C
clonogenic	C
activity	C
.	C

As	O
the	O
thermodynamic	O
stability	O
and	O
DNA	O
binding	O
affinity	O
of	O
the	O
T118A	O
and	O
Y140A/T188A	O
mutant	O
Runt	O
domains	O
are	O
identical	O
,	O
the	O
decreased	O
activity	O
can	O
only	O
be	O
explained	O
by	O
more	O
severely	O
impaired	O
CBFß	O
binding	O
.	O

Disrupting	O
heterodimerization	O
with	O
CBFß	O
substantially	O
abrogates	O
TEL-AML1	O
's	O
ability	O
to	O
enhance	O
the	O
clonogenic	O
potential	O
of	O
c-kit+	O
B-cell	O
precursors	O
.	O

(	O
A	O
)	O
Detection	O
of	O
hemagglutinin	O
(	O
HA	O
)	O
–tagged	O
TEL-AML1	O
and	O
the	O
T188A	O
and	O
Y140A/T188A	O
mutants	O
in	O
NIH3T3	O
cells	O
48	O
hours	O
after	O
retroviral	O
(	O
murine	O
stem	O
cell	O
virus	O
[	O
MSCV	O
]	O
)	O
transduction	O
.	O

Vertical	O
lines	O
have	O
been	O
inserted	O
to	O
indicate	O
a	O
repositioned	O
gel	O
lane	O
.	O

(	O
B	O
)	O
Flow	O
cytometric	O
analysis	O
of	O
EGFP	O
expression	O
in	O
c-kit+	O
fetal	O
liver	O
cells	O
48	O
hours	O
after	O
infection	O
with	O
viral	O
supernatants	O
.	O

(	O
C	O
)	O
Transduced	O
c-kit+	O
cells	O
grown	O
in	O
methylcellulose	O
serial	O
replating	O
assays	O
in	O
conditions	O
promoting	O
B-cell	O
differentiation	O
(	O
IL-7	O
,	O
SCF	O
,	O
and	O
FLT3	O
ligand	O
)	O
.	O

The	O
number	O
of	O
colonies	O
harvested	O
from	O
each	O
culture	O
,	O
per	O
104	O
cells	O
plated	O
,	O
is	O
shown	O
for	O
the	O
first	O
(	O
)	O
,	O
second	O
(	O
)	O
,	O
and	O
third	O
(	O
¦	O
)	O
rounds	O
of	O
plating	O
.	O

Plots	O
show	O
means	O
and	O
SDs	O
of	O
duplicate	O
cultures	O
.	O

The	O
data	O
shown	O
are	O
representative	O
of	O
5	O
independent	O
experiments	O
.	O

(	O
D	O
)	O
Total	O
number	O
of	O
cells	O
,	O
as	O
in	O
panel	O
C.	O
(	O
E	O
)	O
Number	O
of	O
B220+	O
cells	O
as	O
in	O
panel	O
C	O
.	O

Discussion	O

Assessing	O
which	O
protein-protein	O
interactions	O
mediated	O
by	O
oncogenic	O
transcription	O
factors	O
are	O
essential	O
for	O
their	O
leukemogenic	O
activity	O
,	O
and	O
determining	O
the	O
structures	O
of	O
the	O
domains	O
responsible	O
for	O
those	O
interactions	O
will	O
greatly	O
facilitate	O
the	O
development	O
of	O
specific	O
inhibitors	O
by	O
structure-aided	O
drug	O
design	O
.	O

Here	O
,	O
we	O
show	O
that	O
ablation	O
of	O
DNA	O
binding	O
by	O
40000	O
fold30,49	O
or	O
reduction	O
of	O
CBFß	O
heterodimerization	O
by	O
greater	O
than	O
400-fold	O
partially	O
impaired	O
AML1-ETO	O
's	O
ability	O
to	O
inhibit	O
granulocyte	O
differentiation	O
,	O
almost	O
completely	O
reversed	O
its	O
acute	O
inhibition	O
of	O
proliferation	O
,	O
eliminated	O
its	O
ability	O
to	O
confer	O
serial	O
replating	O
to	O
myeloid	O
progenitors	O
,	O
and	O
severely	O
compromised	O
its	O
cooperation	O
with	O
TEL-PDGFßR	O
to	O
cause	O
AML	O
,	O
and	O
thus	O
impaired	O
or	O
delayed	O
AML	O
disease	O
.	O

Similarly	O
,	O
inhibition	O
of	O
both	O
DNA61	O
and	O
CBFß	O
binding	O
by	O
TEL-AML1	O
eliminated	O
its	O
ability	O
to	O
enhance	O
the	O
self-renewal	O
of	O
B-cell	O
progenitors	O
.	O

We	C
are	C
optimistic	C
that	C
targeted	C
disruption	C
of	C
either	C
function	C
may	C
provide	C
an	C
effective	C
therapeutic	C
modality	C
.	C

The	C
more	C
promising	C
of	C
the	C
2	C
interactions	C
for	C
small	C
molecule	C
inhibitors	C
is	C
that	C
between	C
the	C
Runt	C
domain	C
and	C
CBFß	C
,	C
since	C
the	C
Runt	C
domain-DNA	C
interface	C
is	C
highly	C
charged	C
and	C
may	C
be	C
difficult	C
to	C
target	C
with	C
a	C
small	C
molecule	C
.	C

The	C
Runt	C
domain-CBFß	C
interface	C
,	C
on	C
the	C
other	C
hand	C
,	C
contains	C
a	C
large	C
hydrophobic	C
area,36,62	C
which	C
should	C
be	C
more	C
conducive	C
for	C
binding	C
small	C
molecules	C
with	C
drug-like	C
properties	C
.	C

Although	O
small	O
molecules	O
targeting	O
protein-protein	O
interactions	O
are	O
relatively	O
limited	O
thus	O
far	O
,	O
there	O
has	O
been	O
an	O
increase	O
in	O
activity	O
and	O
reported	O
success	O
in	O
developing	O
these	O
inhibitors.85	O

For	O
example	O
,	O
we	O
recently	O
developed	O
a	O
small	O
molecule	O
that	O
binds	O
CBFß	O
and	O
allosterically	O
inhibits	O
CBFß	O
binding	O
to	O
the	O
Runt	O
domain	O
,	O
supporting	O
the	O
notion	O
that	O
disrupting	O
this	O
interaction	O
with	O
drug-like	O
molecules	O
is	O
feasible.86	O

A	C
potential	C
drawback	C
to	C
this	C
approach	C
is	C
that	C
the	C
inhibitors	C
would	C
also	C
further	C
impair	C
the	C
function	C
of	C
the	C
normal	C
core	C
binding	C
factors	C
,	C
in	C
which	C
case	C
there	C
would	C
need	C
to	C
be	C
a	C
therapeutic	C
window	C
for	C
them	C
to	C
be	C
clinically	C
useful	C
.	C

Alternatively	C
,	C
combined	C
therapies	C
using	C
inhibitors	C
targeting	C
other	C
functions	C
specific	C
for	C
AML1-ETO	C
(	C
eg	C
,	C
oligomerization	C
15,49,87	C
)	C
may	C
provide	C
specificity	C
.	C

We	C
find	C
it	C
encouraging	C
that	C
both	C
AML1-ETO	C
and	C
TEL-AML1	C
rely	C
on	C
CBFß	C
for	C
their	C
activity	C
,	C
and	C
therefore	C
a	C
single	C
compound	C
may	C
prove	C
efficacious	C
in	C
both	C
disease	C
settings	C
.	C

In	C
fact	C
,	C
we	C
predict	C
that	C
all	C
the	C
Runx1	C
fusion	C
proteins	C
will	C
require	C
CBFß	C
for	C
their	C
activity	C
and	C
that	C
an	C
inhibitor	C
of	C
the	C
Runt	C
domain-CBFß	C
interaction	C
may	C
be	C
useful	C
for	C
targeting	C
all	C
of	C
these	C
proteins	C
.	C

Although	O
CBFß	O
is	O
clearly	O
important	O
for	O
AML1-ETO	O
and	O
TEL-AML1	O
function	O
,	O
the	O
nature	O
of	O
its	O
activity	O
is	O
not	O
completely	O
understood	O
.	O

It	O
has	O
long	O
been	O
known	O
that	O
CBFß	O
increases	O
the	O
Runx	O
proteins	O
'	O
affinity	O
for	O
DNA,88,89	O
and	O
it	O
was	O
more	O
recently	O
shown	O
that	O
it	O
protects	O
them	O
from	O
ubiquitin-mediated	O
proteolysis.37,90	O

However	O
,	O
genetic	O
data	O
in	O
both	O
flies	O
and	O
worms	O
hint	O
at	O
other	O
functions	O
.	O

For	C
example	C
,	C
overexpression	C
of	C
a	C
Drosophila	C
Runt	C
protein	C
that	C
could	C
bind	C
DNA	C
but	C
not	C
CBFß	C
dominantly	C
inhibited	C
its	C
wild-type	C
counterpart	C
,	C
suggesting	C
that	C
it	C
was	C
occupying	C
its	C
DNA	C
binding	C
sites	C
but	C
forming	C
nonfunctional	C
complexes	C
.91	C

More	O
recently	O
,	O
it	O
was	O
shown	O
that	O
ectopic	O
overexpression	O
of	O
CBFß	O
(	O
BRO-1	O
)	O
could	O
partially	O
restore	O
a	O
Runx	O
(	O
RNT	O
)	O
–deficient	O
defect	O
in	O
Caenorhabditis	O
elegans.92	O

Thus	C
we	C
speculate	C
that	C
CBFß	C
participates	C
in	C
the	C
formation	C
of	C
protein	C
complexes	C
that	C
are	C
necessary	C
for	C
AML1-ETO	C
and	C
TEL-AML1	C
function	C
in	C
vivo	C
.	C

If	C
this	C
is	C
the	C
case	C
,	C
and	C
if	C
the	C
nature	C
of	C
those	C
complexes	C
differs	C
from	C
those	C
formed	C
by	C
the	C
wild-type	C
Runx1-CBFß	C
heterodimer	C
then	C
other	C
protein-protein	C
interactions	C
specific	C
for	C
the	C
fusion	C
protein	C
complexes	C
could	C
lend	C
themselves	C
to	C
targeting	C
with	C
small	C
molecules	C
.	C

It	C
has	C
been	C
suggested	C
that	C
much	C
of	C
AML1-ETO	C
's	C
activity	C
may	C
be	C
mediated	C
in	C
a	C
manner	C
that	C
does	C
not	C
require	C
binding	C
to	C
Runx-dependent	C
promoters	C
.13	C

Our	C
data	C
support	C
the	C
notion	C
that	C
some	C
of	C
AML1-ETO	C
's	C
activity	C
indeed	C
does	C
not	C
require	C
either	C
DNA	C
or	C
CBFß	C
binding	C
,	C
in	C
that	C
ectopic	C
(	C
retroviral	C
)	C
expression	C
of	C
a	C
mutant	C
defective	C
in	C
both	C
functions	C
could	C
still	C
significantly	C
repress	C
granulocyte	C
differentiation	C
of	C
BM	C
cells	C
in	C
vitro	C
.	C

Although	O
repression	O
of	O
granulocyte	O
differentiation	O
is	O
a	O
consistent	O
feature	O
of	O
AML1-ETO	O
overexpression,15,25,70,73,75	O
it	O
is	O
not	O
entirely	O
clear	O
how	O
important	O
it	O
is	O
to	O
AML1-ETO	O
's	O
leukemogenic	O
function	O
.	O

We	O
found	O
several	O
AML1-ETO	O
mutants	O
that	O
were	O
able	O
to	O
partially	O
repress	O
granulocyte	O
differentiation	O
but	O
had	O
no	O
leukemogenic	O
activity	O
,	O
nor	O
was	O
a	O
granulocyte	O
differentiation	O
defect	O
observed	O
in	O
a	O
conditional	O
AML1-ETO	O
knock-in	O
model.69	O

What	O
is	O
clear	O
,	O
however	O
,	O
from	O
our	O
data	O
and	O
that	O
of	O
Yan	O
et	O
al,49	O
is	O
that	O
DNA	O
binding	O
by	O
AML1-ETO	O
is	O
essential	O
for	O
its	O
leukemogenic	O
activity	O
and	O
that	O
this	O
observation	O
must	O
be	O
incorporated	O
into	O
any	O
mechanistic	O
model	O
for	O
AML1-ETO	O
function	O
.	O

O-Linked	O
N-Acetylglucosaminylation	O
of	O
Sp1	O
Inhibits	O
the	O
Human	O
Immunodeficiency	O
Virus	O
Type	O
1	O
Promoter	O

Abstract	O

Human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
gene	O
expression	O
and	O
replication	O
are	O
regulated	O
by	O
the	O
promoter/enhancer	O
located	O
in	O
the	O
U3	O
region	O
of	O
the	O
proviral	O
5	O
'	O
long	O
terminal	O
repeat	O
(	O
LTR	O
)	O
.	O

The	O
binding	O
of	O
cellular	O
transcription	O
factors	O
to	O
specific	O
regulatory	O
sites	O
in	O
the	O
5	O
'	O
LTR	O
is	O
a	O
key	O
event	O
in	O
the	O
replication	O
cycle	O
of	O
HIV-1	O
.	O

Since	C
transcriptional	C
activity	C
is	C
regulated	C
by	C
the	C
posttranslational	C
modification	C
of	C
transcription	C
factors	C
with	C
the	C
monosaccharide	C
O-linked	C
N-acetyl-d-glucosamine	C
(	C
O-GlcNAc	C
)	C
,	C
we	C
evaluated	C
whether	C
increased	C
O-GlcNAcylation	C
affects	C
HIV-1	C
transcription	C
.	C

In	O
the	O
present	O
study	O
we	O
demonstrate	O
that	O
treatment	O
of	O
HIV-1-infected	O
lymphocytes	O
with	O
the	O
O-GlcNAcylation-enhancing	O
agent	O
glucosamine	O
(	O
GlcN	O
)	O
repressed	O
viral	O
transcription	O
in	O
a	O
dose-dependent	O
manner	O
.	O

Overexpression	O
of	O
O-GlcNAc	O
transferase	O
(	O
OGT	O
)	O
,	O
the	O
sole	O
known	O
enzyme	O
catalyzing	O
the	O
addition	O
of	O
O-GlcNAc	O
to	O
proteins	O
,	O
specifically	O
inhibited	O
the	O
activity	O
of	O
the	O
HIV-1	O
LTR	O
promoter	O
in	O
different	O
T-cell	O
lines	O
and	O
in	O
primary	O
CD4+	O
T	O
lymphocytes	O
.	O

Inhibition	O
of	O
HIV-1	O
LTR	O
activity	O
in	O
infected	O
T	O
cells	O
was	O
most	O
efficient	O
(	O
>	O
95	O
%	O
)	O
when	O
OGT	O
was	O
recombinantly	O
overexpressed	O
prior	O
to	O
infection	O
.	O

O-GlcNAcylation	O
of	O
the	O
transcription	O
factor	O
Sp1	O
and	O
the	O
presence	O
of	O
Sp1-binding	O
sites	O
in	O
the	O
LTR	O
were	O
found	O
to	O
be	O
crucial	O
for	O
this	O
inhibitory	O
effect	O
.	O

From	O
this	O
study	O
,	O
we	O
conclude	O
that	O
O-GlcNAcylation	O
of	O
Sp1	O
inhibits	O
the	O
activity	O
of	O
the	O
HIV-1	O
LTR	O
promoter	O
.	O

Modulation	C
of	C
Sp1	C
O-GlcNAcylation	C
may	C
play	C
a	C
role	C
in	C
the	C
regulation	C
of	C
HIV-1	C
latency	C
and	C
activation	C
and	C
links	C
viral	C
replication	C
to	C
the	C
glucose	C
metabolism	C
of	C
the	C
host	C
cell	C
.	C

Hence	C
,	C
the	C
establishment	C
of	C
a	C
metabolic	C
treatment	C
might	C
supplement	C
the	C
repertoire	C
of	C
antiretroviral	C
therapies	C
against	C
AIDS	C
.	C

Human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
gene	O
expression	O
is	O
regulated	O
by	O
the	O
long	O
terminal	O
repeat	O
(	O
LTR	O
)	O
promoter	O
,	O
which	O
is	O
composed	O
of	O
three	O
regions	O
:	O
U3	O
(	O
unique	O
3	O
'	O
end	O
)	O
,	O
R	O
(	O
repeated	O
)	O
,	O
and	O
U5	O
(	O
unique	O
5	O
'	O
end	O
)	O
.	O

The	O
U3	O
region	O
contains	O
an	O
upstream	O
regulatory	O
element	O
including	O
binding	O
sites	O
for	O
several	O
cellular	O
transcription	O
factors	O
such	O
as	O
the	O
nuclear	O
factor	O
of	O
activated	O
T	O
cells	O
1	O
(	O
NFATc1	O
)	O
and	O
the	O
activator	O
protein	O
1	O
(	O
AP-1	O
)	O
,	O
an	O
enhancer	O
with	O
two	O
binding	O
sites	O
for	O
the	O
nuclear	O
factor	O
κB	O
(	O
NF-κB	O
)	O
,	O
and	O
the	O
core	O
promoter	O
composed	O
of	O
three	O
tandem	O
binding	O
sites	O
for	O
specificity	O
protein	O
1	O
(	O
Sp1	O
)	O
and	O
a	O
TATA	O
box	O
.	O

While	O
NF-κB	O
is	O
a	O
strong	O
enhancer	O
of	O
HIV-1	O
transcription	O
(	O
8	O
)	O
,	O
Sp1	O
is	O
essential	O
for	O
basal	O
transcription	O
and	O
Tat-mediated	O
activation	O
of	O
HIV-1	O
(	O
25	O
,	O
69	O
)	O
.	O

This	O
is	O
concordant	O
with	O
the	O
fact	O
that	O
Sp1	O
is	O
upregulated	O
in	O
activated	O
T	O
cells	O
(	O
43	O
)	O
,	O
which	O
compose	O
the	O
primary	O
reservoir	O
for	O
HIV-1	O
replication	O
(	O
68	O
)	O
.	O

Importantly	O
,	O
deletion	O
of	O
all	O
three	O
Sp1-binding	O
sites	O
reduces	O
viral	O
replication	O
in	O
human	O
T-cell	O
cultures	O
(	O
58	O
)	O
.	O

In	O
eukaryotic	O
cells	O
,	O
myriad	O
cytoplasmic	O
and	O
nuclear	O
proteins	O
are	O
posttranslationally	O
modified	O
at	O
the	O
hydroxyl	O
groups	O
of	O
specific	O
serine	O
and	O
threonine	O
residues	O
by	O
a	O
single	O
monosaccharide	O
,	O
N-acetyl-d-glucosamine	O
(	O
GlcNAc	O
)	O
(	O
26	O
,	O
80	O
)	O
.	O

The	O
O-glycosidic	O
linkage	O
of	O
GlcNAc	O
to	O
proteins	O
is	O
a	O
highly	O
dynamic	O
and	O
reversible	O
posttranslational	O
modification	O
and	O
differs	O
from	O
other	O
glycosylation	O
events	O
in	O
that	O
it	O
occurs	O
in	O
the	O
cytosol	O
and	O
the	O
nucleus	O
rather	O
than	O
in	O
the	O
Golgi	O
apparatus	O
or	O
the	O
endoplasmic	O
reticulum	O
.	O

Protein	O
O-linked	O
N-acetyl-d-glucosaminylation	O
(	O
O-GlcNAcylation	O
)	O
is	O
catalyzed	O
by	O
O-GlcNAc	O
transferase	O
(	O
OGT	O
)	O
and	O
reversed	O
by	O
O-GlcNAc	O
hexosaminidase	O
(	O
O-GlcNAcase	O
)	O
(	O
30	O
)	O
.	O

The	O
substrate	O
for	O
protein	O
O-GlcNAcylation	O
is	O
UDP-GlcNAc	O
.	O

Therefore	O
,	O
O-	O
GlcNAcylation	O
is	O
regulated	O
by	O
the	O
cellular	O
levels	O
of	O
OGT	O
and	O
O-GlcNAcase	O
and	O
by	O
the	O
availability	O
of	O
UDP-GlcNAc	O
(	O
81	O
)	O
.	O

As	O
UDP-GlcNAc	O
is	O
synthesized	O
de	O
novo	O
from	O
glucose	O
via	O
the	O
hexosamine	O
biosynthetic	O
pathway	O
,	O
glucose	O
flux	O
through	O
the	O
hexosamine	O
biosynthetic	O
pathway	O
increases	O
O-GlcNAcylation	O
of	O
proteins	O
.	O

Furthermore	O
,	O
compounds	O
like	O
glucosamine	O
(	O
GlcN	O
)	O
,	O
streptozotocin	O
,	O
O-	O
(	O
2-acetamido-2-deoxy-d-glucopyranosylidene	O
)	O
amino-N-phenylcarbamate	O
(	O
PUGNAc	O
)	O
,	O
and	O
2-deoxyglucose	O
enhance	O
O-GlcNAcylation	O
of	O
proteins	O
either	O
by	O
increasing	O
the	O
availability	O
of	O
UDP-GlcNAc	O
or	O
by	O
inhibiting	O
the	O
enzyme	O
O-GlcNAcase	O
(	O
23	O
,	O
37	O
,	O
63	O
)	O
.	O

Protein	O
O-GlcNAcylation	O
has	O
been	O
shown	O
to	O
modulate	O
(	O
i	O
)	O
enzyme	O
activity	O
,	O
(	O
ii	O
)	O
protein-protein	O
interactions	O
,	O
(	O
iii	O
)	O
DNA-binding	O
affinity	O
,	O
(	O
iv	O
)	O
subcellular	O
localization	O
,	O
and	O
(	O
v	O
)	O
the	O
half-life	O
and	O
proteolytic	O
processing	O
of	O
proteins	O
(	O
81	O
)	O
.	O

Furthermore	O
,	O
O-GlcNAcylation	O
often	O
plays	O
an	O
antagonistic	O
role	O
in	O
relation	O
to	O
phosphorylation	O
(	O
36	O
)	O
.	O

The	C
dynamic	C
interplay	C
between	C
O-GlcNAcylation	C
and	C
phosphorylation	C
has	C
therefore	C
been	C
proposed	C
to	C
control	C
protein-protein	C
interactions	C
and	C
protein	C
functions	C
.	C

Furthermore	O
,	O
O-GlcNAc	O
plays	O
a	O
pivotal	O
role	O
in	O
the	O
regulation	O
of	O
gene	O
expression	O
via	O
modification	O
of	O
RNA	O
polymerase	O
II	O
(	O
12	O
,	O
39	O
)	O
and	O
associated	O
transcription	O
factors	O
(	O
31	O
,	O
32	O
)	O
.	O

Thus	O
,	O
O-GlcNAc	O
serves	O
as	O
a	O
nutrient	O
sensor	O
to	O
couple	O
the	O
metabolic	O
status	O
to	O
cellular	O
processes	O
,	O
such	O
as	O
protein	O
degradation	O
,	O
signal	O
transduction	O
,	O
and	O
gene	O
transcription	O
.	O

Some	O
of	O
the	O
transcription	O
factors	O
involved	O
in	O
HIV-1	O
gene	O
regulation	O
are	O
modified	O
by	O
O-GlcNAc	O
,	O
including	O
AP-1	O
(	O
67	O
)	O
,	O
yin-yang	O
1	O
(	O
YY1	O
)	O
(	O
28	O
)	O
,	O
NFATc1	O
(	O
21	O
)	O
,	O
NF-κB	O
(	O
21	O
)	O
,	O
and	O
Sp1	O
(	O
31	O
,	O
62	O
)	O
.	O

Sp1	O
was	O
the	O
first	O
transcription	O
factor	O
identified	O
as	O
being	O
O-GlcNAcylated	O
(	O
31	O
)	O
.	O

Sp1	O
is	O
ubiquitous	O
and	O
belongs	O
to	O
the	O
Sp1-like/Krüppel-like	O
family	O
of	O
transcription	O
factors	O
characterized	O
by	O
three	O
C-terminal	O
Cys2His2	O
zinc	O
finger	O
motifs	O
(	O
34	O
)	O
and	O
a	O
DNA-binding	O
affinity	O
to	O
GC-rich	O
sites	O
(	O
16	O
)	O
.	O

Two	O
decades	O
ago	O
,	O
Tjian	O
and	O
coworkers	O
showed	O
that	O
Sp1	O
bears	O
at	O
least	O
eight	O
O-GlcNAc	O
sites	O
and	O
that	O
the	O
O-GlcNAcylated	O
form	O
of	O
Sp1	O
was	O
more	O
active	O
than	O
the	O
non-O-GlcNAcylated	O
protein	O
(	O
31	O
)	O
.	O

In	C
the	C
meantime	C
,	C
other	C
studies	C
revealed	C
that	C
O-GlcNAcylation	C
of	C
Sp1	C
can	C
also	C
result	C
in	C
a	C
reduction	C
of	C
transcriptional	C
activation	C
(	C
62	C
,	C
77	C
)	C
,	C
indicating	C
that	C
the	C
specific	C
effect	C
of	C
O-GlcNAcylation	C
on	C
Sp1	C
activity	C
strongly	C
depends	C
on	C
the	C
targeted	C
promoter	C
.	C

Since	O
Sp1	O
is	O
critical	O
and	O
important	O
for	O
HIV-1	O
transcription	O
(	O
25	O
)	O
and	O
Sp1	O
activity	O
is	O
modulated	O
by	O
O-GlcNAc	O
(	O
42	O
)	O
,	O
we	O
investigated	O
the	O
effect	O
of	O
Sp1	O
O-GlcNAcylation	O
on	O
the	O
activity	O
of	O
the	O
HIV-1	O
LTR	O
promoter	O
.	O

Here	O
we	O
show	O
that	O
an	O
increased	O
O-GlcNAc	O
level	O
represses	O
the	O
HIV-1	O
LTR	O
promoter	O
activity	O
.	O

This	O
required	O
O-GlcNAcylation	O
of	O
Sp1	O
and	O
the	O
presence	O
of	O
Sp1-binding	O
sites	O
in	O
the	O
HIV-1	O
LTR	O
.	O

Thus	C
,	C
modulation	C
of	C
Sp1	C
O-GlcNAcylation	C
may	C
be	C
useful	C
as	C
a	C
potential	C
therapeutic	C
approach	C
for	C
the	C
inhibition	C
of	C
HIV-1	C
replication	C
.	C

MATERIALS	O
AND	O
METHODS	O

Jurkat	O
and	O
T1	O
(	O
174	O
×	O
CEM.T1	O
)	O
cells	O
were	O
maintained	O
in	O
very-low-endotoxin-Roswell	O
Park	O
Memorial	O
Institute	O
(	O
RPMI	O
)	O
1640	O
medium	O
(	O
Biochrom	O
,	O
Berlin	O
,	O
Germany	O
)	O
supplemented	O
with	O
10	O
%	O
fetal	O
calf	O
serum	O
(	O
FCS	O
;	O
Biochrom	O
)	O
and	O
2	O
mM	O
l-glutamine	O
(	O
PAA	O
,	O
Cölbe	O
,	O
Germany	O
)	O
at	O
37°C	O
in	O
a	O
humidified	O
atmosphere	O
at	O
5	O
%	O
CO2	O
.	O

CD4+	O
T	O
cells	O
were	O
isolated	O
using	O
anti-CD4	O
magnetically	O
activated	O
cell	O
sorting	O
beads	O
(	O
Miltenyi	O
,	O
Bergisch	O
Gladbach	O
,	O
Germany	O
)	O
according	O
to	O
the	O
manufacturer	O
's	O
instructions	O
.	O

CD4+	O
T	O
cells	O
were	O
cultured	O
in	O
MLPC	O
medium	O
consisting	O
of	O
RPMI	O
1640	O
,	O
10	O
%	O
human	O
serum	O
,	O
2	O
mM	O
l-glutamine	O
,	O
20	O
mg/liter	O
gentamicin	O
,	O
10	O
mM	O
HEPES	O
,	O
1	O
mM	O
sodium	O
pyruvate	O
,	O
and	O
1	O
%	O
minimum	O
essential	O
medium	O
nonessential	O
amino	O
acids	O
(	O
all	O
from	O
PAA	O
,	O
Cölbe	O
,	O
Germany	O
)	O
at	O
37°C	O
under	O
5	O
%	O
CO2	O
.	O

HeLa-Tat-III/LTR/d1EGFP	O
cells	O
were	O
obtained	O
through	O
the	O
AIDS	O
Research	O
and	O
Reference	O
Reagent	O
Program	O
,	O
Division	O
of	O
AIDS	O
,	O
NIAID	O
,	O
NIH	O
,	O
from	O
Masahiko	O
Satoh	O
(	O
57	O
)	O
.	O

These	O
cells	O
stably	O
express	O
d1EGFP	O
(	O
which	O
was	O
derived	O
from	O
d2EGFP	O
,	O
a	O
destabilized	O
,	O
redshifted	O
variant	O
of	O
the	O
enhanced	O
green	O
fluorescent	O
protein	O
[	O
EGFP	O
]	O
,	O
and	O
has	O
a	O
half-life	O
of	O
approximately	O
1	O
hour	O
)	O
under	O
the	O
control	O
of	O
the	O
HIV-1	O
LTR	O
promoter	O
.	O

HeLa-Tat-III/LTR/d1EGFP	O
cells	O
were	O
cultivated	O
in	O
Dulbecco	O
's	O
modified	O
Eagle	O
's	O
medium	O
(	O
PAA	O
)	O
supplemented	O
with	O
10	O
%	O
FCS	O
,	O
2	O
mM	O
l-glutamine	O
,	O
and	O
1	O
mg/ml	O
G418	O
at	O
37°C	O
under	O
8.5	O
%	O
CO2	O
.	O

HEK	O
293T	O
cells	O
were	O
cultivated	O
in	O
Dulbecco	O
's	O
modified	O
Eagle	O
's	O
medium	O
supplemented	O
with	O
10	O
%	O
FCS	O
and	O
2	O
mM	O
l-glutamine	O
at	O
37°C	O
under	O
8.5	O
%	O
CO2	O
.	O

Pseudoviruses	O
were	O
produced	O
by	O
cotransfection	O
of	O
HEK	O
293T	O
cells	O
with	O
pNL4-3LucR-E-	O
(	O
obtained	O
through	O
the	O
AIDS	O
Research	O
and	O
Reference	O
Reagent	O
Program	O
,	O
Division	O
of	O
AIDS	O
,	O
NIAID	O
,	O
NIH	O
,	O
from	O
Nathaniel	O
Landau	O
[	O
13	O
,	O
27	O
]	O
)	O
and	O
a	O
vesicular	O
stomatitis	O
virus	O
G	O
protein	O
(	O
VSV-G	O
)	O
-encoding	O
plasmid	O
by	O
using	O
the	O
calcium	O
phosphate	O
technique	O
.	O

Pseudovirus-containing	O
supernatants	O
were	O
harvested	O
2	O
days	O
after	O
transfection	O
,	O
and	O
cellular	O
debris	O
was	O
removed	O
by	O
centrifugation	O
at	O
300	O
×	O
g	O
for	O
5	O
min	O
.	O

HIV-1	O
p24	O
concentration	O
was	O
estimated	O
by	O
antigen	O
enzyme-linked	O
immunosorbent	O
assay	O
.	O

Pseudovirus-containing	O
supernatants	O
were	O
stored	O
in	O
1-ml	O
aliquots	O
at	O
-80°C	O
until	O
use	O
.	O

Jurkat	O
and	O
T1	O
cells	O
were	O
cultured	O
to	O
a	O
density	O
of	O
1.5	O
×	O
106	O
cells/ml	O
and	O
split	O
1:2	O
on	O
the	O
day	O
prior	O
to	O
infection	O
.	O

Cells	O
were	O
infected	O
with	O
VSV-G	O
env	O
pseudotyped	O
HIV-1NL4-3LucR-E-	O
for	O
4	O
h	O
at	O
37°C	O
,	O
using	O
a	O
concentration	O
of	O
30	O
ng	O
p24	O
per	O
1	O
×	O
106	O
cells	O
.	O

Cells	O
were	O
centrifuged	O
at	O
300	O
×	O
g	O
for	O
5	O
min	O
to	O
remove	O
excessive	O
pseudovirus	O
and	O
resuspended	O
in	O
2	O
ml	O
very-low-endotoxin-RPMI	O
1640	O
containing	O
2	O
mM	O
l-glutamine	O
and	O
10	O
%	O
FCS	O
supplemented	O
with	O
the	O
respective	O
concentration	O
of	O
GlcN	O
(	O
Sigma-Aldrich	O
,	O
Munich	O
,	O
Germany	O
)	O
in	O
triplicate	O
.	O

CD4+	O
T	O
cells	O
were	O
stimulated	O
for	O
6	O
days	O
with	O
10	O
U/ml	O
interleukin-2	O
(	O
Roche	O
,	O
Mannheim	O
,	O
Germany	O
)	O
and	O
10	O
µg/ml	O
phytohemagglutinin	O
P	O
(	O
Sigma-Aldrich	O
)	O
prior	O
to	O
infection	O
.	O

Cells	O
were	O
infected	O
with	O
reporter	O
HIV-1	O
for	O
4	O
h	O
at	O
37°C	O
,	O
using	O
a	O
concentration	O
of	O
30	O
ng	O
p24	O
per	O
2	O
×	O
106	O
cells	O
.	O

Cells	O
were	O
centrifuged	O
at	O
250	O
×	O
g	O
for	O
10	O
min	O
to	O
remove	O
excessive	O
pseudovirus	O
and	O
resuspended	O
in	O
1.5	O
ml	O
MLPC	O
medium	O
supplemented	O
with	O
the	O
respective	O
concentration	O
of	O
GlcN	O
in	O
triplicate	O
.	O

After	O
incubation	O
for	O
24	O
h	O
,	O
cells	O
were	O
collected	O
,	O
washed	O
once	O
with	O
phosphate-buffered	O
saline	O
(	O
PBS	O
;	O
Biochrom	O
)	O
,	O
lysed	O
in	O
1×	O
passive	O
lysis	O
buffer	O
(	O
Promega	O
,	O
Mannheim	O
,	O
Germany	O
)	O
,	O
and	O
assayed	O
for	O
luciferase	O
activity	O
as	O
described	O
below	O
.	O

Cell	O
viability	O
was	O
measured	O
using	O
the	O
CellTiter	O
96	O
nonradioactive	O
cell	O
proliferation	O
assay	O
(	O
MTT	O
[	O
3-	O
(	O
4,5-dimethyl-2-thiazolyl	O
)	O
-2,5-diphenyl-2H-tetrazolium	O
bromide	O
]	O
assay	O
;	O
Promega	O
)	O
according	O
to	O
the	O
manufacturer	O
's	O
protocol	O
.	O

Briefly	O
,	O
100-µl	O
cell	O
suspensions	O
containing	O
either	O
1	O
×	O
105	O
HIV-1-infected	O
Jurkat	O
or	O
T1	O
cells	O
or	O
2	O
×	O
105	O
HIV-1-infected	O
CD4+	O
primary	O
T	O
lymphocytes	O
were	O
applied	O
for	O
the	O
assay	O
.	O

The	O
coding	O
sequence	O
of	O
OGT	O
was	O
cloned	O
by	O
amplifying	O
820	O
bp	O
corresponding	O
to	O
the	O
N	O
terminus	O
of	O
nucleocytoplasmic	O
OGT	O
,	O
GenBank	O
accession	O
number	O
NM_181672	O
(	O
24	O
,	O
41	O
)	O
,	O
from	O
human	O
cDNA	O
with	O
specific	O
primers	O
containing	O
the	O
restriction	O
sites	O
for	O
BamHI	O
and	O
EcoRV	O
(	O
underlined	O
)	O
and	O
a	O
Kozak	O
sequence	O
(	O
italics	O
)	O
(	O
forward	O
primer	O
,	O
5'-TAGGGATCCGATATCGCCACCATGGCGTCTTCCGTGGGCAACG-3	O
'	O
)	O
and	O
the	O
restriction	O
site	O
for	O
StuI	O
(	O
underlined	O
)	O
(	O
reverse	O
primer	O
,	O
5'-AGATCTATCAGGCCTTGCTCATAG-3	O
'	O
)	O
.	O

The	O
PCR	O
fragment	O
was	O
then	O
ligated	O
with	O
the	O
StuI	O
restriction	O
site	O
to	O
the	O
part	O
of	O
the	O
Lv4F	O
fragment	O
(	O
also	O
termed	O
mitochondrial	O
OGT	O
;	O
GenBank	O
accession	O
number	O
U77413	O
[	O
46	O
,	O
47	O
]	O
)	O
which	O
corresponds	O
to	O
the	O
C	O
terminus	O
of	O
nucleocytoplasmic	O
OGT	O
and	O
harbors	O
a	O
NotI	O
restriction	O
site	O
at	O
the	O
3	O
'	O
end	O
.	O

The	O
complete	O
sequence	O
for	O
the	O
human	O
nucleocytoplasmic	O
OGT	O
was	O
subsequently	O
inserted	O
into	O
pcDNA4/myc-His	O
B	O
(	O
Invitrogen	O
,	O
Karlsruhe	O
,	O
Germany	O
)	O
at	O
the	O
EcoRV	O
and	O
NotI	O
sites	O
.	O

The	O
rescue	O
mutant	O
resOGT	O
was	O
created	O
by	O
mutagenesis	O
PCR	O
using	O
pcDNA-OGT	O
as	O
template	O
and	O
the	O
QuikChange	O
XL	O
site-directed	O
mutagenesis	O
kit	O
(	O
Stratagene	O
,	O
Amsterdam	O
,	O
The	O
Netherlands	O
)	O
according	O
to	O
the	O
manufacturer	O
's	O
instructions	O
.	O

The	O
mutagenic	O
primers	O
were	O
designed	O
by	O
the	O
QuikChange	O
primer	O
design	O
program	O
:	O
forward	O
primer	O
,	O
5'-GAGGCACGGCAACCTGTGCTTAGATAAGATCAACGTGCTGCACAAGCCACCATATGAACATCCAAAAGA-3	O
'	O
;	O
reverse	O
primer	O
,	O
5'-TCTTTTGGATGTTCATATGGTGGCTTGTGCAGCACGTTGATCTTATCTAAGCACAGGTTGCCGTGCCTC-3	O
'	O
(	O
nucleotide	O
changes	O
compared	O
to	O
the	O
wild-type	O
sequence	O
are	O
in	O
bold	O
)	O
.	O

The	O
expression	O
plasmid	O
for	O
Sp1	O
was	O
generated	O
by	O
subcloning	O
the	O
XbaI/SmaI	O
fragment	O
of	O
the	O
pBS-Sp1-f1	O
vector	O
(	O
GenBank	O
accession	O
number	O
AF252284	O
[	O
35	O
]	O
)	O
,	O
representing	O
the	O
open	O
reading	O
frame	O
of	O
Sp1	O
,	O
into	O
the	O
XbaI/EcoRV-digested	O
pcDNA3.1	O
(	O
-	O
)	O
vector	O
(	O
Invitrogen	O
)	O
.	O

The	O
reporter	O
constructs	O
pXP1-LTR-κB-Sp1wt-Luc	O
,	O
pXP1-LTR-κB-Sp1mut-Luc	O
,	O
and	O
pXP1-LTR-Sp1wt-Luc	O
were	O
kindly	O
provided	O
by	O
Manuel	O
López-Cabrera	O
(	O
2	O
,	O
22	O
)	O
.	O

The	O
plasmid	O
pcDNA4-LTRwt-d2EGFP	O
(	O
destabilized	O
,	O
redshifted	O
variant	O
of	O
the	O
EGFP	O
with	O
a	O
half-life	O
of	O
approximately	O
2	O
hours	O
)	O
was	O
cloned	O
by	O
insertion	O
of	O
d2EGFP	O
into	O
pcDNA4/myc-His	O
B	O
plasmid	O
(	O
Invitrogen	O
)	O
via	O
XhoI	O
and	O
XbaI	O
.	O

HIV-1	O
wild-type	O
LTR	O
(	O
LTRwt	O
)	O
was	O
amplified	O
from	O
pNL4-3	O
,	O
obtained	O
through	O
the	O
AIDS	O
Research	O
and	O
Reference	O
Reagent	O
Program	O
,	O
Division	O
of	O
AIDS	O
,	O
NIAID	O
,	O
NIH	O
,	O
from	O
Malcolm	O
Martin	O
(	O
1	O
)	O
,	O
using	O
the	O
following	O
primers	O
:	O
forward	O
primer	O
,	O
5'-GACAATTGAAGAAAAGGGGGGACTGGAAGGGCTAATTCACTC-3	O
'	O
;	O
reverse	O
primer	O
,	O
5'-ACCTCGAGTTGGCTCACTGCAACCTCTACCTCCTGGGTGCT-3	O
'	O
.	O

The	O
amplified	O
LTRwt	O
DNA	O
was	O
digested	O
with	O
MfeI	O
and	O
XhoI	O
(	O
underlined	O
)	O
and	O
ligated	O
into	O
pcDNA4-d2EGFP	O
.	O

The	O
plasmid	O
pcDNA4-LTRmutSp1-d2EGFP	O
contained	O
the	O
Sp1-binding-site-mutated	O
LTR	O
(	O
LTRmutSp1	O
)	O
and	O
was	O
created	O
by	O
QuikChange	O
XL	O
site-directed	O
mutagenesis	O
PCR	O
using	O
the	O
forward	O
primer	O
5'-GGGGACTTTCCAGGGATTCGTGGCCTGTTCGGGACTGGTTAGTGGCGA-3	O
'	O
and	O
the	O
reverse	O
primer	O
5'-CTCGCCACTAACCAGTCCCGAACAGGCCACGAATCCCTGGAAAGTCCCC-3	O
'	O
(	O
nucleotide	O
changes	O
compared	O
to	O
the	O
wild-type	O
sequence	O
are	O
in	O
bold	O
)	O
.	O

The	O
Tat	O
expression	O
construct	O
pCEP4-Tat	O
was	O
obtained	O
through	O
the	O
AIDS	O
Research	O
and	O
Reference	O
Reagent	O
Program	O
,	O
Division	O
of	O
AIDS	O
,	O
NIAID	O
,	O
NIH	O
,	O
from	O
Lung-Ji	O
Chang	O
(	O
9	O
)	O
.	O

The	O
control	O
reporter	O
plasmid	O
pEF1α-Luc	O
was	O
constructed	O
by	O
subcloning	O
the	O
elongation	O
factor	O
1	O
alpha	O
(	O
EF1α	O
)	O
promoter	O
from	O
pEF1/Myc-His	O
vector	O
(	O
Invitrogen	O
)	O
into	O
the	O
promoterless	O
pGL3-Basic	O
vector	O
(	O
Promega	O
)	O
.	O

pcDNA4-EF1α-d2EGFP	O
was	O
generated	O
by	O
replacing	O
the	O
cytomegalovirus	O
promoter	O
in	O
the	O
plasmid	O
pcDNA4-d2EGFP	O
with	O
the	O
EF1α	O
promoter	O
.	O

All	O
cloned	O
constructs	O
were	O
confirmed	O
by	O
full-length	O
sequencing	O
and	O
expression	O
experiments	O
.	O

The	O
plasmid	O
pGEM4Z-OGT-64A	O
was	O
generated	O
by	O
subcloning	O
the	O
OGT	O
gene	O
from	O
pcDNA4-OGT	O
into	O
the	O
RNA	O
production	O
vector	O
pGEM4Z-5'UTR-sig-huSurvivin-DC.LAMP-3'UTR-64A	O
(	O
kindly	O
provided	O
by	O
Kris	O
Thielemans	O
[	O
4	O
]	O
)	O
,	O
replacing	O
the	O
huSurvivin-DC.LAMP	O
.	O

The	O
pGEM4Z-EGFP-64A	O
vector	O
was	O
provided	O
by	O
I	O
.	O

Tcherepanova	O
,	O
Argos	O
Therapeutics	O
,	O
Durham	O
,	O
NC	O
(	O
66	O
)	O
.	O

The	O
constructs	O
were	O
confirmed	O
by	O
restriction	O
digest	O
and	O
expression	O
experiments	O
.	O

HeLa-Tat-III/LTR/d1EGFP	O
cells	O
were	O
treated	O
with	O
the	O
respective	O
GlcN	O
concentrations	O
for	O
5	O
h	O
in	O
triplicate	O
.	O

HEK	O
293T-LTRwt-d2EGFP	O
and	O
HEK	O
293T-LTRmutSp1-d2EGFP	O
cells	O
were	O
treated	O
with	O
16	O
mM	O
GlcN	O
for	O
20	O
h	O
in	O
duplicate	O
.	O

The	O
cells	O
were	O
harvested	O
with	O
trypsin-EDTA	O
(	O
PAA	O
)	O
,	O
washed	O
twice	O
with	O
FACS-PBS	O
(	O
PBS	O
containing	O
5	O
%	O
FCS	O
and	O
0.1	O
%	O
sodium	O
azide	O
[	O
Sigma-Aldrich	O
]	O
)	O
and	O
resuspended	O
in	O
FACS-PBS	O
.	O

Viable	O
GFP-positive	O
cells	O
(	O
1	O
×	O
104	O
)	O
were	O
analyzed	O
for	O
each	O
sample	O
using	O
a	O
FACSCalibur	O
flow	O
cytometer	O
with	O
CellQuest	O
Pro	O
software	O
(	O
both	O
from	O
BD	O
Biosciences	O
,	O
Heidelberg	O
,	O
Germany	O
)	O
.	O

The	O
relative	O
fluorescence	O
intensity	O
is	O
given	O
as	O
a	O
ratio	O
of	O
the	O
geometric	O
mean	O
of	O
untreated	O
cells	O
to	O
that	O
of	O
GlcN-treated	O
cells	O
.	O

The	O
geometric	O
mean	O
of	O
untreated	O
cells	O
was	O
defined	O
as	O
100	O
%	O
.	O

In	O
vitro	O
transcription	O
of	O
RNA	O
was	O
performed	O
as	O
described	O
previously	O
(	O
65	O
)	O
.	O

In	O
short	O
,	O
the	O
pGEM4Z-OGT-64A	O
and	O
pGEM4Z-EGFP-64A	O
vectors	O
were	O
linearized	O
with	O
NotI	O
and	O
SpeI	O
enzyme	O
,	O
respectively	O
,	O
purified	O
by	O
phenol-chloroform	O
extraction	O
and	O
ethanol	O
precipitation	O
,	O
and	O
used	O
as	O
DNA	O
templates	O
.	O

The	O
in	O
vitro	O
transcription	O
was	O
performed	O
with	O
T7	O
RNA	O
polymerase	O
(	O
mMessage	O
mMachine	O
T7	O
Ultra	O
kit	O
;	O
Ambion/Applied	O
Biosystems	O
,	O
Austin	O
,	O
TX	O
)	O
according	O
to	O
the	O
manufacturer	O
's	O
instructions	O
.	O

After	O
DNase	O
I	O
(	O
Ambion	O
)	O
digestion	O
and	O
poly	O
(	O
A	O
)	O
tailing	O
(	O
Ambion	O
)	O
,	O
the	O
transcribed	O
RNA	O
was	O
recovered	O
on	O
RNeasy	O
columns	O
(	O
Qiagen	O
GmbH	O
,	O
Hilden	O
,	O
Germany	O
)	O
according	O
to	O
the	O
manufacturer	O
's	O
instructions	O
.	O

RNA	O
quality	O
was	O
verified	O
by	O
agarose	O
gel	O
electrophoresis	O
,	O
and	O
the	O
RNA	O
concentration	O
was	O
measured	O
spectrophotometrically	O
.	O

The	O
protein	O
concentration	O
was	O
determined	O
in	O
a	O
microplate	O
reader	O
model	O
680	O
(	O
Bio-Rad	O
,	O
Munich	O
,	O
Germany	O
)	O
at	O
750	O
nm	O
using	O
a	O
detergent-compatible	O
(	O
DC	O
)	O
protein	O
assay	O
kit	O
(	O
Bio-Rad	O
)	O
according	O
to	O
the	O
manufacturer	O
's	O
protocol	O
.	O

Cells	O
were	O
lysed	O
as	O
described	O
under	O
“Cell	O
transfection”	O
and	O
“HIV-1	O
infection	O
and	O
GlcN	O
treatment.”	O

Samples	O
were	O
prepared	O
in	O
6×	O
sodium	O
dodecyl	O
sulfate	O
(	O
SDS	O
)	O
buffer	O
(	O
350	O
mM	O
Tris-HCl	O
,	O
pH	O
6.8	O
,	O
30	O
%	O
glycerol	O
,	O
10	O
%	O
SDS	O
,	O
0.6	O
M	O
dithiothreitol	O
,	O
0.012	O
%	O
bromophenol	O
blue	O
)	O
,	O
boiled	O
for	O
10	O
min	O
at	O
99°C	O
,	O
and	O
loaded	O
on	O
7.5	O
%	O
acrylamide-bisacrylamide	O
gels	O
or	O
4	O
to	O
20	O
%	O
Tris-glycine	O
gradient	O
gels	O
(	O
Anamed	O
,	O
Gross-Bieberau	O
,	O
Germany	O
)	O
.	O

Gel-separated	O
proteins	O
were	O
transferred	O
to	O
a	O
polyvinylidene	O
fluoride	O
membrane	O
(	O
Roth	O
,	O
Karlsruhe	O
,	O
Germany	O
)	O
,	O
which	O
was	O
blocked	O
with	O
5	O
%	O
nonfat	O
dry	O
milk	O
in	O
PBS-Tween	O
(	O
PBS	O
containing	O
0.1	O
%	O
Tween	O
20	O
)	O
for	O
2	O
h	O
,	O
washed	O
with	O
PBS-Tween	O
,	O
and	O
incubated	O
with	O
the	O
primary	O
antibody	O
in	O
2.5	O
%	O
nonfat	O
dry	O
milk	O
in	O
PBS-Tween	O
at	O
room	O
temperature	O
for	O
2	O
h	O
.	O

After	O
washing	O
,	O
the	O
membranes	O
were	O
incubated	O
for	O
45	O
min	O
at	O
room	O
temperature	O
with	O
the	O
secondary	O
antibody	O
in	O
2.5	O
%	O
nonfat	O
dry	O
milk	O
in	O
PBS-Tween	O
(	O
71	O
,	O
76	O
)	O
.	O

In	O
order	O
to	O
prevent	O
cross-reactions	O
with	O
milk	O
proteins	O
,	O
Western	O
blot	O
staining	O
with	O
the	O
O-GlcNAc-recognizing	O
antibody	O
was	O
performed	O
as	O
follows	O
:	O
the	O
membranes	O
were	O
blocked	O
with	O
10	O
%	O
Western	O
blocking	O
reagent	O
(	O
Roche	O
)	O
in	O
PBS-Tween	O
and	O
the	O
antibody	O
was	O
diluted	O
in	O
0.5	O
%	O
Western	O
blocking	O
reagent	O
(	O
Roche	O
)	O
.	O

Subsequent	O
to	O
the	O
final	O
washing	O
step	O
,	O
chemiluminescence	O
was	O
detected	O
according	O
to	O
the	O
manufacturer	O
's	O
protocol	O
(	O
Pierce	O
Biotechnology	O
,	O
Rockford	O
,	O
IL	O
)	O
.	O

The	O
following	O
primary	O
antibodies	O
were	O
used	O
:	O
polyclonal	O
rabbit	O
anti-human	O
Sp1	O
Pep2	O
(	O
1:500	O
;	O
Santa	O
Cruz	O
Biotechnology	O
,	O
Heidelberg	O
,	O
Germany	O
)	O
,	O
polyclonal	O
goat	O
anti-human	O
lamin	O
A/C	O
N-18	O
(	O
1:1,000	O
;	O
Santa	O
Cruz	O
Biotechnology	O
)	O
,	O
polyclonal	O
rabbit	O
anti-human	O
OGT	O
TI-14	O
(	O
1:1,000	O
;	O
Sigma-Aldrich	O
)	O
,	O
polyclonal	O
rabbit	O
anti-human	O
actin	O
(	O
1:1,000	O
;	O
Sigma-Aldrich	O
)	O
,	O
monoclonal	O
mouse	O
anti-human	O
histone	O
H1	O
(	O
1:1,000	O
;	O
Santa	O
Cruz	O
)	O
,	O
monoclonal	O
mouse	O
anti-GFP	O
(	O
1:10,000	O
,	O
Roche	O
)	O
;	O
monoclonal	O
mouse	O
anti-eukaryote	O
O-GlcNAc	O
CTD110.6	O
(	O
1:1,000	O
;	O
Hiss	O
Diagnostics	O
,	O
Freiburg	O
,	O
Germany	O
)	O
,	O
and	O
monoclonal	O
mouse	O
anti-human	O
glyceraldehyde-3-phosphate	O
dehydrogenase	O
(	O
GAPDH	O
;	O
1:70,000	O
,	O
Millipore	O
,	O
Schwalbach	O
,	O
Germany	O
)	O
.	O

The	O
monoclonal	O
rat	O
anti-Tat	O
immunoglobulin	O
G2a	O
(	O
IgG2a	O
)	O
antibody	O
(	O
clone	O
1C9	O
;	O
1:150	O
)	O
was	O
produced	O
by	O
immunization	O
of	O
LOU/C	O
rats	O
with	O
His-tagged	O
purified	O
recombinant	O
Tat	O
protein	O
(	O
50	O
µg	O
)	O
according	O
to	O
a	O
previously	O
described	O
procedure	O
(	O
48	O
)	O
.	O

The	O
secondary	O
,	O
horseradish	O
peroxidase-coupled	O
antibodies	O
goat	O
anti-rat	O
IgG	O
,	O
donkey	O
anti-rabbit	O
IgG	O
,	O
sheep	O
anti-mouse	O
IgG	O
,	O
and	O
rabbit	O
anti-goat	O
IgG	O
(	O
all	O
from	O
Dako	O
,	O
Hamburg	O
,	O
Germany	O
)	O
were	O
diluted	O
1:5,000	O
.	O

Fractionation	O
was	O
performed	O
with	O
a	O
nuclear/cytosol	O
fractionation	O
kit	O
(	O
BioVision	O
,	O
Wiesbaden	O
,	O
Germany	O
)	O
according	O
to	O
the	O
manufacturer	O
's	O
protocol	O
(	O
64	O
)	O
.	O

For	O
gel	O
shift	O
experiments	O
,	O
cells	O
were	O
counted	O
,	O
and	O
the	O
nuclear	O
fractions	O
were	O
lysed	O
in	O
10	O
µl	O
nuclear	O
extraction	O
buffer	O
per	O
1	O
×	O
106	O
HEK	O
293T	O
cells	O
in	O
order	O
to	O
concentrate	O
the	O
fractions	O
.	O

The	O
protein	O
concentration	O
was	O
determined	O
as	O
described	O
above	O
.	O

Equal	O
protein	O
amounts	O
of	O
each	O
fraction	O
were	O
loaded	O
onto	O
the	O
gel	O
and	O
analyzed	O
by	O
Western	O
blotting	O
or	O
applied	O
to	O
gel	O
shift	O
experiments	O
.	O

HEK	O
293T	O
cells	O
(	O
2	O
×	O
106	O
)	O
were	O
seeded	O
in	O
9	O
ml	O
medium	O
in	O
10-cm	O
cell	O
culture	O
dishes	O
.	O

The	O
cells	O
were	O
transfected	O
24	O
h	O
later	O
(	O
via	O
the	O
calcium	O
phosphate	O
method	O
)	O
with	O
pcDNA4	O
,	O
pcDNA-Sp1	O
,	O
or	O
pcDNA-Sp1	O
and	O
pcDNA-OGT	O
.	O

The	O
total	O
transfected	O
DNA	O
amount	O
was	O
adjusted	O
to	O
30	O
µg	O
with	O
the	O
control	O
plasmid	O
pcDNA4	O
.	O

At	O
24	O
h	O
after	O
transfection	O
,	O
cells	O
were	O
washed	O
with	O
PBS	O
and	O
subsequently	O
lysed	O
in	O
IP	O
lysis	O
buffer	O
(	O
20	O
mM	O
Tri	O
s-HCl	O
,	O
pH	O
7.5	O
,	O
150	O
mM	O
NaCl	O
,	O
5	O
mM	O
MgCl2	O
,	O
and	O
1	O
%	O
Igepal	O
[	O
all	O
purchased	O
from	O
Sigma-Aldrich	O
]	O
)	O
,	O
supplemented	O
with	O
one	O
tablet	O
of	O
Complete	O
Mini	O
,	O
EDTA-free	O
protease	O
inhibitor	O
cocktail	O
(	O
Roche	O
)	O
per	O
10	O
ml	O
.	O

The	O
protein	O
concentration	O
was	O
determined	O
,	O
and	O
1	O
mg	O
total	O
protein	O
in	O
a	O
maximal	O
volume	O
of	O
1	O
ml	O
was	O
used	O
for	O
the	O
immunoprecipitation	O
.	O

The	O
lysates	O
were	O
precleared	O
by	O
incubation	O
with	O
100	O
µl	O
Sepharose	O
CL-6B	O
(	O
Sigma-Aldrich	O
)	O
at	O
4°C	O
for	O
1	O
h	O
.	O

The	O
Sp1	O
protein	O
complex	O
was	O
immunoprecipitated	O
at	O
4°C	O
for	O
3	O
h	O
with	O
30	O
µg	O
anti-Sp1	O
Pep2	O
antibody	O
covalently	O
coupled	O
to	O
agarose	O
beads	O
(	O
Santa	O
Cruz	O
Biotechnology	O
)	O
.	O

Bead-coupled	O
protein	O
complexes	O
were	O
washed	O
twice	O
with	O
1	O
ml	O
IP	O
lysis	O
buffer	O
and	O
three	O
times	O
with	O
IP	O
wash	O
buffer	O
(	O
20	O
mM	O
Tris-HCl	O
,	O
pH	O
7.5	O
,	O
150	O
mM	O
NaCl	O
,	O
5	O
mM	O
MgCl2	O
,	O
and	O
0.1	O
%	O
Igepal	O
)	O
.	O

The	O
immunoprecipitates	O
were	O
analyzed	O
by	O
SDS-polyacrylamide	O
gel	O
electrophoresis	O
and	O
Western	O
blotting	O
as	O
described	O
above	O
.	O

HEK	O
293T	O
cells	O
were	O
seeded	O
24	O
h	O
prior	O
to	O
transfection	O
in	O
1.5	O
ml	O
medium	O
at	O
a	O
density	O
of	O
3	O
×	O
105	O
cells	O
per	O
well	O
in	O
a	O
six-well	O
plate	O
.	O

Cells	O
were	O
transiently	O
cotransfected	O
(	O
via	O
the	O
calcium	O
phosphate	O
method	O
)	O
in	O
triplicate	O
with	O
0.5	O
µg	O
pXP1-LTR-Sp1wt-Luc	O
or	O
0.5	O
µg	O
pEF1α-Luc	O
,	O
along	O
with	O
0.75	O
µg	O
pcDNA-Sp1	O
and/or	O
0.25	O
µg	O
pCEP4-Tat	O
and	O
1	O
µg	O
pcDNA-OGT	O
(	O
unless	O
otherwise	O
indicated	O
)	O
.	O

The	O
total	O
DNA	O
amount	O
was	O
adjusted	O
to	O
2.5	O
µg	O
with	O
the	O
control	O
plasmid	O
pcDNA4	O
.	O

For	O
RNA	O
interference	O
experiments	O
,	O
0.22	O
µg	O
(	O
amount	O
corresponds	O
to	O
10	O
nM	O
)	O
short	O
interfering	O
RNA	O
(	O
siRNA	O
)	O
oligonucleotides	O
specific	O
for	O
human	O
OGT	O
(	O
hsOGT_7	O
SI02665131	O
;	O
Qiagen	O
)	O
,	O
human	O
Sp1	O
(	O
hsSP1_1	O
SI00150976	O
;	O
Qiagen	O
)	O
,	O
or	O
human	O
GAPDH	O
(	O
Silencer	O
GAPDH	O
siRNA	O
;	O
Ambion	O
,	O
Darmstadt	O
,	O
Germany	O
)	O
,	O
or	O
a	O
nontargeting	O
control	O
siRNA	O
(	O
Silencer	O
Negative	O
Control	O
no	O
.	O
1	O
siRNA	O
;	O
Ambion	O
)	O
was	O
cotransfected	O
.	O

Twenty-four	O
hours	O
later	O
,	O
cells	O
were	O
lysed	O
in	O
200	O
µl	O
1×	O
passive	O
lysis	O
buffer	O
(	O
Promega	O
)	O
and	O
assayed	O
for	O
luciferase	O
activity	O
as	O
described	O
below	O
.	O

Stable	O
transfection	O
of	O
HEK	O
293T	O
cells	O
with	O
pcDNA4-LTRwt-d2EGFP	O
and	O
pcDNA4-LTRmutSp1-d2EGFP	O
was	O
performed	O
via	O
the	O
calcium	O
phosphate	O
method	O
.	O

Stably	O
transfected	O
cells	O
were	O
selected	O
with	O
600	O
µg/ml	O
Zeocin	O
(	O
Invitrogen	O
)	O
.	O

After	O
10	O
days	O
,	O
single	O
colonies	O
were	O
transferred	O
to	O
new	O
culture	O
plates	O
.	O

Fluorescence	O
intensity	O
of	O
clones	O
was	O
analyzed	O
by	O
flow	O
cytometry	O
.	O

For	O
the	O
final	O
experiment	O
,	O
three	O
clones	O
of	O
each	O
construct	O
,	O
which	O
expressed	O
comparable	O
fluorescence	O
intensities	O
,	O
were	O
selected	O
.	O

Electroporation	O
of	O
Jurkat	O
cells	O
was	O
performed	O
with	O
the	O
Nucleofector	O
II	O
(	O
Amaxa/Lonza	O
,	O
Cologne	O
,	O
Germany	O
)	O
.	O

Therefore	O
,	O
cells	O
were	O
resuspended	O
in	O
100	O
µl	O
Nucleofector	O
solution	O
V	O
at	O
a	O
final	O
concentration	O
of	O
2	O
×	O
107	O
cells/ml	O
and	O
mixed	O
with	O
50	O
µg/ml	O
DNA	O
(	O
pcDNA4-EF1α-d2EGFP	O
or	O
pcDNA4-OGT	O
)	O
.	O

Electroporation	O
was	O
carried	O
out	O
with	O
100	O
µl	O
cell	O
DNA	O
suspension	O
using	O
program	O
X-001	O
.	O

Immediately	O
after	O
transfection	O
,	O
cells	O
were	O
transferred	O
to	O
prewarmed	O
RPMI	O
1640	O
medium	O
supplemented	O
with	O
10	O
%	O
FCS	O
and	O
4	O
mM	O
l-glutamine	O
.	O

At	O
48	O
h	O
posttransfection	O
,	O
stably	O
transfected	O
Jurkat	O
cells	O
were	O
selected	O
with	O
400	O
µg/ml	O
Zeocin	O
(	O
Invitrogen	O
)	O
.	O

After	O
initial	O
selection	O
,	O
cells	O
were	O
singularized	O
by	O
limited	O
dilution	O
into	O
96-well	O
plates	O
.	O

After	O
13	O
days	O
,	O
d2EGFP-expressing	O
Jurkat	O
clones	O
were	O
pooled	O
,	O
while	O
OGT-expressing	O
Jurkat	O
clones	O
were	O
cultivated	O
separately	O
.	O

T	O
lymphocytes	O
were	O
electroporated	O
as	O
described	O
previously	O
(	O
65	O
)	O
.	O

Briefly	O
,	O
cells	O
were	O
washed	O
once	O
with	O
pure	O
RPMI	O
1640	O
and	O
once	O
with	O
OptiMEM	O
without	O
phenol	O
red	O
(	O
Invitrogen	O
)	O
(	O
all	O
at	O
room	O
temperature	O
)	O
.	O

The	O
cells	O
were	O
resuspended	O
in	O
OptiMEM	O
at	O
a	O
concentration	O
of	O
1	O
×	O
108	O
cells/ml	O
.	O

RNA	O
was	O
transferred	O
to	O
a	O
4-mm	O
cuvette	O
(	O
Molecular	O
Bioproducts	O
,	O
San	O
Diego	O
,	O
CA	O
)	O
at	O
a	O
final	O
concentration	O
of	O
150	O
µg/ml	O
.	O

A	O
volume	O
of	O
100	O
µl	O
of	O
cell	O
suspension	O
was	O
added	O
and	O
immediately	O
pulsed	O
in	O
a	O
Gene	O
Pulser	O
Xcell	O
(	O
Bio-Rad	O
)	O
.	O

Pulse	O
conditions	O
for	O
CD4+	O
T	O
lymphocytes	O
were	O
square-wave	O
pulse	O
,	O
500	O
V	O
,	O
and	O
5	O
ms	O
.	O

Immediately	O
after	O
electroporation	O
,	O
cells	O
were	O
transferred	O
to	O
prewarmed	O
MLPC	O
medium	O
.	O

Cell	O
lysates	O
were	O
centrifuged	O
at	O
10,000	O
×	O
g	O
at	O
4°C	O
for	O
3	O
min	O
.	O

Firefly	O
luciferase	O
activity	O
of	O
the	O
supernatants	O
was	O
measured	O
using	O
the	O
luciferase	O
assay	O
system	O
(	O
Promega	O
)	O
in	O
a	O
Luminoskan	O
Ascent	O
instrument	O
(	O
Thermo	O
Fisher	O
Scientific	O
,	O
Langenselbold	O
,	O
Germany	O
)	O
.	O

Each	O
luciferase	O
reporter	O
gene	O
assay	O
was	O
performed	O
in	O
triplicate	O
(	O
except	O
for	O
that	O
shown	O
in	O
Fig	O
.	O
3	O
)	O
.	O

OGT	O
inhibits	O
HIV-1	O
LTR	O
promoter	O
activity	O
in	O
infected	O
primary	O
CD4+	O
T	O
cells	O
.	O

Primary	O
CD4+	O
T	O
cells	O
from	O
two	O
different	O
donors	O
were	O
infected	O
with	O
VSV-G	O
env	O
pseudotyped	O
HIV-1NL4-3LucR-E-	O
.	O

At	O
36	O
h	O
postinfection	O
,	O
cells	O
were	O
electroporated	O
with	O
in	O
vitro-transcribed	O
polyadenylated	O
mRNA	O
encoding	O
either	O
EGFP	O
or	O
OGT	O
.	O

(	O
A	O
)	O
At	O
8	O
h	O
postelectroporation	O
,	O
luciferase	O
activity	O
was	O
measured	O
.	O

(	O
B	O
)	O
The	O
O-GlcNAcylation	O
pattern	O
and	O
overexpression	O
of	O
EGFP	O
and	O
OGT	O
were	O
verified	O
by	O
Western	O
blotting	O
.	O

Staining	O
of	O
GAPDH	O
demonstrates	O
equal	O
loading	O
of	O
proteins	O
.	O

HEK	O
293T	O
cells	O
were	O
transfected	O
with	O
the	O
expression	O
constructs	O
for	O
Sp1	O
,	O
OGT	O
,	O
or	O
both	O
,	O
and	O
nuclear	O
proteins	O
were	O
isolated	O
as	O
already	O
described	O
.	O

The	O
electrophoretic	O
mobility	O
shift	O
assay	O
was	O
essentially	O
performed	O
as	O
described	O
previously	O
(	O
54	O
,	O
56	O
)	O
.	O

Briefly	O
,	O
binding	O
reaction	O
mixtures	O
(	O
final	O
volume	O
,	O
15	O
µl	O
)	O
contained	O
10	O
mM	O
Tris-HCl	O
(	O
pH	O
7.5	O
)	O
,	O
80	O
mM	O
NaCl	O
,	O
1	O
mM	O
EDTA	O
,	O
1	O
mM	O
dithiothreitol	O
,	O
5	O
%	O
glycerol	O
,	O
3	O
µg	O
of	O
poly	O
(	O
dI-dC	O
)	O
·	O
poly	O
(	O
dI-dC	O
)	O
(	O
GE	O
Healthcare	O
)	O
,	O
10	O
µg	O
of	O
nuclear	O
extract	O
,	O
and	O
4	O
×	O
104	O
cpm	O
of	O
the	O
32P-end-labeled	O
double-stranded	O
oligonucleotide	O
probe	O
.	O

The	O
oligonucleotides	O
corresponded	O
either	O
to	O
the	O
wild-type	O
HIV-1	O
LTR	O
region	O
containing	O
the	O
three	O
binding	O
sites	O
for	O
Sp1	O
(	O
wt	O
LTR-Sp1	O
,	O
5'-GGATCGGGAGCGTGGCCTGGGCGGGACTGGGGAGTGGCGAGCCC-3	O
'	O
;	O
Sp1-binding	O
sites	O
are	O
underlined	O
)	O
or	O
to	O
the	O
Sp1-binding-site-mutated	O
HIV-1	O
LTR	O
(	O
mut	O
LTR-Sp1	O
,	O
5'-GGATCGGGATTCGTGGCCTGTTCGGGACTGGTTAGTGGCGAGCCC-3	O
'	O
;	O
nucleotide	O
substitutions	O
in	O
bold	O
)	O
.	O

After	O
incubation	O
for	O
45	O
min	O
on	O
ice	O
,	O
the	O
protein-DNA	O
complexes	O
were	O
resolved	O
on	O
nondenaturing	O
5	O
%	O
polyacrylamide	O
gels	O
run	O
in	O
1×	O
Tris-borate-EDTA	O
buffer	O
containing	O
89	O
mM	O
Tris	O
,	O
89	O
mM	O
boric	O
acid	O
,	O
and	O
2	O
mM	O
EDTA	O
(	O
pH	O
8.0	O
)	O
.	O

For	O
competition	O
experiments	O
,	O
a	O
10-	O
,	O
20-	O
,	O
or	O
50-fold	O
molar	O
excess	O
of	O
unlabeled	O
competitor	O
oligomers	O
was	O
added	O
to	O
the	O
gel	O
shift	O
mixtures	O
prior	O
to	O
the	O
addition	O
of	O
the	O
32P-labeled	O
oligonucleotide	O
probe	O
and	O
incubated	O
for	O
30	O
min	O
at	O
4°C	O
.	O

For	O
supershift	O
assays	O
,	O
antibodies	O
directed	O
against	O
Sp1	O
,	O
O-GlcNAc	O
,	O
or	O
OGT	O
were	O
added	O
to	O
the	O
gel	O
shift	O
mixture	O
and	O
incubated	O
for	O
30	O
min	O
at	O
4°C	O
prior	O
to	O
the	O
addition	O
of	O
the	O
labeled	O
probe	O
.	O

Supershift	O
antibodies	O
were	O
Sp1	O
Pep2	O
sc-59X	O
(	O
Santa	O
Cruz	O
Biotechnology	O
)	O
,	O
O-GlcNAc	O
CTD110.6	O
(	O
Hiss	O
Diagnostics	O
)	O
,	O
and	O
OGT	O
TI-14	O
(	O
Sigma-Aldrich	O
)	O
,	O
as	O
well	O
as	O
IgG	O
(	O
NF-κB	O
p50	O
sc114X	O
[	O
Santa	O
Cruz	O
Biotechnology	O
]	O
)	O
and	O
IgM	O
(	O
heparan	O
sulfate	O
370255	O
[	O
Seikagaku	O
Corporation	O
]	O
)	O
isotype	O
controls	O
.	O

All	O
experiments	O
were	O
repeated	O
three	O
times	O
.	O

One	O
representative	O
gel	O
shift	O
of	O
each	O
assay	O
is	O
shown	O
.	O

RNA	O
was	O
isolated	O
with	O
RNeasy	O
columns	O
(	O
Qiagen	O
GmbH	O
,	O
Hilden	O
,	O
Germany	O
)	O
according	O
to	O
the	O
manufacturer	O
's	O
instructions	O
.	O

RNA	O
quality	O
was	O
verified	O
by	O
agarose	O
gel	O
electrophoresis	O
,	O
and	O
RNA	O
concentration	O
was	O
measured	O
spectrophotometrically	O
.	O

Reverse	O
transcription	O
of	O
total	O
RNA	O
and	O
amplification	O
of	O
OGT	O
and	O
GAPDH	O
cDNA	O
were	O
performed	O
as	O
described	O
previously	O
(	O
53	O
,	O
72	O
)	O
.	O

PCR	O
was	O
carried	O
out	O
in	O
a	O
total	O
reaction	O
volume	O
of	O
25	O
µl	O
with	O
1	O
µl	O
of	O
either	O
undiluted	O
(	O
1	O
)	O
or	O
diluted	O
(	O
1:5	O
and	O
1:10	O
)	O
cDNA	O
.	O

Primers	O
specifically	O
amplifying	O
recombinant	O
OGT	O
were	O
selected	O
:	O
the	O
forward	O
primer	O
recognized	O
specifically	O
the	O
vector-encoded	O
5	O
'	O
untranslated	O
region	O
of	O
the	O
recombinant	O
OGT	O
mRNA	O
(	O
5'-TCCAGTGTGGTGGAATTCTG-3	O
'	O
)	O
;	O
the	O
reverse	O
primer	O
was	O
homologous	O
to	O
a	O
sequence	O
corresponding	O
to	O
the	O
N-terminal	O
region	O
of	O
both	O
endogenous	O
and	O
recombinant	O
OGT	O
(	O
5'-TTGCGTCTCAATTGCTTTCA-3	O
'	O
)	O
.	O

Amplification	O
of	O
GAPDH	O
was	O
performed	O
using	O
the	O
forward	O
primer	O
5'-AGCCACATCGCTCAGAACAC-3	O
'	O
and	O
the	O
reverse	O
primer	O
5'-GAGGCATTGCTGATGATCTTG-3	O
'	O
as	O
described	O
previously	O
(	O
44	O
)	O
.	O

Statistical	O
significances	O
were	O
calculated	O
with	O
the	O
Student	O
t	O
test	O
for	O
paired	O
samples	O
using	O
the	O
SPSS	O
15.0	O
and	O
16.0	O
software	O
for	O
Microsoft	O
Windows	O
(	O
SPSS	O
Inc.	O
,	O
Chicago	O
,	O
IL	O
)	O
.	O

P	O
values	O
smaller	O
than	O
0.05	O
were	O
considered	O
statistically	O
significant	O
(	O
*	O
)	O
,	O
P	O
values	O
smaller	O
than	O
0.01	O
were	O
considered	O
highly	O
significant	O
(	O
**	O
)	O
,	O
and	O
P	O
values	O
smaller	O
than	O
0.001	O
were	O
considered	O
the	O
most	O
significant	O
(	O
***	O
)	O
.	O

RESULTS	O

In	O
order	O
to	O
evaluate	O
whether	O
O-GlcNAcylation	O
affects	O
HIV-1	O
replication	O
,	O
Jurkat	O
,	O
T1	O
,	O
and	O
primary	O
CD4+	O
T	O
lymphocytes	O
were	O
infected	O
with	O
HIV-1NL4-3LucR-E-	O
,	O
a	O
replication-deficient	O
HIV-1	O
clone	O
pseudotyped	O
with	O
the	O
envelope	O
protein	O
VSV-G	O
.	O

Upon	O
integration	O
,	O
this	O
recombinant	O
virus	O
expresses	O
the	O
firefly	O
luciferase	O
gene	O
driven	O
by	O
the	O
HIV-1	O
LTR	O
promoter	O
.	O

Consequently	O
,	O
the	O
luciferase	O
activity	O
in	O
infected	O
cells	O
correlates	O
with	O
the	O
rate	O
of	O
HIV-1	O
gene	O
transcription	O
.	O

Reporter-HIV-1-infected	O
cells	O
were	O
either	O
left	O
untreated	O
(	O
0	O
mM	O
)	O
or	O
treated	O
for	O
24	O
h	O
with	O
increasing	O
concentrations	O
of	O
GlcN	O
(	O
0.25	O
mM	O
,	O
1	O
mM	O
,	O
4	O
mM	O
,	O
and	O
16	O
mM	O
)	O
,	O
and	O
luciferase	O
activity	O
was	O
measured	O
.	O

GlcN	O
significantly	O
inhibited	O
the	O
HIV-1	O
gene	O
transcription	O
by	O
more	O
than	O
60	O
%	O
in	O
Jurkat	O
cells	O
and	O
50	O
%	O
in	O
T1	O
cells	O
(	O
Fig	O
.	O
1A	O
and	O
B	O
)	O
without	O
significantly	O
decreasing	O
cell	O
viability	O
(	O
Fig	O
.	O
1A	O
and	O
B	O
)	O
.	O

Western	O
blot	O
analyses	O
using	O
an	O
antibody	O
which	O
recognizes	O
O-GlcNAcylated	O
proteins	O
demonstrated	O
increased	O
O-GlcNAcylation	O
upon	O
GlcN	O
treatment	O
,	O
whereas	O
expression	O
of	O
OGT	O
remained	O
unchanged	O
(	O
Fig	O
.	O
1C	O
)	O
.	O

Detection	O
of	O
GAPDH	O
and	O
actin	O
demonstrated	O
that	O
equal	O
amounts	O
of	O
protein	O
were	O
loaded	O
.	O

Similar	O
results	O
were	O
obtained	O
in	O
primary	O
CD4+	O
T	O
lymphocytes	O
from	O
two	O
different	O
donors	O
(	O
Fig	O
.	O
1D	O
and	O
E	O
)	O
,	O
although	O
HIV-1	O
replication	O
in	O
donor	O
2	O
(	O
Fig	O
.	O
1E	O
)	O
was	O
inhibited	O
to	O
a	O
lesser	O
extent	O
than	O
was	O
that	O
in	O
donor	O
1	O
(	O
Fig	O
.	O
1D	O
)	O
.	O

This	O
difference	O
is	O
also	O
reflected	O
in	O
smaller	O
amounts	O
of	O
O-GlcNAcylated	O
proteins	O
in	O
the	O
lysates	O
of	O
donor	O
2	O
than	O
in	O
lysates	O
of	O
donor	O
1	O
(	O
compare	O
donor	O
1	O
and	O
donor	O
2	O
in	O
Fig	O
.	O
1F	O
,	O
upper	O
panel	O
)	O
.	O

GlcN	O
inhibits	O
HIV-1	O
transcription	O
in	O
lymphocytes	O
.	O

Jurkat	O
cells	O
(	O
A	O
)	O
,	O
T1	O
cells	O
(	O
B	O
)	O
,	O
and	O
primary	O
CD4+	O
T	O
cells	O
from	O
two	O
different	O
donors	O
(	O
D	O
and	O
E	O
)	O
were	O
infected	O
with	O
VSV-G	O
env	O
pseudotyped	O
HIV-1NL4-3LucR-E-	O
and	O
cultured	O
in	O
the	O
absence	O
(	O
0	O
mM	O
)	O
or	O
presence	O
of	O
different	O
concentrations	O
of	O
GlcN	O
(	O
0.25	O
mM	O
,	O
1	O
mM	O
,	O
4	O
mM	O
,	O
and	O
16	O
mM	O
)	O
for	O
24	O
h	O
.	O

Subsequently	O
,	O
HIV-1	O
LTR-driven	O
luciferase	O
activity	O
was	O
measured	O
(	O
solid	O
lines	O
)	O
.	O

The	O
effect	O
of	O
GlcN	O
on	O
cytotoxicity	O
and	O
proliferation	O
was	O
monitored	O
by	O
MTT	O
assay	O
(	O
dashed	O
lines	O
)	O
.	O

The	O
results	O
are	O
presented	O
in	O
terms	O
of	O
percent	O
activities	O
of	O
untreated	O
control	O
cells	O
.	O

The	O
means	O
±	O
standard	O
deviations	O
from	O
triplicate	O
determinations	O
are	O
indicated	O
.	O

P	O
values	O
are	O
calculated	O
in	O
comparison	O
with	O
control	O
:	O
*	O
,	O
P	O
≤	O
0.05	O
;	O
**	O
,	O
P	O
≤	O
0	O
.	O

01	O
.	O
(	O
C	O
and	O
F	O
)	O
Western	O
blot	O
analyses	O
of	O
O-GlcNAcylated	O
proteins	O
and	O
OGT	O
in	O
Jurkat	O
and	O
T1	O
cells	O
(	O
C	O
)	O
and	O
in	O
primary	O
CD4+	O
T	O
lymphocytes	O
(	O
F	O
)	O
.	O

Actin	O
and	O
GAPDH	O
served	O
as	O
loading	O
controls	O
.	O

To	C
exclude	C
the	C
possibility	C
that	C
reduced	C
HIV-1	C
gene	C
transcription	C
is	C
caused	C
by	C
impaired	C
nuclear	C
transport	C
of	C
the	C
preintegration	C
complex	C
or	C
reduced	C
proviral	C
integration	C
,	C
we	C
evaluated	C
the	C
impact	C
of	C
GlcN	C
treatment	C
on	C
the	C
HIV-1	C
LTR	C
promoter	C
activity	C
.	C

Therefore	O
,	O
HeLa-Tat-III/LTR/d1EGFP	O
cells	O
,	O
which	O
stably	O
express	O
d1EGFP	O
under	O
the	O
control	O
of	O
the	O
HIV-1	O
LTR	O
,	O
were	O
either	O
left	O
untreated	O
(	O
0	O
mM	O
)	O
or	O
treated	O
with	O
increasing	O
concentrations	O
of	O
GlcN	O
(	O
0.25	O
mM	O
,	O
1	O
mM	O
,	O
4	O
mM	O
,	O
and	O
16	O
mM	O
)	O
.	O

Subsequently	O
,	O
fluorescence	O
intensity	O
was	O
measured	O
by	O
flow	O
cytometry	O
.	O

GlcN	O
treatment	O
inhibited	O
the	O
HIV-1	O
LTR-triggered	O
d1EGFP	O
expression	O
in	O
a	O
dose-dependent	O
manner	O
,	O
as	O
detected	O
by	O
the	O
shift	O
of	O
the	O
fluorescence	O
emission	O
peak	O
to	O
a	O
lower	O
fluorescence	O
intensity	O
(	O
Fig	O
.	O
2A	O
,	O
bar	O
diagram	O
)	O
.	O

Quantification	O
of	O
the	O
different	O
values	O
demonstrated	O
that	O
GlcN	O
significantly	O
decreased	O
the	O
HIV-1	O
LTR	O
activity	O
by	O
more	O
than	O
60	O
%	O
(	O
Fig	O
.	O
2A	O
,	O
bar	O
diagram	O
)	O
.	O

Comparable	O
results	O
were	O
obtained	O
after	O
treatment	O
of	O
HeLa-Tat-III/LTR/d1EGFP	O
cells	O
with	O
the	O
UDP-GlcNAc	O
analog	O
streptozotocin	O
(	O
data	O
not	O
shown	O
)	O
,	O
which	O
inhibits	O
the	O
O-GlcNAcase	O
activity	O
and	O
thereby	O
increases	O
O-GlcNAcylation	O
(	O
63	O
)	O
.	O

GlcN	O
inhibits	O
HIV-1	O
LTR	O
promoter	O
activity	O
and	O
increases	O
O-GlcNAcylation	O
in	O
HeLa	O
cells	O
.	O

(	O
A	O
)	O
HeLa-Tat-III/LTR/d1EGFP	O
cells	O
were	O
either	O
left	O
untreated	O
(	O
0	O
mM	O
)	O
or	O
stimulated	O
for	O
5	O
h	O
with	O
increasing	O
concentrations	O
of	O
GlcN	O
(	O
0.25	O
mM	O
,	O
1	O
mM	O
,	O
4	O
mM	O
,	O
and	O
16	O
mM	O
)	O
.	O

The	O
HIV-1	O
LTR	O
activity	O
was	O
assessed	O
by	O
measuring	O
the	O
d1EGFP	O
fluorescence	O
intensity	O
(	O
FI	O
)	O
with	O
flow	O
cytometry	O
analyses	O
.	O

The	O
shift	O
of	O
the	O
fluorescence	O
emission	O
peak	O
(	O
inset	O
)	O
and	O
the	O
bar	O
diagram	O
of	O
the	O
respective	O
geometric	O
mean	O
values	O
compared	O
to	O
those	O
for	O
unstimulated	O
control	O
cells	O
are	O
shown	O
.	O

The	O
means	O
±	O
standard	O
deviations	O
calculated	O
from	O
triplicate	O
determinations	O
are	O
indicated	O
.	O

P	O
values	O
are	O
given	O
for	O
comparison	O
with	O
control	O
:	O
n.s.	O
,	O
not	O
significant	O
;	O
**	O
,	O
P	O
≤	O
0.01	O
;	O
***	O
,	O
P	O
≤	O
0	O
.	O

001	O
.	O
(	O
B	O
)	O
Nuclear	O
and	O
cytosolic	O
fractions	O
of	O
unstimulated	O
(	O
control	O
)	O
or	O
stimulated	O
(	O
16	O
mM	O
GlcN	O
)	O
HeLa-Tat-III/LTR/d1EGFP	O
cells	O
were	O
analyzed	O
by	O
Western	O
blotting	O
to	O
detect	O
O-GlcNAcylated	O
proteins	O
.	O

Arrowheads	O
mark	O
proteins	O
whose	O
O-GlcNAcylation	O
patterns	O
are	O
increased	O
upon	O
GlcN	O
treatment	O
.	O

Staining	O
of	O
OGT	O
(	O
an	O
example	O
of	O
an	O
O-GlcNAcylated	O
protein	O
)	O
and	O
histone	O
H1	O
(	O
non-O-GlcNAcylated	O
)	O
shows	O
that	O
protein	O
expression	O
levels	O
were	O
not	O
altered	O
.	O

Staining	O
of	O
GAPDH	O
and	O
lamin	O
A/C	O
demonstrates	O
successful	O
fractionation	O
.	O

To	O
demonstrate	O
O-GlcNAcylation	O
of	O
cellular	O
proteins	O
in	O
the	O
presence	O
of	O
GlcN	O
,	O
cytosolic	O
and	O
nuclear	O
fractions	O
of	O
control-treated	O
versus	O
GlcN-treated	O
(	O
16	O
mM	O
)	O
HeLa-Tat-III/LTR/d1EGFP	O
cells	O
were	O
analyzed	O
by	O
Western	O
blotting	O
(	O
Fig	O
.	O
2B	O
)	O
.	O

In	O
both	O
fractions	O
,	O
several	O
proteins	O
showed	O
increased	O
O-GlcNAcylation	O
upon	O
GlcN	O
treatment	O
(	O
Fig	O
.	O
2B	O
,	O
upper	O
panels	O
)	O
,	O
whereas	O
the	O
expression	O
of	O
OGT	O
(	O
example	O
of	O
an	O
O-GlcNAc-modified	O
protein	O
)	O
and	O
of	O
histone	O
H1	O
(	O
non-O-GlcNAc-modified	O
protein	O
)	O
remained	O
unchanged	O
(	O
Fig	O
.	O
2B	O
,	O
middle	O
panels	O
)	O
.	O

Successful	O
fractionation	O
of	O
cytoplasmic	O
and	O
nuclear	O
proteins	O
and	O
loading	O
of	O
equal	O
protein	O
amounts	O
were	O
verified	O
by	O
staining	O
of	O
lamin	O
A/C	O
and	O
GAPDH	O
(	O
Fig	O
.	O
2B	O
,	O
lower	O
panels	O
)	O
.	O

Altogether	O
,	O
these	O
results	O
demonstrate	O
that	O
GlcN	O
treatment	O
enhances	O
O-GlcNAcylation	O
of	O
cytoplasmic	O
and	O
nuclear	O
proteins	O
and	O
that	O
this	O
correlates	O
with	O
decreased	O
gene	O
expression	O
from	O
the	O
HIV-1	O
LTR	O
promoter	O
.	O

Since	O
OGT	O
is	O
the	O
only	O
known	O
enzyme	O
to	O
mediate	O
O-GlcNAcylation	O
,	O
we	O
investigated	O
the	O
effect	O
of	O
OGT	O
on	O
HIV-1	O
transcription	O
in	O
primary	O
lymphocytes	O
.	O

To	O
this	O
goal	O
,	O
primary	O
CD4+	O
T	O
lymphocytes	O
from	O
two	O
different	O
donors	O
were	O
infected	O
with	O
pseudotyped	O
reporter	O
HIV-1	O
.	O

At	O
36	O
h	O
postinfection	O
the	O
cells	O
were	O
transfected	O
with	O
in	O
vitro-transcribed	O
polyadenylated	O
mRNA	O
encoding	O
either	O
EGFP	O
or	O
OGT	O
.	O

OGT	O
expression	O
levels	O
were	O
maximal	O
at	O
8	O
h	O
after	O
transfection	O
(	O
data	O
not	O
shown	O
)	O
,	O
and	O
the	O
cells	O
were	O
harvested	O
.	O

Reporter	O
analyses	O
showed	O
that	O
overexpression	O
of	O
OGT	O
inhibited	O
HIV-1	O
transcription	O
to	O
an	O
extent	O
similar	O
to	O
that	O
of	O
treatment	O
with	O
16	O
mM	O
GlcN	O
(	O
compare	O
Fig	O
.	O
3A	O
with	O
Fig	O
.	O
1D	O
and	O
E	O
)	O
.	O

The	O
inhibition	O
was	O
slightly	O
stronger	O
in	O
the	O
cells	O
of	O
donor	O
2	O
than	O
in	O
the	O
cells	O
of	O
donor	O
1	O
,	O
which	O
correlated	O
well	O
with	O
the	O
increased	O
OGT	O
expression	O
and	O
O-GlcNAcylation	O
level	O
observed	O
in	O
the	O
cells	O
of	O
donor	O
2	O
(	O
Fig	O
.	O
3B	O
,	O
upper	O
panels	O
;	O
compare	O
donor	O
1	O
and	O
donor	O
2	O
)	O
.	O

Assuming	C
that	C
O-GlcNAcylation	C
alters	C
the	C
activity	C
of	C
transcription	C
factors	C
,	C
Sp1	C
and	C
NF-κB	C
were	C
prime	C
candidates	C
for	C
the	C
O-GlcNAc-mediated	C
inhibition	C
of	C
the	C
HIV-1	C
LTR	C
.	C

Binding	O
sites	O
for	O
both	O
factors	O
constitute	O
the	O
core	O
promoter/enhancer	O
of	O
HIV-1	O
,	O
and	O
both	O
have	O
been	O
reported	O
to	O
be	O
modified	O
by	O
O-GlcNAc	O
(	O
21	O
,	O
31	O
)	O
.	O

In	O
order	O
to	O
prove	O
this	O
hypothesis	O
,	O
luciferase	O
reporter	O
assays	O
were	O
performed	O
using	O
LTR	O
reporters	O
lacking	O
the	O
upstream	O
modulatory	O
region	O
but	O
containing	O
the	O
NF-κB-	O
and/or	O
Sp1-binding	O
sites	O
(	O
either	O
combined	O
or	O
isolated	O
)	O
,	O
as	O
well	O
as	O
a	O
TATA	O
box	O
and	O
the	O
trans-activation	O
response	O
(	O
TAR	O
)	O
element	O
for	O
Tat-mediated	O
activation	O
(	O
Fig	O
.	O
4A	O
,	O
LTR-κB-Sp1wt	O
,	O
LTR-κB-Sp1mut	O
,	O
and	O
LTR-Sp1wt	O
)	O
.	O

HEK	O
293T	O
cells	O
were	O
cotransfected	O
with	O
the	O
reporter	O
constructs	O
and	O
a	O
Tat-encoding	O
plasmid	O
,	O
along	O
with	O
an	O
OGT-encoding	O
plasmid	O
or	O
a	O
control	O
plasmid	O
(	O
Fig	O
.	O
4B	O
)	O
.	O

Overexpression	O
of	O
OGT	O
inhibited	O
the	O
Tat-induced	O
activity	O
of	O
the	O
promoters	O
containing	O
functional	O
Sp1-binding	O
sites	O
(	O
Fig	O
.	O
4B	O
,	O
LTR-κB-Sp1wt	O
and	O
LTR-Sp1wt	O
)	O
.	O

In	O
contrast	O
,	O
the	O
activity	O
of	O
the	O
promoter	O
containing	O
mutated	O
Sp1-binding	O
sites	O
was	O
increased	O
upon	O
overexpression	O
of	O
OGT	O
(	O
Fig	O
.	O
4B	O
,	O
LTR-κB-Sp1mut	O
)	O
.	O

The	O
transient	O
expression	O
of	O
Tat	O
itself	O
was	O
not	O
significantly	O
affected	O
by	O
overexpression	O
of	O
OGT	O
(	O
Fig	O
.	O
4B	O
,	O
lower	O
panels	O
)	O
.	O

These	C
findings	C
suggest	C
that	C
the	C
presence	C
of	C
functional	C
Sp1-binding	C
sites	C
is	C
crucial	C
for	C
the	C
inhibitory	C
effect	C
of	C
OGT	C
on	C
the	C
HIV-1	C
LTR	C
.	C

The	O
presence	O
of	O
Sp1-binding	O
sites	O
in	O
the	O
HIV-1	O
LTR	O
promoter	O
is	O
required	O
for	O
OGT-mediated	O
inhibition	O
.	O

(	O
A	O
)	O
Schematic	O
representation	O
of	O
the	O
promoter	O
constructs	O
used	O
in	O
the	O
luciferase	O
assay	O
in	O
panel	O
B	O
.	O

The	O
truncated	O
promoters	O
lack	O
the	O
upstream	O
modulatory	O
region	O
but	O
contain	O
the	O
NF-κB-	O
and/or	O
Sp1-binding	O
sites	O
(	O
either	O
combined	O
or	O
isolated	O
)	O
,	O
as	O
well	O
as	O
a	O
TATA	O
box	O
and	O
the	O
TAR	O
element	O
for	O
Tat-mediated	O
activation	O
.	O

Quartered	O
circles	O
represent	O
mutated	O
Sp1-binding	O
sites	O
.	O

Numbers	O
reflect	O
the	O
positions	O
on	O
the	O
wild-type	O
LTRLAI	O
.	O

(	O
B	O
)	O
Promoter	O
activities	O
were	O
detected	O
by	O
measuring	O
the	O
luciferase	O
activity	O
in	O
the	O
cell	O
lysates	O
of	O
HEK	O
293T	O
cells	O
transiently	O
transfected	O
with	O
the	O
reporter	O
constructs	O
(	O
LTR-κB-Sp1wt	O
,	O
LTR-κB-Sp1mut	O
,	O
and	O
LTR-Sp1wt	O
)	O
together	O
with	O
plasmids	O
coding	O
for	O
OGT	O
and	O
Tat	O
as	O
indicated	O
.	O

The	O
total	O
DNA	O
amount	O
was	O
adjusted	O
with	O
pcDNA4	O
.	O

The	O
values	O
were	O
normalized	O
to	O
the	O
total	O
amount	O
of	O
protein	O
and	O
are	O
presented	O
in	O
terms	O
of	O
percentages	O
of	O
the	O
corresponding	O
Tat-induced	O
promoter	O
activity	O
.	O

The	O
means	O
±	O
standard	O
deviations	O
from	O
triplicate	O
determinations	O
are	O
shown	O
(	O
upper	O
panel	O
)	O
.	O

Western	O
blot	O
analyses	O
of	O
Tat	O
and	O
OGT	O
in	O
transfected	O
cells	O
are	O
shown	O
in	O
the	O
lower	O
panel	O
.	O

GAPDH	O
staining	O
demonstrates	O
that	O
equal	O
amounts	O
of	O
protein	O
were	O
loaded	O
.	O

(	O
C	O
)	O
Schematic	O
representation	O
of	O
the	O
full-length	O
wild-type	O
and	O
full-length	O
Sp1-mutated	O
promoter	O
constructs	O
used	O
for	O
the	O
stable	O
transfection	O
of	O
HEK	O
293T	O
cells	O
.	O

(	O
D	O
)	O
HEK	O
293T	O
cells	O
were	O
stably	O
transfected	O
with	O
d2EGFP	O
either	O
under	O
the	O
control	O
of	O
the	O
wild-type	O
HIV-1	O
LTR	O
(	O
LTRwt	O
)	O
or	O
under	O
the	O
control	O
of	O
the	O
LTR	O
containing	O
mutated	O
Sp1-binding	O
sites	O
in	O
the	O
basal	O
promoter	O
(	O
LTRmutSp1	O
)	O
.	O

The	O
effect	O
of	O
GlcN	O
(	O
16	O
mM	O
)	O
on	O
the	O
HIV-1	O
LTR	O
was	O
analyzed	O
by	O
flow	O
cytometry	O
,	O
and	O
the	O
mean	O
fluorescence	O
intensity	O
is	O
represented	O
in	O
the	O
bar	O
diagram	O
.	O

The	O
means	O
±	O
standard	O
deviations	O
were	O
calculated	O
from	O
duplicate	O
determinations	O
of	O
three	O
independent	O
clones	O
with	O
similar	O
fluorescence	O
intensities	O
.	O

P	O
values	O
are	O
given	O
for	O
comparison	O
with	O
control	O
:	O
*	O
,	O
P	O
≤	O
0.05	O
;	O
n.s.	O
,	O
not	O
significant	O
.	O

Western	O
blot	O
analyses	O
of	O
one	O
representative	O
clone	O
verify	O
the	O
increased	O
O-GlcNAcylation	O
pattern	O
upon	O
GlcN	O
treatment	O
and	O
constant	O
OGT	O
expression	O
.	O

GAPDH	O
staining	O
demonstrates	O
that	O
equal	O
amounts	O
of	O
protein	O
were	O
loaded	O
.	O

In	O
a	O
next	O
step	O
,	O
the	O
role	O
of	O
the	O
Sp1-binding	O
sites	O
in	O
the	O
full-length	O
HIV-1	O
LTR	O
integrated	O
into	O
the	O
cellular	O
genome	O
was	O
analyzed	O
.	O

Toward	O
this	O
goal	O
,	O
HEK	O
293T	O
cells	O
were	O
stably	O
transfected	O
with	O
plasmids	O
expressing	O
d2EGFP	O
either	O
under	O
the	O
control	O
of	O
the	O
full-length	O
wild-type	O
HIV-1	O
LTR	O
(	O
Fig	O
.	O
4C	O
,	O
LTRwt	O
)	O
or	O
under	O
the	O
control	O
of	O
the	O
full-length	O
LTR	O
containing	O
mutated	O
Sp1-binding	O
sites	O
(	O
Fig	O
.	O
4C	O
,	O
LTRmutSp1	O
)	O
.	O

Three	O
independent	O
HEK	O
293T	O
cell	O
clones	O
with	O
similar	O
fluorescence	O
intensities	O
were	O
either	O
left	O
untreated	O
or	O
stimulated	O
with	O
16	O
mM	O
GlcN	O
.	O

Subsequently	O
,	O
the	O
promoter	O
activities	O
were	O
measured	O
by	O
flow	O
cytometry	O
.	O

Mutation	O
of	O
the	O
Sp1-binding	O
sites	O
strongly	O
decreased	O
HIV-1	O
LTR	O
activity	O
(	O
Fig	O
.	O
4D	O
,	O
compare	O
fluorescence	O
intensities	O
in	O
the	O
bar	O
diagram	O
)	O
.	O

However	O
,	O
GlcN	O
treatment	O
significantly	O
decreased	O
the	O
fluorescence	O
intensity	O
only	O
in	O
cells	O
expressing	O
d2EGFP	O
under	O
the	O
control	O
of	O
the	O
wild-type	O
HIV-1	O
LTR	O
and	O
had	O
no	O
significant	O
effect	O
on	O
cells	O
expressing	O
d2EGFP	O
under	O
the	O
control	O
of	O
the	O
Sp1-mutated	O
HIV-1	O
LTR	O
(	O
Fig	O
.	O
4D	O
,	O
bar	O
diagram	O
)	O
.	O

Western	O
blot	O
analyses	O
demonstrated	O
that	O
GlcN	O
treatment	O
similarly	O
increased	O
the	O
O-GlcNAcylation	O
pattern	O
in	O
the	O
two	O
cell	O
types	O
,	O
that	O
OGT	O
expression	O
was	O
not	O
altered	O
,	O
and	O
that	O
equal	O
amounts	O
of	O
proteins	O
were	O
loaded	O
(	O
Fig	O
.	O
4D	O
,	O
right	O
panels	O
)	O
.	O

Altogether	O
these	O
results	O
demonstrate	O
that	O
the	O
Sp1-binding	O
sites	O
are	O
required	O
for	O
the	O
GlcN-mediated	O
inhibition	O
of	O
the	O
full-length	O
HIV-1	O
promoter	O
integrated	O
into	O
the	O
cellular	O
genome	O
.	O

Since	C
the	C
presence	C
of	C
the	C
Sp1-binding	C
sites	C
is	C
crucial	C
for	C
the	C
inhibitory	C
effect	C
of	C
OGT	C
on	C
the	C
HIV-1	C
LTR	C
promoter	C
,	C
we	C
investigated	C
whether	C
this	C
is	C
also	C
the	C
case	C
for	C
the	C
Sp1	C
protein	C
itself	C
.	C

To	O
this	O
goal	O
,	O
the	O
sensitivity	O
of	O
the	O
Tat-induced	O
LTR-Sp1wt	O
promoter	O
to	O
OGT	O
was	O
analyzed	O
in	O
HEK	O
293T	O
cells	O
in	O
the	O
absence	O
and	O
presence	O
of	O
Sp1	O
.	O

Sp1	O
was	O
recombinantly	O
overexpressed	O
,	O
and	O
its	O
expression	O
was	O
inhibited	O
with	O
a	O
specific	O
siRNA	O
.	O

A	O
nontargeting	O
siRNA	O
was	O
used	O
as	O
control	O
.	O

Cotransfection	O
of	O
the	O
control	O
siRNA	O
did	O
not	O
affect	O
the	O
OGT-mediated	O
inhibition	O
of	O
the	O
LTR-Sp1wt	O
(	O
Fig	O
.	O
5A	O
,	O
compare	O
bars	O
3	O
and	O
4	O
)	O
.	O

Tat-mediated	O
activation	O
of	O
the	O
LTR-Sp1wt	O
was	O
less	O
pronounced	O
after	O
knockdown	O
of	O
Sp1	O
(	O
Fig	O
.	O
5A	O
,	O
compare	O
protein	O
content-normalized	O
relative	O
light	O
unit	O
values	O
given	O
above	O
bars	O
3	O
and	O
7	O
)	O
.	O

However	O
,	O
OGT	O
clearly	O
did	O
not	O
inhibit	O
LTR-Sp1wt	O
promoter	O
activity	O
under	O
these	O
conditions	O
(	O
Fig	O
.	O
5A	O
,	O
compare	O
bars	O
7	O
and	O
8	O
)	O
.	O

The	O
expression	O
of	O
OGT	O
and	O
Tat	O
was	O
not	O
altered	O
upon	O
depletion	O
of	O
Sp1	O
expression	O
(	O
Fig	O
.	O
5B	O
)	O
.	O

Thus	O
,	O
in	O
addition	O
to	O
the	O
Sp1-binding	O
sites	O
,	O
the	O
presence	O
of	O
the	O
Sp1	O
protein	O
itself	O
is	O
also	O
necessary	O
for	O
the	O
OGT-mediated	O
inhibition	O
of	O
the	O
HIV-1	O
LTR	O
activity	O
.	O

Sp1	O
is	O
crucial	O
for	O
the	O
inhibitory	O
effect	O
of	O
OGT	O
on	O
the	O
HIV-1	O
LTR	O
.	O

(	O
A	O
)	O
HIV-1	O
LTR	O
activity	O
was	O
measured	O
by	O
luciferase	O
assay	O
after	O
cotransfection	O
of	O
HEK	O
293T	O
cells	O
with	O
an	O
LTR-Sp1wt	O
reporter	O
construct	O
along	O
with	O
Tat-and	O
Sp1-encoding	O
plasmids	O
in	O
the	O
absence	O
or	O
presence	O
of	O
an	O
OGT-encoding	O
vector	O
together	O
with	O
10	O
nM	O
control	O
siRNA	O
or	O
an	O
siRNA	O
specifically	O
targeting	O
Sp1	O
.	O

Total	O
DNA	O
amount	O
was	O
adjusted	O
with	O
pcDNA4	O
.	O

The	O
relative	O
light	O
units	O
normalized	O
to	O
the	O
total	O
protein	O
content	O
indicate	O
the	O
means	O
±	O
standard	O
deviations	O
from	O
triplicate	O
determinations	O
(	O
values	O
above	O
the	O
bars	O
)	O
.	O

The	O
results	O
were	O
normalized	O
for	O
each	O
siRNA	O
data	O
set	O
individually	O
and	O
are	O
presented	O
in	O
terms	O
of	O
percentages	O
of	O
control	O
(	O
Tat-	O
and	O
Sp1-induced	O
LTR-Sp1wt	O
activity	O
)	O
.	O

P	O
values	O
are	O
given	O
for	O
comparison	O
with	O
control	O
:	O
**	O
,	O
P	O
≤	O
0.01	O
;	O
n.s.	O
,	O
not	O
significant	O
.	O

(	O
B	O
)	O
Western	O
blot	O
analyses	O
of	O
the	O
lysates	O
verify	O
the	O
knockdown	O
of	O
Sp1	O
by	O
siRNA	O
and	O
prove	O
that	O
the	O
expression	O
of	O
OGT	O
and	O
Tat	O
remains	O
unaffected	O
upon	O
silencing	O
of	O
Sp1	O
.	O

The	O
GAPDH	O
staining	O
demonstrates	O
that	O
equal	O
amounts	O
of	O
protein	O
were	O
loaded	O
.	O

To	C
investigate	C
the	C
role	C
of	C
Sp1	C
in	C
the	C
OGT-mediated	C
inhibition	C
of	C
the	C
HIV-1	C
LTR	C
in	C
more	C
detail	C
,	C
we	C
explored	C
whether	C
overexpression	C
of	C
OGT	C
enhances	C
O-GlcNAcylation	C
of	C
Sp1	C
(	C
Fig	C
.	C
6A	C
)	C
.	C

For	O
this	O
purpose	O
,	O
Sp1	O
was	O
expressed	O
alone	O
or	O
in	O
combination	O
with	O
OGT	O
(	O
Fig	O
.	O
6A	O
,	O
input	O
)	O
.	O

Immunoprecipitation	O
experiments	O
demonstrated	O
that	O
O-GlcNAcylation	O
of	O
Sp1	O
was	O
substantially	O
increased	O
when	O
OGT	O
was	O
overexpressed	O
(	O
Fig	O
.	O
6A	O
,	O
Sp1-IP	O
)	O
.	O

Coimmunoprecipitations	O
revealed	O
that	O
OGT	O
physically	O
interacts	O
with	O
Sp1	O
under	O
these	O
conditions	O
(	O
data	O
not	O
shown	O
)	O
.	O

O-GlcNAcylation	O
of	O
Sp1	O
selectively	O
inhibits	O
HIV-1	O
LTR	O
promoter	O
activity	O
in	O
a	O
dose-dependent	O
manner	O
.	O

(	O
A	O
)	O
HEK	O
293T	O
cells	O
were	O
transfected	O
with	O
control	O
vector	O
(	O
CV	O
)	O
,	O
Sp1	O
,	O
or	O
Sp1-	O
and	O
OGT-expressing	O
vectors	O
.	O

Total	O
DNA	O
amount	O
was	O
adjusted	O
with	O
pcDNA4	O
.	O

Expression	O
of	O
transfected	O
plasmids	O
and	O
O-GlcNAcylation	O
were	O
assessed	O
via	O
Western	O
blotting	O
of	O
cell	O
lysates	O
(	O
input	O
)	O
.	O

Immunoprecipitation	O
of	O
Sp1	O
(	O
Sp1-IP	O
)	O
and	O
O-GlcNAcylation	O
of	O
Sp1	O
were	O
verified	O
by	O
Western	O
blotting	O
of	O
Sp1-IPs	O
with	O
anti-Sp1	O
and	O
anti-O-GlcNAc	O
antibodies	O
,	O
respectively	O
.	O

(	O
B	O
)	O
The	O
effects	O
of	O
OGT	O
on	O
the	O
LTR-Sp1wt	O
and	O
the	O
control	O
promoter	O
EF1α	O
in	O
HEK	O
293T	O
cells	O
cotransfected	O
with	O
the	O
reporter	O
and	O
an	O
Sp1-encoding	O
plasmid	O
were	O
analyzed	O
by	O
luciferase	O
assay	O
.	O

(	O
C	O
)	O
Luciferase	O
activity	O
of	O
HEK	O
293T	O
cells	O
transiently	O
cotransfected	O
with	O
the	O
LTR-Sp1wt	O
reporter	O
construct	O
along	O
with	O
Tat-	O
and	O
Sp1-encoding	O
plasmids	O
and	O
increasing	O
concentrations	O
of	O
an	O
OGT-encoding	O
vector	O
(	O
0.05	O
µg	O
,	O
0.2	O
µg	O
,	O
and	O
1	O
µg	O
)	O
.	O

The	O
total	O
DNA	O
amount	O
in	O
panels	O
B	O
and	O
C	O
was	O
adjusted	O
with	O
pcDNA4	O
.	O

The	O
values	O
were	O
normalized	O
to	O
the	O
total	O
amount	O
of	O
protein	O
and	O
are	O
presented	O
in	O
terms	O
of	O
percentages	O
of	O
control	O
(	O
Sp1	O
induced	O
[	O
B	O
]	O
and	O
Tat-	O
and	O
Sp1-induced	O
[	O
C	O
]	O
promoter	O
activity	O
)	O
.	O

The	O
means	O
±	O
standard	O
deviations	O
from	O
triplicate	O
determinations	O
are	O
indicated	O
.	O

P	O
values	O
are	O
given	O
for	O
comparison	O
with	O
control	O
:	O
n.s.	O
,	O
not	O
significant	O
;	O
*	O
,	O
P	O
≤	O
0.05	O
;	O
**	O
,	O
P	O
≤	O
0	O
.	O

In	C
order	C
to	C
determine	C
whether	C
O-GlcNAcylation	C
of	C
Sp1	C
inhibits	C
solely	C
HIV-1	C
LTR	C
activity	C
or	C
transcription	C
in	C
general	C
,	C
luciferase	C
reporter	C
assays	C
were	C
performed	C
using	C
LTR-Sp1wt	C
and	C
an	C
EF1α	C
promoter	C
construct	C
.	C

The	O
latter	O
triggers	O
the	O
expression	O
of	O
the	O
housekeeping	O
gene	O
EF1α	O
and	O
harbors	O
Sp1-binding	O
sites	O
.	O

Unlike	O
the	O
LTR-Sp1wt	O
promoter	O
,	O
the	O
EF1α	O
promoter	O
has	O
no	O
TAR	O
element	O
.	O

In	O
order	O
to	O
ensure	O
comparable	O
induction	O
levels	O
,	O
both	O
reporter	O
promoters	O
were	O
activated	O
with	O
Sp1	O
alone	O
(	O
Fig	O
.	O
6B	O
)	O
.	O

In	O
agreement	O
with	O
the	O
results	O
above	O
,	O
overexpression	O
of	O
OGT	O
significantly	O
inhibited	O
the	O
Sp1-triggered	O
expression	O
of	O
LTR-Sp1wt	O
(	O
Fig	O
.	O
6B	O
,	O
LTR-Sp1wt	O
)	O
.	O

In	C
contrast	C
,	C
the	C
activity	C
of	C
the	C
EF1α	C
promoter	C
was	C
not	C
repressed	C
but	C
significantly	C
increased	C
by	C
OGT	C
(	C
Fig	C
.	C
6B	C
,	C
EF1α	C
)	C
,	C
suggesting	C
that	C
OGT	C
selectively	C
inhibits	C
the	C
HIV-1	C
LTR	C
promoter	C
and	C
does	C
not	C
generally	C
repress	C
Sp1-regulated	C
gene	C
expression	C
.	C

Furthermore	C
,	C
we	C
evaluated	C
by	C
luciferase	C
reporter	C
assay	C
whether	C
the	C
inhibitory	C
effect	C
of	C
OGT	C
on	C
the	C
Sp1-regulated	C
HIV-1	C
LTR	C
promoter	C
is	C
dose	C
dependent	C
.	C

To	O
this	O
end	O
,	O
the	O
reporter	O
LTR-Sp1wt	O
was	O
cotransfected	O
with	O
Sp1-	O
and	O
Tat-encoding	O
constructs	O
in	O
HEK	O
293T	O
cells	O
together	O
with	O
increasing	O
amounts	O
of	O
OGT-encoding	O
plasmid	O
(	O
0.05	O
µg	O
,	O
0.2	O
µg	O
,	O
and	O
1	O
µg	O
)	O
.	O

OGT	O
clearly	O
inhibited	O
dose	O
dependently	O
the	O
HIV-1	O
LTR	O
promoter	O
activity	O
(	O
Fig	O
.	O
6C	O
)	O
.	O

The	C
inhibitory	C
effect	C
of	C
OGT	C
on	C
the	C
HIV-1	C
LTR	C
may	C
rely	C
on	C
impaired	C
nuclear	C
translocation	C
or	C
decreased	C
DNA-binding	C
affinity	C
of	C
Sp1	C
upon	C
O-GlcNAcylation	C
.	C

The	O
impact	O
of	O
OGT	O
on	O
the	O
nuclear	O
translocation	O
of	O
Sp1	O
was	O
investigated	O
by	O
comparing	O
the	O
nuclear	O
amounts	O
of	O
Sp1	O
in	O
cells	O
expressing	O
endogenous	O
or	O
increased	O
levels	O
of	O
OGT	O
.	O

The	C
amount	C
of	C
nuclear	C
Sp1	C
was	C
not	C
decreased	C
upon	C
overexpression	C
of	C
OGT	C
(	C
Fig	C
.	C
7A	C
)	C
but	C
rather	C
increased	C
,	C
suggesting	C
that	C
the	C
observed	C
decrease	C
in	C
the	C
HIV-1	C
LTR	C
promoter	C
activity	C
was	C
not	C
due	C
to	C
impaired	C
nuclear	C
translocation	C
of	C
Sp1	C
.	C

OGT	O
does	O
not	O
interfere	O
with	O
Sp1	O
expression	O
and	O
DNA	O
binding	O
of	O
Sp1	O
.	O

(	O
A	O
)	O
HEK	O
293T	O
cells	O
were	O
transfected	O
with	O
an	O
Sp1-encoding	O
plasmid	O
,	O
along	O
with	O
an	O
OGT-encoding	O
plasmid	O
or	O
control	O
plasmid	O
.	O

Protein	O
expression	O
was	O
detected	O
in	O
nuclear	O
protein	O
extracts	O
via	O
Western	O
blotting	O
.	O

Staining	O
of	O
lamin	O
A/C	O
was	O
used	O
as	O
a	O
loading	O
control	O
.	O

(	O
B	O
)	O
Electrophoretic	O
mobility	O
shift	O
assays	O
were	O
carried	O
out	O
with	O
32P-end-labeled	O
double-stranded	O
oligonucleotides	O
corresponding	O
to	O
the	O
Sp1-binding	O
sites	O
in	O
the	O
HIV-1	O
LTR	O
promoter	O
(	O
wt	O
LTR-Sp1	O
)	O
or	O
with	O
oligonucleotides	O
containing	O
mutated	O
Sp1-binding	O
sites	O
in	O
order	O
to	O
prevent	O
binding	O
(	O
mut	O
LTR-Sp1	O
)	O
.	O

One	O
representative	O
gel	O
shift	O
assay	O
out	O
of	O
three	O
is	O
shown	O
.	O

Reactions	O
were	O
performed	O
either	O
without	O
nuclear	O
extracts	O
(	O
free	O
)	O
or	O
with	O
lysates	O
from	O
cells	O
transfected	O
with	O
an	O
Sp1-encoding	O
plasmid	O
alone	O
(	O
Sp1	O
)	O
or	O
in	O
combination	O
with	O
an	O
OGT-encoding	O
plasmid	O
(	O
Sp1+OGT	O
)	O
.	O

The	O
Sp1-oligonucleotide	O
complex	O
is	O
indicated	O
as	O
Sp1-C	O
.	O

(	O
C	O
)	O
Competition	O
experiments	O
were	O
carried	O
out	O
with	O
10-	O
,	O
20-	O
,	O
and	O
50-fold	O
molar	O
excesses	O
of	O
unlabeled	O
wild-type	O
(	O
wt	O
LTR-Sp1	O
)	O
or	O
mutated	O
(	O
mut	O
LTR-Sp1	O
)	O
oligonucleotides	O
.	O

(	O
D	O
)	O
Supershift	O
analyses	O
were	O
performed	O
using	O
1	O
µg	O
,	O
2	O
µg	O
,	O
or	O
5	O
µg	O
anti-Sp1	O
,	O
anti-O-GlcNAc	O
,	O
or	O
anti-OGT	O
antibodies	O
as	O
well	O
as	O
5	O
µg	O
anti-IgG	O
or	O
anti-IgM	O
as	O
an	O
isotype	O
control	O
.	O

To	C
investigate	C
whether	C
OGT	C
interferes	C
with	C
the	C
DNA-binding	C
affinity	C
of	C
Sp1	C
,	C
gel	C
shift	C
assays	C
were	C
carried	C
out	C
with	C
templates	C
corresponding	C
to	C
the	C
Sp1-binding	C
sites	C
in	C
the	C
HIV-1	C
LTR	C
promoter	C
(	C
Fig	C
.	C
7B	C
,	C
wt	C
LTR-Sp1	C
)	C
.	C

No	O
decrease	O
in	O
the	O
formation	O
of	O
protein-oligonucleotide	O
complexes	O
was	O
detected	O
upon	O
overexpression	O
of	O
OGT	O
(	O
Fig	O
.	O
7B	O
,	O
compare	O
lane	O
3	O
and	O
5	O
)	O
.	O

As	O
a	O
specificity	O
control	O
,	O
gel	O
shift	O
experiments	O
were	O
performed	O
using	O
templates	O
containing	O
mutated	O
Sp1-binding	O
sites	O
(	O
Fig	O
.	O
7B	O
,	O
mut	O
LTR-Sp1	O
)	O
.	O

The	O
specific	O
Sp1	O
complex	O
(	O
Fig	O
.	O
7B	O
,	O
Sp1-C	O
)	O
was	O
not	O
detectable	O
with	O
these	O
oligonucleotides	O
(	O
Fig	O
.	O
7B	O
,	O
lanes	O
4	O
and	O
6	O
)	O
.	O

The	O
specificity	O
of	O
Sp1-C	O
was	O
confirmed	O
by	O
competition	O
experiments	O
with	O
increasing	O
molar	O
excess	O
of	O
unlabeled	O
wt	O
LTR-Sp1	O
(	O
Fig	O
.	O
7C	O
,	O
lanes	O
2	O
to	O
4	O
)	O
and	O
mut	O
LTR-Sp1	O
oligonucleotides	O
(	O
Fig	O
.	O
7C	O
,	O
lanes	O
5	O
to	O
7	O
)	O
.	O

In	O
addition	O
,	O
the	O
presence	O
of	O
O-GlcNAc-modified	O
Sp1	O
in	O
Sp1-C	O
was	O
confirmed	O
by	O
supershift	O
analyses	O
using	O
increasing	O
amounts	O
of	O
anti-Sp1	O
(	O
Fig	O
.	O
7D	O
,	O
lanes	O
2	O
to	O
4	O
)	O
and	O
anti-O-GlcNAc	O
(	O
Fig	O
.	O
7D	O
,	O
lanes	O
5	O
to	O
7	O
)	O
antibodies	O
.	O

Both	C
antibodies	C
shifted	C
Sp1-C	C
almost	C
completely	C
(	C
Fig	C
.	C
7D	C
,	C
lanes	C
4	C
and	C
7	C
)	C
,	C
suggesting	C
that	C
most	C
of	C
the	C
DNA-bound	C
Sp1	C
is	C
O-GlcNAcylated	C
in	C
OGT-overexpressing	C
cells	C
.	C

Addition	O
of	O
an	O
anti-OGT	O
antibody	O
did	O
not	O
shift	O
Sp1-C	O
(	O
Fig	O
.	O
7D	O
,	O
lanes	O
8	O
to	O
10	O
)	O
.	O

Isotype	O
control	O
anti-IgG	O
(	O
Fig	O
.	O
7D	O
,	O
lane	O
11	O
)	O
and	O
anti-IgM	O
(	O
Fig	O
.	O
7D	O
,	O
lane	O
12	O
)	O
antibodies	O
had	O
no	O
effect	O
on	O
Sp1-C	O
.	O

These	O
results	O
demonstrate	O
that	O
increased	O
O-GlcNAcylation	O
of	O
Sp1	O
inhibits	O
neither	O
the	O
ability	O
of	O
Sp1	O
to	O
translocate	O
into	O
the	O
nucleus	O
nor	O
the	O
DNA-binding	O
affinity	O
of	O
Sp1	O
.	O

To	O
confirm	O
that	O
the	O
inhibition	O
of	O
the	O
HIV-1	O
LTR	O
is	O
dependent	O
on	O
Sp1	O
O-GlcNAcylation	O
,	O
a	O
specific	O
siRNA	O
was	O
used	O
to	O
deplete	O
the	O
expression	O
of	O
OGT	O
.	O

The	O
specificity	O
of	O
the	O
siRNA	O
was	O
verified	O
with	O
an	O
OGT	O
rescue	O
mutant	O
(	O
resOGT	O
)	O
-encoding	O
plasmid	O
,	O
which	O
contains	O
six	O
silent	O
nucleotide	O
exchanges	O
in	O
the	O
siRNA-binding	O
site	O
(	O
Fig	O
.	O
8A	O
)	O
.	O

Western	O
blot	O
analyses	O
proved	O
that	O
overexpression	O
of	O
wild-type	O
OGT	O
(	O
wtOGT	O
)	O
was	O
inhibited	O
in	O
HEK	O
293T	O
cells	O
cotransfected	O
with	O
the	O
wtOGT-specific	O
siRNA	O
(	O
Fig	O
.	O
8B	O
,	O
top	O
panel	O
,	O
lanes	O
2	O
and	O
4	O
)	O
,	O
whereas	O
expression	O
of	O
resOGT	O
was	O
not	O
affected	O
(	O
Fig	O
.	O
8B	O
,	O
top	O
panel	O
,	O
lanes	O
3	O
and	O
5	O
)	O
.	O

Staining	O
of	O
O-GlcNAc-modified	O
proteins	O
served	O
as	O
an	O
additional	O
control	O
for	O
the	O
functionality	O
of	O
resOGT	O
(	O
Fig	O
.	O
8B	O
,	O
middle	O
panel	O
)	O
.	O

Sp1	O
O-GlcNAcylation	O
is	O
necessary	O
for	O
the	O
inhibition	O
of	O
the	O
HIV-1	O
LTR	O
.	O

(	O
A	O
)	O
Generation	O
of	O
a	O
plasmid	O
encoding	O
an	O
OGT	O
rescue	O
mutant	O
in	O
order	O
to	O
escape	O
silencing	O
by	O
the	O
siRNA	O
targeting	O
wild-type	O
OGT	O
:	O
six	O
silent	O
mutations	O
(	O
bold	O
)	O
were	O
introduced	O
into	O
the	O
siRNA-binding	O
sequence	O
of	O
OGT	O
.	O

(	O
B	O
)	O
Western	O
blot	O
analyses	O
of	O
wild-type	O
(	O
wt	O
)	O
and	O
rescue	O
mutant	O
(	O
res	O
)	O
OGT	O
were	O
performed	O
after	O
transfection	O
with	O
the	O
siRNA	O
specifically	O
targeting	O
wtOGT	O
.	O

Detection	O
of	O
O-GlcNAcylation	O
levels	O
was	O
used	O
as	O
a	O
control	O
for	O
the	O
functionality	O
of	O
the	O
rescue	O
mutant	O
.	O

Immunodetection	O
of	O
GAPDH	O
demonstrates	O
that	O
equal	O
amounts	O
of	O
protein	O
were	O
loaded	O
.	O

(	O
C	O
)	O
HEK	O
293T	O
cells	O
were	O
transfected	O
with	O
the	O
reporter	O
construct	O
LTR-Sp1wt	O
along	O
with	O
plasmids	O
encoding	O
Sp1	O
and	O
OGT	O
(	O
wild	O
type	O
or	O
rescue	O
mutant	O
)	O
.	O

Total	O
DNA	O
amount	O
was	O
adjusted	O
with	O
pcDNA4	O
.	O

Control	O
siRNA	O
or	O
siRNA	O
targeting	O
wtOGT	O
(	O
10	O
nM	O
)	O
was	O
cotransfected	O
,	O
and	O
the	O
luciferase	O
activity	O
was	O
measured	O
.	O

The	O
values	O
were	O
adjusted	O
to	O
the	O
total	O
amount	O
of	O
protein	O
and	O
indicate	O
the	O
means	O
±	O
standard	O
deviations	O
from	O
triplicate	O
determinations	O
.	O

The	O
results	O
are	O
presented	O
in	O
terms	O
of	O
percentages	O
of	O
control	O
(	O
Sp1-induced	O
LTR	O
activity	O
)	O
.	O

Applying	O
these	O
tools	O
to	O
test	O
the	O
effect	O
of	O
Sp1	O
O-GlcNAcylation	O
on	O
HIV-1	O
LTR	O
,	O
we	O
showed	O
that	O
the	O
promoter	O
activity	O
(	O
Fig	O
.	O
8C	O
,	O
bar	O
4	O
)	O
was	O
strongly	O
reduced	O
after	O
overexpression	O
of	O
wtOGT	O
or	O
resOGT	O
(	O
Fig	O
.	O
8C	O
,	O
bars	O
5	O
and	O
6	O
)	O
.	O

Cotransfection	O
of	O
a	O
control	O
siRNA	O
targeting	O
GAPDH	O
had	O
no	O
impact	O
on	O
the	O
HIV-1	O
LTR	O
activity	O
(	O
Fig	O
.	O
8C	O
,	O
bars	O
7	O
and	O
8	O
)	O
.	O

Knockdown	O
of	O
wtOGT	O
restored	O
the	O
HIV-1	O
LTR	O
activity	O
(	O
Fig	O
.	O
8C	O
,	O
bar	O
9	O
)	O
,	O
whereas	O
resOGT	O
escaped	O
silencing	O
and	O
was	O
still	O
able	O
to	O
suppress	O
the	O
promoter	O
activity	O
(	O
Fig	O
.	O
8C	O
,	O
bar	O
10	O
)	O
.	O

These	O
findings	O
demonstrate	O
that	O
O-GlcNAcylation	O
of	O
Sp1	O
is	O
required	O
for	O
the	O
inhibition	O
of	O
the	O
HIV-1	O
LTR	O
promoter	O
by	O
OGT	O
.	O

In	O
all	O
previous	O
experiments	O
the	O
O-GlcNAcylation	O
level	O
was	O
increased	O
after	O
infection	O
with	O
HIV-1	O
.	O

Thus	C
,	C
we	C
aimed	C
to	C
investigate	C
whether	C
increased	C
OGT	C
expression	C
prior	C
to	C
infection	C
may	C
amplify	C
the	C
inhibitory	C
effects	C
on	C
HIV-1	C
transcription	C
in	C
lymphocytes	C
.	C

Jurkat	O
cells	O
were	O
stably	O
transfected	O
with	O
OGT	O
or	O
,	O
as	O
a	O
control	O
,	O
with	O
d2EGFP	O
.	O

Expression	O
of	O
recombinant	O
OGT	O
in	O
selected	O
clones	O
was	O
confirmed	O
by	O
RT-PCR	O
(	O
Fig	O
.	O
9A	O
)	O
.	O

The	O
stably	O
transfected	O
cells	O
were	O
infected	O
with	O
VSV-G	O
env	O
pseudotyped	O
HIV-1NL4-3LucR-E-	O
,	O
and	O
HIV-1	O
LTR	O
activity	O
was	O
determined	O
by	O
luciferase	O
assay	O
.	O

Of	O
note	O
,	O
HIV-1	O
LTR	O
activity	O
was	O
40-fold	O
lower	O
in	O
both	O
OGT-overexpressing	O
Jurkat	O
cell	O
clones	O
than	O
in	O
control	O
cells	O
expressing	O
d2EGFP	O
(	O
Fig	O
.	O
9B	O
)	O
.	O

These	O
results	O
demonstrate	O
that	O
OGT	O
is	O
a	O
potent	O
inhibitor	O
of	O
HIV-1	O
LTR	O
activity	O
.	O

OGT	O
overexpression	O
prior	O
to	O
infection	O
amplifies	O
the	O
inhibitory	O
effect	O
on	O
HIV-1	O
replication	O
.	O

(	O
A	O
)	O
Jurkat	O
cells	O
were	O
stably	O
transfected	O
with	O
plasmids	O
encoding	O
either	O
d2EGFP	O
or	O
OGT	O
.	O

Expression	O
of	O
recombinantly	O
expressed	O
OGT	O
mRNA	O
was	O
confirmed	O
by	O
RT-PCR	O
(	O
upper	O
panel	O
)	O
using	O
specific	O
primers	O
.	O

Amplification	O
of	O
GAPDH	O
served	O
as	O
a	O
loading	O
control	O
(	O
lower	O
panel	O
)	O
.	O

Cellular	O
cDNA	O
was	O
subjected	O
to	O
the	O
amplification	O
reactions	O
in	O
increasing	O
dilutions	O
:	O
undiluted	O
(	O
1	O
)	O
,	O
1:5	O
,	O
and	O
1:10	O
.	O

Control	O
reactions	O
were	O
carried	O
out	O
in	O
the	O
absence	O
of	O
reverse	O
transcriptase	O
(	O
-RT	O
)	O
with	O
undiluted	O
cDNA	O
template	O
.	O

(	O
B	O
)	O
Jurkat	O
cells	O
stably	O
expressing	O
d2EGFP	O
or	O
OGT	O
were	O
infected	O
with	O
VSV-G	O
env	O
pseudotyped	O
HIV-1NL4-3LucR-E-	O
.	O

Luciferase	O
activity	O
was	O
measured	O
48	O
h	O
after	O
infection	O
.	O

DISCUSSION	O

Regulation	O
of	O
gene	O
expression	O
by	O
nutrients	O
like	O
glucose	O
and	O
glucosamine	O
is	O
well	O
established	O
(	O
20	O
,	O
37	O
,	O
52	O
,	O
74	O
)	O
and	O
demonstrates	O
that	O
cellular	O
transcription	O
adapts	O
to	O
environmental	O
and	O
metabolic	O
changes	O
.	O

Viruses	O
critically	O
depend	O
on	O
the	O
host	O
cell	O
metabolism	O
(	O
29	O
)	O
.	O

This	O
directed	O
us	O
to	O
investigate	O
the	O
impact	O
of	O
the	O
monosaccharidic	O
metabolite	O
O-GlcNAc	O
on	O
HIV-1	O
gene	O
expression	O
.	O

We	O
showed	O
that	O
increased	O
O-GlcNAc	O
levels	O
inhibit	O
HIV-1	O
transcription	O
in	O
human	O
T-cell	O
lines	O
as	O
well	O
as	O
in	O
human	O
primary	O
CD4+	O
T	O
lymphocytes	O
.	O

This	C
effect	C
appeared	C
to	C
be	C
mediated	C
by	C
the	C
transcription	C
factor	C
Sp1	C
,	C
as	C
supported	C
by	C
several	C
lines	C
of	C
experimental	C
evidence	C
.	C

First	O
,	O
we	O
demonstrated	O
that	O
O-	O
GlcNAc-mediated	O
inhibition	O
of	O
HIV-1	O
transcription	O
required	O
the	O
presence	O
of	O
Sp1-binding	O
sites	O
in	O
the	O
HIV-1	O
LTR	O
promoter	O
.	O

The	O
Sp1-binding	O
sites	O
are	O
well	O
conserved	O
throughout	O
the	O
lentiviral	O
HIV-1	O
LTRs	O
(	O
18	O
)	O
,	O
and	O
mutation	O
of	O
one	O
or	O
more	O
Sp1-binding	O
sites	O
in	O
the	O
basal	O
HIV-1	O
LTR	O
promoter	O
leads	O
to	O
a	O
strong	O
delay	O
in	O
replication	O
in	O
human	O
peripheral	O
blood	O
lymphocytes	O
and	O
in	O
T-cell	O
lines	O
(	O
45	O
,	O
58	O
)	O
.	O

This	O
is	O
also	O
reflected	O
in	O
our	O
observations	O
that	O
mutation	O
of	O
the	O
Sp1-binding	O
sites	O
decreases	O
HIV-1	O
LTR	O
activity	O
in	O
transiently	O
and	O
stably	O
transfected	O
cells	O
.	O

But	O
although	O
Sp1-mutated	O
HIV-1	O
LTR	O
activity	O
was	O
still	O
measurable	O
and	O
inducible	O
,	O
no	O
significant	O
O-GlcNAc-mediated	O
inhibition	O
of	O
promoter	O
activity	O
was	O
observed	O
.	O

Second	O
,	O
the	O
presence	O
of	O
the	O
Sp1	O
protein	O
was	O
crucial	O
for	O
the	O
inhibitory	O
effect	O
of	O
O-GlcNAc	O
on	O
the	O
HIV-1	O
LTR	O
.	O

Inhibition	O
of	O
Sp1	O
expression	O
with	O
siRNA	O
completely	O
abolished	O
OGT-mediated	O
inhibition	O
of	O
HIV-1	O
LTR	O
activity	O
.	O

Interestingly	O
,	O
although	O
Sp1	O
is	O
implicated	O
in	O
the	O
activation	O
of	O
a	O
large	O
number	O
of	O
genes	O
,	O
depletion	O
of	O
the	O
ubiquitous	O
transcription	O
factor	O
did	O
not	O
induce	O
cytotoxicity	O
.	O

This	O
is	O
in	O
agreement	O
with	O
the	O
observation	O
of	O
Philipsen	O
and	O
coworkers	O
,	O
who	O
disrupted	O
the	O
mouse	O
Sp1	O
gene	O
and	O
found	O
that	O
Sp1-deficient	O
embryonic	O
stem	O
cells	O
were	O
viable	O
and	O
showed	O
normal	O
growth	O
characteristics	O
(	O
50	O
)	O
.	O

This	C
might	C
be	C
attributed	C
to	C
the	C
compensation	C
of	C
Sp1-triggered	C
gene	C
transcription	C
by	C
other	C
Sp	C
family	C
members	C
,	C
such	C
as	C
Sp3	C
,	C
which	C
is	C
also	C
ubiquitously	C
expressed	C
and	C
has	C
the	C
potential	C
to	C
activate	C
transcription	C
of	C
certain	C
otherwise	C
Sp1-regulated	C
promoters	C
(	C
70	C
)	C
.	C

Third	O
,	O
Sp1	O
was	O
found	O
to	O
be	O
O-GlcNAcylated	O
by	O
OGT	O
,	O
and	O
this	O
decreased	O
its	O
ability	O
to	O
activate	O
the	O
HIV-1	O
LTR	O
promoter	O
.	O

These	O
findings	O
are	O
in	O
accordance	O
with	O
the	O
results	O
of	O
Kudlow	O
and	O
colleagues	O
,	O
who	O
showed	O
that	O
O-GlcNAcylation	O
decreases	O
the	O
capability	O
of	O
Sp1	O
to	O
activate	O
GC-box-containing	O
promoters	O
(	O
77	O
)	O
.	O

But	O
it	O
has	O
to	O
be	O
emphasized	O
that	O
O-GlcNAcylation	O
of	O
Sp1	O
does	O
not	O
generally	O
inhibit	O
transcription	O
.	O

We	O
have	O
shown	O
here	O
that	O
the	O
human	O
EF1α	O
promoter	O
,	O
which	O
also	O
contains	O
Sp1-binding	O
sites	O
(	O
55	O
,	O
73	O
,	O
75	O
)	O
,	O
is	O
activated	O
by	O
O-GlcNAcylation	O
of	O
Sp1	O
.	O

Additionally	O
,	O
others	O
have	O
shown	O
that	O
the	O
expression	O
of	O
plasminogen	O
activator	O
inhibitor	O
1	O
(	O
14	O
,	O
19	O
,	O
20	O
)	O
,	O
calmodulin	O
(	O
38	O
)	O
,	O
and	O
argininosuccinate	O
synthetase	O
(	O
6	O
,	O
7	O
)	O
is	O
also	O
increased	O
by	O
Sp1	O
O-GlcNAcylation	O
.	O

Thus	O
,	O
O-GlcNAcylation	O
of	O
Sp1	O
differentially	O
modulates	O
gene	O
expression	O
.	O

These	C
differential	C
effects	C
may	C
depend	C
not	C
only	C
on	C
the	C
individual	C
composition	C
of	C
the	C
transcription	C
complexes	C
at	C
different	C
promoters	C
but	C
also	C
on	C
differential	C
Sp1	C
O-GlcNAcylation	C
patterns	C
in	C
different	C
transcription	C
complexes	C
.	C

The	C
latter	C
is	C
supported	C
by	C
the	C
fact	C
that	C
transcriptional	C
corepressors	C
recruit	C
OGT	C
to	C
promoters	C
(	C
78	C
)	C
,	C
indicating	C
that	C
O-GlcNAcylation	C
is	C
modulated	C
directly	C
at	C
the	C
promoter	C
site	C
.	C

Furthermore	O
,	O
it	O
has	O
been	O
shown	O
that	O
phosphorylation	O
of	O
distinct	O
residues	O
differentially	O
regulates	O
Sp1	O
activity	O
(	O
5	O
,	O
10	O
,	O
11	O
)	O
.	O

As	C
O-GlcNAcylation	C
appears	C
to	C
have	C
a	C
yin-yang	C
relationship	C
with	C
phosphorylation	C
,	C
the	C
same	C
may	C
apply	C
for	C
O-GlcNAcylation	C
.	C

Several	C
mechanisms	C
have	C
been	C
suggested	C
for	C
how	C
O-GlcNAcylation	C
of	C
Sp1	C
inhibits	C
promoter	C
activity	C
.	C

For	O
example	O
,	O
O-GlcNAcylation	O
reduces	O
the	O
ability	O
of	O
Sp1	O
to	O
homomultimerize	O
and	O
to	O
interact	O
with	O
transcriptional	O
coactivator	O
TATA-binding	O
protein-associated	O
factor	O
II	O
110	O
(	O
TAFII110	O
)	O
(	O
62	O
,	O
77	O
)	O
.	O

These	O
mechanisms	O
are	O
in	O
accordance	O
with	O
our	O
findings	O
that	O
O-GlcNAcylated	O
Sp1	O
localizes	O
at	O
the	O
HIV-1	O
LTR	O
promoter	O
and	O
does	O
not	O
exhibit	O
a	O
decreased	O
DNA-binding	O
activity	O
.	O

Furthermore	C
,	C
O-GlcNAcylated	C
Sp1	C
seems	C
to	C
act	C
additionally	C
as	C
a	C
repressor	C
of	C
HIV-1	C
transcription	C
,	C
as	C
the	C
presence	C
of	C
the	C
Sp1-binding	C
sites	C
in	C
the	C
HIV-1	C
LTR	C
is	C
crucial	C
for	C
the	C
inhibitory	C
effect	C
of	C
OGT	C
.	C

The	C
HIV-1	C
LTR	C
promoter	C
containing	C
only	C
functional	C
NF-κB-binding	C
sites	C
but	C
mutated	C
Sp1-binding	C
sites	C
(	C
LTR-κB-Sp1mut	C
)	C
was	C
activated	C
by	C
OGT	C
overexpression	C
,	C
indicating	C
that	C
O-GlcNAcylation	C
of	C
NF-κB	C
increases	C
the	C
transcription	C
rate	C
from	C
the	C
LTR-κB-Sp1mut	C
promoter	C
.	C

Accordingly	C
,	C
O-GlcNAcylation	C
of	C
NF-κB	C
has	C
been	C
described	C
and	C
it	C
was	C
suggested	C
to	C
enhance	C
the	C
nuclear	C
translocation	C
of	C
NF-κB	C
(	C
21	C
)	C
.	C

However	O
,	O
the	O
transcription	O
of	O
the	O
wild-type	O
HIV-1	O
LTR	O
(	O
LTR-κB-Sp1wt	O
)	O
containing	O
both	O
NF-κB-	O
and	O
Sp1-binding	O
sites	O
was	O
inhibited	O
by	O
O-GlcNAcylation	O
of	O
Sp1	O
.	O

This	C
indicates	C
that	C
O-GlcNAcylation	C
of	C
Sp1	C
inhibits	C
the	C
activity	C
of	C
the	C
HIV-1	C
LTR	C
in	C
a	C
dominant	C
manner	C
.	C

Unlike	C
the	C
NF-κB-binding	C
sites	C
,	C
the	C
Sp1-binding	C
sites	C
are	C
well	C
conserved	C
throughout	C
primate	C
lentiviral	C
LTRs	C
(	C
18	C
,	C
79	C
)	C
,	C
suggesting	C
a	C
conserved	C
regulation	C
of	C
Sp1-mediated	C
gene	C
transcription	C
for	C
lentiviral	C
LTRs	C
,	C
which	C
is	C
probably	C
dominant	C
over	C
NF-κB	C
regulation	C
.	C

Furthermore	C
,	C
the	C
dominant	C
effect	C
of	C
Sp1	C
over	C
NF-κB	C
might	C
be	C
attributed	C
to	C
the	C
synergistic	C
mode	C
of	C
action	C
of	C
both	C
transcription	C
factors	C
on	C
the	C
HIV-1	C
LTR	C
(	C
59	C
,	C
60	C
)	C
.	C

A	C
potential	C
molecular	C
mechanism	C
for	C
the	C
dominant	C
repressive	C
effect	C
of	C
O-GlcNAcylated	C
Sp1	C
on	C
the	C
HIV-1	C
LTR	C
relies	C
on	C
the	C
ability	C
of	C
Sp1	C
to	C
recruit	C
corepressors	C
to	C
the	C
promoter	C
.	C

It	O
has	O
been	O
reported	O
that	O
Sp1	O
can	O
act	O
as	O
an	O
anchor	O
site	O
for	O
a	O
repressor	O
complex	O
consisting	O
of	O
histone	O
deacetylases	O
and	O
mSin3a	O
(	O
82	O
)	O
.	O

Intriguingly	O
,	O
Sp1	O
has	O
also	O
been	O
detected	O
in	O
a	O
DNA-protein	O
complex	O
with	O
c-Myc	O
and	O
histone	O
deacetylase	O
1	O
at	O
the	O
HIV-1	O
LTR	O
,	O
and	O
it	O
has	O
been	O
shown	O
that	O
this	O
complex	O
is	O
involved	O
in	O
the	O
establishment	O
of	O
proviral	O
latency	O
(	O
33	O
)	O
.	O

Thus	C
,	C
O-GlcNAcylation	C
of	C
Sp1	C
might	C
quickly	C
put	C
initiated	C
viral	C
replication	C
into	C
a	C
state	C
of	C
latency	C
.	C

Most	C
importantly	C
,	C
increased	C
O-GlcNAcylation	C
of	C
Sp1	C
prior	C
to	C
HIV-1	C
infection	C
might	C
efficiently	C
prevent	C
the	C
onset	C
of	C
viral	C
replication	C
.	C

This	O
is	O
supported	O
by	O
the	O
fact	O
that	O
stable	O
overexpression	O
of	O
OGT	O
strongly	O
inhibited	O
replication	O
of	O
HIV-1	O
in	O
de	O
novo-infected	O
lymphocytes	O
.	O

Altogether	C
,	C
these	C
results	C
suggest	C
that	C
O-GlcNAcylated	C
Sp1	C
efficiently	C
inhibits	C
gene	C
expression	C
from	C
the	C
HIV-1	C
LTR	C
and	C
may	C
be	C
involved	C
in	C
the	C
regulation	C
of	C
the	C
viral	C
life	C
cycle	C
.	C

Many	O
reports	O
have	O
evaluated	O
the	O
effect	O
of	O
highly	O
active	O
antiretroviral	O
therapy	O
(	O
HAART	O
)	O
on	O
glucose	O
metabolism	O
(	O
15	O
,	O
17	O
,	O
49	O
)	O
and	O
the	O
appearance	O
of	O
diabetes	O
as	O
a	O
consequence	O
of	O
HAART	O
(	O
40	O
,	O
51	O
)	O
.	O

But	O
up	O
to	O
now	O
,	O
no	O
studies	O
have	O
investigated	O
the	O
effect	O
of	O
glucose	O
metabolism	O
on	O
HIV-1	O
replication	O
.	O

Our	C
results	C
indicate	C
that	C
the	C
O-GlcNAc	C
level	C
,	C
and	C
thus	C
the	C
glucose	C
metabolism	C
,	C
may	C
influence	C
the	C
life	C
cycle	C
of	C
HIV-1	C
.	C

Accordingly	C
,	C
inducers	C
of	C
Sp1	C
O-GlcNAcylation	C
such	C
as	C
GlcN	C
and	C
2-deoxyglucose	C
,	C
which	C
are	C
approved	C
in	C
clinical	C
treatment	C
of	C
osteoarthritis	C
and	C
human	C
genital	C
herpes	C
infections	C
,	C
respectively	C
(	C
3	C
,	C
61	C
)	C
,	C
may	C
support	C
HAART	C
.	C

The	C
establishment	C
of	C
a	C
metabolic	C
treatment	C
may	C
supplement	C
the	C
repertoire	C
of	C
antiretroviral	C
therapies	C
against	C
AIDS	C
.	C

Inactivation	O
of	O
Drosophila	O
Huntingtin	O
affects	O
long-term	O
adult	O
functioning	O
and	O
the	O
pathogenesis	O
of	O
a	O
Huntington’s	O
disease	O
model	O

SUMMARY	O

A	C
polyglutamine	C
expansion	C
in	C
the	C
huntingtin	C
(	C
HTT	C
)	C
gene	C
causes	C
neurodegeneration	C
in	C
Huntington’s	C
disease	C
(	C
HD	C
)	C
,	C
but	C
the	C
in	C
vivo	C
function	C
of	C
the	C
native	C
protein	C
(	C
Htt	C
)	C
is	C
largely	C
unknown	C
.	C

Numerous	C
biochemical	C
and	C
in	C
vitro	C
studies	C
have	C
suggested	C
a	C
role	C
for	C
Htt	C
in	C
neuronal	C
development	C
,	C
synaptic	C
function	C
and	C
axonal	C
trafficking	C
.	C

To	O
test	O
these	O
models	O
,	O
we	O
generated	O
a	O
null	O
mutant	O
in	O
the	O
putative	O
Drosophila	O
HTT	O
homolog	O
(	O
htt	O
,	O
hereafter	O
referred	O
to	O
asdhtt	O
)	O
and	O
,	O
surprisingly	O
,	O
found	O
that	O
dhtt	O
mutant	O
animals	O
are	O
viable	O
with	O
no	O
obvious	O
developmental	O
defects	O
.	O

Instead	O
,	O
dhtt	O
is	O
required	O
for	O
maintaining	O
the	O
mobility	O
and	O
long-term	O
survival	O
of	O
adult	O
animals	O
,	O
and	O
for	O
modulating	O
axonal	O
terminal	O
complexity	O
in	O
the	O
adult	O
brain	O
.	O

Furthermore	C
,	C
removing	C
endogenous	C
dhtt	C
significantly	C
accelerates	C
the	C
neurodegenerative	C
phenotype	C
associated	C
with	C
a	C
Drosophila	C
model	C
of	C
polyglutamine	C
Htt	C
toxicity	C
(	C
HD-Q93	C
)	C
,	C
providing	C
in	C
vivo	C
evidence	C
that	C
disrupting	C
the	C
normal	C
function	C
of	C
Htt	C
might	C
contribute	C
to	C
HD	C
pathogenesis	C
.	C

INTRODUCTION	O

Huntington’s	O
disease	O
(	O
HD	O
)	O
is	O
an	O
autosomal	O
dominant	O
,	O
progressive	O
neurodegenerative	O
disorder	O
characterized	O
clinically	O
by	O
deteriorating	O
choreic	O
movements	O
,	O
psychiatric	O
disturbances	O
and	O
cognitive	O
deficits	O
(	O
Gusella	O
and	O
MacDonald	O
,	O
1995	O
;	O
Martin	O
and	O
Gusella	O
,	O
1986	O
;	O
Vonsattel	O
et	O
al.	O
,	O
1985	O
)	O
.	O

HD	O
is	O
caused	O
by	O
an	O
abnormal	O
expansion	O
of	O
a	O
polyglutamine	O
(	O
polyQ	O
)	O
tract	O
at	O
the	O
N-terminus	O
of	O
a	O
large	O
cytoplasmic	O
protein	O
,	O
huntingtin	O
(	O
Htt	O
)	O
(	O
The	O
Huntington’s	O
Disease	O
Collaborative	O
Research	O
Group	O
,	O
1993	O
)	O
.	O

The	O
polyQ	O
tract	O
contains	O
between	O
6	O
and	O
35	O
repeats	O
in	O
the	O
wild-type	O
Htt	O
protein	O
,	O
whereas	O
it	O
is	O
expanded	O
to	O
beyond	O
36	O
repeats	O
in	O
HD	O
(	O
The	O
Huntington’s	O
Disease	O
Collaborative	O
Research	O
Group	O
,	O
1993	O
)	O
.	O

Numerous	O
studies	O
have	O
demonstrated	O
that	O
mutant	O
Htt	O
containing	O
an	O
expanded	O
polyQ	O
tract	O
is	O
toxic	O
to	O
neurons	O
(	O
Cattaneo	O
et	O
al.	O
,	O
2001	O
;	O
Gusella	O
and	O
MacDonald	O
,	O
2000	O
)	O
.	O

PolyQ	O
expansion	O
is	O
also	O
linked	O
to	O
at	O
least	O
eight	O
other	O
neurodegenerative	O
disorders	O
,	O
collectively	O
referred	O
to	O
as	O
polyQ	O
diseases	O
(	O
Riley	O
and	O
Orr	O
,	O
2006	O
;	O
Zoghbi	O
and	O
Orr	O
,	O
2000	O
)	O
.	O

Although	C
Htt	C
is	C
ubiquitously	C
expressed	C
in	C
the	C
brain	C
,	C
HD	C
mainly	C
affects	C
medium-sized	C
spiny	C
neurons	C
in	C
the	C
striatum	C
and	C
to	C
a	C
lesser	C
extent	C
cortical	C
pyramidal	C
neurons	C
that	C
project	C
to	C
the	C
striatum	C
,	C
suggesting	C
that	C
other	C
cellular	C
factors	C
also	C
contribute	C
to	C
pathogenesis	C
(	C
Cattaneo	C
et	C
al.	C
,	C
2001	C
;	C
Vonsattel	C
and	C
DiFiglia	C
,	C
1998	C
)	C
.	C

Recent	C
studies	C
indicate	C
that	C
an	C
alteration	C
of	C
wild-type	C
Htt	C
function	C
might	C
contribute	C
to	C
this	C
specificity	C
and	C
to	C
subsequent	C
disease	C
progression	C
(	C
Cattaneo	C
et	C
al.	C
,	C
2001	C
)	C
.	C

For	O
example	O
,	O
mutant	O
Htt	O
can	O
sequester	O
wild-type	O
Htt	O
into	O
insoluble	O
aggregates	O
,	O
thereby	O
exerting	O
a	O
dominant	O
negative	O
effect	O
(	O
Huang	O
et	O
al.	O
,	O
1998	O
;	O
Kazantsev	O
et	O
al.	O
,	O
1999	O
;	O
Narain	O
et	O
al.	O
,	O
1999	O
;	O
Preisinger	O
et	O
al.	O
,	O
1999	O
;	O
Wheeler	O
et	O
al.	O
,	O
2000	O
)	O
.	O

In	O
addition	O
,	O
wild-type	O
Htt	O
can	O
suppress	O
the	O
cell	O
death	O
induced	O
by	O
mutant	O
polyQ-expanded	O
Htt	O
in	O
vitro	O
(	O
Leavitt	O
et	O
al.	O
,	O
2001	O
;	O
Van	O
Raamsdonk	O
et	O
al.	O
,	O
2005	O
)	O
.	O

Furthermore	C
,	C
wild-type	C
Htt	C
is	C
proposed	C
to	C
have	C
a	C
neuroprotective	C
role	C
as	C
expression	C
of	C
Htt	C
can	C
protect	C
cultured	C
striatal	C
neurons	C
from	C
stress-	C
and	C
toxin-mediated	C
cell	C
death	C
(	C
Rigamonti	C
et	C
al.	C
,	C
2000	C
)	C
.	C

Since	O
its	O
identification	O
,	O
the	O
normal	O
function	O
of	O
Htt	O
has	O
been	O
subject	O
to	O
extensive	O
investigation	O
(	O
Cattaneo	O
et	O
al.	O
,	O
2001	O
;	O
Harjes	O
and	O
Wanker	O
,	O
2003	O
)	O
.	O

The	O
murine	O
Htt	O
homolog	O
(	O
also	O
known	O
as	O
Hdh	O
)	O
is	O
essential	O
during	O
early	O
mouse	O
development	O
,	O
as	O
Htt-null	O
mice	O
die	O
during	O
gastrulation	O
at	O
embryonic	O
day	O
7.5	O
(	O
Duyao	O
et	O
al.	O
,	O
1995	O
;	O
Nasir	O
et	O
al.	O
,	O
1995	O
;	O
Zeitlin	O
et	O
al.	O
,	O
1995	O
)	O
.	O

Chimeric	C
analysis	C
demonstrated	C
that	C
the	C
early	C
embryonic	C
lethality	C
is	C
the	C
result	C
of	C
a	C
crucial	C
role	C
of	C
Hdh	C
in	C
extraembryonic	C
membranes	C
,	C
as	C
this	C
lethality	C
can	C
be	C
rescued	C
by	C
providing	C
wild-type	C
Hdh	C
function	C
in	C
extraembryonic	C
tissue	C
(	C
Dragatsis	C
et	C
al.	C
,	C
1998	C
)	C
.	C

Conditional	C
knockout	C
of	C
Hdh	C
in	C
the	C
mouse	C
forebrain	C
at	C
postnatal	C
or	C
late	C
embryonic	C
stages	C
causes	C
a	C
progressive	C
neurodegenerative	C
phenotype	C
,	C
lending	C
support	C
to	C
the	C
hypothesis	C
that	C
depletion	C
of	C
normal	C
Htt	C
activity	C
during	C
disease	C
progression	C
contributes	C
to	C
HD	C
pathogenesis	C
(	C
Dragatsis	C
et	C
al.	C
,	C
2000	C
)	C
.	C

A	C
more	C
recent	C
study	C
in	C
zebrafish	C
,	C
which	C
used	C
morpholino	C
oligos	C
to	C
transiently	C
knockdown	C
endogenous	C
Htt	C
,	C
suggests	C
that	C
Htt	C
has	C
a	C
role	C
in	C
normal	C
blood	C
function	C
and	C
iron	C
utilization	C
(	C
Lumsden	C
et	C
al.	C
,	C
2007	C
)	C
.	C

Currently	O
,	O
little	O
is	O
known	O
about	O
the	O
normal	O
biological	O
function	O
of	O
wild-type	O
Htt	O
(	O
Cattaneo	O
et	O
al.	O
,	O
2005	O
)	O
.	O

Htt	O
encodes	O
a	O
large	O
cytoplasmic	O
protein	O
of	O
350	O
kDa	O
.	O

Structural	O
analysis	O
of	O
Htt	O
proteins	O
identified	O
the	O
presence	O
of	O
many	O
HEAT	O
(	O
huntingtin	O
,	O
elongation	O
factor	O
3	O
,	O
the	O
A	O
subunit	O
of	O
protein	O
phosphatase	O
2A	O
and	O
TOR1	O
)	O
repeats	O
,	O
which	O
are	O
approximately	O
40-amino	O
acid	O
(	O
a.a.	O
)	O
long	O
structural	O
motifs	O
,	O
composed	O
of	O
two	O
anti-parallel	O
helices	O
,	O
of	O
unknown	O
function	O
(	O
Andrade	O
and	O
Bork	O
,	O
1995	O
)	O
.	O

No	C
other	C
domains	C
have	C
been	C
identified	C
in	C
Htt	C
to	C
suggest	C
a	C
biological	C
function	C
for	C
the	C
protein	C
.	C

Functional	O
studies	O
in	O
mammalian	O
systems	O
,	O
mainly	O
from	O
protein	O
interaction	O
assays	O
,	O
have	O
associated	O
Htt	O
with	O
diverse	O
cellular	O
processes	O
including	O
:	O
endocytosis	O
;	O
modulation	O
of	O
synapse	O
structure	O
and	O
synaptic	O
transmission	O
;	O
transcriptional	O
regulation	O
,	O
especially	O
of	O
the	O
brain-derived	O
neurotrophic	O
factor	O
(	O
BDNF	O
)	O
which	O
is	O
essential	O
for	O
the	O
survival	O
of	O
the	O
striatal	O
neurons	O
affected	O
in	O
HD	O
;	O
axonal	O
transport	O
of	O
BDNF	O
and	O
vesicles	O
;	O
and	O
apoptosis	O
(	O
Cattaneo	O
et	O
al.	O
,	O
2001	O
;	O
Cattaneo	O
et	O
al.	O
,	O
2005	O
;	O
Harjes	O
and	O
Wanker	O
,	O
2003	O
;	O
Zuccato	O
et	O
al.	O
,	O
2001	O
;	O
Zuccato	O
and	O
Cattaneo	O
,	O
2007	O
)	O
.	O

Importantly	O
,	O
only	O
a	O
few	O
of	O
these	O
proposed	O
functions	O
of	O
Htt	O
have	O
been	O
directly	O
tested	O
in	O
vivo	O
owing	O
to	O
the	O
early	O
embryonic	O
lethality	O
associated	O
with	O
Htt-null	O
mutant	O
mice	O
.	O

In	O
an	O
extensive	O
search	O
for	O
Htt	O
homologs	O
in	O
other	O
species	O
,	O
Li	O
et	O
al	O
.	O
(	O
Li	O
et	O
al.	O
,	O
1999	O
)	O
identified	O
a	O
single	O
HTT	O
homolog	O
in	O
Drosophila	O
(	O
htt	O
,	O
hereafter	O
referred	O
to	O
as	O
dhtt	O
)	O
.	O

By	O
sequence	O
comparison	O
,	O
the	O
homologous	O
regions	O
between	O
Drosophila	O
and	O
human	O
Htt	O
proteins	O
are	O
mainly	O
located	O
within	O
five	O
discrete	O
areas	O
,	O
including	O
three	O
relatively	O
large	O
continuous	O
regions	O
and	O
two	O
small	O
segments	O
,	O
that	O
cover	O
about	O
one-third	O
of	O
the	O
total	O
protein	O
length	O
(	O
supplementary	O
material	O
Fig	O
.	O
S1A	O
)	O
.	O

At	O
the	O
amino	O
acid	O
level	O
,	O
these	O
homologous	O
regions	O
,	O
which	O
are	O
comprised	O
of	O
about	O
1200	O
a.a.	O
residues	O
in	O
Drosophila	O
Htt	O
(	O
dHtt	O
)	O
,	O
share	O
around	O
24	O
%	O
identity	O
and	O
49	O
%	O
similarity	O
(	O
Li	O
et	O
al.	O
,	O
1999	O
)	O
.	O

In	C
addition	C
to	C
the	C
sequence	C
similarity	C
,	C
other	C
shared	C
features	C
support	C
the	C
proposal	C
that	C
the	C
Drosophila	C
gene	C
identified	C
in	C
the	C
study	C
by	C
Li	C
et	C
al	C
.	C
is	C
indeed	C
the	C
fly	C
homolog	C
of	C
human	C
Htt	C
(	C
Li	C
et	C
al.	C
,	C
1999	C
)	C
.	C

For	O
example	O
,	O
in	O
terms	O
of	O
the	O
protein	O
size	O
,	O
both	O
the	O
Drosophila	O
and	O
human	O
Htt	O
proteins	O
are	O
unusually	O
large	O
and	O
contain	O
3583	O
and	O
3144	O
a.a.	O
residues	O
,	O
respectively	O
(	O
Li	O
et	O
al.	O
,	O
1999	O
)	O
.	O

In	O
addition	O
,	O
the	O
regions	O
with	O
a	O
relatively	O
high	O
level	O
of	O
conservation	O
are	O
not	O
only	O
clustered	O
in	O
large	O
continuous	O
stretches	O
,	O
but	O
are	O
also	O
located	O
in	O
the	O
same	O
order	O
and	O
distributed	O
over	O
the	O
entire	O
length	O
of	O
the	O
proteins	O
.	O

Moreover	O
,	O
dhtt	O
and	O
mammalian	O
HD	O
genes	O
share	O
similar	O
patterns	O
of	O
gene	O
expression	O
(	O
Li	O
et	O
al.	O
,	O
1999	O
)	O
(	O
Fig	O
.	O
1	O
)	O
.	O

Interestingly	O
,	O
although	O
an	O
HTT	O
homolog	O
exists	O
in	O
Drosophila	O
,	O
no	O
HTT-like	O
gene	O
has	O
been	O
found	O
in	O
other	O
less	O
complex	O
eukaryote	O
species	O
such	O
as	O
C.	O
elegans	O
or	O
the	O
yeast	O
S.	O
cerevisiae	O
(	O
Li	O
et	O
al.	O
,	O
1999	O
)	O
.	O

Ubiquitous	O
expression	O
of	O
dhtt	O
in	O
Drosophila	O
.	O

(	O
A–F	O
)	O
dhtt	O
is	O
widely	O
expressed	O
at	O
a	O
low	O
level	O
during	O
Drosophila	O
development	O
,	O
as	O
revealed	O
by	O
whole-mount	O
in	O
situ	O
hybridization	O
.	O

(	O
A	O
,	O
B	O
)	O
Stage	O
15	O
Drosophila	O
embryos	O
stained	O
with	O
digoxigenin	O
(	O
DIG	O
)	O
-labeled	O
dhtt	O
antisense	O
probes	O
revealed	O
the	O
low-level	O
and	O
ubiquitous	O
expression	O
of	O
the	O
dhtt	O
transcript	O
(	O
A	O
)	O
;	O
control	O
embryos	O
at	O
the	O
corresponding	O
stage	O
,	O
which	O
were	O
stained	O
with	O
dhtt	O
sense	O
probes	O
,	O
showed	O
only	O
minimal	O
background	O
signals	O
(	O
B	O
)	O
.	O

All	O
embryos	O
are	O
lateral	O
views	O
,	O
anterior	O
to	O
the	O
left	O
and	O
dorsal	O
side	O
up	O
.	O

(	O
C–F	O
)	O
Third	O
instar	O
larval	O
tissues	O
hybridized	O
with	O
dhtt	O
antisense	O
probes	O
.	O

Low-level	O
and	O
ubiquitous	O
dhtt	O
expression	O
was	O
observed	O
in	O
the	O
brain	O
(	O
C	O
)	O
,	O
wing	O
and	O
leg	O
(	O
D	O
)	O
and	O
eye	O
imaginal	O
discs	O
(	O
E	O
)	O
.	O

(	O
F	O
)	O
A	O
negative	O
in	O
situ	O
control	O
–	O
an	O
eye	O
imaginal	O
disc	O
from	O
a	O
dhtt	O
deletion	O
mutant	O
stained	O
in	O
parallel	O
–	O
showed	O
only	O
minimal	O
background	O
signals	O
.	O

(	O
G–K	O
)	O
The	O
dHtt	O
protein	O
predominantly	O
localizes	O
to	O
the	O
cytoplasm	O
.	O

(	O
G	O
,	O
H	O
)	O
In	O
transfected	O
Drosophila	O
S2	O
cells	O
,	O
ectopically	O
expressed	O
dHtt	O
protein	O
(	O
green	O
)	O
was	O
found	O
predominantly	O
in	O
the	O
cytoplasm	O
;	O
it	O
was	O
also	O
found	O
on	O
cellular	O
protrusions	O
,	O
but	O
was	O
mostly	O
excluded	O
from	O
the	O
nucleus	O
.	O

(	O
G	O
)	O
Overlaying	O
images	O
of	O
the	O
S2	O
cells	O
co-stained	O
with	O
phalloidin	O
(	O
red	O
)	O
,	O
which	O
detects	O
F–actin	O
,	O
and	O
the	O
DNA	O
dye	O
DAPI	O
(	O
blue	O
)	O
reveal	O
the	O
overall	O
cell	O
morphology	O
and	O
the	O
cell	O
nuclei	O
,	O
respectively	O
.	O

(	O
I–K	O
)	O
Cytoplasmic	O
localization	O
of	O
the	O
dHtt	O
protein	O
(	O
green	O
)	O
ectopically	O
expressed	O
in	O
Drosophila	O
third	O
instar	O
larval	O
imaginal	O
disc	O
tissues	O
.	O

(	O
I	O
)	O
The	O
anti-dHtt	O
antibody	O
can	O
recognize	O
overexpressed	O
dHtt	O
in	O
the	O
patched	O
expression	O
domain	O
driven	O
by	O
patched-Gal4	O
and	O
shows	O
the	O
characteristic	O
striped	O
dHtt	O
expression	O
pattern	O
in	O
the	O
middle	O
of	O
the	O
wing	O
and	O
leg	O
imaginal	O
discs	O
.	O

Genotype	O
:	O
patched-Gal4/+	O
>	O
UAS-dhtt/+	O
.	O

(	O
J	O
,	O
K	O
)	O
High-magnification	O
view	O
of	O
an	O
eye	O
imaginal	O
disc	O
with	O
ectopically	O
expressed	O
dHtt	O
protein	O
[	O
green	O
(	O
J	O
)	O
]	O
,	O
which	O
shows	O
a	O
mainly	O
cytoplasmic	O
localization	O
.	O

(	O
K	O
)	O
Overlaying	O
images	O
of	O
the	O
same	O
eye	O
disc	O
region	O
co-stained	O
with	O
DAPI	O
(	O
red	O
)	O
to	O
reveal	O
the	O
cell	O
nuclei	O
.	O

Genotype	O
:	O
GMR-Gal4/+	O
>	O
UAS-dhtt/+	O
.	O

The	O
identification	O
of	O
a	O
Drosophila	O
Htt	O
homolog	O
provides	O
a	O
unique	O
opportunity	O
to	O
evaluate	O
the	O
role	O
of	O
Htt	O
in	O
this	O
well-established	O
genetic	O
model	O
system	O
.	O

Several	O
cellular	O
processes	O
implicated	O
in	O
Htt	O
function	O
,	O
including	O
axonal	O
transport	O
and	O
synapse	O
formation	O
,	O
have	O
been	O
well-characterized	O
in	O
Drosophila	O
,	O
allowing	O
an	O
in	O
vivo	O
evaluation	O
of	O
their	O
relationship	O
with	O
Htt	O
.	O

Further	O
,	O
as	O
fly	O
models	O
of	O
HD	O
have	O
been	O
well-established	O
,	O
this	O
model	O
allows	O
an	O
in	O
vivo	O
examination	O
of	O
the	O
function	O
of	O
endogenous	O
Htt	O
in	O
HD	O
pathogenesis	O
(	O
Marsh	O
and	O
Thompson	O
,	O
2006	O
;	O
Steffan	O
et	O
al.	O
,	O
2001	O
)	O
.	O

In	O
this	O
study	O
,	O
we	O
report	O
the	O
isolation	O
of	O
a	O
dhtt	O
mutant	O
and	O
describe	O
its	O
phenotype	O
.	O

Further	O
,	O
we	O
examine	O
how	O
the	O
removal	O
of	O
endogenous	O
dhtt	O
affects	O
several	O
cellular	O
processes	O
that	O
have	O
previously	O
been	O
implicated	O
with	O
Htt	O
,	O
and	O
test	O
how	O
the	O
loss	O
of	O
endogenous	O
dhtt	O
affects	O
the	O
pathogenesis	O
associated	O
with	O
an	O
established	O
Drosophila	O
model	O
of	O
polyQ	O
toxicity	O
(	O
HD-Q93	O
)	O
.	O

RESULTS	O

HEAT	O
repeats	O
in	O
dHtt	O

Considering	O
the	O
limited	O
sequence	O
homology	O
between	O
mammalian	O
and	O
fly	O
Htt	O
,	O
it	O
is	O
important	O
to	O
examine	O
the	O
extent	O
of	O
the	O
structural	O
similarity	O
between	O
these	O
proteins	O
.	O

In	O
the	O
Htt	O
family	O
proteins	O
,	O
the	O
HEAT	O
repeat	O
is	O
the	O
only	O
identifiable	O
structural	O
motif	O
(	O
Andrade	O
and	O
Bork	O
,	O
1995	O
;	O
Cattaneo	O
et	O
al.	O
,	O
2005	O
)	O
.	O

A	O
previous	O
phylogenetic	O
study	O
identified	O
16	O
HEAT	O
repeats	O
in	O
human	O
Htt	O
and	O
,	O
notably	O
,	O
14	O
of	O
these	O
16	O
repeats	O
were	O
also	O
found	O
in	O
insect	O
Htt	O
proteins	O
including	O
dHtt	O
(	O
Tartari	O
et	O
al.	O
,	O
2008	O
)	O
.	O

A	O
less	O
stringent	O
structural	O
analysis	O
predicted	O
up	O
to	O
40	O
HEAT	O
repeats	O
(	O
including	O
the	O
AAA	O
,	O
ADB	O
and	O
IMB	O
subgroups	O
)	O
in	O
human	O
Htt	O
(	O
see	O
Methods	O
)	O
.	O

Interestingly	O
,	O
using	O
the	O
same	O
parameter	O
,	O
38	O
HEAT	O
repeats	O
could	O
be	O
identified	O
in	O
dHtt	O
(	O
see	O
supplementary	O
material	O
Fig	O
.	O
S1	O
for	O
details	O
of	O
the	O
predicted	O
HEAT	O
repeats	O
)	O
.	O

Further	O
,	O
these	O
HEAT	O
repeats	O
span	O
the	O
entire	O
length	O
of	O
each	O
protein	O
and	O
have	O
a	O
similar	O
distribution	O
,	O
clustering	O
in	O
four	O
groups	O
at	O
the	O
N-	O
,	O
middle-	O
and	O
C-terminal	O
regions	O
,	O
which	O
have	O
a	O
large	O
overlap	O
with	O
their	O
segments	O
of	O
homologous	O
sequences	O
(	O
supplementary	O
material	O
Fig	O
.	O
S1B	O
)	O
.	O

Although	C
further	C
studies	C
are	C
needed	C
to	C
elucidate	C
the	C
structure	C
of	C
the	C
Htt	C
proteins	C
,	C
this	C
rather	C
remarkable	C
similarity	C
raises	C
the	C
possibility	C
of	C
a	C
conserved	C
secondary	C
structure	C
among	C
Htt	C
family	C
proteins	C
and	C
that	C
both	C
human	C
and	C
Drosophila	C
Htt	C
proteins	C
are	C
composed	C
largely	C
of	C
repeated	C
HEAT	C
motifs	C
.	C

Ubiquitous	O
expression	O
of	O
dhtt	O
in	O
Drosophila	O

Previous	O
analysis	O
has	O
shown	O
that	O
dhtt	O
is	O
widely	O
expressed	O
during	O
all	O
developmental	O
stages	O
from	O
embryos	O
to	O
adults	O
(	O
Li	O
et	O
al.	O
,	O
1999	O
)	O
.	O

We	O
confirmed	O
the	O
expression	O
of	O
the	O
dhtt	O
transcript	O
in	O
adults	O
using	O
reverse	O
transcription	O
(	O
RT	O
)	O
-PCR	O
(	O
data	O
not	O
shown	O
)	O
(	O
Fig	O
.	O
5C	O
)	O
.	O

To	O
examine	O
the	O
tissue-specific	O
dhtt	O
expression	O
,	O
we	O
performed	O
whole-mount	O
RNA	O
in	O
situ	O
hybridization	O
.	O

Staining	O
with	O
two	O
DIG-labeled	O
antisense	O
probes	O
,	O
targeting	O
different	O
regions	O
of	O
dhtt	O
,	O
revealed	O
similar	O
ubiquitous	O
dhtt	O
expression	O
at	O
different	O
stages	O
of	O
fly	O
embryogenesis	O
and	O
in	O
larval	O
tissues	O
(	O
Fig	O
.	O
1A–F	O
and	O
data	O
not	O
shown	O
)	O
,	O
whereas	O
a	O
positive	O
control	O
performed	O
in	O
parallel	O
gave	O
rise	O
to	O
robust	O
in	O
situ	O
signals	O
(	O
supplementary	O
material	O
Fig	O
.	O
S2	O
)	O
.	O

Importantly	O
,	O
of	O
the	O
two	O
negative	O
controls	O
included	O
in	O
the	O
assay	O
,	O
one	O
using	O
sense	O
dhtt	O
RNA	O
probes	O
on	O
wild-type	O
samples	O
(	O
Fig	O
.	O
1B	O
)	O
and	O
the	O
other	O
using	O
the	O
same	O
set	O
of	O
antisense	O
dhtt	O
RNA	O
probes	O
against	O
tissues	O
from	O
a	O
dhtt	O
deletion	O
mutant	O
that	O
had	O
been	O
generated	O
subsequently	O
(	O
Fig	O
.	O
1F	O
)	O
,	O
both	O
produced	O
much	O
weaker	O
background	O
signals	O
.	O

Together	C
,	C
these	C
data	C
indicate	C
that	C
dhtt	C
is	C
widely	C
expressed	C
at	C
low	C
levels	C
during	C
all	C
stages	C
of	C
Drosophila	C
development	C
.	C

Compromised	O
mobility	O
and	O
viability	O
of	O
aging	O
dhtt-ko	O
mutants	O
.	O

(	O
A	O
)	O
Spontaneous	O
locomotion	O
assay	O
.	O

dhtt-ko	O
mutants	O
show	O
normal	O
mobility	O
at	O
day	O
15	O
but	O
older	O
animals	O
show	O
significantly	O
reduced	O
mobility	O
.	O

(	O
B	O
)	O
Age-dependent	O
survival	O
rate	O
of	O
adult	O
animals	O
.	O

dhtt-ko	O
mutants	O
have	O
a	O
reduced	O
life	O
span	O
.	O

Both	O
the	O
mobility	O
and	O
viability	O
defects	O
in	O
dhtt-ko	O
mutants	O
were	O
rescued	O
by	O
the	O
presence	O
of	O
a	O
dhtt	O
genomic	O
minigene	O
construct	O
(	O
‘dhtt-ko	O
Rescue’	O
)	O
.	O

Flies	O
were	O
collected	O
from	O
at	O
least	O
three	O
different	O
batches	O
.	O

The	O
total	O
number	O
of	O
flies	O
counted	O
for	O
viability	O
quantification	O
were	O
:	O
wild	O
type	O
,	O
n=659	O
;	O
dhtt-ko	O
,	O
n	O
=1573	O
;	O
dhtt-ko	O
Rescue	O
,	O
n=804	O
;	O
elav-Gal4/+	O
;	O
dhtt-ko	O
,	O
n=550	O
.	O

The	O
difference	O
between	O
wild-type	O
and	O
dhtt-ko	O
flies	O
is	O
statistically	O
significant	O
,	O
P=0.0001	O
,	O
Student’s	O
t-test	O
.	O

The	O
difference	O
between	O
wild-type	O
and	O
dhtt-ko	O
Rescue	O
flies	O
is	O
not	O
statistically	O
significant	O
,	O
P=0.36	O
.	O

The	O
difference	O
between	O
wild-type	O
and	O
elav-Gal4/+	O
;	O
dhtt-ko	O
flies	O
is	O
statistically	O
significant	O
,	O
P	O
<	O
0.00001	O
.	O

The	O
data	O
in	O
(	O
A	O
,	O
B	O
)	O
are	O
presented	O
as	O
the	O
means±s.e.m	O
.	O

(	O
C	O
)	O
RT-PCR	O
analysis	O
confirmed	O
that	O
expression	O
of	O
endogenous	O
dhtt	O
was	O
lost	O
in	O
dhtt-ko	O
mutants	O
(	O
lane	O
3	O
)	O
but	O
was	O
restored	O
by	O
the	O
presence	O
of	O
the	O
dhtt	O
genomic	O
minigene	O
rescue	O
construct	O
(	O
lane	O
4	O
)	O
,	O
similar	O
to	O
that	O
in	O
wild-type	O
controls	O
(	O
lane	O
2	O
)	O
.	O

RT-PCR	O
was	O
performed	O
on	O
total	O
RNA	O
samples	O
extracted	O
from	O
adult	O
animals	O
of	O
each	O
of	O
the	O
indicated	O
genotypes	O
.	O

Primers	O
for	O
RT-PCR	O
were	O
located	O
in	O
adjacent	O
exons	O
in	O
the	O
control	O
rp49	O
gene	O
(	O
the	O
group	O
of	O
four	O
wells	O
on	O
the	O
left	O
)	O
or	O
in	O
neighboring	O
exons	O
at	O
the	O
N-terminal	O
(	O
targeting	O
exons	O
5	O
and	O
6	O
,	O
dhtt-N	O
)	O
,	O
middle	O
(	O
targeting	O
exons	O
13	O
and	O
15	O
,	O
dhtt-M	O
)	O
and	O
C-terminal	O
(	O
targeting	O
exons	O
23	O
and	O
24	O
,	O
dhtt-C	O
)	O
regions	O
of	O
the	O
dhtt	O
gene	O
(	O
see	O
Methods	O
)	O
.	O

The	O
lane	O
1s	O
are	O
controls	O
of	O
PCR	O
products	O
from	O
a	O
wild-type	O
genomic	O
DNA	O
template	O
using	O
these	O
primer	O
pairs	O
,	O
which	O
are	O
longer	O
than	O
the	O
RT-PCR	O
products	O
generated	O
by	O
the	O
same	O
pair	O
of	O
primers	O
owing	O
to	O
the	O
spliced-out	O
introns	O
,	O
thus	O
confirming	O
that	O
RT-PCR	O
products	O
were	O
indeed	O
amplified	O
from	O
transcribed	O
RNA	O
templates	O
.	O

w1118	O
:	O
wild-type	O
control	O
.	O

dHtt	O
is	O
a	O
cytoplasmic	O
protein	O

Mammalian	O
Htt	O
proteins	O
are	O
largely	O
cytoplasmic	O
with	O
a	O
widespread	O
expression	O
pattern	O
(	O
DiFiglia	O
et	O
al.	O
,	O
1995	O
;	O
Gutekunst	O
et	O
al.	O
,	O
1995	O
;	O
Sharp	O
et	O
al.	O
,	O
1995	O
)	O
.	O

To	O
determine	O
the	O
expression	O
and	O
subcellular	O
localization	O
of	O
the	O
endogenous	O
dHtt	O
protein	O
,	O
we	O
developed	O
an	O
affinity-purified	O
polyclonal	O
antibody	O
against	O
dHtt	O
.	O

The	O
specificity	O
of	O
this	O
antibody	O
was	O
confirmed	O
by	O
its	O
ability	O
to	O
recognize	O
ectopically	O
expressed	O
dHtt	O
protein	O
in	O
transfected	O
Drosophila	O
S2	O
cells	O
(	O
Fig	O
.	O
1G	O
,	O
H	O
)	O
and	O
larval	O
tissues	O
(	O
Fig	O
.	O
1I–K	O
)	O
.	O

When	O
the	O
dHtt	O
protein	O
was	O
ectopically	O
expressed	O
from	O
a	O
UAS-dhtt	O
transgene	O
by	O
using	O
a	O
patched-Gal4	O
driver	O
,	O
our	O
anti-dHtt	O
antibody	O
could	O
easily	O
detect	O
the	O
striped	O
pattern	O
of	O
dHtt	O
expression	O
in	O
the	O
middle	O
of	O
imaginal	O
discs	O
,	O
which	O
is	O
the	O
characteristic	O
domain	O
of	O
Patched	O
expression	O
(	O
Fig	O
.	O
1I	O
)	O
.	O

In	O
wild-type	O
animals	O
,	O
use	O
of	O
the	O
anti-dHtt	O
antibody	O
resulted	O
in	O
low-level	O
ubiquitous	O
staining	O
in	O
embryos	O
,	O
larval	O
and	O
adult	O
tissues	O
,	O
with	O
no	O
specific	O
pattern	O
of	O
protein	O
expression	O
(	O
data	O
not	O
shown	O
)	O
.	O

At	C
the	C
subcellular	C
level	C
,	C
ectopically	C
expressed	C
dHtt	C
was	C
found	C
predominantly	C
in	C
the	C
cytoplasm	C
in	C
transfected	C
S2	C
cells	C
and	C
in	C
larval	C
tissues	C
(	C
Fig	C
.	C
1G–K	C
and	C
data	C
not	C
shown	C
)	C
,	C
suggesting	C
that	C
dHtt	C
,	C
similar	C
to	C
its	C
human	C
counterpart	C
,	C
is	C
mainly	C
a	C
cytoplasmic	C
protein	C
.	C

Creating	O
a	O
dhtt	O
deletion	O

Similar	O
to	O
human	O
Htt	O
,	O
dhtt	O
encodes	O
an	O
unusually	O
large	O
protein	O
of	O
3583	O
a.a.	O
residues	O
.	O

The	O
cDNA	O
for	O
the	O
dhtt	O
gene	O
is	O
11,579	O
base	O
pairs	O
(	O
bp	O
)	O
long	O
and	O
is	O
derived	O
from	O
29	O
exons	O
in	O
a	O
38	O
kb	O
transcribed	O
genomic	O
region	O
at	O
cytological	O
interval	O
98E2	O
(	O
Li	O
et	O
al.	O
,	O
1999	O
)	O
(	O
Fig	O
.	O
2A	O
,	O
C	O
)	O
.	O

No	O
null	O
mutations	O
in	O
dhtt	O
have	O
been	O
isolated	O
previously	O
.	O

To	O
generate	O
a	O
null	O
mutant	O
for	O
dHtt	O
,	O
we	O
selected	O
two	O
FRT-bearing	O
insertion	O
lines	O
surrounding	O
dhtt	O
:	O
p-element	O
d08071	O
,	O
which	O
is	O
inserted	O
at	O
the	O
5	O
'	O
end	O
of	O
the	O
neighboring	O
CG9990	O
gene	O
,	O
and	O
piggyBac	O
insertion	O
f05417	O
,	O
which	O
is	O
located	O
inside	O
the	O
intron	O
between	O
dhtt	O
exon	O
27	O
and	O
exon	O
28	O
near	O
the	O
3	O
'	O
end	O
of	O
the	O
gene	O
(	O
Fig	O
.	O
2A	O
)	O
.	O

Using	O
flipase	O
(	O
FLP	O
)	O
–FRT-mediated	O
recombination	O
(	O
Parks	O
et	O
al.	O
,	O
2004	O
)	O
,	O
we	O
generated	O
a	O
precise	O
deletion	O
of	O
55	O
kb	O
between	O
the	O
two	O
insertions	O
(	O
see	O
Methods	O
)	O
.	O

This	O
deletion	O
allele	O
,	O
termed	O
Df	O
(	O
98E2	O
)	O
,	O
removed	O
most	O
of	O
the	O
CG9990	O
gene	O
and	O
34	O
kb	O
of	O
the	O
38	O
kb	O
genomic-coding	O
region	O
for	O
dhtt	O
,	O
with	O
only	O
the	O
last	O
two	O
exons	O
of	O
the	O
dhtt	O
gene	O
remaining	O
(	O
Fig	O
.	O
2A–C	O
)	O
.	O

The	O
deletion	O
was	O
confirmed	O
by	O
inverse	O
PCR	O
from	O
extracted	O
genomic	O
DNA	O
and	O
by	O
DNA	O
sequencing	O
(	O
data	O
not	O
shown	O
)	O
.	O

Genomic	O
organization	O
of	O
the	O
dhtt	O
locus	O
and	O
the	O
dhtt-ko	O
deletion	O
.	O

(	O
A	O
)	O
The	O
genomic	O
structure	O
of	O
cytological	O
region	O
98E2	O
.	O

The	O
scale	O
bar	O
on	O
top	O
indicates	O
the	O
gene	O
size	O
(	O
in	O
base	O
pairs	O
)	O
.	O

The	O
position	O
and	O
transcriptional	O
direction	O
of	O
dhtt	O
and	O
nearby	O
genes	O
(	O
open	O
boxes	O
)	O
is	O
shown	O
;	O
introns	O
(	O
dashed	O
lines	O
)	O
and	O
exons	O
(	O
colored	O
filled	O
boxes	O
)	O
are	O
labeled	O
,	O
as	O
well	O
as	O
the	O
FRT	O
insertions	O
(	O
triangles	O
)	O
used	O
for	O
generating	O
the	O
Df	O
(	O
98E2	O
)	O
deficiency	O
.	O

(	O
B	O
)	O
dhtt-ko	O
was	O
generated	O
by	O
an	O
FRT-mediated	O
precise	O
deletion	O
[	O
Df	O
(	O
98E2	O
)	O
]	O
of	O
a	O
55	O
kb	O
genomic	O
region	O
covering	O
most	O
of	O
CG9990	O
and	O
dhtt	O
.	O

A	O
genomic	O
transgene	O
covering	O
the	O
entirety	O
of	O
CG9990	O
(	O
open	O
box	O
)	O
was	O
reintroduced	O
as	O
a	O
transgenic	O
construct	O
in	O
the	O
Df	O
(	O
98E2	O
)	O
background	O
.	O

(	O
C	O
)	O
Detailed	O
genomic	O
structure	O
of	O
the	O
dhtt	O
gene	O
.	O

The	O
scale	O
bar	O
,	O
with	O
predicted	O
BamHI	O
fragments	O
,	O
is	O
drawn	O
at	O
the	O
top	O
.	O

The	O
exons	O
of	O
the	O
dhtt	O
gene	O
are	O
depicted	O
as	O
red	O
arrows	O
and	O
squares	O
,	O
whereas	O
introns	O
are	O
highlighted	O
as	O
red	O
dashed	O
lines	O
,	O
both	O
are	O
drawn	O
to	O
scale	O
.	O

(	O
D	O
)	O
The	O
dhtt-ko	O
removes	O
all	O
but	O
the	O
last	O
two	O
of	O
the	O
29	O
exons	O
in	O
dhtt	O
,	O
as	O
verified	O
by	O
Southern	O
blotting	O
using	O
BamHI	O
digestion	O
of	O
genomic	O
DNA	O
.	O

DNA	O
extracted	O
from	O
control	O
and	O
dhtt-ko	O
adult	O
animals	O
was	O
hybridized	O
with	O
a	O
DNA	O
probe	O
targeting	O
all	O
exons	O
of	O
dhtt	O
(	O
see	O
Methods	O
)	O
.	O

The	O
two	O
BamHI	O
fragments	O
(	O
1.95	O
kb	O
and	O
1.59	O
kb	O
)	O
that	O
contain	O
the	O
last	O
two	O
remaining	O
exons	O
in	O
dhtt-ko	O
mutants	O
are	O
highlighted	O
in	O
(	O
C	O
)	O
.	O

Drosophila	O
containing	O
the	O
Df	O
(	O
98E2	O
)	O
deletion	O
,	O
which	O
removes	O
both	O
CG9990	O
and	O
dhtt	O
,	O
are	O
homozygous	O
lethal	O
at	O
the	O
embryonic	O
stage	O
.	O

CG9990	O
encodes	O
a	O
previously	O
uncharacterized	O
protein	O
belonging	O
to	O
the	O
ABC	O
transporter	O
superfamily	O
(	O
Dean	O
et	O
al.	O
,	O
2001	O
)	O
.	O

To	O
separate	O
the	O
mutant	O
phenotype	O
of	O
dhtt	O
from	O
CG9990	O
,	O
we	O
generated	O
transgenic	O
flies	O
carrying	O
a	O
CG9990	O
genomic	O
rescue	O
transgene	O
in	O
the	O
Df	O
(	O
98E2	O
)	O
background	O
(	O
see	O
Methods	O
)	O
.	O

These	O
lines	O
,	O
referred	O
to	O
as	O
dhtt-ko	O
(	O
dhtt-knockout	O
only	O
)	O
,	O
carry	O
both	O
the	O
CG9990	O
rescue	O
transgene	O
and	O
the	O
Df	O
(	O
98E2	O
)	O
deletion	O
,	O
and	O
thus	O
are	O
mutant	O
only	O
for	O
dhtt	O
(	O
Fig	O
.	O
2B–D	O
)	O
.	O

dhtt	O
is	O
dispensable	O
for	O
Drosophila	O
development	O

The	O
dhtt-ko	O
allele	O
removes	O
27	O
of	O
the	O
29	O
exons	O
of	O
dhtt	O
(	O
Fig	O
.	O
2	O
)	O
.	O

Since	C
Htt	C
homozygous	C
knockout	C
mice	C
die	C
during	C
early	C
embryogenesis	C
(	C
Duyao	C
et	C
al.	C
,	C
1995	C
;	C
Nasir	C
et	C
al.	C
,	C
1995	C
;	C
Zeitlin	C
et	C
al.	C
,	C
1995	C
)	C
,	C
we	C
expected	C
that	C
loss	C
of	C
dhtt	C
in	C
the	C
fly	C
would	C
be	C
associated	C
with	C
prominent	C
developmental	C
defects	C
.	C

However	O
,	O
dhtt-ko	O
flies	O
are	O
homozygous	O
viable	O
,	O
demonstrating	O
that	O
the	O
lethality	O
observed	O
following	O
the	O
Df	O
(	O
98E2	O
)	O
deletion	O
is	O
caused	O
by	O
loss	O
of	O
CG9990	O
.	O

To	O
verify	O
that	O
the	O
dhtt	O
gene	O
is	O
indeed	O
deleted	O
in	O
dhtt-ko	O
flies	O
,	O
we	O
extracted	O
genomic	O
DNA	O
from	O
homozygous	O
dhtt-ko	O
adults	O
and	O
performed	O
a	O
Southern	O
blot	O
analysis	O
.	O

As	O
shown	O
in	O
Fig	O
.	O
2D	O
,	O
all	O
genomic	O
DNA	O
containing	O
the	O
dhtt	O
gene	O
was	O
removed	O
in	O
dhtt-ko	O
flies	O
except	O
for	O
the	O
final	O
two	O
3	O
'	O
exons	O
.	O

Further	O
analyses	O
demonstrated	O
that	O
homozygous	O
dhtt-ko	O
flies	O
develop	O
at	O
a	O
similar	O
rate	O
to	O
wild-type	O
flies	O
and	O
give	O
rise	O
to	O
fertile	O
adults	O
with	O
no	O
discernible	O
morphological	O
abnormalities	O
.	O

The	C
progeny	C
derived	C
from	C
homozygous	C
dhtt-ko	C
flies	C
did	C
not	C
show	C
a	C
reduction	C
in	C
viability	C
or	C
display	C
other	C
obvious	C
developmental	C
defects	C
,	C
suggesting	C
that	C
maternally	C
contributed	C
dhtt	C
has	C
no	C
significant	C
effect	C
on	C
animal	C
development	C
or	C
function	C
.	C

To	C
determine	C
whether	C
developmental	C
defects	C
are	C
present	C
in	C
dhtt-ko	C
animals	C
,	C
we	C
characterized	C
dhtt-ko	C
mutants	C
using	C
a	C
variety	C
of	C
cellular	C
and	C
neuronal	C
markers	C
.	C

These	O
studies	O
failed	O
to	O
reveal	O
any	O
obvious	O
developmental	O
abnormalities	O
during	O
embryogenesis	O
,	O
or	O
during	O
larval	O
and	O
adult	O
stages	O
(	O
Fig	O
.	O
3	O
and	O
data	O
not	O
shown	O
)	O
.	O

In	O
particular	O
,	O
the	O
embryonic	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
(	O
Fig	O
.	O
3A	O
)	O
and	O
muscles	O
,	O
and	O
the	O
larval	O
muscles	O
,	O
CNS	O
,	O
eye	O
and	O
other	O
imaginal	O
discs	O
all	O
appeared	O
normal	O
(	O
Fig	O
.	O
3B	O
and	O
data	O
not	O
shown	O
)	O
.	O

Further	O
,	O
in	O
aged	O
adults	O
(	O
40-day-old	O
flies	O
)	O
,	O
the	O
external	O
eye	O
morphology	O
was	O
normal	O
and	O
the	O
eight	O
neuronal	O
photoreceptor	O
cells	O
in	O
each	O
ommatidium	O
were	O
clearly	O
present	O
,	O
together	O
with	O
their	O
accessory	O
cells	O
(	O
Fig	O
.	O
3C	O
,	O
D	O
)	O
.	O

We	O
note	O
that	O
our	O
finding	O
is	O
different	O
from	O
a	O
recent	O
study	O
that	O
examined	O
dhtt	O
function	O
using	O
RNA	O
interference	O
(	O
RNAi	O
)	O
,	O
which	O
implicated	O
a	O
role	O
for	O
dhtt	O
in	O
axonal	O
transport	O
and	O
eye	O
integrity	O
(	O
Gunawardena	O
et	O
al.	O
,	O
2003	O
)	O
.	O

The	C
exact	C
nature	C
of	C
this	C
phenotype	C
discrepancy	C
is	C
not	C
clear	C
.	C

Given	C
the	C
experiment	C
was	C
carried	C
out	C
at	C
29°C	C
,	C
it	C
is	C
possible	C
that	C
the	C
observed	C
RNAi	C
phenotypes	C
were	C
the	C
result	C
of	C
cellular	C
toxicity	C
caused	C
by	C
the	C
high-level	C
expression	C
of	C
Gal4	C
(	C
Gunawardena	C
et	C
al.	C
,	C
2003	C
)	C
.	C

The	C
more	C
severe	C
phenotypes	C
might	C
also	C
be	C
the	C
result	C
of	C
the	C
non-specific	C
RNAi	C
off-target	C
effects	C
caused	C
by	C
the	C
knockdown	C
of	C
unrelated	C
genes	C
(	C
Kulkarni	C
et	C
al.	C
,	C
2006	C
)	C
.	C

Nevertheless	C
,	C
our	C
results	C
suggest	C
that	C
dhtt	C
is	C
dispensable	C
for	C
normal	C
Drosophila	C
development	C
.	C

This	O
result	O
is	O
in	O
contrast	O
to	O
the	O
essential	O
role	O
of	O
Htt	O
in	O
mouse	O
(	O
Duyao	O
et	O
al.	O
,	O
1995	O
;	O
Nasir	O
et	O
al.	O
,	O
1995	O
;	O
Zeitlin	O
et	O
al.	O
,	O
1995	O
)	O
.	O

These	C
phenotypic	C
differences	C
are	C
probably	C
the	C
result	C
of	C
differences	C
in	C
mouse	C
and	C
fly	C
embryogenesis	C
,	C
as	C
the	C
early	C
lethality	C
of	C
Htt-null	C
mice	C
is	C
due	C
to	C
the	C
function	C
of	C
Hdh	C
in	C
extraembryonic	C
membranes	C
,	C
for	C
which	C
there	C
are	C
no	C
equivalents	C
in	C
Drosophila	C
(	C
Dragatsis	C
et	C
al.	C
,	C
1998	C
)	C
(	C
see	C
Discussion	C
)	C
.	C

dhtt	O
is	O
dispensable	O
for	O
Drosophila	O
development	O
.	O

(	O
A	O
)	O
Normal	O
development	O
of	O
the	O
CNS	O
during	O
embryogenesis	O
in	O
dhtt-ko	O
flies	O
(	O
A3	O
,	O
A4	O
)	O
compared	O
with	O
wild-type	O
controls	O
(	O
A1	O
,	O
A2	O
)	O
,	O
as	O
revealed	O
by	O
anti-Armadillo	O
staining	O
.	O

(	O
A2	O
,	O
A4	O
)	O
Enlarged	O
views	O
of	O
the	O
ventral	O
nerve	O
cord	O
in	O
wild-type	O
(	O
A2	O
)	O
and	O
dhtt-ko	O
(	O
A4	O
)	O
embryos	O
show	O
its	O
regular	O
ladder-like	O
structure	O
.	O

(	O
B	O
)	O
Differentiation	O
and	O
patterning	O
of	O
the	O
eye	O
during	O
the	O
third	O
instar	O
larval	O
stage	O
in	O
dhtt-ko	O
flies	O
(	O
B3	O
,	O
B4	O
)	O
is	O
indistinguishable	O
from	O
wild-type	O
controls	O
(	O
B1	O
,	O
B2	O
)	O
,	O
as	O
revealed	O
by	O
anti-Elav	O
staining	O
(	O
red	O
)	O
(	O
B2	O
,	O
B4	O
)	O
to	O
label	O
differentiated	O
neurons	O
and	O
phalloidin	O
staining	O
for	O
F-actin	O
(	O
green	O
)	O
(	O
B1	O
,	O
B3	O
)	O
to	O
reveal	O
the	O
overall	O
cytoskeleton	O
organization	O
.	O

(	O
C	O
,	O
D	O
)	O
Eye	O
images	O
of	O
40-day-old	O
dhtt-ko	O
mutants	O
.	O

Both	O
the	O
overall	O
external	O
eye	O
morphology	O
(	O
C	O
)	O
and	O
the	O
internal	O
organization	O
of	O
neuronal	O
photoreceptors	O
(	O
D	O
)	O
are	O
normal	O
,	O
even	O
in	O
the	O
40-day-old	O
dhtt-ko	O
adults	O
.	O

(	O
E–I	O
)	O
Synaptic	O
development	O
is	O
normal	O
in	O
dhtt	O
mutants	O
.	O

Low	O
(	O
E1	O
,	O
E5	O
)	O
and	O
high	O
(	O
E2–E4	O
,	O
E6–E8	O
,	O
F1–F8	O
)	O
magnification	O
confocal	O
images	O
of	O
glutamatergic	O
NMJs	O
in	O
the	O
abdominal	O
segment	O
A3	O
of	O
third	O
instar	O
muscles	O
6	O
and	O
7	O
.	O

(	O
E	O
)	O
NMJs	O
are	O
double-labeled	O
with	O
the	O
neuronal	O
membrane	O
marker	O
anti-HRP	O
(	O
red	O
)	O
and	O
anti-Dlg	O
(	O
green	O
)	O
,	O
which	O
reveal	O
the	O
well-defined	O
presynaptic	O
and	O
postsynaptic	O
NMJ	O
structures	O
in	O
wild-type	O
(	O
E1–E4	O
)	O
and	O
dhtt-ko	O
mutants	O
(	O
E5–E8	O
)	O
.	O

(	O
E2–E4	O
,	O
E6–E8	O
)	O
Magnified	O
views	O
of	O
the	O
areas	O
highlighted	O
in	O
(	O
E1	O
,	O
E5	O
)	O
.	O

(	O
F	O
)	O
NMJs	O
are	O
labeled	O
with	O
anti-HRP	O
(	O
white	O
)	O
(	O
F1	O
,	O
F5	O
)	O
,	O
the	O
periactive	O
zone	O
marker	O
anti-FasII	O
(	O
green	O
)	O
(	O
F2	O
,	O
F6	O
)	O
and	O
the	O
active	O
zone	O
marker	O
nc82	O
(	O
red	O
)	O
(	O
F3	O
,	O
F7	O
)	O
,	O
revealing	O
the	O
normal	O
periactive	O
zone	O
and	O
active	O
zone	O
organization	O
in	O
wild-type	O
(	O
F1–F4	O
)	O
and	O
dhtt-ko	O
flies	O
(	O
F5–F8	O
)	O
.	O

(	O
F4	O
,	O
F8	O
)	O
Overlayed	O
images	O
of	O
(	O
F1–F3	O
,	O
F5–F7	O
)	O
,	O
respectively	O
.	O

WT	O
:	O
w1118	O
wild-type	O
control	O
.	O

Bar	O
,	O
5	O
µm	O
(	O
in	O
all	O
panels	O
)	O
.	O

(	O
G–I	O
)	O
Quantitative	O
analysis	O
of	O
NMJs	O
in	O
muscle	O
6	O
and	O
7	O
of	O
the	O
abdominal	O
segment	O
A3	O
for	O
wild-type	O
control	O
(	O
WT	O
,	O
blue	O
)	O
and	O
dhtt-ko	O
mutant	O
(	O
red	O
)	O
flies	O
.	O

(	O
G	O
)	O
Average	O
number	O
of	O
type	O
1b	O
boutons	O
:	O
WT	O
control=34.5±1.6	O
(	O
n=24	O
)	O
,	O
dhtt-ko	O
mutants=33.5±2.4	O
(	O
n=21	O
)	O
;	O
the	O
difference	O
is	O
statistically	O
insignificant	O
,	O
P=0.72	O
(	O
Student’s	O
t-test	O
)	O
.	O

(	O
H	O
)	O
Average	O
number	O
of	O
total	O
boutons	O
:	O
WT	O
control=63.1±1.8	O
(	O
n=24	O
)	O
,	O
dhtt-ko	O
mutants=62.3±2.0	O
(	O
n=21	O
)	O
;	O
P=0.76-	O

(	O
I	O
)	O
Total	O
number	O
of	O
branches	O
:	O
WT	O
control=18.0±0.6	O
(	O
n=28	O
)	O
,	O
dhtt-ko	O
mutants=17.4±0.6	O
(	O
n=34	O
)	O
;	O
P=0.52	O
.	O

The	O
data	O
in	O
(	O
G–I	O
)	O
are	O
presented	O
as	O
the	O
means±s.e.m	O
.	O

(	O
standard	O
error	O
of	O
the	O
mean	O
)	O
.	O

Normal	O
synapse	O
organization	O
in	O
dhtt-ko	O

Htt	O
has	O
been	O
reported	O
to	O
interact	O
with	O
a	O
diverse	O
group	O
of	O
proteins	O
whose	O
functions	O
have	O
been	O
directly	O
or	O
indirectly	O
linked	O
to	O
synapse	O
organization	O
and	O
synaptic	O
activity	O
(	O
Harjes	O
and	O
Wanker	O
,	O
2003	O
)	O
,	O
including	O
proteins	O
that	O
regulate	O
cytoskeleton	O
dynamics	O
and	O
clathrin-mediated	O
endocytosis	O
[	O
e.g	O
.	O
HIP1	O
(	O
Sla2p	O
)	O
,	O
HIP12	O
,	O
PACSIN/syndapin	O
1	O
and	O
endophilin	O
3	O
]	O
(	O
Chopra	O
et	O
al.	O
,	O
2000	O
;	O
Higgins	O
and	O
McMahon	O
,	O
2002	O
;	O
Kalchman	O
et	O
al.	O
,	O
1997	O
;	O
Modregger	O
et	O
al.	O
,	O
2002	O
;	O
Seki	O
et	O
al.	O
,	O
1998	O
;	O
Singaraja	O
et	O
al.	O
,	O
2002	O
;	O
Sittler	O
et	O
al.	O
,	O
1998	O
;	O
Wanker	O
et	O
al.	O
,	O
1997	O
)	O
;	O
axonal	O
vesicle	O
transport	O
(	O
e.g	O
.	O
HAP1	O
)	O
(	O
Engelender	O
et	O
al.	O
,	O
1997	O
;	O
Gunawardena	O
et	O
al.	O
,	O
2003	O
)	O
;	O
and	O
dendritic	O
morphogenesis	O
and	O
synaptic	O
plasticity	O
(	O
e.g	O
.	O
the	O
postsynaptic	O
density	O
protein	O
DLG4/PSD95	O
and	O
the	O
adaptor	O
proteins	O
GRB2	O
and	O
TRIP10/CIP4	O
)	O
(	O
Holbert	O
et	O
al.	O
,	O
2003	O
;	O
Liu	O
et	O
al.	O
,	O
1997	O
;	O
Sun	O
et	O
al.	O
,	O
2001	O
)	O
.	O

To	C
test	C
whether	C
dhtt	C
plays	C
a	C
role	C
in	C
synapse	C
organization	C
,	C
we	C
examined	C
the	C
formation	C
of	C
glutamatergic	C
neuromuscular	C
junctions	C
(	C
NMJs	C
)	C
in	C
third	C
instar	C
larvae	C
,	C
a	C
well-characterized	C
system	C
for	C
studying	C
synapse	C
formation	C
and	C
function	C
in	C
Drosophila	C
(	C
Budnik	C
and	C
Gramates	C
,	C
1999	C
)	C
.	C

Examination	O
with	O
a	O
panel	O
of	O
synapse	O
markers	O
showed	O
that	O
axonal	O
pathfinding	O
,	O
muscle	O
innervation	O
and	O
overall	O
synapse	O
structure	O
are	O
normal	O
in	O
dhtt	O
mutants	O
(	O
Fig	O
.	O
3	O
and	O
data	O
not	O
shown	O
)	O
.	O

Double-labeling	O
with	O
the	O
axonal	O
membrane	O
marker	O
anti-HRP	O
and	O
the	O
postsynaptic	O
density	O
marker	O
anti-Dlg	O
(	O
the	O
Drosophila	O
PSD95	O
homolog	O
)	O
revealed	O
well-organized	O
presynaptic	O
and	O
postsynaptic	O
structures	O
(	O
Fig	O
.	O
3E1–E8	O
)	O
,	O
as	O
well	O
as	O
an	O
enrichment	O
of	O
synaptic	O
vesicles	O
at	O
the	O
synapses	O
,	O
with	O
no	O
obvious	O
synapse	O
retraction	O
phenotype	O
(	O
data	O
not	O
shown	O
)	O
.	O

Moreover	O
,	O
dhtt	O
mutants	O
showed	O
normal	O
organization	O
of	O
the	O
presynaptic	O
microtubule	O
(	O
MT	O
)	O
cytoskeleton	O
,	O
with	O
the	O
presence	O
of	O
stable	O
MT	O
bundles	O
traversing	O
the	O
center	O
of	O
NMJ	O
branches	O
and	O
a	O
dynamically	O
reorganized	O
MT	O
network	O
at	O
distal	O
boutons	O
(	O
data	O
not	O
shown	O
)	O
.	O

Quantification	O
of	O
NMJ	O
bouton	O
number	O
and	O
axonal	O
branching	O
did	O
not	O
reveal	O
a	O
significant	O
difference	O
between	O
wild-type	O
controls	O
and	O
dhtt	O
mutants	O
(	O
Fig	O
.	O
3G–I	O
)	O
.	O

Finally	O
,	O
dhtt	O
mutants	O
displayed	O
the	O
stereotypical	O
complementary	O
pattern	O
of	O
active	O
zones	O
surrounded	O
by	O
the	O
honeycomb-like	O
organization	O
of	O
periactive	O
zones	O
,	O
and	O
examination	O
of	O
multiple	O
synaptic	O
proteins	O
such	O
as	O
nc82	O
(	O
an	O
active	O
zone	O
marker	O
)	O
and	O
fasciclin	O
II	O
(	O
FasII	O
,	O
a	O
periactive	O
zones	O
marker	O
)	O
showed	O
normal	O
synaptic	O
localization	O
(	O
Fig	O
.	O
3F1–F8	O
)	O
.	O

As	O
a	O
control	O
,	O
we	O
also	O
examined	O
synapse	O
organization	O
in	O
CG9990	O
transgenic	O
animals	O
,	O
which	O
displayed	O
similar	O
well-organized	O
NMJ	O
structures	O
(	O
supplementary	O
material	O
Fig	O
.	O
S3	O
and	O
data	O
not	O
shown	O
)	O
.	O

Together	C
,	C
these	C
results	C
suggest	C
that	C
dhtt	C
is	C
not	C
essential	C
for	C
synapse	C
formation	C
and	C
organization	C
at	C
NMJs	C
.	C

dhtt	O
is	O
not	O
essential	O
for	O
axonal	O
transport	O

Htt	C
has	C
also	C
been	C
proposed	C
to	C
regulate	C
axonal	C
vesicle	C
transport	C
because	C
one	C
of	C
its	C
binding	C
partners	C
,	C
HAP1	C
,	C
interacts	C
directly	C
with	C
p150Glued	C
,	C
which	C
is	C
an	C
essential	C
subunit	C
of	C
the	C
dynactin	C
complex	C
involved	C
in	C
regulating	C
dynein-mediated	C
retrograde	C
axonal	C
transport	C
(	C
Engelender	C
et	C
al.	C
,	C
1997	C
;	C
Gunawardena	C
et	C
al.	C
,	C
2003	C
;	C
Harjes	C
and	C
Wanker	C
,	C
2003	C
)	C
.	C

In	O
Drosophila	O
,	O
individuals	O
that	O
are	O
defective	O
for	O
essential	O
components	O
of	O
the	O
axonal	O
transport	O
machinery	O
often	O
display	O
characteristic	O
mobility	O
phenotypes	O
,	O
such	O
as	O
tail	O
flipping	O
during	O
larva	O
crawling	O
,	O
and	O
progressive	O
lethargy	O
and	O
paralysis	O
(	O
Gindhart	O
et	O
al.	O
,	O
1998	O
;	O
Gunawardena	O
and	O
Goldstein	O
,	O
2001	O
;	O
Martin	O
et	O
al.	O
,	O
1999	O
)	O
.	O

Such	O
mutant	O
animals	O
also	O
develop	O
an	O
axonal	O
swelling	O
phenotype	O
,	O
owing	O
to	O
the	O
abnormal	O
accumulation	O
of	O
synaptic	O
vesicles	O
along	O
axons	O
,	O
and	O
fail	O
to	O
properly	O
deliver	O
and	O
localize	O
synaptic	O
components	O
to	O
the	O
termini	O
(	O
Gindhart	O
et	O
al.	O
,	O
1998	O
;	O
Gunawardena	O
and	O
Goldstein	O
,	O
2001	O
;	O
Martin	O
et	O
al.	O
,	O
1999	O
)	O
.	O

dhtt	O
mutants	O
showed	O
normal	O
crawling	O
behavior	O
during	O
larval	O
stages	O
.	O

Furthermore	O
,	O
the	O
distributions	O
of	O
the	O
synaptic	O
vesicle	O
markers	O
anti-synaptotagmin	O
(	O
Syt	O
)	O
and	O
anti-cysteine	O
string	O
protein	O
(	O
CSP	O
)	O
were	O
normal	O
,	O
revealing	O
no	O
obvious	O
accumulation	O
or	O
axonal	O
swellings	O
(	O
Fig	O
.	O
4	O
and	O
data	O
not	O
shown	O
)	O
.	O

Further	O
,	O
immunostaining	O
with	O
other	O
synaptic	O
components	O
,	O
including	O
synapsin	O
(	O
a	O
reserved	O
vesicle	O
pool	O
marker	O
)	O
,	O
FasII	O
(	O
a	O
periactive	O
zone	O
marker	O
)	O
and	O
Dlg	O
,	O
demonstrated	O
that	O
synaptic	O
components	O
were	O
properly	O
delivered	O
to	O
synapses	O
(	O
Fig	O
.	O
3E–F	O
and	O
data	O
not	O
shown	O
)	O
.	O

Similarly	O
,	O
examination	O
of	O
CG9990	O
transgenic	O
animals	O
failed	O
to	O
reveal	O
discernible	O
larval	O
mobility	O
or	O
axonal	O
transport	O
defects	O
(	O
supplementary	O
material	O
Fig	O
.	O
S3	O
)	O
.	O

Together	C
,	C
these	C
results	C
suggest	C
that	C
dhtt	C
does	C
not	C
play	C
an	C
essential	C
role	C
in	C
axonal	C
transport	C
.	C

Normal	O
axonal	O
transport	O
in	O
dhtt-ko	O
mutants	O
.	O

Confocal	O
images	O
of	O
wild-type	O
control	O
(	O
A–C	O
)	O
and	O
dhtt-ko	O
(	O
D–F	O
)	O
NMJs	O
and	O
neighboring	O
axons	O
(	O
white	O
arrows	O
)	O
of	O
the	O
larval	O
peripheral	O
nervous	O
system	O
(	O
anti-HRP	O
,	O
red	O
)	O
.	O

Synaptic	O
vesicles	O
(	O
green	O
,	O
anti-Syt	O
)	O
are	O
properly	O
delivered	O
to	O
NMJs	O
and	O
show	O
no	O
obvious	O
accumulation	O
in	O
the	O
axons	O
of	O
dhtt-komutants	O
(	O
D–F	O
)	O
,	O
similar	O
to	O
the	O
wild-type	O
controls	O
(	O
A–C	O
)	O
.	O

Signals	O
for	O
Syt	O
were	O
overexposed	O
in	O
(	O
B	O
,	O
C	O
,	O
E	O
,	O
F	O
)	O
in	O
order	O
to	O
reveal	O
any	O
possible	O
abnormal	O
accumulations	O
of	O
synaptic	O
vesicles	O
within	O
axons	O
(	O
white	O
arrows	O
)	O
.	O

(	O
C	O
,	O
F	O
)	O
Overlayed	O
images	O
of	O
double	O
staining	O
with	O
anti-HRP	O
and	O
anti-Syt	O
.	O

WT	O
:	O
w1118	O
wild-type	O
control	O
.	O

Bars	O
,	O
10	O
µm	O
.	O

dhtt	O
is	O
crucial	O
for	O
aged	O
adults	O

We	C
next	C
investigated	C
whether	C
dhtt	C
might	C
function	C
in	C
adult	C
animals	C
.	C

We	C
examined	C
whether	C
newly	C
emerged	C
dhtt	C
adults	C
were	C
hypersensitive	C
to	C
stress	C
tests	C
including	C
prolonged	C
heat	C
and	C
cold	C
exposure	C
,	C
vortexing	C
and	C
feeding	C
with	C
the	C
oxidative	C
stress	C
compound	C
paraquat	C
.	C

In	O
these	O
tests	O
,	O
dhtt	O
mutants	O
showed	O
similar	O
responses	O
to	O
wild-type	O
controls	O
(	O
data	O
not	O
shown	O
)	O
.	O

Thus	O
,	O
unlike	O
flies	O
that	O
are	O
mutated	O
for	O
Parkinson’s	O
disease	O
genes	O
such	O
as	O
parkin	O
and	O
pink1	O
,	O
which	O
are	O
sensitive	O
to	O
multiple	O
stress	O
challenges	O
(	O
Clark	O
et	O
al.	O
,	O
2006	O
;	O
Greene	O
et	O
al.	O
,	O
2003	O
;	O
Park	O
et	O
al.	O
,	O
2006	O
)	O
,	O
loss	O
of	O
dhtt	O
does	O
not	O
render	O
young	O
adult	O
animals	O
more	O
vulnerable	O
to	O
environmental	O
stresses	O
.	O

Next	O
,	O
we	O
followed	O
the	O
activity	O
and	O
viability	O
of	O
dhtt	O
animals	O
throughout	O
the	O
adult	O
life	O
cycle	O
.	O

Although	O
no	O
discernible	O
difference	O
in	O
the	O
activity	O
and	O
survival	O
rate	O
was	O
observed	O
between	O
dhtt-ko	O
and	O
wild-type	O
young	O
adults	O
,	O
we	O
observed	O
striking	O
defects	O
in	O
older	O
adult	O
dhtt-ko	O
flies	O
.	O

dhtt-ko	O
animals	O
showed	O
similar	O
spontaneous	O
locomotion	O
to	O
that	O
of	O
wild-type	O
controls	O
at	O
day	O
15	O
and	O
earlier	O
(	O
Fig	O
.	O
5A	O
;	O
supplementary	O
material	O
Movie	O
1	O
)	O
.	O

However	O
,	O
as	O
flies	O
aged	O
,	O
dhtt-ko	O
mutants	O
displayed	O
a	O
rapidly	O
declining	O
mobility	O
,	O
which	O
was	O
evident	O
by	O
day	O
25	O
.	O

By	O
day	O
40	O
,	O
almost	O
all	O
dhtt	O
mutants	O
showed	O
severely	O
compromised	O
mobility	O
(	O
Fig	O
.	O
5A	O
;	O
supplementary	O
material	O
Movie	O
2	O
)	O
and	O
their	O
viability	O
declined	O
quickly	O
.	O

Whereas	O
,	O
on	O
average	O
,	O
half	O
of	O
the	O
wild-type	O
controls	O
died	O
around	O
day	O
59	O
but	O
could	O
live	O
for	O
up	O
to	O
90	O
days	O
,	O
half	O
of	O
the	O
dhtt-ko	O
flies	O
died	O
around	O
day	O
43	O
and	O
almost	O
all	O
by	O
day	O
50	O
(	O
Fig	O
.	O
5B	O
)	O
.	O

To	O
verify	O
that	O
the	O
late-onset	O
mobility	O
and	O
viability	O
defects	O
were	O
because	O
of	O
loss	O
of	O
dhtt	O
,	O
we	O
constructed	O
a	O
dhtt	O
minigene	O
that	O
expressed	O
full-length	O
dhtt	O
under	O
the	O
control	O
of	O
its	O
endogenous	O
regulatory	O
region	O
(	O
see	O
Methods	O
)	O
.	O

In	O
the	O
presence	O
of	O
this	O
mini-dhtt	O
transgene	O
,	O
the	O
expression	O
of	O
the	O
dhtt	O
gene	O
was	O
restored	O
in	O
dhtt-ko	O
mutants	O
,	O
as	O
confirmed	O
by	O
RT-PCR	O
(	O
Fig	O
.	O
5C	O
)	O

Both	O
the	O
late-onset	O
mobility	O
and	O
viability	O
phenotypes	O
observed	O
in	O
dhtt-ko	O
mutants	O
were	O
rescued	O
by	O
the	O
dhtt	O
transgene	O
(	O
Fig	O
.	O
5A	O
,	O
B	O
;	O
supplementary	O
material	O
Movie	O
3	O
)	O
.	O

Importantly	O
,	O
introduction	O
of	O
an	O
unrelated	O
transgene	O
construct	O
,	O
such	O
as	O
elav-Gal4	O
(	O
Fig	O
.	O
5B	O
)	O
or	O
UAS-eGFP	O
(	O
data	O
not	O
shown	O
)	O
,	O
into	O
the	O
dhtt-ko	O
background	O
could	O
not	O
rescue	O
the	O
mobility	O
and	O
viability	O
phenotypes	O
of	O
dhtt-ko	O
mutants	O
,	O
confirming	O
that	O
the	O
rescue	O
was	O
because	O
of	O
the	O
restored	O
expression	O
of	O
dhtt	O
.	O

Thus	O
,	O
although	O
dhtt	O
is	O
not	O
essential	O
for	O
normal	O
Drosophila	O
development	O
,	O
its	O
function	O
is	O
important	O
in	O
maintaining	O
the	O
long-term	O
mobility	O
and	O
survival	O
of	O
adult	O
animals	O
.	O

dhtt-ko	O
is	O
dispensable	O
for	O
normal	O
neurotransmission	O

The	C
observed	C
mobility	C
and	C
viability	C
phenotype	C
could	C
be	C
because	C
of	C
an	C
underlying	C
neurotransmission	C
defect	C
in	C
dhtt	C
mutants	C
as	C
several	C
proposed	C
Htt	C
functions	C
,	C
such	C
as	C
axonal	C
vesicle	C
transport	C
and	C
clathrin-mediated	C
endocytosis	C
in	C
neurons	C
,	C
are	C
essential	C
for	C
the	C
delivery	C
and	C
recycling	C
of	C
synaptic	C
vesicles	C
at	C
nerve	C
terminals	C
to	C
ensure	C
effective	C
neurotransmission	C
(	C
Cattaneo	C
et	C
al.	C
,	C
2001	C
;	C
Eaton	C
et	C
al.	C
,	C
2002	C
;	C
Harjes	C
and	C
Wanker	C
,	C
2003	C
;	C
Hinshaw	C
,	C
2000	C
;	C
Slepnev	C
and	C
De	C
Camilli	C
,	C
2000	C
)	C
.	C

To	O
test	O
the	O
neuronal	O
communication	O
in	O
dhtt	O
mutants	O
,	O
we	O
measured	O
synaptic	O
physiology	O
at	O
the	O
well-characterized	O
third	O
instar	O
larval	O
NMJ	O
.	O

We	O
quantified	O
the	O
amplitude	O
of	O
evoked	O
excitatory	O
junctional	O
potentials	O
(	O
EJPs	O
)	O
,	O
resting	O
membrane	O
potential	O
and	O
paired-pulse	O
facilitation	O
(	O
PPF	O
)	O
(	O
Fig	O
.	O
6A–D	O
and	O
data	O
not	O
shown	O
)	O
.	O

In	O
adult	O
animals	O
,	O
we	O
recorded	O
electroretinogram	O
(	O
ERG	O
)	O
responses	O
in	O
the	O
eye	O
and	O
quantified	O
DLM	O
(	O
dorsal	O
longitudinal	O
flight	O
muscle	O
)	O
bursting	O
activity	O
in	O
the	O
giant	O
fiber	O
flight	O
circuit	O
(	O
Fig	O
.	O
6E	O
and	O
data	O
not	O
shown	O
)	O
.	O

Following	O
exhaustive	O
analysis	O
,	O
we	O
found	O
no	O
significant	O
defect	O
in	O
either	O
synaptic	O
transmission	O
or	O
short-term	O
plasticity	O
in	O
dhtt	O
mutants	O
.	O

Together	C
,	C
these	C
data	C
suggest	C
that	C
dhtt	C
is	C
not	C
essential	C
for	C
neurotransmission	C
.	C

Normal	O
synaptic	O
transmission	O
in	O
dhtt-ko	O
mutants	O
.	O

(	O
A–F	O
)	O
Electrophysiological	O
analyses	O
of	O
dhtt	O
mutants	O
(	O
see	O
Methods	O
)	O
.	O

(	O
A	O
)	O
Voltage	O
traces	O
of	O
evoked	O
EJPs	O
recorded	O
from	O
muscle	O
fiber	O
6	O
in	O
dhtt	O
mutant	O
or	O
control	O
third	O
instar	O
larvae	O
.	O

(	O
B	O
)	O
Measurements	O
of	O
evoked	O
EJP	O
amplitude	O
.	O

The	O
dhtt-ko	O
mutants	O
exhibited	O
no	O
significant	O
difference	O
in	O
synaptic	O
vesicle	O
release	O
following	O
stimulation	O
(	O
P=0.18	O
,	O
Student’s	O
t-test	O
)	O
.	O

Resting	O
membrane	O
potential	O
was	O
unchanged	O
in	O
animals	O
lacking	O
dhtt	O
.	O

(	O
C	O
)	O
Voltage	O
traces	O
and	O
(	O
D	O
)	O
quantification	O
of	O
PPF	O
in	O
control	O
and	O
dhtt	O
mutant	O
third	O
instar	O
larvae	O
.	O

No	C
change	C
in	C
the	C
amplitude	C
of	C
PPF	C
was	C
observed	C
in	C
dhtt	C
mutants	C
,	C
indicating	C
that	C
short-term	C
plasticity	C
is	C
intact	C
.	C

(	O
E	O
)	O
ERGs	O
recorded	O
from	O
controls	O
and	O
dhtt-ko	O
mutants	O
aged	O
40–45	O
days	O
or	O
from	O
dhtt-ko	O
mutants	O
aged	O
1–3	O
days	O
at	O
20°C	O
(	O
top	O
graphs	O
)	O
or	O
at	O
37°C	O
(	O
bottom	O
graphs	O
)	O
;	O
heat	O
pulses	O
were	O
given	O
at	O
regular	O
intervals	O
.	O

The	O
black	O
bar	O
below	O
the	O
trace	O
indicates	O
the	O
test	O
light	O
pulses	O
.	O

(	O
F	O
)	O
Percentage	O
of	O
adult	O
animals	O
aged	O
40–45	O
days	O
with	O
a	O
loss	O
of	O
phototransduction	O
at	O
37°C	O
.	O

dhtt-ko	C
mutants	C
showed	C
a	C
more	C
severe	C
temperature-induced	C
loss	C
of	C
phototransduction	C
than	C
control	C
flies	C
,	C
suggesting	C
that	C
photoreceptors	C
in	C
aged	C
dhtt-ko	C
mutants	C
were	C
stress-sensitive	C
compared	C
with	C
the	C
controls	C
.	C

The	O
dhtt-ko	O
Rescue	O
animals	O
were	O
used	O
as	O
controls	O
in	O
the	O
above	O
electrophysiological	O
analyses	O
to	O
ensure	O
a	O
consistent	O
genetic	O
background	O
(	O
A–F	O
)	O
.	O

The	O
data	O
in	O
(	O
B	O
)	O
and	O
(	O
D	O
)	O
are	O
presented	O
as	O
the	O
means±s.e	O
.	O

To	C
investigate	C
whether	C
the	C
observed	C
mobility	C
and	C
viability	C
phenotypes	C
in	C
aged	C
dhtt	C
mutants	C
are	C
correlated	C
with	C
neuronal	C
communication	C
defects	C
,	C
we	C
screened	C
for	C
electrophysiological	C
phenotypes	C
in	C
animals	C
aged	C
40–45	C
days	C
,	C
when	C
behavioral	C
motor	C
abnormalities	C
are	C
prominent	C
.	C

Aged	O
dhtt	O
mutant	O
adults	O
did	O
not	O
display	O
abnormal	O
seizure	O
activity	O
in	O
extracellular	O
recordings	O
from	O
DLM	O
flight	O
muscles	O
in	O
the	O
giant	O
fiber	O
escape	O
pathway	O
,	O
as	O
has	O
been	O
observed	O
in	O
temperature-sensitive	O
Drosophila	O
mutants	O
that	O
have	O
altered	O
synaptic	O
transmission	O
(	O
Guan	O
et	O
al.	O
,	O
2005	O
)	O
.	O

Aged	O
mutants	O
also	O
showed	O
normal	O
visual	O
transduction	O
and	O
synaptic	O
transmission	O
in	O
the	O
visual	O
system	O
at	O
room	O
temperature	O
(	O
Fig	O
.	O
6E	O
and	O
data	O
not	O
shown	O
)	O
,	O
consistent	O
with	O
the	O
observation	O
that	O
dhtt	O
does	O
not	O
play	O
a	O
crucial	O
role	O
in	O
neurotransmission	O
.	O

Previous	O
studies	O
have	O
shown	O
that	O
mutations	O
affecting	O
synaptic	O
function	O
often	O
manifest	O
a	O
more	O
prominent	O
phenotype	O
under	O
temperature-induced	O
stress	O
(	O
Atkinson	O
et	O
al.	O
,	O
1991	O
;	O
Coyle	O
et	O
al.	O
,	O
2004	O
)	O
.	O

To	C
assess	C
whether	C
phototransduction	C
can	C
be	C
maintained	C
under	C
an	C
elevated	C
temperature	C
in	C
dhtt	C
mutants	C
,	C
we	C
performed	C
ERG	C
recordings	C
at	C
37°C	C
.	C

Although	C
dhtt	C
mutants	C
aged	C
1–3	C
days	C
displayed	C
normal	C
ERGs	C
at	C
both	C
20°C	C
and	C
37°C	C
,	C
aged	C
dhtt	C
mutants	C
displayed	C
abnormal	C
sensitivity	C
to	C
37°C	C
,	C
with	C
over	C
60	C
%	C
of	C
aged	C
mutants	C
losing	C
light-induced	C
phototransduction	C
and	C
the	C
on/off	C
transients	C
at	C
37°C	C
compared	C
with	C
only	C
20	C
%	C
of	C
control	C
aged	C
adults	C
(	C
Fig	C
.	C
6E	C
,	C
F	C
)	C
,	C
indicating	C
an	C
important	C
role	C
of	C
dhtt	C
in	C
maintaining	C
phototransduction	C
under	C
temperature-induced	C
stress	C
.	C

Given	C
that	C
aged	C
dhtt	C
mutant	C
adults	C
did	C
not	C
show	C
additional	C
motor	C
defects	C
when	C
placed	C
at	C
37°C	C
,	C
we	C
hypothesize	C
that	C
the	C
loss	C
of	C
photoreceptor	C
depolarization	C
found	C
in	C
ERG	C
recordings	C
reflects	C
temperature-sensitive	C
defects	C
in	C
the	C
phototransduction	C
cycle	C
,	C
rather	C
than	C
in	C
synaptic	C
transmission	C
.	C

These	C
results	C
suggest	C
that	C
aged	C
dhtt	C
mutants	C
are	C
more	C
sensitive	C
to	C
stress	C
than	C
young	C
dhtt	C
animals	C
or	C
aged	C
controls	C
.	C

Reduced	O
axon	O
terminal	O
complexity	O
in	O
dhtt-ko	O
brains	O

To	O
further	O
test	O
for	O
dhtt	O
function	O
in	O
the	O
adult	O
brain	O
,	O
we	O
examined	O
dhtt	O
brain	O
morphology	O
using	O
a	O
series	O
of	O
cellular	O
markers	O
.	O

The	O
overall	O
patterning	O
and	O
gross	O
morphology	O
of	O
dhtt-ko	O
brains	O
appeared	O
normal	O
,	O
as	O
shown	O
by	O
staining	O
with	O
antibodies	O
such	O
as	O
the	O
glial	O
cell	O
marker	O
anti-Repo	O
,	O
the	O
pan-neuronal	O
marker	O
anti-Elav	O
and	O
the	O
synaptic	O
vesicle	O
marker	O
anti-CSP	O
(	O
data	O
not	O
shown	O
)	O
.	O

In	O
addition	O
,	O
within	O
the	O
ventral	O
nerve	O
cord	O
,	O
the	O
neuropile	O
was	O
similarly	O
enriched	O
with	O
synaptic	O
vesicles	O
.	O

Further	O
,	O
the	O
overall	O
axonal	O
morphology	O
of	O
dhtt-ko	O
mutants	O
appeared	O
normal	O
with	O
no	O
clear	O
axonal	O
blebbing	O
or	O
defasciculation	O
phenotypes	O
(	O
data	O
not	O
shown	O
)	O
.	O

Interestingly	O
,	O
examination	O
of	O
the	O
mushroom	O
bodies	O
(	O
MBs	O
)	O
,	O
which	O
are	O
involved	O
in	O
learning	O
and	O
memory	O
in	O
flies	O
,	O
by	O
anti-FasII	O
staining	O
revealed	O
that	O
the	O
signal	O
intensity	O
was	O
weaker	O
in	O
dhtt	O
mutants	O
than	O
in	O
wild-type	O
controls	O
,	O
despite	O
appearing	O
morphologically	O
normal	O
(	O
Fig	O
.	O
7J	O
,	O
M	O
)	O
.	O

Quantification	O
of	O
MB	O
size	O
and	O
FasII	O
staining	O
signals	O
revealed	O
that	O
,	O
although	O
there	O
was	O
a	O
slight	O
reduction	O
in	O
the	O
average	O
size	O
of	O
MBs	O
in	O
dhtt-ko	O
mutants	O
compared	O
with	O
wild-type	O
controls	O
(	O
Fig	O
.	O
7P	O
)	O
(	O
average	O
area	O
covered	O
by	O
each	O
MB	O
:	O
wild	O
type=13,352±156	O
µm2	O
,	O
dhtt-ko	O
mutant=11,927±310	O
µm2	O
;	O
P=0.0003	O
)	O
,	O
the	O
average	O
signal	O
intensity	O
of	O
FasII	O
signals	O
in	O
the	O
MBs	O
of	O
dhtt-ko	O
mutants	O
was	O
decreased	O
by	O
~50	O
%	O
(	O
Fig	O
.	O
7Q	O
)	O
(	O
relative	O
signal	O
intensity	O
of	O
MBs	O
:	O
wild	O
type=100±5.8/µm2	O
,	O
dhtt-ko	O
mutant=47.7±6.1/µm2	O
;	O
P	O
<	O
0.0001	O
;	O
total	O
number	O
of	O
MBs	O
quantified	O
:	O
wild-type	O
control	O
,	O
n=13	O
;	O
dhtt-ko	O
mutants	O
,	O
n=10	O
)	O
.	O

Reduced	O
complexity	O
of	O
axonal	O
termini	O
in	O
dhtt-ko	O
brains	O
.	O

(	O
A–C	O
)	O
Brain	O
morphology	O
of	O
a	O
40-day-old	O
wild-type	O
adult	O
fly	O
as	O
revealed	O
by	O
anti-FasII	O
staining	O
(	O
red	O
)	O
(	O
A	O
)	O
,	O
which	O
strongly	O
labels	O
the	O
MBs	O
.	O

In	O
the	O
same	O
brain	O
,	O
A307-positive	O
neurons	O
and	O
their	O
axonal	O
projections	O
are	O
revealed	O
by	O
using	O
a	O
membrane-bound	O
mCD8-eGFP	O
reporter	O
(	O
green	O
)	O
(	O
B	O
)	O
.	O

(	O
C	O
)	O
An	O
overlay	O
of	O
images	O
(	O
A	O
)	O
and	O
(	O
B	O
)	O
showing	O
the	O
relative	O
positions	O
of	O
MBs	O
and	O
A307-positive	O
neurons	O
in	O
the	O
brain	O
.	O

A307-positive	O
neurons	O
with	O
prominent	O
axonal	O
projections	O
are	O
highlighted	O
[	O
white	O
arrows	O
in	O
(	O
C	O
)	O
]	O
.	O

The	O
white	O
dashed	O
lines	O
delineate	O
the	O
region	O
magnified	O
in	O
the	O
following	O
pictures	O
(	O
D–O	O
)	O
.	O

(	O
D–I	O
)	O
Axonal	O
projection	O
patterns	O
and	O
axon	O
terminal	O
structures	O
of	O
A307-positive	O
neurons	O
in	O
40-day-old	O
wild-type	O
(	O
D–F	O
)	O
and	O
dhtt-ko	O
mutant	O
(	O
G–I	O
)	O
brains	O
.	O

For	O
clear	O
visualization	O
,	O
the	O
posterior	O
(	O
D	O
,	O
G	O
)	O
and	O
anterior	O
(	O
E	O
,	O
H	O
)	O
of	O
the	O
brains	O
are	O
projected	O
separately	O
.	O

(	O
D	O
,	O
G	O
)	O
A307-positive	O
neurons	O
have	O
a	O
similar	O
axonal	O
projection	O
pattern	O
(	O
white	O
arrows	O
)	O
in	O
dhtt-ko	O
mutant	O
(	O
G	O
)	O
and	O
control	O
brains	O
(	O
D	O
)	O
.	O

(	O
E	O
,	O
H	O
)	O
Anterior	O
views	O
of	O
the	O
same	O
brain	O
regions	O
showing	O
the	O
axon	O
terminal	O
structure	O
.	O

The	O
white	O
dashed	O
lines	O
border	O
one	O
axon	O
terminus	O
in	O
each	O
brain	O
,	O
which	O
are	O
further	O
magnified	O
in	O
(	O
F	O
)	O
and	O
(	O
I	O
)	O
,	O
respectively	O
.	O

Notice	O
the	O
significant	O
reduction	O
in	O
branching	O
and	O
varicosities	O
at	O
the	O
axonal	O
termini	O
of	O
the	O
dhtt-ko	O
mutant	O
(	O
H	O
,	O
I	O
)	O
.	O

(	O
J–O	O
)	O
The	O
MBs	O
(	O
J	O
,	O
M	O
)	O
and	O
axonal	O
termini	O
of	O
A307-labeled	O
neurons	O
(	O
K	O
,	O
N	O
)	O
in	O
another	O
pair	O
of	O
40-day-old	O
wild-type	O
(	O
J–L	O
)	O
and	O
dhtt-ko	O
mutant	O
(	O
M–O	O
)	O
brains	O
.	O

(	O
M	O
)	O
The	O
overall	O
morphology	O
of	O
the	O
MBs	O
is	O
normal	O
but	O
the	O
signal	O
intensity	O
is	O
weaker	O
in	O
the	O
dhtt-ko	O
mutant	O
.	O

The	O
white	O
dashed	O
lines	O
border	O
one	O
axon	O
terminus	O
in	O
each	O
brain	O
.	O

Note	O
the	O
reduced	O
complexity	O
of	O
axonal	O
termini	O
in	O
the	O
dhtt-ko	O
mutant	O
.	O

The	O
top	O
of	O
each	O
image	O
is	O
the	O
dorsal	O
end	O
of	O
the	O
brain	O
.	O

WT=w1118	O
wild-type	O
control	O
.	O

Bars	O
,	O
10	O
µm	O
(	O
F	O
,	O
I	O
)	O
and	O
30	O
µm	O
(	O
all	O
other	O
panels	O
)	O
.	O

(	O
P	O
,	O
Q	O
)	O
Quantification	O
of	O
the	O
average	O
area	O
covered	O
by	O
each	O
MB	O
(	O
P	O
)	O
and	O
the	O
relative	O
signal	O
intensity	O
of	O
MBs	O
(	O
Q	O
)	O
between	O
wild-type	O
controls	O
(	O
WT	O
,	O
blue	O
)	O
and	O
dhtt-ko	O
mutants	O
(	O
red	O
)	O
,	O
as	O
revealed	O
by	O
anti-FasII	O
staining	O
.	O

When	O
calculating	O
the	O
relative	O
signal	O
intensity	O
of	O
MBs	O
,	O
the	O
value	O
for	O
the	O
average	O
signal	O
intensity	O
from	O
the	O
wild-type	O
controls	O
was	O
set	O
as	O
100	O
,	O
(	O
s.e.m.=5.8	O
)	O
;	O
the	O
relative	O
signal	O
intensity	O
of	O
the	O
dhtt-ko	O
mutants=47.7±6.1	O
;	O
P	O
<	O
0.0001	O
.	O
(	O
R	O
)	O

Quantification	O
of	O
the	O
average	O
total	O
area	O
covered	O
by	O
each	O
A307-positive	O
axonal	O
terminus	O
.	O

The	O
genotypes	O
of	O
each	O
fly	O
line	O
tested	O
are	O
indicated	O
under	O
each	O
chart	O
.	O

WT=w1118	O
wild-type	O
control	O
.	O

The	O
data	O
in	O
(	O
P–R	O
)	O
are	O
presented	O
as	O
the	O
means±s.e	O
.	O

To	O
examine	O
the	O
effect	O
of	O
dhtt	O
loss-of-function	O
on	O
the	O
detailed	O
structure	O
of	O
individual	O
neurons	O
in	O
the	O
brain	O
,	O
we	O
used	O
the	O
A307-Gal4	O
line	O
,	O
which	O
labels	O
the	O
pair	O
of	O
giant	O
fiber	O
(	O
GF	O
)	O
neurons	O
and	O
a	O
small	O
number	O
of	O
other	O
neurons	O
of	O
unknown	O
identity	O
in	O
the	O
adult	O
brain	O
,	O
to	O
examine	O
axonal	O
projection	O
patterns	O
and	O
the	O
fine	O
axonal	O
terminal	O
structure	O
of	O
individual	O
neurons	O
(	O
Phelan	O
et	O
al.	O
,	O
1996	O
)	O
(	O
Fig	O
.	O
7	O
)	O
.	O

Among	O
the	O
A307-Gal4	O
labeled	O
neurons	O
,	O
one	O
pair	O
,	O
located	O
at	O
the	O
dorsal-lateral	O
edge	O
of	O
the	O
brain	O
,	O
projects	O
a	O
prominent	O
axon	O
tract	O
along	O
the	O
dorsal-posterior	O
surface	O
to	O
the	O
dorsal-central	O
region	O
of	O
the	O
brain	O
,	O
forming	O
extensive	O
dendritic	O
connections	O
(	O
Fig	O
.	O
7B–D	O
;	O
supplementary	O
material	O
Fig	O
.	O
S4	O
)	O
.	O

These	O
neurons	O
further	O
extend	O
their	O
projections	O
anteriorly	O
,	O
establishing	O
a	O
complex	O
axon	O
terminal	O
structure	O
with	O
extensive	O
varicosities	O
and	O
fine	O
branches	O
above	O
the	O
antennal	O
lobe	O
region	O
of	O
the	O
brain	O
(	O
Fig	O
.	O
7E	O
,	O
F	O
,	O
K	O
;	O
supplementary	O
material	O
Fig	O
.	O
S4	O
)	O
.	O

In	O
dhtt-ko	O
mutants	O
,	O
the	O
axonal	O
projections	O
of	O
A307-positive	O
neurons	O
follow	O
the	O
same	O
path	O
and	O
their	O
axons	O
terminate	O
at	O
similar	O
locations	O
to	O
those	O
in	O
wild-type	O
flies	O
;	O
this	O
is	O
consistent	O
with	O
the	O
observation	O
that	O
dhtt	O
does	O
not	O
affect	O
axonal	O
integrity	O
or	O
pathfinding	O
(	O
Fig	O
.	O
7G	O
,	O
H	O
)	O
.	O

Interestingly	O
,	O
axonal	O
termini	O
from	O
both	O
wild-type	O
and	O
dhtt-ko	O
flies	O
show	O
a	O
similar	O
age-dependent	O
maturation	O
process	O
,	O
whereas	O
axonal	O
termini	O
in	O
young	O
adult	O
brains	O
are	O
mainly	O
composed	O
of	O
a	O
network	O
of	O
variable	O
thin	O
branches	O
with	O
no	O
clearly	O
recognizable	O
synaptic	O
boutons	O
(	O
supplementary	O
material	O
Fig	O
.	O
S4C	O
,	O
F	O
)	O
(	O
3-day-old	O
flies	O
)	O
.	O

Mature	O
boutons	O
develop	O
as	O
the	O
animals	O
age	O
,	O
with	O
many	O
prominent	O
boutons	O
being	O
easily	O
identifiable	O
in	O
the	O
brains	O
of	O
40-day-old	O
flies	O
(	O
Fig	O
.	O
7F	O
,	O
I	O
;	O
compare	O
with	O
supplementary	O
material	O
Fig	O
.	O
S4C	O
,	O
F	O
)	O
.	O

Owing	O
to	O
the	O
significant	O
variation	O
in	O
their	O
structure	O
and	O
the	O
lack	O
of	O
recognizable	O
boutons	O
,	O
it	O
is	O
difficult	O
to	O
directly	O
quantify	O
and	O
compare	O
the	O
size	O
of	O
these	O
axonal	O
termini	O
in	O
young	O
adults	O
.	O

However	C
,	C
in	C
aged	C
dhtt-ko	C
mutants	C
,	C
it	C
is	C
apparent	C
that	C
the	C
axonal	C
termini	C
contain	C
a	C
significantly	C
reduced	C
number	C
of	C
varicosities	C
and	C
branches	C
(	C
Fig	C
.	C
7H	C
,	C
I	C
,	C
N	C
)	C
.	C

Quantification	O
of	O
the	O
total	O
area	O
covered	O
by	O
each	O
axonal	O
terminus	O
revealed	O
that	O
the	O
A307-positive	O
axonal	O
termini	O
in	O
40-day-old	O
dhtt-ko	O
mutants	O
cover	O
about	O
half	O
of	O
the	O
area	O
compared	O
with	O
controls	O
(	O
Fig	O
.	O
7R	O
)	O
(	O
average	O
area	O
covered	O
by	O
each	O
axonal	O
terminus	O
:	O
wild-type	O
control=168.7±8.0	O
µm2	O
,	O
dhtt-ko	O
mutant=86.1±7.2	O
µm2	O
;	O
P	O
<	O
0.0001	O
;	O
total	O
number	O
of	O
A307-positive	O
axonal	O
termini	O
quantified	O
:	O
wild-type	O
control	O
,	O
n=18	O
;	O
dhtt-ko	O
mutants	O
,	O
n=17	O
)	O
.	O

To	C
rule	C
out	C
the	C
possibility	C
that	C
this	C
reduced	C
complexity	C
was	C
because	C
of	C
the	C
accelerated	C
aging	C
process	C
or	C
a	C
secondary	C
effect	C
associated	C
with	C
the	C
reduced	C
mobility	C
of	C
dhtt-ko	C
mutants	C
,	C
we	C
examined	C
the	C
axonal	C
termini	C
of	C
the	C
A307-positive	C
neurons	C
in	C
83-day-old	C
wild-type	C
flies	C
,	C
as	C
animals	C
at	C
this	C
age	C
are	C
near	C
the	C
end	C
of	C
their	C
life	C
span	C
and	C
have	C
severely	C
reduced	C
mobility	C
.	C

The	O
structure	O
of	O
the	O
axonal	O
termini	O
in	O
these	O
flies	O
is	O
similar	O
to	O
that	O
of	O
40-day-old	O
flies	O
and	O
shows	O
no	O
obvious	O
reduction	O
in	O
terminal	O
complexity	O
(	O
supplementary	O
material	O
Fig	O
.	O
S5	O
)	O
.	O

Using	O
the	O
membrane-bound	O
mCD8-eGFP	O
reporter	O
driven	O
by	O
the	O
GF-specific	O
A307-Gal4	O
line	O
,	O
we	O
further	O
analyzed	O
the	O
axonal	O
projection	O
and	O
terminal	O
morphology	O
of	O
the	O
GF	O
neurons	O
in	O
dhtt-ko	O
mutants	O
.	O

The	O
GF	O
neurons	O
are	O
a	O
pair	O
of	O
large	O
interneurons	O
located	O
in	O
the	O
central	O
brain	O
and	O
project	O
their	O
prominent	O
axons	O
,	O
which	O
are	O
unbranched	O
,	O
to	O
the	O
mesothoracic	O
neuromere	O
(	O
T2	O
)	O
in	O
the	O
ventral	O
nerve	O
cord	O
,	O
where	O
they	O
bend	O
laterally	O
and	O
synapse	O
with	O
other	O
interneurons	O
and	O
motor	O
neurons	O
(	O
Phelan	O
et	O
al.	O
,	O
1996	O
)	O
.	O

In	O
both	O
young	O
(	O
3-day-old	O
)	O
and	O
aged	O
(	O
40-day-old	O
)	O
dhtt-ko	O
mutants	O
,	O
GF	O
neurons	O
project	O
normally	O
to	O
the	O
T2	O
neuromere	O
and	O
form	O
the	O
characteristic	O
terminal	O
bends	O
,	O
resembling	O
those	O
observed	O
in	O
wild-type	O
controls	O
(	O
supplementary	O
material	O
Fig	O
.	O
S6	O
)	O
.	O

In	O
3-day-old	O
animals	O
,	O
the	O
signal	O
intensity	O
of	O
the	O
mCD8-eGFP	O
reporter	O
at	O
the	O
GF	O
axonal	O
termini	O
was	O
similar	O
between	O
dhtt-ko	O
mutants	O
and	O
wild-type	O
controls	O
(	O
supplementary	O
material	O
Fig	O
.	O
S6B	O
,	O
C	O
)	O
(	O
total	O
number	O
of	O
3-day-old	O
GF	O
axonal	O
termini	O
examined	O
:	O
wild-type	O
control	O
,	O
n=10	O
;	O
dhtt-ko	O
mutants	O
,	O
n=12	O
)	O
.	O

However	O
,	O
in	O
40-day-old	O
animals	O
,	O
the	O
GF	O
axonal	O
termini	O
in	O
wild-type	O
controls	O
showed	O
a	O
much	O
stronger	O
enrichment	O
for	O
the	O
mCD8-eGFP	O
reporter	O
than	O
in	O
dhtt	O
mutants	O
(	O
supplementary	O
material	O
Fig	O
.	O
S6D–G	O
)	O
(	O
total	O
number	O
of	O
40-day-old	O
GF	O
axonal	O
termini	O
examined	O
:	O
wild-type	O
control	O
,	O
n=16	O
;	O
dhtt-ko	O
mutants	O
,	O
n=20	O
)	O
.	O

The	C
exact	C
nature	C
behind	C
such	C
a	C
difference	C
remains	C
to	C
be	C
clarified	C
,	C
but	C
might	C
represent	C
subtle	C
alterations	C
in	C
axonal	C
transport	C
of	C
membrane	C
proteins	C
in	C
aged	C
neurons	C
.	C

Nevertheless	C
,	C
these	C
results	C
suggest	C
that	C
dhtt	C
does	C
not	C
affect	C
axonal	C
pathfinding	C
and	C
overall	C
brain	C
organization	C
,	C
but	C
has	C
a	C
functional	C
role	C
in	C
regulating	C
the	C
complexity	C
of	C
axonal	C
termini	C
in	C
the	C
adult	C
brain	C
.	C

Loss	O
of	O
dhtt	O
enhances	O
the	O
pathogenesis	O
of	O
HD	O
flies	O

Earlier	O
studies	O
in	O
cell	O
culture	O
and	O
Htt	O
mutant	O
mice	O
have	O
shown	O
that	O
wild-type	O
Htt	O
has	O
a	O
protective	O
role	O
for	O
CNS	O
neurons	O
(	O
Dragatsis	O
et	O
al.	O
,	O
2000	O
;	O
O’Kusky	O
et	O
al.	O
,	O
1999	O
;	O
Rigamonti	O
et	O
al.	O
,	O
2000	O
;	O
Van	O
Raamsdonk	O
et	O
al.	O
,	O
2005	O
)	O
.	O

Further	C
,	C
existing	C
evidence	C
suggests	C
that	C
normal	C
Htt	C
activity	C
can	C
be	C
inactivated	C
by	C
mechanisms	C
such	C
as	C
abnormal	C
sequestration	C
into	C
insoluble	C
aggregates	C
(	C
Huang	C
et	C
al.	C
,	C
1998	C
;	C
Kazantsev	C
et	C
al.	C
,	C
1999	C
;	C
Narain	C
et	C
al.	C
,	C
1999	C
;	C
Preisinger	C
et	C
al.	C
,	C
1999	C
;	C
Wheeler	C
et	C
al.	C
,	C
2000	C
)	C
.	C

These	C
and	C
other	C
observations	C
have	C
lead	C
to	C
the	C
hypothesis	C
that	C
the	C
perturbation	C
of	C
endogenous	C
Htt	C
function	C
,	C
such	C
as	C
by	C
late-onset	C
inactivation	C
of	C
endogenous	C
Htt	C
,	C
contributes	C
to	C
HD	C
pathogenesis	C
(	C
Cattaneo	C
et	C
al.	C
,	C
2001	C
)	C
.	C

Attempts	O
to	O
test	O
this	O
directly	O
in	O
mouse	O
Hdh	O
mutants	O
have	O
been	O
complicated	O
by	O
the	O
crucial	O
role	O
of	O
Hdh	O
in	O
early	O
mouse	O
embryogenesis	O
and	O
in	O
the	O
later	O
stages	O
of	O
brain	O
development	O
(	O
Auerbach	O
et	O
al.	O
,	O
2001	O
;	O
Dragatsis	O
et	O
al.	O
,	O
2000	O
;	O
Duyao	O
et	O
al.	O
,	O
1995	O
;	O
Leavitt	O
et	O
al.	O
,	O
2001	O
;	O
Nasir	O
et	O
al.	O
,	O
1995	O
;	O
Van	O
Raamsdonk	O
et	O
al.	O
,	O
2005	O
;	O
White	O
et	O
al.	O
,	O
1997	O
;	O
Zeitlin	O
et	O
al.	O
,	O
1995	O
)	O
.	O

However	C
,	C
we	C
have	C
a	C
unique	C
opportunity	C
to	C
examine	C
this	C
in	C
Drosophila	C
because	C
dhtt	C
is	C
not	C
essential	C
for	C
fly	C
embryogenesis	C
and	C
dhtt	C
mutants	C
appear	C
to	C
behave	C
normally	C
at	C
young	C
ages	C
,	C
with	C
only	C
a	C
mild	C
axon	C
terminal	C
defect	C
in	C
the	C
brain	C
.	C

We	O
used	O
a	O
well-established	O
fly	O
HD	O
model	O
for	O
polyQ	O
toxicity	O
(	O
HD-Q93	O
)	O
,	O
in	O
which	O
the	O
human	O
HTT	O
exon	O
1	O
,	O
with	O
93	O
glutamine	O
repeats	O
,	O
is	O
expressed	O
in	O
all	O
neuronal	O
tissues	O
(	O
genotype	O
:	O
elav-Gal4/+	O
;	O
UAS-Httexon1-Q93/+	O
)	O
(	O
Steffan	O
et	O
al.	O
,	O
2001	O
)	O
.	O

The	O
HD-Q93	O
flies	O
develop	O
age-dependent	O
neurodegenerative	O
phenotypes	O
in	O
adults	O
,	O
which	O
manifest	O
as	O
initial	O
hyperactivity	O
followed	O
by	O
a	O
gradual	O
loss	O
of	O
coordination	O
and	O
a	O
decline	O
in	O
locomotor	O
ability	O
,	O
with	O
eventual	O
death	O
at	O
around	O
20	O
days	O
of	O
age	O
(	O
Fig	O
.	O
8F–H	O
)	O
.	O

The	O
HD-Q93	O
flies	O
also	O
develop	O
a	O
progressive	O
degeneration	O
of	O
both	O
the	O
brain	O
and	O
other	O
neuronal	O
tissues	O
,	O
most	O
prominently	O
in	O
the	O
photoreceptor	O
cells	O
in	O
the	O
eye	O
(	O
Steffan	O
et	O
al.	O
,	O
2001	O
)	O
.	O

Loss	O
of	O
endogenous	O
dhtt	O
enhances	O
the	O
mobility	O
and	O
viability	O
phenotypes	O
of	O
HD	O
flies	O
.	O

(	O
A–D	O
)	O
Retinal	O
organization	O
,	O
as	O
revealed	O
by	O
pseudopupil	O
imaging	O
of	O
7-day-old	O
adult	O
eyes	O
.	O

Both	O
wild-type	O
(	O
A	O
)	O
and	O
dhtt-ko	O
flies	O
(	O
B	O
)	O
had	O
well-patterned	O
ommatidium	O
with	O
seven	O
rhabdomeres	O
in	O
each	O
.	O

Adult	O
eyes	O
from	O
HD-Q93	O
(	O
C	O
)	O
and	O
HD-Q93	O
;	O
dhtt-ko	O
(	O
D	O
)	O
flies	O
both	O
showed	O
an	O
extensive	O
loss	O
of	O
photoreceptors	O
(	O
arrows	O
highlight	O
ommatidia	O
with	O
only	O
three	O
or	O
four	O
rhabdomeres	O
)	O
.	O

(	O
E	O
)	O
Histogram	O
showing	O
the	O
number	O
of	O
remaining	O
photoreceptors	O
per	O
ommatidium	O
in	O
11-d	O
ay-old	O
adults	O
.	O

A	O
similar	O
profile	O
of	O
degeneration	O
was	O
observed	O
for	O
HD-Q93	O
flies	O
(	O
red	O
)	O
and	O
HD-Q93	O
;	O
dhtt-ko	O
flies	O
(	O
blue	O
)	O
.	O

(	O
F–H	O
)	O
Quantification	O
of	O
climbing	O
ability	O
(	O
F	O
)	O
,	O
spontaneous	O
locomotion	O
(	O
G	O
)	O
and	O
age-dependent	O
survival	O
rate	O
(	O
H	O
)	O
.	O

The	O
genotypes	O
for	O
each	O
of	O
the	O
fly	O
lines	O
tested	O
are	O
provided	O
within	O
each	O
chart	O
.	O

HD	O
flies	O
with	O
a	O
background	O
dhtt-ko	O
mutation	O
show	O
an	O
accelerated	O
loss	O
of	O
mobility	O
(	O
F	O
,	O
G	O
)	O
and	O
earlier	O
lethality	O
(	O
H	O
)	O
.	O

The	O
data	O
in	O
(	O
E–H	O
)	O
are	O
presented	O
as	O
the	O
means±s.e	O
.	O

After	O
introducing	O
HD-Q93	O
into	O
the	O
dhtt	O
mutant	O
background	O
(	O
‘HD-Q93	O
;	O
dhtt-ko’	O
flies	O
;	O
genotype	O
:	O
elav-Gal4/+	O
;	O
UAS-Httexon1-Q93/+	O
;	O
dhtt-ko/dhtt-ko	O
)	O
,	O
we	O
examined	O
the	O
eye	O
degeneration	O
phenotype	O
by	O
quantifying	O
the	O
number	O
of	O
rhabdomeres	O
in	O
each	O
ommatidia	O
as	O
the	O
animals	O
age	O
.	O

The	O
loss	O
of	O
photoreceptor	O
cells	O
in	O
HD-Q93	O
flies	O
was	O
not	O
significantly	O
enhanced	O
in	O
the	O
absence	O
of	O
endogenous	O
dhtt	O
(	O
Fig	O
.	O
8A–E	O
)	O
.	O

For	O
example	O
,	O
at	O
11	O
days	O
of	O
age	O
,	O
approximately	O
40	O
%	O
of	O
ommatidia	O
lost	O
three	O
photoreceptors	O
in	O
both	O
HD-Q93	O
and	O
HD-Q93	O
;	O
dhtt-ko	O
flies	O
(	O
Fig	O
.	O
8E	O
)	O
(	O
number	O
of	O
ommatidia	O
with	O
four	O
photoreceptors	O
:	O
HD-Q93=42.6±2.9	O
%	O
,	O
n=562	O
,	O
eight	O
adult	O
eyes	O
analyzed	O
;	O
HD-Q93	O
;	O
dhtt-ko=37.6±4.1	O
%	O
,	O
n=266	O
,	O
seven	O
adult	O
eyes	O
analyzed	O
;	O
the	O
difference	O
was	O
statistically	O
insignificant	O
,	O
P	O
>	O
0.5	O
)	O
.	O

Further	O
,	O
the	O
overall	O
profile	O
of	O
the	O
remaining	O
photoreceptors	O
per	O
a	O
declining	O
mobility	O
that	O
could	O
be	O
detected	O
as	O
early	O
as	O
5	O
days	O
of	O
age	O
ommatidia	O
was	O
also	O
similar	O
between	O
these	O
flies	O
(	O
Fig	O
.	O
8E	O
)	O
.	O

Interestingly	O
,	O
although	O
these	O
HD-Q93	O
;	O
dhtt-ko	O
flies	O
showed	O
normal	O
mobility	O
at	O
the	O
beginning	O
of	O
their	O
adult	O
life	O
,	O
they	O
displayed	O
a	O
declining	O
mobility	O
that	O
could	O
be	O
detected	O
as	O
early	O
as	O
5	O
days	O
of	O
age	O
and	O
that	O
rapidly	O
deteriorated	O
over	O
the	O
next	O
few	O
days	O
(	O
supplementary	O
material	O
Movies	O
4–8	O
)	O
.	O

During	O
this	O
time	O
,	O
the	O
flies	O
become	O
progressively	O
uncoordinated	O
,	O
showing	O
an	O
increasing	O
frequency	O
of	O
both	O
faltering	O
while	O
walking	O
and	O
falling	O
during	O
climbing	O
(	O
Fig	O
.	O
8G	O
;	O
supplementary	O
material	O
Movies	O
4–8	O
)	O
.	O

In	O
a	O
standard	O
climbing	O
assay	O
,	O
almost	O
all	O
3-day-old	O
HD-Q93	O
;	O
dhtt-ko	O
flies	O
could	O
successfully	O
climb	O
to	O
the	O
top	O
of	O
a	O
vial	O
,	O
which	O
is	O
similar	O
to	O
that	O
observed	O
for	O
wild-type	O
controls	O
.	O

However	O
,	O
by	O
day	O
11	O
,	O
only	O
around	O
10	O
%	O
of	O
viable	O
HD-Q93	O
;	O
dhtt-ko	O
flies	O
could	O
make	O
it	O
to	O
the	O
top	O
,	O
whereas	O
the	O
success	O
rate	O
was	O
61	O
%	O
for	O
HD-Q93	O
flies	O
,	O
and	O
more	O
than	O
94	O
%	O
for	O
wild-type	O
and	O
dhtt-ko	O
flies	O
(	O
Fig	O
.	O
8F	O
)	O
[	O
based	O
on	O
an	O
average	O
of	O
at	O
least	O
five	O
independent	O
assays	O
of	O
20	O
flies	O
for	O
each	O
genotype	O
at	O
the	O
given	O
age	O
;	O
compared	O
with	O
wild-type	O
controls	O
on	O
day	O
11	O
,	O
the	O
results	O
from	O
dhtt-ko	O
flies	O
were	O
not	O
significant	O
(	O
P=0.30	O
)	O
,	O
whereas	O
the	O
results	O
from	O
HD-Q93	O
and	O
HD-Q93	O
;	O
dhtt-ko	O
flies	O
were	O
significant	O
(	O
P	O
<	O
0.0001	O
)	O
]	O
.	O

Similarly	O
,	O
when	O
spontaneous	O
locomotion	O
was	O
tested	O
,	O
the	O
HD-Q93	O
;	O
dhtt-ko	O
flies	O
showed	O
a	O
more	O
rapid	O
decline	O
in	O
motility	O
over	O
time	O
,	O
and	O
by	O
day	O
9	O
,	O
these	O
flies	O
were	O
less	O
than	O
half	O
as	O
active	O
as	O
those	O
in	O
the	O
other	O
groups	O
(	O
Fig	O
.	O
8G	O
)	O
(	O
activity	O
was	O
measured	O
by	O
the	O
number	O
of	O
spontaneous	O
turns	O
performed	O
every	O
4	O
minutes	O
;	O
on	O
day	O
9	O
,	O
HD-Q93	O
;	O
dhtt-ko=26.4±5.9	O
,	O
n=9	O
;	O
HD-Q93=66.5±5.0	O
,	O
n=8	O
;	O
elav-Gal4	O
;	O
dhtt-ko	O
control=60.6±4.3	O
,	O
n=9	O
;	O
UAS-Httex1Q93	O
;	O
dhtt-ko	O
control=66.2±3.0	O
,	O
n=9	O
;	O
the	O
HD-Q93	O
;	O
dhtt-ko	O
results	O
were	O
statistically	O
significant	O
when	O
compared	O
with	O
UAS-Httex1Q93	O
;	O
dhtt-ko	O
control	O
flies	O
,	O
P=0.00002	O
)	O
.	O

Furthermore	O
,	O
the	O
life	O
span	O
of	O
HD-Q93	O
;	O
dhtt-ko	O
flies	O
was	O
shortened	O
significantly	O
,	O
with	O
half	O
of	O
them	O
dying	O
by	O
day	O
8	O
and	O
almost	O
all	O
of	O
them	O
by	O
day	O
14	O
.	O

In	O
contrast	O
,	O
only	O
about	O
7	O
%	O
of	O
the	O
HD-Q93	O
flies	O
died	O
at	O
day	O
8	O
and	O
half	O
of	O
them	O
by	O
day	O
14	O
(	O
Fig	O
.	O
8H	O
)	O
[	O
viability	O
at	O
day	O
8	O
:	O
HD-Q93	O
;	O
dhtt-ko=45.0±3.2	O
%	O
,	O
n=409	O
(	O
from	O
four	O
different	O
crosses	O
)	O
;	O
HD-Q93=93.1±1.7	O
%	O
,	O
n=1082	O
(	O
from	O
eight	O
different	O
crosses	O
)	O
;	O
the	O
difference	O
between	O
HD-Q93	O
and	O
HD-Q93	O
;	O
dhtt-ko	O
flies	O
was	O
statistically	O
significant	O
,	O
P=0.0003	O
]	O
.	O

Notably	O
,	O
at	O
day	O
15	O
,	O
dhtt-ko	O
mutants	O
were	O
healthy	O
and	O
displayed	O
similar	O
mobility	O
to	O
wild-type	O
controls	O
(	O
Fig	O
.	O
5A	O
,	O
B	O
)	O
.	O

To	O
understand	O
the	O
underlying	O
pathology	O
of	O
these	O
phenotypes	O
,	O
we	O
further	O
examined	O
the	O
brain	O
structure	O
of	O
these	O
flies	O
.	O

Compared	O
with	O
HD-Q93	O
flies	O
of	O
the	O
same	O
age	O
,	O
the	O
brains	O
of	O
HD-Q93	O
;	O
dhtt-ko	O
flies	O
had	O
already	O
developed	O
a	O
more	O
severe	O
pathology	O
at	O
5	O
days	O
.	O

Notably	O
,	O
the	O
MBs	O
appeared	O
less	O
organized	O
–	O
the	O
characteristic	O
bulged	O
tip	O
of	O
the	O
vertical	O
α-axonal	O
lobes	O
,	O
which	O
were	O
prominent	O
in	O
HD-Q93	O
flies	O
(	O
Fig	O
.	O
9C	O
,	O
white	O
arrows	O
)	O
(	O
n=14	O
)	O
and	O
other	O
controls	O
,	O
was	O
largely	O
unrecognizable	O
in	O
95	O
%	O
of	O
HD-Q93	O
;	O
dhtt-ko	O
flies	O
(	O
n=17/18	O
)	O
(	O
Fig	O
.	O
9H	O
,	O
white	O
arrows	O
)	O
(	O
supplementary	O
material	O
Figs	O
S7	O
and	O
S8	O
)	O
.	O

The	C
clear	C
separation	C
,	C
along	C
the	C
midline	C
,	C
between	C
the	C
pair	C
of	C
medially	C
projected	C
ß-lobes	C
,	C
which	C
was	C
obvious	C
in	C
HD-Q93	C
flies	C
(	C
Fig	C
.	C
9C	C
,	C
white	C
arrow	C
)	C
(	C
supplementary	C
material	C
Figs	C
S7	C
and	C
S8	C
)	C
(	C
n=14	C
)	C
and	C
wild-type	C
flies	C
(	C
Fig	C
.	C
7J	C
)	C
,	C
also	C
became	C
less	C
distinct	C
and	C
often	C
appeared	C
to	C
be	C
merged	C
in	C
HD-Q93	C
;	C
dhtt-ko	C
flies	C
(	C
n=13/18	C
)	C
(	C
Fig	C
.	C
9H	C
,	C
white	C
arrow	C
)	C
(	C
supplementary	C
material	C
Figs	C
S7	C
and	C
S8	C
)	C
.	C

In	O
addition	O
,	O
the	O
anti-FasII	O
staining	O
of	O
the	O
MBs	O
was	O
not	O
as	O
strong	O
in	O
HD-Q93	O
;	O
dhtt-ko	O
flies	O
as	O
in	O
HD-Q93	O
flies	O
(	O
Fig	O
.	O
9C	O
,	O
H	O
;	O
supplementary	O
material	O
Figs	O
S7	O
and	O
S8	O
)	O
.	O

Quantification	O
of	O
MB	O
size	O
and	O
FasII	O
staining	O
signals	O
revealed	O
that	O
there	O
was	O
approximately	O
a	O
7	O
%	O
reduction	O
in	O
the	O
average	O
size	O
of	O
MBs	O
in	O
HD-Q93	O
;	O
dhtt-ko	O
mutants	O
compared	O
with	O
HD-Q93	O
controls	O
(	O
Fig	O
.	O
9K	O
)	O
.	O

The	O
γ-lobe	O
signals	O
were	O
too	O
weak	O
to	O
be	O
reliably	O
tracked	O
in	O
both	O
HD-Q93	O
and	O
HD-Q93	O
;	O
dhtt-ko	O
flies	O
,	O
so	O
only	O
the	O
α-	O
and	O
ß-lobes	O
in	O
each	O
MB	O
were	O
measured	O
(	O
average	O
MB	O
size	O
:	O
HD-Q93=11,137±314	O
µm2	O
,	O
n=6	O
;	O
HD-Q93	O
;	O
dhtt-ko=10,412±212	O
µm2	O
,	O
n=7	O
;	O
P=0.04	O
)	O
.	O

The	O
average	O
signal	O
intensity	O
of	O
FasII	O
signals	O
in	O
the	O
MBs	O
of	O
dhtt-ko	O
mutants	O
was	O
also	O
decreased	O
,	O
by	O
around	O
31	O
%	O
(	O
Fig	O
.	O
9L	O
)	O
(	O
relative	O
signal	O
intensity	O
of	O
α-	O
and	O
ß-lobes	O
in	O
the	O
MBs	O
:	O
HD-Q93=100±6.7	O
µm2	O
;	O
dhtt-ko	O
mutant=69.3±4.0	O
µm2	O
;	O
P=0.0004	O
)	O
.	O

Furthermore	O
,	O
the	O
HD-Q93	O
;	O
dhtt-ko	O
brains	O
showed	O
larger	O
areas	O
that	O
were	O
devoid	O
of	O
neuronal	O
cells	O
(	O
compare	O
Fig	O
.	O
9A	O
and	O
9D	O
with	O
Fig	O
.	O
9F	O
and	O
9I	O
,	O
respectively	O
;	O
also	O
see	O
supplementary	O
material	O
Figs	O
S7	O
and	O
S8	O
)	O
.	O

The	C
results	C
obtained	C
from	C
quantifying	C
the	C
brain	C
size	C
of	C
these	C
flies	C
suggested	C
that	C
,	C
although	C
the	C
overall	C
size	C
of	C
the	C
brains	C
was	C
similar	C
between	C
HD-Q93	C
and	C
HD-Q93	C
;	C
dhtt-ko	C
flies	C
(	C
Fig	C
.	C
9M	C
)	C
(	C
average	C
brain	C
size	C
:	C
HD-Q93=119,279±2015	C
µm2	C
,	C
n=7	C
;	C
HD-Q93	C
;	C
dhtt-ko=115,389±2412	C
µm2	C
,	C
n=7	C
;	C
P=0.003	C
)	C
,	C
the	C
total	C
area	C
that	C
was	C
devoid	C
of	C
neuronal	C
cells	C
was	C
increased	C
by	C
about	C
25	C
%	C
(	C
Fig	C
.	C
9N	C
)	C
(	C
total	C
area	C
devoid	C
of	C
neurons	C
cells	C
:	C
HD-Q93=26,324±1869	C
µm2	C
,	C
n=7	C
;	C
HD-Q93	C
;	C
dhtt-ko=32,945±2494	C
µm2	C
,	C
n=7	C
;	C
P=0.03	C
)	C
.	C

Together	C
,	C
these	C
results	C
suggest	C
that	C
there	C
is	C
increased	C
disorganization	C
and	C
an	C
increase	C
in	C
neuronal	C
loss	C
in	C
the	C
brains	C
of	C
HD-Q93	C
;	C
dhtt-ko	C
flies	C
.	C

Thus	O
,	O
loss	O
of	O
endogenous	O
dhtt	O
renders	O
animals	O
more	O
vulnerable	O
to	O
the	O
toxicity	O
associated	O
with	O
polyQ-expanded	O
Htt	O
.	O

Loss	O
of	O
endogenous	O
dhtt	O
affects	O
the	O
pathogenesis	O
of	O
HD	O
flies	O
.	O

(	O
A–J	O
)	O
Loss	O
of	O
endogenous	O
dhtt	O
causes	O
enhanced	O
brain	O
pathology	O
in	O
HD	O
flies	O
.	O

Confocal	O
images	O
of	O
adult	O
brains	O
showing	O
the	O
distribution	O
of	O
neuronal	O
cells	O
(	O
anti-Elav	O
,	O
green	O
)	O
,	O
cell	O
nuclei	O
(	O
DAPI	O
,	O
white	O
)	O
and	O
MBs	O
(	O
anti-FasII	O
,	O
red	O
)	O
in	O
5-day-old	O
HD-Q93	O
(	O
D–H	O
)	O
and	O
HD-Q93	O
;	O
dhtt-ko	O
(	O
I–M	O
)	O
brains	O
.	O

As	O
cells	O
in	O
the	O
fly	O
brain	O
are	O
mainly	O
localized	O
at	O
its	O
surface	O
,	O
the	O
anterior	O
(	O
A	O
,	O
B	O
,	O
F	O
,	O
G	O
)	O
and	O
posterior	O
(	O
D	O
,	O
E	O
,	O
I	O
,	O
J	O
)	O
halves	O
of	O
the	O
brains	O
are	O
projected	O
separately	O
for	O
better	O
visualization	O
of	O
the	O
distribution	O
pattern	O
.	O

Note	O
the	O
enlarged	O
regions	O
devoid	O
of	O
neuronal	O
cells	O
in	O
the	O
HD-Q93	O
;	O
dhtt-ko	O
brain	O
(	O
F	O
)	O
(	O
the	O
areas	O
within	O
the	O
white	O
lines	O
)	O
compared	O
with	O
the	O
corresponding	O
regions	O
in	O
the	O
HD-Q93	O
brain	O
(	O
A	O
)	O
.	O

The	O
arrows	O
in	O
(	O
I	O
)	O
indicate	O
the	O
areas	O
lacking	O
neuronal	O
cells	O
at	O
the	O
posterior	O
of	O
the	O
brain	O
.	O

(	O
C	O
,	O
H	O
)	O
The	O
MB	O
in	O
the	O
HD-Q93	O
;	O
dhtt-ko	O
brain	O
(	O
H	O
)	O
is	O
also	O
less	O
well	O
organized	O
and	O
shows	O
weaker	O
signal	O
intensity	O
than	O
in	O
the	O
HD-Q93	O
brain	O
(	O
C	O
)	O
.	O

The	C
white	C
arrowheads	C
highlight	C
the	C
clear	C
separation	C
,	C
along	C
the	C
midline	C
,	C
between	C
the	C
two	C
medial	C
ß-lobes	C
in	C
the	C
HD-Q93	C
;	C
dhtt-ko	C
brain	C
(	C
C	C
)	C
,	C
this	C
is	C
less	C
distinct	C
and	C
appears	C
merged	C
in	C
the	C
HD-Q93	C
brain	C
(	C
H	C
)	C
.	C

White	O
arrows	O
indicate	O
the	O
bulged	O
tip	O
of	O
the	O
vertical	O
α-lobes	O
,	O
which	O
become	O
less	O
distinct	O
in	O
HD-Q93	O
;	O
dhtt-ko	O
brains	O
(	O
H	O
)	O
.	O

WT=w1118	O
wild-type	O
control	O
.	O

Bars	O
,	O
50	O
µm	O
(	O
all	O
panels	O
)	O
.	O

(	O
K	O
,	O
L	O
)	O
Quantification	O
of	O
the	O
average	O
MB	O
size	O
(	O
K	O
)	O
and	O
relative	O
signal	O
intensity	O
(	O
L	O
)	O
of	O
MBs	O
in	O
HD-Q93	O
(	O
blue	O
)	O
and	O
HD-Q93	O
;	O
dhtt-ko	O
mutants	O
(	O
red	O
)	O
,	O
as	O
revealed	O
by	O
anti-FasII	O
staining	O
.	O

In	O
both	O
HD-Q93	O
and	O
HD-Q93	O
;	O
dhtt-ko	O
flies	O
,	O
the	O
FasII	O
signals	O
for	O
the	O
γ-lobe	O
in	O
MBs	O
were	O
too	O
weak	O
to	O
be	O
tracked	O
reliably	O
(	O
see	O
supplementary	O
material	O
Figs	O
S7	O
and	O
S8	O
)	O
;	O
therefore	O
,	O
only	O
the	O
α-	O
and	O
ß-lobes	O
in	O
each	O
MB	O
were	O
measured	O
.	O

(	O
M	O
,	O
N	O
)	O
Quantification	O
of	O
the	O
average	O
brain	O
size	O
(	O
M	O
)	O
and	O
the	O
total	O
size	O
of	O
the	O
regions	O
devoid	O
of	O
neuronal	O
cells	O
in	O
the	O
anterior	O
brain	O
(	O
N	O
)	O
,	O
as	O
revealed	O
by	O
using	O
neuronal-specific	O
staining	O
with	O
an	O
antibody	O
against	O
Elav	O
.	O

The	O
data	O
in	O
(	O
K–N	O
)	O
are	O
presented	O
as	O
the	O
means±s.e	O
.	O

DISCUSSION	O

Htt	O
has	O
been	O
characterized	O
extensively	O
in	O
mammalian	O
cell	O
culture	O
and	O
in	O
mouse	O
systems	O
(	O
Cattaneo	O
et	O
al.	O
,	O
2001	O
;	O
Harjes	O
and	O
Wanker	O
,	O
2003	O
)	O
.	O

However	O
,	O
only	O
a	O
few	O
functional	O
studies	O
have	O
been	O
performed	O
on	O
its	O
homologs	O
in	O
other	O
model	O
organisms	O
.	O

By	O
deleting	O
the	O
dhtt	O
gene	O
,	O
we	O
demonstrate	O
that	O
Htt	O
is	O
not	O
required	O
for	O
normal	O
development	O
of	O
Drosophila	O
,	O
but	O
instead	O
has	O
an	O
essential	O
role	O
for	O
the	O
long-term	O
mobility	O
and	O
survival	O
of	O
adult	O
animals	O
.	O

Subsequent	O
analyses	O
revealed	O
that	O
loss	O
of	O
dhtt	O
mildly	O
affects	O
the	O
integrity	O
of	O
adult	O
brains	O
.	O

Further	O
,	O
in	O
the	O
absence	O
of	O
endogenous	O
dhtt	O
,	O
the	O
neurodegenerative	O
phenotypes	O
associated	O
with	O
a	O
Drosophila	O
model	O
of	O
polyQ	O
toxicity	O
were	O
enhanced	O
significantly	O
.	O

The	O
role	O
of	O
Htt	O
homologs	O
in	O
animal	O
development	O

Earlier	O
studies	O
showed	O
that	O
mice	O
lacking	O
Htt	O
die	O
during	O
early	O
embryogenesis	O
(	O
Duyao	O
et	O
al.	O
,	O
1995	O
;	O
Nasir	O
et	O
al.	O
,	O
1995	O
;	O
Zeitlin	O
et	O
al.	O
,	O
1995	O
)	O
.	O

It	O
is	O
surprising	O
to	O
find	O
that	O
dhtt	O
is	O
dispensable	O
during	O
Drosophila	O
development	O
.	O

As	C
no	C
other	C
Htt	C
homolog	C
exists	C
in	C
the	C
fly	C
genome	C
(	C
Li	C
et	C
al.	C
,	C
1999	C
)	C
,	C
such	C
a	C
mild	C
phenotype	C
is	C
unlikely	C
to	C
be	C
caused	C
by	C
a	C
functional	C
redundancy	C
resulting	C
from	C
another	C
Htt-like	C
gene	C
in	C
Drosophila	C
.	C

Considering	C
the	C
evolutionary	C
distance	C
between	C
Drosophila	C
and	C
mammals	C
,	C
such	C
an	C
observation	C
might	C
indicate	C
that	C
the	C
Drosophila	C
and	C
mammalian	C
Htt	C
proteins	C
,	C
with	C
their	C
relatively	C
restricted	C
sequence	C
homology	C
,	C
are	C
not	C
functionally	C
conserved	C
.	C

However	C
,	C
this	C
phenotypic	C
discrepancy	C
might	C
also	C
reflect	C
intrinsic	C
differences	C
during	C
mouse	C
and	C
fly	C
embryogenesis	C
.	C

In	O
a	O
chimeric	O
analysis	O
of	O
Htt	O
mutant	O
mice	O
,	O
Dragatsis	O
et	O
al	O
.	O
showed	O
that	O
the	O
early	O
embryonic	O
lethality	O
of	O
Htt-null	O
mice	O
was	O
primarily	O
the	O
result	O
of	O
a	O
crucial	O
role	O
of	O
Hdh	O
in	O
extraembryonic	O
membranes	O
(	O
Dragatsis	O
et	O
al.	O
,	O
1998	O
)	O
.	O

It	C
is	C
probable	C
that	C
Drosophila	C
does	C
not	C
require	C
equivalent	C
tissues	C
,	C
such	C
as	C
extraembryonic	C
membranes	C
,	C
to	C
support	C
its	C
early	C
development	C
and	C
that	C
its	C
embryogenesis	C
can	C
proceed	C
normally	C
in	C
the	C
absence	C
of	C
dhtt	C
.	C

Although	O
an	O
Htt	O
homolog	O
is	O
found	O
in	O
Drosophila	O
and	O
vertebrates	O
,	O
no	O
Htt	O
homolog	O
has	O
been	O
found	O
in	O
yeast	O
or	O
C.	O
elegans	O
(	O
Li	O
et	O
al.	O
,	O
1999	O
)	O
.	O

The	C
absence	C
of	C
an	C
Htt	C
homolog	C
in	C
C.	C
elegans	C
suggests	C
that	C
Htt	C
does	C
not	C
have	C
a	C
function	C
that	C
is	C
essential	C
for	C
the	C
development	C
of	C
invertebrates	C
in	C
general	C
,	C
which	C
is	C
in	C
agreement	C
with	C
our	C
observation	C
that	C
dhtt	C
is	C
dispensable	C
for	C
normal	C
development	C
of	C
Drosophila	C
.	C

Interestingly	C
,	C
a	C
phylogenetic	C
comparison	C
of	C
Htt	C
proteins	C
from	C
different	C
species	C
postulates	C
that	C
Htt	C
in	C
the	C
protostome	C
(	C
which	C
includes	C
Drosophilids	C
)	C
might	C
be	C
dispensable	C
because	C
,	C
when	C
compared	C
with	C
the	C
deuterostome	C
branch	C
,	C
evolution	C
of	C
the	C
Htt	C
genes	C
along	C
the	C
protostome	C
branch	C
is	C
more	C
heterogeneous	C
(	C
Tartari	C
et	C
al.	C
,	C
2008	C
)	C
.	C

Further	C
studies	C
will	C
be	C
required	C
to	C
determine	C
whether	C
the	C
mammalian	C
Htt	C
gene	C
can	C
rescue	C
Drosophila	C
dhtt-null	C
phenotypes	C
.	C

Analyses	C
of	C
dhtt-ko	C
mutants	C
suggest	C
that	C
loss	C
of	C
dhtt	C
does	C
not	C
affect	C
synapse	C
formation	C
,	C
neurotransmission	C
or	C
axonal	C
transport	C
(	C
Figs	C
3–6	C
)	C
,	C
which	C
is	C
in	C
agreement	C
with	C
the	C
absence	C
of	C
an	C
Htt	C
homolog	C
in	C
the	C
worm	C
,	C
in	C
which	C
the	C
essential	C
components	C
of	C
these	C
cellular	C
processes	C
are	C
conserved	C
.	C

It	C
is	C
possible	C
that	C
Htt	C
still	C
regulates	C
these	C
cellular	C
processes	C
,	C
but	C
with	C
a	C
minor	C
role	C
.	C

Extrapolating	C
,	C
there	C
is	C
a	C
possibility	C
that	C
the	C
function	C
of	C
Htt	C
is	C
associated	C
with	C
a	C
novel	C
cellular	C
process	C
and/or	C
animal	C
function	C
that	C
has	C
been	C
acquired	C
during	C
evolution	C
.	C

For	O
example	O
,	O
although	O
dhtt	O
is	O
dispensable	O
for	O
Drosophila	O
development	O
,	O
it	O
is	O
important	O
for	O
maintaining	O
the	O
long-term	O
mobility	O
and	O
viability	O
of	O
adult	O
animals	O
(	O
Figs	O
5	O
and	O
6	O
)	O
.	O

Compared	C
to	C
the	C
worm	C
,	C
Drosophila	C
has	C
a	C
relatively	C
long	C
life	C
span	C
,	C
a	C
more	C
complex	C
nervous	C
system	C
and	C
a	C
more	C
active	C
life	C
cycle	C
,	C
raising	C
an	C
intriguing	C
possibility	C
that	C
the	C
function	C
of	C
Htt	C
might	C
be	C
directly	C
related	C
to	C
these	C
higher	C
functions	C
in	C
adult	C
animals	C
.	C

The	O
role	O
of	O
Htt	O
in	O
adult	O
brain	O

Although	C
dhtt	C
is	C
dispensable	C
for	C
normal	C
Drosophila	C
development	C
,	C
dhtt	C
mutants	C
show	C
significantly	C
reduced	C
mobility	C
and	C
viability	C
as	C
they	C
age	C
,	C
indicating	C
an	C
important	C
role	C
of	C
dhtt	C
in	C
maintaining	C
the	C
long-term	C
functioning	C
and	C
survival	C
of	C
adult	C
animals	C
(	C
Fig	C
.	C
5	C
)	C
.	C

Analysis	O
of	O
dhtt	O
mutants	O
revealed	O
a	O
mild	O
abnormality	O
in	O
MB	O
structure	O
and	O
a	O
reduction	O
in	O
the	O
complexity	O
of	O
axonal	O
termini	O
in	O
the	O
brain	O
(	O
Fig	O
.	O
7	O
)	O
.	O

Similarly	O
,	O
Htt	O
mutant	O
mice	O
with	O
a	O
reduced	O
level	O
of	O
Htt	O
expression	O
display	O
severe	O
brain	O
abnormalities	O
,	O
even	O
though	O
non-neuronal	O
tissue	O
forms	O
normally	O
(	O
White	O
et	O
al.	O
,	O
1997	O
)	O
.	O

Targeted	C
inactivation	C
of	C
Hdh	C
in	C
the	C
mouse	C
forebrain	C
also	C
causes	C
a	C
progressive	C
neurodegeneration	C
phenotype	C
,	C
suggesting	C
that	C
Hdh	C
is	C
required	C
in	C
the	C
development	C
and	C
survival	C
of	C
neuronal	C
cells	C
(	C
Dragatsis	C
et	C
al.	C
,	C
2000	C
)	C
.	C

It	C
remains	C
to	C
be	C
determined	C
whether	C
common	C
underlying	C
molecular	C
mechanisms	C
are	C
responsible	C
for	C
the	C
observed	C
brain	C
phenotypes	C
in	C
the	C
fly	C
and	C
mouse	C
.	C

Nonetheless	C
,	C
considering	C
the	C
evolutionary	C
distance	C
between	C
Drosophila	C
and	C
the	C
mouse	C
,	C
the	C
existence	C
of	C
structural	C
defects	C
in	C
the	C
adult	C
brain	C
in	C
both	C
species	C
could	C
indicate	C
a	C
conserved	C
role	C
of	C
Htt	C
in	C
maintaining	C
neuronal	C
integrity	C
.	C

The	O
axonal	O
terminal	O
phenotype	O
in	O
dhtt	O
mutants	O
is	O
also	O
reminiscent	O
of	O
that	O
observed	O
in	O
a	O
mouse	O
knockout	O
model	O
for	O
Htt	O
(	O
Hdhex5	O
)	O
,	O
in	O
which	O
exon	O
5	O
has	O
been	O
deleted	O
(	O
Nasir	O
et	O
al.	O
,	O
1995	O
)	O
.	O

Although	O
mice	O
homozygous	O
for	O
this	O
Hdh	O
deletion	O
are	O
early	O
embryonic	O
lethal	O
,	O
Hdhex5	O
heterozygotes	O
survive	O
to	O
adulthood	O
and	O
display	O
increased	O
neuronal	O
loss	O
,	O
motor	O
and	O
cognitive	O
deficits	O
,	O
and	O
a	O
significant	O
loss	O
of	O
synapses	O
in	O
specific	O
regions	O
of	O
the	O
brain	O
(	O
Nasir	O
et	O
al.	O
,	O
1995	O
;	O
O’Kusky	O
et	O
al.	O
,	O
1999	O
)	O
.	O

Synapse	C
complexity	C
can	C
be	C
modulated	C
by	C
many	C
factors	C
,	C
including	C
neuronal	C
activity	C
and	C
membrane	C
and	C
cytoskeleton	C
dynamics	C
.	C

In	C
the	C
future	C
,	C
many	C
questions	C
remain	C
to	C
be	C
answered	C
,	C
such	C
as	C
the	C
significance	C
of	C
this	C
axonal	C
terminal	C
phenotype	C
,	C
the	C
exact	C
function	C
of	C
Htt	C
in	C
axonal	C
termini	C
complexity	C
and	C
the	C
possibility	C
of	C
a	C
causal	C
link	C
between	C
this	C
brain	C
defect	C
and	C
the	C
observed	C
adult	C
mobility	C
and	C
viability	C
phenotypes	C
.	C

The	O
role	O
of	O
endogenous	O
dhtt	O
in	O
HD	O
pathogenesis	O

Extensive	O
studies	O
on	O
HD	O
and	O
other	O
polyQ	O
diseases	O
have	O
demonstrated	O
that	O
an	O
expanded	O
polyQ	O
tract	O
can	O
itself	O
be	O
neurotoxic	O
(	O
Zoghbi	O
and	O
Orr	O
,	O
2000	O
)	O
.	O

Given	C
that	C
the	C
distinctive	C
neuronal	C
loss	C
observed	C
in	C
each	C
polyQ	C
disease	C
is	C
caused	C
by	C
otherwise	C
unrelated	C
disease	C
genes	C
that	C
are	C
widely	C
expressed	C
,	C
it	C
has	C
been	C
hypothesized	C
that	C
other	C
cellular	C
factors	C
affect	C
disease	C
pathogenesis	C
(	C
Cattaneo	C
et	C
al.	C
,	C
2001	C
;	C
Zoghbi	C
and	C
Orr	C
,	C
2000	C
)	C
.	C

In	C
HD	C
,	C
accumulating	C
evidence	C
from	C
cell	C
culture	C
and	C
mutant	C
mouse	C
studies	C
suggest	C
that	C
wild-type	C
Htt	C
has	C
a	C
neuroprotective	C
function	C
(	C
Cattaneo	C
et	C
al.	C
,	C
2001	C
)	C
.	C

When	C
endogenous	C
wild-type	C
Hdh	C
is	C
replaced	C
by	C
yeast	C
artificial	C
chromosomes	C
(	C
YACs	C
)	C
containing	C
full-length	C
human	C
Htt	C
with	C
an	C
expanded	C
polyQ	C
tract	C
(	C
YAC46	C
,	C
YAC72	C
and	C
YAC128	C
)	C
(	C
Leavitt	C
et	C
al.	C
,	C
2001	C
;	C
Van	C
Raamsdonk	C
et	C
al.	C
,	C
2005	C
)	C
,	C
the	C
mice	C
develop	C
massive	C
cell	C
death	C
in	C
the	C
testes	C
that	C
can	C
be	C
suppressed	C
by	C
the	C
wild-type	C
Hdh	C
gene	C
,	C
suggesting	C
that	C
the	C
normal	C
function	C
of	C
Htt	C
might	C
mitigate	C
the	C
cellular	C
toxicity	C
associated	C
with	C
the	C
polyQ-expanded	C
mutant	C
Htt	C
protein	C
(	C
Leavitt	C
et	C
al.	C
,	C
2001	C
;	C
Van	C
Raamsdonk	C
et	C
al.	C
,	C
2005	C
)	C
.	C

In	C
addition	C
,	C
a	C
genome-wide	C
study	C
of	C
HD	C
animal	C
models	C
and	C
postmortem	C
tissues	C
has	C
shown	C
that	C
neuronal	C
genes	C
regulated	C
by	C
the	C
transcriptional	C
repressor	C
REST/NRSF	C
,	C
including	C
the	C
gene	C
encoding	C
BDNF	C
,	C
could	C
be	C
similarly	C
repressed	C
by	C
either	C
the	C
presence	C
of	C
the	C
polyQ-expanded	C
Htt	C
protein	C
or	C
by	C
depleting	C
endogenous	C
wild-type	C
Htt	C
(	C
Zuccato	C
et	C
al.	C
,	C
2007	C
)	C
.	C

Together	C
,	C
these	C
and	C
other	C
studies	C
support	C
the	C
hypothesis	C
that	C
loss	C
of	C
normal	C
Htt	C
function	C
affects	C
HD	C
pathogenesis	C
.	C

We	O
were	O
able	O
to	O
examine	O
the	O
effect	O
of	O
removing	O
endogenous	O
dhtt	O
on	O
the	O
pathogenesis	O
of	O
an	O
established	O
Drosophila	O
HD	O
model	O
for	O
polyQ	O
toxicity	O
(	O
HD-Q93	O
)	O
.	O

Our	O
results	O
show	O
that	O
the	O
phenotypes	O
of	O
HD-Q93	O
flies	O
,	O
including	O
mobility	O
,	O
viability	O
and	O
brain	O
pathology	O
,	O
are	O
significantly	O
exacerbated	O
in	O
the	O
absence	O
of	O
endogenous	O
dhtt	O
,	O
providing	O
in	O
vivo	O
evidence	O
that	O
loss	O
of	O
normal	O
Htt	O
function	O
can	O
accelerate	O
HD	O
pathogenesis	O
.	O

It	C
should	C
be	C
noted	C
that	C
our	C
results	C
do	C
not	C
directly	C
demonstrate	C
that	C
loss	C
of	C
the	C
endogenous	C
Htt	C
protein	C
specifically	C
affects	C
HD	C
pathogenesis	C
,	C
because	C
the	C
enhanced	C
pathology	C
might	C
be	C
the	C
result	C
of	C
an	C
additive	C
effect	C
of	C
two	C
detrimental	C
factors	C
in	C
the	C
animals	C
,	C
namely	C
the	C
presence	C
of	C
a	C
toxic	C
polyQ	C
tract	C
and	C
the	C
disturbance	C
of	C
the	C
normal	C
function	C
of	C
Htt	C
.	C

Although	C
dhtt-ko	C
mutants	C
exhibit	C
only	C
a	C
mild	C
age-dependent	C
adult	C
phenotype	C
,	C
it	C
is	C
possible	C
that	C
,	C
in	C
the	C
absence	C
of	C
endogenous	C
dhtt	C
,	C
some	C
undetected	C
cellular	C
defects	C
might	C
develop	C
that	C
render	C
the	C
animals	C
more	C
susceptible	C
to	C
other	C
cellular	C
attacks	C
.	C

In	C
the	C
presence	C
of	C
a	C
toxic	C
polyQ	C
tract	C
,	C
this	C
vulnerability	C
might	C
be	C
exposed	C
further	C
,	C
leading	C
to	C
additive	C
phenotypes	C
.	C

Our	C
result	C
is	C
in	C
agreement	C
with	C
the	C
early	C
hypothesis	C
that	C
HD	C
might	C
be	C
caused	C
by	C
the	C
combination	C
of	C
an	C
acquired	C
toxicity	C
,	C
conferred	C
by	C
the	C
expanded	C
polyQ	C
tract	C
in	C
the	C
mutated	C
Htt	C
,	C
and	C
an	C
incurred	C
neuronal	C
vulnerability	C
,	C
arising	C
from	C
the	C
loss	C
of	C
endogenous	C
Htt	C
function	C
(	C
Cattaneo	C
et	C
al.	C
,	C
2001	C
)	C
.	C

It	O
is	O
important	O
to	O
note	O
that	O
previous	O
studies	O
have	O
demonstrated	O
that	O
expansion	O
of	O
polyQ	O
tracts	O
within	O
the	O
Htt	O
protein	O
does	O
not	O
abolish	O
its	O
endogenous	O
function	O
,	O
as	O
full-length	O
Htt	O
with	O
an	O
expanded	O
polyQ	O
tract	O
can	O
fully	O
support	O
the	O
development	O
of	O
Htt-null	O
mice	O
(	O
Leavitt	O
et	O
al.	O
,	O
2001	O
;	O
Van	O
Raamsdonk	O
et	O
al.	O
,	O
2005	O
;	O
White	O
et	O
al.	O
,	O
1997	O
)	O
.	O

Recently	O
,	O
RNAi-mediated	O
depletion	O
of	O
the	O
polyQ-expanded	O
Htt	O
protein	O
has	O
been	O
proposed	O
as	O
a	O
therapeutic	O
approach	O
against	O
HD	O
(	O
Farah	O
,	O
2007	O
)	O
.	O

Our	C
data	C
,	C
together	C
with	C
previous	C
mammalian	C
studies	C
,	C
suggest	C
that	C
the	C
normal	C
function	C
of	C
Htt	C
has	C
a	C
conserved	C
neuroprotective	C
role	C
in	C
the	C
brain	C
and	C
that	C
its	C
depletion	C
could	C
render	C
neuronal	C
cells	C
more	C
vulnerable	C
to	C
the	C
toxicity	C
associated	C
with	C
the	C
polyQ	C
tract	C
(	C
Auerbach	C
et	C
al.	C
,	C
2001	C
;	C
Cattaneo	C
et	C
al.	C
,	C
2001	C
;	C
Dragatsis	C
et	C
al.	C
,	C
2000	C
;	C
Leavitt	C
et	C
al.	C
,	C
2001	C
)	C
.	C

Application	O
of	O
such	O
an	O
RNAi-based	O
strategy	O
requires	O
a	O
consideration	O
that	O
the	O
normal	O
Htt	O
function	O
be	O
preserved	O
.	O

Given	C
the	C
devastating	C
consequence	C
of	C
fully	C
progressed	C
HD	C
,	C
together	C
with	C
the	C
observations	C
that	C
Htt-null	C
neurons	C
can	C
develop	C
and	C
survive	C
in	C
the	C
adult	C
mouse	C
brain	C
and	C
that	C
dhtt-ko	C
animals	C
are	C
largely	C
normal	C
with	C
only	C
mild	C
adult	C
brain	C
defects	C
,	C
our	C
data	C
indicate	C
that	C
the	C
benefit	C
gained	C
from	C
balanced	C
administration	C
of	C
RNAi	C
knockdown	C
therapy	C
in	C
the	C
adult	C
brain	C
might	C
justify	C
the	C
relatively	C
mild	C
loss	C
caused	C
by	C
depletion	C
of	C
the	C
Htt-associated	C
neuroprotective	C
function	C
.	C

METHODS	O

Drosophila	O
stocks	O
and	O
genetics	O

Flies	O
were	O
maintained	O
at	O
25°C	O
and	O
raised	O
on	O
standard	O
Drosophila	O
medium	O
unless	O
specified	O
otherwise	O
.	O

To	O
establish	O
transgenic	O
animals	O
,	O
DNA	O
constructs	O
were	O
injected	O
into	O
w1118	O
embryos	O
together	O
with	O
the	O
pπ25.7wc	O
helper	O
plasmid	O
to	O
generate	O
germ	O
line	O
transformation	O
;	O
transformants	O
were	O
then	O
selected	O
in	O
the	O
next	O
generation	O
,	O
according	O
to	O
standard	O
procedures	O
.	O

Unless	O
specified	O
otherwise	O
,	O
flies	O
of	O
the	O
genotype	O
w1118/w1118	O
were	O
used	O
as	O
controls	O
in	O
all	O
assays	O
because	O
the	O
dhtt-ko	O
mutant	O
allele	O
was	O
generated	O
from	O
this	O
w1118	O
genetic	O
background	O
during	O
the	O
genetic	O
crosses	O
.	O

The	O
p-element	O
line	O
d08071	O
,	O
piggyBac	O
insertional	O
line	O
f05417	O
and	O
the	O
FLP	O
recombinase	O
transgene	O
line	O
[	O
genotype	O
:	O
y	O
,	O
w	O
,	O
pCaspeR-	O
(	O
hs-flipase	O
)	O
]	O
were	O
from	O
Exelixis	O
(	O
Parks	O
et	O
al.	O
,	O
2004	O
)	O
.	O

To	O
analyze	O
the	O
A307-Gal4	O
labeled	O
neurons	O
in	O
adult	O
brains	O
,	O
flies	O
with	O
genotypes	O
of	O
A307-Gal4/+	O
;	O
dhtt-ko/TM6C	O
,	O
Tb	O
and	O
UAS-mCD8-eGFP/+	O
;	O
dhtt-ko/TM6C	O
,	O
Tb	O
were	O
generated	O
and	O
crossed	O
together	O
;	O
their	O
adult	O
progenies	O
carrying	O
A307-Gal4/UAS-mCD8-eGFP	O
;	O
dhtt-ko/dhtt-ko	O
were	O
selected	O
and	O
analyzed	O
.	O

The	O
controls	O
were	O
the	O
progenies	O
from	O
crossing	O
the	O
A307-Gal4	O
line	O
with	O
the	O
UAS-mCD8-eGFP	O
line	O
.	O

HD-Q93	O
flies	O
were	O
obtained	O
by	O
crossing	O
the	O
pan-neuronal	O
line	O
elav-Gal4	O
(	O
C155	O
)	O
with	O
the	O
UAS-Httexon1-Q93	O
line	O
(	O
P468	O
)	O
provided	O
generously	O
by	O
L.	O
Thompson	O
and	O
J.	O
L.	O
Marsh	O
,	O
respectively	O
(	O
Steffan	O
et	O
al.	O
,	O
2001	O
)	O
.	O

To	O
generate	O
‘HD-Q93	O
;	O
dhtt-ko’	O
flies	O
,	O
flies	O
with	O
genotypes	O
of	O
elav-Gal4	O
(	O
c155	O
)	O
/+	O
;	O
dhtt-ko/TM6C	O
,	O
Tb	O
and	O
UAS-Httexon1-Q93/Cyo	O
;	O
dhtt-ko/TM6C	O
,	O
Tb	O
were	O
established	O
and	O
then	O
crossed	O
together	O
;	O
adult	O
progenies	O
with	O
the	O
genotype	O
of	O
elav-Gal4/+	O
;	O
UAS-Httexon1-Q93/+	O
;	O
dhtt-ko/dhtt-ko	O
were	O
then	O
selected	O
and	O
analyzed	O
.	O

Controls	O
flies	O
had	O
the	O
following	O
genotypes	O
:	O
elav-Gal4	O
(	O
C155	O
)	O
/+	O
;	O
UAS-Httexon1-Q93/+	O
;	O
elav-Gal4	O
(	O
C155	O
)	O
/+	O
;	O
dhtt-ko/dhtt-ko	O
;	O
and	O
UAS-Httexon1-Q93/+	O
;	O
dhtt-ko/dhtt-ko	O
.	O

Genetics	O
and	O
molecular	O
clonings	O
to	O
generate	O
the	O
dhtt-ko	O
mutant	O
allele	O

The	O
Df	O
(	O
98E2	O
)	O
deficiency	O
,	O
in	O
which	O
both	O
CG9990	O
and	O
dhtt	O
are	O
deleted	O
,	O
was	O
generated	O
by	O
following	O
the	O
Flp-FRT-based	O
procedure	O
,	O
as	O
described	O
previously	O
(	O
Parks	O
et	O
al.	O
,	O
2004	O
)	O
.	O

Briefly	O
,	O
the	O
p-element	O
line	O
d08071	O
(	O
inserted	O
at	O
the	O
5	O
'	O
end	O
of	O
the	O
neighboring	O
CG9990	O
gene	O
)	O
was	O
crossed	O
to	O
virgin	O
flies	O
carrying	O
an	O
FLP	O
recombinase	O
transgene	O
[	O
genotype	O
:	O
y	O
,	O
w	O
,	O
pCaspeR-	O
(	O
hs-flipase	O
)	O
]	O
.	O

For	O
the	O
next	O
generation	O
(	O
F1	O
)	O
,	O
the	O
male	O
progenies	O
carrying	O
both	O
the	O
d08071	O
and	O
the	O
hs-flipase	O
lines	O
were	O
selected	O
and	O
mated	O
with	O
virgins	O
carrying	O
the	O
f05417	O
line	O
,	O
inserted	O
near	O
the	O
3	O
'	O
end	O
of	O
the	O
dhtt	O
gene	O
.	O

The	O
progenies	O
(	O
i.e	O
.	O
the	O
F1	O
flies	O
)	O
from	O
the	O
above	O
crosses	O
were	O
heat-shocked	O
at	O
37°C	O
for	O
1	O
hour	O
,	O
48	O
hours	O
after	O
egg-laying	O
,	O
and	O
were	O
then	O
heat-shocked	O
for	O
a	O
further	O
1	O
hour	O
during	O
each	O
of	O
the	O
following	O
4	O
days	O
.	O

In	O
the	O
third	O
generation	O
(	O
F2	O
)	O
,	O
the	O
virgin	O
females	O
were	O
collected	O
and	O
crossed	O
to	O
males	O
carrying	O
balancer	O
chromosomes	O
(	O
w	O
;	O
TM3	O
,	O
Sb/TM6B	O
,	O
Tb	O
,	O
Hu	O
)	O
.	O

In	O
the	O
fourth	O
generation	O
(	O
F3	O
)	O
,	O
progeny	O
flies	O
carrying	O
the	O
Df	O
(	O
98E2	O
)	O
deletion	O
from	O
the	O
above	O
crosses	O
(	O
between	O
F2	O
flies	O
)	O
were	O
selected	O
based	O
on	O
their	O
darker	O
eye	O
color	O
,	O
and	O
crossed	O
with	O
flies	O
carrying	O
balancer	O
chromosomes	O
to	O
establish	O
individual	O
fly	O
lines	O
.	O

The	O
presence	O
of	O
the	O
deletion	O
in	O
these	O
lines	O
was	O
confirmed	O
by	O
PCR	O
analysis	O
of	O
extracted	O
genomic	O
DNA	O
and	O
by	O
DNA	O
sequencing	O
.	O

To	O
generate	O
the	O
genomic	O
rescue	O
construct	O
for	O
the	O
CG9990	O
gene	O
,	O
a	O
24.7	O
kb	O
genomic	O
DNA	O
fragment	O
,	O
covering	O
the	O
CG9990	O
genomic	O
region	O
,	O
was	O
isolated	O
from	O
the	O
bacterial	O
artificial	O
chromosome	O
(	O
BAC	O
)	O
clone	O
BACR10P23	O
(	O
CHORI	O
)	O
following	O
double	O
digestion	O
with	O
the	O
restriction	O
enzymes	O
XbaI	O
and	O
XmaI	O
.	O

This	O
24.7	O
kb	O
genomic	O
DNA	O
fragment	O
starts	O
at	O
an	O
XbaI	O
site	O
near	O
the	O
end	O
of	O
the	O
neighboring	O
CG9989	O
gene	O
,	O
2.66	O
kb	O
from	O
the	O
inserted	O
site	O
of	O
the	O
p-element	O
line	O
d08071	O
,	O
and	O
ends	O
at	O
the	O
XmaI	O
site	O
within	O
the	O
second	O
exon	O
of	O
the	O
dhtt	O
gene	O
,	O
thus	O
covering	O
the	O
whole	O
genomic	O
region	O
of	O
the	O
CG9990	O
gene	O
(	O
Fig	O
.	O
1B	O
)	O
.	O

To	O
generate	O
the	O
CG9990	O
rescue	O
transgene	O
,	O
this	O
24.7	O
kb	O
genomic	O
DNA	O
fragment	O
was	O
cloned	O
into	O
the	O
NotI	O
and	O
SmaI	O
sites	O
in	O
the	O
pCaspeR-4	O
transgenic	O
vector	O
.	O

The	O
DNA	O
for	O
the	O
pCaspeR-4–CG9990	O
genomic	O
rescue	O
construct	O
was	O
injected	O
into	O
w1118	O
embryos	O
and	O
transformants	O
were	O
then	O
selected	O
following	O
standard	O
procedures	O
.	O

Three	O
independent	O
CG9990	O
transgenic	O
lines	O
were	O
established	O
and	O
then	O
tested	O
by	O
crossing	O
them	O
into	O
the	O
Df	O
(	O
98E2	O
)	O
deletion	O
.	O

Flies	O
with	O
the	O
Df	O
(	O
98E2	O
)	O
deletion	O
,	O
which	O
removes	O
both	O
CG9990	O
and	O
dhtt	O
,	O
are	O
homozygous	O
lethal	O
at	O
the	O
embryonic	O
stage	O
.	O

Through	O
genetic	O
crossings	O
,	O
we	O
reintroduced	O
the	O
CG9990	O
genomic	O
rescue	O
transgene	O
back	O
into	O
the	O
Df	O
(	O
98E2	O
)	O
deletion	O
background	O
,	O
generating	O
fly	O
lines	O
that	O
are	O
defective	O
at	O
the	O
molecular	O
level	O
for	O
only	O
the	O
dhtt	O
gene	O
(	O
referred	O
to	O
as	O
dhtt-ko	O
flies	O
)	O
.	O

Three	O
independent	O
genomic	O
CG9990	O
transgenic	O
lines	O
were	O
tested	O
by	O
crossing	O
them	O
into	O
the	O
Df	O
(	O
98E2	O
)	O
deletion	O
;	O
all	O
of	O
them	O
rescued	O
the	O
embryonic	O
lethality	O
of	O
the	O
Df	O
(	O
98E2	O
)	O
deletion	O
,	O
producing	O
viable	O
adults	O
.	O

Thus	O
,	O
dhtt-ko	O
flies	O
,	O
which	O
carry	O
both	O
the	O
Df	O
(	O
98E2	O
)	O
and	O
the	O
CG9990	O
transgene	O
,	O
are	O
homozygous	O
viable	O
and	O
can	O
fully	O
develop	O
into	O
adulthood	O
,	O
demonstrating	O
that	O
the	O
lethality	O
observed	O
with	O
the	O
Df	O
(	O
98E2	O
)	O
deletion	O
is	O
caused	O
by	O
the	O
loss	O
of	O
CG9990	O
.	O

To	O
verify	O
further	O
that	O
the	O
dhtt	O
gene	O
is	O
indeed	O
deleted	O
,	O
as	O
expected	O
,	O
in	O
this	O
dhtt-ko	O
allele	O
,	O
we	O
extracted	O
genomic	O
DNA	O
from	O
the	O
homozygous	O
dhtt-ko	O
and	O
wild-type	O
control	O
adults	O
and	O
performed	O
Southern	O
blots	O
.	O

Genomic	O
DNA	O
was	O
extracted	O
from	O
the	O
dhtt-ko	O
adults	O
or	O
from	O
control	O
w1118	O
adults	O
and	O
digested	O
with	O
the	O
restriction	O
enzyme	O
BamHI	O
.	O

DNA	O
fragments	O
were	O
separated	O
on	O
a	O
1	O
%	O
agarose	O
gel	O
and	O
transferred	O
onto	O
a	O
nitrocellular	O
membrane	O
,	O
according	O
to	O
the	O
standard	O
protocol	O
for	O
Southern	O
blotting	O
.	O

DNA	O
fragments	O
specifically	O
targeting	O
all	O
exons	O
of	O
the	O
dhtt	O
gene	O
were	O
labeled	O
with	O
32P-dCTP	O
using	O
the	O
Klenow	O
polymerase	O
and	O
random-hexamer	O
primer	O
method	O
(	O
Amersham	O
)	O
and	O
used	O
as	O
probe	O
.	O

Hybridization	O
was	O
performed	O
overnight	O
at	O
65°C	O
and	O
the	O
fragments	O
were	O
subsequently	O
washed	O
with	O
SDS/SSC	O
buffers	O
,	O
following	O
standard	O
procedures	O
for	O
Southern	O
blotting	O
.	O

The	O
size	O
of	O
the	O
genomic	O
region	O
covering	O
dhtt	O
is	O
about	O
43	O
kb	O
(	O
Li	O
et	O
al.	O
,	O
1999	O
)	O
,	O
which	O
is	O
too	O
large	O
to	O
be	O
cloned	O
into	O
a	O
transgenic	O
vector	O
by	O
conventional	O
approaches	O
.	O

Therefore	O
,	O
we	O
engineered	O
a	O
dhtt	O
minigene	O
rescue	O
construct	O
that	O
expresses	O
full-length	O
dhtt	O
under	O
the	O
control	O
of	O
its	O
own	O
endogenous	O
regulatory	O
region	O
.	O

In	O
Drosophila	O
,	O
the	O
regulatory	O
elements	O
controlling	O
the	O
endogenous	O
expression	O
pattern	O
of	O
a	O
gene	O
are	O
normally	O
located	O
at	O
the	O
5	O
'	O
region	O
of	O
the	O
gene	O
,	O
within	O
the	O
upstream	O
5	O
'	O
untranscribed	O
region	O
and	O
in	O
the	O
first	O
few	O
introns	O
.	O

In	O
addition	O
,	O
the	O
expression	O
level	O
of	O
a	O
gene	O
is	O
also	O
affected	O
by	O
its	O
3	O
'	O
untranslated	O
region	O
.	O

As	O
a	O
result	O
,	O
we	O
isolated	O
a	O
14.9	O
kb	O
genomic	O
DNA	O
fragment	O
from	O
the	O
BAC	O
clone	O
BACR10P23	O
(	O
CHORI	O
)	O
following	O
double	O
digestion	O
with	O
the	O
restriction	O
enzymes	O
XbaI	O
and	O
AscI	O
.	O

The	O
XbaI	O
site	O
was	O
located	O
at	O
the	O
end	O
of	O
the	O
CG9990	O
gene	O
and	O
the	O
AscI	O
site	O
was	O
within	O
the	O
tenth	O
exon	O
of	O
the	O
dhtt-coding	O
region	O
,	O
thus	O
the	O
DNA	O
fragment	O
covered	O
all	O
of	O
the	O
5	O
'	O
untranscribed	O
region	O
of	O
the	O
dhtt	O
gene	O
together	O
with	O
the	O
first	O
ten	O
introns	O
and	O
exons	O
of	O
the	O
gene	O
.	O

We	O
also	O
isolated	O
a	O
1.2	O
kb	O
genomic	O
DNA	O
fragment	O
,	O
by	O
double	O
digestion	O
with	O
StuI-EcoRI	O
,	O
that	O
covers	O
the	O
3	O
'	O
end	O
of	O
the	O
dhtt	O
gene	O
,	O
including	O
the	O
last	O
exon	O
of	O
dhtt	O
and	O
the	O
remaining	O
polyA	O
sites	O
and	O
untranscribed	O
region	O
at	O
the	O
3	O
'	O
end	O
of	O
the	O
gene	O
.	O

Next	O
,	O
we	O
assembled	O
and	O
isolated	O
a	O
6.6	O
kb	O
dhtt	O
cDNA	O
fragment	O
,	O
by	O
digestion	O
with	O
AscI	O
and	O
StuI	O
,	O
that	O
covered	O
most	O
of	O
the	O
3	O
'	O
cDNA	O
region	O
of	O
dhtt	O
,	O
from	O
the	O
single	O
AscI	O
site	O
within	O
the	O
tenth	O
exon	O
to	O
the	O
StuI	O
site	O
within	O
the	O
last	O
exon	O
.	O

The	O
dhtt	O
minigene	O
rescue	O
construct	O
was	O
generated	O
by	O
ligating	O
and	O
fusing	O
,	O
in	O
frame	O
,	O
the	O
three	O
fragments	O
that	O
cover	O
all	O
of	O
the	O
dhtt	O
regulatory	O
and	O
coding	O
regions	O
:	O
(	O
1	O
)	O
the	O
5	O
'	O
14.9	O
kb	O
genomic	O
DNA	O
fragment	O
that	O
covered	O
all	O
of	O
the	O
5	O
'	O
untranscribed	O
region	O
of	O
the	O
dhtt	O
gene	O
,	O
as	O
well	O
as	O
the	O
first	O
ten	O
introns	O
and	O
exons	O
of	O
dhtt	O
;	O
(	O
2	O
)	O
the	O
middle	O
6.6	O
kb	O
of	O
the	O
dhtt	O
cDNA	O
fragment	O
that	O
covered	O
from	O
exon	O
10	O
to	O
exon	O
29	O
;	O
and	O
(	O
3	O
)	O
the	O
3	O
'	O
1.2	O
kb	O
genomic	O
DNA	O
fragment	O
that	O
covered	O
exon	O
29	O
and	O
the	O
polyA	O
sites	O
at	O
the	O
3	O
'	O
end	O
of	O
the	O
gene	O
,	O
as	O
well	O
as	O
the	O
remaining	O
3	O
'	O
untranscribed	O
region	O
.	O

The	O
22.7	O
kb	O
dhtt	O
minigene	O
was	O
cloned	O
into	O
the	O
NotI	O
and	O
XbaI	O
sites	O
in	O
the	O
pCaspeR-4	O
transgenic	O
vector	O
.	O

After	C
generating	C
transgenic	C
flies	C
with	C
this	C
dhtt	C
minigene	C
rescue	C
construct	C
,	C
we	C
crossed	C
these	C
animals	C
into	C
the	C
dhtt-ko	C
mutant	C
background	C
to	C
test	C
whether	C
the	C
mobility	C
and	C
viability	C
phenotypes	C
of	C
dhtt-ko	C
mutants	C
could	C
be	C
rescued	C
.	C

Based	O
on	O
the	O
published	O
dhtt	O
cDNA	O
sequence	O
(	O
Li	O
et	O
al.	O
,	O
1999	O
)	O
,	O
we	O
isolated	O
overlapping	O
fragments	O
covering	O
the	O
full-length	O
of	O
the	O
dhtt	O
cDNA	O
by	O
PCR	O
amplification	O
using	O
Pfu	O
polymerase	O
.	O

We	O
then	O
assembled	O
a	O
full-length	O
dhtt	O
cDNA	O
construct	O
using	O
these	O
sequencing-verified	O
dhtt	O
fragments	O
,	O
cloned	O
it	O
into	O
a	O
pUASP	O
vector	O
,	O
and	O
generated	O
transgenic	O
fly	O
lines	O
by	O
following	O
standard	O
protocols	O
.	O

Total	O
RNA	O
samples	O
were	O
isolated	O
,	O
using	O
Trizol	O
reagent	O
(	O
Invitrogen	O
)	O
,	O
from	O
adult	O
animals	O
of	O
the	O
following	O
genotypes	O
:	O
w1118	O
wild-type	O
control	O
,	O
homozygous	O
dhtt-ko	O
mutants	O
and	O
dhtt-ko	O
Rescue	O
.	O

RT-PCR	O
reactions	O
were	O
performed	O
using	O
Superscript	O
one-step	O
RT-PCR	O
with	O
Platinum	O
Taq	O
(	O
Invitrogen	O
)	O
following	O
the	O
manufacturer’s	O
instructions	O
.	O

PCR	O
primers	O
were	O
designed	O
as	O
follows	O
:	O
rp49	O
control	O
:	O
forward	O
(	O
in	O
exon	O
1	O
of	O
rp49	O
)	O
5'-ACCATCCGCCCAGCATACAGG-3	O
'	O
,	O
reverse	O
(	O
in	O
exon	O
2	O
of	O
rp49	O
)	O
5	O
'	O
-TTGGCGCGCTCGACAATCTCC-3	O
'	O
;	O
dhtt-N	O
:	O
forward	O
(	O
in	O
exon	O
5	O
of	O
dhtt	O
)	O
5	O
'	O
-GCCAATGTAGCCAGAGTCTG-3	O
'	O
,	O
reverse	O
(	O
in	O
exon	O
6	O
of	O
dhtt	O
)	O
5	O
'	O
-CGCATTCGCTGATGCTGCGTG-3	O
'	O
;	O
dhtt-M	O
:	O
forward	O
(	O
in	O
exon	O
13	O
of	O
dhtt	O
)	O
5'-AAGCTATTCGAGCCGATGGTC-3	O
'	O
,	O
reverse	O
(	O
in	O
exon	O
15	O
of	O
dhtt	O
)	O
5'-GCACCAGGAATCTCAGCATGG-3	O
'	O
;	O
dhtt-C	O
:	O
forward	O
(	O
in	O
exon	O
23	O
of	O
dhtt	O
)	O
5'-TCGGGAATTGACTTTCGCAGC-3	O
'	O
,	O
reverse	O
(	O
in	O
exon	O
24	O
of	O
dhtt	O
)	O
5'-TGCAGTTTGAGGCAGCGTTCC-3	O
'	O
.	O

Using	O
the	O
motif-predicting	O
program	O
developed	O
by	O
M.A	O
.	O
Andrade	O
at	O
the	O
EMBL	O
(	O
http	O
:	O
//www.embl-heidelberg.de/~andrade/papers/rep/search.html	O
)	O
,	O
both	O
dHtt	O
and	O
human	O
Htt	O
were	O
analyzed	O
for	O
the	O
presence	O
of	O
HEAT	O
repeats	O
.	O

Using	O
the	O
default	O
parameters	O
at	O
the	O
site	O
and	O
including	O
the	O
AAA	O
,	O
ADB	O
and	O
IMB	O
groups	O
of	O
HEAT	O
repeats	O
(	O
Andrade	O
et	O
al.	O
,	O
2001	O
)	O
,	O
a	O
total	O
of	O
40	O
and	O
38	O
HEAT	O
repeats	O
were	O
identified	O
for	O
Htt	O
and	O
dHtt	O
,	O
respectively	O
.	O

Sample	O
preparation	O
and	O
staining	O
for	O
embryos	O
,	O
larval	O
tissues	O
and	O
adult	O
fly	O
eyes	O
have	O
been	O
described	O
previously	O
(	O
Sullivan	O
et	O
al.	O
,	O
2000	O
)	O
.	O

To	O
analyze	O
NMJs	O
,	O
wandering	O
third	O
instar	O
larvae	O
were	O
dissected	O
in	O
Ca2+-free	O
saline	O
(	O
128	O
mM	O
NaCl	O
,	O
2	O
mM	O
KCl	O
,	O
0.1	O
mM	O
CaCl2	O
,	O
4	O
mM	O
MgCl2	O
,	O
35.5	O
mM	O
sucrose	O
,	O
5	O
mM	O
Hepes	O
at	O
pH	O
7.2	O
,	O
1	O
mM	O
EGTA	O
)	O
and	O
stained	O
,	O
as	O
described	O
(	O
Sullivan	O
et	O
al.	O
,	O
2000	O
)	O
.	O

1–2	O
µM	O
thin	O
sections	O
of	O
embedded	O
adult	O
eyes	O
were	O
cut	O
using	O
a	O
microtome	O
and	O
imaged	O
directly	O
without	O
further	O
dye	O
staining	O
.	O

To	O
stain	O
and	O
image	O
the	O
adult	O
brains	O
,	O
flies	O
were	O
dissected	O
in	O
1×	O
PBS	O
or	O
in	O
Drosophila	O
M3	O
medium	O
,	O
to	O
remove	O
cuticles	O
and	O
external	O
eye	O
tissues	O
,	O
then	O
fixed	O
in	O
4	O
%	O
formaldehyde	O
in	O
1×	O
PBS	O
for	O
1	O
hour	O
at	O
room	O
temperature	O
(	O
RT	O
)	O
,	O
washed	O
six	O
times	O
with	O
1×	O
PBT	O
for	O
1	O
hour	O
,	O
and	O
stained	O
with	O
primary	O
and	O
secondary	O
antibodies	O
.	O

Collection	O
and	O
fixation	O
of	O
Drosophila	O
embryos	O
,	O
larvae	O
tissue	O
dissection	O
and	O
fixation	O
,	O
as	O
well	O
as	O
RNA	O
in	O
situ	O
hybridization	O
were	O
carried	O
out	O
according	O
to	O
standard	O
procedures	O
(	O
Hauptmann	O
and	O
Gerster	O
,	O
2000	O
)	O
.	O

The	O
DIG-labeled	O
RNA	O
probes	O
were	O
generated	O
according	O
to	O
the	O
manufacturer’s	O
instructions	O
(	O
Roche	O
,	O
Indianapolis	O
,	O
IN	O
)	O
.	O

The	O
dhtt	O
exon	O
8	O
and	O
exon	O
20	O
sequences	O
were	O
used	O
to	O
generate	O
dhtt-specific	O
in	O
situ	O
probes	O
,	O
which	O
gave	O
similar	O
in	O
situ	O
results	O
.	O

The	O
samples	O
for	O
in	O
situ	O
hybridization	O
were	O
analyzed	O
with	O
a	O
Zeiss	O
Axiophot	O
2	O
compound	O
microscope	O
.	O

To	O
generate	O
the	O
antibody	O
against	O
dHtt	O
,	O
a	O
cDNA	O
fragment	O
corresponding	O
to	O
the	O
N-terminal	O
459	O
amino	O
acids	O
of	O
dHtt	O
was	O
cloned	O
into	O
the	O
pGEX-4T1	O
vector	O
;	O
the	O
corresponding	O
GST-fusion	O
protein	O
was	O
purified	O
according	O
to	O
manufacturer’s	O
instructions	O
(	O
Promega	O
)	O
and	O
used	O
to	O
produce	O
polyclonal	O
antibody	O
in	O
a	O
rabbit	O
(	O
Convance	O
)	O
.	O

The	O
antiserum	O
was	O
affinity-purified	O
and	O
used	O
at	O
a	O
final	O
dilution	O
of	O
1:200	O
.	O

Primary	O
antibodies	O
were	O
applied	O
at	O
4°C	O
overnight	O
at	O
the	O
following	O
dilutions	O
:	O
rabbit	O
anti-GFP	O
(	O
1:1000	O
,	O
Molecular	O
Probes	O
)	O
;	O
rabbit	O
anti-fasciclin	O
II	O
(	O
1:400	O
)	O
and	O
anti-DIG	O
(	O
1:40,000	O
)	O
,	O
both	O
generously	O
provided	O
by	O
Mary	O
Packard	O
and	O
Vivian	O
Budnik	O
(	O
Budnik	O
et	O
al.	O
,	O
1996	O
;	O
Koh	O
et	O
al.	O
,	O
1999	O
)	O
;	O
rabbit	O
anti-synaptotagmin	O
(	O
1:500	O
)	O
(	O
Littleton	O
et	O
al.	O
,	O
1993	O
)	O
;	O
mouse	O
anti-α-tubulin	O
(	O
1:10,000	O
,	O
Sigma	O
)	O
;	O
monoclonal	O
mouse	O
anti-fasciclin	O
II	O
(	O
1D4	O
,	O
1:20	O
)	O
,	O
anti-DIG	O
(	O
1:20	O
)	O
,	O
anti-CSP	O
(	O
1:20	O
)	O
,	O
anti-synapsin	O
(	O
1:50	O
)	O
,	O
anti-α-spectrin	O
(	O
1:20	O
)	O
,	O
anti-Armadillo	O
(	O
1:100	O
)	O
,	O
nc-82	O
(	O
1:50	O
)	O
and	O
anti-Futsch	O
(	O
22C10	O
,	O
1:100	O
)	O
(	O
all	O
from	O
Developmental	O
Studies	O
Hybridoma	O
Bank	O
)	O
(	O
Hummel	O
et	O
al.	O
,	O
2000	O
;	O
Roos	O
et	O
al.	O
,	O
2000	O
)	O
;	O
goat	O
anti-HRP	O
(	O
1:500	O
,	O
Jackson	O
Labs	O
)	O
;	O
Alexa488-	O
,	O
Alexa594-	O
and	O
Alexa647-conjugated	O
secondary	O
antibodies	O
(	O
all	O
used	O
at	O
1:500	O
,	O
Molecular	O
Probes	O
)	O
.	O

Rhodamine	O
Red	O
X-conjugated	O
goat	O
anti-HRP	O
and	O
CY5-conjugated	O
secondary	O
antibodies	O
were	O
used	O
at	O
1:200	O
(	O
both	O
from	O
Jackson	O
Labs	O
)	O
.	O

DAPI	O
(	O
0.2	O
µg/ml	O
,	O
Molecular	O
Probes	O
)	O
and	O
TRITC-conjugated	O
phalloidin	O
(	O
10	O
ng/ml	O
,	O
Sigma	O
)	O
were	O
applied	O
in	O
PBS-Tween	O
(	O
PBST	O
)	O
for	O
30	O
minutes	O
to	O
label	O
nuclei	O
and	O
F-actin	O
,	O
respectively	O
.	O

Image	O
analysis	O

To	O
quantify	O
MBs	O
,	O
adult	O
brains	O
were	O
prepared	O
for	O
imaging	O
as	O
described	O
above	O
.	O

Dissected	O
adult	O
brains	O
from	O
both	O
wild-type	O
controls	O
and	O
dhtt-ko	O
mutants	O
were	O
stained	O
side	O
by	O
side	O
in	O
a	O
12-well	O
plate	O
with	O
mouse	O
anti-Fas	O
II	O
antibody	O
(	O
1D4	O
,	O
1:20	O
)	O
overnight	O
at	O
4°C	O
.	O

After	O
washing	O
six	O
times	O
with	O
1×	O
PBT	O
for	O
2	O
hours	O
,	O
samples	O
were	O
stained	O
with	O
Alexa-594-conjugated	O
secondary	O
antibodies	O
(	O
1:500	O
)	O
at	O
RT	O
for	O
2	O
hours	O
,	O
followed	O
by	O
extensive	O
washing	O
with	O
1×	O
PBST	O
for	O
2	O
hours	O
at	O
RT	O
.	O

To	O
ensure	O
that	O
the	O
stained	O
samples	O
had	O
a	O
similar	O
background	O
signal	O
during	O
imaging	O
analysis	O
,	O
brains	O
from	O
both	O
wild-type	O
controls	O
and	O
dhtt-ko	O
mutants	O
were	O
mounted	O
onto	O
opposite	O
ends	O
of	O
the	O
same	O
slide	O
.	O

The	O
samples	O
were	O
photographed	O
at	O
20×	O
magnification	O
,	O
under	O
the	O
same	O
optical	O
parameters	O
,	O
using	O
a	O
Zeiss	O
fluorescent	O
microscope	O
(	O
Axioskop	O
2	O
Mot	O
Plus	O
)	O
.	O

The	O
boundaries	O
of	O
MBs	O
were	O
traced	O
manually	O
using	O
AxioVision	O
Rel	O
4.5	O
software	O
(	O
Zeiss	O
)	O
,	O
and	O
both	O
the	O
overall	O
size	O
of	O
each	O
MB	O
and	O
the	O
total	O
intensity	O
of	O
FasII	O
staining	O
signals	O
within	O
the	O
MB	O
boundary	O
were	O
computed	O
using	O
the	O
same	O
software	O
.	O

FasII	O
staining	O
signals	O
from	O
outside	O
the	O
MB	O
boundary	O
were	O
also	O
measured	O
and	O
used	O
as	O
a	O
reference	O
to	O
subtract	O
out	O
the	O
background	O
signals	O
.	O

Since	O
we	O
could	O
not	O
confidently	O
measure	O
the	O
thickness	O
of	O
the	O
MBs	O
in	O
these	O
samples	O
,	O
only	O
the	O
overall	O
area	O
covered	O
by	O
each	O
MB	O
was	O
measured	O
.	O

The	O
average	O
FasII	O
signal	O
intensity	O
in	O
each	O
MB	O
was	O
calculated	O
by	O
dividing	O
the	O
‘total	O
intensity	O
of	O
FasII	O
staining	O
signals	O
within	O
the	O
MB	O
boundary’	O
by	O
‘the	O
overall	O
size	O
of	O
the	O
MB’	O
.	O

To	O
calculate	O
the	O
relative	O
signal	O
intensity	O
,	O
the	O
average	O
signal	O
intensity	O
of	O
FasII	O
signals	O
from	O
all	O
wild-type	O
brains	O
was	O
calculated	O
and	O
its	O
mean	O
was	O
set	O
as	O
a	O
reference	O
point	O
of	O
100	O
.	O

To	O
measure	O
the	O
overall	O
brain	O
size	O
and	O
the	O
regions	O
that	O
were	O
devoid	O
of	O
neurons	O
in	O
the	O
brain	O
,	O
adult	O
flies	O
were	O
dissected	O
and	O
stained	O
with	O
rat	O
anti-Elav	O
antibody	O
(	O
1:40	O
)	O
,	O
which	O
labels	O
all	O
neuronal	O
cells	O
.	O

The	O
boundary	O
of	O
the	O
whole	O
protocerebrum	O
in	O
the	O
brain	O
and	O
the	O
regions	O
devoid	O
of	O
neurons	O
were	O
tracked	O
manually	O
and	O
quantified	O
with	O
AxioVision	O
Rel	O
4.5	O
software	O
,	O
as	O
described	O
above	O
.	O

To	O
quantify	O
the	O
size	O
of	O
the	O
A307-positive	O
axonal	O
terminals	O
,	O
adult	O
brains	O
from	O
both	O
wild-type	O
controls	O
and	O
dhtt-ko	O
mutants	O
were	O
dissected	O
,	O
fixed	O
and	O
stained	O
side	O
by	O
side	O
with	O
an	O
anti-GFP	O
antibody	O
,	O
as	O
described	O
above	O
,	O
then	O
mounted	O
on	O
the	O
two	O
sides	O
of	O
the	O
same	O
slide	O
to	O
ensure	O
that	O
they	O
had	O
a	O
similar	O
background	O
for	O
imaging	O
analysis	O
.	O

Both	O
the	O
wild-type	O
control	O
and	O
dhtt-ko	O
mutant	O
samples	O
were	O
imaged	O
by	O
confocal	O
microscopy	O
at	O
40×	O
magnification	O
under	O
the	O
same	O
optical	O
parameters	O
.	O

A	O
Z-serial	O
section	O
of	O
confocal	O
images	O
covering	O
the	O
entire	O
depth	O
of	O
each	O
axonal	O
terminus	O
was	O
collected	O
using	O
a	O
Leica	O
TCS	O
confocal	O
microscope	O
and	O
then	O
projected	O
into	O
one	O
merged	O
image	O
(	O
using	O
the	O
Leica	O
software	O
)	O
to	O
generate	O
the	O
whole	O
picture	O
of	O
each	O
axonal	O
terminus	O
.	O

Since	O
the	O
branches	O
and	O
boutons	O
in	O
the	O
brain	O
were	O
too	O
small	O
to	O
distinguish	O
clearly	O
,	O
only	O
the	O
overall	O
area	O
covered	O
by	O
each	O
axonal	O
terminus	O
was	O
measured	O
.	O

Fluorescent	O
images	O
were	O
analyzed	O
and	O
captured	O
by	O
fluorescent	O
microscopy	O
(	O
Axioskop	O
2	O
Mot	O
Plus	O
,	O
Zeiss	O
)	O
or	O
by	O
confocal	O
microscopy	O
(	O
Leica	O
TCS	O
SP2	O
AOBS	O
system	O
)	O
.	O

Confocal	O
images	O
were	O
analyzed	O
and	O
projected	O
using	O
Leica	O
confocal	O
software	O
(	O
LCS	O
)	O
.	O

Viability	O
assay	O

Drosophila	O
viability	O
was	O
measured	O
by	O
placing	O
30	O
newly	O
hatched	O
female	O
flies	O
of	O
each	O
genotype	O
into	O
individual	O
vials	O
,	O
containing	O
fly	O
food	O
,	O
at	O
25°C	O
.	O

The	O
number	O
of	O
dead	O
flies	O
was	O
recorded	O
daily	O
.	O

Flies	O
were	O
transferred	O
into	O
a	O
new	O
food	O
vial	O
every	O
3–4	O
days	O
to	O
prevent	O
them	O
from	O
sticking	O
to	O
old	O
food	O
.	O

For	O
each	O
genotype	O
,	O
at	O
least	O
two	O
independent	O
cohorts	O
of	O
flies	O
,	O
raised	O
at	O
different	O
times	O
from	O
independent	O
crosses	O
,	O
were	O
tested	O
and	O
the	O
results	O
were	O
averaged	O
.	O

Mobility	O
tests	O
of	O
adult	O
flies	O
and	O
videos	O

Female	O
flies	O
were	O
chosen	O
in	O
all	O
the	O
mobility	O
tests	O
.	O

Fly	O
videos	O
were	O
captured	O
using	O
a	O
Sony	O
digital	O
camcorder	O
(	O
DCR-TRV140	O
)	O
and	O
edited	O
in	O
Apple’s	O
iMovie	O
program	O
.	O

Climbing	O
assays	O
were	O
performed	O
as	O
described	O
previously	O
(	O
Ganetzky	O
and	O
Flanagan	O
,	O
1978	O
;	O
Le	O
Bourg	O
and	O
Lints	O
,	O
1992	O
)	O
.	O

Briefly	O
,	O
20	O
flies	O
of	O
a	O
specified	O
age	O
were	O
knocked	O
to	O
the	O
bottom	O
of	O
a	O
plastic	O
vial	O
.	O

The	O
number	O
of	O
flies	O
that	O
could	O
climb	O
to	O
the	O
top	O
of	O
the	O
vial	O
after	O
18	O
seconds	O
was	O
counted	O
.	O

The	O
test	O
was	O
repeated	O
6–7	O
times	O
for	O
each	O
genotype	O
at	O
the	O
specified	O
age	O
.	O

The	O
assay	O
was	O
performed	O
as	O
described	O
previously	O
(	O
Feany	O
and	O
Bender	O
,	O
2000	O
;	O
Joiner	O
and	O
Griffith	O
,	O
1999	O
;	O
Wang	O
et	O
al.	O
,	O
2004	O
)	O
.	O

For	O
each	O
genotype	O
,	O
6–14	O
flies	O
of	O
a	O
specific	O
age	O
were	O
tested	O
.	O

Flies	O
were	O
fed	O
30	O
mM	O
of	O
methyl	O
viologen	O
(	O
Sigma	O
)	O
in	O
instant	O
Drosophila	O
medium	O
(	O
Carolina	O
)	O
,	O
providing	O
a	O
dosage	O
of	O
paraquat	O
that	O
kills	O
about	O
50	O
%	O
of	O
wild-type	O
flies	O
after	O
48	O
hours	O
of	O
exposure	O
.	O

Control	O
flies	O
were	O
fed	O
instant	O
medium	O
only	O
.	O

Adult	O
flies	O
that	O
had	O
eclosed	O
within	O
the	O
last	O
24	O
hours	O
were	O
kept	O
in	O
30	O
mM	O
paraquat	O
or	O
in	O
drug-free	O
medium	O
for	O
48	O
hours	O
after	O
eclosion	O
.	O

The	O
number	O
of	O
survivors	O
was	O
counted	O
at	O
48	O
hours	O
after	O
the	O
start	O
of	O
paraquat	O
treatment	O
.	O

An	O
electrophysiological	O
analysis	O
of	O
wandering-stage	O
third	O
instar	O
larvae	O
was	O
performed	O
in	O
Drosophila	O
HL3.1	O
saline	O
(	O
NaCl	O
,	O
70	O
mM	O
;	O
KCl	O
,	O
5	O
mM	O
;	O
MgCl2	O
,	O
4	O
mM	O
;	O
CaCl2	O
,	O
0.2	O
mM	O
;	O
NaHCO3	O
,	O
10	O
mM	O
;	O
trehalose	O
,	O
5	O
mM	O
;	O
sucrose	O
,	O
115	O
mM	O
;	O
HEPES-NaOH	O
,	O
5	O
mM	O
;	O
pH	O
7.2	O
)	O
using	O
an	O
Axoclamp	O
2B	O
amplifer	O
(	O
Axon	O
Instrument	O
)	O
at	O
22°C	O
.	O

Recordings	O
were	O
performed	O
at	O
muscle	O
fiber	O
6/7	O
of	O
segments	O
A3	O
to	O
A5	O
under	O
current	O
clamp	O
.	O

PPF	O
was	O
measured	O
by	O
determining	O
the	O
peak	O
amplitude	O
responses	O
(	O
P2/P1	O
)	O
of	O
two	O
stimuli	O
separated	O
by	O
the	O
indicated	O
latency	O
.	O

All	O
error	O
bars	O
are	O
s.e.m	O
.	O

In	O
adults	O
,	O
extracellular	O
field	O
potentials	O
were	O
recorded	O
by	O
placing	O
a	O
sharp	O
glass	O
electrode	O
near	O
the	O
longitudinal	O
flight	O
muscles	O
after	O
piercing	O
the	O
cuticle	O
,	O
with	O
a	O
reference	O
electrode	O
placed	O
in	O
the	O
fly	O
head	O
.	O

ERGs	O
were	O
performed	O
as	O
described	O
previously	O
(	O
Rieckhof	O
et	O
al.	O
,	O
2003	O
)	O
.	O

Temperature	O
shifts	O
were	O
performed	O
by	O
heating	O
mounting	O
clay	O
,	O
which	O
encompassed	O
the	O
fly	O
,	O
to	O
the	O
desired	O
temperature	O
with	O
a	O
peltier	O
heating	O
device	O
.	O

For	O
measurements	O
of	O
evoked	O
EJP	O
amplitude	O
(	O
Fig	O
.	O
6A	O
,	O
B	O
)	O
,	O
the	O
number	O
of	O
NMJs	O
examined	O
were	O
:	O
control	O
,	O
n=8	O
;	O
dhtt-ko	O
,	O
n=23	O
.	O

Voltage	O
traces	O
of	O
evoked	O
EJPs	O
were	O
recorded	O
from	O
muscle	O
fiber	O
6	O
in	O
third	O
instar	O
larvae	O
in	O
0.2	O
mM	O
extracellular	O
calcium	O
.	O

Average	O
resting	O
potential	O
:	O
60.2±1.2	O
mV	O
in	O
control	O
animals	O
and	O
62.4±0.8	O
mV	O
in	O
dhtt	O
mutants	O
.	O

Average	O
EJP	O
amplitude	O
:	O
19.5±1.2	O
mV	O
in	O
control	O
animals	O
and	O
17.8±1.0	O
mV	O
in	O
dhtt	O
mutants	O
.	O

Measurements	O
of	O
voltage	O
traces	O
of	O
PPF	O
(	O
Fig	O
.	O
6C	O
)	O
were	O
performed	O
at	O
25	O
millisecond	O
intervals	O
in	O
control	O
(	O
rescued	O
)	O
and	O
dhtt	O
mutant	O
third	O
instar	O
larvae	O
in	O
0.2	O
mM	O
extracellular	O
calcium	O
.	O

Quantification	O
of	O
PPF	O
(	O
the	O
amplitude	O
of	O
EJP	O
2	O
divided	O
by	O
the	O
amplitude	O
of	O
EJP	O
1	O
)	O
was	O
performed	O
in	O
control	O
and	O
dhtt	O
mutants	O
for	O
25-	O
,	O
50-	O
and	O
75-millisecond	O
intervals	O
(	O
Fig	O
.	O
6D	O
)	O
.	O

The	O
number	O
of	O
preparations	O
analyzed	O
were	O
:	O
control	O
,	O
n=9	O
;	O
dhtt-ko	O
,	O
n=8	O
.	O

The	O
GF	O
flight	O
circuit	O
can	O
be	O
activated	O
by	O
stimulation	O
of	O
the	O
brain	O
,	O
and	O
extracellular	O
recordings	O
can	O
be	O
made	O
from	O
the	O
DLMs	O
.	O

Neither	O
the	O
control	O
nor	O
the	O
dhtt-ko	O
mutants	O
displayed	O
abnormal	O
activity	O
in	O
the	O
DLM	O
flight	O
muscles	O
(	O
data	O
not	O
shown	O
)	O
.	O

To	O
measure	O
ERGs	O
at	O
the	O
elevated	O
temperature	O
(	O
37°C	O
)	O
,	O
flies	O
were	O
rapidly	O
heated	O
from	O
20°C	O
to	O
37°C	O
,	O
with	O
test	O
light	O
pulses	O
(	O
black	O
bar	O
below	O
trace	O
in	O
Fig	O
.	O
6E	O
)	O
given	O
at	O
regular	O
intervals	O
.	O

A	O
total	O
of	O
ten	O
dhtt-ko	O
mutants	O
,	O
aged	O
1–3	O
days	O
,	O
were	O
tested	O
and	O
all	O
showed	O
normal	O
ERGs	O
at	O
20°C	O
and	O
37°C	O
(	O
Fig	O
.	O
6E	O
)	O
.	O

The	O
number	O
of	O
preparations	O
for	O
the	O
40–45-day-old	O
animals	O
analyzed	O
was	O
:	O
control	O
,	O
n=10	O
;	O
dhtt-ko	O
,	O
n=16	O
.	O

Evidence	O
of	O
a	O
tick	O
RNAi	O
pathway	O
by	O
comparative	O
genomics	O
and	O
reverse	O
genetics	O
screen	O
of	O
targets	O
with	O
known	O
loss-of-function	O
phenotypes	O
in	O
Drosophila	O

Abstract	O

Background	O

The	O
Arthropods	O
are	O
a	O
diverse	O
group	O
of	O
organisms	O
including	O
Chelicerata	O
(	O
ticks	O
,	O
mites	O
,	O
spiders	O
)	O
,	O
Crustacea	O
(	O
crabs	O
,	O
shrimps	O
)	O
,	O
and	O
Insecta	O
(	O
flies	O
,	O
mosquitoes	O
,	O
beetles	O
,	O
silkworm	O
)	O
.	O

The	O
cattle	O
tick	O
,	O
Rhipicephalus	O
(	O
Boophilus	O
)	O
microplus	O
,	O
is	O
an	O
economically	O
significant	O
ectoparasite	O
of	O
cattle	O
affecting	O
cattle	O
industries	O
world	O
wide	O
.	O

With	O
the	O
availability	O
of	O
sequence	O
reads	O
from	O
the	O
first	O
Chelicerate	O
genome	O
project	O
(	O
the	O
Ixodes	O
scapularis	O
tick	O
)	O
and	O
extensive	O
R.	O
microplus	O
ESTs	O
,	O
we	O
investigated	O
evidence	O
for	O
putative	O
RNAi	O
proteins	O
and	O
studied	O
RNA	O
interference	O
in	O
tick	O
cell	O
cultures	O
and	O
adult	O
female	O
ticks	O
targeting	O
Drosophila	O
homologues	O
with	O
known	O
cell	O
viability	O
phenotype	O
.	O

Results	O

We	O
screened	O
13,643	O
R.	O
microplus	O
ESTs	O
and	O
I.	O
scapularis	O
genome	O
reads	O
to	O
identify	O
RNAi	O
related	O
proteins	O
in	O
ticks	O
.	O

Our	O
analysis	O
identified	O
31	O
RNAi	O
proteins	O
including	O
a	O
putative	O
tick	O
Dicer	O
,	O
RISC	O
associated	O
(	O
Ago-2	O
and	O
FMRp	O
)	O
,	O
RNA	O
dependent	O
RNA	O
polymerase	O
(	O
EGO-1	O
)	O
and	O
23	O
homologues	O
implicated	O
in	O
dsRNA	O
uptake	O
and	O
processing	O
.	O

We	O
selected	O
10	O
R.	O
microplus	O
ESTs	O
with	O
>	O
80	O
%	O
similarity	O
to	O
D.	O
melanogaster	O
proteins	O
associated	O
with	O
cell	O
viability	O
for	O
RNAi	O
functional	O
screens	O
in	O
both	O
BME26	O
R.	O
microplus	O
embryonic	O
cells	O
and	O
female	O
ticks	O
in	O
vivo	O
.	O

Only	O
genes	O
associated	O
with	O
proteasomes	O
had	O
an	O
effect	O
on	O
cell	O
viability	O
in	O
vitro	O
.	O

In	O
vivo	O
RNAi	O
showed	O
that	O
9	O
genes	O
had	O
significant	O
effects	O
either	O
causing	O
lethality	O
or	O
impairing	O
egg	O
laying	O
.	O

Conclusion	O

We	O
have	O
identified	O
key	O
RNAi-related	O
proteins	O
in	O
ticks	O
and	O
along	O
with	O
our	O
loss-of-function	O
studies	O
support	O
a	O
functional	O
RNAi	O
pathway	O
in	O
R.	O
microplus	O
.	O

Our	C
preliminary	C
studies	C
indicate	C
that	C
tick	C
RNAi	C
pathways	C
may	C
differ	C
from	C
that	C
of	C
other	C
Arthropods	C
such	C
as	C
insects	C
.	C

Background	O

The	C
understanding	C
of	C
gene	C
function	C
in	C
a	C
poorly	C
studied	C
Arthropod	C
such	C
as	C
the	C
cattle	C
tick	C
Rhipicephalus	C
(	C
Boophilus	C
)	C
microplus	C
(	C
subphylum	C
Chelicerata	C
:	C
order	C
Acari	C
:	C
suborder	C
Ixodida	C
)	C
can	C
benefit	C
from	C
the	C
knowledge	C
generated	C
by	C
genome-wide	C
resources	C
of	C
the	C
model	C
insect	C
Drosophila	C
melanogaster	C
(	C
subphylum	C
Mandibulata	C
:	C
order	C
Hexapoda	C
:	C
suborder	C
Insecta	C
)	C
.	C

The	O
genome	O
of	O
the	O
fruit	O
fly	O
D.	O
melanogaster	O
was	O
among	O
the	O
first	O
eukaryotic	O
genomes	O
to	O
be	O
sequenced	O
and	O
assembled	O
[	O
1	O
]	O
.	O

D.	O
melanogaster	O
and	O
R.	O
microplus	O
evolved	O
from	O
a	O
common	O
ancestor	O
ca	O
.	O
500	O
million	O
years	O
ago	O
[	O
2	O
]	O
.	O

In	O
comparison	O
to	O
the	O
existing	O
comprehensive	O
genome	O
resources	O
for	O
the	O
fruit	O
fly	O
D.	O
melanogaster	O
,	O
the	O
cattle	O
tick	O
genome	O
resources	O
are	O
limited	O
to	O
approximately	O
45,000	O
EST	O
sequences	O
[	O
3	O
]	O
.	O

In	C
addition	C
,	C
the	C
tick	C
genome	C
size	C
of	C
7.1	C
Gbp	C
[	C
2	C
]	C
compared	C
to	C
the	C
D.	C
melanogaster	C
of	C
139	C
Mbp	C
[	C
4	C
]	C
will	C
likely	C
delay	C
the	C
generation	C
of	C
a	C
complete	C
R.	C
microplus	C
genome	C
sequence	C
[	C
5	C
]	C
.	C

A	O
genome	O
project	O
for	O
the	O
related	O
tick	O
species	O
,	O
Ixodes	O
scapularis	O
,	O
with	O
an	O
estimated	O
genome	O
size	O
of	O
2.1	O
Gbp	O
,	O
is	O
currently	O
underway	O
[	O
6	O
]	O
.	O

Although	O
there	O
are	O
many	O
invertebrate	O
genomes	O
completed	O
including	O
worms	O
,	O
nematodes	O
,	O
beetle	O
,	O
wasp	O
,	O
honey	O
bee	O
,	O
flies	O
,	O
and	O
mosquitoes	O
http	O
:	O
//www.genome.gov/	O
,	O
I.	O
scapularis	O
will	O
be	O
the	O
first	O
Chelicerate	O
:	O
Arachnida	O
genome	O
sequence	O
available	O
representing	O
mites	O
,	O
ticks	O
,	O
scorpions	O
and	O
spiders	O
.	O

Among	O
the	O
many	O
methods	O
available	O
for	O
reverse	O
genetic	O
studies	O
,	O
RNA	O
interference	O
(	O
RNAi	O
)	O
has	O
gained	O
popularity	O
because	O
of	O
its	O
demonstrated	O
efficient	O
post	O
transcriptional	O
gene-silencing	O
effects	O
in	O
plants	O
,	O
fungi	O
,	O
nematodes	O
,	O
flies	O
and	O
cultured	O
mammalians	O
cells	O
(	O
reviewed	O
by	O
[	O
7-11	O
]	O
)	O
.	O

RNA	O
mediated	O
gene	O
silencing	O
is	O
a	O
widely	O
conserved	O
mechanism	O
in	O
eukaryotes	O
and	O
can	O
be	O
categorized	O
into	O
two	O
partially	O
overlapping	O
pathways	O
,	O
the	O
RNAi	O
pathway	O
and	O
the	O
microRNA	O
(	O
miRNA	O
)	O
pathway	O
.	O

The	O
RNAi	O
pathway	O
is	O
triggered	O
by	O
exogenous	O
or	O
endogenous	O
dsRNAs	O
that	O
are	O
recognized	O
by	O
Dicer	O
RNase	O
III	O
proteins	O
which	O
'dice	O
'	O
these	O
molecules	O
into	O
double-stranded	O
small	O
interfering	O
RNAs	O
(	O
siRNAs	O
)	O
of	O
21–23	O
nt	O
in	O
length	O
[	O
12	O
]	O
.	O

A	O
typical	O
eukaryotic	O
Dicer	O
consists	O
of	O
2	O
helicase	O
domains	O
,	O
a	O
PAZ	O
domain	O
,	O
2	O
RNAse	O
domains	O
and	O
a	O
dsRNA-binding	O
domain	O
(	O
dsRBD	O
)	O
[	O
12,13	O
]	O
,	O
however	O
some	O
variations	O
in	O
this	O
domain	O
structure	O
have	O
been	O
noted	O
for	O
insect	O
Dicers	O
[	O
14	O
]	O
.	O

D.	O
melanogaster	O
has	O
2	O
Dicer	O
enzymes	O
,	O
Dcr-1	O
and	O
Dcr-2	O
which	O
are	O
responsible	O
for	O
miRNA	O
and	O
siRNA	O
production	O
respectively	O
[	O
15	O
]	O
.	O

By	O
contrast	O
most	O
other	O
animals	O
contain	O
a	O
single	O
Dicer	O
that	O
generates	O
both	O
siRNAs	O
and	O
miRNAs	O
.	O

The	O
next	O
phase	O
in	O
the	O
RNAi	O
pathway	O
involves	O
the	O
loading	O
of	O
siRNAs	O
into	O
RNA-induced	O
silencing	O
complexes	O
(	O
RISCs	O
)	O
.	O

dsRNA	O
binding	O
motif	O
proteins	O
(	O
dsRBM	O
)	O
,	O
such	O
as	O
D.	O
melanogaster	O
R2D2	O
and	O
Caenorhabditiselegans	O
Rde-4	O
help	O
siRNAs	O
to	O
be	O
loaded	O
properly	O
into	O
silencing	O
complexes	O
[	O
16,17	O
]	O
.	O

Using	O
the	O
siRNAs	O
as	O
a	O
guide	O
,	O
RISCs	O
find	O
target	O
mRNAs	O
and	O
cleave	O
them	O
.	O

Argonaute	O
(	O
Ago	O
)	O
family	O
proteins	O
are	O
the	O
main	O
components	O
of	O
silencing	O
complexes	O
,	O
mediating	O
target	O
recognition	O
and	O
silencing	O
[	O
18-20	O
]	O
.	O

Most	O
organisms	O
have	O
multiple	O
members	O
of	O
the	O
Ago	O
proteins	O
,	O
for	O
example	O
both	O
insect	O
species	O
D.	O
melanogaster	O
and	O
Tribolium	O
castaneum	O
(	O
beetle	O
)	O
have	O
5	O
,	O
whereas	O
C.	O
elegans	O
(	O
nematode	O
)	O
has	O
27	O
[	O
14,21-25	O
]	O
.	O

In	O
Drosophila	O
Ago-1	O
and	O
Ago-2	O
are	O
known	O
to	O
be	O
associated	O
with	O
RISC	O
[	O
21	O
]	O
.	O

In	O
C.	O
elegans	O
,	O
the	O
primary	O
siRNAs	O
processed	O
by	O
Dicer	O
can	O
also	O
trigger	O
the	O
amplification	O
of	O
siRNAs	O
through	O
a	O
RNA-dependent	O
RNA	O
polymerase	O
(	O
RdRP	O
)	O
to	O
produce	O
secondary	O
dsRNAs	O
in	O
a	O
two-step	O
mechanism	O
involving	O
secondary	O
Argonaute	O
proteins	O
[	O
26-28	O
]	O
.	O

This	O
mechanism	O
has	O
not	O
been	O
demonstrated	O
in	O
other	O
animals	O
to	O
date	O
and	O
is	O
commonly	O
found	O
in	O
plants	O
rather	O
than	O
animals	O
.	O

An	C
additional	C
phenomenon	C
identified	C
in	C
plants	C
and	C
C.	C
elegans	C
is	C
the	C
systemic	C
spread	C
of	C
RNAi	C
from	C
cell	C
to	C
cell	C
throughout	C
the	C
organism	C
and	C
its	C
potential	C
systemic	C
transfer	C
to	C
subsequent	C
generations	C
through	C
the	C
germ-line	C
[	C
29-31	C
]	C
.	C

Proteins	C
related	C
to	C
this	C
phenomenon	C
in	C
C.	C
elegans	C
include	C
Sid-1	C
,	C
which	C
encodes	C
a	C
multi-transmembrane	C
domain	C
protein	C
thought	C
to	C
act	C
as	C
a	C
channel	C
for	C
dsRNA	C
uptake	C
,	C
and	C
RNAi	C
spreading	C
defective	C
proteins	C
(	C
Rsd-2	C
,	C
Rsd-3	C
and	C
Rsd-6	C
)	C
shown	C
to	C
be	C
required	C
for	C
the	C
systemic	C
RNAi	C
response	C
[	C
32,33	C
]	C
.	C

Originally	C
,	C
systemic	C
RNAi	C
was	C
thought	C
to	C
be	C
unique	C
to	C
C.	C
elegans	C
in	C
animals	C
,	C
however	C
preliminary	C
evidence	C
suggests	C
that	C
silkworm	C
,	C
honeybee	C
,	C
wasp	C
and	C
beetle	C
utilize	C
a	C
Sid-1-like	C
(	C
sil	C
)	C
protein	C
not	C
found	C
in	C
mosquitoes	C
or	C
flies	C
(	C
reviewed	C
by	C
Tomoyasu	C
et	C
al	C
[	C
14	C
]	C
)	C
.	C

Furthermore	O
,	O
over	O
20	O
genes	O
identified	O
as	O
necessary	O
for	O
dsRNA	O
uptake	O
in	O
Drosophila	O
cultured	O
cells	O
have	O
also	O
been	O
identified	O
in	O
other	O
insect	O
species	O
[	O
14,34-36	O
]	O
.	O

The	O
specific	O
mechanisms	O
associated	O
with	O
dsRNA	O
uptake	O
and	O
systemic	O
RNAi	O
in	O
Arthropods	O
including	O
some	O
insect	O
species	O
are	O
thus	O
currently	O
undefined	O
.	O

Of	O
the	O
above	O
described	O
proteins	O
associated	O
with	O
RNAi	O
pathways	O
,	O
only	O
one	O
RNAi	O
tick	O
protein	O
has	O
been	O
identified	O
to	O
date	O
,	O
a	O
putative	O
R.	O
microplus	O
Ago-2	O
[	O
37	O
]	O
.	O

RNAi	C
pathways	C
in	C
Arthropods	C
other	C
than	C
fruit	C
flies	C
and	C
mosquitoes	C
are	C
beginning	C
to	C
demonstrate	C
that	C
there	C
are	C
evolutionary	C
variations	C
in	C
these	C
pathways	C
with	C
a	C
higher	C
level	C
of	C
divergence	C
within	C
the	C
Arthropoda	C
than	C
previously	C
thought	C
[	C
14,38-41	C
]	C
.	C

Similarly	O
,	O
long	O
dsRNAs	O
have	O
been	O
successfully	O
applied	O
in	O
R.	O
microplus	O
[	O
42	O
]	O
and	O
other	O
tick	O
species	O
(	O
e.g	O
.	O
Amblyomma	O
,	O
Ixodes	O
,	O
Haemaphysalis	O
,	O
and	O
Dermacentor	O
spp	O
.	O
)	O
for	O
targeted	O
gene	O
knockdown	O
to	O
demonstrate	O
the	O
function	O
of	O
tick-specific	O
genes	O
in	O
various	O
tick	O
life	O
stages	O
,	O
with	O
some	O
studies	O
producing	O
evidence	O
of	O
systemic	O
RNAi	O
spread	O
into	O
subsequent	O
stages	O
(	O
reviewed	O
by	O
de	O
la	O
Fuente	O
et	O
al	O
[	O
37	O
]	O
)	O
.	O

With	C
the	C
advent	C
of	C
increasing	C
Arthropod	C
genome	C
resources	C
,	C
it	C
may	C
be	C
feasible	C
to	C
identify	C
more	C
putative	C
tick	C
homologues	C
of	C
essential	C
RNAi	C
pathway-associated	C
proteins	C
to	C
better	C
elucidate	C
the	C
tick	C
RNAi	C
mechanism	C
.	C

Improving	O
the	O
understanding	O
of	O
the	O
mechanisms	O
used	O
by	O
ticks	O
for	O
gene	O
knockdown	O
will	O
assist	O
to	O
develop	O
specific	O
tick	O
RNA	O
interference	O
reagents	O
and	O
improved	O
techniques	O
for	O
gene	O
functional	O
studies	O
.	O

In	C
this	C
study	C
we	C
provide	C
evidence	C
for	C
the	C
presence	C
of	C
RNAi	C
pathway	C
associated	C
proteins	C
in	C
R.	C
microplus	C
ESTs	C
and	C
I.	C
scapularis	C
genome	C
reads	C
,	C
including	C
a	C
tick	C
homologue	C
for	C
Dicer	C
,	C
Argonaute	C
proteins	C
,	C
RdRP	C
and	C
proteins	C
associated	C
with	C
dsRNA	C
uptake	C
and	C
processing	C
,	C
and	C
thus	C
propose	C
a	C
putative	C
tick	C
RNAi	C
pathway	C
.	C

We	C
then	C
determined	C
whether	C
targeting	C
genes	C
in	C
the	C
cattle	C
tick	C
which	C
are	C
homologous	C
to	C
D.	C
melanogaster	C
genes	C
with	C
known	C
RNAi	C
in	C
vitro	C
phenotypes	C
[	C
43	C
]	C
would	C
similarly	C
result	C
in	C
abnormal	C
phenotypes	C
.	C

We	O
identified	O
10	O
candidate	O
genes	O
and	O
conducted	O
in	O
vitro	O
and	O
in	O
vivo	O
(	O
female	O
tick	O
injections	O
)	O
RNAi	O
loss-of-function	O
assays	O
.	O

Interestingly	O
,	O
only	O
proteasomal	O
genes	O
impaired	O
tick	O
cell	O
viability	O
in	O
vitro	O
,	O
whilst	O
9	O
candidates	O
impaired	O
tick	O
egg	O
and	O
larval	O
development	O
in	O
vivo	O
.	O

Results	O

Evidence	C
of	C
putative	C
RNAi	C
pathway	C
in	C
R.	C
microplus	C

A	O
Dicer	O
homologue	O
was	O
not	O
confirmed	O
in	O
R.	O
microplus	O
however	O
conserved	O
domains	O
commonly	O
found	O
in	O
Dicer	O
proteins	O
of	O
higher	O
eukaryotes	O
were	O
identified	O
in	O
the	O
R.	O
microplus	O
BmiGI2	O
EST	O
database	O
(	O
[	O
3	O
]	O
(	O
summarized	O
in	O
Additional	O
File	O
1	O
)	O
.	O

A	O
single	O
R.	O
microplus	O
EST	O
sequ	O
ence	O
(	O
TC9337	O
)	O
was	O
identified	O
as	O
containing	O
an	O
ORF	O
of	O
250	O
amino	O
acids	O
(	O
aa	O
)	O
encoding	O
a	O
putative	O
RNase	O
III	O
(	O
Pfam	O
:	O
PF00636	O
)	O
domain	O
.	O

The	O
pairwise	O
alignment	O
of	O
the	O
ORF	O
with	O
the	O
amino	O
acid	O
sequence	O
of	O
C.	O
elegans	O
Dcr-1	O
[	O
GenBank	O
:	O
NP_498761	O
]	O
showed	O
24	O
%	O
identity	O
and	O
an	O
e-value	O
of	O
8e-12	O
(	O
Additional	O
File	O
1	O
)	O
.	O

A	O
Dicer	O
tick	O
homologue	O
with	O
the	O
expected	O
domain	O
structure	O
for	O
a	O
eukaryotic	O
Dicer	O
was	O
identified	O
in	O
I.	O
scapularis	O
in	O
a	O
recently	O
assembled	O
supercontig	O
[	O
GenBank	O
:	O
DS643033	O
]	O
from	O
the	O
Ixodes	O
Genome	O
Project	O
(	O
IGP	O
)	O
[	O
6	O
]	O
.	O

This	O
supercontig	O
represents	O
a	O
350	O
kb	O
region	O
of	O
the	O
I.	O
scapularis	O
tick	O
genome	O
and	O
we	O
identified	O
a	O
22.3	O
kb	O
genomic	O
region	O
containing	O
a	O
single	O
gene	O
that	O
has	O
14	O
exons	O
(	O
the	O
annotation	O
described	O
here	O
has	O
been	O
submitted	O
to	O
the	O
IGP	O
)	O
.	O

The	O
predicted	O
I.	O
scapularis	O
Dicer	O
protein	O
is	O
1799aa	O
long	O
and	O
has	O
31	O
%	O
similarity	O
to	O
the	O
predicted	O
Dicer-1	O
isoform	O
4	O
from	O
the	O
dog	O
Canis	O
lupus	O
familiaris	O
[	O
GenBank	O
:	O
XP_868526	O
]	O
.	O

Furthermore	O
,	O
Figure	O
1a	O
shows	O
that	O
the	O
predicted	O
I.	O
scapularis	O
Dcr-1	O
homologue	O
has	O
the	O
same	O
domain	O
composition	O
as	O
its	O
counterparts	O
in	O
D.	O
melanogaster	O
and	O
C.	O
elegans	O
.	O

The	O
identified	O
I.	O
scapularis	O
Dicer	O
homologue	O
clusters	O
with	O
the	O
Dicer	O
protein	O
from	O
the	O
bovine	O
Bos	O
taurus	O
(	O
Figure	O
1b	O
)	O
.	O

The	O
schematic	O
domain	O
structure	O
of	O
Dicer	O
proteins	O
.	O

(	O
a	O
)	O
Comparison	O
of	O
the	O
conserved	O
domain	O
structures	O
of	O
D.	O
melanogaster	O
Dicer-1	O
and	O
Dicer-2	O
,	O
C.	O
elegans	O
DCR-1	O
and	O
our	O
predicted	O
I.	O
scapularis	O
Dicer-1	O
protein	O
.	O

Names	O
and	O
IDs	O
of	O
the	O
conserved	O
domains	O
are	O
given	O
as	O
stored	O
in	O
the	O
Pfam	O
database	O
.	O
*	O
=	O

The	O
Pfam	O
search	O
did	O
not	O
detect	O
a	O
signal	O
for	O
this	O
domain	O
in	O
the	O
sequence	O
of	O
the	O
Dicer-1	O
protein	O
of	O
D.	O
melanogaster	O
.	O

(	O
b	O
)	O
Phylogenetic	O
analysis	O
of	O
full-length	O
Dicer	O
proteins	O
(	O
Bos	O
=	O
B.	O
taurus	O
,	O
Cele	O
=	O
C.	O
elegans	O
,	O
Dmel	O
=	O
D.	O
melanogaster	O
,	O
Iscap	O
=	O
I.	O
scapularis	O
,	O
Tcas	O
=	O
T.	O
castaneum	O
)	O
.	O

The	O
analysis	O
of	O
R.	O
microplus	O
ESTs	O
and	O
I.	O
scapularis	O
genome	O
reads	O
identified	O
putative	O
tick	O
homologues	O
of	O
D.	O
melanogaster	O
Argonaute-1	O
and	O
2	O
proteins	O
in	O
both	O
species	O
(	O
Table	O
1	O
,	O
Figures	O
2	O
and	O
3	O
)	O
.	O

Putative	O
tick	O
RNAi	O
candidate	O
homologues	O

Domain	O
structure	O
and	O
phylogenetic	O
tree	O
of	O
tick	O
Argonaute-1	O
proteins	O
.	O

(	O
a	O
)	O
Schematic	O
structure	O
of	O
the	O
Argonaute-1	O
proteins	O
from	O
D.	O
melanogaster	O
and	O
our	O
predictions	O
of	O
the	O
structures	O
of	O
the	O
I.	O
scapularis	O
and	O
R.	O
microplus	O
Argonaute-1	O
homologues	O
.	O

(	O
b	O
)	O
Phylogenetic	O
analysis	O
of	O
Argonaute-1	O
proteins	O
.	O

(	O
Bos	O
=	O
B.	O
taurus	O
,	O
Cat	O
=	O
R.	O
microplus	O
,	O
Cele	O
=	O
C.	O
elegans	O
,	O
Dmel	O
=	O
D.	O
melanogaster	O
,	O
Iscap	O
=	O
I.	O
scapularis	O
,	O
Tcas	O
=	O
T.	O
castaneum	O
)	O
.	O

Domain	O
structure	O
and	O
phylogenetic	O
tree	O
of	O
tick	O
Argonaute-2	O
proteins	O
.	O

(	O
a	O
)	O
The	O
structure	O
of	O
the	O
predicted	O
Argonaute-2	O
proteins	O
from	O
I.	O
scapularis	O
and	O
R.	O
microplus	O
in	O
comparison	O
to	O
the	O
structure	O
of	O
Argonaute-2	O
in	O
D.	O
melanogaster	O
.	O

The	O
predicted	O
structural	O
property	O
of	O
both	O
tick	O
Argonaute-2	O
candidates	O
is	O
similar	O
to	O
the	O
structure	O
of	O
the	O
fruit	O
fly	O
Argonaute-2	O
protein	O
.	O

No	O
R.	O
microplus	O
ORF	O
with	O
a	O
Piwi	O
domain	O
similar	O
to	O
Argonaute-2	O
Piwi	O
was	O
identified	O
.	O

(	O
b	O
)	O
Phylogenetic	O
analysis	O
of	O
Argonaute-2	O
proteins	O
(	O
Bos	O
=	O
B.	O
taurus	O
,	O
Cat	O
=	O
R.	O
microplus	O
,	O
Cele	O
=	O
C.	O
elegans	O
,	O
Dmel	O
=	O
D.	O
melanogaster	O
,	O
Iscap	O
=	O
I.	O
scapularis	O
,	O
Tcas	O
=	O
T.	O
castaneum	O
)	O
.	O

Figure	O
2a	O
summarizes	O
the	O
domain	O
structure	O
of	O
the	O
identified	O
tick	O
Ago-1	O
proteins	O
.	O

The	O
cattle	O
tick	O
Argonaute-1	O
protein	O
(	O
Cat-Ago-1	O
)	O
is	O
partially	O
encoded	O
by	O
two	O
ESTs	O
(	O
Figure	O
2a	O
)	O
.	O

TC13769	O
encodes	O
an	O
ORF	O
of	O
352aa	O
containing	O
the	O
DUF1785	O
domain	O
located	O
from	O
aa	O
162	O
to	O
213	O
and	O
a	O
PAZ	O
domain	O
from	O
aa	O
226	O
to	O
350	O
.	O

A	O
pairwise	O
alignment	O
using	O
blastp	O
showed	O
43	O
%	O
identity	O
with	O
the	O
respective	O
domains	O
of	O
D.	O
melanogaster	O
Argonaute-1	O
protein	O
.	O

Another	C
EST	C
,	C
TC6448	C
encodes	C
the	C
putative	C
Piwi	C
domain	C
of	C
the	C
Cat-Ago-1	C
protein	C
,	C
which	C
has	C
46	C
%	C
identity	C
with	C
the	C
Piwi	C
domain	C
of	C
D.	C
melanogaster	C
Ago-1	C
.	C

The	O
Piwi	O
domain	O
encoded	O
in	O
TC6448	O
is	O
located	O
from	O
aa	O
120	O
to	O
430	O
.	O

The	O
I.	O
scapularis	O
contig	O
ABJB010128003.1	O
(	O
Iscap-Ago-1	O
)	O
encodes	O
an	O
ORF	O
of	O
967aa	O
containing	O
all	O
three	O
known	O
domains	O
of	O
Ago-1	O
proteins	O
(	O
Figure	O
2a	O
)	O
.	O

The	O
PAZ	O
domain	O
of	O
Iscap-Ago-1	O
has	O
41	O
%	O
and	O
47	O
%	O
similarity	O
with	O
the	O
PAZ	O
domains	O
of	O
Dmel-Ago-1	O
and	O
Cat-Ago-1	O
,	O
respectively	O
.	O

Interestingly	O
,	O
the	O
Piwi	O
domain	O
of	O
Iscap-Ago-1	O
shows	O
a	O
higher	O
sequence	O
similarity	O
,	O
being	O
52	O
%	O
and	O
57	O
%	O
identical	O
to	O
its	O
counterpart	O
in	O
Drosophila	O
and	O
cattle	O
tick	O
.	O

Based	O
on	O
the	O
multiple	O
sequence	O
alignments	O
of	O
the	O
DUF1785	O
and	O
PAZ	O
of	O
the	O
Argonaute-1	O
proteins	O
a	O
clustering	O
of	O
I.	O
scapularis	O
and	O
R.	O
microplus	O
is	O
observed	O
(	O
Figure	O
2b	O
)	O
.	O

The	O
second	O
cluster	O
consists	O
of	O
the	O
sequences	O
from	O
the	O
insect	O
species	O
T.	O
castaneum	O
and	O
D.	O
melanogaster	O
.	O

The	O
sequences	O
of	O
the	O
Argonaute-1	O
proteins	O
from	O
C.	O
elegans	O
and	O
B.	O
taurus	O
form	O
two	O
separate	O
outlying	O
groups	O
.	O

Figure	O
3a	O
summarizes	O
the	O
domain	O
structure	O
of	O
the	O
identified	O
tick	O
Ago-2	O
proteins	O
.	O

TC8091	O
represents	O
a	O
putative	O
cattle	O
tick	O
Argonaute-2	O
protein	O
(	O
Cat-Ago-2	O
)	O
encoding	O
an	O
ORF	O
of	O
269aa	O
harboring	O
the	O
DUF1785	O
and	O
PAZ	O
domains	O
located	O
from	O
aa	O
81	O
to	O
134	O
and	O
aa	O
135	O
to	O
269	O
(	O
27	O
%	O
identity	O
)	O
,	O
respectively	O
.	O

The	C
R.	C
microplus	C
Ago-2	C
homologue	C
TC984	C
(	C
TC9244/TC16832	C
,	C
BmiGI2	C
)	C
identified	C
by	C
de	C
la	C
Fuente	C
et	C
al	C
[	C
37	C
]	C
was	C
also	C
confirmed	C
in	C
our	C
search	C
and	C
appears	C
to	C
encode	C
a	C
Piwi	C
domain	C
.	C

Interestingly	O
,	O
the	O
pairwise	O
alignment	O
using	O
blastp	O
with	O
both	O
D.	O
melanogaster	O
Argonaute	O
proteins	O
showed	O
an	O
overall	O
identity	O
of	O
42	O
%	O
with	O
Argonaute-1	O
and	O
39	O
%	O
with	O
Argonaute-2	O
.	O

The	O
I.	O
scapularis	O
contig	O
ABJB010009424.1	O
(	O
Iscap-Ago-2	O
,	O
Figure	O
3a	O
)	O
encodes	O
an	O
ORF	O
of	O
896aa	O
consisting	O
of	O
a	O
DUF1785	O
domain	O
from	O
aa	O
304	O
to	O
357	O
,	O
a	O
PAZ	O
domain	O
from	O
aa	O
358	O
to	O
498	O
and	O
a	O
Piwi	O
domain	O
located	O
in	O
the	O
region	O
from	O
aa	O
640	O
to	O
896	O
.	O

Sequence	O
comparison	O
of	O
the	O
putative	O
Iscap-Ago-2	O
with	O
the	O
Dmel-Ago-1	O
(	O
[	O
GenBank	O
:	O
NP_725341.1	O
]	O
,	O
27	O
%	O
identity	O
)	O
and	O
Dmel-Ago-2	O
(	O
[	O
GenBank	O
:	O
NP_730054.1	O
]	O
,	O
41	O
%	O
identity	O
)	O
proteins	O
revealed	O
a	O
higher	O
homology	O
between	O
Iscap-Ago-2	O
and	O
Dmel-Ago-1	O
,	O
nevertheless	O
the	O
predicted	O
domain	O
structure	O
of	O
this	O
putative	O
I.	O
scapularis	O
Argonaute	O
was	O
more	O
similar	O
to	O
Dmel-Ago-2	O
(	O
Figure	O
3a	O
)	O
.	O

The	O
phylogenetic	O
tree	O
of	O
the	O
Argonaute-2	O
proteins	O
shows	O
three	O
clusters	O
(	O
Figure	O
3b	O
)	O
.	O

The	O
I.	O
scapularis	O
and	O
R.	O
microplus	O
sequences	O
group	O
together	O
,	O
the	O
second	O
cluster	O
consists	O
of	O
the	O
Argonaute-2	O
proteins	O
from	O
D.	O
melanogaster	O
and	O
T.	O
castaneum	O
,	O
and	O
in	O
the	O
third	O
group	O
the	O
sequences	O
from	O
C.	O
elegans	O
and	O
B.	O
taurus	O
are	O
clustered	O
.	O

Available	O
R.	O
microplus	O
ESTs	O
and	O
I.	O
scapularis	O
genomic	O
contigs	O
were	O
screened	O
for	O
homologous	O
genes	O
to	O
C.	O
elegans	O
proteins	O
involved	O
in	O
RNAi	O
systemic	O
spread	O
(	O
Rsd-2	O
,	O
Rsd-3	O
,	O
and	O
Rsd-6	O
)	O
and	O
dsRNA	O
uptake	O
(	O
Epn-1	O
)	O
(	O
Table	O
1	O
)	O
.	O

We	C
identified	C
putative	C
hits	C
to	C
Rsd-3	C
and	C
Epn-1	C
in	C
both	C
R.	C
microplus	C
and	C
I.	C
scapularis	C
with	C
45	C
%	C
and	C
48	C
%	C
(	C
Rsd-3	C
)	C
and	C
71	C
%	C
and	C
43	C
%	C
(	C
Epn-1	C
)	C
identities	C
,	C
respectively	C
.	C

Screening	O
for	O
tick	O
homologues	O
against	O
the	O
30	O
D.	O
melanogaster	O
proteins	O
implicated	O
in	O
dsRNA	O
uptake	O
and	O
processing	O
[	O
35	O
]	O
identified	O
14	O
and	O
16	O
homologues	O
in	O
R.	O
microplus	O
and	O
I.	O
scapularis	O
,	O
respectively	O
,	O
at	O
varying	O
levels	O
of	O
similarity	O
for	O
the	O
23	O
hits	O
(	O
22–91	O
%	O
)	O
.	O

The	O
highest	O
similarity	O
was	O
observed	O
with	O
dsRNA	O
uptake	O
homologues	O
associated	O
with	O
vesicle	O
mediated	O
transport	O
,	O
intracellular	O
transport	O
,	O
oogenesis	O
,	O
endosome	O
transport	O
and	O
ATPase	O
for	O
both	O
tick	O
species	O
(	O
Table	O
1	O
)	O
.	O

Similarity	O
searches	O
with	O
the	O
protein	O
sequences	O
of	O
the	O
putative	O
RNA	O
helicases	O
Armitage	O
and	O
Rm62	O
,	O
involved	O
in	O
the	O
assembly	O
of	O
RISC	O
,	O
resulted	O
in	O
best	O
hits	O
on	O
R.	O
microplus	O
sequences	O
TC9347	O
and	O
TC14966	O
respectively	O
but	O
no	O
homologues	O
of	O
Spindle	O
E	O
were	O
found	O
(	O
Table	O
1	O
)	O
.	O

Searches	O
using	O
D.	O
melanogaster	O
protein	O
sequences	O
for	O
FMRp	O
and	O
TudorSN	O
returned	O
best	O
hits	O
on	O
the	O
R.	O
microplus	O
ESTs	O
BEAE145TR	O
(	O
53	O
%	O
identity	O
)	O
and	O
BEAFW62TR	O
(	O
46	O
%	O
identity	O
)	O
,	O
respectively	O
.	O

It	C
must	C
be	C
noted	C
that	C
only	C
one	C
SN	C
domain	C
was	C
identified	C
in	C
the	C
putative	C
homologue	C
which	C
either	C
indicates	C
that	C
it	C
is	C
not	C
a	C
true	C
TudorSN	C
homologue	C
or	C
that	C
the	C
consensus	C
sequence	C
is	C
currently	C
incomplete	C
.	C

However	C
,	C
a	C
recent	C
GenBank	C
submission	C
indicates	C
the	C
presence	C
of	C
a	C
putative	C
I.	C
scapularis	C
TudorSN	C
identified	C
simultaneously	C
with	C
this	C
study	C
(	C
[	C
GenBank	C
:	C
EEC18716.1	C
]	C
Ixodes	C
scapularis	C
Genome	C
Project	C
Consortium	C
)	C
.	C

The	O
EGO-1	O
protein	O
from	O
C.	O
elegans	O
has	O
RNA-directed	O
RNA	O
polymerase	O
(	O
RdRP	O
)	O
activity	O
and	O
is	O
associated	O
with	O
the	O
C.	O
elegans	O
transitive	O
RNAi	O
pathway	O
by	O
amplifying	O
the	O
trigger	O
dsRNA	O
and/or	O
siRNAs	O
[	O
28	O
]	O
.	O

The	O
EST	O
BEAEL55TR	O
exhibited	O
a	O
41	O
%	O
identity	O
with	O
the	O
C.	O
elegans	O
RdRP	O
–	O
EGO-1	O
(	O
Table	O
1	O
)	O
.	O

Nine	O
putative	O
I.	O
scapularis	O
RdRP	O
accessions	O
have	O
been	O
deposited	O
into	O
GenBank	O
by	O
the	O
Ixodes	O
scapularis	O
Genome	O
Project	O
Consortium	O
simultaneously	O
with	O
this	O
study	O
.	O

A	O
total	O
of	O
4	O
of	O
these	O
I.	O
scapularis	O
RdRP	O
sequences	O
share	O
conserved	O
regions	O
with	O
the	O
partial	O
R.	O
microplus	O
RdRP	O
and	O
thus	O
the	O
new	O
Accessions	O
EEC04985.1	O
,	O
EEC05952.1	O
,	O
EEC12509.1	O
and	O
EEC12909.1	O
were	O
utilized	O
for	O
the	O
I.	O
scapularis	O
RdRP	O
sequences	O
in	O
the	O
consensus	O
tree	O
presented	O
in	O
Figure	O
4	O
.	O

All	O
5	O
tick	O
RdRPs	O
demonstrate	O
a	O
close	O
phylogenetic	O
relationship	O
with	O
the	O
partial	O
R.	O
microplus	O
RdRP	O
clustering	O
with	O
I.	O
scapularis	O
EEC12909.1	O
.	O

I.	O
scapularis	O
sequences	O
EEC12509.1	O
and	O
EEC04985.1	O
,	O
and	O
EEC05952.1	O
,	O
form	O
separate	O
branches	O
respectively	O
.	O

The	O
RdRP	O
proteins	O
from	O
C.	O
elegans	O
form	O
another	O
distinct	O
cluster	O
with	O
the	O
tick	O
RdRPs	O
branching	O
between	O
C.	O
elegans	O
and	O
those	O
from	O
fungi	O
,	O
plants	O
and	O
protists	O
(	O
Figure	O
4	O
)	O
.	O

Apart	O
from	O
the	O
Armitage	O
homologue	O
,	O
all	O
R.	O
microplus	O
hits	O
associated	O
with	O
RISC	O
components	O
and	O
RdRP	O
above	O
were	O
confirmed	O
in	O
I.	O
scapularis	O
genome	O
reads	O
in	O
this	O
study	O
(	O
Table	O
1	O
)	O
.	O

Phylogenetic	O
tree	O
constructed	O
from	O
the	O
multiple	O
sequence	O
alignment	O
of	O
the	O
partial	O
R.	O
microplus	O
RdRP	O
domain	O
(	O
Cat-RdRP	O
)	O
and	O
hypothetical	O
I.	O
scapularis	O
RdRP	O
proteins	O
(	O
Iscap	O
)	O
to	O
RdRP	O
sequences	O
from	O
selected	O
plants	O
(	O
Nicotiana	O
tabacum	O
,	O
Hordeum	O
vulgare	O
,	O
Arabidopsis	O
thaliana	O
,	O
Solanum	O
lycopersicum	O
)	O
,	O
fungi	O
(	O
Schizosaccharomyces	O
pombe	O
,	O
Neurospora	O
crassa	O
and	O
Aspergillus	O
fumigatus	O
)	O
,	O
protists	O
(	O
Tetrahymena	O
thermophila	O
and	O
Dictyostelium	O
discoideum	O
)	O
and	O
the	O
metazoan	O
C.	O
elegans	O
(	O
Cele-ego-1	O
,	O
Cele-rrf-1/3	O
)	O
.	O

The	O
branch	O
labels	O
display	O
the	O
consensus	O
support	O
in	O
%	O
.	O

Figure	C
5	C
shows	C
a	C
schematic	C
diagram	C
of	C
a	C
putative	C
tick	C
RNAi	C
pathway	C
.	C

Putative	C
proteins	C
identified	C
in	C
R.	C
microplus	C
ESTs	C
have	C
been	C
described	C
using	C
the	C
'Cat	C
'	C
(	C
Cattle	C
tick	C
)	C
prefix	C
.	C

dsRNA	O
is	O
taken	O
up	O
by	O
tick	O
cells	O
and	O
the	O
RNAi	O
effect	O
spreads	O
to	O
subsequent	O
tick	O
stages	O
by	O
an	O
unknown	O
mechanism	O
[	O
42	O
]	O
.	O

It	C
is	C
yet	C
unconfirmed	C
whether	C
a	C
SID-1	C
or	C
Sil-1	C
homologue	C
exist	C
in	C
ticks	C
,	C
however	C
,	C
it	C
is	C
feasible	C
that	C
RdRP	C
and	C
associated	C
proteins	C
are	C
involved	C
in	C
germ-line	C
spread	C
similar	C
to	C
the	C
C.	C
elegans	C
RdRP	C
pathway	C
[	C
28	C
]	C
.	C

Here	C
we	C
postulate	C
the	C
potential	C
amplification	C
of	C
both	C
trigger	C
dsRNA	C
and	C
secondary	C
siRNAs	C
through	C
the	C
involvement	C
of	C
a	C
Cat-RdRP	C
.	C

A	O
R.	O
microplus	O
Dicer	O
was	O
not	O
identified	O
,	O
although	O
a	O
homologue	O
was	O
identified	O
in	O
the	O
I.	O
scapularis	O
genome	O
reads	O
as	O
described	O
above	O
.	O

A	C
definitive	C
dsRNA	C
binding	C
protein	C
(	C
such	C
as	C
D.	C
melanogaster	C
R2D2	C
or	C
C.	C
elegans	C
Rde-4	C
)	C
potentially	C
associated	C
with	C
Dicer	C
was	C
not	C
found	C
using	C
the	C
current	C
tick	C
sequence	C
resources	C
.	C

A	O
confirmed	O
tick	O
Rde-1	O
was	O
not	O
identified	O
but	O
has	O
been	O
associated	O
with	O
the	O
RdRP	O
pathway	O
if	O
present	O
[	O
25	O
]	O
.	O

Dicer	O
guides	O
the	O
siRNA	O
to	O
the	O
RISC	O
structure	O
which	O
has	O
been	O
adapted	O
from	O
the	O
Sontheimer	O
RNAi	O
published	O
diagram	O
[	O
44	O
]	O
.	O

The	O
RISC	O
structure	O
demonstrates	O
homologues	O
for	O
a	O
cattle	O
tick	O
Drosophila	O
Fragile	O
×	O
protein	O
(	O
Cat-FMRp	O
)	O
,	O
tick	O
TudorSN	O
(	O
Ixodes	O
scapularis	O
Genome	O
Project	O
Consortium	O
)	O
and	O
the	O
Cat-Ago-2	O
described	O
above	O
[	O
44-46	O
]	O
.	O

Other	C
proteins	C
putatively	C
associated	C
with	C
dsRNA	C
uptake	C
,	C
systemic	C
or	C
germ-line	C
RNAi	C
listed	C
in	C
Table	C
1	C
were	C
not	C
included	C
in	C
this	C
diagram	C
.	C

Schematic	C
representation	C
of	C
a	C
putative	C
tick	C
RNAi	C
pathway	C
.	C

Cattle	O
tick	O
homologues	O
are	O
indicated	O
using	O
a	O
'Cat	O
'	O
prefix	O
for	O
proteins	O
where	O
Rhicipephalus	O
(	O
Boophilus	O
)	O
microplus	O
homologues	O
are	O
identified	O
in	O
this	O
study	O
(	O
GenBank	O
Accessions	O
are	O
listed	O
in	O
Additional	O
File	O
6	O
)	O
.	O

The	O
proposed	O
activity	O
of	O
the	O
Cat-RdRP	O
(	O
RNA	O
dependent	O
RNA	O
polymerase	O
,	O
EGO1-like	O
)	O
is	O
indicated	O
as	O
amplifying	O
trigger	O
dsRNA	O
or	O
cleaved	O
siRNAs	O
.	O

Long	O
dsRNAs	O
are	O
recruited	O
to	O
Dicer	O
(	O
putative	O
tick	O
Dicer	O
identified	O
in	O
I.	O
scapularis	O
genome	O
reads	O
)	O
via	O
a	O
yet	O
to	O
be	O
identified	O
dsRNA	O
Binding	O
Protein	O
.	O

The	O
RNA-Induced-Silencing	O
Complex	O
(	O
RISC	O
)	O
includes	O
a	O
Cat-Ago-2	O
(	O
Argonaute-2	O
homologue	O
)	O
,	O
tick	O
TudorSN	O
(	O
I.	O
scapularis	O
tudor-staphylococcal	O
nuclease	O
–	O
GenBank	O
EEC18716.1	O
)	O
and	O
a	O
Cat-FmRp	O
(	O
representing	O
the	O
D.	O
melanogaster	O
orthologue	O
of	O
the	O
fragile-X	O
mental-retardation	O
protein	O
essential	O
to	O
RISC	O
)	O
.	O

Homologues	O
for	O
a	O
tick	O
RNA	O
unwinding	O
protein	O
and	O
a	O
vasa	O
intronic	O
gene	O
(	O
associated	O
with	O
RISC	O
)	O
were	O
not	O
identified	O
.	O

The	O
schematic	O
diagram	O
was	O
partly	O
adapted	O
from	O
Sontheimer	O
2005	O
[	O
44	O
]	O
and	O
was	O
drawn	O
using	O
Solid	O
Edge	O
Version	O
20	O
(	O
Siemens	O
PLM	O
Software	O
,	O
TX	O
,	O
USA	O
)	O
.	O

Selection	O
of	O
R.	O
microplus	O
conserved	O
homologues	O
for	O
RNAi	O
gene	O
silencing	O

To	C
validate	C
further	C
a	C
putative	C
functional	C
RNAi	C
pathway	C
in	C
R.	C
microplus	C
we	C
conducted	C
RNAi-mediated	C
loss-of-function	C
assays	C
in	C
vitro	C
and	C
in	C
vivo	C
.	C

We	O
first	O
selected	O
tick	O
RNAi	O
targets	O
based	O
on	O
their	O
homology	O
to	O
Drosophila	O
genes	O
known	O
to	O
display	O
an	O
RNAi	O
phenotype	O
[	O
43	O
]	O
.	O

Of	O
the	O
438	O
Drosophila	O
genes	O
known	O
to	O
affect	O
growth	O
and	O
viability	O
,	O
40	O
were	O
identified	O
in	O
the	O
I.	O
scapularis	O
genome	O
reads	O
and	O
37	O
in	O
the	O
R.	O
microplus	O
BmiGI2	O
database	O
with	O
31	O
hits	O
common	O
between	O
the	O
tick	O
species	O
(	O
results	O
not	O
shown	O
)	O
.	O

These	O
results	O
were	O
based	O
on	O
blastn	O
searches	O
with	O
an	O
e-value	O
cut-off	O
of	O
<	O
1e-10	O
.	O

To	O
select	O
the	O
most	O
conserved	O
sequences	O
for	O
tick	O
in	O
vitro	O
studies	O
,	O
using	O
high	O
stringency	O
searches	O
(	O
>	O
80	O
%	O
identity	O
,	O
e-value	O
<	O
1e-50	O
)	O
,	O
11	O
R.	O
microplus	O
ESTs	O
were	O
identified	O
in	O
the	O
BmiGI2	O
database	O
as	O
homologous	O
to	O
D.	O
melanogaster	O
genes	O
with	O
RNAi	O
phenotypes	O
affecting	O
growth	O
and	O
viability	O
at	O
z	O
scores	O
>	O
3	O
[	O
43	O
]	O
(	O
Table	O
2	O
)	O
.	O

An	O
additional	O
2	O
highly	O
conserved	O
homologues	O
were	O
selected	O
as	O
negative	O
controls	O
,	O
one	O
with	O
a	O
lower	O
z	O
score	O
(	O
Drosophila	O
string	O
of	O
perls	O
)	O
and	O
one	O
with	O
a	O
nil	O
z	O
score	O
thus	O
with	O
a	O
nil	O
effect	O
on	O
cell	O
culture	O
growth	O
and	O
viability	O
(	O
Drosophila	O
Tat-binding	O
protein-1	O
)	O
,	O
Table	O
2	O
.	O

The	C
putative	C
function	C
of	C
these	C
13	C
R.	C
microplus	C
ESTs	C
were	C
then	C
assigned	C
by	C
retrieving	C
the	C
annotated	C
InterPro	C
domains	C
of	C
their	C
Drosophila	C
counterparts	C
(	C
Table	C
2	C
)	C
.	C

Evaluation	C
of	C
the	C
assigned	C
functional	C
information	C
revealed	C
that	C
5	C
sequences	C
putatively	C
have	C
a	C
role	C
in	C
ribosome	C
and	C
protein	C
synthesis	C
(	C
TC5762	C
,	C
TC9037	C
,	C
TC12306	C
,	C
TC12372	C
,	C
TC12393	C
)	C
,	C
4	C
in	C
proteasome	C
and	C
ubiquitinylation	C
(	C
TC6372	C
,	C
TC9852	C
,	C
TC10417	C
,	C
TC13930	C
)	C
,	C
3	C
in	C
DNA	C
binding	C
(	C
TC6116	C
,	C
TC12182	C
,	C
TC9417	C
)	C
,	C
and	C
one	C
in	C
energy	C
and	C
metabolism	C
(	C
TC5823	C
)	C
.	C

The	O
controls	O
used	O
were	O
the	O
Drosophila	O
string	O
of	O
perls	O
(	O
TC5762	O
)	O
and	O
Tat-binding	O
protein-1	O
(	O
TC13930	O
)	O
homologues	O
respectively	O
.	O

R.	O
microplus	O
homologues	O
with	O
high	O
conservation	O
(	O
≥	O
80	O
%	O
identity	O
)	O
to	O
13	O
D.	O
melanogaster	O
proteins	O
following	O
RNAi	O
knockdown	O
in	O
vitro	O
(	O
11	O
associated	O
with	O
significant	O
cell	O
viability	O
z	O
scores	O
at	O
>	O
3	O
and	O
2	O
controls	O
at	O
<	O
3	O
)	O

Although	O
all	O
primers	O
for	O
target	O
amplification	O
prior	O
to	O
RNA	O
transcription	O
were	O
designed	O
by	O
targeting	O
conserved	O
consensus	O
regions	O
as	O
described	O
in	O
the	O
methods	O
,	O
amplification	O
of	O
TC5823	O
(	O
energy	O
and	O
metabolism/ATP	O
biosynthesis	O
)	O
,	O
TC9417	O
(	O
DNA	O
binding	O
)	O
and	O
TC12372	O
(	O
ribosome	O
and	O
protein	O
synthesis	O
)	O
was	O
inconsistent	O
with	O
poor	O
yields	O
which	O
were	O
inadequate	O
for	O
RNA	O
transcription	O
(	O
not	O
shown	O
)	O
.	O

dsRNAs	O
were	O
transcribed	O
successfully	O
for	O
the	O
remaining	O
10	O
target	O
genes	O
(	O
8	O
high	O
z	O
scores	O
,	O
2	O
controls	O
)	O
used	O
for	O
RNAi	O
experiments	O
in	O
cultured	O
R.	O
microplus	O
BME26	O
cells	O
and	O
adult	O
female	O
ticks	O
.	O

Gene	O
silencing	O
in	O
cultured	O
tick	O
cells	O

None	O
of	O
the	O
dsRNA	O
treatments	O
had	O
significant	O
effects	O
on	O
tick	O
cell	O
viability	O
(	O
Figure	O
6a	O
)	O
compared	O
to	O
controls	O
and	O
compared	O
to	O
z	O
scores	O
>	O
3	O
as	O
described	O
for	O
the	O
same	O
targets	O
in	O
Drosophila	O
cells	O
(	O
Table	O
2	O
,	O
[	O
43	O
]	O
)	O
.	O

However	O
,	O
TC6372	O
(	O
Ubiquitin-63E	O
homologue	O
)	O
knockdown	O
demonstrated	O
the	O
most	O
severe	O
effect	O
on	O
growth	O
and	O
viability	O
(	O
inverse	O
z	O
score	O
2.1	O
)	O
(	O
Figure	O
6	O
)	O
,	O
also	O
confirmed	O
by	O
microscopic	O
examination	O
of	O
the	O
cells	O
(	O
not	O
shown	O
)	O
.	O

An	O
additional	O
2	O
target	O
genes	O
(	O
Rpt1	O
TC10417	O
,	O
and	O
Tat-binding	O
protein-1	O
TC13930	O
)	O
demonstrated	O
a	O
slight	O
reduction	O
on	O
cell	O
viability	O
with	O
z	O
scores	O
0.8	O
and	O
1.0	O
respectively	O
.	O

It	C
is	C
feasible	C
that	C
the	C
TC13930	C
treatment	C
may	C
have	C
had	C
a	C
stronger	C
viability	C
phenotype	C
if	C
the	C
knockdown	C
had	C
been	C
more	C
effective	C
(	C
only	C
31	C
%	C
compared	C
to	C
other	C
treatments	C
~	C
>	C
79	C
%	C
)	C
.	C

Collectively	O
the	O
effects	O
are	O
less	O
significant	O
in	O
tick	O
cells	O
than	O
for	O
their	O
Drosophila	O
counterparts	O
in	O
Drosophila	O
cells	O
,	O
these	O
3	O
treatments	O
are	O
all	O
associated	O
with	O
proteins	O
involved	O
in	O
proteasome	O
and	O
ubiquitin	O
function	O
.	O

Quantitative	O
RT-PCR	O
analysis	O
confirmed	O
that	O
all	O
RNAi	O
targeted	O
genes	O
resulted	O
in	O
a	O
substantial	O
reduction	O
of	O
the	O
corresponding	O
target	O
mRNA	O
(	O
79.9	O
–	O
100	O
%	O
)	O
except	O
for	O
TC13930	O
at	O
31	O
%	O
(	O
Figure	O
6b	O
)	O
.	O

Cell	O
culture	O
knockdown	O
.	O

(	O
a	O
)	O
.	O

Growth	O
and	O
viability	O
RNAi	O
phenotypes	O
expressed	O
as	O
inverse	O
z-scores	O
of	O
genes	O
involved	O
in	O
ribosome	O
and	O
protein	O
synthesis	O
(	O
TC5762	O
,	O
TC9037	O
,	O
TC12306	O
,	O
TC12393	O
)	O
,	O
encoding	O
proteasome	O
components	O
and	O
participating	O
in	O
ubiquitinylation	O
(	O
TC6372	O
,	O
TC9852	O
,	O
TC10417	O
,	O
TC13930	O
)	O
,	O
and	O
having	O
DNA	O
binding	O
functions	O
(	O
TC6116	O
,	O
TC12182	O
)	O
.	O

A	O
positive	O
z-score	O
indicates	O
reduced	O
cell	O
growth	O
and	O
viability	O
.	O

(	O
b	O
)	O
.	O

Effect	O
of	O
dsRNA-induced	O
knockdown	O
on	O
RNAi	O
targets	O
measured	O
by	O
quantitative	O
RT-PCR	O
and	O
presented	O
as	O
%	O
of	O
gene	O
expression	O
levels	O
relative	O
to	O
the	O
housekeeping	O
gene	O
.	O

Gene	O
silencing	O
in	O
adult	O
female	O
ticks	O
(	O
reproduction	O
phenotype	O
)	O

The	O
same	O
treatments	O
were	O
tested	O
in	O
live	O
adult	O
female	O
ticks	O
to	O
measure	O
any	O
in	O
vivo	O
effects	O
of	O
gene	O
silencing	O
on	O
tick	O
survivability	O
,	O
egg	O
output	O
and	O
larval	O
hatching	O
.	O

Eggs	O
laid	O
by	O
ticks	O
from	O
the	O
control	O
groups	O
showed	O
no	O
obvious	O
morphological	O
changes	O
(	O
see	O
Figure	O
7a	O
for	O
eggs	O
from	O
``	O
no	O
treatment	O
''	O
group	O
)	O
.	O

The	O
average	O
egg	O
mass	O
weight	O
was	O
0.118	O
g	O
for	O
the	O
control	O
dsRNA	O
group	O
,	O
0.134	O
for	O
the	O
tick	O
actin	O
dsRNA	O
group	O
,	O
0.107	O
g	O
for	O
the	O
PBS	O
injection	O
control	O
group	O
and	O
0.128	O
g	O
for	O
the	O
negative	O
control	O
group	O
(	O
nil	O
injection	O
)	O
.	O

Eggs	O
from	O
the	O
control	O
groups	O
showed	O
a	O
normal	O
embryonic	O
development	O
time	O
to	O
larval	O
hatching	O
at	O
27	O
days	O
.	O

The	O
larval	O
hatching	O
rates	O
for	O
control	O
treatments	O
ranged	O
between	O
62.0–69.8	O
%	O
(	O
Table	O
3	O
)	O
.	O

Differences	O
in	O
egg	O
morphologies	O
following	O
treatment	O
of	O
R.	O
microplus	O
adult	O
female	O
ticks	O
with	O
dsRNA	O
.	O

(	O
a	O
)	O
Egg	O
from	O
untreated	O
females	O
approximately	O
15	O
day	O
after	O
laying	O
,	O
(	O
b	O
)	O
Eggs	O
from	O
females	O
treated	O
with	O
TC6372	O
(	O
D.	O
melanogaster	O
Ubiquitin	O
63E-like	O
transcript	O
)	O
dsRNA	O
approximately	O
15	O
days	O
after	O
laying	O
.	O

(	O
c	O
)	O
Eggs	O
from	O
females	O
treated	O
with	O
dsRNA	O
targeting	O
TC12306	O
(	O
D.	O
melanogaster	O
ribosomal	O
protein	O
L8-like	O
transcript	O
)	O
approximately	O
15	O
days	O
after	O
egg	O
laying	O
.	O

Effect	O
of	O
tick	O
in	O
vivo	O
dsRNA	O
gene	O
knockdown	O
treatments	O
on	O
female	O
tick	O
survival	O
and	O
subsequent	O
reproduction	O
fecundity	O
by	O
targeting	O
Drosophila	O
homologues	O
described	O
in	O
Table	O
2	O

Ubiquitin-63E	O
dsRNA	O
treatment	O
had	O
the	O
most	O
significant	O
effect	O
on	O
adult	O
tick	O
survival	O
(	O
average	O
10	O
days	O
,	O
approximately	O
5	O
days	O
less	O
than	O
the	O
controls	O
,	O
Table	O
3	O
)	O
.	O

Eggs	O
laid	O
by	O
R.	O
microplus	O
females	O
injected	O
with	O
dsRNA	O
targeting	O
genes	O
associated	O
with	O
ribosome/protein	O
synthesis	O
(	O
TC5762/string	O
of	O
perls	O
;	O
TC12306/Rpl-8	O
;	O
TC9037/Ribosomal	O
protein	O
L11	O
;	O
TC9852/Proteasome	O
26S	O
subunit	O
;	O
TC12393/Ribosomal	O
protein	O
S13	O
)	O
and	O
proteasome/ubiquitin	O
(	O
TC6372/Ubiquitin-63E	O
)	O
demonstrated	O
the	O
most	O
lethal	O
effect	O
on	O
tick	O
reproduction	O
with	O
deformed	O
egg	O
morphology	O
and	O
no	O
larvae	O
hatching	O
(	O
Table	O
3	O
)	O
.	O

RNAi	O
targeting	O
of	O
TC12306	O
(	O
Rpl-8	O
)	O
and	O
TC6372	O
(	O
Ubiquitin-63E	O
)	O
generated	O
the	O
greatest	O
reductions	O
in	O
average	O
egg	O
output	O
,	O
with	O
Ubiquitin-63E	O
(	O
TC6372	O
)	O
treated	O
ticks	O
again	O
being	O
significantly	O
affected	O
compared	O
with	O
the	O
controls	O
(	O
Table	O
3	O
)	O
.	O

Figures	O
7b	O
and	O
7c	O
show	O
examples	O
of	O
phenotypic	O
effects	O
on	O
embryo	O
development	O
due	O
to	O
TC6372	O
(	O
dehydrated	O
in	O
appearance	O
,	O
embryo	O
not	O
visible	O
)	O
and	O
TC12306	O
(	O
embryo	O
smaller	O
in	O
size	O
)	O
knockdown	O
respectively	O
.	O

Down-regulation	O
of	O
the	O
TC13930/Tat-binding	O
protein-1	O
also	O
associated	O
with	O
proteasome/ubiquitin	O
function	O
,	O
impaired	O
embryo	O
development	O
leading	O
to	O
a	O
poor	O
larval	O
hatching	O
rate	O
(	O
0.4	O
%	O
)	O
.	O

In	O
contrast	O
,	O
another	O
gene	O
associated	O
with	O
proteasome/ubiquitin	O
(	O
TC10417/rpt	O
1	O
)	O
had	O
no	O
effect	O
on	O
egg	O
development	O
and	O
hatching	O
rates	O
compared	O
with	O
controls	O
,	O
although	O
this	O
target	O
demonstrated	O
a	O
decrease	O
in	O
cell	O
viability	O
in	O
cell	O
culture	O
experiments	O
above	O
.	O

The	O
2	O
ESTs	O
associated	O
with	O
DNA	O
binding	O
(	O
TC6116	O
and	O
TC12182/histone	O
H3.3A	O
)	O
both	O
induced	O
slower	O
embryo	O
development	O
and	O
reductions	O
in	O
egg	O
hatching	O
at	O
3.1	O
%	O
and	O
35.2	O
%	O
respectively	O
.	O

A	O
single	O
(	O
sixth	O
)	O
tick	O
was	O
harvested	O
to	O
confirm	O
the	O
relative	O
reduction	O
of	O
transcript	O
levels	O
(	O
%	O
knockdown	O
determined	O
by	O
qRT-PCR	O
)	O
for	O
both	O
the	O
adult	O
ticks	O
and	O
eggs	O
(	O
where	O
applicable	O
)	O
for	O
each	O
Drosophila	O
homologue	O
treatment	O
.	O

All	O
treatments	O
except	O
TC9037	O
demonstrated	O
high	O
knockdown	O
of	O
transcripts	O
in	O
adult	O
tick	O
viscera	O
(	O
≥	O
94	O
%	O
)	O
,	O
with	O
knockdown	O
also	O
confirmed	O
in	O
eggs	O
tested	O
(	O
≥	O
76	O
%	O
)	O
.	O

As	C
the	C
viscera	C
from	C
only	C
one	C
tick	C
per	C
treatment	C
was	C
harvested	C
for	C
RT-qPCR	C
,	C
it	C
is	C
feasible	C
that	C
the	C
TC9037	C
treatment	C
on	C
this	C
single	C
tick	C
was	C
not	C
delivered	C
successfully	C
,	C
however	C
,	C
none	C
of	C
the	C
5	C
ticks	C
injected	C
produced	C
viable	C
eggs	C
indicating	C
a	C
knockdown	C
phenotype	C
for	C
the	C
TC9037	C
treatment	C
overall	C
.	C

Thus	C
9	C
of	C
the	C
10	C
Drosophila	C
tick	C
homologues	C
demonstrated	C
either	C
a	C
lethal	C
effect	C
on	C
reproduction	C
or	C
a	C
reduction	C
in	C
larval	C
hatching	C
rates	C
when	C
using	C
dsRNA	C
targeted	C
knockdown	C
in	C
vivo	C
.	C

The	O
significant	O
effects	O
associated	O
with	O
the	O
Ubiquitin-63E	O
homologue	O
TC6372	O
treatments	O
correlates	O
with	O
the	O
highest	O
z	O
scores	O
for	O
the	O
same	O
target	O
in	O
Drosophila	O
cell	O
viability	O
out	O
of	O
the	O
sub-set	O
of	O
targets	O
used	O
here	O
(	O
Table	O
2	O
,	O
[	O
43	O
]	O
)	O
.	O

Data	O
from	O
the	O
FlyBase	O
website	O
http	O
:	O
//flybase.org/	O
identified	O
that	O
in	O
vivo	O
studies	O
involving	O
dsRNA	O
injection	O
into	O
Drosophila	O
embryos	O
was	O
lethal	O
for	O
both	O
Rpt1	O
and	O
RpS13	O
(	O
correlating	O
to	O
TC10417	O
and	O
TC12393	O
above	O
)	O
.	O

However	O
,	O
Rpt1	O
(	O
TC10417	O
)	O
was	O
the	O
only	O
treatment	O
which	O
did	O
not	O
have	O
an	O
effect	O
in	O
vivo	O
for	O
ticks	O
.	O

Fly	O
in	O
vivo	O
knockdown	O
studies	O
associated	O
with	O
the	O
8	O
of	O
the	O
remaining	O
targets	O
were	O
not	O
found	O
.	O

Discussion	O

The	C
lack	C
of	C
tick	C
genome	C
sequence	C
resources	C
has	C
limited	C
the	C
ability	C
to	C
mine	C
for	C
RNAi	C
protein	C
homologues	C
however	C
research	C
to	C
date	C
has	C
suggested	C
that	C
ticks	C
utilize	C
a	C
dsRNA-mediated	C
RNAi	C
similar	C
to	C
that	C
described	C
in	C
insects	C
such	C
as	C
flies	C
and	C
mosquitoes	C
[	C
47,48	C
]	C
.	C

De	C
la	C
Fuente	C
and	C
colleagues	C
[	C
37	C
]	C
postulated	C
a	C
model	C
for	C
tick	C
dsRNA-mediated	C
RNAi	C
following	C
the	C
identification	C
of	C
a	C
putative	C
Ago-2	C
protein	C
in	C
the	C
R.	C
microplus	C
EST	C
database	C
.	C

Our	C
results	C
support	C
the	C
diagram	C
represented	C
in	C
de	C
la	C
Fuente	C
et	C
al	C
[	C
37	C
]	C
demonstrating	C
evidence	C
for	C
putative	C
tick	C
Dicer	C
,	C
RISC	C
associated	C
proteins	C
and	C
dsRNA	C
uptake	C
homologues	C
,	C
however	C
we	C
identified	C
a	C
R.	C
microplus	C
EGO-1	C
homologue	C
known	C
to	C
be	C
implicated	C
in	C
RNA-directed	C
RNA	C
polymerase	C
activity	C
previously	C
not	C
identified	C
in	C
animals	C
other	C
than	C
C.	C
elegans	C
.	C

We	O
also	O
identified	O
a	O
Cat-Ago-2	O
at	O
higher	O
similarity	O
than	O
the	O
tick	O
homologue	O
identified	O
by	O
de	O
la	O
Fuente	O
et	O
al	O
[	O
37	O
]	O
which	O
exhibited	O
higher	O
similarity	O
to	O
the	O
Argonaute-1	O
protein	O
of	O
D.	O
melanogaster	O
in	O
this	O
study	O
.	O

This	O
is	O
the	O
first	O
comprehensive	O
analysis	O
of	O
RNAi	O
sequence	O
domains	O
for	O
a	O
tick	O
species	O
and	O
for	O
the	O
Chelicerate	O
Arthropods	O
.	O

Compared	O
to	O
the	O
vast	O
insect	O
genome	O
resources	O
(	O
flies	O
,	O
mosquitoes	O
,	O
beetle	O
,	O
silkworm	O
,	O
wasp	O
–	O
to	O
name	O
a	O
few	O
)	O
,	O
there	O
is	O
currently	O
only	O
one	O
Chelicerate	O
genome	O
available	O
with	O
the	O
I.	O
scapularis	O
tick	O
genome	O
project	O
nearing	O
completion	O
.	O

To	C
provide	C
an	C
evolutionary	C
perspective	C
to	C
demonstrate	C
relationships	C
within	C
the	C
Ecdysozoan	C
infraphylum	C
it	C
is	C
important	C
to	C
note	C
that	C
their	C
common	C
ancestors	C
may	C
have	C
existed	C
over	C
1	C
billion	C
years	C
ago	C
[	C
49	C
]	C
.	C

Comparative	O
genomics	O
between	O
these	O
phyla	O
is	O
in	O
its	O
infancy	O
and	O
pathways	O
such	O
as	O
RNAi	O
interference	O
and	O
gene	O
regulation	O
to	O
date	O
have	O
been	O
based	O
on	O
the	O
fruit	O
fly	O
D.	O
melanogaster	O
as	O
the	O
model	O
organism	O
.	O

As	C
differences	C
between	C
RNAi	C
pathway	C
mechanisms	C
between	C
C.	C
elegans	C
and	C
D.	C
melanogaster	C
are	C
evident	C
,	C
it	C
is	C
thus	C
feasible	C
that	C
Chelicerates	C
could	C
also	C
vary	C
from	C
insects	C
albeit	C
their	C
evolutionary	C
distance	C
is	C
less	C
(	C
~500	C
million	C
years	C
)	C
[	C
2	C
]	C
.	C

Indeed	O
,	O
definitive	O
hits	O
for	O
the	O
domains	O
and	O
proteins	O
here	O
were	O
not	O
exclusive	O
to	O
the	O
Arthropoda	O
,	O
with	O
the	O
putative	O
tick	O
RNAi	O
proteins	O
matching	O
homologues	O
in	O
diverse	O
species	O
such	O
as	O
insects	O
(	O
beetle	O
,	O
silkworm	O
,	O
wasp	O
)	O
,	O
nematodes	O
,	O
and	O
mammals	O
(	O
data	O
not	O
shown	O
)	O
.	O

While	O
only	O
a	O
single	O
Dicer	O
protein	O
is	O
present	O
in	O
mammals	O
and	O
in	O
C.	O
elegans	O
,	O
in	O
D.	O
melanogaster	O
siRNAs	O
and	O
miRNAs	O
are	O
produced	O
by	O
distinct	O
Dicer	O
enzymes	O
[	O
15	O
]	O
.	O

In	C
this	C
study	C
we	C
identified	C
one	C
putative	C
tick	C
Dicer	C
in	C
the	C
I.	C
scapularis	C
genome	C
reads	C
however	C
evidence	C
for	C
more	C
than	C
one	C
Dicer	C
can	C
not	C
at	C
this	C
stage	C
be	C
confirmed	C
.	C

This	O
I.	O
scapularis	O
Dicer	O
was	O
found	O
to	O
be	O
most	O
similar	O
to	O
a	O
Dicer-1	O
from	O
a	O
mammal	O
.	O

A	O
R.	O
microplus	O
Dicer	O
could	O
not	O
be	O
confirmed	O
,	O
however	O
an	O
I.	O
scapularis	O
homologue	O
was	O
also	O
not	O
previously	O
identified	O
using	O
EST	O
data	O
alone	O
.	O

Our	C
preliminary	C
evidence	C
points	C
to	C
a	C
'single	C
'	C
tick	C
Dicer	C
with	C
yet	C
un-confirmed	C
structure	C
,	C
though	C
until	C
complete	C
tick	C
genome	C
resources	C
are	C
available	C
the	C
presence	C
of	C
more	C
than	C
one	C
Dicer	C
can	C
not	C
be	C
entirely	C
dismissed	C
.	C

The	O
RISC	O
structure	O
contains	O
the	O
following	O
essential	O
proteins	O
:	O
D.	O
melanogaster	O
R2D2	O
or	O
C.	O
elegans	O
Rde-4	O
[	O
17	O
]	O
,	O
D.	O
melanogaster	O
homologue	O
of	O
the	O
Fragile	O
×	O
mental	O
retardation	O
protein	O
(	O
FMRP	O
)	O
dFXR	O
[	O
45	O
]	O
,	O
Vasa	O
Intronic	O
gene	O
(	O
VIG	O
)	O
and	O
a	O
Tudor	O
Staphylococcal	O
nuclease	O
[	O
46,50	O
]	O
.	O

We	O
were	O
able	O
to	O
confirm	O
the	O
presence	O
of	O
putative	O
tick	O
FMRp	O
but	O
no	O
significant	O
hits	O
for	O
TudorSN	O
or	O
VIG	O
homologues	O
and	O
no	O
significant	O
similarity	O
to	O
known	O
RNA	O
binding	O
proteins	O
using	O
the	O
current	O
tick	O
resources	O
.	O

However	O
,	O
a	O
concurrent	O
study	O
has	O
identified	O
a	O
putative	O
I.	O
scapularis	O
TudorSN	O
(	O
GenBank	O
,	O
Ixodes	O
scapularis	O
Genome	O
Project	O
Consortium	O
)	O
yet	O
to	O
be	O
confirmed	O
in	O
R.	O
microplus	O
.	O

The	O
Argonaute	O
(	O
Ago	O
)	O
family	O
of	O
proteins	O
contains	O
2	O
distinct	O
RNA-binding	O
domains	O
PAZ	O
and	O
PIWI	O
(	O
PPD	O
)	O
required	O
to	O
bind	O
the	O
siRNA	O
and	O
to	O
slice	O
the	O
cognate	O
RNA	O
to	O
be	O
degraded	O
,	O
respectively	O
and	O
thus	O
are	O
essential	O
to	O
RISC	O
[	O
51,52	O
]	O
.	O

Our	O
study	O
confirmed	O
the	O
presence	O
of	O
tick	O
Ago-1	O
and	O
Ago-2	O
in	O
the	O
I.	O
scapularis	O
genome	O
reads	O
and	O
found	O
evidence	O
for	O
a	O
complete	O
Ago-1	O
protein	O
in	O
the	O
R.	O
microplus	O
EST	O
database	O
.	O

A	O
R.	O
microplus	O
sequence	O
containing	O
a	O
partial	O
Ago-2	O
protein	O
was	O
also	O
identified	O
.	O

The	C
functions	C
of	C
these	C
tick	C
Argonaute	C
proteins	C
remains	C
to	C
be	C
confirmed	C
and	C
further	C
research	C
is	C
required	C
to	C
identify	C
the	C
full	C
complement	C
of	C
tick	C
PPD	C
proteins	C
.	C

Flies	O
and	O
mosquitoes	O
do	O
not	O
possess	O
C.	O
elegans	O
Sid-1	O
homologues	O
known	O
to	O
be	O
responsible	O
for	O
systemic	O
and	O
germ-line	O
RNAi	O
.	O

Tick	O
RNAi	O
observed	O
in	O
this	O
study	O
and	O
the	O
literature	O
demonstrate	O
that	O
a	O
systemic	O
RNAi	O
silencing	O
mechanism	O
is	O
active	O
in	O
ticks	O
[	O
42	O
]	O
.	O

Although	O
a	O
tick	O
Sid-1	O
was	O
not	O
found	O
,	O
we	O
did	O
however	O
identify	O
a	O
tick	O
homologue	O
of	O
the	O
C.	O
elegans	O
EGO-1	O
,	O
an	O
RNA	O
dependent	O
RNA	O
polymerase	O
(	O
RdRP	O
)	O
known	O
to	O
amplify	O
trigger	O
dsRNA	O
(	O
transitive	O
RNAi	O
)	O
and	O
systemic	O
RNAi	O
[	O
27,53	O
]	O
.	O

RdRP	O
is	O
otherwise	O
absent	O
in	O
flies	O
,	O
mosquitoes	O
and	O
other	O
animals	O
.	O

Perhaps	C
an	C
RdRP-based	C
RNAi	C
amplification	C
mechanism	C
within	C
the	C
Ecdysozoans	C
(	C
including	C
ticks	C
and	C
C.	C
elegans	C
)	C
is	C
common	C
,	C
but	C
lost	C
in	C
insect	C
species	C
?	C

Mechanisms	O
for	O
cell	O
to	O
cell	O
dsRNA	O
uptake	O
within	O
ticks	O
requires	O
further	O
investigation	O
,	O
as	O
well	O
as	O
the	O
confirmation	O
of	O
the	O
activity	O
of	O
the	O
tick	O
RdRP	O
and	O
Rsd-3	O
homologues	O
identified	O
here	O
.	O

Further	O
research	O
to	O
identify	O
putative	O
tick	O
secondary	O
Argonautes	O
associated	O
with	O
the	O
transitive	O
RNAi	O
pathway	O
in	O
C.	O
elegans	O
is	O
also	O
warranted	O
.	O

These	O
mechanisms	O
have	O
not	O
been	O
studied	O
in	O
spiders	O
,	O
mites	O
or	O
ticks	O
to	O
date	O
,	O
thus	O
confirmation	O
of	O
RNAi	O
mechanisms	O
within	O
the	O
Cheliceromorpha	O
will	O
assist	O
to	O
confirm	O
potentially	O
new	O
evolutionary	O
mechanisms	O
previously	O
not	O
defined	O
and	O
which	O
can	O
not	O
be	O
based	O
on	O
pathways	O
observed	O
in	O
insect	O
species	O
.	O

An	C
additional	C
aim	C
of	C
our	C
study	C
was	C
to	C
investigate	C
whether	C
fruit	C
fly	C
RNAi	C
screens	C
of	C
conserved	C
genes	C
could	C
be	C
associated	C
with	C
similar	C
tick	C
phenotypes	C
and	C
tick	C
gene	C
function	C
.	C

We	C
used	C
a	C
stringent	C
search	C
to	C
enable	C
the	C
selection	C
of	C
the	C
most	C
similar	C
sequences	C
to	C
maximize	C
the	C
probability	C
of	C
selecting	C
a	C
tick	C
sequence	C
which	C
following	C
dsRNA	C
mediated	C
knockdown	C
could	C
also	C
affect	C
growth	C
and	C
viability	C
in	C
vitro	C
.	C

With	O
the	O
exception	O
of	O
proteasome/ubiquitin	O
protein	O
homologues	O
,	O
the	O
RNAi	O
experiments	O
with	O
cultured	O
R.	O
microplus	O
BME26	O
cells	O
did	O
not	O
replicate	O
the	O
effects	O
observed	O
by	O
Boutros	O
and	O
co-workers	O
in	O
D.	O
melanogaster	O
cells	O
[	O
43	O
]	O
for	O
all	O
targets	O
.	O

However	O
,	O
in	O
vivo	O
knockdown	O
confirmed	O
a	O
lethal	O
effect	O
for	O
6	O
of	O
the	O
10	O
targets	O
,	O
with	O
only	O
one	O
demonstrating	O
nil	O
effects	O
on	O
tick	O
reproduction	O
.	O

The	O
ubiquitin-63E	O
homologue	O
which	O
demonstrated	O
the	O
highest	O
z	O
score	O
and	O
impact	O
on	O
Drosophila	O
cell	O
viability	O
exhibited	O
the	O
strongest	O
effects	O
on	O
viability	O
in	O
our	O
tick	O
study	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

However	O
the	O
effects	O
on	O
tick	O
cell	O
growth	O
and	O
viability	O
from	O
the	O
remaining	O
9	O
(	O
including	O
2	O
negative	O
controls	O
)	O
dsRNA	O
targets	O
tested	O
did	O
not	O
correlate	O
well	O
with	O
Drosophila	O
demonstrating	O
poor	O
statistical	O
significance	O
at	O
least	O
under	O
our	O
in	O
vitro	O
conditions	O
.	O

Kurtti	O
et	O
al	O
[	O
54	O
]	O
found	O
that	O
cationic	O
lipid-based	O
reagents	O
greatly	O
improved	O
the	O
transfection	O
of	O
I.	O
scapularis	O
cultured	O
tick	O
cells	O
as	O
well	O
as	O
subsequent	O
silencing	O
of	O
transgenes	O
by	O
dsRNAi	O
.	O

Perhaps	C
uptake	C
of	C
nucleic	C
acids	C
by	C
cultured	C
tick	C
cells	C
is	C
less	C
efficient	C
than	C
with	C
Drosophila	C
cells	C
.	C

In	O
addition	O
,	O
although	O
tick	O
genome	O
resources	O
are	O
currently	O
incomplete	O
,	O
we	O
did	O
not	O
identify	O
tick	O
homologues	O
of	O
Scavenger	O
receptors	O
(	O
Eater	O
and	O
SrCI	O
)	O
known	O
to	O
be	O
required	O
for	O
dsRNA	O
uptake	O
in	O
Drosophila	O
cell	O
culture	O
[	O
36	O
]	O
.	O

This	C
suggests	C
the	C
recruitment	C
of	C
different	C
receptors	C
for	C
dsRNA	C
uptake	C
in	C
tick	C
cells	C
compared	C
to	C
those	C
described	C
in	C
Drosophila	C
.	C

It	C
is	C
also	C
possible	C
that	C
the	C
cell	C
line	C
types	C
utilized	C
in	C
D.	C
melanogaster	C
and	C
R.	C
microplus	C
are	C
not	C
directly	C
comparable	C
and	C
functionally	C
different	C
.	C

The	C
438	C
genes	C
targeted	C
by	C
Boutros	C
and	C
co-workers	C
[	C
43	C
]	C
compared	C
the	C
effects	C
using	C
2	C
embryonic	C
cell	C
lines	C
,	C
Kc167	C
which	C
is	C
an	C
'early	C
'	C
embryonic	C
cell	C
line	C
and	C
S2R+	C
which	C
is	C
a	C
'late	C
'	C
embryonic	C
cell	C
line	C
–	C
potentially	C
more	C
comparable	C
to	C
BME26	C
cells	C
which	C
are	C
'late	C
'	C
embryonic	C
in	C
origin	C
[	C
55-57	C
]	C
.	C

However	O
,	O
the	O
BME26	O
average	O
cell	O
size	O
is	O
smaller	O
at	O
15–20	O
µM	O
compared	O
to	O
SR2+	O
cells	O
at	O
50	O
µM	O
[	O
56,58	O
]	O
.	O

The	O
BME26	O
cell	O
line	O
also	O
has	O
a	O
doubling	O
time	O
of	O
7	O
days	O
,	O
considerably	O
slower	O
than	O
the	O
Drosophila	O
cell	O
lines	O
.	O

Our	O
in	O
vivo	O
studies	O
were	O
more	O
convincing	O
demonstrating	O
lethal	O
and	O
inhibitory	O
effects	O
on	O
tick	O
reproduction	O
for	O
9	O
(	O
including	O
the	O
2	O
controls	O
)	O
of	O
the	O
10	O
targets	O
.	O

In	O
vivo	O
studies	O
in	O
C.	O
elegans	O
showed	O
that	O
47	O
%	O
of	O
the	O
C.	O
elegans	O
orthologues	O
of	O
the	O
438	O
genes	O
associated	O
with	O
the	O
Drosophila	O
RNAi	O
phenotypes	O
exhibited	O
developmental	O
phenotypes	O
[	O
43,59	O
]	O
.	O

Perhaps	C
the	C
fact	C
that	C
we	C
chose	C
highly	C
conserved	C
homologues	C
increased	C
the	C
probability	C
of	C
success	C
in	C
our	C
in	C
vivo	C
experiments	C
compared	C
with	C
C.	C
elegans	C
.	C

However	C
,	C
it	C
is	C
clear	C
that	C
tick	C
in	C
vitro	C
RNAi	C
analysis	C
using	C
BME26	C
can	C
not	C
be	C
directly	C
correlated	C
to	C
available	C
Drosophila	C
in	C
vitro	C
data	C
,	C
unless	C
perhaps	C
only	C
target	C
genes	C
with	C
higher	C
z	C
scores	C
(	C
as	C
demonstrated	C
here	C
for	C
ubiquitin-63E	C
)	C
can	C
be	C
studied	C
to	C
increase	C
the	C
probability	C
of	C
a	C
phenotype	C
correlation	C
.	C

The	O
challenges	O
encountered	O
during	O
the	O
initial	O
PCR	O
amplification	O
of	O
tick	O
template	O
DNA	O
(	O
results	O
not	O
shown	O
)	O
prompted	O
re-design	O
of	O
conserved	O
primer	O
sets	O
for	O
targets	O
amplified	O
and	O
transcribed	O
in	O
this	O
study	O
.	O

Other	C
tick	C
dsRNA	C
studies	C
have	C
used	C
cDNA	C
clones	C
[	C
42	C
]	C
as	C
templates	C
for	C
amplification	C
and	C
subsequent	C
transcription	C
verifying	C
that	C
perhaps	C
the	C
tick	C
genomic	C
DNA	C
templates	C
are	C
not	C
amenable	C
for	C
high	C
throughput	C
gene	C
amplification	C
required	C
for	C
RNAi	C
functional	C
screens	C
.	C

The	O
tick	O
genome	O
is	O
large	O
(	O
7.1	O
Gbp	O
)	O
with	O
a	O
high	O
ratio	O
of	O
repetitive	O
and	O
exonic	O
sequences	O
[	O
2	O
]	O
also	O
confirmed	O
here	O
with	O
the	O
I.	O
scapularis	O
putative	O
Dicer	O
genomic	O
sequence	O
structure	O
with	O
14	O
exons	O
.	O

The	C
presence	C
of	C
complex	C
intronic/exonic	C
structure	C
can	C
inhibit	C
satisfactory	C
PCR	C
amplification	C
of	C
gDNA	C
possibly	C
due	C
to	C
poor	C
primer	C
binding	C
.	C

This	O
was	O
mostly	O
overcome	O
in	O
this	O
study	O
by	O
improving	O
primers	O
by	O
targeting	O
conserved	O
ORFs	O
across	O
several	O
arthropod	O
species	O
,	O
however	O
,	O
amplification	O
was	O
not	O
always	O
consistent	O
(	O
not	O
shown	O
)	O
.	O

It	C
may	C
be	C
feasible	C
to	C
develop	C
short	C
interfering	C
RNA	C
treatments	C
which	C
would	C
be	C
simpler	C
to	C
prepare	C
than	C
long	C
dsRNA	C
treatments	C
for	C
difficult	C
templates	C
such	C
as	C
the	C
tick	C
,	C
to	C
date	C
siRNAs	C
have	C
not	C
been	C
applied	C
in	C
R.	C
microplus	C
loss-off-function	C
assays	C
.	C

Long	C
dsRNA	C
gene	C
silencing	C
can	C
also	C
lead	C
to	C
off	C
target	C
effects	C
and	C
false	C
positive	C
RNAi	C
phenotypes	C
[	C
60,61	C
]	C
.	C

Until	C
complete	C
annotated	C
tick	C
genome	C
resources	C
are	C
available	C
,	C
false	C
positive	C
knockdown	C
resulting	C
from	C
long	C
dsRNA	C
treatments	C
and	C
the	C
specificity	C
of	C
(	C
siRNAs	C
)	C
tick	C
RNAi	C
reagents	C
can	C
not	C
be	C
confirmed	C
.	C

Conclusion	O

We	C
utilized	C
the	C
existing	C
R.	C
microplus	C
BmiGI2	C
database	C
(	C
13,643	C
ESTs	C
)	C
and	C
the	C
I.	C
scapularis	C
genome	C
reads	C
to	C
identify	C
31	C
putative	C
tick	C
RNAi	C
proteins	C
which	C
confirmed	C
the	C
presence	C
of	C
a	C
putative	C
Dicer	C
,	C
RISC	C
associated	C
,	C
dsRNA	C
uptake	C
and	C
RdRP	C
proteins	C
in	C
ticks	C
and	C
constructed	C
a	C
putative	C
tick	C
RNAi	C
pathway	C
.	C

Apart	C
for	C
proteasome/ubiquitinylation	C
homologues	C
,	C
it	C
was	C
not	C
feasible	C
to	C
replicate	C
D.	C
melanogaster	C
embryonic	C
cell	C
culture	C
RNAi	C
functional	C
data	C
in	C
R.	C
microplus	C
BME26	C
embryonic	C
cells	C
.	C

This	C
could	C
either	C
be	C
attributed	C
to	C
transfection/uptake	C
issues	C
and/or	C
a	C
difference	C
in	C
cell	C
types	C
in	C
the	C
fly	C
and	C
tick	C
embryonic	C
cell	C
lines	C
.	C

We	O
did	O
demonstrate	O
a	O
correlating	O
in	O
vivo	O
effect	O
on	O
embryogenesis	O
for	O
9	O
of	O
the	O
10	O
D.	O
melanogaster	O
tick	O
homologues	O
.	O

The	C
findings	C
in	C
this	C
manuscript	C
support	C
the	C
fact	C
that	C
perhaps	C
the	C
Chelicerates	C
may	C
not	C
be	C
amenable	C
to	C
modeling	C
based	C
on	C
insect	C
pathways	C
(	C
Subphylum	C
Mandibulata	C
)	C
as	C
perhaps	C
expected	C
for	C
Arthropods	C
.	C

With	O
the	O
evidence	O
of	O
a	O
tick	O
RdRP	O
and	O
the	O
propensity	O
for	O
systemic	O
or	O
germ-line	O
RNAi	O
,	O
it	O
will	O
be	O
better	O
to	O
compare	O
gene	O
function	O
and	O
RNAi	O
pathways	O
between	O
members	O
of	O
the	O
Arachnida	O
and	O
the	O
Superphylum	O
Nemathelminthes	O
(	O
C.	O
elegans	O
)	O
.	O

Until	C
more	C
tick	C
and	C
related	C
genomes	C
(	C
mites	C
and	C
spiders	C
)	C
are	C
available	C
,	C
such	C
comparative	C
studies	C
within	C
these	C
Subphyla	C
are	C
not	C
feasible	C
.	C

Clearly	O
the	O
RNAi	O
pathways	O
warrant	O
further	O
elucidation	O
,	O
and	O
tick	O
specific	O
genome	O
and	O
functional	O
data	O
will	O
be	O
beneficial	O
for	O
tick	O
research	O
and	O
for	O
the	O
development	O
of	O
improved	O
tick	O
control	O
measures	O
.	O

Methods	O

Sources	O
of	O
input	O
sequence	O
data	O

13,643	O
ESTs	O
(	O
9,403	O
Tentative	O
Consensus/TC	O
and	O
4,240	O
singleton	O
)	O
sequences	O
for	O
R.	O
microplus	O
were	O
obtained	O
from	O
the	O
Boophilus	O
microplus	O
Gene	O
Index	O
(	O
BmiGI	O
)	O
at	O
http	O
:	O
//compbio.dfci.harvard.edu/tgi/cgi-bin/tgi/gimain.pl	O
?	O
gudb=b_microplus	O
(	O
last	O
accessed	O
:	O
17/6/2008	O
)	O
[	O
3	O
]	O
.	O

I.	O
scapularis	O
(	O
black	O
legged	O
tick	O
)	O
genome	O
project	O
(	O
IGP	O
)	O
data	O
was	O
accessed	O
through	O
http	O
:	O
//www.ncbi.nlm.nih.gov/sites/entrez	O
?	O

Db=genomeprj	O
&	O
cmd=ShowDetailView	O
&	O
TermToSearch=16233	O
(	O
last	O
accessed	O
:	O
13/6/2008	O
)	O
;	O
and	O
38,276	O
I.	O
scapularis	O
EST	O
sequences	O
were	O
obtained	O
from	O
the	O
Ixodes	O
scapularis	O
Gene	O
Index	O
(	O
ISGI	O
)	O
at	O
http	O
:	O
//compbio.dfci.harvard.edu/tgi/cgi-bin/tgi/gimain.pl	O
?	O
gudb=i_scapularis	O
(	O
last	O
accessed	O
:	O
17/6/2008	O
)	O
.	O

All	O
other	O
nucleotide	O
and	O
amino	O
acid	O
sequences	O
were	O
obtained	O
from	O
the	O
Entrez	O
nucleotide	O
and	O
protein	O
databases	O
http	O
:	O
//www.ncbi.nlm.nih.gov/sites/entrez	O
.	O

Identification	O
of	O
conserved	O
genes	O
in	O
R.	O
microplus	O

Key	O
RNAi	O
pathway-associated	O
proteins	O
from	O
D.	O
melanogaster	O
and	O
C.	O
elegans	O
described	O
previously	O
[	O
28,32,35,36,45,46,50,73,74	O
]	O
were	O
screened	O
against	O
the	O
available	O
tick	O
ESTs	O
(	O
BmiGI2	O
)	O
[	O
3	O
]	O
and	O
I.	O
scapularis	O
genome	O
contig	O
reads	O
obtained	O
from	O
the	O
NCBI	O
whole	O
genome	O
project	O
database	O
(	O
project	O
ID	O
16233	O
)	O
using	O
BLAST	O
[	O
62	O
]	O
.	O

For	O
the	O
BLAST	O
searches	O
an	O
initial	O
e-value	O
of	O
<	O
1e-05	O
was	O
set	O
as	O
a	O
threshold	O
.	O

The	O
best	O
hits	O
from	O
the	O
R.	O
microplus	O
and	O
I.	O
scapularis	O
sequences	O
where	O
then	O
used	O
as	O
query	O
sequences	O
in	O
a	O
second	O
round	O
of	O
BLAST	O
searches	O
against	O
the	O
D.	O
melanogaster	O
and	O
C.	O
elegans	O
subsets	O
of	O
the	O
NCBI	O
non-redundant	O
protein	O
database	O
.	O

Results	O
of	O
this	O
reciprocal	O
BLAST	O
search	O
validated	O
the	O
sequence	O
similarity	O
between	O
the	O
key	O
RNAi	O
pathway-associated	O
proteins	O
from	O
D.	O
melanogaster	O
and	O
C.	O
elegans	O
and	O
the	O
two	O
ixodid	O
tick	O
species	O
,	O
sequences	O
which	O
did	O
not	O
return	O
the	O
corresponding	O
RNAi	O
protein	O
were	O
subsequently	O
disregarded	O
.	O

Further	O
confirmation	O
was	O
obtained	O
by	O
performing	O
searches	O
against	O
the	O
InterPro	O
database	O
using	O
InterProScan	O
(	O
data	O
not	O
shown	O
)	O
[	O
63	O
]	O
.	O

All	O
searches	O
were	O
performed	O
with	O
the	O
BLAST	O
default	O
settings	O
.	O

Specific	O
approaches	O
for	O
Dicer	O
,	O
Argonautes	O
and	O
RdRP	O
homologues	O
are	O
described	O
below	O
.	O

Multiple	O
sequence	O
alignments	O
for	O
the	O
domains	O
typical	O
for	O
proteins	O
of	O
the	O
Dicer	O
family	O
were	O
retrieved	O
from	O
the	O
Pfam	O
website	O
.	O

Specifically	O
these	O
were	O
the	O
alignments	O
for	O
the	O
Helicase	O
conserved	O
C	O
terminal	O
domain	O
(	O
Pfam	O
:	O
PF00271	O
)	O
,	O
double-stranded	O
RNA	O
binding	O
domain	O
(	O
Pfam	O
:	O
PF03368	O
)	O
,	O
PAZ	O
domain	O
(	O
Pfam	O
:	O
PF02170	O
)	O
,	O
RNase3	O
domain	O
(	O
Pfam	O
:	O
PF00636	O
)	O
,	O
and	O
the	O
double-stranded	O
RNA	O
binding	O
motif	O
(	O
Pfam	O
:	O
PF00035	O
)	O
.	O

Hidden	O
Markov	O
Models	O
(	O
HMMs	O
)	O
were	O
constructed	O
locally	O
using	O
hmmbuild	O
of	O
the	O
HMMER2	O
package	O
[	O
64	O
]	O
with	O
default	O
settings	O
.	O

The	O
programs	O
estwisedb	O
and	O
genewisedb	O
of	O
the	O
Wise2	O
package	O
[	O
65	O
]	O
were	O
used	O
to	O
perform	O
searches	O
with	O
each	O
HMM	O
as	O
a	O
query	O
in	O
a	O
local	O
copy	O
of	O
the	O
BmiGI2	O
database	O
and	O
the	O
I.	O
scapularis	O
sequences	O
obtained	O
from	O
NCBI	O
whole	O
genome	O
sequencing	O
projects	O
.	O

The	O
best	O
hit	O
sequences	O
from	O
these	O
searches	O
were	O
retrieved	O
from	O
the	O
respective	O
databases	O
and	O
a	O
conceptual	O
translation	O
of	O
encoded	O
open	O
reading	O
frames	O
(	O
ORFs	O
)	O
was	O
performed	O
using	O
the	O
program	O
getorf	O
,	O
part	O
of	O
the	O
EMBOSS	O
package	O
of	O
computational	O
biology	O
tools	O
.	O

The	O
ORFs	O
were	O
then	O
used	O
as	O
the	O
query	O
sequence	O
for	O
a	O
blastp	O
search	O
against	O
the	O
NCBI	O
Reference	O
Sequence	O
protein	O
database	O
to	O
verify	O
the	O
validity	O
of	O
the	O
initial	O
search	O
results	O
.	O

Further	O
confirmation	O
of	O
the	O
search	O
results	O
was	O
achieved	O
by	O
screening	O
the	O
ORFs	O
against	O
the	O
Pfam	O
database	O
using	O
the	O
global	O
search	O
model	O
.	O

For	O
the	O
prediction	O
of	O
gene	O
models	O
and	O
the	O
identification	O
of	O
the	O
exon/intron	O
structure	O
,	O
the	O
program	O
genewise	O
from	O
the	O
Wise2	O
package	O
was	O
used	O
to	O
map	O
the	O
detected	O
ORFs	O
to	O
the	O
genomic	O
sequences	O
.	O

I.	O
scapularis	O
expressed	O
sequence	O
tags	O
from	O
the	O
I.	O
scapularis	O
ISGI2	O
database	O
were	O
used	O
in	O
blastn	O
searches	O
to	O
verify	O
the	O
validity	O
of	O
the	O
predicted	O
exon/intron	O
structure	O
by	O
genewise	O
.	O

The	O
sequences	O
of	O
the	O
ORFs	O
were	O
also	O
screened	O
against	O
a	O
local	O
copy	O
of	O
the	O
Pfam	O
database	O
using	O
the	O
program	O
hmmpfam	O
of	O
the	O
HMMER2	O
package	O
to	O
reveal	O
the	O
sequence	O
structure	O
of	O
the	O
conserved	O
domains	O
.	O

Multiple	O
sequence	O
alignments	O
of	O
amino	O
acid	O
sequences	O
stored	O
in	O
the	O
Pfam	O
database	O
were	O
obtained	O
for	O
following	O
protein	O
domains	O
and	O
domain	O
families	O
:	O
Domain	O
of	O
unknown	O
function	O
(	O
DUF	O
)	O
1785	O
(	O
Pfam	O
:	O
PF08699	O
)	O
,	O
PAZ	O
domain	O
(	O
Pfam	O
:	O
PF02170	O
)	O
and	O
Piwi	O
(	O
Pfam	O
:	O
PF02171	O
)	O
.	O

HMMs	O
were	O
built	O
from	O
the	O
multiple	O
sequence	O
alignments	O
using	O
the	O
program	O
hmmbuild	O
with	O
default	O
settings	O
.	O

The	O
BmiGI2	O
database	O
and	O
I.	O
scapularis	O
sequences	O
were	O
searched	O
with	O
the	O
programs	O
estwisedb	O
and	O
genewisedb	O
using	O
the	O
HMMs	O
as	O
query	O
sequences	O
.	O

The	O
program	O
getorf	O
was	O
used	O
to	O
conceptually	O
translate	O
the	O
ORFs	O
of	O
the	O
best	O
hits	O
.	O

The	O
validity	O
of	O
the	O
initial	O
search	O
results	O
was	O
verified	O
by	O
blastp	O
searches	O
against	O
the	O
NCBI	O
Reference	O
Sequence	O
protein	O
database	O
.	O

Further	O
confirmation	O
of	O
the	O
search	O
results	O
was	O
achieved	O
by	O
screening	O
the	O
ORFs	O
against	O
the	O
Pfam	O
database	O
using	O
the	O
global	O
search	O
model	O
.	O

A	O
comparison	O
between	O
known	O
Argonaute	O
proteins	O
from	O
D.	O
melanogaster	O
and	O
C.	O
elegans	O
was	O
performed	O
using	O
the	O
program	O
bl2seq	O
,	O
which	O
uses	O
the	O
BLAST	O
algorithm	O
for	O
a	O
pairwise	O
comparison	O
.	O

Multiple	O
sequence	O
alignments	O
of	O
the	O
protein	O
sequences	O
and	O
ORFs	O
were	O
performed	O
using	O
Clustalw	O
[	O
66	O
]	O
with	O
default	O
program	O
settings	O
.	O

In	O
addition	O
to	O
the	O
Dicer	O
sequences	O
illustrated	O
in	O
Figure	O
1a	O
,	O
following	O
protein	O
sequences	O
were	O
included	O
in	O
the	O
construction	O
of	O
the	O
phylogenetic	O
tree	O
(	O
Figure	O
1b	O
)	O
:	O
Bos	O
taurus	O
Dicer-1	O
[	O
GenBank	O
:	O
NP_976235.1	O
]	O
and	O
T.	O
castaneum	O
Dicer-2	O
[	O
GenBank	O
:	O
NP_001107840.1	O
]	O
.	O

The	O
phylogenetic	O
trees	O
(	O
Figures	O
2b	O
and	O
3b	O
)	O
for	O
Argonaute-1	O
and	O
Argonaute-2	O
were	O
constructed	O
using	O
additional	O
sequences	O
from	O
C.	O
elegans	O
[	O
GenBank	O
:	O
NP_510322.2	O
]	O
and	O
[	O
GenBank	O
:	O
NP_871992.1	O
]	O
,	O
T.	O
castaneum	O
[	O
GenBank	O
:	O
XP_971295.2	O
]	O
and	O
[	O
GenBank	O
:	O
NP_001107842.1	O
]	O
and	O
B.	O
taurus	O
[	O
GenBank	O
:	O
NP_991363.1	O
]	O
and	O
[	O
GenBank	O
:	O
AAS21301.1	O
]	O
.	O

For	O
both	O
Argonaute-1	O
and	O
2	O
proteins	O
,	O
the	O
phylogenetic	O
trees	O
were	O
based	O
on	O
the	O
alignments	O
of	O
the	O
DUF1785	O
and	O
PAZ	O
domains	O
.	O

The	O
phylogenetic	O
tree	O
(	O
Figure	O
4	O
)	O
for	O
the	O
partial	O
R.	O
microplus	O
RdRP	O
protein	O
(	O
Cat-RdRP	O
)	O
was	O
constructed	O
using	O
additional	O
RdRP	O
domain	O
(	O
Pfam:05183	O
)	O
sequences	O
from	O
the	O
metazoans	O
:	O
C.	O
elegans	O
(	O
Ego-1	O
[	O
GenBank	O
:	O
NP_492132.1	O
]	O
,	O
rrf-1	O
[	O
GenBank	O
:	O
NP_492131.1	O
]	O
and	O
rrf-3	O
[	O
GenBank	O
:	O
NP_495713.1	O
]	O
)	O
and	O
I.	O
scapularis	O
(	O
[	O
GenBank	O
:	O
EEC04985.1	O
]	O
,	O
[	O
GenBank	O
:	O
EEC05952.1	O
]	O
,	O
[	O
GenBank	O
:	O
EEC12509.1	O
]	O
,	O
[	O
GenBank	O
:	O
EEC12909.1	O
]	O
)	O
;	O
plants	O
:	O
Arabidopsis	O
thaliana	O
[	O
GenBank	O
:	O
NP_172932	O
]	O
,	O
Hordeum	O
vulgare	O
[	O
GenBank	O
:	O
ACH53360.1	O
]	O
,	O
Nicotiana	O
tabacum	O
[	O
GenBank	O
:	O
CAR47810.1	O
]	O
,	O
and	O
Solanum	O
lycopersicum	O
[	O
GenBank	O
:	O
ABI34311.1	O
]	O
;	O
fungi	O
:	O
Aspergillus	O
fumigatus	O
[	O
GenBank	O
:	O
EDP48577.1	O
]	O
,	O
Neurospora	O
crassa	O
[	O
GenBank	O
:	O
XP_964248.2	O
]	O
and	O
Schizosaccharomyces	O
pombe	O
[	O
GenBank	O
:	O
NP_593295.1	O
]	O
;	O
and	O
protists	O
:	O
Dictyostelium	O
discoideum	O
[	O
GenBank	O
:	O
XP_636093.1	O
]	O
and	O
Tetrahymena	O
thermophila	O
[	O
GenBank	O
:	O
XP_001026321.1	O
]	O
.	O

The	O
conserved	O
RdRP	O
domains	O
were	O
extracted	O
from	O
these	O
sequences	O
and	O
then	O
used	O
for	O
the	O
alignment	O
to	O
the	O
partial	O
R.	O
microplus	O
RdRP	O
domain	O
.	O

The	O
multiple	O
sequence	O
alignments	O
for	O
all	O
3	O
studied	O
proteins	O
were	O
visually	O
inspected	O
and	O
the	O
phylogenetic	O
trees	O
were	O
constructed	O
using	O
Geneious	O
3.8.5	O
http	O
:	O
//www.geneious.com	O
,	O
last	O
accessed	O
on	O
12/08/08	O
)	O
.	O

Pairwise	O
distances	O
were	O
calculated	O
based	O
on	O
the	O
BLOSUM62	O
matrix	O
and	O
the	O
respective	O
trees	O
were	O
constructed	O
using	O
Neighbor-Joining	O
.	O

No	O
outgroups	O
were	O
selected	O
and	O
the	O
consensus	O
trees	O
were	O
built	O
using	O
bootstrapping	O
with	O
5,000	O
samples	O
.	O

Identification	O
of	O
R.	O
microplus	O
homologues	O
for	O
known	O
Drosophila	O
RNAi	O
viability	O
phenotypes	O

Raw	O
experimental	O
results	O
of	O
the	O
genome	O
wide	O
RNAi	O
screen	O
of	O
D.	O
melanogaster	O
are	O
publicly	O
available	O
at	O
the	O
website	O
http	O
:	O
//www.flyrnai.org	O
[	O
67	O
]	O
.	O

The	O
gene	O
ontology	O
data	O
for	O
the	O
identified	O
RNAi	O
targets	O
were	O
retrieved	O
from	O
http	O
:	O
//www.flybase.org	O
[	O
4	O
]	O
.	O

Genes	O
of	O
interest	O
were	O
selected	O
based	O
upon	O
a	O
phenotypic	O
z	O
score	O
>	O
3	O
[	O
43	O
]	O
.	O

For	O
these	O
genes	O
,	O
corresponding	O
translations	O
were	O
retrieved	O
from	O
FlyBase	O
and	O
used	O
for	O
the	O
subsequent	O
amino	O
acid	O
similarity	O
searches	O
.	O

The	O
D.	O
melanogaster	O
cDNA	O
sequences	O
from	O
the	O
selected	O
RNAi	O
targets	O
were	O
used	O
to	O
screen	O
to	O
search	O
the	O
13,643	O
of	O
the	O
R.	O
microplus	O
ESTs	O
and	O
TCs	O
for	O
highly	O
conserved	O
genes	O
using	O
blastn	O
[	O
62	O
]	O
.	O

Sequences	C
with	C
a	C
similarity	C
of	C
at	C
least	C
80	C
%	C
and	C
an	C
e-value	C
less	C
than	C
e1-50	C
were	C
selected	C
,	C
conceptually	C
translated	C
and	C
their	C
putative	C
function	C
was	C
further	C
analyzed	C
by	C
assigning	C
GO	C
terms	C
using	C
InterProScan	C
[	C
63,68,69	C
]	C
.	C

Additional	O
Files	O
2	O
and	O
3	O
describe	O
this	O
selection	O
process	O
and	O
the	O
GO	O
terms	O
utilized	O
respectively	O
.	O

Tick	O
cell	O
culture	O
and	O
sources	O
of	O
ticks	O
for	O
dsRNA	O
treatment	O
studies	O

BME26	O
was	O
derived	O
in	O
1985	O
from	O
R.	O
microplus	O
embryonated	O
eggs	O
in	O
the	O
USA	O
[	O
57	O
]	O
and	O
supplied	O
by	O
Dr.	O
Munderloh	O
(	O
Department	O
of	O
Entomology	O
,	O
University	O
of	O
Minnesota	O
,	O
St.	O
Paul	O
,	O
Minnesota	O
55108	O
)	O
to	O
the	O
Queensland	O
Department	O
of	O
Primary	O
Industries	O
&	O
Fisheries	O
in	O
Australia	O
.	O

Cell	O
culture	O
protocols	O
to	O
maintain	O
and	O
passage	O
the	O
cell	O
line	O
(	O
obtained	O
at	O
passage	O
55	O
)	O
have	O
been	O
previously	O
described	O
[	O
70	O
]	O
.	O

N	O
strain	O
adult	O
female	O
ticks	O
were	O
obtained	O
from	O
the	O
DPI	O
&	O
F	O
Animal	O
Research	O
Institute	O
tick	O
cell	O
colony	O
[	O
71	O
]	O
.	O

DNA	O
and	O
RNA	O
extraction	O
methods	O

DNA	O
from	O
BME26	O
cells	O
was	O
prepared	O
using	O
the	O
QIAamp	O
DNA	O
mini	O
kit	O
(	O
QIAGEN	O
Sciences	O
,	O
MD	O
,	O
USA	O
)	O
–	O
protocol	O
for	O
cultured	O
cells	O
as	O
described	O
by	O
the	O
manufacturer	O
.	O

RNA	O
for	O
qRT-PCR	O
analysis	O
prepared	O
from	O
BME26	O
cells	O
,	O
adult	O
tick	O
viscera	O
,	O
and	O
tick	O
eggs	O
was	O
extracted	O
using	O
TRIzol®	O
reagent	O
(	O
Invitrogen	O
,	O
CA	O
,	O
USA	O
)	O
following	O
the	O
manufacturer	O
's	O
instructions	O
.	O

For	O
RNA	O
extractions	O
from	O
larvae	O
,	O
the	O
larvae	O
were	O
first	O
ground	O
in	O
liquid	O
nitrogen	O
using	O
a	O
mortar	O
and	O
pestle	O
prior	O
to	O
TRIzol®	O
reagent	O
extraction	O
following	O
the	O
manufacturer	O
's	O
instruction	O
(	O
Invitrogen	O
,	O
CA	O
,	O
USA	O
)	O
.	O

dsRNA	O
synthesis	O
methods	O

Sequences	O
from	O
Anopheles	O
gambiae	O
,	O
D.	O
melanogaster	O
,	O
I.	O
scapularis	O
,	O
and	O
R.	O
microplus	O
(	O
Additional	O
File	O
4	O
)	O
were	O
aligned	O
using	O
AlignX	O
(	O
Invitrogen	O
Vector	O
NTI	O
,	O
CA	O
,	O
USA	O
)	O
to	O
identify	O
conserved	O
regions	O
for	O
primer	O
design	O
.	O

Primers	O
were	O
subsequently	O
designed	O
using	O
Invitrogen	O
Vector	O
NTI	O
to	O
amplify	O
the	O
corresponding	O
conserved	O
region	O
in	O
R.	O
microplus	O
(	O
Additional	O
File	O
5	O
)	O
.	O

T7	O
promoter	O
sequences	O
were	O
added	O
to	O
the	O
5'-ends	O
of	O
the	O
primers	O
to	O
allow	O
for	O
subsequent	O
RNA	O
transcription	O
as	O
described	O
in	O
the	O
manufacturer	O
's	O
instructions	O
(	O
Ambion	O
MEGAScript	O
RNAi	O
kit	O
,	O
Applied	O
Biosystems	O
,	O
CA	O
,	O
USA	O
)	O
.	O

PCR	O
products	O
were	O
amplified	O
from	O
20	O
ng	O
DNA	O
prepared	O
from	O
BME26	O
cells	O
as	O
template	O
using	O
10	O
pM	O
each	O
primer	O
,	O
10	O
pmol	O
dNTPs	O
,	O
HotStart	O
Taq	O
Plus	O
enzyme	O
and	O
the	O
buffer	O
provided	O
by	O
the	O
manufacturer	O
(	O
QIAGEN	O
Sciences	O
,	O
MD	O
,	O
USA	O
)	O
in	O
a	O
20	O
µl	O
reaction	O
volume	O
.	O

The	O
optimal	O
annealing	O
temperature	O
for	O
each	O
assay	O
was	O
determined	O
using	O
gradient	O
PCR	O
and	O
a	O
temperature	O
gradient	O
of	O
55°C	O
to	O
70°C	O
in	O
twelve	O
discrete	O
steps	O
in	O
a	O
G-storm	O
GS-1	O
thermocycler	O
(	O
Geneworks	O
Technologies	O
Pty	O
Ltd	O
,	O
SA	O
,	O
Australia	O
)	O
.	O

The	O
PCR	O
thermal	O
profile	O
was	O
as	O
follows	O
:	O
95°C	O
2	O
min	O
,	O
followed	O
by	O
35	O
cycles	O
at	O
95°C	O
10s	O
,	O
annealing	O
temp	O
30s	O
,	O
72°C	O
1	O
min	O
(	O
annealing	O
temperatures	O
for	O
each	O
primer	O
pair	O
described	O
in	O
Additional	O
File	O
5	O
)	O
,	O
and	O
a	O
final	O
extension	O
at	O
72°C	O
7	O
min	O
.	O

The	O
size	O
of	O
the	O
PCR	O
products	O
(	O
Additional	O
File	O
5	O
)	O
were	O
confirmed	O
by	O
gel	O
electrophoresis	O
using	O
1.5	O
%	O
Agarose	O
in	O
TAE	O
Buffer	O
(	O
Tris	O
acetate	O
40	O
mM	O
,	O
EDTA	O
2	O
mM	O
,	O
pH	O
8.5	O
)	O
after	O
45	O
minutes	O
at	O
90	O
V	O
.	O

The	O
PCR	O
products	O
were	O
purified	O
using	O
the	O
QIAquick	O
kit	O
(	O
QIAGEN	O
Sciences	O
,	O
MD	O
,	O
USA	O
)	O
following	O
the	O
manufacturer	O
's	O
protocol	O
.	O

Long	O
dsRNA	O
were	O
synthesized	O
from	O
the	O
purified	O
PCR	O
products	O
(	O
5	O
pooled	O
20	O
µl	O
reactions	O
per	O
gene	O
target	O
)	O
using	O
the	O
MEGAScript	O
RNAi	O
kit	O
as	O
described	O
by	O
the	O
manufacturer	O
(	O
Ambion	O
,	O
Applied	O
Biosystems	O
,	O
CA	O
,	O
USA	O
)	O
.	O

Purified	O
dsRNAs	O
were	O
stored	O
in	O
elution	O
buffer	O
at	O
-70°C	O
until	O
further	O
use	O
.	O

Actin	O
(	O
TC12168	O
)	O
and	O
the	O
dsRNA	O
control	O
supplied	O
by	O
the	O
manufacturer	O
(	O
MEGAScript	O
,	O
Ambion	O
,	O
Applied	O
Biosystems	O
,	O
CA	O
,	O
USA	O
)	O
were	O
prepared	O
as	O
tick	O
specific	O
and	O
non-specific	O
dsRNA	O
treatments	O
,	O
respectively	O
.	O

Transfection	O
of	O
BME26	O
tick	O
cells	O

In	O
vitro	O
transfection	O
methods	O
for	O
the	O
dsRNA	O
treatment	O
of	O
tick	O
cells	O
were	O
modified	O
from	O
D.	O
melanogaster	O
methods	O
originally	O
described	O
by	O
Boutros	O
et	O
al	O
[	O
43	O
]	O
.	O

BME26	O
cells	O
at	O
passage	O
57	O
were	O
grown	O
in	O
96-well	O
plates	O
freshly	O
seeded	O
with	O
48,000	O
cells/40	O
µl	O
per	O
well	O
.	O

Cells	O
were	O
transfected	O
with	O
800	O
ng	O
dsRNA	O
and	O
incubated	O
at	O
31°C	O
for	O
60	O
mins	O
prior	O
to	O
the	O
addition	O
of	O
complete	O
medium	O
(	O
final	O
total	O
well	O
volume	O
of	O
120	O
µl	O
)	O
.	O

Treatments	O
were	O
incubated	O
for	O
4	O
days	O
at	O
31°C	O
and	O
each	O
well	O
was	O
supplemented	O
with	O
80	O
µl	O
complete	O
medium	O
at	O
Day	O
2	O
.	O

Each	O
treatment	O
contained	O
6	O
replicates	O
to	O
provide	O
3	O
replicates	O
for	O
viability	O
assay	O
and	O
3	O
for	O
qRT-PCR	O
.	O

On	O
Day	O
4	O
(	O
96	O
hrs	O
post	O
treatment	O
)	O
,	O
3	O
wells	O
were	O
subjected	O
to	O
cell	O
viability	O
testing	O
using	O
the	O
Cell	O
Glow	O
kit	O
as	O
per	O
manufacturer	O
's	O
instructions	O
(	O
Promega	O
Corporation	O
,	O
WI	O
,	O
USA	O
)	O
and	O
3	O
wells	O
were	O
subject	O
to	O
RNA	O
extraction	O
for	O
qRT-PCR	O
screening	O
.	O

Controls	O
included	O
nil	O
treatment	O
(	O
media	O
only	O
)	O
and	O
the	O
dsRNA	O
control	O
from	O
the	O
Ambion	O
MEGAScript	O
RNAi	O
kit	O
(	O
non-specific	O
dsRNA	O
treatment	O
)	O
.	O

Impairment	O
of	O
growth	O
and	O
viability	O
relative	O
to	O
the	O
nil	O
treatment	O
control	O
was	O
statistically	O
determined	O
by	O
calculating	O
inverse	O
z-scores	O
for	O
every	O
treatment	O
[	O
43	O
]	O
.	O

Injection	O
of	O
R.	O
microplus	O
ticks	O
with	O
dsRNA	O
,	O
monitoring	O
and	O
statistical	O
analysis	O
of	O
mortality	O
and	O
egg	O
output	O

Female	O
adult	O
ticks	O
fed	O
to	O
repletion	O
were	O
collected	O
within	O
24	O
hrs	O
from	O
dropping	O
from	O
the	O
bovine	O
host	O
for	O
dsRNA	O
injection	O
.	O

Six	O
ticks	O
per	O
treatment	O
(	O
10	O
Drosophila	O
homologues	O
,	O
no	O
injection	O
control	O
,	O
PBS	O
injection	O
control	O
,	O
tick	O
actin	O
dsRNA	O
and	O
the	O
MEGAScript	O
dsRNA	O
control	O
)	O
were	O
injected	O
with	O
1–2	O
×	O
1012	O
dsRNA	O
molecules	O
using	O
a	O
micro-injector	O
(	O
World	O
Precision	O
Instruments	O
Inc.	O
,	O
Florida	O
,	O
USA	O
)	O
as	O
described	O
previously	O
by	O
Nijhof	O
and	O
colleagues	O
[	O
42	O
]	O
,	O
except	O
ticks	O
were	O
first	O
pierced	O
using	O
a	O
30	O
G	O
needle	O
rather	O
than	O
27	O
G	O
.	O

Five	O
out	O
of	O
the	O
6	O
ticks	O
per	O
treatment	O
were	O
monitored	O
daily	O
for	O
effects	O
on	O
mortality	O
,	O
egg	O
output	O
and	O
larval	O
hatching	O
rates	O
until	O
all	O
ticks	O
had	O
died	O
[	O
42	O
]	O
.	O

Statistical	O
analyses	O
were	O
conducted	O
using	O
GenStat	O
10	O
(	O
VSN	O
International	O
)	O
.	O

The	O
following	O
variables	O
were	O
subjected	O
to	O
analysis	O
of	O
variance	O
assessing	O
the	O
effect	O
of	O
replicates	O
and	O
treatments	O
:	O
1.	O
total	O
wt	O
of	O
eggs	O
produced	O
;	O
2.	O
days	O
ticks	O
survived	O
post	O
injection	O
;	O
3.	O
days	O
from	O
laying	O
to	O
larval	O
hatch	O
;	O
and	O
4.	O
percent	O
larvae	O
hatched	O
.	O

A	O
protected	O
least	O
significant	O
difference	O
(	O
LSD	O
)	O
procedure	O
was	O
used	O
to	O
compare	O
treatment	O
means	O
using	O
a	O
significance	O
level	O
of	O
0.05	O
.	O

RNA	O
was	O
extracted	O
from	O
the	O
viscera	O
and	O
from	O
the	O
eggs	O
collected	O
from	O
the	O
6th	O
replicate	O
tick	O
per	O
treatment	O
for	O
qRT-PCR	O
analysis	O
on	O
days	O
6	O
and	O
14	O
respectively	O
(	O
see	O
below	O
)	O
.	O

Quantitative	O
RT-PCR	O
gene	O
expression	O
analysis	O

Primer	O
sequences	O
,	O
PCR	O
product	O
and	O
annealing	O
temperatures	O
for	O
all	O
targets	O
are	O
described	O
in	O
Additional	O
File	O
5	O
.	O

cDNA	O
was	O
synthesized	O
using	O
a	O
cDNA	O
synthesis	O
kit	O
(	O
Bioline	O
International	O
,	O
London	O
,	O
UK	O
)	O
,	O
and	O
triplicate	O
qPCRs	O
(	O
50	O
ng	O
per	O
reaction	O
)	O
of	O
BME26	O
cells	O
was	O
undertaken	O
using	O
SensiMixPlus	O
SYBR	O
kit	O
(	O
Quantace	O
Ltd	O
,	O
Watford	O
,	O
UK	O
)	O
in	O
the	O
Corbett	O
RotorGene	O
3000	O
(	O
Corbett	O
,	O
Sydney	O
,	O
Australia	O
)	O
using	O
the	O
following	O
profile	O
:	O
95°C	O
10	O
mins	O
;	O
40	O
cycles	O
of	O
95°C	O
15	O
s	O
,	O
55°C	O
30	O
s	O
,	O
72°C	O
30	O
sec	O
,	O
followed	O
by	O
a	O
melt	O
analysis	O
72–90°C	O
30	O
s	O
on	O
the	O
first	O
step	O
,	O
5	O
s	O
holds	O
for	O
subsequent	O
steps	O
,	O
according	O
to	O
manufacturer	O
's	O
instructions	O
for	O
SYBR	O
green	O
detection	O
.	O

All	O
the	O
results	O
corresponded	O
to	O
relative	O
quantification	O
using	O
R.	O
microplus	O
actin	O
(	O
Additional	O
File	O
5	O
)	O
as	O
an	O
internal	O
control	O
gene	O
using	O
the	O
2-ΔΔCt	O
method	O
[	O
72	O
]	O
.	O

Viscera	O
from	O
the	O
6th	O
replicate	O
tick	O
of	O
each	O
Drosophila	O
homologue	O
group	O
were	O
homogenized	O
in	O
TRIzol®	O
to	O
extract	O
total	O
RNA	O
.	O

The	O
semi	O
quantitative	O
analysis	O
of	O
the	O
samples	O
was	O
undertaken	O
using	O
the	O
QuantiTect	O
SYBR	O
green	O
RT-PCR	O
Kit®	O
(	O
QIAGEN	O
,	O
Australia	O
)	O
as	O
recommended	O
by	O
the	O
manufacturer	O
.	O

The	O
expression	O
profiles	O
were	O
normalised	O
against	O
R.	O
microplus	O
actin	O
as	O
above	O
.	O

Reactions	O
contained	O
125	O
ng	O
of	O
total	O
RNA	O
,	O
12.5	O
µl	O
of	O
2×	O
QuantiTect	O
SYBR	O
Green	O
RT-PCR	O
Master	O
mix	O
,	O
10	O
pmol	O
of	O
each	O
primer	O
,	O
0.25	O
µl	O
QuantiTect	O
RT	O
Mix	O
,	O
the	O
final	O
reaction	O
volume	O
was	O
25	O
µl	O
.	O

RT-PCR	O
reaction	O
were	O
conducted	O
on	O
Rotor-Gene	O
3000	O
under	O
the	O
following	O
conditions	O
:	O
reverse	O
transcription	O
50°C	O
for	O
30	O
min	O
,	O
PCR	O
initial	O
activation	O
at	O
95°C	O
for	O
15	O
min	O
,	O
followed	O
by	O
40	O
cycles	O
at	O
94°C	O
,	O
15	O
s	O
,	O
55°C	O
,	O
30	O
s	O
and	O
72°C	O
30	O
s	O
.	O

Calculation	O
of	O
percent	O
gene	O
expression	O
and	O
knockdown	O
(	O
average	O
of	O
3	O
triplicate	O
reactions	O
)	O
was	O
determined	O
by	O
comparative	O
CT	O
method	O
for	O
relative	O
quantification	O
as	O
described	O
above	O
.	O

R.	O
microplus	O
EST	O
Accessions	O

GenBank	O
Accessions	O
describing	O
the	O
R.	O
microplus	O
ESTs	O
identified	O
in	O
this	O
study	O
have	O
been	O
appended	O
as	O
Additional	O
File	O
6	O
.	O

Abbreviations	O

dsRNA	O
:	O
double-stranded	O
RNA	O
;	O
cDNA	O
:	O
complementary	O
DNA	O
;	O
EST	O
:	O
expressed	O
sequence	O
tags	O
;	O
GO	O
:	O
Gene	O
Ontology	O
;	O
PCR	O
:	O
polymerase	O
chain	O
reaction	O
;	O
RISC	O
:	O
RNA-induced	O
silencing	O
complex	O
;	O
RNAi	O
:	O
RNA	O
interference	O
;	O
siRNA	O
:	O
small	O
interfering	O
RNA	O
;	O

Positional	O
Cues	O
in	O
the	O
Drosophila	O
Nerve	O
Cord	O
:	O
Semaphorins	O
Pattern	O
the	O
Dorso-Ventral	O
Axis	O

Abstract	O

During	O
the	O
development	O
of	O
neural	O
circuitry	O
,	O
neurons	O
of	O
different	O
kinds	O
establish	O
specific	O
synaptic	O
connections	O
by	O
selecting	O
appropriate	O
targets	O
from	O
large	O
numbers	O
of	O
alternatives	O
.	O

The	O
range	O
of	O
alternative	O
targets	O
is	O
reduced	O
by	O
well	O
organised	O
patterns	O
of	O
growth	O
,	O
termination	O
,	O
and	O
branching	O
that	O
deliver	O
the	O
terminals	O
of	O
appropriate	O
pre-	O
and	O
postsynaptic	O
partners	O
to	O
restricted	O
volumes	O
of	O
the	O
developing	O
nervous	O
system	O
.	O

We	O
use	O
the	O
axons	O
of	O
embryonic	O
Drosophila	O
sensory	O
neurons	O
as	O
a	O
model	O
system	O
in	O
which	O
to	O
study	O
the	O
way	O
in	O
which	O
growing	O
neurons	O
are	O
guided	O
to	O
terminate	O
in	O
specific	O
volumes	O
of	O
the	O
developing	O
nervous	O
system	O
.	O

The	O
mediolateral	O
positions	O
of	O
sensory	O
arbors	O
are	O
controlled	O
by	O
the	O
response	O
of	O
Robo	O
receptors	O
to	O
a	O
Slit	O
gradient	O
.	O

Here	O
we	O
make	O
a	O
genetic	O
analysis	O
of	O
factors	O
regulating	O
position	O
in	O
the	O
dorso-ventral	O
axis	O
.	O

We	O
find	O
that	O
dorso-ventral	O
layers	O
of	O
neuropile	O
contain	O
different	O
levels	O
and	O
combinations	O
of	O
Semaphorins	O
.	O

We	O
demonstrate	O
the	O
existence	O
of	O
a	O
central	O
to	O
dorsal	O
and	O
central	O
to	O
ventral	O
gradient	O
of	O
Sema	O
2a	O
,	O
perpendicular	O
to	O
the	O
Slit	O
gradient	O
.	O

We	O
show	O
that	O
a	O
combination	O
of	O
Plexin	O
A	O
(	O
Plex	O
A	O
)	O
and	O
Plexin	O
B	O
(	O
Plex	O
B	O
)	O
receptors	O
specifies	O
the	O
ventral	O
projection	O
of	O
sensory	O
neurons	O
by	O
responding	O
to	O
high	O
concentrations	O
of	O
Semaphorin	O
1a	O
(	O
Sema	O
1a	O
)	O
and	O
Semaphorin	O
2a	O
(	O
Sema	O
2a	O
)	O
.	O

Together	C
our	C
findings	C
support	C
the	C
idea	C
that	C
axons	C
are	C
delivered	C
to	C
particular	C
regions	C
of	C
the	C
neuropile	C
by	C
their	C
responses	C
to	C
systems	C
of	C
positional	C
cues	C
in	C
each	C
dimension	C
.	C

Author	O
Summary	O

Axons	O
and	O
dendrites	O
of	O
synaptic	O
partners	O
must	O
be	O
targeted	O
to	O
a	O
common	O
region	O
of	O
the	O
developing	O
neural	O
network	O
so	O
that	O
appropriate	O
connections	O
can	O
be	O
formed	O
.	O

The	O
mechanisms	O
underlying	O
this	O
targeting	O
are	O
incompletely	O
understood	O
.	O

We	O
showed	O
previously	O
that	O
a	O
positional	O
cue	O
(	O
Slit	O
)	O
acting	O
in	O
the	O
medio-lateral	O
axis	O
of	O
the	O
Drosophila	O
nerve	O
cord	O
controls	O
the	O
position	O
of	O
sensory	O
terminals	O
independently	O
of	O
their	O
synaptic	O
partners	O
.	O

This	C
work	C
revealed	C
that	C
there	C
might	C
be	C
additional	C
cues	C
operating	C
in	C
a	C
similar	C
fashion	C
in	C
the	C
dorso-ventral	C
axis	C
of	C
the	C
nerve	C
cord	C
.	C

Here	O
we	O
report	O
the	O
discovery	O
of	O
a	O
dorso-ventral	O
system	O
of	O
positional	O
cues	O
,	O
in	O
the	O
form	O
of	O
a	O
gradient	O
of	O
secreted	O
Semaphorin	O
2a	O
acting	O
at	O
right	O
angles	O
to	O
the	O
Slit	O
gradient	O
,	O
and	O
membrane	O
bound	O
Semaphorin	O
1a	O
differentially	O
distributed	O
across	O
the	O
neuropile	O
.	O

The	O
two	O
Semaphorins	O
dictate	O
the	O
termination	O
positions	O
of	O
sensory	O
axons	O
in	O
the	O
dorso-ventral	O
axis	O
.	O

Together	O
with	O
a	O
third	O
signal	O
acting	O
in	O
the	O
antero-posterior	O
axis	O
,	O
Semaphorins	O
and	O
Slit	O
deliver	O
axons	O
to	O
appropriate	O
volumes	O
of	O
the	O
neural	O
network	O
.	O

These	O
studies	O
support	O
a	O
model	O
in	O
which	O
axons	O
branch	O
and	O
terminate	O
,	O
independently	O
of	O
synaptic	O
partners	O
,	O
in	O
response	O
to	O
pervasive	O
systems	O
of	O
volumetric	O
positional	O
cues	O
.	O

Introduction	O

During	O
the	O
development	O
of	O
neural	O
circuitry	O
,	O
neurons	O
of	O
different	O
kinds	O
must	O
establish	O
specific	O
synaptic	O
connections	O
by	O
selecting	O
appropriate	O
targets	O
from	O
large	O
numbers	O
of	O
different	O
alternatives	O
.	O

The	O
range	O
of	O
these	O
alternative	O
targets	O
is	O
reduced	O
by	O
well	O
organised	O
patterns	O
of	O
growth	O
,	O
termination	O
,	O
and	O
branching	O
that	O
deliver	O
the	O
terminals	O
of	O
appropriate	O
pre-	O
and	O
postsynaptic	O
partners	O
to	O
restricted	O
regions	O
of	O
the	O
developing	O
nervous	O
system	O
.	O

The	O
mechanisms	O
that	O
control	O
the	O
coordinate	O
projection	O
of	O
pre-	O
and	O
postsynaptic	O
neurites	O
to	O
a	O
common	O
region	O
are	O
incompletely	O
understood	O
.	O

Although	O
there	O
has	O
been	O
substantial	O
progress	O
in	O
identifying	O
molecular	O
mechanisms	O
of	O
axon	O
growth	O
and	O
guidance	O
,	O
far	O
less	O
is	O
known	O
about	O
the	O
way	O
in	O
which	O
appropriate	O
target	O
areas	O
are	O
identified	O
,	O
leading	O
to	O
termination	O
and	O
branching	O
[	O
1	O
]	O
–	O
[	O
4	O
]	O
.	O

The	C
extent	C
to	C
which	C
these	C
processes	C
depend	C
on	C
target	C
specific	C
signals	C
as	C
opposed	C
to	C
pervasive	C
guidance	C
cues	C
,	C
to	C
which	C
many	C
different	C
neurons	C
can	C
respond	C
,	C
is	C
far	C
from	C
clear	C
.	C

We	O
have	O
used	O
the	O
axons	O
of	O
embryonic	O
Drosophila	O
sensory	O
neurons	O
as	O
a	O
model	O
system	O
in	O
which	O
to	O
study	O
the	O
way	O
in	O
which	O
growing	O
neurons	O
are	O
guided	O
to	O
terminate	O
in	O
a	O
specific	O
region	O
of	O
the	O
developing	O
nervous	O
system	O
.	O

These	O
neurons	O
have	O
their	O
cell	O
bodies	O
in	O
the	O
periphery	O
of	O
the	O
embryo	O
,	O
either	O
close	O
to	O
or	O
embedded	O
in	O
the	O
body	O
wall	O
.	O

Their	O
axons	O
grow	O
into	O
a	O
central	O
ganglion	O
where	O
they	O
terminate	O
in	O
a	O
neuropile	O
that	O
consists	O
of	O
a	O
dense	O
meshwork	O
of	O
interweaving	O
axons	O
and	O
dendrites	O
.	O

Anatomically	O
the	O
neuropile	O
shows	O
few	O
overt	O
signs	O
of	O
organisation	O
apart	O
from	O
clear	O
regularities	O
such	O
as	O
the	O
commissures	O
that	O
cross	O
the	O
midline	O
and	O
a	O
set	O
of	O
longitudinal	O
axon	O
bundles	O
at	O
stereotyped	O
positions	O
that	O
provide	O
a	O
series	O
of	O
landmarks	O
with	O
respect	O
to	O
which	O
other	O
structures	O
can	O
be	O
mapped	O
[	O
5	O
]	O
.	O

Functionally	O
however	O
the	O
neuropile	O
is	O
an	O
obviously	O
well-organised	O
structure	O
,	O
with	O
,	O
for	O
example	O
,	O
motor	O
neuron	O
dendrites	O
and	O
the	O
endings	O
of	O
sensory	O
neurons	O
terminating	O
and	O
branching	O
in	O
distinct	O
and	O
characteristic	O
domains	O
.	O

Thus	C
it	C
is	C
clear	C
that	C
there	C
must	C
be	C
cues	C
operating	C
in	C
the	C
neuropile	C
that	C
deliver	C
terminals	C
to	C
these	C
specific	C
destinations	C
within	C
the	C
forming	C
network	C
.	C

In	O
the	O
case	O
of	O
the	O
sensory	O
neurons	O
,	O
it	O
is	O
clear	O
that	O
specific	O
types	O
of	O
neurons	O
serving	O
particular	O
modalities	O
terminate	O
in	O
well	O
ordered	O
and	O
characteristically	O
different	O
parts	O
of	O
the	O
neuropile	O
.	O

These	O
termination	O
zones	O
together	O
with	O
the	O
overall	O
structure	O
of	O
the	O
neuropile	O
are	O
shown	O
in	O
diagrammatic	O
form	O
in	O
Figure	O
1	O
.	O

Because	O
the	O
sensory	O
neurons	O
provide	O
us	O
with	O
an	O
accessible	O
set	O
of	O
cells	O
whose	O
terminals	O
grow	O
to	O
different	O
parts	O
of	O
the	O
forming	O
neuropile	O
,	O
we	O
can	O
readily	O
use	O
these	O
neurons	O
to	O
investigate	O
the	O
guidance	O
mechanisms	O
that	O
operate	O
to	O
determine	O
these	O
distinctive	O
patterns	O
of	O
growth	O
and	O
termination	O
.	O

Different	O
neuron	O
classes	O
project	O
to	O
different	O
medio-lateral	O
domains	O
and	O
to	O
different	O
dorso-ventral	O
layers	O
of	O
neuropile	O
.	O

We	O
previously	O
showed	O
that	O
Slit	O
secreted	O
at	O
the	O
midline	O
and	O
acting	O
through	O
its	O
Robo	O
receptors	O
constitutes	O
a	O
repellent	O
gradient	O
to	O
which	O
sensory	O
neurons	O
respond	O
by	O
terminating	O
and	O
branching	O
at	O
specific	O
positions	O
in	O
the	O
medio-lateral	O
axis	O
of	O
the	O
neuropile	O
[	O
6	O
]	O
.	O

Expression	O
of	O
a	O
particular	O
Robo	O
receptor	O
by	O
a	O
sensory	O
axon	O
is	O
necessary	O
and	O
sufficient	O
to	O
determine	O
the	O
distance	O
from	O
the	O
midline	O
at	O
which	O
that	O
axon	O
will	O
terminate	O
.	O

Thus	O
,	O
in	O
the	O
medio-lateral	O
axis	O
at	O
least	O
,	O
the	O
position	O
at	O
which	O
an	O
axon	O
terminates	O
within	O
the	O
forming	O
neuropile	O
is	O
determined	O
not	O
by	O
some	O
putative	O
signals	O
from	O
its	O
postsynaptic	O
target	O
,	O
but	O
by	O
the	O
presynaptic	O
neuron	O
's	O
response	O
to	O
a	O
pervasive	O
cue	O
secreted	O
from	O
the	O
midline	O
.	O

However	C
,	C
the	C
neuropile	C
is	C
a	C
3-D	C
structure	C
and	C
there	C
must	C
therefore	C
be	C
additional	C
cues	C
that	C
determine	C
the	C
dorso-ventral	C
and	C
antero-posterior	C
termination	C
domains	C
for	C
each	C
axonal	C
and	C
dendritic	C
arbor	C
.	C

Our	O
previous	O
study	O
provided	O
evidence	O
for	O
at	O
least	O
one	O
further	O
signal	O
that	O
operates	O
to	O
determine	O
positions	O
in	O
the	O
dorso-ventral	O
axis	O
.	O

Sensory	C
terminals	C
that	C
are	C
shifted	C
experimentally	C
along	C
the	C
medio-lateral	C
axis	C
of	C
the	C
neuropile	C
maintain	C
their	C
characteristic	C
dorso-ventral	C
location	C
in	C
their	C
new	C
position	C
,	C
suggesting	C
that	C
the	C
factor	C
that	C
determines	C
this	C
position	C
may	C
be	C
a	C
“dorso-ventral”	C
patterning	C
cue	C
that	C
is	C
present	C
at	C
different	C
positions	C
in	C
the	C
medio-lateral	C
axis	C
.	C

This	O
additional	O
finding	O
led	O
us	O
to	O
propose	O
a	O
general	O
model	O
for	O
the	O
cues	O
that	O
delineate	O
domains	O
within	O
a	O
neuropile	O
in	O
which	O
presynaptic	O
axons	O
and	O
their	O
postsynaptic	O
partners	O
terminate	O
and	O
form	O
connections	O
[	O
6	O
]	O
.	O

In	C
this	C
model	C
,	C
termination	C
sites	C
depend	C
on	C
the	C
response	C
of	C
axons	C
to	C
a	C
system	C
of	C
positional	C
cues	C
that	C
dictate	C
the	C
behaviour	C
and	C
final	C
location	C
of	C
many	C
,	C
perhaps	C
all	C
terminals	C
within	C
a	C
developing	C
network	C
of	C
pre-	C
and	C
postsynaptic	C
neurons	C
.	C

Specific	O
locations	O
are	O
given	O
not	O
by	O
the	O
target	O
,	O
but	O
by	O
the	O
set	O
of	O
receptors	O
for	O
these	O
positional	O
cues	O
that	O
each	O
neuron	O
expresses	O
.	O

Here	O
,	O
we	O
test	O
and	O
augment	O
this	O
model	O
by	O
using	O
a	O
genetic	O
screen	O
to	O
identify	O
cues	O
and	O
their	O
receptors	O
that	O
guide	O
terminating	O
axons	O
in	O
the	O
dorso-ventral	O
axis	O
of	O
the	O
neuropile	O
.	O

We	O
find	O
that	O
dorso-ventral	O
layers	O
of	O
neuropile	O
contain	O
different	O
levels	O
and	O
combinations	O
of	O
semaphorins	O
.	O

We	O
demonstrate	O
the	O
existence	O
of	O
a	O
central	O
to	O
dorsal	O
and	O
central	O
to	O
ventral	O
gradient	O
of	O
Sema	O
2a	O
,	O
perpendicular	O
to	O
the	O
Slit	O
gradient	O
.	O

We	O
show	O
that	O
a	O
combination	O
of	O
Plexin	O
A	O
(	O
Plex	O
A	O
)	O
and	O
Plexin	O
B	O
(	O
Plex	O
B	O
)	O
receptors	O
specifies	O
the	O
ventral	O
projection	O
of	O
sensory	O
neurons	O
by	O
responding	O
to	O
high	O
concentrations	O
of	O
Semaphorin	O
1a	O
(	O
Sema	O
1a	O
)	O
and	O
Semaphorin	O
2a	O
(	O
Sema	O
2a	O
)	O
.	O

These	O
signals	O
together	O
with	O
the	O
Slit/Robo	O
system	O
acting	O
in	O
the	O
medio-lateral	O
axis	O
limit	O
the	O
arborisations	O
of	O
sensory	O
axons	O
to	O
specific	O
termination	O
domains	O
within	O
the	O
neuropile	O
.	O

Since	O
these	O
are	O
the	O
domains	O
within	O
which	O
specific	O
functional	O
sets	O
of	O
connections	O
will	O
be	O
formed	O
,	O
the	O
terminating	O
sensory	O
axons	O
,	O
by	O
responding	O
to	O
pervasive	O
positional	O
cues	O
,	O
are	O
able	O
to	O
lay	O
out	O
part	O
of	O
the	O
characteristic	O
functional	O
architecture	O
of	O
the	O
forming	O
network	O
.	O

Results	O

The	C
Drosophila	C
Embryonic	C
Neuropile	C
Can	C
Be	C
Divided	C
into	C
Four	C
Dorso-Ventral	C
Layers	C
,	C
Which	C
Are	C
Likely	C
to	C
Have	C
Distinct	C
Functions	C
in	C
Information	C
Processing	C

Previous	O
studies	O
have	O
shown	O
that	O
the	O
axons	O
of	O
sensory	O
neurons	O
project	O
to	O
distinct	O
medio-lateral	O
,	O
dorso-ventral	O
,	O
and	O
antero-posterior	O
domains	O
in	O
the	O
neuropile	O
in	O
correlation	O
with	O
their	O
modality	O
and	O
dendritic	O
morphology	O
[	O
7	O
]	O
–	O
[	O
9	O
]	O
.	O

We	O
have	O
extended	O
these	O
studies	O
using	O
Fasciclin	O
II	O
(	O
Fas	O
II	O
)	O
positive	O
tracts	O
as	O
reference	O
points	O
(	O
Figure	O
1A	O
)	O
[	O
6	O
]	O
,	O
[	O
10	O
]	O
.	O

We	O
divide	O
the	O
neuropile	O
into	O
three	O
medio-lateral	O
domains	O
and	O
four	O
dorso-ventral	O
layers	O
(	O
Figure	O
1C	O
)	O
.	O

With	O
the	O
exception	O
of	O
the	O
chordotonal	O
(	O
ch	O
)	O
neurons	O
,	O
sensory	O
axons	O
terminate	O
in	O
the	O
medial	O
domain	O
of	O
the	O
neuropile	O
.	O

Ch	O
axons	O
terminate	O
and	O
branch	O
in	O
the	O
intermediate	O
domain	O
.	O

There	O
is	O
very	O
little	O
sensory	O
input	O
to	O
the	O
dorsal-most	O
layer	O
(	O
layer	O
1	O
)	O
where	O
motor	O
neurons	O
establish	O
their	O
dendritic	O
arbors	O
.	O

The	O
proprioceptive	O
dorsal	O
bipolar	O
dendritic	O
(	O
dbd	O
)	O
and	O
class	O
I	O
md	O
(	O
multidendritic	O
)	O
neurons	O
terminate	O
in	O
the	O
upper	O
central	O
layer	O
(	O
layer	O
2	O
)	O
[	O
6	O
]	O
,	O
[	O
9	O
]	O
,	O
[	O
11	O
]	O
.	O

The	O
ch	O
neurons	O
terminate	O
in	O
the	O
lower	O
central	O
layer	O
(	O
layer	O
3	O
)	O
[	O
6	O
]	O
,	O
whereas	O
nociceptive	O
class	O
IV	O
md	O
neurons	O
terminate	O
in	O
the	O
ventral-most	O
layer	O
(	O
layer	O
4	O
)	O
.	O

Class	O
IV	O
md	O
neurons	O
can	O
be	O
identified	O
with	O
ppkEGFP	O
,	O
which	O
labels	O
one	O
intersegmental	O
nerve	O
(	O
ISN	O
)	O
and	O
two	O
segmental	O
nerve	O
(	O
SN	O
)	O
neurons	O
in	O
each	O
hemisegment	O
[	O
9	O
]	O
,	O
[	O
12	O
]	O
.	O

The	O
position	O
of	O
termination	O
in	O
the	O
neuropile	O
does	O
not	O
correlate	O
with	O
the	O
nerve	O
route	O
by	O
which	O
the	O
sensory	O
neurons	O
reach	O
the	O
neuropile	O
(	O
see	O
Figure	O
S1	O
)	O
.	O

Sensory	O
axons	O
whose	O
cell	O
bodies	O
are	O
located	O
ventrally	O
in	O
the	O
body	O
wall	O
travel	O
in	O
the	O
SN	O
,	O
whereas	O
axons	O
whose	O
cell	O
bodies	O
are	O
located	O
dorsally	O
or	O
laterally	O
in	O
the	O
body	O
wall	O
travel	O
in	O
the	O
ISN	O
[	O
13	O
]	O
.	O

Sensory	O
axons	O
running	O
in	O
the	O
SN	O
and	O
ISN	O
terminate	O
in	O
layers	O
2	O
,	O
3	O
,	O
or	O
4	O
,	O
in	O
correlation	O
with	O
their	O
modality	O
and	O
dendritic	O
morphology	O
[	O
9	O
]	O
,	O
[	O
11	O
]	O
.	O

Since	O
each	O
of	O
the	O
three	O
modality-specific	O
sensory	O
termination	O
domains	O
contains	O
some	O
neurons	O
that	O
have	O
travelled	O
through	O
the	O
SN	O
,	O
and	O
others	O
that	O
have	O
travelled	O
through	O
the	O
ISN	O
,	O
differences	O
in	O
axon	O
routing	O
to	O
the	O
neuropile	O
can	O
not	O
account	O
for	O
differences	O
in	O
termination	O
within	O
the	O
neuropile	O
.	O

Expressing	O
plex	O
B	O
or	O
plex	O
A	O
in	O
Sensory	O
Neurons	O
Shifts	O
Their	O
Terminals	O
away	O
from	O
Central	O
and	O
Dorsal	O
Layers	O
of	O
the	O
Ventral	O
Nerve	O
Cord	O

To	O
investigate	O
mechanisms	O
that	O
confine	O
sensory	O
projections	O
of	O
different	O
modalities	O
to	O
different	O
dorso-ventral	O
layers	O
of	O
the	O
neuropile	O
,	O
we	O
carried	O
out	O
a	O
gain-of-function	O
screen	O
for	O
trans-membrane	O
proteins	O
,	O
which	O
,	O
when	O
expressed	O
selectively	O
in	O
sensory	O
neurons	O
,	O
shift	O
sensory	O
terminals	O
with	O
respect	O
to	O
Fas	O
II	O
tracts	O
.	O

We	O
used	O
PO163GAL4	O
,	O
UAS-n-synaptobrevin-GFP	O
flies	O
to	O
target	O
gene	O
expression	O
selectively	O
to	O
sensory	O
neurons	O
and	O
simultaneously	O
to	O
visualise	O
their	O
terminals	O
(	O
Figure	O
2A	O
)	O
[	O
14	O
]	O
.	O

As	O
a	O
test	O
of	O
our	O
method	O
,	O
we	O
confirmed	O
that	O
expressing	O
the	O
Robo	O
3	O
receptor	O
for	O
Slit	O
in	O
sensory	O
neurons	O
shifts	O
their	O
terminals	O
away	O
from	O
the	O
medial	O
domain	O
of	O
neuropile	O
(	O
Figure	O
2B	O
)	O
[	O
6	O
]	O
.	O

Effects	O
of	O
altering	O
levels	O
of	O
receptors	O
for	O
Slit	O
,	O
Sema	O
2a	O
,	O
or	O
Sema	O
1a	O
in	O
sensory	O
neurons	O
and	O
the	O
distribution	O
of	O
cues	O
in	O
neuropile	O
.	O

We	O
screened	O
418	O
lines	O
with	O
UAS	O
inserts	O
in	O
front	O
of	O
trans-membrane	O
protein	O
coding	O
genes	O
(	O
see	O
Materials	O
and	O
Methods	O
and	O
Table	O
S1	O
for	O
detailed	O
results	O
of	O
the	O
screen	O
)	O
by	O
systematically	O
expressing	O
them	O
in	O
sensory	O
neurons	O
and	O
analysing	O
the	O
pattern	O
of	O
sensory	O
terminals	O
in	O
abdominal	O
segments	O
(	O
A1–A7	O
)	O
at	O
21-h	O
after	O
egg	O
laying	O
(	O
AEL	O
)	O
.	O

We	O
identified	O
11	O
genes	O
(	O
2.6	O
%	O
)	O
that	O
change	O
the	O
pattern	O
of	O
sensory	O
terminals	O
,	O
without	O
altering	O
the	O
number	O
of	O
neurons	O
or	O
preventing	O
sensory	O
axons	O
from	O
reaching	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
(	O
Table	O
S1	O
)	O
.	O

Of	O
the	O
11	O
genes	O
expressed	O
,	O
two	O
produced	O
obvious	O
shifts	O
along	O
the	O
dorso-ventral	O
axis	O
.	O

Both	O
belong	O
to	O
the	O
same	O
family	O
:	O
plex	O
B	O
and	O
A	O
.	O

If	O
plex	O
B	O
is	O
expressed	O
in	O
all	O
sensory	O
neurons	O
,	O
sensory	O
terminals	O
are	O
excluded	O
from	O
layer	O
2	O
(	O
Figure	O
2C	O
)	O
.	O

If	O
plex	O
A	O
is	O
expressed	O
,	O
terminals	O
are	O
excluded	O
from	O
the	O
intermediate	O
regions	O
of	O
layer	O
3	O
and	O
from	O
layer	O
1	O
(	O
Figure	O
2D	O
)	O
.	O

We	O
also	O
co-expressed	O
Robo3	O
and	O
Plex	O
B	O
in	O
sensory	O
neurons	O
and	O
found	O
that	O
this	O
produces	O
a	O
“combination”	O
of	O
Robo	O
3	O
and	O
Plex	O
B	O
expression	O
phenotypes	O
.	O

In	O
these	O
embryos	O
sensory	O
terminals	O
are	O
now	O
mostly	O
confined	O
to	O
the	O
lateral-most	O
portion	O
of	O
layers	O
3	O
and	O
4	O
(	O
Figure	O
2E	O
)	O
.	O

Sema	O
2a	O
and	O
Sema	O
1a	O
Are	O
Expressed	O
in	O
Central	O
and	O
Dorsal	O
Layers	O
of	O
the	O
Ventral	O
Nerve	O
Cord	O

The	O
Plexins	O
are	O
receptors	O
for	O
the	O
Semaphorins	O
(	O
Semas	O
)	O
,	O
a	O
diverse	O
family	O
of	O
secreted	O
and	O
membrane-associated	O
proteins	O
[	O
15	O
]	O
–	O
[	O
19	O
]	O
.	O

In	O
Drosophila	O
there	O
are	O
two	O
Plexins	O
(	O
A	O
and	O
B	O
)	O
and	O
five	O
Semas	O
:	O
1a	O
,	O
1b	O
,	O
and	O
5c	O
(	O
transmembrane	O
)	O
and	O
2a	O
and	O
2b	O
(	O
secreted	O
)	O
.	O

Plex	O
B	O
binds	O
Sema	O
2a	O
and	O
mediates	O
the	O
Sema	O
2a-dependent	O
repulsion	O
of	O
motor	O
and	O
sensory	O
axons	O
in	O
the	O
periphery	O
and	O
the	O
fasciculation	O
of	O
longitudinal	O
tracts	O
in	O
the	O
ventral	O
nerve	O
cord	O
(	O
VNC	O
)	O
[	O
20	O
]	O
,	O
[	O
21	O
]	O
.	O

Plex	O
A	O
binds	O
strongly	O
to	O
Sema	O
1a	O
and	O
Sema	O
1b	O
and	O
mediates	O
the	O
Sema-dependent	O
repulsion	O
of	O
embryonic	O
motor	O
axons	O
in	O
the	O
periphery	O
and	O
the	O
repulsion	O
of	O
adult	O
olfactory	O
receptor	O
axons	O
by	O
Sema	O
1a	O
in	O
the	O
antennal	O
lobes	O
[	O
22	O
]	O
–	O
[	O
24	O
]	O
.	O

The	C
Plexin	C
overexpression	C
phenotypes	C
suggested	C
that	C
their	C
Sema	C
ligands	C
might	C
act	C
as	C
cues	C
to	C
position	C
the	C
terminals	C
of	C
neurons	C
along	C
the	C
dorso-ventral	C
axis	C
of	C
the	C
forming	C
neuropile	C
.	C

We	O
therefore	O
used	O
antibody	O
labelling	O
to	O
analyse	O
the	O
expression	O
of	O
Semas	O
2a	O
and	O
1a	O
in	O
the	O
CNS	O
at	O
different	O
stages	O
of	O
embryogenesis	O
:	O
prior	O
to	O
sensory	O
axon	O
ingrowth	O
(	O
11-h	O
AEL	O
)	O
,	O
at	O
stages	O
when	O
sensory	O
axons	O
form	O
their	O
terminal	O
arbors	O
(	O
13-h	O
AEL	O
)	O
,	O
and	O
several	O
hours	O
after	O
sensory	O
axons	O
have	O
completed	O
their	O
terminal	O
arbors	O
(	O
21-h	O
AEL	O
)	O
.	O

Sema	O
2a	O
expression	O
first	O
becomes	O
detectable	O
at	O
11	O
h	O
as	O
the	O
outgrowth	O
of	O
sensory	O
axons	O
begins	O
,	O
persists	O
strongly	O
until	O
16	O
h	O
,	O
but	O
has	O
disappeared	O
by	O
21	O
h	O
,	O
when	O
the	O
embryo	O
is	O
mature	O
and	O
ready	O
to	O
hatch	O
.	O

At	O
13	O
h	O
,	O
when	O
sensory	O
axons	O
are	O
forming	O
their	O
terminal	O
arbors	O
,	O
the	O
highest	O
levels	O
of	O
Sema	O
2a	O
are	O
in	O
layer	O
2	O
in	O
the	O
centre	O
of	O
the	O
neuropile	O
(	O
Figure	O
2F	O
and	O
2H	O
)	O
.	O

Strikingly	O
,	O
the	O
protein	O
forms	O
gradients	O
of	O
expression	O
in	O
the	O
neuropile	O
that	O
extend	O
dorsally	O
and	O
ventrally	O
from	O
layer	O
2	O
(	O
Figure	O
2L	O
)	O
,	O
at	O
right	O
angles	O
to	O
the	O
mediolateral	O
gradient	O
of	O
Slit	O
(	O
Figure	O
2F	O
,	O
2G	O
,	O
2J	O
,	O
and	O
2K	O
)	O
.	O

There	O
is	O
no	O
detectable	O
expression	O
in	O
layer	O
4	O
.	O

Our	O
experiments	O
show	O
that	O
the	O
effect	O
of	O
overexpressing	O
Plex	O
B	O
in	O
sensory	O
neurons	O
is	O
to	O
shift	O
their	O
terminals	O
away	O
from	O
regions	O
with	O
high	O
Sema	O
2a	O
levels	O
.	O

This	O
effect	O
is	O
still	O
detectable	O
at	O
21	O
h	O
when	O
there	O
is	O
no	O
Sema	O
2a	O
expression	O
and	O
we	O
conclude	O
that	O
misplaced	O
terminals	O
do	O
not	O
compensate	O
by	O
delayed	O
growth	O
into	O
central	O
neuropile	O
(	O
Figure	O
2C	O
)	O
.	O

Sema	O
1a	O
expression	O
is	O
present	O
at	O
10-h	O
AEL	O
,	O
before	O
sensory	O
axons	O
have	O
entered	O
the	O
neuropile	O
and	O
persists	O
throughout	O
embryogenesis	O
(	O
unpublished	O
data	O
)	O
.	O

By	O
13	O
h	O
the	O
highest	O
levels	O
of	O
Sema	O
1a	O
are	O
in	O
the	O
lateral	O
and	O
intermediate	O
portions	O
of	O
layers	O
1	O
and	O
3	O
,	O
at	O
lower	O
levels	O
in	O
layer	O
2	O
,	O
and	O
not	O
detectable	O
in	O
layer	O
4	O
(	O
Figure	O
2F	O
and	O
2I	O
)	O
.	O

In	O
addition	O
to	O
differences	O
in	O
the	O
levels	O
of	O
Sema	O
1a	O
expression	O
in	O
different	O
dorso-ventral	O
layers	O
of	O
the	O
neuropile	O
,	O
we	O
also	O
find	O
an	O
apparent	O
decrease	O
in	O
concentration	O
from	O
intermediate	O
(	O
high	O
)	O
to	O
medial	O
(	O
low	O
)	O
in	O
layers	O
1	O
and	O
3	O
.	O

At	O
21	O
h	O
Sema	O
1a	O
is	O
still	O
strong	O
in	O
intermediate	O
portions	O
of	O
layers	O
1	O
and	O
3	O
.	O

The	O
effect	O
of	O
overexpressing	O
Plex	O
A	O
is	O
to	O
exclude	O
sensory	O
terminals	O
from	O
these	O
high	O
levels	O
of	O
Sema	O
1a	O
expression	O
(	O
Figure	O
2D	O
)	O
.	O

We	O
also	O
analyzed	O
the	O
distributions	O
of	O
Sema	O
1a	O
and	O
Sema	O
2a	O
in	O
the	O
antero-posterior	O
axis	O
,	O
at	O
the	O
time	O
of	O
sensory	O
axon	O
ingrowth	O
into	O
the	O
CNS	O
,	O
and	O
found	O
they	O
appear	O
uniform	O
(	O
Figure	O
S2A	O
and	O
S2B	O
)	O
.	O

To	O
confirm	O
that	O
Sema	O
2a	O
and	O
Sema	O
1a	O
act	O
as	O
the	O
ligands	O
for	O
Plex	O
B	O
and	O
Plex	O
A	O
in	O
our	O
experiments	O
,	O
we	O
tested	O
the	O
sema	O
2a	O
and	O
sema	O
1a	O
dependence	O
of	O
the	O
Plex	O
B	O
and	O
Plex	O
A	O
overexpression	O
phenotypes	O
in	O
sensory	O
neurons	O
.	O

We	O
analysed	O
patterns	O
of	O
sensory	O
terminals	O
in	O
sema	O
2a03021	O
loss	O
of	O
function	O
embryos	O
[	O
25	O
]	O
and	O
in	O
embryos	O
in	O
which	O
plex	O
B	O
was	O
overexpressed	O
in	O
sensory	O
neurons	O
in	O
a	O
sema	O
2a03021	O
background	O
.	O

In	O
sema	O
2a03021	O
embryos	O
we	O
find	O
ectopic	O
sensory	O
terminals	O
in	O
layer	O
2	O
(	O
Figure	O
3A	O
)	O
.	O

Overexpression	O
of	O
Plex	O
B	O
in	O
sensory	O
neurons	O
in	O
a	O
sema	O
2a03021	O
background	O
fails	O
to	O
exclude	O
sensory	O
terminals	O
from	O
central	O
and	O
dorsal	O
neuropile	O
(	O
compare	O
Figures	O
2C	O
and	O
3B	O
)	O
.	O

The	O
pattern	O
of	O
sensory	O
terminals	O
in	O
these	O
embryos	O
is	O
similar	O
to	O
their	O
pattern	O
in	O
sema	O
2a03021	O
mutants	O
(	O
compare	O
Figure	O
3A	O
and	O
3B	O
)	O
.	O

We	O
conclude	O
that	O
Sema	O
2a	O
is	O
the	O
functional	O
ligand	O
for	O
Plex	O
B	O
in	O
this	O
system	O
.	O

sema	O
2a	O
and	O
sema	O
1a	O
mutations	O
suppress	O
the	O
phenotypes	O
of	O
Plex	O
B	O
and	O
Plex	O
A	O
overexpression	O
in	O
sensory	O
neurons	O
.	O

We	O
recombined	O
the	O
UAS-plex	O
A-HA	O
[	O
24	O
]	O
transgene	O
with	O
the	O
sema	O
1aP1	O
[	O
26	O
]	O
mutation	O
to	O
express	O
Plex	O
A	O
in	O
a	O
sema	O
1a	O
mutant	O
background	O
.	O

We	O
analysed	O
patterns	O
of	O
sensory	O
terminals	O
in	O
sema	O
1aP1	O
mutant	O
embryos	O
and	O
in	O
embryos	O
in	O
which	O
Plex	O
A	O
was	O
overexpressed	O
in	O
sensory	O
neurons	O
in	O
a	O
sema	O
1aP1	O
background	O
.	O

In	O
sema	O
1aP1	O
embryos	O
,	O
we	O
found	O
ectopic	O
sensory	O
terminals	O
in	O
layers	O
1	O
and	O
3	O
(	O
Figure	O
3C	O
)	O
.	O

Overexpression	O
of	O
Plex	O
A	O
in	O
sensory	O
neurons	O
in	O
a	O
sema	O
1aP1	O
background	O
failed	O
to	O
exclude	O
them	O
from	O
layers	O
1	O
and	O
3	O
(	O
compare	O
Figures	O
2D	O
and	O
3D	O
)	O
.	O

The	O
pattern	O
of	O
sensory	O
terminals	O
in	O
these	O
embryos	O
is	O
strikingly	O
similar	O
to	O
their	O
pattern	O
in	O
sema	O
1aP1	O
mutants	O
(	O
compare	O
Figure	O
3C	O
and	O
3D	O
)	O
.	O

We	O
conclude	O
that	O
Sema	O
1a	O
is	O
the	O
functional	O
ligand	O
for	O
Plex	O
A	O
in	O
this	O
system	O
.	O

We	O
were	O
able	O
to	O
identify	O
potential	O
cellular	O
sources	O
of	O
the	O
transmembrane	O
Semaphorin	O
Sema	O
1a	O
by	O
looking	O
for	O
neuronal	O
populations	O
that	O
project	O
to	O
layers	O
1	O
and	O
3	O
(	O
Figure	O
S3	O
)	O
.	O

One	O
such	O
population	O
are	O
the	O
motorneurons	O
,	O
most	O
of	O
which	O
project	O
dendrites	O
to	O
layer	O
1	O
(	O
Figures	O
1	O
and	O
S3A	O
)	O
.	O

Using	O
the	O
OK371-GAL4	O
we	O
targeted	O
the	O
expression	O
of	O
the	O
cell	O
death	O
gene	O
reaper	O
and	O
of	O
the	O
CD8GFP	O
reporter	O
(	O
OK371-GAL4	O
,	O
UASCD8GFP	O
;	O
UAS-reaper	O
)	O
to	O
the	O
motor	O
neurons	O
[	O
27	O
]	O
.	O

This	O
resulted	O
in	O
the	O
death	O
of	O
most	O
motor	O
neurons	O
by	O
the	O
early	O
first	O
instar	O
larval	O
stage	O
(	O
as	O
judged	O
both	O
by	O
the	O
onset	O
of	O
larval	O
paralysis	O
and	O
by	O
the	O
loss	O
of	O
GFP	O
signal	O
)	O
(	O
Figure	O
S3C	O
)	O
.	O

Immunofluorescence	O
visualisation	O
of	O
Sema	O
1a	O
shows	O
a	O
significant	O
reduction	O
in	O
Sema	O
1a	O
levels	O
in	O
layer	O
1	O
in	O
animals	O
that	O
lack	O
motor	O
neurons	O
,	O
compared	O
to	O
animals	O
with	O
intact	O
motor	O
neurons	O
(	O
Figure	O
S3B	O
,	O
S3D	O
,	O
and	O
S3E	O
)	O
.	O

We	C
conclude	C
that	C
the	C
motorneuron	C
dendrites	C
are	C
likely	C
to	C
be	C
a	C
source	C
of	C
Sema	C
1a	C
in	C
the	C
dorsal	C
neuropile	C
.	C

Another	O
cell	O
population	O
that	O
projects	O
to	O
layer	O
1	O
,	O
as	O
well	O
as	O
to	O
layer	O
3	O
,	O
are	O
the	O
GABAergic	O
interneurons	O
(	O
Figure	O
S3F	O
)	O
.	O

We	O
used	O
GADGAL4	O
[	O
28	O
]	O
,	O
[	O
29	O
]	O
to	O
visualise	O
and	O
kill	O
both	O
the	O
motor	O
neurons	O
and	O
the	O
GABAergic	O
interneurons	O
and	O
found	O
that	O
this	O
resulted	O
in	O
nearly	O
complete	O
loss	O
of	O
Sema	O
1a	O
staining	O
from	O
both	O
layers	O
1	O
and	O
3	O
(	O
Figure	O
S3G	O
,	O
n=10	O
embryos	O
)	O
.	O

We	C
conclude	C
that	C
the	C
GABAergic	C
interneurons	C
are	C
likely	C
to	C
be	C
a	C
significant	C
source	C
of	C
Sema	C
1a	C
in	C
layer	C
1	C
and	C
also	C
in	C
layer	C
3	C
.	C

We	C
have	C
so	C
far	C
been	C
unable	C
to	C
identify	C
cellular	C
populations	C
that	C
project	C
exclusively	C
to	C
layer	C
2	C
,	C
but	C
since	C
the	C
expression	C
is	C
continuous	C
across	C
the	C
midline	C
(	C
see	C
Figure	C
S2A	C
)	C
,	C
at	C
least	C
some	C
midline	C
cells	C
could	C
be	C
involved	C
.	C

One	C
possibility	C
is	C
that	C
the	C
recently	C
described	C
extensions	C
of	C
midline	C
glial	C
cells	C
,	C
the	C
gliopodia	C
[	C
30	C
]	C
,	C
might	C
provide	C
a	C
vehicle	C
by	C
which	C
high	C
levels	C
of	C
Sema	C
2a	C
are	C
deployed	C
across	C
the	C
developing	C
neuropile	C
.	C

Interestingly	O
these	O
extensions	O
of	O
the	O
glial	O
cells	O
have	O
a	O
limited	O
life	O
span	O
,	O
becoming	O
much	O
reduced	O
late	O
in	O
embryogenesis	O
and	O
we	O
find	O
that	O
Sema	O
2a	O
expression	O
also	O
declines	O
in	O
these	O
late	O
stages	O
.	O

The	O
VNC	O
of	O
embryos	O
that	O
lack	O
midline	O
glial	O
cells	O
(	O
for	O
example	O
in	O
single	O
minded	O
mutants	O
;	O
[	O
31	O
]	O
)	O
are	O
too	O
fragile	O
and	O
disorganized	O
to	O
allow	O
analysis	O
of	O
levels	O
of	O
Sema	O
2a	O
along	O
the	O
dorso-ventral	O
axis	O
.	O

Instead	O
we	O
restored	O
Sema	O
2a	O
expression	O
in	O
the	O
midline	O
glial	O
cells	O
using	O
the	O
single	O
mindedGAL4	O
line	O
[	O
31	O
]	O
,	O
in	O
an	O
otherwise	O
sema	O
2a	O
mutant	O
background	O
(	O
sema	O
2a	O
,	O
UAS-sema	O
2a	O
;	O
single-mindedGAL4	O
)	O
(	O
see	O
Figure	O
S4A–S4C	O
for	O
details	O
of	O
these	O
experiments	O
)	O
.	O

We	O
were	O
able	O
to	O
restore	O
Sema	O
2a	O
expression	O
in	O
the	O
neuropile	O
(	O
Figure	O
S4B	O
)	O
,	O
in	O
layers	O
1	O
,	O
2	O
,	O
and	O
3	O
(	O
Figure	O
S4C	O
)	O
,	O
but	O
in	O
a	O
pattern	O
that	O
appeared	O
broader	O
than	O
the	O
endogenous	O
stripe	O
in	O
layer	O
2	O
.	O

Thus	C
a	C
source	C
of	C
the	C
Sema	C
2a	C
gradients	C
could	C
potentially	C
be	C
a	C
subset	C
of	C
the	C
midline	C
cells	C
,	C
although	C
we	C
can	C
not	C
exclude	C
the	C
possibility	C
that	C
some	C
other	C
cells	C
are	C
the	C
endogenous	C
source	C
of	C
this	C
cue	C
in	C
the	C
CNS	C
.	C

Ventrally	O
Projecting	O
Sensory	O
Neurons	O
Terminate	O
in	O
Regions	O
of	O
Low	O
Sema	O
1a	O
and	O
Low	O
Sema	O
2a	O
Expression	O
Levels	O

To	O
investigate	O
the	O
role	O
of	O
the	O
Sema/Plexin	O
system	O
in	O
determining	O
the	O
position	O
at	O
which	O
axons	O
terminate	O
within	O
the	O
layered	O
structure	O
of	O
the	O
neuropile	O
we	O
decided	O
to	O
focus	O
our	O
experiments	O
on	O
a	O
single	O
class	O
of	O
sensory	O
cells	O
with	O
well	O
defined	O
terminal	O
branches	O
,	O
the	O
nociceptive	O
class	O
IV	O
md	O
neurons	O
.	O

Class	O
IV	O
md	O
neurons	O
can	O
be	O
identified	O
with	O
ppkEGFP	O
[	O
9	O
]	O
,	O
[	O
12	O
]	O
,	O
which	O
labels	O
one	O
ISN	O
and	O
two	O
SN	O
neurons	O
in	O
each	O
hemisegment	O
.	O

The	O
axons	O
of	O
these	O
cells	O
terminate	O
medially	O
in	O
the	O
ventral-most	O
part	O
of	O
the	O
neuropile	O
,	O
layer	O
4	O
(	O
Figure	O
1C	O
)	O
,	O
where	O
they	O
branch	O
asymmetrically	O
in	O
the	O
antero-posterior	O
axis	O
(	O
Figure	O
S7A	O
)	O
.	O

By	O
examining	O
the	O
location	O
of	O
these	O
ppkEGFP-expressing	O
axons	O
with	O
respect	O
to	O
Sema	O
expression	O
we	O
confirmed	O
that	O
at	O
13-h	O
AEL	O
these	O
axons	O
terminate	O
in	O
a	O
region	O
of	O
low	O
Sema	O
2a	O
(	O
Figure	O
4A	O
)	O
and	O
just	O
below	O
regions	O
of	O
high	O
Sema	O
1a	O
expression	O
levels	O
(	O
Figure	O
4B	O
)	O
.	O

At	O
21-h	O
AEL	O
the	O
class	O
IV	O
terminals	O
remain	O
in	O
a	O
region	O
with	O
low	O
Sema	O
1a	O
expression	O
(	O
Figure	O
4C	O
)	O
.	O

Class	O
IV	O
md	O
neurons	O
terminate	O
in	O
a	O
neuropile	O
region	O
with	O
low	O
levels	O
of	O
Sema	O
1a	O
and	O
Sema	O
2a	O
.	O

sema	O
1a	O
and	O
sema	O
2a	O
Are	O
Required	O
to	O
Exclude	O
Ventrally	O
Projecting	O
Class	O
IV	O
md	O
Neurons	O
from	O
Dorsal	O
and	O
Central	O
Neuropile	O

We	C
now	C
asked	C
whether	C
sema	C
1a	C
and	C
sema	C
2a	C
are	C
required	C
to	C
confine	C
class	C
IV	C
projections	C
to	C
layer	C
4	C
.	C

In	O
embryos	O
mutant	O
for	O
sema	O
1aP1	O
[	O
26	O
]	O
,	O
sema	O
2a03021	O
[	O
25	O
]	O
,	O
and	O
in	O
sema	O
1aP1	O
,	O
sema	O
2a03021	O
double	O
mutants	O
,	O
the	O
class	O
IV	O
axons	O
have	O
aberrant	O
patterns	O
of	O
termination	O
and/or	O
growth	O
in	O
the	O
dorso-ventral	O
axis	O
(	O
compare	O
Figure	O
5A	O
with	O
5B	O
,	O
5C	O
and	O
5D	O
;	O
see	O
also	O
Figure	O
S6	O
for	O
details	O
of	O
the	O
effects	O
of	O
these	O
mutations	O
on	O
the	O
dorso-ventral	O
position	O
of	O
Fas	O
II	O
tracts	O
)	O
.	O

We	O
make	O
a	O
distinction	O
between	O
growth	O
and	O
termination	O
phenotypes	O
of	O
class	O
IV	O
axons	O
(	O
For	O
details	O
of	O
this	O
distinction	O
and	O
examples	O
of	O
different	O
kinds	O
of	O
growth	O
and	O
termination	O
phenotypes	O
see	O
Figure	O
S5	O
)	O
.	O

sema	O
1a	O
and	O
sema	O
2a	O
are	O
required	O
to	O
exclude	O
Class	O
IV	O
axons	O
from	O
dorsal	O
and	O
central	O
neuropile	O
.	O

We	O
found	O
a	O
significant	O
increase	O
in	O
the	O
percentage	O
of	O
hemisegments	O
with	O
aberrant	O
terminals	O
in	O
sema	O
1aP1	O
,	O
sema	O
2a03021	O
,	O
and	O
sema	O
1aP1	O
,	O
sema	O
2a03021	O
double	O
mutants	O
with	O
respect	O
to	O
sema	O
1aP1/+	O
controls	O
(	O
Figure	O
5A–5H	O
)	O
.	O

Moreover	O
,	O
the	O
percentage	O
of	O
hemisegments	O
with	O
aberrant	O
termination	O
in	O
sema	O
1aP1	O
,	O
sema	O
2a03021	O
double	O
mutants	O
,	O
was	O
significantly	O
higher	O
than	O
in	O
either	O
sema	O
1aP1	O
or	O
sema	O
2a0302	O
single	O
mutants	O
(	O
Figure	O
5E	O
)	O
.	O

We	O
found	O
that	O
in	O
sema	O
1aP1	O
mutants	O
aberrant	O
class	O
IV	O
axons	O
tend	O
to	O
terminate	O
in	O
layer	O
1	O
more	O
often	O
than	O
in	O
layer	O
2	O
(	O
Figure	O
5F	O
)	O
.	O

Conversely	O
,	O
in	O
2a03021	O
mutants	O
,	O
we	O
found	O
that	O
aberrant	O
class	O
IV	O
axons	O
tend	O
to	O
terminate	O
in	O
layer	O
2	O
more	O
often	O
than	O
in	O
layer	O
1	O
(	O
Figure	O
5G	O
)	O
.	O

In	O
sema	O
1aP1	O
,	O
sema	O
2a03021	O
double	O
mutants	O
(	O
Figure	O
5H	O
)	O
class	O
IV	O
axons	O
terminate	O
with	O
roughly	O
equal	O
probability	O
in	O
layers	O
1	O
,	O
2	O
,	O
or	O
3	O
.	O

Sema	C
1a	C
appears	C
to	C
play	C
a	C
more	C
important	C
role	C
in	C
preventing	C
termination	C
in	C
layer	C
1	C
,	C
followed	C
by	C
layer	C
3	C
,	C
and	C
a	C
minor	C
role	C
in	C
preventing	C
termination	C
in	C
layer	C
2	C
.	C

Sema	C
2a	C
appears	C
to	C
play	C
a	C
more	C
important	C
role	C
in	C
preventing	C
termination	C
in	C
layer	C
2	C
,	C
and	C
a	C
minor	C
role	C
in	C
preventing	C
termination	C
in	C
layers	C
1	C
and	C
3	C
.	C

Our	C
results	C
suggest	C
that	C
Sema	C
1a	C
and	C
Sema	C
2a	C
are	C
instructive	C
for	C
termination	C
of	C
class	C
IV	C
axons	C
along	C
the	C
dorso-ventral	C
axis	C
.	C

We	C
also	C
assessed	C
the	C
potential	C
roles	C
of	C
Sema	C
1a	C
and	C
Sema	C
2a	C
in	C
controlling	C
the	C
termination	C
of	C
class	C
IV	C
axons	C
in	C
the	C
antero-posterior	C
axis	C
by	C
analysing	C
their	C
projections	C
in	C
a	C
top-down	C
view	C
of	C
the	C
neuropile	C
in	C
wild	C
type	C
and	C
in	C
sema	C
1a	C
,	C
sema	C
2a	C
double	C
mutants	C
(	C
Figure	C
S7	C
)	C
.	C

We	O
chose	O
the	O
sema	O
1a	O
,	O
sema	O
2a	O
double	O
mutant	O
for	O
this	O
analysis	O
,	O
because	O
it	O
exhibited	O
the	O
strongest	O
phenotypes	O
in	O
the	O
dorso-ventral	O
axis	O
.	O

Wild-type	O
class	O
IV	O
axons	O
grow	O
asymmetrically	O
,	O
within	O
their	O
normal	O
ventral	O
and	O
medial	O
termination	O
domain	O
,	O
forming	O
thicker	O
terminal	O
in	O
the	O
anterior	O
than	O
in	O
the	O
posterior	O
portion	O
of	O
the	O
segment	O
(	O
Figure	O
S7A	O
)	O
.	O

We	O
did	O
not	O
observe	O
a	O
significant	O
loss	O
of	O
this	O
asymmetry	O
in	O
the	O
sema	O
1a	O
,	O
sema	O
2a	O
double	O
mutant	O
compared	O
to	O
wild	O
type	O
(	O
Figure	O
S7B	O
and	O
S7C	O
)	O
.	O

In	C
top	C
down	C
view	C
,	C
class	C
IV	C
terminals	C
do	C
appear	C
disorganized	C
compared	C
to	C
wild	C
type	C
,	C
but	C
we	C
assume	C
this	C
disorganization	C
is	C
a	C
consequence	C
of	C
the	C
major	C
defects	C
in	C
growth	C
and	C
termination	C
in	C
the	C
dorsoventral	C
axis	C
.	C

Thus	C
Sema	C
1a	C
and	C
Sema	C
2a	C
do	C
not	C
appear	C
to	C
play	C
a	C
major	C
role	C
in	C
confining	C
class	C
IV	C
terminals	C
to	C
the	C
anterior	C
portion	C
of	C
the	C
segment	C
.	C

Consistent	O
with	O
this	O
idea	O
is	O
also	O
our	O
finding	O
that	O
the	O
distributions	O
of	O
Sema	O
1a	O
and	O
Sema	O
2a	O
appear	O
uniform	O
in	O
the	O
antero-posterior	O
axis	O
,	O
at	O
the	O
time	O
of	O
sensory	O
axon	O
ingrowth	O
into	O
the	O
CNS	O
(	O
Figure	O
S2A	O
and	O
S2B	O
)	O
.	O

sema	O
1a	O
Is	O
Required	O
Non-Cell-Autonomously	O
to	O
Exclude	O
Class	O
IV	O
Axons	O
from	O
Dorsal	O
Neuropile	O

In	O
some	O
cases	O
membrane-bound	O
Sema	O
1a	O
acts	O
as	O
a	O
receptor	O
[	O
18	O
]	O
,	O
[	O
32	O
]	O
.	O

Thus	C
,	C
rather	C
than	C
a	C
requirement	C
to	C
act	C
as	C
a	C
cue	C
,	C
the	C
class	C
IV	C
mutant	C
phenotypes	C
could	C
reflect	C
a	C
cell-autonomous	C
requirement	C
for	C
Sema	C
1a	C
in	C
the	C
sensory	C
neurons	C
themselves	C
.	C

To	O
resolve	O
this	O
,	O
we	O
performed	O
two	O
kinds	O
of	O
rescue	O
experiments	O
.	O

First	O
,	O
we	O
restored	O
sema	O
1a	O
expression	O
to	O
sensory	O
neurons	O
in	O
sema	O
1aP1mutant	O
embryos	O
using	O
PO163GAL4	O
.	O

Antibody	O
labelling	O
confirms	O
that	O
Sema	O
1a	O
is	O
successfully	O
targeted	O
to	O
embryonic	O
sensory	O
terminals	O
using	O
this	O
driver	O
(	O
compare	O
Figure	O
6A	O
,	O
6C	O
,	O
and	O
6E	O
)	O
and	O
shows	O
that	O
in	O
the	O
mutant	O
a	O
large	O
fraction	O
of	O
Sema	O
1a-expressing	O
sensory	O
neurons	O
aberrantly	O
project	O
to	O
the	O
dorsal	O
part	O
of	O
the	O
neuropile	O
(	O
Figure	O
6E	O
)	O
.	O

We	O
then	O
analysed	O
specifically	O
the	O
projections	O
of	O
class	O
IV	O
neurons	O
in	O
embryos	O
where	O
sema	O
1a	O
expression	O
had	O
been	O
restored	O
to	O
sensory	O
neurons	O
in	O
the	O
sema	O
1aP1	O
mutant	O
background	O
(	O
compare	O
Figure	O
6B	O
,	O
6D	O
,	O
and	O
6F	O
)	O
.	O

There	O
was	O
no	O
rescue	O
of	O
the	O
dorsal	O
termination	O
phenotype	O
of	O
class	O
IV	O
axons	O
in	O
these	O
embryos	O
.	O

Quantification	O
revealed	O
no	O
significant	O
reduction	O
in	O
dorsal	O
termination	O
of	O
class	O
IV	O
axons	O
,	O
compared	O
to	O
sema	O
1aP1	O
mutants	O
(	O
Figure	O
6I	O
)	O
.	O

Thus	O
,	O
sema	O
1a	O
is	O
not	O
required	O
in	O
class	O
IV	O
neurons	O
themselves	O
to	O
exclude	O
their	O
terminals	O
from	O
dorsal	O
neuropile	O
.	O

sema	O
1a	O
is	O
required	O
non-cell	O
autonomously	O
in	O
dorsal	O
neuropile	O
for	O
the	O
ventral	O
projection	O
of	O
Class	O
IV	O
axons	O
.	O

In	O
a	O
second	O
set	O
of	O
experiments	O
,	O
we	O
selectively	O
restored	O
Sema	O
1a	O
to	O
dorsal	O
neuropile	O
in	O
an	O
otherwise	O
sema	O
1aP1	O
mutant	O
background	O
,	O
by	O
using	O
HB9GAL4	O
to	O
drive	O
its	O
expression	O
in	O
a	O
subset	O
of	O
motor	O
neurons	O
[	O
33	O
]	O
.	O

We	O
used	O
the	O
HB9GAL4	O
line	O
for	O
this	O
rescue	O
experiment	O
,	O
because	O
it	O
is	O
expressed	O
before	O
sensory	O
neurons	O
grow	O
into	O
the	O
neuropile	O
,	O
unlike	O
GADGAL4	O
or	O
OK371GAL4	O
,	O
which	O
are	O
expressed	O
later	O
.	O

We	O
confirmed	O
that	O
Sema	O
1a	O
is	O
selectively	O
present	O
in	O
dorsal	O
neuropile	O
in	O
these	O
experiments	O
(	O
compare	O
Figure	O
6A	O
,	O
6C	O
,	O
and	O
6G	O
)	O
,	O
and	O
we	O
observed	O
a	O
significant	O
reduction	O
in	O
the	O
dorsal	O
termination	O
of	O
class	O
IV	O
axons	O
compared	O
to	O
sema	O
1aP1	O
mutants	O
(	O
Figure	O
6H	O
and	O
6I	O
)	O
.	O

Thus	O
in	O
an	O
otherwise	O
mutant	O
background	O
,	O
the	O
mutant	O
phenotype	O
of	O
class	O
IV	O
axons	O
can	O
be	O
partially	O
rescued	O
by	O
expressing	O
sema1a	O
dorsally	O
in	O
the	O
dendrites	O
of	O
motor	O
neurons	O
.	O

We	C
also	C
asked	C
whether	C
restoration	C
of	C
Sema	C
2a	C
expression	C
in	C
the	C
midline	C
glial	C
cells	C
using	C
the	C
single	C
mindedGAL4	C
line	C
in	C
an	C
otherwise	C
sema	C
2a	C
mutant	C
background	C
(	C
sema	C
2a	C
,	C
UAS-sema	C
2a	C
;	C
single-mindedGAL4	C
,	C
ppkeGFP	C
)	C
rescues	C
the	C
sema	C
2a	C
mutant	C
phenotype	C
of	C
class	C
IV	C
axons	C
(	C
see	C
Figure	C
S4	C
for	C
details	C
of	C
these	C
experiments	C
)	C
.	C

We	O
observed	O
a	O
significant	O
reduction	O
in	O
the	O
aberrant	O
termination	O
of	O
class	O
IV	O
axons	O
in	O
layer	O
2	O
compared	O
to	O
sema	O
2a	O
mutant	O
embryos	O
(	O
Figure	O
S4D	O
and	O
S4E	O
)	O
.	O

plex	O
A	O
and	O
plex	O
B	O
Are	O
Both	O
Required	O
to	O
Exclude	O
Class	O
IV	O
Terminals	O
from	O
Regions	O
with	O
High	O
Sema	O
1a	O
and	O
Sema	O
2a	O
Expression	O
Levels	O

The	C
experiments	C
we	C
describe	C
suggest	C
that	C
both	C
Sema	C
1a	C
and	C
Sema	C
2a	C
are	C
required	C
as	C
cues	C
to	C
confine	C
class	C
IV	C
sensory	C
axons	C
to	C
ventral	C
neuropile	C
.	C

We	O
also	O
find	O
that	O
expressing	O
either	O
plex	O
A	O
or	O
plex	O
B	O
in	O
sensory	O
neurons	O
is	O
sufficient	O
to	O
shift	O
their	O
terminals	O
away	O
from	O
regions	O
with	O
high	O
levels	O
of	O
Sema	O
1a	O
and	O
2a	O
.	O

Thus	C
,	C
a	C
combination	C
of	C
Plexins	C
could	C
be	C
required	C
in	C
ventrally	C
projecting	C
sensory	C
neurons	C
to	C
exclude	C
them	C
from	C
dorsal	C
and	C
central	C
neuropile	C
.	C

By	O
in	O
situ	O
hybridization	O
we	O
confirmed	O
previous	O
reports	O
[	O
20	O
]	O
that	O
ch	O
,	O
dbd	O
,	O
and	O
class	O
I–IV	O
md	O
neurons	O
express	O
plex	O
B	O
at	O
the	O
time	O
that	O
sensory	O
axons	O
grow	O
into	O
and	O
terminate	O
in	O
the	O
VNC	O
(	O
Figure	O
S8D	O
)	O
.	O

By	O
double	O
labelling	O
with	O
anti-Plex	O
A	O
and	O
anti-horseradish	O
peroxidase	O
we	O
confirmed	O
that	O
Plex	O
A	O
is	O
expressed	O
in	O
sensory	O
neuron	O
cell	O
bodies	O
at	O
13-h	O
AEL	O
(	O
Figure	O
S8A	O
)	O
,	O
and	O
by	O
double	O
labelling	O
with	O
anti-Plex	O
A	O
and	O
anti-GFP	O
showed	O
that	O
Plex	O
A	O
is	O
strongly	O
expressed	O
in	O
the	O
ppk-expressing	O
class	O
IV	O
neurons	O
(	O
Figure	O
S8B	O
)	O
.	O

Unfortunately	O
,	O
none	O
of	O
these	O
experiments	O
allows	O
us	O
to	O
draw	O
quantitative	O
conclusions	O
about	O
levels	O
of	O
expression	O
in	O
different	O
cells	O
.	O

High	O
background	O
levels	O
also	O
prevented	O
a	O
reliable	O
analysis	O
of	O
Plex	O
A	O
expression	O
along	O
the	O
dorso-ventral	O
axis	O
of	O
the	O
CNS	O
.	O

However	O
antibody	O
labelling	O
against	O
Plex	O
A	O
does	O
reveal	O
expression	O
in	O
the	O
neuropile	O
at	O
13-h	O
AEL	O
(	O
Figure	O
S8C	O
)	O
.	O

To	C
show	C
whether	C
both	C
Plexins	C
are	C
required	C
to	C
exclude	C
the	C
ventrally	C
projecting	C
sensory	C
neurons	C
from	C
central	C
and/or	C
dorsal	C
neuropile	C
,	C
we	C
analysed	C
the	C
projection	C
pattern	C
of	C
class	C
IV	C
axons	C
in	C
plex	C
A	C
and	C
B	C
mutants	C
.	C

In	O
plex	O
ADf	O
(	O
4	O
)	O
C3	O
mutants	O
,	O
class	O
IV	O
axons	O
project	O
aberrantly	O
to	O
central	O
and/or	O
dorsal	O
neuropile	O
(	O
Figure	O
7A	O
and	O
7B	O
)	O
.	O

Quantification	O
reveals	O
significantly	O
more	O
terminals	O
in	O
dorsal	O
and	O
central	O
neuropile	O
,	O
compared	O
to	O
wild	O
type	O
(	O
Figure	O
7G	O
)	O
.	O

Plex	O
A	O
and	O
Plex	O
B	O
are	O
required	O
in	O
sensory	O
neurons	O
for	O
the	O
ventral	O
termination	O
of	O
Class	O
IV	O
axons	O
.	O

In	O
plex	O
BKG00878	O
mutants	O
class	O
IV	O
axons	O
also	O
project	O
to	O
dorsal	O
or	O
central	O
neuropile	O
(	O
Figures	O
7D	O
and	O
7E	O
)	O
.	O

Quantification	O
reveals	O
significantly	O
more	O
terminals	O
in	O
dorsal	O
and	O
central	O
neuropile	O
compared	O
to	O
wild	O
type	O
(	O
Figure	O
7G	O
)	O
.	O

We	O
also	O
quantified	O
the	O
proportion	O
of	O
terminals	O
in	O
each	O
of	O
the	O
different	O
layers	O
of	O
the	O
neuropile	O
(	O
Figure	O
7H	O
and	O
7I	O
)	O
.	O

We	O
found	O
that	O
in	O
plex	O
B	O
mutants	O
Class	O
IV	O
axons	O
terminate	O
with	O
roughly	O
equal	O
probability	O
in	O
layers	O
1	O
,	O
2	O
,	O
or	O
3	O
.	O

This	C
suggests	C
that	C
Plex	C
B	C
may	C
normally	C
have	C
a	C
role	C
in	C
preventing	C
termination	C
in	C
layers	C
with	C
high	C
levels	C
of	C
Sema	C
2a	C
or	C
Sema	C
1a	C
and	C
may	C
therefore	C
be	C
a	C
functional	C
receptor	C
for	C
both	C
ligands	C
.	C

We	C
also	C
observed	C
that	C
embryos	C
transheterozygous	C
for	C
plex	C
B	C
and	C
either	C
sema	C
1a	C
(	C
sema	C
1a/+	C
;	C
plex	C
B/+	C
)	C
,	C
sema	C
2a	C
(	C
sema	C
2a/+	C
;	C
plex	C
B/+	C
)	C
,	C
or	C
plex	C
A	C
(	C
plex	C
B/plex	C
A	C
)	C
all	C
exhibit	C
class	C
IV	C
termination	C
phenotypes	C
,	C
indicating	C
a	C
genetic	C
interaction	C
between	C
these	C
mutations	C
(	C
unpublished	C
data	C
)	C
.	C

To	C
further	C
test	C
whether	C
Plex	C
B	C
functions	C
to	C
prevent	C
termination	C
in	C
regions	C
with	C
high	C
Sema	C
1a	C
levels	C
we	C
analysed	C
the	C
patterns	C
of	C
sensory	C
terminals	C
that	C
overexpress	C
Plex	C
B	C
in	C
a	C
sema	C
1a	C
mutant	C
(	C
Figure	C
S9	C
)	C
.	C

In	O
these	O
embryos	O
we	O
observed	O
a	O
striking	O
expansion	O
of	O
sensory	O
terminals	O
into	O
the	O
intermediate	O
region	O
of	O
layer	O
1	O
that	O
normally	O
contains	O
highest	O
Sema	O
1a	O
levels	O
within	O
this	O
layer	O
(	O
compare	O
Figure	O
S9A	O
and	O
S9B	O
)	O
.	O

In	O
a	O
wild-type	O
background	O
Plex	O
B-overexpressing	O
sensory	O
terminals	O
remain	O
confined	O
in	O
the	O
most	O
medial	O
portion	O
of	O
layer	O
1	O
,	O
even	O
though	O
they	O
become	O
excluded	O
from	O
layer	O
2	O
(	O
Figures	O
2C	O
,	O
S9A	O
)	O
.	O

A	C
similar	C
expansion	C
is	C
also	C
observed	C
in	C
plex	C
ADf	C
(	C
4	C
)	C
C3	C
mutants	C
,	C
indicating	C
that	C
Plex	C
A	C
function	C
is	C
required	C
to	C
prevent	C
termination	C
in	C
regions	C
with	C
highest	C
levels	C
of	C
Sema	C
1a	C
(	C
Figure	C
S9C	C
)	C
.	C

Interestingly	O
,	O
we	O
found	O
that	O
in	O
the	O
absence	O
of	O
plex	O
A	O
,	O
Plex	O
B	O
overexpression	O
in	O
sensory	O
neurons	O
is	O
sufficient	O
to	O
prevent	O
their	O
expansion	O
into	O
regions	O
with	O
highest	O
Sema	O
1a	O
levels	O
(	O
in	O
PO163GAL4	O
,	O
UAS-plex	O
B	O
;	O
plex	O
ADf	O
(	O
4	O
)	O
C3	O
embryos	O
)	O
(	O
Figure	O
S9D	O
)	O
.	O

Rescuing	O
plex	O
A	O
and	O
plex	O
B	O
in	O
Sensory	O
Neurons	O
Alone	O
Is	O
Sufficient	O
to	O
Prevent	O
the	O
Aberrant	O
Projection	O
of	O
Class	O
IV	O
Neurons	O
to	O
Dorsal	O
and	O
Central	O
Neuropile	O

To	C
exclude	C
(	C
a	C
)	C
the	C
possibility	C
that	C
plex	C
A	C
and	C
B	C
are	C
required	C
in	C
the	C
central	C
targets	C
of	C
sensory	C
neurons	C
,	C
in	C
which	C
case	C
the	C
mutant	C
phenotypes	C
might	C
be	C
a	C
result	C
of	C
aberrations	C
in	C
normal	C
target	C
directed	C
growth	C
and	C
(	C
b	C
)	C
the	C
possibility	C
that	C
Plex	C
A	C
and	C
B	C
are	C
acting	C
as	C
guidance	C
cues	C
we	C
restored	C
their	C
expression	C
selectively	C
to	C
sensory	C
neurons	C
using	C
the	C
P0163	C
GAL4	C
driver	C
.	C

Restoration	O
of	O
Plex	O
B	O
expression	O
selectively	O
in	O
sensory	O
neurons	O
in	O
a	O
plex	O
BKG00878	O
mutant	O
background	O
,	O
rescues	O
the	O
phenotype	O
of	O
class	O
IV	O
md	O
neurons	O
(	O
Figure	O
7E	O
)	O
.	O

Quantification	O
reveals	O
significantly	O
fewer	O
aberrant	O
class	O
IV	O
terminals	O
in	O
plex	O
B-rescue	O
embryos	O
as	O
compared	O
to	O
plex	O
B	O
mutants	O
(	O
Figure	O
7G	O
)	O
.	O

The	O
Fas	O
II	O
tracts	O
continued	O
to	O
exhibit	O
mutant	O
phenotypes	O
in	O
these	O
experiments	O
,	O
as	O
would	O
be	O
expected	O
if	O
the	O
rest	O
of	O
the	O
neuropile	O
,	O
other	O
than	O
the	O
sensory	O
neurons	O
,	O
remained	O
mutant	O
(	O
Figure	O
S10	O
)	O
.	O

Likewise	O
,	O
restoration	O
of	O
Plex	O
A	O
expression	O
in	O
sensory	O
neurons	O
in	O
a	O
plex	O
ADf	O
(	O
4	O
)	O
C3	O
mutant	O
background	O
,	O
rescued	O
the	O
phenotype	O
of	O
class	O
IV	O
md	O
neurons	O
(	O
Figures	O
7C	O
)	O
.	O

Quantification	O
reveals	O
significantly	O
fewer	O
aberrant	O
class	O
IV	O
terminals	O
in	O
plex	O
A-rescue	O
embryos	O
compared	O
to	O
plex	O
A	O
mutants	O
(	O
Figure	O
7G	O
)	O
.	O

We	O
conclude	O
that	O
both	O
plex	O
A	O
and	O
plex	O
B	O
are	O
required	O
in	O
sensory	O
neurons	O
for	O
the	O
appropriate	O
targeting	O
of	O
class	O
IV	O
axons	O
to	O
the	O
ventral	O
neuropile	O
.	O

Discussion	O

In	O
the	O
work	O
we	O
report	O
here	O
,	O
we	O
have	O
addressed	O
the	O
general	O
issue	O
of	O
how	O
neuronal	O
termination	O
is	O
regulated	O
within	O
a	O
complex	O
meshwork	O
of	O
differentiating	O
axons	O
and	O
dendrites	O
.	O

Connections	O
are	O
formed	O
within	O
a	O
central	O
neuropile	O
from	O
which	O
cell	O
bodies	O
are	O
excluded	O
.	O

As	O
first	O
noted	O
by	O
Cajal	O
[	O
34	O
]	O
,	O
removing	O
cell	O
bodies	O
to	O
the	O
periphery	O
,	O
while	O
multiple	O
connections	O
are	O
formed	O
within	O
a	O
central	O
core	O
,	O
maximises	O
the	O
economy	O
with	O
which	O
the	O
network	O
is	O
wired	O
together	O
.	O

As	O
a	O
consequence	O
of	O
this	O
organisation	O
the	O
processes	O
of	O
neurons	O
of	O
all	O
kinds—motor	O
,	O
sensory	O
,	O
and	O
interneurons—grow	O
into	O
a	O
common	O
volume	O
of	O
the	O
nervous	O
system	O
within	O
which	O
connections	O
will	O
be	O
formed	O
.	O

This	O
growth	O
is	O
patterned	O
and	O
consistent	O
,	O
so	O
that	O
the	O
forming	O
network	O
is	O
partitioned	O
into	O
different	O
domains	O
within	O
which	O
limited	O
subsets	O
of	O
neurons	O
terminate	O
and	O
form	O
characteristic	O
arborisations	O
.	O

In	O
the	O
VNC	O
of	O
Drosophila	O
embryo	O
,	O
for	O
example	O
,	O
motor	O
neurons	O
place	O
their	O
dendrites	O
in	O
the	O
most	O
dorsal	O
domain	O
of	O
the	O
neuropile	O
where	O
they	O
arborise	O
to	O
form	O
a	O
myotopic	O
map	O
that	O
represents	O
centrally	O
the	O
distribution	O
of	O
innervated	O
muscles	O
in	O
the	O
periphery	O
[	O
35	O
]	O
.	O

While	O
these	O
dendritic	O
maps	O
are	O
forming	O
dorsally	O
,	O
the	O
axons	O
of	O
sensory	O
neurons	O
are	O
growing	O
into	O
the	O
same	O
neuropile	O
and	O
terminating	O
in	O
other	O
characteristic	O
and	O
consistent	O
domains	O
.	O

Here	O
too	O
,	O
each	O
modality	O
is	O
targeted	O
to	O
a	O
particular	O
volume	O
of	O
the	O
neuropile	O
where	O
the	O
terminals	O
form	O
a	O
characteristic	O
pattern	O
of	O
arborisations	O
[	O
7	O
]	O
.	O

In	C
a	C
system	C
in	C
which	C
neither	C
the	C
axonal	C
nor	C
dendritic	C
terminals	C
are	C
constrained	C
by	C
the	C
cell	C
bodies	C
or	C
by	C
the	C
position	C
of	C
entry	C
of	C
the	C
main	C
dendrite	C
or	C
axon	C
trunk	C
into	C
the	C
neuropile	C
,	C
we	C
envisage	C
that	C
connectivity	C
develops	C
in	C
stages	C
with	C
an	C
initial	C
phase	C
in	C
which	C
growing	C
axons	C
and	C
dendrites	C
are	C
both	C
delivered	C
to	C
appropriate	C
volumes	C
of	C
the	C
neuropile	C
,	C
followed	C
by	C
a	C
phase	C
of	C
targeted	C
connection	C
between	C
appropriate	C
pre-	C
and	C
postsynaptic	C
partners	C
.	C

A	C
pattern	C
of	C
growth	C
of	C
this	C
kind	C
would	C
resemble	C
that	C
seen	C
in	C
the	C
developing	C
olfactory	C
system	C
of	C
the	C
adult	C
fly	C
where	C
coarse	C
targeting	C
to	C
particular	C
regions	C
of	C
the	C
antennal	C
lobe	C
is	C
followed	C
by	C
precise	C
recognition	C
and	C
matching	C
between	C
axons	C
and	C
dendrites	C
[	C
36	C
]	C
,	C
[	C
37	C
]	C
.	C

Alternatively	C
it	C
may	C
be	C
that	C
the	C
mechanisms	C
that	C
pattern	C
the	C
growth	C
of	C
fibres	C
representing	C
a	C
single	C
modality	C
such	C
as	C
olfaction	C
are	C
different	C
from	C
those	C
required	C
to	C
organise	C
the	C
distribution	C
of	C
terminals	C
within	C
a	C
highly	C
heterogeneous	C
network	C
such	C
as	C
that	C
seen	C
in	C
the	C
VNC	C
.	C

In	C
our	C
view	C
the	C
initial	C
delivery	C
and	C
restriction	C
of	C
fibres	C
to	C
particular	C
subvolumes	C
of	C
the	C
VNC	C
neuropile	C
is	C
likely	C
to	C
be	C
by	C
individual	C
growth	C
responses	C
to	C
generalised	C
systems	C
of	C
cues	C
that	C
operate	C
to	C
pattern	C
the	C
network	C
as	C
it	C
develops	C
.	C

In	O
a	O
previous	O
paper	O
we	O
were	O
able	O
to	O
demonstrate	O
the	O
operation	O
of	O
one	O
such	O
cue	O
,	O
Slit	O
,	O
which	O
,	O
acting	O
through	O
its	O
Robo	O
receptors	O
dictates	O
the	O
different	O
positions	O
in	O
the	O
mediolateral	O
axis	O
at	O
which	O
specific	O
sensory	O
axons	O
will	O
terminate	O
and	O
arborise	O
.	O

Here	O
we	O
have	O
shown	O
that	O
membrane	O
bound	O
and	O
secreted	O
Semas	O
acting	O
through	O
their	O
receptors	O
the	O
Plexins	O
restrict	O
growing	O
axons	O
and	O
their	O
terminals	O
to	O
particular	O
dorso-ventral	O
layers	O
of	O
the	O
forming	O
neuropile	O
.	O

Evidence	O
for	O
Sema/Plexin	O
Signalling	O
Acting	O
in	O
the	O
Dorso-Ventral	O
Axis	O
of	O
the	O
Neuropile	O

Our	C
initial	C
approach	C
of	C
using	C
a	C
misexpression	C
screen	C
targeted	C
to	C
all	C
sensory	C
axons	C
was	C
sufficient	C
to	C
reveal	C
the	C
existence	C
of	C
the	C
Semas	C
as	C
putative	C
cues	C
in	C
the	C
dorso-ventral	C
axis	C
by	C
showing	C
that	C
there	C
were	C
generalised	C
redistributions	C
of	C
sensory	C
endings	C
in	C
this	C
axis	C
when	C
the	C
cells	C
concerned	C
were	C
forced	C
to	C
express	C
either	C
of	C
the	C
two	C
Sema	C
receptors	C
,	C
Plex	C
A	C
or	C
Plex	C
B	C
.	C

These	O
shifts	O
were	O
readily	O
detectable	O
when	O
the	O
nervous	O
system	O
was	O
viewed	O
in	O
a	O
plane	O
at	O
right	O
angles	O
to	O
the	O
neuraxis	O
.	O

Viewing	O
the	O
nervous	O
system	O
in	O
this	O
plane	O
also	O
reveals	O
the	O
largely	O
complementary	O
patterns	O
of	O
expression	O
for	O
the	O
two	O
Semas	O
.	O

The	O
membrane	O
bound	O
Sema	O
1a	O
is	O
distributed	O
in	O
an	O
alternating	O
pattern	O
across	O
the	O
neuropile	O
with	O
high	O
levels	O
in	O
both	O
layers	O
1	O
and	O
3	O
.	O

The	O
secreted	O
Sema	O
,	O
Sema	O
2a	O
,	O
on	O
the	O
other	O
hand	O
,	O
is	O
expressed	O
at	O
high	O
levels	O
in	O
a	O
central	O
strip	O
that	O
extends	O
across	O
the	O
midline	O
and	O
in	O
gradients	O
that	O
decline	O
ventrally	O
and	O
dorsally	O
orthogonal	O
to	O
the	O
Slit	O
gradient	O
(	O
Figure	O
2	O
)	O
.	O

A	O
gradient	O
of	O
Sema	O
2a	O
has	O
also	O
been	O
described	O
in	O
the	O
embryonic	O
limb	O
of	O
the	O
grasshopper	O
[	O
38	O
]	O
.	O

There	O
it	O
contributes	O
to	O
the	O
polarized	O
growth	O
of	O
pioneer	O
sensory	O
axons	O
away	O
from	O
the	O
region	O
of	O
highest	O
Sema	O
2a	O
expression	O
at	O
the	O
tip	O
.	O

In	C
the	C
developing	C
Drosophila	C
embryo	C
selective	C
overexpression	C
of	C
the	C
putative	C
receptors	C
for	C
Sema	C
1a	C
and	C
Sema	C
2a	C
in	C
sensory	C
neurons	C
acts	C
in	C
a	C
predictable	C
fashion	C
to	C
exclude	C
sensory	C
axons	C
and	C
terminals	C
from	C
those	C
regions	C
where	C
the	C
ligands	C
are	C
highly	C
expressed	C
:	C
overexpression	C
of	C
Plex	C
A	C
excludes	C
projections	C
from	C
high	C
levels	C
of	C
Sema	C
1a	C
expression	C
in	C
layers	C
1	C
and	C
3	C
.	C

Overexpression	O
of	O
Plex	O
B	O
shifts	O
sensory	O
terminals	O
further	O
away	O
from	O
the	O
central	O
layer	O
of	O
the	O
neuropile	O
.	O

These	C
findings	C
suggest	C
that	C
Sema	C
2a	C
and	C
Sema	C
1a	C
provide	C
guidance	C
cues	C
to	C
the	C
growth	C
cones	C
of	C
sensory	C
neurons	C
that	C
express	C
Plex	C
A	C
and	C
Plex	C
B	C
.	C

It	O
is	O
consistent	O
with	O
this	O
idea	O
that	O
in	O
the	O
absence	O
of	O
Sema	O
1a	O
,	O
Plex	O
A	O
overexpression	O
in	O
sensory	O
neurons	O
does	O
not	O
exclude	O
their	O
terminals	O
from	O
regions	O
that	O
normally	O
contain	O
high	O
Sema	O
1a	O
levels	O
.	O

Similarly	O
,	O
in	O
the	O
absence	O
of	O
Sema	O
2a	O
,	O
Plex	O
B	O
overexpression	O
in	O
sensory	O
neurons	O
does	O
not	O
exclude	O
their	O
terminals	O
from	O
the	O
central	O
layer	O
of	O
the	O
neuropile	O
.	O

The	O
manipulations	O
of	O
the	O
pattern	O
of	O
sensory	O
terminals	O
in	O
the	O
dorso-ventral	O
axis	O
found	O
with	O
Plexin	O
overexpression	O
are	O
analogous	O
to	O
the	O
manipulations	O
in	O
the	O
medio-lateral	O
axis	O
that	O
are	O
found	O
with	O
Robo3	O
misexpression	O
.	O

In	O
both	O
dimensions	O
the	O
position	O
at	O
which	O
sensory	O
neurons	O
form	O
their	O
terminals	O
is	O
determined	O
by	O
their	O
expression	O
of	O
receptors	O
for	O
positional	O
cues	O
.	O

Sema/Plexin	O
Signalling	O
Guides	O
Termination	O
in	O
the	O
Dorso-Ventral	O
Axis	O

The	O
most	O
ventrally	O
located	O
sensory	O
terminals	O
,	O
the	O
ppk-expressing	O
md	O
neurons	O
are	O
derived	O
from	O
axons	O
that	O
actually	O
enter	O
the	O
nervous	O
system	O
dorsally	O
and	O
grow	O
downwards	O
,	O
skirting	O
alternative	O
neuropile	O
regions	O
before	O
turning	O
inwards	O
to	O
reach	O
their	O
characteristic	O
medial	O
,	O
ventral	O
domain	O
of	O
termination	O
.	O

A	O
consequence	O
of	O
Sema	O
signalling	O
is	O
that	O
these	O
ventrally	O
targeted	O
axons	O
are	O
excluded	O
from	O
more	O
dorsal	O
regions	O
of	O
the	O
neuropile	O
and	O
channelled	O
instead	O
through	O
a	O
limited	O
lateral	O
region	O
where	O
the	O
expression	O
of	O
both	O
proteins	O
is	O
low	O
,	O
so	O
that	O
their	O
inward	O
migration	O
towards	O
the	O
midline	O
is	O
blocked	O
until	O
they	O
reach	O
the	O
most	O
ventral	O
region	O
.	O

In	O
the	O
absence	O
of	O
either	O
of	O
the	O
Semas	O
or	O
their	O
Plexin	O
receptors	O
,	O
ppk-expressing	O
axons	O
aberrantly	O
enter	O
and	O
terminate	O
in	O
more	O
dorsal	O
regions	O
of	O
the	O
neuropile	O
.	O

This	C
suggests	C
that	C
the	C
growth	C
cones	C
of	C
these	C
cells	C
are	C
attracted	C
towards	C
to	C
midline	C
(	C
we	C
assume	C
by	C
Netrins	C
)	C
[	C
39	C
]	C
as	C
soon	C
as	C
they	C
enter	C
the	C
CNS	C
,	C
but	C
that	C
entry	C
and	C
termination	C
in	C
the	C
more	C
dorsal	C
region	C
of	C
the	C
neuropile	C
is	C
prevented	C
by	C
high	C
levels	C
of	C
Sema	C
1a	C
in	C
layer	C
1	C
.	C

In	O
vertebrates	O
genetic	O
studies	O
show	O
that	O
proprioceptive	O
axons	O
are	O
excluded	O
from	O
the	O
superficial	O
dorsal	O
horn	O
by	O
Sema	O
6D/6C	O
signalling	O
mediated	O
by	O
Plex	O
A1	O
.	O

Loss	O
of	O
Plex	O
A1	O
allows	O
proprioceptive	O
collaterals	O
to	O
invade	O
the	O
superficial	O
dorsal	O
horn	O
although	O
most	O
succeed	O
in	O
projecting	O
through	O
it	O
to	O
their	O
normal	O
more	O
ventral	O
target	O
zones	O
[	O
19	O
]	O
.	O

In	O
an	O
analogous	O
(	O
though	O
not	O
topologically	O
equivalent	O
)	O
fashion	O
,	O
ventrally	O
projecting	O
afferents	O
in	O
Drosophila	O
require	O
Sema	O
signalling	O
through	O
Plex	O
A	O
for	O
their	O
proper	O
exclusion	O
from	O
the	O
most	O
dorsal	O
neuropile	O
.	O

Loss	C
of	C
plex	C
A	C
appears	C
to	C
affect	C
class	C
IV	C
terminals	C
less	C
strongly	C
than	C
loss	C
of	C
sema	C
1a	C
.	C

One	C
explanation	C
could	C
be	C
that	C
Plex	C
B	C
might	C
also	C
function	C
as	C
a	C
receptor	C
for	C
Sema	C
1a	C
in	C
this	C
system	C
.	C

Our	O
observation	O
that	O
in	O
plex	O
B	O
mutants	O
class	O
IV	O
axons	O
aberrantly	O
terminate	O
in	O
layers	O
1	O
,	O
2	O
,	O
or	O
3	O
supports	O
this	O
possibility	O
.	O

We	O
also	O
find	O
that	O
Plex	O
B	O
overexpression	O
in	O
sensory	O
neurons	O
in	O
plex	O
A	O
mutant	O
embryos	O
,	O
prevents	O
aberrant	O
expansion	O
of	O
sensory	O
terminals	O
into	O
intermediate	O
portion	O
of	O
layer	O
1	O
,	O
which	O
contains	O
very	O
high	O
levels	O
of	O
Sema	O
1a	O
(	O
Figure	O
S9	O
)	O
.	O

Such	O
an	O
expansion	O
occurs	O
in	O
both	O
plex	O
A	O
and	O
sema	O
1a	O
mutant	O
embryos	O
.	O

High	C
levels	C
of	C
Plex	C
B	C
signalling	C
thus	C
appear	C
to	C
be	C
able	C
to	C
substitute	C
for	C
the	C
absence	C
of	C
Plex	C
A	C
signalling	C
and	C
prevent	C
expansion	C
into	C
regions	C
with	C
high	C
Sema	C
1a	C
levels	C
.	C

These	C
findings	C
could	C
be	C
explained	C
if	C
Plex	C
B	C
were	C
to	C
function	C
as	C
a	C
lower	C
affinity	C
receptor	C
for	C
Sema	C
1a	C
,	C
as	C
well	C
as	C
a	C
high	C
affinity	C
receptor	C
for	C
Sema	C
2a	C
.	C

Sema	C
1a	C
and	C
Sema	C
2a	C
are	C
unlikely	C
to	C
be	C
the	C
only	C
cues	C
that	C
operate	C
in	C
the	C
dorso-ventral	C
axis	C
.	C

The	C
incomplete	C
penetrance	C
of	C
the	C
termination	C
phenotype	C
in	C
the	C
sema	C
1a	C
,	C
sema	C
2a	C
double	C
mutant	C
suggests	C
that	C
additional	C
factors	C
may	C
operate	C
to	C
control	C
the	C
ventral	C
targeting	C
of	C
class	C
IV	C
axons	C
.	C

There	C
may	C
be	C
long	C
range	C
ventral	C
attractants	C
or	C
local	C
substrate	C
bound	C
attractive	C
cues	C
for	C
these	C
axons	C
in	C
the	C
neuropile	C
.	C

It	C
is	C
also	C
likely	C
that	C
dorsally	C
and	C
centrally	C
located	C
sensory	C
and	C
interneuron	C
terminals	C
,	C
as	C
well	C
as	C
dendrites	C
of	C
motor	C
neurons	C
may	C
require	C
additional	C
signals	C
to	C
exclude	C
them	C
from	C
ventral	C
neuropile	C
.	C

Such	C
signals	C
could	C
be	C
the	C
other	C
Semas	C
.	C

Alternatively	C
,	C
by	C
analogy	C
with	C
the	C
optic	C
tectum	C
,	C
where	C
Wnt	C
signalling	C
drives	C
dorsal	C
projections	C
and	C
Ephrins	C
dictate	C
ventral	C
projections	C
,	C
it	C
is	C
possible	C
that	C
some	C
other	C
signalling	C
system	C
may	C
operate	C
with	C
Semas	C
to	C
confine	C
dorsally	C
projecting	C
neurons	C
to	C
dorsal	C
neuropile	C
[	C
3	C
]	C
,	C
[	C
40	C
]	C
,	C
[	C
41	C
]	C
.	C

Type-Specific	O
Repulsion	O
in	O
the	O
VNC	O

In	O
the	O
fly	O
antennal	O
lobe	O
,	O
during	O
the	O
formation	O
of	O
the	O
olfactory	O
map	O
,	O
Sema	O
1a	O
expression	O
on	O
the	O
surfaces	O
of	O
antennal	O
olfactory	O
receptor	O
neuron	O
(	O
ORN	O
)	O
axons	O
excludes	O
Plex	O
A	O
expressing	O
maxillary	O
palp	O
ORN	O
axons	O
from	O
inappropriate	O
glomeruli	O
[	O
22	O
]	O
,	O
[	O
23	O
]	O
.	O

Our	C
findings	C
suggest	C
that	C
much	C
of	C
the	C
Sema	C
1a	C
expression	C
in	C
the	C
neuropile	C
of	C
the	C
VNC	C
is	C
on	C
the	C
surfaces	C
of	C
motor	C
neuron	C
dendrites	C
and	C
on	C
the	C
projections	C
of	C
the	C
GABAergic	C
interneurons	C
.	C

Thus	C
,	C
there	C
appear	C
to	C
be	C
two	C
kinds	C
of	C
positional	C
cues	C
in	C
the	C
neuropile	C
.	C

Slit	C
and	C
Sema	C
2a	C
are	C
examples	C
of	C
secreted	C
and	C
possibly	C
glia-mediated	C
positional	C
cues	C
.	C

Sema	O
1a	O
on	O
the	O
other	O
hand	O
is	O
presented	O
on	O
membranes	O
of	O
particular	O
neuronal	O
classes	O
(	O
GABAergic	O
interneurons	O
and	O
motorneurons	O
)	O
and	O
is	O
a	O
repellent	O
for	O
the	O
axons	O
of	O
at	O
least	O
one	O
other	O
type	O
of	O
neuron	O
(	O
class	O
IV	O
md	O
neurons	O
)	O
.	O

Thus	C
,	C
the	C
presentation	C
of	C
repellent	C
molecules	C
on	C
the	C
surfaces	C
of	C
subsets	C
of	C
neurons	C
can	C
act	C
to	C
exclude	C
specific	C
classes	C
of	C
axons	C
from	C
particular	C
regions	C
of	C
the	C
neuropile	C
.	C

Positional	O
Cues	O
Subdivide	O
the	O
Neuropile	O
into	O
Different	O
Termination	O
Domains	O
within	O
Which	O
Connections	O
Form	O

Theoretical	O
models	O
for	O
gradient-guided	O
axonal	O
growth	O
and	O
targeting	O
during	O
the	O
formation	O
of	O
2-D	O
neural	O
maps	O
,	O
such	O
as	O
the	O
retinotopic	O
projections	O
,	O
require	O
at	O
least	O
one	O
gradient	O
in	O
each	O
of	O
the	O
two—not	O
necessarily	O
Cartesian—dimensions	O
[	O
42	O
]	O
.	O

These	O
ideas	O
have	O
been	O
borne	O
out	O
by	O
experimental	O
findings	O
.	O

Gradients	O
of	O
attractants	O
and	O
repellents	O
in	O
one	O
dimension	O
have	O
been	O
implicated	O
in	O
providing	O
positional	O
information	O
for	O
terminating	O
sensory	O
axons	O
during	O
the	O
formation	O
of	O
both	O
continuous	O
and	O
discrete	O
neural	O
maps	O
[	O
18	O
]	O
,	O
[	O
43	O
]	O
,	O
[	O
44	O
]	O
.	O

Furthermore	O
,	O
a	O
recent	O
study	O
has	O
shown	O
that	O
two	O
orthogonal	O
systems	O
of	O
graded	O
cues	O
operate	O
to	O
specify	O
position	O
of	O
termination	O
along	O
each	O
axis	O
of	O
a	O
somatotopic	O
map	O
in	O
the	O
optic	O
tectum	O
.	O

Our	O
findings	O
address	O
the	O
larger	O
issue	O
of	O
how	O
termination	O
of	O
distinct	O
neuron	O
classes	O
is	O
regulated	O
within	O
a	O
complex	O
meshwork	O
of	O
differentiating	O
axons	O
and	O
dendrites	O
.	O

They	C
suggest	C
that	C
similar	C
mechanisms	C
that	C
are	C
used	C
for	C
the	C
establishment	C
of	C
neural	C
maps	C
,	C
only	C
involving	C
generalized	C
positional	C
cues	C
in	C
each	C
dimension	C
,	C
control	C
targeting	C
of	C
many	C
different	C
classes	C
of	C
neurons	C
to	C
specific	C
termination	C
domains	C
within	C
a	C
complex	C
neuropile	C
.	C

Although	C
the	C
evidence	C
we	C
provide	C
here	C
suggests	C
that	C
positional	C
cues	C
can	C
specify	C
particular	C
domains	C
for	C
the	C
termination	C
of	C
sensory	C
neurons	C
,	C
we	C
do	C
not	C
suppose	C
that	C
the	C
control	C
of	C
termination	C
and	C
branching	C
by	C
a	C
pervasive	C
system	C
of	C
positional	C
cues	C
would	C
necessarily	C
be	C
sufficient	C
to	C
allow	C
connections	C
to	C
form	C
selectively	C
and	C
specifically	C
between	C
appropriate	C
pre-	C
and	C
postsynaptic	C
partners	C
.	C

What	C
such	C
a	C
system	C
does	C
provide	C
is	C
a	C
framework	C
of	C
signals	C
that	C
could	C
regulate	C
simultaneously	C
the	C
growth	C
of	C
axons	C
and	C
dendrites	C
of	C
many	C
different	C
neurons	C
and	C
induce	C
their	C
termination	C
and	C
branching	C
in	C
appropriate	C
parts	C
of	C
the	C
developing	C
network	C
.	C

Within	C
these	C
restricted	C
regions	C
it	C
is	C
likely	C
that	C
further	C
,	C
localised	C
mechanisms	C
,	C
including	C
competitive	C
interactions	C
,	C
patterns	C
of	C
activity	C
,	C
and	C
target	C
derived	C
cues	C
might	C
all	C
be	C
required	C
to	C
control	C
synaptogenesis	C
and	C
determine	C
the	C
emergence	C
of	C
precise	C
patterns	C
of	C
connectivity	C
within	C
a	C
termination	C
domain	C
.	C

Coordinate	O
Positioning	O
of	O
Pre-	O
and	O
Postsynaptic	O
Terminals	O
by	O
the	O
Same	O
Cues	O
?	O

If	C
the	C
pattern	C
of	C
sensory	C
axon	C
termination	C
within	C
the	C
neuropile	C
is	C
controlled	C
by	C
a	C
system	C
of	C
positional	C
cues	C
,	C
most	C
likely	C
,	C
in	C
three	C
dimensions	C
,	C
it	C
may	C
well	C
be	C
that	C
the	C
location	C
of	C
their	C
postsynaptic	C
dendrites	C
is	C
determined	C
in	C
a	C
similar	C
fashion	C
.	C

If	O
this	O
were	O
the	O
case	O
,	O
the	O
matched	O
expression	O
of	O
receptors	O
for	O
the	O
same	O
system	O
of	O
signals	O
by	O
pre-	O
and	O
postsynaptic	O
neurites	O
would	O
guide	O
them	O
to	O
a	O
common	O
volume	O
as	O
a	O
prelude	O
to	O
the	O
formation	O
of	O
synaptic	O
connections	O
between	O
them	O
.	O

Recent	O
studies	O
that	O
show	O
that	O
developing	O
motor	O
neuron	O
dendrites	O
respond	O
to	O
some	O
of	O
the	O
same	O
cues	O
as	O
terminating	O
sensory	O
axons	O
provide	O
indirect	O
evidence	O
for	O
common	O
systems	O
of	O
positional	O
cues	O
leading	O
to	O
the	O
coordinate	O
targeting	O
of	O
presynaptic	O
axons	O
and	O
postsynaptic	O
dendrites	O
[	O
45	O
]	O
,	O
[	O
46	O
]	O
.	O

A	O
direct	O
test	O
of	O
this	O
hypothesis	O
,	O
however	O
,	O
must	O
await	O
the	O
identification	O
of	O
the	O
postsynaptic	O
interneurons	O
with	O
which	O
developing	O
sensory	O
neurons	O
form	O
connections	O
.	O

It	C
will	C
then	C
be	C
possible	C
to	C
make	C
a	C
direct	C
investigation	C
of	C
the	C
molecular	C
mechanisms	C
that	C
control	C
the	C
termination	C
and	C
branching	C
of	C
pre-	C
and	C
postsynaptic	C
endings	C
and	C
thereby	C
lay	C
out	C
a	C
ground	C
plan	C
for	C
connectivity	C
within	C
the	C
developing	C
neuropile	C
.	C

Materials	O
and	O
Methods	O

Fly	O
Stocks	O

For	O
mutant	O
analyses	O
sema	O
2a03021	O
[	O
25	O
]	O
,	O
sema	O
1aP1	O
[	O
26	O
]	O
,	O
plex	O
ADf	O
(	O
4	O
)	O
C3	O
[	O
47	O
]	O
,	O
and	O
plex	O
BKG00878	O
[	O
21	O
]	O
,	O
[	O
48	O
]	O
were	O
crossed	O
into	O
the	O
ppkEGFP	O
[	O
9	O
]	O
stock	O
.	O

Stocks	O
were	O
made	O
using	O
GFP	O
balancers	O
[	O
49	O
]	O
.	O

Homozygous	O
mutant	O
embryos	O
were	O
identified	O
by	O
lack	O
of	O
GFP	O
.	O

For	O
misexpression	O
we	O
used	O
the	O
following	O
stocks	O
:	O
UAS-robo3	O
[	O
50	O
]	O
,	O
[	O
51	O
]	O
inserts	O
on	O
second	O
and	O
third	O
chromosome	O
,	O
UAS-plexB	O
[	O
21	O
]	O
and	O
UAS-plexA-HA	O
[	O
47	O
]	O
,	O
UAS-robo2	O
[	O
51	O
]	O
,	O
UAS-ephrin	O
[	O
52	O
]	O
,	O
[	O
53	O
]	O
,	O
UAS-eph	O
[	O
52	O
]	O
,	O
UAS-unc5	O
[	O
54	O
]	O
,	O
UAS-frazzled	O
[	O
55	O
]	O
,	O
UAS-drl-DN	O
[	O
56	O
]	O
,	O
UAS-comm	O
[	O
57	O
]	O
,	O
UAS-robo	O
,	O
410	O
EP-lines	O
from	O
the	O
Rorth	O
collection	O
[	O
58	O
]	O
,	O
[	O
59	O
]	O
.	O

For	O
the	O
misexpression	O
screen	O
the	O
UAS-lines	O
were	O
crossed	O
into	O
the	O
PO163GAL4	O
,	O
UAS-n-syb-GFP	O
stock	O
[	O
14	O
]	O
,	O
[	O
60	O
]	O
.	O

For	O
rescue	O
experiments	O
the	O
following	O
embryos	O
were	O
analysed	O
:	O
UAS-sema	O
1a	O
,	O
sema	O
1aP1	O
;	O
PO163GAL4	O
,	O
ppkEGFP	O
[	O
26	O
]	O
,	O
UAS-sema	O
1a	O
,	O
sema	O
1aP1	O
;	O
HB9GAL4	O
,	O
ppkEGFP	O
;	O
UAS-plexA-HA/+	O
;	O
PO163GAL4	O
,	O
ppkEGFP/+	O
;	O
plex	O
ADf	O
(	O
4	O
)	O
C3	O
,	O
and	O
UAS-plex	O
B/PO163GAL4	O
,	O
ppkEGFP	O
;	O
plex	O
BKG00878	O
.	O

We	O
also	O
used	O
OK371GAL4	O
(	O
gift	O
of	O
M	O
.	O

Landgraf	O
)	O
,	O
GADGAL4	O
[	O
29	O
]	O
,	O
single	O
mindedGAL4	O
[	O
31	O
]	O
,	O
UAS-reaper	O
[	O
27	O
]	O
and	O
wnt5D7	O
stocks	O
[	O
56	O
]	O
.	O

Dissection	O

Embryos	O
were	O
staged	O
and	O
VNCs	O
dissected	O
out	O
embryos	O
as	O
previously	O
described	O
[	O
6	O
]	O
,	O
[	O
61	O
]	O
,	O
[	O
62	O
]	O
.	O

For	O
overexpression	O
experiments	O
embryos	O
were	O
grown	O
at	O
29°C	O
.	O

VNCs	O
were	O
mounted	O
with	O
brain	O
lobes	O
down	O
and	O
VNC	O
up	O
to	O
allow	O
rapid	O
,	O
high-resolution	O
,	O
confocal	O
imaging	O
of	O
transverse	O
planes	O
,	O
perpendicular	O
to	O
the	O
neuraxis	O
.	O

Immunocytochemistry	O

We	O
used	O
the	O
following	O
primary	O
antibodies	O
:	O
anti-Sema	O
2a	O
(	O
MAb	O
19C2	O
,	O
developed	O
by	O
C.	O
Goodman	O
)	O
,	O
anti-Slit	O
(	O
MAb	O
C555.6D	O
,	O
developed	O
by	O
S.	O
Artavanis-Tsakonas	O
)	O
,	O
anti-Fas	O
II	O
(	O
MAb	O
1D4	O
,	O
developed	O
by	O
C.	O
Goodman	O
)	O
,	O
and	O
anti-Repo	O
(	O
MAb	O
8D12	O
,	O
developed	O
by	O
C.	O
Goodman	O
)	O
supplied	O
by	O
the	O
Developmental	O
Studies	O
Hybridoma	O
bank	O
(	O
110	O
dilution	O
)	O
;	O
anti-Sema	O
1a	O
(	O
11,000	O
dilution	O
,	O
kindly	O
provided	O
by	O
A.	O
Kolodkin	O
[	O
26	O
]	O
;	O
anti-Plex	O
A	O
(	O
1500	O
dilution	O
,	O
kindly	O
provided	O
by	O
L.	O
Luo	O
)	O
[	O
23	O
]	O
,	O
and	O
Cy5-conjugated	O
goat	O
anti-horseradish	O
peroxidase	O
(	O
1100	O
dilution	O
;	O
Jackson	O
ImmunoResearch	O
)	O
.	O

Secondary	O
antibodies	O
were	O
used	O
at	O
1500	O
dilution	O
:	O
Alexa488-conjugated	O
donkey	O
anti-goat	O
,	O
Alexa488-conjugated	O
goat	O
anti-rabbit	O
,	O
Alexa633-conjugated	O
goat	O
anti-mouse	O
,	O
Alexa633-conjugated	O
rabbit	O
anti-mouse	O
(	O
Molecular	O
Probes	O
)	O
.	O

Standard	O
immunocytochemical	O
procedures	O
were	O
followed	O
[	O
63	O
]	O
,	O
and	O
immunofluorescence	O
was	O
visualised	O
with	O
Leica	O
SP1	O
and	O
Zeiss	O
LSM	O
confocal	O
microscopes	O
.	O

Images	O
are	O
maximum	O
projections	O
of	O
confocal	O
z	O
series	O
processed	O
with	O
Adobe	O
Photoshop	O
software	O
.	O

Quantification	O
Procedures	O

For	O
quantification	O
of	O
Sema	O
2a	O
gradients	O
at	O
13-h	O
AEL	O
nine	O
VNCs	O
stained	O
for	O
Sema	O
2a	O
were	O
randomly	O
chosen	O
and	O
A7	O
imaged	O
using	O
a	O
Leica	O
SP1	O
.	O

A	O
confocal	O
section	O
was	O
randomly	O
chosen	O
from	O
each	O
stack	O
,	O
the	O
dorso-ventral	O
axis	O
manually	O
drawn	O
,	O
and	O
the	O
neuropile	O
was	O
divided	O
into	O
nine	O
equal	O
dorso-ventral	O
stripes	O
,	O
perpendicular	O
to	O
the	O
midline	O
and	O
the	O
average	O
fluorescence	O
intensity	O
in	O
each	O
stripe	O
was	O
calculated	O
.	O

Values	O
from	O
different	O
nerve	O
cords	O
were	O
normalized	O
such	O
that	O
the	O
average	O
intensity	O
from	O
each	O
nerve	O
cord	O
was	O
1	O
.	O

For	O
quantification	O
of	O
the	O
Slit	O
gradient	O
at	O
13	O
h	O
,	O
12	O
VNCs	O
stained	O
for	O
Slit	O
were	O
randomly	O
chosen	O
,	O
and	O
A7	O
was	O
imaged	O
using	O
a	O
Leica	O
SP1	O
.	O

A	O
confocal	O
section	O
was	O
randomly	O
chosen	O
from	O
each	O
stack	O
,	O
a	O
line	O
on	O
either	O
side	O
of	O
the	O
midline	O
was	O
manually	O
drawn	O
,	O
and	O
the	O
neuropile	O
on	O
either	O
side	O
of	O
the	O
midline	O
was	O
divided	O
into	O
four	O
mediolateral	O
stripes	O
.	O

The	O
average	O
fluorescence	O
intensity	O
in	O
each	O
stripe	O
was	O
calculated	O
and	O
normalised	O
as	O
above	O
.	O

For	O
a	O
statistical	O
analysis	O
of	O
defects	O
in	O
the	O
pattern	O
of	O
sensory	O
terminals	O
(	O
visualized	O
with	O
PO163GAL4	O
,	O
UAS-n-syb-GFP	O
)	O
along	O
the	O
medio-lateral	O
axis	O
we	O
quantified	O
the	O
normalised	O
surface	O
area	O
occupied	O
by	O
sensory	O
terminals	O
(	O
sensory	O
area	O
,	O
SA	O
)	O
in	O
the	O
medial	O
domain	O
of	O
the	O
neuropile	O
(	O
SAM/T=SA	O
[	O
medial	O
]	O
/SA	O
[	O
medial+intermediate+lateral	O
]	O
)	O
in	O
randomly	O
chosen	O
transverse	O
confocal	O
sections	O
from	O
30	O
different	O
hemisegments	O
for	O
each	O
genotype	O
.	O

Within	O
a	O
single	O
embryo	O
,	O
we	O
selected	O
every	O
tenth	O
section	O
(	O
all	O
confocal	O
sections	O
were	O
1-µm	O
thick	O
so	O
that	O
the	O
analyzed	O
sections	O
were	O
10	O
µm	O
apart	O
from	O
each	O
other	O
)	O
.	O

A	O
Student	O
's	O
t-test	O
was	O
used	O
to	O
compare	O
the	O
mean	O
SAM/T	O
for	O
the	O
different	O
genotypes	O
.	O

For	O
a	O
statistical	O
analysis	O
of	O
expansion	O
or	O
exclusion	O
of	O
sensory	O
terminals	O
(	O
visualized	O
with	O
PO163GAL4	O
,	O
UAS-n-syb-GFP	O
)	O
into	O
different	O
dorso-ventral	O
layers	O
we	O
compared	O
SA	O
in	O
layer	O
2	O
(	O
SA2/h=SA	O
(	O
layer	O
2	O
)	O
/	O
[	O
hemisegment	O
surface	O
area	O
]	O
)	O
or	O
SA	O
in	O
layers	O
1	O
,	O
3	O
,	O
and	O
4	O
(	O
SA1+3+4/h=SA	O
[	O
layer	O
1+3+4	O
]	O
/	O
[	O
hemisegment	O
surface	O
area	O
]	O
)	O
in	O
randomly	O
chosen	O
transverse	O
confocal	O
sections	O
from	O
more	O
than	O
30	O
different	O
hemisegments	O
for	O
each	O
genotype	O
.	O

Within	O
a	O
single	O
embryo	O
,	O
we	O
selected	O
every	O
tenth	O
section	O
(	O
all	O
confocal	O
sections	O
were	O
1-µm	O
thick	O
so	O
that	O
the	O
analyzed	O
sections	O
were	O
10	O
µm	O
apart	O
from	O
each	O
other	O
)	O
.	O

A	O
Student	O
's	O
t-test	O
was	O
used	O
to	O
compare	O
the	O
mean	O
SA2/h	O
or	O
SA1+3+4/h	O
for	O
the	O
different	O
genotypes	O
.	O

For	O
a	O
statistical	O
analysis	O
of	O
termination	O
defects	O
class	O
IV	O
md	O
axons	O
in	O
the	O
dorso-ventral	O
axis	O
,	O
we	O
quantified	O
the	O
percentage	O
of	O
hemisegments	O
with	O
aberrant	O
terminals	O
(	O
Hat	O
)	O
in	O
layers	O
1	O
,	O
2	O
,	O
and	O
3	O
per	O
embryo	O
(	O
per	O
14	O
hemisegments	O
)	O
:	O
Hat	O
(	O
1	O
,	O
2	O
,	O
or	O
3	O
)	O
=	O
(	O
n	O
hemisegments	O
with	O
terminals	O
in	O
1	O
,	O
2	O
,	O
or	O
3/14	O
)	O
×100	O
and	O
the	O
total	O
percentage	O
of	O
hemisegments	O
with	O
aberrant	O
terminals	O
per	O
embryo	O
[	O
Hat	O
(	O
1+2+3	O
)	O
=Hat	O
(	O
1	O
)	O
+Hat	O
(	O
2	O
)	O
+Hat	O
(	O
3	O
)	O
]	O
.	O

A	O
Student	O
's	O
t-test	O
was	O
used	O
to	O
compare	O
the	O
mean	O
Hat	O
for	O
the	O
different	O
genotypes	O
.	O

In	O
some	O
cases	O
we	O
also	O
quantified	O
the	O
average	O
(	O
per	O
embryo	O
)	O
relative	O
proportion	O
of	O
hemisegments	O
with	O
aberrant	O
terminal	O
in	O
each	O
layer	O
:	O
Hat	O
(	O
1	O
)	O
/Hat	O
(	O
1+2+3	O
)	O
,	O
Hat	O
(	O
2	O
)	O
/Hat	O
(	O
1+2+3	O
)	O
,	O
and	O
Hat	O
(	O
3	O
)	O
/Hat	O
(	O
1+2+3	O
)	O
.	O

We	O
counted	O
as	O
“aberrant”	O
only	O
those	O
hemisegments	O
with	O
terminals	O
in	O
layers	O
1	O
,	O
2	O
,	O
or	O
3	O
(	O
Figure	O
S5A	O
and	O
S5B	O
)	O
.	O

We	O
did	O
not	O
count	O
as	O
“aberrant”	O
those	O
axons	O
that	O
exhibit	O
the	O
aberrant	O
growth	O
,	O
with	O
normal	O
termination	O
phenotype	O
(	O
Figure	O
S5C	O
)	O
.	O

Supporting	O
Information	O

Figure	O
S1	O
Sensory	O
neuron	O
termination	O
does	O
not	O
correlate	O
with	O
nerve	O
route	O
and	O
position	O
of	O
entry	O
into	O
the	O
neuropile	O
.	O

(	O
A	O
)	O
Diagram	O
showing	O
the	O
pathways	O
in	O
the	O
neuropile	O
taken	O
by	O
sensory	O
neurons	O
that	O
run	O
in	O
the	O
ISN	O
(	O
magenta	O
)	O
and	O
the	O
SN	O
(	O
green	O
)	O
en	O
route	O
to	O
their	O
termination	O
domains	O
(	O
yellow	O
)	O
in	O
wild	O
type	O
(	O
21	O
AEL	O
)	O
,	O
with	O
respect	O
to	O
Fas	O
II	O
tracks	O
(	O
red	O
)	O
.	O

Diagram	O
represents	O
a	O
projection	O
of	O
a	O
confocal	O
z	O
series	O
of	O
transverse	O
sections	O
through	O
an	O
abdominal	O
segment	O
.	O

Dorsal	O
up	O
.	O

White	O
arrowhead	O
shows	O
midline	O
.	O

Magenta	O
lines	O
indicate	O
the	O
pathways	O
taken	O
by	O
ISN	O
neurons	O
in	O
the	O
neuropile	O
.	O

Green	O
lines	O
indicate	O
the	O
pathways	O
taken	O
by	O
SN	O
neurons	O
in	O
the	O
neuropile	O
.	O

2	O
,	O
3	O
,	O
and	O
4	O
indicate	O
sensory	O
neuron	O
termination	O
domains	O
in	O
layers	O
2	O
,	O
3	O
,	O
and	O
4	O
,	O
respectively	O
.	O

Scale	O
bar	O
:	O
10	O
mm	O
.	O

Sensory	O
axons	O
whose	O
cell	O
bodies	O
are	O
located	O
ventrally	O
in	O
the	O
body	O
wall	O
join	O
the	O
SN	O
nerve	O
,	O
whereas	O
axons	O
whose	O
cell	O
bodies	O
are	O
located	O
dorsally	O
or	O
laterally	O
in	O
the	O
body	O
wall	O
join	O
the	O
ISN	O
nerve	O
.	O

There	O
is	O
no	O
correlation	O
between	O
the	O
nerve	O
that	O
axons	O
travel	O
in	O
and	O
the	O
position	O
of	O
their	O
termination	O
in	O
the	O
neuropile	O
.	O

Sensory	O
axons	O
running	O
in	O
the	O
SN	O
terminate	O
in	O
layers	O
2	O
,	O
3	O
,	O
or	O
4	O
,	O
in	O
correlation	O
with	O
their	O
modality	O
and	O
dendritic	O
morphology	O
[	O
9	O
]	O
,	O
[	O
11	O
]	O
.	O

For	O
example	O
,	O
the	O
ventral	O
class	O
IV	O
neuron	O
(	O
vdaB	O
)	O
terminates	O
in	O
layer	O
4	O
,	O
the	O
ventral	O
ch	O
neurons	O
terminate	O
in	O
layer	O
3	O
,	O
and	O
the	O
ventral	O
proprioceptive	O
class	O
I	O
neuron	O
vpda	O
terminates	O
in	O
layer	O
2	O
(	O
M	O
.	O

Zlatic	O
,	O
unpublished	O
data	O
)	O
[	O
9	O
]	O
,	O
[	O
11	O
]	O
.	O

Similarly	O
,	O
those	O
sensory	O
neurons	O
that	O
travel	O
in	O
the	O
ISN	O
terminate	O
in	O
layers	O
2	O
,	O
3	O
,	O
or	O
4	O
,	O
depending	O
on	O
their	O
modality	O
and	O
dendritic	O
morphology	O
.	O

Dbd	O
and	O
the	O
ddaE	O
and	O
ddaD	O
class	O
I	O
md	O
neurons	O
,	O
terminate	O
in	O
layer	O
2	O
,	O
the	O
lateral	O
ch	O
neurons	O
terminate	O
in	O
layer	O
3	O
,	O
and	O
the	O
dorsal	O
class	O
IV	O
neuron	O
ddaC	O
terminates	O
in	O
layer	O
4	O
[	O
9	O
]	O
,	O
[	O
11	O
]	O
.	O

Each	O
of	O
the	O
three	O
characteristic	O
modality-specific	O
sensory	O
termination	O
domains	O
,	O
therefore	O
,	O
contains	O
some	O
neurons	O
that	O
have	O
travelled	O
through	O
the	O
SN	O
,	O
and	O
others	O
that	O
have	O
travelled	O
through	O
the	O
ISN	O
.	O

Thus	C
,	C
the	C
position	C
of	C
termination	C
in	C
the	C
neuropile	C
does	C
not	C
seem	C
to	C
depend	C
on	C
the	C
nerve	C
through	C
which	C
the	C
sensory	C
neurons	C
travel	C
towards	C
the	C
neuropile	C
nor	C
on	C
the	C
position	C
of	C
entry	C
into	C
the	C
neuropile	C
.	C

(	O
B	O
)	O
Images	O
show	O
the	O
patterns	O
of	O
growth	O
and	O
termination	O
of	O
md	O
axons	O
labelled	O
with	O
109	O
(	O
280	O
)	O
GAL4	O
,	O
UAS-CD8GFPGFP	O
(	O
white	O
)	O
in	O
21-h	O
embryos	O
.	O

Dorsal	O
is	O
up	O
.	O

Red	O
arrowheads	O
show	O
the	O
midline	O
.	O

Magenta	O
arrows	O
indicate	O
pathways	O
taken	O
by	O
ISN	O
neurons	O
in	O
the	O
neuropile	O
.	O

Green	O
arrows	O
indicate	O
pathways	O
taken	O
by	O
SN	O
neurons	O
in	O
the	O
neuropile	O
.	O

2	O
and	O
4	O
indicate	O
md	O
neuron	O
termination	O
domains	O
in	O
layers	O
2	O
and	O
4	O
,	O
respectively	O
.	O

Scale	O
bar	O
:	O
10	O
µm	O
.	O

Upper	O
:	O
a	O
single	O
section	O
from	O
a	O
confocal	O
z	O
series	O
through	O
an	O
abdominal	O
segment	O
showing	O
the	O
ISN	O
pathways	O
.	O

Lower	O
:	O
a	O
single	O
section	O
from	O
the	O
same	O
series	O
showing	O
the	O
SN	O
pathways	O
.	O

Both	O
ISN	O
and	O
SN	O
md	O
neurons	O
terminate	O
in	O
layers	O
2	O
or	O
4	O
,	O
depending	O
on	O
their	O
dendritic	O
morphology	O
.	O
(	O
0.93	O
MB	O
TIF	O
)	O

Figure	O
S2	O
Distributions	O
of	O
Sema	O
2a	O
and	O
Sema	O
1a	O
along	O
the	O
antero-posterior	O
axis	O
of	O
the	O
neuropile	O
.	O

(	O
A	O
and	O
B	O
)	O
Immunofluorescence	O
visualisation	O
of	O
Sema	O
2a	O
(	O
A	O
)	O
and	O
Sema	O
1a	O
(	O
B	O
)	O
(	O
white	O
)	O
in	O
ppkeGFP	O
embryos	O
(	O
13-h	O
AEL	O
)	O
.	O

Upper	O
images	O
show	O
projections	O
of	O
confocal	O
z	O
series	O
of	O
longitudinal	O
sections	O
through	O
the	O
VNC	O
.	O

Central	O
and	O
lower	O
images	O
show	O
single	O
more	O
dorsal	O
and	O
more	O
ventral	O
sections	O
from	O
the	O
stack	O
,	O
respectively	O
.	O

Anterior	O
is	O
to	O
the	O
left	O
.	O

Red	O
arrowheads	O
show	O
midline	O
.	O

a	O
and	O
p	O
indicate	O
the	O
position	O
of	O
anterior	O
(	O
a	O
)	O
and	O
posterior	O
(	O
p	O
)	O
commissures	O
in	O
each	O
segment	O
.	O

Scale	O
bar	O
:	O
35	O
µm	O
.	O

(	C
A	C
)	C
Levels	C
of	C
Sema	C
2a	C
are	C
uniform	C
along	C
the	C
antero-posterior	C
axis	C
,	C
thus	C
Sema	C
2a	C
is	C
unlikely	C
to	C
provide	C
instructive	C
information	C
for	C
controlling	C
neurite	C
termination	C
along	C
this	C
axis	C
.	C

Both	O
in	O
more	O
dorsal	O
(	O
layer	O
2	O
)	O
and	O
in	O
more	O
ventral	O
(	O
layer	O
3	O
)	O
longitudinal	O
sections	O
,	O
levels	O
of	O
Sema	O
2a	O
appear	O
uniform	O
along	O
the	O
antero-posterior	O
axis	O
.	O

(	O
B	O
)	O
Levels	O
of	O
Sema	O
1a	O
are	O
uniform	O
along	O
the	O
antero-posterior	O
axis	O
.	O

Thus	C
Sema	C
1a	C
is	C
unlikely	C
to	C
provide	C
instructive	C
information	C
for	C
controlling	C
neurite	C
termination	C
along	C
this	C
axis	C
.	C

Both	O
in	O
more	O
dorsal	O
(	O
layer	O
1	O
)	O
and	O
in	O
more	O
ventral	O
(	O
layer	O
3	O
)	O
longitudinal	O
sections	O
,	O
levels	O
of	O
Sema	O
1a	O
appear	O
uniform	O
along	O
the	O
antero-posterior	O
axis	O
.	O
(	O
1.34	O
MB	O
TIF	O
)	O

Figure	O
S3	O
Cellular	O
sources	O
of	O
Sema	O
1a	O
in	O
the	O
neuropile	O
.	O

(	O
A–E	O
)	O
Sema	O
1a	O
is	O
brought	O
into	O
dorsal	O
neuropile	O
,	O
in	O
part	O
,	O
by	O
motor	O
neurons	O
.	O

(	O
A	O
,	O
C	O
)	O
Immunofluorescence	O
visualisation	O
of	O
motor	O
neuron	O
dendrites	O
labelled	O
with	O
OK371GAL	O
,	O
UAS-CD8-GFP	O
control	O
(	O
white	O
)	O
,	O
in	O
OK371GAL4	O
,	O
UASCD8GFP	O
embryos	O
(	O
A	O
)	O
and	O
in	O
OK371GAL4	O
,	O
UASCD8GFP	O
,	O
UAS-reaper	O
embryos	O
(	O
B	O
)	O
at	O
21-h	O
AEL	O
.	O

(	O
B	O
,	O
D	O
)	O
Immunofluorescence	O
visualisation	O
of	O
Sema	O
1a	O
pattern	O
(	O
white	O
)	O
in	O
OK371GAL4	O
,	O
UASCD8GFP	O
control	O
(	O
B	O
)	O
and	O
OK371GAL4	O
,	O
UAS-CD8GFP	O
,	O
UAS-reaper	O
(	O
C	O
)	O
embryos	O
21-h	O
AEL	O
.	O

Dorsal	O
is	O
up	O
.	O

Arrowheads	O
indicate	O
the	O
midline	O
.	O

Magenta	O
lines	O
,	O
neuropile	O
boundaries	O
.	O

Red	O
lines	O
,	O
layer	O
boundaries	O
.	O

Numbers	O
indicate	O
layers	O
.	O

Scale	O
bar	O
:	O
10	O
µm	O
.	O

A	O
.	O

In	O
control	O
embryos	O
processes	O
of	O
motor	O
neurons	O
labelled	O
with	O
OK371GAL	O
,	O
UAS-CD8-GFP	O
are	O
readily	O
detectable	O
and	O
they	O
are	O
located	O
in	O
layer	O
1	O
,	O
which	O
normally	O
contains	O
high	O
levels	O
of	O
Sema1a	O
.	O

(	O
B	O
)	O
In	O
control	O
embryos	O
Sema	O
1a	O
is	O
present	O
at	O
high	O
levels	O
in	O
layers	O
1	O
and	O
3	O
.	O

(	O
C	O
)	O
Motor	O
neuron	O
dendrites	O
are	O
not	O
detectable	O
in	O
OK371GAL4	O
,	O
UAS-CD8GFP	O
,	O
UAS-reaper	O
.	O

(	O
D	O
)	O
Sema	O
1a	O
expression	O
in	O
the	O
same	O
animal	O
,	O
as	O
in	O
(	O
C	O
)	O
.	O

Sema	O
1a	O
levels	O
in	O
layer	O
1	O
are	O
reduced	O
relative	O
to	O
layer	O
3	O
in	O
the	O
absence	O
of	O
motor	O
neuron	O
dendrites	O
.	O

(	O
E	O
)	O
Quantification	O
of	O
Sema	O
1a	O
levels	O
in	O
layer	O
1	O
relative	O
to	O
layer	O
3	O
in	O
the	O
same	O
hemisegment	O
,	O
for	O
OK371-GAL4	O
,	O
UASCD8GFP	O
control	O
and	O
OK371GAL4	O
,	O
UAS-CD8GFP	O
,	O
UAS-reaper	O
,	O
21-h	O
old	O
embryos	O
.	O

For	O
this	O
purpose	O
,	O
embryos	O
of	O
the	O
two	O
genotypes	O
were	O
stained	O
with	O
antibody	O
against	O
GFP	O
(	O
to	O
distinguish	O
between	O
embryos	O
with	O
and	O
without	O
motor	O
neurons	O
)	O
.	O

In	O
each	O
embryo	O
seven	O
sections	O
from	O
seven	O
different	O
hemisegments	O
where	O
chosen	O
at	O
random	O
,	O
and	O
for	O
each	O
section	O
the	O
ratio	O
of	O
the	O
pixel	O
intensity	O
(	O
PI	O
)	O
for	O
the	O
channel	O
showing	O
Sema	O
1a	O
staining	O
in	O
layer	O
1	O
relative	O
to	O
layer	O
3	O
(	O
PI1/3=PI	O
[	O
Sema	O
1a	O
in	O
layer	O
1	O
]	O
/PI	O
[	O
Sema	O
1a	O
in	O
layer	O
3	O
]	O
)	O
was	O
calculated	O
.	O

A	O
significant	O
decrease	O
(	O
p=2×10-6	O
;	O
Student	O
's	O
t-test	O
)	O
in	O
pixel	O
intensity	O
in	O
layer	O
1	O
relative	O
to	O
layer	O
3	O
was	O
observed	O
in	O
OK371GAL4	O
,	O
UAS-CD8GFP	O
,	O
UAS-reaper	O
embryos	O
(	O
average	O
PI1/3=0.73	O
;	O
standard	O
deviation	O
[	O
SD	O
]	O
=0.09	O
,	O
n=65	O
hemisegments	O
)	O
compared	O
to	O
OK371GAL4	O
,	O
UAS-CD8GFP	O
controls	O
(	O
average	O
PI1/3=0.81	O
;	O
SD=0.08	O
,	O
n=48	O
hemisegments	O
)	O
.	O

(	O
F	O
and	O
G	O
)	O
Sema	O
1a	O
is	O
brought	O
into	O
dorsal	O
and	O
ventral	O
neuropile	O
,	O
in	O
part	O
,	O
by	O
GABAergic	O
interneurons	O
.	O

(	O
F	O
and	O
G	O
)	O
Immunofluorescence	O
visualisation	O
of	O
motor	O
neurons	O
and	O
GABAergic	O
processes	O
labelled	O
with	O
GADGAL	O
,	O
UAS-CD8-GFP	O
(	O
white	O
)	O
(	O
F	O
)	O
and	O
of	O
Sema	O
1a	O
pattern	O
(	O
white	O
)	O
in	O
GADGAL4	O
,	O
UAS-CD8GFP	O
,	O
UAS-reaper	O
(	O
G	O
)	O
,	O
21-h	O
old	O
embryos	O
.	O

Dorsal	O
is	O
up	O
.	O

Arrowheads	O
indicate	O
the	O
midline	O
.	O

Magenta	O
lines	O
,	O
neuropile	O
boundaries	O
.	O

Red	O
lines	O
,	O
layer	O
boundaries	O
.	O

Numbers	O
indicate	O
layers	O
.	O

M	O
,	O
medial	O
;	O
I	O
,	O
intermediate	O
;	O
L	O
,	O
lateral	O
domains	O
.	O

Scale	O
bar	O
:	O
10	O
µm	O
.	O

(	O
F	O
)	O
Processes	O
of	O
GABAergic	O
interneurons	O
and	O
motor	O
neurons	O
together	O
(	O
white	O
)	O
cover	O
the	O
dorsal	O
and	O
central	O
regions	O
of	O
the	O
neuropile	O
,	O
which	O
normally	O
contain	O
high	O
levels	O
of	O
Sema	O
1a	O
.	O

(	O
G	O
)	O
Sema	O
1a	O
(	O
white	O
)	O
levels	O
appear	O
highly	O
reduced	O
in	O
embryos	O
that	O
lack	O
both	O
GABAergic	O
interneurons	O
and	O
motor	O
neurons	O
.	O

The	O
characteristic	O
Sema	O
1a	O
distribution	O
pattern	O
is	O
no	O
longer	O
detectable	O
.	O
(	O
1.73	O
MB	O
TIF	O
)	O

Figure	O
S4	O
Restoration	O
of	O
sema	O
2a	O
in	O
midline	O
cells	O
partially	O
rescues	O
the	O
aberrant	O
central	O
projection	O
of	O
Class	O
IV	O
axons	O
.	O

(	O
A–C	O
)	O
Immunofluorescence	O
visualisation	O
of	O
Sema	O
2a	O
(	O
white	O
)	O
,	O
in	O
sema	O
2a	O
mutant	O
(	O
A	O
)	O
and	O
in	O
sema	O
2a	O
,	O
UAS-sema	O
2a	O
;	O
single-mindedGAL4	O
,	O
ppkeGFP	O
(	O
B	O
and	O
C	O
)	O
embryos	O
(	O
21-h	O
old	O
)	O
.	O

(	O
D	O
)	O
Projections	O
of	O
class	O
IV	O
axons	O
(	O
green	O
)	O
and	O
Fas	O
II	O
tracts	O
(	O
red	O
)	O
in	O
sema	O
2a	O
,	O
UAS-sema	O
2a	O
;	O
single-mindedGAL4	O
,	O
ppkeGFP	O
embryos	O
(	O
21-h	O
old	O
)	O
.	O

(	O
A	O
and	O
B	O
)	O
Image	O
shows	O
projections	O
of	O
a	O
confocal	O
z	O
series	O
of	O
longitudinal	O
sections	O
through	O
the	O
VNC	O
.	O

Anterior	O
is	O
to	O
the	O
left	O
.	O

Red	O
arrowheads	O
show	O
midline	O
.	O

Magenta	O
line	O
:	O
neuropile	O
boundary	O
.	O

Scale	O
bar	O
:	O
14	O
µm	O
.	O

(	O
C	O
and	O
D	O
)	O
Images	O
show	O
projections	O
of	O
a	O
confocal	O
z	O
series	O
of	O
transverse	O
sections	O
through	O
A7	O
.	O

Dorsal	O
is	O
up	O
.	O

Arrowheads	O
show	O
midline	O
.	O

Magenta	O
line	O
(	O
C	O
)	O
:	O
neuropile	O
boundary	O
.	O

Red	O
(	O
C	O
)	O
and	O
white	O
(	O
D	O
)	O
lines	O
,	O
layer	O
boundaries	O
.	O

Numbers	O
indicate	O
layers	O
:	O
M	O
,	O
medial	O
;	O
I	O
,	O
intermediate	O
;	O
L	O
,	O
lateral	O
domains	O
.	O

Scale	O
bar	O
:	O
9	O
µm	O
.	O

(	O
A	O
)	O
Sema	O
2a	O
expression	O
is	O
not	O
detectable	O
above	O
background	O
levels	O
in	O
the	O
neuropile	O
of	O
21-h-old	O
sema	O
2a	O
mutant	O
embryos	O
.	O

(	O
B	O
)	O
High	O
levels	O
of	O
Sema	O
2a	O
expression	O
are	O
detectable	O
in	O
sema	O
2a	O
,	O
UAS-sema	O
2a	O
;	O
single-mindedGAL4	O
,	O
ppkeGFP	O
embryos	O
.	O

(	O
C	O
)	O
Transverse	O
view	O
of	O
Sema	O
2a	O
expression	O
in	O
sema	O
2a	O
,	O
UAS-sema	O
2a	O
;	O
single-mindedGAL4	O
,	O
ppkeGFP	O
embryos	O
.	O

Sema	O
2a	O
expression	O
in	O
midline	O
cells	O
,	O
in	O
an	O
otherwise	O
mutant	O
background	O
,	O
results	O
in	O
its	O
distribution	O
throughout	O
the	O
neuropile	O
,	O
with	O
lower	O
levels	O
detectable	O
on	O
the	O
lateral	O
edges	O
of	O
the	O
neuropile	O
and	O
in	O
the	O
ventral-most	O
neuropile	O
.	O

(	O
D	O
)	O
Restoration	O
of	O
Sema	O
2a	O
expression	O
in	O
midline	O
cells	O
alone	O
reduces	O
the	O
aberrant	O
central	O
projection	O
of	O
class	O
IV	O
neurons	O
(	O
compare	O
to	O
Figure	O
5C	O
)	O
.	O

However	O
,	O
this	O
rescue	O
was	O
accompanied	O
by	O
additional	O
defects	O
in	O
the	O
medio-lateral	O
axis	O
,	O
with	O
increased	O
lateral	O
termination	O
of	O
class	O
IV	O
axons	O
.	O

Thus	C
the	C
source	C
of	C
the	C
Sema	C
2a	C
gradients	C
could	C
potentially	C
be	C
a	C
subset	C
of	C
the	C
midline	C
cells	C
,	C
although	C
we	C
can	C
not	C
exclude	C
the	C
possibility	C
that	C
some	C
other	C
cells	C
are	C
the	C
endogenous	C
source	C
of	C
this	C
cue	C
in	C
the	C
CNS	C
.	C

(	O
E	O
)	O
Chart	O
shows	O
average	O
percentage	O
of	O
hemisegments	O
per	O
embryo	O
(	O
per	O
14	O
abdominal	O
hemisegments	O
)	O
with	O
aberrant	O
class	O
IV	O
terminals	O
in	O
layer	O
2	O
(	O
Hat	O
(	O
2	O
)	O
)	O
,	O
in	O
sema	O
2a/+	O
,	O
sema	O
2a	O
mutant	O
and	O
sema	O
2a	O
,	O
UAS-sema	O
2a	O
;	O
single-mindedGAL4	O
,	O
ppkeGFP	O
embryos	O
.	O

Hat	O
(	O
2	O
)	O
is	O
significantly	O
higher	O
in	O
sema	O
2a	O
(	O
p=4×10-4	O
;	O
Student	O
's	O
t-test	O
;	O
average	O
Hat	O
(	O
2	O
)	O
=3.3	O
%	O
;	O
n=24	O
embryos	O
,	O
336	O
hemisegments	O
)	O
,	O
than	O
in	O
sema	O
2a/+	O
controls	O
(	O
average	O
Hat	O
(	O
2	O
)	O
=0	O
%	O
,	O
n=30	O
embryos	O
,	O
420	O
hemisegments	O
)	O
.	O
sema	O
2a	O
,	O
UAS-sema	O
2a	O
;	O
sim-GAL4	O
,	O
ppkeGFP	O
show	O
a	O
significant	O
reduction	O
in	O
Hat	O
(	O
2	O
)	O
(	O
red	O
**	O
,	O
p=0.006	O
;	O
Student	O
's	O
t-test	O
;	O
average	O
Hat	O
(	O
2	O
)	O
=0.7	O
%	O
,	O
n=29	O
embryos	O
,	O
406	O
hemisegments	O
)	O
,	O
compared	O
to	O
sema	O
2a	O
mutant	O
embryos	O
(	O
average	O
Hat	O
(	O
2	O
)	O
=3.3	O
%	O
)	O
.	O
(	O
1.28	O
MB	O
TIF	O
)	O

Figure	O
S5	O
Examples	O
of	O
growth	O
and	O
termination	O
errors	O
of	O
class	O
IV	O
axons	O
in	O
mutant	O
embryos	O
.	O

Projections	O
of	O
class	O
IV	O
axons	O
(	O
white	O
)	O
in	O
mutant	O
embryos	O
(	O
21-h	O
AEL	O
)	O
.	O

Images	O
show	O
projections	O
of	O
a	O
confocal	O
z	O
series	O
of	O
transverse	O
sections	O
through	O
A7	O
.	O

Dorsal	O
is	O
up	O
.	O

Arrowheads	O
show	O
midline	O
.	O

Magenta	O
arrows	O
point	O
to	O
aberrant	O
(	O
dorsal	O
or	O
central	O
)	O
terminals	O
of	O
class	O
IV	O
axons	O
.	O

Green	O
arrows	O
point	O
to	O
class	O
IV	O
axons	O
that	O
initially	O
grow	O
normally	O
(	O
ventrally	O
)	O
in	O
the	O
neuropile	O
,	O
but	O
afterwards	O
turn	O
dorsally	O
,	O
and	O
terminate	O
in	O
aberrant	O
layers	O
(	O
1	O
,	O
2	O
,	O
or	O
3	O
)	O
.	O

Red	O
arrows	O
point	O
to	O
class	O
IV	O
axons	O
that	O
grow	O
aberrantly	O
in	O
dorsal	O
or	O
central	O
neuropile	O
.	O

We	O
define	O
terminals	O
as	O
large	O
structures	O
that	O
form	O
at	O
the	O
tips	O
of	O
axons	O
(	O
although	O
sometimes	O
they	O
form	O
along	O
the	O
axon	O
path	O
,	O
on	O
either	O
side	O
of	O
the	O
main	O
axon	O
trunk	O
,	O
which	O
continues	O
growing	O
)	O
.	O

These	C
structures	C
are	C
thicker	C
than	C
the	C
axon	C
itself	C
and	C
we	C
assume	C
they	C
contain	C
presynaptic	C
specialisations	C
.	C

Class	O
IV	O
axons	O
exhibit	O
several	O
kinds	O
of	O
phenotypes	O
in	O
sema	O
and	O
plex	O
mutant	O
embryos	O
.	O

The	O
most	O
striking	O
is	O
normal	O
initial	O
growth	O
with	O
aberrant	O
termination	O
,	O
where	O
the	O
axon	O
initially	O
grows	O
appropriately	O
towards	O
its	O
target	O
area	O
in	O
the	O
ventral	O
medial	O
neuropile	O
,	O
but	O
then	O
makes	O
a	O
sharp	O
dorsal	O
turn	O
,	O
and	O
terminates	O
in	O
layers	O
1	O
,	O
2	O
,	O
or	O
3	O
(	O
for	O
examples	O
see	O
Figures	O
5D	O
,	O
left	O
axons	O
,	O
7E	O
,	O
right	O
axon	O
,	O
and	O
S5A	O
)	O
.	O

In	O
the	O
case	O
of	O
aberrant	O
growth	O
,	O
with	O
aberrant	O
termination	O
,	O
the	O
misrouted	O
axon	O
grows	O
through	O
and	O
forms	O
terminals	O
in	O
layers	O
1	O
,	O
2	O
,	O
or	O
3	O
(	O
for	O
examples	O
see	O
Figures	O
5B	O
,	O
6F	O
,	O
7B	O
,	O
7D	O
,	O
right	O
axon	O
,	O
and	O
S5B	O
)	O
.	O

Some	O
of	O
these	O
axons	O
never	O
reach	O
their	O
wild-type	O
layer	O
4	O
(	O
Figures	O
5B	O
,	O
6F	O
,	O
7B	O
,	O
and	O
S5B	O
)	O
while	O
others	O
send	O
a	O
branch	O
ventrally	O
,	O
after	O
they	O
have	O
formed	O
a	O
terminal	O
dorsally	O
or	O
centrally	O
(	O
right	O
axon	O
in	O
Figure	O
7D	O
)	O
.	O

In	O
the	O
case	O
of	O
aberrant	O
growth	O
,	O
with	O
normal	O
termination	O
,	O
the	O
misrouted	O
axon	O
turns	O
ventrally	O
after	O
growing	O
through	O
dorsal	O
or	O
central	O
layers	O
and	O
terminates	O
in	O
its	O
wild-type	O
layer	O
4	O
(	O
for	O
example	O
see	O
Figures	O
7D	O
,	O
left	O
axon	O
,	O
and	O
S5C	O
)	O
.	O

For	O
all	O
our	O
statistical	O
analysis	O
of	O
termination	O
defects	O
(	O
see	O
below	O
)	O
we	O
counted	O
as	O
“aberrant”	O
only	O
those	O
hemisegments	O
that	O
exhibit	O
the	O
aberrant	O
termination	O
phenotypes	O
(	O
Figure	O
S5A	O
and	O
S5B	O
)	O
,	O
but	O
we	O
counted	O
as	O
“normal”	O
those	O
hemisegments	O
that	O
exhibit	O
the	O
aberrant	O
growth	O
,	O
with	O
normal	O
termination	O
phenotype	O
(	O
Figure	O
S5C	O
)	O
.	O

(	O
A	O
)	O
Examples	O
of	O
normal	O
initial	O
growth	O
with	O
aberrant	O
termination	O
,	O
where	O
class	O
IV	O
axons	O
grew	O
in	O
normally	O
,	O
and	O
afterwards	O
aberrantly	O
turned	O
dorsally	O
or	O
centrally	O
and	O
terminated	O
there	O
,	O
in	O
sema1a	O
,	O
sema	O
2a	O
double	O
mutant	O
embryos	O
(	O
21	O
AEL	O
)	O
.	O

These	O
examples	O
show	O
that	O
the	O
position	O
of	O
entry	O
does	O
not	O
determine	O
the	O
position	O
of	O
termination	O
.	O

Despite	O
the	O
fact	O
that	O
these	O
axons	O
initially	O
grow	O
appropriately	O
in	O
the	O
ventral	O
neuropile	O
,	O
they	O
afterwards	O
alter	O
direction	O
of	O
growth	O
and	O
invade	O
aberrant	O
neuropile	O
layers	O
,	O
where	O
they	O
terminate	O
.	O

(	O
B	O
)	O
Example	O
of	O
class	O
IV	O
axons	O
showing	O
both	O
aberrant	O
growth	O
and	O
aberrant	O
termination	O
in	O
a	O
sema	O
1a	O
mutant	O
embryo	O
.	O

The	O
axons	O
initially	O
grow	O
in	O
dorsal	O
neuropile	O
,	O
where	O
they	O
also	O
forms	O
a	O
terminal	O
at	O
the	O
midline	O
.	O

(	O
C	O
)	O
Example	O
of	O
class	O
IV	O
axons	O
showing	O
aberrant	O
growth	O
,	O
but	O
normal	O
termination	O
in	O
a	O
plex	O
B	O
mutant	O
embryo	O
.	O

The	O
axon	O
grows	O
through	O
dorsal	O
neuropile	O
,	O
but	O
turns	O
ventrally	O
at	O
the	O
midline	O
,	O
without	O
forming	O
a	O
terminal	O
.	O

It	O
forms	O
a	O
terminal	O
once	O
it	O
reaches	O
the	O
ventral	O
neuropile	O
,	O
in	O
its	O
appropriate	O
location	O
.	O
(	O
1.35	O
MB	O
TIF	O
)	O

Figure	O
S6	O
Defective	O
positioning	O
of	O
Fas	O
II	O
tracts	O
in	O
different	O
mutant	O
backgrounds	O
.	O

Graphs	O
show	O
percentages	O
of	O
segments	O
(	O
n=175	O
)	O
in	O
which	O
L1	O
(	O
blue	O
)	O
,	O
I2	O
(	O
green	O
)	O
,	O
I3	O
(	O
yellow	O
)	O
,	O
M1	O
(	O
black	O
)	O
,	O
and	O
M2	O
(	O
white	O
)	O
tracts	O
project	O
aberrantly	O
in	O
sema	O
1aP1/+	O
(	O
A	O
)	O
,	O
sema	O
1aP1	O
(	O
B	O
)	O
,	O
sema	O
2a	O
(	O
C	O
)	O
,	O
and	O
sema	O
1aP1	O
,	O
sema	O
2a	O
double	O
mutant	O
(	O
D	O
)	O
21-h	O
embryos	O
.	O

(	O
A	O
)	O
In	O
sema	O
1aP1/+	O
control	O
embryos	O
Fas	O
II	O
tracts	O
grow	O
normally	O
in	O
the	O
dorso-ventral	O
axis	O
.	O

In	O
both	O
sema	O
1aP1	O
and	O
sema	O
2a	O
embryos	O
Fas	O
II	O
tracts	O
are	O
affected	O
(	O
B	O
and	O
C	O
)	O
and	O
the	O
disruption	O
is	O
more	O
severe	O
in	O
double	O
mutants	O
(	O
D	O
)	O
.	O
(	O
0.29	O
MB	O
TIF	O
)	O

Figure	O
S7	O
Role	O
of	O
Semas	O
in	O
patterning	O
the	O
antero-posterior	O
axis	O
of	O
the	O
neuropile	O
.	O

We	C
assessed	C
the	C
potential	C
role	C
of	C
Sema	C
1a	C
and	C
Sema	C
2a	C
in	C
controlling	C
termination	C
of	C
class	C
IV	C
axons	C
in	C
the	C
antero-posterior	C
axis	C
by	C
analysing	C
their	C
projections	C
in	C
a	C
top-down	C
view	C
of	C
the	C
neuropile	C
in	C
wild	C
type	C
and	C
in	C
sema	C
1a	C
,	C
sema	C
2a	C
double	C
mutants	C
(	C
see	C
Figure	C
S5A	C
and	C
S5B	C
)	C
.	C

We	O
chose	O
the	O
sema	O
1a	O
,	O
sema	O
2a	O
double	O
mutant	O
for	O
this	O
analysis	O
,	O
because	O
it	O
exhibited	O
the	O
strongest	O
phenotypes	O
in	O
the	O
dorso-ventral	O
axis	O
.	O

(	O
A	O
and	O
B	O
)	O
Projections	O
of	O
class	O
IV	O
axons	O
labelled	O
with	O
ppkEGFP	O
(	O
white	O
)	O
in	O
sema	O
1a/+	O
;	O
ppkEGFP	O
control	O
(	O
A	O
)	O
and	O
sema	O
1a	O
,	O
sema	O
2a	O
;	O
ppkEGFP	O
(	O
B	O
)	O
,	O
21-h	O
embryos	O
.	O

Images	O
show	O
projections	O
of	O
confocal	O
z	O
series	O
of	O
longitudinal	O
sections	O
of	O
the	O
VNC	O
(	O
from	O
T1	O
to	O
A4	O
)	O
.	O

Anterior	O
left	O
.	O

Arrowheads	O
show	O
midline	O
.	O

a	O
,	O
anterior	O
half	O
of	O
the	O
segment	O
;	O
p	O
,	O
posterior	O
half	O
of	O
the	O
segment	O
.	O

Scale	O
bar	O
:	O
16	O
µm	O
.	O

(	O
A	O
)	O
Top-down	O
view	O
of	O
wild-type	O
class	O
IV	O
projections	O
in	O
T1–A4	O
.	O

Wild-type	O
class	O
IV	O
axons	O
grow	O
asymmetrically	O
,	O
within	O
their	O
normal	O
ventral	O
and	O
medial	O
termination	O
domain	O
,	O
forming	O
a	O
thick	O
anterior	O
branch	O
and	O
very	O
thin	O
processes	O
that	O
extend	O
posteriorly	O
.	O

(	O
B	O
)	O
Top-down	O
view	O
of	O
class	O
IV	O
projections	O
in	O
T1–A4	O
in	O
sema	O
2a	O
,	O
sema	O
1a	O
double	O
mutants	O
.	O

Note	O
that	O
while	O
the	O
class	O
IV	O
terminals	O
appear	O
disorganised	O
compared	O
to	O
wild	O
type	O
,	O
they	O
still	O
appear	O
asymmetric	O
and	O
largely	O
confined	O
to	O
the	O
anterior	O
portion	O
of	O
the	O
segment	O
.	O

We	C
assume	C
the	C
observed	C
disorganization	C
is	C
a	C
consequence	C
of	C
the	C
major	C
defects	C
in	C
growth	C
and	C
termination	C
in	C
the	C
dorsoventral	C
axis	C
.	C

(	O
C	O
)	O
Quantification	O
of	O
the	O
average	O
surface	O
area	O
occupied	O
by	O
class	O
IV	O
terminals	O
in	O
the	O
posterior	O
half	O
of	O
the	O
hemisegment	O
,	O
relative	O
to	O
the	O
total	O
surface	O
area	O
covered	O
by	O
class	O
IV	O
terminals	O
in	O
a	O
hemisegment	O
[	O
SAp/	O
(	O
p+a	O
)	O
=SA	O
(	O
posterior	O
)	O
/SA	O
(	O
posterior+anterior	O
]	O
.	O

Quantification	O
of	O
SAp/	O
(	O
p+a	O
)	O
does	O
not	O
reveal	O
a	O
significant	O
increase	O
(	O
p=0.09	O
;	O
Student	O
's	O
t-test	O
average	O
SAp/	O
(	O
p+a	O
)	O
=0.22	O
;	O
SD=0.16	O
;	O
n=50	O
hemisegments	O
)	O
for	O
the	O
double	O
mutants	O
with	O
respect	O
to	O
wild-type	O
embryos	O
(	O
average	O
SAp/	O
(	O
p+a	O
)	O
=0.19	O
;	O
SD=0.1	O
;	O
n=55	O
hemisegments	O
)	O
.	O

For	O
comparison	O
we	O
analyzed	O
the	O
antero-posterior	O
distribution	O
of	O
class	O
IV	O
projections	O
in	O
embryos	O
mutant	O
for	O
the	O
gene	O
wnt	O
5	O
,	O
that	O
has	O
previously	O
been	O
implicated	O
in	O
controlling	O
axon	O
projections	O
in	O
the	O
antero-posterior	O
axis	O
[	O
56	O
]	O
.	O

Wnt	O
5	O
is	O
secreted	O
by	O
neurites	O
in	O
the	O
posterior	O
commissure	O
of	O
each	O
segment	O
.	O

We	O
also	O
analyzed	O
class	O
IV	O
projections	O
in	O
embryos	O
in	O
which	O
the	O
dominant	O
negative	O
form	O
of	O
Derailed	O
(	O
Drl	O
)	O
has	O
been	O
selectively	O
targeted	O
to	O
sensory	O
neurons	O
(	O
PO163GAL4	O
,	O
UAS-DN-drl	O
)	O
.	O

The	O
Wnt	O
5	O
receptor	O
Drl	O
is	O
present	O
on	O
the	O
growth	O
cones	O
and	O
axons	O
of	O
neurons	O
crossing	O
in	O
the	O
anterior	O
commissure	O
and	O
is	O
required	O
to	O
prevent	O
these	O
cells	O
from	O
crossing	O
aberrantly	O
in	O
the	O
posterior	O
commissure	O
[	O
56	O
]	O
.	O

In	O
contrast	O
,	O
to	O
the	O
sema1a	O
,	O
sema	O
2a	O
double	O
mutants	O
,	O
when	O
we	O
analysed	O
class	O
IV	O
projections	O
in	O
wnt	O
5D7	O
mutants	O
and	O
in	O
PO163GAL4	O
,	O
UAS-DN-drl	O
embryos	O
,	O
we	O
did	O
find	O
a	O
significant	O
increase	O
in	O
SAp/	O
(	O
p+a	O
)	O
compared	O
to	O
wild	O
type	O
(	O
for	O
wnt	O
5	O
,	O
p=1.8×10-7	O
;	O
Student	O
's	O
t-test	O
;	O
average	O
SAp/	O
(	O
p+a	O
)	O
=0.34	O
;	O
SD=0.12	O
;	O
n=16	O
hemisegments	O
;	O
for	O
PO163-DN-drl	O
,	O
p=2.2×10-7	O
;	O
Student	O
's	O
t-test	O
;	O
average	O
SAp/	O
(	O
p+a	O
)	O
=0.33	O
;	O
SD=0.12	O
;	O
n=30	O
hemisegments	O
)	O
.	O

Thus	C
Sema	C
1a	C
and	C
Sema	C
2a	C
do	C
not	C
appear	C
to	C
play	C
a	C
major	C
role	C
in	C
confining	C
class	C
IV	C
terminals	C
to	C
the	C
anterior	C
portion	C
of	C
the	C
segment	C
.	C
(	C
1.15	C
MB	C
TIF	C
)	C

Figure	O
S8	O
Plexin	O
expression	O
in	O
sensory	O
neurons	O
(	O
A	O
,	O
B	O
,	O
and	O
D	O
)	O
and	O
in	O
the	O
CNS	O
(	O
C	O
)	O
.	O

(	O
A	O
and	O
B	O
)	O
Immunofluorescence	O
visualisation	O
of	O
sensory	O
neuron	O
cell	O
bodies	O
labelled	O
with	O
antibody	O
against	O
horseradish	O
peroxidase	O
(	O
HRP	O
)	O
(	O
A	O
)	O
or	O
PPK-EGFP	O
(	O
red	O
)	O
(	O
in	O
B	O
)	O
and	O
Plex	O
A	O
(	O
A	O
and	O
B	O
)	O
at	O
13-h	O
AEL	O
.	O

Dorsal	O
is	O
up	O
.	O

(	O
A	O
)	O
Plex	O
A	O
expression	O
(	O
white	O
in	O
ii	O
and	O
green	O
in	O
iii	O
)	O
in	O
dorsal	O
(	O
d	O
)	O
and	O
lateral	O
(	O
l	O
)	O
clusters	O
of	O
sensory	O
neurons	O
(	O
white	O
in	O
i	O
and	O
red	O
in	O
iii	O
)	O
.	O

Strong	O
Plex	O
A	O
expression	O
is	O
visible	O
in	O
sensory	O
neuron	O
cell	O
bodies	O
in	O
both	O
clusters	O
.	O

Scale	O
bar	O
:	O
15	O
µm	O
.	O

(	O
B	O
)	O
Plex	O
A	O
protein	O
(	O
white	O
in	O
ii	O
and	O
green	O
in	O
iii	O
)	O
is	O
strongly	O
expressed	O
in	O
class	O
IV	O
md	O
neuron	O
cell	O
bodies	O
(	O
white	O
in	O
i	O
and	O
red	O
in	O
iii	O
)	O
.	O

Scale	O
bar	O
:	O
10	O
µm	O
.	O

(	O
C	O
)	O
Immunofluorescence	O
visualisation	O
of	O
Plex	O
A	O
protein	O
(	O
white	O
in	O
ii	O
and	O
green	O
in	O
iii	O
)	O
in	O
a	O
transverse	O
section	O
of	O
the	O
neuropile	O
labelled	O
with	O
HRP	O
(	O
white	O
in	O
i	O
and	O
red	O
in	O
iii	O
)	O
at	O
13-h	O
AEL	O
.	O

Image	O
shows	O
a	O
projection	O
of	O
a	O
confocal	O
z	O
series	O
of	O
1-mm	O
thick	O
transverse	O
sections	O
through	O
abdominal	O
segment	O
A7	O
.	O

Dorsal	O
is	O
up	O
.	O

Arrowheads	O
show	O
the	O
midline	O
.	O

Outlines	O
indicate	O
neuropile	O
boundaries	O
.	O

Scale	O
bar	O
:	O
5	O
mm	O
.	O

(	O
D	O
)	O
In	O
situ	O
hybridisation	O
showing	O
plex	O
B	O
mRNA	O
expression	O
in	O
dorsal	O
(	O
d	O
)	O
and	O
lateral	O
(	O
l	O
)	O
clusters	O
of	O
sensory	O
neurons	O
in	O
the	O
embryonic	O
body	O
wall	O
.	O

Dorsal	O
is	O
up	O
.	O

Scale	O
bar	O
:	O
20	O
µm	O
.	O

In	O
situ	O
hybridization	O
protocol	O
:	O
DIG-labelled	O
RNA	O
antisense	O
and	O
sense	O
probes	O
were	O
generated	O
with	O
the	O
Ambion	O
Megascript	O
kit	O
and	O
DIG-UTP	O
(	O
purchased	O
from	O
Roche	O
)	O
,	O
following	O
the	O
manufacturer	O
's	O
instructions	O
.	O

In	O
situ	O
hybridization	O
was	O
performed	O
according	O
to	O
a	O
protocol	O
kindly	O
provided	O
by	O
Nipam	O
Patel	O
(	O
University	O
of	O
California	O
,	O
Berkeley	O
)	O
.	O

DNA	O
templates	O
for	O
in	O
vitro	O
transcription	O
:	O
DNA	O
fragments	O
were	O
amplified	O
by	O
PCR	O
with	O
Primer1	O
(	O
GCGCGCGTAATACGACTCACTATAGGG	O
)	O
and	O
Primer2	O
(	O
GCGCGCAATTAACCCTCACTAAAGGG	O
)	O
from	O
pBluescript	O
(	O
SK	O
)	O
-PlexinB-CK00213	O
(	O
AA142091	O
)	O
(	O
EST	O
,	O
~1.7-kb	O
insert	O
)	O
using	O
the	O
following	O
key	O
PCR	O
parameters	O
:	O
annealing	O
at	O
66°C	O
,	O
5	O
min	O
extension	O
at	O
72°C	O
,	O
30	O
cycles	O
;	O
Primer1	O
and	O
Primer2	O
include	O
the	O
T7	O
and	O
T3	O
promoter	O
sequences	O
.	O

In	O
vitro	O
transcription	O
:	O
plex	O
B	O
:	O
T3	O
(	O
antisense	O
)	O
,	O
T7	O
(	O
sense	O
)	O
.	O
(	O
3.90	O
MB	O
TIF	O
)	O

Figure	O
S9	O
Plex	O
B	O
and	O
Plex	O
A	O
prevent	O
expansion	O
of	O
sensory	O
terminals	O
into	O
regions	O
with	O
high	O
Sema	O
1a	O
levels	O
.	O

(	O
A–D	O
)	O
Representative	O
images	O
of	O
sensory	O
terminals	O
labelled	O
with	O
PO163GAL4	O
,	O
UAS-n-syb-GFP	O
(	O
white	O
)	O
in	O
21-h	O
embryos	O
(	O
left	O
)	O
and	O
diagrams	O
showing	O
patterns	O
of	O
sensory	O
terminals	O
superimposed	O
for	O
different	O
genotypes	O
(	O
right	O
)	O
.	O

In	O
all	O
cases	O
images	O
show	O
projections	O
of	O
a	O
confocal	O
z	O
series	O
of	O
transverse	O
sections	O
through	O
A7	O
.	O

Dorsal	O
is	O
up	O
.	O

Arrowheads	O
show	O
midline	O
.	O

White	O
lines	O
,	O
layer	O
boundaries	O
.	O

Numbers	O
indicate	O
layers	O
:	O
M	O
,	O
medial	O
;	O
I	O
,	O
intermediate	O
;	O
L	O
,	O
lateral	O
domains	O
.	O

Scale	O
bar	O
:	O
10	O
µm	O
.	O

(	O
A	O
)	O
Expressing	O
Plex	O
B	O
in	O
sensory	O
neurons	O
in	O
a	O
wild-type	O
background	O
results	O
in	O
exclusion	O
of	O
sensory	O
neuron	O
terminals	O
from	O
neuropile	O
layer	O
2	O
(	O
see	O
also	O
Figure	O
2C	O
)	O
.	O

Quantification	O
of	O
SA2/h	O
(	O
SA2/h=SA	O
(	O
layer	O
2	O
)	O
/	O
[	O
hemisegment	O
surface	O
area	O
]	O
)	O
reveals	O
a	O
significant	O
decrease	O
(	O
***	O
,	O
p=4×10-17	O
;	O
Student	O
's	O
t-test	O
;	O
average	O
SA2/h=0.003	O
;	O
SD=0.006	O
;	O
n=30	O
hemisegments	O
)	O
with	O
respect	O
to	O
wild-type	O
embryos	O
(	O
average	O
SA2/h=0.06	O
;	O
SD=0.02	O
;	O
n=30	O
hemisegments	O
)	O
.	O

However	O
,	O
in	O
these	O
embryos	O
,	O
ectopic	O
sensory	O
terminals	O
in	O
layer	O
1	O
still	O
remain	O
largely	O
excluded	O
from	O
intermediate	O
and	O
lateral	O
portions	O
of	O
layer	O
1	O
,	O
which	O
contain	O
highest	O
Sema	O
1a	O
levels	O
.	O

Right	O
:	O
Diagram	O
showing	O
the	O
pattern	O
of	O
Plex	O
B	O
expressing	O
sensory	O
terminals	O
(	O
green	O
)	O
superimposed	O
on	O
the	O
wild-type	O
pattern	O
(	O
yellow	O
)	O
.	O

(	O
B	O
)	O
Expressing	O
Plex	O
B	O
in	O
sensory	O
neurons	O
in	O
a	O
sema	O
1a	O
mutant	O
background	O
still	O
excludes	O
sensory	O
terminals	O
from	O
neuropile	O
layer	O
2	O
.	O

However	O
,	O
in	O
these	O
embryos	O
ectopic	O
sensory	O
terminals	O
invade	O
the	O
entire	O
layer	O
1	O
and	O
are	O
no	O
longer	O
excluded	O
from	O
its	O
lateral	O
portions	O
,	O
which	O
normally	O
contain	O
highest	O
Sema	O
1a	O
levels	O
.	O

This	O
results	O
in	O
an	O
overall	O
increase	O
in	O
the	O
surface	O
area	O
occupied	O
by	O
sensory	O
neuron	O
terminals	O
in	O
layers	O
1	O
and	O
3	O
.	O

Right	O
:	O
Diagram	O
showing	O
the	O
patterns	O
of	O
Plex	O
B	O
expressing	O
sensory	O
terminals	O
in	O
sema	O
1a	O
mutant	O
(	O
green	O
)	O
and	O
wild-type	O
(	O
yellow	O
)	O
backgrounds	O
,	O
superimposed	O
.	O

Quantification	O
reveals	O
a	O
significant	O
increase	O
in	O
SA1+3+4/h	O
(	O
SA1+3+4/h=SA	O
[	O
layer	O
1+3+4	O
]	O
/	O
[	O
hemisegment	O
surface	O
area	O
]	O
)	O
(	O
***	O
,	O
p=4×10-5	O
;	O
Student	O
's	O
t-test	O
)	O
when	O
Plex	O
B	O
is	O
overexpressed	O
in	O
sensory	O
neurons	O
in	O
a	O
sema	O
1a	O
mutant	O
background	O
(	O
average	O
SA1+3+4/h=0.6	O
and	O
SD=0.08	O
,	O
n=22	O
hemisegments	O
)	O
,	O
compared	O
to	O
embryos	O
in	O
which	O
Plex	O
B	O
is	O
overexpressed	O
in	O
wild-type	O
background	O
(	O
average	O
SA1+3+4/h=0.5	O
;	O
SD=0.06	O
;	O
n=32	O
hemisegments	O
)	O
.	O

(	O
C	O
)	O
In	O
plex	O
A	O
mutant	O
embryos	O
,	O
sensory	O
terminals	O
aberrantly	O
invade	O
neuropile	O
layers	O
1	O
,	O
3	O
,	O
and	O
to	O
a	O
lesser	O
extent	O
layer	O
2	O
.	O

As	O
in	O
the	O
case	O
of	O
sema	O
1a	O
mutant	O
embryos	O
,	O
this	O
results	O
in	O
an	O
overall	O
increase	O
in	O
the	O
surface	O
area	O
occupied	O
by	O
sensory	O
neuron	O
terminals	O
in	O
layers	O
1	O
and	O
3	O
.	O

Right	O
:	O
Diagram	O
showing	O
the	O
patterns	O
of	O
sensory	O
terminals	O
in	O
plex	O
A	O
mutant	O
(	O
green	O
)	O
and	O
wild-type	O
(	O
yellow	O
)	O
backgrounds	O
,	O
superimposed	O
.	O

Quantification	O
reveals	O
a	O
significant	O
increase	O
of	O
SA1+3+4/h	O
(	O
***	O
,	O
p=6×10-34	O
;	O
Student	O
's	O
t-test	O
)	O
in	O
plex	O
A	O
mutants	O
(	O
average	O
SA1+3+4/h=0.7	O
and	O
SD=0.08	O
,	O
n=62	O
hemisegments	O
)	O
,	O
with	O
respect	O
to	O
wild	O
type	O
(	O
average	O
SA1+3+4/h=0.3	O
;	O
SD=0.05	O
;	O
n=32	O
hemisegments	O
)	O
.	O

(	O
D	O
)	O
Expressing	O
Plex	O
B	O
in	O
sensory	O
neurons	O
in	O
a	O
plex	O
A	O
mutant	O
background	O
is	O
sufficient	O
to	O
exclude	O
sensory	O
terminals	O
from	O
lateral	O
and	O
intermediate	O
portions	O
of	O
neuropile	O
layer	O
1	O
.	O

In	O
these	O
embryos	O
ectopic	O
sensory	O
terminals	O
do	O
not	O
invade	O
regions	O
of	O
layer	O
1	O
,	O
which	O
contain	O
highest	O
Sema	O
1a	O
levels	O
.	O

As	O
a	O
result	O
,	O
sensory	O
neuron	O
terminals	O
in	O
layers	O
1	O
and	O
3	O
occupy	O
a	O
smaller	O
surface	O
area	O
than	O
in	O
plex	O
A	O
mutants	O
.	O

Thus	O
,	O
in	O
the	O
absence	O
of	O
Plex	O
A	O
,	O
Plex	O
B	O
is	O
sufficient	O
to	O
exclude	O
sensory	O
terminals	O
from	O
regions	O
of	O
highest	O
Sema	O
1a	O
expression	O
.	O

Plex	C
B	C
may	C
therefore	C
function	C
as	C
a	C
receptor	C
for	C
Sema	C
1a	C
.	C

Right	O
:	O
Diagram	O
showing	O
superimposed	O
patterns	O
of	O
sensory	O
terminals	O
with	O
and	O
without	O
Plex	O
B	O
expression	O
in	O
plex	O
A	O
mutants	O
.	O

Terminals	O
with	O
Plex	O
B	O
expression	O
:	O
green	O
.	O

Terminals	O
without	O
Plex	O
B	O
expression	O
:	O
yellow	O
.	O

Quantification	O
reveals	O
a	O
significant	O
decrease	O
of	O
SA1+3+4/h	O
(	O
***	O
,	O
p=4×10-9	O
;	O
Student	O
's	O
t-test	O
)	O
when	O
Plex	O
B	O
is	O
expressed	O
in	O
sensory	O
terminals	O
in	O
a	O
plex	O
A	O
mutant	O
background	O
(	O
SA1+3+4/h=0.5	O
and	O
SD=0.1	O
,	O
n=55	O
hemisegments	O
)	O
,	O
compared	O
to	O
plex	O
A	O
mutants	O
(	O
SA1+3+4/h=0.7	O
and	O
SD=0.08	O
,	O
n=62	O
hemisegments	O
)	O
.	O

(	O
E	O
and	O
F	O
)	O
Bar	O
charts	O
show	O
the	O
average	O
SA1+3+4/h	O
under	O
different	O
conditions	O
as	O
indicated	O
.	O

(	O
E	O
)	O
The	O
average	O
SA1+3+4/h	O
(	O
average	O
SA1+3+4/h=0.6	O
,	O
SD=0.08	O
,	O
n=22	O
hemisegments	O
)	O
is	O
significantly	O
higher	O
(	O
***	O
,	O
p=4×10-5	O
;	O
Student	O
's	O
t-test	O
)	O
,	O
when	O
Plex	O
B	O
is	O
expressed	O
in	O
a	O
sema	O
1a	O
mutant	O
background	O
,	O
compared	O
to	O
its	O
expression	O
in	O
wild-type	O
background	O
(	O
average	O
SA1+3+4/h=0.5	O
;	O
SD=0.06	O
;	O
n=32	O
hemisegments	O
)	O
.	O

(	O
F	O
)	O
The	O
average	O
SA1+3+4/h	O
(	O
average	O
SA1+3/h=0.5	O
and	O
SD=0.1	O
,	O
n=55	O
hemisegments	O
)	O
is	O
significantly	O
lower	O
(	O
***	O
,	O
p=4×10-9	O
;	O
Student	O
's	O
t-test	O
)	O
for	O
sensory	O
terminals	O
that	O
express	O
Plex	O
B	O
in	O
a	O
plex	O
A	O
mutant	O
background	O
,	O
compared	O
to	O
plex	O
A	O
mutants	O
(	O
average	O
SA1+3+4/h=0.7	O
and	O
SD=0.08	O
,	O
n=62	O
hemisegments	O
)	O
.	O

In	O
contrast	O
,	O
we	O
did	O
not	O
observe	O
a	O
significant	O
difference	O
(	O
p=0.6	O
;	O
Student	O
's	O
t-test	O
)	O
between	O
the	O
SA1+3+4/h	O
of	O
sensory	O
terminals	O
that	O
express	O
Plex	O
B	O
in	O
a	O
plex	O
A	O
mutant	O
background	O
(	O
average	O
SA1+3+4/h=0.5	O
and	O
SD=0.1	O
,	O
n=55	O
hemisegments	O
)	O
and	O
those	O
that	O
express	O
Plex	O
B	O
in	O
wild-type	O
background	O
(	O
SA1+3+4/h=0.5	O
;	O
SD=0.06	O
;	O
n=32	O
hemisegments	O
)	O
.	O
(	O
1.24	O
MB	O
TIF	O
)	O

Figure	O
S10	O
Fas	O
II	O
defects	O
are	O
not	O
rescued	O
by	O
selective	O
restoration	O
of	O
Plex	O
B	O
expression	O
in	O
sensory	O
neurons	O
.	O

Graphs	O
show	O
percentage	O
of	O
segments	O
(	O
n=175	O
)	O
in	O
which	O
L1	O
(	O
blue	O
)	O
,	O
I2	O
(	O
green	O
)	O
,	O
I3	O
(	O
yellow	O
)	O
,	O
M1	O
(	O
black	O
)	O
,	O
M2	O
(	O
white	O
)	O
tracts	O
project	O
aberrantly	O
.	O

(	O
A	O
)	O
In	O
ppkEGFP	O
;	O
plexB	O
embryos	O
Fas	O
II	O
tracts	O
are	O
severely	O
affected	O
.	O

(	O
B	O
)	O
When	O
Plex	O
B	O
expression	O
is	O
selectively	O
restored	O
in	O
sensory	O
neurons	O
alone	O
,	O
in	O
UAS-plexB	O
;	O
PO163GAL4	O
,	O
ppkEGFP	O
;	O
plexB	O
embryos	O
,	O
Fas	O
II	O
tracts	O
continue	O
to	O
exhibit	O
the	O
mutant	O
phenotype	O
.	O
(	O
0.19	O
MB	O
TIF	O
)	O

Table	O
S1	O
Results	O
of	O
the	O
misexpression	O
screen	O
.	O

We	O
identified	O
11	O
genes	O
(	O
2.6	O
%	O
)	O
that	O
change	O
the	O
pattern	O
of	O
sensory	O
terminals	O
,	O
without	O
producing	O
pronounced	O
changes	O
in	O
neuron	O
number	O
or	O
preventing	O
sensory	O
axons	O
from	O
reaching	O
the	O
CNS	O
.	O

In	O
these	O
experiments	O
,	O
sensory	O
terminals	O
shift	O
independently	O
of	O
Fas	O
II	O
tracts	O
,	O
which	O
remain	O
in	O
their	O
wild-type	O
position	O
and	O
relation	O
to	O
each	O
other	O
.	O

Of	O
the	O
11	O
genes	O
,	O
two	O
produced	O
specific	O
shifts	O
along	O
the	O
dorso-ventral	O
axis	O
.	O

The	O
table	O
gives	O
the	O
list	O
of	O
11	O
genes	O
,	O
which	O
,	O
when	O
misexpressed	O
in	O
sensory	O
neurons	O
alone	O
,	O
produce	O
specific	O
shifts	O
in	O
the	O
dorso-ventral	O
,	O
medio-lateral	O
or	O
antero-posterior	O
axes	O
.	O
(	O
0.04	O
MB	O
DOC	O
)	O

Time	O
warping	O
of	O
evolutionary	O
distant	O
temporal	O
gene	O
expression	O
data	O
based	O
on	O
noise	O
suppression	O

Abstract	O

Comparative	O
analysis	O
of	O
genome	O
wide	O
temporal	O
gene	O
expression	O
data	O
has	O
a	O
broad	O
potential	O
area	O
of	O
application	O
,	O
including	O
evolutionary	O
biology	O
,	O
developmental	O
biology	O
,	O
and	O
medicine	O
.	O

However	O
,	O
at	O
large	O
evolutionary	O
distances	O
,	O
the	O
construction	O
of	O
global	O
alignments	O
and	O
the	O
consequent	O
comparison	O
of	O
the	O
time-	O
series	O
data	O
are	O
difficult	O
.	O

The	O
main	O
reason	O
is	O
the	O
accumulation	O
of	O
variability	O
in	O
expression	O
profiles	O
of	O
orthologous	O
genes	O
,	O
in	O
the	O
course	O
of	O
evolution	O
.	O

Results	O

We	O
applied	O
Pearson	O
distance	O
matrices	O
,	O
in	O
combination	O
with	O
other	O
noise-suppression	O
techniques	O
and	O
data	O
filtering	O
to	O
improve	O
alignments	O
.	O

This	O
novel	O
framework	O
enhanced	O
the	O
capacity	O
to	O
capture	O
the	O
similarities	O
between	O
the	O
temporal	O
gene	O
expression	O
datasets	O
separated	O
by	O
large	O
evolutionary	O
distances	O
.	O

We	O
aligned	O
and	O
compared	O
the	O
temporal	O
gene	O
expression	O
data	O
in	O
budding	O
(	O
Saccharomyces	O
cerevisiae	O
)	O
and	O
fission	O
(	O
Schizosaccharomyces	O
pombe	O
)	O
yeast	O
,	O
which	O
are	O
separated	O
by	O
more	O
then	O
~400	O
myr	O
of	O
evolution	O
.	O

We	O
found	O
that	O
the	O
global	O
alignment	O
(	O
time	O
warping	O
)	O
properly	O
matched	O
the	O
duration	O
of	O
cell	O
cycle	O
phases	O
in	O
these	O
distant	O
organisms	O
,	O
which	O
was	O
measured	O
in	O
prior	O
studies	O
.	O

At	O
the	O
same	O
time	O
,	O
when	O
applied	O
to	O
individual	O
ortholog	O
pairs	O
,	O
this	O
alignment	O
procedure	O
revealed	O
groups	O
of	O
genes	O
with	O
distinct	O
alignments	O
,	O
different	O
from	O
the	O
global	O
alignment	O
.	O

Conclusion	O

Our	O
alignment-based	O
predictions	O
of	O
differences	O
in	O
the	O
cell	O
cycle	O
phases	O
between	O
the	O
two	O
yeast	O
species	O
were	O
in	O
a	O
good	O
agreement	O
with	O
the	O
existing	O
data	O
,	O
thus	O
supporting	O
the	O
computational	O
strategy	O
adopted	O
in	O
this	O
study	O
.	O

We	C
propose	C
that	C
the	C
existence	C
of	C
the	C
alternative	C
alignments	C
,	C
specific	C
to	C
distinct	C
groups	C
of	C
genes	C
,	C
suggests	C
presence	C
of	C
different	C
synchronization	C
modes	C
between	C
the	C
two	C
organisms	C
and	C
possible	C
functional	C
decoupling	C
of	C
particular	C
physiological	C
gene	C
networks	C
in	C
the	C
course	C
of	C
evolution	C
.	C

Background	O

Comparative	C
analysis	C
of	C
evolutionary	C
changes	C
in	C
distant	C
organisms	C
at	C
the	C
level	C
of	C
gene	C
expression	C
requires	C
cross-matching	C
(	C
alignment	C
)	C
of	C
temporal	C
microarray	C
data	C
covering	C
developmental	C
time	C
courses	C
or	C
cell	C
cycles	C
.	C

Alignment	O
of	O
time	O
series	O
data	O
or	O
time	O
warping	O
allows	O
side	O
by	O
side	O
comparison	O
of	O
orthologous	O
gene	O
expression	O
on	O
a	O
relative	O
time	O
scale	O
[	O
1-5	O
]	O
.	O

The	O
time	O
warping	O
produces	O
non-linear	O
alignment	O
paths	O
,	O
which	O
help	O
estimate	O
the	O
relative	O
duration	O
of	O
similar	O
steps	O
in	O
the	O
life	O
cycle	O
of	O
diverged	O
species	O
.	O

In	C
addition	C
,	C
aligned	C
temporal	C
datasets	C
can	C
reveal	C
concordantly	C
and	C
discordantly	C
expressed	C
pairs	C
of	C
orthologous	C
genes	C
or	C
groups	C
of	C
genes	C
.	C

Currently	O
available	O
time-warping	O
algorithms	O
[	O
6	O
]	O
stem	O
out	O
from	O
early	O
methods	O
of	O
speech	O
recognition	O
[	O
7	O
]	O
.	O

Benchmarking	O
tests	O
show	O
that	O
the	O
existing	O
methods	O
under	O
perform	O
on	O
noisy	O
datasets	O
and	O
require	O
accommodation	O
to	O
temporal	O
expression	O
data	O
from	O
organisms	O
separated	O
by	O
large	O
evolutionary	O
distances	O
[	O
see	O
Additional	O
file	O
1	O
-	O
Figures	O
S1-S3	O
]	O
(	O
and	O
at	O
UC	O
Berkeley	O
online	O
resource	O
:	O
http	O
:	O
//flydev.berkeley.edu/cgi-	O
bin/GTEM/yeast_analysis/similarity_matrices.html	O
)	O
.	O

Here	O
,	O
we	O
tested	O
several	O
noise	O
suppression	O
techniques	O
,	O
in	O
order	O
to	O
optimize	O
global	O
alignment	O
between	O
the	O
time	O
series	O
data	O
from	O
two	O
species	O
,	O
separated	O
by	O
~400	O
million	O
years	O
of	O
evolution	O
,	O
budding	O
(	O
Saccharomyces	O
cerevisiae	O
)	O
and	O
fission	O
(	O
Schizosaccharomyces	O
pombe	O
)	O
yeasts	O
.	O

Traditionally	O
,	O
yeast	O
cell	O
cycle	O
served	O
as	O
a	O
model	O
system	O
to	O
study	O
regulation	O
of	O
the	O
periodic	O
gene	O
expression	O
,	O
replication	O
,	O
and	O
cell	O
division	O
[	O
8,9	O
]	O
.	O

Evolution	O
of	O
the	O
periodic	O
gene	O
expression	O
in	O
yeast	O
has	O
been	O
explored	O
based	O
on	O
classification	O
approaches	O
using	O
temporal	O
gene	O
expression	O
data	O
[	O
10-12	O
]	O
,	O
where	O
an	O
individual	O
periodicity	O
score	O
was	O
assigned	O
to	O
each	O
ortholog	O
and	O
these	O
periodicities	O
and	O
phases	O
were	O
then	O
compared	O
.	O

In	O
contrast	O
to	O
the	O
classification	O
approach	O
,	O
time	O
warping	O
captures	O
information	O
from	O
all	O
orthologous	O
profiles	O
in	O
a	O
single	O
test	O
.	O

Exploration	O
of	O
alignments	O
,	O
constructed	O
for	O
S.	O
cerevisiae	O
and	O
S.	O
pombe	O
using	O
available	O
methods	O
and	O
programs	O
[	O
1,6	O
]	O
[	O
see	O
Additional	O
file	O
1	O
-	O
Figures	O
S1-S3	O
]	O
(	O
and	O
the	O
UC	O
Berkeley	O
online	O
resource	O
)	O
revealed	O
presence	O
of	O
long	O
gaps	O
and	O
noisy	O
alignment	O
paths	O
.	O

In	O
this	O
study	O
,	O
we	O
introduced	O
and	O
thoroughly	O
tested	O
a	O
novel	O
data	O
treatment	O
and	O
alignment	O
framework	O
,	O
based	O
on	O
noise-suppression	O
methods	O
and	O
elements	O
of	O
Kruscal-Liberman	O
alignment	O
algorithm	O
[	O
6	O
]	O
.	O

The	O
framework	O
allowed	O
us	O
to	O
override	O
interspecific	O
noise	O
and	O
to	O
construct	O
a	O
global	O
alignment	O
for	O
the	O
two	O
yeast	O
species	O
.	O

This	O
global	O
alignment	O
supported	O
previously	O
observed	O
differences	O
in	O
duration	O
of	O
G1	O
and	O
G2	O
cell	O
cycle	O
phases	O
[	O
13	O
]	O
.	O

In	O
order	O
to	O
explore	O
alternative	O
alignments	O
,	O
the	O
pairs	O
of	O
the	O
orthologous	O
expression	O
profiles	O
have	O
been	O
aligned	O
individually	O
and	O
the	O
resulting	O
individual	O
alignment	O
paths	O
were	O
clustered	O
using	O
common	O
clustering	O
algorithms	O
[	O
14	O
]	O
.	O

Using	O
this	O
approach	O
,	O
we	O
found	O
gene	O
groups	O
or	O
``	O
time	O
clusters	O
,	O
''	O
in	O
which	O
the	O
relative	O
synchronization	O
modes	O
(	O
alignment	O
paths	O
,	O
characteristic	O
to	O
each	O
time	O
cluster	O
)	O
were	O
different	O
from	O
the	O
global	O
alignment	O
path	O
.	O

Our	C
analysis	C
suggested	C
that	C
evolutionary	C
shifts	C
in	C
durations	C
of	C
G1/G2	C
cell	C
cycle	C
phases	C
are	C
manifested	C
in	C
the	C
expression	C
timing	C
of	C
replication	C
machinery	C
and	C
ribosomal	C
genes	C
.	C

Instead	O
,	O
gene	O
expression	O
in	O
mitochondria	O
was	O
desynchronized	O
or	O
evolutionary	O
``	O
disconnected	O
''	O
from	O
the	O
replication	O
and	O
housekeeping	O
genes	O
due	O
to	O
high	O
autonomy	O
of	O
that	O
organelle	O
.	O

Results	O
and	O
discussion	O

Data	O
selection	O
and	O
noise	O
removal	O

Success	O
of	O
the	O
cross-specific	O
time	O
warping	O
critically	O
depends	O
on	O
the	O
level	O
of	O
noise	O
in	O
time	O
series	O
expression	O
data	O
,	O
``	O
internal	O
noise	O
''	O
and	O
on	O
the	O
evolutionary	O
variability	O
in	O
the	O
gene	O
expression	O
between	O
the	O
two	O
species	O
or	O
``	O
external	O
noise	O
''	O
.	O

The	O
internal	O
noise	O
appears	O
,	O
for	O
instance	O
,	O
due	O
to	O
the	O
measurement	O
errors	O
between	O
different	O
microarrays	O
(	O
time	O
points	O
)	O
and	O
due	O
to	O
desynchronization	O
of	O
cell	O
culture	O
over	O
time	O
;	O
the	O
external	O
noise	O
is	O
the	O
result	O
of	O
accumulated	O
in	O
evolution	O
differences	O
in	O
the	O
orthologous	O
expression	O
or	O
differences	O
in	O
expression	O
caused	O
by	O
experimental	O
conditions	O
,	O
such	O
as	O
selection	O
of	O
cell	O
culture	O
synchronization	O
method	O
.	O

In	O
this	O
perspective	O
,	O
problems	O
connected	O
with	O
the	O
alignment	O
construction	O
are	O
largely	O
problems	O
related	O
to	O
noise	O
reduction	O
and	O
noise	O
overriding	O
.	O

Ability	O
to	O
judge	O
quality	O
of	O
alignments	O
critically	O
depends	O
on	O
the	O
input	O
data	O
;	O
data	O
selection	O
helps	O
to	O
find	O
the	O
least	O
noisy/most	O
reliable	O
datasets	O
.	O

Therefore	O
all	O
70	O
pairwise	O
combinations	O
of	O
publicly	O
available	O
S.	O
cerevisiae	O
and	O
S.	O
pombe	O
datasets	O
[	O
10-13,15-17	O
]	O
were	O
explored	O
using	O
Kruscal-Liberman	O
algorithm	O
[	O
6	O
]	O
based	O
on	O
either	O
Euclidean	O
or	O
Pearson	O
distance	O
matrices	O
(	O
see	O
Methods	O
and	O
UC	O
Berkeley	O
online	O
resource	O
)	O
.	O

We	O
adopted	O
Pearson	O
distance	O
matrices	O
to	O
produce	O
highly	O
informative	O
comparisons	O
between	O
time	O
series	O
and	O
to	O
cope	O
with	O
the	O
external	O
(	O
evolutionary	O
)	O
noise	O
(	O
see	O
Methods	O
)	O
.	O

The	O
distance	O
matrices	O
revealed	O
discernible	O
periodic	O
patterns	O
similar	O
to	O
that	O
observed	O
in	O
simulated	O
periodic	O
datasets	O
[	O
see	O
Additional	O
file	O
1	O
-	O
Figure	O
S1	O
]	O
.	O

Notably	O
,	O
alignments	O
based	O
on	O
the	O
Pearson	O
distance	O
matrices	O
sustained	O
much	O
higher	O
external	O
noise	O
and	O
were	O
capable	O
of	O
capturing	O
even	O
subtle	O
similarities	O
between	O
orthologous	O
datasets	O
[	O
see	O
Additional	O
file	O
1	O
-	O
Figures	O
S1-S3	O
]	O
(	O
and	O
the	O
matrices	O
for	O
all	O
72	O
pairwise	O
comparisons	O
,	O
available	O
from	O
UC	O
Berkeley	O
web	O
resource	O
)	O
.	O

Judged	O
by	O
the	O
quality	O
of	O
the	O
observed	O
periodic	O
patterns	O
,	O
we	O
have	O
selected	O
for	O
detailed	O
analysis	O
two	O
pairs	O
of	O
datasets	O
:	O
S.	O
cerevisiae	O
synchronized	O
by	O
α-factor	O
[	O
12	O
]	O
,	O
and	O
S.	O
pombe	O
synchronized	O
either	O
using	O
cdc25	O
temperature	O
sensitive	O
mutant	O
or	O
elutriation	O
[	O
17	O
]	O
.	O

Based	C
on	C
the	C
amplitude	C
of	C
gene	C
expression	C
in	C
the	C
course	C
of	C
the	C
life	C
cycle	C
,	C
all	C
genes	C
in	C
the	C
yeast	C
genome	C
can	C
be	C
conditionally	C
separated	C
into	C
(	C
i	C
)	C
cell-cycle	C
dependent	C
(	C
oscillating	C
)	C
(	C
ii	C
)	C
constitutively	C
expressed	C
and	C
(	C
iii	C
)	C
inducible	C
(	C
not	C
expressed	C
or	C
expressed	C
constitutively	C
in	C
our	C
datasets	C
)	C
.	C

Low	C
oscillating	C
and	C
constitutive	C
genes	C
contribute	C
less	C
or	C
no	C
information	C
to	C
the	C
global	C
alignment	C
,	C
moreover	C
,	C
their	C
actual	C
expression	C
dynamics	C
can	C
be	C
masked	C
by	C
the	C
internal	C
noise	C
.	C

Therefore	O
,	O
we	O
removed	O
the	O
low-variant	O
genes	O
from	O
the	O
selected	O
datasets	O
to	O
improve	O
sensitivity	O
of	O
the	O
method	O
.	O

In	O
the	O
prior	O
studies	O
[	O
10,17	O
]	O
,	O
Fourier	O
analysis	O
was	O
used	O
to	O
eliminate	O
the	O
low-cycling	O
genes	O
.	O

However	C
,	C
several	C
factors	C
,	C
such	C
as	C
biased	C
contribution	C
of	C
synchronization	C
approaches	C
,	C
short	C
duration	C
of	C
the	C
datasets	C
(	C
two	C
cell	C
cycles	C
)	C
and	C
high	C
internal	C
noise	C
can	C
make	C
Fourier	C
analysis	C
fail	C
for	C
many	C
genes	C
,	C
which	C
,	C
in	C
fact	C
,	C
do	C
cycle	C
significantly	C
.	C

In	O
the	O
case	O
of	O
the	O
yeast	O
cell	O
cycle	O
,	O
biological	O
replicates	O
were	O
not	O
available	O
,	O
and	O
standard	O
ANOVA-based	O
filtering	O
could	O
not	O
be	O
applied	O
.	O

Therefore	O
,	O
we	O
designed	O
SNR	O
(	O
Signal-to-Noise	O
Ratio	O
)	O
filter	O
to	O
eliminate	O
noisy	O
and	O
low-cycling	O
profiles	O
.	O

The	O
SNR	O
filter	O
is	O
analogous	O
to	O
ANOVA	O
,	O
but	O
requires	O
no	O
replicates	O
[	O
see	O
Additional	O
file	O
1	O
-	O
Figures	O
S4	O
,	O
S5	O
]	O
(	O
and	O
Methods	O
section	O
)	O
.	O

Statistical	C
model	C
for	C
SNR	C
takes	C
into	C
account	C
assumption	C
that	C
periodically	C
expressed	C
genes	C
would	C
gradually	C
increase	C
or	C
decrease	C
expression	C
level	C
from	C
one	C
time	C
point	C
to	C
another	C
.	C

In	O
mathematical	O
terms	O
,	O
the	O
variance	O
of	O
point-to-point	O
changes	O
in	O
a	O
gene	O
expression	O
profile	O
should	O
be	O
less	O
than	O
the	O
variance	O
of	O
the	O
data	O
itself	O
.	O

The	O
two	O
selected	O
datasets	O
were	O
filtered	O
using	O
the	O
SNR	O
method	O
to	O
remove	O
the	O
low-variance	O
profiles	O
and	O
smoothed	O
using	O
Gaussian	O
method	O
to	O
minimize	O
the	O
internal	O
noise	O
(	O
see	O
Methods	O
section	O
)	O
.	O

The	C
SNR	C
filtering	C
reduced	C
the	C
initial	C
number	C
of	C
the	C
orthologous	C
profile	C
pairs	C
in	C
the	C
selected	C
datasets	C
(	C
α-factor	C
-	C
S.	C
cerevisiae	C
vs.	C
cdc25	C
-	C
S.	C
pombe	C
)	C
to	C
3193	C
or	C
otherwise	C
to	C
2518	C
genes	C
in	C
S.	C
pombe	C
and	C
2169	C
genes	C
in	C
S.	C
cerevisiae	C
(	C
see	C
ortholog	C
matching	C
in	C
Methods	C
)	C
.	C

An	C
apparent	C
contradiction	C
between	C
the	C
previously	C
reported	C
number	C
of	C
cycling	C
genes	C
(	C
500	C
)	C
[	C
18	C
]	C
and	C
the	C
number	C
of	C
genes	C
investigated	C
in	C
this	C
study	C
(	C
>	C
2000	C
)	C
is	C
explained	C
by	C
the	C
fact	C
that	C
all	C
significantly	C
changing	C
profiles	C
(	C
high	C
variance	C
)	C
were	C
scored	C
in	C
our	C
study	C
,	C
even	C
if	C
they	C
displayed	C
moderate	C
Fourier	C
power	C
at	C
the	C
desired	C
period	C
[	C
see	C
Additional	C
file	C
1	C
-	C
Figure	C
S5	C
]	C
.	C

We	C
believe	C
that	C
in	C
most	C
instances	C
low	C
Fourier	C
scores	C
reflected	C
biased	C
expression	C
at	C
the	C
start	C
of	C
the	C
cell	C
culture	C
synchronization	C
,	C
desynchronization	C
of	C
cells	C
after	C
several	C
cycles	C
and/or	C
measurement	C
errors	C
.	C

After	O
removal	O
of	O
the	O
previously	O
reported	O
best	O
cycling	O
500	O
profiles	O
from	O
our	O
dataset	O
,	O
the	O
distance	O
matrix	O
and	O
the	O
alignment	O
did	O
not	O
change	O
significantly	O
[	O
see	O
Additional	O
file	O
1	O
-	O
Figure	O
S6	O
]	O
.	O

This	C
test	C
provided	C
evidence	C
that	C
periodicity	C
is	C
present	C
in	C
the	C
additional	C
genes	C
,	C
as	C
compared	C
to	C
prior	C
studies	C
,	C
although	C
it	C
might	C
be	C
masked	C
by	C
the	C
noise	C
or	C
conditions	C
of	C
the	C
culture	C
synchronization	C
.	C

We	O
also	O
found	O
that	O
Gaussian	O
smoothing	O
significantly	O
improved	O
detection	O
of	O
periodicity	O
in	O
the	O
expression	O
profiles	O
(	O
data	O
not	O
shown	O
)	O
.	O

Time	O
warping	O
results	O

Distance	O
matrices	O
for	O
the	O
full	O
datasets	O
,	O
each	O
spanning	O
approximately	O
2	O
cell	O
cycles	O
,	O
were	O
inspected	O
to	O
identify	O
data	O
ranges	O
,	O
corresponding	O
to	O
a	O
single	O
cell	O
cycle	O
in	O
each	O
species	O
(	O
see	O
Figure	O
1B	O
)	O
.	O

A	O
global	O
alignment	O
path	O
has	O
been	O
constructed	O
using	O
time	O
warping	O
based	O
on	O
Kruscal-Liberman	O
algorithm	O
[	O
6	O
]	O
using	O
Pearson	O
distance	O
matrices	O
(	O
Figure	O
1A	O
,	O
B	O
)	O
.	O

Variations	O
in	O
the	O
data	O
treatment	O
and	O
the	O
Pearson	O
matrix	O
construction	O
parameters	O
produced	O
several	O
possible	O
paths	O
;	O
nevertheless	O
,	O
all	O
successful	O
alignments	O
(	O
gapless	O
or	O
with	O
minimal	O
gaps	O
)	O
followed	O
nearly	O
identical	O
paths	O
[	O
see	O
Additional	O
file	O
1	O
-	O
Figure	O
S7	O
]	O
.	O

Data	O
ranges	O
,	O
corresponding	O
to	O
a	O
single	O
cell	O
cycle	O
were	O
selected	O
based	O
on	O
the	O
periodic	O
patterns	O
observed	O
on	O
the	O
distance	O
matrix	O
and	O
standard	O
cell	O
cycle	O
markers	O
,	O
characteristic	O
to	O
specific	O
phases	O
of	O
the	O
cell	O
cycle	O
[	O
10,17	O
]	O
.	O

The	O
selected	O
data	O
ranges	O
were	O
aligned	O
according	O
to	O
the	O
global	O
alignment	O
path	O
shown	O
in	O
the	O
Figure	O
1C	O
.	O

Time	O
warping	O
for	O
a	O
single	O
cell	O
cycle	O
has	O
clearly	O
shown	O
that	O
the	O
comparative	O
duration	O
of	O
cell	O
cycle	O
phases	O
in	O
the	O
two	O
species	O
is	O
different	O
(	O
see	O
Figure	O
2E	O
)	O
and	O
it	O
is	O
in	O
a	O
good	O
agreement	O
with	O
the	O
existing	O
data	O
[	O
13	O
]	O
.	O

According	O
to	O
the	O
global	O
alignment	O
path	O
,	O
S.	O
pombe	O
has	O
longer	O
G2	O
phase	O
and	O
shorter	O
G1	O
phase	O
.	O

This	O
result	O
supported	O
our	O
computational	O
strategy	O
,	O
selected	O
with	O
respect	O
to	O
the	O
high	O
divergence	O
between	O
the	O
analyzed	O
species	O
.	O

Time	O
warping	O
and	O
concordantly	O
expressed	O
genes	O
.	O

(	O
A	O
,	O
B	O
)	O
Orthologous	O
expression	O
profiles	O
for	O
genes	O
from	O
the	O
two	O
yeast	O
species	O
are	O
superimposed	O
on	O
the	O
absolute	O
timescale	O
,	O
before	O
alignment	O
.	O

The	O
selected	O
data	O
ranges	O
correspond	O
to	O
ranges	O
marked	O
in	O
Figure	O
1B	O
.	O

(	O
C	O
,	O
D	O
)	O
Profiles	O
for	O
the	O
same	O
genes	O
,	O
adjusted	O
according	O
to	O
the	O
global	O
alignment	O
path	O
,	O
(	O
relative	O
time	O
scale	O
)	O
.	O

(	O
E	O
)	O
Correspondence	O
between	O
the	O
cell	O
cycle	O
phases	O
in	O
S.	O
cerevisiae	O
and	O
S.	O
pombe	O
,	O
established	O
based	O
on	O
the	O
global	O
alignment	O
.	O

Notice	O
collapse	O
of	O
M-G1	O
phase	O
and	O
expansion	O
of	O
S-G2	O
phase	O
region	O
in	O
S.	O
pombe	O
.	O

Inspection	O
of	O
orthologous	O
profile	O
pairs	O
in	O
the	O
aligned	O
datasets	O
revealed	O
instances	O
of	O
both	O
concordantly	O
and	O
discordantly	O
expressed	O
genes	O
.	O

518	O
expression	O
profiles	O
,	O
corresponding	O
to	O
approximately	O
~400	O
genes	O
had	O
very	O
similar	O
or	O
nearly	O
identical	O
expression	O
phasing	O
in	O
both	O
organisms	O
.	O

Figure	O
2	O
shows	O
the	O
expression	O
profiles	O
of	O
two	O
orthologous	O
pairs	O
,	O
which	O
appear	O
discordant	O
on	O
the	O
absolute	O
timescale	O
(	O
unaligned	O
)	O
and	O
are	O
nearly	O
identical	O
on	O
the	O
relative	O
timescale	O
,	O
after	O
time	O
warping	O
.	O

DIA2	O
(	O
Figure	O
2A	O
,	O
C	O
)	O
is	O
the	O
origin-binding	O
F-box	O
protein	O
that	O
plays	O
a	O
critical	O
role	O
in	O
DNA	O
replication	O
and	O
maintaining	O
genome	O
integrity	O
.	O

S.	O
cerevisiae	O
strains	O
with	O
DIA2	O
deletions	O
have	O
a	O
high	O
rate	O
of	O
endogenous	O
DNA	O
damage	O
and	O
are	O
defective	O
in	O
S-phase	O
progression	O
[	O
19,20	O
]	O
.	O

Gene	O
pof3	O
,	O
the	O
ortholog	O
of	O
DIA2	O
in	O
S.	O
pombe	O
has	O
a	O
similar	O
function	O
.	O

In	O
pof3	O
mutants	O
the	O
telomeres	O
are	O
substantially	O
shortened	O
and	O
the	O
no	O
rmal	O
telomere	O
transcription/silencing	O
is	O
disrupted	O
[	O
21	O
]	O
.	O

Another	O
example	O
,	O
gene	O
RPS17B	O
(	O
Figure	O
2B	O
,	O
D	O
)	O
encodes	O
the	O
ribosomal	O
protein	O
51	O
(	O
rp51	O
)	O
of	O
the	O
small	O
(	O
40S	O
)	O
subunit	O
and	O
displays	O
concordant	O
expression	O
in	O
the	O
unaligned	O
data	O
sets	O
as	O
well	O
.	O

However	O
,	O
after	O
time	O
warping	O
,	O
the	O
ribosomal	O
protein	O
has	O
identical	O
expression	O
phasing	O
in	O
both	O
yeast	O
species	O
.	O

The	O
majority	O
of	O
other	O
ribosomal	O
genes	O
and	O
genes	O
involved	O
into	O
the	O
ribosome	O
biogenesis	O
also	O
displayed	O
identical	O
phasing	O
of	O
expression	O
in	O
the	O
aligned	O
datasets	O
[	O
see	O
Additional	O
file	O
1	O
-	O
Figure	O
S8	O
]	O
(	O
and	O
Figure	O
3	O
)	O
.	O

Alternative	O
alignment	O
paths	O
and	O
heterochrony	O

Along	O
with	O
the	O
global	O
alignment	O
,	O
alignments	O
for	O
each	O
individual	O
pair	O
of	O
orthologs	O
from	O
the	O
selected	O
datasets	O
were	O
constructed	O
and	O
explored	O
as	O
well	O
.	O

This	O
analysis	O
has	O
shown	O
that	O
the	O
majority	O
of	O
concordantly	O
expressed	O
orthologous	O
genes	O
produced	O
pairwise	O
alignment	O
paths	O
similar	O
to	O
the	O
global	O
one	O
(	O
see	O
examples	O
in	O
Figure	O
2	O
and	O
Figure	O
3C	O
)	O
.	O

At	O
the	O
same	O
time	O
,	O
individual	O
alignments	O
of	O
discordantly	O
expressed	O
ortholog	O
pairs	O
often	O
produced	O
alignment	O
paths	O
different	O
from	O
the	O
global	O
(	O
Figure	O
3A	O
,	O
B	O
)	O
.	O

We	C
explored	C
the	C
pairwise	C
alignments	C
to	C
see	C
whether	C
there	C
are	C
alternative	C
alignment	C
paths	C
,	C
common	C
to	C
certain	C
groups	C
of	C
genes	C
expressed	C
discordantly	C
with	C
respect	C
to	C
the	C
global	C
alignment	C
(	C
idea	C
first	C
proposed	C
by	C
J.	C
Aach	C
and	C
G.	C
Church	C
[	C
1	C
]	C
)	C
.	C

In	O
order	O
to	O
reveal	O
the	O
alternative	O
paths	O
of	O
time	O
warping	O
,	O
all	O
ortholog	O
pairs	O
were	O
aligned	O
one	O
by	O
one	O
,	O
using	O
the	O
Gene-warp	O
program	O
and	O
the	O
resulting	O
individual	O
alignment	O
paths	O
were	O
clustered	O
using	O
k-means	O
clustering	O
with	O
arbitrarily	O
selected	O
number	O
of	O
clusters	O
k	O
=	O
10	O
[	O
14	O
]	O
(	O
see	O
Methods	O
section	O
)	O
.	O

Figure	O
3	O
shows	O
``	O
time	O
clusters	O
''	O
produced	O
by	O
the	O
clustering	O
of	O
individual	O
alignment	O
paths	O
.	O

Technically	O
,	O
each	O
time	O
cluster	O
corresponds	O
to	O
a	O
group	O
of	O
individual	O
profile	O
pairs	O
with	O
similar	O
pairwise	O
time	O
warping	O
.	O

From	C
the	C
biological	C
standpoint	C
,	C
the	C
time	C
clusters	C
correspond	C
to	C
synchronization	C
groups	C
;	C
within	C
each	C
group	C
,	C
the	C
expression	C
synchrony	C
among	C
all	C
genes	C
is	C
maintained	C
during	C
evolution	C
,	C
while	C
synchrony	C
between	C
the	C
groups	C
(	C
time	C
clusters	C
)	C
is	C
apparently	C
lost	C
(	C
see	C
Figure	C
3A-	C
C	C
)	C
.	C

The	O
concordantly	O
expressed	O
genes	O
(	O
regardless	O
of	O
the	O
phasing	O
of	O
their	O
expression	O
)	O
formed	O
the	O
largest	O
time	O
cluster	O
or	O
the	O
largest	O
synchronization	O
group	O
(	O
Figure	O
3C	O
,	O
D	O
)	O
,	O
containing	O
518	O
expression	O
profiles	O
.	O

As	O
expected	O
,	O
the	O
average	O
alignment	O
path	O
of	O
this	O
largest	O
synchronization	O
cluster	O
was	O
close	O
to	O
the	O
global	O
alignment	O
path	O
.	O

Other	O
time	O
clusters	O
revealed	O
different	O
levels	O
of	O
desynchronization	O
with	O
the	O
global	O
path	O
,	O
varying	O
from	O
moderate	O
(	O
see	O
cluster	O
8	O
in	O
Figure	O
3D	O
)	O
to	O
extreme	O
(	O
clusters	O
3	O
and	O
4	O
in	O
Figure	O
3D	O
)	O
.	O

To	O
explore	O
why	O
certain	O
gene	O
groups	O
maintained	O
synchronization	O
in	O
evolution	O
,	O
expression	O
data	O
,	O
composing	O
individual	O
time	O
clusters	O
,	O
have	O
been	O
explored	O
further	O
in	O
S.	O
cerevisiae	O
dataset	O
by	O
consequent	O
clustering	O
of	O
the	O
expression	O
profiles	O
and	O
GO-terms	O
enrichment	O
analysis	O
.	O

It	O
has	O
been	O
found	O
that	O
the	O
largest	O
S.	O
cerevisiae	O
time	O
cluster	O
(	O
Figure	O
3C	O
)	O
matched	O
the	O
global	O
alignment	O
path	O
and	O
contained	O
expression	O
profiles	O
for	O
many	O
ribosomal	O
and	O
replication-related	O
genes	O
(	O
Figure	O
3I	O
,	O
J	O
)	O
[	O
see	O
also	O
Additional	O
file	O
1	O
-	O
Table	O
S1	O
]	O
.	O

Synchronization	C
between	C
the	C
replication	C
machinery	C
,	C
ribosomal	C
and	C
housekeeping	C
genes	C
suggests	C
coordination	C
between	C
the	C
cell	C
division	C
and	C
the	C
cell	C
growth	C
[	C
22	C
]	C
in	C
both	C
yeast	C
species	C
.	C

We	O
also	O
inspected	O
the	O
composition	O
of	O
the	O
time	O
clusters	O
deviating	O
from	O
the	O
global	O
alignment	O
path	O
(	O
Figure	O
3D	O
,	O
clusters	O
0	O
and	O
5	O
)	O
.	O

According	O
to	O
the	O
results	O
of	O
the	O
GO-term	O
enrichment	O
assays	O
,	O
some	O
of	O
these	O
time	O
clusters	O
contained	O
genes	O
involved	O
in	O
respiration	O
and	O
protein	O
synthesis	O
in	O
mitochondria	O
(	O
see	O
Figure	O
3E-H	O
)	O
.	O

Such	C
desynchronization	C
or	C
heterochrony	C
observed	C
between	C
the	C
mitochondrial	C
and	C
the	C
ribosomal/replication	C
genes	C
can	C
be	C
attributed	C
to	C
the	C
semi-autonomy	C
of	C
mitochondria	C
and	C
the	C
mitochondrial	C
gene	C
expression	C
[	C
23	C
]	C
.	C

Mitochondrial	C
biogenesis	C
in	C
S.	C
pombe	C
is	C
more	C
similar	C
to	C
higher	C
eukaryotes	C
[	C
24	C
]	C
,	C
so	C
it	C
is	C
quite	C
possible	C
that	C
the	C
independent	C
synchronization	C
of	C
some	C
mitochondrial	C
genes	C
is	C
maintained	C
in	C
higher	C
eukaryotes	C
as	C
well	C
.	C

According	O
to	O
endosymbiotic	O
theory	O
[	O
25	O
]	O
,	O
mitochondria	O
entered	O
eukaryotic	O
cells	O
nearly	O
a	O
billion	O
years	O
ago	O
.	O

Apparently	C
,	C
since	C
then	C
,	C
some	C
of	C
the	C
mitochondrial	C
pathways	C
(	C
respiration	C
,	C
ribosome	C
biogenesis	C
)	C
maintained	C
their	C
own	C
,	C
internal	C
,	C
synchronization	C
of	C
gene	C
expression	C
.	C

Phase	C
shift	C
in	C
expression	C
of	C
ribosomal	C
and	C
mitochondrial	C
ribosomal	C
genes	C
detected	C
in	C
this	C
study	C
(	C
see	C
Figure	C
3G-J	C
)	C
appears	C
to	C
support	C
hypothesis	C
of	C
decoupling	C
of	C
oxidative	C
and	C
reductive	C
biochemical	C
pathways	C
in	C
the	C
yeast	C
cell	C
cycle	C
[	C
26,27	C
]	C
,	C
and	C
possibly	C
represents	C
an	C
example	C
of	C
heterochrony	C
[	C
28	C
]	C
at	C
the	C
level	C
of	C
gene	C
expression	C
.	C

Time	O
clustering	O
,	O
combined	O
with	O
the	O
consequent	O
profile	O
clustering	O
,	O
helps	O
in	O
the	O
superimposing	O
and	O
interpretation	O
the	O
evolutionary	O
changes	O
in	O
gene	O
expression	O
.	O

Without	O
time	O
clustering	O
[	O
see	O
Additional	O
file	O
1	O
-	O
Figure	O
S9	O
]	O
,	O
superposition	O
of	O
the	O
orthologous	O
profiles	O
is	O
much	O
less	O
informative	O
(	O
compare	O
Figure	O
3E-	O
J	O
with	O
Figure	O
S9	O
D	O
,	O
E	O
)	O
.	O

Conclusion	O

Desynchronization	O
of	O
gene	O
expression	O
in	O
evolution	O

Data	O
selection/filtering	O
and	O
noise	O
suppression	O
strategy	O
made	O
it	O
possible	O
to	O
build	O
a	O
global	O
alignment	O
between	O
very	O
diverse	O
temporal	O
expression	O
data	O
for	O
yeast	O
species	O
,	O
separated	O
by	O
~400	O
million	O
years	O
of	O
evolution	O
.	O

Specifically	O
,	O
it	O
has	O
been	O
found	O
that	O
the	O
Pearson	O
metrics	O
in	O
the	O
context	O
of	O
Kruscal-Liberman	O
time	O
warping	O
enables	O
aligning	O
very	O
diverse	O
time	O
series	O
data	O
.	O

Alignments	O
,	O
constructed	O
for	O
the	O
yeast	O
species	O
have	O
been	O
validated	O
using	O
prior	O
biological	O
knowledge	O
.	O

Recent	C
studies	C
in	C
the	C
evolutionary	C
genomics	C
field	C
suggested	C
presence	C
of	C
conservation	C
between	C
sub	C
domains	C
of	C
large	C
gene	C
networks	C
[	C
29-31	C
]	C
.	C

Preceding	O
genome-wide	O
studies	O
of	O
conserved	O
genetic	O
interactions	O
in	O
S.	O
cerevisiae	O
and	O
S.	O
pombe	O
demonstrated	O
conservation	O
of	O
genetic	O
interactions	O
between	O
particular	O
sets	O
of	O
genes	O
,	O
corresponding	O
to	O
protein	O
complexes	O
or	O
pathways	O
[	O
32	O
]	O
.	O

In	C
this	C
work	C
,	C
comparative	C
analysis	C
of	C
gene	C
expression	C
dynamics	C
has	C
shown	C
that	C
parts	C
of	C
large	C
gene	C
networks	C
(	C
presumably	C
corresponding	C
to	C
time-clusters	C
)	C
maintained	C
substantial	C
temporal	C
synchrony	C
in	C
the	C
course	C
of	C
evolution	C
.	C

The	O
time	O
warping	O
in	O
combination	O
with	O
the	O
path	O
and	O
profile	O
clustering	O
allowed	O
tracing	O
synchronization	O
for	O
some	O
housekeeping	O
,	O
structural	O
and	O
replication	O
genes	O
.	O

However	O
,	O
analysis	O
of	O
regulatory	O
components	O
of	O
cell	O
cycle	O
,	O
such	O
as	O
cyclins	O
,	O
revealed	O
no	O
such	O
synchronization	O
or	O
other	O
shared	O
evolutionary	O
trends	O
(	O
data	O
not	O
shown	O
)	O
.	O

One	C
possible	C
reason	C
for	C
this	C
is	C
the	C
dramatic	C
rewiring	C
of	C
regulatory	C
pathways	C
during	C
evolution	C
.	C

Mathematical	O
strategies	O
,	O
described	O
in	O
the	O
current	O
work	O
,	O
can	O
be	O
applied	O
to	O
comparative	O
analysis	O
of	O
expression	O
data	O
in	O
any	O
pair	O
of	O
organisms	O
,	O
separated	O
by	O
hundreds	O
of	O
millions	O
years	O
of	O
evolution	O
.	O

The	C
following	C
factors	C
may	C
limit	C
the	C
area	C
of	C
application	C
:	C
(	C
i	C
)	C
variability	C
in	C
gene	C
expression	C
under	C
different	C
experimental	C
conditions	C
(	C
synchronization	C
method	C
,	C
[	C
see	C
Additional	C
file	C
1	C
-	C
Figure	C
S10	C
and	C
Table	C
S2	C
]	C
;	C
(	C
ii	C
)	C
strikingly	C
different	C
alternative	C
alignment	C
paths	C
,	C
specific	C
to	C
large	C
group	C
of	C
genes	C
(	C
heterochrony	C
,	C
see	C
Figure	C
3	C
)	C
;	C
(	C
iii	C
)	C
distortion	C
of	C
gene	C
expression	C
profiles	C
as	C
the	C
result	C
of	C
normalization	C
and	C
Gaussian	C
smoothing	C
.	C

Methods	O

Microarray	O
data	O
and	O
low-	O
level	O
data	O
processing	O

All	O
available	O
microarray	O
time-series	O
data	O
sets	O
for	O
S.	O
cerevisiae	O
and	O
S.	O
pombe	O
[	O
10-13,15-17	O
]	O
were	O
downloaded	O
from	O
the	O
author	O
's	O
sources	O
[	O
33	O
]	O
or	O
NCBI	O
GEO	O
database	O
[	O
34	O
]	O
;	O
ortholog	O
tables	O
were	O
obtained	O
from	O
Valerie	O
Wood	O
(	O
Sanger	O
Institute	O
)	O
[	O
35	O
]	O
.	O

In	O
cases	O
where	O
a	O
single	O
gene	O
in	O
one	O
species	O
corresponded	O
to	O
multiple	O
orthologs	O
in	O
another	O
species	O
,	O
multiple	O
profile	O
pairs	O
were	O
generated	O
by	O
duplicating	O
the	O
single	O
expression	O
profile	O
and	O
superimposing	O
it	O
to	O
all	O
matching	O
orthologs	O
.	O

Alignment	O
of	O
data	O
,	O
obtained	O
using	O
different	O
methods	O
of	O
cell	O
synchronization	O
has	O
shown	O
that	O
there	O
is	O
50-80	O
%	O
of	O
consistency	O
between	O
dataset	O
pairs	O
displaying	O
clear	O
periodic	O
patterns	O
[	O
see	O
Additional	O
file	O
1	O
-	O
Figure	O
S10	O
and	O
Table	O
S2	O
]	O
.	O

Low-level	O
data	O
processing	O
included	O
the	O
following	O
steps	O
:	O
signal-to-noise	O
filtering	O
(	O
SNR	O
)	O
,	O
upsampling	O
,	O
Gaussian	O
smoothing	O
and	O
Z-score	O
normalization	O
.	O

Z-score	O
normalization	O
was	O
done	O
using	O
standard	O
methods	O
[	O
36	O
]	O
.	O

Upsampling	O
and	O
Gaussian	O
smoothing	O
were	O
performed	O
in	O
order	O
to	O
reduce	O
noise	O
and	O
improve	O
quality	O
of	O
alignments	O
.	O

Upsampling	C
is	C
a	C
standard	C
way	C
of	C
converting	C
analog	C
signals	C
to	C
digital	C
,	C
new	C
sample	C
rate	C
should	C
be	C
at	C
least	C
2×	C
higher	C
than	C
the	C
highest	C
frequency	C
in	C
the	C
original	C
signal	C
(	C
Nyquist-	C
Shannon	C
sampling	C
theorem	C
)	C
.	C

Accordingly	O
,	O
all	O
input	O
datasets	O
(	O
37	O
time	O
points	O
maximum	O
)	O
were	O
upsampled	O
in	O
this	O
study	O
to	O
100	O
time	O
points	O
.	O

Gaussian	C
filter	C
was	C
used	C
to	C
remove	C
high	C
frequencies	C
,	C
much	C
higher	C
than	C
frequencies	C
related	C
to	C
the	C
cell	C
cycle	C
,	C
assuming	C
that	C
the	C
high	C
frequencies	C
are	C
noise	C
.	C

Together	C
,	C
upsampling	C
and	C
Gaussian	C
filtering	C
might	C
have	C
effects	C
similar	C
to	C
the	C
interpolated	C
time	C
warping	C
described	C
earlier	C
[	C
1	C
]	C
.	C

Attempts	O
to	O
filter	O
out	O
non-periodic	O
profiles	O
using	O
Fourier	O
methods	O
[	O
10	O
]	O
eliminated	O
too	O
many	O
profiles	O
with	O
high	O
variance	O
,	O
which	O
is	O
not	O
surprising	O
given	O
very	O
small	O
number	O
of	O
periods	O
in	O
the	O
microarray	O
data	O
(	O
~2.5	O
)	O
.	O

Therefore	O
,	O
Fourier	O
filter	O
was	O
replaced	O
by	O
signal-to-noise	O
filter	O
(	O
SNR	O
)	O
[	O
see	O
Additional	O
file	O
1	O
-	O
Figure	O
S1	O
]	O
.	O

Original	O
SNR	O
filter	O
based	O
on	O
non-parametric	O
statistics	O
has	O
been	O
designed	O
for	O
the	O
analysis	O
of	O
microarray	O
time	O
series	O
data	O
,	O
which	O
lacks	O
biological	O
replicates	O
.	O

Consider	O
local	O
point-to-point	O
variation	O
Δx	O
between	O
the	O
neighboring	O
time	O
points	O
i	O
and	O
i+1	O
in	O
jth	O
expression	O
profile	O
:	O

If	O
the	O
variance	O
,	O
the	O
noise	O
is	O
high	O
and	O
the	O
profile	O
(	O
probe	O
)	O
needs	O
to	O
be	O
excluded	O
from	O
consideration	O
(	O
see	O
additional	O
file	O
1	O
)	O
.	O

Each	O
expression	O
profile	O
in	O
every	O
data	O
set	O
was	O
scored	O
using	O
the	O
following	O
log-	O
ratio	O
:	O

In	O
this	O
formula	O
,	O
σ2	O
(	O
Αx	O
)	O
(	O
pseudocount	O
)	O
is	O
the	O
average	O
variance	O
of	O
the	O
point-to	O
point	O
variation	O
(	O
noise	O
)	O
taken	O
for	O
all	O
profiles	O
of	O
the	O
entire	O
data	O
set	O
(	O
see	O
eq	O
.	O
S1-S6	O
in	O
the	O
additional	O
file	O
1	O
)	O
.	O

Similarity	O
matrices	O
and	O
Time	O
warping	O

Euclidean	O
similarity	O
matrices	O
take	O
into	O
account	O
only	O
the	O
levels	O
of	O
gene	O
expression	O
at	O
a	O
given	O
time	O
point	O
[	O
1	O
]	O
.	O

We	O
found	O
that	O
this	O
commonly	O
used	O
method	O
failed	O
in	O
the	O
case	O
of	O
alignment	O
between	O
S.	O
cerevisiae	O
and	O
S.	O
pombe	O
[	O
see	O
Additional	O
file	O
1	O
-	O
Figure	O
S2	O
]	O
.	O

To	O
improve	O
sensitivity	O
of	O
time	O
warping	O
,	O
we	O
replaced	O
Euclidean	O
matrices	O
by	O
Pearson	O
similarity	O
matrices	O
.	O

Given	O
time	O
window	O
size	O
parameter	O
n	O
,	O
{	O
n	O
∈	O
(	O
2N	O
+	O
1	O
)	O
{	O
one	O
can	O
compute	O
value	O
of	O
the	O
Uncentered	O
Pearson	O
correlation	O
r	O
for	O
a	O
given	O
kth	O
pair	O
of	O
the	O
orthologous	O
profiles	O
a	O
and	O
b	O
at	O
the	O
time	O
points	O
i	O
and	O
j	O
as	O
follows	O
:	O

This	O
procedure	O
returns	O
agreement	O
between	O
segments	O
of	O
the	O
two	O
profiles	O
,	O
each	O
of	O
length	O
n	O
time	O
points	O
,	O
centered	O
on	O
time	O
point	O
i	O
and	O
j	O
correspondingly	O
.	O

Similarity	O
between	O
the	O
time	O
point	O
i	O
from	O
dataset	O
and	O
the	O
time	O
point	O
j	O
from	O
dataset	O
,	O
for	O
all	O
M	O
pairs	O
of	O
orthologous	O
profiles	O
,	O
was	O
computed	O
as	O
a	O
standard	O
Pearson	O
distance	O
:	O

The	O
Pearson	O
similarity	O
matrices	O
have	O
higher	O
sensitivity	O
and	O
produce	O
better	O
alignments	O
[	O
see	O
Additional	O
file	O
1	O
-	O
Figure	O
S2	O
]	O
(	O
and	O
UC	O
Berkeley	O
web	O
resource	O
)	O
then	O
Euclidean	O
as	O
they	O
collect	O
more	O
information	O
in	O
each	O
point-to-	O
point	O
comparison	O
(	O
see	O
eq	O
.	O
S7-S12	O
in	O
the	O
additional	O
file	O
1	O
for	O
more	O
details	O
)	O
.	O

The	O
described	O
method	O
has	O
been	O
implemented	O
in	O
software	O
package	O
GT-Warp	O
.	O

The	O
package	O
includes	O
the	O
following	O
programs	O
and	O
utilities	O
:	O
``	O
AVF-filer	O
''	O
and	O
``	O
RZ-smooth	O
''	O
are	O
programs	O
for	O
low-level	O
data	O
filtering	O
and	O
processing	O
.	O

These	O
programs	O
include	O
common	O
methods	O
such	O
as	O
Fourier	O
analysis	O
,	O
ANOVA	O
,	O
F-test	O
,	O
Gaussian	O
smoothing	O
,	O
resampling	O
,	O
and	O
normalization	O
.	O

AVF-filer	O
program	O
also	O
includes	O
SNR	O
method	O
described	O
above	O
and	O
``	O
VF-stat	O
''	O
utility	O
for	O
simulating	O
SNR	O
score	O
distribution	O
in	O
random	O
data	O
.	O

The	O
program	O
``	O
Time-warp	O
''	O
incorporates	O
both	O
Euclidean	O
and	O
Pearson	O
methods	O
(	O
see	O
above	O
)	O
,	O
generates	O
global	O
alignment	O
matrices	O
using	O
Kruscal-Liberman	O
algorithm	O
[	O
6	O
]	O
,	O
and	O
has	O
graphical	O
outputs	O
,	O
such	O
as	O
shown	O
in	O
Figure	O
1	O
.	O

The	O
program	O
``	O
Gene-warp	O
''	O
incorporates	O
the	O
same	O
methods	O
and	O
is	O
intended	O
for	O
one-to-one	O
alignment	O
of	O
orthologous	O
profiles	O
.	O

Gene-warp	O
produces	O
alignment	O
paths	O
data	O
,	O
which	O
can	O
be	O
clustered	O
using	O
standard	O
methods	O
,	O
such	O
as	O
Cluster	O
3.0	O
[	O
37	O
]	O
.	O

GT-Warp	O
package	O
also	O
includes	O
program	O
``	O
M-align	O
''	O
for	O
aligning	O
datasets	O
based	O
on	O
matrices	O
produced	O
by	O
Time-warp	O
and	O
a	O
``	O
Prf-browser	O
''	O
to	O
browse	O
and	O
display	O
orthologous	O
profiles	O
on	O
the	O
same	O
plot	O
.	O

GT-Warp	O
package	O
has	O
been	O
written	O
in	O
Perl	O
and	O
compiled	O
for	O
Win32	O
;	O
source	O
code	O
is	O
available	O
upon	O
request	O
,	O
Win32	O
distribution	O
,	O
help	O
,	O
and	O
test	O
files	O
are	O
available	O
from	O
UC	O
Berkeley	O
online	O
resource	O
.	O

Clustering	O
alignment	O
paths	O

Alignment	O
paths	O
for	O
individual	O
profile	O
pairs	O
were	O
generated	O
using	O
Euclidean	O
method	O
(	O
Gene-warp	O
program	O
)	O
.	O

The	O
paths	O
were	O
clustered	O
using	O
K-means	O
clustering	O
method	O
,	O
producing	O
10	O
temporal	O
clusters	O
using	O
Cluster	O
3.0	O
program	O
with	O
default	O
parameter	O
settings	O
[	O
14,37	O
]	O
.	O

S.	O
cerevisiae	O
expression	O
profiles	O
from	O
each	O
temporal	O
cluster	O
(	O
or	O
``	O
time	O
cluster	O
''	O
)	O
were	O
clustered	O
again	O
,	O
using	O
K-mean	O
clustering	O
method	O
,	O
producing	O
10	O
sub-clusters	O
within	O
each	O
of	O
the	O
10	O
time	O
clusters	O
.	O

Enrichment	O
of	O
gene	O
ontology	O
terms	O
in	O
the	O
time	O
clusters	O
and	O
subclusters	O
was	O
carried	O
out	O
using	O
GeneMapp	O
2.0	O
package	O
[	O
38	O
]	O
[	O
see	O
Additional	O
file	O
1	O
-	O
Table	O
S1	O
]	O
.	O

Construction	O
of	O
an	O
annotated	O
corpus	O
to	O
support	O
biomedical	O
information	O
extraction	O

Abstract	O

Background	O

Information	O
Extraction	O
(	O
IE	O
)	O
is	O
a	O
component	O
of	O
text	O
mining	O
that	O
facilitates	O
knowledge	O
discovery	O
by	O
automatically	O
locating	O
instances	O
of	O
interesting	O
biomedical	O
events	O
from	O
huge	O
document	O
collections	O
.	O

As	O
events	O
are	O
usually	O
centred	O
on	O
verbs	O
and	O
nominalised	O
verbs	O
,	O
understanding	O
the	O
syntactic	O
and	O
semantic	O
behaviour	O
of	O
these	O
words	O
is	O
highly	O
important	O
.	O

Corpora	C
annotated	C
with	C
information	C
concerning	C
this	C
behaviour	C
can	C
constitute	C
a	C
valuable	C
resource	C
in	C
the	C
training	C
of	C
IE	C
components	C
and	C
resources	C
.	C

Results	O

We	O
have	O
defined	O
a	O
new	O
scheme	O
for	O
annotating	O
sentence-bound	O
gene	O
regulation	O
events	O
,	O
centred	O
on	O
both	O
verbs	O
and	O
nominalised	O
verbs	O
.	O

For	O
each	O
event	O
instance	O
,	O
all	O
participants	O
(	O
arguments	O
)	O
in	O
the	O
same	O
sentence	O
are	O
identified	O
and	O
assigned	O
a	O
semantic	O
role	O
from	O
a	O
rich	O
set	O
of	O
13	O
roles	O
tailored	O
to	O
biomedical	O
research	O
articles	O
,	O
together	O
with	O
a	O
biological	O
concept	O
type	O
linked	O
to	O
the	O
Gene	O
Regulation	O
Ontology	O
.	O

To	O
our	O
knowledge	O
,	O
our	O
scheme	O
is	O
unique	O
within	O
the	O
biomedical	O
field	O
in	O
terms	O
of	O
the	O
range	O
of	O
event	O
arguments	O
identified	O
.	O

Using	O
the	O
scheme	O
,	O
we	O
have	O
created	O
the	O
Gene	O
Regulation	O
Event	O
Corpus	O
(	O
GREC	O
)	O
,	O
consisting	O
of	O
240	O
MEDLINE	O
abstracts	O
,	O
in	O
which	O
events	O
relating	O
to	O
gene	O
regulation	O
and	O
expression	O
have	O
been	O
annotated	O
by	O
biologists	O
.	O

A	O
novel	O
method	O
of	O
evaluating	O
various	O
different	O
facets	O
of	O
the	O
annotation	O
task	O
showed	O
that	O
average	O
inter-annotator	O
agreement	O
rates	O
fall	O
within	O
the	O
range	O
of	O
66	O
%	O
-	O
90	O
%	O
.	O

Conclusion	O

The	O
GREC	O
is	O
a	O
unique	O
resource	O
within	O
the	O
biomedical	O
field	O
,	O
in	O
that	O
it	O
annotates	O
not	O
only	O
core	O
relationships	O
between	O
entities	O
,	O
but	O
also	O
a	O
range	O
of	O
other	O
important	O
details	O
about	O
these	O
relationships	O
,	O
e.g.	O
,	O
location	O
,	O
temporal	O
,	O
manner	O
and	O
environmental	O
conditions	O
.	O

As	O
such	O
,	O
it	O
is	O
specifically	O
designed	O
to	O
support	O
bio-specific	O
tool	O
and	O
resource	O
development	O
.	O

It	O
has	O
already	O
been	O
used	O
to	O
acquire	O
semantic	O
frames	O
for	O
inclusion	O
within	O
the	O
BioLexicon	O
(	O
a	O
lexical	O
,	O
terminological	O
resource	O
to	O
aid	O
biomedical	O
text	O
mining	O
)	O
.	O

Initial	C
experiments	C
have	C
also	C
shown	C
that	C
the	C
corpus	C
may	C
viably	C
be	C
used	C
to	C
train	C
IE	C
components	C
,	C
such	C
as	C
semantic	C
role	C
labellers	C
.	C

The	O
corpus	O
and	O
annotation	O
guidelines	O
are	O
freely	O
available	O
for	O
academic	O
purposes	O
.	O

Background	O

Due	O
to	O
the	O
rapid	O
advances	O
in	O
biomedical	O
research	O
,	O
scientific	O
literature	O
is	O
being	O
published	O
at	O
an	O
ever-increasing	O
rate	O
[	O
1	O
]	O
.	O

Without	O
automated	O
means	O
,	O
it	O
is	O
difficult	O
for	O
researchers	O
to	O
keep	O
abreast	O
of	O
developments	O
within	O
biomedicine	O
[	O
2-6	O
]	O
.	O

Text	O
mining	O
,	O
which	O
is	O
receiving	O
increasing	O
interest	O
within	O
the	O
biomedical	O
field	O
[	O
7,8	O
]	O
,	O
enriches	O
text	O
via	O
the	O
addition	O
of	O
semantic	O
metadata	O
,	O
and	O
thus	O
permits	O
tasks	O
such	O
as	O
analysing	O
molecular	O
pathways	O
[	O
9	O
]	O
and	O
semantic	O
searching	O
.	O

Semantic	O
searching	O
above	O
the	O
level	O
of	O
concepts	O
depends	O
on	O
prior	O
processing	O
to	O
recognise	O
relations	O
or	O
events	O
in	O
texts	O
,	O
which	O
is	O
carried	O
out	O
by	O
information	O
extraction	O
(	O
IE	O
)	O
systems	O
.	O

Due	O
to	O
domain-specific	O
features	O
of	O
texts	O
and	O
the	O
types	O
of	O
events	O
to	O
be	O
recognised	O
,	O
IE	O
systems	O
must	O
be	O
adapted	O
to	O
deal	O
with	O
specific	O
domains	O
.	O

A	O
well-established	O
method	O
of	O
carrying	O
out	O
this	O
adaptation	O
is	O
through	O
training	O
using	O
annotated	O
corpora	O
(	O
e.g.	O
,	O
[	O
10-12	O
]	O
)	O
.	O

Our	O
work	O
has	O
been	O
concerned	O
with	O
the	O
development	O
of	O
such	O
a	O
corpus	O
for	O
the	O
biomedical	O
field	O
,	O
the	O
Gene	O
Regulation	O
Event	O
Corpus	O
(	O
GREC	O
)	O
,	O
consisting	O
of	O
MEDLINE	O
abstracts	O
semantically	O
annotated	O
with	O
event	O
information	O
.	O

Our	O
approach	O
is	O
based	O
on	O
the	O
fact	O
that	O
many	O
events	O
are	O
focussed	O
on	O
either	O
verbs	O
(	O
e.g.	O
,	O
transcribe	O
,	O
regulate	O
)	O
or	O
nominalised	O
verbs	O
(	O
e.g.	O
,	O
transcription	O
,	O
regulation	O
)	O
.	O

Both	C
types	C
of	C
word	C
behave	C
in	C
similar	C
ways	C
,	C
in	C
that	C
they	C
specify	C
arguments	C
that	C
can	C
convey	C
a	C
range	C
of	C
different	C
types	C
of	C
information	C
related	C
to	C
the	C
event	C
.	C

For	O
each	O
relevant	O
event	O
,	O
our	O
annotation	O
aims	O
to	O
identify	O
,	O
as	O
exhaustively	O
as	O
possible	O
,	O
all	O
structurally-related	O
arguments	O
within	O
the	O
same	O
sentence	O
.	O

Each	O
argument	O
is	O
assigned	O
a	O
semantic	O
role	O
from	O
a	O
fixed	O
set	O
of	O
13	O
roles	O
.	O

Where	O
appropriate	O
,	O
arguments	O
are	O
also	O
assigned	O
a	O
biological	O
concept	O
type	O
.	O

The	O
GREC	O
may	O
be	O
downloaded	O
from	O
http	O
:	O
//www.nactem.ac.uk/GREC/	O
.	O

A	O
copy	O
of	O
the	O
corpus	O
is	O
also	O
available	O
in	O
Additional	O
file	O
1	O
.	O

To	O
our	O
knowledge	O
,	O
the	O
GREC	O
provides	O
the	O
richest	O
annotation	O
to	O
date	O
within	O
the	O
biomedical	O
field	O
,	O
in	O
terms	O
of	O
the	O
number	O
of	O
arguments	O
types	O
and	O
their	O
characterisation	O
.	O

As	O
such	O
,	O
the	O
corpus	O
is	O
specifically	O
designed	O
to	O
contribute	O
to	O
the	O
development	O
of	O
bio-specific	O
semantic	O
frame	O
resources	O
and	O
semantic	O
role	O
labellers	O
(	O
SRLs	O
)	O
which	O
,	O
although	O
active	O
areas	O
of	O
research	O
within	O
the	O
general	O
language	O
domain	O
,	O
have	O
received	O
less	O
attention	O
within	O
the	O
bio-IE	O
domain	O
.	O

Related	O
work	O

Within	O
the	O
field	O
of	O
bio-IE	O
,	O
evaluations	O
such	O
as	O
the	O
LLL05	O
challenge	O
[	O
13	O
]	O
and	O
BioCreative	O
II	O
[	O
14	O
]	O
have	O
focussed	O
attention	O
on	O
the	O
recognition	O
of	O
protein-protein	O
interaction	O
(	O
PPI	O
)	O
events	O
from	O
the	O
literature	O
.	O

There	O
now	O
exists	O
a	O
number	O
of	O
corpora	O
(	O
e.g.	O
,	O
[	O
13,15,16	O
]	O
)	O
and	O
systems	O
(	O
e.g.	O
,	O
[	O
17-19	O
]	O
)	O
tailored	O
to	O
this	O
task	O
.	O

However	O
,	O
many	O
other	O
types	O
of	O
events	O
and	O
information	O
are	O
relevant	O
within	O
biomedicine	O
,	O
such	O
as	O
gene	O
regulation	O
and	O
expression	O
events	O
,	O
location	O
of	O
protein	O
in	O
the	O
cell	O
,	O
protein-DNA	O
interaction	O
,	O
etc	O
.	O
[	O
20	O
]	O
.	O

Extraction	O
of	O
such	O
events	O
often	O
requires	O
the	O
recognition	O
of	O
more	O
complex	O
information	O
than	O
just	O
interacting	O
proteins	O
.	O

Several	O
corpora	O
and	O
systems	O
concerned	O
with	O
the	O
annotation	O
of	O
more	O
complex	O
events	O
have	O
recently	O
been	O
developed	O
,	O
e.g.	O
,	O
[	O
21-24	O
]	O
.	O

These	O
differ	O
in	O
a	O
number	O
of	O
ways	O
,	O
including	O
:	O

•	C
Range	C
of	C
events	C
-	C
whether	C
a	C
single	C
type	C
of	C
event	C
or	C
multiple	C
event	C
types	C
are	C
annotated	C
.	C

•	C
Event	C
arguments	C
-	C
the	C
number	C
and	C
types	C
of	C
arguments	C
(	C
i.e.	C
,	C
participants	C
)	C
in	C
each	C
event	C
may	C
be	C
fixed	C
or	C
flexible	C
.	C

More	C
detailed	C
information	C
types	C
,	C
e.g.	C
,	C
location	C
,	C
time	C
or	C
experimental	C
setup	C
may	C
or	C
may	C
not	C
be	C
identified	C
as	C
event	C
arguments	C
.	C

•	C
Scope	C
of	C
events	C
-	C
whether	C
event	C
arguments	C
must	C
occur	C
within	C
a	C
single	C
sentence	C
or	C
whether	C
they	C
may	C
occur	C
across	C
multiple	C
sentences	C
.	C

•	C
Semantic	C
information	C
assigned	C
to	C
arguments	C
-	C
this	C
may	C
correspond	C
to	C
named	C
entity	C
types	C
and/or	C
semantic	C
roles	C
.	C

In	C
the	C
case	C
of	C
semantic	C
roles	C
being	C
assigned	C
,	C
they	C
may	C
be	C
tailored	C
to	C
a	C
particular	C
type	C
of	C
event	C
,	C
or	C
they	C
may	C
apply	C
to	C
a	C
large	C
range	C
of	C
different	C
events	C
.	C

Whilst	O
events	O
are	O
often	O
identified	O
by	O
verbs	O
,	O
nominalised	O
verbs	O
play	O
a	O
particularly	O
important	O
role	O
within	O
biomedical	O
texts	O
,	O
and	O
often	O
outnumber	O
other	O
domain-specific	O
verbal	O
forms	O
[	O
25	O
]	O
.	O

However	O
,	O
it	O
is	O
acknowledged	O
that	O
they	O
are	O
more	O
difficult	O
to	O
process	O
than	O
verbs	O
[	O
26	O
]	O
and	O
are	O
currently	O
only	O
dealt	O
with	O
by	O
a	O
small	O
number	O
of	O
systems	O
,	O
often	O
in	O
a	O
limited	O
way	O
(	O
e.g.	O
,	O
[	O
17,27,28	O
]	O
)	O
.	O

Due	O
to	O
the	O
central	O
nature	O
of	O
verbs	O
and	O
nominalised	O
verbs	O
in	O
the	O
description	O
of	O
events	O
,	O
accurate	O
event	O
extraction	O
requires	O
information	O
about	O
the	O
way	O
they	O
behave	O
in	O
text	O
,	O
in	O
terms	O
of	O
:	O

•	O
Their	O
syntactically-related	O
arguments	O
,	O
e.g	O
.	O
causality	O
,	O
location	O
,	O
manner	O
,	O
etc	O
.	O

•	O
Semantic	O
information	O
relating	O
to	O
each	O
argument	O
(	O
e.g.	O
,	O
semantic	O
roles	O
or	O
restrictions	O
on	O
the	O
types	O
of	O
phrase	O
that	O
can	O
constitute	O
each	O
argument	O
)	O
.	O

The	O
production	O
of	O
corpora	O
annotated	O
with	O
such	O
information	O
allows	O
real	O
usage	O
within	O
text	O
to	O
be	O
taken	O
into	O
account	O
.	O

Large-scale	O
annotation	O
of	O
corpora	O
within	O
the	O
general	O
language	O
domain	O
at	O
this	O
level	O
of	O
detail	O
has	O
resulted	O
in	O
the	O
production	O
of	O
resources	O
containing	O
syntactic	O
and	O
semantic	O
frame	O
information	O
,	O
which	O
deal	O
with	O
both	O
verbs	O
and	O
nominalised	O
verbs	O
[	O
29-32	O
]	O
.	O

Such	O
annotated	O
corpora	O
also	O
facilitate	O
the	O
training	O
of	O
components	O
of	O
IE	O
systems	O
,	O
with	O
a	O
large	O
amount	O
of	O
research	O
having	O
been	O
devoted	O
to	O
semantic	O
role	O
labelling	O
(	O
SRL	O
)	O
[	O
33	O
]	O
.	O

Some	C
studies	C
(	C
e.g.	C
,	C
[	C
34,35	C
]	C
)	C
have	C
shown	C
that	C
,	C
to	C
a	C
certain	C
extent	C
,	C
general	C
language	C
resources	C
can	C
also	C
be	C
useful	C
in	C
the	C
training	C
of	C
SRLs	C
for	C
biomedical	C
texts	C
,	C
due	C
to	C
the	C
fact	C
that	C
many	C
verbs	C
appear	C
in	C
texts	C
from	C
both	C
the	C
general	C
language	C
and	C
biomedical	C
domains	C
,	C
and	C
often	C
behave	C
in	C
similar	C
ways	C
.	C

However	C
,	C
the	C
cited	C
works	C
concede	C
that	C
,	C
whilst	C
such	C
SRLs	C
may	C
produce	C
adequate	C
results	C
for	C
certain	C
predicates	C
,	C
training	C
using	C
biomedical	C
corpora	C
is	C
also	C
needed	C
.	C

This	O
is	O
because	O
domains	O
such	O
as	O
biomedicine	O
employ	O
sublanguages	O
[	O
36	O
]	O
,	O
in	O
which	O
the	O
``	O
informational	O
content	O
and	O
structure	O
form	O
a	O
specialized	O
language	O
that	O
can	O
be	O
delineated	O
in	O
the	O
form	O
of	O
a	O
sublanguage	O
grammar	O
''	O
.	O

NLP	O
systems	O
must	O
take	O
such	O
grammars	O
into	O
account	O
to	O
allow	O
accurate	O
processing	O
of	O
text	O
within	O
specialist	O
domains	O
[	O
37	O
]	O
.	O

Sublanguage	O
grammar	O
features	O
that	O
are	O
relevant	O
to	O
our	O
work	O
include	O
the	O
following	O
:	O

•	O
The	O
types	O
of	O
events	O
found	O
in	O
biological	O
sciences	O
are	O
often	O
described	O
using	O
verbs/nominalised	O
verbs	O
that	O
do	O
not	O
feature	O
prominently	O
in	O
general	O
language	O
[	O
26	O
]	O
,	O
e.g.	O
,	O
methylate	O
.	O

•	C
Verbs/nominalised	C
verbs	C
that	C
occur	C
in	C
both	C
the	C
general	C
and	C
specialised	C
language	C
domains	C
may	C
have	C
different	C
syntactic	C
and	C
semantic	C
properties	C
in	C
each	C
domain	C
,	C
e.g.	C
,	C
differing	C
numbers	C
of	C
arguments	C
[	C
38	C
]	C
,	C
as	C
well	C
as	C
different	C
meanings	C
.	C

For	O
example	O
,	O
translation	O
generally	O
means	O
rendering	O
one	O
language	O
into	O
other	O
,	O
while	O
in	O
Molecular	O
Biology	O
it	O
specifies	O
the	O
process	O
of	O
protein	O
synthesis	O
from	O
an	O
mRNA	O
template	O
.	O

Whilst	O
there	O
have	O
been	O
some	O
attempts	O
to	O
produce	O
bio-specific	O
extensions	O
to	O
the	O
general	O
language	O
resources	O
described	O
above	O
,	O
e.g.	O
,	O
[	O
38,39	O
]	O
,	O
together	O
with	O
semantic	O
role	O
labellers	O
[	O
20,40	O
]	O
,	O
they	O
currently	O
have	O
limited	O
coverage	O
.	O

The	O
UMLS	O
SPECIALIST	O
lexicon	O
[	O
41	O
]	O
,	O
which	O
includes	O
many	O
biomedical	O
terms	O
,	O
is	O
larger	O
scale	O
,	O
but	O
includes	O
only	O
syntactic	O
,	O
and	O
not	O
semantic	O
,	O
information	O
about	O
verbs	O
.	O

Motivation	O

Existing	O
event	O
corpora	O
within	O
the	O
domain	O
(	O
e.g.	O
,	O
[	O
21	O
]	O
and	O
[	O
23	O
]	O
)	O
are	O
not	O
specifically	O
geared	O
to	O
support	O
the	O
acquisition	O
of	O
semantic	O
frame	O
information	O
for	O
verbs	O
.	O

The	O
bio-NLP	O
community	O
has	O
,	O
until	O
now	O
,	O
lacked	O
a	O
domain-specific	O
linguistically-oriented	O
corpus	O
in	O
which	O
detailed	O
semantic	O
information	O
for	O
a	O
wide	O
range	O
of	O
both	O
verbs	O
and	O
nominalised	O
verbs	O
has	O
been	O
annotated	O
.	O

This	O
has	O
limited	O
the	O
amount	O
of	O
research	O
undertaken	O
on	O
the	O
production	O
of	O
domain-specific	O
semantic	O
frame	O
resources	O
and	O
SRLs	O
.	O

In	O
response	O
to	O
this	O
,	O
we	O
have	O
designed	O
a	O
new	O
event	O
annotation	O
scheme	O
which	O
is	O
specifically	O
tailored	O
to	O
this	O
purpose	O
.	O

The	O
scheme	O
has	O
subsequently	O
been	O
applied	O
to	O
the	O
annotation	O
of	O
event	O
instances	O
relating	O
to	O
gene	O
regulation	O
and	O
expression	O
in	O
MEDLINE	O
abstracts	O
.	O

Our	O
scheme	O
differs	O
from	O
those	O
of	O
previous	O
event	O
corpora	O
in	O
the	O
field	O
in	O
a	O
number	O
of	O
important	O
ways	O
:	O

•	O
It	O
captures	O
the	O
semantic	O
annotation	O
of	O
as	O
many	O
structurally-related	O
arguments	O
as	O
possible	O
of	O
a	O
large	O
number	O
of	O
verbs	O
and	O
nominalised	O
verbs	O
describing	O
gene	O
regulation	O
and	O
expression	O
events	O
.	O

This	C
is	C
important	C
since	C
,	C
according	C
to	C
[	C
20	C
]	C
,	C
and	C
as	C
confirmed	C
by	C
us	C
through	C
consultation	C
with	C
biologists	C
,	C
types	C
of	C
information	C
such	C
as	C
location	C
,	C
manner	C
,	C
timing	C
and	C
condition	C
,	C
which	C
can	C
appear	C
in	C
various	C
syntactic	C
positions	C
,	C
are	C
all	C
essential	C
for	C
describing	C
biomedical	C
relations	C
.	C

A	O
sentence-based	O
approach	O
facilitates	O
the	O
linking	O
between	O
semantic	O
information	O
and	O
syntactic	O
structure	O
.	O

•	O
It	O
bridges	O
linguistic	O
and	O
biological	O
knowledge	O
:	O

From	O
the	O
linguistic	O
perspective	O
,	O
all	O
arguments	O
are	O
characterised	O
using	O
semantic	O
roles	O
.	O

We	O
have	O
defined	O
a	O
new	O
,	O
closed	O
set	O
of	O
event-independent	O
roles	O
which	O
are	O
designed	O
for	O
application	O
to	O
arguments	O
of	O
a	O
range	O
of	O
types	O
of	O
biomedical	O
events	O
.	O

Closed	O
sets	O
of	O
semantic	O
roles	O
are	O
advantageous	O
in	O
that	O
they	O
facilitate	O
generalization	O
over	O
different	O
types	O
of	O
events	O
[	O
25,42	O
]	O
.	O

Although	C
their	C
application	C
to	C
general	C
language	C
may	C
be	C
problematic	C
[	C
30	C
]	C
,	C
the	C
use	C
of	C
a	C
closed	C
set	C
is	C
viable	C
in	C
a	C
restricted	C
domain	C
,	C
as	C
domain-specific	C
definitions	C
can	C
be	C
provided	C
for	C
each	C
semantic	C
role	C
type	C
.	C

From	O
the	O
biological	O
perspective	O
,	O
appropriate	O
arguments	O
are	O
additionally	O
assigned	O
a	O
biological	O
concept	O
type	O
from	O
a	O
hierarchically-structured	O
set	O
that	O
is	O
tailored	O
to	O
the	O
gene	O
regulation	O
domain	O
.	O

The	O
concepts	O
are	O
mapped	O
to	O
classes	O
in	O
the	O
Gene	O
Regulation	O
Ontology	O
(	O
GRO	O
)	O
[	O
43	O
]	O
.	O

The	O
combination	O
of	O
semantic	O
role	O
and	O
biological	O
concept	O
labels	O
provides	O
a	O
rich	O
annotation	O
,	O
aimed	O
at	O
allowing	O
users	O
to	O
have	O
a	O
large	O
amount	O
of	O
flexibility	O
over	O
the	O
type	O
of	O
query	O
they	O
specify	O
and	O
to	O
have	O
control	O
over	O
the	O
specificity	O
or	O
generality	O
of	O
certain	O
parts	O
of	O
the	O
query	O
,	O
e.g	O
.	O
:	O

In	O
LOCATION	O
:	O
E.	O
coli	O
,	O
AGENT	O
:	O
NifA	O
activates	O
which	O
THEME	O
:	O
GENE	O
.	O

This	O
query	O
would	O
search	O
for	O
instances	O
of	O
events	O
in	O
which	O
a	O
LOCATION	O
,	O
AGENT	O
and	O
THEME	O
are	O
specified	O
.	O

The	C
values	C
of	C
the	C
semantic	C
roles	C
may	C
be	C
specified	C
either	C
as	C
specific	C
words	C
or	C
phrases	C
(	C
e.g.	C
,	C
E.	C
coli	C
or	C
NifA	C
)	C
or	C
more	C
general	C
named	C
entity	C
categories	C
(	C
e.g.	C
,	C
GENE	C
)	C
.	C

The	O
GREC	O
consists	O
of	O
240	O
MEDLINE	O
abstracts	O
,	O
which	O
have	O
been	O
annotated	O
with	O
a	O
total	O
of	O
3067	O
events	O
.	O

Whilst	O
of	O
modest	O
size	O
compared	O
to	O
some	O
other	O
domain-specific	O
event-annotated	O
corpora	O
(	O
e.g.	O
,	O
[	O
21	O
]	O
)	O
,	O
this	O
is	O
balanced	O
by	O
the	O
richness	O
of	O
the	O
annotations	O
.	O

The	O
corpus	O
has	O
already	O
been	O
used	O
in	O
the	O
development	O
of	O
the	O
BioLexicon	O
[	O
44	O
]	O
.	O

This	O
unique	O
text	O
mining	O
resource	O
for	O
biology	O
provides	O
and	O
links	O
syntactic	O
and	O
semantic	O
frame	O
information	O
for	O
a	O
large	O
number	O
of	O
biomedical	O
sublanguage	O
verbs	O
.	O

In	O
addition	O
,	O
the	O
lexicon	O
contains	O
(	O
1	O
)	O
derived	O
forms	O
of	O
these	O
verbs	O
(	O
including	O
nominalisations	O
)	O
,	O
(	O
2	O
)	O
general	O
English	O
words	O
frequently	O
used	O
within	O
the	O
biology	O
domain	O
and	O
(	O
3	O
)	O
domain	O
terms	O
,	O
gathered	O
(	O
and	O
interlinked	O
)	O
both	O
from	O
existing	O
databases	O
and	O
through	O
the	O
application	O
of	O
text	O
mining	O
techniques	O
.	O

Initial	C
machine	C
learning	C
experiments	C
using	C
the	C
GREC	C
[	C
45	C
]	C
suggest	C
that	C
it	C
can	C
be	C
used	C
to	C
train	C
IE	C
components	C
with	C
reasonably	C
good	C
performance	C
,	C
with	C
both	C
named	C
entity	C
extraction	C
and	C
semantic	C
role	C
labelling	C
having	C
achieved	C
F-scores	C
of	C
around	C
60	C
%	C
,	C
based	C
on	C
10-fold	C
cross	C
validation	C
.	C

A	C
further	C
direction	C
of	C
research	C
which	C
could	C
help	C
to	C
improve	C
the	C
performance	C
of	C
IE	C
systems	C
trained	C
on	C
the	C
GREC	C
is	C
introduced	C
in	C
[	C
46	C
]	C
,	C
in	C
which	C
it	C
is	C
demonstrated	C
that	C
,	C
due	C
to	C
the	C
differing	C
perspectives	C
of	C
different	C
annotation	C
schemes	C
,	C
it	C
is	C
not	C
always	C
the	C
case	C
that	C
larger	C
corpora	C
contain	C
the	C
most	C
useful	C
information	C
.	C

The	C
reported	C
study	C
found	C
that	C
,	C
whilst	C
small	C
corpora	C
may	C
not	C
be	C
large	C
enough	C
to	C
train	C
IE	C
systems	C
in	C
their	C
own	C
right	C
,	C
augmenting	C
such	C
corpora	C
with	C
training	C
instances	C
derived	C
from	C
other	C
corpora	C
can	C
help	C
to	C
improve	C
the	C
performance	C
of	C
the	C
trained	C
system	C
.	C

This	C
provides	C
convincing	C
evidence	C
that	C
combining	C
smaller	C
,	C
richly	C
annotated	C
corpora	C
,	C
such	C
as	C
our	C
own	C
,	C
with	C
larger	C
corpora	C
which	C
are	C
slightly	C
poorer	C
in	C
information	C
content	C
,	C
could	C
provide	C
a	C
future	C
direction	C
of	C
research	C
for	C
training	C
more	C
accurate	C
biomedical	C
IE	C
systems	C
.	C

This	C
idea	C
is	C
especially	C
attractive	C
,	C
given	C
that	C
the	C
production	C
of	C
large	C
,	C
richly	C
annotated	C
corpora	C
can	C
be	C
very	C
time	C
consuming	C
.	C

In	O
the	O
remainder	O
of	O
this	O
paper	O
,	O
we	O
firstly	O
cover	O
the	O
key	O
aspects	O
of	O
our	O
annotation	O
scheme	O
,	O
followed	O
by	O
a	O
description	O
of	O
the	O
recruitment	O
and	O
training	O
of	O
annotators	O
.	O

We	O
follow	O
this	O
by	O
providing	O
detailed	O
statistics	O
,	O
results	O
and	O
evaluation	O
of	O
the	O
GREC	O
,	O
and	O
finally	O
present	O
some	O
conclusions	O
and	O
directions	O
for	O
further	O
research	O
.	O

Methods	O

This	O
section	O
is	O
concerned	O
with	O
the	O
preparatory	O
work	O
required	O
prior	O
to	O
the	O
annotation	O
of	O
the	O
GREC	O
.	O

Beginning	O
with	O
a	O
clarification	O
of	O
our	O
notion	O
of	O
an	O
event	O
,	O
we	O
then	O
provide	O
a	O
description	O
of	O
the	O
key	O
features	O
of	O
our	O
annotation	O
scheme	O
.	O

A	O
brief	O
overview	O
of	O
the	O
annotation	O
software	O
used	O
and	O
of	O
its	O
customisation	O
is	O
followed	O
by	O
details	O
regarding	O
the	O
annotators	O
and	O
their	O
training	O
.	O

As	O
performance	O
during	O
training	O
was	O
measured	O
quantitively	O
through	O
the	O
calculation	O
of	O
inter-annotator	O
agreement	O
(	O
IAA	O
)	O
scores	O
following	O
each	O
cycle	O
of	O
training	O
,	O
we	O
provide	O
details	O
and	O
motivation	O
for	O
our	O
chosen	O
evaluation	O
metric	O
,	O
the	O
F-measure	O
.	O

Finally	O
,	O
we	O
provide	O
an	O
analysis	O
of	O
the	O
IAA	O
results	O
attained	O
during	O
training	O
.	O

Events	O
in	O
biomedical	O
texts	O

In	O
this	O
section	O
,	O
we	O
clarify	O
our	O
notion	O
of	O
an	O
event	O
.	O

Firstly	O
,	O
we	O
provide	O
some	O
simple	O
examples	O
of	O
event	O
instances	O
that	O
relate	O
to	O
gene	O
regulation	O
and	O
expression	O
within	O
biomedical	O
texts	O
:	O

1	C
)	C
In	C
Escherichia	C
Coli	C
,	C
glnAP2	C
may	C
be	C
activated	C
by	C
NifA	C
.	C

2	O
)	O
Our	O
results	O
show	O
that	O
glnA	O
encodes	O
glutamine	O
synthetase	O
.	O

For	C
each	C
event	C
,	C
two	C
types	C
of	C
information	C
may	C
be	C
specified	C
in	C
the	C
text	C
,	C
both	C
of	C
which	C
are	C
important	C
to	C
its	C
correct	C
interpretation	C
:	C

•	O
The	O
participants	O
(	O
or	O
arguments	O
)	O
of	O
the	O
event	O
.	O

In	O
sentence	O
1	O
)	O
,	O
there	O
are	O
3	O
arguments	O
specified	O
by	O
the	O
verb	O
activated	O
,	O
i.e.	O
,	O
In	O
Escherichia	O
Coli	O
,	O
glnAP2	O
and	O
NifA	O
.	O

•	C
Higher	C
level	C
information	C
(	C
called	C
modality	C
)	C
about	C
how	C
the	C
event	C
should	C
be	C
interpreted	C
.	C

For	O
example	O
,	O
the	O
word	O
may	O
in	O
sentence	O
1	O
)	O
indicates	O
that	O
there	O
is	O
some	O
uncertainty	O
about	O
the	O
truth	O
of	O
the	O
event	O
,	O
whilst	O
the	O
phrase	O
Our	O
results	O
show	O
that	O
in	O
2	O
)	O
indicates	O
that	O
there	O
is	O
experimental	O
evidence	O
to	O
back	O
up	O
the	O
event	O
described	O
by	O
encodes	O
.	O

Several	O
recent	O
articles	O
(	O
e.g.	O
,	O
[	O
47-51	O
]	O
)	O
have	O
reported	O
on	O
attempts	O
to	O
annotate	O
information	O
such	O
as	O
certainty	O
,	O
evidence	O
or	O
negation	O
within	O
biomedical	O
texts	O
.	O

Our	O
current	O
work	O
concerns	O
the	O
first	O
of	O
these	O
information	O
types	O
.	O

Specifically	O
,	O
the	O
annotation	O
task	O
consists	O
of	O
the	O
following	O
,	O
in	O
sequence	O
:	O

a	O
)	O
Identifying	O
relevant	O
instances	O
of	O
events	O
that	O
relate	O
to	O
gene	O
regulation	O
and	O
expression	O
.	O

b	O
)	O
Identifying	O
all	O
arguments	O
of	O
the	O
event	O
that	O
are	O
specified	O
within	O
the	O
same	O
sentence	O
.	O

c	O
)	O
Finally	O
,	O
assigning	O
semantic	O
roles	O
and	O
biological	O
concepts	O
to	O
these	O
arguments	O
.	O

Table	O
1	O
illustrates	O
the	O
type	O
of	O
information	O
that	O
would	O
be	O
annotated	O
for	O
sentences	O
1	O
)	O
and	O
2	O
)	O
above	O
.	O

Example	O
annotation	O
output	O

Annotation	O
scheme	O

In	O
this	O
section	O
,	O
we	O
outline	O
some	O
key	O
aspects	O
of	O
the	O
annotation	O
scheme	O
.	O

Firstly	O
,	O
we	O
describe	O
the	O
types	O
of	O
events	O
on	O
which	O
the	O
annotation	O
is	O
focussed	O
,	O
i.e.	O
,	O
gene	O
regulation	O
and	O
expression	O
.	O

This	O
is	O
followed	O
by	O
a	O
more	O
detailed	O
description	O
of	O
the	O
semantic	O
roles	O
and	O
biological	O
concepts	O
assigned	O
to	O
event	O
arguments	O
.	O

Finally	O
,	O
we	O
provide	O
an	O
account	O
of	O
some	O
of	O
the	O
steps	O
taken	O
to	O
ensure	O
the	O
consistency	O
of	O
annotated	O
text	O
spans	O
.	O

To	O
accompany	O
the	O
annotation	O
scheme	O
,	O
we	O
have	O
produced	O
a	O
detailed	O
set	O
of	O
annotation	O
guidelines	O
,	O
as	O
these	O
are	O
necessary	O
to	O
aid	O
in	O
the	O
achievement	O
of	O
high	O
quality	O
annotations	O
[	O
52-54	O
]	O
.	O

The	O
structure	O
and	O
content	O
of	O
these	O
guidelines	O
were	O
iteratively	O
refined	O
in	O
discussion	O
with	O
domain	O
experts	O
and	O
with	O
annotators	O
(	O
via	O
group	O
discussion	O
sessions	O
following	O
annotation	O
training	O
phrases	O
and	O
full	O
annotation	O
cycles	O
)	O
.	O

The	O
guidelines	O
are	O
available	O
to	O
download	O
from	O
http	O
:	O
//www.nactem.ac.uk/GREC/	O
,	O
and	O
are	O
also	O
available	O
in	O
Additional	O
file	O
1	O
.	O

Gene	O
regulation	O
and	O
expression	O
events	O

The	C
current	C
annotation	C
effort	C
is	C
concerned	C
with	C
events	C
relating	C
only	C
to	C
gene	C
regulation	C
or	C
expression	C
,	C
i.e.	C
,	C
events	C
that	C
describe	C
any	C
interaction	C
which	C
leads	C
,	C
either	C
directly	C
or	C
indirectly	C
,	C
to	C
the	C
production	C
of	C
a	C
protein	C
.	C

Annotation	O
is	O
restricted	O
to	O
sentences	O
that	O
contain	O
some	O
mechanical	O
description	O
of	O
transcription	O
,	O
translation	O
or	O
post-transcriptional	O
modifications	O
and/or	O
their	O
controls	O
.	O

Annotators	C
were	C
helped	C
by	C
(	C
but	C
not	C
restricted	C
to	C
)	C
a	C
list	C
of	C
verbs	C
which	C
we	C
created	C
that	C
potentially	C
denote	C
gene	C
regulation	C
and	C
expression	C
events	C
.	C

These	O
are	O
automatically	O
highlighted	O
by	O
the	O
annotation	O
software	O
,	O
WordFreak	O
(	O
see	O
Software	O
section	O
below	O
)	O
,	O
in	O
each	O
abstract	O
to	O
be	O
annotated	O
.	O

The	O
basis	O
of	O
this	O
list	O
was	O
a	O
set	O
of	O
229	O
hand-picked	O
gene	O
regulation	O
verbs	O
provided	O
by	O
the	O
European	O
Bioinformatics	O
Institute	O
(	O
EMBL-EBI	O
)	O
.	O

We	O
augmented	O
this	O
list	O
through	O
the	O
automatic	O
extraction	O
of	O
further	O
verbs	O
from	O
an	O
E.	O
coli	O
corpus	O
.	O

This	O
corpus	O
contains	O
approximately	O
33,000	O
MEDLINE	O
abstracts	O
and	O
was	O
also	O
provided	O
by	O
EMBL-EBI	O
.	O

The	C
automatic	C
extraction	C
was	C
carried	C
out	C
by	C
identifying	C
those	C
verbs	C
whose	C
syntactic	C
arguments	C
corresponded	C
either	C
to	C
terms	C
identified	C
by	C
the	C
TerMine	C
tool	C
(	C
http	C
:	C
//www.nactem.ac.uk/software/termine/	C
)	C
or	C
biological	C
named	C
entities	C
identified	C
by	C
the	C
GENIA	C
tagger	C
[	C
55	C
]	C
.	C

The	O
complete	O
list	O
was	O
subsequently	O
reviewed	O
for	O
relevance	O
by	O
a	O
biology	O
expert	O
,	O
resulting	O
in	O
a	O
list	O
of	O
353	O
verbs	O
.	O

Semantic	O
roles	O

Starting	O
with	O
the	O
generic	O
semantic	O
roles	O
proposed	O
for	O
VerbNet	O
[	O
29	O
]	O
and	O
PropBank	O
[	O
30	O
]	O
,	O
we	O
examined	O
a	O
large	O
number	O
of	O
relevant	O
events	O
within	O
MEDLINE	O
abstracts	O
,	O
in	O
consultation	O
with	O
biologists	O
.	O

We	C
concluded	C
that	C
arguments	C
of	C
gene	C
regulation	C
and	C
expression	C
events	C
may	C
be	C
characterised	C
using	C
a	C
subset	C
of	C
these	C
general	C
language	C
roles	C
,	C
with	C
the	C
addition	C
of	C
the	C
domain-specific	C
CONDITION	C
role	C
.	C

In	O
some	O
cases	O
,	O
we	O
changed	O
the	O
names	O
of	O
the	O
roles	O
used	O
in	O
other	O
resources	O
in	O
an	O
attempt	O
to	O
make	O
them	O
more	O
easily	O
understandable	O
to	O
biologist	O
annotators	O
.	O

From	O
VerbNet	O
,	O
we	O
have	O
used	O
the	O
roles	O
AGENT	O
,	O
THEME	O
,	O
INSTRUMENT	O
,	O
LOCATION	O
,	O
SOURCE	O
and	O
DESTINATION	O
.	O

Our	O
RATE	O
and	O
TEMPORAL	O
roles	O
are	O
based	O
on	O
the	O
VerbNet	O
EXTENT	O
and	O
TIME	O
roles	O
,	O
respectively	O
.	O

MANNER	O
and	O
PURPOSE	O
come	O
from	O
PropBank	O
's	O
set	O
of	O
general	O
roles	O
that	O
are	O
applicable	O
to	O
any	O
verb	O
.	O

We	O
also	O
saw	O
a	O
need	O
for	O
a	O
role	O
similar	O
to	O
the	O
VerbNet	O
PREDICATE	O
role	O
,	O
to	O
deal	O
with	O
cases	O
such	O
as	O
:	O

The	O
(	O
cAMP	O
)	O
-cAMP	O
receptor	O
protein	O
complex	O
functions	O
as	O
an	O
activator	O
...	O
,	O
where	O
an	O
activator	O
corresponds	O
to	O
the	O
PREDICATE	O
role	O
of	O
functions	O
.	O

For	C
our	C
own	C
purposes	C
,	C
we	C
created	C
2	C
separate	C
roles	C
,	C
DESCRIPTIVE-AGENT	C
and	C
DESCRIPTIVE-THEME	C
,	C
and	C
extended	C
the	C
characterisation	C
of	C
these	C
roles	C
to	C
apply	C
not	C
only	C
to	C
predicatives	C
,	C
but	C
also	C
to	C
any	C
argument	C
which	C
describes	C
characteristics	C
or	C
behaviour	C
of	C
either	C
the	C
AGENT	C
or	C
the	C
THEME	C
of	C
the	C
event	C
.	C

The	O
full	O
set	O
of	O
roles	O
is	O
shown	O
in	O
Table	O
2	O
.	O

In	C
general	C
,	C
definitions	C
of	C
argument	C
types	C
normally	C
specified	C
as	C
adjuncts	C
,	C
such	C
as	C
MANNER	C
,	C
INSTRUMENT	C
,	C
CONDITION	C
and	C
LOCATION	C
,	C
can	C
be	C
problematic	C
to	C
distinguish	C
from	C
each	C
other	C
.	C

However	O
,	O
our	O
use	O
of	O
more	O
biologically-oriented	O
definitions	O
for	O
these	O
cases	O
aims	O
to	O
reduce	O
discrepancies	O
.	O

Semantic	O
roles	O

Biological	O
concepts	O

Our	O
biological	O
concept	O
labels	O
are	O
organised	O
into	O
hierarchies	O
based	O
on	O
the	O
Gene	O
Regulation	O
Ontology	O
(	O
GRO	O
)	O
[	O
43	O
]	O
.	O

This	O
ontology	O
,	O
which	O
integrates	O
and	O
builds	O
on	O
parts	O
of	O
other	O
established	O
bio-ontologies	O
,	O
such	O
as	O
Gene	O
Ontology	O
[	O
56	O
]	O
and	O
Sequence	O
Ontology	O
[	O
57	O
]	O
,	O
is	O
also	O
included	O
within	O
the	O
list	O
of	O
ontologies	O
of	O
the	O
OBO	O
Foundry	O
[	O
58	O
]	O
.	O

Our	O
biological	O
concept	O
labels	O
are	O
arranged	O
within	O
5	O
different	O
hierarchies	O
,	O
corresponding	O
to	O
the	O
following	O
supercategories	O
:	O
Nucleic_Acids	O
,	O
Proteins	O
,	O
Living_Systems	O
,	O
Processes	O
and	O
Experimental	O
.	O

During	O
annotation	O
,	O
biological	O
concepts	O
are	O
identified	O
within	O
each	O
semantic	O
argument	O
.	O

In	O
each	O
case	O
,	O
the	O
most	O
specific	O
concept	O
category	O
possible	O
within	O
the	O
appropriate	O
hierarchy	O
is	O
assigned	O
,	O
based	O
on	O
the	O
context	O
in	O
which	O
the	O
concept	O
occurs	O
.	O

The	C
aim	C
of	C
this	C
is	C
to	C
allow	C
queries	C
over	C
extracted	C
event	C
instances	C
to	C
be	C
performed	C
at	C
different	C
levels	C
of	C
granularity	C
,	C
i.e.	C
,	C
users	C
could	C
specify	C
more	C
general	C
or	C
less	C
general	C
concept	C
types	C
according	C
to	C
their	C
requirements	C
.	C

Consider	O
the	O
following	O
example	O
:	O

To	O
map	O
the	O
regulatory	O
domain	O
of	O
Escherichia	O
coli	O
T-protein	O
...	O

Here	O
,	O
it	O
is	O
possible	O
to	O
assign	O
the	O
specific	O
concept	O
category	O
Domain	O
(	O
within	O
the	O
Proteins	O
hierarchy	O
)	O
to	O
the	O
concept	O
the	O
regulatory	O
domain	O
,	O
which	O
is	O
a	O
functional	O
part	O
of	O
a	O
protein	O
.	O

However	O
,	O
the	O
following	O
example	O
presents	O
a	O
greater	O
challenge	O
:	O

IHF	C
may	C
inhibit	C
ompF	C
transcription	C
by	C
altering	C
how	C
OmpR	C
interacts	C
with	C
the	C
ompF	C
promoter	C
.	C

Here	O
,	O
IHF	O
is	O
clearly	O
a	O
repressor	O
.	O

However	O
,	O
the	O
specific	O
category	O
of	O
OmpR	O
is	O
ambiguous	O
from	O
the	O
context	O
of	O
the	O
sentence	O
between	O
:	O

•	O
An	O
activator	O
of	O
the	O
ompF	O
promoter	O
.	O

•	O
A	O
repressor	O
of	O
the	O
ompF	O
promoter	O
.	O

Therefore	O
,	O
the	O
more	O
general	O
category	O
of	O
Regulator	O
is	O
assigned	O
to	O
OmpR	O
.	O

Consistent	O
annotation	O
of	O
text	O
spans	O

The	O
task	O
of	O
annotating	O
consistent	O
text	O
spans	O
is	O
often	O
challenging	O
[	O
52	O
]	O
,	O
but	O
is	O
important	O
to	O
ensure	O
a	O
cleanly	O
annotated	O
corpus	O
which	O
is	O
easy	O
to	O
understand	O
,	O
reuse	O
and	O
process	O
.	O

Consider	O
the	O
following	O
sentence	O
:	O

The	O
Klebsiella	O
rcsA	O
gene	O
encoded	O
a	O
polypeptide	O
of	O
23	O
kDa	O

The	C
AGENT	C
of	C
encoded	C
may	C
be	C
viewed	C
as	C
any	C
of	C
the	C
following	C
spans	C
:	C
Klebsiella	C
rcsA	C
,	C
Klebsiella	C
rcsA	C
gene	C
,	C
or	C
The	C
Klebsiella	C
rcsA	C
gene	C
.	C

Similarly	C
,	C
the	C
THEME	C
could	C
be	C
polypeptide	C
,	C
a	C
polypeptide	C
or	C
a	C
polypeptide	C
of	C
23	C
kDa	C
.	C

In	O
order	O
to	O
promote	O
consistent	O
choice	O
of	O
spans	O
,	O
we	O
have	O
created	O
a	O
number	O
of	O
guidelines	O
which	O
are	O
mostly	O
based	O
on	O
syntactic	O
chunks	O
.	O

Prior	O
to	O
annotation	O
,	O
chunks	O
are	O
automatically	O
identified	O
by	O
the	O
GENIA	O
tagger	O
[	O
55	O
]	O
.	O

The	O
example	O
below	O
illustrates	O
the	O
output	O
of	O
the	O
tagger	O
,	O
in	O
terms	O
of	O
the	O
chunks	O
identified	O
.	O

Note	O
that	O
,	O
according	O
to	O
the	O
output	O
of	O
the	O
GENIA	O
tagger	O
,	O
PP	O
chunks	O
contain	O
only	O
the	O
preposition	O
,	O
and	O
not	O
the	O
following	O
NP	O
.	O

[	O
NP	O
The	O
Klebsiella	O
rcsA	O
gene	O
]	O
[	O
VP	O
encoded	O
]	O
[	O
NP	O
a	O
polypeptide	O
]	O
[	O
PP	O
of	O
]	O
[	O
NP	O
23	O
kDa	O
]	O

According	C
to	C
our	C
guidelines	C
,	C
annotated	C
text	C
spans	C
should	C
normally	C
consist	C
of	C
(	C
sequences	C
of	C
)	C
complete	C
chunks	C
,	C
thus	C
alleviating	C
many	C
issues	C
relating	C
to	C
the	C
exact	C
words	C
that	C
should	C
be	C
included	C
within	C
an	C
argument	C
text	C
span	C
.	C

This	C
means	C
that	C
,	C
for	C
example	C
,	C
in	C
the	C
above	C
sentence	C
,	C
the	C
AGENT	C
of	C
encoded	C
should	C
be	C
chosen	C
as	C
The	C
Klebsiella	C
rcsA	C
gene	C
,	C
as	C
this	C
corresponds	C
to	C
a	C
complete	C
NP	C
chunk	C
.	C

A	O
further	O
guideline	O
stipulates	O
that	O
argument	O
text	O
spans	O
must	O
consist	O
only	O
of	O
base	O
NP	O
chunks	O
,	O
and	O
that	O
additional	O
descriptive	O
information	O
,	O
usually	O
introduced	O
by	O
prepositions	O
,	O
must	O
be	O
excluded	O
from	O
argument	O
text	O
spans	O
.	O

In	O
the	O
above	O
sentence	O
,	O
application	O
of	O
this	O
rule	O
means	O
that	O
the	O
THEME	O
of	O
encoded	O
is	O
only	O
the	O
chunk	O
a	O
polypeptide	O
,	O
whilst	O
of	O
23	O
kDa	O
is	O
excluded	O
from	O
the	O
argument	O
text	O
span	O
.	O

Software	O

The	O
annotation	O
of	O
the	O
GREC	O
was	O
performed	O
using	O
a	O
Java-based	O
annotation	O
tool	O
called	O
WordFreak	O
(	O
http	O
:	O
//wordfreak.sourceforge.net/	O
[	O
59	O
]	O
)	O
.	O

The	C
tool	C
is	C
designed	C
to	C
support	C
many	C
kinds	C
of	C
annotation	C
of	C
text	C
documents	C
,	C
and	C
can	C
be	C
adapted	C
to	C
new	C
tasks	C
fairly	C
straightforwardly	C
by	C
producing	C
new	C
Java	C
classes	C
that	C
define	C
the	C
task	C
.	C

Much	O
of	O
the	O
work	O
to	O
customise	O
WordFreak	O
for	O
the	O
current	O
task	O
was	O
carried	O
out	O
by	O
ILC-CNR	O
(	O
http	O
:	O
//www.ilc.cnr.it	O
)	O
in	O
Pisa	O
.	O

The	O
customisation	O
helps	O
annotators	O
to	O
conform	O
to	O
the	O
guidelines	O
in	O
a	O
number	O
of	O
ways	O
.	O

For	O
example	O
,	O
occurrences	O
of	O
biologically-relevant	O
verbs	O
are	O
automatically	O
highlighted	O
.	O

In	O
addition	O
,	O
colour-coding	O
is	O
used	O
to	O
distinguish	O
different	O
types	O
of	O
chunks	O
,	O
whilst	O
certain	O
restrictions	O
are	O
imposed	O
in	O
the	O
tool	O
as	O
regards	O
the	O
types	O
of	O
chunks	O
that	O
can	O
constitute	O
different	O
types	O
of	O
semantic	O
arguments	O
,	O
e.g.	O
,	O
ADVP	O
chunks	O
can	O
only	O
be	O
labelled	O
with	O
the	O
MANNER	O
role	O
.	O

Annotators	O
and	O
training	O

Due	O
to	O
the	O
requirement	O
for	O
biological	O
knowledge	O
and	O
complete	O
understanding	O
of	O
the	O
abstracts	O
,	O
annotation	O
was	O
undertaken	O
by	O
6	O
biology	O
PhD	O
students	O
with	O
native	O
or	O
near-native	O
competency	O
in	O
English	O
.	O

It	O
was	O
also	O
required	O
that	O
annotators	O
had	O
at	O
least	O
some	O
experience	O
in	O
gene	O
regulation	O
.	O

Linguistic	C
expertise	C
would	C
be	C
acquired	C
through	C
the	C
training	C
programme	C
and	C
through	C
study	C
of	C
the	C
annotation	C
guidelines	C
.	C

As	O
the	O
annotation	O
was	O
carried	O
out	O
as	O
part	O
of	O
the	O
EC	O
BOOTStrep	O
project	O
(	O
http	O
:	O
//www.bootstrep.org	O
)	O
,	O
it	O
was	O
subject	O
to	O
strict	O
time	O
constraints	O
,	O
with	O
the	O
amount	O
of	O
time	O
to	O
complete	O
the	O
annotation	O
work	O
being	O
limited	O
to	O
three	O
months	O
.	O

This	O
time	O
constraint	O
firstly	O
meant	O
that	O
we	O
were	O
unable	O
to	O
recruit	O
annotators	O
who	O
all	O
had	O
a	O
similarly	O
high	O
level	O
of	O
knowledge	O
of	O
gene	O
regulation	O
and	O
expression	O
.	O

In	O
addition	O
,	O
due	O
to	O
the	O
envisaged	O
steep	O
learning	O
curve	O
for	O
annotators	O
,	O
it	O
was	O
decided	O
to	O
devote	O
the	O
majority	O
of	O
the	O
time	O
available	O
to	O
annotator	O
training	O
.	O

The	O
employment	O
of	O
6	O
annotators	O
,	O
however	O
,	O
allowed	O
a	O
medium-sized	O
final	O
GREC	O
to	O
be	O
annotated	O
in	O
a	O
relatively	O
short	O
space	O
of	O
time	O
.	O

Initial	O
training	O
sessions	O
introduced	O
the	O
annotation	O
tool	O
and	O
the	O
task	O
,	O
with	O
a	O
particular	O
emphasis	O
being	O
placed	O
on	O
clear	O
positive	O
and	O
negative	O
examples	O
of	O
gene	O
regulation	O
and	O
expression	O
events	O
.	O

This	O
was	O
considered	O
particularly	O
important	O
for	O
those	O
annotators	O
with	O
less	O
experience	O
in	O
gene	O
regulation	O
and	O
expression	O
.	O

The	O
initial	O
training	O
sessions	O
were	O
followed	O
up	O
by	O
5	O
fortnightly	O
cycles	O
,	O
during	O
which	O
abstracts	O
were	O
firstly	O
annotated	O
by	O
the	O
annotators	O
and	O
then	O
examined	O
by	O
2	O
of	O
the	O
authors	O
(	O
one	O
with	O
biological	O
expertise	O
and	O
the	O
other	O
with	O
linguistic	O
expertise	O
)	O
,	O
who	O
produced	O
individual	O
feedback	O
reports	O
for	O
each	O
annotator	O
prior	O
to	O
the	O
start	O
of	O
the	O
next	O
cycle	O
of	O
annotation	O
.	O

Additional	O
regular	O
group	O
sessions	O
allowed	O
problems	O
to	O
be	O
discussed	O
in	O
more	O
detail	O
.	O

The	O
calculation	O
of	O
IAA	O
scores	O
after	O
each	O
training	O
cycle	O
provided	O
a	O
quantitative	O
measure	O
of	O
improvement	O
during	O
the	O
training	O
period	O
.	O

Prior	O
to	O
providing	O
these	O
scores	O
,	O
we	O
first	O
describe	O
our	O
method	O
of	O
calculating	O
agreement	O
.	O

Calculating	O
inter-annotator	O
agreement	O

We	O
have	O
defined	O
a	O
novel	O
evaluation	O
methodology	O
which	O
calculates	O
IAA	O
for	O
a	O
number	O
of	O
separate	O
subtasks	O
of	O
the	O
annotation	O
process	O
.	O

These	O
subtasks	O
are	O
as	O
follows	O
:	O

•	O
Event	O
identification	O
(	O
how	O
frequently	O
annotators	O
agree	O
on	O
which	O
events	O
to	O
annotate	O
)	O
.	O

•	O
Argument	O
identification	O
(	O
for	O
agreed	O
events	O
,	O
how	O
frequently	O
the	O
same	O
arguments	O
are	O
chosen	O
by	O
each	O
annotator	O
)	O
.	O

For	O
this	O
task	O
,	O
we	O
calculate	O
separate	O
agreement	O
rates	O
corresponding	O
to	O
:	O

a	O
.	O
Relaxed	O
span	O
matches	O
,	O
where	O
argument	O
text	O
spans	O
identified	O
by	O
a	O
pair	O
of	O
annotators	O
at	O
least	O
overlap	O
with	O
each	O
other	O
,	O
but	O
do	O
not	O
necessarily	O
match	O
exactly	O
.	O

b	O
.	O
Exact	O
span	O
matches	O
,	O
where	O
argument	O
text	O
spans	O
identified	O
by	O
a	O
pair	O
of	O
annotators	O
match	O
exactly	O
.	O

This	O
statistic	O
helps	O
us	O
to	O
evaluate	O
the	O
effectiveness	O
of	O
our	O
rules	O
for	O
consistent	O
span	O
annotation	O
.	O

•	O
Semantic	O
role	O
assignment	O
(	O
for	O
agreed	O
arguments	O
,	O
how	O
often	O
the	O
same	O
semantic	O
roles	O
are	O
assigned	O
by	O
each	O
annotator	O
)	O
.	O

•	O
Biological	O
concept	O
identification	O
(	O
within	O
agreed	O
arguments	O
,	O
how	O
often	O
annotators	O
identify	O
the	O
same	O
biological	O
concepts	O
)	O
.	O

•	O
Biological	O
concept	O
category	O
assignment	O
(	O
for	O
agreed	O
biological	O
concepts	O
,	O
how	O
often	O
the	O
assigned	O
categories	O
are	O
agreed	O
upon	O
by	O
each	O
annotator	O
)	O
.	O

For	O
this	O
task	O
,	O
we	O
calculate	O
3	O
different	O
agreement	O
rates	O
,	O
i.e.	O
,	O

a	O
.	O
Exact	O
category	O
matches	O
,	O
where	O
each	O
annotator	O
has	O
assigned	O
exactly	O
the	O
same	O
concept	O
label	O
.	O

b.	O
Matches	O
including	O
parent	O
,	O
where	O
we	O
also	O
consider	O
as	O
matches	O
those	O
cases	O
where	O
the	O
category	O
assigned	O
by	O
one	O
annotator	O
is	O
the	O
parent	O
concept	O
of	O
the	O
category	O
assigned	O
by	O
the	O
other	O
annotator	O
.	O

c.	O
Supercategory	O
assignment	O
,	O
where	O
we	O
consider	O
only	O
whether	O
each	O
annotator	O
has	O
assigned	O
a	O
concept	O
within	O
the	O
same	O
top	O
level	O
superclass	O
,	O
i.e.	O
,	O
Nucleic_Acids	O
,	O
Proteins	O
,	O
Living_Systems	O
,	O
Processes	O
and	O
Experimental	O
.	O

Whilst	O
the	O
Kappa	O
statistic	O
[	O
60	O
]	O
has	O
become	O
a	O
standard	O
way	O
of	O
calculating	O
IAA	O
for	O
classification	O
tasks	O
,	O
it	O
is	O
problematic	O
for	O
most	O
of	O
the	O
annotation	O
subtasks	O
outlined	O
above	O
,	O
as	O
it	O
requires	O
classifications	O
to	O
correspond	O
to	O
mutually	O
exclusive	O
and	O
discrete	O
categories	O
.	O

The	O
only	O
subtask	O
which	O
fits	O
neatly	O
into	O
this	O
category	O
is	O
the	O
semantic	O
role	O
assignment	O
subtask	O
.	O

We	O
have	O
thus	O
chosen	O
to	O
follow	O
[	O
61	O
]	O
in	O
choosing	O
the	O
F-Score	O
to	O
calculate	O
IAA	O
,	O
as	O
it	O
can	O
be	O
applied	O
straightforwardly	O
to	O
all	O
of	O
the	O
above	O
annotation	O
subtasks	O
.	O

The	O
F-Score	O
is	O
the	O
harmonic	O
mean	O
of	O
precision	O
and	O
recall	O
scores	O
,	O
which	O
are	O
normally	O
calculated	O
to	O
compare	O
the	O
performance	O
of	O
an	O
information	O
retrieval	O
or	O
extraction	O
system	O
to	O
a	O
gold	O
standard	O
.	O

For	O
the	O
purposes	O
of	O
calculating	O
IAA	O
,	O
precision	O
and	O
recall	O
between	O
two	O
annotators	O
can	O
be	O
calculated	O
by	O
treating	O
one	O
set	O
of	O
annotations	O
as	O
the	O
gold	O
standard	O
.	O

The	O
F-score	O
is	O
the	O
same	O
whichever	O
set	O
of	O
annotations	O
is	O
used	O
as	O
the	O
gold	O
standard	O
[	O
62	O
]	O
.	O

Agreement	O
during	O
training	O

Table	O
3	O
reports	O
the	O
changes	O
in	O
the	O
IAA	O
rates	O
as	O
the	O
training	O
period	O
progressed	O
.	O

Four	O
of	O
the	O
cycles	O
(	O
C1	O
-	O
C4	O
)	O
concerned	O
E.	O
coli	O
abstracts	O
,	O
whilst	O
the	O
final	O
cycle	O
(	O
C5	O
)	O
switched	O
to	O
annotation	O
of	O
human	O
abstracts	O
.	O

As	O
the	O
final	O
corpus	O
would	O
consist	O
of	O
both	O
E.	O
coli	O
and	O
human	O
abstracts	O
,	O
we	O
wanted	O
to	O
verify	O
to	O
what	O
extent	O
annotation	O
quality	O
could	O
be	O
maintained	O
if	O
the	O
species	O
referred	O
to	O
in	O
the	O
abstracts	O
is	O
changed	O
.	O

Inter-annotator	O
agreement	O
during	O
training	O

The	O
general	O
trend	O
was	O
for	O
the	O
agreement	O
rates	O
to	O
rise	O
gradually	O
between	O
training	O
cycles	O
C1	O
and	O
C4	O
.	O

In	O
addition	O
,	O
the	O
discrepancy	O
between	O
relaxed	O
and	O
exact	O
span	O
matches	O
narrowed	O
as	O
the	O
training	O
progressed	O
.	O

For	O
most	O
tasks	O
,	O
the	O
agreement	O
rates	O
peaked	O
at	O
the	O
end	O
of	O
cycle	O
C4	O
,	O
with	O
most	O
agreement	O
levels	O
falling	O
in	O
the	O
range	O
70	O
%	O
-	O
90	O
%	O
,	O
which	O
we	O
consider	O
to	O
be	O
acceptable	O
[	O
47	O
]	O
.	O

When	C
the	C
species	C
referred	C
to	C
in	C
the	C
abstract	C
was	C
changed	C
(	C
from	C
E.	C
coli	C
to	C
human	C
)	C
,	C
this	C
resulted	C
in	C
a	C
drop	C
in	C
agreement	C
rates	C
for	C
most	C
tasks	C
,	C
particularly	C
bio-concept	C
assignment	C
,	C
suggesting	C
that	C
a	C
period	C
of	C
adjustment	C
is	C
required	C
when	C
switching	C
to	C
a	C
new	C
species	C
.	C

Two	C
tasks	C
,	C
however	C
,	C
i.e.	C
,	C
semantic	C
role	C
assignment	C
and	C
argument	C
identification	C
,	C
seem	C
more	C
domain-independent	C
,	C
in	C
that	C
the	C
agreement	C
rates	C
stayed	C
constant	C
,	C
or	C
even	C
continued	C
to	C
rise	C
slightly	C
,	C
when	C
the	C
species	C
referred	C
to	C
in	C
the	C
text	C
was	C
changed	C
.	C

The	O
main	O
exception	O
to	O
the	O
general	O
trend	O
for	O
improvement	O
is	O
in	O
the	O
assignment	O
of	O
biological	O
concept	O
categories	O
,	O
for	O
which	O
there	O
was	O
no	O
discernible	O
improvement	O
during	O
the	O
training	O
period	O
.	O

Differing	C
levels	C
of	C
experience	C
in	C
gene	C
regulation	C
may	C
have	C
caused	C
annotators	C
to	C
vary	C
in	C
their	C
ability	C
to	C
accurately	C
assign	C
fine-grain	C
ed	C
biological	C
concept	C
categories	C
.	C

However	O
,	O
higher	O
levels	O
of	O
agreement	O
are	O
achieved	O
if	O
we	O
take	O
the	O
hierarchical	O
structure	O
of	O
the	O
concept	O
categories	O
into	O
account	O
,	O
and	O
look	O
at	O
cases	O
where	O
the	O
category	O
assigned	O
by	O
one	O
annotator	O
is	O
the	O
parent	O
of	O
the	O
term	O
assigned	O
by	O
the	O
other	O
.	O

If	O
we	O
map	O
all	O
concept	O
categories	O
to	O
their	O
top	O
level	O
supercategories	O
,	O
then	O
agreement	O
rates	O
of	O
up	O
to	O
90	O
%	O
(	O
after	O
cycle	O
C4	O
)	O
are	O
achieved	O
.	O

Results	O
and	O
discussion	O

Following	O
the	O
training	O
period	O
,	O
the	O
final	O
annotated	O
GREC	O
was	O
produced	O
.	O

In	O
this	O
section	O
,	O
we	O
provide	O
details	O
,	O
statistics	O
and	O
analysis	O
of	O
this	O
corpus	O
.	O

Following	O
some	O
initial	O
general	O
statistics	O
regarding	O
the	O
corpus	O
,	O
we	O
move	O
on	O
to	O
examine	O
the	O
most	O
commonly	O
annotated	O
verbs	O
and	O
nominalised	O
verbs	O
on	O
which	O
events	O
are	O
centred	O
.	O

Subsequently	O
,	O
we	O
examine	O
in	O
more	O
detail	O
the	O
arguments	O
of	O
events	O
,	O
including	O
an	O
analysis	O
of	O
the	O
numbers	O
of	O
arguments	O
that	O
occur	O
in	O
different	O
events	O
,	O
the	O
distribution	O
of	O
different	O
semantic	O
argument	O
types	O
,	O
and	O
the	O
most	O
commonly	O
occurring	O
patterns	O
of	O
arguments	O
.	O

Biological	O
concept	O
assignment	O
is	O
then	O
covered	O
,	O
including	O
the	O
distribution	O
of	O
the	O
assigned	O
concepts	O
amongst	O
the	O
five	O
different	O
supercategories	O
,	O
together	O
with	O
an	O
analysis	O
of	O
the	O
most	O
commonly	O
assigned	O
concepts	O
.	O

Finally	O
,	O
we	O
consider	O
quality	O
control	O
of	O
the	O
GREC	O
,	O
including	O
both	O
IAA	O
scores	O
and	O
annotator	O
discrepancies	O
that	O
were	O
found	O
through	O
manual	O
examination	O
of	O
the	O
corpus	O
.	O

Corpus	O
characteristics	O
and	O
statistics	O

Candidate	O
abstracts	O
for	O
annotation	O
for	O
the	O
final	O
GREC	O
were	O
selected	O
from	O
species-specific	O
corpora	O
of	O
MEDLINE	O
abstracts	O
collected	O
by	O
EMBL-EBI	O
,	O
who	O
chose	O
abstracts	O
relevant	O
to	O
the	O
E.	O
coli	O
and	O
human	O
species	O
using	O
their	O
own	O
rule-based	O
species-filtering	O
methods	O
.	O

The	O
candidate	O
abstracts	O
were	O
further	O
screened	O
for	O
relevance	O
to	O
gene	O
regulation	O
by	O
one	O
of	O
the	O
authors	O
with	O
biological	O
expertise	O
.	O

General	O
statistics	O
regarding	O
the	O
GREC	O
are	O
shown	O
in	O
Table	O
4	O
.	O

The	O
effort	O
expended	O
by	O
the	O
6	O
annotators	O
amounted	O
to	O
a	O
total	O
of	O
876	O
person	O
hours	O
(	O
equivalent	O
to	O
6.4	O
person	O
months	O
)	O
.	O

General	O
corpus	O
statistics	O

The	O
statistics	O
in	O
Table	O
4	O
reinforce	O
the	O
importance	O
of	O
considering	O
events	O
that	O
are	O
described	O
by	O
nominalised	O
verbs	O
as	O
well	O
as	O
those	O
that	O
are	O
described	O
by	O
verbs	O
.	O

In	O
the	O
E.	O
coli	O
corpus	O
,	O
events	O
that	O
are	O
centred	O
on	O
nominalised	O
verbs	O
are	O
almost	O
as	O
common	O
as	O
those	O
centred	O
on	O
verbs	O
,	O
although	O
the	O
range	O
of	O
different	O
words	O
that	O
are	O
used	O
to	O
describe	O
events	O
is	O
much	O
greater	O
for	O
verbs	O
than	O
for	O
nominalised	O
verbs	O
.	O

Verbs	O
and	O
nominalised	O
verbs	O
expressing	O
events	O

Table	O
5	O
shows	O
the	O
top	O
10	O
most	O
common	O
words	O
(	O
verbs	O
and	O
nominalised	O
verbs	O
)	O
which	O
express	O
events	O
,	O
both	O
in	O
the	O
corpus	O
as	O
a	O
whole	O
,	O
and	O
separately	O
for	O
the	O
E.	O
coli	O
and	O
human	O
parts	O
of	O
the	O
corpus	O
.	O

In	C
each	C
case	C
,	C
events	C
centred	C
on	C
these	C
10	C
words	C
constitute	C
45	C
-	C
50	C
%	C
of	C
the	C
total	C
events	C
annotated	C
,	C
suggesting	C
that	C
the	C
majority	C
of	C
relevant	C
events	C
are	C
centred	C
on	C
a	C
relatively	C
small	C
set	C
of	C
words	C
.	C

Indeed	O
,	O
in	O
the	O
corpus	O
as	O
a	O
whole	O
,	O
only	O
55	O
words	O
(	O
either	O
verbs	O
or	O
nominalised	O
verbs	O
)	O
have	O
been	O
used	O
to	O
annotate	O
10	O
or	O
more	O
events	O
.	O

Most	O
common	O
words	O
describing	O
events	O

Most	O
of	O
the	O
words	O
in	O
Table	O
5	O
correspond	O
to	O
important	O
biological	O
processes	O
.	O

For	O
some	O
of	O
these	O
processes	O
,	O
occurrences	O
of	O
both	O
the	O
verbal	O
and	O
nominalised	O
forms	O
are	O
quite	O
common	O
,	O
e.g.	O
,	O
regulate/regulation	O
,	O
bind/binding	O
,	O
repress/repression	O
,	O
activate/activation	O
.	O

In	C
other	C
cases	C
,	C
there	C
appears	C
to	C
be	C
a	C
stronger	C
preference	C
for	C
either	C
the	C
verb	C
or	C
the	C
nominalised	C
verb	C
.	C

In	O
the	O
E.	O
coli	O
portion	O
of	O
the	O
corpus	O
,	O
for	O
example	O
,	O
twice	O
as	O
many	O
events	O
are	O
centred	O
on	O
the	O
nominalised	O
verb	O
expression	O
than	O
any	O
other	O
word	O
.	O

Transcription	O
is	O
also	O
rarely	O
used	O
in	O
its	O
verbal	O
form	O
,	O
i.e	O
.	O
transcribe	O
(	O
16	O
times	O
in	O
the	O
complete	O
corpus	O
)	O
,	O
whilst	O
encode	O
is	O
only	O
ever	O
used	O
in	O
its	O
verbal	O
form	O
.	O

Event	O
arguments	O

In	O
this	O
section	O
,	O
we	O
provide	O
some	O
statistics	O
regarding	O
annotated	O
event	O
arguments	O
.	O

Firstly	O
,	O
Figure	O
1	O
provides	O
an	O
analysis	O
of	O
the	O
numbers	O
of	O
arguments	O
that	O
were	O
identified	O
for	O
different	O
events	O
.	O

Distribution	O
of	O
event	O
argument	O
counts	O
.	O

Each	O
section	O
of	O
the	O
chart	O
shows	O
the	O
percentage	O
of	O
events	O
in	O
the	O
GREC	O
that	O
have	O
been	O
annotated	O
with	O
the	O
indicated	O
number	O
of	O
arguments	O
.	O

Whilst	O
it	O
is	O
most	O
common	O
for	O
1	O
or	O
2	O
arguments	O
to	O
be	O
specified	O
,	O
15	O
%	O
of	O
events	O
specify	O
3	O
or	O
more	O
arguments	O
.	O

However	O
,	O
as	O
Figure	O
1	O
shows	O
,	O
it	O
is	O
extremely	O
rare	O
in	O
our	O
corpus	O
for	O
4	O
or	O
more	O
arguments	O
to	O
be	O
specified	O
.	O

Table	O
6	O
provides	O
statistics	O
regarding	O
the	O
semantic	O
roles	O
that	O
were	O
assigned	O
to	O
arguments	O
.	O

Semantic	O
role	O
occurrences	O

In	O
addition	O
to	O
the	O
13	O
roles	O
already	O
introduced	O
,	O
there	O
is	O
a	O
further	O
role	O
named	O
Underspecified	O
,	O
which	O
was	O
to	O
be	O
assigned	O
by	O
annotators	O
to	O
arguments	O
that	O
could	O
not	O
be	O
characterised	O
by	O
one	O
of	O
the	O
13	O
defined	O
roles	O
.	O

However	C
,	C
the	C
fact	C
that	C
the	C
Underspecified	C
role	C
was	C
only	C
assigned	C
11	C
times	C
in	C
the	C
whole	C
corpus	C
suggests	C
that	C
our	C
originally-defined	C
role	C
set	C
is	C
sufficient	C
to	C
characterise	C
the	C
vast	C
majority	C
of	C
semantic	C
arguments	C
.	C

The	O
AGENT	O
and	O
THEME	O
roles	O
,	O
which	O
provide	O
the	O
most	O
fundamental	O
information	O
about	O
events	O
,	O
are	O
by	O
far	O
the	O
most	O
commonly	O
assigned	O
.	O

Whilst	C
it	C
may	C
seem	C
surprising	C
that	C
only	C
about	C
half	C
of	C
the	C
events	C
specify	C
an	C
AGENT	C
,	C
this	C
can	C
partly	C
be	C
explained	C
by	C
the	C
relatively	C
high	C
occurrence	C
of	C
events	C
that	C
are	C
centred	C
on	C
nominalised	C
verbs	C
(	C
42	C
%	C
of	C
all	C
events	C
)	C
and	C
passive	C
constructions	C
(	C
14	C
%	C
of	C
events	C
)	C
.	C

According	O
to	O
our	O
corpus	O
,	O
only	O
around	O
20	O
%	O
of	O
events	O
centred	O
on	O
nominalised	O
verbs	O
and	O
50	O
%	O
of	O
events	O
using	O
passive	O
verb	O
constructions	O
specify	O
an	O
AGENT	O
.	O

Several	O
other	O
roles	O
feature	O
fairly	O
prominently	O
in	O
the	O
events	O
,	O
particularly	O
MANNER	O
,	O
LOCATION	O
,	O
DESTINATION	O
and	O
CONDITION	O
,	O
which	O
is	O
in	O
line	O
with	O
observations	O
made	O
by	O
[	O
20	O
]	O
.	O

In	O
Table	O
7	O
,	O
the	O
most	O
common	O
patterns	O
semantic	O
roles	O
assigned	O
to	O
event	O
arguments	O
are	O
shown	O
.	O

The	O
most	O
common	O
pattern	O
is	O
for	O
only	O
an	O
AGENT	O
and	O
a	O
THEME	O
to	O
be	O
a	O
specified	O
,	O
constituting	O
almost	O
a	O
third	O
of	O
all	O
events	O
.	O

When	O
events	O
do	O
specify	O
a	O
third	O
argument	O
,	O
it	O
is	O
most	O
common	O
for	O
the	O
AGENT	O
and	O
THEME	O
,	O
plus	O
one	O
additional	O
type	O
of	O
argument	O
,	O
to	O
be	O
present	O
.	O

Most	O
common	O
semantic	O
role	O
patterns	O

Biological	O
concepts	O

In	O
the	O
corpus	O
as	O
a	O
whole	O
,	O
5026	O
biological	O
concepts	O
were	O
identified	O
.	O

The	O
distribution	O
of	O
the	O
categories	O
assigned	O
to	O
these	O
concepts	O
amongst	O
the	O
five	O
supercategories	O
is	O
shown	O
in	O
Figure	O
2	O
.	O

Distribution	O
of	O
biological	O
concept	O
supercategories	O
.	O

Each	O
section	O
of	O
the	O
chart	O
shows	O
the	O
percentage	O
of	O
annotated	O
biological	O
concepts	O
in	O
the	O
GREC	O
that	O
have	O
been	O
assigned	O
a	O
concept	O
class	O
belonging	O
to	O
the	O
indicated	O
supercategory	O
.	O

The	O
supercategories	O
Nucleic_Acids	O
and	O
Proteins	O
are	O
so	O
dominant	O
because	O
most	O
gene	O
regulation	O
and	O
expression	O
events	O
describe	O
some	O
kind	O
of	O
relationship	O
between	O
entities	O
of	O
these	O
two	O
types	O
.	O

The	O
Processes	O
supercategory	O
is	O
also	O
very	O
common	O
,	O
as	O
concepts	O
assigned	O
to	O
this	O
correspond	O
to	O
``	O
embedded	O
''	O
events	O
that	O
describe	O
a	O
mechanistic	O
link	O
between	O
Nucleic_Acid	O
and	O
Proteins	O
,	O
e.g	O
.	O
:	O

Expression	O
of	O
the	O
ompF	O
and	O
ompC	O
genes	O
is	O
affected	O
in	O
a	O
reciprocal	O
manner	O
by	O
the	O
osmolarity	O
of	O
the	O
growth	O
medium	O
.	O

Annotators	O
were	O
instructed	O
to	O
assign	O
the	O
most	O
specific	O
concept	O
possible	O
in	O
the	O
hierarchy	O
;	O
the	O
results	O
show	O
that	O
66.91	O
%	O
of	O
assignments	O
indeed	O
constitute	O
the	O
most	O
specific	O
concepts	O
.	O

Table	O
8	O
compares	O
the	O
most	O
commonly	O
assigned	O
concepts	O
in	O
the	O
E.	O
coli	O
and	O
human	O
parts	O
of	O
the	O
corpus	O
.	O

Comparison	O
of	O
concept	O
assignments	O
in	O
E.	O
coli	O
and	O
human	O
abstracts	O

Gene	O
constitutes	O
the	O
most	O
commonly	O
assigned	O
concept	O
in	O
both	O
parts	O
of	O
the	O
corpus	O
.	O

It	O
is	O
a	O
general	O
,	O
rather	O
than	O
a	O
specific	O
concept	O
in	O
the	O
Nucleic_Acids	O
hierarchy	O
.	O

However	O
,	O
the	O
frequency	O
of	O
assignments	O
of	O
its	O
specific	O
subtypes	O
,	O
i.e.	O
,	O
Mutant_Gene	O
,	O
ORF	O
and	O
Allele	O
is	O
very	O
low	O
,	O
with	O
19	O
,	O
10	O
and	O
1	O
assignment	O
,	O
respectively	O
.	O

This	C
suggests	C
that	C
more	C
specific	C
concept	C
type	C
assignment	C
for	C
genes	C
can	C
be	C
problematic	C
.	C

The	O
category	O
Transcription_Factor	O
also	O
has	O
far	O
more	O
assignments	O
than	O
its	O
sub-categories	O
,	O
Repressor	O
and	O
Activator	O
in	O
the	O
human	O
part	O
of	O
the	O
corpus	O
.	O

However	O
,	O
Transcription_Factor	O
is	O
not	O
nearly	O
as	O
frequent	O
in	O
E.	O
coli	O
abstracts	O
as	O
in	O
human	O
corpus	O
(	O
see	O
Table	O
7	O
)	O
.	O

These	O
differences	O
represent	O
important	O
biological	O
information	O
:	O
due	O
to	O
the	O
relative	O
complexity	O
of	O
eukaryotic	O
systems	O
,	O
transcription	O
factors	O
play	O
a	O
very	O
important	O
role	O
in	O
gene	O
regulation	O
compared	O
to	O
prokaryotes	O
,	O
like	O
E.	O
coli	O
.	O

Quality	O
control	O

Previously	O
,	O
we	O
showed	O
that	O
good	O
rates	O
of	O
agreement	O
were	O
achieved	O
by	O
the	O
end	O
of	O
the	O
training	O
period	O
.	O

To	O
ensure	O
annotation	O
quality	O
was	O
maintained	O
in	O
the	O
final	O
GREC	O
,	O
approximately	O
one	O
quarter	O
of	O
the	O
abstracts	O
was	O
annotated	O
by	O
all	O
annotators	O
.	O

In	O
this	O
section	O
,	O
we	O
firstly	O
present	O
some	O
general	O
agreement	O
statistics	O
relating	O
to	O
the	O
whole	O
corpus	O
,	O
followed	O
by	O
more	O
detailed	O
statistics	O
regarding	O
semantic	O
role	O
and	O
biological	O
concept	O
assignment	O
.	O

Finally	O
,	O
we	O
examine	O
some	O
types	O
of	O
annotator	O
discrepancies	O
that	O
were	O
found	O
through	O
manual	O
examination	O
of	O
the	O
corpus	O
.	O

General	O
agreement	O
statistics	O

Average	O
agreement	O
rates	O
for	O
the	O
final	O
corpus	O
were	O
calculated	O
in	O
the	O
same	O
way	O
and	O
for	O
the	O
same	O
annotation	O
subtasks	O
as	O
during	O
the	O
training	O
period	O
.	O

These	O
are	O
reported	O
in	O
Table	O
9	O
,	O
categorised	O
according	O
to	O
abstract	O
subject	O
.	O

In	O
most	O
cases	O
,	O
agreement	O
rates	O
are	O
maintain	O
the	O
same	O
level	O
,	O
or	O
in	O
some	O
cases	O
exceed	O
those	O
attained	O
by	O
the	O
end	O
of	O
the	O
training	O
period	O
.	O

General	O
agreement	O
statistics	O
in	O
the	O
GREC	O

Particularly	O
high	O
levels	O
of	O
agreement	O
(	O
88	O
%	O
or	O
above	O
)	O
are	O
achieved	O
for	O
both	O
the	O
identification	O
of	O
semantic	O
arguments	O
and	O
the	O
assignment	O
of	O
semantic	O
roles	O
to	O
these	O
arguments	O
.	O

As	C
these	C
are	C
the	C
subtasks	C
that	C
we	C
originally	C
identified	C
as	C
being	C
more	C
linguistically-oriented	C
than	C
others	C
,	C
our	C
results	C
suggest	C
that	C
a	C
detailed	C
set	C
of	C
guidelines	C
,	C
together	C
with	C
an	C
intensive	C
training	C
programme	C
,	C
allow	C
these	C
tasks	C
to	C
be	C
carried	C
out	C
by	C
biologists	C
to	C
a	C
high	C
degree	C
of	C
accuracy	C
.	C

Semantic	O
role	O
assignment	O

Table	O
10	O
provides	O
more	O
detailed	O
agreement	O
rates	O
for	O
semantic	O
role	O
assignment	O
.	O

High	O
levels	O
of	O
agreement	O
(	O
over	O
84	O
%	O
)	O
are	O
achieved	O
amongst	O
many	O
of	O
the	O
most	O
commonly	O
occurring	O
roles	O
,	O
including	O
AGENT	O
,	O
THEME	O
,	O
MANNER	O
,	O
LOCATION	O
,	O
DESTINATION	O
and	O
SOURCE	O
.	O

However	O
,	O
CONDITION	O
and	O
DESCRIPTIVE-THEME	O
are	O
also	O
fairly	O
common	O
,	O
but	O
have	O
lower	O
rates	O
of	O
agreement	O
.	O

Discrepancies	O
have	O
been	O
examined	O
and	O
are	O
further	O
discussed	O
in	O
the	O
Annotator	O
Discrepancies	O
section	O
below	O
.	O

Most	C
of	C
the	C
other	C
role	C
types	C
occur	C
much	C
less	C
frequently	C
in	C
the	C
corpus	C
(	C
varying	C
between	C
1-5	C
%	C
of	C
events	C
)	C
,	C
meaning	C
that	C
the	C
agreement	C
rates	C
shown	C
may	C
be	C
less	C
reliable	C
.	C

Individual	O
role	O
agreement	O
statistics	O

Biological	O
concept	O
assignment	O

Whilst	O
Table	O
9	O
showed	O
that	O
coarse-grained	O
biological	O
category	O
assignment	O
achieved	O
around	O
95	O
%	O
agreement	O
,	O
the	O
assignment	O
of	O
finer-grained	O
categories	O
achieved	O
the	O
lowest	O
agreement	O
rates	O
amongst	O
all	O
annotation	O
subtasks	O
.	O

Table	O
11	O
shows	O
the	O
most	O
commonly	O
assigned	O
categories	O
in	O
each	O
portion	O
of	O
the	O
corpus	O
,	O
together	O
with	O
their	O
agreement	O
rates	O
.	O

Individual	O
biological	O
concept	O
category	O
agreement	O
statistics	O

Table	O
11	O
illustrates	O
that	O
there	O
are	O
several	O
differences	O
in	O
the	O
most	O
commonly	O
assigned	O
concepts	O
according	O
to	O
the	O
species	O
referred	O
to	O
in	O
the	O
abstract	O
(	O
i.e.	O
,	O
E.	O
coli	O
or	O
human	O
)	O
.	O

There	O
are	O
also	O
large	O
differences	O
in	O
the	O
rates	O
of	O
agreement	O
for	O
different	O
categories	O
,	O
which	O
are	O
not	O
correlated	O
with	O
their	O
frequency	O
of	O
occurrence	O
.	O

High	O
levels	O
of	O
agreement	O
(	O
over	O
75	O
%	O
)	O
are	O
achieved	O
for	O
a	O
number	O
of	O
these	O
categories	O
,	O
most	O
notably	O
Transcription	O
,	O
Cells	O
,	O
Regulation	O
,	O
Promoter	O
,	O
Gene	O
and	O
Enzyme	O
.	O

In	O
general	O
,	O
the	O
classes	O
with	O
the	O
highest	O
agreement	O
seem	O
to	O
be	O
those	O
that	O
do	O
not	O
have	O
very	O
specific	O
interpretations	O
,	O
i.e.	O
,	O
those	O
concepts	O
with	O
broader	O
interpretations	O
which	O
are	O
understandable	O
by	O
biologists	O
with	O
different	O
backgrounds	O
.	O

This	O
means	O
that	O
the	O
highest	O
levels	O
of	O
agreement	O
have	O
been	O
reached	O
when	O
the	O
context	O
dictates	O
that	O
a	O
very	O
specific	O
concept	O
can	O
not	O
be	O
assigned	O
.	O

Less	O
agreement	O
is	O
achieved	O
for	O
categories	O
that	O
are	O
more	O
specific	O
to	O
the	O
context	O
of	O
gene	O
regulation	O
and	O
expression	O
,	O
such	O
as	O
Activator	O
,	O
Repressor	O
,	O
Transcription_Factor	O
,	O
etc	O
.	O

Annotator	O
discrepancies	O

Certain	O
discrepancies	O
between	O
annotators	O
exist	O
in	O
the	O
final	O
corpus	O
,	O
of	O
which	O
a	O
number	O
are	O
highlighted	O
in	O
this	O
section	O
.	O

Whilst	O
the	O
identification	O
of	O
these	O
discrepancies	O
will	O
help	O
to	O
refine	O
the	O
guidelines	O
for	O
future	O
phases	O
of	O
annotation	O
,	O
it	O
was	O
also	O
found	O
that	O
certain	O
errors	O
were	O
being	O
made	O
which	O
were	O
already	O
covered	O
in	O
the	O
guidelines	O
.	O

Thus	C
,	C
there	C
may	C
be	C
a	C
need	C
to	C
more	C
carefully	C
balance	C
conciseness	C
with	C
comprehensiveness	C
in	C
the	C
guidelines	C
.	C

Event	O
identification	O

The	O
majority	O
of	O
discrepancies	O
in	O
event	O
identification	O
concern	O
nominalised	O
verbs	O
.	O

A	C
particular	C
example	C
is	C
the	C
word	C
mutation	C
,	C
which	C
can	C
be	C
used	C
either	C
as	C
a	C
nominalised	C
verb	C
(	C
i.e.	C
,	C
the	C
action	C
of	C
mutating	C
)	C
,	C
or	C
as	C
an	C
entity	C
(	C
e.g.	C
,	C
a	C
mutated	C
gene	C
)	C
.	C

However	C
,	C
the	C
distinction	C
can	C
sometimes	C
be	C
problematic	C
.	C

Consider	O
the	O
following	O
examples	O
:	O

1	O
)	O
In	O
addition	O
,	O
the	O
pleiotropic	O
phenotypes	O
conferred	O
by	O
a	O
particular	O
envZ	O
mutation	O
(	O
envZ473	O
)	O
required	O
the	O
presence	O
of	O
functional	O
OmpR	O
protein	O
.	O

2	O
)	O
Therefore	O
,	O
OmpF	O
reduction	O
resulted	O
in	O
a	O
mutation	O
in	O
the	O
marA	O
region	O
.	O

In	C
sentence	C
1	C
)	C
,	C
a	C
particular	C
envZ	C
mutation	C
seems	C
to	C
describe	C
a	C
mutated	C
entity	C
rather	C
than	C
the	C
action	C
of	C
mutation	C
.	C

In	O
contrast	O
,	O
the	O
mutation	O
in	O
sentence	O
2	O
)	O
describes	O
the	O
action	O
of	O
marA	O
being	O
mutated	O
due	O
to	O
reduction	O
of	O
OmpF	O
.	O

Argument	O
identification	O

Argument	O
identification	O
discrepancies	O
often	O
occurred	O
in	O
more	O
complex	O
sentences	O
,	O
in	O
which	O
a	O
``	O
double	O
layer	O
''	O
of	O
annotation	O
was	O
sometimes	O
required	O
.	O

In	C
the	C
following	C
sentence	C
,	C
Alpha	C
interferon	C
should	C
be	C
seen	C
as	C
the	C
AGENT	C
of	C
converting	C
as	C
well	C
as	C
the	C
AGENT	C
of	C
stimulates	C
:	C

Alpha	O
interferon	O
stimulates	O
transcription	O
by	O
converting	O
the	O
positive	O
transcriptional	O
regulator	O
ISGF3	O
from	O
a	O
latent	O
to	O
an	O
active	O
form	O
.	O

LOCATION	C
arguments	C
can	C
also	C
be	C
problematic	C
in	C
sentences	C
containing	C
multiple	C
events	C
.	C

In	O
the	O
following	O
sentence	O
,	O
for	O
example	O
,	O
different	O
annotators	O
associated	O
the	O
LOCATION	O
in	O
Escherichia	O
coli	O
K-12	O
with	O
either	O
the	O
event	O
described	O
by	O
the	O
verb	O
control	O
or	O
the	O
nominalised	O
verb	O
expression	O
.	O

EnvZ	O
functions	O
through	O
OmpR	O
to	O
control	O
porin	O
gene	O
expression	O
in	O
Escherichia	O
coli	O
K-12	O
.	O

Semantic	O
role	O
assignment	O

Amongst	O
the	O
most	O
important	O
semantic	O
roles	O
,	O
both	O
in	O
terms	O
of	O
frequency	O
of	O
occurrence	O
and	O
according	O
to	O
[	O
20	O
]	O
,	O
CONDITION	O
is	O
the	O
one	O
with	O
the	O
lowest	O
rates	O
of	O
agreement	O
.	O

We	O
thus	O
examined	O
more	O
closely	O
the	O
types	O
of	O
disagreements	O
that	O
occur	O
.	O

According	O
to	O
our	O
study	O
,	O
the	O
most	O
common	O
confusions	O
are	O
with	O
the	O
MANNER	O
and	O
TEMPORAL	O
roles	O
.	O

Typical	O
examples	O
include	O
the	O
following	O
:	O

1	O
)	O
In	O
contrast	O
,	O
the	O
anaerobic	O
repression	O
of	O
ethanol	O
dehydrogenase	O
by	O
nitrate	O
does	O
not	O
require	O
the	O
narL	O
product	O
.	O

2	O
)	O
Nitrate	O
repression	O
,	O
however	O
,	O
was	O
significantly	O
enhanced	O
(	O
sevenfold	O
)	O
when	O
the	O
cells	O
were	O
cultured	O
in	O
minimal	O
medium	O
.	O

For	O
the	O
repression	O
event	O
in	O
sentence	O
1	O
)	O
,	O
anaerobic	O
was	O
confused	O
between	O
MANNER	O
and	O
CONDITION	O
.	O

The	C
confusion	C
may	C
occur	C
because	C
anaerobic	C
can	C
be	C
used	C
in	C
the	C
description	C
of	C
environmental	C
conditions	C
in	C
a	C
phrase	C
such	C
as	C
under	C
anaerobic	C
conditions	C
.	C

Here	O
,	O
however	O
,	O
it	O
is	O
being	O
used	O
to	O
describe	O
the	O
method	O
of	O
repression	O
,	O
and	O
hence	O
the	O
MANNER	O
role	O
is	O
most	O
appropriate	O
.	O

In	O
sentence	O
2	O
)	O
,	O
the	O
phrase	O
the	O
cells	O
were	O
cultured	O
in	O
minimal	O
medium	O
was	O
annotated	O
either	O
as	O
a	O
CONDITION	O
or	O
as	O
a	O
TEMPORAL	O
argument	O
of	O
the	O
enhanced	O
event	O
.	O

Whilst	C
this	C
would	C
normally	C
be	C
interpreted	C
as	C
a	C
CONDITION	C
,	C
the	C
confusion	C
may	C
have	C
arisen	C
due	C
to	C
the	C
use	C
of	C
when	C
at	C
the	C
beginning	C
of	C
the	C
phrase	C
.	C

Regarding	O
the	O
DESCRIPTIVE-THEME	O
role	O
,	O
the	O
most	O
common	O
type	O
of	O
confusion	O
is	O
with	O
THEME	O
.	O

According	C
to	C
the	C
guidelines	C
,	C
one	C
of	C
the	C
situations	C
in	C
which	C
DESCRIPTIVE-THEME	C
should	C
be	C
assigned	C
is	C
to	C
objects	C
of	C
verbs	C
that	C
describe	C
states	C
rather	C
than	C
actions	C
e.g.	C
,	C
The	C
fru	C
operon	C
contains	C
the	C
genes	C
for	C
IIFru	C
.	C

Here	O
,	O
there	O
is	O
no	O
action	O
and	O
hence	O
no	O
AGENT	O
.	O

Thus	O
,	O
the	O
fru	O
operon	O
is	O
the	O
THEME	O
and	O
the	O
genes	O
for	O
IIFru	O
is	O
the	O
DESCRIPTIVE-THEME	O
.	O

However	C
,	C
problems	C
sometimes	C
arose	C
for	C
certain	C
verbs	C
such	C
as	C
exhibit	C
,	C
where	C
there	C
may	C
be	C
some	C
confusion	C
as	C
to	C
whether	C
a	C
``	C
state	C
''	C
or	C
``	C
active	C
''	C
interpretation	C
should	C
be	C
taken	C
,	C
e.g.	C
,	C
The	C
wild-type	C
and	C
mutant	C
ompR	C
genes	C
exhibit	C
different	C
phenotypes	C
of	C
osmoregulation	C
...	C

The	C
interpretation	C
taken	C
by	C
the	C
annotator	C
determines	C
whether	C
different	C
phenotypes	C
is	C
assigned	C
the	C
role	C
THEME	C
or	C
DESCRIPTIVE-THEME	C
(	C
and	C
also	C
whether	C
The	C
wild-type	C
and	C
mutant	C
ompR	C
genes	C
is	C
assigned	C
AGENT	C
or	C
THEME	C
)	C
.	C

In	C
general	C
,	C
DESCRIPTIVE-THEME	C
and	C
DESCRIPTIVE-AGENT	C
have	C
less	C
strict	C
definitions	C
than	C
other	C
roles	C
,	C
in	C
that	C
the	C
only	C
restriction	C
imposed	C
is	C
that	C
they	C
should	C
be	C
assigned	C
to	C
arguments	C
that	C
describe	C
characteristics	C
or	C
behaviour	C
of	C
the	C
AGENT	C
or	C
THEME	C
.	C

This	C
,	C
together	C
with	C
the	C
fact	C
that	C
they	C
are	C
not	C
particularly	C
commonly	C
occurring	C
,	C
could	C
have	C
made	C
them	C
more	C
difficult	C
to	C
assign	C
accurately	C
.	C

As	C
future	C
work	C
,	C
we	C
will	C
consider	C
tightening	C
the	C
definitions	C
and	C
possibly	C
splitting	C
them	C
into	C
different	C
roles	C
.	C

Although	C
it	C
is	C
desirable	C
to	C
keep	C
the	C
set	C
of	C
roles	C
used	C
as	C
small	C
and	C
as	C
general	C
as	C
possible	C
in	C
order	C
to	C
ease	C
the	C
burden	C
on	C
the	C
annotator	C
,	C
a	C
slightly	C
larger	C
range	C
of	C
more	C
tightly-defined	C
roles	C
may	C
help	C
to	C
improve	C
agreement	C
rates	C
.	C

Biological	O
concept	O
assignment	O

As	O
observed	O
in	O
Table	O
11	O
,	O
there	O
is	O
much	O
more	O
discrepancy	O
between	O
certain	O
biological	O
concept	O
categories	O
than	O
others	O
,	O
especially	O
those	O
that	O
constitute	O
context-specific	O
concepts	O
.	O

An	O
exception	O
to	O
this	O
is	O
Protein	O
,	O
which	O
is	O
a	O
more	O
general	O
concept	O
category	O
within	O
the	O
Proteins	O
supercategory	O
.	O

We	O
therefore	O
examined	O
the	O
most	O
common	O
concept	O
categories	O
with	O
which	O
Protein	O
was	O
confused	O
.	O

These	O
are	O
shown	O
in	O
Table	O
12	O
.	O

Most	O
common	O
concept	O
categories	O
confused	O
with	O
Protein	O

With	O
the	O
exception	O
of	O
Gene	O
(	O
which	O
belongs	O
to	O
the	O
Nucleic_Acids	O
superclass	O
)	O
,	O
all	O
other	O
categories	O
confused	O
with	O
Protein	O
are	O
also	O
categories	O
within	O
the	O
Proteins	O
supercategory	O
.	O

This	C
suggests	C
that	C
some	C
annotators	C
were	C
using	C
the	C
Protein	C
category	C
to	C
encompass	C
all	C
things	C
related	C
to	C
proteins	C
,	C
rather	C
than	C
assigning	C
more	C
specific	C
category	C
labels	C
.	C

This	C
may	C
be	C
related	C
to	C
their	C
differing	C
levels	C
of	C
knowledge	C
regarding	C
gene	C
regulation	C
and	C
expression	C
.	C

Conclusion	O

We	O
have	O
designed	O
an	O
event	O
annotation	O
scheme	O
for	O
biomedical	O
texts	O
and	O
produced	O
an	O
associated	O
corpus	O
,	O
the	O
GREC	O
,	O
consisting	O
of	O
240	O
MEDLINE	O
abstracts	O
annotated	O
with	O
3067	O
gene	O
regulation	O
event	O
instances	O
.	O

The	O
corpus	O
is	O
unique	O
within	O
the	O
biomedical	O
field	O
in	O
that	O
it	O
combines	O
both	O
linguistically-oriented	O
features	O
(	O
i.e.	O
,	O
event-independent	O
semantic	O
roles	O
tuned	O
to	O
the	O
domain	O
)	O
and	O
biologically-oriented	O
features	O
(	O
i.e.	O
,	O
biological	O
concepts	O
linked	O
to	O
the	O
Gene	O
Regulation	O
Ontology	O
[	O
43	O
]	O
)	O
.	O

The	O
corpus	O
can	O
act	O
as	O
a	O
basis	O
for	O
creating	O
domain-specific	O
semantic	O
frame	O
resources	O
,	O
and	O
has	O
already	O
been	O
used	O
in	O
the	O
production	O
of	O
semantic	O
frames	O
for	O
inclusion	O
within	O
the	O
BioLexicon	O
[	O
44	O
]	O
,	O
in	O
which	O
the	O
semantic	O
frames	O
are	O
linked	O
with	O
syntactic	O
information	O
.	O

It	C
is	C
also	C
hoped	C
that	C
the	C
corpus	C
will	C
boost	C
research	C
into	C
other	C
areas	C
of	C
bio-IE	C
,	C
such	C
as	C
the	C
production	C
of	C
domain-specific	C
SRLs	C
,	C
which	C
have	C
previously	C
suffered	C
due	C
to	C
the	C
lack	C
of	C
a	C
suitably	C
annotated	C
corpus	C
.	C

Initial	O
experiments	O
have	O
demonstrated	O
the	O
feasibility	O
of	O
training	O
an	O
SRL	O
using	O
the	O
corpus	O
and	O
as	O
such	O
,	O
we	O
hope	O
to	O
exploit	O
the	O
corpus	O
in	O
future	O
shared	O
tasks	O
with	O
such	O
an	O
aim	O
.	O

There	C
is	C
also	C
evidence	C
to	C
suggest	C
that	C
combining	C
the	C
GREC	C
with	C
other	C
larger	C
biomedical	C
corpora	C
may	C
help	C
to	C
train	C
more	C
accurate	C
IE	C
systems	C
.	C

Evaluation	O
of	O
the	O
corpus	O
quality	O
was	O
carried	O
out	O
using	O
a	O
newly-devised	O
methodology	O
,	O
taking	O
into	O
account	O
multiple	O
aspects	O
of	O
the	O
annotation	O
task	O
.	O

Average	O
agreement	O
rates	O
for	O
the	O
various	O
tasks	O
fell	O
within	O
the	O
range	O
of	O
66	O
%	O
-	O
90	O
%	O
F-score	O
.	O

Through	O
error	O
analysis	O
of	O
the	O
corpus	O
,	O
we	O
identified	O
the	O
most	O
problematic	O
issues	O
,	O
which	O
included	O
difficulties	O
in	O
assigning	O
particular	O
semantic	O
roles	O
,	O
particularly	O
CONDITION	O
and	O
DESCRIPTIVE-THEME	O
.	O

A	C
full	C
examination	C
of	C
the	C
problematic	C
cases	C
will	C
allow	C
us	C
to	C
further	C
improve	C
the	C
guidelines	C
and	C
possibly	C
impose	C
further	C
restrictions	C
in	C
the	C
annotation	C
software	C
,	C
to	C
prevent	C
common	C
types	C
of	C
errors	C
being	C
made	C
.	C

As	C
regards	C
biological	C
concepts	C
,	C
our	C
results	C
show	C
that	C
,	C
although	C
high	C
levels	C
of	C
agreement	C
can	C
be	C
achieved	C
when	C
considering	C
a	C
coarse-grained	C
set	C
of	C
categories	C
,	C
the	C
use	C
of	C
a	C
fine-grained	C
classification	C
caused	C
some	C
difficulties	C
.	C

This	C
is	C
possibly	C
due	C
to	C
the	C
differing	C
levels	C
of	C
expertise	C
of	C
annotators	C
within	C
the	C
gene	C
regulation	C
and	C
expression	C
domain	C
,	C
which	C
may	C
have	C
resulted	C
in	C
varying	C
levels	C
of	C
confidence	C
in	C
assigning	C
more	C
specific	C
concepts	C
.	C

A	C
solution	C
for	C
further	C
phases	C
of	C
annotation	C
would	C
be	C
to	C
analyze	C
the	C
domain	C
knowledge	C
of	C
annotators	C
in	C
greater	C
detail	C
and	C
,	C
where	C
appropriate	C
,	C
provide	C
extra	C
training	C
in	C
the	C
assignment	C
of	C
more	C
specific	C
categories	C
.	C

This	C
may	C
be	C
combined	C
with	C
a	C
re-evaluation	C
and	C
possible	C
simplification	C
of	C
the	C
concept	C
hierarchies	C
.	C

A	O
further	O
major	O
direction	O
of	O
future	O
work	O
will	O
be	O
to	O
apply	O
our	O
scheme	O
to	O
a	O
greater	O
range	O
of	O
biomedical	O
texts	O
that	O
describe	O
a	O
wider	O
range	O
of	O
event	O
types	O
.	O

Whilst	C
other	C
event	C
types	C
may	C
require	C
the	C
use	C
of	C
alternative	C
biological	C
concepts	C
or	C
ontologies	C
,	C
we	C
would	C
like	C
to	C
verify	C
that	C
our	C
set	C
of	C
semantic	C
roles	C
is	C
applicable	C
to	C
events	C
in	C
other	C
areas	C
of	C
biomedicine	C
.	C

The	C
texts	C
we	C
will	C
consider	C
will	C
also	C
include	C
full	C
texts	C
,	C
in	C
which	C
events	C
may	C
be	C
expressed	C
in	C
different	C
ways	C
from	C
abstracts	C
,	C
and	C
may	C
involve	C
different	C
(	C
higher	C
)	C
numbers	C
of	C
arguments	C
.	C

Finally	O
,	O
we	O
wish	O
to	O
ensure	O
that	O
others	O
can	O
use	O
and	O
evaluate	O
the	O
GREC	O
as	O
simply	O
as	O
possible	O
.	O

Our	O
future	O
plan	O
includes	O
facilitating	O
this	O
in	O
two	O
different	O
ways	O
:	O

Firstly	O
,	O
in	O
response	O
to	O
the	O
current	O
diversity	O
of	O
corpus	O
annotation	O
formats	O
and	O
the	O
problems	O
this	O
causes	O
in	O
their	O
comparative	O
evaluation	O
[	O
63	O
]	O
,	O
a	O
shared	O
format	O
has	O
been	O
created	O
for	O
resources	O
for	O
biomedical	O
relation	O
extraction	O
[	O
15	O
]	O
,	O
together	O
with	O
a	O
standard	O
for	O
the	O
evaluation	O
of	O
relation	O
extraction	O
methods	O
using	O
this	O
data	O
[	O
64	O
]	O
.	O

We	O
plan	O
to	O
convert	O
our	O
own	O
corpus	O
to	O
this	O
format	O
,	O
which	O
has	O
already	O
been	O
carried	O
out	O
for	O
several	O
biomedical	O
corpora	O
,	O
e.g.	O
,	O
[	O
13,16,21,23	O
]	O
.	O

Secondly	O
,	O
we	O
plan	O
to	O
develop	O
a	O
corpus	O
reader	O
which	O
will	O
allow	O
the	O
GREC	O
to	O
be	O
made	O
available	O
within	O
the	O
U-Compare	O
system	O
[	O
65	O
]	O
(	O
http	O
:	O
//u-compare.org	O
)	O
.	O

This	O
is	O
an	O
integrated	O
text	O
mining/natural	O
language	O
processing	O
system	O
based	O
on	O
the	O
UIMA	O
Framework	O
[	O
66	O
]	O
,	O
which	O
provides	O
access	O
to	O
a	O
large	O
collection	O
of	O
ready-to-use	O
interoperable	O
natural	O
language	O
processing	O
components	O
.	O

A	O
structure	O
filter	O
for	O
the	O
Eukaryotic	O
Linear	O
Motif	O
Resource	O

Abstract	O

Background	O

Many	O
proteins	O
are	O
highly	O
modular	O
,	O
being	O
assembled	O
from	O
globular	O
domains	O
and	O
segments	O
of	O
natively	O
disordered	O
polypeptides	O
.	O

Linear	O
motifs	O
,	O
short	O
sequence	O
modules	O
functioning	O
independently	O
of	O
protein	O
tertiary	O
structure	O
,	O
are	O
most	O
abundant	O
in	O
natively	O
disordered	O
polypeptides	O
but	O
are	O
also	O
found	O
in	O
accessible	O
parts	O
of	O
globular	O
domains	O
,	O
such	O
as	O
exposed	O
loops	O
.	O

The	O
prediction	O
of	O
novel	O
occurrences	O
of	O
known	O
linear	O
motifs	O
attempts	O
the	O
difficult	O
task	O
of	O
distinguishing	O
functional	O
matches	O
from	O
stochastically	O
occurring	O
non-functional	O
matches	O
.	O

Although	O
functionality	O
can	O
only	O
be	O
confirmed	O
experimentally	O
,	O
confidence	O
in	O
a	O
putative	O
motif	O
is	O
increased	O
if	O
a	O
motif	O
exhibits	O
attributes	O
associated	O
with	O
functional	O
instances	O
such	O
as	O
occurrence	O
in	O
the	O
correct	O
taxonomic	O
range	O
,	O
cellular	O
compartment	O
,	O
conservation	O
in	O
homologues	O
and	O
accessibility	O
to	O
interacting	O
partners	O
.	O

Several	O
tools	O
now	O
use	O
these	O
attributes	O
to	O
classify	O
putative	O
motifs	O
based	O
on	O
confidence	O
of	O
functionality	O
.	O

Results	O

Current	O
methods	O
assessing	O
motif	O
accessibility	O
do	O
not	O
consider	O
much	O
of	O
the	O
information	O
available	O
,	O
either	O
predicting	O
accessibility	O
from	O
primary	O
sequence	O
or	O
regarding	O
any	O
motif	O
occurring	O
in	O
a	O
globular	O
region	O
as	O
low	O
confidence	O
.	O

We	O
present	O
a	O
method	O
considering	O
accessibility	O
and	O
secondary	O
structural	O
context	O
derived	O
from	O
experimentally	O
solved	O
protein	O
structures	O
to	O
rectify	O
this	O
situation	O
.	O

Putatively	C
functional	C
motif	C
occurrences	C
are	C
mapped	C
onto	C
a	C
representative	C
domain	C
,	C
given	C
that	C
a	C
high	C
quality	C
reference	C
SCOP	C
domain	C
structure	C
is	C
available	C
for	C
the	C
protein	C
itself	C
or	C
a	C
close	C
relative	C
.	C

Candidate	O
motifs	O
can	O
then	O
be	O
scored	O
for	O
solvent-accessibility	O
and	O
secondary	O
structure	O
context	O
.	O

The	O
scores	O
are	O
calibrated	O
on	O
a	O
benchmark	O
set	O
of	O
experimentally	O
verified	O
motif	O
instances	O
compared	O
with	O
a	O
set	O
of	O
random	O
matches	O
.	O

A	O
combined	O
score	O
yields	O
3-fold	O
enrichment	O
for	O
functional	O
motifs	O
assigned	O
to	O
high	O
confidence	O
classifications	O
and	O
2.5-fold	O
enrichment	O
for	O
random	O
motifs	O
assigned	O
to	O
low	O
confidence	O
classifications	O
.	O

The	O
structure	O
filter	O
is	O
implemented	O
as	O
a	O
pipeline	O
with	O
both	O
a	O
graphical	O
interface	O
via	O
the	O
ELM	O
resource	O
http	O
:	O
//elm.eu.org/	O
and	O
through	O
a	O
Web	O
Service	O
protocol	O
.	O

Conclusion	O

New	O
occurrences	O
of	O
known	O
linear	O
motifs	O
require	O
experimental	O
validation	O
as	O
the	O
bioinformatics	O
tools	O
currently	O
have	O
limited	O
reliability	O
.	O

The	O
ELM	O
structure	O
filter	O
will	O
aid	O
users	O
assessing	O
candidate	O
motifs	O
presenting	O
in	O
globular	O
structural	O
regions	O
.	O

Most	O
importantly	O
,	O
it	O
will	O
help	O
users	O
to	O
decide	O
whether	O
to	O
expend	O
their	O
valuable	O
time	O
and	O
resources	O
on	O
experimental	O
testing	O
of	O
interesting	O
motif	O
candidates	O
.	O

Background	O

In	O
recent	O
years	O
it	O
has	O
become	O
clear	O
that	O
proteins	O
with	O
highly	O
modular	O
architectures	O
possess	O
numerous	O
short	O
peptide	O
motifs	O
that	O
are	O
essential	O
to	O
their	O
function	O
[	O
1-5	O
]	O
.	O

Such	O
peptides	O
are	O
termed	O
Linear	O
Motifs	O
(	O
LM	O
)	O
as	O
,	O
in	O
contrast	O
to	O
the	O
globular	O
domains	O
,	O
their	O
function	O
is	O
independent	O
of	O
tertiary	O
structure	O
and	O
encoded	O
solely	O
by	O
the	O
amino	O
acid	O
sequence	O
.	O

They	C
are	C
found	C
in	C
a	C
diverse	C
range	C
of	C
proteins	C
,	C
such	C
as	C
membrane	C
receptors	C
,	C
adaptors	C
,	C
scaffolds	C
and	C
transcription	C
factors	C
,	C
and	C
mediate	C
numerous	C
tasks	C
,	C
which	C
can	C
be	C
as	C
disparate	C
as	C
directing	C
subcellular	C
localization	C
or	C
acting	C
as	C
sites	C
of	C
cleavage	C
.	C

Well-known	O
LMs	O
include	O
peptides	O
binding	O
SH3	O
,	O
Cyclin	O
,	O
PDZ	O
and	O
WW	O
domains	O
[	O
6-10	O
]	O
and	O
phosphorylated	O
peptides	O
interacting	O
with	O
SH2	O
,	O
PTB	O
,	O
BRCT	O
and	O
FHA	O
phosphopeptide-binding	O
domains	O
[	O
11-17	O
]	O
.	O

The	O
biological	O
properties	O
and	O
range	O
of	O
functions	O
mediated	O
by	O
LMs	O
are	O
reviewed	O
in	O
detail	O
elsewhere	O
[	O
4,18-20	O
]	O
.	O

In	O
order	O
to	O
deconvolute	O
the	O
functional	O
components	O
of	O
modular	O
protein	O
architectures	O
,	O
it	O
is	O
necessary	O
to	O
identify	O
the	O
set	O
of	O
LMs	O
as	O
well	O
as	O
the	O
folded	O
components	O
.	O

However	O
,	O
this	O
is	O
not	O
straightforward	O
because	O
simple	O
searches	O
with	O
short	O
sequence	O
patterns	O
,	O
known	O
to	O
act	O
as	O
functional	O
modules	O
,	O
are	O
uninformative	O
-	O
returning	O
a	O
flood	O
of	O
false	O
positive	O
matches	O
.	O

Several	O
tools	O
have	O
been	O
developed	O
to	O
rank	O
motifs	O
based	O
on	O
confidence	O
of	O
functionality	O
by	O
classifying	O
putative	O
motifs	O
based	O
on	O
the	O
hypothesis	O
that	O
functional	O
motifs	O
will	O
have	O
attributes	O
similar	O
to	O
experimentally	O
discovered	O
motifs	O
.	O

Although	C
classification	C
tools	C
can	C
not	C
definitely	C
confirm	C
a	C
motif	C
as	C
functional	C
(	C
only	C
experimental	C
analysis	C
can	C
achieve	C
this	C
)	C
they	C
can	C
be	C
used	C
to	C
attach	C
a	C
level	C
of	C
confidence	C
to	C
a	C
motif	C
.	C

For	C
example	C
motifs	C
which	C
occur	C
in	C
an	C
incorrect	C
cellular	C
compartment	C
,	C
or	C
outside	C
the	C
known	C
taxonomic	C
range	C
,	C
are	C
unlikely	C
to	C
be	C
functional	C
as	C
are	C
those	C
which	C
are	C
not	C
conserved	C
in	C
closely	C
related	C
proteins	C
or	C
buried	C
in	C
a	C
globular	C
domain	C
inaccessible	C
for	C
interaction	C
.	C

Available	O
motif	O
discovery	O
tools	O
vary	O
in	O
their	O
implementation	O
of	O
confidence-related	O
metrics	O
.	O

ScanProsite	O
[	O
21	O
]	O
,	O
the	O
web-based	O
tool	O
for	O
detecting	O
PROSITE	O
[	O
22	O
]	O
signature	O
matches	O
in	O
protein	O
sequences	O
,	O
recently	O
integrated	O
ProRules	O
[	O
23	O
]	O
,	O
a	O
database	O
containing	O
additional	O
information	O
about	O
PROSITE	O
profiles	O
,	O
with	O
the	O
aim	O
of	O
increasing	O
the	O
discriminatory	O
power	O
of	O
PROSITE	O
profiles	O
to	O
facilitate	O
function	O
determination	O
and	O
provide	O
biologically	O
relevant	O
information	O
for	O
the	O
annotation	O
of	O
proteins	O
.	O

MnM	O
[	O
24,25	O
]	O
,	O
a	O
motif	O
database	O
and	O
a	O
web-based	O
tool	O
for	O
identifying	O
candidate	O
motif	O
occurrences	O
in	O
proteins	O
,	O
addresses	O
the	O
issue	O
of	O
non-functional	O
false	O
positives	O
by	O
implementing	O
evolutionary	O
conservation	O
,	O
surface	O
prediction	O
and	O
frequency	O
scores	O
to	O
rank	O
motif	O
occurrences	O
in	O
a	O
protein	O
query	O
.	O

The	O
Eukaryotic	O
Linear	O
Motif	O
(	O
ELM	O
)	O
resource	O
filters	O
implausible	O
motif	O
occurrences	O
according	O
to	O
cell	O
compartment	O
and	O
taxonomic	O
range	O
[	O
2	O
]	O
.	O

It	C
also	C
indicates	C
less	C
likely	C
matches	C
that	C
lie	C
within	C
globular	C
domains	C
annotated	C
in	C
the	C
SMART	C
[	C
26	C
]	C
and	C
Pfam	C
[	C
27	C
]	C
resources	C
and	C
contrasts	C
these	C
with	C
intrinsically	C
unstructured	C
polypeptide	C
(	C
IUP	C
)	C
regions	C
predicted	C
by	C
GlobPlot	C
[	C
28	C
]	C
that	C
are	C
more	C
likely	C
to	C
be	C
motif-rich	C
[	C
5	C
]	C
.	C

DILIMOT	O
and	O
SLiMFinder	O
-	O
tools	O
designed	O
for	O
discovery	O
of	O
candidate	O
novel	O
peptide	O
patterns	O
significantly	O
enriched	O
in	O
protein	O
interaction	O
datasets	O
-	O
also	O
use	O
some	O
of	O
these	O
techniques	O
to	O
improve	O
confidence	O
in	O
returned	O
motifs	O
[	O
29,30	O
]	O
.	O

Sequence	O
conservation	O
has	O
also	O
been	O
shown	O
to	O
be	O
effective	O
in	O
up-weighting	O
true	O
motifs	O
relative	O
to	O
false	O
positive	O
matches	O
[	O
31-33	O
]	O
.	O

In	O
the	O
intracellular	O
milieu	O
,	O
LMs	O
are	O
found	O
to	O
be	O
particularly	O
abundant	O
in	O
segments	O
of	O
IUP	O
where	O
they	O
are	O
readily	O
accessible	O
[	O
34	O
]	O
.	O

Accessibility	O
is	O
a	O
basic	O
requirement	O
of	O
LM	O
function	O
which	O
is	O
almost	O
always	O
mediated	O
by	O
direct	O
interaction	O
with	O
globular	O
domain	O
ligands	O
.	O

Extracellular	O
proteins	O
tend	O
to	O
have	O
much	O
less	O
natively	O
disordered	O
polypeptide	O
and	O
therefore	O
the	O
extracellular	O
linear	O
motifs	O
such	O
as	O
N-glycosylation	O
sites	O
[	O
35	O
]	O
and	O
the	O
integrin-binding	O
RGD	O
motif	O
[	O
36	O
]	O
usually	O
occur	O
within	O
globular	O
domains	O
,	O
most	O
often	O
residing	O
in	O
exposed	O
loop	O
regions	O
.	O

LMs	O
are	O
also	O
regularly	O
found	O
in	O
globular	O
regions	O
of	O
intracellular	O
proteins	O
-	O
for	O
example	O
phosphorylation	O
sites	O
are	O
common	O
in	O
flexible	O
loops	O
[	O
37	O
]	O
.	O

However	O
,	O
close	O
inspection	O
of	O
the	O
literature	O
also	O
reveals	O
many	O
instances	O
of	O
candidate	O
motifs	O
falsely	O
reported	O
as	O
functional	O
on	O
the	O
basis	O
of	O
loss	O
of	O
function	O
mutagenesis	O
and	O
out-of-context	O
peptide-binding	O
experiments	O
,	O
despite	O
the	O
motif	O
being	O
well	O
structured	O
and	O
sometimes	O
deeply	O
buried	O
in	O
a	O
globular	O
domain	O
[	O
38-41	O
]	O
.	O

This	C
observation	C
suggests	C
that	C
stringent	C
examination	C
of	C
motif	C
structural	C
context	C
should	C
be	C
an	C
essential	C
processing	C
step	C
for	C
experimental	C
analysis	C
.	C

It	C
also	C
advocates	C
the	C
importance	C
of	C
high	C
quality	C
tools	C
to	C
identify	C
such	C
cases	C
,	C
as	C
the	C
cost	C
associated	C
with	C
failure	C
is	C
detrimental	C
both	C
in	C
terms	C
of	C
effort	C
and	C
quality	C
of	C
the	C
literature	C
.	C

Despite	O
this	O
,	O
neither	O
the	O
ELM	O
globular	O
domain	O
classification	O
nor	O
the	O
MnM	O
surface	O
prediction	O
score	O
take	O
advantage	O
of	O
all	O
the	O
information	O
available	O
to	O
them	O
in	O
the	O
form	O
of	O
the	O
plethora	O
of	O
experimentally	O
solved	O
protein	O
structures	O
.	O

ELM	O
globular	O
domain	O
classification	O
is	O
overly	O
strict	O
,	O
classifying	O
motifs	O
occurring	O
in	O
these	O
regions	O
as	O
low	O
confidence	O
.	O

The	O
MnM	O
surface	O
prediction	O
score	O
uses	O
primary	O
sequence	O
based	O
prediction	O
both	O
in	O
those	O
cases	O
where	O
a	O
structure	O
is	O
available	O
and	O
in	O
regions	O
where	O
a	O
disorder	O
predictor	O
will	O
render	O
secondary	O
structure	O
prediction	O
unnecessary	O
.	O

In	O
the	O
present	O
manuscript	O
,	O
we	O
address	O
the	O
issue	O
of	O
LM	O
accessibility	O
when	O
the	O
matches	O
occur	O
within	O
globular	O
domains	O
for	O
which	O
a	O
reference	O
three-dimensional	O
(	O
3D	O
)	O
structure	O
is	O
available	O
.	O

Development	O
and	O
calibration	O
of	O
a	O
structure	O
filter	O
is	O
currently	O
not	O
straightforward	O
as	O
there	O
are	O
relatively	O
few	O
available	O
structures	O
for	O
most	O
motif	O
classes	O
(	O
an	O
obvious	O
exception	O
being	O
N-glycosylation	O
sites	O
)	O
,	O
placing	O
limitations	O
on	O
the	O
training	O
and	O
benchmarking	O
possibilities	O
.	O

Nevertheless	O
,	O
we	O
have	O
been	O
able	O
to	O
develop	O
a	O
protocol	O
in	O
which	O
reference	O
domain	O
structures	O
are	O
selected	O
and	O
then	O
the	O
matched	O
motifs	O
evaluated	O
using	O
accessibility	O
and	O
secondary	O
structure	O
parameters	O
.	O

Benchmarking	C
of	C
the	C
structure	C
filter	C
suggests	C
that	C
deeply	C
buried	C
LM	C
candidates	C
are	C
unlikely	C
to	C
be	C
functional	C
,	C
and	C
that	C
the	C
likelihood	C
of	C
motif	C
matches	C
being	C
valid	C
functional	C
sites	C
improves	C
with	C
accessibility	C
.	C

In	C
this	C
way	C
,	C
the	C
new	C
filter	C
can	C
aid	C
researchers	C
to	C
decide	C
whether	C
they	C
wish	C
to	C
invest	C
effort	C
inexperimentaltesting	C
of	C
candidate	C
motifs	C
.	C

The	O
structure	O
filter	O
pipeline	O
is	O
implemented	O
in	O
a	O
publicly	O
available	O
Python	O
program	O
accessible	O
via	O
a	O
web-service	O
interface	O
[	O
42	O
]	O
.	O

The	O
structure	O
filter	O
is	O
fully	O
integrated	O
into	O
the	O
ELM	O
server	O
[	O
43	O
]	O
,	O
providing	O
graphical	O
representation	O
of	O
the	O
results	O
in	O
the	O
context	O
of	O
the	O
other	O
filters	O
.	O

Results	O

The	O
ELM	O
structure	O
filter	O
scoring	O
scheme	O

Structural	O
analysis	O
of	O
true	O
motif	O
instances	O
annotated	O
in	O
ELM	O
supported	O
what	O
is	O
expected	O
from	O
LM	O
biology	O
[	O
3	O
]	O
,	O
i.e	O
.	O
that	O
they	O
tend	O
to	O
lie	O
on	O
the	O
surface	O
of	O
protein	O
domains	O
and	O
prefer	O
unstructured	O
and	O
loop	O
regions	O
(	O
See	O
below	O
``	O
Analysis	O
of	O
the	O
ELM	O
3D	O
benchmarking	O
dataset	O
''	O
)	O
.	O

Figure	O
1	O
shows	O
two	O
examples	O
of	O
motifs	O
lying	O
on	O
domain	O
interfaces	O
whereas	O
Figure	O
2	O
reports	O
cases	O
of	O
motif	O
instances	O
whose	O
functional	O
residues	O
protrude	O
outwards	O
from	O
the	O
domain	O
surface	O
and	O
hence	O
are	O
accessible	O
to	O
the	O
solvent	O
.	O

This	O
observation	O
was	O
further	O
supported	O
by	O
the	O
comparison	O
between	O
the	O
accessibility	O
and	O
secondary	O
structure	O
distributions	O
of	O
true	O
motifs	O
vs	O
random	O
matches	O
(	O
determined	O
as	O
described	O
in	O
Methods	O
)	O
in	O
our	O
datasets	O
(	O
Figure	O
3	O
)	O
,	O
which	O
highlights	O
that	O
true	O
motifs	O
are	O
on	O
average	O
more	O
accessible	O
than	O
random	O
matches	O
(	O
p-value	O
=	O
1.9e-55	O
)	O
;	O
moreover	O
,	O
loops	O
are	O
more	O
represented	O
(	O
p-value	O
=	O
1.13e-35	O
)	O
in	O
true	O
motifs	O
than	O
in	O
random	O
matches	O
and	O
both	O
alpha-helices	O
and	O
strands	O
are	O
less	O
represented	O
in	O
true	O
motifs	O
than	O
in	O
random	O
matches	O
(	O
p-value	O
=	O
3.69e-12	O
and	O
2.66e-16	O
,	O
respectively	O
)	O
.	O

These	O
results	O
convinced	O
us	O
to	O
base	O
the	O
structure	O
filter	O
scoring	O
scheme	O
on	O
accessibility	O
and	O
secondary	O
structure	O
assignments	O
.	O

Two	O
examples	O
of	O
linear	O
motifs	O
packed	O
into	O
structured	O
domains	O
.	O
a	O
)	O
PDB	O
2D07	O
:	O
Sumo-interacting	O
motif	O
(	O
orange	O
)	O
of	O
TDG	O
domain	O
(	O
green	O
)	O
bound	O
to	O
SUMO-3	O
protein	O
(	O
cyan	O
)	O
;	O
b	O
)	O
PDB	O
2PTK	O
:	O
closed	O
conformation	O
of	O
the	O
proto-oncogene	O
tyrosine-protein	O
kinase	O
Src	O
.	O
Blue	O
:	O
SH2	O
domain	O
;	O
red	O
:	O
SH3	O
domain	O
;	O
green	O
:	O
protein	O
kinase	O
;	O
orange	O
:	O
pTyr-527	O
;	O
yellow	O
:	O
linkers	O
;	O
yellow	O
spheres	O
:	O
SH3	O
binding	O
peptide	O
.	O

All	O
structure	O
views	O
were	O
prepared	O
with	O
PyMOL	O
http	O
:	O
//www.pymol.org/	O
.	O

Examples	O
of	O
linear	O
motifs	O
with	O
functional	O
residues	O
protruding	O
outwards	O
from	O
the	O
structural	O
domain	O
surface	O
.	O
a	O
)	O
A	O
very	O
exposed	O
instance	O
(	O
in	O
white	O
)	O
of	O
LIG_RGD	O
in	O
a	O
loop	O
of	O
SCOP	O
domain	O
d1	O
mfn_2	O
;	O
b	O
)	O
An	O
instance	O
(	O
in	O
violet	O
)	O
of	O
LIG_RGD	O
in	O
a	O
region	O
outside	O
a	O
domain	O
(	O
SCOP	O
d1ssua_	O
)	O
;	O
c	O
)	O
An	O
instance	O
(	O
in	O
pink	O
)	O
of	O
MOD_SUMO	O
in	O
an	O
exposed	O
loop	O
of	O
the	O
d1kpsd_	O
SCOP	O
domain	O
;	O
d	O
)	O
The	O
MOD_CMANNOS	O
C-Mannosylation	O
site	O
(	O
in	O
magenta	O
)	O
in	O
the	O
SCOP	O
domain	O
d1k2aa_	O
;	O
e	O
)	O
The	O
two	O
MOD_N-GLC_1	O
N-glycosylation	O
sites	O
(	O
in	O
yellow	O
)	O
in	O
the	O
SCOP	O
domain	O
d1qm3a_	O
;	O
f	O
)	O
The	O
N-glycosylation	O
site	O
(	O
in	O
red	O
)	O
in	O
the	O
SCOP	O
domain	O
d1fl7b_	O
;	O
g	O
)	O
,	O
h	O
)	O
The	O
N-glycosylation	O
site	O
(	O
in	O
green	O
)	O
in	O
the	O
SCOP	O
domain	O
d1o7ae2	O
and	O
(	O
in	O
red	O
)	O
in	O
the	O
SCOP	O
domain	O
d1n26a1	O
.	O

Secondary	O
structure	O
frequency	O
and	O
accessibility	O
distribution	O
for	O
true	O
motif	O
instances	O
and	O
for	O
random	O
matches	O
.	O

3a	O
)	O
Boxplots	O
representing	O
the	O
accessibility	O
distributions	O
of	O
true	O
motif	O
instances	O
(	O
orange	O
)	O
and	O
of	O
random	O
matches	O
(	O
yellow	O
)	O
,	O
calculated	O
for	O
all	O
motif	O
positions	O
(	O
all	O
positions	O
)	O
,	O
non-wildcard	O
positions	O
only	O
(	O
non-wildcard	O
)	O
and	O
wildcard	O
positions	O
only	O
(	O
wildcard	O
)	O
.	O

The	O
solid	O
box	O
lower	O
and	O
upper	O
bounds	O
represent	O
the	O
25th	O
and	O
75th	O
percentile	O
,	O
respectively	O
.	O

Circles	O
represent	O
outliers	O
;	O
3b	O
)	O
frequencies	O
of	O
each	O
secondary	O
structure	O
element	O
type	O
in	O
true	O
motif	O
instances	O
and	O
in	O
random	O
matches	O
,	O
calculated	O
for	O
all	O
motif	O
positions	O
,	O
for	O
non-wildcard	O
positions	O
only	O
and	O
for	O
wildcard	O
positions	O
only	O
.	O

The	O
aim	O
of	O
the	O
scoring	O
procedure	O
is	O
to	O
assign	O
a	O
score	O
to	O
LM	O
candidates	O
in	O
the	O
user	O
query	O
sequence	O
given	O
that	O
a	O
reference	O
structure	O
is	O
available	O
.	O

In	O
order	O
to	O
do	O
this	O
,	O
the	O
structure	O
filter	O
scans	O
the	O
LM	O
match	O
3D	O
context	O
position	O
by	O
position	O
,	O
evaluates	O
the	O
relative	O
accessibility	O
and	O
the	O
secondary	O
structure	O
of	O
each	O
single	O
position	O
i	O
,	O
and	O
assigns	O
an	O
accessibility	O
score	O
(	O
Qacc	O
)	O
and	O
a	O
secondary	O
structure	O
score	O
(	O
Qsse	O
)	O
to	O
the	O
motif	O
match	O
as	O
the	O
normalized	O
sums	O
of	O
its	O
single	O
position	O
scores	O
.	O

More	O
specifically	O
,	O
the	O
score	O
of	O
a	O
motif	O
match	O
is	O
calculated	O
on	O
the	O
non-wildcard	O
positions	O
of	O
the	O
regular	O
expression	O
pattern	O
for	O
the	O
motif	O
as	O
:	O

where	O
N	O
is	O
the	O
number	O
of	O
non-wildcard	O
positions	O
of	O
a	O
match	O
,	O
i.e	O
.	O
the	O
number	O
of	O
non-wildcard	O
residues	O
in	O
a	O
LM	O
occurrence	O
,	O
i	O
is	O
the	O
ith	O
position	O
along	O
the	O
match	O
,	O
i	O
∈	O
Ω	O
means	O
that	O
the	O
sum	O
is	O
limited	O
to	O
the	O
set	O
of	O
non-wildcard	O
positions	O
,	O
Ω	O
,	O
and	O
q	O
(	O
i	O
)	O
is	O
the	O
positional	O
score	O
of	O
position	O
i	O
.	O

Note	O
that	O
Qacc	O
and	O
Qsse	O
were	O
also	O
calculated	O
for	O
all	O
LM	O
positions	O
(	O
i.e	O
.	O
not	O
limiting	O
the	O
sum	O
to	O
the	O
set	O
of	O
non-wildcard	O
positions	O
)	O
and	O
found	O
to	O
be	O
marginally	O
less	O
discriminating	O
than	O
those	O
only	O
based	O
on	O
non-wildcard	O
positions	O
.	O

In	O
this	O
regard	O
,	O
Figure	O
3	O
shows	O
that	O
the	O
accessibility	O
differences	O
between	O
wildcard	O
and	O
non-wildcard	O
positions	O
are	O
statistically	O
significant	O
in	O
the	O
case	O
of	O
true	O
motifs	O
(	O
t-test	O
's	O
confidence	O
level	O
=	O
0.99	O
,	O
p-value	O
=	O
3.058e-05	O
)	O
(	O
Figure	O
3a	O
)	O
and	O
that	O
true	O
motif	O
non-wildcard	O
positions	O
have	O
a	O
more	O
pronounced	O
tendency	O
to	O
be	O
in	O
loops	O
and	O
a	O
less	O
marked	O
disposition	O
to	O
be	O
in	O
helices	O
and	O
strands	O
as	O
opposed	O
to	O
the	O
frequencies	O
both	O
of	O
true	O
motifs	O
for	O
all	O
positions	O
and	O
for	O
wildcard	O
positions	O
,	O
even	O
if	O
none	O
of	O
these	O
differences	O
is	O
statistically	O
significant	O
(	O
Figure	O
3b	O
)	O
.	O

For	O
further	O
details	O
see	O
additional	O
file	O
1	O
,	O
additional	O
file	O
2	O
(	O
Figure	O
S1	O
)	O
and	O
additional	O
file	O
3	O
(	O
Figure	O
S2	O
)	O
.	O

We	O
adopted	O
as	O
accessibility	O
positional	O
score	O
,	O
qacc	O
(	O
i	O
)	O
,	O
of	O
position	O
i	O
,	O
the	O
normalized	O
solvent	O
exposure	O
value	O
of	O
the	O
residue	O
in	O
i	O
,	O
which	O
ranges	O
between	O
0	O
(	O
non	O
exposed	O
)	O
and	O
1	O
.	O

5	O
.	O
Thus	O
,	O
the	O
higher	O
the	O
residue	O
exposure	O
,	O
the	O
more	O
the	O
corresponding	O
position	O
is	O
rewarded	O
.	O

The	O
secondary	O
structure	O
positional	O
score	O
,	O
qsse	O
(	O
i	O
)	O
,	O
was	O
determined	O
in	O
a	O
more	O
complex	O
manner	O
.	O

The	O
analysis	O
of	O
LM	O
instances	O
on	O
structural	O
domains	O
showed	O
that	O
they	O
occur	O
more	O
frequently	O
in	O
loops	O
and	O
unstructured	O
regions	O
than	O
expected	O
by	O
chance	O
.	O

In	O
order	O
to	O
quantify	O
this	O
observation	O
,	O
we	O
calculated	O
,	O
for	O
each	O
secondary	O
structure	O
element	O
(	O
SSE	O
)	O
type	O
(	O
loop	O
,	O
helix	O
,	O
strand	O
,	O
3/10	O
helix	O
-	O
see	O
Methods	O
)	O
,	O
the	O
ratio	O
between	O
the	O
SSE	O
type	O
frequency	O
(	O
ν	O
)	O
among	O
true	O
motif	O
instances	O
and	O
among	O
random	O
matches	O
.	O

The	O
corresponding	O
values	O
are	O
reported	O
in	O
Table	O
1	O
.	O

Frequency	O
of	O
secondary	O
structure	O
elements	O
in	O
true	O
and	O
in	O
random	O
motifs	O

Thus	O
,	O
the	O
secondary	O
structure	O
score	O
of	O
a	O
position	O
i	O
whose	O
SSE	O
assignment	O
is	O
loop	O
(	O
or	O
3/10	O
helix	O
,	O
helix	O
,	O
strand	O
)	O
,	O
is	O
the	O
ratio	O
between	O
the	O
frequency	O
of	O
loops	O
(	O
or	O
3/10	O
helices	O
,	O
helices	O
,	O
strands	O
)	O
in	O
the	O
instance	O
dataset	O
and	O
the	O
frequency	O
of	O
loops	O
(	O
or	O
3/10	O
helices	O
,	O
helices	O
,	O
strands	O
)	O
in	O
the	O
random	O
dataset	O
.	O

Assessing	O
the	O
predictive	O
ability	O
of	O
the	O
ELM	O
structure	O
filter	O

In	O
order	O
to	O
assess	O
the	O
predictive	O
ability	O
of	O
the	O
ELM	O
structure	O
filter	O
scoring	O
scheme	O
,	O
we	O
made	O
use	O
of	O
five	O
strategies	O
,	O
each	O
introducing	O
useful	O
parameters	O
for	O
the	O
evaluation	O
of	O
the	O
discrimination	O
power	O
of	O
our	O
procedure	O
:	O
1	O
)	O
we	O
plotted	O
ROC	O
curves	O
and	O
calculated	O
AUCs	O
;	O
2	O
)	O
we	O
assigned	O
a	O
p-value	O
to	O
predictions	O
;	O
3	O
)	O
we	O
built	O
LM-specific	O
background	O
distributions	O
;	O
4	O
)	O
we	O
identified	O
sparse/neutral/enriched	O
score	O
intervals	O
;	O
5	O
)	O
we	O
carried	O
out	O
a	O
5-fold	O
cross	O
validation	O
in	O
order	O
to	O
determine	O
sensitivity	O
,	O
specificity	O
and	O
accuracy	O
.	O

In	C
order	C
that	C
the	C
structure	C
filter	C
may	C
be	C
a	C
useful	C
guide	C
to	C
the	C
ELM	C
resource	C
user	C
,	C
we	C
propose	C
that	C
the	C
values	C
of	C
the	C
above-mentioned	C
parameters	C
are	C
used	C
as	C
decision-making	C
tools	C
in	C
evaluating	C
the	C
score	C
of	C
LM	C
predictions	C
.	C

In	C
particular	C
,	C
since	C
having	C
high	C
accessibility	C
and	C
belonging	C
to	C
loop	C
regions	C
is	C
not	C
a	C
prerogative	C
of	C
LMs	C
alone	C
and	C
the	C
random	C
match	C
dataset	C
might	C
in	C
principle	C
be	C
``	C
contaminated	C
''	C
by	C
not	C
yet	C
annotated	C
spurious	C
true	C
motifs	C
,	C
we	C
suggest	C
using	C
as	C
many	C
indicators	C
as	C
possible	C
in	C
evaluating	C
a	C
prediction	C
score	C
and	C
not	C
relying	C
on	C
each	C
single	C
tool	C
as	C
a	C
unique	C
criterion	C
for	C
retaining/rejecting	C
a	C
prediction	C
.	C

In	C
order	C
to	C
establish	C
if	C
one	C
score	C
is	C
more	C
discriminative	C
than	C
the	C
others	C
,	C
we	C
assigned	C
an	C
accessibility	C
score	C
(	C
Qacc	C
)	C
,	C
a	C
secondary	C
structure	C
score	C
(	C
Qsse	C
)	C
and	C
a	C
combined	C
score	C
(	C
Qand	C
=	C
Qacc	C
+	C
Qsse	C
)	C
to	C
the	C
true	C
positive	C
instances	C
of	C
our	C
dataset	C
and	C
to	C
the	C
random	C
matches	C
of	C
the	C
random	C
dataset	C
,	C
plotted	C
cumulative	C
score	C
distributions	C
and	C
ROC	C
curves	C
and	C
calculated	C
the	C
area	C
under	C
the	C
ROC	C
curves	C
(	C
AUCs	C
)	C
.	C

In	C
calculating	C
the	C
ROC	C
curves	C
,	C
we	C
assumed	C
that	C
random	C
matches	C
are	C
all	C
negative	C
matches	C
.	C

Figure	O
4	O
shows	O
that	O
the	O
cumulative	O
distribution	O
of	O
true	O
motifs	O
is	O
clearly	O
separated	O
from	O
that	O
of	O
random	O
matches	O
for	O
each	O
score	O
type	O
.	O

Moreover	O
,	O
the	O
ROC	O
curves	O
(	O
Figure	O
5	O
)	O
show	O
that	O
all	O
three	O
score	O
types	O
are	O
able	O
to	O
discriminate	O
between	O
the	O
true	O
motif	O
and	O
random	O
match	O
sets	O
and	O
that	O
both	O
Qacc	O
and	O
Qand	O
perform	O
better	O
than	O
Qsse	O
;	O
the	O
AUC	O
values	O
for	O
the	O
three	O
scores	O
are	O
0.73	O
(	O
Qacc	O
)	O
,	O
0.66	O
(	O
Qsse	O
)	O
and	O
0.72	O
(	O
Qand	O
)	O
;	O
notice	O
that	O
,	O
even	O
though	O
the	O
AUC	O
for	O
Qand	O
is	O
slightly	O
lower	O
than	O
that	O
of	O
Qacc	O
,	O
Qand	O
performs	O
similarly	O
or	O
better	O
than	O
Qacc	O
in	O
the	O
range	O
corresponding	O
to	O
the	O
20	O
%	O
of	O
the	O
ROC	O
x-axis	O
values	O
.	O

Cumulative	O
score	O
distributions	O
.	O
a	O
)	O
The	O
cumulative	O
distribution	O
of	O
(	O
a	O
)	O
Qacc	O
,	O
(	O
b	O
)	O
Qsse	O
,	O
and	O
(	O
c	O
)	O
Qand	O
=	O
Qacc	O
+	O
Qsse	O
scores	O
calculated	O
for	O
true	O
motif	O
matches	O
(	O
true	O
motifs	O
)	O
,	O
and	O
for	O
random	O
matches	O
(	O
random	O
matches	O
)	O
in	O
non-wildcard	O
positions	O
.	O

Red	O
dashed	O
lines	O
indicate	O
the	O
percentile	O
cut-off	O
ensuring	O
that	O
the	O
lower	O
40	O
%	O
random	O
matches	O
fall	O
in	O
the	O
``	O
sparse	O
''	O
bin	O
.	O

The	O
consequent	O
percentage	O
of	O
true	O
motifs	O
falling	O
in	O
the	O
``	O
sparse	O
''	O
bin	O
is	O
about	O
15	O
%	O
(	O
accessibility	O
)	O
and	O
20	O
%	O
(	O
secondary	O
structure	O
)	O
.	O

This	O
cut-off	O
corresponds	O
to	O
Qacc~0.3	O
and	O
Qsse~0.7	O
.	O

Black	O
dotted	O
lines	O
indicate	O
the	O
percentile	O
cut-off	O
that	O
guarantees	O
that	O
the	O
enriched	O
bin	O
collects	O
at	O
least	O
the	O
top	O
30	O
%	O
true	O
motifs	O
.	O

This	O
cut-off	O
corresponds	O
to	O
Qacc	O
=	O
0.76	O
,	O
Qsse	O
=	O
1.5	O
,	O
and	O
Qand	O
=	O
2	O
.	O

Qacc	O
,	O
Qsse	O
and	O
Qand	O
=	O
Qacc+	O
Qsse	O
ROC	O
curves	O
.	O

We	O
determined	O
the	O
distribution	O
of	O
random	O
matches	O
and	O
use	O
it	O
to	O
assign	O
a	O
p-value	O
to	O
the	O
score	O
of	O
each	O
ELM	O
prediction	O
.	O

This	C
p-value	C
,	C
which	C
is	C
implemented	C
both	C
in	C
the	C
Web	C
Server	C
and	C
in	C
the	C
Web	C
Service	C
,	C
is	C
calculated	C
using	C
a	C
Z-test	C
and	C
is	C
a	C
conservative	C
estimate	C
of	C
the	C
probability	C
that	C
a	C
LM	C
prediction	C
with	C
a	C
given	C
score	C
is	C
a	C
true	C
positive	C
;	C
more	C
specifically	C
it	C
is	C
the	C
probability	C
of	C
obtaining	C
a	C
random	C
match	C
with	C
a	C
score	C
at	C
least	C
as	C
high	C
as	C
the	C
one	C
that	C
was	C
actually	C
observed	C
,	C
and	C
therefore	C
we	C
expect	C
it	C
to	C
be	C
very	C
stringent	C
.	C

Due	O
to	O
the	O
paucity	O
of	O
true	O
motif	O
instance	O
data	O
,	O
we	O
can	O
not	O
build	O
a	O
true	O
motif	O
score	O
distribution	O
for	O
each	O
ELM	O
motif	O
(	O
and	O
therefore	O
we	O
can	O
not	O
build	O
a	O
LM-specific	O
structure	O
filter	O
yet	O
)	O
and	O
compare	O
it	O
to	O
the	O
corresponding	O
random	O
motif	O
score	O
distribution	O
.	O

However	O
,	O
we	O
built	O
,	O
and	O
displayed	O
in	O
the	O
ELM	O
web	O
server	O
output	O
page	O
,	O
LM-specific	O
random	O
score	O
distributions	O
(	O
as	O
described	O
in	O
Methods	O
)	O
in	O
order	O
to	O
use	O
them	O
as	O
background	O
score	O
contexts	O
,	O
telling	O
the	O
users	O
something	O
about	O
the	O
average	O
behavior	O
(	O
in	O
terms	O
of	O
accessibility	O
,	O
secondary	O
structure	O
and	O
combined	O
scores	O
)	O
,	O
on	O
a	O
large	O
dataset	O
of	O
structures	O
,	O
of	O
each	O
single	O
LM	O
.	O

These	C
background	C
distributions	C
are	C
only	C
intended	C
as	C
a	C
supplementary	C
guideline	C
for	C
the	C
web	C
users	C
to	C
evaluate	C
whether	C
or	C
not	C
the	C
score	C
assigned	C
to	C
a	C
LM	C
match	C
is	C
reasonably	C
higher	C
than	C
the	C
random	C
match	C
score	C
average	C
for	C
that	C
LM	C
.	C

The	O
background	O
score	O
distributions	O
for	O
103/112	O
motifs	O
are	O
shown	O
in	O
the	O
additional	O
file	O
4	O
(	O
Figure	O
S3	O
)	O
.	O

Correspondences	O
between	O
x-axis	O
labels	O
and	O
ELM	O
names	O
are	O
reported	O
in	O
the	O
additional	O
file	O
5	O

We	O
chose	O
two	O
score	O
thresholds	O
for	O
each	O
score	O
type	O
aimed	O
at	O
defining	O
three	O
score	O
intervals	O
(	O
or	O
``	O
bins	O
''	O
)	O
,	O
one	O
``	O
sparse	O
''	O
,	O
lacking	O
in	O
true	O
motifs	O
and	O
enriched	O
in	O
random	O
matches	O
,	O
one	O
identifying	O
``	O
neutral	O
''	O
matches	O
,	O
and	O
one	O
lacking	O
in	O
random	O
matches	O
and	O
enriched	O
in	O
true	O
motifs	O
.	O

We	C
consider	C
that	C
such	C
a	C
three-interval	C
scheme	C
might	C
effectively	C
help	C
the	C
user	C
in	C
deciding	C
whether	C
to	C
retain	C
or	C
reject	C
a	C
prediction	C
.	C

In	C
fact	C
it	C
is	C
based	C
on	C
the	C
idea	C
that	C
a	C
predicted	C
match	C
that	C
is	C
assigned	C
a	C
score	C
in	C
the	C
``	C
enriched	C
''	C
interval	C
will	C
be	C
indicated	C
by	C
our	C
procedure	C
as	C
a	C
good	C
true	C
motif	C
candidate	C
(	C
i.e	C
.	C
likely	C
to	C
be	C
a	C
valid	C
functional	C
site	C
)	C
,	C
motif	C
matches	C
scoring	C
in	C
the	C
bottom	C
interval	C
(	C
``	C
sparse	C
''	C
interval	C
)	C
as	C
unlikely	C
to	C
be	C
valid	C
functional	C
sites	C
and	C
those	C
ranking	C
in	C
the	C
middle	C
one	C
as	C
``	C
neutral	C
''	C
.	C

The	O
score	O
thresholds	O
were	O
chosen	O
on	O
the	O
basis	O
of	O
the	O
cumulative	O
distributions	O
of	O
Figure	O
4	O
by	O
selecting	O
two	O
cut-offs	O
(	O
one	O
in	O
the	O
percentile	O
range	O
0-50	O
%	O
and	O
one	O
in	O
the	O
percentile	O
range	O
50	O
%	O
-100	O
%	O
)	O
,	O
roughly	O
corresponding	O
to	O
the	O
inflection	O
points	O
of	O
the	O
random	O
match	O
cumulative	O
distributions	O
,	O
and	O
guaranteeing	O
that	O
at	O
least	O
the	O
top	O
30	O
%	O
true	O
motifs	O
are	O
retained	O
in	O
the	O
enriched	O
bin	O
and	O
at	O
least	O
the	O
lower	O
40	O
%	O
random	O
matches	O
fall	O
in	O
the	O
sparse	O
bin	O
.	O

The	O
``	O
neutral	O
''	O
bin	O
is	O
delimited	O
by	O
the	O
``	O
sparse	O
''	O
and	O
``	O
enriched	O
''	O
cut-offs	O
and	O
contains	O
the	O
medium	O
quality	O
matches	O
.	O

Table	O
2	O
reports	O
Qacc	O
,	O
Qsse	O
and	O
Qand	O
thresholds	O
defining	O
the	O
three	O
bins	O
.	O

From	C
Figure	C
4	C
and	C
Table	C
3	C
,	C
it	C
can	C
be	C
seen	C
that	C
,	C
in	C
the	C
case	C
of	C
the	C
accessibility	C
score	C
(	C
Figure	C
4a	C
)	C
,	C
the	C
cut-off	C
on	C
the	C
top	C
30	C
%	C
of	C
true	C
motifs	C
implies	C
that	C
only	C
10	C
%	C
of	C
random	C
matches	C
are	C
retained	C
in	C
the	C
enriched	C
bin	C
and	C
that	C
the	C
cut-off	C
on	C
the	C
lower	C
40	C
%	C
random	C
matches	C
implies	C
that	C
only	C
15	C
%	C
true	C
motifs	C
incorrectly	C
fall	C
in	C
the	C
``	C
sparse	C
''	C
bin	C
.	C

In	O
contrast	O
,	O
Qsse	O
thresholds	O
(	O
Figure	O
4b	O
)	O
actually	O
assign	O
about	O
the	O
top	O
60	O
%	O
true	O
motifs	O
and	O
32	O
%	O
random	O
matches	O
to	O
the	O
enriched	O
bin	O
(	O
see	O
Table	O
3	O
)	O
.	O

This	O
is	O
due	O
to	O
the	O
fact	O
that	O
the	O
top	O
60	O
%	O
true	O
motifs	O
(	O
and	O
32	O
%	O
random	O
matches	O
)	O
uniformly	O
get	O
the	O
highest	O
score	O
.	O

Finally	O
,	O
in	O
the	O
case	O
of	O
Qand	O
(	O
Figure	O
4c	O
)	O
,	O
only	O
9	O
%	O
random	O
matches	O
are	O
retained	O
in	O
the	O
enriched	O
bin	O
and	O
only	O
16	O
%	O
of	O
true	O
motifs	O
fall	O
in	O
the	O
sparse	O
bin	O
(	O
Table	O
3	O
)	O
.	O

This	C
gives	C
to	C
the	C
users	C
a	C
measure	C
of	C
the	C
percentage	C
of	C
false	C
hits	C
that	C
they	C
can	C
expect	C
in	C
the	C
enriched	C
bin	C
and	C
of	C
the	C
percentage	C
of	C
true	C
hits	C
that	C
they	C
would	C
miss	C
if	C
discarding	C
all	C
the	C
predictions	C
falling	C
in	C
the	C
sparse	C
interval	C
.	C

Score	O
thresholds	O
defining	O
the	O
``	O
sparse	O
''	O
,	O
``	O
neutral	O
''	O
and	O
``	O
enriched	O
''	O
bins	O

Number	O
and	O
percentage	O
of	O
true	O
and	O
random	O
motifs	O
assigned	O
to	O
each	O
bin	O
by	O
the	O
different	O
score	O
types	O

In	O
order	O
to	O
establish	O
more	O
rigorously	O
the	O
predictive	O
ability	O
of	O
the	O
structure	O
filter	O
in	O
the	O
enriched	O
and	O
sparse	O
intervals	O
,	O
we	O
carried	O
out	O
a	O
5-fold	O
cross	O
validation	O
experiment	O
.	O

Referring	O
to	O
score	O
calibration	O
and	O
within	O
the	O
limits	O
of	O
the	O
5-fold	O
cross	O
validation	O
experiment	O
only	O
,	O
we	O
defined	O
two	O
intervals	O
instead	O
of	O
the	O
three	O
implemented	O
in	O
the	O
ELM	O
Web	O
Server	O
,	O
by	O
incorporating	O
the	O
neutral	O
interval	O
first	O
into	O
the	O
enriched	O
one	O
and	O
then	O
into	O
the	O
sparse	O
one	O
.	O

This	O
made	O
it	O
possible	O
to	O
properly	O
determine	O
sensitivity	O
and	O
specificity	O
values	O
in	O
two	O
different	O
situations	O
:	O
the	O
first	O
accounting	O
for	O
an	O
enrichment	O
of	O
sensitivity	O
and	O
the	O
second	O
for	O
an	O
enrichment	O
of	O
specificity	O
.	O

We	O
defined	O
the	O
positive	O
dataset	O
as	O
the	O
one	O
made	O
up	O
of	O
the	O
ELM	O
true	O
instances	O
and	O
the	O
negative	O
dataset	O
as	O
the	O
set	O
of	O
all	O
the	O
un-annotated	O
random	O
matches	O
.	O

We	O
split	O
both	O
the	O
positive	O
and	O
the	O
negative	O
datasets	O
into	O
five	O
subsets	O
by	O
random	O
sampling	O
the	O
datasets	O
without	O
replacement	O
,	O
thus	O
obtaining	O
five	O
non-overlapping	O
positive	O
and	O
five	O
non-overlapping	O
negative	O
training	O
sets	O
.	O

Five	O
positive	O
(	O
negative	O
)	O
test	O
sets	O
were	O
determined	O
by	O
depriving	O
cyclically	O
the	O
whole	O
positive	O
(	O
negative	O
)	O
dataset	O
of	O
each	O
of	O
the	O
five	O
positive	O
(	O
negative	O
)	O
training	O
sets	O
.	O

We	O
built	O
the	O
scoring	O
schemes	O
as	O
described	O
in	O
the	O
section	O
``	O
The	O
ELM	O
structure	O
filter	O
scoring	O
scheme	O
''	O
and	O
set	O
up	O
score	O
acceptance/rejection	O
thresholds	O
on	O
the	O
training	O
sets	O
as	O
explained	O
above	O
(	O
subsection	O
``	O
Sparse/neutral/enriched	O
score	O
intervals	O
''	O
)	O
.	O

Then	O
,	O
we	O
validated	O
them	O
on	O
the	O
corresponding	O
test	O
sets	O
by	O
calculating	O
sensitivity	O
(	O
Sn	O
)	O
,	O
specificity	O
(	O
Sp	O
)	O
,	O
and	O
accuracy	O
defined	O
as	O
:	O

In	C
evaluating	C
Sn	C
,	C
Sp	C
and	C
Accuracy	C
,	C
we	C
assumed	C
that	C
a	C
match	C
belonging	C
to	C
the	C
negative	C
set	C
and	C
scoring	C
above	C
the	C
``	C
accept	C
''	C
threshold	C
,	C
is	C
a	C
FP	C
and	C
one	C
scoring	C
below	C
,	C
is	C
a	C
TN	C
;	C
a	C
true	C
instance	C
scoring	C
above	C
the	C
``	C
accept	C
''	C
threshold	C
is	C
a	C
TP	C
and	C
one	C
scoring	C
below	C
is	C
a	C
FN	C
.	C

Sensitivity	O
(	O
Sn	O
)	O
and	O
specificity	O
(	O
Sp	O
)	O
and	O
accuracy	O
averaged	O
over	O
the	O
five	O
sets	O
are	O
reported	O
in	O
Table	O
4	O
.	O

Since	C
the	C
structure	C
filter	C
is	C
designed	C
as	C
a	C
guide	C
to	C
experimentation	C
,	C
we	C
consider	C
that	C
sensitivity	C
should	C
be	C
privileged	C
over	C
specificity	C
-	C
for	C
not	C
missing	C
too	C
many	C
true	C
motifs	C
.	C

Based	O
on	O
this	O
viewpoint	O
,	O
it	O
can	O
be	O
observed	O
in	O
Tables	O
3	O
(	O
last	O
column	O
)	O
and	O
4	O
that	O
the	O
best	O
performing	O
scoring	O
schemes	O
-	O
in	O
terms	O
of	O
a	O
trade-off	O
between	O
sensitivity	O
,	O
specificity	O
,	O
the	O
percentage	O
of	O
true	O
motifs	O
erroneously	O
discarded	O
and	O
the	O
percentage	O
of	O
true	O
motifs	O
correctly	O
retained	O
-	O
are	O
Qacc	O
and	O
Qand	O
.	O

Sensitivity	O
,	O
specificity	O
and	O
accuracy	O
obtained	O
with	O
the	O
5-fold	O
cross	O
validation	O
experiment	O
.	O

Notice	C
that	C
the	C
Accuracy	C
values	C
reported	C
in	C
Table	C
4	C
might	C
be	C
affected	C
by	C
the	C
fact	C
that	C
the	C
positive	C
and	C
negative	C
datasets	C
are	C
unbalanced	C
.	C

The	C
analysis	C
of	C
the	C
ROC	C
curves	C
,	C
of	C
the	C
cumulative	C
distributions	C
and	C
of	C
the	C
filter	C
performance	C
in	C
the	C
three	C
score	C
bins	C
suggests	C
a	C
more	C
relevant	C
role	C
of	C
the	C
accessibility	C
in	C
discriminating	C
true	C
from	C
false	C
motifs	C
than	C
the	C
secondary	C
structure	C
assignment	C
.	C

This	C
observation	C
is	C
biologically	C
sound	C
since	C
,	C
while	C
a	C
buried	C
motif	C
is	C
unlikely	C
to	C
be	C
a	C
genuine	C
functional	C
site	C
,	C
an	C
exposed	C
motif	C
lying	C
e.g	C
.	C
on	C
a	C
helix	C
can	C
in	C
any	C
case	C
possess	C
an	C
interaction	C
ability	C
.	C

Finally	O
,	O
our	O
results	O
show	O
that	O
the	O
combined	O
score	O
is	O
slightly	O
more	O
effective	O
than	O
the	O
accessibility	O
score	O
and	O
markedly	O
better	O
than	O
the	O
secondary	O
structure	O
score	O
.	O

The	O
combined	O
score	O
Qand	O
is	O
implemented	O
in	O
both	O
the	O
Web	O
Server	O
and	O
Web	O
Service	O
.	O

Usage	O
of	O
the	O
ELM	O
structure	O
filter	O

For	C
practical	C
purposes	C
,	C
the	C
filter	C
exploits	C
available	C
information	C
on	C
protein	C
structures	C
to	C
answer	C
the	C
question	C
``	C
Is	C
it	C
worth	C
testing	C
this	C
motif	C
candidate	C
experimentally	C
?	C
''	C
rather	C
than	C
to	C
categorically	C
tell	C
the	C
users	C
whether	C
they	C
have	C
a	C
real	C
motif	C
or	C
not	C
.	C

In	C
deciding	C
if	C
a	C
prediction	C
is	C
a	C
good	C
experimental	C
candidate	C
,	C
the	C
user	C
should	C
give	C
more	C
weight	C
to	C
accessibility	C
score	C
than	C
to	C
secondary	C
structure	C
score	C
since	C
a	C
buried	C
motif	C
is	C
unlikely	C
to	C
carry	C
a	C
function	C
,	C
whereas	C
an	C
exposed	C
motif	C
may	C
function	C
properly	C
even	C
if	C
it	C
is	C
part	C
of	C
a	C
beta	C
strand	C
or	C
belongs	C
to	C
a	C
helix	C
(	C
see	C
examples	C
in	C
the	C
benchmarking	C
dataset	C
,	C
additional	C
file	C
6	C
(	C
Table	C
S1	C
)	C
.	C

The	O
main	O
exception	O
to	O
well	O
buried	O
candidates	O
being	O
nonfunctional	O
concerns	O
allosteric	O
rearrangements	O
[	O
44	O
]	O
.	O

If	O
the	O
motif	O
is	O
in	O
the	O
core	O
of	O
a	O
well-known	O
domain	O
like	O
SH3	O
or	O
a	O
TIM	O
barrel	O
,	O
a	O
review	O
of	O
the	O
accumulated	O
structural	O
knowledge	O
will	O
allow	O
the	O
user	O
to	O
conclude	O
that	O
the	O
chance	O
of	O
valid	O
function	O
is	O
negligible	O
.	O

If	C
there	C
is	C
evidence	C
of	C
allostery	C
,	C
however	C
,	C
depending	C
on	C
which	C
parts	C
of	C
the	C
structure	C
are	C
flexible	C
,	C
this	C
might	C
support	C
or	C
invalidate	C
the	C
motif	C
.	C

If	C
nothing	C
is	C
known	C
,	C
then	C
it	C
should	C
be	C
kept	C
in	C
mind	C
that	C
most	C
parts	C
of	C
most	C
globular	C
domains	C
do	C
not	C
undergo	C
major	C
rearrangements	C
,	C
hence	C
candidates	C
from	C
the	C
sparse	C
bin	C
should	C
not	C
be	C
eyed	C
with	C
hope	C
.	C

The	O
user	O
should	O
also	O
consider	O
overall	O
context	O
in	O
assessing	O
the	O
structure	O
filter	O
results	O
.	O

Is	O
the	O
cell	O
compartment	O
correct	O
:	O
An	O
exposed	O
RGD	O
motif	O
with	O
a	O
significant	O
p-value	O
in	O
an	O
extracellular	O
protein	O
is	O
a	O
very	O
good	O
integrin-binding	O
candidate	O
:	O
one	O
in	O
a	O
nuclear	O
protein	O
is	O
worthless	O
.	O

Is	C
the	C
motif	C
conserved	C
,	C
at	C
least	C
within	C
a	C
phylogenetic	C
lineage	C
such	C
as	C
mammals	C
,	C
tetrapods	C
or	C
vertebrates	C
:	C
the	C
motif	C
should	C
be	C
conserved	C
in	C
such	C
groups	C
if	C
it	C
is	C
functional	C
in	C
a	C
regulatory	C
system	C
common	C
to	C
related	C
organisms	C
.	C

Is	O
the	O
biological	O
context	O
sensible	O
:	O
Is	O
the	O
query	O
protein	O
in	O
some	O
way	O
functionally	O
associated	O
with	O
the	O
ligand	O
protein	O
;	O
Are	O
they	O
in	O
the	O
same	O
regulatory	O
pathway	O
;	O
Are	O
they	O
in	O
the	O
same	O
protein	O
complex	O
?	O

Structural	O
analysis	O
of	O
LMs	O
:	O
Classification	O
and	O
examples	O
of	O
motifs	O
in	O
protein	O
structures	O

Before	O
the	O
structural	O
context	O
of	O
LMs	O
can	O
be	O
evaluated	O
,	O
it	O
is	O
necessary	O
to	O
define	O
and	O
select	O
the	O
structural	O
unit	O
.	O

Structure	C
files	C
may	C
contain	C
large	C
protein	C
complexes	C
,	C
single	C
proteins	C
,	C
single	C
or	C
multiple	C
chains	C
,	C
single	C
globular	C
domains	C
and	C
many	C
other	C
types	C
of	C
molecule	C
.	C

LMs	C
may	C
be	C
bound	C
to	C
their	C
ligands	C
or	C
in	C
an	C
unliganded	C
state	C
.	C

Figure	O
1a	O
shows	O
the	O
Sumo-Interacting	O
Motif	O
(	O
SIM	O
)	O
of	O
TDG	O
bound	O
to	O
SUMO-3	O
by	O
beta	O
augmentation	O
but	O
also	O
well	O
packed	O
into	O
the	O
main	O
TDG	O
domain	O
.	O

Clearly	O
we	O
need	O
to	O
measure	O
accessibility	O
of	O
the	O
SIM	O
in	O
the	O
absence	O
of	O
the	O
SUMO	O
protein	O
.	O

The	O
open	O
(	O
active	O
)	O
and	O
closed	O
(	O
inactive	O
)	O
conformations	O
of	O
the	O
Src	O
kinase	O
are	O
dependent	O
on	O
the	O
phosphorylation	O
states	O
of	O
several	O
tyrosines	O
.	O

In	O
particular	O
,	O
the	O
closed	O
conformation	O
is	O
specified	O
by	O
an	O
interaction	O
between	O
the	O
Src	O
SH2	O
domain	O
and	O
the	O
C-terminal	O
pTyr-527	O
and	O
an	O
interaction	O
between	O
the	O
Src	O
SH3	O
domain	O
with	O
a	O
peptide	O
linking	O
the	O
SH2	O
and	O
kinase	O
domains	O
.	O

Figure	O
1b	O
shows	O
the	O
closed	O
conformation	O
with	O
these	O
elements	O
highlighted	O
.	O

In	O
particular	O
,	O
the	O
SH3	O
binding	O
peptide	O
is	O
fully	O
buried	O
,	O
even	O
though	O
it	O
is	O
not	O
part	O
of	O
a	O
globular	O
domain	O
.	O

In	O
the	O
open	O
conformation	O
this	O
peptide	O
is	O
much	O
more	O
accessible	O
,	O
as	O
is	O
the	O
C-terminal	O
peptide	O
which	O
is	O
released	O
from	O
the	O
SH2	O
domain	O
(	O
e.g	O
.	O
1Y57	O
,	O
[	O
45	O
]	O
)	O
.	O

The	C
dependency	C
of	C
LM	C
accessibility	C
on	C
globular	C
domain	C
rearrangements	C
implies	C
that	C
multi-domain	C
structures	C
are	C
not	C
a	C
suitable	C
structural	C
unit	C
for	C
structure	C
filtering	C
.	C

The	C
appropriate	C
units	C
therefore	C
in	C
the	C
cases	C
of	C
LMs	C
would	C
be	C
the	C
individual	C
globular	C
domains	C
themselves	C
.	C

At	C
least	C
for	C
domains	C
that	C
do	C
not	C
undergo	C
allosteric	C
rearrangement	C
,	C
a	C
motif	C
which	C
is	C
buried	C
in	C
the	C
core	C
of	C
a	C
structural	C
domain	C
unit	C
is	C
unlikely	C
to	C
be	C
a	C
true	C
one	C
.	C

Therefore	O
we	O
chose	O
the	O
SCOP	O
[	O
46	O
]	O
protein	O
domain	O
definition	O
as	O
provided	O
by	O
the	O
ASTRAL	O
resource	O
[	O
47	O
]	O
as	O
the	O
structure	O
dataset	O
to	O
be	O
used	O
to	O
implement	O
the	O
structure	O
filter	O
.	O

The	O
inception	O
of	O
this	O
work	O
required	O
the	O
collection	O
and	O
analysis	O
of	O
the	O
3D	O
occurrences	O
of	O
LM	O
instances	O
annotated	O
in	O
the	O
ELM	O
resource	O
[	O
1	O
]	O
.	O

Here	O
we	O
present	O
a	O
discussion	O
of	O
our	O
benchmark	O
dataset	O
.	O

Many	O
details	O
and	O
specific	O
examples	O
are	O
reported	O
in	O
the	O
supplementary	O
information	O
(	O
additional	O
file	O
1	O
)	O
.	O

As	O
described	O
in	O
Methods	O
,	O
we	O
obtained	O
a	O
set	O
of	O
158	O
3D	O
non-redundant	O
instances	O
from	O
36	O
different	O
LM	O
entries	O
(	O
reported	O
in	O
additional	O
file	O
6	O
(	O
Table	O
S1	O
)	O
from	O
the	O
ELM	O
resource	O
release	O
June	O
2007	O
.	O

Sixteen	O
motifs	O
match	O
only	O
one	O
instance	O
and	O
twenty	O
match	O
two	O
or	O
more	O
.	O

The	O
majority	O
(	O
~60	O
%	O
)	O
of	O
LM	O
instances	O
are	O
made	O
up	O
of	O
residues	O
whose	O
relative	O
accessibility	O
to	O
the	O
solvent	O
is	O
at	O
least	O
50	O
%	O
and	O
are	O
located	O
entirely	O
in	O
loop	O
,	O
turn	O
or	O
unstructured	O
regions	O
.	O

Figure	O
2	O
shows	O
two	O
typical	O
examples	O
(	O
LIG_RGD	O
and	O
MOD_SUMO	O
)	O
of	O
a	O
motif	O
in	O
a	O
very	O
exposed	O
loop	O
of	O
a	O
domain	O
(	O
2a	O
and	O
2c	O
)	O
and	O
a	O
motif	O
in	O
a	O
flexible	O
region	O
which	O
is	O
not	O
in	O
a	O
domain	O
(	O
LIG_RGD	O
,	O
Figure	O
2b	O
)	O
.	O

LIG_RGD	O
is	O
a	O
short	O
peptide	O
ligand	O
motif	O
which	O
interacts	O
directly	O
with	O
extracellular	O
domains	O
of	O
integrins	O
whereas	O
MOD_SUMO	O
is	O
a	O
motif	O
recognised	O
for	O
modification	O
by	O
SUMO-1	O
.	O

The	O
SUMO	O
proteins	O
are	O
Small	O
Ubiquitin-related	O
MOdifiers	O
that	O
are	O
covalently	O
conjugated	O
onto	O
lysine	O
residues	O
within	O
target	O
sequences	O
.	O

Eight	C
out	C
of	C
36	C
LM	C
entries	C
have	C
at	C
least	C
one	C
instance	C
which	C
is	C
entirely	C
or	C
almost	C
entirely	C
in	C
helical	C
conformation	C
while	C
two	C
entries	C
have	C
at	C
least	C
one	C
instance	C
almost	C
entirely	C
in	C
a	C
strand	C
conformation	C
.	C

Notwithstanding	O
the	O
greater	O
rigidity	O
of	O
helices	O
as	O
opposed	O
to	O
loops	O
and	O
unstructured	O
regions	O
,	O
LMs	O
found	O
in	O
helical	O
conformation	O
are	O
not	O
necessarily	O
prevented	O
from	O
being	O
exposed	O
to	O
the	O
solvent	O
and	O
carrying	O
out	O
their	O
functions	O
.	O

Two	O
clear	O
examples	O
are	O
shown	O
in	O
Figure	O
2d	O
and	O
2e	O
.	O

Figure	O
2d	O
shows	O
an	O
instance	O
of	O
the	O
MOD_CMANNOS	O
motif	O
,	O
which	O
is	O
part	O
of	O
a	O
helix	O
and	O
is	O
partly	O
hidden	O
by	O
the	O
C-term	O
of	O
the	O
protein	O
.	O

C-Mannosylation	O
is	O
a	O
type	O
of	O
protein	O
glycosylation	O
involving	O
the	O
attachment	O
of	O
a	O
mannosyl	O
residue	O
to	O
a	O
tryptophan	O
.	O

In	O
this	O
particular	O
case	O
,	O
the	O
most	O
buried	O
residues	O
are	O
those	O
corresponding	O
to	O
wildcard	O
positions	O
in	O
the	O
MOD_MANNOS	O
regular	O
expression	O
(	O
W..W	O
)	O
,	O
whereas	O
the	O
conserved	O
tryptophan	O
needed	O
for	O
the	O
mannose	O
attachment	O
is	O
protruding	O
outwards	O
from	O
the	O
domain	O
surface	O
.	O

Figure	O
2e	O
reports	O
two	O
MOD_N-GLC_1	O
N-glycosylation	O
sites	O
on	O
the	O
same	O
domain	O
.	O

N-linked	O
glycosylation	O
is	O
a	O
co-translational	O
process	O
involving	O
the	O
transfer	O
of	O
an	O
oligosaccharide	O
chain	O
to	O
an	O
asparagine	O
residue	O
in	O
the	O
protein	O
.	O

In	O
this	O
case	O
,	O
one	O
site	O
is	O
part	O
of	O
a	O
well	O
exposed	O
helix	O
whereas	O
the	O
other	O
one	O
consists	O
of	O
a	O
loop	O
with	O
small	O
helix	O
overlap	O
and	O
it	O
is	O
very	O
exposed	O
.	O

Figure	O
2f	O
,	O
g	O
and	O
2h	O
show	O
cases	O
of	O
LMs	O
in	O
partly	O
buried	O
beta	O
strands	O
.	O

In	O
figure	O
2f	O
an	O
instance	O
of	O
the	O
MOD_N-GLC_1	O
motif	O
is	O
in	O
a	O
long	O
edge	O
beta	O
strand	O
,	O
slightly	O
disrupted	O
,	O
and	O
quite	O
exposed	O
.	O

The	O
N-glycosylation	O
sites	O
of	O
figures	O
2g	O
and	O
2h	O
are	O
two	O
examples	O
of	O
motifs	O
lying	O
on	O
partially	O
hidden	O
beta	O
strands	O
but	O
whose	O
modified	O
asparagine	O
(	O
involved	O
in	O
the	O
functional	O
activity	O
)	O
side	O
chain	O
is	O
exposed	O
to	O
the	O
solvent	O
.	O

In	O
our	O
benchmarking	O
dataset	O
,	O
29/158	O
instances	O
belonging	O
to	O
11	O
different	O
LMs	O
[	O
marked	O
in	O
dark	O
orange	O
in	O
additional	O
file	O
6	O
(	O
Table	O
S1	O
)	O
]	O
have	O
a	O
very	O
low	O
average	O
accessibility	O
.	O

In	O
15/29	O
of	O
these	O
instances	O
,	O
however	O
,	O
residues	O
belonging	O
to	O
non-wildcard	O
positions	O
in	O
the	O
LM	O
regular	O
expression	O
(	O
e.g	O
.	O
the	O
two	O
tryptophans	O
in	O
the	O
C-Mannosylation	O
site	O
regular	O
expression	O
W..W	O
)	O
display	O
equal	O
or	O
higher	O
accessibility	O
values	O
as	O
opposed	O
to	O
wildcard	O
positions	O
(	O
marked	O
in	O
bold	O
in	O
the	O
acc_nwc	O
column	O
of	O
Table	O
S1	O
,	O
additional	O
file	O
6	O
)	O
.	O

This	O
seems	O
reasonable	O
since	O
LMs	O
are	O
involved	O
in	O
protein	O
interactions	O
and	O
the	O
non-wildcard	O
positions	O
specify	O
LM	O
function	O
.	O

Importantly	O
,	O
this	O
trend	O
is	O
not	O
seen	O
in	O
the	O
case	O
of	O
LM	O
false	O
positive	O
matches	O
,	O
an	O
observation	O
which	O
helped	O
us	O
to	O
improve	O
the	O
benchmark	O
set	O
as	O
it	O
brought	O
to	O
light	O
some	O
poorly	O
annotated	O
instances	O
.	O

See	O
additional	O
file	O
1	O
for	O
details	O
.	O

In	O
the	O
benchmark	O
dataset	O
there	O
are	O
a	O
few	O
cases	O
(	O
10/158	O
)	O
of	O
almost	O
completely	O
buried	O
true	O
motif	O
instances	O
,	O
i.e	O
.	O
displaying	O
an	O
average	O
relative	O
accessibility	O
<	O
0.2	O
on	O
the	O
non-wildcard	O
positions	O
.	O

We	O
analysed	O
them	O
one	O
by	O
one	O
by	O
manual	O
inspection	O
and	O
concluded	O
that	O
they	O
fall	O
in	O
one	O
of	O
two	O
situations	O
:	O
either	O
their	O
functional	O
residue	O
(	O
s	O
)	O
,	O
or	O
at	O
least	O
their	O
side	O
chains	O
,	O
are	O
favourably	O
oriented	O
outwards	O
from	O
the	O
domain	O
surface	O
(	O
see	O
additional	O
file	O
1	O
,	O
additional	O
file	O
6	O
,	O
and	O
Figure	O
2g	O
and	O
2h	O
)	O
,	O
or	O
an	O
allosteric	O
effect	O
is	O
either	O
known	O
or	O
reasonable	O
to	O
hypothesize	O
.	O

Additional	O
file	O
1	O
reports	O
details	O
and	O
specific	O
examples	O
.	O

Discussion	O

We	O
have	O
set	O
up	O
a	O
procedure	O
to	O
help	O
in	O
the	O
discrimination	O
of	O
true	O
from	O
false	O
positive	O
LM	O
matches	O
,	O
that	O
is	O
based	O
on	O
the	O
information	O
coming	O
from	O
two	O
important	O
features	O
inherent	O
to	O
the	O
3D	O
structure	O
of	O
proteins	O
:	O
accessibility	O
to	O
the	O
solvent	O
and	O
secondary	O
structure	O
element	O
.	O

The	O
fact	O
that	O
functional	O
LMs	O
tend	O
to	O
be	O
in	O
flexible	O
and	O
accessible	O
regions	O
of	O
proteins	O
is	O
biologically	O
sound	O
and	O
is	O
furthermore	O
supported	O
by	O
the	O
structural	O
analysis	O
of	O
experimentally	O
validated	O
instances	O
of	O
LMs	O
carried	O
out	O
in	O
this	O
work	O
.	O

As	O
a	O
consequence	O
,	O
our	O
approach	O
will	O
advise	O
a	O
user	O
against	O
considering	O
a	O
match	O
as	O
a	O
true	O
motif	O
if	O
it	O
resides	O
in	O
an	O
unfavourable	O
structural	O
context	O
.	O

Nevertheless	C
,	C
the	C
function	C
of	C
proteins	C
can	C
be	C
regulated	C
by	C
an	C
assortment	C
of	C
different	C
mechanisms	C
,	C
and	C
allosteric	C
modifications	C
or	C
unusual	C
LM	C
position	C
and/or	C
conformation	C
are	C
infrequent	C
but	C
possible	C
.	C

In	C
this	C
sense	C
,	C
we	C
encourage	C
the	C
user	C
to	C
carefully	C
evaluate	C
the	C
possibility	C
that	C
a	C
hidden	C
motif	C
can	C
become	C
exposed	C
upon	C
protein	C
interaction	C
and	C
to	C
use	C
the	C
ELM	C
structure	C
filter	C
cum	C
grano	C
salis	C
,	C
i.e	C
.	C
not	C
as	C
a	C
deterministic	C
predictor	C
but	C
rather	C
by	C
exploiting	C
the	C
supplied	C
3D	C
information	C
on	C
LM	C
predictions	C
as	C
a	C
supplement	C
to	C
a	C
prior	C
knowledge	C
of	C
the	C
LM	C
biological	C
context	C
.	C

The	O
ELM	O
resource	O
now	O
provides	O
three	O
ways	O
to	O
aid	O
the	O
user	O
about	O
structural	O
context	O
for	O
the	O
query	O
sequence	O
.	O

The	C
disorder	C
predictor	C
GlobPlot	C
highlights	C
potential	C
motif-rich	C
regions	C
that	C
are	C
likely	C
to	C
be	C
intrinsically	C
unstructured	C
.	C

SMART	O
and	O
Pfam	O
domains	O
define	O
regions	O
of	O
well-defined	O
globular	O
structure	O
where	O
LMs	O
are	O
expected	O
to	O
be	O
rare	O
.	O

Where	O
it	O
can	O
be	O
applied	O
,	O
the	O
new	O
structure	O
filter	O
now	O
provides	O
a	O
benchmarked	O
estimate	O
of	O
LM	O
likelihood	O
.	O

MnM	O
has	O
taken	O
a	O
different	O
approach	O
to	O
structural	O
context	O
,	O
a	O
single	O
score	O
for	O
each	O
pattern	O
match	O
being	O
provided	O
by	O
an	O
accessibility	O
prediction	O
algorithm	O
,	O
SPS	O
[	O
24,48	O
]	O
.	O

While	O
MnM	O
does	O
not	O
supply	O
domain	O
and	O
tertiary	O
structural	O
information	O
that	O
is	O
highly	O
informative	O
to	O
the	O
user	O
,	O
an	O
accessibility	O
predictor	O
does	O
have	O
a	O
unique	O
value	O
for	O
a	O
substantial	O
fraction	O
of	O
protein	O
sequence	O
space	O
that	O
is	O
predicted	O
to	O
be	O
globular	O
but	O
is	O
not	O
known	O
to	O
be	O
related	O
to	O
a	O
solved	O
domain	O
structure	O
.	O

In	C
future	C
,	C
we	C
may	C
also	C
consider	C
introducing	C
a	C
predictive	C
accessibility	C
filter	C
into	C
ELM	C
for	C
poorly	C
characterised	C
globular	C
peptide	C
segments	C
.	C

There	O
are	O
many	O
algorithms	O
in	O
the	O
literature	O
,	O
with	O
the	O
current	O
best	O
performing	O
reported	O
to	O
be	O
NetSurfP	O
and	O
Real_SPINE	O
[	O
49,50	O
]	O
.	O

Besides	O
the	O
results	O
on	O
the	O
structure	O
filter	O
discrimination	O
power	O
presented	O
in	O
this	O
work	O
,	O
we	O
want	O
to	O
point	O
out	O
that	O
the	O
process	O
of	O
developing	O
the	O
structure	O
filter	O
has	O
already	O
proven	O
of	O
value	O
to	O
the	O
ELM	O
resource	O
.	O

The	O
structural	O
analysis	O
of	O
annotated	O
motifs	O
reported	O
in	O
section	O
2.1	O
highlighted	O
a	O
number	O
of	O
questionable	O
motifs	O
that	O
turned	O
out	O
to	O
be	O
incorrectly	O
annotated	O
with	O
weak	O
or	O
conflicting	O
support	O
in	O
the	O
literature	O
.	O

In	O
this	O
regard	O
,	O
experimentalists	O
should	O
be	O
aware	O
that	O
accurate	O
annotation	O
of	O
LMs	O
concurs	O
with	O
developing	O
effective	O
methodologies	O
aimed	O
at	O
identifying	O
new	O
putative	O
motifs	O
and	O
that	O
inference	O
of	O
shortlists	O
of	O
candidate	O
true	O
motifs	O
is	O
especially	O
useful	O
to	O
reduce	O
the	O
number	O
of	O
assays	O
needed	O
to	O
experimentally	O
validate	O
a	O
new	O
LM	O
.	O

Thus	C
,	C
the	C
experimental	C
strategy	C
adopted	C
to	C
detect	C
functional	C
motifs	C
plays	C
a	C
fundamental	C
role	C
and	C
incorporating	C
some	C
simple	C
stratagems	C
in	C
experimental	C
protocols	C
might	C
crucially	C
help	C
in	C
reducing	C
the	C
number	C
of	C
false	C
motifs	C
in	C
the	C
literature	C
.	C

We	O
consider	O
a	O
pair	O
of	O
much	O
too	O
rarely	O
undertaken	O
controls	O
to	O
be	O
especially	O
important	O
when	O
candidate	O
motifs	O
are	O
mutated	O
[	O
4	O
]	O
:	O
(	O
1	O
)	O

Check	C
if	C
the	C
motif	C
mutation	C
unfolds	C
the	C
protein	C
by	C
cloning	C
in	C
a	C
tagged	C
expression	C
construct	C
that	C
allows	C
fast	C
and	C
easy	C
purification	C
of	C
the	C
protein	C
and	C
examine	C
folding	C
status	C
by	C
e.g	C
.	C
circular	C
dichroism	C
(	C
or	C
NMR	C
if	C
available	C
)	C
;	C
(	C
2	C
)	C

When	O
transfecting	O
with	O
mutated	O
proteins	O
,	O
examine	O
the	O
cells	O
by	O
microscopy	O
for	O
intracellular	O
amyloid	O
caused	O
by	O
massive	O
overexpression	O
of	O
unfolded	O
protein	O
and	O
,	O
if	O
it	O
is	O
present	O
,	O
then	O
reason	O
out	O
why	O
the	O
assay	O
is	O
misleading	O
(	O
e.g	O
.	O
remember	O
that	O
amyloids	O
are	O
not	O
subject	O
to	O
ubiquitin-mediated	O
destruction	O
processes	O
so	O
destruction	O
box	O
and	O
degron	O
motif	O
mutation	O
assays	O
give	O
misleading	O
results	O
)	O
.	O

We	C
expect	C
that	C
the	C
predictive	C
power	C
of	C
the	C
structure	C
filter	C
can	C
be	C
improved	C
as	C
more	C
data	C
becomes	C
available	C
.	C

For	C
example	C
,	C
one	C
might	C
devise	C
a	C
procedure	C
trained	C
on	C
the	C
structural	C
data	C
of	C
specific	C
motifs	C
and	C
qualified	C
to	C
make	C
predictions	C
only	C
for	C
those	C
motifs	C
.	C

We	C
investigated	C
this	C
approach	C
and	C
concluded	C
that	C
it	C
would	C
currently	C
be	C
applicable	C
only	C
to	C
the	C
very	C
few	C
LMs	C
that	C
have	C
enough	C
instances	C
in	C
the	C
database	C
.	C

For	C
the	C
great	C
majority	C
of	C
LMs	C
,	C
appropriate	C
training	C
and	C
tests	C
can	C
not	C
be	C
carried	C
out	C
and	C
predictions	C
turned	C
out	C
to	C
be	C
unacceptably	C
stringent	C
:	C
An	C
effective	C
procedure	C
should	C
be	C
based	C
on	C
many	C
more	C
instances	C
per	C
LM	C
and	C
these	C
are	C
not	C
available	C
at	C
the	C
moment	C
.	C

We	C
believe	C
that	C
in	C
the	C
future	C
,	C
as	C
an	C
increasing	C
number	C
of	C
protein	C
structures	C
become	C
available	C
and	C
the	C
quantity	C
of	C
ELM	C
annotation	C
data	C
grows	C
,	C
it	C
will	C
be	C
possible	C
to	C
appropriately	C
train	C
and	C
test	C
motif-specific	C
structure	C
filters	C
for	C
a	C
significant	C
number	C
of	C
LMs	C
.	C

Conclusion	O

In	O
conclusion	O
,	O
LMs	O
are	O
subject	O
to	O
enormous	O
over-prediction	O
,	O
so	O
that	O
the	O
few	O
true	O
motifs	O
are	O
lost	O
amongst	O
the	O
many	O
false	O
positives	O
.	O

Whenever	C
a	C
query	C
can	C
be	C
modelled	C
on	C
a	C
structure	C
,	C
the	C
structure	C
filter	C
can	C
help	C
in	C
discriminating	C
true	C
from	C
false	C
positive	C
matches	C
of	C
LMs	C
.	C

Moreover	O
,	O
since	O
the	O
number	O
of	O
solved	O
structures	O
is	O
rapidly	O
increasing	O
,	O
a	O
benchmark	O
set	O
of	O
true	O
positive	O
structures	O
is	O
going	O
to	O
be	O
available	O
for	O
an	O
increasing	O
number	O
of	O
motifs	O
,	O
thus	O
allowing	O
more	O
reliable	O
tests	O
and	O
consistent	O
score	O
threshold	O
setups	O
.	O

As	C
a	C
consequence	C
,	C
the	C
structure	C
filter	C
,	C
which	C
can	C
be	C
considered	C
to	C
all	C
intents	C
and	C
purposes	C
as	C
a	C
precursor	C
in	C
the	C
use	C
of	C
structural	C
information	C
for	C
short	C
LM	C
false	C
positive	C
discrimination	C
,	C
is	C
going	C
to	C
become	C
increasingly	C
indispensable	C
for	C
the	C
ELM	C
resource	C
's	C
filtering	C
framework	C
in	C
the	C
structural	C
genomics	C
era	C
.	C

Methods	O

Dataset	O
of	O
structural	O
instances	O

The	O
ELM	O
database	O
(	O
[	O
1	O
]	O
,	O
release	O
June	O
2007	O
)	O
collected	O
112	O
LM	O
,	O
93	O
of	O
which	O
have	O
annotated	O
instances	O
.	O

The	O
set	O
of	O
1898	O
annotated	O
instances	O
in	O
1037	O
sequences	O
from	O
the	O
93	O
different	O
LMs	O
obtained	O
from	O
the	O
ELM	O
database	O
represented	O
our	O
initial	O
dataset	O
.	O

In	O
our	O
vocabulary	O
,	O
``	O
instance	O
''	O
means	O
a	O
true	O
annotated	O
LM	O
occurrence	O
,	O
whereas	O
``	O
match	O
''	O
indicates	O
any	O
regular	O
expression	O
hit	O
on	O
a	O
query	O
sequence	O
.	O

The	O
instances	O
were	O
modeled	O
onto	O
SCOP	O
domains	O
[	O
46	O
]	O
by	O
BLAST	O
alignment	O
[	O
51	O
]	O
of	O
the	O
sequence	O
containing	O
the	O
instance	O
to	O
the	O
reference	O
domain	O
sequence	O
extracted	O
from	O
the	O
PDB	O
entry	O
[	O
52	O
]	O
.	O

In	O
order	O
to	O
assign	O
a	O
``	O
sequence	O
instance	O
''	O
to	O
a	O
``	O
structure	O
instance	O
''	O
,	O
the	O
aligned	O
sequences	O
must	O
have	O
at	O
least	O
70	O
%	O
global	O
identity	O
(	O
over	O
the	O
domain	O
)	O
and	O
100	O
%	O
local	O
identity	O
(	O
i.e	O
.	O
along	O
the	O
instance	O
positions	O
)	O
.	O

The	O
final	O
dataset	O
of	O
structural	O
instances	O
comprised	O
of	O
185	O
3D	O
instances	O
from	O
37	O
different	O
LMs	O
.	O

Redundancy	O
was	O
removed	O
at	O
the	O
structure	O
level	O
:	O
if	O
two	O
or	O
more	O
instances	O
mapped	O
on	O
identical	O
3D	O
sites	O
,	O
all	O
but	O
one	O
were	O
discarded	O
,	O
thus	O
reducing	O
the	O
dataset	O
to	O
158	O
3D	O
instances	O
from	O
36	O
different	O
LMs	O
.	O

For	O
each	O
position	O
of	O
a	O
3D	O
instance	O
,	O
the	O
solvent	O
accessibility	O
and	O
secondary	O
structure	O
values	O
are	O
collected	O
from	O
the	O
DSSP	O
[	O
53	O
]	O
file	O
of	O
the	O
target	O
structure	O
mapping	O
the	O
instance	O
.	O

For	O
the	O
solvent	O
exposure	O
of	O
a	O
residue	O
,	O
a	O
relative	O
(	O
normalized	O
)	O
value	O
is	O
calculated	O
as	O
the	O
ratio	O
of	O
the	O
residue	O
's	O
DSSP	O
accessibility	O
value	O
to	O
the	O
residue	O
accessible	O
surface	O
area	O
value	O
as	O
defined	O
by	O
Miller	O
and	O
co-workers	O
[	O
54	O
]	O
and	O
which	O
is	O
calculated	O
for	O
the	O
residue	O
in	O
a	O
Gly-Xaa-Gly	O
tripeptide	O
in	O
extended	O
conformation	O
.	O

The	O
DSSP	O
secondary	O
structure	O
types	O
are	O
:	O
H	O
=	O
alpha	O
helix	O
,	O
B	O
=	O
residue	O
in	O
isolated	O
beta-bridge	O
,	O
E	O
=	O
extended	O
strand	O
(	O
participates	O
in	O
beta	O
ladder	O
)	O
,	O
G	O
=	O
3-helix	O
(	O
3/10	O
helix	O
)	O
,	O
I	O
=	O
5	O
helix	O
(	O
pi	O
helix	O
)	O
,	O
T	O
=	O
hydrogen	O
bonded	O
turn	O
,	O
and	O
S	O
=	O
bend	O
.	O

Unstructured	O
regions	O
are	O
marked	O
as	O
U	O
.	O

In	O
our	O
study	O
we	O
grouped	O
the	O
SSE	O
types	O
in	O
four	O
categories	O
:	O
1	O
)	O
helices	O
(	O
H	O
,	O
I	O
)	O
;	O
2	O
)	O
3/10	O
helices	O
(	O
G	O
)	O
;	O
3	O
)	O
strand	O
(	O
E	O
)	O
;	O
4	O
)	O
loops	O
(	O
B	O
,	O
T	O
,	O
S	O
,	O
U	O
)	O
.	O

Pi	O
helices	O
are	O
usually	O
attached	O
to	O
larger	O
alpha	O
helices	O
;	O
therefore	O
we	O
grouped	O
them	O
with	O
helices	O
.	O

3/10	O
helices	O
are	O
often	O
poorly	O
conserved	O
as	O
part	O
of	O
a	O
larger	O
loop	O
but	O
sometimes	O
they	O
are	O
continuously	O
linked	O
to	O
a	O
larger	O
helix	O
and	O
so	O
we	O
decided	O
to	O
treat	O
them	O
separately	O
.	O

B	O
,	O
T	O
,	O
S	O
and	O
U	O
are	O
grouped	O
together	O
because	O
they	O
usually	O
belong	O
to	O
3D	O
flexible	O
loop-like	O
regions	O
.	O

The	O
non-redundant	O
instance	O
dataset	O
is	O
reported	O
in	O
Table	O
S1	O
(	O
additional	O
file	O
6	O
)	O
.	O

Random	O
structural	O
matches	O

Since	O
the	O
aim	O
of	O
our	O
study	O
was	O
to	O
set	O
up	O
a	O
scoring	O
scheme	O
and	O
to	O
establish	O
accessibility	O
and	O
secondary	O
structure	O
score	O
thresholds	O
for	O
discriminating	O
true	O
motifs	O
among	O
random	O
(	O
mostly	O
FP	O
)	O
matches	O
,	O
we	O
performed	O
a	O
pattern	O
search	O
using	O
all	O
the	O
LM	O
regular	O
expressions	O
available	O
in	O
the	O
ELM	O
database	O
(	O
112	O
)	O
in	O
the	O
1037	O
sequences	O
known	O
for	O
having	O
at	O
least	O
one	O
true	O
annotated	O
instance	O
.	O

True	O
motif	O
instances	O
were	O
filtered	O
out	O
from	O
the	O
resulting	O
list	O
of	O
matches	O
.	O

Applying	O
the	O
same	O
sequence-to-structure	O
mapping	O
procedure	O
used	O
for	O
true	O
motif	O
instances	O
,	O
the	O
sequences	O
of	O
random	O
matches	O
were	O
modeled	O
onto	O
SCOP	O
domains	O
,	O
resulting	O
in	O
22,058	O
3D	O
non-identical	O
matches	O
from	O
105	O
motifs	O
.	O

LM-specific	O
background	O
score	O
distributions	O

Background	O
score	O
distributions	O
have	O
been	O
obtained	O
by	O
scanning	O
the	O
13,582	O
sequences	O
of	O
a	O
non	O
redundant	O
PDB	O
dataset	O
(	O
<	O
50	O
%	O
sequence	O
identity	O
,	O
downloaded	O
from	O
PDB	O
clusters	O
[	O
55	O
]	O
)	O
with	O
the	O
regular	O
expressions	O
of	O
the	O
112	O
ELM	O
motifs	O
(	O
total	O
number	O
of	O
available	O
motifs	O
)	O
,	O
mapping	O
the	O
323,5412	O
matches	O
onto	O
SCOP	O
domains	O
and	O
assigning	O
them	O
an	O
accessibility	O
score	O
and	O
a	O
secondary	O
structure	O
score	O
.	O

Score	O
distributions	O
(	O
for	O
each	O
feature	O
)	O
were	O
then	O
plotted	O
for	O
103	O
LMs	O
:	O
score	O
distributions	O
for	O
the	O
9	O
LMs	O
with	O
less	O
than	O
10	O
matches	O
are	O
not	O
reported	O
.	O

LM-specific	O
score	O
distributions	O
are	O
shown	O
in	O
additional	O
file	O
4	O
(	O
Figure	O
S3	O
)	O
.	O

The	O
ELM	O
structure	O
filter	O
pipeline	O

The	O
user	O
query	O
sequence	O
submitted	O
through	O
either	O
the	O
Web	O
Interface	O
or	O
the	O
Web	O
Service	O
is	O
first	O
scanned	O
for	O
LM	O
matches	O
and	O
then	O
aligned	O
to	O
the	O
database	O
of	O
ASTRAL	O
sequences	O
[	O
47	O
]	O
derived	O
from	O
SCOP	O
domains	O
[	O
46	O
]	O
.	O

The	O
hit	O
with	O
the	O
highest	O
sequence	O
identity	O
and	O
coverage	O
to	O
the	O
query	O
sequence	O
is	O
selected	O
as	O
a	O
reference	O
structure	O
.	O

If	O
more	O
than	O
one	O
hit	O
has	O
the	O
same	O
sequence	O
identity	O
and	O
coverage	O
to	O
the	O
query	O
sequence	O
,	O
the	O
structure	O
with	O
the	O
best	O
experimental	O
resolution	O
is	O
taken	O
as	O
reference	O
and	O
,	O
for	O
the	O
same	O
resolution	O
,	O
one	O
hit	O
is	O
chosen	O
randomly	O
.	O

This	C
approach	C
may	C
result	C
,	C
for	C
example	C
,	C
in	C
the	C
organism	C
of	C
the	C
reference	C
structure	C
being	C
different	C
from	C
the	C
source	C
organism	C
of	C
the	C
user	C
query	C
sequence	C
.	C

However	O
,	O
since	O
proteins	O
with	O
identical	O
sequences	O
fold	O
into	O
identical	O
structures	O
,	O
the	O
procedure	O
for	O
the	O
selection	O
of	O
the	O
reference	O
structure	O
does	O
not	O
introduce	O
any	O
bias	O
in	O
the	O
calculation	O
of	O
solvent	O
accessibility	O
and	O
secondary	O
structure	O
values	O
.	O

For	O
the	O
structure	O
filter	O
to	O
be	O
applicable	O
,	O
two	O
conditions	O
must	O
hold	O
:	O
1	O
)	O
the	O
query	O
sequence	O
or	O
a	O
region	O
of	O
it	O
can	O
be	O
aligned	O
to	O
one	O
or	O
more	O
(	O
non-overlapping	O
)	O
structural	O
domains	O
;	O
2	O
)	O
at	O
least	O
one	O
LM	O
match	O
falls	O
in	O
an	O
aligned	O
region	O
,	O
i.e	O
.	O
can	O
be	O
mapped	O
onto	O
a	O
3D	O
domain	O
.	O

The	O
structural	O
positions	O
of	O
the	O
match	O
are	O
then	O
analysed	O
one	O
by	O
one	O
and	O
solvent	O
accessibility	O
and	O
secondary	O
structure	O
values	O
are	O
collected	O
and	O
scored	O
as	O
described	O
in	O
Methods	O
.	O

The	O
structure	O
filter	O
pipeline	O
for	O
a	O
LM	O
match	O
is	O
schematised	O
in	O
Figure	O
6	O
and	O
a	O
snapshot	O
of	O
the	O
ELM	O
server	O
output	O
page	O
,	O
displaying	O
results	O
of	O
the	O
structural	O
filtering	O
procedure	O
,	O
is	O
reported	O
and	O
described	O
in	O
Figure	O
7	O
.	O

This	O
latter	O
,	O
shows	O
that	O
a	O
solved	O
structure	O
of	O
the	O
C-terminal	O
domain	O
of	O
the	O
RanGAP1	O
protein	O
is	O
available	O
in	O
SCOP	O
entry	O
d1kpsd_	O
that	O
is	O
used	O
for	O
structure	O
filtering	O
.	O

The	O
remainder	O
of	O
the	O
sequence	O
is	O
filtered	O
by	O
the	O
cruder	O
domain	O
filter	O
.	O

It	C
can	C
be	C
observed	C
that	C
mouseover	C
of	C
the	C
known	C
sumoylation	C
site	C
reveals	C
that	C
it	C
scores	C
in	C
the	C
enriched	C
bin	C
and	C
receives	C
a	C
significant	C
p-value	C
:	C
if	C
we	C
did	C
not	C
already	C
know	C
it	C
was	C
a	C
true	C
motif	C
,	C
it	C
would	C
be	C
an	C
attractive	C
candidate	C
for	C
experimental	C
testing	C
.	C

Moreover	O
,	O
mouseover	O
of	O
a	O
match	O
to	O
the	O
NES	O
motif	O
reveals	O
that	O
it	O
has	O
poor	O
accessibility	O
and	O
is	O
assigned	O
to	O
the	O
sparse	O
bin	O
.	O

The	O
NES	O
motif	O
is	O
predominantly	O
hydrophobic	O
and	O
this	O
example	O
,	O
like	O
many	O
others	O
falling	O
in	O
globular	O
domains	O
,	O
is	O
not	O
a	O
plausible	O
functional	O
site	O
and	O
experimental	O
follow	O
up	O
would	O
be	O
a	O
waste	O
of	O
valuable	O
experimental	O
effort	O
.	O

The	O
Structure	O
Filter	O
(	O
SF	O
)	O
pipeline	O
.	O

SA	O
:	O
Solvent	O
Accessibility	O
;	O
SSE	O
:	O
Secondary	O
Structure	O
Element	O
.	O

The	O
ELM	O
server	O
output	O
page	O
.	O

An	O
example	O
of	O
the	O
graphical	O
output	O
of	O
the	O
ELM	O
structure	O
filter	O
for	O
the	O
RAGP1_MOUSE	O
Swissprot	O
[	O
63	O
]	O
entry	O
.	O

The	O
key	O
shows	O
the	O
elements	O
of	O
the	O
graphic	O
.	O

Secondary	O
structure	O
elements	O
(	O
in	O
this	O
case	O
helical	O
)	O
are	O
shown	O
as	O
yellow	O
boxes	O
connected	O
by	O
black	O
lines	O
(	O
unstructured	O
loops	O
that	O
tend	O
to	O
be	O
surface	O
accessible	O
)	O
.	O

Mouseover	O
of	O
the	O
site	O
rectangles	O
turns	O
on	O
a	O
window	O
reporting	O
structural	O
information	O
;	O
further	O
details	O
of	O
the	O
structure	O
filter	O
results	O
are	O
available	O
by	O
clicking	O
on	O
the	O
site	O
rectangle	O
.	O

The	O
ELM	O
structure	O
filter	O
Web	O
interface	O
and	O
Web	O
service	O

As	O
an	O
initial	O
step	O
for	O
feedback	O
in	O
the	O
development	O
process	O
of	O
the	O
structure	O
filter	O
pipeline	O
methods	O
,	O
the	O
ELM	O
structure	O
filter	O
functionality	O
was	O
implemented	O
directly	O
into	O
the	O
ELM	O
server	O
.	O

This	O
involved	O
integration	O
work	O
on	O
both	O
the	O
display	O
representation	O
in	O
the	O
graphical	O
output	O
in	O
addition	O
to	O
links	O
to	O
the	O
more	O
specific	O
details	O
of	O
the	O
results	O
.	O

As	O
a	O
second	O
step	O
,	O
in	O
order	O
to	O
facilitate	O
a	O
clean	O
encapsulation	O
of	O
the	O
structure	O
filter	O
pipeline	O
code	O
functionality	O
and	O
to	O
enable	O
future	O
remote	O
tool	O
integration	O
,	O
a	O
SOAP	O
Web	O
Service	O
to	O
access	O
the	O
functionality	O
programmatically	O
has	O
been	O
implemented	O
and	O
is	O
available	O
at	O
http	O
:	O
//structurefilter.embl.de/webservice/structureFilter.wsdl	O
.	O

At	O
this	O
link	O
the	O
user	O
can	O
find	O
a	O
detailed	O
description	O
of	O
the	O
web	O
service	O
operations	O
and	O
an	O
example	O
client	O
implementation	O
.	O

The	O
functionality	O
provided	O
by	O
the	O
web	O
service	O
encompasses	O
the	O
current	O
ELM	O
server	O
interface	O
functionality	O
with	O
some	O
additional	O
options	O
.	O

For	O
the	O
ELM	O
Server	O
interface	O
functionality	O
,	O
all	O
LMs	O
in	O
the	O
ELM	O
database	O
are	O
matched	O
against	O
the	O
query	O
sequence	O
and	O
this	O
is	O
also	O
the	O
default	O
functionality	O
of	O
the	O
Web	O
Service	O
.	O

The	O
extra	O
options	O
implemented	O
in	O
the	O
Web	O
Service	O
are	O
to	O
search	O
the	O
query	O
sequence	O
by	O
one	O
or	O
more	O
user-specified	O
regular	O
expressions	O
,	O
rather	O
than	O
the	O
default	O
ELM	O
database	O
regular	O
expressions	O
,	O
and/or	O
by	O
one	O
or	O
more	O
user-specified	O
ELM	O
identifiers	O
from	O
the	O
ELM	O
database	O
.	O

Where	O
possible	O
,	O
to	O
a	O
limited	O
extent	O
,	O
if	O
the	O
user-specified	O
regular	O
expression	O
corresponds	O
to	O
an	O
existing	O
ELM	O
this	O
information	O
is	O
made	O
known	O
to	O
the	O
user	O
.	O

The	O
WSDL	O
(	O
Web	O
Service	O
Description	O
Language	O
)	O
[	O
56	O
]	O
file	O
is	O
WS-I	O
compatible	O
.	O

The	O
WS-Interoperability	O
Basic	O
Profile	O
[	O
57	O
]	O
proposes	O
a	O
set	O
of	O
rules	O
to	O
achieve	O
interoperability	O
of	O
web	O
services	O
between	O
different	O
platforms	O
.	O

The	O
WSDL	O
file	O
implements	O
an	O
XML	O
document/literal	O
style	O
[	O
58	O
]	O
.	O

The	O
back-end	O
code	O
is	O
implemented	O
in	O
Java	O
and	O
runs	O
on	O
Axis2	O
[	O
59	O
]	O
inside	O
a	O
Tomcat	O
servlet	O
container	O
[	O
60	O
]	O
.	O

Statistical	O
Details	O

Score	O
distributions	O
turned	O
out	O
to	O
be	O
normal	O
after	O
visual	O
inspection	O
and	O
quantitative	O
Shapiro-Wilk	O
test	O
[	O
61	O
]	O
at	O
the	O
0.01	O
significance	O
level	O
.	O

The	O
average	O
and	O
standard	O
deviation	O
values	O
from	O
random	O
match	O
score	O
distributions	O
are	O
used	O
for	O
the	O
dynamical	O
calculation	O
of	O
the	O
Z-score	O
and	O
the	O
corresponding	O
one-sided	O
p-value	O
.	O

The	O
significance	O
of	O
the	O
differences	O
observed	O
for	O
accessibility	O
and	O
secondary	O
structure	O
frequencies	O
in	O
true	O
motifs	O
vs	O
random	O
matches	O
was	O
assessed	O
through	O
t-tests	O
(	O
for	O
accessibility	O
values	O
)	O
and	O
chi-square	O
tests	O
(	O
for	O
secondary	O
structure	O
assignments	O
)	O
.	O

All	O
the	O
statistical	O
calculations	O
were	O
performed	O
with	O
the	O
R	O
package	O
[	O
62	O
]	O
.	O

List	O
of	O
abbreviations	O

LM	O
:	O
Linear	O
Motif	O
;	O
3D	O
:	O
Three-dimensional	O
;	O
TM	O
:	O
True	O
Motif	O
;	O
FP	O
:	O
False	O
Positive	O
;	O
regexp	O
:	O
regular	O
expression	O
;	O
SSE	O
:	O
Secondary	O
Structure	O
Element	O
;	O
Sn	O
:	O
Sensitivity	O
;	O
Sp	O
:	O
Specificity	O
.	O

multiplierz	O
:	O
an	O
extensible	O
API	O
based	O
desktop	O
environment	O
for	O
proteomics	O
data	O
analysis	O

Abstract	O

Background	O

Efficient	O
analysis	O
of	O
results	O
from	O
mass	O
spectrometry-based	O
proteomics	O
experiments	O
requires	O
access	O
to	O
disparate	O
data	O
types	O
,	O
including	O
native	O
mass	O
spectrometry	O
files	O
,	O
output	O
from	O
algorithms	O
that	O
assign	O
peptide	O
sequence	O
to	O
MS/MS	O
spectra	O
,	O
and	O
annotation	O
for	O
proteins	O
and	O
pathways	O
from	O
various	O
database	O
sources	O
.	O

Moreover	O
,	O
proteomics	O
technologies	O
and	O
experimental	O
methods	O
are	O
not	O
yet	O
standardized	O
;	O
hence	O
a	O
high	O
degree	O
of	O
flexibility	O
is	O
necessary	O
for	O
efficient	O
support	O
of	O
high-	O
and	O
low-throughput	O
data	O
analytic	O
tasks	O
.	O

Development	O
of	O
a	O
desktop	O
environment	O
that	O
is	O
sufficiently	O
robust	O
for	O
deployment	O
in	O
data	O
analytic	O
pipelines	O
,	O
and	O
simultaneously	O
supports	O
customization	O
for	O
programmers	O
and	O
non-programmers	O
alike	O
,	O
has	O
proven	O
to	O
be	O
a	O
significant	O
challenge	O
.	O

Results	O

We	O
describe	O
multiplierz	O
,	O
a	O
flexible	O
and	O
open-source	O
desktop	O
environment	O
for	O
comprehensive	O
proteomics	O
data	O
analysis	O
.	O

We	O
use	O
this	O
framework	O
to	O
expose	O
a	O
prototype	O
version	O
of	O
our	O
recently	O
proposed	O
common	O
API	O
(	O
mzAPI	O
)	O
designed	O
for	O
direct	O
access	O
to	O
proprietary	O
mass	O
spectrometry	O
files	O
.	O

In	O
addition	O
to	O
routine	O
data	O
analytic	O
tasks	O
,	O
multiplierz	O
supports	O
generation	O
of	O
information	O
rich	O
,	O
portable	O
spreadsheet-based	O
reports	O
.	O

Moreover	O
,	O
multiplierz	O
is	O
designed	O
around	O
a	O
``	O
zero	O
infrastructure	O
''	O
philosophy	O
,	O
meaning	O
that	O
it	O
can	O
be	O
deployed	O
by	O
end	O
users	O
with	O
little	O
or	O
no	O
system	O
administration	O
support	O
.	O

Finally	O
,	O
access	O
to	O
multiplierz	O
functionality	O
is	O
provided	O
via	O
high-level	O
Python	O
scripts	O
,	O
resulting	O
in	O
a	O
fully	O
extensible	O
data	O
analytic	O
environment	O
for	O
rapid	O
development	O
of	O
custom	O
algorithms	O
and	O
deployment	O
of	O
high-throughput	O
data	O
pipelines	O
.	O

Conclusion	O

Collectively	O
,	O
mzAPI	O
and	O
multiplierz	O
facilitate	O
a	O
wide	O
range	O
of	O
data	O
analysis	O
tasks	O
,	O
spanning	O
technology	O
development	O
to	O
biological	O
annotation	O
,	O
for	O
mass	O
spectrometry-based	O
proteomics	O
research	O
.	O

Background	O

Mass	O
spectrometry-based	O
proteomics	O
,	O
particularly	O
liquid	O
chromatography	O
coupled	O
to	O
electrospray	O
ionization	O
,	O
has	O
become	O
the	O
predominant	O
technique	O
for	O
identification	O
and	O
quantification	O
of	O
proteins	O
in	O
biological	O
systems	O
[	O
1	O
]	O
.	O

Growing	O
demand	O
for	O
improved	O
annotation	O
of	O
primary	O
proteomics	O
data	O
with	O
biological	O
information	O
from	O
various	O
public	O
databases	O
has	O
catalyzed	O
interest	O
in	O
the	O
development	O
of	O
software	O
tools	O
to	O
support	O
integration	O
of	O
these	O
data	O
types	O
.	O

Unfortunately	O
,	O
a	O
number	O
of	O
factors	O
,	O
including	O
lack	O
of	O
experimental	O
standardization	O
,	O
rapid	O
introduction	O
of	O
novel	O
mass	O
spectrometry	O
technology	O
,	O
and	O
the	O
evolution	O
of	O
proprietary	O
file	O
formats	O
associated	O
with	O
proteomics	O
platforms	O
represent	O
a	O
significant	O
hurdle	O
to	O
the	O
development	O
of	O
efficient	O
and	O
comprehensive	O
software	O
frameworks	O
.	O

To	O
accommodate	O
the	O
emergent	O
nature	O
of	O
proteomics-related	O
technologies	O
and	O
the	O
burgeoning	O
number	O
of	O
databases	O
that	O
contain	O
various	O
biological	O
annotations	O
,	O
data	O
analytic	O
systems	O
must	O
emphasize	O
(	O
i	O
)	O
intuitive	O
and	O
interactive	O
interfaces	O
,	O
(	O
ii	O
)	O
user-accessible	O
coding	O
frameworks	O
to	O
facilitate	O
rapid	O
prototyping	O
of	O
algorithms	O
,	O
and	O
(	O
iii	O
)	O
customizable	O
sets	O
of	O
tools	O
that	O
can	O
be	O
readily	O
integrated	O
to	O
provide	O
pipelines	O
that	O
support	O
a	O
variety	O
of	O
proteomic	O
workflows	O
.	O

Task	O
specific	O
Windows	O
desktop	O
applications	O
such	O
as	O
MSQuant	O
[	O
2	O
]	O
and	O
InsilicosViewer	O
[	O
3	O
]	O
can	O
access	O
a	O
subset	O
of	O
native	O
mass	O
spectrometry	O
data	O
files	O
directly	O
and	O
provide	O
flexibility	O
through	O
adjustable	O
parameters	O
,	O
but	O
are	O
not	O
readily	O
extended	O
across	O
the	O
full	O
spectrum	O
of	O
data	O
analytic	O
activities	O
required	O
in	O
modern	O
proteomics	O
research	O
.	O

To	O
address	O
the	O
full	O
spectrum	O
of	O
analyses	O
,	O
open	O
source	O
projects	O
such	O
as	O
The	O
OpenMS	O
Proteomics	O
Pipeline	O
(	O
TOPP	O
)	O
[	O
4	O
]	O
and	O
ProteoWizard	O
[	O
5	O
]	O
offer	O
a	O
set	O
of	O
modular	O
tools	O
for	O
generation	O
of	O
pipelines	O
.	O

The	O
C++	O
coding	O
environment	O
of	O
these	O
tools	O
is	O
designed	O
for	O
performance	O
and	O
throughput	O
,	O
although	O
researchers	O
who	O
lack	O
programming	O
experience	O
often	O
struggle	O
to	O
implement	O
novel	O
algorithms	O
or	O
other	O
ad	O
hoc	O
tasks	O
.	O

Therefore	O
,	O
software	O
libraries	O
such	O
as	O
InSilicoSpectro	O
[	O
6	O
]	O
and	O
mspire	O
[	O
7	O
]	O
have	O
been	O
developed	O
based	O
on	O
high-level	O
languages	O
such	O
as	O
Perl	O
and	O
Ruby	O
respectively	O
.	O

These	O
libraries	O
allow	O
scripting	O
of	O
common	O
data	O
analysis	O
tasks	O
but	O
can	O
not	O
access	O
raw	O
binary	O
data	O
directly	O
,	O
and	O
must	O
rely	O
instead	O
on	O
surrogate	O
text	O
files	O
.	O

Historically	O
the	O
proprietary	O
nature	O
of	O
binary	O
files	O
associated	O
with	O
proteomics	O
technologies	O
represented	O
a	O
significant	O
obstacle	O
to	O
efforts	O
aimed	O
at	O
development	O
of	O
integrated	O
,	O
desktop	O
environments	O
.	O

One	O
solution	O
proposed	O
specifically	O
for	O
mass	O
spectrometry	O
is	O
extraction	O
of	O
native	O
data	O
to	O
a	O
common	O
file	O
format	O
,	O
typically	O
a	O
dialect	O
of	O
XML	O
[	O
8,9	O
]	O
.	O

We	O
[	O
10	O
]	O
and	O
others	O
[	O
11	O
]	O
have	O
challenged	O
the	O
technical	O
merits	O
of	O
this	O
approach	O
.	O

Given	O
that	O
mass	O
spectrometry	O
manufacturers	O
implicitly	O
carry	O
the	O
burden	O
of	O
maintaining	O
up-to-date	O
libraries	O
for	O
access	O
to	O
their	O
native	O
data	O
,	O
we	O
recently	O
proposed	O
that	O
a	O
common	O
API	O
[	O
10	O
]	O
is	O
a	O
more	O
rational	O
solution	O
for	O
shared	O
access	O
to	O
proprietary	O
mass	O
spectrometry	O
files	O
.	O

Here	O
we	O
define	O
and	O
implement	O
a	O
minimal	O
API	O
(	O
mzAPI	O
)	O
that	O
provides	O
direct	O
,	O
programmatic	O
interaction	O
with	O
binary	O
raw	O
files	O
and	O
we	O
demonstrate	O
that	O
performance	O
for	O
practical	O
tasks	O
is	O
significantly	O
faster	O
as	O
compared	O
to	O
equivalent	O
operations	O
for	O
access	O
to	O
mzXML	O
files	O
.	O

We	O
implement	O
mzAPI	O
in	O
Python	O
to	O
maximize	O
accessibility	O
;	O
similarly	O
,	O
mzAPI	O
is	O
exposed	O
to	O
users	O
through	O
multiplierz	O
,	O
a	O
Python-based	O
desktop	O
environment	O
that	O
combines	O
an	O
intuitive	O
interface	O
with	O
a	O
powerful	O
and	O
flexible	O
high-level	O
scripting	O
platform	O
.	O

Together	O
,	O
mzAPI	O
and	O
multiplierz	O
support	O
a	O
wide	O
range	O
of	O
data	O
analytic	O
tasks	O
and	O
facilitate	O
rapid	O
prototyping	O
of	O
novel	O
algorithms	O
.	O

In	O
addition	O
,	O
the	O
multiplierz	O
environment	O
is	O
designed	O
with	O
a	O
``	O
zero-infrastructure	O
''	O
philosophy	O
,	O
meaning	O
that	O
it	O
can	O
be	O
deployed	O
by	O
end	O
users	O
who	O
lack	O
system	O
administration	O
experience	O
or	O
support	O
.	O

We	O
demonstrate	O
the	O
capabilities	O
of	O
multiplierz	O
through	O
a	O
variety	O
of	O
proteomics	O
case	O
studies	O
such	O
as	O
(	O
i	O
)	O
label-free	O
quantitative	O
comparison	O
and	O
interactive	O
validation	O
of	O
datasets	O
from	O
multi-acquisition	O
experiments	O
,	O
(	O
ii	O
)	O
automatic	O
quality	O
control	O
of	O
mass	O
spectrometer	O
performance	O
,	O
(	O
iii	O
)	O
improved	O
peptide	O
sequence	O
assignment	O
via	O
deisotoping	O
of	O
MS/MS	O
spectra	O
,	O
and	O
(	O
iv	O
)	O
assessment	O
of	O
phosphopeptide	O
enrichment	O
efficiency	O
through	O
programmatic	O
fragment	O
ion	O
extraction	O
.	O

Implementation	O

mzAPI	O
:	O
A	O
Common	O
API	O
for	O
Direct	O
Access	O
to	O
Proprietary	O
File	O
Formats	O

As	O
described	O
above	O
,	O
direct	O
access	O
to	O
native	O
mass	O
spectrometry	O
data	O
files	O
is	O
a	O
key	O
factor	O
in	O
the	O
assembly	O
of	O
a	O
powerful	O
and	O
flexible	O
framework	O
for	O
proteomics	O
data	O
analysis	O
.	O

Towards	O
this	O
end	O
,	O
we	O
define	O
a	O
minimal	O
mzAPI	O
as	O
consisting	O
of	O
the	O
following	O
key	O
procedures	O
:	O

1.	O
scan	O
(	O
time	O
)	O
›	O
[	O
(	O
mz	O
,	O
intensity	O
)	O
]	O

2.	O
scan_list	O
(	O
start_time	O
,	O
stop_time	O
)	O
›	O
[	O
(	O
time	O
,	O
precursor	O
)	O
]	O

3.	O
time_range	O
(	O
)	O
›	O
(	O
start_time	O
,	O
stop_time	O
)	O

4.	O
scan_time_from_scan_name	O
(	O
scan_name	O
)	O
›	O
time	O

5.	O
ric	O
(	O
start_time	O
,	O
stop_time	O
,	O
start_mz	O
,	O
stop_mz	O
)	O
›	O
[	O
(	O
time	O
,	O
intensity	O
)	O
]	O

The	O
first	O
two	O
procedures	O
in	O
mzAPI	O
return	O
:	O
1	O
)	O
individual	O
scans	O
in	O
the	O
form	O
of	O
a	O
list	O
of	O
(	O
mz	O
,	O
intensity	O
)	O
pairs	O
,	O
and	O
2	O
)	O
a	O
catalog	O
of	O
all	O
scan	O
descriptions	O
in	O
the	O
form	O
of	O
a	O
list	O
of	O
(	O
time	O
,	O
precursor	O
)	O
pairs	O
in	O
the	O
experiment	O
.	O

In	O
addition	O
,	O
the	O
API	O
provides	O
:	O
3	O
)	O
'time_range	O
'	O
that	O
returns	O
the	O
earliest	O
and	O
latest	O
acquisition	O
times	O
in	O
the	O
experiment	O
,	O
and	O
4	O
)	O
'scan_time_from_scan_name	O
'	O
for	O
translation	O
of	O
manufacturer-specific	O
scan	O
nomenclature	O
to	O
the	O
mzAPI	O
naming	O
convention	O
.	O

We	O
opted	O
to	O
rely	O
on	O
acquisition	O
time	O
as	O
a	O
common	O
naming	O
convention	O
.	O

In	O
the	O
case	O
of	O
LC-MS	O
this	O
is	O
equivalent	O
to	O
chromatographic	O
retention	O
time	O
.	O

Finally	O
,	O
a	O
fifth	O
procedure	O
generates	O
a	O
reconstructed	O
ion	O
chromatogram	O
(	O
RIC	O
)	O
for	O
a	O
given	O
time	O
and	O
mass-to-charge	O
range	O
,	O
returned	O
as	O
a	O
set	O
of	O
(	O
time	O
,	O
intensity	O
)	O
pairs	O
.	O

While	C
in	C
principle	C
RICs	C
can	C
be	C
generated	C
using	C
the	C
first	C
two	C
calls	C
,	C
we	C
believe	C
that	C
ubiquitous	C
use	C
of	C
the	C
RIC	C
operation	C
in	C
proteomics	C
data	C
analysis	C
justifies	C
exposure	C
of	C
RIC	C
extraction	C
as	C
a	C
primitive	C
in	C
the	C
API	C
.	C

Given	O
that	O
RIC	O
extraction	O
is	O
provided	O
by	O
all	O
manufacturer	O
libraries	O
,	O
this	O
procedure	O
represents	O
an	O
excellent	O
example	O
of	O
efficient	O
re-use	O
of	O
native	O
data	O
system	O
indexing	O
and	O
software	O
.	O

We	C
propose	C
that	C
a	C
proprietary	C
file	C
format	C
is	C
considered	C
mzAPI	C
compliant	C
when	C
the	C
manufacturer	C
provides	C
a	C
freely	C
available	C
,	C
and	C
preferably	C
redistributable	C
,	C
implementation	C
of	C
the	C
aforementioned	C
5	C
core	C
procedures	C
,	C
or	C
an	C
extended	C
version	C
that	C
may	C
evolve	C
from	C
a	C
community-driven	C
standardization	C
effort	C
.	C

For	O
example	O
,	O
ThermoFisher	O
Scientific	O
provides	O
a	O
data	O
access	O
library	O
for	O
.RAW	O
files	O
through	O
the	O
MSFileReader	O
program	O
,	O
freely	O
available	O
for	O
download	O
at	O
:	O
http	O
:	O
//sjsupport.thermofinnigan.com/public/detail.asp	O
?	O
id=586	O
or	O
http	O
:	O
//blais.dfci.harvard.edu/research/mass-informatics/mzAPI/vendor-libraries/	O
.	O

Naturally	C
,	C
additional	C
procedure	C
calls	C
,	C
such	C
as	C
charge	C
state	C
or	C
signal-to-noise	C
values	C
for	C
each	C
isotope	C
cluster	C
in	C
MS	C
or	C
MS/MS	C
scans	C
,	C
can	C
be	C
incorporated	C
into	C
the	C
mzAPI	C
framework	C
by	C
essentially	C
subclassing	C
the	C
core	C
mzFile	C
class	C
.	C

As	O
a	O
basic	O
test	O
of	O
file	O
access	O
speed	O
,	O
we	O
compared	O
the	O
time	O
required	O
for	O
random	O
access	O
of	O
scans	O
in	O
an	O
LC-MS	O
acquisition	O
from	O
a	O
ThermoFisher	O
.RAW	O
file	O
using	O
mzAPI	O
(	O
through	O
its	O
Python	O
implementation	O
)	O
versus	O
libraries	O
provided	O
by	O
the	O
manufacturer	O
and	O
included	O
in	O
the	O
native	O
Xcalibur	O
file	O
browser	O
(	O
note	O
that	O
mzXML	O
data	O
was	O
not	O
considered	O
for	O
this	O
comparison	O
since	O
it	O
does	O
not	O
provide	O
access	O
by	O
acquisition	O
time	O
as	O
a	O
primitive	O
in	O
the	O
RAP	O
or	O
RAMP	O
API	O
)	O
.	O

Table	O
1	O
demonstrates	O
that	O
,	O
as	O
expected	O
,	O
random	O
file	O
access	O
via	O
mzAPI	O
is	O
slower	O
than	O
that	O
obtained	O
when	O
working	O
directly	O
in	O
the	O
manufacturer	O
's	O
native	O
environment	O
.	O

The	C
performance	C
of	C
the	C
common	C
API	C
could	C
be	C
further	C
improved	C
by	C
implementation	C
in	C
C++	C
or	C
C	C
#	C
,	C
but	C
we	C
explicitly	C
chose	C
Python	C
to	C
maintain	C
maximum	C
flexibility	C
through	C
user	C
defined	C
scripts	C
(	C
see	C
below	C
)	C
.	C

Interestingly	O
,	O
one	O
consequence	O
of	O
the	O
common	O
API	O
strategy	O
is	O
that	O
it	O
provides	O
a	O
direct	O
measure	O
of	O
manufacturer	O
data	O
system	O
efficiency	O
,	O
as	O
evidenced	O
by	O
the	O
additional	O
time	O
required	O
for	O
random	O
access	O
to	O
scans	O
in	O
.WIFF	O
versus	O
.RAW	O
files	O
.	O

Regardless	C
of	C
native	C
file	C
type	C
,	C
the	C
use	C
of	C
a	C
common	C
API	C
eliminates	C
the	C
need	C
for	C
storage	C
and	C
tracking	C
of	C
surrogate	C
files	C
;	C
based	C
on	C
previous	C
reports	C
,	C
this	C
can	C
be	C
particularly	C
problematic	C
for	C
full	C
profile	C
data	C
files	C
,	C
which	C
can	C
grow	C
significantly	C
in	C
size	C
upon	C
conversion	C
to	C
XML	C
[	C
9	C
]	C
.	C

Access	O
Efficiency	O
for	O
Open	O
and	O
Proprietary	O
Mass	O
Spectrometry	O
Data	O
Files	O
.	O

Given	O
the	O
multidimensional	O
nature	O
of	O
mass-spectrometry	O
data	O
,	O
extraction	O
based	O
on	O
specific	O
slices	O
through	O
the	O
data	O
space	O
,	O
rather	O
than	O
random	O
file	O
access	O
,	O
is	O
a	O
more	O
relevant	O
performance	O
metric	O
for	O
mass	O
spectrometry	O
files	O
.	O

Generation	C
of	C
RICs	C
is	C
perhaps	C
the	C
best	C
example	C
of	C
a	C
data	C
slice	C
procedure	C
supported	C
by	C
all	C
manufacturer	C
data	C
systems	C
.	C

Consequently	O
we	O
next	O
sought	O
to	O
test	O
the	O
performance	O
of	O
mzAPI	O
for	O
creation	O
of	O
RICs	O
directly	O
from	O
a	O
.RAW	O
file	O
.	O

As	O
a	O
point	O
of	O
comparison	O
we	O
generated	O
the	O
corresponding	O
mzXML	O
file	O
(	O
using	O
TPP	O
version	O
4.0	O
)	O
[	O
12	O
]	O
and	O
extracted	O
RICs	O
using	O
both	O
a	O
graphical	O
user	O
interface	O
(	O
GUI	O
)	O
based	O
browser	O
tool	O
(	O
InsilicosViewer	O
version	O
1.5.1	O
)	O
[	O
3	O
]	O
as	O
well	O
as	O
the	O
Perl-based	O
InSilicoSpectro	O
environment	O
(	O
version	O
1.3.19	O
)	O
[	O
6	O
]	O
and	O
the	O
R-based	O
XCMS	O
(	O
version	O
1.12.1	O
)	O
,	O
[	O
13	O
]	O
scriptable	O
interface	O
platforms	O
.	O

Although	O
the	O
latter	O
two	O
are	O
designed	O
to	O
access	O
a	O
number	O
of	O
third-party	O
file	O
formats	O
,	O
none	O
of	O
the	O
GUI-	O
or	O
command-line	O
based	O
tools	O
supports	O
access	O
to	O
specified	O
subsets	O
(	O
in	O
chromatographic	O
time	O
)	O
of	O
the	O
underlying	O
data	O
.	O

As	O
a	O
result	O
we	O
generated	O
RICs	O
by	O
extraction	O
of	O
a	O
specific	O
mass-to-charge	O
range	O
over	O
the	O
full	O
data	O
file	O
,	O
or	O
in	O
the	O
case	O
of	O
InSilicoSpectro	O
,	O
which	O
had	O
no	O
support	O
for	O
RIC	O
generation	O
,	O
we	O
simply	O
timed	O
the	O
opening	O
of	O
mzXML	O
files	O
.	O

While	O
the	O
mzXML	O
schema	O
includes	O
a	O
scan	O
index	O
that	O
provides	O
for	O
random	O
access	O
to	O
scans	O
at	O
speeds	O
competitive	O
with	O
,	O
or	O
exceeding	O
,	O
proprietary	O
data	O
system	O
(	O
in	O
this	O
case	O
ThermoFisher	O
Xcalibur	O
)	O
[	O
9	O
]	O
,	O
Table	O
1	O
shows	O
that	O
generation	O
of	O
specific	O
data	O
slices	O
,	O
or	O
in	O
this	O
case	O
RICs	O
,	O
is	O
5-	O
to	O
10-fold	O
faster	O
when	O
leveraging	O
the	O
underlying	O
manufacturer	O
's	O
API	O
compared	O
to	O
GUI	O
or	O
command	O
line	O
based	O
access	O
to	O
mzXML	O
(	O
scripts	O
used	O
for	O
all	O
timings	O
included	O
in	O
Additional	O
File	O
1	O
)	O
.	O

This	C
result	C
supports	C
the	C
notion	C
that	C
pragmatic	C
data	C
access	C
patterns	C
are	C
well	C
supported	C
by	C
existing	C
,	C
albeit	C
proprietary	C
,	C
manufacturer	C
libraries	C
,	C
and	C
more	C
importantly	C
,	C
that	C
these	C
libraries	C
can	C
be	C
efficiently	C
utilized	C
through	C
a	C
common	C
and	C
redistributable	C
API	C
.	C

multiplierz	O
:	O
An	O
Open-Source	O
and	O
Interactive	O
Environment	O
for	O
Proteomics	O
Data	O
Analysis	O

We	O
extend	O
the	O
functionality	O
of	O
mzAPI	O
by	O
integration	O
into	O
multiplierz	O
,	O
an	O
open-source	O
Python-based	O
environment	O
that	O
provides	O
a	O
flexible	O
framework	O
for	O
comprehensive	O
analysis	O
of	O
proteomics	O
data	O
.	O

Figure	O
1	O
illustrates	O
our	O
proposed	O
implementation	O
;	O
all	O
associated	O
code	O
and	O
scripts	O
are	O
available	O
for	O
download	O
at	O
:	O
http	O
:	O
//blais.dfci.harvard.edu/multiplierz	O
.	O

In	O
the	O
following	O
sections	O
,	O
we	O
provide	O
a	O
detailed	O
description	O
of	O
core	O
multiplierz	O
capabilities	O
.	O

A	O
Common	O
API	O
and	O
Desktop	O
Environment	O
for	O
Mass	O
Spectrometry	O
Data	O
Analysis	O
.	O

The	O
multiplierz	O
environment	O
provides	O
a	O
central	O
point	O
for	O
user	O
interaction	O
with	O
proprietary	O
data	O
files	O
(	O
via	O
mzAPI	O
)	O
,	O
protein/peptide	O
identification	O
algorithms	O
,	O
publicly	O
available	O
annotation	O
databases	O
,	O
and	O
commercial	O
reporting	O
and	O
spreadsheet	O
tools	O
.	O

Our	O
proposal	O
calls	O
for	O
manufacturers	O
to	O
provide	O
a	O
minimal	O
set	O
of	O
libraries	O
for	O
access	O
to	O
their	O
native	O
data	O
files	O
.	O

Ad	O
hoc	O
data	O
analysis	O
tasks	O
are	O
supported	O
through	O
multiplierz	O
scripting	O
capability	O
,	O
including	O
programmatic	O
access	O
for	O
integration	O
into	O
data	O
analytic	O
pipelines	O
.	O

Regardless	O
of	O
final	O
experimental	O
goals	O
,	O
peptide	O
identification	O
is	O
often	O
the	O
first	O
or	O
default	O
operation	O
performed	O
subsequent	O
to	O
LC-MS	O
data	O
acquisition	O
.	O

We	O
designed	O
multiplierz	O
to	O
serve	O
as	O
a	O
user-friendly	O
,	O
desktop	O
tool	O
for	O
interaction	O
with	O
proteomics	O
database	O
search	O
engines	O
;	O
consistent	O
with	O
our	O
zero-infrastructure	O
philosophy	O
,	O
X	O
!	O
Tandem	O
[	O
14	O
]	O
is	O
fully	O
integrated	O
into	O
the	O
multiplierz	O
installation	O
package	O
.	O

Similarly	O
we	O
include	O
support	O
for	O
automated	O
retrieval	O
of	O
Mascot	O
search	O
results	O
.	O

In	O
this	O
case	O
,	O
the	O
URL	O
for	O
a	O
particular	O
search	O
is	O
easily	O
and	O
unambiguously	O
accessed	O
using	O
the	O
Mascot	O
job	O
ID	O
(	O
after	O
completion	O
of	O
the	O
search	O
,	O
the	O
Mascot	O
ID	O
is	O
both	O
on	O
the	O
search	O
submission	O
page	O
and	O
in	O
the	O
Mascot	O
Daemon	O
)	O
.	O

The	O
multiplierz	O
module	O
for	O
downloading	O
Mascot	O
search	O
results	O
also	O
allows	O
input	O
for	O
Mascot-specific	O
export	O
options	O
such	O
as	O
``	O
Require	O
Bold	O
Red	O
''	O
and	O
``	O
Maximum	O
Number	O
of	O
Protein	O
hits	O
.	O
''	O

Multiple	O
search	O
results	O
are	O
specified	O
using	O
either	O
a	O
comma-	O
or	O
dash-separated	O
list	O
of	O
Mascot	O
Job	O
IDs	O
(	O
e.g.	O
,	O
6556	O
,	O
5878	O
,	O
5120-5125	O
)	O
.	O

Users	O
can	O
optionally	O
include	O
Mascot	O
MS/MS	O
fragment	O
annotation	O
images	O
(	O
that	O
are	O
displayed	O
in	O
multiple	O
Mascot	O
report	O
web	O
pages	O
)	O
and	O
embed	O
them	O
within	O
a	O
singular	O
multiplierz	O
report	O
;	O
thus	O
multiplierz	O
provides	O
users	O
with	O
comprehensive	O
Mascot	O
information	O
,	O
including	O
images	O
,	O
in	O
a	O
convenient	O
and	O
portable	O
report	O
(	O
described	O
below	O
)	O
.	O

Importantly	O
,	O
none	O
of	O
the	O
above	O
tasks	O
require	O
server	O
level	O
administrative	O
privileges	O
.	O

For	O
example	O
,	O
query	O
of	O
MS/MS	O
peak	O
annotations	O
typically	O
requires	O
logon	O
credentials	O
within	O
the	O
web	O
browser	O
.	O

multiplierz	O
interacts	O
with	O
the	O
browser	O
to	O
``	O
screen	O
scrape	O
''	O
MS/MS	O
images	O
and	O
store	O
them	O
within	O
the	O
default	O
report	O
format	O
.	O

Users	C
with	C
full	C
access	C
to	C
the	C
Mascot	C
server	C
may	C
parse	C
results	C
directly	C
from	C
the	C
.DAT	C
file	C
using	C
.mz	C
scripts	C
(	C
multiplierz	C
reports	C
and	C
.mz	C
scripts	C
and	C
described	C
below	C
)	C
.	C

Similar	O
support	O
is	O
also	O
provided	O
for	O
Protein	O
Pilot	O
[	O
15	O
]	O
and	O
OMSSA	O
[	O
16	O
]	O
.	O

For	O
maximum	O
flexibility	O
in	O
conversion	O
of	O
parsed	O
data	O
from	O
other	O
search	O
engines	O
we	O
include	O
modules	O
for	O
generation	O
of	O
multiplierz-compatible	O
spreadsheets	O
.	O

Calculation	O
of	O
a	O
false	O
discovery	O
rate	O
(	O
FDR	O
)	O
for	O
peptide	O
sequence	O
identifications	O
is	O
one	O
mechanism	O
to	O
assess	O
the	O
overall	O
quality	O
of	O
search	O
results	O
[	O
17,18	O
]	O
.	O

multiplierz	O
supports	O
calculation	O
of	O
a	O
FDR	O
upon	O
retrieval	O
of	O
peptide	O
identification	O
data	O
from	O
both	O
forward	O
and	O
reverse	O
database	O
searches	O
.	O

The	O
FDR	O
for	O
a	O
given	O
score	O
threshold	O
is	O
calculated	O
as	O
the	O
ratio	O
of	O
reverse	O
database	O
search	O
identifications	O
to	O
that	O
from	O
the	O
forward	O
plus	O
reverse	O
searches	O
,	O
each	O
with	O
a	O
score	O
greater	O
than	O
or	O
equal	O
to	O
the	O
chosen	O
threshold	O
.	O

The	O
FDR	O
thus	O
represents	O
the	O
percentage	O
of	O
identified	O
peptides	O
in	O
the	O
forward	O
search	O
that	O
would	O
also	O
be	O
detected	O
in	O
the	O
reverse	O
database	O
search	O
.	O

multiplierz	O
identifies	O
score	O
thresholds	O
for	O
commonly	O
used	O
FDR	O
(	O
1	O
%	O
,	O
2	O
%	O
,	O
and	O
5	O
%	O
)	O
as	O
well	O
as	O
calculates	O
the	O
FDR	O
for	O
each	O
forward	O
peptide	O
score	O
via	O
an	O
.mz	O
Script	O
(	O
see	O
below	O
;	O
scripts	O
for	O
generating	O
a	O
reverse	O
database	O
and	O
calculating	O
the	O
FDR	O
are	O
included	O
in	O
Additional	O
File	O
2	O
)	O
.	O

Correlation	O
of	O
identified	O
peptide	O
sequences	O
with	O
specific	O
features	O
in	O
the	O
source	O
mass	O
spectrometry	O
data	O
,	O
such	O
as	O
chromatographic	O
peak	O
width	O
or	O
maximum	O
precursor	O
intensity	O
,	O
is	O
often	O
complicated	O
by	O
the	O
requirement	O
for	O
users	O
to	O
move	O
between	O
disparate	O
programs	O
and	O
interfaces	O
.	O

The	O
multiplierz	O
desktop	O
environment	O
provides	O
users	O
with	O
a	O
centralized	O
point	O
of	O
interaction	O
with	O
both	O
search	O
results	O
and	O
the	O
underlying	O
mass	O
spectrometry	O
files	O
.	O

For	C
example	C
,	C
high-confidence	C
peptide	C
identifications	C
may	C
be	C
used	C
for	C
direct	C
generation	C
of	C
RICs	C
across	C
user-defined	C
time	C
and	C
mass-to-charge	C
ranges	C
.	C

Various	O
metrics	O
such	O
as	O
full	O
peak	O
width	O
at	O
half	O
maximum	O
(	O
FWHM	O
)	O
,	O
peak	O
area	O
,	O
and	O
apex	O
precursor	O
intensity	O
for	O
peptide	O
elution	O
profiles	O
are	O
included	O
in	O
the	O
output	O
report	O
.	O

As	O
described	O
below	O
these	O
data	O
are	O
combined	O
,	O
annotated	O
,	O
and	O
made	O
available	O
in	O
portable	O
,	O
user-friendly	O
reports	O
.	O

Consistent	O
with	O
our	O
underlying	O
motivation	O
to	O
combine	O
open-source	O
and	O
commercial	O
software	O
where	O
appropriate	O
,	O
we	O
opted	O
to	O
export	O
multiplierz	O
results	O
into	O
Microsoft	O
Excel	O
.	O

We	C
take	C
advantage	C
of	C
Excel	C
's	C
ability	C
to	C
store	C
images	C
in	C
the	C
worksheet	C
(	C
as	C
comments	C
)	C
,	C
thereby	C
creating	C
an	C
information-rich	C
,	C
yet	C
portable	C
,	C
report	C
that	C
may	C
be	C
readily	C
formatted	C
to	C
meet	C
specific	C
scientific	C
journal	C
data	C
submission	C
requirements	C
[	C
19	C
]	C
.	C

Moreover	O
,	O
we	O
note	O
that	O
the	O
tendency	O
towards	O
analysis	O
of	O
increasingly	O
complex	O
mixtures	O
along	O
with	O
continued	O
efforts	O
in	O
relative	O
protein	O
quantification	O
have	O
placed	O
increased	O
emphasis	O
on	O
data	O
reproducibility	O
in	O
proteomics	O
experiments	O
.	O

Hence	O
it	O
has	O
become	O
common	O
practice	O
to	O
derive	O
a	O
``	O
proteomics	O
result	O
''	O
from	O
comparison	O
,	O
or	O
other	O
manipulation	O
,	O
of	O
multiple	O
mass	O
spectrometry	O
acquisitions	O
.	O

In	O
support	O
of	O
this	O
experimental	O
paradigm	O
,	O
multiplierz	O
includes	O
``	O
multi-detect	O
''	O
and	O
``	O
multi-filter	O
''	O
tools	O
that	O
provide	O
users	O
tremendous	O
flexibility	O
in	O
filtering	O
and	O
collating	O
(	O
e.g.	O
,	O
by	O
common	O
or	O
unique	O
proteins	O
,	O
peptides	O
,	O
post-translational	O
modifications	O
,	O
charge	O
state	O
,	O
etc	O
.	O
)	O
each	O
data	O
file	O
obtained	O
from	O
a	O
multiple	O
acquisition	O
study	O
.	O

This	O
feature	O
provides	O
database-like	O
functionality	O
without	O
the	O
need	O
to	O
install	O
and	O
maintain	O
dedicated	O
database	O
servers	O
.	O

Importantly	O
,	O
all	O
multiplierz	O
functions	O
provide	O
spreadsheet-based	O
output	O
with	O
optional	O
embedded	O
images	O
(	O
see	O
Figure	O
2	O
and	O
discussion	O
below	O
)	O
.	O

Integration	O
of	O
Commercial	O
Tools	O
for	O
multiplierz	O
Reports	O
.	O

A	O
spreadsheet-based	O
report	O
from	O
multiplierz	O
analysis	O
of	O
11	O
LC-MS	O
analyses	O
,	O
designed	O
to	O
interrogate	O
performance	O
of	O
LC	O
column	O
geometry	O
and	O
flow	O
rate	O
(	O
see	O
also	O
Figure	O
5	O
and	O
Additional	O
File	O
5	O
)	O
.	O

For	O
clarity	O
the	O
spreadsheet	O
shows	O
peptide	O
entries	O
and	O
characterization	O
data	O
from	O
the	O
two	O
extremes	O
in	O
column	O
size	O
and	O
flow	O
rate	O
.	O

Informative	O
images	O
are	O
embedded	O
within	O
spreadsheet	O
cell	O
comments	O
and	O
are	O
accessed	O
by	O
mouse-over	O
,	O
thus	O
facilitating	O
rapid	O
visual	O
inspection	O
.	O

Optional	O
embedded	O
images	O
include	O
:	O
1	O
.	O
)	O

MS/MS	O
spectra	O
that	O
are	O
annotated	O
with	O
b-	O
and	O
y-type	O
fragment	O
ion	O
labels	O
,	O
peptide	O
sequence	O
,	O
search	O
engine	O
score	O
(	O
in	O
this	O
case	O
Mascot	O
peptide	O
score	O
)	O
,	O
and	O
precursor	O
charge	O
state	O
.	O

A	O
color	O
scheme	O
highlights	O
modified	O
amino	O
acids	O
(	O
in	O
this	O
case	O
oxidized	O
methionine	O
)	O
and	O
those	O
residues	O
inferred	O
from	O
b-	O
and	O
y-type	O
fragment	O
ion	O
assignments	O
(	O
horizontal	O
lines	O
,	O
red	O
and	O
blue	O
denote	O
singly-	O
and	O
doubly-charged	O
ions	O
,	O
respectively	O
)	O
.	O
2	O
.	O
)	O

RIC	O
images	O
in	O
which	O
MS	O
scans	O
are	O
annotated	O
with	O
green	O
squares	O
,	O
while	O
yellow	O
circles	O
and	O
blue	O
triangles	O
denote	O
MS/MS	O
scans	O
for	O
the	O
precursor	O
of	O
interest	O
,	O
with	O
the	O
latter	O
indicating	O
the	O
specific	O
MS2	O
event	O
described	O
in	O
the	O
selected	O
row	O
of	O
the	O
spreadsheet	O
.	O
3	O
.	O
)	O
precursor	O
region	O
of	O
the	O
MS	O
spectrum	O
(	O
not	O
shown	O
)	O
.	O

The	O
highly	O
embedded	O
,	O
spreadsheet-based	O
multiplierz	O
reports	O
provide	O
a	O
very	O
flexible	O
and	O
user-friendly	O
mechanism	O
to	O
query	O
various	O
metrics	O
of	O
the	O
underlying	O
native	O
mass	O
spectrometry	O
data	O
and	O
quickly	O
collate	O
search	O
results	O
based	O
on	O
user-defined	O
filter	O
criteria	O
.	O

However	O
,	O
it	O
is	O
often	O
the	O
case	O
that	O
researchers	O
must	O
go	O
beyond	O
these	O
general	O
characterizations	O
and	O
focus	O
on	O
a	O
small	O
subset	O
of	O
their	O
proteomics	O
data	O
in	O
support	O
of	O
targeted	O
biological	O
questions	O
.	O

To	O
enable	O
this	O
mode	O
of	O
data	O
analysis	O
,	O
multiplierz	O
includes	O
a	O
Peak	O
Viewer	O
tool	O
(	O
Figure	O
3	O
)	O
that	O
provides	O
dynamic	O
and	O
interactive	O
plots	O
for	O
precursor	O
RICs	O
,	O
and	O
corresponding	O
MS	O
and	O
MS/MS	O
scans	O
.	O

Additionally	O
,	O
users	O
can	O
edit	O
and	O
export	O
publication	O
quality	O
images	O
through	O
a	O
built-in	O
Scrapbook	O
tool	O
(	O
Figure	O
4	O
)	O
.	O

Features	O
of	O
the	O
Peak	O
Viewer	O
include	O
(	O
i	O
)	O
visualization	O
of	O
theoretical	O
fragments	O
superimposed	O
on	O
MS/MS	O
spectra	O
,	O
(	O
ii	O
)	O
automatic	O
zoom-in	O
display	O
for	O
iTRAQ	O
and	O
theoretical	O
ions	O
for	O
rapid	O
manual	O
validation	O
,	O
and	O
(	O
iii	O
)	O
comparison	O
of	O
scans	O
and	O
RICs	O
via	O
mirror	O
and	O
overlay	O
functions	O
.	O

For	O
added	O
convenience	O
the	O
Peak	O
Viewer	O
opens	O
multiplierz	O
spreadsheets	O
and	O
users	O
can	O
generate	O
plots	O
by	O
a	O
simple	O
double-click	O
on	O
specific	O
rows	O
or	O
peptide	O
entries	O
.	O

Dynamic	O
Visualization	O
of	O
Proprietary	O
Mass	O
Spectrometry	O
Data	O
Files	O
.	O

The	O
Peak	O
Viewer	O
tool	O
in	O
multiplierz	O
provides	O
interactive	O
plots	O
for	O
precursor	O
RICs	O
,	O
and	O
corresponding	O
MS	O
and	O
MS/MS	O
scans	O
,	O
in	O
centroid	O
or	O
profile	O
modes	O
.	O

Green	O
squares	O
in	O
the	O
RIC	O
denote	O
MS	O
scans	O
and	O
red	O
triangles	O
indicate	O
MS/MS	O
events	O
.	O

In	C
addition	C
,	C
users	C
may	C
adjust	C
the	C
time	C
or	C
m/z	C
range	C
displayed	C
in	C
each	C
data	C
window	C
.	C

Verification	O
of	O
peptide	O
sequence	O
is	O
facilitated	O
by	O
overlay	O
of	O
theoretical	O
fragment	O
ions	O
on	O
the	O
MS/MS	O
spectra	O
.	O

Users	O
may	O
dynamically	O
evaluate	O
multiple	O
peptide	O
assignment	O
options	O
by	O
changing	O
the	O
proposed	O
sequence	O
or	O
post-translational	O
modification	O
state	O
in	O
the	O
left-most	O
pane	O
.	O

Generation	O
of	O
Publication	O
Quality	O
Images	O
.	O

A	O
Scrapbook	O
tool	O
allows	O
manipulation	O
of	O
Peak	O
Viewer	O
plot	O
properties	O
such	O
as	O
axes	O
labels	O
,	O
titles	O
,	O
and	O
size	O
.	O

Multi-plot	O
comparison	O
via	O
the	O
mirror	O
and	O
overlay	O
functions	O
provide	O
further	O
modes	O
for	O
in-depth	O
,	O
manual	O
data	O
interrogation	O
.	O

Users	C
may	C
export	C
publication	C
quality	C
images	C
from	C
all	C
Scrapbook	C
plots	C
.	C

Researchers	O
are	O
increasingly	O
focused	O
on	O
integration	O
of	O
disparate	O
data	O
types	O
in	O
order	O
to	O
better	O
understand	O
biological	O
phenomena	O
at	O
the	O
so-called	O
network	O
or	O
systems	O
level	O
.	O

As	O
a	O
first	O
step	O
in	O
support	O
of	O
these	O
and	O
similar	O
activities	O
,	O
multiplierz	O
automatically	O
downloads	O
GenBank	O
data	O
over	O
the	O
internet	O
based	O
on	O
an	O
identified	O
protein	O
list	O
,	O
parses	O
information	O
such	O
as	O
gene	O
ontology	O
and	O
domain	O
classification	O
,	O
along	O
with	O
the	O
corresponding	O
Entrez	O
Gene	O
,	O
HPRD	O
,	O
HGNC	O
,	O
and	O
OMIM	O
entries	O
,	O
and	O
then	O
creates	O
hyperlinks	O
directly	O
in	O
the	O
spreadsheet	O
reports	O
.	O

This	O
and	O
other	O
tools	O
including	O
an	O
in	O
silico	O
protein	O
digestion	O
tool	O
and	O
a	O
peptide	O
fragment	O
calculator	O
are	O
described	O
in	O
Additional	O
File	O
3	O
.	O

While	O
multiplierz	O
includes	O
many	O
built-in	O
features	O
and	O
tools	O
,	O
we	O
also	O
recognize	O
the	O
difficulty	O
of	O
building	O
a	O
``	O
one	O
size	O
fits	O
all	O
''	O
application	O
given	O
the	O
diversity	O
of	O
ideas	O
and	O
efforts	O
pursued	O
within	O
individual	O
research	O
laboratories	O
.	O

Hence	O
multiplierz	O
includes	O
a	O
command	O
line	O
console	O
as	O
well	O
as	O
scripting	O
capability	O
(	O
through	O
``	O
.mz	O
''	O
scripts	O
)	O
which	O
together	O
support	O
ad	O
hoc	O
data	O
analysis	O
tasks	O
.	O

The	O
scripting	O
capability	O
is	O
particularly	O
useful	O
for	O
niche	O
experiments	O
or	O
proteomics	O
workflows	O
not	O
otherwise	O
supported	O
by	O
other	O
open-source	O
or	O
proprietary	O
data	O
systems	O
.	O

All	O
multiplierz	O
tools	O
are	O
available	O
through	O
both	O
the	O
desktop	O
GUI	O
as	O
well	O
as	O
scriptable	O
procedures	O
.	O

In	O
addition	O
,	O
a	O
pre-launch	O
initialization	O
(	O
``	O
rc.mz	O
''	O
)	O
script	O
enables	O
full	O
customization	O
of	O
the	O
application	O
and	O
its	O
interfaces	O
without	O
recompiling	O
the	O
underlying	O
code	O
.	O

Finally	O
,	O
we	O
note	O
that	O
programmatic	O
access	O
to	O
mzAPI	O
allows	O
incorporation	O
of	O
multiplierz	O
into	O
automated	O
data-analytic	O
pipelines	O
.	O

For	O
example	O
,	O
users	O
can	O
submit	O
jobs	O
through	O
a	O
laboratory	O
information	O
management	O
system	O
(	O
LIMS	O
)	O
.	O

Upon	O
completion	O
of	O
LC-MS	O
acquisition	O
(	O
s	O
)	O
and	O
database	O
search	O
(	O
es	O
)	O
,	O
multiplierz	O
executes	O
.mz	O
scripts	O
to	O
access	O
both	O
the	O
search	O
results	O
and	O
underlying	O
.RAW	O
or	O
.WIFF	O
file	O
(	O
s	O
)	O
,	O
in	O
order	O
to	O
create	O
a	O
spreadsheet-based	O
report	O
.	O

Users	O
can	O
be	O
notified	O
by	O
email	O
and	O
access	O
their	O
results	O
via	O
the	O
multiplierz	O
desktop	O
environment	O
.	O

Importantly	O
,	O
multiplierz	O
spreadsheet	O
reports	O
,	O
whether	O
generated	O
in	O
low-	O
or	O
high-throughput	O
mode	O
,	O
are	O
portable	O
and	O
readily	O
formatted	O
in	O
accordance	O
with	O
journal-specific	O
requirements	O
for	O
proteomics	O
data	O
.	O

Collectively	O
the	O
features	O
described	O
above	O
facilitate	O
a	O
wide	O
range	O
of	O
data	O
analysis	O
tasks	O
for	O
mass	O
spectrometry-based	O
proteomics	O
activities	O
from	O
technology	O
development	O
and	O
evaluation	O
to	O
prioritization	O
of	O
protein	O
identifications	O
for	O
subsequent	O
biochemical	O
validation	O
.	O

Importantly	O
,	O
multiplierz	O
provides	O
these	O
capabilities	O
to	O
individual	O
users	O
at	O
the	O
desktop	O
level	O
.	O

Results	O

In	O
the	O
following	O
sections	O
,	O
we	O
demonstrate	O
the	O
functionality	O
of	O
multiplierz	O
through	O
relevant	O
examples	O
based	O
on	O
data	O
and	O
results	O
from	O
work	O
in	O
our	O
laboratory	O
.	O

Significantly	O
we	O
note	O
that	O
these	O
examples	O
encompass	O
data	O
generated	O
on	O
mass	O
spectrometers	O
manufactured	O
by	O
ThermoFisher	O
Scientific	O
and	O
AB-SCIEX	O
.	O

Optimization	O
of	O
LC	O
Assemblies	O
and	O
Methods	O

We	O
recently	O
described	O
a	O
novel	O
protocol	O
for	O
fabrication	O
of	O
miniaturized	O
LC-electrospray	O
assemblies	O
that	O
provided	O
significantly	O
improved	O
LC-MS	O
performance	O
[	O
20	O
]	O
.	O

Not	O
surprisingly	O
,	O
elucidation	O
of	O
relevant	O
analytical	O
figures	O
of	O
merit	O
required	O
in-depth	O
and	O
large	O
scale	O
data	O
analysis	O
.	O

Figure	O
5	O
shows	O
the	O
multiplierz-dependent	O
workflow	O
required	O
to	O
evaluate	O
the	O
relative	O
performance	O
improvement	O
for	O
analysis	O
of	O
tryptic	O
peptides	O
derived	O
from	O
whole	O
cell	O
lysate	O
as	O
a	O
function	O
of	O
column	O
size	O
and	O
flow	O
rate	O
(	O
also	O
see	O
Additional	O
File	O
5	O
)	O
.	O

From	O
approximately	O
90,000	O
MS/MS	O
scans	O
encompassing	O
almost	O
23,000	O
peptide	O
assignments	O
(	O
combination	O
of	O
sequence	O
,	O
charge	O
state	O
,	O
and	O
modification	O
)	O
multiplierz	O
identified	O
198	O
unique	O
peptide	O
sequences	O
and	O
modifications	O
in	O
common	O
across	O
11	O
LC-MS	O
acquisitions	O
.	O

In	O
addition	O
,	O
multiplierz	O
used	O
Mascot-derived	O
peptide	O
identifications	O
to	O
generate	O
RICs	O
,	O
calculate	O
full	O
chromatographic	O
peak	O
width	O
at	O
half-maximum	O
(	O
FWHM	O
)	O
,	O
and	O
determine	O
precursor	O
apex	O
intensity	O
.	O

The	O
entire	O
analysis	O
was	O
performed	O
via	O
the	O
multiplierz	O
GUI	O
.	O

Finally	O
,	O
the	O
embedded	O
RIC	O
images	O
facilitated	O
rapid	O
validation	O
and	O
comparison	O
of	O
chromatographic	O
features	O
.	O

Multiplierz	O
-based	O
Workflow	O
for	O
Analysis	O
of	O
LC	O
Column	O
Geometry	O
and	O
Flow	O
Rate	O
.	O

Relative	O
performance	O
improvement	O
for	O
analysis	O
of	O
peptides	O
derived	O
from	O
whole	O
cell	O
lysate	O
as	O
a	O
function	O
of	O
column	O
size	O
and	O
flow	O
rate	O
(	O
a	O
)	O
.	O

Original	O
data	O
contained	O
~90,000	O
MS/MS	O
scans	O
(	O
b	O
)	O
encompassing	O
almost	O
23,000	O
peptide	O
assignments	O
(	O
combination	O
of	O
sequence	O
,	O
charge	O
state	O
,	O
and	O
modification	O
)	O
,	O
across	O
11	O
LC-MS	O
acquisitions	O
.	O

In	O
addition	O
,	O
multiplierz	O
used	O
Mascot-derived	O
peptide	O
identifications	O
(	O
c	O
)	O
to	O
generate	O
RICs	O
,	O
calculate	O
full	O
chromatographic	O
peak	O
width	O
at	O
half-maximum	O
(	O
FWHM	O
)	O
,	O
and	O
determine	O
precursor	O
apex	O
intensity	O
(	O
d	O
)	O
.	O

Common	O
peptide	O
sequences	O
and	O
associated	O
analytical	O
metrics	O
are	O
extracted	O
(	O
e	O
)	O
into	O
a	O
final	O
,	O
spreadsheet	O
based	O
report	O
(	O
f	O
)	O
.	O

Figure	O
2	O
(	O
see	O
above	O
)	O
shows	O
an	O
example	O
of	O
a	O
multiplierz	O
standard	O
format	O
report	O
.	O

To	O
simplify	O
the	O
display	O
we	O
generated	O
a	O
comparison	O
report	O
(	O
using	O
multiplierz	O
)	O
for	O
the	O
two	O
extremes	O
in	O
the	O
11	O
LC-MS	O
acquisitions	O
described	O
above	O
.	O

The	O
insets	O
show	O
examples	O
of	O
optional	O
embedded	O
images	O
.	O

We	O
note	O
that	O
,	O
unlike	O
many	O
web-based	O
reports	O
that	O
often	O
require	O
frequent	O
page	O
updates	O
,	O
multiplierz	O
images	O
display	O
immediately	O
upon	O
mouse-over	O
,	O
and	O
hence	O
facilitate	O
rapid	O
data	O
validation	O
and	O
interrogation	O
exercises	O
.	O

Optimization	O
of	O
Phosphopeptide	O
Enrichment	O
Methods	O

In	O
the	O
aforementioned	O
study	O
,	O
we	O
leveraged	O
the	O
improved	O
performance	O
of	O
our	O
miniaturized	O
LC-electrospray	O
assemblies	O
to	O
elucidate	O
signaling	O
events	O
in	O
embryonic	O
stem	O
cells	O
[	O
20	O
]	O
.	O

Our	O
specific	O
choice	O
to	O
focus	O
on	O
tyrosine	O
phosphorylation	O
as	O
a	O
direct	O
probe	O
of	O
the	O
molecular	O
events	O
required	O
for	O
self-renewal	O
and	O
differentiation	O
in	O
these	O
cells	O
required	O
optimization	O
of	O
enrichment	O
protocols	O
for	O
peptides	O
carrying	O
this	O
rare	O
post-translational	O
modification	O
.	O

A	C
typical	C
strategy	C
would	C
be	C
to	C
simply	C
adjust	C
experimental	C
conditions	C
to	C
yield	C
a	C
maximum	C
number	C
of	C
phosphotyrosine	C
sites	C
subsequent	C
to	C
LC-MS/MS	C
and	C
database	C
search	C
.	C

However	C
,	C
given	C
the	C
acutely	C
low	C
levels	C
of	C
tyrosine	C
phosphorylation	C
in	C
embryonic	C
stem	C
cells	C
,	C
we	C
chose	C
instead	C
to	C
gauge	C
enrichment	C
efficiency	C
based	C
on	C
the	C
relative	C
fraction	C
of	C
MS/MS	C
scans	C
that	C
contained	C
a	C
phosphotyrosine	C
immonium	C
ion	C
(	C
m/z	C
=	C
216.04	C
)	C
[	C
21,22	C
]	C
,	C
irrespective	C
of	C
any	C
putative	C
peptide	C
sequence	C
assignment	C
.	C

This	O
strategy	O
allowed	O
us	O
to	O
readily	O
decouple	O
low	O
overall	O
peptide	O
yield	O
from	O
poor	O
enrichment	O
of	O
phosphotyrosine	O
containing	O
peptides	O
in	O
experiments	O
that	O
generally	O
provided	O
modest	O
numbers	O
of	O
peptide	O
identifications	O
(	O
compared	O
to	O
typical	O
large-scale	O
proteomics	O
studies	O
)	O
.	O

Figure	O
6a	O
shows	O
the	O
.mz	O
script	O
used	O
to	O
probe	O
MS/MS	O
scans	O
for	O
the	O
presence	O
of	O
a	O
diagnostic	O
fragment	O
ion	O
at	O
m/z	O
=	O
216	O
.	O

Note	O
that	O
Python	O
's	O
clear	O
and	O
concise	O
syntax	O
is	O
readily	O
accessible	O
,	O
as	O
compared	O
to	O
that	O
encountered	O
with	O
manufacturer	O
libraries	O
and	O
data	O
systems	O
.	O

Consistent	O
with	O
our	O
reporting	O
strategy	O
,	O
this	O
script	O
outputs	O
a	O
tab	O
delimited	O
file	O
that	O
we	O
readily	O
filter	O
in	O
Excel	O
to	O
generate	O
a	O
histogram	O
view	O
of	O
our	O
phosphotyrosine	O
enrichment	O
efficiency	O
(	O
Figure	O
6b	O
)	O
.	O

User-defined	O
Customization	O
Through	O
.mz	O
Scripts	O
.	O

A	O
short	O
.mz	O
script	O
(	O
a	O
)	O
opens	O
each	O
MS/MS	O
spectrum	O
within	O
a	O
given	O
LC-MS	O
acquisition	O
and	O
returns	O
those	O
scans	O
that	O
contain	O
the	O
phosphotyrosine	O
immonium	O
ion	O
(	O
m/z	O
=	O
216	O
)	O
.	O

The	O
tab-delimited	O
multiplierz	O
output	O
is	O
readily	O
opened	O
in	O
Excel	O
and	O
(	O
b	O
)	O
a	O
histogram	O
view	O
facilitates	O
rapid	O
evaluation	O
of	O
enrichment	O
efficiency	O
.	O

In	O
this	O
example	O
,	O
the	O
majority	O
of	O
peptides	O
in	O
the	O
heart	O
of	O
the	O
LC	O
gradient	O
(	O
~25	O
-	O
65	O
min	O
.	O
)	O
contain	O
phosphotyrosine	O
residues	O
as	O
evidenced	O
by	O
the	O
presence	O
of	O
an	O
m/z	O
=	O
216	O
immonium	O
ion	O
.	O

In	O
a	O
separate	O
report	O
we	O
described	O
the	O
novel	O
application	O
of	O
niobium	O
(	O
V	O
)	O
oxide	O
(	O
Nb2O5	O
)	O
for	O
global	O
enrichment	O
of	O
phosphopeptides	O
from	O
complex	O
,	O
biologically	O
derived	O
mixtures	O
[	O
23	O
]	O
.	O

The	O
``	O
multi-detect	O
''	O
and	O
``	O
multi-filter	O
''	O
tools	O
in	O
multiplierz	O
were	O
used	O
to	O
compare	O
phosphopeptides	O
enriched	O
via	O
Nb2O5	O
and	O
TiO2	O
,	O
(	O
the	O
current	O
standard	O
)	O
,	O
and	O
detected	O
across	O
multiple	O
LC-MS/MS	O
analyses	O
.	O

Furthermore	O
,	O
to	O
assess	O
potential	O
bias	O
introduced	O
by	O
the	O
stochastic	O
nature	O
of	O
MS/MS	O
,	O
we	O
compared	O
the	O
precursor	O
peak	O
intensities	O
of	O
unique	O
versus	O
commonly	O
detected	O
phosphopeptides	O
that	O
resulted	O
from	O
each	O
method	O
,	O
and	O
confirmed	O
that	O
Nb2O5	O
and	O
TiO2	O
exhibited	O
an	O
empirically	O
useful	O
degree	O
of	O
divergence	O
with	O
respect	O
to	O
phosphopeptide	O
enrichment	O
(	O
Figure	O
7	O
,	O
reprinted	O
from	O
Ficarro	O
et	O
al	O
.	O
[	O
23	O
]	O
by	O
permission	O
from	O
the	O
American	O
Chemical	O
Society	O
)	O
.	O

Quantitative	O
Comparison	O
of	O
Phosphopeptide	O
Enrichment	O
Methods	O
.	O

Histogram	O
distributions	O
of	O
peak	O
heights	O
for	O
unique	O
and	O
overlapping	O
phosphopeptides	O
detected	O
in	O
conjunction	O
with	O
(	O
a	O
)	O
(	O
TiO2	O
)	O
-	O
,	O
and	O
(	O
b	O
)	O
(	O
Nb2O5	O
)	O
-based	O
enrichment	O
.	O

The	C
intensity	C
distributions	C
for	C
phosphopeptides	C
assigned	C
uniquely	C
to	C
either	C
metal	C
oxide	C
did	C
not	C
differ	C
significantly	C
from	C
the	C
intensity	C
distributions	C
for	C
commonly	C
detected	C
phosphopeptides	C
,	C
indicating	C
that	C
the	C
unique	C
precursors	C
were	C
not	C
confined	C
to	C
low	C
signal-to-noise	C
regions	C
.	C

Reprinted	O
from	O
[	O
23	O
]	O
by	O
permission	O
from	O
the	O
American	O
Chemical	O
Society	O
.	O

Improved	O
Peptide	O
Sequence	O
Assignment	O
via	O
De-isotoped	O
MS/MS	O
Spectra	O

In	O
another	O
recent	O
study	O
,	O
we	O
optimized	O
performance	O
of	O
orbitrap	O
HCD	O
MS/MS	O
through	O
systematic	O
exploration	O
of	O
various	O
instrument	O
and	O
post-acquisition	O
parameters	O
[	O
24	O
]	O
.	O

In	O
the	O
context	O
of	O
this	O
work	O
,	O
we	O
observed	O
that	O
high	O
charge	O
state	O
(	O
z	O
>	O
2+	O
)	O
precursors	O
were	O
frequently	O
not	O
assigned	O
to	O
a	O
peptide	O
sequence	O
despite	O
an	O
otherwise	O
high	O
quality	O
fragment	O
ion	O
spectrum	O
.	O

We	C
speculated	C
that	C
the	C
presence	C
of	C
multiple	C
isotope	C
peaks	C
per	C
fragment	C
ion	C
in	C
the	C
high	C
resolution	C
Orbitrap	C
MS/MS	C
scans	C
may	C
degrade	C
the	C
sensitivity	C
of	C
the	C
search	C
algorithm	C
,	C
resulting	C
in	C
fewer	C
high-confidence	C
sequence	C
assignments	C
.	C

Therefore	O
,	O
we	O
generated	O
an	O
.mz	O
Script	O
(	O
see	O
Additional	O
File	O
2	O
)	O
that	O
de-isotoped	O
[	O
25	O
]	O
each	O
fragment	O
ion	O
cluster	O
and	O
output	O
a	O
charge	O
state	O
reduced	O
peak	O
list	O
for	O
submission	O
to	O
Mascot	O
.	O

A	C
variety	C
of	C
parameters	C
can	C
be	C
used	C
to	C
adjust	C
the	C
stringency	C
of	C
spectrum	C
filtering	C
such	C
as	C
maximum	C
charge	C
state	C
,	C
minimum	C
fragment	C
ion	C
mass-to-charge	C
ratio	C
,	C
as	C
well	C
as	C
an	C
option	C
to	C
remove	C
any	C
precursor	C
signal	C
that	C
may	C
remain	C
in	C
the	C
MS/MS	C
spectrum	C
.	C

Overall	O
we	O
realized	O
an	O
approximate	O
30	O
%	O
gain	O
in	O
the	O
number	O
of	O
high-confidence	O
(	O
Mascot	O
score	O
>	O
30	O
)	O
peptide	O
sequence	O
assignments	O
for	O
high	O
charge	O
state	O
precursors	O
(	O
Table	O
2	O
)	O
.	O

Improved	O
Peptide	O
Sequence	O
Assignment	O
via	O
De-isotoped	O
MS/MS	O
Spectra	O
.	O

Label-Free	O
Quantitative	O
Proteomics	O

Relative	C
protein	C
quantitation	C
can	C
be	C
achieved	C
via	C
a	C
label-free	C
approach	C
whereby	C
tryptic	C
digests	C
of	C
protein	C
samples	C
are	C
analyzed	C
without	C
incorporation	C
of	C
stable	C
isotope	C
labels	C
;	C
the	C
resulting	C
peak	C
intensities	C
(	C
or	C
areas	C
)	C
for	C
the	C
constituent	C
peptides	C
are	C
combined	C
and	C
compared	C
across	C
samples	C
as	C
well	C
as	C
within	C
replicates	C
[	C
26	C
]	C
.	C

Typically	O
3-5	O
replicates	O
of	O
each	O
sample	O
are	O
required	O
to	O
account	O
for	O
non-systematic	O
errors	O
associated	O
with	O
shifts	O
in	O
chromatographic	O
elution	O
time	O
,	O
temperature	O
,	O
electrospray	O
stability	O
,	O
etc	O
.	O

For	O
very	O
large	O
studies	O
,	O
performed	O
across	O
extended	O
periods	O
of	O
time	O
and	O
multiple	O
labs	O
,	O
complex	O
software	O
is	O
typically	O
required	O
to	O
combine	O
,	O
align	O
and	O
analyze	O
the	O
resulting	O
native	O
mass	O
spectrometry	O
files	O
.	O

In	O
contrast	O
,	O
we	O
demonstrate	O
a	O
strategy	O
similar	O
to	O
the	O
one	O
described	O
by	O
Bondarenko	O
et	O
al	O
.	O
[	O
27	O
]	O
,	O
which	O
is	O
deployed	O
entirely	O
within	O
multiplierz	O
:	O
extraction	O
of	O
MS/MS	O
peak	O
lists	O
,	O
X	O
!	O
Tandem	O
based	O
peptide	O
identification	O
,	O
and	O
the	O
generation	O
of	O
common	O
sequences	O
(	O
detected	O
in	O
at	O
least	O
k	O
out	O
of	O
the	O
n	O
RAW	O
files	O
being	O
analyzed	O
)	O
are	O
implemented	O
directly	O
from	O
the	O
multiplierz	O
menu-system	O
.	O

Finally	O
,	O
feature	O
extraction	O
,	O
quantitation	O
,	O
and	O
report	O
generation	O
is	O
performed	O
via	O
an	O
additional	O
mz	O
script	O
(	O
see	O
Additional	O
File	O
2	O
)	O
.	O

Figure	O
8	O
shows	O
an	O
Excel-based	O
report	O
for	O
label-free	O
analysis	O
of	O
two	O
standard	O
protein	O
mixtures	O
(	O
5	O
proteins	O
each	O
,	O
containing	O
ratios	O
of	O
1:11	O
,	O
1:5	O
,	O
1:1	O
,	O
2:1	O
and	O
5:1	O
,	O
respectively	O
,	O
and	O
analyzed	O
in	O
duplicate	O
)	O
.	O

Label-Free	O
Relative	O
Protein	O
Quantification	O
.	O

A	O
multiplierz	O
Excel	O
report	O
provides	O
data	O
analytic	O
figures	O
of	O
merit	O
,	O
including	O
:	O
(	O
a	O
)	O
the	O
ratio	O
of	O
each	O
protein	O
across	O
two	O
conditions	O
with	O
an	O
embedded	O
box	O
plot	O
that	O
illustrates	O
the	O
distribution	O
of	O
feature-level	O
ratios	O
,	O
where	O
each	O
feature	O
is	O
defined	O
as	O
a	O
(	O
peptide	O
,	O
modification	O
,	O
charge	O
state	O
)	O
combination	O
;	O
(	O
b	O
)	O
p-value	O
for	O
the	O
significance	O
of	O
the	O
ratio	O
;	O
(	O
c	O
)	O
the	O
number	O
(	O
N	O
)	O
of	O
features	O
underlying	O
the	O
protein	O
quantification	O
;	O
(	O
d	O
)	O
the	O
ratio	O
and	O
embedded	O
RIC	O
plot	O
(	O
showing	O
all	O
RICs	O
used	O
to	O
quantify	O
the	O
peptide	O
-	O
colored	O
by	O
sample	O
source	O
)	O
from	O
the	O
peptide	O
most	O
representative	O
of	O
the	O
final	O
protein	O
ratio	O
;	O
(	O
e	O
)	O
``	O
expected	O
''	O
field	O
is	O
added	O
manually	O
by	O
the	O
user	O
based	O
on	O
the	O
experimental	O
design	O
.	O

Users	C
may	C
also	C
generate	C
associated	C
graphs	C
using	C
native	C
plotting	C
capabilities	C
in	C
Excel	C
.	C

Automated	O
Quality	O
Control	O
of	O
Mass	O
Spectrometer	O
Instrument	O
Performance	O

High	O
throughput	O
or	O
other	O
core-type	O
operations	O
designed	O
to	O
run	O
in	O
an	O
unattended	O
manner	O
benefit	O
from	O
automated	O
quality	O
control	O
assessment	O
of	O
platform	O
performance	O
.	O

For	O
example	O
,	O
periodic	O
confirmation	O
of	O
measured	O
peptide	O
mass	O
accuracy	O
is	O
required	O
to	O
ensure	O
the	O
integrity	O
of	O
instrument	O
calibration	O
routines	O
.	O

Towards	O
this	O
end	O
,	O
we	O
created	O
a	O
short	O
.mz	O
script	O
(	O
see	O
Additional	O
File	O
2	O
)	O
,	O
which	O
extracts	O
measured	O
mass-to-charge	O
values	O
for	O
a	O
list	O
of	O
standard	O
peptides	O
from	O
a	O
native	O
data	O
file	O
,	O
and	O
automatically	O
calculates	O
mass	O
errors	O
.	O

The	O
output	O
is	O
a	O
calibration	O
report	O
(	O
Figure	O
9	O
)	O
that	O
shows	O
a	O
reconstructed	O
ion	O
chromatogram	O
and	O
experimental	O
mass	O
accuracy	O
for	O
each	O
standard	O
peptide	O
.	O

The	C
measured	C
mass	C
errors	C
may	C
be	C
used	C
as	C
input	C
for	C
mass	C
tolerance	C
parameters	C
in	C
subsequent	C
database	C
search	C
algorithms	C
(	C
e.g.	C
,	C
Mascot	C
,	C
SEQUEST	C
,	C
X	C
!	C
Tandem	C
,	C
etc	C
.	C
)	C
for	C
peptide	C
sequence	C
identification	C
.	C

Instrument	O
Calibration	O
Quality	O
Control	O
Report	O
.	O

An	O
.mz	O
script	O
is	O
used	O
to	O
automatically	O
generate	O
a	O
spreadsheet	O
report	O
that	O
indicates	O
mass	O
errors	O
(	O
in	O
ppm	O
)	O
for	O
a	O
set	O
of	O
standard	O
peptides	O
.	O

Images	O
of	O
the	O
precursor	O
isotope	O
distribution	O
and	O
reconstructed	O
ion	O
chromatogram	O
are	O
embedded	O
within	O
the	O
report	O
for	O
rapid	O
confirmation	O
of	O
mass	O
spectrometry	O
and	O
chromatographic	O
performance	O
.	O

In	O
a	O
second	O
application	O
,	O
we	O
developed	O
a	O
routine	O
for	O
recalibration	O
of	O
MS/MS	O
spectra	O
.	O

It	O
is	O
widely	O
recognized	O
that	O
increased	O
mass	O
accuracy	O
provides	O
for	O
higher	O
stringency	O
searches	O
and	O
yields	O
improved	O
results	O
[	O
28	O
]	O
.	O

First	O
,	O
a	O
given	O
set	O
of	O
MS/MS	O
spectra	O
are	O
searched	O
with	O
mass	O
tolerance	O
values	O
based	O
on	O
the	O
most	O
recent	O
mass	O
calibration	O
parameters	O
.	O

Under	O
these	O
conditions	O
we	O
typically	O
observe	O
a	O
monotonic	O
increase	O
in	O
mass	O
error	O
as	O
a	O
function	O
of	O
fragment	O
ion	O
mass	O
(	O
Figure	O
10a	O
)	O
.	O

A	O
high-confidence	O
peptide	O
is	O
selected	O
from	O
the	O
search	O
output	O
,	O
and	O
the	O
corresponding	O
annotated	O
MS/MS	O
spectrum	O
is	O
used	O
to	O
compute	O
the	O
slope	O
and	O
intercept	O
of	O
the	O
linear	O
mass	O
error	O
function	O
.	O

This	O
equation	O
is	O
then	O
used	O
to	O
recalibrate	O
precursor	O
and	O
product	O
ion	O
masses	O
via	O
an	O
.mz	O
script	O
(	O
see	O
Additional	O
File	O
2	O
)	O
.	O

Finally	O
,	O
we	O
re-search	O
the	O
newly	O
calibrated	O
dataset	O
with	O
a	O
narrower	O
tolerance	O
,	O
reducing	O
the	O
average	O
mass	O
error	O
(	O
Figure	O
10b	O
)	O
.	O

Recalibration	O
of	O
Data	O
Acquired	O
on	O
a	O
Quadrupole	O
Time-of-Flight	O
(	O
QTOF	O
)	O
Mass	O
Spectrometer	O
.	O

Fragment	O
ion	O
mass	O
errors	O
for	O
the	O
peptide	O
ADISSDQIAAIGITNQR	O
(	O
based	O
on	O
Mascot	O
assignment	O
)	O
,	O
derived	O
from	O
the	O
protein	O
glycerol	O
kinase	O
(	O
a	O
)	O
before	O
and	O
(	O
b	O
)	O
after	O
recalibration	O
.	O

Conclusion	O

We	O
recognize	O
that	O
some	O
aspects	O
of	O
our	O
proposal	O
diverge	O
from	O
current	O
efforts	O
to	O
establish	O
community	O
standards	O
in	O
proteomics	O
.	O

For	O
example	O
,	O
the	O
use	O
of	O
mzAPI	O
within	O
multiplierz	O
to	O
provide	O
direct	O
access	O
to	O
binary	O
mass	O
spectrometry	O
files	O
does	O
not	O
rely	O
on	O
XML-based	O
surrogate	O
files	O
.	O

We	C
note	C
however	C
,	C
that	C
the	C
two	C
strategies	C
are	C
not	C
mutually	C
exclusive	C
;	C
that	C
is	C
,	C
support	C
for	C
mzXML	C
[	C
9	C
]	C
,	C
or	C
the	C
recently	C
described	C
mzML	C
[	C
29	C
]	C
can	C
be	C
readily	C
incorporated	C
into	C
mzAPI	C
.	C

Similarly	C
,	C
output	C
from	C
multiplierz	C
can	C
be	C
readily	C
formatted	C
in	C
pepXML	C
[	C
12	C
]	C
.	C

In	C
addition	C
,	C
recent	C
discussions	C
focused	C
on	C
data	C
sharing	C
in	C
proteomics	C
suggest	C
that	C
standards	C
may	C
evolve	C
beyond	C
XML-based	C
formats	C
[	C
30,31	C
]	C
.	C

Equally	C
important	C
,	C
the	C
emergence	C
of	C
translation	C
layers	C
such	C
as	C
cygwin	C
[	C
32	C
]	C
and	C
Wine	C
[	C
33	C
]	C
,	C
continue	C
to	C
blur	C
inter-platform	C
boundaries	C
,	C
such	C
that	C
software	C
solutions	C
amenable	C
to	C
the	C
widest	C
audience	C
may	C
eclipse	C
those	C
based	C
largely	C
on	C
platform	C
independence	C
.	C

In	O
fact	O
,	O
our	O
use	O
of	O
Microsoft	O
Excel	O
as	O
the	O
default	O
report	O
output	O
for	O
multiplierz	O
is	O
one	O
such	O
example	O
.	O

Similar	C
image-enhanced	C
spreadsheets	C
may	C
be	C
generated	C
in	C
open	C
formats	C
such	C
as	C
OpenOffice.org	C
XML	C
[	C
34	C
]	C
(	C
see	C
Additional	C
File	C
4	C
)	C
,	C
but	C
our	C
experience	C
to	C
date	C
indicates	C
that	C
the	C
majority	C
of	C
biomedical	C
researchers	C
still	C
opt	C
for	C
commercial	C
spreadsheet	C
solutions	C
,	C
either	C
out	C
of	C
familiarity	C
or	C
because	C
of	C
existing	C
institutional	C
support	C
.	C

The	O
multiplierz	O
framework	O
is	O
accessible	O
to	O
a	O
wide	O
range	O
of	O
researchers	O
,	O
and	O
simultaneously	O
provides	O
support	O
for	O
novel	O
algorithm	O
development	O
as	O
well	O
as	O
deployment	O
of	O
automated	O
data	O
pipelines	O
.	O

As	O
a	O
central	O
point	O
of	O
integration	O
for	O
information	O
from	O
publically	O
available	O
databases	O
and	O
native	O
data	O
from	O
proprietary	O
instrument	O
platforms	O
,	O
multiplierz	O
offers	O
compelling	O
addition	O
to	O
the	O
ongoing	O
discourse	O
aimed	O
at	O
identifying	O
an	O
effective	O
means	O
to	O
enable	O
broad	O
access	O
and	O
data	O
exchange	O
in	O
the	O
proteomics	O
community	O
.	O

In	C
particular	C
,	C
incorporation	C
of	C
mzAPI	C
into	C
the	C
multiplierz	C
desktop	C
architecture	C
may	C
offer	C
a	C
better	C
impedance	C
match	C
between	C
the	C
rate	C
of	C
proprietary	C
mass	C
spectrometry	C
innovation	C
and	C
researchers	C
'	C
demands	C
for	C
increased	C
autonomy	C
in	C
their	C
data	C
analysis	C
tasks	C
.	C

Availability	O
and	O
Requirements	O

•	O
Project	O
name	O
:	O
multiplierz	O

•	O
Project	O
home	O
page	O
:	O
http	O
:	O
//blais.dfci.harvard.edu/multiplierz	O

•	O
Operating	O
system	O
(	O
s	O
)	O
:	O
Microsoft	O
Windows	O

•	O
Programming	O
language	O
:	O
Python	O

•	O
License	O
:	O
open	O
source	O
under	O
LGPL	O

(	O
PS	O
)	O
2-v2	O
:	O
template-based	O
protein	O
structure	O
prediction	O
server	O

Abstract	O

Background	O

Template	O
selection	O
and	O
target-template	O
alignment	O
are	O
critical	O
steps	O
for	O
template-based	O
modeling	O
(	O
TBM	O
)	O
methods	O
.	O

To	O
identify	O
the	O
template	O
for	O
the	O
twilight	O
zone	O
of	O
15~25	O
%	O
sequence	O
similarity	O
between	O
targets	O
and	O
templates	O
is	O
still	O
difficulty	O
for	O
template-based	O
protein	O
structure	O
prediction	O
.	O

This	O
study	O
presents	O
the	O
(	O
PS	O
)	O
2-v2	O
server	O
,	O
based	O
on	O
our	O
original	O
server	O
with	O
numerous	O
enhancements	O
and	O
modifications	O
,	O
to	O
improve	O
reliability	O
and	O
applicability	O
.	O

Results	O

To	O
detect	O
homologous	O
proteins	O
with	O
remote	O
similarity	O
,	O
the	O
(	O
PS	O
)	O
2-v2	O
server	O
utilizes	O
the	O
S2A2	O
matrix	O
,	O
which	O
is	O
a	O
60	O
×	O
60	O
substitution	O
matrix	O
using	O
the	O
secondary	O
structure	O
propensities	O
of	O
20	O
amino	O
acids	O
,	O
and	O
the	O
position-specific	O
sequence	O
profile	O
(	O
PSSM	O
)	O
generated	O
by	O
PSI-BLAST	O
.	O

In	O
addition	O
,	O
our	O
server	O
uses	O
multiple	O
templates	O
and	O
multiple	O
models	O
to	O
build	O
and	O
assess	O
models	O
.	O

Our	O
method	O
was	O
evaluated	O
on	O
the	O
Lindahl	O
benchmark	O
for	O
fold	O
recognition	O
and	O
ProSup	O
benchmark	O
for	O
sequence	O
alignment	O
.	O

Evaluation	C
results	C
indicated	C
that	C
our	C
method	C
outperforms	C
sequence-profile	C
approaches	C
,	C
and	C
had	C
comparable	C
performance	C
to	C
that	C
of	C
structure-based	C
methods	C
on	C
these	C
benchmarks	C
.	C

Finally	O
,	O
we	O
tested	O
our	O
method	O
using	O
the	O
154	O
TBM	O
targets	O
of	O
the	O
CASP8	O
(	O
Critical	O
Assessment	O
of	O
Techniques	O
for	O
Protein	O
Structure	O
Prediction	O
)	O
dataset	O
.	O

Experimental	O
results	O
show	O
that	O
(	O
PS	O
)	O
2-v2	O
is	O
ranked	O
6th	O
among	O
72	O
severs	O
and	O
is	O
faster	O
than	O
the	O
top-rank	O
five	O
serves	O
,	O
which	O
utilize	O
ab	O
initio	O
methods	O
.	O

Conclusion	O

Experimental	O
results	O
demonstrate	O
that	O
(	O
PS	O
)	O
2-v2	O
with	O
the	O
S2A2	O
matrix	O
is	O
useful	O
for	O
template	O
selections	O
and	O
target-template	O
alignments	O
by	O
blending	O
the	O
amino	O
acid	O
and	O
structural	O
propensities	O
.	O

The	O
multiple-template	O
and	O
multiple-model	O
strategies	O
are	O
able	O
to	O
significantly	O
improve	O
the	O
accuracies	O
for	O
target-template	O
alignments	O
in	O
the	O
twilight	O
zone	O
.	O

We	C
believe	C
that	C
this	C
server	C
is	C
useful	C
in	C
structure	C
prediction	C
and	C
modeling	C
,	C
especially	C
in	C
detecting	C
homologous	C
templates	C
with	C
sequence	C
similarity	C
in	C
the	C
twilight	C
zone	C
.	C

Background	O

For	C
template-based	C
modeling	C
(	C
TBM	C
)	C
and	C
fold	C
recognition	C
methods	C
,	C
a	C
prediction	C
model	C
can	C
be	C
built	C
based	C
on	C
the	C
coordinates	C
of	C
the	C
appropriate	C
template	C
(	C
s	C
)	C
[	C
1	C
]	C
.	C

These	C
approaches	C
generally	C
involve	C
four	C
steps	C
:	C
1	C
)	C
a	C
representative	C
protein	C
structure	C
database	C
is	C
searched	C
to	C
identify	C
a	C
template	C
that	C
is	C
structurally	C
similar	C
to	C
the	C
protein	C
target	C
;	C
2	C
)	C
an	C
alignment	C
between	C
the	C
target	C
and	C
the	C
template	C
is	C
generated	C
that	C
should	C
align	C
equivalent	C
residues	C
together	C
as	C
in	C
the	C
case	C
of	C
a	C
structural	C
alignment	C
;	C
3	C
)	C
a	C
prediction	C
structure	C
of	C
the	C
target	C
is	C
built	C
based	C
on	C
the	C
alignment	C
and	C
the	C
selected	C
template	C
structure	C
,	C
and	C
4	C
)	C
model	C
quality	C
evaluation	C
.	C

The	O
first	O
two	O
steps	O
significantly	O
affect	O
the	O
quality	O
of	O
the	O
final	O
model	O
prediction	O
in	O
TBM	O
methods	O
.	O

The	O
secondary	O
structure	O
of	O
a	O
protein	O
is	O
often	O
more	O
conserved	O
than	O
the	O
amino	O
acid	O
sequence	O
,	O
and	O
the	O
prediction	O
accuracy	O
of	O
the	O
secondary	O
structure	O
has	O
been	O
achieved	O
~80	O
%	O
on	O
average	O
.	O

Recently	O
,	O
a	O
number	O
of	O
methods	O
,	O
integrating	O
secondary	O
structures	O
(	O
i.e.	O
,	O
α-helix	O
,	O
ß-strand	O
and	O
coil	O
)	O
with	O
primary	O
amino	O
acid	O
sequences	O
,	O
have	O
successfully	O
detected	O
the	O
homologs	O
with	O
remote	O
similarity	O
for	O
automated	O
comparative	O
modeling	O
[	O
2-6	O
]	O
and	O
fold	O
recognition	O
[	O
7-12	O
]	O
.	O

These	O
methods	O
often	O
used	O
two	O
separated	O
substitution	O
matrices	O
[	O
9,10,13	O
]	O
to	O
score	O
secondary	O
structures	O
and	O
primary	O
amino	O
acids	O
,	O
respectively	O
,	O
for	O
aligning	O
a	O
residue	O
pair	O
.	O

The	O
separated	O
matrices	O
are	O
unable	O
to	O
reflect	O
the	O
real	O
score	O
because	O
the	O
amino	O
acid	O
type	O
often	O
prefers	O
to	O
a	O
specific	O
secondary	O
structure	O
.	O

Here	O
,	O
we	O
have	O
developed	O
a	O
substitution	O
matrix	O
,	O
called	O
S2A2	O
,	O
which	O
considers	O
the	O
properties	O
of	O
the	O
secondary	O
structures	O
and	O
amino	O
acid	O
types	O
.	O

The	C
S2A2	C
is	C
a	C
60	C
×	C
60	C
matrix	C
that	C
considers	C
all	C
possible	C
pair	C
combination	C
of	C
20	C
amino	C
acid	C
types	C
and	C
three	C
secondary	C
structure	C
elements	C
.	C

This	O
matrix	O
was	O
evaluated	O
on	O
the	O
Lindahl	O
benchmark	O
[	O
14	O
]	O
for	O
fold	O
recognition	O
and	O
the	O
ProSup	O
benchmark	O
[	O
15	O
]	O
for	O
alignment	O
accuracies	O
.	O

According	O
to	O
these	O
evaluation	O
results	O
,	O
the	O
S2A2	O
matrix	O
has	O
higher	O
accuracy	O
than	O
position	O
specific	O
scoring	O
matrix	O
(	O
PSSM	O
)	O
generated	O
by	O
PSI-BLAST	O
and	O
prof_sim	O
for	O
fold	O
recognition	O
and	O
sequence	O
alignments	O
.	O

By	O
integrating	O
the	O
S2A2	O
matrix	O
and	O
PSSM	O
,	O
each	O
having	O
a	O
unique	O
scoring	O
mechanism	O
,	O
the	O
(	O
PS	O
)	O
2-v2	O
server	O
blends	O
the	O
sequence	O
profile	O
and	O
secondary	O
structure	O
information	O
so	O
that	O
they	O
work	O
cooperatively	O
.	O

Numerous	O
enhancements	O
and	O
modifications	O
were	O
applied	O
to	O
original	O
(	O
PS	O
)	O
2	O
servers	O
(	O
namely	O
(	O
PS	O
)	O
2-original	O
)	O
[	O
16	O
]	O
and	O
(	O
PS	O
)	O
2-CASP8	O
[	O
17	O
]	O
which	O
participates	O
the	O
CASP8	O
experiment	O
,	O
thereby	O
improving	O
the	O
reliability	O
and	O
applicability	O
of	O
the	O
method	O
.	O

There	O
are	O
four	O
main	O
differences	O
in	O
methodology	O
between	O
the	O
present	O
server	O
(	O
(	O
PS	O
)	O
2-v2	O
)	O
and	O
our	O
previous	O
works	O
(	O
Table	O
1	O
)	O
.	O

First	O
,	O
(	O
PS	O
)	O
2-v2	O
integrates	O
S2A2	O
matrix	O
and	O
PSSM	O
for	O
the	O
template	O
selection	O
and	O
the	O
target-template	O
alignment	O
to	O
replace	O
a	O
consensus	O
strategy	O
applied	O
in	O
the	O
(	O
PS	O
)	O
2-original	O
server	O
.	O

Second	O
,	O
we	O
modified	O
the	O
SSEARCH	O
[	O
18	O
]	O
search	O
method	O
to	O
replace	O
the	O
PSI-BLAST	O
search	O
method	O
and	O
Smith-Waterman	O
algorithm	O
applied	O
in	O
the	O
(	O
PS	O
)	O
2-original	O
server	O
and	O
(	O
PS	O
)	O
2-CASP8	O
,	O
respectively	O
.	O

Third	O
,	O
(	O
PS	O
)	O
2-v2	O
utilized	O
a	O
new	O
multiple	O
template	O
method	O
for	O
modeling	O
different	O
domains	O
of	O
the	O
target	O
sequence	O
.	O

Finally	O
,	O
(	O
PS	O
)	O
2-v2	O
added	O
a	O
multiple	O
model	O
strategy	O
and	O
utilized	O
ProQ	O
[	O
19	O
]	O
to	O
assess	O
and	O
select	O
the	O
final	O
model	O
.	O

We	O
have	O
assessed	O
the	O
prediction	O
accuracy	O
of	O
the	O
(	O
PS	O
)	O
2-v2	O
server	O
based	O
on	O
the	O
154	O
TBM	O
targets	O
of	O
the	O
CASP8	O
dataset	O
.	O

The	O
experimental	O
results	O
show	O
that	O
the	O
S2A2	O
matrix	O
,	O
multiple-template	O
and	O
multiple-model	O
strategies	O
are	O
able	O
to	O
significantly	O
improve	O
the	O
accuracies	O
for	O
protein	O
structure	O
prediction	O
and	O
modeling	O
when	O
the	O
sequence	O
similarity	O
between	O
the	O
template	O
and	O
the	O
target	O
is	O
in	O
the	O
twilight	O
zone	O
.	O

The	O
essential	O
differences	O
of	O
(	O
PS	O
)	O
2-original	O
,	O
(	O
PS	O
)	O
2-CASP8	O
and	O
(	O
PS	O
)	O
2-v2	O

Methods	O

Figures	O
1	O
and	O
2	O
show	O
the	O
framework	O
of	O
the	O
(	O
PS	O
)	O
2-v2	O
server	O
for	O
protein	O
structure	O
prediction	O
.	O

(	O
PS	O
)	O
2-v2	O
uses	O
the	O
S2A2	O
matrix	O
and	O
the	O
PSSM	O
for	O
the	O
template	O
selection	O
and	O
the	O
target-template	O
alignment	O
.	O

(	O
PS	O
)	O
2-v2	O
first	O
applied	O
the	O
query	O
sequence	O
to	O
generate	O
a	O
PSSM	O
by	O
running	O
three	O
iterations	O
of	O
PSI-BLAST	O
against	O
a	O
non-redundant	O
sequence	O
UniRef90	O
[	O
20	O
]	O
with	O
an	O
E-value	O
cutoff	O
of	O
0.001	O
.	O

The	O
PSSM	O
was	O
then	O
used	O
as	O
the	O
input	O
for	O
the	O
PSIPRED	O
[	O
21	O
]	O
tool	O
to	O
predict	O
the	O
secondary	O
structure	O
of	O
this	O
query	O
.	O

We	O
then	O
modified	O
the	O
SSEARCH	O
[	O
18	O
]	O
search	O
method	O
,	O
using	O
the	O
S2A2	O
matrix	O
and	O
the	O
PSSM	O
as	O
the	O
scoring	O
matrices	O
,	O
to	O
identify	O
the	O
template	O
(	O
s	O
)	O
from	O
the	O
protein	O
structure	O
library	O
,	O
and	O
to	O
generate	O
the	O
target-template	O
alignment	O
(	O
s	O
)	O
.	O

The	O
library	O
consists	O
of	O
20,982	O
non-redundant	O
structures	O
(	O
April	O
,	O
2008	O
)	O
selected	O
from	O
protein	O
data	O
bank	O
(	O
PDB	O
)	O
[	O
22	O
]	O
.	O

The	O
secondary	O
structures	O
of	O
each	O
structure	O
in	O
the	O
library	O
were	O
assigned	O
using	O
DSSP	O
[	O
23	O
]	O
.	O

Based	O
on	O
various	O
target-template	O
alignments	O
of	O
top-ranking	O
5	O
selected	O
templates	O
,	O
(	O
PS	O
)	O
2-v2	O
generates	O
30	O
protein	O
structures	O
using	O
MODELLER	O
[	O
24	O
]	O
.	O

Finally	O
,	O
the	O
program	O
ProQ	O
was	O
used	O
to	O
evaluate	O
these	O
models	O
and	O
to	O
select	O
the	O
final	O
model	O
for	O
the	O
target	O
.	O

The	O
S2A2	O
matrix	O
,	O
the	O
aligned	O
method	O
,	O
the	O
modeling	O
process	O
and	O
the	O
final	O
model	O
selection	O
are	O
described	O
in	O
the	O
following	O
subsections	O
.	O

The	O
components	O
of	O
the	O
(	O
PS	O
)	O
2-v2	O
server	O
were	O
built	O
using	O
C	O
,	O
Perl	O
and	O
PHP	O
(	O
Additional	O
file	O
1	O
)	O
.	O

The	O
framework	O
of	O
the	O
(	O
PS	O
)	O
2-v2	O
server	O
for	O
protein	O
structure	O
prediction	O
.	O

Overview	O
of	O
the	O
(	O
PS	O
)	O
2-v2	O
server	O
.	O

The	O
protein	O
sequence	O
of	O
telomere	O
replication	O
protein	O
Est3	O
(	O
UniProt	O
Q03096	O
)	O
in	O
Saccharomyces	O
cerevisiae	O
was	O
used	O
as	O
the	O
query	O
.	O

(	O
A	O
)	O
Input	O
format	O
of	O
the	O
(	O
PS	O
)	O
2-v2	O
server	O
.	O

(	O
B	O
)	O
Search	O
results	O
of	O
a	O
query	O
protein	O
,	O
comprising	O
target	O
name	O
,	O
sequence	O
,	O
predicted	O
secondary	O
structure	O
,	O
the	O
graph	O
of	O
the	O
aligned	O
regions	O
and	O
the	O
hits	O
list	O
of	O
the	O
templates	O
of	O
the	O
query	O
.	O

(	O
C	O
)	O
The	O
selected	O
template	O
,	O
target-template	O
alignment	O
and	O
prediction	O
structure	O
of	O
Est3	O
.	O

(	O
D	O
)	O
The	O
visualization	O
of	O
the	O
predicted	O
structure	O
for	O
Est3	O
.	O

(	O
E	O
)	O
The	O
model	O
quality	O
assessment	O
.	O

S2A2	O
matrix	O

A	O
substitution	O
matrix	O
is	O
the	O
key	O
component	O
of	O
protein	O
sequence	O
alignment	O
methods	O
.	O

We	O
developed	O
the	O
S2A2	O
substitution	O
matrix	O
(	O
Figure	O
3	O
and	O
Figure	O
S1	O
in	O
Additional	O
file	O
2	O
)	O
applying	O
a	O
general	O
mathematical	O
structure	O
[	O
25	O
]	O
.	O

To	O
calculate	O
the	O
S2A2	O
,	O
674	O
structural	O
pairs	O
(	O
1,348	O
proteins	O
)	O
[	O
26	O
]	O
,	O
which	O
are	O
structurally	O
similar	O
and	O
with	O
low	O
sequence	O
identity	O
,	O
were	O
selected	O
from	O
SCOP	O
1.65	O
[	O
27	O
]	O
based	O
on	O
two	O
criteria	O
:	O
1	O
)	O
the	O
root-mean-square	O
deviation	O
(	O
rmsd	O
)	O
of	O
a	O
protein	O
pair	O
was	O
be	O
less	O
than	O
3.5	O
A	O
,	O
with	O
more	O
than	O
70	O
%	O
of	O
aligned	O
residues	O
included	O
in	O
the	O
rmsd	O
calculation	O
,	O
and	O
2	O
)	O
the	O
sequence	O
identity	O
of	O
a	O
pair	O
is	O
less	O
than	O
40	O
%	O
.	O

The	O
selected	O
protein	O
pairs	O
had	O
an	O
average	O
sequence	O
identity	O
of	O
26	O
%	O
,	O
an	O
average	O
rmsd	O
of	O
2.3	O
A	O
and	O
average	O
aligned	O
residues	O
of	O
90	O
%	O
(	O
207,492	O
aligned	O
residues	O
out	O
of	O
230,915	O
residues	O
)	O
.	O

The	O
program	O
DSSP	O
was	O
used	O
to	O
assign	O
the	O
secondary	O
structure	O
for	O
each	O
residue	O
of	O
these	O
674	O
structural	O
pairs	O
.	O

The	O
eight	O
types	O
of	O
the	O
secondary	O
structure	O
used	O
in	O
DSSP	O
were	O
reduced	O
to	O
three	O
commonly	O
accepted	O
types	O
(	O
H	O
(	O
helix	O
)	O
,	O
E	O
(	O
strand	O
)	O
and	O
C	O
(	O
coil	O
)	O
)	O
according	O
to	O
the	O
following	O
scheme	O
:	O
(	O
H	O
,	O
G	O
,	O
I	O
)	O
›	O
H	O
;	O
(	O
E	O
,	O
B	O
)	O
›	O
E	O
;	O
(	O
T	O
,	O
S	O
,	O
blank	O
)	O
›	O
C	O
.	O

The	O
20	O
amino	O
acid	O
types	O
and	O
3	O
secondary	O
structure	O
types	O
were	O
converted	O
into	O
60	O
residue-structure	O
(	O
RS	O
)	O
types	O
.	O

The	O
S2A2	O
substitution	O
matrix	O
.	O

The	O
scores	O
are	O
high	O
if	O
the	O
residue-structure	O
(	O
RS	O
)	O
letters	O
with	O
similar	O
residue	O
types	O
and	O
the	O
same	O
secondary	O
structure	O
are	O
aligned	O
(	O
red	O
blocks	O
)	O
.	O

When	O
two	O
identical	O
RS	O
letters	O
(	O
e.g	O
.	O
diagonal	O
entries	O
)	O
are	O
aligned	O
,	O
the	O
substitution	O
scores	O
are	O
very	O
high	O
.	O

In	O
contrast	O
,	O
the	O
scores	O
are	O
low	O
when	O
helix	O
letters	O
are	O
aligned	O
with	O
strand	O
letters	O
(	O
blue	O
blocks	O
)	O
.	O

The	O
S2A2	O
matrix	O
(	O
60	O
×	O
60	O
)	O
reveals	O
substitution	O
preferences	O
between	O
homologs	O
with	O
low	O
sequence	O
identity	O
,	O
and	O
was	O
developed	O
in	O
a	O
similar	O
way	O
to	O
BLOSUM62	O
[	O
25	O
]	O
based	O
on	O
these	O
674	O
structural	O
pairs	O
.	O

The	O
entry	O
(	O
Sij	O
)	O
,	O
which	O
is	O
the	O
substitution	O
score	O
for	O
aligning	O
a	O
RS	O
letter	O
i	O
,	O
j	O
pair	O
(	O
1	O
≤	O
i	O
,	O
j	O
≤	O
60	O
)	O
,	O
of	O
the	O
S2A2	O
matrix	O
is	O
defined	O
as	O
Sij	O
=	O
λlog2	O
(	O
qij/eij	O
)	O
,	O
where	O
λ	O
is	O
a	O
scale	O
factor	O
,	O
and	O
qij	O
and	O
eij	O
are	O
the	O
observed	O
and	O
expected	O
probabilities	O
,	O
respectively	O
,	O
of	O
the	O
occurrence	O
of	O
each	O
i	O
,	O
j	O
pair	O
.	O

The	O
observed	O
probability	O
is	O
given	O
by	O
,	O
where	O
fij	O
is	O
the	O
total	O
number	O
of	O
aligning	O
i	O
,	O
j	O
pairs	O
in	O
these	O
207,492	O
RS	O
letters	O
.	O

The	O
factor	O
eij	O
=	O
pipj	O
if	O
i	O
=	O
j	O
;	O
otherwise	O
,	O
eij	O
=	O
2pipj	O
(	O
if	O
i	O
≠	O
j	O
)	O
,	O
where	O
pi	O
is	O
the	O
background	O
probability	O
of	O
occurrence	O
of	O
the	O
letter	O
i	O
,	O
and	O
equals	O
.	O

The	O
substitution	O
score	O
is	O
greater	O
than	O
zero	O
(	O
Sij	O
>	O
0	O
)	O
if	O
the	O
observed	O
probability	O
is	O
greater	O
than	O
the	O
expected	O
probability	O
.	O

By	O
contrast	O
,	O
Sij	O
<	O
0	O
if	O
qij	O
<	O
eij	O
.	O

The	O
λ	O
is	O
optimized	O
by	O
the	O
SALIGN	O
set	O
[	O
28	O
]	O
,	O
and	O
is	O
set	O
to	O
1.6	O
according	O
to	O
the	O
performance	O
and	O
efficiency	O
.	O

Scoring	O
and	O
alignment	O
methods	O

We	O
modified	O
the	O
SSEARCH	O
program	O
[	O
18	O
]	O
,	O
which	O
used	O
a	O
rigorous	O
Smith-Waterman	O
algorithm	O
[	O
29	O
]	O
,	O
to	O
search	O
for	O
similarity	O
between	O
a	O
query	O
sequence	O
and	O
template	O
sequences	O
in	O
a	O
library	O
.	O

We	O
optimized	O
the	O
score	O
between	O
the	O
query	O
and	O
template	O
(	O
s	O
)	O
using	O
both	O
S2A2	O
and	O
PSSM	O
matrices	O
based	O
on	O
alignment	O
accuracies	O
on	O
the	O
SALIGN	O
set	O
.	O

The	O
score	O
is	O
given	O
as	O
where	O
i	O
and	O
j	O
are	O
RS	O
letters	O
on	O
the	O
query	O
and	O
the	O
template	O
,	O
respectively	O
;	O
wstru	O
(	O
i	O
,	O
j	O
)	O
is	O
a	O
structure-dependent	O
scoring	O
weight	O
,	O
and	O
is	O
set	O
to	O
1.3	O
,	O
1.7	O
and	O
0.8	O
for	O
α-helix	O
,	O
ß-strand	O
and	O
coil	O
,	O
respectively	O
;	O
wS2A2	O
(	O
here	O
,	O
wS2A2	O
is	O
set	O
to	O
0.64	O
)	O
is	O
the	O
weight	O
of	O
the	O
S2A2	O
matrix	O
;	O
S2A2	O
(	O
i	O
,	O
j	O
)	O
and	O
PSSMquery	O
(	O
i	O
,	O
j	O
)	O
are	O
the	O
scores	O
of	O
S2A2	O
and	O
PSSM	O
matrices	O
,	O
respectively	O
,	O
when	O
the	O
RS	O
letter	O
i	O
is	O
aligned	O
to	O
the	O
RS	O
letter	O
j	O
.	O

In	O
addition	O
,	O
we	O
considered	O
structure-dependent	O
gap	O
penalty	O
.	O

Here	O
,	O
wgap	O
is	O
a	O
structure-dependent	O
gapping	O
weight	O
,	O
set	O
to	O
2.0	O
(	O
α-helix	O
)	O
,	O
2.0	O
(	O
ß-strand	O
)	O
and	O
0.15	O
(	O
coil	O
)	O
,	O
respectively	O
;	O
gS2A2	O
is	O
the	O
gap	O
opening	O
penalty	O
(	O
set	O
to	O
7.2	O
)	O
and	O
the	O
gap	O
extension	O
(	O
set	O
to	O
1.2	O
)	O
for	O
the	O
S2A2	O
matrix	O
.	O

These	O
weights	O
were	O
optimized	O
based	O
on	O
the	O
SALIGN	O
set	O
.	O

gpssm	O
refers	O
to	O
the	O
PSSM	O
,	O
where	O
the	O
gap	O
opening	O
penalty	O
is	O
11	O
and	O
gap	O
extension	O
is	O
1	O
according	O
to	O
the	O
default	O
parameters	O
of	O
PSI-BLAST	O
.	O

Statistics	O
and	O
template	O
selection	O

SSEARCH	O
provides	O
the	O
statistical	O
significance	O
for	O
library	O
searches	O
.	O

The	O
local	O
sequence	O
similarity	O
score	O
(	O
S	O
)	O
follows	O
the	O
extreme	O
value	O
distribution	O
,	O
so	O
that	O
P	O
(	O
S	O
>	O
x	O
)	O
=	O
1	O
-	O
exp	O
(	O
-Kmn	O
exp	O
(	O
-λx	O
)	O
)	O
where	O
m	O
,	O
n	O
are	O
the	O
lengths	O
of	O
the	O
query	O
and	O
library	O
sequence	O
.	O

The	O
score	O
shows	O
that	O
the	O
average	O
score	O
for	O
an	O
unrelated	O
library	O
sequence	O
increases	O
with	O
the	O
logarithm	O
of	O
the	O
length	O
of	O
the	O
library	O
sequence	O
.	O

SSEARCH	O
uses	O
simple	O
linear	O
regression	O
against	O
the	O
log	O
of	O
the	O
library	O
sequence	O
length	O
to	O
calculate	O
a	O
normalized	O
``	O
z-score	O
''	O
with	O
mean	O
50	O
,	O
regardless	O
of	O
library	O
sequence	O
length	O
,	O
and	O
variance	O
10	O
.	O

These	O
z-scores	O
can	O
then	O
be	O
used	O
with	O
the	O
extreme	O
value	O
distribution	O
and	O
the	O
Poisson	O
distribution	O
to	O
calculate	O
the	O
number	O
of	O
library	O
sequences	O
to	O
obtain	O
a	O
score	O
(	O
i.e	O
.	O
E-value	O
)	O
greater	O
than	O
or	O
equal	O
to	O
the	O
score	O
obtained	O
in	O
the	O
search	O
.	O

The	O
top-ranking	O
5	O
templates	O
with	O
the	O
lowest	O
E-values	O
were	O
considered	O
as	O
the	O
templates	O
if	O
the	O
E-values	O
<	O
0.1	O
.	O

For	O
each	O
structure	O
in	O
the	O
top-ranking	O
5	O
templates	O
,	O
The	O
(	O
PS	O
)	O
2-v2	O
server	O
generated	O
six	O
alternative	O
target-template	O
alignments	O
by	O
using	O
different	O
S2A2-matrix	O
(	O
wS2A2	O
)	O
weights	O
,	O
including	O
0	O
,	O
0.2	O
,	O
0.4	O
,	O
0.64	O
,	O
0.8	O
and	O
1.0	O
.	O

Finally	O
,	O
we	O
yielded	O
30	O
target-template	O
alignments	O
for	O
a	O
target	O
protein	O
.	O

Model	O
building	O
and	O
evaluation	O

Protein	O
structure	O
models	O
were	O
built	O
using	O
the	O
homology	O
modeling	O
tool	O
,	O
MODELLER	O
[	O
24	O
]	O
according	O
to	O
the	O
selected	O
template	O
(	O
s	O
)	O
and	O
target-template	O
alignment	O
(	O
s	O
)	O
and	O
then	O
the	O
ability	O
to	O
discriminate	O
a	O
correct	O
protein	O
model	O
from	O
incorrect	O
models	O
is	O
critical	O
when	O
a	O
server	O
used	O
multiple	O
model	O
methods	O
.	O

Here	O
,	O
we	O
utilized	O
the	O
program	O
ProQ	O
[	O
19	O
]	O
to	O
assess	O
the	O
quality	O
of	O
protein	O
models	O
based	O
on	O
the	O
LGscore	O
[	O
30	O
]	O
and	O
a	O
model	O
was	O
considered	O
correct	O
if	O
the	O
LGscore	O
was	O
greater	O
than	O
1.5	O
[	O
19	O
]	O
.	O

The	O
(	O
PS	O
)	O
2-v2	O
server	O
first	O
selected	O
the	O
protein	O
model	O
,	O
generated	O
by	O
the	O
first	O
rank	O
template	O
with	O
wS2A2	O
=	O
0.64	O
as	O
the	O
seed	O
model	O
.	O

The	O
LGscore	O
of	O
the	O
seed	O
model	O
was	O
then	O
compared	O
with	O
those	O
of	O
the	O
other	O
models	O
based	O
on	O
the	O
top-rank	O
5	O
templates	O
with	O
different	O
wS2A2	O
weights	O
.	O

A	O
model	O
was	O
chosen	O
as	O
the	O
final	O
one	O
if	O
it	O
had	O
the	O
highest	O
LGscore	O
and	O
its	O
LGscore	O
(	O
>	O
0.7	O
)	O
was	O
significantly	O
better	O
than	O
that	O
of	O
the	O
seed	O
model	O
.	O

Otherwise	O
,	O
the	O
server	O
selected	O
the	O
seed	O
model	O
as	O
the	O
final	O
model	O
.	O

Multiple-template	O
method	O

(	O
PS	O
)	O
2-v2	O
considered	O
a	O
target	O
as	O
a	O
multiple	O
domain	O
protein	O
if	O
any	O
region	O
with	O
>	O
40	O
residues	O
has	O
non-aligned	O
residues	O
to	O
the	O
template	O
(	O
s	O
)	O
when	O
using	O
above	O
``	O
model	O
building	O
and	O
evaluation	O
''	O
steps	O
.	O

For	O
a	O
multiple	O
domain	O
protein	O
,	O
(	O
PS	O
)	O
2-v2	O
automatically	O
decided	O
domain	O
boundaries	O
based	O
on	O
the	O
borders	O
of	O
the	O
large	O
gaps	O
between	O
the	O
target	O
and	O
the	O
template	O
(	O
s	O
)	O
,	O
and	O
repeatedly	O
executed	O
above	O
steps	O
to	O
model	O
the	O
structures	O
of	O
the	O
non-aligned	O
residues	O
(	O
Figure	O
1	O
)	O
.	O

Finally	O
,	O
these	O
multiple	O
models	O
were	O
then	O
used	O
as	O
structure	O
templates	O
to	O
generate	O
the	O
full-length	O
final	O
model	O
for	O
the	O
query	O
protein	O
.	O

Utility	O

Input	O
format	O

The	O
(	O
PS	O
)	O
2-v2	O
server	O
is	O
an	O
easy-to-use	O
web	O
server	O
(	O
Figure	O
2	O
)	O
.	O

Users	O
input	O
the	O
query	O
protein	O
sequence	O
in	O
FASTA	O
format	O
.	O

The	O
server	O
provides	O
three	O
modes	O
(	O
Automatic	O
,	O
Manual	O
and	O
'Use	O
this	O
template	O
'	O
)	O
for	O
choosing	O
template	O
(	O
s	O
)	O
(	O
Figure	O
2A	O
)	O
.	O

The	O
default	O
mode	O
is	O
'Automatic	O
'	O
.	O

In	O
this	O
mode	O
,	O
(	O
PS	O
)	O
2-v2	O
automatically	O
selects	O
the	O
modeling	O
template	O
(	O
s	O
)	O
.	O

For	O
the	O
'Manual	O
'	O
mode	O
,	O
our	O
server	O
enables	O
users	O
to	O
assign	O
specific	O
template	O
(	O
s	O
)	O
from	O
a	O
list	O
of	O
candidates	O
(	O
Figure	O
2B	O
)	O
.	O

The	O
'Use	O
this	O
template	O
'	O
mode	O
allows	O
users	O
to	O
assign	O
a	O
specific	O
protein	O
structure	O
as	O
the	O
template	O
.	O

Finally	O
,	O
(	O
PS	O
)	O
2-v2	O
transmits	O
the	O
predicted	O
results	O
to	O
the	O
users	O
by	O
email	O
addresses	O
.	O

Output	O
format	O

The	O
(	O
PS	O
)	O
2-v2	O
server	O
typically	O
yields	O
a	O
predicted	O
structure	O
within	O
7	O
minutes	O
if	O
the	O
query	O
sequence	O
length	O
is	O
~200	O
.	O

The	O
server	O
shows	O
a	O
list	O
of	O
templates	O
,	O
selected	O
template	O
(	O
s	O
)	O
,	O
target-template	O
alignment	O
(	O
s	O
)	O
,	O
predicted	O
structure	O
(	O
s	O
)	O
and	O
structure	O
evaluations	O
(	O
Figures	O
2B	O
and	O
2C	O
)	O
.	O

The	O
predicted	O
structures	O
are	O
visualized	O
in	O
PNG	O
format	O
generated	O
by	O
the	O
MolScript	O
[	O
31	O
]	O
and	O
Raster3D	O
[	O
32	O
]	O
packages	O
.	O

If	O
the	O
user	O
clicks	O
a	O
PNG	O
picture	O
,	O
then	O
the	O
corresponding	O
protein	O
3D	O
structure	O
is	O
also	O
displayed	O
on	O
the	O
AstexViewer	O
[	O
33	O
]	O
(	O
Figure	O
2D	O
)	O
.	O

A	O
user	O
can	O
download	O
the	O
predicted	O
structure	O
coordinates	O
in	O
the	O
PDB	O
format	O
.	O

The	O
server	O
also	O
provides	O
the	O
target-template	O
alignments	O
and	O
the	O
structure	O
quality	O
factors	O
(	O
Figure	O
2E	O
)	O
.	O

Modeling	O
of	O
ever	O
shorter	O
telomeres	O
3	O

The	O
ever	O
shorter	O
telomeres	O
3	O
(	O
Est3	O
,	O
UniProt	O
Q03096	O
)	O
,	O
which	O
is	O
essential	O
for	O
telomere	O
replication	O
in	O
vivo	O
,	O
is	O
a	O
small	O
regulatory	O
subunit	O
of	O
telomerase	O
from	O
Saccharomyces	O
cerevisiae	O
.	O

According	O
to	O
structure	O
prediction	O
combined	O
with	O
in	O
vivo	O
characterization	O
,	O
it	O
has	O
been	O
reported	O
that	O
Est3	O
consists	O
of	O
a	O
predicted	O
OB-fold	O
(	O
oligosaccharide/oligonucleotide	O
binding	O
)	O
with	O
structurally	O
similar	O
to	O
the	O
OB-fold	O
of	O
the	O
human	O
Tpp1	O
protein	O
[	O
34	O
]	O
.	O

Because	O
of	O
the	O
limited	O
degree	O
of	O
conservation	O
between	O
these	O
two	O
protein	O
families	O
,	O
these	O
two	O
proteins	O
could	O
not	O
be	O
recognized	O
from	O
simple	O
sequence	O
profile	O
methods	O
.	O

Additionally	O
,	O
the	O
original	O
(	O
PS	O
)	O
2	O
-v2	O
server	O
could	O
not	O
recognize	O
them	O
.	O

For	O
the	O
target	O
Est3	O
,	O
the	O
(	O
PS	O
)	O
2	O
-v2	O
server	O
selected	O
the	O
OB-fold	O
domain	O
of	O
the	O
Tpp1	O
protein	O
(	O
PDB	O
code	O
2i46	O
)	O
from	O
Homo	O
sapiens	O
as	O
the	O
template	O
[	O
35	O
]	O
,	O
with	O
an	O
E-value	O
of	O
0.014	O
.	O

This	O
template	O
shared	O
only	O
17.6	O
%	O
sequence	O
identity	O
with	O
the	O
query	O
sequence	O
.	O

Figure	O
2C	O
shows	O
the	O
target-template	O
alignment	O
.	O

The	O
server	O
successfully	O
recognized	O
Tpp1	O
as	O
the	O
template	O
since	O
the	O
secondary	O
structure	O
identity	O
between	O
the	O
template	O
and	O
Est3	O
was	O
66.7	O
%	O
.	O

Our	O
method	O
could	O
align	O
together	O
three	O
conserved	O
residues	O
(	O
i.e	O
.	O
Trp21/Trp98	O
,	O
Asp86/Asp148	O
and	O
Leu155/Leu204	O
,	O
in	O
Est3	O
versus	O
Tpp1	O
;	O
green	O
blocks	O
in	O
Figure	O
2C	O
)	O
,	O
which	O
are	O
primarily	O
involved	O
in	O
protein	O
folding	O
and/or	O
stability	O
of	O
the	O
OB-fold	O
.	O

Seven	O
amino	O
acid	O
positions	O
(	O
yellow	O
blocks	O
in	O
Figure	O
2C	O
)	O
,	O
which	O
are	O
structurally	O
similar	O
between	O
the	O
two	O
protein	O
families	O
,	O
were	O
also	O
aligned	O
.	O

These	O
10	O
aligned	O
residues	O
,	O
depicted	O
in	O
cyan	O
,	O
are	O
clustered	O
in	O
the	O
interior	O
of	O
the	O
core	O
of	O
the	O
OB-fold	O
(	O
Figure	O
2D	O
)	O
.	O

Results	O
and	O
Discussion	O

In	O
the	O
template-based	O
protein	O
structure	O
prediction	O
,	O
the	O
template	O
selection	O
and	O
the	O
target-template	O
alignment	O
are	O
the	O
two	O
critical	O
steps	O
,	O
since	O
they	O
will	O
significantly	O
affect	O
the	O
quality	O
of	O
the	O
final	O
model	O
prediction	O
.	O

The	O
template	O
selections	O
and	O
the	O
sequence	O
alignments	O
of	O
the	O
proposed	O
method	O
with	O
the	O
S2A2	O
matrix	O
were	O
evaluated	O
by	O
the	O
Lindahl	O
benchmark	O
[	O
14	O
]	O
and	O
ProSup	O
benchmark	O
[	O
15	O
]	O
,	O
respectively	O
.	O

In	O
general	O
,	O
it	O
is	O
neither	O
straightforward	O
nor	O
completely	O
fair	O
to	O
compare	O
the	O
results	O
of	O
different	O
fold-recognition	O
and	O
alignment	O
methods	O
given	O
that	O
each	O
employs	O
different	O
sequence	O
databases	O
for	O
sequence	O
profiles	O
,	O
structure	O
databases	O
for	O
structure	O
profiles	O
and	O
properties	O
,	O
release	O
dates	O
,	O
and	O
scoring	O
functions	O
.	O

Therefore	O
,	O
the	O
comparisons	O
between	O
our	O
methods	O
and	O
other	O
published	O
methods	O
serve	O
as	O
an	O
approximate	O
guide	O
.	O

Here	O
,	O
we	O
evaluated	O
S2A2	O
matrix	O
,	O
PSI-BLAST	O
and	O
prof_sim	O
using	O
the	O
same	O
sequence	O
database	O
,	O
UniRef90	O
[	O
20	O
]	O
,	O
with	O
the	O
same	O
parameters	O
to	O
generate	O
a	O
PSSM	O
for	O
fold	O
recognitions	O
(	O
Lindahl	O
benchmark	O
)	O
and	O
sequence	O
alignment	O
(	O
ProSup	O
benchmark	O
)	O
.	O

Furthermore	O
,	O
(	O
PS	O
)	O
2-v2	O
was	O
assessed	O
and	O
compared	O
with	O
other	O
71	O
automatic	O
servers	O
on	O
154	O
TBM	O
targets	O
in	O
CASP8	O
.	O

Please	O
note	O
that	O
(	O
PS	O
)	O
2-v2	O
did	O
not	O
participate	O
in	O
the	O
CASP8	O
experiment	O
.	O

Evaluation	O
of	O
S2A2	O
matrix	O

The	O
S2A2	O
matrix	O
(	O
60	O
×	O
60	O
)	O
offers	O
insights	O
about	O
substitution	O
preferences	O
of	O
RS	O
letters	O
between	O
homologous	O
protein	O
sequences	O
(	O
Figure	O
3	O
and	O
Figure	O
S1	O
in	O
Additional	O
file	O
2	O
)	O
.	O

The	O
highest	O
substitution	O
score	O
in	O
this	O
matrix	O
is	O
for	O
the	O
alignment	O
of	O
a	O
RS	O
letter	O
'Wß	O
'	O
with	O
a	O
RS	O
letter	O
'Wß	O
'	O
,	O
where	O
Wß	O
is	O
the	O
residue	O
Trp	O
with	O
the	O
ß-strand	O
structure	O
(	O
Figure	O
S1	O
in	O
Additional	O
file	O
2	O
)	O
.	O

This	O
substitution	O
score	O
is	O
6.2	O
.	O

In	O
addition	O
,	O
the	O
substitution	O
scores	O
are	O
also	O
high	O
when	O
two	O
identical	O
structural	O
letters	O
(	O
e.g.	O
,	O
diagonal	O
entries	O
)	O
are	O
aligned	O
.	O

For	O
example	O
,	O
the	O
alignment	O
scores	O
are	O
5.6	O
and	O
6.1	O
while	O
'Wα	O
'	O
and	O
'Cα	O
'	O
are	O
aligned	O
with	O
'Wα	O
'	O
and	O
'Cß	O
'	O
,	O
respectively	O
;	O
where	O
Wα	O
is	O
the	O
residue	O
Trp	O
with	O
the	O
α-helix	O
structure	O
and	O
Cα	O
represents	O
the	O
residue	O
Cys	O
with	O
the	O
α-helix	O
structure	O
.	O

Most	O
of	O
the	O
substitution	O
scores	O
are	O
positive	O
if	O
two	O
RS	O
letters	O
in	O
the	O
same	O
secondary	O
structure	O
are	O
aligned	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
lowest	O
substitution	O
score	O
is	O
-7.8	O
in	O
this	O
S2A2	O
.	O

All	O
of	O
the	O
substitution	O
scores	O
are	O
low	O
when	O
the	O
helix	O
RS	O
letters	O
are	O
aligned	O
with	O
the	O
strand	O
RS	O
letters	O
.	O

The	O
above	O
relationships	O
are	O
in	O
good	O
agreement	O
with	O
biological	O
functions	O
of	O
the	O
relevant	O
structures	O
,	O
showing	O
that	O
the	O
matrix	O
S2A2	O
embodies	O
conventional	O
knowledge	O
about	O
secondary	O
structure	O
conservation	O
in	O
proteins	O
.	O

We	O
compared	O
the	O
S2A2	O
matrix	O
with	O
BLOSUM62	O
.	O

The	O
highest	O
substitution	O
scores	O
are	O
6.2	O
(	O
S2A2	O
)	O
and	O
11	O
(	O
BLOSUM62	O
)	O
.	O

In	O
contrast	O
,	O
the	O
lowest	O
score	O
for	O
S2A2	O
(	O
-7.8	O
)	O
is	O
much	O
lower	O
than	O
that	O
for	O
BLOSUM62	O
(	O
-4	O
)	O
.	O

The	O
main	O
reasons	O
for	O
this	O
large	O
difference	O
are	O
that	O
α-helices	O
and	O
ß-strands	O
constitute	O
very	O
different	O
protein	O
secondary	O
structures	O
,	O
and	O
the	O
RS	O
letters	O
pertaining	O
to	O
these	O
two	O
types	O
of	O
structure	O
are	O
more	O
conserved	O
than	O
amino	O
acid	O
sequences	O
.	O

These	C
results	C
demonstrate	C
that	C
the	C
RS	C
letters	C
with	C
the	C
S2A2	C
matrix	C
may	C
be	C
able	C
to	C
more	C
accurately	C
find	C
remote	C
homologous	C
sequences	C
than	C
simple	C
amino	C
acid	C
sequence	C
analyses	C
.	C

Template	O
selection	O

For	O
the	O
template	O
selection	O
,	O
our	O
method	O
with	O
S2A2	O
matrix	O
was	O
compared	O
to	O
other	O
methods	O
on	O
Lindahl	O
benchmark	O
[	O
14	O
]	O
,	O
which	O
consists	O
of	O
976	O
proteins	O
,	O
for	O
the	O
fold	O
recognition	O
.	O

This	O
set	O
included	O
555	O
,	O
434	O
and	O
321	O
assignments	O
for	O
the	O
family	O
,	O
superfamily	O
and	O
fold	O
levels	O
,	O
respectively	O
.	O

The	O
S2A2	O
matrix	O
outperforms	O
PSI-BLAST	O
and	O
is	O
comparative	O
to	O
other	O
methods	O
on	O
this	O
set	O
(	O
Table	O
2	O
)	O
.	O

Our	O
method	O
(	O
S2A2+PSSM	O
)	O
,	O
incorporating	O
PSSM	O
into	O
S2A2	O
,	O
is	O
the	O
best	O
for	O
detecting	O
similarity	O
on	O
the	O
superfamily	O
and	O
fold	O
levels	O
for	O
the	O
top	O
five	O
ranks	O
among	O
the	O
10	O
comparative	O
methods	O
.	O

At	O
the	O
superfamily	O
level	O
,	O
the	O
S2A2+PSSM	O
,	O
PSI-BLAST	O
and	O
prof_sim	O
[	O
36	O
]	O
identified	O
75.6	O
%	O
,	O
49.1	O
%	O
and	O
61.3	O
%	O
of	O
assignments	O
,	O
respectively	O
.	O

At	O
the	O
fold	O
level	O
,	O
the	O
S2A2+PSSM	O
(	O
54.5	O
%	O
)	O
outperformed	O
PSI-BLAST	O
(	O
14.6	O
%	O
)	O
and	O
prof_sim	O
(	O
39.6	O
%	O
)	O
in	O
identifying	O
homologous	O
pairs	O
.	O

Comparing	O
S2A2	O
matrix	O
with	O
other	O
methods	O
for	O
fold	O
recognition	O
on	O
the	O
Lindahl	O
benchmark	O

Target-template	O
alignment	O

For	O
the	O
alignment	O
between	O
the	O
target	O
and	O
the	O
template	O
,	O
our	O
algorithm	O
was	O
evaluated	O
based	O
on	O
the	O
ProSup	O
benchmark	O
[	O
15	O
]	O
,	O
which	O
consists	O
of	O
127	O
protein	O
pairs	O
with	O
significant	O
structural	O
similarity	O
but	O
with	O
sequence	O
identity	O
of	O
no	O
more	O
than	O
30	O
%	O
.	O

The	O
total	O
numbers	O
of	O
correctly	O
aligned	O
residue	O
pairs	O
(	O
Tc	O
)	O
of	O
the	O
S2A2	O
,	O
S2A2+PSSM	O
,	O
prof_sim	O
and	O
SSALN	O
[	O
10	O
]	O
were	O
8732	O
,	O
9470	O
,	O
8009	O
and	O
9256	O
pairs	O
,	O
respectively	O
(	O
Table	O
3	O
)	O
.	O

The	O
percentage	O
σ0	O
(	O
average	O
percentage	O
of	O
correctly	O
aligned	O
residues	O
,	O
divided	O
by	O
the	O
length	O
of	O
the	O
structural	O
alignment	O
per	O
protein	O
pair	O
)	O
of	O
the	O
S2A2	O
,	O
S2A2+PSSM	O
,	O
PSI-BLAST	O
,	O
prof_sim	O
and	O
SSALN	O
were	O
53.4	O
%	O
,	O
58.7	O
%	O
,	O
36.4	O
%	O
,	O
43.6	O
%	O
and	O
58.3	O
%	O
,	O
respectively	O
.	O

The	O
S2A2	O
matrix	O
is	O
significantly	O
better	O
than	O
those	O
of	O
sequence-based	O
approaches	O
,	O
including	O
FASTA	O
,	O
PSI-BLAST	O
and	O
prof_sim	O
.	O

The	O
S2A2+PSSM	O
achieved	O
the	O
highest	O
alignment	O
accuracy	O
with	O
slightly	O
better	O
than	O
SPARKS	O
[	O
9	O
]	O
and	O
SSALN	O
,	O
and	O
much	O
better	O
than	O
the	O
other	O
comparative	O
methods	O
.	O

Comparing	O
S2A2	O
matrix	O
with	O
other	O
methods	O
for	O
sequence	O
alignment	O
accuracies	O
on	O
the	O
ProSup	O
benchmark	O

CASP8	O
structure	O
prediction	O

Our	O
previous	O
server	O
(	O
(	O
PS	O
)	O
2-CASP8	O
)	O
and	O
other	O
70	O
servers	O
participated	O
in	O
the	O
CASP8	O
competition	O
,	O
involving	O
121	O
targets	O
for	O
tertiary	O
structure	O
prediction	O
.	O

These	O
121	O
targets	O
are	O
officially	O
classified	O
into	O
154	O
TBM	O
domains	O
(	O
Table	O
S1	O
in	O
Additional	O
file	O
3	O
)	O
.	O

The	O
accuracies	O
of	O
these	O
71	O
servers	O
were	O
evaluated	O
based	O
on	O
the	O
GDT_TS	O
[	O
37	O
]	O
scores	O
directly	O
summarized	O
from	O
the	O
CASP8	O
website	O
http	O
:	O
//predictioncenter.org/casp8/	O
.	O

(	O
PS	O
)	O
2-v2	O
,	O
(	O
PS	O
)	O
2-original	O
and	O
(	O
PS	O
)	O
2-CASP8	O
servers	O
were	O
evaluated	O
on	O
these	O
154	O
TBM	O
targets	O
(	O
Figure	O
4	O
,	O
Table	O
4	O
and	O
Table	O
S2	O
in	O
Additional	O
file	O
4	O
)	O
.	O

The	O
sum	O
of	O
GDT_TS	O
scores	O
were	O
10331.4	O
(	O
(	O
PS	O
)	O
2-v2	O
)	O
,	O
9954.4	O
(	O
(	O
PS	O
)	O
2-CASP8	O
)	O
and	O
9447.5	O
(	O
(	O
PS	O
)	O
2-original	O
)	O
,	O
respectively	O
.	O

(	O
PS	O
)	O
2-v2	O
yielded	O
99	O
and	O
34	O
higher	O
GDT_TS	O
scores	O
than	O
(	O
PS	O
)	O
2-original	O
and	O
(	O
PS	O
)	O
2-CASP8	O
,	O
respectively	O
,	O
among	O
154	O
targets	O
.	O

When	O
the	O
sequence	O
identity	O
between	O
the	O
target	O
and	O
template	O
was	O
more	O
than	O
30	O
%	O
,	O
these	O
three	O
servers	O
achieved	O
similar	O
GDT_TS	O
scores	O
.	O

However	O
,	O
if	O
the	O
sequence	O
identity	O
was	O
less	O
than	O
20	O
%	O
,	O
the	O
(	O
PS	O
)	O
2-v2	O
server	O
was	O
significantly	O
better	O
than	O
(	O
PS	O
)	O
2-original	O
server	O
(	O
p-value	O
is	O
4.0E-7	O
)	O
and	O
(	O
PS	O
)	O
2-CASP8	O
(	O
p-value	O
is	O
6.6E-4	O
)	O
using	O
the	O
paired	O
Student	O
's	O
t-test	O
(	O
Table	O
4	O
)	O
.	O

For	O
each	O
target	O
in	O
CASP8	O
,	O
Table	O
S2	O
(	O
in	O
Additional	O
file	O
4	O
)	O
shows	O
the	O
GDT_TS	O
score	O
improvement	O
with	O
contributing	O
components	O
(	O
i.e	O
.	O
multiple	O
templates	O
,	O
multiple	O
models	O
,	O
and	O
template	O
search	O
method	O
)	O
between	O
the	O
(	O
PS	O
)	O
2-v2	O
and	O
our	O
previous	O
servers	O
.	O

Comparison	O
the	O
(	O
PS	O
)	O
2-v2	O
server	O
with	O
(	O
A	O
)	O
(	O
PS	O
)	O
2-original	O
and	O
(	O
B	O
)	O
(	O
PS	O
)	O
2-CASP8	O
servers	O
on	O
the	O
154	O
TBM	O
targets	O
in	O
CASP8	O
.	O

(	O
PS	O
)	O
2-v2	O
yields	O
99	O
and	O
34	O
higher	O
GDT_TS	O
scores	O
than	O
(	O
PS	O
)	O
2-original	O
and	O
(	O
PS	O
)	O
2-CASP8	O
,	O
respectively	O
,	O
among	O
these	O
154	O
targets	O
.	O

These	O
three	O
servers	O
have	O
the	O
similar	O
GDT_TS	O
scores	O
when	O
the	O
sequence	O
identity	O
(	O
SI	O
)	O
between	O
the	O
target	O
and	O
template	O
is	O
more	O
than	O
30	O
%	O
(	O
blue	O
+	O
)	O
.	O

(	O
PS	O
)	O
2-v2	O
outperforms	O
our	O
previous	O
servers	O
when	O
SI	O
is	O
less	O
than	O
20	O
%	O
(	O
green	O
×	O
)	O
.	O

Comparison	O
the	O
(	O
PS	O
)	O
2-	O
v2	O
server	O
with	O
(	O
PS	O
)	O
2-original	O
and	O
(	O
PS	O
)	O
2-CASP8	O
servers	O
on	O
the	O
154	O
TBM	O
targets	O
in	O
CASP8	O
based	O
on	O
GDT_TS	O
scores	O

These	O
154	O
TBM	O
targets	O
were	O
also	O
used	O
to	O
evaluate	O
the	O
automatic	O
servers	O
participating	O
in	O
CASP8	O
.	O

For	O
the	O
templates	O
selection	O
,	O
the	O
accuracy	O
of	O
identifying	O
the	O
best	O
template	O
of	O
the	O
target	O
protein	O
was	O
used	O
to	O
evaluate	O
the	O
performance	O
of	O
these	O
servers	O
(	O
Figure	O
S2	O
in	O
Additional	O
file	O
5	O
)	O
.	O

The	O
accuracies	O
of	O
the	O
(	O
PS	O
)	O
2-v2	O
server	O
were	O
54.1	O
%	O
and	O
75.0	O
%	O
for	O
identifying	O
the	O
Top	O
1	O
templates	O
and	O
Top	O
10	O
templates	O
,	O
respectively	O
.	O

In	O
addition	O
,	O
(	O
PS	O
)	O
2-v2	O
was	O
the	O
rank	O
6th	O
among	O
these	O
72	O
severs	O
based	O
on	O
GDT_TS	O
scores	O
(	O
Table	O
5	O
)	O
.	O

This	O
server	O
is	O
often	O
able	O
to	O
yield	O
reliable	O
predicted	O
structures	O
(	O
i.e	O
.	O
GDT_TS	O
score	O
=	O
60	O
%	O
)	O
if	O
the	O
E-value	O
is	O
less	O
than	O
10-2	O
(	O
Figure	O
S3	O
in	O
Additional	O
file	O
6	O
)	O
.	O

Comparing	O
(	O
PS	O
)	O
2-v2	O
with	O
71	O
automatic	O
servers	O
on	O
154	O
targets	O
in	O
CASP8	O

The	O
top-rank	O
five	O
serves	O
(	O
Zhang-Server	O
,	O
RAPTOR	O
,	O
pro-sp3-TASSER	O
,	O
Phyre_de_novo	O
and	O
BAKER-ROBETTA	O
)	O
are	O
better	O
than	O
(	O
PS	O
)	O
2-v2	O
on	O
40	O
hard	O
targets	O
(	O
i.e.	O
,	O
LGA_S	O
score	O
<	O
70	O
%	O
)	O
(	O
Table	O
S3	O
in	O
Additional	O
file	O
7	O
)	O
.	O

These	O
serves	O
were	O
much	O
slower	O
than	O
(	O
PS	O
)	O
2-v2	O
because	O
they	O
often	O
utilized	O
ab	O
initio	O
methods	O
to	O
build	O
the	O
unaligned	O
loop	O
regions	O
and	O
to	O
generate	O
the	O
models	O
,	O
such	O
as	O
the	O
Poing	O
folding	O
system	O
for	O
Phyre_de_novo	O
server	O
,	O
the	O
chunk-TASSER	O
[	O
38	O
]	O
for	O
pro-sp3-TASSER	O
server	O
,	O
and	O
the	O
Rosetta	O
fragment-assembly	O
methodology	O
[	O
39	O
]	O
for	O
BAKER-ROBETTA	O
server	O
.	O

In	O
the	O
near	O
future	O
,	O
our	O
(	O
PS	O
)	O
2-v2	O
server	O
will	O
incorporate	O
ab	O
initio	O
methods	O
to	O
model	O
long-length	O
loops	O
and	O
hard	O
targets	O
.	O

Multiple	O
templates	O
for	O
multiple	O
domains	O

We	O
used	O
the	O
target	O
T0504	O
as	O
an	O
example	O
to	O
describe	O
(	O
PS	O
)	O
2-v2	O
for	O
selecting	O
multiple	O
templates	O
to	O
model	O
protein	O
structures	O
(	O
Figure	O
5	O
)	O
.	O

The	O
(	O
PS	O
)	O
2-v2	O
server	O
first	O
selected	O
the	O
53BP1	O
tandem	O
tudor	O
domains	O
(	O
PDB	O
code	O
2g3r	O
)	O
as	O
the	O
best	O
template	O
.	O

The	O
template	O
2g3rA	O
aligned	O
a	O
part	O
of	O
regions	O
(	O
138	O
residues	O
,	O
residues	O
10-147	O
)	O
to	O
the	O
target	O
,	O
and	O
the	O
model	O
yielded	O
the	O
GDT_TS	O
scores	O
of	O
74.2	O
and	O
32.2	O
for	O
the	O
target	O
T0504-D1	O
and	O
T0504-D2	O
.	O

Since	O
the	O
number	O
of	O
the	O
unaligned	O
residues	O
is	O
61	O
(	O
residue	O
148-208	O
)	O
,	O
the	O
(	O
PS	O
)	O
2-v2	O
server	O
used	O
unaligned	O
residues	O
to	O
search	O
the	O
new	O
template	O
for	O
modeling	O
this	O
segment	O
.	O

After	O
search	O
template	O
library	O
,	O
(	O
PS	O
)	O
2-v2	O
selected	O
the	O
PHD	O
finger	O
protein	O
20-like	O
1	O
(	O
PDB	O
code	O
2eqm	O
)	O
as	O
the	O
template	O
for	O
modeling	O
this	O
unmodeling	O
residues	O
(	O
T0504-D3	O
)	O
.	O

The	O
GDT_TS	O
score	O
of	O
this	O
model	O
is	O
80.7	O
for	O
the	O
target	O
T0504-D3	O
.	O

The	O
total	O
GDT_TS	O
score	O
improvement	O
is	O
136.42	O
when	O
(	O
PS	O
)	O
2-v2	O
utilizes	O
a	O
multiple-template	O
strategy	O
.	O

Conversely	O
,	O
the	O
GDT-TS	O
scores	O
of	O
the	O
(	O
PS	O
)	O
2-original	O
server	O
,	O
using	O
PDB	O
code	O
2g3r	O
as	O
the	O
template	O
,	O
are	O
17.3	O
(	O
T0504-D1	O
)	O
,	O
48.9	O
(	O
T0504-D2	O
)	O
and	O
56.1	O
(	O
T0504-D3	O
)	O
,	O
respectively	O
.	O

For	O
the	O
(	O
PS	O
)	O
2-CASP8	O
server	O
,	O
the	O
GDT-TS	O
scores	O
using	O
PDB	O
code	O
2ns2	O
as	O
the	O
template	O
are	O
44.4	O
(	O
T0504-D1	O
)	O
,	O
25.6	O
(	O
T0504-D2	O
)	O
and	O
41.0	O
(	O
T0504-D3	O
)	O
,	O
respectively	O
.	O

Comparison	O
the	O
(	O
PS	O
)	O
2-v2	O
server	O
with	O
(	O
PS	O
)	O
2-original	O
and	O
(	O
PS	O
)	O
2-CASP8	O
servers	O
on	O
the	O
target	O
T0504	O
in	O
CASP8	O
.	O

The	O
(	O
PS	O
)	O
2-CASP8	O
server	O
uses	O
human	O
spindlin1	O
(	O
PDB	O
code	O
2ns2	O
)	O
as	O
the	O
template	O
,	O
conversely	O
,	O
(	O
PS	O
)	O
2-v2	O
utilizes	O
a	O
multiple-template	O
strategy	O
and	O
selects	O
both	O
53BP1	O
tandem	O
tudor	O
domains	O
(	O
PDB	O
code	O
2g3r	O
)	O
and	O
PHD	O
finger	O
protein	O
20-like	O
1	O
(	O
PDB	O
code	O
2eqm	O
)	O
as	O
templates	O
.	O

(	O
PS	O
)	O
2-v2	O
significantly	O
outperforms	O
(	O
PS	O
)	O
2-CASP8	O
on	O
the	O
T0504-D1	O
and	O
T0504-D3	O
domains	O
.	O

Multiple	O
models	O
and	O
model	O
selection	O

Figure	O
6	O
shows	O
the	O
improvement	O
in	O
GDT_TS	O
scores	O
of	O
(	O
PS	O
)	O
2-v2	O
by	O
applying	O
a	O
multiple-model	O
strategy	O
and	O
using	O
the	O
program	O
ProQ	O
for	O
the	O
final	O
model	O
selection	O
.	O

Among	O
these	O
154	O
CASP8	O
targets	O
,	O
(	O
PS	O
)	O
2-v2	O
improved	O
GDT_TS	O
scores	O
for	O
23	O
targets	O
;	O
conversely	O
,	O
only	O
4	O
targets	O
are	O
lightly	O
worse	O
when	O
(	O
PS	O
)	O
2-v2	O
used	O
a	O
multiple-model	O
strategy	O
.	O

For	O
the	O
other	O
127	O
targets	O
,	O
(	O
PS	O
)	O
2-v2	O
obtained	O
the	O
same	O
GDT_TS	O
scores	O
and	O
the	O
total	O
GDT_TS	O
improvement	O
is	O
145.3	O
.	O

According	O
to	O
the	O
paired	O
Student	O
's	O
t-test	O
(	O
p-value	O
is	O
0.0045	O
shown	O
in	O
Table	O
S4	O
Additional	O
file	O
8	O
)	O
,	O
(	O
PS	O
)	O
2-v2	O
applying	O
the	O
multiple-model	O
strategy	O
significantly	O
improved	O
the	O
GDT_TS	O
scores	O
when	O
the	O
sequence	O
identity	O
between	O
the	O
target	O
and	O
the	O
template	O
is	O
less	O
than	O
20	O
%	O
.	O

(	O
PS	O
)	O
2-v2	O
results	O
for	O
using	O
single-model	O
and	O
multiple-model	O
strategies	O
on	O
154	O
targets	O
in	O
CASP8	O
based	O
on	O
GDT_TS	O
scores	O
.	O

(	O
PS	O
)	O
2-v2	O
improves	O
and	O
decreases	O
the	O
GDT_TS	O
scores	O
for	O
23	O
and	O
4	O
targets	O
,	O
respectively	O
,	O
when	O
the	O
multiple-model	O
method	O
is	O
utilized	O
.	O

For	O
the	O
other	O
127	O
targets	O
,	O
(	O
PS	O
)	O
2-v2	O
obtains	O
the	O
same	O
GDT_TS	O
scores	O
.	O

The	O
symbols	O
``	O
+	O
''	O
,	O
``	O
▫	O
''	O
and	O
``	O
×	O
''	O
represent	O
the	O
performance	O
when	O
the	O
sequence	O
identity	O
(	O
SI	O
)	O
≥	O
30	O
%	O
,	O
between	O
30	O
%	O
and	O
20	O
%	O
,	O
and	O
less	O
than	O
20	O
%	O
,	O
respectively	O
.	O

The	O
target	O
T0471	O
selected	O
from	O
CASP8	O
was	O
taken	O
as	O
an	O
example	O
to	O
describe	O
the	O
structure	O
modeling	O
of	O
the	O
(	O
PS	O
)	O
2-v2	O
server	O
using	O
multiple-model	O
strategy	O
(	O
Figure	O
7	O
)	O
.	O

When	O
the	O
multiple-model	O
strategy	O
was	O
not	O
considered	O
,	O
(	O
PS	O
)	O
2-v2	O
selected	O
the	O
2-dehydro-3-deoxyphosphooctonate	O
aldolase	O
(	O
PDB	O
code	O
2nwr	O
)	O
as	O
the	O
best	O
template	O
with	O
an	O
E-value	O
of	O
0.055	O
.	O

GDT_TS	O
score	O
of	O
this	O
model	O
is	O
32.67	O
.	O

If	O
we	O
considered	O
the	O
top-ranking	O
5	O
structures	O
(	O
PDB	O
codes	O
2nwr	O
,	O
1pea	O
,	O
1nv8	O
,	O
1ufr	O
and	O
1v2d	O
)	O
as	O
the	O
modeling	O
templates	O
,	O
(	O
PS	O
)	O
2-v2	O
generated	O
6	O
alternative	O
target-template	O
alignments	O
for	O
each	O
template	O
,	O
and	O
obtained	O
30	O
alignments	O
for	O
this	O
target	O
.	O

The	O
software	O
MODELLER	O
was	O
then	O
applied	O
to	O
generate	O
30	O
structures	O
for	O
these	O
30	O
target-template	O
alignments	O
.	O

Figure	O
7	O
shows	O
the	O
best	O
model	O
with	O
the	O
highest	O
LGscores	O
,	O
assessing	O
by	O
the	O
program	O
ProQ	O
,	O
for	O
each	O
template	O
.	O

The	O
model	O
generated	O
by	O
the	O
template	O
1nv8A	O
was	O
selected	O
as	O
the	O
final	O
model	O
,	O
because	O
it	O
had	O
the	O
best	O
LGscore	O
(	O
2.838	O
)	O
among	O
these	O
30	O
models	O
.	O

The	O
GDT_TS	O
score	O
of	O
this	O
final	O
model	O
is	O
61.65	O
.	O

The	O
(	O
PS	O
)	O
2-v2	O
server	O
using	O
multiple	O
models	O
is	O
often	O
able	O
to	O
effectively	O
improve	O
accuracies	O
when	O
the	O
E-value	O
between	O
the	O
target	O
and	O
the	O
template	O
is	O
more	O
than	O
0.01	O
.	O

The	O
average	O
GDT_TS	O
improvements	O
are	O
8.53	O
and	O
2.23	O
,	O
respectively	O
,	O
when	O
the	O
E-value	O
≥	O
0.01	O
and	O
E-value	O
≤	O
1e-6	O
.	O

(	O
PS	O
)	O
2-v2	O
models	O
the	O
target	O
T0471	O
in	O
CASP	O
8	O
using	O
multiple	O
models	O
.	O

This	O
server	O
models	O
T0471	O
by	O
selecting	O
top-ranking	O
five	O
structures	O
(	O
PDB	O
code	O
2nwrA	O
,	O
1peaA	O
,	O
1nv8A	O
,	O
1ufrA	O
and	O
1v2dA	O
)	O
as	O
templates	O
using	O
S2A2	O
matrix	O
and	O
PSSM	O
scoring	O
matrices	O
.	O

For	O
each	O
template	O
,	O
(	O
PS	O
)	O
2-v2	O
generates	O
5	O
structures	O
and	O
(	O
D	O
)	O
the	O
final	O
model	O
(	O
1nv8	O
)	O
is	O
identified	O
by	O
the	O
program	O
ProQ	O
based	O
on	O
LGscore	O
.	O

T0409	O
in	O
CASP8	O

The	O
target	O
T0409	O
selected	O
from	O
CASP8	O
was	O
taken	O
to	O
describe	O
the	O
structure	O
modeling	O
of	O
the	O
(	O
PS	O
)	O
2-v2	O
server	O
(	O
Figure	O
8	O
)	O
.	O

The	C
target	C
is	C
the	C
BIG_1156.2	C
domain	C
of	C
putative	C
penicillin-binding	C
protein	C
MrcA	C
from	C
Nitrosomonas	C
europaea	C
ATCC	C
19718	C
.	C

This	O
server	O
yielded	O
the	O
best	O
GDT_TS	O
score	O
(	O
77.8	O
)	O
among	O
all	O
participating	O
servers	O
for	O
this	O
target	O
.	O

An	O
example	O
of	O
the	O
prediction	O
results	O
of	O
the	O
target	O
T0409	O
from	O
the	O
(	O
PS	O
)	O
2-v2	O
server	O
.	O

The	C
alignment	C
and	C
predicted	C
structure	C
of	C
the	C
BIG_1156.2	C
domain	C
of	C
putative	C
penicillin-binding	C
protein	C
MrcA	C
from	C
Nitrosomonas	C
europaea	C
ATCC	C
19718	C
using	C
the	C
(	C
PS	C
)	C
2-v2	C
server	C
.	C

(	O
A	O
)	O
The	O
alignment	O
between	O
the	O
query	O
and	O
the	O
selected	O
template	O
,	O
translation	O
initiation	O
factor	O
5A	O
protein	O
(	O
PDB	O
code	O
1bkbA	O
)	O
,	O
from	O
Pyrobaculum	O
aerophilum	O
.	O

(	O
B	O
)	O
The	O
superposition	O
,	O
the	O
native	O
structure	O
of	O
T0409	O
(	O
broad	O
,	O
PDB	O
code	O
3d0f	O
)	O
and	O
the	O
predicted	O
structure	O
(	O
thin	O
)	O
.	O

The	O
green	O
blocks	O
are	O
the	O
regions	O
that	O
the	O
predicted	O
structure	O
matches	O
to	O
the	O
native	O
structure	O
.	O

The	O
yellow	O
and	O
purple	O
blocks	O
indicate	O
the	O
shift	O
errors	O
between	O
predicted	O
structure	O
and	O
native	O
structure	O
,	O
the	O
Cα	O
distances	O
between	O
them	O
are	O
<	O
5	O
A	O
and	O
>	O
5	O
A	O
,	O
respectively	O
.	O

For	O
the	O
target	O
T0409	O
,	O
the	O
(	O
PS	O
)	O
2-v2	O
server	O
selected	O
the	O
C-terminal	O
domain	O
of	O
translation	O
initiation	O
factor	O
5A	O
protein	O
(	O
PDB	O
code	O
1bkb	O
)	O
from	O
Pyrobaculum	O
aerophilum	O
as	O
the	O
template	O
[	O
40	O
]	O
.	O

The	O
C-terminal	O
domain	O
is	O
found	O
to	O
be	O
homologous	O
to	O
the	O
cold-shock	O
protein	O
CspA	O
of	O
E.	O
coli	O
,	O
which	O
has	O
a	O
well	O
characterized	O
RNA-binding	O
fold	O
.	O

The	O
best	O
template	O
reported	O
in	O
the	O
CASP8	O
website	O
is	O
the	O
yeast	O
exosome	O
core	O
,	O
Rrp44	O
(	O
PDB	O
code	O
2vnvD	O
)	O
[	O
41	O
]	O
,	O
which	O
contains	O
four	O
domains	O
(	O
CSD1	O
,	O
CSD2	O
,	O
RNB	O
and	O
S1	O
)	O
.	O

The	O
S1	O
domain	O
has	O
the	O
most	O
similar	O
structure	O
to	O
the	O
target	O
T0409-D1	O
.	O

The	O
S1	O
domain	O
also	O
has	O
a	O
common	O
OB	O
fold	O
characteristic	O
of	O
RNA-binding	O
protein	O
,	O
with	O
five	O
anti-parallel	O
ß	O
strands	O
.	O

Figure	O
8A	O
shows	O
the	O
target-template	O
alignment	O
and	O
the	O
template	O
shares	O
17.0	O
%	O
sequence	O
identity	O
with	O
the	O
query	O
sequence	O
.	O

Our	O
server	O
could	O
align	O
the	O
five	O
anti-parallel	O
ß	O
strands	O
together	O
.	O

Figure	O
8B	O
shows	O
the	O
superposition	O
of	O
the	O
predicted	O
structure	O
(	O
thin	O
)	O
and	O
the	O
X-ray	O
structure	O
(	O
broad	O
)	O
of	O
the	O
target	O
T0409	O
.	O

Conclusion	O

This	O
study	O
presents	O
an	O
automatic	O
server	O
for	O
protein	O
structure	O
predictions	O
by	O
applying	O
numerous	O
enhancements	O
and	O
modifications	O
to	O
the	O
original	O
technique	O
,	O
thereby	O
improving	O
the	O
reliability	O
and	O
applicability	O
.	O

By	O
integrating	O
the	O
S2A2	O
and	O
PSSM	O
matrixes	O
,	O
the	O
(	O
PS	O
)	O
2-v2	O
server	O
seamlessly	O
blends	O
the	O
amino	O
acid	O
and	O
structural	O
propensities	O
so	O
that	O
they	O
work	O
cooperatively	O
for	O
the	O
template	O
selection	O
and	O
target-template	O
alignments	O
.	O

In	O
addition	O
,	O
our	O
(	O
PS	O
)	O
2-v2	O
utilizes	O
multiple	O
templates	O
and	O
multiple	O
models	O
for	O
building	O
models	O
and	O
assessing	O
models	O
.	O

Experimental	O
results	O
demonstrate	O
that	O
the	O
(	O
PS	O
)	O
2-v2	O
server	O
is	O
efficient	O
and	O
effective	O
for	O
template	O
selections	O
and	O
target-template	O
alignments	O
in	O
template-based	O
modeling	O
.	O

We	C
believe	C
that	C
this	C
server	C
is	C
useful	C
in	C
protein	C
structure	C
prediction	C
and	C
modeling	C
,	C
especially	C
in	C
detecting	C
homologous	C
templates	C
with	C
sequence	C
similarity	C
in	C
the	C
twilight	C
zone	C
.	C

Availability	O
and	O
requirements	O

Project	O
home	O
page	O
:	O
http	O
:	O
//ps2v2.life.nctu.edu.tw	O

Operating	O
system	O
(	O
s	O
)	O
:	O
Platform	O
independent	O

Programming	O
language	O
:	O
C	O
,	O
Perl	O
and	O
PHP	O

Other	O
requirements	O
:	O
JavaScript-enabled	O
web	O
browser	O

Any	O
restrictions	O
to	O
use	O
by	O
non-academics	O
:	O
None	O

Competing	O
interests	O

The	O
authors	O
declare	O
that	O
they	O
have	O
no	O
competing	O
interests	O
.	O

